PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wu, MT; Wu, CF; Chen, BH; Chen, EK; Chen, YL; Shiea, J; Lee, WT; Chao, MC; Wu, JR				Wu, Ming-Tsang; Wu, Chia-Fang; Chen, Bai-Hsiun; Chen, Eric K.; Chen, Yi-Ling; Shiea, Jentaie; Lee, Wei-Te; Chao, Mei-Chyn; Wu, Jiunn-Ren			Intake of Phthalate-Tainted Foods Alters Thyroid Functions in Taiwanese Children	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BISPHENOL-A; EXPOSURE; HEALTH; LESSONS	Background: On April-May, 2011, two Taiwan chemical companies were found to have intentionally added phthalates, Di-(2-ethylhexyl) phthalate (DEHP) and/or Di-isononyl phthalate, as a substitute of emulsifier to many foodstuffs. This study aimed to investigate whether exposure to these foods altered endocrine functions in children aged <= 10 years and, if so, whether those changes could be reversed by stopping exposure. Methods: One Phthalates Clinic for Children was established in southern Taiwan between May 31 and June 17, 2011. All eligible children had their exposure information, blood and/or urine specimens collected. Endocrine functions were assessed in serum. The exposure groups were categorized into three (High, >500 ppm, Low, 1-500 ppm, and No, <1 ppm of DEHP). After six months, some children were followed up for the selected endocrine hormones. Results: Sixty children were eligible in this study; all were Tanner stage 1 with no pubic hair. Compared to non-exposed group, both high and low exposure groups had significantly lower serum thyroid-stimulating hormone (TSH) levels (P = 0.001 and 0.024). At six months follow-up, serum triiodothyronine (T3) levels was significantly changed (P = 0.034) in high exposure group (n = 13). For serum estradiol (E2), the detectable rate (>= 8 pg/mL) decreased from 76.9% (10/13) to 30.8% (4/13) (P = 0.070). Conclusions: This study shows that serum TSH levels can be altered when children were exposed to high concentrations of phthalate-tainted foodstuffs. Serum E2 and T3 may be partially recovered after stopping exposure.	[Wu, Ming-Tsang; Wu, Chia-Fang] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan; [Chen, Bai-Hsiun; Chao, Mei-Chyn; Wu, Jiunn-Ren] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Eric K.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Superintendants Off, Kaohsiung, Taiwan; [Chen, Eric K.] Kaohsiung Med Univ, Ctr Gen Educ, Kaohsiung, Taiwan; [Chen, Yi-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Shiea, Jentaie] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Lee, Wei-Te] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Pediat, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan.	960021@ms.kmuh.org.tw; jirewu@cc.kmu.edu.tw	Wu, Ming-Tsang/G-5637-2012	Wu, Ming-Tsang/0000-0001-7307-7816; Chen, Bai Hsiun/0000-0001-9496-553X; Wu, Meiye/0000-0003-3712-1554	Taiwan National Science Council [NSC 101-2314-B-037-037-MY3]; Kaohsiung Medical University Hospital [KMUH100-0R55, KMUH101-1I04]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This work was supported by the Taiwan National Science Council (NSC 101-2314-B-037-037-MY3) and Kaohsiung Medical University Hospital (KMUH100-0R55 and KMUH101-1I04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Chiang YL, 2011, J FORMOS MED ASSOC, V110, P551, DOI 10.1016/j.jfma.2011.07.001; Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712; Environmental Protection Agency (EPA) USA, DI 2 ETH PHTH DEHP C; European Food Safety Authority (EFSA), OP SCI PAN FOOD ADD; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lu JY, 2011, J FORMOS MED ASSOC, V110, P553, DOI 10.1016/j.jfma.2011.07.002; Meeker JD, 2012, ARCH PEDIAT ADOLESC, V4, P1; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Pak VM, 2011, AAOHN J, V59, P228, DOI 10.3928/08910162-20110426-01; Presu JL, 2010, ENV HLTH PERSPECT, V118, P1748; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893; Tai SSC, 2005, ANAL CHEM, V77, P6359, DOI 10.1021/ac050837i; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002	22	127	128	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55005	10.1371/journal.pone.0055005	http://dx.doi.org/10.1371/journal.pone.0055005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383031	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800101
J	Baranovic, J; Ramanujan, CS; Kasai, N; Midgett, CR; Madden, DR; Torimitsu, K; Ryan, JF				Baranovic, Jelena; Ramanujan, Chandra S.; Kasai, Nahoko; Midgett, Charles R.; Madden, Dean R.; Torimitsu, Keiichi; Ryan, John F.			Reconstitution of Homomeric GluA2(flop) Receptors in Supported Lipid Membranes FUNCTIONAL AND STRUCTURAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE RECEPTORS; PERMEABLE AMPA RECEPTOR; ACETYLCHOLINE-RECEPTOR; PROTEIN RECONSTITUTION; POTASSIUM CHANNEL; SINGLE; SOLUBILIZATION; VISUALIZATION; ARCHITECTURE	AMPA receptors (AMPARs) are glutamate-gated ion channels ubiquitous in the vertebrate central nervous system, where they mediate fast excitatory neurotransmission and act as molecular determinants of memory formation and learning. Together with detailed analyses of individual AMPAR domains, structural studies of full-length AMPARs by electron microscopy and x-ray crystallography have provided important insights into channel assembly and function. However, the correlation between the structure and functional states of the channel remains ambiguous particularly because these functional states can be assessed only with the receptor bound within an intact lipid bilayer. To provide a basis for investigating AMPAR structure in a membrane environment, we developed an optimized reconstitution protocol using a receptor whose structure has previously been characterized by electron microscopy. Single-channel recordings of reconstituted homomeric GluA2(flop) receptors recapitulate key electrophysiological parameters of the channels expressed in native cellular membranes. Atomic force microscopy studies of the reconstituted samples provide high-resolution images of membrane-embedded full-length AMPARs at densities comparable to those in postsynaptic membranes. The data demonstrate the effect of protein density on conformational flexibility and dimensions of the receptors and provide the first structural characterization of functional membrane-embedded AMPARs, thus laying the foundation for correlated structure-function analyses of the predominant mediators of excitatory synaptic signals in the brain.	[Ryan, John F.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Kasai, Nahoko; Torimitsu, Keiichi] NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Midgett, Charles R.; Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	University of Oxford; Nippon Telegraph & Telephone Corporation; Dartmouth College	Baranovic, J (corresponding author), Leibniz Inst Mol Pharmacol FMP, Campus Berlin Buch,Robert Rossle Str 10, D-13125 Berlin, Germany.	baranovic@fmp-berlin.de	TORIMITSU, KEIICHI/GQR-2299-2022; Torimitsu, Keiichi/AAE-4333-2019; Torimitsu, Keiichi/A-3078-2011	Baranovic, Jelena/0000-0003-2310-960X	Hitchcock Foundation; Medical Research Council, United Kingdom	Hitchcock Foundation; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Hitchcock Foundation (to D. R. M.) and the Medical Research Council, United Kingdom (to J. B.).	BAHR BA, 1992, J NEUROCHEM, V59, P1979, DOI 10.1111/j.1471-4159.1992.tb11038.x; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043; Jespersen LK, 2000, EUR J BIOCHEM, V267, P1382, DOI 10.1046/j.1432-1327.2000.01137.x; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kasai N, 2010, BBA-GEN SUBJECTS, V1800, P655, DOI 10.1016/j.bbagen.2010.03.002; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Madden Dean R, 2007, Methods Mol Biol, V363, P39, DOI 10.1007/978-1-59745-209-0_3; Mari SA, 2011, P NATL ACAD SCI USA, V108, P20802, DOI 10.1073/pnas.1111149108; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Midgett CR, 2008, J MOL BIOL, V382, P578, DOI 10.1016/j.jmb.2008.07.021; Midgett CR, 2012, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmol.2011.00056, 10.3389/fnmo1.2011.00056]; Momiyama A, 2003, J PHYSIOL-LONDON, V549, P75, DOI 10.1113/jphysiol.2002.033472; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292; Muller DJ, 1997, J STRUCT BIOL, V119, P149, DOI 10.1006/jsbi.1997.3878; Nakagawa T, 2006, BIOL CHEM, V387, P179, DOI 10.1515/BC.2006.024; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Rasband W., 2006, IMAGEJ; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005; Schurholz T, 1996, BIOPHYS CHEM, V58, P87, DOI 10.1016/0301-4622(95)00088-7; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Smith TC, 2000, J NEUROSCI, V20, P2073; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Suhara W, 2006, NEUROSCI LETT, V391, P102, DOI 10.1016/j.neulet.2005.08.066; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; VODYANOY V, 1993, NEUROSCI LETT, V150, P80, DOI 10.1016/0304-3940(93)90113-Y; Vuong N, 2010, CHEM PHYS LIPIDS, V163, P117, DOI 10.1016/j.chemphyslip.2009.09.003; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	48	4	4	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8647	8657		10.1074/jbc.M112.422105	http://dx.doi.org/10.1074/jbc.M112.422105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382380	hybrid, Green Published			2022-12-25	WOS:000316564500065
J	Brinkmann, CR; Jensen, L; Dagnaes-Hansen, F; Holm, IE; Endo, Y; Fujita, T; Thiel, S; Jensenius, JC; Degn, SE				Brinkmann, Christel R.; Jensen, Lisbeth; Dagnaes-Hansen, Frederik; Holm, Ida E.; Endo, Yuichi; Fujita, Teizo; Thiel, Steffen; Jensenius, Jens C.; Degn, Soren E.			Mitochondria and the Lectin Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; SERINE-PROTEASE (MASP)-1; H-FICOLIN; LYSOSOMAL DEGRADATION; ALTERNATIVE PATHWAY; APOPTOTIC CELLS; ACTIVATION; PURIFICATION; ASSOCIATION; DEFICIENCY	Mitochondria, the powerhouses of our cells, are remnants of a eubacterial endosymbiont. Notwithstanding the evolutionary time that has passed since the initial endosymbiotic event, mitochondria have retained many hallmarks of their eubacterial origin. Recent studies have indicated that during perturbations of normal homeostasis, such as following acute trauma leading to massive necrosis and release of mitochondria, the immune system might mistake symbiont for enemy and initiate an inappropriate immune response. The innate immune system is the first line of defense against invading microbial pathogens, and as such is the primary suspect in the recognition of mitochondria-derived danger-associated molecular patterns and initiation of an aberrant response. Conversely, innate immune mechanisms are also central to noninflammatory clearance of innocuous agents. Here we investigated the role of a central humoral component of innate immunity, the lectin pathway of complement, in recognition of mitochondria in vitro and in vivo. We found that the soluble pattern recognition molecules, mannan-binding lectin (MBL), L-ficolin, and M-ficolin, were able to recognize mitochondria. Furthermore, MBL in complex with MBL-associated serine protease 2 (MASP-2) was able to activate the lectin pathway and deposit C4 onto mitochondria, suggesting that these molecules are involved either in homeostatic clearance of mitochondria or in induction of untoward inflammatory reactions. We found that following mitochondrial challenge, C3 was consumed in vivo in the absence of overt inflammation, indicating a potential role of complement in noninflammatory clearance of mitochondria. Thus, we report here the first indication of involvement of the lectin pathway in mitochondrial immune handling.	[Thiel, Steffen; Jensenius, Jens C.; Degn, Soren E.] Aarhus Univ, Dept Biomed, Fac Hlth Sci, DK-8000 Aarhus C, Denmark; [Holm, Ida E.] Aarhus Univ, Inst Clin Med, DK-8000 Aarhus C, Denmark; [Holm, Ida E.] Randers Cent Hosp, Expt Neuropathol Lab, Dept Pathol, DK-8930 Randers NO, Denmark; [Endo, Yuichi; Fujita, Teizo] Fukushima Med Univ, Dept Immunol, Fukushima 9601295, Japan	Aarhus University; Aarhus University; Fukushima Medical University	Degn, SE (corresponding author), Aarhus Univ, Dept Biomed, Bartholin Bldg,Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	sdegn@microbiology.au.dk	Degn, Søren E/G-7936-2017	Degn, Søren E/0000-0001-5409-045X; Thiel, Steffen/0000-0002-4817-155X; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	This work was supported by a postdoctoral grant from the Carlsberg Foundation (to S.E.D.).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; COMIS A, 1985, FEBS LETT, V185, P105, DOI 10.1016/0014-5793(85)80749-3; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dodds AW, 2002, IMMUNOBIOLOGY, V205, P340, DOI 10.1078/0171-2985-00137; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GLAUMANN H, 1975, LAB INVEST, V33, P239; GLAUMANN H, 1975, LAB INVEST, V33, P262; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Hirano S, 1996, AM J PHYSIOL-LUNG C, V270, pL836, DOI 10.1152/ajplung.1996.270.5.L836; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Kolln J, 2007, PROTEIN PEPTIDE LETT, V14, P475, DOI 10.2174/092986607780782795; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Peterslund NA, 2001, LANCET, V358, P637, DOI 10.1016/S0140-6736(01)05785-3; PINCKARD RN, 1975, J CLIN INVEST, V56, P740, DOI 10.1172/JCI108145; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; Schlapbach LJ, 2009, MOL IMMUNOL, V46, P2597, DOI 10.1016/j.molimm.2009.05.003; Schmid M, 2012, IMMUNOBIOLOGY, V217, P610, DOI 10.1016/j.imbio.2011.10.020; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THIEL S, 1995, PEDIATR ALLERGY IMMU, V6, P20, DOI 10.1111/j.1399-3038.1995.tb00252.x; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	46	32	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8016	8027		10.1074/jbc.M112.430249	http://dx.doi.org/10.1074/jbc.M112.430249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378531	Green Published, hybrid			2022-12-25	WOS:000316564500003
J	Danielsen, AA; Parker, MD; Lee, S; Boron, WF; Aalkjaer, C; Boedtkjer, E				Danielsen, Andreas A.; Parker, Mark D.; Lee, Soojung; Boron, Walter F.; Aalkjaer, Christian; Boedtkjer, Ebbe			Splice Cassette II of Na+, HCO3- Cotransporter NBCn1 (slc4a7) Interacts with Calcineurin A IMPLICATIONS FOR TRANSPORTER ACTIVITY AND INTRACELLULAR pH CONTROL DURING RAT ARTERY CONTRACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ELECTRONEUTRAL SODIUM/BICARBONATE COTRANSPORTER; FUNCTIONAL-CHARACTERIZATION; BICARBONATE TRANSPORT; HOMOLOGOUS PROTEIN; CALCIUM; CHANNELS; HYPERTENSION; CYCLOSPORINE; CA2+-ATPASE	Activation of Na+, HCO3- cotransport in vascular smooth muscle cells (VSMCs) contributes to intracellular pH (pH(i)) control during artery contraction, but the signaling pathways involved have been unknown. We investigated whether physical and functional interactions between the Na+, HCO3- cotransporter NBCn1 (slc4a7) and the Ca2+/calmodulin-activated serine/threonine phosphatase calcineurin exist and play a role for pH(i) control in VSMCs. Using a yeast two-hybrid screen, we found that splice cassette II from the N terminus of NBCn1 interacts with calcineuri A beta. When cassette II was truncated or mutated to disrupt the putative calcineurin binding motif PTV-VIH, the interaction was abolished. Native NBCn1 and calcineurin A beta co-immunoprecipitated from A7r5 rat VSMCs. A peptide (acetyl-DDIPTVVIH-amide), which mimics the putative calcineurin binding motif, inhibited the co-immunoprecipitation whereas a mutated peptide (acetyl-DDIATAVAA-amide) did not. Na+, HCO3- cotransport activity was investigated in VSMCs of mesenteric arteries after an NH4+ prepulse. During depolarization with 50mM extracellular K+ to raise intracellular [Ca2+], Na+, HCO3- cotransport activity was inhibited 20-30% by calcineurin inhibitors (FK506 and cyclosporine A). FK506 did not affect Na+, HCO3- cotransport activity in VSMCs when cytosolic [Ca2+] was lowered by buffering, nor did it disrupt binding between NBCn1 and calcineuri A beta. FK506 augmented the intracellular acidification of VSMCs during norepinephrine-induced artery contractions. No physical or functional interactions between calcineurin A beta and the Na+/H+ exchanger NHE1 were observed in VSMCs. In conclusion, we demonstrate a physical interaction between calcineurin A beta and cassette II of NBCn1. Intracellular Ca2+ activates Na+, HCO3- cotransport activity in VSMCs in a calcineurin-dependent manner which is important for protection against intracellular acidification.	[Danielsen, Andreas A.; Lee, Soojung; Aalkjaer, Christian; Boedtkjer, Ebbe] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Danielsen, Andreas A.; Lee, Soojung; Aalkjaer, Christian; Boedtkjer, Ebbe] Aarhus Univ, Water & Salt Res Ctr, DK-8000 Aarhus C, Denmark; [Parker, Mark D.; Boron, Walter F.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Aarhus University; Aarhus University; Case Western Reserve University	Boedtkjer, E (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	eb@fi.au.dk	Boron, Walter/ABI-1564-2020; Parker, Mark/AAH-5575-2020; Boedtkjer, Ebbe/O-8449-2019; Boedtkjer, Ebbe/B-7315-2008	Boedtkjer, Ebbe/0000-0002-5078-9279; Boedtkjer, Ebbe/0000-0002-5078-9279; Aalkjaer, Christian/0000-0003-2618-4015; Boron, Walter/0000-0003-4741-7287	National Institutes of Health [K01DK082646, NS18400]; Danish National Research Foundation; Danish Council for Independent Research Grants [10-094816, 09-066609]; Lundbeck Foundation [R93-A8859]; Novo Nordisk Foundation; Lundbeck Foundation [R93-2011-8859] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research Grants; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Harindarpal S. Gill (who was supported by National Institutes of Health Grant K01DK082646) for providing the cassette II clone that was used as a PCR template in the construction of the yeast two-hybrid expression vector. The Water and Salt Research Center at Aarhus University was established and supported by the Danish National Research Foundation.; This work was supported, in whole or in part, by National Institutes of Health Grant NS18400 (to W.F.B.). This work was also supported by the Danish Council for Independent Research Grants 10-094816 (to E.B.) and 09-066609 (to C.A.), the Lundbeck Foundation Grant R93-A8859 (to E.B.), and the Novo Nordisk Foundation (to E.B.).	AALKJAER C, 1991, AM J PHYSIOL, V261, pC1010, DOI 10.1152/ajpcell.1991.261.6.C1010; AALKJAER C, 1991, J PHYSIOL-LONDON, V436, P57, DOI 10.1113/jphysiol.1991.sp018539; Aalkjaer C, 1988, Prog Biochem Pharmacol, V23, P150; Aalkjaer C., 2012, TRENDS CARDIOVASC S, VS1050-1738, P00324; ABERCROMBIE RF, 1986, AM J PHYSIOL, V250, pC391, DOI 10.1152/ajpcell.1986.250.3.C391; AHN K, 1992, P NATL ACAD SCI USA, V89, P8606, DOI 10.1073/pnas.89.18.8606; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BATLLE DC, 1993, AM J PHYSIOL, V264, pC932, DOI 10.1152/ajpcell.1993.264.4.C932; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Boedtkjer E, 2006, CIRC RES, V98, P515, DOI 10.1161/01.RES.0000204750.04971.76; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Boedtkjer E, 2008, AM J PHYSIOL-CELL PH, V294, pC591, DOI 10.1152/ajpcell.00281.2007; Boedtkjer E, 2012, J VASC RES, V49, P479, DOI 10.1159/000341235; Boedtkjer E, 2012, J PHYSIOL-LONDON, V590, P1895, DOI 10.1113/jphysiol.2011.227132; Boedtkjer E, 2011, CIRCULATION, V124, P1819, DOI 10.1161/CIRCULATIONAHA.110.015974; Boedtkjer E, 2009, AM J PHYSIOL-HEART C, V296, pH247, DOI 10.1152/ajpheart.00725.2008; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Cooper DS, 2006, J BIOMED SCI, V13, P593, DOI 10.1007/s11373-006-9078-6; Cooper DS, 2005, J BIOL CHEM, V280, P17823, DOI 10.1074/jbc.M408646200; Damkier HH, 2006, AM J PHYSIOL-HEART C, V290, pH172, DOI 10.1152/ajpheart.00713.2005; DAUGIRDAS JT, 1995, J CLIN INVEST, V95, P1480, DOI 10.1172/JCI117819; EISNER DA, 1989, PFLUG ARCH EUR J PHY, V413, P553, DOI 10.1007/BF00594188; Epstein A, 1998, SURGERY, V123, P456, DOI 10.1016/S0039-6060(98)70168-0; Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503; FLEMING I, 1994, CIRC RES, V74, P1220, DOI 10.1161/01.RES.74.6.1220; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; KLOCKNER U, 1994, J GEN PHYSIOL, V103, P647, DOI 10.1085/jgp.103.4.647; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Maier LS, 2011, HEART RHYTHM, V8, P474, DOI 10.1016/j.hrthm.2010.09.080; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Naderali EK, 1997, J PHYSIOL-LONDON, V505, P329, DOI 10.1111/j.1469-7793.1997.329bb.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Park M, 2002, J BIOL CHEM, V277, P50503, DOI 10.1074/jbc.M201862200; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schubert R, 2001, J VASC RES, V38, P30, DOI 10.1159/000051027; Schuhmann K, 1997, J GEN PHYSIOL, V110, P503, DOI 10.1085/jgp.110.5.503; Shing CM, 2012, TRANSPL INT, V25, P337, DOI 10.1111/j.1432-2277.2011.01420.x; Yu LY, 2008, AM J RESP CRIT CARE, V177, P1276, DOI 10.1164/rccm.200710-1522OC	50	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8146	8155		10.1074/jbc.M113.455386	http://dx.doi.org/10.1074/jbc.M113.455386			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382378	hybrid, Green Published			2022-12-25	WOS:000316564500015
J	Xiao, XW; Guo, P; Chen, Z; El-Gohary, Y; Wiersch, J; Gaffar, I; Prasadan, K; Shiota, C; Gittes, GK				Xiao, Xiangwei; Guo, Ping; Chen, Zean; El-Gohary, Yousef; Wiersch, John; Gaffar, Iljana; Prasadan, Krishna; Shiota, Chiyo; Gittes, George K.			Hypoglycemia Reduces Vascular Endothelial Growth Factor A Production by Pancreatic Beta Cells as a Regulator of Beta Cell Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LASER CAPTURE MICRODISSECTION; VEGF-A; GENE-EXPRESSION; ISLETS; REVASCULARIZATION; DIFFERENTIATION; CONTRIBUTE; INDUCTION; LETHALITY; INCREASES	VEGF-A expression in beta cells is critical for pancreatic development, formation of islet-specific vasculature, and Insulin secretion. However, two key questions remain. First, is VEGF-A release from beta cells coupled to VEGF-A production in beta cells? Second, how is the VEGF-A response by beta cells affected by metabolic signals? Here, we show that VEGF-A secretion, but not gene transcription, in either cultured islets or purified pancreatic beta cells, was significantly reduced early on during low glucose conditions. In vivo, a sustained hypoglycemia in mice was induced with Insulin pellets, resulting in a significant reduction in beta cell mass. This loss of beta cell mass could be significantly rescued with continuous delivery of exogenous VEGF-A, which had no effect on beta cell mass in normoglycemic mice. In addition, an increase in apoptotic endothelial cells during hypoglycemia preceded an increase in apoptotic beta cells. Both endothelial and beta cell apoptosis were prevented by exogenous VEGF-A, suggesting a possible causative relationship between reduced VEGF-A and the loss of islet vasculature and beta cells. Furthermore, in none of these experimental groups did beta cell proliferation and islet vessel density change, suggesting a tightly regulated balance between these two cellular compartments. The average islet size decreased in hypoglycemia, which was also prevented by exogenous VEGF-A. Taken together, our data suggest that VEGF-A release in beta cells is independent of VEGF-A synthesis. Beta cell mass can be regulated through modulated release of VEGF-A from beta cells based on physiological need.	[Xiao, Xiangwei; Guo, Ping; Chen, Zean; El-Gohary, Yousef; Wiersch, John; Gaffar, Iljana; Prasadan, Krishna; Shiota, Chiyo; Gittes, George K.] Univ Pittsburgh, Div Pediat Surg, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittes, GK (corresponding author), 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gittesgk@upmc.edu	xiao, xiangwei/K-1218-2012	El-Gohary, Yousef/0000-0002-8655-0948; Xiao, Xiangwei/0000-0003-0890-9203	National Institutes of Health [RO1 DK064952, R01 DK083541]; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083541, R01DK064952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK064952 and R01 DK083541 (to G. K. G.) and the Children's Hospital of Pittsburgh.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Akirav EM, 2011, DIABETES, V60, P876, DOI 10.2337/db10-0793; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Cai Q, 2012, DEV BIOL, V367, P40, DOI 10.1016/j.ydbio.2012.04.022; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen Z., 2013, J CLIN INVE IN PRESS; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cleaver O, 2012, DEVELOPMENT, V139, P2833, DOI 10.1242/dev.065953; Darland DC, 2011, DEV BIOL, V358, P9, DOI 10.1016/j.ydbio.2011.06.045; Eichler W, 2000, NEUROREPORT, V11, P3533, DOI 10.1097/00001756-200011090-00026; El-Gohary Y, 2012, ANAT REC, V295, P1473, DOI 10.1002/ar.22530; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Magenheim J, 2011, DEVELOPMENT, V138, P4743, DOI 10.1242/dev.066548; Marselli L, 2009, METHODS MOL BIOL, V560, P87, DOI 10.1007/978-1-59745-448-3_8; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Vasir B, 1998, DIABETES, V47, P1894, DOI 10.2337/diabetes.47.12.1894; Wada T, 2006, J NEUROSCI, V26, P6803, DOI 10.1523/JNEUROSCI.0526-06.2006; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428	41	77	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8636	8646		10.1074/jbc.M112.422949	http://dx.doi.org/10.1074/jbc.M112.422949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378532	Green Published, hybrid			2022-12-25	WOS:000316564500064
J	Kessler, RL; Soares, MJ; Probst, CM; Krieger, MA				Kessler, Rafael Luis; Soares, Maurilio Jose; Probst, Christian Macagnan; Krieger, Marco Aurelio			Trypanosoma cruzi Response to Sterol Biosynthesis Inhibitors: Morphophysiological Alterations Leading to Cell Death	PLOS ONE			English	Article							DELTA(24(25))-STEROL METHYL TRANSFERASE; LOVASTATIN-INDUCED APOPTOSIS; ISCHEMIC NEURONAL DEATH; SCHIZOTRYPANUM CRUZI; IN-VITRO; 3-HYDROXY-3-METHYL-GLUTARYL-COA REDUCTASE; ULTRASTRUCTURAL ALTERATIONS; CANDIDA-ALBICANS; PLASMA-MEMBRANES; SCH 56592	The protozoan parasite Trypanosoma cruzi displays similarities to fungi in terms of its sterol lipid biosynthesis, as ergosterol and other 24-alkylated sterols are its principal endogenous sterols. The sterol pathway is thus a potential drug target for the treatment of Chagas disease. We describe here a comparative study of the growth inhibition, ultrastructural and physiological changes leading to the death of T. cruzi cells following treatment with the sterol biosynthesis inhibitors (SBIs) ketoconazole and lovastatin. We first calculated the drug concentration inhibiting epimastigote growth by 50% (EC50/72 h) or killing all cells within 24 hours (EC100/24 h). Incubation with inhibitors at the EC50/72 h resulted in interesting morphological changes: intense proliferation of the inner mitochondrial membrane, which was corroborated by flow cytometry and confocal microscopy of the parasites stained with rhodamine 123, and strong swelling of the reservosomes, which was confirmed by acridine orange staining. These changes to the mitochondria and reservosomes may reflect the involvement of these organelles in ergosterol biosynthesis or the progressive autophagic process culminating in cell lysis after 6 to 7 days of treatment with SBIs at the EC50/72 h. By contrast, treatment with SBIs at the EC100/24 h resulted in rapid cell death with a necrotic phenotype: time-dependent cytosolic calcium overload, mitochondrial depolarization and reservosome membrane permeabilization (RMP), culminating in cell lysis after a few hours of drug exposure. We provide the first demonstration that RMP constitutes the "point of no return" in the cell death cascade, and propose a model for the necrotic cell death of T. cruzi. Thus, SBIs trigger cell death by different mechanisms, depending on the dose used, in T. cruzi. These findings shed new light on ergosterol biosynthesis and the mechanisms of programmed cell death in this ancient protozoan parasite.	[Kessler, Rafael Luis; Soares, Maurilio Jose; Probst, Christian Macagnan; Krieger, Marco Aurelio] Fiocruz MS, Inst Carlos Chagas, Curitiba, PR, Brazil	Fundacao Oswaldo Cruz	Krieger, MA (corresponding author), Fiocruz MS, Inst Carlos Chagas, Curitiba, PR, Brazil.	mkrieger@fiocruz.br	Soares, Maurilio J/I-4627-2016; Probst, Christian/B-8678-2009; Kessler, Rafael/E-9291-2018; Krieger, Marco/AAE-8611-2020	Soares, Maurilio J/0000-0001-9701-836X; Probst, Christian/0000-0001-9993-6375; Kessler, Rafael/0000-0002-6365-8251; Krieger, Marco Aurelio/0000-0003-0030-3952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fiocruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fiocruz	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Andrade-Neto VV, 2011, ACTA TROP; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; Braga MV, 2005, MICROSC MICROANAL, V11, P506, DOI 10.1017/S143192760505035X; Braga MV, 2004, INT J ANTIMICROB AG, V24, P72, DOI 10.1016/j.ijantimicag.2003.12.009; BRENER Z, 1993, MEM I OSWALDO CRUZ, V88, P149, DOI 10.1590/S0074-02761993000100023; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Buckner FS, 2008, ADV EXP MED BIOL, V625, P61, DOI 10.1007/978-0-387-77570-8_6; Camargo EP, 2009, MEM I OSWALDO CRUZ, V104, P275, DOI 10.1590/S0074-02762009000900036; Concepcion JL, 1998, ARCH BIOCHEM BIOPHYS, V352, P114, DOI 10.1006/abbi.1998.0577; Contreras LM, 1997, BIOCHEM PHARMACOL, V53, P697, DOI 10.1016/S0006-2952(96)00903-3; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; Dantas AP, 2006, MEM I OSWALDO CRUZ, V101, P207, DOI 10.1590/S0074-02762006000200013; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Dumonteil E, 2009, INFECT GENET EVOL, V9, P1075, DOI 10.1016/j.meegid.2009.02.009; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; ENDO A, 1992, J LIPID RES, V33, P1569; Fernandes MP, 2010, J BIOENERG BIOMEMBR, V42, P69, DOI 10.1007/s10863-010-9268-9; FLORINCHRISTENSEN M, 1990, BIOCHEM BIOPH RES CO, V166, P1441, DOI 10.1016/0006-291X(90)91028-Q; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Giusti C, 2009, EXP CELL RES, V315, P26, DOI 10.1016/j.yexcr.2008.09.028; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Grijalba MT, 1999, BIOCHEMISTRY-US, V38, P13279, DOI 10.1021/bi9828674; Guerra-Slompo EP, 2012, BIOCH BIOPHYS RES CO; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Ho YS, 1998, TOXICOL APPL PHARM, V153, P39, DOI 10.1006/taap.1998.8467; Hurtado-Guerrrero R, 2002, FEBS LETT, V510, P141, DOI 10.1016/S0014-5793(01)03238-0; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lamb DC, 2000, CHEM-BIOL INTERACT, V125, P165, DOI 10.1016/S0009-2797(99)00169-6; Laporte C, 2007, CELL DEATH DIFFER, V14, P266, DOI 10.1038/sj.cdd.4401994; Laverriere M, 2012, CELL DEATH DIFFER, V19, P1358, DOI 10.1038/cdd.2012.12; LAZARDI K, 1991, ANTIMICROB AGENTS CH, V35, P736, DOI 10.1128/AAC.35.4.736; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Liendo A, 1998, J ANTIMICROB CHEMOTH, V41, P197, DOI 10.1093/jac/41.2.197; Liendo A, 1999, MOL BIOCHEM PARASIT, V104, P81, DOI 10.1016/S0166-6851(99)00129-2; Lin KL, 2009, TOXICOL IN VITRO, V23, P1268, DOI 10.1016/j.tiv.2009.07.025; Marcelli M, 1998, CANCER RES, V58, P76; MCCABE R, 1988, J INFECT DIS, V158, P1408, DOI 10.1093/infdis/158.6.1408; MCCABE RE, 1984, J INFECT DIS, V150, P594, DOI 10.1093/infdis/150.4.594; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Menna-Barreto RFS, 2007, PARASITOL RES, V101, P895, DOI 10.1007/s00436-007-0556-1; Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Padayatty SJ, 1997, J CLIN ENDOCR METAB, V82, P1434, DOI 10.1210/jc.82.5.1434; Pena-Diaz J, 2004, MOL BIOL CELL, V15, P1356, DOI 10.1091/mbc.E03-10-0720; PEREZSALA D, 1994, BIOCHEM BIOPH RES CO, V199, P1209, DOI 10.1006/bbrc.1994.1359; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; REEDQUIST KA, 1995, BIOCHEM BIOPH RES CO, V211, P665, DOI 10.1006/bbrc.1995.1863; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Rodrigues CO, 2001, J EUKARYOT MICROBIOL, V48, P588, DOI 10.1111/j.1550-7408.2001.tb00195.x; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; Rubins JB, 1998, AM J RESP CRIT CARE, V157, P1616, DOI 10.1164/ajrccm.157.5.9709020; Sant'Anna C, 2008, HISTOCHEM CELL BIOL, V130, P1187, DOI 10.1007/s00418-008-0486-8; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; Santa-Rita RM, 2005, J ANTIMICROB CHEMOTH, V55, P780, DOI 10.1093/jac/dki087; Sanz-Rodriguez CE, 2007, J BIOL CHEM, V282, P12377, DOI 10.1074/jbc.M607286200; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; SOARES MJ, 1988, J SUBMICR CYTOL PATH, V20, P349; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007; URBINA JA, 1991, ANTIMICROB AGENTS CH, V35, P730, DOI 10.1128/AAC.35.4.730; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; URBINA JA, 1995, MOL BIOCHEM PARASIT, V73, P199, DOI 10.1016/0166-6851(95)00117-J; Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969; Urbina JA, 1998, ANTIMICROB AGENTS CH, V42, P1771, DOI 10.1128/AAC.42.7.1771; URBINA JA, 1988, ANTIMICROB AGENTS CH, V32, P1237, DOI 10.1128/AAC.32.8.1237; Urbina JA, 2000, ANTIMICROB AGENTS CH, V44, P2498, DOI 10.1128/AAC.44.9.2498-2502.2000; Urbina JA, 2003, INT J ANTIMICROB AG, V21, P39, DOI 10.1016/S0924-8579(02)00274-1; Urbina JA, 2003, INT J ANTIMICROB AG, V21, P27, DOI 10.1016/S0924-8579(02)00273-X; URBINA JA, 1988, MOL BIOCHEM PARASIT, V30, P185, DOI 10.1016/0166-6851(88)90111-9; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vannier-Santos MA, 2009, CURR DRUG TARGETS, V10, P246, DOI 10.2174/138945009787581168; Vivas J, 1997, INT J ANTIMICROB AG, V8, P1, DOI 10.1016/S0924-8579(96)00345-7; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X	97	62	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55497	10.1371/journal.pone.0055497	http://dx.doi.org/10.1371/journal.pone.0055497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383204	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600112
J	Shembekar, N; Mallajosyula, VVA; Mishra, A; Yeolekar, L; Dhere, R; Kapre, S; Varadarajan, R; Gupta, SK				Shembekar, Nachiket; Mallajosyula, Vamsee V. Aditya; Mishra, Arpita; Yeolekar, Leena; Dhere, Rajeev; Kapre, Subhash; Varadarajan, Raghavan; Gupta, Satish Kumar			Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the 'Sa' Antigenic Site	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; INFLUENZA-VIRUS; HEMAGGLUTININ; EPITOPE; IMMUNOGEN; IMMUNITY; DESIGN	Influenza virus evades host immunity through antigenic drift and shift, and continues to circulate in the human population causing periodic outbreaks including the recent 2009 pandemic. A large segment of the population was potentially susceptible to this novel strain of virus. Historically, monoclonal antibodies (MAbs) have been fundamental tools for diagnosis and epitope mapping of influenza viruses and their importance as an alternate treatment option is also being realized. The current study describes isolation of a high affinity (K-D = 2.1 +/- 0.4 pM) murine MAb, MA2077 that binds specifically to the hemagglutinin (HA) surface glycoprotein of the pandemic virus. The antibody neutralized the 2009 pandemic H1N1 virus in an in vitro microneutralization assay (IC50 = 0.08 mu g/ml). MA2077 also showed hemagglutination inhibition activity (HI titre of 0.50 mu g/ml) against the pandemic virus. In a competition ELISA, MA2077 competed with the binding site of the human MAb, 2D1 (isolated from a survivor of the 1918 Spanish flu pandemic) on pandemic H1N1 HA. Epitope mapping studies using yeast cell-surface display of a stable HA1 fragment, wherein 'Sa' and 'Sb' sites were independently mutated, localized the binding site of MA2077 within the 'Sa' antigenic site. These studies will facilitate our understanding of antigen antibody interaction in the context of neutralization of the pandemic influenza virus.	[Shembekar, Nachiket; Mishra, Arpita; Gupta, Satish Kumar] Natl Inst Immunol, Reprod Cell Biol Lab, New Delhi 110067, India; [Mallajosyula, Vamsee V. Aditya; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Yeolekar, Leena; Dhere, Rajeev; Kapre, Subhash] Serum Inst India Ltd, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore; Serum Institute of India	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in; skgupta@nii.ac.in	Gupta, Satish/B-9934-2009	Gupta, Satish/0000-0003-3717-0436; Mallajosyula, Vamsee/0000-0002-0658-3652	Department of Biotechnology, Government of India [BT/BIPP/0213/04/09]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnology, Government of India (BT/BIPP/0213/04/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WORLDWIDE H1N1 SWINE; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Burioni R, 2009, NEW MICROBIOL, V32, P319; Cabral TM, 2012, J VIROL METHODS, V183, P25, DOI 10.1016/j.jviromet.2012.03.016; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Drescher J, 1987, INTERVIROLOGY, V4, P205; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Govind CK, 2000, BIOL REPROD, V62, P67, DOI 10.1095/biolreprod62.1.67; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harlow E, 1999, USING ANTIBODIES LAB, P384; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUBECK MD, 1981, VIROLOGY, V113, P64, DOI 10.1016/0042-6822(81)90136-7; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	33	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55516	10.1371/journal.pone.0055516	http://dx.doi.org/10.1371/journal.pone.0055516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383214	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000314610600118
J	Puig, MS; Zapata, LP; Aznar-Casanova, JA; Super, H				Sole Puig, Maria; Perez Zapata, Laura; Antonio Aznar-Casanova, J.; Super, Hans			A Role of Eye Vergence in Covert Attention	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR DISPARITY; SPATIAL ATTENTION; DEPTH-PERCEPTION; MOVEMENTS; MECHANISMS; OVERT; MICROSACCADES; SHIFTS	Covert spatial attention produces biases in perceptual and neural responses in the absence of overt orienting movements. The neural mechanism that gives rise to these effects is poorly understood. Here we report the relation between fixational eye movements, namely eye vergence, and covert attention. Visual stimuli modulate the angle of eye vergence as a function of their ability to capture attention. This illustrates the relation between eye vergence and bottom-up attention. In visual and auditory cue/no-cue paradigms, the angle of vergence is greater in the cue condition than in the no-cue condition. This shows a top-down attention component. In conclusion, observations reveal a close link between covert attention and modulation in eye vergence during eye fixation. Our study suggests a basis for the use of eye vergence as a tool for measuring attention and may provide new insights into attention and perceptual disorders.	[Sole Puig, Maria; Perez Zapata, Laura; Antonio Aznar-Casanova, J.; Super, Hans] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Antonio Aznar-Casanova, J.; Super, Hans] Univ Barcelona, Inst Brain Cognit & Behav, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain.	hans.super@icrea.es	/B-3900-2011; Aznar-Casanova, J.Antonio/Z-1011-2019	/0000-0002-3084-3135; Aznar-Casanova, J.Antonio/0000-0002-3084-3135; Super, Hans/0000-0001-9328-0096; Sole Puig, Maria/0000-0002-4331-3432	Spanish Ministry of Education and Science (MICINN) [PSI2010-18139, SAF2009-10367]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (PSI2010-18139 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from the Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Hoecks B., 1993, BEHAV RES METH INSTR, V25, P16; Horowitz TS, 2007, PSYCHOL SCI, V18, P356, DOI 10.1111/j.1467-9280.2007.01903.x; Hunt AR, 2003, COGNITIVE BRAIN RES, V18, P102, DOI 10.1016/j.cogbrainres.2003.08.006; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P776; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Super H, 2004, P NATL ACAD SCI USA, V101, P3230, DOI 10.1073/pnas.0400433101; Thompson KA, 2005, ABA J, V91, P25; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wright R.D, 2008, ORIENTING ATTENTION; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	31	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52955	10.1371/journal.pone.0052955	http://dx.doi.org/10.1371/journal.pone.0052955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23382827	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600009
J	Khan, R; Lee, JE; Yang, YM; Liang, FX; Sehgal, PB				Khan, Rasel; Lee, Jason E.; Yang, Yang-Ming; Liang, Feng-Xia; Sehgal, Pravin B.			Live-Cell Imaging of the Association of STAT6-GFP with Mitochondria	PLOS ONE			English	Article							PROTEIN-PROTEIN; STAT3; COLOCALIZATION; LOCALIZATION; CYTOPLASM; PY-STAT3	The transcription factor STAT3 has been previously reported to be associated with mitochondria. However, we have been unable to visualize an association of STAT3-GFP, STAT3-DsRed or STAT3-Flag with mitochondria in human Hep3B hepatocytes thus far even though an association of these molecules with other cytoplasmic organelles (endosomes) was readily demonstrable. We then addressed the broader question of a possible association of other STAT-family of proteins with mitochondria by first using immunolocalization assays in Hep3B and human pulmonary arterial endothelial and smooth muscle cells. Strong anti-STAT6-immunolocalization with mitochondria was apparent in fluorescence and electron microscopy assays of cells first washed with a digitonin-sucrose buffer to remove bulk soluble STAT proteins. In live-cell imaging studies, STAT6-GFP, but not N1-GFP, was observed to constitutively colocalize with MitoTracker-and tetramethylrhodamine ethyl ester (TMRE)-positive mitochondria, and with mitochondrial F1-ATPase when assayed by immunofluorescence after fixation. This association was Tyr-phosphorylation independent in that a STAT6 truncated protein (STAT6(1-459)-GFP) which lacked the SH2 domain (517-632) and the cytokine-activated Y641 phosphorylation site also accumulated in MitoTracker-positive mitochondria. This was consistent with the unexpected discovery that anti-STAT6-immunofluoresence also associated with mitochondria in mouse embryo fibroblasts (MEFs) from both wild-type and the STAT6(SH2-/SH2-) mouse. MEFs from the latter mouse, which had been engineered in 1996 to be deleted in the STAT6 SH2 domain (amino acids 505-584) expressed an immune-specific similar to 50 kDa protein detectable in whole cell and mitochondria-enriched fractions. Taken together, the present data provide the first definitive evidence of the association of any STAT-protein family member with mitochondria - that of STAT6.	[Khan, Rasel; Lee, Jason E.; Yang, Yang-Ming; Sehgal, Pravin B.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Liang, Feng-Xia] NYU, Sch Med, OCS Microscopy Core, New York, NY USA; [Sehgal, Pravin B.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA	New York Medical College; New York University; New York Medical College	Sehgal, PB (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	Pravin_sehgal@nymc.edu	Liang, Fenghua/HHM-3798-2022; Liang, Feng/GZK-4305-2022	LEE, JASON/0000-0001-5757-5954	National Institutes of Health [R01HL087176, F31HL107013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087176, F31HL107013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants R01HL087176 (P. B. S.) and F31HL107013 (J.E.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chapoval SP, 2011, J IMMUNOL, V186, P2571, DOI 10.4049/jimmunol.1002567; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Chueh FY, 2010, BIOCHEM BIOPH RES CO, V402, P778, DOI 10.1016/j.bbrc.2010.10.112; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Lee JE, 2013, AM J PHYSIOL-CELL PH, V304, pC312, DOI 10.1152/ajpcell.00311.2012; Lee JE, 2012, AM J PHYSIOL-CELL PH, V302, pC804, DOI 10.1152/ajpcell.00379.2011; Mukhopadhyay S, 2008, AM J PHYSIOL-LUNG C, V294, pL449, DOI 10.1152/ajplung.00377.2007; Peters PJ, 2006, CURR PROTOCOLS CELL, DOI 0.1002/0471143030.cb0407s30; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Shah M, 2006, J BIOL CHEM, V281, P7302, DOI 10.1074/jbc.M508527200; Suzuki K, 2002, J EXP MED, V196, P27, DOI 10.1084/jem.20011682; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xu F, 2007, AM J PHYSIOL-CELL PH, V293, pC1374, DOI 10.1152/ajpcell.00220.2007; Zhou P, 2000, J IMMUNOL, V165, P5580, DOI 10.4049/jimmunol.165.10.5580	26	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55426	10.1371/journal.pone.0055426	http://dx.doi.org/10.1371/journal.pone.0055426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383189	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800154
J	Luo, SL; Christensen, S; Zhangsun, DT; Wu, Y; Hu, YY; Zhu, XP; Chhabra, S; Norton, RS; McIntosh, JM				Luo, Sulan; Christensen, Sean; Zhangsun, Dongting; Wu, Yong; Hu, Yuanyan; Zhu, Xiaopeng; Chhabra, Sandeep; Norton, Raymond S.; McIntosh, J. Michael			A Novel Inhibitor of alpha 9 alpha 10 Nicotinic Acetylcholine Receptors from Conus vexillum Delineates a New Conotoxin Superfamily	PLOS ONE			English	Article							ALPHA-D-CONOPEPTIDES; CYSTEINE PATTERN; CDNA CLONING; IN-VITRO; PEPTIDE; PROTEIN; DIVERSITY; CHANNEL; UNIQUE; SEQUENCES	Conotoxins (CTxs) selectively target a range of ion channels and receptors, making them widely used tools for probing nervous system function. Conotoxins have been previously grouped into superfamilies according to signal sequence and into families based on their cysteine framework and biological target. Here we describe the cloning and characterization of a new conotoxin, from Conus vexillum, named alpha B-conotoxin VxXXIVA. The peptide does not belong to any previously described conotoxin superfamily and its arrangement of Cys residues is unique among conopeptides. Moreover, in contrast to previously characterized conopeptide toxins, which are expressed initially as prepropeptide precursors with a signal sequence, a "pro'' region, and the toxin-encoding region, the precursor sequence of alpha B-VxXXIVA lacks a "pro'' region. The predicted 40-residue mature peptide, which contains four Cys, was synthesized in each of the three possible disulfide arrangements. Investigation of the mechanism of action of alpha B-VxXXIVA revealed that the peptide is a nicotinic acetylcholine receptor (nAChR) antagonist with greatest potency against the alpha 9 alpha 10 subtype. H-1 nuclear magnetic resonance (NMR) spectra indicated that all three alpha B-VxXXIVA isomers were poorly structured in aqueous solution. This was consistent with circular dichroism (CD) results which showed that the peptides were unstructured in buffer, but adopted partially helical conformations in aqueous trifluoroethanol (TFE) solution. The alpha 9 alpha 10 nAChR is an important target for the development of analgesics and cancer chemotherapeutics, and alpha B-VxXXIVA represents a novel ligand with which to probe the structure and function of this protein.	[Luo, Sulan; Zhangsun, Dongting; Wu, Yong; Hu, Yuanyan; Zhu, Xiaopeng] Hainan Univ, Key Lab Marine Drug Haikou, Minist Educ, Key Lab Trop Biol Resources, Haikou Hainan, Peoples R China; [Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	Hainan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Monash University	Luo, SL (corresponding author), Hainan Univ, Key Lab Marine Drug Haikou, Minist Educ, Key Lab Trop Biol Resources, Haikou Hainan, Peoples R China.	luosulan2003@163.com	Chhabra, Sandeep/T-5468-2018; chhabra, sandeep/R-9942-2017	Chhabra, Sandeep/0000-0002-5225-1333; Norton, Raymond/0000-0001-8893-0584	Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT) [IRT1123]; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China [2012AA021706]; International Science & Technology Cooperation Program of China [2011DFR31210]; National Natural Science Foundation of China [81160503]; National Institute of Health [GM 48677, GM103801]; Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China; International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT, IRT1123), State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China (2012AA021706), International Science & Technology Cooperation Program of China (2011DFR31210), and National Natural Science Foundation of China (No. 81160503). A preliminary account of some of this work was presented in the patent literature (Luo,S, et al. CN(201210117928.9)-A 2012). Support also was received from National Institute of Health Grants GM 48677 and GM103801 and RSN acknowledges fellowship support from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Biggs JS, 2010, MOL PHYLOGENET EVOL, V56, P1, DOI 10.1016/j.ympev.2010.03.029; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Chikova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027978; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Conticello SG, 2003, J BIOL CHEM, V278, P26311, DOI 10.1074/jbc.C300141200; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Daly NL, 2009, IUBMB LIFE, V61, P144, DOI 10.1002/iub.158; Dowell C, 2003, J NEUROSCI, V23, P8445; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; England LJ, 1998, SCIENCE, V281, P575, DOI 10.1126/science.281.5376.575; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Fan CX, 2003, J BIOL CHEM, V278, P12624, DOI 10.1074/jbc.M210200200; Favreau P, 2012, BRIT J PHARMACOL, V166, P1654, DOI 10.1111/j.1476-5381.2012.01837.x; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hidaka Y, 1998, BIOCHEMISTRY-US, V37, P8498, DOI 10.1021/bi9731246; Holtman JR, 2011, EUR J PHARMACOL, V670, P500, DOI 10.1016/j.ejphar.2011.08.053; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Jakubowski JA, 2004, J MASS SPECTROM, V39, P548, DOI 10.1002/jms.624; Jimenez EC, 2007, BIOCHEMISTRY-US, V46, P8717, DOI 10.1021/bi700582m; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kauferstein S, 2009, TOXICON, V54, P295, DOI 10.1016/j.toxicon.2009.04.016; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lee CH, 2010, JNCI-J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; Lluisma AO, 2008, TOXICON, V51, P174, DOI 10.1016/j.toxicon.2007.07.009; Loughnan M, 2006, J BIOL CHEM, V281, P24745, DOI 10.1074/jbc.M603703200; Loughnan ML, 2009, BIOCHEMISTRY-US, V48, P3717, DOI 10.1021/bi9000326; Lu BS, 1999, PEPTIDES, V20, P1139; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2007, J PEPT SCI, V13, P44, DOI 10.1002/psc.802; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; McIntosh JM, 2009, BIOCHEM PHARMACOL, V78, P693, DOI 10.1016/j.bcp.2009.05.020; Mebs D, 2011, ACTA CHIM SLOV, V58, P730; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Peng C, 2008, PEPTIDES, V29, P985, DOI 10.1016/j.peptides.2008.01.007; Pi CH, 2006, GENOMICS, V88, P809, DOI 10.1016/j.ygeno.2006.06.014; Plazas PV, 2005, J NEUROSCI, V25, P10905, DOI 10.1523/JNEUROSCI.3805-05.2005; PriceCarter M, 1996, BIOCHEMISTRY-US, V35, P15537, DOI 10.1021/bi961574c; Quan Ya-ru, 2005, Zhongguo Haiyang Yaowu, V24, P1; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Teichert RW, 2005, J NEUROSCI, V25, P732, DOI 10.1523/JNEUROSCI.4065-04.2005; Teichertt RW, 2005, BIOCHEMISTRY-US, V44, P7897, DOI 10.1021/bi047274+; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; WOODWARD SR, 1990, EMBO J, V9, P1015, DOI 10.1002/j.1460-2075.1990.tb08204.x; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Ye MY, 2012, J BIOL CHEM, V287, P14973, DOI 10.1074/jbc.M111.334615; Yuan DD, 2008, PEPTIDES, V29, P1521, DOI 10.1016/j.peptides.2008.05.015; Yuan DD, 2009, PEPTIDES, V30, P861, DOI 10.1016/j.peptides.2009.01.012; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x; Zheng GR, 2011, BIOORG MED CHEM LETT, V21, P2476, DOI 10.1016/j.bmcl.2011.02.043	68	39	50	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54648	10.1371/journal.pone.0054648	http://dx.doi.org/10.1371/journal.pone.0054648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382933	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800060
J	Missbach, S; Weis, BL; Martin, R; Simm, S; Bohnsack, MT; Schleiff, E				Missbach, Sandra; Weis, Benjamin L.; Martin, Roman; Simm, Stefan; Bohnsack, Markus T.; Schleiff, Enrico			40S Ribosome Biogenesis Co-Factors Are Essential for Gametophyte and Embryo Development	PLOS ONE			English	Article							INITIATION-FACTOR 6; FEMALE GAMETOPHYTE; SACCHAROMYCES-CEREVISIAE; DOUBLE FERTILIZATION; POLLEN GERMINATION; RNA BIOGENESIS; PIN DOMAIN; ARABIDOPSIS; PROTEIN; CLEAVAGE	Ribosome biogenesis is well described in Saccharomyces cerevisiae. In contrast only very little information is available on this pathway in plants. This study presents the characterization of five putative protein co-factors of ribosome biogenesis in Arabidopsis thaliana, namely Rrp5, Pwp2, Nob1, Enp1 and Noc4. The characterization of the proteins in respect to localization, enzymatic activity and association with pre-ribosomal complexes is shown. Additionally, analyses of T-DNA insertion mutants aimed to reveal an involvement of the plant co-factors in ribosome biogenesis. The investigated proteins localize mainly to the nucleolus or the nucleus, and atEnp1 and atNob1 co-migrate with 40S pre-ribosomal complexes. The analysis of T-DNA insertion lines revealed that all proteins are essential in Arabidopsis thaliana and mutant plants show alterations of rRNA intermediate abundance already in the heterozygous state. The most significant alteration was observed in the NOB1 T-DNA insertion line where the P-A3 fragment, a 23S-like rRNA precursor, accumulated. The transmission of the T-DNA through the male and female gametophyte was strongly inhibited indicating a high importance of ribosome cofactor genes in the haploid stages of plant development. Additionally impaired embryogenesis was observed in some mutant plant lines. All results support an involvement of the analyzed proteins in ribosome biogenesis but differences in rRNA processing, gametophyte and embryo development suggested an alternative regulation in plants.	[Missbach, Sandra; Weis, Benjamin L.; Martin, Roman; Simm, Stefan; Bohnsack, Markus T.; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci, D-60054 Frankfurt, Germany; [Bohnsack, Markus T.; Schleiff, Enrico] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci, D-60054 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Bohnsack, Markus T./D-3076-2011; Simm, Stefan/AAX-4991-2020; Schleiff, Enrico/C-5105-2017	Bohnsack, Markus T./0000-0001-7063-5456; Schleiff, Enrico/0000-0002-0518-3489	Cluster of Excellence Frankfurt; Goethe University in the Forderfond; SFB 902	Cluster of Excellence Frankfurt; Goethe University in the Forderfond; SFB 902	This project was funded by the Cluster of Excellence Frankfurt "Macromolecular Complexes'' (MTB, ES), the Goethe University in the Forderfond program (MTB, ES), and the SFB 902 "Molecular mechanisms of RNA-based regulation'' (MTB, ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Bohnsack MT, 2008, EMBO REP, V9, P1230, DOI 10.1038/embor.2008.184; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Brown JWS, 1998, PLANT CELL, V10, P649, DOI 10.1105/tpc.10.5.649; Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comella P, 2008, NUCLEIC ACIDS RES, V36, P1163, DOI 10.1093/nar/gkm1130; De Boer P, 2006, RNA, V12, P263, DOI 10.1261/rna.2257606; De Storme N, 2011, PLANT PHYSIOL, V155, P1403, DOI 10.1104/pp.110.170415; Devic M, 2008, CR BIOL, V331, P726, DOI 10.1016/j.crvi.2008.07.014; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Faure JE, 2001, CR ACAD SCI III-VIE, V324, P551, DOI 10.1016/S0764-4469(01)01325-7; Feldmann KA, 1997, GENETICS, V147, P1411; Forreiter C, 1997, PLANT CELL, V9, P2171, DOI 10.1105/tpc.9.12.2171; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Guo JJ, 2011, PLANT SIGNAL BEHAV, V6, P766, DOI 10.4161/psb.6.5.15438; Harrison-Lowe NJ, 2008, AUTOPHAGY, V4, P339, DOI 10.4161/auto.5629; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Howden R, 1998, GENETICS, V149, P621; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Im CH, 2011, J BIOL CHEM, V286, P8620, DOI 10.1074/jbc.M110.200816; Ingouff M, 2006, PLANT CELL, V18, P3491, DOI 10.1105/tpc.106.047266; Kato Y, 2010, BIOCHEM BIOPH RES CO, V397, P673, DOI 10.1016/j.bbrc.2010.06.001; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kuhn H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008370; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Li N, 2009, PLANT PHYSIOL, V151, P1486, DOI 10.1104/pp.109.142414; Liu JJ, 2008, MOL PLANT, V1, P564, DOI 10.1093/mp/ssn033; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Pontvianne F, 2007, MOL BIOL CELL, V18, P369, DOI 10.1091/mbc.E06-08-0751; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Roos J, 1997, GENE, V185, P137, DOI 10.1016/S0378-1119(96)00661-0; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Sambrook J, 2001, MOL CLONING LAB MANU; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Sommer MS, 2011, P NATL ACAD SCI USA, V108, P13841, DOI 10.1073/pnas.1108626108; Thole V, 2009, NAT PROTOC, V4, P650, DOI 10.1038/nprot.2009.32; Veith T, 2012, NUCLEIC ACIDS RES, V40, P3259, DOI 10.1093/nar/gkr1186; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vicient CM, 1999, ANAL BIOCHEM, V268, P412, DOI 10.1006/abio.1998.3045; Vos HR, 2004, EUKARYOT CELL, V3, P1504, DOI 10.1128/EC.3.6.1504-1512.2004; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1192, DOI 10.1093/pcp/pcg147; Young CL, 2011, RNA, V17, P512, DOI 10.1261/rna.2458811; Zakrzewska-Placzek M, 2010, NUCLEIC ACIDS RES, V38, P4487, DOI 10.1093/nar/gkq172; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x	69	57	60	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54084	10.1371/journal.pone.0054084	http://dx.doi.org/10.1371/journal.pone.0054084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382868	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800031
J	Miyagi, H; Kanemoto, S; Saito, A; Asada, R; Iwamoto, H; Izumi, S; Kido, M; Gomi, F; Nishida, K; Kiuchi, Y; Imaizumi, K				Miyagi, Hidetaka; Kanemoto, Soshi; Saito, Atsushi; Asada, Rie; Iwamoto, Hideo; Izumi, Soutarou; Kido, Miori; Gomi, Fumi; Nishida, Kohji; Kiuchi, Yoshiaki; Imaizumi, Kazunori			Transcriptional Regulation of VEGFA by the Endoplasmic Reticulum Stress Transducer OASIS in ARPE-19 Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; ER STRESS; CREB/ATF-FAMILY; ATF6; IRE1; IDENTIFICATION; ANGIOGENESIS; CLEAVAGE; PATHWAY	Background: Vascular endothelial growth factor-A (VEGFA) is the main mediator of angiogenesis. Angiogenesis plays important roles not only in many physiological processes, but also in the pathophysiology of many diseases. VEGFA is one of the therapeutic targets of treatment for ocular diseases with neovascularization. Therefore, elucidation of the regulatory mechanisms for VEGFA expression is important for the development of pharmaceutical drugs. Recent studies have demonstrated that the unfolded protein response is involved in the transcriptional regulation of VEGFA. However, the precise regulation of VEGFA in the human retina is not fully understood. Principal Findings: When human retinal pigment epithelial cells, ARPE-19, were exposed to endoplasmic reticulum stressors, VEGFA mRNA was significantly upregulated. The unfolded protein response-related transcription factors XBP1, ATF4, ATF6, and OASIS were expressed in ARPE-19 cells. To determine which transcription factors preferentially contribute to the induction of VEGFA expression after endoplasmic reticulum stress, we carried out reporter assays using an approximately 6-kbp 5'-upstream region of the human VEGFA gene. Among these transcription factors, OASIS acted most effectively on the VEGFA promoter in ARPE-19 cells. Based on data obtained for certain deleted and mutated reporter constructs, we determined that OASIS promoted VEGFA expression by acting on a cyclic AMP-responsive element-like site located at around -500 bp relative to the VEGFA transcription start site. Furthermore, we confirmed that OASIS directly bound to the promoter region containing this site by chromatin immunoprecipitation assays. Conclusions and Significance: We have demonstrated a novel regulatory mechanism for VEGFA transcription by OASIS in human retinal pigment epithelial cells. Chemical compounds that regulate the binding of OASIS to the promoter region of the VEGFA gene may have potential as therapeutic agents for ocular diseases with neovascularization.	[Miyagi, Hidetaka; Kanemoto, Soshi; Saito, Atsushi; Asada, Rie; Iwamoto, Hideo; Izumi, Soutarou; Kido, Miori; Imaizumi, Kazunori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan; [Miyagi, Hidetaka; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Gomi, Fumi; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan	Hiroshima University; Hiroshima University; Osaka University	Imaizumi, K (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan.	imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909; Nishida, Kohji/0000-0001-9069-3610; Gomi, Fumi/0000-0003-0807-8817	Takeda Science Foundation; Naito Foundation; Senri Life Science Foundation; Hokuto Foundation for Bioscience; Japan Prize Foundation; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [25650069] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Senri Life Science Foundation; Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Japan Prize Foundation(Japan Prize Foundation); Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Takeda Science Foundation, Naito Foundation, Senri Life Science Foundation, Hokuto Foundation for Bioscience, Japan Prize Foundation, and Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chihara K, 2009, J NEUROCHEM, V110, P956, DOI 10.1111/j.1471-4159.2009.06188.x; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Funamoto T, 2011, BONE, V49, P724, DOI 10.1016/j.bone.2011.06.012; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2011, BONE, V48, P514, DOI 10.1016/j.bone.2010.10.176; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XY, 2008, DIABETES, V57, P1026, DOI 10.2337/db07-0982; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	50	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55155	10.1371/journal.pone.0055155	http://dx.doi.org/10.1371/journal.pone.0055155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383089	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800123
J	Laforenza, U; Scaffino, MF; Gastaldi, G				Laforenza, Umberto; Scaffino, Manuela F.; Gastaldi, Giulia			Aquaporin-10 Represents an Alternative Pathway for Glycerol Efflux from Human Adipocytes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; ADIPOSE GENE-EXPRESSION; WATER PERMEABILITY; MEMBRANE-VESICLES; CHANNEL; OBESITY; TISSUE; CLONING; AQP10; LOCALIZATION	Background: Glycerol outflow from adipocytes has been considered for a decade to be mediated by aquaporin-7, an aquaglyceroporin highly expressed in the adipose tissue. Its involvement in glycerol metabolism has been widely studied also in humans. Recent studies in different aquaporin-7 KO mice models pose two different questions 1) the exact localization of aquaporin-7 in human white adipose tissue; 2) the existence of other aquaglyceroporins that work with aquaporin-7 to guarantee glycerol efflux and thus a normal adiposity in humans. To this purpose we investigated the expression, the localization and the functioning of aquaglyceroporin-10 in subcutaneous white adipose tissue, in isolated and cultured differentiated adipocytes. Methodology/Principal Findings: Aquaporin-7 and -10 were expressed in the white adipose tissue both at mRNA and at protein level. Immunofluorescence revealed aquaporin-7 and -10 labelling in the human adipose tissue both to the plasma membrane and to a thin rim of cytoplasm of adipocytes. Aquaporin-7, but not aquaporin-10, colocalized with the endothelial marker CD34. Human cultured differentiated adipocytes showed an aquaporin-7 and -10 labelling mainly in the cytoplasm and in the lipid droplets with insulin reinforcing the lipid droplets staining and isoproterenol inducing its translocation to the plasma membrane compartment. Water and glycerol permeability measurements using adipocytes and adipose membrane vesicles confirmed the presence of functioning aquaglyceroporins. Aquaporin-10 silencing in human differentiated adipocytes resulted in a 50% decrease of glycerol and osmotic water permeability. Conclusions/Significance: The results indicate that aquaporin-7, differently from mice, is present in both adipocyte and capillary plasma membranes of human adipose tissue. Aquaporin-10, on the contrary, is expressed exclusively in the adipocytes. The expression of two aquaglyceroporins in human adipose tissue is particularly important for the maintenance of normal or low glycerol contents inside the adipocyte, thus protecting humans from obesity.	[Laforenza, Umberto; Scaffino, Manuela F.; Gastaldi, Giulia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	University of Pavia	Laforenza, U (corresponding author), Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	lumberto@unipv.it		Laforenza, Umberto/0000-0003-2951-5983				Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceperuelo-Mallafre V, 2007, J CLIN ENDOCR METAB, V92, P3640, DOI 10.1210/jc.2007-0531; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Fasshauer M, 2003, HORM METAB RES, V35, P222; Fruhbeck G, 2005, NATURE, V438, P436, DOI 10.1038/438436b; Fruhbeck G, 2006, TRENDS PHARMACOL SCI, V27, P345, DOI 10.1016/j.tips.2006.05.002; Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P15493, DOI 10.1074/jbc.C500028200; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Ishibashi K, 2006, CELL MOL BIOL, V52, P20, DOI 10.1170/T745; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kishida K, 2001, J BIOL CHEM, V276, P48572, DOI 10.1074/jbc.M108213200; Kondo H, 2002, EUR J BIOCHEM, V269, P1814, DOI 10.1046/j.1432-1033.2002.02821.x; Kuriyama H, 1997, BIOCHEM BIOPH RES CO, V241, P53, DOI 10.1006/bbrc.1997.7769; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laforenza U, 2005, BIOL CELL, V97, P605, DOI 10.1042/BC20040090; Laforenza U, 2005, J NUTR, V135, P2329, DOI 10.1093/jn/135.10.2329; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; Laforenza U, 2010, BIOL CELL, V102, P457, DOI 10.1042/BC20100023; Li HP, 2005, BIOL CELL, V97, P823, DOI 10.1042/BC20040091; MA TH, 1993, J BIOL CHEM, V268, P22756; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Marrades MP, 2006, BIOCHEM BIOPH RES CO, V339, P785, DOI 10.1016/j.bbrc.2005.11.080; Matsumura K, 2007, MOL CELL BIOL, V27, P6026, DOI 10.1128/MCB.00384-07; Mobasheri A, 2004, HISTOCHEM CELL BIOL, V121, P463, DOI 10.1007/s00418-004-0657-1; Morinaga T, 2002, BIOCHEM BIOPH RES CO, V294, P630, DOI 10.1016/S0006-291X(02)00536-3; OKA Y, 1988, J BIOL CHEM, V263, P13432; Prudente S, 2007, DIABETES, V56, P1468, DOI 10.2337/db06-1389; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Tritto S, 2007, BIOCHEM CELL BIOL, V85, P675, DOI 10.1139/O07-142; Verkman AS, 2000, J MEMBRANE BIOL, V173, P73, DOI 10.1007/s002320001009; Walker CG, 2007, INT J OBESITY, V31, P1165, DOI 10.1038/sj.ijo.0803555; WIENER H, 1989, J MEMBRANE BIOL, V110, P147, DOI 10.1007/BF01869470; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017	42	65	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54474	10.1371/journal.pone.0054474	http://dx.doi.org/10.1371/journal.pone.0054474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382902	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200008
J	Loeser, RF; Olex, AL; McNulty, MA; Carlson, CS; Callahan, M; Ferguson, C; Fetrow, JS				Loeser, Richard F.; Olex, Amy L.; McNulty, Margaret A.; Carlson, Cathy S.; Callahan, Michael; Ferguson, Cristin; Fetrow, Jacquelyn S.			Disease Progression and Phasic Changes in Gene Expression in a Mouse Model of Osteoarthritis	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; PROTEIN; PRELP; MICE; CHONDROGENESIS; FIBROMODULIN; COMPLEMENT; REVEALS; REPAIR; CELLS	Osteoarthritis (OA) is the most common form of arthritis and has multiple risk factors including joint injury. The purpose of this study was to characterize the histologic development of OA in a mouse model where OA is induced by destabilization of the medial meniscus (DMM model) and to identify genes regulated during different stages of the disease, using RNA isolated from the joint "organ'' and analyzed using microarrays. Histologic changes seen in OA, including articular cartilage lesions and osteophytes, were present in the medial tibial plateaus of the DMM knees beginning at the earliest (2 week) time point and became progressively more severe by 16 weeks. 427 probe sets (371 genes) from the microarrays passed consistency and significance filters. There was an initial up-regulation at 2 and 4 weeks of genes involved in morphogenesis, differentiation, and development, including growth factor and matrix genes, as well as transcription factors including Atf2, Creb3l1, and Erg. Most genes were off or down-regulated at 8 weeks with the most highly down-regulated genes involved in cell division and the cytoskeleton. Gene expression increased at 16 weeks, in particular extracellular matrix genes including Prelp, Col3a1 and fibromodulin. Immunostaining revealed the presence of these three proteins in cartilage and soft tissues including ligaments as well as in the fibrocartilage covering osteophytes. The results support a phasic development of OA with early matrix remodeling and transcriptional activity followed by a more quiescent period that is not maintained. This implies that the response to an OA intervention will depend on the timing of the intervention. The quiescent period at 8 weeks may be due to the maturation of the osteophytes which are thought to temporarily stabilize the joint.	[Loeser, Richard F.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA; [Olex, Amy L.; Fetrow, Jacquelyn S.] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA; [McNulty, Margaret A.; Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Callahan, Michael; Ferguson, Cristin] Wake Forest Univ, Bowman Gray Sch Med, Dept Orthoped Surg, Winston Salem, NC USA; [Fetrow, Jacquelyn S.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Loeser, RF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA.	rloeser@wakehealth.edu		Fetrow, Jacquelyn/0000-0002-0528-2049; McNulty, Margaret/0000-0001-6638-253X	Arthritis Foundation; Wake Forest University Translational Science Institute; NIH Musculoskeletal Training Grant [T32 AR050938]; NIH Orthopaedics and Skeletal Biology Training Grant [T32 AR052272]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938, T32AR052272] Funding Source: NIH RePORTER	Arthritis Foundation; Wake Forest University Translational Science Institute; NIH Musculoskeletal Training Grant; NIH Orthopaedics and Skeletal Biology Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by an Innovative Research Award from the Arthritis Foundation, The Wake Forest University Translational Science Institute, NIH Musculoskeletal Training Grant (T32 AR050938) and NIH Orthopaedics and Skeletal Biology Training Grant (T32 AR052272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1261; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Chou Jeff W., 2005, Journal of Bioinformatics and Computational Biology, V3, P225, DOI 10.1142/S0219720005001028; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Grover J, 2007, MATRIX BIOL, V26, P140, DOI 10.1016/j.matbio.2006.10.005; Happonen KE, 2012, J BIOL CHEM, V287, P8092, DOI 10.1074/jbc.M111.291476; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; McNulty MA, 2012, OSTEOARTHR CARTILAGE, V20, P949, DOI 10.1016/j.joca.2012.05.001; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Neame PJ, 1999, CELL MOL LIFE SCI, V55, P1327, DOI 10.1007/s000180050373; Olex AL, 2011, BIOINFORMATICS, V27, P1330, DOI 10.1093/bioinformatics/btr115; Olex AL, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-41; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Sharif M, 2004, ARTHRITIS RHEUM, V50, P2479, DOI 10.1002/art.20365; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Young RD, 2000, J HISTOCHEM CYTOCHEM, V48, P423, DOI 10.1177/002215540004800312	31	81	81	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54633	10.1371/journal.pone.0054633	http://dx.doi.org/10.1371/journal.pone.0054633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382930	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500021
J	Walker, ML; Farcot, E; Traas, J; Godin, C				Walker, Michael Luke; Farcot, Etienne; Traas, Jan; Godin, Christophe			The Flux-Based PIN Allocation Mechanism Can Generate Either Canalyzed or Diffuse Distribution Patterns Depending on Geometry and Boundary Conditions	PLOS ONE			English	Article							AUXIN TRANSPORT; CANALIZATION; MODEL; ENDOCYTOSIS; PHYLLOTAXIS; DYNAMICS; POLARITY; LEAVES; ABP1	Growth and morphogenesis in plants require controlled transport of the plant hormone auxin. An important participant is the auxin effluxing protein PIN, whose polarized subcellular localization allows it to effectively transport auxin large distances through tissues. The flux-based model, in which auxin flux through a wall stimulates PIN allocation to that wall, is a dominant contender among models determining where and in what quantity PIN is allocated to cell walls. In this paper we characterise the behaviour of flux-based PIN allocation models in various tissues of the shoot apical meristem. Arguing from both mathematical analysis and computer simulations, we describe the natural behaviours of this class of models under various circumstances. In particular, we demonstrate the important dichotomy between sink- and source-driven systems, and show that both diffuse and canalized PIN distributions can be generated simultaneously in the same tissue, without model hybridization or variation of PIN-related parameters. This work is performed in the context of the shoot apical and floral meristems and is applicable to the construction of a unified PIN allocation model.	[Walker, Michael Luke; Farcot, Etienne; Godin, Christophe] INRIA, UMR AGAP, Virtual Plants Project Team, Montpellier, France; [Traas, Jan] Univ Lyon 1, INRA, CNRS, ENS Lyon,Lab Reprod & Dev Plantes, F-69365 Lyon, France	Inria; Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Walker, ML (corresponding author), INRIA, UMR AGAP, Virtual Plants Project Team, Montpellier, France.	Michael.Walker@inria.fr; Christophe.Godin@inria.fr	Traas, Jan/AAZ-7004-2020; Godin, Christophe/C-1218-2008	Traas, Jan/0000-0001-5107-1472; Godin, Christophe/0000-0002-1202-8460	ANR under EU	ANR under EU(French National Research Agency (ANR))	This work was funded by ANR, partners of the ERASysBio+ initiative supported under the EU ERA-NET Plus scheme in FP7, iSAM project. It also received funding from the ANR grant GeneShape and from the Institute for Computational Biology of Montpellier (IBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Balla J, 2011, PLANT J, V65, P571, DOI 10.1111/j.1365-313X.2010.04443.x; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Feugier FG, 2005, J THEOR BIOL, V236, P366, DOI 10.1016/j.jtbi.2005.03.017; Feugier FG, 2006, GENE DEV; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Kramer EM, 2009, TRENDS PLANT SCI, V14, P242, DOI 10.1016/j.tplants.2009.02.005; Krupinski P, 2010, COLD SPRING HARBOR P, V2; Lin DS, 2012, CURR BIOL, V22, P1319, DOI 10.1016/j.cub.2012.05.019; Merks RMH, 2007, TRENDS PLANT SCI, V12, P384, DOI 10.1016/j.tplants.2007.08.004; MITCHISON GJ, 1981, PHILOS T ROY SOC B, V295, P461, DOI 10.1098/rstb.1981.0154; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Prusinkiewicz P, 2009, P NATL ACAD SCI USA, V106, P17431, DOI 10.1073/pnas.0906696106; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Rolland-Lagan AG, 2005, PLANT J, V44, P854, DOI 10.1111/j.1365-313X.2005.02581.x; SACHS T, 1969, ANN BOT-LONDON, V33, P263, DOI 10.1093/oxfordjournals.aob.a084281; Scarpella E, 2004, DEVELOPMENT, V131, P3445, DOI 10.1242/dev.01182; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Steinacher A, 2012, J THEOR BIOL, V296, P84, DOI 10.1016/j.jtbi.2011.11.020; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; van Mourik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028762; Wabnik K, 2012, MOL SYST BIOL, V6, P1; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003	30	12	12	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54802	10.1371/journal.pone.0054802	http://dx.doi.org/10.1371/journal.pone.0054802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382973	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500029
J	Otegui, J; Arino, AH; Encinas, MA; Pando, F				Otegui, Javier; Arino, Arturo H.; Encinas, Maria A.; Pando, Francisco			Assessing the Primary Data Hosted by the Spanish Node of the Global Biodiversity Information Facility (GBIF)	PLOS ONE			English	Article							DIVERSITY; CONSERVATION; PREDICTIONS; INDEX	In order to effectively understand and cope with the current 'biodiversity crisis', having large-enough sets of qualified data is necessary. Information facilitators such as the Global Biodiversity Information Facility (GBIF) are ensuring increasing availability of primary biodiversity records by linking data collections spread over several institutions that have agreed to publish their data in a common access schema. We have assessed the primary records that one such publisher, the Spanish node of GBIF (GBIF. ES), hosts on behalf of a number of institutions, considered to be a highly representative sample of the total mass of available data for a country in order to know the quantity and quality of the information made available. Our results may provide an indication of the overall fitness-for-use in these data. We have found a number of patterns in the availability and accrual of data that seem to arise naturally from the digitization processes. Knowing these patterns and features may help deciding when and how these data can be used. Broadly, the error level seems low. The available data may be of capital importance for the development of biodiversity research, both locally and globally. However, wide swaths of records lack data elements such as georeferencing or taxonomical levels. Although the remaining information is ample and fit for many uses, improving the completeness of the records would likely increase the usability span for these data.	[Otegui, Javier; Arino, Arturo H.] Univ Navarra, Dept Zool & Ecol, Navarra, Spain; [Encinas, Maria A.; Pando, Francisco] Unidad Coordinac Infraestruct Mundial Informac Bi, Madrid, Spain	University of Navarra	Otegui, J (corresponding author), Univ Navarra, Dept Zool & Ecol, Navarra, Spain.	javier.otegui@gmail.com	Otegui, Javier/B-3973-2012; Arino, Arturo H./A-2262-2012	Otegui, Javier/0000-0002-8997-3559; Arino, Arturo H./0000-0003-4620-6445	'Friends of the University of Navarra' Association	'Friends of the University of Navarra' Association	JO has received financial support of the 'Friends of the University of Navarra' Association (http://www.unav.es/servicio/amigos/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, GLOBAL BIODIVERSITY; Arino AH, 2008, P TDWG, P77; Arino AH, 2005, DIGITAL IMAGING BIOL, P87; Arino AH, 2009, METAANALISIS DATOS B; Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI DOI 10.17161/BI.V7I2.3991; Arino AH, 2006, P TDWG 2006, P84; Berendsohn WG, 2010, BIODIVERSITY INFORM, V7, P67, DOI [10.1016/j.ppees.2012.10.002, DOI 10.17161/BI.V7I2.3989]; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; BISBY FA, 2011, SPECIES 2000 ITIS CA; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Chapman AD, 2004, ENV DAT QUALITY; Chapman AD, 2006, GLOBAL BIODIVERSITY; Chavan V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S2; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Encinas MA, 2010, ANALISIS COMP DATOS; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Global Biodiversity Information Facility, 2006, TERMS REF PART NOD M; Global Biodiversity Information Facility, 2006, MEM UND; Guralnick R, 2009, BIOINFORMATICS, V25, P421, DOI 10.1093/bioinformatics/btn659; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Hill AW, 2011, GBIF POSITION PAPER; Ingwersen P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S3; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson NF, 2007, ANNU REV ENTOMOL, V52, P421, DOI 10.1146/annurev.ento.52.110405.091259; Kent R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025440; Krishtalka L, 2000, BIOSCIENCE, V50, P611, DOI 10.1641/0006-3568(2000)050[0611:CNHMCT]2.0.CO;2; Lira-Noriega A, 2007, DIVERS DISTRIB, V13, P185, DOI 10.1111/j.1472-4642.2006.00304.x; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; Mace GM, 2005, NATURE, V434, P32, DOI 10.1038/434032a; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Otegui J, 2009, E BIOSPH C BIOD INF; Otegui J, BIODIVERSIT IN PRESS; Otegui J, 2009, P TDWG 2009, P31; Palmer CL, 2007, 3 INT DIG CUR C 11 1; Pando F, 2011, 2011 GBIF SCI S ARG; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Sarkar IN, 2007, BRIEF BIOINFORM, V8, P347, DOI 10.1093/bib/bbm037; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Telenius A, 2011, NORD J BOT, V29, P378, DOI 10.1111/j.1756-1051.2011.01167.x; Valdecasas AG, 2003, BIODIVERS CONSERV, V12, P1113, DOI 10.1023/A:1023082606162; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wilson E.O., 1988, P3; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	44	27	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55144	10.1371/journal.pone.0055144	http://dx.doi.org/10.1371/journal.pone.0055144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372828	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400069
J	Welzen-Coppens, JMC; van Helden-Meeuwsen, CG; Leenen, PJM; Drexhage, HA; Versnel, MA				Welzen-Coppens, Jojanneke M. C.; van Helden-Meeuwsen, Cornelia G.; Leenen, Pieter J. M.; Drexhage, Hemmo A.; Versnel, Marjan A.			The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis	PLOS ONE			English	Article							NONOBESE DIABETIC MOUSE; T-CELL; INTERFERON-ALPHA; AUTOIMMUNE-DISEASES; CXCR3 LIGANDS; I INTERFERON; SIGLEC-H; MICE; MACROPHAGES; RECEPTOR	In non-obese diabetic (NOD) mice that spontaneously develop autoimmune diabetes, plasmacytoid dendritic cells (pDCs) have a diabetes-promoting role through IFN-alpha production on one hand, while a diabetes-inhibiting role through indoleamine 2,3-dioxygenase (IDO) production on the other. Little is known about the kinetics and phenotype of pDCs in the NOD pancreas during the development of autoimmune diabetes. While para/peri-insular accumulation of conventional dendritic cells (cDCs) could be observed from 4 weeks of age onwards in NOD mice, pDCs only started to accumulate around the islets of Langerhans from 10 weeks onwards, which is concomitant with the influx of lymphocytes. NOD pancreatic pDCs showed a tolerogenic phenotype as assessed by their high expression of IDO and non-detectable levels of IFN-alpha and MxA. Furthermore, expression of the pDC-attracting chemokines CXCL10 and CXCL12 was significantly increased in the NOD pancreas at 10 weeks and the circulating pDC numbers were increased at 4 and 10 weeks. Our data suggest that a simultaneous accumulation of IDO+ pDCs and lymphocytes in the pancreas in 10 weeks old NOD mice, which may reflect both an immunogenic influx of T cells as well as a tolerogenic attempt to control these immunogenic T cells.	[Welzen-Coppens, Jojanneke M. C.; van Helden-Meeuwsen, Cornelia G.; Leenen, Pieter J. M.; Drexhage, Hemmo A.; Versnel, Marjan A.] Erasmus MC Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Welzen-Coppens, JMC (corresponding author), Erasmus MC Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands.	j.coppens@erasmusmc.nl	Leenen, Pieter JM/I-5839-2013	Leenen, Pieter JM/0000-0001-9860-2920	Juvenile Diabetes Research Foundation [5-2006-31]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors would like to thank the Juvenile Diabetes Research Foundation for supporting this study, grant number 5-2006-31 (http://www.jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bouma G, 2005, EUR J IMMUNOL, V35, P2386, DOI 10.1002/eji.200526251; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Chen XQ, 2008, CLIN IMMUNOL, V129, P413, DOI 10.1016/j.clim.2008.08.013; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Fox CJ, 1998, DIABETES, V47, P331, DOI 10.2337/diabetes.47.3.331; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Hinkmann C, 2008, HORM METAB RES, V40, P767, DOI 10.1055/s-2008-1080896; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; LEITER EH, 1987, AM J PATHOL, V128, P380; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Nikolic T, 2005, LAB INVEST, V85, P487, DOI 10.1038/labinvest.3700238; Nikolic T, 2009, IMMUNOBIOLOGY, V214, P791, DOI 10.1016/j.imbio.2009.06.002; REDDY S, 1995, PANCREAS, V11, P16, DOI 10.1097/00006676-199507000-00002; Ronnblom L, 2003, AUTOIMMUNITY, V36, P463, DOI 10.1080/08916930310001602128; Rosmalen JGM, 2002, TRENDS ENDOCRIN MET, V13, P209, DOI 10.1016/S1043-2760(02)00600-8; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; SIGNORE A, 1989, DIABETOLOGIA, V32, P282, DOI 10.1007/BF00265543; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Welzen-Coppens JM, 2012, EUR J IMMUNOL; Wildenberg ME, 2008, EUR J IMMUNOL, V38, P2024, DOI 10.1002/eji.200738008; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	36	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55071	10.1371/journal.pone.0055071	http://dx.doi.org/10.1371/journal.pone.0055071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372814	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400057
J	Rodriguez-Tornos, FM; San Aniceto, I; Cubelos, B; Nieto, M				Rodriguez-Tornos, Fernanda M.; San Aniceto, Inigo; Cubelos, Beatriz; Nieto, Marta			Enrichment of Conserved Synaptic Activity-Responsive Element in Neuronal Genes Predicts a Coordinated Response of MEF2, CREB and SRF	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; AUTISM; EXPRESSION; MEMORY; HOMER; TRANSCRIPTION; HIPPOCAMPAL; REQUIREMENT; PLASTICITY; SYNAPSES	A unique synaptic activity-responsive element (SARE) sequence, composed of the consensus binding sites for SRF, MEF2 and CREB, is necessary for control of transcriptional upregulation of the Arc gene in response to synaptic activity. We hypothesize that this sequence is a broad mechanism that regulates gene expression in response to synaptic activation and during plasticity; and that analysis of SARE-containing genes could identify molecular mechanisms involved in brain disorders. To search for conserved SARE sequences in the mammalian genome, we used the SynoR in silico tool, and found the SARE cluster predominantly in the regulatory regions of genes expressed specifically in the nervous system; most were related to neural development and homeostatic maintenance. Two of these SARE sequences were tested in luciferase assays and proved to promote transcription in response to neuronal activation. Supporting the predictive capacity of our candidate list, up-regulation of several SARE containing genes in response to neuronal activity was validated using external data and also experimentally using primary cortical neurons and quantitative real time RT-PCR. The list of SARE-containing genes includes several linked to mental retardation and cognitive disorders, and is significantly enriched in genes that encode mRNA targeted by FMRP (fragile X mental retardation protein). Our study thus supports the idea that SARE sequences are relevant transcriptional regulatory elements that participate in plasticity. In addition, it offers a comprehensive view of how activity-responsive transcription factors coordinate their actions and increase the selectivity of their targets. Our data suggest that analysis of SARE-containing genes will reveal yet-undescribed pathways of synaptic plasticity and additional candidate genes disrupted in mental disease.	[Rodriguez-Tornos, Fernanda M.; Nieto, Marta] CSIC, CNB, Madrid, Spain; [San Aniceto, Inigo] Univ Complutense Madrid, Fac Informat, Madrid, Spain; [Cubelos, Beatriz] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Nieto, M (corresponding author), CSIC, CNB, Darwin 3,Campus Cantoblanco, Madrid, Spain.	mnlopez@cnb.csic.es	Nieto, Marta/F-1434-2013	Nieto, Marta/0000-0002-8349-8435; Cubelos Alvarez, Beatriz/0000-0002-2280-8233	Ministerio de Ciencia e Innovacion (MICINN) [SAF2008-00211, PIE- 200820I166]; Spanish Comunidad de Madrid [CCG08-CSIC/SAL-3464]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Comunidad de Madrid(Comunidad de Madrid)	This work was funded by the Ministerio de Ciencia e Innovacion (MICINN) grants (SAF2008-00211; PIE- 200820I166), and a grant from the Spanish Comunidad de Madrid CCG08-CSIC/SAL-3464. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Inoue N, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-7; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Laumonnier F, 2006, AM J PSYCHIAT, V163, P1622, DOI 10.1176/appi.ajp.163.9.1622; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu XL, 2012, GENOME RES, V22, P611, DOI 10.1101/gr.127324.111; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ovcharenko I, 2005, NUCLEIC ACIDS RES, V33, pW403, DOI 10.1093/nar/gki466; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Upadhya SC, 2011, NEUROCHEM INT, V59, P787, DOI 10.1016/j.neuint.2011.08.009; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	36	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53848	10.1371/journal.pone.0053848	http://dx.doi.org/10.1371/journal.pone.0053848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382855	Green Published, gold			2022-12-25	WOS:000314610600019
J	Cullen, CL; Burne, THJ; Lavidis, NA; Moritz, KM				Cullen, Carlie L.; Burne, Thomas H. J.; Lavidis, Nickolas A.; Moritz, Karen M.			Low Dose Prenatal Ethanol Exposure Induces Anxiety-Like Behaviour and Alters Dendritic Morphology in the Basolateral Amygdala of Rat Offspring	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; FEAR-POTENTIATED STARTLE; SOCIAL-INTERACTION; MODERATE LEVELS; BINGE DRINKING; CELL LOSS; STRESS; BRAIN; PREGNANCY; SPINES	Prenatal exposure to high levels of alcohol is strongly associated with poor cognitive outcomes particularly in relation to learning and memory. It is also becoming more evident that anxiety disorders and anxiety-like behaviour can be associated with prenatal alcohol exposure. This study used a rat model to determine if prenatal exposure to a relatively small amount of alcohol would result in anxiety-like behaviour and to determine if this was associated with morphological changes in the basolateral amygdala. Pregnant Sprague Dawley rats were fed a liquid diet containing either no alcohol (Control) or 6% (vol/vol) ethanol (EtOH) throughout gestation. Male and Female offspring underwent behavioural testing at 8 months (Adult) or 15 months (Aged) of age. Rats were perfusion fixed and brains were collected at the end of behavioural testing for morphological analysis of pyramidal neuron number and dendritic morphology within the basolateral amygdala. EtOH exposed offspring displayed anxiety-like behaviour in the elevated plus maze, holeboard and emergence tests. Although sexually dimorphic behaviour was apparent, sex did not impact anxiety-like behaviour induced by prenatal alcohol exposure. This increase in anxiety - like behaviour could not be attributed to a change in pyramidal cell number within the BLA but rather was associated with an increase in dendritic spines along the apical dendrite which is indicative of an increase in synaptic connectivity and activity within these neurons. This study is the first to link increases in anxiety like behaviour to structural changes within the basolateral amygdala in a model of prenatal ethanol exposure. In addition, this study has shown that exposure to even a relatively small amount of alcohol during development leads to long term alterations in anxiety-like behaviour.	[Cullen, Carlie L.; Lavidis, Nickolas A.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	k.moritz1@uq.edu.au	Moritz, Karen/G-2508-2015; Burne, Thomas H/C-5656-2009; Cullen, Carlie/H-6535-2013; Cullen, Carlie/J-7706-2014	Moritz, Karen/0000-0002-8085-0034; Burne, Thomas H/0000-0003-3502-9789; Cullen, Carlie/0000-0001-6929-6258	National Health and Medical Research Council of Australia; NHMRC; Australian post-graduate award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian post-graduate award(Australian Government)	This work was supported by a project grant from the National Health and Medical Research Council of Australia. KMM is supported by a NH&MRC Senior Research Fellowship and CC by an Australian post-graduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1983, NEUROBEH TOXICOL TER, V5, P363; ABEL EL, 1995, NEUROTOXICOL TERATOL, V17, P437, DOI 10.1016/0892-0362(95)00005-C; Adamec RE, 2005, NEUROSCI BIOBEHAV R, V29, P1225, DOI 10.1016/j.neubiorev.2005.05.007; Allan AM, 2003, ALCOHOL CLIN EXP RES, V27, P2009, DOI 10.1097/01.ALC.0000100940.95053.72; Allison C, 2003, PHARMACOL THERAPEUT, V98, P171, DOI 10.1016/S0163-7258(03)00029-9; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P509, DOI 10.1093/alcalc/35.5.509; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; Baker S, 2009, BRAIN RES, V1302, P194, DOI 10.1016/j.brainres.2009.09.023; Barr HM, 2006, AM J PSYCHIAT, V163, P1061, DOI 10.1176/appi.ajp.163.6.1061; Barr HM, 2001, ALCOHOL CLIN EXP RES, V25, P283, DOI 10.1111/j.1530-0277.2001.tb02210.x; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; Bogoch Y, 2007, J NEUROCHEM, V101, P1018, DOI 10.1111/j.1471-4159.2006.04402.x; Brocardo PS, 2012, NEUROPHARMACOLOGY, V62, P1607, DOI 10.1016/j.neuropharm.2011.10.006; BROWN RT, 1991, NEUROTOXICOL TERATOL, V13, P369, DOI 10.1016/0892-0362(91)90085-B; Burden MJ, 2011, ALCOHOL CLIN EXP RES, V35, P69, DOI 10.1111/j.1530-0277.2010.01323.x; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; Cui ZJ, 2010, ALCOHOL ALCOHOLISM, V45, P312, DOI 10.1093/alcalc/agq036; Dursun I, 2006, PHARMACOL BIOCHEM BE, V85, P345, DOI 10.1016/j.pbb.2006.09.001; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Elliott EJ, 2008, ARCH DIS CHILD, V93, P732, DOI 10.1136/adc.2007.120220; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Gabriel KI, 2006, PSYCHONEUROENDOCRINO, V31, P1046, DOI 10.1016/j.psyneuen.2006.06.003; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giglia Roslyn C, 2008, Breastfeed Rev, V16, P17; Gonzalez-Burgos I, 2006, NEUROSCI RES, V56, P400, DOI 10.1016/j.neures.2006.08.007; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; HALL JL, 1994, PSYCHOBIOLOGY, V22, P181; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; Hamilton GF, 2010, SYNAPSE, V64, P127, DOI 10.1002/syn.20711; Harris KR, 2003, J PAEDIATR CHILD H, V39, P528, DOI 10.1046/j.1440-1754.2003.00208.x; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Hellemans KGC, 2008, ANN NY ACAD SCI, V1144, P154, DOI 10.1196/annals.1418.016; Hofmann CE, 2005, PHARMACOL BIOCHEM BE, V82, P549, DOI 10.1016/j.pbb.2005.10.010; JONES KL, 1973, LANCET, V1, P1267; KELLY SJ, 1988, BEHAV BRAIN RES, V27, P247, DOI 10.1016/0166-4328(88)90121-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee PR, 2007, BRAIN RES, V1156, P152, DOI 10.1016/j.brainres.2007.04.042; Lee S, 1990, MOL CELLULAR NEUROSC, V1; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Maier SE, 2003, ALCOHOL, V30, P67, DOI 10.1016/S0741-8329(03)00096-X; Maier SE, 2001, ALCOHOL, V23, P49, DOI 10.1016/S0741-8329(00)00133-6; MARCUSSEN BL, 1994, ALCOHOL, V11, P147, DOI 10.1016/0741-8329(94)90056-6; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Moonat S, 2011, ADDICT BIOL, V16, P238, DOI 10.1111/j.1369-1600.2010.00275.x; Morley KC, 2001, EUR J PHARMACOL, V433, P91, DOI 10.1016/S0014-2999(01)01512-6; NAPPER RMA, 1995, J COMP NEUROL, V362, P283, DOI 10.1002/cne.903620210; Ogilvie KM, 1997, ALCOHOL CLIN EXP RES, V21, P424, DOI 10.1111/j.1530-0277.1997.tb03786.x; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Probyn ME, 2012, REPROD FERT DEVELOP, V24, P859, DOI 10.1071/RD11200; Rainnie DG, 2004, J NEUROSCI, V24, P3471, DOI 10.1523/JNEUROSCI.5740-03.2004; Rasmussen C, 2011, CHILD CARE HLTH DEV, V37, P711, DOI 10.1111/j.1365-2214.2010.01152.x; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; SANDERS SK, 1995, BRAIN RES, V699, P250, DOI 10.1016/0006-8993(95)00915-D; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; Sayal K, 2009, PEDIATRICS, V123, pE289, DOI 10.1542/peds.2008-1861; Schneider ML, 2001, ALCOHOL CLIN EXP RES, V25, P1383; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Streissguth A P, 2000, Semin Clin Neuropsychiatry, V5, P177, DOI 10.1053/scnp.2000.6729; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; WEST JR, 1990, ANN MED, V22, P319, DOI 10.3109/07853899009147914; WEST JR, 1994, METAB BRAIN DIS, V9, P291, DOI 10.1007/BF02098878; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Westergren S, 1996, PHARMACOL BIOCHEM BE, V55, P515, DOI 10.1016/S0091-3057(96)00277-8; Willford JA, 2004, ALCOHOL CLIN EXP RES, V28, P497, DOI 10.1097/01.ALC.0000117868.97486.2D; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhou R, 2010, NEUROSCIENCE, V170, P749, DOI 10.1016/j.neuroscience.2010.07.055; ZIMMERBERG B, 1991, BEHAV BRAIN RES, V42, P49, DOI 10.1016/S0166-4328(05)80039-7	76	71	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54924	10.1371/journal.pone.0054924	http://dx.doi.org/10.1371/journal.pone.0054924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383000	Green Published, gold			2022-12-25	WOS:000315563800088
J	Hure, AJ; Powers, JR; Chojenta, CL; Byles, JE; Loxton, D				Hure, Alexis J.; Powers, Jennifer R.; Chojenta, Catherine L.; Byles, Julie E.; Loxton, Deborah			Poor Adherence to National and International Breastfeeding Duration Targets in an Australian Longitudinal Cohort	PLOS ONE			English	Article							MATERNAL RECALL	Objectives: To report on the proportion and characteristics of Australian infants who are fed, and mothers who feed, in accordance with the national and international breastfeeding duration targets of six, 12 and 24 months. Furthermore, to examine the longitudinal breastfeeding duration patterns for women with more than one child. Methods: Breastfeeding duration data for 9773 children have been self-reported by a national sample of 5091 mothers aged 30-36 years in 2009, participating in the Australian Longitudinal Study on Women's Health. Results: Only 60% of infants received the minimum recommended 6 months of breast milk, irrespective of breastfeeding exclusivity. Less than 30% of infants received any breast milk at 12 months, and less than 3% were breastfed to the international target of 24 months. Young, less educated, unmarried or low-income women were at an increased risk of premature breastfeeding cessation. For women with three or more children, nearly 75% of women who breastfed their first child for at least six months reached this breastfeeding duration target for their next two children. Conclusion: While national breastfeeding rates are typically evaluated in relation to the infant, a novel component of our study is that we have assessed maternal adherence to breastfeeding duration targets and the longitudinal feeding practices of women with more than one child. Separate evaluations of maternal and infant breastfeeding rates are important as they differ in their implications for public health policy and practice.	[Hure, Alexis J.; Powers, Jennifer R.; Chojenta, Catherine L.; Byles, Julie E.; Loxton, Deborah] Univ Newcastle, Sch Med & Publ Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia	University of Newcastle	Hure, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia.	alexis.hure@newcastle.edu.au	Byles, Julie E/C-5062-2008; Chojenta, Catherine L/B-2521-2008; Powers, Jennifer R/A-8108-2011	Byles, Julie E/0000-0002-3984-6877; Chojenta, Catherine L/0000-0002-2541-4491; Hure, Alexis/0000-0003-2225-0986	Department of Health and Ageing; National Health and Medical Research Council	Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Longitudinal Study on Women's Health is funded by the Department of Health and Ageing. AJH is a Postdoctoral Research Fellow with the Centre for Research Excellence in Women's Health in the 21st Century, funded by the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2010, 4102 0 AUSTR SOC TRE; Australian Government Department of Health and Ageing, 2009, AUSTR HLTH MIN C 200; Australian Institute of Health and Welfare, 2009, PICT AUSTR CHILDR 20; Australian Institute of Health and Welfare, 2005, PICT AUSTR CHILDR 20; Australian Institute of Health and Welfare, 2011, 2010 AUSTR NAT INF F; Blyth R, 2002, BIRTH-ISS PERINAT C, V29, P278, DOI 10.1046/j.1523-536X.2002.00202.x; Bolling K, 2007, INFANT FEEDING SURVE; Bonet M, 2012, MATERN CHILD HLTH J; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Centers for Disease Control and Prevention, 2012, BREASTF US CHILDR BO; Chinese Nutrition Society, 2022, DIET GUID SCH AG CHI; Hure AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037109; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Meedya Shahla, 2010, Women Birth, V23, P135, DOI 10.1016/j.wombi.2010.02.002; Powers J, 2010, ANN EPIDEMIOL, V20, P318, DOI 10.1016/j.annepidem.2010.01.002; Promislow JHE, 2005, AM J EPIDEMIOL, V161, P289, DOI 10.1093/aje/kwi044; UNICEF, 2012, BREASTF; Webb K, 2001, NATL SYSTEM MONITORI; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	20	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54409	10.1371/journal.pone.0054409	http://dx.doi.org/10.1371/journal.pone.0054409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382897	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800048
J	Rakosy, Z; Ecsedi, S; Toth, R; Vizkeleti, L; Herandez-Vargas, H; Lazar, V; Emri, G; Szatmari, I; Herceg, Z; Adany, R; Balazs, M				Rakosy, Zsuzsa; Ecsedi, Szilvia; Toth, Reka; Vizkeleti, Laura; Herandez-Vargas, Hector; Lazar, Viktoria; Emri, Gabriella; Szatmari, Istvan; Herceg, Zdenko; Adany, Roza; Balazs, Margit			Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration	PLOS ONE			English	Article							COPY NUMBER ALTERATIONS; MALIGNANT-MELANOMA; DNA-METHYLATION; IN-SITU; MOLECULAR CLASSIFICATION; EXPRESSION SIGNATURES; SOMATIC ALTERATIONS; CUTANEOUS MELANOMA; TUMOR PROGRESSION; TRANSITION	Background: Despite the extensive research approaches applied to characterise malignant melanoma, no specific molecular markers are available that are clearly related to the progression of this disease. In this study, our aims were to define a gene expression signature associated with the clinical outcome of melanoma patients and to provide an integrative interpretation of the gene expression -, copy number alterations -, and promoter methylation patterns that contribute to clinically relevant molecular functional alterations. Methods: Gene expression profiles were determined using the Affymetrix U133 Plus2.0 array. The NimbleGen Human CGH Whole-Genome Tiling array was used to define CNAs, and the Illumina GoldenGate Methylation platform was applied to characterise the methylation patterns of overlapping genes. Results: We identified two subclasses of primary melanoma: one representing patients with better prognoses and the other being characteristic of patients with unfavourable outcomes. We assigned 1,080 genes as being significantly correlated with ulceration, 987 genes were downregulated and significantly enriched in the p53, Nf-kappaB, and WNT/beta-catenin pathways. Through integrated genome analysis, we defined 150 downregulated genes whose expression correlated with copy number losses in ulcerated samples. These genes were significantly enriched on chromosome 6q and 10q, which contained a total of 36 genes. Ten of these genes were downregulated and involved in cell-cell and cell-matrix adhesion or apoptosis. The expression and methylation patterns of additional genes exhibited an inverse correlation, suggesting that transcriptional silencing of these genes is driven by epigenetic events. Conclusion: Using an integrative genomic approach, we were able to identify functionally relevant molecular hotspots characterised by copy number losses and promoter hypermethylation in distinct molecular subtypes of melanoma that contribute to specific transcriptomic silencing and might indicate a poor clinical outcome of melanoma.	[Rakosy, Zsuzsa; Ecsedi, Szilvia; Toth, Reka; Vizkeleti, Laura; Lazar, Viktoria; Adany, Roza; Balazs, Margit] Univ Debrecen, Med & Hlth Sci Ctr, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary; [Rakosy, Zsuzsa; Ecsedi, Szilvia; Vizkeleti, Laura; Adany, Roza; Balazs, Margit] Univ Debrecen, Hungarian Acad Sci, Publ Hlth Res Grp, H-4012 Debrecen, Hungary; [Emri, Gabriella] Univ Debrecen, Med & Hlth Sci Ctr, Fac Med, Dept Dermatol, H-4012 Debrecen, Hungary; [Szatmari, Istvan] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Herandez-Vargas, Hector; Herceg, Zdenko] WHO, Int Agcy Res Canc, Epigenet Grp, Lyon, France	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; University of Debrecen; World Health Organization; International Agency for Research on Cancer (IARC)	Balazs, M (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary.	balazs.margit@sph.unideb.hu	Toth, Reka/AAB-1695-2020; Szatmari, Istvan/B-3152-2010; Lazar, Vladimir/AAQ-2086-2020; Vizkeleti, Laura/T-4416-2017	Toth, Reka/0000-0002-6096-1052; Szatmari, Istvan/0000-0001-5260-1498; Vizkeleti, Laura/0000-0001-6870-3499; Hernandez-Vargas, Hector/0000-0001-6045-2103; Lazar, Viktoria/0000-0002-9778-941X; Zsuzsa, Rakosy/0000-0002-9852-1159	Hungarian National Research Fund [OTKA K75191]; National Research and Development Program of Hungary [NKFP1-00003/2005]; Hungarian Medical Research Council [193/09-ETT]; Hungarian Academy of Sciences [2011 TKI 473]; European Union; European Social Fund;  [TAMOP 4.2.1/B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV-2012-0031]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Program of Hungary; Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); European Social Fund(European Social Fund (ESF)); ; 	This work was supported by the Hungarian National Research Fund (OTKA K75191), the National Research and Development Program of Hungary (NKFP1-00003/2005), the Hungarian Medical Research Council (193/09-ETT), the Hungarian Academy of Sciences (grant number 2011 TKI 473), by the TAMOP 4.2.1/B-09/1/KONV-2010-0007 and TAMOP-4.2.2.A-11/1/KONV-2012-0031 projects; the TAMOP projects are co-financed by the European Union and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Berger MF, 2009, HEMATOL ONCOL CLIN N, V23, P397, DOI 10.1016/j.hoc.2009.03.005; Berthier-Vergnes O, 2011, BRIT J CANCER, V104, P155, DOI 10.1038/sj.bjc.6605994; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blokx WAM, 2010, HISTOPATHOLOGY, V56, P121, DOI 10.1111/j.1365-2559.2009.03452.x; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Christensen BC, 2010, CANCER RES, V70, P5686, DOI 10.1158/0008-5472.CAN-10-0190; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Conway C, 2010, GENE CHROMOSOME CANC, V49, P425, DOI 10.1002/gcc.20753; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Daryanani D, 2006, EJSO-EUR J SURG ONC, V32, P218, DOI 10.1016/j.ejso.2005.11.011; Dietel Manfred, 2007, V176, P25; Eggermont AMM, 2012, CURR OPIN ONCOL, V24, P137, DOI 10.1097/CCO.0b013e32834fcb0d; Forschner A, 2010, CLIN DERMATOL, V28, P275, DOI 10.1016/j.clindermatol.2009.06.012; Freedman JA, 2011, AM J PATHOL, V178, P2513, DOI 10.1016/j.ajpath.2011.02.037; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Gao K, 2008, INT J ONCOL, V32, P1343; Gast A, 2010, GENE CHROMOSOME CANC, V49, P733, DOI 10.1002/gcc.20785; Gaudi Sudeep, 2011, Patholog Res Int, V2011, P159421, DOI 10.4061/2011/159421; Gerami P, 2011, J CUTAN PATHOL, V38, P329, DOI 10.1111/j.1600-0560.2010.01666.x; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Goppner D, 2011, J SKIN CANC, V2011, DOI DOI 10.1155/2011/521947; Ha LN, 2008, CELL CYCLE, V7, P1944, DOI 10.4161/cc.7.13.6230; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; in't Hout FEM, 2012, ANN SURG, V255, P1165, DOI 10.1097/SLA.0b013e31824c4b0b; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Jensen EH, 2007, ANN SURG ONCOL, V14, P1416, DOI 10.1245/s10434-006-9226-2; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Koh SS, 2009, MODERN PATHOL, V22, P538, DOI 10.1038/modpathol.2009.8; Kunz M, 2008, Curr Drug Discov Technol, V5, P9, DOI 10.2174/157016308783769423; Macdonald JB, 2011, J CANCER, V2, P538, DOI 10.7150/jca.2.538; Mandruzzato S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-50; Martins WK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-76; Mitra A, 2010, BRIT J CANCER, V103, P1229, DOI 10.1038/sj.bjc.6605849; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; Rakosy Z, 2008, CANCER GENET CYTOGEN, V182, P116, DOI 10.1016/j.cancergencyto.2008.01.008; Rakosy Z, 2007, INT J CANCER, V121, P1729, DOI 10.1002/ijc.22928; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rose AE, 2011, CANCER RES, V71, P2561, DOI 10.1158/0008-5472.CAN-10-2958; Schinke C, 2010, MELANOMA RES, V20, P253, DOI 10.1097/CMR.0b013e328338a35a; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Soong SJ, 2010, ANN SURG ONCOL, V17, P2006, DOI 10.1245/s10434-010-1050-z; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369; van de Wiel MA, 2007, CANCER INFORM, V3, P55; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yeang CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-495; Yuan YY, 2012, IEEE ACM T COMPUT BI, V9, P947, DOI 10.1109/TCBB.2011.105	63	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54958	10.1371/journal.pone.0054958	http://dx.doi.org/10.1371/journal.pone.0054958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383013	Green Published, gold			2022-12-25	WOS:000315563800090
J	Johnson, RM; Dahlgren, L; Siegfried, BD; Ellis, MD				Johnson, Reed M.; Dahlgren, Lizette; Siegfried, Blair D.; Ellis, Marion D.			Acaricide, Fungicide and Drug Interactions in Honey Bees (Apis mellifera)	PLOS ONE			English	Article							DEGRADATION-PRODUCTS; PESTICIDE-RESIDUES; VARROA-DESTRUCTOR; OXALIC-ACID; MECHANISM; TOXICITY; HYMENOPTERA; COLONIES; DELTAMETHRIN; COUMAPHOS	Background: Chemical analysis shows that honey bees (Apis mellifera) and hive products contain many pesticides derived from various sources. The most abundant pesticides are acaricides applied by beekeepers to control Varroa destructor. Beekeepers also apply antimicrobial drugs to control bacterial and microsporidial diseases. Fungicides may enter the hive when applied to nearby flowering crops. Acaricides, antimicrobial drugs and fungicides are not highly toxic to bees alone, but in combination there is potential for heightened toxicity due to interactive effects. Methodology/Principal Findings: Laboratory bioassays based on mortality rates in adult worker bees demonstrated interactive effects among acaricides, as well as between acaricides and antimicrobial drugs and between acaricides and fungicides. Toxicity of the acaricide tau-fluvalinate increased in combination with other acaricides and most other compounds tested (15 of 17) while amitraz toxicity was mostly unchanged (1 of 15). The sterol biosynthesis inhibiting (SBI) fungicide prochloraz elevated the toxicity of the acaricides tau-fluvalinate, coumaphos and fenpyroximate, likely through inhibition of detoxicative cytochrome P450 monooxygenase activity. Four other SBI fungicides increased the toxicity of tau-fluvalinate in a dose-dependent manner, although possible evidence of P450 induction was observed at the lowest fungicide doses. Non-transitive interactions between some acaricides were observed. Sublethal amitraz pre-treatment increased the toxicity of the three P450-detoxified acaricides, but amitraz toxicity was not changed by sublethal treatment with the same three acaricides. A two-fold change in the toxicity of tau-fluvalinate was observed between years, suggesting a possible change in the genetic composition of the bees tested. Conclusions/Significance: Interactions with acaricides in honey bees are similar to drug interactions in other animals in that P450-mediated detoxication appears to play an important role. Evidence of non-transivity, year-to-year variation and induction of detoxication enzymes indicates that pesticide interactions in bees may be as complex as drug interactions in mammals.	[Johnson, Reed M.; Dahlgren, Lizette; Siegfried, Blair D.; Ellis, Marion D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Johnson, RM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	johnson.5005@osu.edu	Johnson, Reed M./H-3742-2011	Johnson, Reed M./0000-0002-2431-0180	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2009-85118-05718]	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	Funding support was provided by the United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative, Managed Pollinator Coordinated Agricultural Project 2009-85118-05718 (http://www.csrees.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk S, 2005, J AGR FOOD CHEM, V53, P10085, DOI 10.1021/jf051813f; Aliano NP, 2006, J ECON ENTOMOL, V99, P1579, DOI 10.1603/0022-0493-99.5.1579; ANKE T, 1995, CAN J BOT, V73, pS940, DOI 10.1139/b95-342; Atkins EL, 1992, HIVE HONEY BEE, P1153; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Bogdanov S, 2004, BEE WORLD, V85, P46, DOI 10.1080/0005772X.2004.11099623; Bogdanov S, 1998, APIDOLOGIE, V29, P513, DOI 10.1051/apido:19980604; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Corta E, 1999, TALANTA, V48, P189, DOI 10.1016/S0039-9140(98)00237-9; Corta E, 2000, TALANTA, V52, P169, DOI 10.1016/S0039-9140(00)00333-7; Dai PL, 2010, ENVIRON TOXICOL CHEM, V29, P644, DOI 10.1002/etc.67; De-Oliveira ACAX, 1999, TOXICOLOGY, V135, P33, DOI 10.1016/S0300-483X(99)00043-8; Elzen PJ, 2003, SOUTHWEST ENTOMOL, V28, P255; Elzen PJ, 2002, AM BEE J, V142, P291; FINNEY D J, 1971, P333; Fungicide Resistance Action Committee, 2012, FRAC COD LIST 2012; Garcia DA, 2006, NEUROPHARMACOLOGY, V50, P25, DOI 10.1016/j.neuropharm.2005.07.009; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gregorc A, 2000, CELL BIOL INT, V24, P319, DOI 10.1006/cbir.1999.0490; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kale M, 1999, TOXICOL LETT, V105, P197, DOI 10.1016/S0378-4274(98)00399-3; Kubik M, 2000, APIDOLOGIE, V31, P531, DOI 10.1051/apido:2000144; Kuhn P. J., 1984, Mode of action of antifungal agents, P155; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; LIU MY, 1992, PESTIC BIOCHEM PHYS, V43, P134, DOI 10.1016/0048-3575(92)90027-W; LODESANI M, 1995, APIDOLOGIE, V26, P67, DOI 10.1051/apido:19950109; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Medici SK, 2012, J APICULT RES, V51, P164, DOI 10.3896/IBRA.1.51.2.03; Meimaridou E, 2005, FREE RADICAL BIO MED, V38, P1553, DOI 10.1016/j.freeradbiomed.2005.02.020; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P449, DOI 10.1111/1523-1747.ep12285793; MOTOBA K, 1992, PESTIC BIOCHEM PHYS, V43, P37, DOI 10.1016/0048-3575(92)90017-T; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mussen EC, 2004, ENVIRON ENTOMOL, V33, P1151, DOI 10.1603/0046-225X-33.5.1151; ORR GL, 1990, PESTIC SCI, V30, P285, DOI 10.1002/ps.2780300305; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; R Core Team, 2021, R LANG ENV STAT COMP; Rademacher E, 2006, APIDOLOGIE, V37, P98, DOI 10.1051/apido:2005063; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Sokol Rajmund, 1996, Medycyna Weterynaryjna, V52, P718; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SANDERS WE, 1979, ANNU REV PHARMACOL, V19, P53, DOI 10.1146/annurev.pa.19.040179.000413; Savin N. E., 1977, Bulletin of the Entomological Society of America, V23, P257; Seeley T., 1995, WISDOM HIVE; Sergent T, 2009, TOXICOL LETT, V184, P159, DOI 10.1016/j.toxlet.2008.11.009; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Sparks T, 2012, MOA CLASSIFICATION F; Suzuki T, 2004, TOXICOLOGY, V204, P97, DOI 10.1016/j.tox.2004.06.025; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Tremolada P, 2004, ECOTOXICOLOGY, V13, P589, DOI 10.1023/B:ECTX.0000037193.28684.05; USMANI KA, 1995, J ECON ENTOMOL, V88, P1580, DOI 10.1093/jee/88.6.1580; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; Willoughby L, 2007, PEST MANAG SCI, V63, P803, DOI 10.1002/ps.1391; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yu S. J., 2014, The toxicology and biochemistry of insecticides; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010	75	250	260	12	274	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54092	10.1371/journal.pone.0054092	http://dx.doi.org/10.1371/journal.pone.0054092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382869	Green Published, gold			2022-12-25	WOS:000315483200004
J	Martinez-Beamonte, R; Navarro, MA; Acin, S; Guillen, N; Barranquero, C; Arnal, C; Surra, J; Osada, J				Martinez-Beamonte, Roberto; Navarro, Maria A.; Acin, Sergio; Guillen, Natalia; Barranquero, Cristina; Arnal, Carmen; Surra, Joaquin; Osada, Jesus			Postprandial Changes in High Density Lipoproteins in Rats Subjected to Gavage Administration of Virgin Olive Oil	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; CHOLESTERYL ESTER TRANSFER; KNOCKOUT MICE; SPHINGOMYELIN METABOLISM; PLASMA-LIPOPROTEINS; SERUM-LIPOPROTEINS; TRANSFER PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; INHIBITION	Background and Aims: The present study was designed to verify the influence of acute fat loading on high density lipoprotein (HDL) composition, and the involvement of liver and different segments of small intestine in the changes observed. Methods and Results: To address these issues, rats were administered a bolus of 5-ml of extra-virgin olive oil and sacrificed 4 and 8 hours after feeding. In these animals, lipoproteins were analyzed and gene expressions of apolipoprotein and HDL enzymes were assessed in duodenum, jejunum, ileum and liver. Using this experimental design, total plasma and HDL phospholipids increased at the 8-hour-time-point due to increased sphingomyelin content. An increase in apolipoprotein A4 was also observed mainly in lipid-poor HDL. Increased expression of intestinal Apoa1, Apoa4 and Sgms1 mRNA was accompanied by hepatic decreases in the first two genes in liver. Hepatic expression of Abcg1, Apoa1bp, Apoa2, Apoe, Ptlp, Pon1 and Scarb1 decreased significantly following fat gavage, while no changes were observed for Abca1, Lcat or Pla2g7. Significant associations were also noted for hepatic expression of apolipoproteins and Pon1. Manipulation of postprandial triglycerides using an inhibitor of microsomal transfer protein -CP-346086- or of lipoprotein lipase -tyloxapol- did not influence hepatic expression of Apoa1 or Apoa4 mRNA. Conclusion: All these data indicate that dietary fat modifies the phospholipid composition of rat HDL, suggesting a mechanism of down-regulation of hepatic HDL when intestine is the main source of those particles and a coordinated regulation of hepatic components of these lipoproteins at the mRNA level, independently of plasma postprandial triglycerides.	[Martinez-Beamonte, Roberto; Navarro, Maria A.; Acin, Sergio; Guillen, Natalia; Barranquero, Cristina; Osada, Jesus] Univ Zaragoza, Fac Vet, Dept Bioquim & Biol Mol & Celular, Inst Invest Sanitaria Aragon, Zaragoza, Spain; [Arnal, Carmen] Univ Zaragoza, Fac Vet, Dept Patol Anim, Zaragoza, Spain; [Surra, Joaquin] Escuela Politecn Super Huesca, Dept Anim Prod, Huesca, Spain; [Martinez-Beamonte, Roberto; Navarro, Maria A.; Acin, Sergio; Guillen, Natalia; Barranquero, Cristina; Arnal, Carmen; Surra, Joaquin; Osada, Jesus] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Osada, J (corresponding author), Univ Zaragoza, Fac Vet, Dept Bioquim & Biol Mol & Celular, Inst Invest Sanitaria Aragon, Zaragoza, Spain.	Josada@unizar.es	Surra, Joaquín Carlos/G-1128-2014; Acin, Sergio/S-5185-2017; Martinez Beamonte, Roberto/E-4981-2016	Surra, Joaquín Carlos/0000-0002-5841-0462; Acin, Sergio/0000-0001-7335-2865; Guillen Monzon, Natalia/0000-0001-6627-298X; Martinez Beamonte, Roberto/0000-0002-8100-5596	Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional [SAF2010-14958]; CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon [PI025/08]; Gobierno de Aragon-Fondo Social Europeo [B-69]; Fundacion ARAID; Miguel Servet grants	Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional; CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon(Gobierno de Aragon); Gobierno de Aragon-Fondo Social Europeo(Gobierno de Aragon); Fundacion ARAID; Miguel Servet grants	Funding provided by the Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional SAF2010-14958 (www.micinn.es/.../Anexo_ayudas_concedidas_proyectos_2010.xls); CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon (PI025/08); Gobierno de Aragon-Fondo Social Europeo (B-69); and Fundacion ARAID 2010/2012. M.A.N. and S.A. were recipients of Miguel Servet grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APFELBAUM TF, 1987, AM J PHYSIOL, V252, pG662, DOI 10.1152/ajpgi.1987.252.5.G662; Arbones-Mainar JM, 2006, J NUTR, V136, P353, DOI 10.1093/jn/136.2.353; BAGDADE JD, 1990, DIABETES, V39, P426, DOI 10.2337/diabetes.39.4.426; Barter P, 2011, TRENDS PHARMACOL SCI, V32, P694, DOI 10.1016/j.tips.2011.07.004; Bergeron N, 1997, CURR OPIN LIPIDOL, V8, P43, DOI 10.1097/00041433-199702000-00010; Bladergroen BA, 1999, J NUTR, V129, P628, DOI 10.1093/jn/129.3.628; BORENSZTAJN J, 1976, BIOCHEM J, V156, P539, DOI 10.1042/bj1560539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Calleja L, 2000, ATHEROSCLEROSIS, V152, P69, DOI 10.1016/S0021-9150(99)00451-7; Calleja L, 1999, ARTERIOSCL THROM VAS, V19, P2368, DOI 10.1161/01.ATV.19.10.2368; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70; Cianflone K, 2008, ATHEROSCLEROSIS SUPP, V9, P63, DOI 10.1016/j.atherosclerosissup.2008.05.014; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; DUVERGER N, 1994, BBA-LIPID LIPID MET, V1211, P23, DOI 10.1016/0005-2760(94)90134-1; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P8242, DOI 10.1073/pnas.82.23.8242; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; GEELEN MJH, 1995, J NUTR, V125, P2294, DOI 10.1093/jn/125.9.2294; Geelen MJH, 2000, BRIT J NUTR, V83, P541; Geelen MJH, 1999, J NUTR, V129, P2119, DOI 10.1093/jn/129.12.2119; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Glatzle J, 2004, AM J PHYSIOL-REG I, V287, pR354, DOI 10.1152/ajpregu.00705.2003; Guillen N, 2008, ATHEROSCLEROSIS, V196, P558; Guillen N, 2007, GENE, V388, P117, DOI 10.1016/j.gene.2006.10.013; He XX, 2002, ANAL BIOCHEM, V306, P115, DOI 10.1006/abio.2002.5686; Hewing B, 2012, CURR OPIN LIPIDOL; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Hussain MM, 2001, FRONT BIOSCI, V6, pD320, DOI 10.2741/Hussain; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Kalogeris TJ, 1997, J NUTR, V127, pS537, DOI 10.1093/jn/127.3.537S; Kalogeris TJ, 1996, AM J PHYSIOL-GASTR L, V270, pG277, DOI 10.1152/ajpgi.1996.270.2.G277; KALOGERIS TJ, 1994, J LIPID RES, V35, P1141; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; KELLEY JL, 1986, METHOD ENZYMOL, V128, P170; Kusunoki J, 2000, ARTERIOSCL THROM VAS, V20, P171, DOI 10.1161/01.ATV.20.1.171; Lairon D, 2008, ATHEROSCLEROSIS SUPP, V9, P45, DOI 10.1016/j.atherosclerosissup.2008.05.006; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Lou-Bonafonte JM, 2012, CURR VASC PHARMACOL, V10, P392; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Mahley RW, 1999, J LIPID RES, V40, P1933; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Martinez-Beamonte Roberto, 2011, Front Biosci (Elite Ed), V3, P11, DOI 10.2741/e215; MERRIL CR, 1984, METHOD ENZYMOL, V104, P441; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Nuno-Ayala M, 2010, ATHEROSCLEROSIS, V212, P268, DOI 10.1016/j.atherosclerosis.2010.04.028; OSADA J, 1994, ATHEROSCLEROSIS, V108, P83, DOI 10.1016/0021-9150(94)90039-6; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Overturf ML, 1992, CURR OPIN LIPIDOL, V3, P179, DOI DOI 10.1097/00041433-199206000-00004; Perez-Martinez P, 2008, ATHEROSCLEROSIS SUPP, V9, P49, DOI 10.1016/j.atherosclerosissup.2008.05.005; Redgrave TG, 2008, ATHEROSCLEROSIS SUPP, V9, P3, DOI 10.1016/j.atherosclerosissup.2008.05.002; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Rodriguez MD, 1997, AM J PHYSIOL-REG I, V272, pR1170, DOI 10.1152/ajpregu.1997.272.4.R1170; RUBIN DC, 1992, AM J PHYSIOL, V263, pG853, DOI 10.1152/ajpgi.1992.263.6.G853; Sonoyama K, 2000, J NUTR, V130, P637, DOI 10.1093/jn/130.3.637; Spaulding HL, 2006, AM J PHYSIOL-CELL PH, V290, pC95, DOI 10.1152/ajpcell.00388.2005; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; TALL A, 1986, J CLIN INVEST, V77, P1163, DOI 10.1172/JCI112417; TERPSTRA AHM, 1981, ANAL BIOCHEM, V111, P149, DOI 10.1016/0003-2697(81)90243-8; Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Xu TT, 2009, LIPIDS, V44, P161, DOI 10.1007/s11745-008-3258-2; Young SG, 1995, J CLIN INVEST, V96, P2932, DOI 10.1172/JCI118365	67	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55231	10.1371/journal.pone.0055231	http://dx.doi.org/10.1371/journal.pone.0055231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383120	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200049
J	Pan, YB; Zhou, FL; Zhang, RH; Claret, FX				Pan, Yunbao; Zhou, Fuling; Zhang, Ronghua; Claret, Francois X.			Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							MOLECULAR TARGETS; GROWTH-FACTOR; ACTIVATION; CANCER; EXPRESSION; JAB1/CSN5; PROLIFERATION; INVASIVENESS; RESISTANCE; SURVIVAL	Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated malignancy most common in East Asia, Africa and Alaska. Radiotherapy and cisplatin-based chemotherapy are the main treatment options. Unfortunately, disease response to concurrent chemoradiotherapy varies among patients with NPC, and many cases are resistant to cisplatin and radiotherapy. Signal transducer and activator of transcription 3 (Stat3) has been implicated in the development and progression of various solid tumors. In this study, we assessed the activation and expression of Stat3 in NPC cells. We found that Stat3 was activated and could be blocked by the small molecule inhibitor Stattic. The inhibition of Stat3 in NPC cells by Stattic decreased the expression of cyclin D1 in a dose- and time-dependent manner. Thus, Stattic was used to target Stat3 in NPC cell lines. We found that Stattic could inhibit cell viability and proliferation in NPC cells and significantly induced apoptosis. Additionally, Stat3 transfection attenuated, whereas Stat3 knockdown enhanced, the effects of Stattic upon cell viability inhibition and apoptosis induction. Furthermore, Stattic sensitized NPC cells to cisplatin and ionizing radiation (IR) by preventing cell proliferation and inducing apoptosis. Taken together, Stattic inhibit Stat3 and display antitumor effect in NPC, and enhanced chemosensitivity and radiosensitivity in NPC. Therefore, our findings provide the base for more rational approaches to treat NPC in the clinic.	[Pan, Yunbao; Zhou, Fuling; Zhang, Ronghua; Claret, Francois X.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Pan, Yunbao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Fuling] Xi An Jiao Tong Univ, Hosp 2, Dept Clin Hematol, Xian 710049, Shanxi, Peoples R China; [Claret, Francois X.] Univ Texas Grad Sch Biomed Sci Houston, Expt Therapeut Acad Program, Houston, TX USA; [Claret, Francois X.] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; Xi'an Jiaotong University	Claret, FX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	fxclaret@mdanderson.org	Claret, Francois X/R-2104-2016; Pan, Yunbao/J-9016-2013	Claret, Francois X/0000-0003-4629-6495; Pan, Yunbao/0000-0002-6311-2945; Zhou, Fuling/0000-0003-0982-0382	China Scholarship Council [2010638087]; National Cancer Institute [RO1-CA90853]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA090853] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a fellowship from China Scholarship Council (2010638087) (YP) and a grant from National Cancer Institute (RO1-CA90853) (FXC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2012, ORAL ONCOLOGY; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bonner JA, 2009, RADIOTHER ONCOL, V92, P339, DOI 10.1016/j.radonc.2009.06.022; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Hsiao JR, 2003, BRIT J CANCER, V89, P344, DOI 10.1038/sj.bjc.6601003; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pan Y, 2012, ONCOGENE, DOI [10.1038/onc.2012.1294, DOI 10.1038/ONC.2012.1294]; Pan YB, 2012, CANCER LETT, V326, P155, DOI 10.1016/j.canlet.2012.07.033; Pan YB, 2012, CANCER RES, V72, P1890, DOI 10.1158/0008-5472.CAN-11-3472; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Tu B, 2012, CANC LETT; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Wang ZL, 2010, EUR J CANCER, V46, P2996, DOI 10.1016/j.ejca.2010.07.008; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yip KW, 2005, CLIN CANCER RES, V11, P8131, DOI 10.1158/1078-0432.CCR-05-1266; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	41	100	103	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54565	10.1371/journal.pone.0054565	http://dx.doi.org/10.1371/journal.pone.0054565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382914	gold, Green Published, Green Submitted			2022-12-25	WOS:000315483200057
J	Agliari, E; Asti, L; Barra, A; Scrivo, R; Valesini, G; Wallis, RS				Agliari, Elena; Asti, Lorenzo; Barra, Adriano; Scrivo, Rossana; Valesini, Guido; Wallis, Robert S.			Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors	PLOS ONE			English	Article							ANNUAL RISK; TNF; MECHANISMS; NEUTRALIZATION; REACTIVATION; INFLIXIMAB; THERAPIES; DISEASE	In this manuscript we apply stochastic modeling to investigate the risk of reactivation of latent mycobacterial infections in patients undergoing treatment with tumor necrosis factor inhibitors. First, we review the perspective proposed by one of the authors in a previous work and which consists in predicting the occurrence of reactivation of latent tuberculosis infection or newly acquired tuberculosis during treatment; this is based on variational procedures on a simple set of parameters (e.g. rate of reactivation of a latent infection). Then, we develop a full analytical study of this approach through a Markov chain analysis and we find an exact solution for the temporal evolution of the number of cases of tuberculosis infection (re) activation. The analytical solution is compared with Monte Carlo simulations and with experimental data, showing overall excellent agreement. The generality of this theoretical framework allows to investigate also the case of non-tuberculous mycobacteria infections; in particular, we show that reactivation in that context plays a minor role. This may suggest that, while the screening for tuberculous is necessary prior to initiating biologics, when considering non-tuberculous mycobacteria only a watchful monitoring during the treatment is recommended. The framework outlined in this paper is quite general and could be extremely promising in further researches on drug-related adverse events.	[Agliari, Elena] Univ Parma, Dipartimento Fis, I-43100 Parma, Italy; [Agliari, Elena] Ist Nazl Fis Nucl, Grp Collegato Parma, Parma, Italy; [Asti, Lorenzo] Univ Roma La Sapienza, Dipartimento Sci Base & Applicate Ingn, Rome, Italy; [Barra, Adriano] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Scrivo, Rossana; Valesini, Guido] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Rome, Italy; [Wallis, Robert S.] Pfizer, Groton, CT USA	University of Parma; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Pfizer	Agliari, E (corresponding author), Univ Parma, Dipartimento Fis, Viale Sci, I-43100 Parma, Italy.	elena.agliari@fis.unipr.it	Wallis, Robert S/A-8018-2009; Agliari, Elena/AAA-2311-2021; Agliari, Elena/I-3921-2012	Wallis, Robert S/0000-0001-6152-5183; Agliari, Elena/0000-0002-5121-3511; Agliari, Elena/0000-0002-5121-3511	FIRB from Ministero dell' Instruzione Universita Ricerca [RBFR08EKEV]; Sapienza Universita di Roma	FIRB from Ministero dell' Instruzione Universita Ricerca; Sapienza Universita di Roma	This research was sponsored by the FIRB grant RBFR08EKEV from Ministero dell' Instruzione Universita Ricerca and by Sapienza Universita di Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliari E, 2012, J BIOL DYNAM, V6, P740, DOI 10.1080/17513758.2012.704083; Agliari E, 2011, J THEOR BIOL, V287, P48, DOI 10.1016/j.jtbi.2011.07.027; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooper EL, 2010, PHYS LIFE REV, V7, P55, DOI 10.1016/j.plrev.2009.12.001; Daniel TM, 1997, J INFECT DIS, V175, P1535, DOI 10.1086/516495; ELLIOTT MJ, 1995, INT J IMMUNOPHARMACO, V17, P141, DOI 10.1016/0192-0561(94)00092-3; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Fallahi-Sichani M, 2012, J IMMUNOL, V188, P3169, DOI 10.4049/jimmunol.1103298; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Iliopoulos A, 2006, CLIN RHEUMATOL, V25, P121, DOI 10.1007/s10067-005-1135-4; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Liberopoulos EN, 2002, AM J MED, V113, P615, DOI 10.1016/S0002-9343(02)01205-6; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pearson RK, 1952, EXPLORING DATA ENG S; Peschon JJ, 1998, J IMMUNOL, V160, P943; Plessner HL, 2007, J INFECT DIS, V195, P1643, DOI 10.1086/517519; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Scrivo R, 2012, J RHEUMATOL IN PRESS; Scrivo R, 2012, CLIN RHEUMATOL, V31, P1567, DOI 10.1007/s10067-012-2049-6; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; SUTHERLAND I, 1983, TUBERCLE, V64, P241, DOI 10.1016/0041-3879(83)90021-1; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Verhave JC, 2008, NETH J MED, V66, P77; Wagner D, 2003, INFECTION, V31; Wallis RS, 2008, ARTHRITIS RHEUM, V58, P947, DOI 10.1002/art.23285; Wallis RS, 2005, SEMIN ARTHRITIS RHEU, V34, P34, DOI 10.1016/j.semarthrit.2005.01.009; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989; Winthrop KL, 2009, EMERG INFECT DIS, V15, P1556, DOI 10.3201/eid1510.090310	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55017	10.1371/journal.pone.0055017	http://dx.doi.org/10.1371/journal.pone.0055017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383039	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500047
J	Rahman, M; Sohel, N; Yunus, M; Chowdhury, ME; Hore, SK; Zaman, K; Bhuiya, A; Streatfield, PK				Rahman, Mahfuzar; Sohel, Nazmul; Yunus, Mohammad; Chowdhury, Mahbub Elahi; Hore, Samar Kumar; Zaman, Khalequ; Bhuiya, Abbas; Streatfield, Peter Kim			Increased Childhood Mortality and Arsenic in Drinking Water in Matlab, Bangladesh: A Population-Based Cohort Study	PLOS ONE			English	Article							CANCER-MORTALITY; BLACKFOOT DISEASE; SODIUM ARSENITE; LUNG-CANCER; EXPOSURE; CONTAMINATION; HEALTH; CHILE; METABOLISM; GENDER	Background: Arsenic in drinking water was associated with increased risk of all-cause, cancer, and cardiovascular death in adults. However, the extent to which exposure is related to all-cause and deaths from cancer and cardiovascular condition in young age is unknown. Therefore, we prospectively assessed whether long-term and recent arsenic exposures are associated with all-cause and cancer and cardiovascular mortalities in Bangladeshi childhood population. Methods and Findings: We assembled a cohort of 58406 children aged 5-18 years from the Health and Demographic Surveillance System of icddrb in Bangladesh and followed during 2003-2010. There were 185 non-accidental deaths registered in-about 0.4 million person-years of observation. We calculated hazard ratios for cause-specific death in relation to exposure at baseline (mu g/L), time-weighted lifetime average (mg/L) and cumulative concentration (mu g-years/L). After adjusting covariates, hazard ratios (HRs) for all-cause childhood deaths comparing lifetime average exposure 10-50.0, 50.1-150.0, 150.1-300.0 and >= 300.1 mu g/L were 1.37 (95% confidence interval [CI], 0.74-2.57), 1.44 (95% CI, 0.88-2.38), 1.22 (95% CI, 0.75-1.98) and 1.88 (95% CI, 1.14-3.10) respectively. Significant increased risk was also observed for baseline (P for trend = 0.023) and cumulative exposure categories (P for trend = 0.036). Girls had higher mortality risk compared to boys (HR for girls 1.79, 1.21, 1.64, 2.31; HR for boys 0.52, 0.53, 1.14, 0.99) in relation to baseline exposure. For all cancers and cardiovascular deaths combined, multivariable adjusted HRs amounted to 1.53 (95% CI 0.51-4.57); 1.29 (95% CI 0.43-3.87); 2.18 (95% CI 1.15-4.16) for 10.0-50.0, 50.1-150.0, and >= 150.1, comparing lowest exposure as reference (P for trend = 0.009). Adolescents had higher mortality risk compared to children (HRs = 1.53, 95% CI 1.03-2.28 vs. HRs = 1.30, 95% CI 0.78-2.17). Conclusions: Arsenic exposure was associated with substantial increased risk of deaths at young age from all-cause, and cancers and cardiovascular conditions. Girls and adolescents (12-18 years) had higher risk compared to boys and child.	[Rahman, Mahfuzar; Sohel, Nazmul; Yunus, Mohammad; Chowdhury, Mahbub Elahi; Hore, Samar Kumar; Zaman, Khalequ; Bhuiya, Abbas; Streatfield, Peter Kim] Icddrb, Dhaka, Bangladesh; [Rahman, Mahfuzar] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Sohel, Nazmul] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); Columbia University; McMaster University	Rahman, M (corresponding author), Icddrb, Dhaka, Bangladesh.	mahfuzar@icddrb.org		Yunus, Mohammed/0000-0003-1116-4978	Swedish International Development Agency (Sida) [ICDDR] [GR-00123, GR-00211, GR-00212, U11 BB/1.5.5-3, 1998-05440, U11 BB/1.5.5-3/A]; World Health Organization (WHO) [ICDDR] [GR-00024, SE/01/037664]; United States of Agency for International Development (USAID) [ICDDR] [GR-00118, 388-G-00-02-00125-00]; Department for International Development (DFID) [ICDDR] [GR-00210]	Swedish International Development Agency (Sida) [ICDDR]; World Health Organization (WHO) [ICDDR]; United States of Agency for International Development (USAID) [ICDDR](United States Agency for International Development (USAID)); Department for International Development (DFID) [ICDDR]	The base study was supported by Swedish International Development Agency (Sida) [ICDDR, B ref. GR-00123, GR-00211 & GR-00212; Donor ref. U11 BB/1.5.5-3, 1998-05440 & U11 BB/1.5.5-3/A], World Health Organization (WHO) [ICDDR, B ref. GR-00024, Donor ref. SE/01/037664] and United States of Agency for International Development (USAID) [ICDDR, B ref. GR-00118, Donor ref. 388-G-00-02-00125-00]. Matlab HDSS is primarily supported by the Department for International Development (DFID) [ICDDR, B ref. GR-00210]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S A, 1999, J Prev Soc Med, V18, P35; Alam N, 2010, J HEALTH POPUL NUTR, V28, P520; Pou SA, 2011, CANCER CAUSE CONTROL, V22, P407, DOI 10.1007/s10552-010-9711-6; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; CHEN CJ, 1985, CANCER RES, V45, P5895; FALK H, 1981, CANCER, V47, P382, DOI 10.1002/1097-0142(19810115)47:2<382::AID-CNCR2820470228>3.0.CO;2-N; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P1; Infante-Rivard C, 2001, EPIDEMIOLOGY, V12, P13, DOI 10.1097/00001648-200101000-00004; Jakariya M, 2005, SUSTAINABLE SAFE WAT, P319; Kadono T, 2002, INT J DERMATOL, V41, P841, DOI 10.1046/j.1365-4362.2002.01668.x; Liaw J, 2008, CANCER EPIDEM BIOMAR, V17, P1982, DOI 10.1158/1055-9965.EPI-07-2816; Lindberg AL, 2008, ENVIRON RES, V106, P110, DOI 10.1016/j.envres.2007.08.011; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; McLellan F, 2002, LANCET, V359, P1127, DOI 10.1016/S0140-6736(02)08179-5; Moore LE, 2002, ARCH ENVIRON HEALTH, V57, P201, DOI 10.1080/00039890209602937; Nahar N, 2008, J ENVIRON HEALTH, V70, P42; National Research Council (NRC), 2001, ARS DRINK WAT 2001 U; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Rahman M, 1999, HYPERTENSION, V33, P74, DOI 10.1161/01.HYP.33.1.74; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Ramirez P, 1997, MUTAT RES-REV MUTAT, V386, P291, DOI 10.1016/S1383-5742(97)00018-5; Razzaque A, 2002, MATLAB DEMOGRAPHIC S, V1, p[387, 287]; Rubin CS, 2007, ENVIRON HEALTH PERSP, V115, P151, DOI 10.1289/ehp.9022; Ruzicka LT, 1978, DEMOGRAPHIC SURVEILL, V2; Sampayo-Reyes A, 2010, TOXICOL SCI, V117, P63, DOI 10.1093/toxsci/kfq173; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Smith AH, 2011, AM J EPIDEMIOL, V173, P414, DOI 10.1093/aje/kwq383; Sohel N, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-53; Sohel N, 2010, J ENVIRON MONITOR, V12, P1341, DOI 10.1039/c001708f; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Sudo N, 2004, INT J FOOD SCI NUTR, V55, P499, DOI 10.1080/09637480400015844; TSENG WP, 1977, ENVIRON HEALTH PERSP, V19, P109, DOI 10.2307/3428460; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; Yih LH, 1997, CANCER RES, V57, P5051; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Yunus M, 2011, KAOHSIUNG J MED SCI, P1	44	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55014	10.1371/journal.pone.0055014	http://dx.doi.org/10.1371/journal.pone.0055014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383038	Green Submitted, gold, Green Published			2022-12-25	WOS:000315211500046
J	Senatore, A; Monteil, A; van Minnen, J; Smit, AB; Spafford, JD				Senatore, Adriano; Monteil, Arnaud; van Minnen, Jan; Smit, August B.; Spafford, J. David			NALCN Ion Channels Have Alternative Selectivity Filters Resembling Calcium Channels or Sodium Channels	PLOS ONE			English	Article							VOLTAGE-GATED SODIUM; CATION CHANNEL; NEURONAL EXCITABILITY; HYDROZOAN JELLYFISH; GENETIC-ANALYSIS; NERVOUS-SYSTEM; LYMNAEA; ACID; LEAK; CA2+	NALCN is a member of the family of ion channels with four homologous, repeat domains that include voltage-gated calcium and sodium channels. NALCN is a highly conserved gene from simple, extant multicellular organisms without nervous systems such as sponges and placozoans and mostly remains a single gene compared to the calcium and sodium channels which diversified into twenty genes in humans. The single NALCN gene has alternatively-spliced exons at exons 15 or exon 31 that splices in novel selectivity filter residues that resemble calcium channels (EEEE) or sodium channels (EKEE or EEKE). NALCN channels with alternative calcium, (EEEE) and sodium, (EKEE or EEKE) -selective pores are conserved in simple bilaterally symmetrical animals like flatworms to non-chordate deuterostomes. The single NALCN gene is limited as a sodium channel with a lysine (K)-containing pore in vertebrates, but originally NALCN was a calcium-like channel, and evolved to operate as both a calcium channel and sodium channel for different roles in many invertebrates. Expression patterns of NALCN-EKEE in pond snail, Lymnaea stagnalis suggest roles for NALCN in secretion, with an abundant expression in brain, and an up-regulation in secretory organs of sexually-mature adults such as albumen gland and prostate. NALCN-EEEE is equally abundant as NALCN-EKEE in snails, but is greater expressed in heart and other muscle tissue, and 50% less expressed in the brain than NALCN-EKEE. Transfected snail NALCN-EEEE and NALCN-EKEE channel isoforms express in HEK-293T cells. We were not able to distinguish potential NALCN currents from background, non-selective leak conductances in HEK293T cells. Native leak currents without expressing NALCN genes in HEK-293T cells are NMDG(+) impermeant and blockable with 10 mu M Gd3+ ions and are indistinguishable from the hallmark currents ascribed to mammalian NALCN currents expressed in vitro by Lu et al. in Cell. 2007 Apr 20;129(2):371-83.	[Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Monteil, Arnaud] CNRS, Inst Genom Fonct, Montpellier, France; [Monteil, Arnaud] INSERM, Montpellier, France; [Monteil, Arnaud] Univ Montpellier I, Montpellier, France; [Monteil, Arnaud] Univ Montpellier 2, Montpellier, France; [van Minnen, Jan] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands	University of Waterloo; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; University of Calgary; Vrije Universiteit Amsterdam	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Monteil, Arnaud/G-3113-2012	Monteil, Arnaud/0000-0003-1632-7318	National Sciences and Engineering Research Council of Canada (NSERC) Canada; Heart and Stroke Foundation of Canada	National Sciences and Engineering Research Council of Canada (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was funded through a National Sciences and Engineering Research Council of Canada (NSERC) Canada Discovery grant and Heart and Stroke Foundation of Canada Grant-In-Aid to JDS and an NSERC Canada Graduate Scholarship and Ontario Graduate Scholarship award to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ANDERSON PAV, 1993, P NATL ACAD SCI USA, V90, P7419, DOI 10.1073/pnas.90.15.7419; Bannister RA, 2009, J GEN PHYSIOL, V134, P35, DOI 10.1085/jgp.200910241; Bouhours M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-16; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; CAMPBELL DB, 1994, P NATL ACAD SCI USA, V91, P2135, DOI 10.1073/pnas.91.6.2135; Catterall WA, 2010, NEUROSCI LETT, V486, P107, DOI 10.1016/j.neulet.2010.08.085; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DeLange RPJ, 1997, NEUROSCIENCE, V78, P289, DOI 10.1016/S0306-4522(96)00576-3; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Grigoriev NG, 1996, J NEUROPHYSIOL, V76, P2240, DOI 10.1152/jn.1996.76.4.2240; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Lu TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018745; MAROIS R, 1992, J COMP NEUROL, V322, P255, DOI 10.1002/cne.903220211; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; Miller HM, 1934, DROSOPH INF SERV, V2, P9; Morgan P G, 2007, WormBook, P1; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Singaram VK, 2011, CURR BIOL, V21, P2070, DOI 10.1016/j.cub.2011.10.042; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Snutch TP, 2007, NEURON, V54, P505, DOI 10.1016/j.neuron.2007.05.005; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; Spafford JD, 1999, RECEPTOR CHANNEL, V6, P493; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Wicher D, 2004, J BIOL CHEM, V279, P50410, DOI 10.1074/jbc.M405800200; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	52	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55088	10.1371/journal.pone.0055088	http://dx.doi.org/10.1371/journal.pone.0055088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383067	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500056
J	Yang, Y; Wang, Y; Shi, ZW; Zhu, DL; Gao, PJ				Yang, Yan; Wang, Yan; Shi, Zhong-wei; Zhu, Ding-liang; Gao, Ping-jin			Association of E/E' and NT-proBNP with Renal Function in Patients with Essential Hypertension	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; CHRONIC HEART-FAILURE; NATRIURETIC PEPTIDE; DOPPLER-ECHOCARDIOGRAPHY; INSUFFICIENCY; MORTALITY; VELOCITY; DISEASE; MICROALBUMINURIA; RECOMMENDATIONS	Objectives: To evaluate the association of left ventricular (LV) diastolic function and N-terminal pro-brain natriuretic peptide (NT-proBNP) with renal function in essential hypertension. Methods: LV diastolic function was estimated by the ratio of early diastolic velocities (E) from transmitral inflow to early diastolic velocities (E') of tissue Doppler at mitral annulus (septal corner); NT-proBNP was measured in 207 hypertensive patients (mean age 56 +/- 14 years). The subjects were classified into 3 groups: E/E'<= 10 group (n = 48), 10<E/E'<= 15 group (n = 109) and E/E'>15 group (n = 50). The renal function was estimated by glomerular filtration rate (GFR) with Tc-99m-DTPA. GFR from 30 to 59 ml/min/1.73 m(2) was defined as Stage 3 chronic kidney disease (CKD). GFR was also estimated using the modified MDRD equation. Albuminuria was defined by urinary albumin/creatinine ratio (UACR). Results: GFR was lower and UACR was higher in E/E'>15 group than in 10<E/E' <= 15 group or E/E' <= 10 group (p<0.0001), GFR was significantly negative and UACR was positive correlated with E/E' and NT-proBNP (p<0.0001). In multivariate stepwise linear analysis, GFR had significant correlation with age (p = 0.001), gender (p = 0.003), E/E' (p = 0.03), lgNT-proBNP (p = 0.001) and lgUACR (p = 0.01), while eGFR had no significant correlation with E/E' or lgNT-proBNP. Multivariate logistic regression analysis, adjusted for potential confounding factors, showed that participants in E/E'>15 group were more likely to have Stage 3 CKD compared with those in E/E'<= 10 group with an adjusted odds ratio of 8.31 (p = 0.0036). Conclusions: LV diastolic function, assessed with E/E' and NT-proBNP is associated with renal function in essential hypertension.	[Yang, Yan; Wang, Yan; Zhu, Ding-liang; Gao, Ping-jin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,State Key Lab Med Genom, Shanghai Inst Hypertens,Dept Hypertens,Shanghai K, Shanghai 200030, Peoples R China; [Shi, Zhong-wei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Zhu, Ding-liang; Gao, Ping-jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Vasc Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,State Key Lab Med Genom, Shanghai Inst Hypertens,Dept Hypertens,Shanghai K, Shanghai 200030, Peoples R China.	gaopingjin@yahoo.com.cn	Yang, Sophie/GQB-2082-2022		National Natural Science Foundation of China [81070261]; National Basic Research Program of China [2011CB503905]; National Hightech RD Program [2012AA02A516]; Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Hightech RD Program(National High Technology Research and Development Program of China); Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine	This study was supported financially by grants from the National Natural Science Foundation of China (81070261), National Basic Research Program of China (2011CB503905), National Hightech R&D Program (2012AA02A516) and Doctor Innovation Fund (BXJ201046) of Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Bruch C, 2007, INT J CARDIOL, V118, P375, DOI 10.1016/j.ijcard.2006.06.066; Chinese committee on guide of hypertension prevention and treatment, 2005, CHINESE J HYPERTEN S, V134, P2; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; DEVEREUX RB, 1993, EUR HEART J, V14, P8, DOI 10.1093/eurheartj/14.suppl_D.8; Esler M, 2000, AM J HYPERTENS, V13, p99S, DOI 10.1016/S0895-7061(00)00225-9; Farias CA, 1999, J AM SOC ECHOCARDIOG, V12, P609, DOI 10.1053/je.1999.v12.a99249; Fathi R, 2003, AM J KIDNEY DIS, V41, P1016, DOI 10.1016/S0272-6386(03)00199-9; Joles JA, 2004, HYPERTENSION, V43, P699, DOI 10.1161/01.HYP.0000121881.77212.b1; Khan NA, 2006, J AM SOC NEPHROL, V17, P244, DOI 10.1681/ASN.2005030270; Lainchbury JG, 1998, CLIN SCI, V95, P547, DOI 10.1042/cs0950547; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2009, J HYPERTENSION, V27, P000; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McConnaughey MM, 1999, J CLIN PHARMACOL, V39, P547, DOI 10.1177/00912709922008155; McCullough Peter A, 2003, Rev Cardiovasc Med, V4 Suppl 4, pS13; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nardi E, 2007, J NEPHROL, V20, P320; Nardi E, 2009, J HYPERTENS, V27, P633, DOI 10.1097/HJH.0b013e3283220ecd; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Olsen MJ, 2004, J HUM HYPERTENS, V18, P453, DOI 10.1038/sj.jhh.1001711; Olsson LG, 2007, EUR J HEART FAIL, V9, P795, DOI 10.1016/j.ejheart.2007.07.010; Osranek M, 2007, AM HEART J, V154, P130, DOI 10.1016/j.ahj.2007.03.026; Otsuka T, 2009, J CARDIOL, V54, P199, DOI 10.1016/j.jjcc.2009.05.002; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; PERRONE RD, 1990, AM J KIDNEY DIS, V16, P224, DOI 10.1016/S0272-6386(12)81022-5; Prigent A, 2008, SEMIN NUCL MED, V38, P32, DOI 10.1053/j.semnuclmed.2007.09.003; RICHARDS AM, 1993, BRIT HEART J, V69, P414; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schillaci G, 2002, J AM COLL CARDIOL, V39, P2005, DOI 10.1016/S0735-1097(02)01896-X; Shah AM, 2011, J HYPERTENS, V29, P1829, DOI 10.1097/HJH.0b013e32834a4d38; Silverberg D, 2004, CURR OPIN NEPHROL HY, V13, P163, DOI 10.1097/00041552-200403000-00004; Slama M, 2002, CURR OPIN CARDIOL, V17, P368, DOI 10.1097/00001573-200207000-00008; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Svensson M, 2009, CLIN NEPHROL, V71, P380; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54513	10.1371/journal.pone.0054513	http://dx.doi.org/10.1371/journal.pone.0054513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382907	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500014
J	Ackerman, SH; Gatti, DL				Ackerman, Sharon H.; Gatti, Domenico L.			Biapenem Inactivation by B2 Metallo beta-Lactamases: Energy Landscape of the Hydrolysis Reaction	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ANTIBIOTIC BINDING; CRYSTAL-STRUCTURE; STENOTROPHOMONAS-MALTOPHILIA; ENTROPIC CONTRIBUTIONS; REACTION INTERMEDIATE; CATALYTIC EFFICIENCY; ENZYME; MECHANISM; CPHA	Background: A general mechanism has been proposed for metallo beta-lactamases (M beta Ls), in which deprotonation of a water molecule near the Zn ion(s) results in the formation of a hydroxide ion that attacks the carbonyl oxygen of the beta-lactam ring. However, because of the absence of X-ray structures that show the exact position of the antibiotic in the reactant state (RS) it has been difficult to obtain a definitive validation of this mechanism. Methodology/Principal Findings: We have employed a strategy to identify the RS, which does not rely on substrate docking and/or molecular dynamics. Starting from the X-ray structure of the enzyme: product complex (the product state, PS), a QM/MM scan was used to drive the reaction uphill from product back to reactant. Since in this process also the enzyme changes from PS to RS, we actually generate the enzyme: substrate complex from product and avoid the uncertainties associated with models of the reactant state. We used this strategy to study the reaction of biapenem hydrolysis by B2 M beta L CphA. QM/MM simulations were carried out under 14 different ionization states of the active site, in order to generate potential energy surfaces (PESs) corresponding to a variety of possible reaction paths. Conclusions/Significance: The calculations support a model for biapenem hydrolysis by CphA, in which the nucleophile that attacks the b-lactam ring is not the water molecule located in proximity of the active site Zn, but a second water molecule, hydrogen bonded to the first one, which is used up in the reaction, and thus is not visible in the X-ray structure of the enzyme: product complex.	[Ackerman, Sharon H.; Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA	Wayne State University; Wayne State University	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu			United States Public Health Service [GM69840, GM48157]; Wayne State University Research Enhancement Program in Computational Biology Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157, R01GM069840] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University Research Enhancement Program in Computational Biology Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by United States Public Health Service Grants GM69840 to DLG and GM48157 to SHA, and by a Wayne State University Research Enhancement Program in Computational Biology Grant to DLG. Funding was used for the purchase of computational equipment and software licenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebrone C, 2005, J BIOL CHEM, V280, P28195, DOI 10.1074/jbc.M414052200; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bebrone C, 2009, ANTIMICROB AGENTS CH, V53, P4464, DOI 10.1128/AAC.00288-09; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; Diaz N, 2001, J AM CHEM SOC, V123, P9867, DOI 10.1021/ja0113246; E WN, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2720838; Estiu G, 2006, J COMPUT CHEM, V27, P1240, DOI 10.1002/jcc.20411; Fast W, 2001, BIOCHEMISTRY-US, V40, P1640, DOI 10.1021/bi001860v; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; Gatti DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030079; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; GONZALEZ C, 1991, J CHEM PHYS, V95, P5853, DOI 10.1063/1.461606; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Hamelberg D, 2004, J AM CHEM SOC, V126, P7683, DOI 10.1021/ja0377908; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENSEN A, 1983, THEOR CHIM ACTA, V63, P269, DOI 10.1007/BF01151605; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Perez-Llarena FJ, 2009, CURR MED CHEM, V16, P3740, DOI 10.2174/092986709789104957; Leiros HKS, 2012, ANTIMICROB AGENTS CH, V56, P4341, DOI 10.1128/AAC.00448-12; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Oelschlaeger P, 2008, J INORG BIOCHEM, V102, P2043, DOI 10.1016/j.jinorgbio.2008.05.007; Olsen L, 2004, J COMPUT AID MOL DES, V18, P287, DOI 10.1023/B:JCAM.0000046821.15502.71; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Page MGP, 2006, CURR OPIN PHARMACOL, V6, P480, DOI 10.1016/j.coph.2006.06.002; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Parr R. G., 1989, DENSITY FUNCTIONAL T; Queenan AM, 2007, ANTIMICROB AGENTS CH, V51, P3089, DOI 10.1128/AAC.00218-07; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Sgrignani J, 2012, J COMPUT AID MOL DES, V26, P425, DOI 10.1007/s10822-012-9571-0; Sharma N, 2008, J AM CHEM SOC, V130, P8215, DOI 10.1021/ja0774562; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Simona F, 2007, PROTEINS, V69, P595, DOI 10.1002/prot.21476; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Snider MJ, 2000, BIOCHEMISTRY-US, V39, P9746, DOI 10.1021/bi000914y; Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062; Spencer J, 2001, J BIOL CHEM, V276, P33638, DOI 10.1074/jbc.M105550200; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Suarez D, 2001, J AM CHEM SOC, V123, P3759, DOI 10.1021/ja003796a; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Villa J, 2000, P NATL ACAD SCI USA, V97, P11899, DOI 10.1073/pnas.97.22.11899; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Warshel A, 2001, Q REV BIOPHYS, V34, P563, DOI 10.1017/S0033583501003730; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Widmann M, 2012, ANTIMICROB AGENTS CH, V56, P3481, DOI 10.1128/AAC.00255-12; Wu SS, 2010, J AM CHEM SOC, V132, P17986, DOI 10.1021/ja104241g; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu DG, 2005, J MED CHEM, V48, P6679, DOI 10.1021/jm0505112; Xu DG, 2007, J PHYS CHEM A, V111, P5630, DOI 10.1021/jp068746s; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409; [No title captured]	77	11	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55136	10.1371/journal.pone.0055136	http://dx.doi.org/10.1371/journal.pone.0055136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23372827	Green Published, gold, Green Submitted			2022-12-25	WOS:000314023600156
J	Fukusumi, H; Shofuda, T; Kanematsu, D; Yamamoto, A; Suemizu, H; Nakamura, M; Yamasaki, M; Ohgushi, M; Sasai, Y; Kanemura, Y				Fukusumi, Hayato; Shofuda, Tomoko; Kanematsu, Daisuke; Yamamoto, Atsuyo; Suemizu, Hiroshi; Nakamura, Masato; Yamasaki, Mami; Ohgushi, Masatoshi; Sasai, Yoshiki; Kanemura, Yonehiro			Feeder-Free Generation and Long-Term Culture of Human Induced Pluripotent Stem Cells Using Pericellular Matrix of Decidua Derived Mesenchymal Cells	PLOS ONE			English	Article							UNDIFFERENTIATED GROWTH; X-INACTIVATION; SELF-RENEWAL; RECOMBINANT VITRONECTIN; FORESKIN FIBROBLASTS; DEFINED CONDITIONS; GENE-EXPRESSION; LINES; DERIVATION; DIFFERENTIATION	Human ES cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are usually generated and maintained on living feeder cells like mouse embryonic fibroblasts or on a cell-free substrate like Matrigel. For clinical applications, a quality-controlled, xenobiotic-free culture system is required to minimize risks from contaminating animal-derived pathogens and immunogens. We previously reported that the pericellular matrix of decidua-derived mesenchymal cells (PCM-DM) is an ideal human-derived substrate on which to maintain hiPSCs/hESCs. In this study, we examined whether PCM-DM could be used for the generation and long-term stable maintenance of hiPSCs. Decidua-derived mesenchymal cells (DMCs) were reprogrammed by the retroviral transduction of four factors (OCT4, SOX2, KLF4, c-MYC) and cultured on PCM-DM. The established hiPSC clones expressed alkaline phosphatase, hESC-specific genes and cell-surface markers, and differentiated into three germ layers in vitro and in vivo. At over 20 passages, the hiPSCs cultured on PCM-DM held the same cellular properties with genome integrity as those at early passages. Global gene expression analysis showed that the GDF3, FGF4, UTF1, and XIST expression levels varied during culture, and GATA6 was highly expressed under our culture conditions; however, these gene expressions did not affect the cells' pluripotency. PCM-DM can be conveniently prepared from DMCs, which have a high proliferative potential. Our findings indicate that PCM-DM is a versatile and practical human-derived substrate that can be used for the feeder-cell-free generation and long-term stable maintenance of hiPSCs.	[Fukusumi, Hayato; Kanematsu, Daisuke; Kanemura, Yonehiro] Natl Hosp Org, Div Regenerat Med, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan; [Shofuda, Tomoko; Yamamoto, Atsuyo] Natl Hosp Org, Div Stem Cell Res, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan; [Yamasaki, Mami] Natl Hosp Org, Div Mol Med, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan; [Yamasaki, Mami; Kanemura, Yonehiro] Natl Hosp Org, Dept Neurosurg, Osaka Natl Hosp, Osaka, Japan; [Suemizu, Hiroshi; Nakamura, Masato] Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan; [Nakamura, Masato] Tokai Univ, Sch Med, Dept Pathol & Regenerat Med, Isehara, Kanagawa 25911, Japan; [Ohgushi, Masatoshi] RIKEN, Unit Human Stem Cell Technol, Ctr Dev Biol, Kobe, Hyogo, Japan; [Sasai, Yoshiki] RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan; [Yamasaki, Mami] Takatsuki Gen Hosp, Dept Pediat Neurosurg, Takatsuki, Osaka, Japan	Osaka National Hospital; Osaka National Hospital; Osaka National Hospital; Osaka National Hospital; Tokai University; RIKEN; RIKEN	Kanemura, Y (corresponding author), Natl Hosp Org, Div Regenerat Med, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan.	kanemura@onh.go.jp		Fukusumi, Hayato/0000-0002-5723-7506; Suemizu, Hiroshi/0000-0002-3706-2454	Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) project from MEXT, Japan; Research on New Drug Development, Health and Labour Sciences Research Grants; Ministry of Health, Labour and Welfare (MHLW) of Japan	Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) project from MEXT, Japan; Research on New Drug Development, Health and Labour Sciences Research Grants; Ministry of Health, Labour and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) project from MEXT, Japan, and the Research on New Drug Development, Health and Labour Sciences Research Grants, the Ministry of Health, Labour and Welfare (MHLW) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Caricasole AAD, 1998, ONCOGENE, V16, P95, DOI 10.1038/sj.onc.1201515; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Fu X, 2011, TISSUE ENG PART C-ME, V17, P927, DOI [10.1089/ten.tec.2010.0735, 10.1089/ten.TEC.2010.0735]; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kanematsu D, 2011, DIFFERENTIATION, V82, P77, DOI 10.1016/j.diff.2011.05.010; Kitajima H, 2010, BIOCHEM BIOPH RES CO, V396, P933, DOI 10.1016/j.bbrc.2010.05.026; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Meng GL, 2010, STEM CELLS DEV, V19, P547, DOI 10.1089/scd.2009.0303; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60; Nagase T, 2009, DEV DYNAM, V238, P1118, DOI 10.1002/dvdy.21944; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P27, DOI 10.3727/000000008783906900; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Pan CY, 2010, J GENET GENOMICS, V37, P241, DOI 10.1016/S1673-8527(09)60042-4; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Shofuda T, 2013, CELL MED IN PRESS; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yap LYW, 2011, TISSUE ENG PART C-ME, V17, P193, DOI [10.1089/ten.tec.2010.0328, 10.1089/ten.TEC.2010.0328]; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	57	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55226	10.1371/journal.pone.0055226	http://dx.doi.org/10.1371/journal.pone.0055226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383118	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600078
J	Homouz, D; Kudlicki, AS				Homouz, Dirar; Kudlicki, Andrzej S.			The 3D Organization of the Yeast Genome Correlates with Co-Expression and Reflects Functional Relations between Genes	PLOS ONE			English	Article							CHROMOSOME CONFORMATION CAPTURE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-ORGANIZATION; BUDDING YEAST; TRANSCRIPTIONAL REGULATION; EXPRESSION; HYBRIDIZATION; LOCALIZATION; ARCHITECTURE; TERRITORIES	The spatial organization of eukaryotic genomes is thought to play an important role in regulating gene expression. The recent advances in experimental methods including chromatin capture techniques, as well as the large amounts of accumulated gene expression data allow studying the relationship between spatial organization of the genome and co-expression of protein-coding genes. To analyse this genome-wide relationship at a single gene resolution, we combined the interchromosomal DNA contacts in the yeast genome measured by Duan et al. with a comprehensive collection of 1,496 gene expression datasets. We find significant enhancement of co-expression among genes with contact links. The co-expression is most prominent when two gene loci fall within 1,000 base pairs from the observed contact. We also demonstrate an enrichment of inter-chromosomal links between functionally related genes, which suggests that the non random nature of the genome organization serves to facilitate coordinated transcription in groups of genes.	[Homouz, Dirar; Kudlicki, Andrzej S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Homouz, Dirar; Kudlicki, Andrzej S.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Homouz, Dirar] Khalifa Univ Sci Technol & Res, Dept Appl Math & Sci, Abu Dhabi, U Arab Emirates; [Kudlicki, Andrzej S.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Khalifa University of Science & Technology; University of Texas System; University of Texas Medical Branch Galveston	Kudlicki, AS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	askudlic@utmb.edu	Kudlicki, Andrzej/AAG-8537-2019; Homouz, Dirar/E-2922-2017	Kudlicki, Andrzej/0000-0001-8158-9600; Homouz, Dirar/0000-0002-8859-0265	March of Dimes grant [5-FY10-136]; University of Texas Medical Branch	March of Dimes grant(March of Dimes); University of Texas Medical Branch	This research was supported partly by March of Dimes grant 5-FY10-136 and partly by startup funds provided by University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2008, CURR OPIN GENET DEV, V18, P571, DOI 10.1016/j.gde.2008.10.002; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bussey H, 1997, NATURE, V387, P103, DOI 10.1038/387s103; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gehlen LR, 2012, NUCLEUS, V3, P15; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Janga SC, 2008, P NATL ACAD SCI USA, V105, P15761, DOI 10.1073/pnas.0806317105; Jin QW, 2000, J CELL SCI, V113, P1903; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; O'Sullivan JM, 2010, CURR OPIN CELL BIOL, V22, P298, DOI 10.1016/j.ceb.2010.03.008; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Rowicka M, 2007, P NATL ACAD SCI USA, V104, P16892, DOI 10.1073/pnas.0706022104; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stone EM, 2000, CURR BIOL, V10, P373, DOI 10.1016/S0960-9822(00)00413-9; Taddei A, 2010, COLD SPRING HARBOR P; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong H, 2012, CURR BIOL, V22, P1881, DOI 10.1016/j.cub.2012.07.069; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058	45	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54699	10.1371/journal.pone.0054699	http://dx.doi.org/10.1371/journal.pone.0054699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382942	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600036
J	Liu, H; Wu, R; Jia, RP; Zhong, B; Zhu, JG; Yu, P; Zhao, Y; Ge, YZ; Wu, JP				Liu, Hao; Wu, Ran; Jia, Rui-Peng; Zhong, Bing; Zhu, Jia-Geng; Yu, Peng; Zhao, Yan; Ge, Yu-Zheng; Wu, Jian-Ping			Ischemic Preconditioning Increases Endothelial Progenitor Cell Number to Attenuate Partial Nephrectomy-Induced Ischemia/Reperfusion Injury	PLOS ONE			English	Article							RENAL CORTICAL TUMORS; GROWTH-FACTOR; INFLAMMATORY RESPONSE; REPERFUSION INJURY; RAT-KIDNEY; REPAIR; TRANSPLANTATION; ANGIOGENESIS; MOBILIZATION; ACTIVATION	Objectives: The objective of this study was to investigate the role of endothelial progenitor cells (EPCs) in the modulation of ischemia-reperfusion injury (IRI) in a partial nephrectomy (PN) rat model using early-phase ischemic preconditioning (IPC). Materials and Methods: Ninety male Sprague-Dawley rats were randomly divided into three groups following right-side nephrectomy: Sham-operated rats (surgery without vascular clamping); PN rats (renal blood vessels were clamped for 40 min and PN was performed); and IPC rats (pretreated with 15 min ischemia and 10 min reperfusion). At 1, 3, 6, 12, 24 h, and 3 days after reperfusion, the pool of circulating EPCs and kidneys were harvested. The extent of renal injury was assessed, along with EPC number, cell proliferation, angiogenesis, and vascular growth factor expression. Results: Pretreated rats exhibited significant improvements in renal function and morphology. EPC numbers in the kidneys were increased at 12 h following reperfusion in the IPC group as compared to the PN or Sham groups. Cell proliferation (including endothelial and tubular epithelial cells) and angiogenesis in peritubular capillaries were markedly increased in kidneys treated with IPC. In addition, vascular endothelial growth factor-A (VEGF-A) and stromal cell-derived factor-1 alpha (SDF-1 alpha) expression in the kidneys of pretreated rats was increased compared to rats subjected to PN. Conclusions: Our investigation suggested that: (1) the early phase of IPC may attenuate renal IRI induced by PN; (2) EPCs play an important role in renal protection, involving promotion of cell proliferation and angiogenesis through release of several angiogenic factors.	[Liu, Hao; Wu, Ran; Jia, Rui-Peng; Zhong, Bing; Zhu, Jia-Geng; Yu, Peng; Zhao, Yan; Ge, Yu-Zheng; Wu, Jian-Ping] Nanjing Med Univ, Dept Urol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Jia, RP (corresponding author), Nanjing Med Univ, Dept Urol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	urologist025@sohu.com			National Natural Science Foundation of China [81070597]; Open Key Program of the Jiangsu Province Health Bureau [KF200942]; Science and Education Development Program of the Jiangsu Province Health Board [LJ201107]; Six Talent Peaks of the Jiangsu Province Health Bureau [2011-WS-093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Key Program of the Jiangsu Province Health Bureau; Science and Education Development Program of the Jiangsu Province Health Board; Six Talent Peaks of the Jiangsu Province Health Bureau	This work was supported by grants from the National Natural Science Foundation of China (81070597), the Open Key Program of the Jiangsu Province Health Bureau (KF200942), Science and Education Development Program of the Jiangsu Province Health Board (LJ201107) and Six Talent Peaks of the Jiangsu Province Health Bureau (2011-WS-093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow LJ, 2010, BJU INT, V106, P489, DOI 10.1111/j.1464-410X.2009.09147.x; Blanco Miguel, 2006, Cerebrovasc Dis, V21 Suppl 2, P38, DOI 10.1159/000091702; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Breau RH, 2010, J UROLOGY, V183, P903, DOI 10.1016/j.juro.2009.11.037; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Cao CC, 2010, AM J NEPHROL, V31, P1, DOI 10.1159/000252844; Chen L, 2010, CARDIOVASC RES, V88, P462, DOI 10.1093/cvr/cvq207; Chen X, 2009, AM J NEPHROL, V30, P287, DOI 10.1159/000225928; Czeiger D, 2011, STEM CELL REV REP, V7, P639, DOI 10.1007/s12015-011-9234-x; Desai MM, 2005, BJU INT, V95, P377, DOI 10.1111/j.1464-410X.2005.05304.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Goligorsky MS, 2010, J AM SOC NEPHROL, V21, P911, DOI 10.1681/ASN.2009111119; Gupta GN, 2010, J UROLOGY, V184, P59, DOI 10.1016/j.juro.2010.03.035; Henrich D, 2004, SHOCK, V21, P13, DOI 10.1097/01.shk.0000101669.49265.50; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Jefayri MK, 2000, BJU INT, V85, P1007, DOI 10.1046/j.1464-410x.2000.00678.x; Jia RP, 2009, TRANSPL P, V41, P69, DOI 10.1016/j.transproceed.2008.11.001; Jiang SH, 2007, CELL BIOCHEM FUNCT, V25, P335, DOI 10.1002/cbf.1395; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Karellas ME, 2010, BJU INT, V106, P1484, DOI 10.1111/j.1464-410X.2010.09405.x; Kim JM, 2010, KOREAN J UROL, V51, P596, DOI 10.4111/kju.2010.51.9.596; Kwon O, 2010, J HISTOCHEM CYTOCHEM, V58, P687, DOI 10.1369/jhc.2010.956011; Lane BR, 2010, J UROLOGY, V184, P1286, DOI 10.1016/j.juro.2010.06.011; Lane BR, 2010, J UROLOGY, V183, P473, DOI 10.1016/j.juro.2009.10.023; Lesage K, 2007, EUR UROL, V51, P614, DOI 10.1016/j.eururo.2006.10.040; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Patschan D, 2006, CURR OPIN PHARMACOL, V6, P176, DOI 10.1016/j.coph.2005.10.013; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Sola A, 2003, TRANSPLANTATION, V75, P744, DOI 10.1097/01.TP.0000054683.72223.2D; Sutton TA, 2003, AM J PHYSIOL-RENAL, V285, pF191, DOI 10.1152/ajprenal.00042.2003; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Torras J, 2002, KIDNEY INT, V61, P2218, DOI 10.1046/j.1523-1755.2002.00360.x; Van Poppel H, 2010, INT J UROL, V17, P314, DOI 10.1111/j.1442-2042.2010.02482.x; Weight CJ, 2010, J UROLOGY, V183, P1317, DOI 10.1016/j.juro.2009.12.030; Xu SJ, 2012, J CARDIOVASC PHARM, V59, P387, DOI 10.1097/FJC.0b013e3182440338; Yi CG, 2006, J SURG RES, V135, P100, DOI 10.1016/j.jss.2006.01.014; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049; Yu Y, 2010, BASIC RES CARDIOL, V105, P713, DOI 10.1007/s00395-010-0117-0; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	46	13	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55389	10.1371/journal.pone.0055389	http://dx.doi.org/10.1371/journal.pone.0055389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383174	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600096
J	Piggott, DA; Muzaale, AD; Mehta, SH; Brown, TT; Patel, KV; Leng, SX; Kirk, GD				Piggott, Damani A.; Muzaale, Abimereki D.; Mehta, Shruti H.; Brown, Todd T.; Patel, Kushang V.; Leng, Sean X.; Kirk, Gregory D.			Frailty, HIV Infection, and Mortality in an Aging Cohort of Injection Drug Users	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CARE; INFLAMMATION; POPULATION; DISABILITY; BALTIMORE; SURVIVAL; SUPPRESSION; PREVENTION; PHENOTYPE	Background: Frailty is associated with morbidity and premature mortality among elderly HIV-uninfected adults, but the determinants and consequences of frailty in HIV-infected populations remain unclear. We evaluated the correlates of frailty, and the impact of frailty on mortality in a cohort of aging injection drug users (IDUs). Methods: Frailty was assessed using standard criteria among HIV-infected and uninfected IDUs in 6-month intervals from 2005 to 2008. Generalized linear mixed-model analyses assessed correlates of frailty. Cox proportional hazards models estimated risk for all-cause mortality. Results: Of 1230 participants at baseline, the median age was 48 years and 29% were HIV-infected; the frailty prevalence was 12.3%. In multivariable analysis of 3,365 frailty measures, HIV-infected IDUs had an increased likelihood of frailty (OR, 1.66; 95% CI, 1.24-2.21) compared to HIV-uninfected IDUs; the association was strongest (OR, 2.37; 95% CI, 1.62-3.48) among HIV-infected IDUs with advanced HIV disease (CD4<350 cells/mm3 and detectable HIV RNA). No significant association was seen with less advanced disease. Sociodemographic factors, comorbidity, depressive symptoms, and prescription drug abuse were also independently associated with frailty. Mortality risk was increased with frailty alone (HR 2.63, 95% CI, 1.23-5.66), HIV infection alone (HR 3.29, 95% CI, 1.85-5.88), and being both HIV-infected and frail (HR, 7.06; 95% CI 3.49-14.3). Conclusion: Frailty was strongly associated with advanced HIV disease, but IDUs with well-controlled HIV had a similar prevalence to HIV-uninfected IDUs. Frailty was independently associated with mortality, with a marked increase in mortality risk for IDUs with both frailty and HIV infection.	[Piggott, Damani A.; Muzaale, Abimereki D.; Brown, Todd T.; Leng, Sean X.; Kirk, Gregory D.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Piggott, Damani A.; Muzaale, Abimereki D.; Mehta, Shruti H.; Brown, Todd T.; Kirk, Gregory D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Patel, Kushang V.] Univ Washington, Sch Med, Seattle, WA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle	Piggott, DA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	dpiggott@jhsph.edu			National Institutes of Health [RC1-AI-086053, R01-DA-04334, R01-DA-12568]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036297, R01DA004334, R01DA012568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (grants RC1-AI-086053, R01-DA-04334, and R01-DA-12568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J GERONTOL A; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Carroll JE, 2011, BRAIN BEHAV IMMUN; Celentano DD, 1998, JAMA-J AM MED ASSOC, V280, P544, DOI 10.1001/jama.280.6.544; Crystal S, 2003, JAIDS-J ACQ IMM DEF, V33, pS76, DOI 10.1097/00126334-200306012-00004; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Desquilbet L, 2011, J GERONTOL A; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Joseph Cherian, 2005, Molecular Aspects of Medicine, V26, P181, DOI 10.1016/j.mam.2005.01.004; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Khosla N, 2011, ADDICT BEHAV, V36, P1282, DOI 10.1016/j.addbeh.2011.07.046; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mehta SH, 2010, CLIN INFECT DIS, V50, P1664, DOI 10.1086/652867; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Nijhawan Ank, 2008, Curr Infect Dis Rep, V10, P432, DOI 10.1007/s11908-008-0068-x; Onen NF, 2009, J INFECTION, V59, P346, DOI 10.1016/j.jinf.2009.08.008; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Salter ML, 2011, CLIN INFECT DIS, V53, P1256, DOI 10.1093/cid/cir673; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Szanton SL, 2010, J EPIDEMIOL COMMUN H, V64, P63, DOI 10.1136/jech.2008.078428; Terzian AS, 2009, J WOMENS HEALTH, V18, P1965, DOI 10.1089/jwh.2008.1090; Vlahov D, 2005, AM J EPIDEMIOL, V161, P999, DOI 10.1093/aje/kwi133; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2005, LANCET INFECT DIS, V5, P407, DOI 10.1016/S1473-3099(05)70162-6; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; Yao X, 2011, CLIN GERIATR MED, V27, P79, DOI 10.1016/j.cger.2010.08.002	52	116	116	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54910	10.1371/journal.pone.0054910	http://dx.doi.org/10.1371/journal.pone.0054910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23382997	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600049
J	Banigan, MG; Kao, PF; Kozubek, JA; Winslow, AR; Medina, J; Costa, J; Schmitt, A; Schneider, A; Cabral, H; Cagsal-Getkin, O; Vanderburg, CR; Delalle, I				Banigan, Meredith G.; Kao, Patricia F.; Kozubek, James A.; Winslow, Ashley R.; Medina, Juan; Costa, Joan; Schmitt, Andrea; Schneider, Anja; Cabral, Howard; Cagsal-Getkin, Ozge; Vanderburg, Charles R.; Delalle, Ivana			Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SHRUNKEN CENTROIDS; DENDRITIC SPINES; GENE-EXPRESSION; AMYLOID-BETA; BRAIN; PATHWAY; SECRETION; RNA; MICROARRAYS	Exosomes are cellular secretory vesicles containing microRNAs (miRNAs). Once secreted, exosomes are able to attach to recipient cells and release miRNAs potentially modulating the function of the recipient cell. We hypothesized that exosomal miRNA expression in brains of patients diagnosed with schizophrenia (SZ) and bipolar disorder (BD) might differ from controls, reflecting either disease-specific or common aberrations in SZ and BD patients. The sources of the analyzed samples included McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center), BrainNet Europe II (BNE, a consortium of 18 brain banks across Europe) and Boston Medical Center (BMC). Exosomal miRNAs from frozen postmortem prefrontal cortices with well-preserved RNA were isolated and submitted to profiling by Luminex FLEXMAP 3D microfluidic device. Multiple statistical analyses of microarray data suggested that certain exosomal miRNAs were differentially expressed in SZ and BD subjects in comparison to controls. RT-PCR validation confirmed that two miRNAs, miR-497 in SZ samples and miR-29c in BD samples, have significantly increased expression when compared to control samples. These results warrant future studies to evaluate the potential of exosome-derived miRNAs to serve as biomarkers of SZ and BD.	[Banigan, Meredith G.; Kao, Patricia F.; Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Banigan, Meredith G.; Cagsal-Getkin, Ozge; Vanderburg, Charles R.] Harvard NeuroDiscovery Ctr, Adv Tissue Resource Ctr, Charlestown, MA USA; [Kozubek, James A.] Boston Univ, Sch Med, Dept Biomed Genet, Boston, MA 02118 USA; [Winslow, Ashley R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Medina, Juan; Costa, Joan] Neurol Tissue Bank, Barcelona, Spain; [Schmitt, Andrea] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Schmitt, Andrea] Univ Sao Paulo, Fac Med, Dept Psychiat, Neurosci Lab, Sao Paulo, Brazil; [Schmitt, Andrea] Univ Sao Paulo, Fac Med, Inst Psychiat, Sao Paulo, Brazil; [Schneider, Anja] Univ Med Goettingen, Dept Psychiat, Gottingen, Germany; [Schneider, Anja] German Res Ctr Neurodegenerat Dis, Gottingen, Germany; [Cabral, Howard] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Cabral, Howard] Boston Univ, Clin & Translat Sci Inst, Boston, MA 02118 USA	Boston University; Harvard University; Boston University; Harvard University; Massachusetts General Hospital; University of Munich; Universidade de Sao Paulo; Universidade de Sao Paulo; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Boston University; Boston University	Delalle, I (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	idelalle@bu.edu	Schmitt, Andrea/V-3003-2018; Vanderburg, Charles/C-4516-2013	Schmitt, Andrea/0000-0002-5426-4023; Vanderburg, Charles/0000-0001-8979-5054; Delalle, Ivana/0000-0002-1873-3064; Cabral, Howard/0000-0002-1185-8331; Schneider, Anja/0000-0001-9540-8700	National Institute of Mental Health [R21 MH086079]; National Institute of Aging [T32 AG00015-21]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023480] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Mental Health (R21 MH086079; ID and CRV) and National Institute of Aging (T32 AG00015-21; PFK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barbato C, 2010, J NEUROCHEM, V113, P591, DOI 10.1111/j.1471-4159.2009.06560.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Gallego JA, 2012, J MOL NEUROSCI, V47, P243, DOI 10.1007/s12031-012-9731-7; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Ghosh Debashis, 2005, Functional & Integrative Genomics, V5, P18, DOI 10.1007/s10142-004-0120-3; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HOLM S, 1979, SCAND J STAT, V6, P65; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lakhal S, 2011, BIOESSAYS, V33, P737, DOI 10.1002/bies.201100076; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Okabayashi S, 2010, NEUROREPORT, V21, P606, DOI 10.1097/WNR.0b013e3283383467; Owen MJ, 2005, BRIT MED J, V330, P158, DOI 10.1136/bmj.330.7484.158; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Presutti C, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S5; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Suedof Thomas C., 2008, V184, P1; TARRANT SB, 1977, TISSUE CELL, V9, P461, DOI 10.1016/0040-8166(77)90006-4; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 2003, STAT SCI, V18, P104, DOI 10.1214/ss/1056397488; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vawter MP, 2000, BIOL PSYCHIAT, V48, P486, DOI 10.1016/S0006-3223(00)00978-1; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	67	150	160	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e48814	10.1371/journal.pone.0048814	http://dx.doi.org/10.1371/journal.pone.0048814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382797	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800002
J	Freeman, EE; Roy-Gagnon, MH; Descovich, D; Masse, H; Lesk, MR				Freeman, Ellen E.; Roy-Gagnon, Marie-Helene; Descovich, Denise; Masse, Hugues; Lesk, Mark R.			The Heritability of Glaucoma-Related Traits Corneal Hysteresis, Central Corneal Thickness, Intraocular Pressure, and Choroidal Blood Flow Pulsatility	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GUANGZHOU TWIN EYE; TO-DISC RATIO; ASSOCIATION; PEDIGREES; NUCLEAR; CHINESE	Purpose: The purpose of this work was to investigate the heritability of potential glaucoma endophenotypes. We estimated for the first time the heritability of the pulsatility of choroidal blood flow. We also sought to confirm the heritability of corneal hysteresis, central corneal thickness, and 3 ways of measuring intraocular pressure. Methods: Measurements were performed on 96 first-degree relatives recruited from Maisonneuve-Rosemont Hospital in Montreal. Corneal hysteresis was determined using the Reichert Ocular Response Analyser. Central corneal thickness was measured with an ultrasound pachymeter. Three measures of intraocular pressure were obtained: Goldmann-correlated and corneal compensated intraocular pressure using the Ocular Response Analyser, and Pascal intraocular pressure using the Pascal Dynamic Contour Tonometer. The pulsatility of choroidal blood velocity and flow were measured in the sub-foveolar choroid using single-point laser Doppler flowmetry (Oculix). We estimated heritability using maximum-likelihood variance components methods implemented in the SOLAR software. Results: No significant heritability was detected for the pulsatility of choroidal blood flow or velocity. The Goldman-correlated, corneal compensated, and Pascal measures of intraocular pressure measures were all significantly heritable at 0.94, 0.79, and 0.53 after age and sex adjustment (p = 0.0003, p = 0.0023, p = 0.0239). Central corneal thickness was significantly heritable at 0.68 (p = 0.0078). Corneal hysteresis was highly heritable but the estimate was at the upper boundary of 1.00 preventing us from giving a precise estimate. Conclusion: Corneal hysteresis, central corneal thickness, and intraocular pressure are all heritable and may be suitable as glaucoma endophenotypes. The pulsatility of choroidal blood flow and blood velocity were not significantly heritable in this sample.	[Freeman, Ellen E.; Descovich, Denise; Lesk, Mark R.] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada; [Freeman, Ellen E.; Lesk, Mark R.] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Roy-Gagnon, Marie-Helene; Masse, Hugues] Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Roy-Gagnon, Marie-Helene] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Freeman, EE (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada.	eefreeman@gmail.com		Freeman, Ellen/0000-0002-1403-8427; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846	Canadian Glaucoma Clinical Research Council; Canadian National Institute for the Blind; Fonds de Recherche en Ophtalmologie de l'Universite de Montreal	Canadian Glaucoma Clinical Research Council; Canadian National Institute for the Blind; Fonds de Recherche en Ophtalmologie de l'Universite de Montreal	This project was funded through a grant from the Canadian Glaucoma Clinical Research Council and the Canadian National Institute for the Blind, and also by the Fonds de Recherche en Ophtalmologie de l'Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bahrami H, 2006, OPHTHAL EPIDEMIOL, V13, P283, DOI 10.1080/09286580600681339; Carbonaro F, 2008, BRIT J OPHTHALMOL, V92, P1125, DOI 10.1136/bjo.2007.133272; Carbonaro F, 2008, OPHTHALMOLOGY, V115, P1545, DOI 10.1016/j.ophtha.2008.02.011; Chang TC, 2005, OPHTHALMOLOGY, V112, P1186, DOI 10.1016/j.ophtha.2005.03.006; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; De Moraes CGV, 2012, J GLAUCOMA, V21, P209, DOI 10.1097/IJG.0b013e3182071b92; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Goldman David, 2007, ScientificWorldJournal, V7, P124; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Kochkorov A, 2010, GRAEF ARCH CLIN EXP, V248, P833, DOI 10.1007/s00417-009-1277-1; Landers JA, 2009, INVEST OPHTH VIS SCI, V50, P4087, DOI 10.1167/iovs.08-3271; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Mangouritsas G, 2009, ACTA OPHTHALMOL, V87, P901, DOI 10.1111/j.1755-3768.2008.01370.x; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Parssinen O, 2007, OPHTHALMOLOGY, V114, P2227, DOI 10.1016/j.ophtha.2007.03.011; Polska E, 2004, BRIT J OPHTHALMOL, V88, P533, DOI 10.1136/bjo.2003.028480; Roy-Gagnon MH, 2008, ANN HUM GENET, V72, P115, DOI 10.1111/j.1469-1809.2007.00401.x; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Toh TY, 2005, INVEST OPHTH VIS SCI, V46, P3718, DOI 10.1167/iovs.04-1497; Ulmer M, 2012, INVEST OPHTH VIS SCI, V53, P4468, DOI 10.1167/iovs.12-9784; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934; Zheng YF, 2009, INVEST OPHTH VIS SCI, V50, P2040, DOI 10.1167/iovs.08-3082	31	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55573	10.1371/journal.pone.0055573	http://dx.doi.org/10.1371/journal.pone.0055573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383229	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800168
J	Hu, LN; Wang, TG; Gocke, AR; Nath, A; Zhang, H; Margolick, JB; Whartenby, KA; Calabresi, PA				Hu, Lina; Wang, Tongguang; Gocke, Anne R.; Nath, Avindra; Zhang, Hao; Margolick, Joseph B.; Whartenby, Katharine A.; Calabresi, Peter A.			Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+T Effector Memory Lymphocytes	PLOS ONE			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; GATED K+ CHANNELS; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; CLONAL EXPANSIONS; PERIPHERAL-BLOOD; BINDING-SITES; IN-VIVO; CHARYBDOTOXIN	Increased expression of the voltage-gated potassium channel Kn1.3 on activated effector memory T cells (T-EM) is associated with pathology in multiple sclerosis (MS). To date, most studies of Kn1.3 channels in MS have focused on CD4+ T-EM cells. Much less is known about the functional relevance of Kv1.3 on CD8+ T-EM cells. Herein, we examined the effects of Kn1.3 blockade on CD8+ T cell proliferation, differentiation into cytotoxic effector cells, and release of granzyme B (GrB), a key effector of CD8+ T cell-mediated cytotoxicity. We confirmed the expression of Kv1.3 channels on activated human CD8+ T lymphocytes by immunofluorescent staining. To test the functional relevance of the Kv1.3 channel in CD8+ T cells, we inhibited this channel via pharmacological blockers or a lentiviral-dominant negative (Kv1.xDN) approach and determined the effects of the blockade on critical pathogenic parameters of CD8+ T cells. We found that blockade of Kv1.3 with both lentivirus and pharmacologic agents effectively inhibited cytotoxic effector memory cells' proliferation, secretion of GrB, and their ability to kill neural progenitor cells. Intriguingly, the KvDN transduced T cells exhibited arrested differentiation from central memory (T-CM) to effector memory (T-EM) states. Transduction of cells that had already differentiated into T-EM with KvDN led to their conversion into T-CM. CD8+ T-EM have a critical role in MS and other autoimmune diseases. Our present results indicate a critical role for Kv1.3 in the conversion of CD8+ T cells into potential pathogenic effector cells with cytotoxic function.	[Hu, Lina; Gocke, Anne R.; Whartenby, Katharine A.; Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wang, Tongguang; Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bethesda, MD 20892 USA; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Calabresi, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	Calabresi@jhmi.edu	Calabresi, Peter A./AAF-2288-2019	Calabresi, Peter/0000-0002-7776-6472	National Institutes of Health [NS041435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003134, R01NS041435, ZIANS003130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from National Institutes of Health: NS041435 (PAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Babichuk CK, 1996, J BIOL CHEM, V271, P16485, DOI 10.1074/jbc.271.28.16485; Babichuk CK, 1997, J BIOL CHEM, V272, P18564, DOI 10.1074/jbc.272.30.18564; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BOOSS J, 1983, J NEUROL SCI, V62, P219, DOI 10.1016/0022-510X(83)90201-0; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Calabresi PA, 2003, J NEUROIMMUNOL, V139, P58, DOI 10.1016/S0165-5728(03)00127-9; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; DEUTSCH C, 1991, J BIOL CHEM, V266, P3668; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Koo GC, 1997, J IMMUNOL, V158, P5120; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mullen KM, 2006, ANN NEUROL, V60, P118, DOI 10.1002/ana.20884; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Perez-Garcia MT, 2000, J NEUROSCI, V20, P5689, DOI 10.1523/JNEUROSCI.20-15-05689.2000; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Rock MT, 2005, J IMMUNOL, V174, P3757, DOI 10.4049/jimmunol.174.6.3757; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SANDS SB, 1989, J GEN PHYSIOL, V93, P1061, DOI 10.1085/jgp.93.6.1061; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; Wang T, 2006, FASEB J, V20, P1209, DOI 10.1096/fj.05-5022fje; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120	43	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54267	10.1371/journal.pone.0054267	http://dx.doi.org/10.1371/journal.pone.0054267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382885	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800041
J	Leteneur, S; Simoneau, E; Gillet, C; Dessery, Y; Barbier, F				Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Dessery, Yoann; Barbier, Franck			Trunk's Natural Inclination Influences Stance Limb Kinetics, but Not Body Kinematics, during Gait Initiation in Able Men	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; AGE-RELATED-CHANGES; MOVEMENTS; JOINT; ANKLE; YOUNG; STEP; CLASSIFICATION; ORGANIZATION; STRATEGIES	The imposing mass of the trunk in relation to the whole body has an important impact on human motion. The objective of this study is to determine the influence of trunk's natural inclination - forward (FW) or backward (BW) with respect to the vertical - on body kinematics and stance limb kinetics during gait initiation. Twenty-five healthy males were divided based on their natural trunk inclination (FW or BW) during gait initiation. Instantaneous speed was calculated at the center of mass at the first heel strike. The antero-posterior impulse was calculated by integrating the antero-posterior ground reaction force in time. Ankle, knee, hip and thoraco-lumbar (L5) moments were calculated using inverse dynamics and only peaks of the joint moments were analyzed. Among all the investigated parameters, only joint moments present significant differences between the two groups. The knee extensor moment is 1.4 times higher (P<0.001) for the BW group, before the heel contact. At the hip, although the BW group displays a flexor moment 2.4 times higher (P<0.001) before the swing limb's heel-off, the FW group displays an extensor moment 3.1 times higher (P<0.01) during the swing phase. The three L5 extensor peaks after the toe-off are respectively 1.7 (P<0.001), 1.4 (P<0.001) and 1.7 (P<0.01) times higher for the FW group. The main results support the idea that the patterns described during steady-state gait are already observable during gait initiation. This study also provides reference data to further investigate stance limb kinetics in specific or pathologic populations during gait initiation. It will be of particular interest for elderly people, knowing that this population displays atypical trunk postures and present a high risk of falling during this forward stepping.	[Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Barbier, Franck] Univ Lille Nord France, Lille, France; [Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Barbier, Franck] UVHC, LAMIH, Valenciennes, France; [Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Barbier, Franck] CNRS, UMR 8201, Valenciennes, France; [Leteneur, Sebastien] Ctr Reeduc Fonct La Rougeville, St Saulve, France; [Dessery, Yoann] Univ Laval, Fac Med, Div Kinesiol, Quebec City, PQ G1K 7P4, Canada	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite Polytechnique Hauts-de-France; Laval University	Leteneur, S (corresponding author), Univ Lille Nord France, Lille, France.	sebastien.leteneur@univ-valenciennes.fr	Simoneau, Emilie/ABA-6405-2020	SIMONEAU-BUESSINGER, Emilie/0000-0003-2059-884X; Dessery, Yoann/0000-0001-5198-356X	International Campus on Safety and Intermodality in Transportation; Nord/Pas-de-Calais Region; European Community; Regional Delegation for Research and Technology; Ministry of Higher Education and Research; French National Research Agency; National Center for Scientific Research	International Campus on Safety and Intermodality in Transportation; Nord/Pas-de-Calais Region(Region Hauts-de-FranceEuropean Commission); European Community(European Commission); Regional Delegation for Research and Technology; Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); French National Research Agency(French National Research Agency (ANR)); National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS))	This research was supported by International Campus on Safety and Intermodality in Transportation, the Nord/Pas-de-Calais Region, the European Community, the Regional Delegation for Research and Technology, the Ministry of Higher Education and Research, the French National Research Agency and the National Center for Scientific Research. The authors gratefully acknowledge the support of these institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2007, GAIT POSTURE, V26, P526, DOI 10.1016/j.gaitpost.2006.11.203; BRENIERE Y, 1987, J BIOPHYS BIOMEC, V11, P161; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; BRENIERE Y, 1987, J MOTOR BEHAV, V19, P62, DOI 10.1080/00222895.1987.10735400; BRENIERE Y, 1981, J BIOPHYS BIOMEC, V5, P197; Brunt D, 1999, GAIT POSTURE, V10, P121, DOI 10.1016/S0966-6362(99)00020-X; Brunt D, 2000, NEUROSCI LETT, V285, P228, DOI 10.1016/S0304-3940(00)01063-6; Bruyneel A. -V., 2008, Annales de Readaptation et de Medecine Physique, V51, P630, DOI 10.1016/j.annrmp.2008.05.004; Callaghan JP, 1999, CLIN BIOMECH, V14, P203, DOI 10.1016/S0268-0033(98)00069-2; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Couillandre A, 2000, NEUROSCI LETT, V285, P150, DOI 10.1016/S0304-3940(00)01015-6; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dessery Y, 2011, GAIT POSTURE, V33, P550, DOI 10.1016/j.gaitpost.2011.01.008; DIETRICH G, 1994, HUM MOVEMENT SCI, V13, P195, DOI 10.1016/0167-9457(94)90036-1; ENG JJ, 1995, J BIOMECH, V28, P753, DOI 10.1016/0021-9290(94)00124-M; Engsberg JR, 2001, SPINE, V26, P2020, DOI 10.1097/00007632-200109150-00016; Gillet A, 2003, AM J PHYS MED REHAB, V82, P101, DOI 10.1097/01.PHM.0000046629.78324.28; Goh JH, 1998, CLIN BIOMECH, V13, pS26, DOI 10.1016/S0268-0033(97)00071-5; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hirose D, 2004, CLIN BIOMECH, V19, P57, DOI 10.1016/j.clinbiomech.2003.08.005; Laudani L, 2006, J ELECTROMYOGR KINES, V16, P603, DOI 10.1016/j.jelekin.2006.08.001; Leardini A, 2009, CLIN BIOMECH, V24, P542, DOI 10.1016/j.clinbiomech.2009.05.005; LEPERS R, 1995, EXP BRAIN RES, V107, P118; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leteneur S, 2009, CLIN BIOMECH, V24, P190, DOI 10.1016/j.clinbiomech.2008.10.005; MANN RA, 1979, J BONE JOINT SURG AM, V61, P232, DOI 10.2106/00004623-197961020-00011; McGibbon CA, 2001, J NEUROPHYSIOL, V85, P1923, DOI 10.1152/jn.2001.85.5.1923; Michel V, 2002, NEUROSCI LETT, V325, P139, DOI 10.1016/S0304-3940(02)00255-0; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Nikravesh P.E., 1988, COMPUTER AIDED ANAL; NISSAN M, 1990, J BIOMED ENG, V12, P165, DOI 10.1016/0141-5425(90)90139-E; Patchay S, 2003, GAIT POSTURE, V18, P85, DOI 10.1016/S0966-6362(02)00167-4; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Saha D, 2008, GAIT POSTURE, V27, P653, DOI 10.1016/j.gaitpost.2007.08.009; Surgeons AAOO, 1966, JOINT MOT METH MEAS; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; Vardaxis VG, 1998, HUM MOVEMENT SCI, V17, P121, DOI 10.1016/S0167-9457(97)00024-9; Watelain E, 2000, ARCH PHYS MED REHAB, V81, P579, DOI 10.1053/mr.2000.4415; Wicart P, 2003, NEUROSCI LETT, V351, P67, DOI 10.1016/S0304-3940(03)00619-0; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	44	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55256	10.1371/journal.pone.0055256	http://dx.doi.org/10.1371/journal.pone.0055256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383128	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800137
J	Sato, A; Shibuya, H				Sato, Atsushi; Shibuya, Hiroshi			WNK Signaling Is Involved in Neural Development via Lhx8/Awh Expression	PLOS ONE			English	Article							FOREBRAIN CHOLINERGIC NEURONS; ALANINE-RICH KINASE; LIM-HOMEOBOX GENE; PROTEIN-KINASE; MONOCLONAL-ANTIBODIES; COTRANSPORTERS; HYPERTENSION; CELLS; MICE; OSR1	WNK kinase family is conserved among many species and regulates SPAK/OSR1 and ion co-transporters. Some mutations in human WNK1 or WNK4 are associated with Pseudohypoaldosteronism type II, a form of hypertension. WNK is also involved in developmental and cellular processes, but the molecular mechanisms underlying its regulation in these processes remain unknown. Here, we identify a new target gene in WNK signaling, Arrowhead and Lhx8, which is a mammalian homologue of Drosophila Arrowhead. In Drosophila, WNK was shown to genetically interact with Arrowhead. In Wnk1 knockout mice, levels of Lhx8 expression were reduced. Ectopic expression of WNK1, WNK4 or Osr1 in mammalian cells induced the expression of the Lhx8. Moreover, neural specification was inhibited by the knockdown of both Wnk1 and Wnk4 or Lhx8. Drosophila WNK mutant caused defects in axon guidance during embryogenesis. These results suggest that WNK signaling is involved in the morphological and neural development via Lhx8/Arrowhead.	[Sato, Atsushi; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Shibuya, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo, Japan.	shibuya.mcb@mri.tmd.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan to A.S. and H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; CURTISS J, 1995, DEVELOPMENT, V121, P3819; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Huang HS, 2007, J NEUROSCI, V27, P11254, DOI 10.1523/JNEUROSCI.3272-07.2007; Kahle KT, 2004, CURR OPIN NEPHROL HY, V13, P557, DOI 10.1097/00041552-200409000-00012; Lawrence P.A., 1986, P229; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Manabe T, 2005, J NEUROCHEM, V94, P723, DOI 10.1111/j.1471-4159.2005.03261.x; Matsumoto K, 1996, NEUROSCI LETT, V204, P113, DOI 10.1016/0304-3940(96)12341-7; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Sato A, 1999, DEVELOPMENT, V126, P4421; Shibaguchi T, 2003, ARCH HISTOL CYTOL, V66, P95, DOI 10.1679/aohc.66.95; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang YP, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-29; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55301	10.1371/journal.pone.0055301	http://dx.doi.org/10.1371/journal.pone.0055301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383144	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800140
J	Zhao, YH; Larson-Rabin, Z; Wang, GY; Moller, M; Li, CY; Zhang, JP; Li, HT; Li, DZ				Zhao, Yin-He; Larson-Rabin, Zachary; Wang, Guo-Ying; Moeller, Michael; Li, Cheng-Yun; Zhang, Jin-Peng; Li, Hong-Tao; Li, De-Zhu			Developmental Genetics of the Perianthless Flowers and Bracts of a Paleoherb Species, Saururus chinensis	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL ORGAN IDENTITY; HOMEOTIC GENES; EXPRESSION; EVOLUTION; APETALA3; SEQUENCE; PROTEINS; PISTILLATA; LEAVES	Saururus chinensis is a core member of Saururaceae, a perianthless (lacking petals or sepals) family. Due to its basal phylogenetic position and unusual floral composition, study of this plant family is important for understanding the origin and evolution of perianthless flowers and petaloid bracts among angiosperm species. To isolate genes involved in S. chinensis flower development, subtracted floral cDNA libraries were constructed by using suppression subtractive hybridization (SSH) on transcripts isolated from developing inflorescences and seedling leaves. The subtracted cDNA libraries contained a total of 1,141 ESTs and were used to create cDNA microarrays to analyze transcript profiles of developing inflorescence tissues. Subsequently, qRT-PCR analyses of eight MADS-box transcription factors and in situ hybridizations of two B-class MADS-box transcription factors were performed to verify and extend the cDNA microarray results. Finally, putative phylogenetic relationships within the B-class MADS-box gene family were determined using the discovered S. chinensis B-class genes to compare K-domain sequences with B genes from other basal angiosperms. Two hundred seventy-seven of the 1,141 genes were found to be expressed differentially between S. chinensis inflorescence tissues and seedling leaves, 176 of which were grouped into at least one functional category, including transcription (14.75%), energy (12.59%), metabolism (9.12%), protein-related function (8.99%), and cellular transport (5.76%). qRT-PCR and in situ hybridization of selected MADS-box genes supported our microarray data. Phylogenetic analysis indicated that a total of six B-class MADS-box genes were isolated from S. chinensis. The differential regulation of S. chinensis B-class MADSbox transcription factors likely plays a role during the development of subtending bracts and perianthless flowers. This study contributes to our understanding of inflorescence development in Saururus, and represents an initial step toward understanding the formation of petaloid bracts in this species.	[Zhao, Yin-He; Larson-Rabin, Zachary; Li, Hong-Tao; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China; [Zhao, Yin-He; Li, Cheng-Yun] Yunnan Agr Univ, Coll Agron, Kunming, Peoples R China; [Zhao, Yin-He; Li, Cheng-Yun] Yunnan Agr Univ, Key Lab Plant Pathol Yunnan Prov, Kunming, Peoples R China; [Wang, Guo-Ying; Zhang, Jin-Peng] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Moeller, Michael] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Agricultural University; Yunnan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China.	dzl@mail.kib.ac.cn	Moeller, Michael/O-9748-2015; Li, De-Zhu/G-8203-2011	Moeller, Michael/0000-0002-2819-0323; Li, De-Zhu/0000-0002-4990-724X; Li, Hong Tao/0000-0002-1290-0917	Ministry of Science and Technology of China [2004DKA30430]; National Natural Science Foundation of China [NSFC30860130, NSFC31060166]; Yunnan Natural Science Foundation [2007C209M]; Large-scale Scientific Facilities of the Chinese Academy of Sciences program [2009-LSFGBOWS-01]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Large-scale Scientific Facilities of the Chinese Academy of Sciences program	This work was supported by the Ministry of Science and Technology of China [2004DKA30430]; the National Natural Science Foundation of China [NSFC30860130 and NSFC31060166]; the Yunnan Natural Science Foundation [2007C209M]; and the Large-scale Scientific Facilities of the Chinese Academy of Sciences program [2009-LSFGBOWS-01]. Z.L.R. was supported by a Chinese Academy of Sciences Young International Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Bowman JL, 1997, J BIOSCIENCE, V22, P515, DOI 10.1007/BF02703197; Buzgo M, 2004, INT J PLANT SCI, V165, P925, DOI 10.1086/424024; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; De Craene LPR, 2007, ANN BOT-LONDON, V100, P621, DOI 10.1093/aob/mcm076; De Craene Louis P. Ronse, 2004, Annals of Botany (London), V94, P741; Di Stilio VS, 2005, PLANT J, V41, P755, DOI 10.1111/j.1365-313X.2005.02336.x; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Fernandes J, 2002, PLANT PHYSIOL, V128, P896, DOI 10.1104/pp.010681; Ferrario S, 2003, PLANT CELL, V15, P914, DOI 10.1105/tpc.010280; Furutani I, 2006, PLANT J, V46, P503, DOI 10.1111/j.1365-313X.2006.02703.x; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hu W, 2003, PLANT MOL BIOL, V53, P545, DOI 10.1023/B:PLAN.0000019063.18097.62; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; Jaramillo MA, 2007, MOL PHYLOGENET EVOL, V44, P598, DOI 10.1016/j.ympev.2007.03.015; Jaramillo MA, 2004, EVOL DEV, V6, P449, DOI 10.1111/j.1525-142X.2004.04053.x; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Johansen B, 2002, MOL PHYLOGENET EVOL, V23, P458, DOI 10.1016/S1055-7903(02)00032-5; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim S, 2005, INT J PLANT SCI, V166, P185, DOI 10.1086/427479; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Kramer EM, 2007, PLANT CELL, V19, P750, DOI 10.1105/tpc.107.050385; Kramer EM, 2005, J EXP ZOOL PART B, V304B, P526, DOI 10.1002/jez.b.21046; Kramer EM, 2000, INT J PLANT SCI, V161, pS29, DOI 10.1086/317576; Liang HX, 1996, ACTA PHYTOTAXONOMICA, V34, P565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mouradov A, 1999, DEV GENET, V25, P245, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;245::AID-DVG7&gt;3.0.CO;2-N; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Shindo S, 1999, EVOL DEV, V1, P180, DOI 10.1046/j.1525-142x.1999.99024.x; Soltis PS, 2009, AM J BOT, V96, P110, DOI 10.3732/ajb.0800182; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUCKER SC, 1993, SYST BOT, V18, P614, DOI 10.2307/2419537; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Whipple CJ, 2010, PLANT CELL, V22, P565, DOI 10.1105/tpc.109.073536; Winter KU, 2002, MOL BIOL EVOL, V19, P587, DOI 10.1093/oxfordjournals.molbev.a004118; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yang YZ, 2003, PLANT J, V33, P47, DOI 10.1046/j.0960-7412.2003.01473.x; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zhang XH, 2005, PLANT MOL BIOL, V58, P401, DOI 10.1007/s11103-005-5434-6; Zhao DL, 1999, PHOTOSYNTHETICA, V36, P279, DOI 10.1023/A:1007059930011; Zhao YH, 2010, PLANTA, V231, P265, DOI 10.1007/s00425-009-1048-6; Zhao YH, 2006, ANN BOT-LONDON, V98, P157, DOI 10.1093/aob/mcl081	55	10	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53019	10.1371/journal.pone.0053019	http://dx.doi.org/10.1371/journal.pone.0053019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382831	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800017
J	Benseddik, K; Sen Nkwe, N; Daou, P; Verdier-Pinard, P; Badache, A				Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali			ErbB2-Dependent Chemotaxis Requires Microtubule Capture and Stabilization Coordinated by Distinct Signaling Pathways	PLOS ONE			English	Article							CELL-MIGRATION; BREAST-CANCER; KINASE; PHOSPHORYLATION; POLARITY; NETWORK; PROTEIN; CDC42; ERBB2; ACTIVATION	Activation of the ErbB2 receptor tyrosine kinase stimulates breast cancer cell migration. Cell migration is a complex process that requires the synchronized reorganization of numerous subcellular structures including cell-to-matrix adhesions, the actin cytoskeleton and microtubules. How the multiple signaling pathways triggered by ErbB2 coordinate, in time and space, the various processes involved in cell motility, is poorly defined. We investigated the mechanism whereby ErbB2 controls microtubules and chemotaxis. We report that activation of ErbB2 increased both cell velocity and directed migration. Impairment of the Cdc42 and RhoA GTPases, but not of Rac1, prevented the chemotactic response. RhoA is a key component of the Memo/ACF7 pathway whereby ErbB2 controls microtubule capture at the leading edge. Upon Memo or ACF7 depletion, microtubules failed to reach the leading edge and cells lost their ability to follow the chemotactic gradient. Constitutive ACF7 targeting to the membrane in Memo-depleted cells reestablished directed migration. ErbB2-mediated activation of phospholipase C gamma (PLC gamma) also contributed to cell guidance. We further showed that PLC gamma signaling, via classical protein kinases C, and Memo signaling converged towards a single pathway controlling the microtubule capture complex. Finally, inhibiting the PI3K/Akt pathway did not affect microtubule capture, but disturbed microtubule stability, which also resulted in defective chemotaxis. PI3K/Akt-dependent stabilization of microtubules involved repression of GSK3 activity on the one hand and inhibition of the microtubule destabilizing protein, Stathmin, on the other hand. Thus, ErbB2 triggers distinct and complementary pathways that tightly coordinate microtubule capture and microtubule stability to control chemotaxis.	[Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] INSERM, Ctr Rech Cancerol Marseille, U1068, F-13258 Marseille, France; [Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] Aix Marseille Univ, Marseille, France; [Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] CNRS, UMR7258, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Badache, A (corresponding author), INSERM, Ctr Rech Cancerol Marseille, U1068, F-13258 Marseille, France.	ali.badache@inserm.fr	Badache, Ali/Q-6098-2017	Badache, Ali/0000-0001-7710-2505; Verdier-Pinard, Pascal/0000-0002-6149-6578	Bourse Franco-Algerienne fellowship; Fondation pour la Recherche Medicale fellowship; GEFLUC fellowship; Association pour la Recherche sur le Cancer; Institut National du Cancer; Inserm Avenir Program	Bourse Franco-Algerienne fellowship; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale); GEFLUC fellowship; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm))	KB was supported by Bourse Franco-Algerienne, Fondation pour la Recherche Medicale and GEFLUC fellowships. AB was supported by Association pour la Recherche sur le Cancer, Institut National du Cancer and Inserm Avenir Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Badache A, 2006, J MAMMARY GLAND BIOL, V11, P13, DOI 10.1007/s10911-006-9009-1; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Goold RG, 1999, J CELL SCI, V112, P3373; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Holmfeldt P, 2009, CELL MOL LIFE SCI, V66, P3263, DOI 10.1007/s00018-009-0084-5; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Manneville JB, 2010, J CELL BIOL, V191, P585, DOI 10.1083/jcb.201002151; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wittmann T, 2001, J CELL SCI, V114, P3795; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; ZICHA D, 1995, EXP CELL RES, V221, P526, DOI 10.1006/excr.1995.1404	40	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55211	10.1371/journal.pone.0055211	http://dx.doi.org/10.1371/journal.pone.0055211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383112	gold, Green Published, Green Submitted			2022-12-25	WOS:000315483200025
J	Suginta, W; Chumjan, W; Mahendran, KR; Janning, P; Schulte, A; Winterhalter, M				Suginta, Wipa; Chumjan, Watcharin; Mahendran, Kozhinjampara R.; Janning, Petra; Schulte, Albert; Winterhalter, Mathias			Molecular Uptake of Chitooligosaccharides through Chitoporin from the Marine Bacterium Vibrio harveyi	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CHITIN CATABOLIC CASCADE; LAMB MALTOPORIN CHANNEL; CENTRAL CONSTRICTION SITE; ESCHERICHIA-COLI; OUTER-MEMBRANE; SUGAR-TRANSPORT; PSEUDOMONAS-AERUGINOSA; ENZYMATIC-PROPERTIES; SINGLE-CHANNEL	Background: Chitin is the most abundant biopolymer in marine ecosystems. However, there is no accumulation of chitin in the ocean-floor sediments, since marine bacteria Vibrios are mainly responsible for a rapid turnover of chitin biomaterials. The catabolic pathway of chitin by Vibrios is a multi-step process that involves chitin attachment and degradation, followed by chitooligosaccharide uptake across the bacterial membranes, and catabolism of the transport products to fructose-6-phosphate, acetate and NH3. Principal Findings: This study reports the isolation of the gene corresponding to an outer membrane chitoporin from the genome of Vibrio harveyi. This porin, expressed in E. coli, (so called VhChiP) was found to be a SDS-resistant, heat-sensitive trimer. Immunoblotting using anti-ChiP polyclonal antibody confirmed the expression of the recombinant ChiP, as well as endogenous expression of the native protein in the V. harveyi cells. The specific function of VhChiP was investigated using planar lipid membrane reconstitution technique. VhChiP nicely inserted into artificial membranes and formed stable, trimeric channels with average single conductance of 1.8 +/- 0.13 nS. Single channel recordings at microsecond-time resolution resolved translocation of chitooligosaccharides, with the greatest rate being observed for chitohexaose. Liposome swelling assays showed no permeation of other oligosaccharides, including maltose, sucrose, maltopentaose, maltohexaose and raffinose, indicating that VhChiP is a highly-specific channel for chitooligosaccharides. Conclusion/Significance: We provide the first evidence that chitoporin from V. harveyi is a chitooligosaccharide specific channel. The results obtained from this study help to establish the fundamental role of VhChiP in the chitin catabolic cascade as the molecular gateway that Vibrios employ for chitooligosaccharide uptake for energy production.	[Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Sch Chem, Nakhon Ratchasima, Thailand; [Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Sch Biochem, Nakhon Ratchasima, Thailand; [Mahendran, Kozhinjampara R.; Winterhalter, Mathias] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany; [Janning, Petra] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany	Suranaree University of Technology; Suranaree University of Technology; University of Bremen; Max Planck Society	Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Sch Chem, Nakhon Ratchasima, Thailand.	wipa@sut.ac.th		Winterhalter, Mathias/0000-0002-1604-3318	Thailand Research Fund [RMU5380055]; Alexander von Humboldt Foundation, Germany; Commission of Higher Education, Ministry of University Affairs (MUA), Thailand through a CHE-PHD-SW [60/2550]; Deutsche Forschungsgemeinschaft (DFG) [WI 2278/18-1]	Thailand Research Fund(Thailand Research Fund (TRF)); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation); Commission of Higher Education, Ministry of University Affairs (MUA), Thailand through a CHE-PHD-SW; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work is financially supported by the Thailand Research Fund (contract no. RMU5380055). WS was a Humboldt fellow under the Alexander von Humboldt Fellowship for Experienced Researchers, The Alexander von Humboldt Foundation, Germany. WC was funded by the Commission of Higher Education, Ministry of University Affairs (MUA), Thailand through a CHE-PHD-SW scholarship (contract no 60/2550). MW acknowledges funding through WI 2278/18-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1991, J BIOL CHEM, V266, P24268; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Bouma CL, 1996, J BIOL CHEM, V271, P33457, DOI 10.1074/jbc.271.52.33457; Bouma CL, 1996, J BIOL CHEM, V271, P33468, DOI 10.1074/jbc.271.52.33468; CLEMENT JM, 1981, CELL, V27, P507, DOI 10.1016/0092-8674(81)90392-5; Dando RT, 1990, NCIMB CATALOGUE STRA, P172; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Denker K, 2005, J MOL BIOL, V352, P534, DOI 10.1016/j.jmb.2005.07.025; Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200; Dutzler R, 2002, STRUCTURE, V10, P1273, DOI 10.1016/S0969-2126(02)00811-0; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; JEUNIAUX C, 1991, BIOCHEM SYST ECOL, V19, P347, DOI 10.1016/0305-1978(91)90051-Z; Jung BO, 2008, MACROMOL RES, V16, P1, DOI 10.1007/BF03218953; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Keyhani NO, 1996, J BIOL CHEM, V271, P33425, DOI 10.1074/jbc.271.52.33425; Keyhani NO, 1996, J BIOL CHEM, V271, P33414, DOI 10.1074/jbc.271.52.33414; Keyhani NO, 1996, J BIOL CHEM, V271, P33409, DOI 10.1074/jbc.271.52.33409; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; LUCKEY M, 1980, BIOCHEM BIOPH RES CO, V93, P166, DOI 10.1016/S0006-291X(80)80261-0; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Mahendran KR, 2009, EUR BIOPHYS J BIOPHY, V38, P1141, DOI 10.1007/s00249-009-0495-0; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Orlik F, 2002, BIOPHYS J, V82, P2466, DOI 10.1016/S0006-3495(02)75589-6; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Park JK, 2002, J BIOL CHEM, V277, P15573, DOI 10.1074/jbc.M107953200; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Suginta W, 2005, FEBS J, V272, P3376, DOI 10.1111/j.1742-4658.2005.04753.x; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; TRIAS J, 1988, BIOCHIM BIOPHYS ACTA, V938, P493, DOI 10.1016/0005-2736(88)90148-4; Van Gelder P, 2000, BIOPHYS CHEM, V85, P153, DOI 10.1016/S0301-4622(99)00153-2; WYLIE JL, 1994, EUR J BIOCHEM, V220, P505, DOI 10.1111/j.1432-1033.1994.tb18649.x; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; YU C, 1991, J BIOL CHEM, V266, P24260; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938	52	33	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55126	10.1371/journal.pone.0055126	http://dx.doi.org/10.1371/journal.pone.0055126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383078	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200043
J	Da, H; Jia, SJ; Meng, GL; Cheng, JH; Zhou, W; Xiong, Z; Mu, YJ; Liu, J				Da, Hu; Jia, Shuai-Jun; Meng, Guo-Lin; Cheng, Jian-Hua; Zhou, Wei; Xiong, Zhuo; Mu, Yun-Jing; Liu, Jian			The Impact of Compact Layer in Biphasic Scaffold on Osteochondral Tissue Engineering	PLOS ONE			English	Article							ARTICULAR-CARTILAGE REPAIR; IN-VITRO; CONSTRUCTS; DEFECTS; BONE; COMPOSITE; CHONDROCYTES; MORPHOLOGY; INTERFACE; HYPOXIA	The structure of an osteochondral biphasic scaffold is required to mimic native tissue, which owns a calcified layer associated with mechanical and separation function. The two phases of biphasic scaffold should possess efficient integration to provide chondrocytes and osteocytes with an independent living environment. In this study, a novel biphasic scaffold composed of a bony phase, chondral phase and compact layer was developed. The compact layer-free biphasic scaffold taken as control group was also fabricated. The purpose of current study was to evaluate the impact of the compact layer in the biphasic scaffold. Bony and chondral phases were seeded with autogeneic osteoblast-or chondrocyte-induced bone marrow stromal cells (BMSCs), respectively. The biphasic scaffolds-cells constructs were then implanted into osteochondral defects of rabbits' knees, and the regenerated osteochondral tissue was evaluated at 3 and 6 months after surgery. Anti-tensile and anti-shear properties of the compact layer-containing biphasic scaffold were significantly higher than those of the compact layer-free biphasic scaffold in vitro. Furthermore, in vivo studies revealed superior macroscopic scores, glycosaminoglycan (GAG) and collagen content, micro tomograph imaging results, and histological properties of regenerated tissue in the compact layer-containing biphasic scaffold compared to the control group. These results indicated that the compact layer could significantly enhance the biomechanical properties of biphasic scaffold in vitro and regeneration of osteochondral tissue in vivo, and thus represented a promising approach to osteochondral tissue engineering.	[Da, Hu; Meng, Guo-Lin; Liu, Jian] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China; [Da, Hu; Cheng, Jian-Hua; Zhou, Wei] 82nd Hosp PLA, Huaian, Peoples R China; [Jia, Shuai-Jun] Shannxi Hosp Armed Police Force, Xian, Peoples R China; [Xiong, Zhuo] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China; [Mu, Yun-Jing] 309 Hosp PLA, Zhan Tan Si Clin, Beijing, Peoples R China	Air Force Military Medical University; Tsinghua University	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China.	jianliufmmu@sina.com			National Natural Science Foundation of China [31070860]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	work was supported by the National Natural Science Foundation of China (Grant No. 31070860, http://nsfc.pubmed.cn/f9fe39817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081; Beris AE, 2005, INJURY, V36, pS14, DOI 10.1016/j.injury.2005.10.007; BULLOUGH PG, 1983, J BONE JOINT SURG BR, V65, P72, DOI 10.1302/0301-620X.65B1.6337169; Cao T, 2003, TISSUE ENG, V9, pS103, DOI 10.1089/10763270360697012; Chang CH, 2004, J BIOMED MATER RES B, V71B, P313, DOI 10.1002/jbm.b.30090; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187; Ghosh S, 2008, MAT SCI ENG C-BIO S, V28, P80, DOI 10.1016/j.msec.2006.12.012; Hughes L C, 2005, Eur Cell Mater, V9, P68; Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182; Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135; Hwang YS, 2010, TISSUE ENG PT A, V16, P3033, DOI [10.1089/ten.tea.2010.0045, 10.1089/ten.TEA.2010.0045]; Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009; Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442; Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005; Khanarian NT, 2012, BIOMATERIALS, V33, P5247, DOI 10.1016/j.biomaterials.2012.03.076; Koh JL, 2004, AM J SPORT MED, V32, P317, DOI 10.1177/0363546503261730; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lima EG, 2008, BIOMATERIALS, V29, P4292, DOI 10.1016/j.biomaterials.2008.07.018; Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007; Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1; Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; REDLER I, 1975, CLIN ORTHOP RELAT R, P357; Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7; Schaefer D, 2002, ARTHRITIS RHEUM-US, V46, P2524, DOI 10.1002/art.10493; Schek RM, 2004, ORTHOD CRANIOFAC RES, V8, P313; Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110; Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040; Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5; Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Sun Xiao-tang, 2006, Chin J Traumatol, V9, P381; Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008; Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169; Urrutia J, 2010, J CLIN NEUROSCI, V17, P481, DOI 10.1016/j.jocn.2009.06.024; Wang CJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579141; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	51	49	56	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54838	10.1371/journal.pone.0054838	http://dx.doi.org/10.1371/journal.pone.0054838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382984	Green Submitted, gold, Green Published			2022-12-25	WOS:000315211500034
J	Nosyk, B; Colley, G; Yip, B; Chan, K; Heath, K; Lima, VD; Gilbert, M; Hogg, RS; Harrigan, PR; Montaner, JSG				Nosyk, Bohdan; Colley, Guillaume; Yip, Benita; Chan, Keith; Heath, Katherine; Lima, Viviane D.; Gilbert, Mark; Hogg, Robert S.; Harrigan, P. Richard; Montaner, Julio S. G.		STOP HIV AIDS Study Grp	Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada	PLOS ONE			English	Article							PREVALENCE; VERIFICATION; PREVENTION; PEOPLE; CARE	Objective: To define a population-level cohort of individuals infected with the human immunodeficiency virus (HIV) in the province of British Columbia from available registries and administrative datasets using a validated case-finding algorithm. Methods: Individuals were identified for possible cohort inclusion from the BC Centre for Excellence in HIV/AIDS (CfE) drug treatment program (antiretroviral therapy) and laboratory testing datasets (plasma viral load (pVL) and CD4 diagnostic test results), the BC Centre for Disease Control (CDC) provincial HIV surveillance database (positive HIV tests), as well as databases held by the BC Ministry of Health (MoH); the Discharge Abstract Database (hospitalizations), the Medical Services Plan (physician billing) and PharmaNet databases (additional HIV-related medications). A validated case-finding algorithm was applied to distinguish true HIV cases from those likely to have been misclassified. The sensitivity of the algorithms was assessed as the proportion of confirmed cases (those with records in the CfE, CDC and MoH databases) positively identified by each algorithm. A priori hypotheses were generated and tested to verify excluded cases. Results: A total of 25,673 individuals were identified as having at least one HIV-related health record. Among 9,454 unconfirmed cases, the selected case-finding algorithm identified 849 individuals believed to be HIV-positive. The sensitivity of this algorithm among confirmed cases was 88%. Those excluded from the cohort were more likely to be female (44.4% vs. 22.5%; p<0.01), had a lower mortality rate (2.18 per 100 person years (100PY) vs. 3.14/100PY; p<0.01), and had lower median rates of health service utilization (days of medications dispensed: 9745/100PY vs. 10266/100PY; p<0.01; days of inpatient care: 29/100PY vs. 98/100PY; p<0.01; physician billings: 602/100PY vs. 2,056/100PY; p<0.01). Conclusions: The application of validated case-finding algorithms and subsequent hypothesis testing provided a strong framework for defining a population-level cohort of HIV infected people in BC using administrative databases.	[Nosyk, Bohdan; Colley, Guillaume; Yip, Benita; Chan, Keith; Heath, Katherine; Lima, Viviane D.; Hogg, Robert S.; Harrigan, P. Richard; Montaner, Julio S. G.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.; Harrigan, P. Richard; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Div Aids, Vancouver, BC V5Z 1M9, Canada; [Gilbert, Mark] BC Ctr Dis Control, Clin Prevent Serv, Vancouver, BC, Canada; [Gilbert, Mark] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; Simon Fraser University	Montaner, JSG (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	jmontaner@cfenet.ubc.ca		Hogg, Robert/0000-0003-3463-5488	BC Ministry of Health-funded 'Seek and treat for optimal prevention of HIV & AIDS' pilot project; Abbott; Biolytical; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; National Institute of Drug Abuse, at the US National Institutes of Health [1DP1DA026182]; International AIDS Society; United Nations AIDS Program; World Health Organization; National Institute on Drug Abuse; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); Bill & Melinda Gates Foundation; French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033851, R01DA036307, R01DA032551] Funding Source: NIH RePORTER	BC Ministry of Health-funded 'Seek and treat for optimal prevention of HIV & AIDS' pilot project; Abbott(Abbott Laboratories); Biolytical; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; National Institute of Drug Abuse, at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the BC Ministry of Health-funded 'Seek and treat for optimal prevention of HIV & AIDS' pilot project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. JSGM has received grants from Abbott, Biolytical, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. He is also supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse, at the US National Institutes of Health. He has also received support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institute on Drug Abuse, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), Bill & Melinda Gates Foundation, French National Agency for Research on AIDS & Viral Hepatitis (ANRS), Public Health Agency of Canada. These do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1999, EPIDEMIOLOGIC METHOD; Antoniou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021748; BC Centre for Disease Control, 2012, BRIT COL HIV PREV IN; BC Centre for Excellence in HIV/AIDS, 2010, STOP HIV AIDS PIL PR; BC Ministry of Health, EL ENR; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; Cohen MS, 2011, NEW ENGL J MED, DOI [10.1056/NEJMoa1105243, DOI 10.1056/NEJMOAL105243]; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; KEYES M, 1991, J ACQ IMMUN DEF SYND, V4, P1015; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lima VD, 2010, CAN J PUBLIC HEALTH, V101, P44, DOI 10.1007/BF03405561; Lix L, 2006, DEFINING VALIDATING; Manuel DG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-174; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; WHO, 2012, M REP FRAM METR SUPP; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	26	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54416	10.1371/journal.pone.0054416	http://dx.doi.org/10.1371/journal.pone.0054416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382898	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500012
J	Schultke, E; Trippel, M; Brauer-Krisch, E; Renier, M; Bartzsch, S; Requardt, H; Dobrossy, MD; Nikkhah, G				Schueltke, Elisabeth; Trippel, Michael; Braeuer-Krisch, Elke; Renier, Michel; Bartzsch, Stefan; Requardt, Herwig; Doebroessy, Mate D.; Nikkhah, Guido			Pencilbeam Irradiation Technique for Whole Brain Radiotherapy: Technical and Biological Challenges in a Small Animal Model	PLOS ONE			English	Article							MICROBEAM RADIATION-THERAPY; X-RAY-BEAMS; 9L GLIOSARCOMA; SYNCHROTRON	We have conducted the first in-vivo experiments in pencilbeam irradiation, a new synchrotron radiation technique based on the principle of microbeam irradiation, a concept of spatially fractionated high-dose irradiation. In an animal model of adult C57 BL/6J mice we have determined technical and physiological limitations with the present technical setup of the technique. Fifty-eight animals were distributed in eleven experimental groups, ten groups receiving whole brain radiotherapy with arrays of 50 mu m wide beams. We have tested peak doses ranging between 172 Gy and 2,298 Gy at 3 mm depth. Animals in five groups received whole brain radiotherapy with a center-to-center (ctc) distance of 200 mu m and a peak-to-valley ratio (PVDR) of similar to 100, in the other five groups the ctc was 400 mm (PVDR similar to 400). Motor and memory abilities were assessed during a six months observation period following irradiation. The lower dose limit, determined by the technical equipment, was at 172 Gy. The LD50 was about 1,164 Gy for a ctc of 200 mu m and higher than 2,298 Gy for a ctc of 400 mu m. Age-dependent loss in motor and memory performance was seen in all groups. Better overall performance (close to that of healthy controls) was seen in the groups irradiated with a ctc of 400 mu m.	[Schueltke, Elisabeth; Trippel, Michael; Doebroessy, Mate D.; Nikkhah, Guido] Univ Freiburg, Med Ctr, Div Stereotact & Funct Neurosurg, Hugstetter Str 55, D-79106 Freiburg, Germany; [Braeuer-Krisch, Elke; Renier, Michel; Requardt, Herwig] ESRF, Grenoble, France; [Bartzsch, Stefan] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany	University of Freiburg; European Synchrotron Radiation Facility (ESRF); Helmholtz Association; German Cancer Research Center (DKFZ)	Schultke, E (corresponding author), Univ Freiburg, Med Ctr, Div Stereotact & Funct Neurosurg, Hugstetter Str 55, D-79106 Freiburg, Germany.	elisabeth.schueltke@uniklinik-freiburg.de	Schultke, Elisabeth/M-3959-2013; Dobrossy, Mate/AAL-7897-2021; Brauer-Krisch, Elke/O-6026-2017	Dobrossy, Mate/0000-0002-0187-2252; Bartzsch, Stefan/0000-0001-9550-9122; Brauer-Krisch, Elke/0000-0003-4587-1160	FP 7 Programme of the European Union [PIRG07-GA-2010]; Research Commission of the Faculty of Medicine at the Albert-Ludwigs-University Freiburg	FP 7 Programme of the European Union; Research Commission of the Faculty of Medicine at the Albert-Ludwigs-University Freiburg	Dr. Schultke holds a Marie-Curie-Reintegration Grant from the FP 7 Programme of the European Union (PIRG07-GA-2010; http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction = UserSite.peopleDetailsCallPage&call_id = 168). Drs. Schultke and Trippel received funding from the Research Commission of the Faculty of Medicine at the Albert-Ludwigs-University Freiburg (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ISP EBT PRODUCT BRIE; [Anonymous], GAFCHR HD 810 RAD DO; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Brauer-Krisch E, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3170035; Brauer-Krisch E, 2009, IFMBE P, V25, P174, DOI [10.1007/978-3-642-03902-7-49, DOI 10.1007/978-3-642-03902-7-49]; D'Ambrosio DJ, 2007, J NEURO-ONCOL, V85, P77, DOI 10.1007/s11060-007-9384-5; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Kerklaan JP, 2011, J NEUROL, V258, P1098, DOI 10.1007/s00415-010-5892-x; Laissue JA, 2001, P SOC PHOTO-OPT INS, V4508, P65, DOI 10.1117/12.450774; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Martinez-Rovira I, 2012, MED PHYS, V39, P119, DOI 10.1118/1.3665768; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Qiu D, 2007, INT J RADIAT ONCOL, V69, P846, DOI 10.1016/j.ijrobp.2007.04.041; Regnard P, 2008, PHYS MED BIOL, V53, P861, DOI 10.1088/0031-9155/53/4/003; Schultke E, 2008, EUR J RADIOL, V68, pS142, DOI 10.1016/j.ejrad.2008.04.051; Serduc R, 2009, PHYS MED BIOL, V54, P6711, DOI 10.1088/0031-9155/54/21/017; Shi L, 2009, J NEUROL SCI, V285, P178, DOI 10.1016/j.jns.2009.06.031; Szerlip N, 2011, J NEURO-ONCOL, V103, P111, DOI 10.1007/s11060-010-0358-7; Uyama A, 2011, J SYNCHROTRON RADIAT, V18, P1	21	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54960	10.1371/journal.pone.0054960	http://dx.doi.org/10.1371/journal.pone.0054960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383014	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500040
J	van de Bunt, M; Gaulton, KJ; Parts, L; Moran, I; Johnson, PR; Lindgren, CM; Ferrer, J; Gloyn, AL; McCarthy, MI				van de Bunt, Martijn; Gaulton, Kyle J.; Parts, Leopold; Moran, Ignasi; Johnson, Paul R.; Lindgren, Cecilia M.; Ferrer, Jorge; Gloyn, Anna L.; McCarthy, Mark I.			The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENOME-WIDE ASSOCIATION; INSULIN SENSITIVITY; SUSCEPTIBILITY LOCI; GENETIC ASSOCIATION; MICRORNAS; TARGET; RNAS	Recent advances in the understanding of the genetics of type 2 diabetes (T2D) susceptibility have focused attention on the regulation of transcriptional activity within the pancreatic beta-cell. MicroRNAs (miRNAs) represent an important component of regulatory control, and have proven roles in the development of human disease and control of glucose homeostasis. We set out to establish the miRNA profile of human pancreatic islets and of enriched beta-cell populations, and to explore their potential involvement in T2D susceptibility. We used Illumina small RNA sequencing to profile the miRNA fraction in three preparations each of primary human islets and of enriched beta-cells generated by fluorescence-activated cell sorting. In total, 366 miRNAs were found to be expressed (i.e. >100 cumulative reads) in islets and 346 in beta-cells; of the total of 384 unique miRNAs, 328 were shared. A comparison of the islet-cell miRNA profile with those of 15 other human tissues identified 40 miRNAs predominantly expressed (i.e. >50% of all reads seen across the tissues) in islets. Several highly-expressed islet miRNAs, such as miR-375, have established roles in the regulation of islet function, but others (e.g. miR-27b-3p, miR-192-5p) have not previously been described in the context of islet biology. As a first step towards exploring the role of islet-expressed miRNAs and their predicted mRNA targets in T2D pathogenesis, we looked at published T2D association signals across these sites. We found evidence that predicted mRNA targets of islet-expressed miRNAs were globally enriched for signals of T2D association (p-values <0.01, q-values <0.1). At six loci with genome-wide evidence for T2D association (AP3S2, KCNK16, NOTCH2, SCL30A8, VPS26A, and WFS1) predicted mRNA target sites for islet-expressed miRNAs overlapped potentially causal variants. In conclusion, we have described the miRNA profile of human islets and beta-cells and provide evidence linking islet miRNAs to T2D pathogenesis.	[McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [van de Bunt, Martijn; Johnson, Paul R.; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [van de Bunt, Martijn; Gaulton, Kyle J.; Lindgren, Cecilia M.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Parts, Leopold] Wellcome Trust Sanger Inst, Hinxton, England; [Parts, Leopold] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Moran, Ignasi; Ferrer, Jorge] Inst Invest August Pi I Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain; [Johnson, Paul R.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Johnson, Paul R.; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Toronto; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford; University of Oxford	McCarthy, MI (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	Mark.McCarthy@drl.ox.ac.uk	Ferrer, Jorge/A-3176-2012; Moran, Ignasi/AAA-6417-2020; Duarte, Graziela Biude Silva/Q-7728-2016; McCarthy, Mark/M-3763-2015	Ferrer, Jorge/0000-0002-5959-5729; Moran, Ignasi/0000-0002-3307-7106; Gloyn, Anna/0000-0003-1205-1844; Gaulton, Kyle/0000-0003-1318-7161; McCarthy, Mark/0000-0002-4393-0510; Lindgren, Cecilia/0000-0002-4903-9374; Parts, Leopold/0000-0002-2618-670X; van de Bunt, Martijn/0000-0002-6744-6125	Oxford NIHR Biomedical Research Centre, NIDDK [R01 DK073490]; Wellcome Trust [090532/Z/09/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073490] Funding Source: NIH RePORTER	Oxford NIHR Biomedical Research Centre, NIDDK; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MvdB is a Nuffield Department of Medicine Prize Student. LP is a Canadian Institute for Advanced Research Junior Fellow. CML is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). ALG is a Wellcome Trust Senior Research Fellow in Basic & Biomedical Science (095101/2/10/Z). The work was funded by the Oxford NIHR Biomedical Research Centre, NIDDK (R01 DK073490), and the Wellcome Trust (090532/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Nieto M, 2011, CELL TRANSPLANT; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Parts L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002704; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; van de Bunt M, 2012, DIABETOLOGIA; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	46	113	114	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55272	10.1371/journal.pone.0055272	http://dx.doi.org/10.1371/journal.pone.0055272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372846	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400086
J	Hong, L; Kenney, SR; Phillips, GK; Simpson, D; Schroeder, CE; Noth, J; Romero, E; Swanson, S; Waller, A; Strouse, JJ; Carter, M; Chigaev, A; Ursu, O; Oprea, T; Hjelle, B; Golden, JE; Aube, J; Hudson, LG; Buranda, T; Sklar, LA; Wandinger-Ness, A				Hong, Lin; Kenney, S. Ray; Phillips, Genevieve K.; Simpson, Denise; Schroeder, Chad E.; Noeth, Julica; Romero, Elsa; Swanson, Scarlett; Waller, Anna; Strouse, J. Jacob; Carter, Mark; Chigaev, Alexandre; Ursu, Oleg; Oprea, Tudor; Hjelle, Brian; Golden, Jennifer E.; Aube, Jeffrey; Hudson, Laurie G.; Buranda, Tione; Sklar, Larry A.; Wandinger-Ness, Angela			Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REAL-TIME MEASUREMENT; RHO-GTPASES; NUCLEOTIDE-BINDING; FLOW-CYTOMETRY; DIRECTED MIGRATION; ACTIN DYNAMICS; CELL MIGRATION; LUNG-CANCER; E-CADHERIN; RAS	Cdc42 plays important roles in cytoskeleton organization, cell cycle progression, signal transduction, and vesicle trafficking. Overactive Cdc42 has been implicated in the pathology of cancers, immune diseases, and neuronal disorders. Therefore, Cdc42 inhibitors would be useful in probing molecular pathways and could have therapeutic potential. Previous inhibitors have lacked selectivity and trended toward toxicity. We report here the characterization of a Cdc42-selective guanine nucleotide binding lead inhibitor that was identified by high throughput screening. A second active analog was identified via structure-activity relationship studies. The compounds demonstrated excellent selectivity with no inhibition toward Rho and Rac in the same GTPase family. Biochemical characterization showed that the compounds act as noncompetitive allosteric inhibitors. When tested in cellular assays, the lead compound inhibited Cdc42-related filopodia formation and cell migration. The lead compound was also used to clarify the involvement of Cdc42 in the Sin Nombre virus internalization and the signaling pathway of integrin VLA-4. Together, these data present the characterization of a novel Cdc42-selective allosteric inhibitor and a related analog, the use of which will facilitate drug development targeting Cdc42-related diseases and molecular pathway studies that involve GTPases.	[Hong, Lin; Romero, Elsa; Swanson, Scarlett; Waller, Anna; Strouse, J. Jacob; Carter, Mark; Chigaev, Alexandre; Hjelle, Brian; Buranda, Tione; Sklar, Larry A.; Wandinger-Ness, Angela] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Hong, Lin; Waller, Anna; Strouse, J. Jacob; Carter, Mark; Ursu, Oleg; Oprea, Tudor; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Kenney, S. Ray; Hudson, Laurie G.; Wandinger-Ness, Angela] Univ New Mexico, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Phillips, Genevieve K.; Ursu, Oleg; Oprea, Tudor; Hudson, Laurie G.; Sklar, Larry A.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Ursu, Oleg; Oprea, Tudor] Univ New Mexico, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Simpson, Denise; Schroeder, Chad E.; Noeth, Julica; Golden, Jennifer E.; Aube, Jeffrey] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66047 USA; [Aube, Jeffrey] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; University of Kansas; University of Kansas	Sklar, LA (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	lsklar@salud.unm.edu; wness@unm.edu	Jean-Louis, Denise/AAD-5029-2021; Wandinger-Ness, Angela/J-9104-2012; Oprea, Tudor I/A-5746-2011; Chigaev, Alexandre/A-3103-2010	Wandinger-Ness, Angela/0000-0003-0613-3157; Oprea, Tudor I/0000-0002-6195-6976; Chigaev, Alexandre/0000-0002-7726-638X; Golden, Jennifer/0000-0002-6813-3710; Aube, Jeffrey/0000-0003-1049-5767; Waller, Anna/0000-0003-3676-2501	National Science Foundation (NSF) [MCB0956027]; National Institutes of Health from the Molecular Libraries Program [R03 MH081231-01]; University of New Mexico Center for Molecular Discovery Molecular Libraries Probe Production Centers (UNMCMD MLPCN) National Institutes of Health [U54MH084690, R01HL081062]; UNM National Center for Research Resources (NCRR) [5P20RR016480]; National Institutes of Health through the NCI [R21 CA170375-01]; National Institutes of Health [NS066429, AI092130]; University of Kansas Specialized Chemistry Center (KUSCC) MLPCN National Institutes of Health [U54HG005031]; NATIONAL CANCER INSTITUTE [R21CA170375] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI092130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH081231, U54MH084690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066429] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health from the Molecular Libraries Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Center for Molecular Discovery Molecular Libraries Probe Production Centers (UNMCMD MLPCN) National Institutes of Health; UNM National Center for Research Resources (NCRR); National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Specialized Chemistry Center (KUSCC) MLPCN National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation (NSF) Grant MCB0956027 and National Institutes of Health Grant R03 MH081231-01 from the Molecular Libraries Program (to A. W. N.); University of New Mexico Center for Molecular Discovery Molecular Libraries Probe Production Centers (UNMCMD MLPCN) National Institutes of Health Grants U54MH084690 and R01HL081062 (to L. A. S.); UNM National Center for Research Resources (NCRR) Grant 5P20RR016480 (to L. G. H.); National Institutes of Health Grant R21 CA170375-01 through the NCI (to A. W. N., L. G. H., and J. E. G.); National Institutes of Health Grants NS066429 and AI092130 (to T. B.); and University of Kansas Specialized Chemistry Center (KUSCC) MLPCN National Institutes of Health Grant U54HG005031 (to J. A.).	Ahn SJ, 2003, CANCER LETT, V193, P99, DOI 10.1016/S0304-3835(03)00004-1; Antoine-Bertrand J, 2011, CURR DRUG TARGETS, V12, P1202, DOI 10.2174/138945011795906543; ASHMAN LK, 1985, LEUKEMIA RES, V9, P157, DOI 10.1016/0145-2126(85)90029-3; Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chen QY, 2012, INT J ONCOL, V40, P1561, DOI 10.3892/ijo.2012.1336; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2011, METHODS MOL BIOL, V757, P3, DOI 10.1007/978-1-61779-166-6_1; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Copeland R. A., 2005, EVALUATION ENZYME IN; Cotteret S, 2002, GENOME BIOL, V3; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faure Sandrine, 2011, Small GTPases, V2, P310; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kikuchi K, 2011, FEBS LETT, V585, P286, DOI 10.1016/j.febslet.2010.12.010; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; Korlach J, 2004, P NATL ACAD SCI USA, V101, P2800, DOI 10.1073/pnas.0308579100; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mitra S, 2011, SEMIN CELL DEV BIOL, V22, P57, DOI 10.1016/j.semcdb.2010.12.005; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Petermann P, 2009, J VIROL, V83, P9759, DOI 10.1128/JVI.00835-09; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Reeder MK, 2001, J BIOL CHEM, V276, P40606, DOI 10.1074/jbc.M103925200; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Schwartz SL, 2008, ANAL BIOCHEM, V381, P258, DOI 10.1016/j.ab.2008.06.039; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Surviladze Z., 2010, PROBE REPORTS NIH MO; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Torimura M, 2001, ANAL SCI, V17, P155, DOI 10.2116/analsci.17.155; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Woodside DG, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-2; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; YUMURA S, 1983, J CELL BIOL, V96, P857, DOI 10.1083/jcb.96.3.857; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	70	106	113	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8531	8543		10.1074/jbc.M112.435941	http://dx.doi.org/10.1074/jbc.M112.435941			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382385	Green Published, hybrid			2022-12-25	WOS:000316564500049
J	Brenna, O; Furnes, MW; Drozdov, I; Granlund, AV; Flatberg, A; Sandvik, AK; Zwiggelaar, RTM; Marvik, R; Nordrum, IS; Kidd, M; Gustafsson, BI				Brenna, Oystein; Furnes, Marianne W.; Drozdov, Ignat; Granlund, Atle van Beelen; Flatberg, Arnar; Sandvik, Arne K.; Zwiggelaar, Rosalie T. M.; Marvik, Ronald; Nordrum, Ivar S.; Kidd, Mark; Gustafsson, Bjorn I.			Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Historical and Transcripttomic Characterization and Correlation to IBD	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; TRINITROBENZENE SULFONIC-ACID; CELLULAR PRION PROTEIN; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; INTESTINAL EPITHELIUM; ULCERATIVE-COLITIS; BINDING PROTEIN; CROHNS-DISEASE	Background: Rectal instillation of trinitrobenzene sulphonic acid (TNBS) in ethanol is an established model for inflammatory bowel disease (IBD). We aimed to 1) set up a TNBS-colitis protocol resulting in an endoscopic and histologic picture resembling IBD, 2) study the correlation between endoscopic, histologic and gene expression alterations at different time points after colitis induction, and 3) compare rat and human IBD mucosal transcriptomic data to evaluate whether TNBS-colitis is an appropriate model of IBD. Methodology/Principal Findings: Five female Sprague Daley rats received TNBS diluted in 50% ethanol (18 mg/0.6 ml) rectally. The rats underwent colonoscopy with biopsy at different time points. RNA was extracted from rat biopsies and microarray was performed. PCR and in situ hybridization (ISH) were done for validation of microarray results. Rat microarray profiles were compared to human IBD expression profiles (25 ulcerative colitis Endoscopic score demonstrated mild to moderate colitis after three and seven days, but declined after twelve days. Histologic changes corresponded with the endoscopic appearance. Over-represented Gene Ontology Biological Processes included: Cell Adhesion, Immune Response, Lipid Metabolic Process, and Tissue Regeneration. IL-1 alpha, IL-1 beta, TLR2, TLR4, PRNP were all significantly up-regulated, while PPAR gamma was significantly down-regulated. Among genes with highest fold change (FC) were SPINK4, LBP, ADA, RETNLB and IL-1 alpha. The highest concordance in differential expression between TNBS and IBD transcriptomes was three days after colitis induction. ISH and PCR results corresponded with the microarray data. The most concordantly expressed biologically relevant pathways included TNF signaling, Cell junction organization, and Interleukin-1 processing. Conclusions/Significance: Endoscopy with biopsies in TNBS-colitis is useful to follow temporal changes of inflammation visually and histologically, and to acquire tissue for gene expression analyses. TNBS-colitis is an appropriate model to study specific biological processes in IBD.	[Brenna, Oystein; Sandvik, Arne K.; Gustafsson, Bjorn I.] Univ Trondheim Hosp, St Olavs Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway; [Brenna, Oystein; Furnes, Marianne W.; Granlund, Atle van Beelen; Flatberg, Arnar; Sandvik, Arne K.; Zwiggelaar, Rosalie T. M.; Marvik, Ronald; Nordrum, Ivar S.; Gustafsson, Bjorn I.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Drozdov, Ignat] Bering Ltd, Richmond, Surrey, England; [Marvik, Ronald] Univ Trondheim Hosp, St Olavs Hosp, Dept Gastrointestinal Surg, Trondheim, Norway; [Nordrum, Ivar S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Pathol & Med Genet, Trondheim, Norway; [Kidd, Mark] Yale Univ, Sch Med, Dept Surg, Gastroenterol Sect, New Haven, CT 06510 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Yale University	Brenna, O (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway.	Oystein.Brenna@stolav.no	Brenna, Øystein/AAH-2774-2020	Granlund, Atle van Beelen/0000-0001-8117-2637; Drozdov, Ignat/0000-0001-6727-4688	NIH [DK080871]; National Technology Microarray Platform (Norwegian Microarray Consortium); DMF/NTNU [96990]; Kontaktutvalget, St. Olavs Hospital, Trondheim University Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Technology Microarray Platform (Norwegian Microarray Consortium); DMF/NTNU; Kontaktutvalget, St. Olavs Hospital, Trondheim University Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Kontaktutvalget, St. Olavs Hospital, Trondheim University Hospital and DMF/NTNU (Project number 96990)(BIG); MK is supported by NIH DK080871; The microarray work was carried out with support from the National Technology Microarray Platform (Norwegian Microarray Consortium) funded the Functional Genomics Programme (FUGE) of the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Akcan A, 2008, WORLD J GASTROENTERO, V14, P918, DOI 10.3748/wjg.14.918; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Antonioli L, 2007, J PHARMACOL EXP THER, V322, P435, DOI 10.1124/jpet.107.122762; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Brinkman BM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.101; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Celinski K, 2011, MED SCI MONITOR, V17, pBR116, DOI 10.12659/MSM.881712; Chen Y, 2009, J GASTROEN HEPATOL, V24, P912, DOI 10.1111/j.1440-1746.2008.05721.x; Cominelli F, 1996, ALIMENT PHARM THERAP, V10, P49, DOI 10.1046/j.1365-2036.1996.22164020.x; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Drozdov Ignat, 2011, BMC Res Notes, V4, P462, DOI 10.1186/1756-0500-4-462; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Gollamudi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036191; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Granlund AV, 2011, SCAND J GASTROENTERO, V46, P1316, DOI 10.3109/00365521.2011.605463; Guarner F, 2003, BEST PRACT RES CL GA, V17, P793, DOI 10.1016/S1521-6918(03)00068-4; Hasler R, 2012, GENOME RES, V22, P2130, DOI 10.1101/gr.138347.112; Hammer HF, 2011, DIGEST DIS, V29, P550, DOI 10.1159/000332981; Heimerl S, 2006, BBA-MOL BASIS DIS, V1762, P341, DOI 10.1016/j.bbadis.2005.12.006; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hugot JP, 2005, GASTROENTEROLOGY, V128, P500, DOI 10.1053/j.gastro.2004.12.041; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim I, 2009, PHARM RES-DORDR, V26, P415, DOI 10.1007/s11095-008-9758-1; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Knollmann FD, 2002, J MAGN RESON IMAGING, V15, P165, DOI 10.1002/jmri.10054; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lakatos PL, 2011, INFLAMM BOWEL DIS, V17, P767, DOI 10.1002/ibd.21402; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee J, 2008, SEMIN IMMUNOPATHOL, V30, P3, DOI 10.1007/s00281-007-0099-7; Lee J, 2006, ANN NY ACAD SCI, V1072, P351, DOI 10.1196/annals.1326.022; Lehrke M, 2008, SCAND J GASTROENTERO, V43, P283, DOI 10.1080/00365520701679249; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; MacDonald TT, 2012, INFLAMM BOWEL DIS, V18, P2180, DOI 10.1002/ibd.22967; Marcos Z, 2004, J HISTOCHEM CYTOCHEM, V52, P1357, DOI 10.1369/jhc.4A6321.2004; Martin GR, 2011, AM J PATHOL, V179, P2290, DOI 10.1016/j.ajpath.2011.07.025; Martinez-Augustin O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-490; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Ohta N, 2003, NUTR RES, V23, P279, DOI 10.1016/S0271-5317(02)00511-0; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ostvik AE, 2012, INFLAMM BOWEL DIS; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; Pastorelli Luca, 2011, Therap Adv Gastroenterol, V4, P311, DOI 10.1177/1756283X11410770; Petit CS, 2012, GASTROENTEROLOGY, V143, P122; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Pohlmann A, 2009, INFLAMM BOWEL DIS, V15, P534, DOI 10.1002/ibd.20800; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rieder F, 2008, CURR OPIN GASTROEN, V24, P462, DOI 10.1097/MOG.0b013e3282ff8b36; Sanchez-Hidalgo M, 2007, EUR J PHARMACOL, V562, P247, DOI 10.1016/j.ejphar.2007.01.047; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Shen C, 2007, INFLAMM BOWEL DIS, V13, P308, DOI 10.1002/ibd.20005; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; SHIBATA Y, 1993, GASTROENTEROL JPN, V28, P518; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Sugawara K, 2005, GASTROENTEROLOGY, V128, P351, DOI 10.1053/j.gastro.2004.11.001; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Vermeulen W, 2011, ACTA GASTRO-ENT BELG, V74, P304; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Wang DZ, 2010, GASTROENTEROL CLIN N, V39, P697, DOI 10.1016/j.gtc.2010.08.014; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	105	50	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54543	10.1371/journal.pone.0054543	http://dx.doi.org/10.1371/journal.pone.0054543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382912	Green Published, Green Accepted, gold			2022-12-25	WOS:000314610600030
J	Freling, HG; Pieper, PG; Vermeulen, KM; van Swieten, JM; Sijens, PE; van Veldhuisen, DJ; Willems, TP				Freling, Hendrik G.; Pieper, Petronella G.; Vermeulen, Karin M.; van Swieten, Jeroen M.; Sijens, Paul E.; van Veldhuisen, Dirk J.; Willems, Tineke P.			Improved Cardiac MRI Volume Measurements in Patients with Tetralogy of Fallot by Independent End-Systolic and End-Diastolic Phase Selection	PLOS ONE			English	Article							PULMONARY VALVE-REPLACEMENT; CARDIOVASCULAR MAGNETIC-RESONANCE; CONGENITAL HEART-DISEASE; REPAIRED TETRALOGY; AGE; ECHOCARDIOGRAPHY; DYSSYNCHRONY; DYSFUNCTION; GUIDELINES; MANAGEMENT	Objectives: To investigate to what extent cardiac MRI derived measurements of right ventricular (RV) volumes using the left ventricular (LV) end-systolic and end-diastolic frame misrepresent RV end-systolic and end-diastolic volumes in patients with tetralogy of Fallot (ToF) and a right bundle branch block. Methods: Sixty-five cardiac MRI scans of patients with ToF and a right bundle branch block, and 50 cardiac MRI scans of control subjects were analyzed. RV volumes and function using the end-systolic and end-diastolic frame of the RV were compared to using the end-systolic and end-diastolic frame of the LV. Results: Timing of the RV end-systolic frame was delayed compared to the LV end-systolic frame in 94% of patients with ToF and in 50% of control subjects. RV end-systolic volume using the RV end-systolic instead of LV end-systolic frame was smaller in ToF (median -3.3 ml/m(2), interquartile range -1.9 to 25.6 ml/m(2); p<0.001) and close to unchanged in control subjects. Using the RV instead of LV end-systolic and end-diastolic frame hardly affected RV end-diastolic volumes in both groups and ejection fraction in control subjects (54 +/- 4%, both methods), while increasing ejection fraction from 45 +/- 7% to 48 +/- 7% for patients with ToF (p<0.001). QRS duration correlated positively with the changes in the RV end-systolic volume (p<0.001) and RV ejection fraction obtained in ToF patients when using the RV instead of the LV end-systolic and end-diastolic frame (p=0.004). Conclusion: For clinical decision making in ToF patients RV volumes derived from cardiac MRI should be measured in the end-systolic frame of the RV instead of the LV.	[Freling, Hendrik G.; van Swieten, Jeroen M.; Sijens, Paul E.; Willems, Tineke P.] Univ Groningen, Dept Radiol, Groningen, Netherlands; [Freling, Hendrik G.; Pieper, Petronella G.; Vermeulen, Karin M.; van Swieten, Jeroen M.; Sijens, Paul E.; van Veldhuisen, Dirk J.; Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Pieper, Petronella G.; van Veldhuisen, Dirk J.] Univ Groningen, Dept Cardiol, Groningen, Netherlands; [Vermeulen, Karin M.] Univ Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Willems, TP (corresponding author), Univ Groningen, Dept Radiol, Groningen, Netherlands.	t.p.willems@umcg.nl	van Veldhuisen, Dirk Jan/E-8967-2014		radiology department University of Groningen	radiology department University of Groningen	This study was supported by the radiology department University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfakih K, 2003, J MAGN RESON IMAGING, V17, P323, DOI 10.1002/jmri.10262; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Buechel ERV, 2005, EUR HEART J, V26, P2721, DOI 10.1093/eurheartj/ehi581; Clarke CJ, 2012, JACC-CARDIOVASC IMAG, V5, P28, DOI 10.1016/j.jcmg.2011.05.007; CULLEN S, 1995, CIRCULATION, V91, P1782, DOI 10.1161/01.CIR.91.6.1782; D'Andrea A, 2004, Eur J Echocardiogr, V5, P123, DOI 10.1016/S1525-2167(03)00053-2; Edwards R, 2009, INT J CARDIOVAS IMAG, V25, P791, DOI 10.1007/s10554-009-9496-4; Frigiola A, 2004, CIRCULATION, V110, pII153, DOI 10.1161/01.CIR.0000138397.60956.c2; Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825; GELBAND H, 1971, CIRCULATION, V44, P1022, DOI 10.1161/01.CIR.44.6.1022; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Mirvis DM, 2011, BRAUNWALDS HEART DIS, P126; Mueller M, 2010, EUR J ECHOCARDIOGR, V11, P786, DOI 10.1093/ejechocard/jeq067; Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664; Sun AM, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-43; Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037; van den Berg J, 2007, RADIOLOGY, V243, P212, DOI 10.1148/radiol.2431060213; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Yu CM, 2003, ECHOCARDIOGR-J CARD, V20, P19, DOI 10.1046/j.1540-8175.2003.00003.x	20	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55462	10.1371/journal.pone.0055462	http://dx.doi.org/10.1371/journal.pone.0055462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383197	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600106
J	Jiang, LL; Song, LB; Wu, JH; Yang, Y; Zhu, X; Hu, B; Cheng, SY; Li, MF				Jiang, Lili; Song, Libing; Wu, Jueheng; Yang, Yi; Zhu, Xun; Hu, Bo; Cheng, Shi-Yuan; Li, Mengfeng			Bmi-1 Promotes Glioma Angiogenesis by Activating NF-kappa B Signaling	PLOS ONE			English	Article							CELL-PROLIFERATION; TUMOR ANGIOGENESIS; STEM-CELLS; EXPRESSION; GROWTH; CANCER; LOCUS; GLIOMAGENESIS; PROGRESSION; METASTASIS	Angiogenesis in glioma is associated with the poor prognosis of the disease and closely correlates with the highly invasive phenotype of glioma cells, which represents the most challenging impediment against the currently glioma treatments. Bmi-1, an onco-protein, has been implicated in the progression of various human cancers, including gliomas, whereas its role in glioma angiogenesis remains unclear. Our current study examined the effects of Bmi-1 on glioma angiogenesis in vitro as well as in vivo. We found that overexpression of Bmi-1 enhanced, whereas knockdown of Bmi-1 diminished, the capability of glioma cells to induce tubule formation and migration of endothelial cells and neovascularization in chicken chorioallantoic membrane. In vivo, Bmi-1 overexpression and knockdown, respectively, promoted and inhibited angiogenesis in orthotopically transplanted human gliomas. Furthermore, NF-kappa B activity and VEGF-C expression was induced by Bmi-1 overexpression, whereas Bmi-1 knockdown attenuated NF-kappa B signaling and decreased VEGF-C expression. Additionally suppression of NF-kappa B activity using a specific chemical inhibitor abrogated the NF-kappa B activation and the pro-angiogenic activities of glioma cells. Together, our data suggest that Bmi-1 plays an important role in glioma angiogenesis and therefore could represent a potential target for anti-angiogenic therapy against the disease.	[Jiang, Lili] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Song, Libing] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Zhu, Xun; Li, Mengfeng] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yi] Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Yang, Yi; Zhu, Xun; Li, Mengfeng] Sun Yat Sen Univ, Chinese Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Bo; Cheng, Shi-Yuan] Northwestern Univ, Dept Neurol, NW Brain Tumor Inst, Ctr Genet Med,Feinberg Sch Med, Chicago, IL 60611 USA; [Hu, Bo; Cheng, Shi-Yuan] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Li, MF (corresponding author), Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn	Song, LB/AAL-1968-2020; meng, li/GVT-2063-2022		Natural Science Foundation of China [81071762, 81071780, 81101680]; National Science and Technique Major Project [201005022-2, 2012ZX09102101-017, 2012ZX10004213, 311030]; Key Science and Technique Research Project of Guangdong Province [2010B030600003, 2009010058]; Science and Technology Department of Guangdong Province, China [S2011020002757]; NATIONAL CANCER INSTITUTE [R01CA159811, R01CA130966] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technique Major Project; Key Science and Technique Research Project of Guangdong Province; Science and Technology Department of Guangdong Province, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Natural Science Foundation of China (81071762, 81071780, 81101680); National Science and Technique Major Project (201005022-2, 2012ZX09102101-017, 2012ZX10004213, 311030); The Key Science and Technique Research Project of Guangdong Province (2010B030600003, 2009010058); The Science and Technology Department of Guangdong Province, China (No. S2011020002757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Birlik B, 2006, NEUROPATH APPL NEURO, V32, P532, DOI 10.1111/j.1365-2990.2006.00763.x; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cea Valentina, 2012, J Signal Transduct, V2012, P483040, DOI 10.1155/2012/483040; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Chowdhury M, 2007, LEUKEMIA, V21, P1116, DOI 10.1038/sj.leu.2404623; Clarke J, 2006, ARCH NEUROL-CHICAGO, V67, P279; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Guo BH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-10; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hong TM, 2009, J NEURO-ONCOL, V93, P289, DOI 10.1007/s11060-008-9786-z; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Jiang LL, 2009, ACTA BIOCH BIOPH SIN, V41, P527, DOI 10.1093/abbs/gmp040; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Lindstrom MS, 2001, ONCOGENE, V20, P2171, DOI 10.1038/sj.onc.1204303; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Meng X, 2012, LUNG CANC; Miyagami Mitsusuke, 2005, Medical Molecular Morphology, V38, P36, DOI 10.1007/s00795-004-0273-0; Orpana A, 2002, LEUKEMIA LYMPHOMA, V43, P219, DOI 10.1080/10428190290005964; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor LP, 2010, NEUROLOGY, V75, pS28, DOI 10.1212/WNL.0b013e3181fb3661; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yan CH, 2004, FASEB J, V18, P540, DOI 10.1096/fj.03-0960fje; Yu Q, 2000, GENE DEV, V14, P163; Zhang FB, 2008, BRIT J BIOMED SCI, V65, P172, DOI 10.1080/09674845.2008.11732824; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	44	34	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55527	10.1371/journal.pone.0055527	http://dx.doi.org/10.1371/journal.pone.0055527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383216	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600120
J	Parthsarathy, V; McClean, PL; Holscher, C; Taylor, M; Tinker, C; Jones, G; Kolosov, O; Salvati, E; Gregori, M; Masserini, M; Allsop, D				Parthsarathy, Vadivel; McClean, Paula L.; Hoelscher, Christian; Taylor, Mark; Tinker, Claire; Jones, Glynn; Kolosov, Oleg; Salvati, Elisa; Gregori, Maria; Masserini, Massimo; Allsop, David			A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							BETA-SHEET CONFORMATION; LONG-TERM POTENTIATION; FIBRIL FORMATION; IN-VIVO; OLIGOMERS; PROTEIN; AGGREGATION; CURCUMIN; FIBRILLOGENESIS; THERAPEUTICS	Previously, we have developed a retro-inverso peptide inhibitor (RI-OR2, rGffvlkGr) that blocks the in vitro formation and toxicity of the Ab oligomers which are thought to be a cause of neurodegeneration and memory loss in Alzheimer's disease. We have now attached a retro-inverted version of the HIV protein transduction domain 'TAT' to RI-OR2 to target this new inhibitor (RI-OR2-TAT, Ac-rGffvlkGrrrrqrrkkrGy-NH2) into the brain. Following its peripheral injection, a fluorescein-labelled version of RI-OR2-TAT was found to cross the blood brain barrier and bind to the amyloid plaques and activated microglial cells present in the cerebral cortex of 17-months-old APPswe/PS1 Delta E9 transgenic mice. Daily intraperitoneal injection of RI-OR2- TAT (at 100 nmol/kg) for 21 days into 10-months-old APPswe/PS1 Delta E9 mice resulted in a 25% reduction (p<0.01) in the cerebral cortex of A beta oligomer levels, a 32% reduction (p<0.0001) of beta-amyloid plaque count, a 44% reduction (p<0.0001) in the numbers of activated microglial cells, and a 25% reduction (p<0.0001) in oxidative damage, while the number of young neurons in the dentate gyrus was increased by 210% (p<0.0001), all compared to control APPswe/PS1 Delta E9 mice injected with vehicle (saline) alone. Our data suggest that oxidative damage, inflammation, and inhibition of neurogenesis are all a downstream consequence of A beta aggregation, and identify a novel brain-penetrant retro-inverso peptide inhibitor of A beta oligomer formation for further testing in humans as a potential disease-modifying treatment for Alzheimer's disease.	[Parthsarathy, Vadivel; McClean, Paula L.; Hoelscher, Christian] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Co Londonderry, North Ireland; [Taylor, Mark; Tinker, Claire; Jones, Glynn; Allsop, David] Univ Lancaster, Div Biomed & Life Sci, Lancaster, England; [Kolosov, Oleg] Univ Lancaster, Dept Phys, Lancaster, England; [Salvati, Elisa; Gregori, Maria; Masserini, Massimo] Univ Milano Bicocca, Dept Expt Med, Milan, Italy	Ulster University; Lancaster University; Lancaster University; University of Milano-Bicocca	Allsop, D (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Lancaster, England.	d.allsop@lancaster.ac.uk	Kolosov, Oleg V/D-3815-2013; Allsop, David/B-9725-2008	Kolosov, Oleg V/0000-0003-3278-9643; Allsop, David/0000-0002-0513-5575; Tinker-Mill, Claire/0000-0002-1981-3111; Parthsarathy, Vadivel/0000-0002-2037-7804; Holscher, Christian/0000-0002-8159-3260; McClean, Paula/0000-0002-3906-1172	Alzheimer's Research UK; EPSRC [EP/K023373/1] Funding Source: UKRI; Alzheimers Research UK [ART-ESG2009-4] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1064552, EP/K023373/1] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work was funded by a grant from Alzheimer's Research UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Chafekar SM, 2007, CHEMBIOCHEM, V8, P1857, DOI 10.1002/cbic.200700338; Chen SY, 2011, BIOORGAN MED CHEM, V19, P5596, DOI 10.1016/j.bmc.2011.07.033; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cunningham C, 2012, J NEUROIMMUNE PHARM, V7, P60, DOI 10.1007/s11481-011-9312-5; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gordon DJ, 2001, BIOCHEMISTRY-US, V40, P8237, DOI 10.1021/bi002416v; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holscher C, 1998, NEUROBIOL DIS, V5, P129, DOI 10.1006/nbdi.1998.0193; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Howlett DR, 2011, HISTOL HISTOPATHOL, V26, P1611, DOI 10.14670/HH-26.1611; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kagan BL, 2010, ADV EXP MED BIOL, V677, P150; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Klaver DW, 2010, BIOL CHEM, V391, P849, DOI 10.1515/BC.2010.089; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nunomura A, 2012, J NEUROPATH EXP NEUR, V71, P233, DOI 10.1097/NEN.0b013e318248e614; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Ramanathan S, 2009, MOL PHAR, V6, P836; Repici M, 2001, PHARM RES, V18, P950; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Taylor M, 2011, NANOMED-NANOTECHNOL, V7, P541, DOI 10.1016/j.nano.2011.06.015; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang GB, 2003, BIOCONJUGATE CHEM, V14, P86, DOI 10.1021/bc025526i; Zhang X, 2007, NEUROSCIENCE, V150, P950, DOI 10.1016/j.neuroscience.2007.09.059; Zhang Y, 2011, J ALZHEIMERS DIS, V23, P551, DOI 10.3233/JAD-2010-091195	55	63	66	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54769	10.1371/journal.pone.0054769	http://dx.doi.org/10.1371/journal.pone.0054769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382963	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600040
J	Cheallaigh, CN; Fitzgeral, I; Grace, J; Singh, GJ; El-Eraki, N; Gibbons, N; Keane, J; Rogers, TR; Clarke, S; Bergin, C				Cheallaigh, Cliona Ni; Fitzgeral, Ian; Grace, Jacinta; Singh, Gurmit Jagjit; El-Eraki, Nahla; Gibbons, Noel; Keane, Joseph; Rogers, Thomas R.; Clarke, Susan; Bergin, Colm			Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; TUBERCULIN SKIN-TEST; ACTIVE TUBERCULOSIS; SOUTH-AFRICA; OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY; DRUG-USERS; RISK; SENSITIVITY; RESPONSES	Background: Interferon gamma release assays (IGRAs) are used to diagnose latent tuberculosis infection. Two IGRAs are commercially available: the Quantiferon TB Gold In Tube (QFT-IT) and the T-SPOT. TB. There is debate as to which test to use in HIV+ individuals. Previous publications from high TB burden countries have raised concerns that the sensitivity of the QFT-IT assay, but not the T-SPOT. TB, may be impaired in HIV+ individuals with low CD4+ T-cell counts. We sought to compare the tests in a low TB burden setting. Methodology/Principal Findings: T-SPOT. TB, QFT-IT, and tuberculin skin tests (TST) were performed in HIV infected individuals. Results were related to patient characteristics. McNemar's test, multivariate regression and correlation analysis were carried out using SPSS (SPSS Inc). 256 HIV infected patients were enrolled in the study. The median CD4+ T-cell count was 338 cells/mu L (range 1-1328). 37 (14%) patients had a CD4+ T-cell count of,100 cells/mu L. 46/256 (18%) of QFT-IT results and 28/256 (11%) of T-SPOT. TB results were positive. 6 (2%) of QFT-IT and 18 (7%) of T-SPOT. TB results were indeterminate. An additional 9 (4%) of T-SPOT. TB results were unavailable as tests were not performed due to insufficient cells or clotting of the sample. We found a statistically significant association between lower CD4+ T-cell count and negative QFT-IT results (OR 1.055, p = 0.03), and indeterminate/unavailable T-SPOT. TB results (OR 1.079, p = 0.02). Conclusions/Significance: In low TB prevalence settings, the QFT-IT yields more positive and fewer indeterminate results than T-SPOT. TB. Negative results on the QFT-IT and indeterminate/unavailable results on the T-SPOT. TB were more common in individuals with low CD4+ T-cell counts.	[Cheallaigh, Cliona Ni; Grace, Jacinta; Singh, Gurmit Jagjit; El-Eraki, Nahla; Clarke, Susan; Bergin, Colm] St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin, Ireland; [Fitzgeral, Ian; Rogers, Thomas R.] St James Hosp, Dept Clin Microbiol, Dublin, Ireland; [Cheallaigh, Cliona Ni; Keane, Joseph] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Cheallaigh, Cliona Ni; Keane, Joseph] St James Hosp, Dublin, Ireland; [Gibbons, Noel] St James Hosp, Irish Mycobacterial Reference Lab, Cent Pathol Lab, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Cheallaigh, CN (corresponding author), St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin, Ireland.	nicheacm@tcd.ie; cbergin@stjames.ie	Keane, Joseph/AAX-6658-2021; Cheallaigh, Cliona Ni/C-5482-2017	Keane, Joseph/0000-0001-5313-385X; Cheallaigh, Cliona Ni/0000-0002-0842-425X; Rogers, Thomas/0000-0003-4336-7729; Clarke, Susie/0000-0001-7251-0040	Health Protection Surveillance Centre, Ireland; Health Research Board, Ireland; Health Services Executive, Ireland	Health Protection Surveillance Centre, Ireland; Health Research Board, Ireland; Health Services Executive, Ireland	This work was supported by the Health Protection Surveillance Centre, Ireland. CNC was funded by the Health Research Board, Ireland and the Health Services Executive, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; BROCK I, 2006, RESP RES, V7, pNIL_0001, DOI DOI 10.1186/1465-9921-7-56; CAIAFFA WT, 1995, ARCH INTERN MED, V155, P2111, DOI 10.1001/archinte.155.19.2111; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Chaisson RE, 1996, J ACQ IMMUN DEF SYND, V11, P455, DOI 10.1097/00042560-199604150-00005; Christopher A, 2010, COCHRANE DATABASE SY; Clark SA, 2007, CLIN EXP IMMUNOL, V150, P238, DOI 10.1111/j.1365-2249.2007.03477.x; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Elzi L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-319; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Golub JE, 2008, JAIDS-J ACQ IMM DEF, V49, P532, DOI 10.1097/QAI.0b013e31818d5c1c; Health Protection Surveillance Centre, 2009, REP EP TUB IR 2007; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Laurie ED, 1995, T ROY SOC TROP MED H, V89, P37; Lee SSJ, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P133; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Oxford Immunotec, 2010, T SPOT TB PACK INS; Quantiferon, 2011, QUANTIFERON CMI PACK; Rangaka MX, 2007, CLIN INFECT DIS, V44, P1639, DOI 10.1086/518234; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; World Health Organization, 2011, TUB COUNTR PROF	38	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53330	10.1371/journal.pone.0053330	http://dx.doi.org/10.1371/journal.pone.0053330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382842	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800021
J	Kang, JH; Yun, SI; Park, MH; Park, JH; Jeong, SY; Park, HO				Kang, Ji-Hee; Yun, Sung-Il; Park, Mi-Hee; Park, Jun-Hong; Jeong, So-Young; Park, Han-Oh			Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; LOW-PROTEIN; ADIPOCYTE SIZE; LINOLEIC-ACID; LIPID-CONTENT; BODY-WEIGHT; PROBIOTICS; EXPRESSION; INCREASES; CHOLESTEROL	Previously, we reported that Lactobacillus gasseri BNR17 (BNR17), a probiotic strain isolated from human breast milk, inhibited increases in body weight and adipocyte tissue weight in high-sucrose diet-fed Sprague-Dawley (SD) rats and reduced glucose levels in type 2 diabetes mice. In the current study, we conducted further experiments to extend these observations and elucidate the mechanism involved. C57BL/6J mice received a normal diet, high-sucrose diet or high-sucrose diet containing L. gasseri BNR17 (10(9) or 10(10) CFU) for 10 weeks. The administration of L. gasseri BNR17 significantly reduced the body weight and white adipose tissue weight regardless of the dose administered. In BNR17-fed groups, mRNA levels of fatty acid oxidation-related genes (ACO, CPT1, PPAR alpha, PPAR delta) were significantly higher and those of fatty acid synthesis-related genes (SREBP-1c, ACC) were lower compared to the high-sucrose-diet group. The expression of GLUT4, main glucose transporter-4, was elevated in BNR17-fed groups. L. gasseri BNR17 also reduced the levels of leptin and insulin in serum. These results suggest that the anti-obesity actions of L. gasseri BNR17 can be attributed to elevated expression of fatty acid oxidation-related genes and reduced levels of leptin. Additionally, data suggested the anti-diabetes activity of L. gasseri BNR17 may be to due elevated GLUT4 and reduced insulin levels.	[Kang, Ji-Hee; Yun, Sung-Il; Park, Mi-Hee; Park, Jun-Hong; Jeong, So-Young; Park, Han-Oh] Bioneer Corp, R&D Ctr, Taejon, South Korea		Kang, JH (corresponding author), Bioneer Corp, R&D Ctr, Taejon, South Korea.	arachnoa@pknu.ac.kr		Park, Jun hong/0000-0001-8905-4125	High Value-Added Food Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	High Value-Added Food Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by High Value-Added Food Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Ali AA, 2005, J NUTR BIOCHEM, V16, P693, DOI 10.1016/j.jnutbio.2005.03.011; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Blaut M, 2010, ANN NUTR METAB, V57, P20, DOI 10.1159/000309079; Buzelle SL, 2010, CAN J PHYSIOL PHARM, V88, P1157, DOI 10.1139/Y10-096; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Choi H, 2012, NUTR RES, V32, P100, DOI 10.1016/j.nutres.2011.12.013; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; de Franca SA, 2009, NUTRITION, V25, P1186, DOI 10.1016/j.nut.2009.03.011; dos Santos MP, 2012, LIPIDS, V47, P279, DOI 10.1007/s11745-011-3648-8; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fukuchi S, 2004, EXP BIOL MED, V229, P486, DOI 10.1177/153537020422900606; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gill H, 2008, ADV EXP MED BIOL, V606, P423, DOI 10.1007/978-0-387-74087-4_17; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Ikarashi N, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep241; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Kouidhi S, 2011, ACTA DIABET IN PRESS; Kumar M, 2010, INT J FOOD SCI NUTR, V61, P473, DOI 10.3109/09637480903455971; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Mennigen R, 2009, ANN NY ACAD SCI, V1165, P183, DOI 10.1111/j.1749-6632.2009.04059.x; Park DY, 2011, J MED FOOD, V14, P670, DOI 10.1089/jmf.2010.1355; Shin HS, 2010, ARCH PHARM RES, V33, P1425, DOI 10.1007/s12272-010-0917-7; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Sousa R, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-5; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wickelgren I, 1998, SCIENCE, V280, P1364, DOI 10.1126/science.280.5368.1364; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	41	113	120	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54617	10.1371/journal.pone.0054617	http://dx.doi.org/10.1371/journal.pone.0054617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382926	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800058
J	Nguyen, TT; Calvano, SE; Lowry, SF; Androulakis, IP				Nguyen, Tung T.; Calvano, Steve E.; Lowry, Stephen F.; Androulakis, Ioannis P.			An Agent-Based Model of Cellular Dynamics and Circadian Variability in Human Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; GENE-EXPRESSION; IMMUNE-RESPONSE; TNF-ALPHA; JAK-STAT; ANTIINFLAMMATORY CYTOKINES; SYSTEMIC INFLAMMATION; PINEAL MELATONIN; PROTEIN	As cellular variability and circadian rhythmicity play critical roles in immune and inflammatory responses, we present in this study an agent-based model of human endotoxemia to examine the interplay between circadian controls, cellular variability and stochastic dynamics of inflammatory cytokines. The model is qualitatively validated by its ability to reproduce circadian dynamics of inflammatory mediators and critical inflammatory responses after endotoxin administration in vivo. Novel computational concepts are proposed to characterize the cellular variability and synchronization of inflammatory cytokines in a population of heterogeneous leukocytes. Our results suggest that there is a decrease in cell-to-cell variability of inflammatory cytokines while their synchronization is increased after endotoxin challenge. Model parameters that are responsible for I kappa B production stimulated by NF kappa B activation and for the production of anti-inflammatory cytokines have large impacts on system behaviors. Additionally, examining time-dependent systemic responses revealed that the system is least vulnerable to endotoxin in the early morning and most vulnerable around midnight. Although much remains to be explored, proposed computational concepts and the model we have pioneered will provide important insights for future investigations and extensions, especially for single-cell studies to discover how cellular variability contributes to clinical implications.	[Nguyen, Tung T.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Calvano, Steve E.; Lowry, Stephen F.; Androulakis, Ioannis P.] UMDNJ, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Androulakis, IP (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	yannis@rci.rutgers.edu			National Institutes of Health (NIH) [GM082974]; NIH [GM34695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034695, R01GM082974, R37GM034695] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TTN and IPA acknowledge support from National Institutes of Health (NIH) GM082974. SEC and SFL are supported, in part, from NIH GM34695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; An G, 2009, MATH BIOSCI, V217, P43, DOI 10.1016/j.mbs.2008.10.001; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; An GC, 2009, MATH BIOSCI, V217, P53, DOI 10.1016/j.mbs.2008.08.013; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Bahcall OG, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100020; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; Chavali AK, 2008, TRENDS IMMUNOL, V29, P589, DOI 10.1016/j.it.2008.08.006; Coogan AN, 2008, BRAIN RES, V1232, P104, DOI 10.1016/j.brainres.2008.07.087; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Cutolo M, 2003, ANN RHEUM DIS, V62, P593, DOI 10.1136/ard.62.7.593; Fernandes PACM, 2009, J NEUROENDOCRINOL, V21, P90, DOI 10.1111/j.1365-2826.2008.01817.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; Foteinou PT, 2009, MATH BIOSCI, V217, P27, DOI 10.1016/j.mbs.2008.09.003; Foteinou PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004706; Gori AM, 2009, ATHEROSCLEROSIS, V202, P255, DOI 10.1016/j.atherosclerosis.2008.04.001; Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335; Hermann C, 2006, EUR J IMMUNOL, V36, P371, DOI 10.1002/eji.200535470; Hermida Ramon C, 2007, Ther Clin Risk Manag, V3, P119, DOI 10.2147/tcrm.2007.3.1.119; Hermida RC, 2005, CURR OPIN NEPHROL HY, V14, P453, DOI 10.1097/01.mnh.0000174144.07174.74; Hess A, 2001, ATMOS ENVIRON, V35, P5211, DOI 10.1016/S1352-2310(01)00342-9; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Jerin A, 2003, CLIN CHEM LAB MED, V41, P899, DOI 10.1515/CCLM.2003.136; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kilfoil ML, 2009, HFSP J, V3, P379, DOI 10.2976/1.3223356; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lissoni P, 1998, NAT IMMUN, V16, P1, DOI 10.1159/000069464; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Mager DE, 2003, DRUG METAB DISPOS, V31, P510, DOI 10.1124/dmd.31.5.510; MAH RSH, 1995, COMPUT CHEM ENG, V19, P129, DOI 10.1016/0098-1354(94)E0042-L; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nguyen TT, 2009, OMICS, V13, P219, DOI 10.1089/omi.2008.0074; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Paramalingam SS, 2007, ANN ACAD MED SINGAP, V36, P96; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Pontes GN, 2007, J PINEAL RES, V43, P365, DOI 10.1111/j.1600-079X.2007.00487.x; Prabhakar U, 2005, DNA CELL BIOL, V24, P410, DOI 10.1089/dna.2005.24.410; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rausenberger J, 2008, BIOPHYS J, V95, P4523, DOI 10.1529/biophysj.107.127035; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothman S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-25; Scheff JD, 2010, J THEOR BIOL, V264, P1068, DOI 10.1016/j.jtbi.2010.03.026; Schooley K, 2003, BIOCHEM J, V369, P331, DOI 10.1042/BJ20020253; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skwarlo-Sonta K, 2003, CAN J PHYSIOL PHARM, V81, P342, DOI 10.1139/Y03-026; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tetta C, 2005, Crit Care Resusc, V7, P32; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; VELDHUIS J D, 1989, American Journal of Physiology, V257, pE6; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Warrender C, 2006, B MATH BIOL, V68, P2233, DOI 10.1007/s11538-006-9103-y; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	96	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55550	10.1371/journal.pone.0055550	http://dx.doi.org/10.1371/journal.pone.0055550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383223	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800165
J	Nilsson, D; Andiappan, AK; Hallden, C; Chew, FT; Sall, T; Wang, DY; Cardell, LO				Nilsson, Daniel; Andiappan, Anand Kumar; Hallden, Christer; Chew, Fook Tim; Sall, Torbjorn; Wang, De Yun; Cardell, Lars-Olaf			Poor Reproducibility of Allergic Rhinitis SNP Associations	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; JAPANESE CEDAR POLLINOSIS; GENE POLYMORPHISMS; EOSINOPHIL PEROXIDASE; CHINESE POPULATION; SINGAPORE CHINESE; KOREAN POPULATION; REPORTED ASTHMA; HAY-FEVER; SENSITIZATION	Replication of reported associations is crucial to the investigation of complex disease. More than 100 SNPs have previously been reported as associated with allergic rhinitis (AR), but few of these have been replicated successfully. To investigate the general reproducibility of reported AR-associations in candidate gene studies, one Swedish (352 AR-cases, 709 controls) and one Singapore Chinese population (948 AR-cases, 580 controls) were analyzed using 49 AR-associated SNPs. The overall pattern of P-values indicated that very few of the investigated SNPs were associated with AR. Given published odds ratios (ORs) most SNPs showed high power to detect an association, but no correlations were found between the ORs of the two study populations or with published ORs. None of the association signals were in common to the two genome-wide association studies published in AR, indicating that the associations represent false positives or have much lower effect-sizes than reported.	[Nilsson, Daniel; Cardell, Lars-Olaf] Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Nilsson, Daniel; Hallden, Christer] Kristianstad Univ, Kristianstad, Sweden; [Andiappan, Anand Kumar; Chew, Fook Tim] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Andiappan, Anand Kumar] Singapore Immunol Network SIgN, Singapore, Singapore; [Sall, Torbjorn] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Wang, De Yun] Natl Univ Singapore, Dept Otolaryngol, Singapore 117548, Singapore	Karolinska Institutet; Kristianstad University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Lund University; National University of Singapore	Cardell, LO (corresponding author), Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	lars-olaf.cardell@ki.se	Andiappan, Anand Kumar/AAT-2336-2021; Chew, Fook Tim/E-7259-2010	Chew, Fook Tim/0000-0003-1337-5146; Andiappan, Anand Kumar/0000-0002-8442-1544; Carlberg, Daniel/0000-0002-8098-6396	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiappan AK, 2011, CYTOKINE, V56, P218, DOI 10.1016/j.cyto.2011.05.008; Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Andiappan AK, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-39; Andiappan AK, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-36; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, ALLERGY, V67, P18, DOI 10.1111/j.1398-9995.2011.02728.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Bryborn M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-29; Chae SC, 2005, IMMUNOGENETICS, V56, P760, DOI 10.1007/s00251-004-0746-2; Chae SC, 2004, HUM IMMUNOL, V65, P1427, DOI 10.1016/j.humimm.2004.07.002; Chae SC, 2006, EXP MOL MED, V38, P302, DOI 10.1038/emm.2006.36; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; Gulen F, 2007, CLIN BIOCHEM, V40, P392, DOI 10.1016/j.clinbiochem.2006.11.014; Hrdlickova B, 2009, INT ARCH ALLERGY IMM, V150, P184, DOI 10.1159/000218122; Imboden M, 2006, Clin Mol Allergy, V4, P9, DOI 10.1186/1476-7961-4-9; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kang I, 2010, EUR ARCH OTO-RHINO-L, V267, P391, DOI 10.1007/s00405-009-1103-8; Kawai T, 2009, CLIN EXP ALLERGY, V39, P1508, DOI 10.1111/j.1365-2222.2009.03316.x; Kim JJ, 2004, LARYNGOSCOPE, V114, P666, DOI 10.1097/00005537-200404000-00013; Klein RJ, 2012, EUR UROL, V61, P471, DOI 10.1016/j.eururo.2011.10.047; Kruse S, 2003, J ALLERGY CLIN IMMUN, V111, P117, DOI 10.1067/mai.2003.43; Li CS, 2006, J HUM GENET, V51, P292, DOI 10.1007/s10038-006-0359-8; Llanes E, 2009, INT ARCH ALLERGY IMM, V148, P228, DOI 10.1159/000161583; Murk W, 2011, HUM HERED, V71, P97, DOI 10.1159/000319536; Nagata H, 2001, HUM GENET, V109, P262, DOI 10.1007/s004390100561; Nakamura H, 2003, J ALLERGY CLIN IMMUN, V112, P1127, DOI 10.1016/j.jaci.2003.08.051; Nakamura H, 2007, INT ARCH ALLERGY IMM, V142, P329, DOI 10.1159/000097502; Nieters A, 2004, CLIN EXP ALLERGY, V34, P346, DOI 10.1111/j.1365-2222.2004.01889.x; Nilsson D, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-66; R Development Core Team, 2009, R FDN STAT COMP; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rasanen M, 1998, ALLERGY, V53, P885, DOI 10.1111/j.1398-9995.1998.tb03996.x; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su DJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-82; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Warnes G., 2008, GENETICS POPULATION; Weidinger S, 2005, CLIN EXP ALLERGY, V35, P866, DOI 10.1111/j.1365-2222.2005.02269.x; Zhang L, 2009, ACTA OTO-LARYNGOL, V129, P190, DOI 10.1080/00016480802139846	42	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53975	10.1371/journal.pone.0053975	http://dx.doi.org/10.1371/journal.pone.0053975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382861	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800027
J	Muchero, W; Sewell, MM; Ranjan, P; Gunter, LE; Tschaplinski, TJ; Yin, TM; Tuskan, GA				Muchero, Wellington; Sewell, Mitchell M.; Ranjan, Priya; Gunter, Lee E.; Tschaplinski, Timothy J.; Yin, Tongming; Tuskan, Gerald A.			Genome Anchored QTLs for Biomass Productivity in Hybrid Populus Grown under Contrasting Environments	PLOS ONE			English	Article							MOLECULAR-GENETICS; PHENOTYPIC VARIATION; SHORT-ROTATION; IDENTIFICATION; TRAITS; YIELD; L.	Traits related to biomass production were analyzed for the presence of quantitative trait loci (QTLs) in a Populus trichocarpa x P. deltoides F-2 population. A genetic linkage map composed of 841 SSR, AFLP, and RAPD markers and phenotypic data from 310 progeny were used to identify genomic regions harboring biomass QTLs. Twelve intervals were identified, of which BM-1, BM-2, and BM-7 were identified in all three years for both height and diameter. One putative QTL, BM-7, and one suggestive QTL exhibited significant evidence of over-dominance in all three years for both traits. Conversely, QTLs BM-4 and BM-6 exhibited evidence of under-dominance in both environments for height and diameter. Seven of the nine QTLs were successfully anchored, and QTL peak positions were estimated for each one on the P. trichocarpa genome assembly using flanking SSR markers with known physical positions. Of the 3,031 genes located in genome-anchored QTL intervals, 1,892 had PFAM annotations. Of these, 1,313, representing 255 unique annotations, had at least one duplicate copy in a QTL interval identified on a separate scaffold. This observation suggests that some QTLs identified in this study may have shared the same ancestral sequence prior to the salicoid genome duplication in Populus.	[Muchero, Wellington; Sewell, Mitchell M.; Ranjan, Priya; Gunter, Lee E.; Tschaplinski, Timothy J.; Yin, Tongming; Tuskan, Gerald A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Muchero, Wellington; Ranjan, Priya; Gunter, Lee E.; Tschaplinski, Timothy J.; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Muchero, W (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.	mucherow@ornl.gov	Gunter, Lee E/L-3480-2016; Tuskan, Gerald/A-6225-2011; Tschaplinski, Timothy/D-6382-2018	Gunter, Lee E/0000-0003-1211-7532; Tuskan, Gerald/0000-0003-0106-1289; Tschaplinski, Timothy/0000-0002-9540-6622; muchero, wellington/0000-0002-0200-9856; Ranjan, Priya/0000-0002-0357-1939	Biomass Feedstock Development Program, United States Department of Energy; Office of Industrial Technology, Energy Efficiency Renewable Energy, United States Department of Energy; Office of Science, Biological, and Environmental Research, United States Department of Energy; Department of Energy, Office of Science, Biological and Environmental Research of the Plant Microbe Interfaces Scientific Focus Area; BioEnergy Science Center; United States Department of Energy [DE-AC05-00OR22725]	Biomass Feedstock Development Program, United States Department of Energy; Office of Industrial Technology, Energy Efficiency Renewable Energy, United States Department of Energy; Office of Science, Biological, and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Department of Energy, Office of Science, Biological and Environmental Research of the Plant Microbe Interfaces Scientific Focus Area; BioEnergy Science Center; United States Department of Energy(United States Department of Energy (DOE))	This research was supported, in part, by the Biomass Feedstock Development Program, United States Department of Energy; by the Office of Industrial Technology, Energy Efficiency Renewable Energy, United States Department of Energy; by the Office of Science, Biological, and Environmental Research, United States Department of Energy; by the Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area and by the BioEnergy Science Center. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the United States Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1991, SCIENCE, V252, P1469, DOI 10.1126/science.252.5012.1469; BRADSHAW HD, 1995, GENETICS, V139, P963; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Brown GR, 2003, GENETICS, V164, P1537; CHURCHILL GA, 1994, GENETICS, V138, P963; Eckenwalder J.E., 2001, POPLAR CULTURE N AM, P331; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Muchero W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-8; Muchero W, 2010, THEOR APPL GENET, V120, P509, DOI 10.1007/s00122-009-1171-6; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Rae AM, 2008, TREE GENET GENOMES, V4, P97, DOI 10.1007/s11295-007-0091-3; Ranjan P, 2010, BIOENERG RES, V3, P172, DOI 10.1007/s12155-009-9060-z; RANNEY JW, 1987, J FOREST, V85, P17; ScarasciaMugnozza GE, 1997, CAN J FOREST RES, V27, P285, DOI 10.1139/x96-180; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Stettler RF, 1996, BIOL POPULUS ITS IMP, P87; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tschaplinski TJ, 2006, TREE PHYSIOL, V26, P595, DOI 10.1093/treephys/26.5.595; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 1998, BIOMASS BIOENERG, V14, P307, DOI 10.1016/S0961-9534(97)10065-4; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu R, 1997, AM J BOT, V84, P143, DOI 10.2307/2446076; Wu R, 1997, HEREDITY, V78, P124; Wu RL, 1997, THEOR APPL GENET, V94, P104, DOI 10.1007/s001220050388; Wullschleger S, 2005, CAN J FOREST RES, V35, P1779, DOI 10.1139/x05-101; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Yin TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014021; Zhuang Y, 2007, GENETICS, V177, P1987, DOI 10.1534/genetics.107.080325; Zsuffa L., 1996, P515	31	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54468	10.1371/journal.pone.0054468	http://dx.doi.org/10.1371/journal.pone.0054468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382900	Green Submitted, Green Published, gold			2022-12-25	WOS:000315483200030
J	Herbert, BS; Grimes, BR; Xu, WM; Werner, M; Ward, C; Rossetti, S; Harris, P; Bello-Reuss, E; Ward, HH; Miller, C; Gattone, VH; Phillips, CL; Wandinger-Ness, A; Bacallao, RL				Herbert, Brittney-Shea; Grimes, Brenda R.; Xu, Wei Min; Werner, Michael; Ward, Christopher; Rossetti, Sandro; Harris, Peter; Bello-Reuss, Elsa; Ward, Heather H.; Miller, Caroline; Gattone, Vincent H., II; Phillips, Carrie L.; Wandinger-Ness, Angela; Bacallao, Robert L.			A Telomerase Immortalized Human Proximal Tubule Cell Line with a Truncation Mutation (Q4004X) in Polycystin-1	PLOS ONE			English	Article							CYST EPITHELIAL-CELLS; KIDNEY-DISEASE; CYCLIC-AMP; PKD1 GENE; IN-VITRO; EXPRESSION; GROWTH; CHANNEL; PROTEIN; ADPKD	Autosomal dominant polycystic kidney disease (ADPKD) is associated with a variety of cellular phenotypes in renal epithelial cells. Cystic epithelia are secretory as opposed to absorptive, have higher proliferation rates in cell culture and have some characteristics of epithelial to mesenchymal transitions [1,2]. In this communication we describe a telomerase immortalized cell line that expresses proximal tubule markers and is derived from renal cysts of an ADPKD kidney. These cells have a single detectable truncating mutation (Q4004X) in polycystin-1. These cells make normal appearing but shorter cilia and fail to assemble polycystin-1 in the cilia, and less uncleaved polycystin-1 in membrane fractions. This cell line has been maintained in continuous passage for over 35 passages without going into senescence. Nephron segment specific markers suggest a proximal tubule origin for these cells and the cell line will be useful to study mechanistic details of cyst formation in proximal tubule cells.	[Herbert, Brittney-Shea; Grimes, Brenda R.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Ward, Christopher; Rossetti, Sandro; Harris, Peter] Mayo Clin, Div Nephrol, Rochester, MN USA; [Miller, Caroline; Gattone, Vincent H., II] Indiana Univ, Dept Anat & Cell Biol, Indianapolis, IN 46204 USA; [Ward, Heather H.; Wandinger-Ness, Angela] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Phillips, Carrie L.] Indiana Univ, Dept Pathol, Indianapolis, IN 46204 USA; [Bello-Reuss, Elsa] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Div Nephrol & Hypertens, Lubbock, TX 79430 USA; [Xu, Wei Min; Werner, Michael; Bacallao, Robert L.] Richard L Roudebush VAMC, Div Nephrol, Indianapolis, IN USA; [Xu, Wei Min; Werner, Michael; Bacallao, Robert L.] Indiana Univ, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis; University of New Mexico; Indiana University System; Indiana University-Purdue University Indianapolis; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Bacallao, RL (corresponding author), Richard L Roudebush VAMC, Div Nephrol, Indianapolis, IN USA.	rbacalla@iupui.edu	Ward, Heather/R-7785-2016; Wandinger-Ness, Angela/J-9104-2012	Ward, Heather/0000-0002-8502-3679; Wandinger-Ness, Angela/0000-0003-0613-3157; Herbert, Brittney-Shea/0000-0003-3192-2203; Bacallao, Robert/0000-0002-5703-5701; Phillips, Carrie/0000-0002-0256-0736	National Institutes of Health/NIDDK [R21DK067246, R01DK050141, RO1 DK58816]; Indiana Genomics Initiative (INGEN); Lilly Endowment Inc.; PKD Foundation; NIH [DK59597, DK065056, DK090726]; IUSM Cytogenetics division; Department of Medicine at Indiana University; Mayo Translational Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050141, R21DK067246, R01DK059597, R01DK065056, R01DK058816] Funding Source: NIH RePORTER	National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indiana Genomics Initiative (INGEN); Lilly Endowment Inc.; PKD Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUSM Cytogenetics division; Department of Medicine at Indiana University; Mayo Translational Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/NIDDK grants R21DK067246, R01DK050141 to RLB and AWN respectively, and the Indiana Genomics Initiative (INGEN) to BH and BG. INGEN of Indiana University is supported in part by Lilly Endowment Inc. Electron microscopy work was supported by a generous center grant from the PKD Foundation to VG. CW is supported by NIH R01 R01 grants DK59597, DK065056 grants. PH is supported by RO1 DK58816 grant from the NIH/NIDDK. BRG received funding support from the PKD Foundation and the IUSM Cytogenetics division. RLB has received funding support from the Department of Medicine at Indiana University. Mutation analysis was supported by the Mayo Translational Core which is supported by NIH P30 grant DK090726. URLs: www.niddk.nih.gov; www.pkdcure.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Boucher C, 2004, EUR J HUM GENET, V12, P347, DOI 10.1038/sj.ejhg.5201162; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; CARONE FA, 1993, LAB INVEST, V68, P413; CARONE FA, 1989, KIDNEY INT, V35, P1351, DOI 10.1038/ki.1989.134; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Cotsiki M, 2004, P NATL ACAD SCI USA, V101, P947, DOI 10.1073/pnas.0308006100; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Germino GG, 1997, HOSP PRACT, V32, P81, DOI 10.1080/21548331.1997.11443444; Glasspool RM, 2005, NEOPLASIA, V7, P614, DOI 10.1593/neo.04766; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hackmann K, 2005, HUM MOL GENET, V14, P3249, DOI 10.1093/hmg/ddi356; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Kher R, 2011, AM J PHYSIOL-CELL PH, V301, pC99, DOI 10.1152/ajpcell.00151.2010; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Lewis CM, 2006, BREAST CANCER RES TR, V99, P103, DOI 10.1007/s10549-006-9189-9; Li NF, 2009, ONCOGENE, V28, P773, DOI 10.1038/onc.2008.412; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; MACKAY K, 1987, KIDNEY INT, V32, P827, DOI 10.1038/ki.1987.283; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; Montesano R, 1997, J CELL PHYSIOL, V173, P152, DOI 10.1002/(SICI)1097-4652(199711)173:2<152::AID-JCP14>3.0.CO;2-I; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Takakura A, 2008, J AM SOC NEPHROL, V19, P2351, DOI 10.1681/ASN.2007101139; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Watnick T, 1999, SEMIN NEPHROL, V19, P327; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WILSON PD, 1991, KIDNEY INT, V39, P450, DOI 10.1038/ki.1991.56; Xu C, 2007, AM J PHYSIOL-RENAL, V292, pF930, DOI 10.1152/ajprenal.00285.2006; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55191	10.1371/journal.pone.0055191	http://dx.doi.org/10.1371/journal.pone.0055191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383103	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500063
J	Di Milia, L; Waage, S; Pallesen, S; Bjorvatn, B				Di Milia, Lee; Waage, Siri; Pallesen, Stale; Bjorvatn, Bjorn			Shift Work Disorder in a Random Population Sample - Prevalence and Comorbidities	PLOS ONE			English	Article							SLEEP DURATION; HORDALAND HEALTH; INSOMNIA SCALE; NORTH-SEA; OIL RIG; VALIDATION; MANAGEMENT; PERMANENT; WORKHOURS	Few studies have investigated the presence of shift work disorder (SWD) in the general community. We addressed many of the limitations in this literature and present new findings. SWD has been treated as an 'all or none' construct but we propose the need to consider the 'severity' of the disorder. Using random digit dialling, we randomly recruited 1163 participants. Participants completed an extensive battery of scales and questions concerning work, health and individual differences. Three questions based on the criteria from the International Classification for Sleep Disorders were used to categorise participants with SWD (n = 176). In addition, we asked participants whether SWD interfered with aspects of their life and high ratings were used to define severe shift work disorder (SSWD). The prevalence of SWD was 32.1% among night workers and 10.1% in day workers (p<.001). SSWD was present in 9.1% of night workers and 1.3% of day workers (p<.001). Adjusted logistic regression analyses found significant associations between SWD and night work (OR = 3.35, CI 2.19-5.12), weekly work hours (OR = 1.02, CI 1.00-1.04), short sleep (<= 6 h; OR = 2.93, CI 1.94-4.41), languidity (OR = 1.11, CI 1.06-1.16) and resilience (OR = 0.56, CI 0.43-0.81). Night work, short sleep, languidity, and hypertension were significantly associated with SSWD. Overall, participants with SSWD slept 0.80 h less than other participants (p<.001). Night work, short sleep and languidity were associated with both SWD and SSWD. Day workers with SWD symptoms reported significantly shorter sleep duration, higher levels of languidity and worked longer working hours compared to day workers without SWD.	[Di Milia, Lee] Cent Queensland Univ, Sch Management, Rockhampton, Qld 4702, Australia; [Di Milia, Lee] Cent Queensland Univ, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia; [Waage, Siri; Pallesen, Stale; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Waage, Siri; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway	Central Queensland University; Central Queensland University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Di Milia, L (corresponding author), Cent Queensland Univ, Sch Management, Rockhampton, Qld 4702, Australia.	v.dimilia@cqu.edu.au	Di Milia, Lee/A-6810-2008	Di Milia, Lee/0000-0001-7681-5589	Institute for Health and Social Science Research at Central Queensland University	Institute for Health and Social Science Research at Central Queensland University	The study was funded by an internal grant from the Institute for Health and Social Science Research at Central Queensland University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akerstedt T, 2010, CHRONOBIOL INT, V27, P975, DOI 10.3109/07420528.2010.489001; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Australian Bureau of Statistics, 2009, WORK TIM ARR; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Bin YS, 2012, SLEEP MED REV, V16, P223, DOI 10.1016/j.smrv.2011.07.003; Bjorvatn B, 2006, SLEEP, V29, P821, DOI 10.1093/sleep/29.6.821; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Costa G, 2008, CHRONOBIOL INT, V25, P165, DOI 10.1080/07420520802103410; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Di Milia L, 2005, PERS INDIV DIFFER, V39, P1293, DOI 10.1016/j.paid.2005.04.012; Di Milia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045856; Di Milia L, 2012, PERS INDIV DIFFER, V52, P702, DOI 10.1016/j.paid.2011.12.033; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; FOLKARD S, 1993, ERGONOMICS, V36, P85, DOI 10.1080/00140139308967858; Folkard S, 2008, CHRONOBIOL INT, V25, P215, DOI 10.1080/07420520802106835; Francis A, 1994, DIAGNOSTIC STAT MANU; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Harma M, 2006, SCAND J WORK ENV HEA, V32, P502; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Marquie JC, 2012, SLEEP, V35, P1115, DOI 10.5665/sleep.2000; Natvik S, 2011, APPL ERGON, V42, P719, DOI 10.1016/j.apergo.2010.11.006; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Pilcher JJ, 2000, SLEEP, V23, P155; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Puttonen S, 2012, SCAND J WORK ENV HEA, V38, P343, DOI 10.5271/sjweh.3267; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Roth T, 2012, SLEEP MED, V13, P335, DOI 10.1016/j.sleep.2011.11.006; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Schwartz JRL, 2006, DRUGS, V66, P2357, DOI 10.2165/00003495-200666180-00007; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Ursin R, 2009, SCAND J WORK ENV HEA, V35, P193, DOI 10.5271/sjweh.1325; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001	42	60	62	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55306	10.1371/journal.pone.0055306	http://dx.doi.org/10.1371/journal.pone.0055306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372847	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400087
J	Harter, TS; Verreth, JAJ; Heinsbroek, LTN; Schrama, JW				Harter, Till S.; Verreth, Johan A. J.; Heinsbroek, Leon T. N.; Schrama, Johan W.			Isoenergetic Replacement of Fat by Starch in Diets for African Catfish (Clarias gariepinus): Effect on Water Fluxes in the Gastro Intestinal Tract	PLOS ONE			English	Article							RAINBOW-TROUT; IN-VIVO; ABSORPTION; DRINKING; DRY	The effect of an isoenergetic replacement of dietary fat by starch, on chyme characteristics and water fluxes in the gastro intestinal tract (GIT) was assessed. Adult African catfish (Clarias gariepinus) were fed a starch (SD) or fat (FD) diet and groups of fish were dissected at 2, 5 and 8 h after the consumption of a single meal. Chyme was collected quantitatively and was analysed for osmolality and dry matter (DM) content. Postprandial water fluxes were calculated, while using yttrium oxide (Y2O3) as an inert marker to account for the absorption of DM along the GIT. The largest differences in chyme characteristics between diets were observed in the stomach and decreased towards subsequent compartments. A high initial osmotic pressure was measured in the stomach for both diets (up to 498 +/- 2 mOsm kg(-1)) and was likely the driver for the endogeneous water influx to this compartment. Large additions of water were recorded to the stomach and proximal intestine for both diets and absorption of water took place in the mid-and distal intestine. Interestingly, the dietary treatment had an impact on water balance in the stomach and proximal intestine of the fish, but not in the mid-and distal intestine. A strong complementary relationship suggested that 59% of the water fluxes in the proximal intestine could be explained by previous additions to the stomach. Therefore, a higher dietary inclusion of starch led to a shift in water additions from the proximal intestine to the stomach. However, the sum of water additions to the GIT was not different between diets and was on average 6.52 +/- 0.85 ml water g(-1) DM. The interactions between osmoregulation and digestion, in the GIT of fed freshwater fish, deserve further attention in future research.	[Harter, Till S.; Verreth, Johan A. J.; Heinsbroek, Leon T. N.; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Schrama, JW (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	Johan.Schrama@wur.nl	Verreth, Johan/ABD-7198-2020	Verreth, Johan/0000-0001-7277-5129; Schrama, Johan/0000-0001-7156-8806	Wageningen University, The Netherlands	Wageningen University, The Netherlands(Netherlands Government)	This research project has been funded by Wageningen University, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Amirkolaie AK, 2006, AQUACULTURE, V260, P194, DOI 10.1016/j.aquaculture.2006.06.039; Anguita M, 2006, ANIM FEED SCI TECH, V129, P99, DOI 10.1016/j.anifeedsci.2005.12.004; Bakke AM, 2010, FISH PHYSL MULTIFUNC, P56; BOGE G, 1988, COMP BIOCHEM PHYS A, V91, P9, DOI 10.1016/0300-9629(88)91584-8; Bucking C, 2006, J EXP BIOL, V209, P1883, DOI 10.1242/jeb.02205; Bucking C, 2006, AM J PHYSIOL-REG I, V291, pR1764, DOI 10.1152/ajpregu.00224.2006; Buddington RK, 1997, ACTA PHYSL SCANDINAV, V161; FAICHNEY GA, 1988, AUST J AGR RES, V39, P481; FAICHNEY GJ, 1981, AGR SYST, V6, P261, DOI 10.1016/0308-521X(81)90062-7; Fuentes J., 1997, P135; Grosell M, 2000, AM J PHYSIOL-REG I, V278, pR1674, DOI 10.1152/ajpregu.2000.278.6.R1674; HEISLER N, 1984, FISH PHYSIOL, V10, P315; Kristiansen HR, 2001, AQUAT LIVING RESOUR, V14, P359, DOI 10.1016/S0990-7440(01)01131-7; Marshall William S., 2006, P177; Nobata S, 2011, AM J PHYSIOL-REG I, V300, P1569, DOI 10.1152/ajpregu.00056.2011; Owens F. N., 1988, RUMINANT ANIMAL DIGE; Ruohonen K, 1997, J FISH BIOL, V51, P93, DOI 10.1111/j.1095-8649.1997.tb02516.x; Smith HW, 1930, AM J PHYSIOL, V93, P480, DOI 10.1152/ajplegacy.1930.93.2.480; Stone DAJ, 2003, REV FISH SCI, V11, P337, DOI 10.1080/10641260390260884; Takei Y, 2002, EXPTL BIOL REV, P61; TAKEI Y, 1979, GEN COMP ENDOCR, V38, P466, DOI 10.1016/0016-6480(79)90155-2; Takei Y, 2008, FISH NEUROENDOCRINOL, P365; van Bussel W, 2010, ATOM SPECTROSC, V31, P81; van de Nieuwegiessen PG, 2009, AQUACULTURE, V288, P69, DOI 10.1016/j.aquaculture.2008.11.009; WINDELL JT, 1969, J FISH RES BOARD CAN, V26, P1801, DOI 10.1139/f69-164; Wood CM, 2012, J EXP BIOL, V215, P508, DOI 10.1242/jeb.060004; Wood CM, 2011, FISH PHYSIOL, V30, P165, DOI 10.1016/S1546-5098(10)03005-0	27	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55245	10.1371/journal.pone.0055245	http://dx.doi.org/10.1371/journal.pone.0055245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372842	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400082
J	Xu, F; Li, J; Ni, W; Shen, YW; Zhang, XP				Xu, Feng; Li, Jian; Ni, Wei; Shen, Yi-wen; Zhang, Xiao-ping			Peroxisome Proliferator-Activated Receptor-gamma Agonist 15d-Prostaglandin J(2) Mediates Neuronal Autophagy after Cerebral Ischemia-Reperfusion Injury	PLOS ONE			English	Article							NEONATAL HYPOXIA-ISCHEMIA; PPAR-GAMMA; OXIDATIVE STRESS; CELL-DEATH; APOPTOSIS; MECHANISMS; TRANSIENT; PROTEIN; LIGAND; BRAIN	Peroxisome proliferator-activated receptor-c (PPAR-c) has recently emerged as potential therapeutic agents for cerebral ischemia-reperfusion (I/R) injury because of anti-neuronal apoptotic actions. However, whether PPAR-c activation mediates neuronal autophagy in such conditions remains unclear. Therefore, in this study, we investigated the role of PPAR-gamma agonist 15-PGJ(2) on neuronal autophagy induced by I/R. The expression of autophagic-related protein in ischemic cortex such as LC3-II, Beclin 1, cathepsin-B and LAMP1 increased significantly after cerebral I/R injury. Furthermore, increased punctate LC3 labeling and cathepsin-B staining occurred in neurons. Treatment with PPAR-gamma agonist 15d-PGJ(2) decreased not only autophagic-related protein expression in ischemic cortex, but also immunoreactivity of LC3 and cathepsin-B in neurons. Autophagic inhibitor 3-methyladenine (3-MA) decreased LC3-II levels, reduced the infarct volume, and mimicked some protective effect of 15d-PGJ(2) against cerebral I/R injury. These results indicate that PPAR-c agonist 15d-PGJ(2) exerts neuroprotection by inhibiting neuronal autophagy after cerebral I/R injury. Although the molecular mechanisms underlying PPAR-c agonist in mediating neuronal autophagy remain to be determined, neuronal autophagy may be a new target for PPAR-c agonist treatment in cerebral I/R injury.	[Xu, Feng; Ni, Wei; Shen, Yi-wen] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Li, Jian] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhang, Xiao-ping] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Tongji University	Xu, F (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	fengxu.dr@gmail.com			National Nature Science Foundation of China [81000488]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (No. 81000488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Clark WM, 1997, NEUROL RES, V19, P641; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin TN, 2006, ARTERIOSCL THROM VAS, V26, P481, DOI 10.1161/01.ATV.0000201933.53964.5b; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Marino G., 2010, CURR OPIN CELL BIOL, V23, P1; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; NITATORI T, 1995, J NEUROSCI, V15, P1001; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shimazu T, 2005, STROKE, V36, P353, DOI 10.1161/01.STR.0000152271.21943.a2; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Xu F, 2012, NEUROSCI BULL, V28, P658, DOI 10.1007/s12264-012-1268-9; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zheng YQ, 2009, ACTA PHARMACOL SIN, V30, P919, DOI 10.1038/aps.2009.79; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	39	46	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55080	10.1371/journal.pone.0055080	http://dx.doi.org/10.1371/journal.pone.0055080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372817	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400060
J	Gregus, AM; Dumlao, DS; Wei, SC; Norris, PC; Catella, LC; Meyerstein, FG; Buczynski, MW; Steinauer, JJ; Fitzsimmons, BL; Yaksh, TL; Dennis, EA				Gregus, Ann M.; Dumlao, Darren S.; Wei, Spencer C.; Norris, Paul C.; Catella, Laura C.; Meyerstein, Flore G.; Buczynski, Matthew W.; Steinauer, Joanne J.; Fitzsimmons, Bethany L.; Yaksh, Tony L.; Dennis, Edward A.			Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia	FASEB JOURNAL			English	Article						pain; eicosanoid; Aloxe3	POSITIONAL SPECIFICITY; FUNCTIONAL EXPRESSION; SELECTIVE INHIBITORS; GENOMIC STRUCTURE; ARACHIDONIC-ACID; CELL-DEATH; 12-LIPOXYGENASE; LIPOXYGENASE; GENE; CLONING	Previously, we observed significant increases in spinal 12-lipoxygenase (LOX) metabolites, in particular, hepoxilins, which contribute to peripheral inflammation-induced tactile allodynia. However, the enzymatic sources of hepoxilin synthase (HXS) activity in rats remain elusive. Therefore, we overexpressed each of the 6 rat 12/15-LOX enzymes in HEK-293T cells and measured by LC-MS/MS the formation of HXB3, 12-HETE, 8-HETE, and 15-HETE from arachidonic acid (AA) at baseline and in the presence of LOX inhibitors (NDGA, AA-861, CDC, baicalein, and PD146176) vs. vehicle-treated and mock-transfected controls. We detected the following primary intrinsic activities: 12-LOX (Alox12, Alox15), 15-LOX (Alox15b), and HXS (Alox12, Alox15). Similar to human and mouse orthologs, proteins encoded by rat Alox12b and Alox12e possessed minimal 12-LOX activity with AA as substrate, while eLOX3 (encoded by Aloxe3) exhibited HXS without 12-LOX activity when coexpressed with Alox12b or supplemented with 12-HpETE. CDC potently inhibited HXS and 12-LOX activity in vitro (relative IC(50)s: CDC, similar to 0.5 and 0.8 mu M, respectively) and carrageenan-evoked tactile allodynia in vivo. Notably, peripheral inflammation significantly increased spinal eLOX3; intrathecal pretreatment with either siRNA targeting Aloxe3 or an eLOX3-selective antibody attenuated the associated allodynia. These findings implicate spinal eLOX3-mediated hepoxilin synthesis in inflammatory hyperesthesia and underscore the importance of developing more selective 12-LOX/HXS inhibitors.-Gregus, A. M., Dumlao, D. S., Wei, S. C., Norris, P. C., Catella, L. C., Meyerstein, F. G., Buczynski, M. W., Steinauer, J. J., Fitzsimmons, B. L., Yaksh, T. L., Dennis, E. A. Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia. FASEB J. 27, 1939-1949 (2013). www.fasebj.org	[Gregus, Ann M.; Catella, Laura C.; Meyerstein, Flore G.; Steinauer, Joanne J.; Fitzsimmons, Bethany L.; Yaksh, Tony L.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Dumlao, Darren S.; Norris, Paul C.; Buczynski, Matthew W.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dumlao, Darren S.; Wei, Spencer C.; Yaksh, Tony L.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Yaksh, TL (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tyaksh@ucsd.edu; edennis@ucsd.edu	Dennis, Edward A./M-5554-2019; Yaksh, Tony/D-4119-2009	Dennis, Edward A./0000-0003-3738-3140; Norris, Paul/0000-0003-2512-0829	U.S. National Institutes of Health [NS16541, DA02110, GM064611, GM069338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM064611, T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016541, R37NS016541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002110] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Dr. Jing Yang for sharing equipment and Drs. Xiao-Ying Hua, Camilla I. Svensson, and Qinghao Xu for helpful discussions. This work was supported by U.S. National Institutes of Health grants NS16541 and DA02110 (T.L.Y.) and GM064611 and GM069338 (E.A.D.).	Aley KO, 2003, EXP BRAIN RES, V148, P482, DOI 10.1007/s00221-002-1323-2; ASHIDA Y, 1983, PROSTAGLANDINS, V26, P955, DOI 10.1016/0090-6980(83)90157-0; BENDANI MK, 1995, NEUROSCI LETT, V189, P159, DOI 10.1016/0304-3940(95)11482-C; Buczynski MW, 2010, J NEUROCHEM, V114, P981, DOI 10.1111/j.1471-4159.2010.06815.x; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Burger F, 2000, BIOCHEM J, V348, P329, DOI 10.1042/bj3480329; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEN XS, 1994, J BIOL CHEM, V269, P13979; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Christianson CA, 2010, PAIN, V151, P394, DOI 10.1016/j.pain.2010.07.030; Cornicelli JA, 1999, CURR PHARM DESIGN, V5, P11; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Funk CD, 1996, J BIOL CHEM, V271, P23338, DOI 10.1074/jbc.271.38.23338; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Hallenborg P, 2010, MOL CELL BIOL, V30, P4077, DOI 10.1128/MCB.01806-08; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jacquot C, 2008, BIOCHEMISTRY-US, V47, P7295, DOI 10.1021/bi800308q; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kawajiri H, 2000, J HISTOCHEM CYTOCHEM, V48, P1411, DOI 10.1177/002215540004801011; Kenyon V, 2011, J MED CHEM, V54, P5485, DOI 10.1021/jm2005089; Krieg P, 1999, FEBS LETT, V446, P142, DOI 10.1016/S0014-5793(99)00196-9; Krieg P, 2001, GENOMICS, V73, P323, DOI 10.1006/geno.2001.6519; Krieg P, 2013, J INVEST DERMATOL, V133, P172, DOI 10.1038/jid.2012.250; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Malkmus SA, 2004, METH MOLEC MED, P109; McDonnell M, 2001, PROSTAG OTH LIPID M, V63, P93, DOI 10.1016/S0090-6980(00)00100-3; MITA H, 1986, ALLERGY, V41, P493, DOI 10.1111/j.1398-9995.1986.tb00334.x; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; Mrsny RJ, 2004, P NATL ACAD SCI USA, V101, P7421, DOI 10.1073/pnas.0400832101; Nair DG, 2009, PROSTAG OTH LIPID M, V90, P98, DOI 10.1016/j.prostaglandins.2009.09.006; Nigam S, 2004, J BIOL CHEM, V279, P29023, DOI 10.1074/jbc.M307576200; NIGAM S, 1990, BIOCHEM BIOPH RES CO, V171, P944, DOI 10.1016/0006-291X(90)90775-I; Obrosova IG, 2010, AM J PATHOL, V177, P1436, DOI 10.2353/ajpath.2010.100178; Pace-Asciak CR, 2009, BRIT J PHARMACOL, V158, P972, DOI 10.1111/j.1476-5381.2009.00168.x; Pergola C, 2011, J PHARMACOL EXP THER, V338, P205, DOI 10.1124/jpet.111.180794; Rai G, 2010, J MED CHEM, V53, P7392, DOI 10.1021/jm1008852; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; SEKIYA K, 1982, BIOCHEM BIOPH RES CO, V105, P1090, DOI 10.1016/0006-291X(82)91081-6; Shen YC, 2003, EUR J PHARMACOL, V465, P171, DOI 10.1016/S0014-2999(03)01378-5; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; Sun D, 1998, CYTOGENET CELL GENET, V81, P79, DOI 10.1159/000014993; Sun DX, 1998, J BIOL CHEM, V273, P33540, DOI 10.1074/jbc.273.50.33540; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Trang T, 2004, EUR J PHARMACOL, V491, P21, DOI 10.1016/j.ejphar.2004.03.022; Wang H, 2004, EUR J NEUROSCI, V20, P2049, DOI 10.1111/j.1460-9568.2004.03650.x; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Wu MY, 2012, J CELL BIOCHEM, V113, P2279, DOI 10.1002/jcb.24098; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yoo S, 2009, MOL CELLS, V27, P417, DOI 10.1007/s10059-009-0059-2; Yu ZY, 2006, ARCH BIOCHEM BIOPHYS, V455, P188, DOI 10.1016/j.abb.2006.09.002; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100	60	30	37	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1939	1949		10.1096/fj.12-217414	http://dx.doi.org/10.1096/fj.12-217414			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23382512	Green Submitted, Green Published			2022-12-25	WOS:000318226100014
J	Han, WJ; Gu, JY; Liu, HH; Li, FC; Wu, ZH; Li, YZ				Han, Wen-Jun; Gu, Jing-Yan; Liu, Hui-Hui; Li, Fu-Chuan; Wu, Zhi-Hong; Li, Yue-Zhong			An Extra Peptide within the Catalytic Module of a beta-Agarase Affects the Agarose Degradation Pattern	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINE BACTERIUM; ZOBELLIA-GALACTANIVORANS; PSEUDOMONAS-ATLANTICA; FLAMMEOVIRGA-APRICA; ALPHA-AGARASE; COMB-NOV; PURIFICATION; CLONING; AGAB; EXPRESSION	Agarase hydrolyzes agarose into a series of oligosaccharides with repeating disaccharide units. The glycoside hydrolase (GH) module of agarase is known to be responsible for its catalytic activity. However, variations in the composition of the GH module and its effects on enzymatic functions have been minimally elucidated. The agaG4 gene, cloned from the genome of the agarolytic Flammeovirga strain MY04, encodes a 503-amino acid protein, AgaG4. Compared with elucidated agarases, AgaG4 contains an extra peptide (Asn(246)-Gly(302)) within its GH module. Heterologously expressed AgaG4 (recombinant AgaG4; rAgaG4) was determined to be an endo-type beta-agarase. The protein degraded agarose into neoagarotetraose and neoagarohexaose at a final molar ratio of 1.5:1. Neoagarooctaose was the smallest substrate for rAgaG4, whereas neoagarotetraose was the minimal degradation product. Removing the extra fragment from the GH module led to the inability of the mutant (rAgaG4-T57) to degrade neoagarooctaose, and the final degradation products of agarose by the truncated protein were neoagarotetraose, neoagarohexaose, and neoagarooctaose at a final molar ratio of 2.7:2.8:1. The optimal temperature for agarose degradation also decreased to 40 degrees C for this mutant. Bioinformatic analysis suggested that tyrosine 276 within the extra fragment was a candidate active site residue for the enzymatic activity. Site-swapping experiments of Tyr(276) to 19 various other amino acids demonstrated that the characteristics of this residue were crucial for the AgaG4 degradation of agarose and the cleavage pattern of substrate.	[Han, Wen-Jun; Gu, Jing-Yan; Liu, Hui-Hui; Wu, Zhi-Hong; Li, Yue-Zhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Han, Wen-Jun; Li, Fu-Chuan] Shandong Univ, Sch Life Sci, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Li, YZ (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, 27 S Shanda Rd, Jinan 250100, Peoples R China.	lilab@sdu.edu.cn	wu, zhi/GXH-3041-2022; Han, Wenjun/N-7214-2014; Han, Wen Jun/A-4859-2013; Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638	National Natural Science Foundation of China [30825001, 31130004, 30870001]; Independent Innovation Foundation of Shandong University Grant [2012GN014]; State Key Laboratory of Microbial Technology Grant [M2010-12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University Grant; State Key Laboratory of Microbial Technology Grant	This work was financially supported by National Natural Science Foundation of China Grants 30825001, 31130004, and 30870001; Independent Innovation Foundation of Shandong University Grant 2012GN014; and State Key Laboratory of Microbial Technology Grant M2010-12.	Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; Dong JH, 2006, APPL ENVIRON MICROB, V72, P6399, DOI 10.1128/AEM.00935-06; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; Fu XT, 2010, MAR DRUGS, V8, P200, DOI 10.3390/md8010200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han WJ, 2012, J OCEAN U CHINA, V11, P375, DOI 10.1007/s11802-012-1929-3; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2010, ACTA CRYSTALLOGR F, V66, P413, DOI 10.1107/S174430911000429X; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hosoya S, 2007, INT J SYST EVOL MICR, V57, P1327, DOI 10.1099/ijs.0.64977-0; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Jang MK, 2010, BIOTECHNOL LETT, V32, P943, DOI 10.1007/s10529-010-0237-5; Lee S, 2011, J MICROBIOL BIOTECHN, V21, P1116, DOI 10.4014/jmb.1107.07001; Ma CP, 2007, J BIOL CHEM, V282, P3747, DOI 10.1074/jbc.M607888200; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Michel G, 2009, GLYCOBIOLOGY, V19, P615, DOI 10.1093/glycob/cwp028; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MORRICE LM, 1983, EUR J BIOCHEM, V137, P149, DOI 10.1111/j.1432-1033.1983.tb07808.x; MORRICE LM, 1983, EUR J BIOCHEM, V135, P553, DOI 10.1111/j.1432-1033.1983.tb07688.x; Nakagawa Y, 1997, INT J SYST BACTERIOL, V47, P220, DOI 10.1099/00207713-47-1-220; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Ohta Y, 2005, CURR MICROBIOL, V50, P212, DOI 10.1007/s00284-004-4435-z; POTIN P, 1993, EUR J BIOCHEM, V214, P599, DOI 10.1111/j.1432-1033.1993.tb17959.x; Rees D A, 1969, Adv Carbohydr Chem Biochem, V24, P267; Ren AM, 2010, ACTA CRYSTALLOGR F, V66, P1635, DOI 10.1107/S174430911004114X; ROCHAS C, 1994, CARBOHYD RES, V253, P69, DOI 10.1016/0008-6215(94)80056-1; ROCHAS C, 1986, CARBOHYD RES, V148, P199, DOI 10.1016/S0008-6215(00)90388-4; Sambrook J, 2001, MOL CLONING LAB MANU; Shi C, 2008, APPL BIOCHEM BIOTECH, V151, P51, DOI 10.1007/s12010-008-8169-4; Suzuki H, 2002, J BIOSCI BIOENG, V93, P456, DOI 10.1263/jbb.93.456; Takahashi M, 2006, INT J SYST EVOL MICR, V56, P2095, DOI 10.1099/ijs.0.64324-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang SY, 2012, APPL MICROBIOL BIOT, V93, P1503, DOI 10.1007/s00253-011-3480-3; Xu H, 2012, INT J SYST EVOL MICR, V62, P937, DOI 10.1099/ijs.0.030676-0; Yang JL, 2011, J BIOSCI BIOENG, V112, P225, DOI 10.1016/j.jbiosc.2011.05.016; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001	41	18	22	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9519	9531		10.1074/jbc.M112.412247	http://dx.doi.org/10.1074/jbc.M112.412247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23378534	Green Published, hybrid			2022-12-25	WOS:000316862200067
J	Aguirre, JD; Clark, HM; McIlvin, M; Vazquez, C; Palmere, SL; Grab, DJ; Seshu, J; Hart, PJ; Saito, M; Culotta, VC				Aguirre, J. Dafhne; Clark, Hillary M.; McIlvin, Matthew; Vazquez, Christine; Palmere, Shaina L.; Grab, Dennis J.; Seshu, J.; Hart, P. John; Saito, Mak; Culotta, Valeria C.			A Manganese-rich Environment Supports Superoxide Dismutase Activity in a Lyme Disease Pathogen, Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LEUCINE AMINOPEPTIDASE; NEISSERIA-GONORRHOEAE; STAPHYLOCOCCUS-AUREUS; OXIDATIVE STRESS; BINDING PROTEIN; IRON; RESISTANCE; TRANSPORTER; SPECIFICITY	The Lyme disease pathogen Borrelia burgdorferi represents a novel organism in which to study metalloprotein biology in that this spirochete has uniquely evolved with no requirement for iron. Not only is iron low, but we show here that B. burgdorferi has the capacity to accumulate remarkably high levels of manganese. This high manganese is necessary to activate the SodA superoxide dismutase (SOD) essential for virulence. Using a metalloproteomic approach, we demonstrate that a bulk of B. burgdorferi SodA directly associates with manganese, and a smaller pool of inactive enzyme accumulates as apoprotein. Other metalloproteins may have similarly adapted to using manganese as co-factor, including the BB0366 aminopeptidase. Whereas B. burgdorferi SodA has evolved in a manganese-rich, iron-poor environment, the opposite is true for Mn-SODs of organisms such as Escherichia coli and bakers' yeast. These Mn-SODs still capture manganese in an iron-rich cell, and we tested whether the same is true for Borrelia SodA. When expressed in the iron-rich mitochondria of Saccharomyces cerevisiae, B. burgdorferi SodA was inactive. Activity was only possible when cells accumulated extremely high levels of manganese that exceeded cellular iron. Moreover, there was no evidence for iron inactivation of the SOD. B. burgdorferi SodA shows strong overall homology with other members of the Mn-SOD family, but computer-assisted modeling revealed some unusual features of the hydrogen bonding network near the enzyme's active site. The unique properties of B. burgdorferi SodA may represent adaptation to expression in the manganese-rich and iron-poor environment of the spirochete.	[Aguirre, J. Dafhne; Clark, Hillary M.; Vazquez, Christine; Palmere, Shaina L.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [McIlvin, Matthew; Saito, Mak] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Grab, Dennis J.] Johns Hopkins Univ, Sch Med, Div Med Microbiol, Dept Pathol, Baltimore, MD 21205 USA; [Seshu, J.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Woods Hole Oceanographic Institution; Johns Hopkins University; University of Texas System; University of Texas at San Antonio (UTSA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Saito, Mak/ADT-4986-2022; McIlvin, Matthew/ABB-4762-2020	Vazquez, Christine/0000-0001-7647-1966; Aguirre, J. Dafhne/0000-0001-7056-9719; Saito, Mak/0000-0001-6040-9295	National Institutes of Health [R01 ES08996, GM50016, SC1 AI078559, T32 GM080189]; Johns Hopkins University NIEHS, National Institutes of Health, center; Robert A. Welch Foundation [AQ-1399]; Veterans Affairs Department Grant, South Texas Veterans Health Care System [I01BX000506]; Gordon and Betty Moore Foundation Marine Microbiology Program; National Science Foundation Chemical Oceanography Grant [OCE-1031271]; Division Of Ocean Sciences [1260233] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI078559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, R01ES008996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, R01GM050016, R37GM050016] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University NIEHS, National Institutes of Health, center; Robert A. Welch Foundation(The Welch Foundation); Veterans Affairs Department Grant, South Texas Veterans Health Care System; Gordon and Betty Moore Foundation Marine Microbiology Program; National Science Foundation Chemical Oceanography Grant(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES08996 and GM50016 (to V. C. C.) and SC1 AI078559 (to J. S.). This work was also supported in part by the Johns Hopkins University NIEHS, National Institutes of Health, center, by Robert A. Welch Foundation Grant AQ-1399, and in part by Veterans Affairs Department Grant I01BX000506, South Texas Veterans Health Care System (to P. J. H.). Metalloproteomic studies were funded by the Gordon and Betty Moore Foundation Marine Microbiology Program and National Science Foundation Chemical Oceanography Grant OCE-1031271 (to M. A. S.).; Supported by National Institutes of Health Grant T32 GM080189.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; BEYER WF, 1991, J BIOL CHEM, V266, P303; Cassat JE, 2012, SEMIN IMMUNOPATHOL, V34, P215, DOI 10.1007/s00281-011-0294-4; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gleason JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024741; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Guan Y, 1998, BIOCHEMISTRY-US, V37, P4722, DOI 10.1021/bi972394l; HAFKENSCHEID JCM, 1985, J CLIN CHEM CLIN BIO, V23, P393; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Iranzo O, 2011, BIOORG CHEM, V39, P73, DOI 10.1016/j.bioorg.2011.02.001; Jackson TA, 2004, ACCOUNTS CHEM RES, V37, P461, DOI 10.1021/ar030272h; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kale A, 2010, J MOL BIOL, V398, P703, DOI 10.1016/j.jmb.2010.03.042; Kang Y, 2011, ACTA CRYSTALLOGR F, V67, P1173, DOI 10.1107/S1744309111029186; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Lancaster WA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-64; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Perry JJP, 2009, BIOCHEMISTRY-US, V48, P3417, DOI 10.1021/bi8023288; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; PRIVALLE CT, 1992, J BIOL CHEM, V267, P9140; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Robinson N., 2008, PROTOC EXCH, DOI [10.1038/nprot.2008.236, DOI 10.1038/NPROT.2008.236]; Rosenfeld L, 2012, BIOCHEM BIOPH RES CO, V418, P414, DOI 10.1016/j.bbrc.2012.01.047; Rosenfeld L, 2010, J BIOL INORG CHEM, V15, P1051, DOI 10.1007/s00775-010-0664-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Sheng YW, 2012, P NATL ACAD SCI USA, V109, P14314, DOI 10.1073/pnas.1212367109; SIKORSKI RS, 1989, GENETICS, V122, P19; Sule N, 2012, J INORG BIOCHEM, V106, P84, DOI 10.1016/j.jinorgbio.2011.09.020; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Troxell B, 2012, J BIOL CHEM, V287, P19284, DOI 10.1074/jbc.M112.344903; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; Wang P, 2012, MOL MICROBIOL, V86, P1441, DOI 10.1111/mmi.12068; Whitehouse CA, 1997, INFECT IMMUN, V65, P4865, DOI 10.1128/IAI.65.11.4865-4868.1997; Whittaker MM, 2012, ARCH BIOCHEM BIOPHYS, V523, P191, DOI 10.1016/j.abb.2012.04.016; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Yamakura F, 2007, FREE RADICAL BIO MED, V43, P423, DOI 10.1016/j.freeradbiomed.2007.04.024; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Yannone SM, 2012, CURR OPIN BIOTECH, V23, P89, DOI 10.1016/j.copbio.2011.11.005	57	57	59	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8468	8478		10.1074/jbc.M112.433540	http://dx.doi.org/10.1074/jbc.M112.433540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23376276	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000316564500044
J	Thornton, PDJ; Gwynne, RM; McMillan, DJ; Bornstein, JC				Thornton, Peter D. J.; Gwynne, Rachel M.; McMillan, Darren J.; Bornstein, Joel C.			Transmission to Interneurons Is via Slow Excitatory Synaptic Potentials Mediated by P2Y(1) Receptors during Descending Inhibition in Guinea-Pig Ileum	PLOS ONE			English	Article							NEURO-NEURONAL TRANSMISSION; MYENTERIC NEURONS; POSTSYNAPTIC POTENTIALS; MOTOR-NEURONS; NEUROMUSCULAR-TRANSMISSION; MUCOSAL STIMULATION; MOTILITY REFLEXES; ATP; PERISTALSIS; DISTENSION	Background: The nature of synaptic transmission at functionally distinct synapses in intestinal reflex pathways has not been fully identified. In this study, we investigated whether transmission between interneurons in the descending inhibitory pathway is mediated by a purine acting at P2Y receptors to produce slow excitatory synaptic potentials (EPSPs). Methodology/Principal findings: Myenteric neurons from guinea-pig ileum in vitro were impaled with intracellular microelectrodes. Responses to distension 15 mm oral to the recording site, in a separately perfused stimulation chamber and to electrical stimulation of local nerve trunks were recorded. A subset of neurons, previously identified as nitric oxide synthase immunoreactive descending interneurons, responded to both stimuli with slow EPSPs that were reversibly abolished by a high concentration of PPADS (30 mu M, P2 receptor antagonist). When added to the central chamber of a three chambered organ bath, PPADS concentration-dependently depressed transmission through that chamber of descending inhibitory reflexes, measured as inhibitory junction potentials in the circular muscle of the anal chamber. Reflexes evoked by distension in the central chamber were unaffected. A similar depression of transmission was seen when the specific P2Y(1) receptor antagonist MRS 2179 (10 mu M) was in the central chamber. Blocking either nicotinic receptors (hexamethonium 200 mM) or 5-HT3 receptors (granisetron 1 mu M) together with P2 receptors had no greater effect than blocking P2 receptors alone. Conclusions/Significance: Slow EPSPs mediated by P2Y(1) receptors, play a primary role in transmission between descending interneurons of the inhibitory reflexes in the guinea-pig ileum. This is the first demonstration for a primary role of excitatory metabotropic receptors in physiological transmission at a functionally identified synapse.	[Thornton, Peter D. J.; Gwynne, Rachel M.; McMillan, Darren J.; Bornstein, Joel C.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia	University of Melbourne	Bornstein, JC (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia.	j.bornstein@unimelb.edu.au	Bornstein, Joel/I-3322-2019; Gwynne, Rachel/A-6039-2019	Bornstein, Joel/0000-0002-7518-7717; Gwynne, Rachel/0000-0002-3545-2045	National Health and Medical Research Project [566642]	National Health and Medical Research Project	This work was supported by National Health and Medical Research Project grants (566642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex G, 2002, NEUROSCIENCE, V110, P361, DOI 10.1016/S0306-4522(01)00583-8; Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Aoyama T, 2010, BRAIN RES, V1340, P10, DOI 10.1016/j.brainres.2010.04.053; Bayliss W M, 1899, J Physiol, V24, P99; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bian XC, 2000, J PHYSIOL-LONDON, V528, P551, DOI 10.1111/j.1469-7793.2000.00551.x; BORNSTEIN JC, 1986, J PHYSIOL-LONDON, V370, P61, DOI 10.1113/jphysiol.1986.sp015922; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; BROOKES SJH, 1991, NEUROSCIENCE, V42, P863, DOI 10.1016/0306-4522(91)90050-X; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Foong JPP, 2009, FRONT NEUROSCI, DOI [10.3389/neuro.3321.3001.2009, DOI 10.3389/NEURO.3321.3001.2009]; Furness J.B., 2006, ENTERIC NERVOUS SYST; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P159, DOI 10.1111/j.1365-2982.2007.01004.x; Gallego D, 2008, AM J PHYSIOL-GASTR L, V295, pG522, DOI 10.1152/ajpgi.00510.2007; Gallego D, 2006, AM J PHYSIOL-GASTR L, V291, pG584, DOI 10.1152/ajpgi.00474.2005; Grider JR, 1998, GASTROENTEROLOGY, V115, P370, DOI 10.1016/S0016-5085(98)70203-3; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1660, DOI 10.1152/ajpgi.00580.2006; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1162, DOI 10.1152/ajpgi.00441.2006; Gwynne RM, 2007, CURR NEUROPHARMACOL, V5, P1, DOI 10.2174/157015907780077141; Gwynne RM, 2009, AM J PHYSIOL-GASTR L, V297, pG179, DOI 10.1152/ajpgi.90700.2008; Hu HZ, 2003, J PHYSIOL-LONDON, V550, P493, DOI 10.1113/jphysiol.2003.041731; Hwang SJ, 2011, GASTROENTEROLOGY, V140, P608, DOI 10.1053/j.gastro.2010.09.039; Johnson PJ, 2004, NEUROSCIENCE, V126, P137, DOI 10.1016/j.neuroscience.2004.03.021; Johnson PJ, 1998, BRIT J PHARMACOL, V124, P1375, DOI 10.1038/sj.bjp.0701967; Johnson PJ, 1996, BRIT J PHARMACOL, V118, P973, DOI 10.1111/j.1476-5381.1996.tb15495.x; Johnson PJ, 1999, NEUROSCI LETT, V266, P169, DOI 10.1016/S0304-3940(99)00275-X; Katayama Y, 1989, J PHYSL, V408, P1; Kunze WAA, 1998, J PHYSIOL-LONDON, V506, P827, DOI 10.1111/j.1469-7793.1998.827bv.x; LePard KJ, 1997, GASTROENTEROLOGY, V113, P1522, DOI 10.1053/gast.1997.v113.pm9352854; Monro RL, 2005, NEUROSCIENCE, V134, P975, DOI 10.1016/j.neuroscience.2005.05.006; Monro RL, 2004, J PHYSIOL-LONDON, V556, P571, DOI 10.1113/jphysiol.2004.060848; Monro RL, 2002, NEUROGASTROENT MOTIL, V14, P255, DOI 10.1046/j.1365-2982.2002.00325.x; Mutafova-Yambolieva VN, 2007, P NATL ACAD SCI USA, V104, P16359, DOI 10.1073/pnas.0705510104; Neunlist M, 1999, J PHYSIOL-LONDON, V517, P533, DOI 10.1111/j.1469-7793.1999.0533t.x; Pin JP, 1998, NATURE, V394, P19, DOI 10.1038/27771; Ralevic V, 1998, PHARMACOL REV, V50, P413; Riedel G, 1996, PROG NEURO-PSYCHOPH, V20, P761, DOI 10.1016/0278-5846(96)00058-9; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; SMITH TK, 1991, J AUTONOM NERV SYST, V34, P69, DOI 10.1016/0165-1838(91)90009-R; Spencer N, 1999, J PHYSIOL-LONDON, V517, P889, DOI 10.1111/j.1469-7793.1999.0889s.x; Spencer NJ, 2000, J PHYSIOL-LONDON, V522, P321, DOI 10.1111/j.1469-7793.2000.t01-1-00321.x; Spencer NJ, 2001, J PHYSIOL-LONDON, V530, P295, DOI 10.1111/j.1469-7793.2001.0295l.x; Thornton PDJ, 2002, J PHYSIOL-LONDON, V539, P589, DOI 10.1113/jphysiol.2001.013399; Tonini M, 2005, GASTROENTEROLOGY, V129, P1557, DOI 10.1053/j.gastro.2005.08.005	44	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e40840	10.1371/journal.pone.0040840	http://dx.doi.org/10.1371/journal.pone.0040840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23382795	gold, Green Published			2022-12-25	WOS:000315157200001
J	Chua, GL; Patra, AT; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit			NMR Structure of Integrin alpha 4 Cytosolic Tail and Its Interactions with Paxillin	PLOS ONE			English	Article							CYTOPLASMIC DOMAIN; ADHESION; BINDING; ACTIVATION; REGION; VLA-4; SITE; PHOSPHORYLATION; RECOGNITION; ASSOCIATION	Background: Integrins are a group of transmembrane signaling proteins that are important in biological processes such as cell adhesion, proliferation and migration. Integrins are alpha/beta hetero-dimers and there are 24 different integrins formed by specific combinations of 18 alpha and 8 beta subunits in humans. Generally, each of these subunits has a large extracellular domain, a single pass transmembrane segment and a cytosolic tail (CT). CTs of integrins are important in bidirectional signal transduction and they associate with a large number of intracellular proteins. Principal Findings: Using NMR spectroscopy, we determined the 3-D structure of the full-length alpha 4 CT (Lys968-Asp999) and characterize its interactions with the adaptor protein paxillin. The alpha 4 CT assumes an overall helical structure with a kink in its membrane proximal region. Residues Gln981-Asn997 formed a continuous helical conformation that may be sustained by potential ionic and/or hydrogen bond interactions and packing of aromatic-aliphatic side-chains. N-15-H-1 HSQC NMR experiments reveal interactions of the alpha 4 CT C-terminal region with a fragment of paxillin (residues G139-K277) that encompassed LD2-LD4 repeats. Residues of these LD repeats including their adjoining linkers showed alpha 4 CT binding-induced chemical shift changes. Furthermore, NMR studies using LD-containing peptides showed predominant interactions between LD3 and LD4 of paxillin and alpha 4 CT. Docked structures of the alpha 4 CT with these LD repeats suggest possible polar and/or salt-bridge and non-polar packing interactions. Significance: The current study provides molecular insights into the structural diversity of alpha CTs of integrins and interactions of integrin alpha 4 CT with the adaptor protein paxillin.	[Chua, Geok-Lin; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	PATRA, ALOK/HCH-9797-2022; Tan, Suet/A-2224-2011	PATRA, ALOK/0000-0001-6983-911X; Tan, Suet-Mien/0000-0003-2371-8739	Ministry of Education (MOE) Singapore [ARC4/11, RG34/08]	Ministry of Education (MOE) Singapore(Ministry of Education, Singapore)	This work was supported by the Ministry of Education (MOE) Singapore to SB (ARC4/11) and to SMT (RG34/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Boettiger D, 2012, CURRENT OPINION CELL; Briskin M, 1997, AM J PATHOL, V151, P97; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Chua GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041924; Chua GL, 2011, J BIOL CHEM, V286, P43842, DOI 10.1074/jbc.M111.280164; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; Kummer C, 2010, J BIOL CHEM, V285, P9462, DOI 10.1074/jbc.M109.066993; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2002, J BIOL CHEM, V277, P20887, DOI 10.1074/jbc.M110928200; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; May AE, 2000, BLOOD, V96, P506; MOULD AP, 1991, J BIOL CHEM, V266, P3579; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Rose DM, 2006, EXP MOL MED, V38, P191, DOI 10.1038/emm.2006.23; Sandborn WJ, 2003, AM J GASTROENTEROL, V98, P2372, DOI 10.1016/j.amjgastroenterol.2003.08.009; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; YANG JT, 1995, DEVELOPMENT, V121, P549; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	49	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55184	10.1371/journal.pone.0055184	http://dx.doi.org/10.1371/journal.pone.0055184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383101	Green Published, gold			2022-12-25	WOS:000314610600073
J	Tsao, N; Cheng, MH; Yang, HC; Wang, YC; Liu, YL; Kuo, CF				Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh; Liu, Yi-Ling; Kuo, Chih-Feng			Determining Antibody-Binding Site of Streptococcal Pyrogenic Exotoxin B to Protect Mice from Group A Streptococcus Infection	PLOS ONE			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; MEDIATED OPSONOPHAGOCYTOSIS; IMMUNOGLOBULIN-G; RHEUMATIC-FEVER; GLOBAL BURDEN; PYOGENES; SPEB; PROTEINASE; ACTIVATION; CLEAVAGE	Streptococcal pyrogenic exotoxin B (SPE B), a cysteine protease, is an important virulence factor in group A streptococcal (GAS) infection. SPE B binds and cleaves antibody isotypes and further impairs the immune system by inhibiting complement activation. In this study, we examined the antibody-binding site of SPE B and used it to block SPE B actions during GAS infection. We constructed different segments of the spe B gene and induced them to express different recombinant fragments of SPE B. Using an enzyme-linked immunosorbent assay (ELISA), we found that residues 345-398 of the C-terminal domain of SPE B (rSPE B345-398), but not the N-terminal domain, was the major binding site for antibody isotypes. Using a competitive ELISA, we also found that rSPE B345-398 bound to the Fc portion of IgG. The in vitro functional assays indicate that rSPE B345-398 not only interfered with cleavage of antibody isotypes but also interfered with SPE B-induced inhibition of complement activation. Immunization of BALB/c mice using rSPE B345-398 was able to induce production of a high titer of anti-rSPE B345-398 antibodies and efficiently protected mice from GAS-induced death. These findings suggest that SPE B uses its C-terminal domain to bind the Fc portion of IgG and that immunization of mice with this binding domain (rSPE B345-398) could protect mice from GAS infection.	[Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Liu, Yi-Ling; Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan	I Shou University; I Shou University	Kuo, CF (corresponding author), I Shou Univ, Dept Nursing, Kaohsiung, Taiwan.	kuo@isu.edu.tw			I-Shou University [ISU101-04-02]; National Science Council, Taiwan [NSC97-2320-B214-001-MY3, NSC100-2320-B-214-007, NSC101-2320-B-214-004]	I-Shou University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants ISU101-04-02 from I-Shou University and NSC97-2320-B214-001-MY3, NSC100-2320-B-214-007 as well as NSC101-2320-B-214-004 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Chiang-Ni C, 2006, MED MICROBIOL IMMUN, V195, P55, DOI 10.1007/s00430-005-0001-y; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Eriksson BKG, 1999, J INFECT DIS, V180, P410, DOI 10.1086/314872; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; Jackson SJ, 2011, TROP MED INT HEALTH, V16, P2, DOI 10.1111/j.1365-3156.2010.02670.x; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Luo YH, 2010, LAB INVEST, V90, P1492, DOI 10.1038/labinvest.2010.93; Matsuka YV, 1999, INFECT IMMUN, V67, P4326, DOI 10.1128/IAI.67.9.4326-4333.1999; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nilsson M, 2005, EUR J IMMUNOL, V35, P1472, DOI 10.1002/eji.200424850; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Uchiyama S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002736; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; WOLF BB, 1994, J BIOL CHEM, V269, P30682	39	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55028	10.1371/journal.pone.0055028	http://dx.doi.org/10.1371/journal.pone.0055028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383045	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600058
J	Fraser, B; DuVal, MG; Wang, H; Allison, WT				Fraser, Brittany; DuVal, Michele G.; Wang, Hao; Allison, W. Ted			Regeneration of Cone Photoreceptors when Cell Ablation Is Primarily Restricted to a Particular Cone Subtype	PLOS ONE			English	Article							RETINAL STEM-CELLS; TROUT ONCORHYNCHUS-MYKISS; OPSIN GENE-EXPRESSION; ZEBRAFISH RETINA; RAINBOW-TROUT; MULLER GLIA; PATTERN-FORMATION; NEURONAL PROGENITORS; REARRANGEMENT MODEL; ROD PHOTORECEPTORS	We sought to characterize the regenerated cells, if any, when photoreceptor ablation was mostly limited to a particular cone subtype. This allowed us to uniquely assess whether the remaining cells influence specification of regenerating photoreceptors. The ability to replace lost photoreceptors via stem cell therapy holds promise for treating many retinal degenerative diseases. Zebrafish are potent for modelling this because they have robust regenerative capacity emanating from endogenous stem cells, and abundant cone photoreceptors including multiple spectral subtypes similar to human fovea. We ablated the homolog of the human S-cones, the ultraviolet-sensitive (UV) cones, and tested the hypothesis that the photoreceptors regenerating in their place take on identities matching those expected from normal cone mosaic development. We created transgenic fish wherein UV cones can be ablated by addition of a prodrug. Thus photoreceptors developed normally and only the UV cones expressed nitroreductase; the latter converts the prodrug metronidazole to a cell-autonomous neurotoxin. A significant increase in proliferation of progenitor cell populations (p<0.01) was observed when cell ablation was primarily limited to UV cones. In control fish, we found that BrdU primarily incorporated into rod photoreceptors, as expected. However the majority of regenerating photoreceptors became cones when retinal cell ablation was predominantly restricted to UV cones: a 2-fold increase in the relative abundance of cones (p = 0.008) was mirrored by a 35% decrease in rods. By primarily ablating only a single photoreceptor type, we show that the subsequent regeneration is biased towards restoring the cognate photoreceptor type. We discuss the hypothesis that, after cone death, the microenvironment formed by the remaining retinal cells may be influential in determining the identity of regenerating photoreceptors, though other interpretations are plausible. Our novel animal model provides control of ablation that will assist in identifying mechanisms required to replace cone photoreceptors clinically to restore daytime vision.	[Fraser, Brittany; DuVal, Michele G.; Wang, Hao; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Ctr Pr & Prot Folding Dis, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014; Allison, W. Ted/K-5228-2012	Allison, W. Ted/0000-0002-8461-4864; DuVal, Michele/0000-0001-6975-8117	NSERC; CIHR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	NSERC (www.nserc-crsng.gc.ca) Discovery Grant to WTA, and Studentships from NSERC and CIHR (www.cihr-irsc.gc.ca) to BF and MGD, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake CM, 2011, DEV BIOL, V352, P191, DOI 10.1016/j.ydbio.2011.01.002; Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Allison WT, 2006, MOL VIS, V12, P655; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2006, VISUAL NEUROSCI, V23, P25, DOI 10.1017/S0952523806231031; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Allison WT, 2004, THESIS U VICTORIA VI; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Ariga Junko, 2010, J Vis Exp, DOI 10.3791/2093; BEAUDET L, 1993, VISION RES, V33, P1739, DOI 10.1016/0042-6989(93)90164-R; Beaudet L., 1999, P413; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bernardos RL, 2004, J COMP NEUR IN PRESS; Bernardos RL, 2005, INVEST OPHTHALMOL, V46, P5327; Bhatia B, 2011, EXP EYE RES, V93, P852, DOI 10.1016/j.exer.2011.09.015; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; CAMERON DA, 1995, J NEUROSCI, V15, P2255, DOI 10.1523/JNEUROSCI.15-03-02255.1995; Cameron DA, 2000, J COMP NEUROL, V416, P356; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; DuVal MG, 2012, MOL VISION IN PRESS; Easter SS, 2000, NEUROSCIENTIST, V6, P454, DOI 10.1177/107385840000600608; EASTER SS, 1992, J NEUROSCI, V12, P2381; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P201, DOI 10.1093/jac/31.2.201; Eglen SJ, 2000, NETWORK-COMP NEURAL, V11, P103, DOI 10.1088/0954-898X/11/1/306; Eglen SJ, 2002, DEVELOPMENT, V129, P5399, DOI 10.1242/dev.00118; Eglen SJ, 2008, VISUAL NEUROSCI, V25, P209, DOI 10.1017/S0952523808080176; Eglen SJ, 2006, RETINAL DEVELOPMENT, P193, DOI 10.1017/CBO9780511541629.012; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; FERNALD RD, 1990, J EXP ZOOL, P167; Flamarique IN, 1996, J EXP BIOL, V199, P869; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Giannelli SG, 2011, STEM CELLS, V29, P344, DOI 10.1002/stem.579; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Inoue T, 2010, STEM CELLS, V28, P489, DOI 10.1002/stem.279; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; Jomary C, 2008, INVEST OPHTH VIS SCI, V49, P429, DOI 10.1167/iovs.07-0812; Jomary C, 2010, INVEST OPHTH VIS SCI, V51, P1181, DOI 10.1167/iovs.09-4385; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba DA, 2009, PROG BRAIN RES, V175, P23, DOI 10.1016/S0079-6123(09)17502-7; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; LYALL AH, 1957, Q J MICROSC SCI, V98, P101; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mochizuki A, 2002, J THEOR BIOL, V215, P345, DOI 10.1006/jtbi.2001.2508; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; RAYMOND PA, 1991, CIBA F SYMP, V160, P171; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1988, J NEUROBIOL, V19, P431, DOI 10.1002/neu.480190504; Raymond PA, 1991, CIBA F SYMP, V160, P186; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; REH TA, 1994, PERSPECT DEV NEUROBI, V2, P183; Rister J, 2011, DEV NEUROBIOL, V71, P1212, DOI 10.1002/dneu.20905; Stenkamp DL, 2002, MOL VIS, V8, P280; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Temple SE, 2008, J EXP BIOL, V211, P3879, DOI 10.1242/jeb.020289; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Togashi H, 2011, SCIENCE, V333, P1144, DOI 10.1126/science.1208467; Tohya S, 1999, J THEOR BIOL, V200, P231, DOI 10.1006/jtbi.1999.0990; Tohya S, 2003, J THEOR BIOL, V221, P289, DOI 10.1006/jtbi.2003.3192; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Veldhoen K, 2006, VISUAL NEUROSCI, V23, P169, DOI 10.1017/S0952523806232139; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; West EL, 2012, STEM CELLS; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhao XF, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-107	83	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55410	10.1371/journal.pone.0055410	http://dx.doi.org/10.1371/journal.pone.0055410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383182	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800151
J	He, S; Chen, XP				He, Sen; Chen, Xiaoping			Could the New Body Shape Index Predict the New Onset of Diabetes Mellitus in the Chinese Population?	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; RISK; TYPE-2; EPIDEMIOLOGY; ASSOCIATION; OBESITY; RATIO	Background: Anthropometric measures could predict the new onset of diabetes mellitus (DM). Recently, a new anthropometric measure (a body shape index, ABSI) was developed, and ABSI could predict premature mortality, even better than WC and BMI. The main aims of the study were to assess the DM predictive power of ABSI based on the follow-up data over 15 years collected from a general Chinese population. Methods and Findings: The data were collected in 1992 and then again in 2007 from the same group of 711 individuals. Because 24 of them were diagnosed with DM in 1992, our analysis was eventually based on the usable data collected from the remaining 687 individuals (male: 58.1%). ABSI was defined as WC/(BMI (2/3) height (1/2)), expressing WC and height in m. After adjusting for confounders, increasing the population ABSI by one standard deviation would result in an increased HR of 41% (95% CI: 12%-77%), compared to 73% (95% CI: 37%-118%) for BMI and 96% (95% CI: 53%-150%) for WC. WC had the best discriminatory power for DM (AROC: 0.701, 95% CI: 0.641-0.760), followed by BMI (AROC: 0.668, 95% CI: 0.601-0.734) and ABSI (AROC: 0.647, 95% CI: 0.581-0.713). Conclusions: ABSI could predict the new onset of DM in the Chinese population independently. Since the confidence intervals for the HR coefficients and AROCs overlapped, the predictive ability of ABSI for DM was not better than WC and BMI. The three measures had similar predictive abilities for DM. Further studies about ethnic specificities of ABSI are needed and warranted.	[He, Sen; Chen, Xiaoping] Sichuan Univ, West China Hosp, Dept Cardiovasc Med, Chengdu 610064, Peoples R China	Sichuan University	Chen, XP (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiovasc Med, Chengdu 610064, Peoples R China.	happensky@163.com			National Eighth Five-Year Research Plan, China [85-915-01-02]; Mega-projects of Science Research for the 11th Five-Year Plan, China [2006BAI01A01]	National Eighth Five-Year Research Plan, China; Mega-projects of Science Research for the 11th Five-Year Plan, China(National Key Technology R&D Program)	This study was supported by a project from the National Eighth Five-Year Research Plan, China (grant no: 85-915-01-02), and by Mega-projects of Science Research for the 11th Five-Year Plan, China (grant no: 2006BAI01A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berentzen TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023104; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Ren J, 2010, ATHEROSCLEROSIS, V211, P327, DOI 10.1016/j.atherosclerosis.2010.02.020; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	15	66	73	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e50573	10.1371/journal.pone.0050573	http://dx.doi.org/10.1371/journal.pone.0050573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382801	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800004
J	Kumala, S; Fujarewicz, K; Jayaraju, D; Rzeszowska-Wolny, J; Hancock, R				Kumala, Slawomir; Fujarewicz, Krzysztof; Jayaraju, Dheekollu; Rzeszowska-Wolny, Joanna; Hancock, Ronald			Repair of DNA Strand Breaks in a Minichromosome In Vivo: Kinetics, Modeling, and Effects of Inhibitors	PLOS ONE			English	Article							BASE EXCISION-REPAIR; FIELD GEL-ELECTROPHORESIS; DEPENDENT PROTEIN-KINASE; ADP-RIBOSE POLYMERASE-1; BARR-VIRUS GENOMES; TOPOISOMERASE-II; SINGLE-STRAND; POLY(ADP-RIBOSE) POLYMERASE-1; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS	To obtain an overall picture of the repair of DNA single and double strand breaks in a defined region of chromatin in vivo, we studied their repair in a similar to 170 kb circular minichromosome whose length and topology are analogous to those of the closed loops in genomic chromatin. The rate of repair of single strand breaks in cells irradiated with c photons was quantitated by determining the sensitivity of the minichromosome DNA to nuclease S1, and that of double strand breaks by assaying the reformation of supercoiled DNA using pulsed field electrophoresis. Reformation of supercoiled DNA, which requires that all single strand breaks have been repaired, was not slowed detectably by the inhibitors of poly(ADP-ribose) polymerase-1 NU1025 or 1,5-IQD. Repair of double strand breaks was slowed by 20-30% when homologous recombination was supressed by KU55933, caffeine, or siRNA-mediated depletion of Rad51 but was completely arrested by the inhibitors of nonhomologous end-joining wortmannin or NU7441, responses interpreted as reflecting competition between these repair pathways similar to that seen in genomic DNA. The reformation of supercoiled DNA was unaffected when topoisomerases I or II, whose participation in repair of strand breaks has been controversial, were inhibited by the catalytic inhibitors ICRF-193 or F11782. Modeling of the kinetics of repair provided rate constants and showed that repair of single strand breaks in minichromosome DNA proceeded independently of repair of double strand breaks. The simplicity of quantitating strand breaks in this minichromosome provides a usefull system for testing the efficiency of new inhibitors of their repair, and since the sequence and structural features of its DNA and its transcription pattern have been studied extensively it offers a good model for examining other aspects of DNA breakage and repair.	[Kumala, Slawomir; Jayaraju, Dheekollu; Hancock, Ronald] Univ Laval, Canc Res Ctr, Hotel Dieu Hosp, Quebec City, PQ, Canada; [Fujarewicz, Krzysztof] Silesian Tech Univ, Bioinformat Grp, Inst Automat Control, Gliwice, Poland; [Rzeszowska-Wolny, Joanna] Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland	Laval University; Silesian University of Technology; Silesian University of Technology	Hancock, R (corresponding author), Univ Laval, Canc Res Ctr, Hotel Dieu Hosp, Quebec City, PQ, Canada.	ronald.hancock@crhdq.ulaval.ca	Hancock, Ronald/F-8009-2016; Fujarewicz, Krzysztof/B-9667-2013	Fujarewicz, Krzysztof/0000-0002-1837-6466; Rzeszowska-Wolny, Joanna/0000-0002-5804-4757	Polish Ministry of Education and Science [N N518 4976 39]	Polish Ministry of Education and Science(Ministry of Science and Higher Education, Poland)	This work was supported partially by the Polish Ministry of Education and Science (Grant N N518 4976 39 to K.F. and J.R-W.).No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1987, J VIROL, V61, P1743, DOI 10.1128/JVI.61.5.1743-1746.1987; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; AHN SY, 1991, INT J RADIAT BIOL, V59, P661, DOI 10.1080/09553009114550591; ALAOUIJAMALI MA, 1992, RADIAT RES, V129, P37, DOI 10.2307/3577900; Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169; Aneja RK, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-3; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Banath JP, 1998, INT J RADIAT BIOL, V73, P649, DOI 10.1080/095530098141906; Bandstra JZ, 2005, J MATH CHEM, V37, P409, DOI 10.1007/s10910-004-1107-y; BENYAJATI C, 1976, CELL, V9, P393, DOI 10.1016/0092-8674(76)90084-2; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Bowman KJ, 1998, BRIT J CANCER, V78, P1269, DOI 10.1038/bjc.1998.670; Caldecott KW, 2009, DNA DAMAGE RESPONSE: IMPLICATIONS ON CANCER FORMATION AND TREATMENT, P261, DOI 10.1007/978-90-481-2561-6_12; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; Deutsch MJ, 2010, J VIROL, V84, P2533, DOI 10.1128/JVI.01909-09; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Etievant C, 2000, CANCER CHEMOTH PHARM, V46, P101, DOI 10.1007/s002800000133; Falk M, 2008, J PHYS CONF SER, V101, DOI 10.1088/1742-6596/101/1/012018; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Foray N, 1996, INT J RADIAT BIOL, V69, P241, DOI 10.1080/095530096146084; Foray N, 2005, J THEOR BIOL, V236, P448, DOI 10.1016/j.jtbi.2005.03.027; Fowler JF, 1999, RADIAT RES, V152, P124, DOI 10.2307/3580085; Fung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020514; Gaffney DK, 2000, RADIAT RES, V154, P461, DOI 10.1667/0033-7587(2000)154[0461:EOMTIL]2.0.CO;2; Gao HL, 2000, CANCER RES, V60, P5937; GEIGL EM, 1990, MOL MICROBIOL, V4, P801, DOI 10.1111/j.1365-2958.1990.tb00650.x; GIOCANTI N, 1993, CANCER RES, V53, P2105; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; GRIFFIN RJ, 1995, ANTI-CANCER DRUG DES, V10, P507; GUSSANDER E, 1984, J VIROL, V52, P549, DOI 10.1128/JVI.52.2.549-556.1984; Hancock R, 2012, GENOME ORGANIZATION AND FUNCTION IN THE CELL NUCLEUS, P169; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HSIANG YH, 1989, J BIOL CHEM, V264, P9713; ISHIDA R, 1991, CANCER RES, V51, P4909; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Jacob S, 2005, NUCLEIC ACIDS RES, V33, P106, DOI 10.1093/nar/gki154; Jensen LH, 2003, BIOCHEM PHARMACOL, V66, P623, DOI 10.1016/S0006-2952(03)00342-3; Johnson M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp480; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kumala S, 2012, NUCLEIC ACIDS RES, V40, P9417, DOI 10.1093/nar/gks723; Leach TJ, 1998, NUCLEIC ACIDS RES, V26, P4787, DOI 10.1093/nar/26.20.4787; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Legault J, 1997, MOL CELL BIOL, V17, P5437, DOI 10.1128/MCB.17.9.5437; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; LUCHNIK AN, 1988, NUCLEIC ACIDS RES, V16, P5175, DOI 10.1093/nar/16.11.5175; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Maleszka R., 1993, Applied and Theoretical Electrophoresis, V3, P259; Mateos S, 2006, MUTAT RES-FUND MOL M, V599, P105, DOI 10.1016/j.mrfmmm.2006.02.002; MAYER PJ, 1986, EXP CELL RES, V166, P497, DOI 10.1016/0014-4827(86)90494-5; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; NELSON SJ, 1982, RADIAT RES, V92, P120, DOI 10.2307/3575849; Nevaldine B, 1999, RADIAT RES, V152, P154, DOI 10.2307/3580088; NG CE, 1994, INT J RADIAT BIOL, V66, P49, DOI 10.1080/09553009414550941; Noel G, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-7; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okayasu R, 1998, RADIAT RES, V149, P440, DOI 10.2307/3579783; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Pachkowski BF, 2009, MUTAT RES-FUND MOL M, V671, P93, DOI 10.1016/j.mrfmmm.2009.09.006; Perrin D, 2000, BIOCHEM PHARMACOL, V59, P807, DOI 10.1016/S0006-2952(99)00382-2; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; RYDBERG B, 1994, RADIAT RES, V139, P133, DOI 10.2307/3578657; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sato M, 1997, BIOCHEM PHARMACOL, V54, P545, DOI 10.1016/S0006-2952(97)00201-3; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; SHAW JE, 1979, J VIROL, V29, P657, DOI 10.1128/JVI.29.2.657-665.1979; SHIN CG, 1990, TERATOGEN CARCIN MUT, V10, P41, DOI 10.1002/tcm.1770100106; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Sugden B, 2001, CURR TOP MICROBIOL, V258, P3; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tambini CE, 2010, DNA REPAIR, V9, P517, DOI 10.1016/j.dnarep.2010.01.016; Terry SYA, 2009, MUTAT RES-FUND MOL M, V663, P40, DOI 10.1016/j.mrfmmm.2009.01.003; TRIVEDI P, 1993, J GEN VIROL, V74, P1393, DOI 10.1099/0022-1317-74-7-1393; Trzeciak AR, 2008, FREE RADICAL BIO MED, V45, P1631, DOI 10.1016/j.freeradbiomed.2008.08.031; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; WANG M, 1995, ELECTROPHORESIS, V16, P1, DOI 10.1002/elps.1150160102; Whitaker SJ, 1992, PULSED FIELD GEL ELE; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; WLODEK D, 1987, RADIAT RES, V112, P146, DOI 10.2307/3577085; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017	105	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52966	10.1371/journal.pone.0052966	http://dx.doi.org/10.1371/journal.pone.0052966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382828	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800014
J	Shao, M; Yue, Y; Sun, GY; You, QH; Wang, N; Zhang, D				Shao, Min; Yue, Yang; Sun, Geng-Yun; You, Qing-Hai; Wang, Nan; Zhang, Dan			Caveolin-1 Regulates Rac1 Activation and Rat Pulmonary Microvascular Endothelial Hyperpermeability Induced by TNF-alpha	PLOS ONE			English	Article							NF-KAPPA-B; RHO-GTPASES; INTRACELLULAR CA2+; CELL POLARIZATION; BARRIER INTEGRITY; REACTIVE OXYGEN; SMOOTH-MUSCLE; NITRIC-OXIDE; PERMEABILITY; KINASE	A multiplicity of vital cellular and tissue level functions are controlled by caveolin-1 and it is considered to be an important candidate for targeted therapeutics. Rac1-cortactin signaling plays an important role in maintaining the functions of the endothelial barrier in microvascular endothelial cells. The activity of Rac1 has been shown to be regulated by caveolin-1. Therefore, the present study investigated the consequences of down-regulating caveolin-1 and the subsequent changes in activity of Rac1 and the endothelial barrier functions in primary rat pulmonary microvascular endothelial cells (RPMVECs). RPMVECs were transfected with a small hairpin RNA duplex to down-regulate caveolin-1 expression. This procedure significantly increased the activity of Rac1. Moreover, down-regulation of caveolin-1 attenuated TNF-alpha-induced decrease in TER, increase in the flux of FITC-BSA and the disappearance of cortactin from the cell periphery in RPMVEC. Rac1 inhibitors significantly abolished this barrier-protective effect induced by down-regulation of caveolin-1 in response to TNF-alpha in RPMVECs. In conclusion, our data suggest a mechanism for the regulation of Rac1 activity by caveolin-1, with consequences for activation of endothelial cells in response to TNF-alpha.	[Shao, Min; Yue, Yang; Sun, Geng-Yun; You, Qing-Hai; Wang, Nan; Zhang, Dan] Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China; [Shao, Min] Anhui Med Univ, Dept Crit Care Med, Anhui Prov Hosp, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Sun, GY (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China.	sungengyun@yahoo.com.cn			National Natural Science Foundation of China [81070054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This was a research article and the work supported by a grant from the National Natural Science Foundation of China (No. 81070054)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2010, CARDIOVASC RES, V88, P344, DOI 10.1093/cvr/cvq184; Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6; Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P143, DOI 10.4161/cam.3.2.8279; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; May JM, 2011, BIOCHEM BIOPH RES CO, V404, P701, DOI 10.1016/j.bbrc.2010.12.046; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Nasarre P, 2003, NEOPLASIA, V5, P83, DOI 10.1016/S1476-5586(03)80020-9; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Sathish V, 2011, AM J PHYSIOL-LUNG C, V301, pL607, DOI 10.1152/ajplung.00019.2011; Schlegel N, 2009, MICROCIRCULATION, V16, P521, DOI 10.1080/10739680902967427; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Sumida GM, 2010, INVEST OPHTH VIS SCI, V51, P6633, DOI 10.1167/iovs.10-5391; Sun XH, 2009, FEBS LETT, V583, P3681, DOI 10.1016/j.febslet.2009.10.055; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; Wang L, 2008, METABOLISM, V57, P1328, DOI 10.1016/j.metabol.2008.01.036; Waschke J, 2006, HISTOCHEM CELL BIOL, V125, P397, DOI 10.1007/s00418-005-0080-2; Weed SA, 1998, J CELL SCI, V111, P2433; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; You QH, 2010, INFLAMM RES, V59, P949, DOI 10.1007/s00011-010-0207-3; You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	60	13	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55213	10.1371/journal.pone.0055213	http://dx.doi.org/10.1371/journal.pone.0055213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383114	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800132
J	Maulik, M; Thinakaran, G; Kar, S				Maulik, Mahua; Thinakaran, Gopal; Kar, Satyabrata			Alterations in Gene Expression in Mutant Amyloid Precursor Protein Transgenic Mice Lacking Niemann-Pick Type C1 Protein	PLOS ONE			English	Article							BETA-DEGRADING ENZYMES; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; MOUSE MODEL; A-BETA; CHOLESTEROL ACCUMULATION; TRAFFICKING; PATHOGENESIS; NEURODEGENERATION; HOMEOSTASIS	Niemann-Pick type C (NPC) disease, a rare autosomal recessive disorder caused mostly by mutation in NPC1 gene, is pathologically characterized by the accumulation of free cholesterol in brain and other tissues. This is accompanied by gliosis and loss of neurons in selected brain regions, including the cerebellum. Recent studies have shown that NPC disease exhibits intriguing parallels with Alzheimer's disease, including the presence of neurofibrillary tangles and increased levels of amyloid precursor protein (APP)-derived beta-amyloid (A beta) peptides in vulnerable brain neurons. To evaluate the role of A beta in NPC disease, we determined the gene expression profile in selected brain regions of our recently developed bigenic ANPC mice, generated by crossing APP transgenic (Tg) mice with heterozygous Npc1-deficient mice. The ANPC mice exhibited exacerbated neuronal and glial pathology compared to other genotypes [i.e., APP-Tg, double heterozygous (Dhet), Npc1-null and wild-type mice]. Analysis of expression profiles of 86 selected genes using real-time RT-PCR arrays showed a wide-spectrum of alterations in the four genotypes compared to wild-type controls. The changes observed in APP-Tg and Dhet mice are limited to only few genes involved mostly in the regulation of cholesterol metabolism, whereas Npc1-null and ANPC mice showed alterations in the expression profiles of a number of genes regulating cholesterol homeostasis, APP metabolism, vesicular trafficking and cell death mechanism in both hippocampus and cerebellum compared to wild-type mice. Intriguingly, ANPC and Npc1-null mice, with some exceptions, exhibited similar changes, although more genes were differentially expressed in the affected cerebellum than the relatively spared hippocampus. The altered gene profiles were found to match with the corresponding protein levels. These results suggest that lack of Npc1 protein can alter the expression profile of selected transcripts as well as proteins, and APP overexpression influences cerebral pathology by enhancing changes triggered by Npc1 deficiency in the bigenic line.	[Maulik, Mahua; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Maulik, Mahua; Kar, Satyabrata] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kar, Satyabrata] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Kar, Satyabrata] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Chicago; University of Chicago; University of Chicago; University of Alberta; University of Alberta	Kar, S (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	skar@ualberta.ca		Maulik, Mahua/0000-0002-9046-3716	Canadian Institutes of Health Research; National Institutes of Health, United States of America [AG021495, AG019070]; University of Alberta; Alberta Innovates Health Solutions (AIHS); Canada Research Chair (Tier-II) in Neurodegenerative Diseases; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alberta(University of Alberta); Alberta Innovates Health Solutions (AIHS); Canada Research Chair (Tier-II) in Neurodegenerative Diseases; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Canadian Institutes of Health Research (SK). GT is supported by grants AG021495 and AG019070 from the National Institutes of Health, United States of America. MM is a recipient of President's International Doctoral Award from the University of Alberta and a studentship award from the Alberta Innovates Health Solutions (AIHS). SK is a recipient of Canada Research Chair (Tier-II) in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2009, BRAIN, V132, P402, DOI 10.1093/brain/awn312; Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Canevari L, 2007, NEUROCHEM RES, V32, P739, DOI 10.1007/s11064-006-9200-1; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; Hartmann T, 2001, TRENDS NEUROSCI, V24, pS45, DOI 10.1016/S0166-2236(00)01990-1; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kodam A, 2010, GLIA, V58, P1267, DOI 10.1002/glia.21001; Lai A. Y., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/548380; Li GP, 2011, CURR DRUG TARGETS, V12, P1188, DOI 10.2174/138945011795906561; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Mattsson N, 2011, NEUROLOGY, V76, P366, DOI 10.1212/WNL.0b013e318208f4ab; Maulik M, 2012, MOL NEUROBI IN PRESS; Maulik M, 2012, HUM MOL GENET, V21, P4857, DOI 10.1093/hmg/dds322; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Ohm TG, 2003, PHARMACOPSYCHIATRY, V36, pS120; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Paul CA, 2004, BBA-MOL CELL BIOL L, V1685, P63, DOI 10.1016/j.bbalip.2004.08.012; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Poirier J, 2003, TRENDS MOL MED, V9, P94, DOI 10.1016/S1471-4914(03)00007-8; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Vanier MT, 1998, BRAIN PATHOL, V8, P163; Wu YP, 2005, MOL GENET METAB, V84, P9, DOI 10.1016/j.ymgme.2004.08.017; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	51	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54605	10.1371/journal.pone.0054605	http://dx.doi.org/10.1371/journal.pone.0054605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382922	Green Submitted, Green Published, gold			2022-12-25	WOS:000315483200005
J	Qian, AR; Gao, X; Zhang, W; Li, JB; Wang, Y; Di, SM; Hu, LF; Shang, P				Qian, Ai-Rong; Gao, Xiang; Zhang, Wei; Li, Jing-Bao; Wang, Yang; Di, Sheng-Meng; Hu, Li-Fang; Shang, Peng			Large Gradient High Magnetic Fields Affect Osteoblast Ultrastructure and Function by Disrupting Collagen I or Fibronectin/alpha beta 1 Integrin	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPACE-FLIGHT; DIFFERENTIATION; LEVITATION; GRAVITY; EXPRESSION; GROWTH; PROLIFERATION; OSTEOCALCIN; SPACEFLIGHT	The superconducting magnet generates a field and field gradient product that can levitate diamagnetic materials. In this study a specially designed superconducting magnet with a large gradient high magnetic field (LG-HMF), which can provide three apparent gravity levels (mu-g, 1-g, and 2-g), was used to simulate a space-like gravity environment. The effects of LG-HMF on the ultrastructure and function of osteoblast-like cells (MG-63 and MC3T3-E1) and the underlying mechanism were investigated by transmission electromicroscopy (TEM), MTT, and cell western (ICW) assays. Under LG-HMF significant morphologic changes in osteoblast-like cells occurred, including expansion of endoplasmic reticulum and mitochondria, an increased number of lysosomes, distorted microvilli, and aggregates of actin filaments. Compared to controls, cell viability and alkaline phosphatase (ALP) secretion were significantly increased, and collagen I (col I), fibronectin (FN), vinculin, integrin alpha 3, alpha v, and beta 1 expression were changed under LG-HMF conditions. In conclusion, LG-HMF affects osteoblast ultrastructure, cell viability, and ALP secretion, and the changes caused by LG-HMF may be related to disrupting col I or FN/alpha beta 1 integrin.	[Qian, Ai-Rong; Gao, Xiang; Zhang, Wei; Li, Jing-Bao; Wang, Yang; Di, Sheng-Meng; Hu, Li-Fang; Shang, Peng] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Inst Special Environm Biophys, Xian 710072, Peoples R China	Northwestern Polytechnical University	Shang, P (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Inst Special Environm Biophys, Xian 710072, Peoples R China.	shangpeng@nwpu.edu.cn	Hu, Lifang/W-8020-2019		National Basic Research Program of China [2011CB710903]; National Natural Science Foundation of China [30970706]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2011CB710903) and National Natural Science Foundation of China (No. 30970706). The funders had a role in study design and data collection and analysis.	Babbick M, 2007, ADV SPACE RES, V39, P1182, DOI 10.1016/j.asr.2007.01.001; BEAUGNON E, 1991, NATURE, V349, P470, DOI 10.1038/349470a0; Brooks JS, 2000, J APPL PHYS, V87, P6194, DOI 10.1063/1.372653; Caillot-Augusseau A, 2000, CLIN CHEM, V46, P1136; Candeliere GA, 1999, NUCLEIC ACIDS RES, V27, P1079, DOI 10.1093/nar/27.4.1079; Carmeliet G, 1998, BONE, V22, p139S, DOI 10.1016/S8756-3282(98)00007-6; Collet P, 1997, BONE, V20, P547, DOI 10.1016/S8756-3282(97)00052-5; Di S, 2012, INT J RAD BIOL; Garcia-Ovejero D, 2001, DEV BRAIN RES, V130, P191, DOI 10.1016/S0165-3806(01)00236-X; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Hammer BE, 2009, MICROGRAVITY SCI TEC, V21, P311, DOI 10.1007/s12217-008-9092-6; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Hughes-Fulford M, 1999, FASEB J, V13, pS121; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Kawakami S, 2006, JPN J APPL PHYS 1, V45, P6055, DOI 10.1143/JJAP.45.6055; Kondrachuk AV, 2001, ADV SPACE RES, V27, P1001, DOI 10.1016/S0273-1177(01)00167-3; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Kuznetsov OA, 1997, J EXP BOT, V48, P1951, DOI 10.1093/jexbot/48.316.1951; Kuznetsov OA, 1996, PLANTA, V198, P87; Landis WJ, 2000, J BONE MINER RES, V15, P1099, DOI 10.1359/jbmr.2000.15.6.1099; Li J, 2011, INT J MICROGRAVITY S, V28, pS36; Li JB, 2010, ANAL BIOCHEM, V398, P254, DOI 10.1016/j.ab.2009.12.013; Liu YM, 2010, ADV SPACE RES, V45, P208, DOI 10.1016/j.asr.2009.08.033; Meng R, 2011, ACTA BIOCH BIOPH SIN, V43, P133, DOI 10.1093/abbs/gmq121; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; National Research Council Committee on Opportunities in High Magnetic Field Science Solid State Sciences Committee, 2005, OPP HIGH MAGN FIELD; Qian AR, 2012, IEEE T BIO-MED ENG, V59, P68, DOI 10.1109/TBME.2010.2103377; Qian AR, 2010, ADV SPACE RES, V46, P687, DOI 10.1016/j.asr.2010.04.012; Qian AR, 2009, BIOELECTROMAGNETICS, V30, P545, DOI 10.1002/bem.20511; Qian AR, 2008, ACTA ASTRONAUT, V63, P929, DOI 10.1016/j.actaastro.2008.03.005; Qian AR, 2009, ACTA BIOCH BIOPH SIN, V41, P561, DOI 10.1093/abbs/gmp041; Qian AR, 2009, IEEE T APPL SUPERCON, V19, P42, DOI 10.1109/TASC.2009.2012422; Rodionova NV, 2002, ADV SPACE RES, V30, P765, DOI 10.1016/S0273-1177(02)00393-9; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Shi DY, 2010, STEM CELL REV REP, V6, P567, DOI 10.1007/s12015-010-9182-x; Simon MD, 2000, J APPL PHYS, V87, P6200, DOI 10.1063/1.372654; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tian ZC, 2010, MICROGRAVITY SCI TEC, V22, P163, DOI 10.1007/s12217-009-9170-4; Valiron O, 2005, J MAGN RESON IMAGING, V22, P334, DOI 10.1002/jmri.20398; Valles JM, 2005, ADV SPACE RES, V36, P114, DOI 10.1016/j.asr.2005.01.081; Valles JM, 2002, BIOPHYS J, V82, P1260, DOI 10.1016/S0006-3495(02)75482-9; Valles JM, 1997, BIOPHYS J, V73, P1130, DOI 10.1016/S0006-3495(97)78145-1; Wang J, 2008, J DENT RES, V87, P650, DOI 10.1177/154405910808700713; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamaguchi M, 2006, SPRINGER SER MATER S, V89, P41	49	27	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e51036	10.1371/journal.pone.0051036	http://dx.doi.org/10.1371/journal.pone.0051036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382804	gold, Green Submitted, Green Published			2022-12-25	WOS:000315483200040
J	Sawada, M; Kawayama, T; Imaoka, H; Sakazaki, Y; Oda, H; Takenaka, S; Kaku, Y; Azuma, K; Tajiri, M; Edakuni, N; Okamoto, M; Kato, S; Hoshino, T				Sawada, Masanori; Kawayama, Tomotaka; Imaoka, Haruki; Sakazaki, Yuki; Oda, Hanako; Takenaka, Shin-ichi; Kaku, Yoichiro; Azuma, Koichi; Tajiri, Morihiro; Edakuni, Nobutaka; Okamoto, Masaki; Kato, Seiya; Hoshino, Tomoaki			IL-18 Induces Airway Hyperresponsiveness and Pulmonary Inflammation via CD4(+) T Cell and IL-13	PLOS ONE			English	Article							IFN-GAMMA; ALLERGIC-ASTHMA; POTENTIAL ROLE; INTERLEUKIN-18; EXPRESSION; CYTOKINES; MICE; EMPHYSEMA; RECEPTOR; TH1	IL-18 plays a key role in the pathogenesis of pulmonary inflammatory diseases including pulmonary infection, pulmonary fibrosis, lung injury and chronic obstructive pulmonary disease (COPD). However, it is unknown whether IL-18 plays any role in the pathogenesis of asthma. We hypothesized that overexpression of mature IL-18 protein in the lungs may exacerbate disease activities of asthma. We established lung-specific IL-18 transgenic mice on a Balb/c genetic background. Female mice sensitized-and challenged-with antigen (ovalbumin) were used as a mouse asthma model. Pulmonary inflammation and emphysema were not observed in the lungs of naive transgenic mice. However, airway hyperresponsiveness and airway inflammatory cells accompanied with CD4(+) T cells, CD8(+) T cells, eosinophils, neutrophils, and macrophages were significantly increased in ovalbumin-sensitized and challenged transgenic mice, as compared to wild type Balb/c mice. We also demonstrate that IL-18 induces IFN-gamma, IL-13, and eotaxin in the lungs of ovalbumin-sensitized and challenged transgenic mice along with an increase in IL-13 producing CD4(+) T cells. Treatment with anti-CD4 monoclonal antibody or deletion of the IL-13 gene improves ovalbumin-induced airway hyperresponsiveness and reduces airway inflammatory cells in transgenic mice. Overexpressing the IL-18 protein in the lungs induces type 1 and type 2 cytokines and airway inflammation, and results in increasing airway hyperresponsiveness via CD4(+) T cells and IL-13 in asthma.	[Sawada, Masanori; Kawayama, Tomotaka; Imaoka, Haruki; Sakazaki, Yuki; Oda, Hanako; Takenaka, Shin-ichi; Kaku, Yoichiro; Azuma, Koichi; Tajiri, Morihiro; Edakuni, Nobutaka; Okamoto, Masaki; Hoshino, Tomoaki] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Med 1, Fukuoka, Japan; [Kato, Seiya] Univ Ryukyus, Grad Sch, Div Pathol & Cell Biol, Nishihara, Okinawa 90301, Japan; [Kato, Seiya] Univ Ryukyus, Fac Med, Nishihara, Okinawa 90301, Japan	Kurume University; University of the Ryukyus; University of the Ryukyus	Hoshino, T (corresponding author), Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Med 1, Fukuoka, Japan.	hoshino@med.kurume-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Science, Sports, and Culture of Japan [21590977]; Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan); Kaibara Morikazu Medical Science Promotion Foundation; Allergy Foundation; Takeda Science Foundation	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan); Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation); Allergy Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan, a Grant-in-Aid for Scientific Research (C) (no. 21590977: TH) from the Ministry of Education, Science, Sports, and Culture of Japan, Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan) (TH), Kaibara Morikazu Medical Science Promotion Foundation (HI), Allergy Foundation (HI) and Takeda Science Foundation (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Harada M, 2009, AM J RESP CRIT CARE, V180, P1048, DOI 10.1164/rccm.200905-0652OC; Hashino T, 1999, J IMMUNOL, V162, P51; Hoshino T, 1999, J IMMUNOL, V162, P5070; Hoshino T, 2001, J IMMUNOL, V166, P7014, DOI 10.4049/jimmunol.166.12.7014; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Ichiki H, 2005, BIOCHEM BIOPH RES CO, V334, P1141, DOI 10.1016/j.bbrc.2005.07.007; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Imaoka H, 2011, EUR RESPIR J, V38, P981, DOI 10.1183/09031936.00033811; Imaoka H, 2007, BIOCHEM BIOPH RES CO, V360, P525, DOI 10.1016/j.bbrc.2007.06.019; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; Kang MJ, 2012, AM J RESP CRIT CARE, V185, P1205, DOI 10.1164/rccm.201108-1545OC; Kawase Y, 2003, J INVEST DERMATOL, V121, P502, DOI 10.1046/j.1523-1747.2003.12407.x; Kitasato Y, 2004, AM J RESP CELL MOL, V31, P619, DOI 10.1165/rcmb.2003-0306OC; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakanishi Kenji, 2010, Allergology International, V59, P137, DOI 10.2332/allergolint.10-RAI-0208; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Okamoto M, 2002, BLOOD, V99, P1289, DOI 10.1182/blood.V99.4.1289; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Sakai A, 2008, J IMMUNOL, V181, P2898, DOI 10.4049/jimmunol.181.4.2898; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takei S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3295; Tanaka H, 2001, J ALLERGY CLIN IMMUN, V107, P331, DOI 10.1067/mai.2001.112275; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhu GH, 2008, EUR J HUM GENET, V16, P1083, DOI 10.1038/ejhg.2008.67	37	39	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54623	10.1371/journal.pone.0054623	http://dx.doi.org/10.1371/journal.pone.0054623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382928	Green Submitted, gold, Green Published			2022-12-25	WOS:000315483200037
J	Bouwman, LI; Niewold, P; van Putten, JPM				Bouwman, Lieneke I.; Niewold, Paula; van Putten, Jos P. M.			Basolateral Invasion and Trafficking of Campylobacter jejuni in Polarized Epithelial Cells	PLOS ONE			English	Article							ENTEROINVASIVE PATHOGENS; INTRACELLULAR SURVIVAL; CACO-2 CELLS; HEP-2 CELLS; INFECTION; TRANSLOCATION; MECHANISMS; PROTEIN; ENTRY; CYTOSKELETON	Campylobacter jejuni is a major cause of bacterial diarrheal disease. Most enteropathogenic bacteria including C. jejuni can invade cultured eukaryotic cells via an actin-and/or microtubule-dependent and an energy-consuming uptake process. Recently, we identified a novel highly efficient C. jejuni invasion pathway that involves bacterial migration into the subcellular space of non-polarized epithelial cells (termed subvasion) followed by invasion from the cell basis. Here we report cellular requirements of this entry mechanism and the subsequent intracellular trafficking route of C. jejuni in polarized islands of Caco-2 intestinal epithelial cells. Advanced microscopy on infected cells revealed that C. jejuni invades the polarized intestinal cells via the subcellular invasion pathway. Remarkably, invasion was not blocked by the inhibitors of microtubule dynamics colchicine or paclitaxel, and was even enhanced after disruption of host cell actin filaments by cytochalasin D. Invasion also continued after dinitrophenol-induced cellular depletion of ATP, whereas this compound effectively inhibited the uptake of invasive Escherichia coli. Confocal microscopy demonstrated that intracellular C. jejuni resided in membrane-bound CD63-positive cellular compartments for up to 24 h. Establishment of a novel luciferase reporter-based bacterial viability assay, developed to overcome the limitations of the classical bacterial recovery assay, demonstrated that a subset of C. jejuni survived intracellularly for up to 48 h. Taken together, our results indicate that C. jejuni is able to actively invade polarized intestinal epithelial cells via a novel actin-and microtubule-independent mechanism and remains metabolically active in the intracellular niche for up to 48 hours.	[Bouwman, Lieneke I.; Niewold, Paula; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	van Putten, JPM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	j.vanputten@uu.nl		Bouwman, Lieneke/0000-0002-4949-3892; Niewold, Paula/0000-0002-9614-4601; van Putten, Jos/0000-0002-4126-8172	Utrecht University, The Netherlands	Utrecht University, The Netherlands(Netherlands Government)	This research received financial support from Utrecht University, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; BARROW PA, 1989, J MED MICROBIOL, V28, P59, DOI 10.1099/00222615-28-1-59; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Bouwman LI, 2012, FOODBORNE AND WATERBORNE BACTERIAL PATHOGENS: EPIDEMIOLOGY, EVOLUTION AND MOLECULAR BIOLOGY, P231; Bras AM, 1999, FEMS MICROBIOL LETT, V179, P209, DOI 10.1016/S0378-1097(99)00413-9; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DEMELO MA, 1989, INFECT IMMUN, V57, P2214, DOI 10.1128/IAI.57.7.2214-2222.1989; Dersch P, 1999, EMBO J; Duncan MJ, 2002, CELL MICROBIOL, V4, P783, DOI 10.1046/j.1462-5822.2002.00230.x; FERRERO RL, 1988, J GEN MICROBIOL, V134, P53; Friis LM, 2005, J MICROBIOL METH, V61, P145, DOI 10.1016/j.mimet.2004.12.003; Girard MP, 2006, VACCINE, V24, P2732, DOI 10.1016/j.vaccine.2005.10.014; Grassme HUC, 1996, INFECT IMMUN, V64, P1621; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hu L, 2006, MICROB PATHOGENESIS, V40, P91, DOI 10.1016/j.micpath.2005.11.004; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Hu L, 2008, CAMPYLOBACTER, 3RD EDITION, P297; Kalischuk LD, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-2; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; KONKEL ME, 1992, MICROB PATHOGENESIS, V13, P357, DOI 10.1016/0882-4010(92)90079-4; KONKEL ME, 1992, J INFECT DIS, V166, P308, DOI 10.1093/infdis/166.2.308; Kopecko DJ, 2001, TRENDS MICROBIOL, V9, P389, DOI 10.1016/S0966-842X(01)02107-2; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Liu XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002562; Louwen R, 2012, INFECT IMMUN, V80, P3307, DOI 10.1128/IAI.06270-11; MacCallum A, 2005, MICROBIOL-SGM, V151, P2451, DOI 10.1099/mic.0.27950-0; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Monteville MR, 2002, INFECT IMMUN, V70, P6665, DOI 10.1128/IAI.70.12.6665-6671.2002; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Pryjma M, 2012, J BACTERIOL, V194, P3803, DOI 10.1128/JB.06665-11; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Rodriguez MS, 1996, ONCOGENE, V12, P2425; RUSSELL RG, 1994, INFECT IMMUN, V62, P3773, DOI 10.1128/IAI.62.9.3773-3779.1994; Sansonetti P, 2002, GUT, V50, P2; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; van Alphen LB, 2008, CELL MICROBIOL, V10, P53, DOI 10.1111/j.1462-5822.2007.01014.x; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; WALKER RI, 1988, CAN J MICROBIOL, V34, P1142, DOI 10.1139/m88-201; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Young KT, 2007, NATURE REV MICROBIOL, P5665	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54759	10.1371/journal.pone.0054759	http://dx.doi.org/10.1371/journal.pone.0054759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382959	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500024
J	Cherubini, P; Humbel, T; Beeckman, H; Gartner, H; Mannes, D; Pearson, C; Schoch, W; Tognetti, R; Lev-Yadun, S				Cherubini, Paolo; Humbel, Turi; Beeckman, Hans; Gaertner, Holger; Mannes, David; Pearson, Charlotte; Schoch, Werner; Tognetti, Roberto; Lev-Yadun, Simcha			Olive Tree-Ring Problematic Dating: A Comparative Analysis on Santorini (Greece)	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; EASTERN SPAIN; WOOD; ANATOMY; GROWTH; AGE	Olive trees are a classic component of Mediterranean environments and some of them are known historically to be very old. In order to evaluate the possibility to use olive tree-rings for dendrochronology, we examined by various methods the reliability of olive tree-rings identification. Dendrochronological analyses of olive trees growing on the Aegean island Santorini (Greece) show that the determination of the number of tree-rings is impossible because of intra-annual wood density fluctuations, variability in tree-ring boundary structure, and restriction of its cambial activity to shifting sectors of the circumference, causing the tree-ring sequences along radii of the same cross section to differ.	[Cherubini, Paolo; Humbel, Turi; Gaertner, Holger; Schoch, Werner] WSL Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland; [Humbel, Turi] Univ Zurich, Dept Geog, Zurich, Switzerland; [Beeckman, Hans] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Mannes, David] Paul Scherrer Inst, Villigen, Switzerland; [Pearson, Charlotte] Cornell Univ, Malcolm & Carolyn Wiener Lab Aegean & Near Easter, Ithaca, NY USA; [Pearson, Charlotte] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Tognetti, Roberto] Univ Molise, Dept Biosci & Terr, Pesche, Italy; [Lev-Yadun, Simcha] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Oranim, Tivon, Israel	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Zurich; Royal Museum for Central Africa; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Cornell University; University of Arizona; University of Molise; University of Haifa	Cherubini, P (corresponding author), WSL Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland.	paolo.cherubini@wsl.ch	Pearson, Charlotte/AAP-3087-2020; Beeckman, Hans/I-7653-2019; Tognetti, Roberto/C-4962-2008; Cherubini, Paolo/AAC-3121-2021; Cherubini, Paolo/N-9702-2013; Gärtner, Holger W/J-7887-2013	Pearson, Charlotte/0000-0002-3594-3194; Beeckman, Hans/0000-0001-8954-6277; Tognetti, Roberto/0000-0002-7771-6176; Cherubini, Paolo/0000-0002-9809-250X; Cherubini, Paolo/0000-0002-9809-250X; Gärtner, Holger W/0000-0001-6243-9578; Mannes, David/0000-0003-4028-7504	Institute for Aegean Prehistory (INSTAP); Division Of Behavioral and Cognitive Sci [1236981] Funding Source: National Science Foundation	Institute for Aegean Prehistory (INSTAP); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Institute for Aegean Prehistory (INSTAP) funded the sampling work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battipaglia G, 2010, NEW PHYTOL, V188, P1099, DOI 10.1111/j.1469-8137.2010.03443.x; BORMANN F.H., 1981, AGE GROWTH RATE TROP; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; Copenheaver CA, 2010, BOTANY, V88, P545, DOI 10.1139/B10-029; De Micco V, 2007, IAWA J, V28, P61, DOI 10.1163/22941932-90001619; Fritts H. C., 1976, TREE RINGS CLIMATE; GOURLAY ID, 1995, J TROP ECOL, V11, P121, DOI 10.1017/S0266467400008488; Keunecke D., 2011, WOOD RES, V55, P49; Krzyszkowska, 2010, CRETAN OFFERINGS STU, P367; LIPHSCHITZ N, 1986, IAWA BULL, V7, P145, DOI 10.1163/22941932-90000978; Mannes D, 2007, TREES-STRUCT FUNCT, V21, P605, DOI 10.1007/s00468-007-0149-8; Martin RR, 2001, X-RAY SPECTROM, V30, P338, DOI 10.1002/xrs.507; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Pearson CL, 2011, FOREST ECOL MANAG, V262, P1258, DOI 10.1016/j.foreco.2011.06.023; Poussart PM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026929; Schweingruber F. H., 1988, TREE RINGS BASICS AP; STUIVER M, 1986, RADIOCARBON, V28, P969, DOI 10.1017/S0033822200060252; Terral JF, 1996, QUATERNARY RES, V46, P176, DOI 10.1006/qres.1996.0057; Terral JF, 1999, PALAEOGEOGR PALAEOCL, V153, P71, DOI 10.1016/S0031-0182(99)00079-6; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary M, 1973, GEOBOTANICAL FDN MID	21	46	46	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54730	10.1371/journal.pone.0054730	http://dx.doi.org/10.1371/journal.pone.0054730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382949	Green Published, gold, Green Accepted			2022-12-25	WOS:000315211500023
J	Fantin, YS; Neverov, AD; Favorov, AV; Alvarez-Figueroa, MV; Braslavskaya, SI; Gordukova, MA; Karandashova, IV; Kuleshov, KV; Myznikova, AI; Polishchuk, MS; Reshetov, DA; Voiciehovskaya, YA; Mironov, AA; Chulanov, VP				Fantin, Yuri S.; Neverov, Alexey D.; Favorov, Alexander V.; Alvarez-Figueroa, Maria V.; Braslavskaya, Svetlana I.; Gordukova, Maria A.; Karandashova, Inga V.; Kuleshov, Konstantin V.; Myznikova, Anna I.; Polishchuk, Maya S.; Reshetov, Denis A.; Voiciehovskaya, Yana A.; Mironov, Andrei A.; Chulanov, Vladimir P.			Base-Calling Algorithm with Vocabulary (BCV) Method for Analyzing Population Sequencing Chromatograms	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RIBOSOMAL-RNA SEQUENCES; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; PNCA MUTATIONS; DNA; PYRAZINAMIDE; HIV; DATABASE; DETECT	Sanger sequencing is a common method of reading DNA sequences. It is less expensive than high-throughput methods, and it is appropriate for numerous applications including molecular diagnostics. However, sequencing mixtures of similar DNA of pathogens with this method is challenging. This is important because most clinical samples contain such mixtures, rather than pure single strains. The traditional solution is to sequence selected clones of PCR products, a complicated, time-consuming, and expensive procedure. Here, we propose the base-calling with vocabulary (BCV) method that computationally deciphers Sanger chromatograms obtained from mixed DNA samples. The inputs to the BCV algorithm are a chromatogram and a dictionary of sequences that are similar to those we expect to obtain. We apply the base-calling function on a test dataset of chromatograms without ambiguous positions, as well as one with 3-14% sequence degeneracy. Furthermore, we use BCV to assemble a consensus sequence for an HIV genome fragment in a sample containing a mixture of viral DNA variants and to determine the positions of the indels. Finally, we detect drug-resistant Mycobacterium tuberculosis strains carrying frameshift mutations mixed with wild-type bacteria in the pncA gene, and roughly characterize bacterial communities in clinical samples by direct 16S rRNA sequencing.	[Fantin, Yuri S.; Neverov, Alexey D.; Alvarez-Figueroa, Maria V.; Braslavskaya, Svetlana I.; Gordukova, Maria A.; Karandashova, Inga V.; Kuleshov, Konstantin V.; Myznikova, Anna I.; Voiciehovskaya, Yana A.; Chulanov, Vladimir P.] Minist Publ Hlth Russia, Cent Res Inst Epidemiol, Fed State Inst Sci, Moscow, Russia; [Neverov, Alexey D.; Reshetov, Denis A.; Mironov, Andrei A.] Lomonosov Moscow State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Favorov, Alexander V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Favorov, Alexander V.] State Res Inst Genet & Select Ind Microorganisms, Moscow, Russia; [Favorov, Alexander V.; Reshetov, Denis A.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Polishchuk, Maya S.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Polishchuk, Maya S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Mironov, Andrei A.] Kharkevich Inst, Inst Informat Transmiss Problems, Moscow, Russia	Lomonosov Moscow State University; Johns Hopkins University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of California System; University of California Berkeley; Kharkevich Institute for Information Transmission Problems of the RAS	Neverov, AD (corresponding author), Minist Publ Hlth Russia, Cent Res Inst Epidemiol, Fed State Inst Sci, Moscow, Russia.	neva_2000@mail.ru	Gordukova, Maria A/S-7654-2018; Kuleshov, Konstantin V/U-5294-2018; Chulanov, Vladimir/S-4708-2016; Kuznetsova, Anna/AAJ-6484-2021; Chulanov, Vladimir/AAY-7277-2020; Favorov, Alexander V/K-2699-2018	Gordukova, Maria A/0000-0002-3948-8491; Kuleshov, Konstantin V/0000-0002-5238-7900; Chulanov, Vladimir/0000-0001-6303-9293; Chulanov, Vladimir/0000-0001-6303-9293; Favorov, Alexander V/0000-0003-2595-1091; Kuznetsova (Myznikova), Anna/0000-0001-5299-3081	Russian Foundation of Basic Research [11-04-02016-a, 10-04-92663-IND a, 11-04-02051-a]; State Contract of Russian Ministry of Education and Science [07.514.11.4007, 11.G34.31.0008]; Presidium of Russian Academy of Science; National Institutes of Health Core Grant [P30 CA006973]; Johns Hopkins University; Commonwealth Foundation; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); State Contract of Russian Ministry of Education and Science; Presidium of Russian Academy of Science(Russian Academy of Sciences); National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); Commonwealth Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by Russian Foundation of Basic Research [grant numbers 11-04-02016-a, 10-04-92663-IND a and 11-04-02051-a]; State Contract of Russian Ministry of Education and Science [grant numbers 07.514.11.4007, 11.G34.31.0008]; Programs 6 and 17 of the Presidium of Russian Academy of Science; by the National Institutes of Health Core Grant P30 CA006973, the Johns Hopkins University Framework for the Future and by the Commonwealth Foundation. Funding for open access charge: State Contract of Russian Ministry of Education and Science [grant numbers 07.514.11.4007, 11.G34.31.0008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade-Cetto L, 2005, MACHINE LEARN SIGN P, P369, DOI 10.1109/MLSP.2005.1532931; Andrade-Cetto L, 2002, WORKSH GEN SIGN PROC, P1; Applied Biosystems, 2009, SEQ CAP EL APPL BIOS, P201; Barco P, 2006, J ANTIMICROB CHEMOTH, V58, P930, DOI 10.1093/jac/dkl363; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; BICHKO VV, 1982, GENE, V20, P481, DOI 10.1016/0378-1119(82)90218-9; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Celera Diagnostics, 2002, VIROSEQ HIV 1 GENOTY, P48; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Denisov GA, 2004, US Patent, Patent No. 6681186; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gajer P, 2004, NUCLEIC ACIDS RES, V32, P562, DOI 10.1093/nar/gkh216; Hagemann TL, 1999, MOL BIOTECHNOL, V13, P137, DOI 10.1385/MB:13:2:137; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Karp R. M, 1972, REDUCIBILITY COMBINA, P85; Kommedal O, 2008, J CLIN MICROBIOL, V46, P3766, DOI 10.1128/JCM.00213-08; Kwong Ann D, 2011, Gastroenterology, V140, P755, DOI 10.1053/j.gastro.2011.01.029; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Lemaitre N, 1999, ANTIMICROB AGENTS CH, V43, P1761, DOI 10.1128/AAC.43.7.1761; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Manaster C, 2005, HUM MUTAT, V26, P11, DOI 10.1002/humu.20188; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Mascolini M, 2011, ANTIVIR THER, V16, P263, DOI 10.3851/IMP1761; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2210, DOI 10.1128/AAC.49.6.2210-2217.2005; McIlroy SJ, 2011, ENVIRON MICROBIOL, V13, P33, DOI 10.1111/j.1462-2920.2010.02306.x; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P2291, DOI 10.1128/AAC.44.9.2291-2295.2000; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nomenclature Committee for the International Union of Biochemistry (NC- IUB), 1986, MOL BIOL EVOL, V3, P99; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pozhitkov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-281; PUMPEN PP, 1981, DOKL AKAD NAUK SSSR+, V260, P1022; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Seroussi E, 2002, BIOINFORMATICS, V18, P1137, DOI 10.1093/bioinformatics/18.8.1137; Seroussi Y, 2007, BIOTECHNIQUES, V43, P452, DOI 10.2144/000112552; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Shafer RW, 2001, HIV SEQUENCE COMPEND, P83; Shaw T, 2006, J HEPATOL, V44, P593, DOI 10.1016/j.jhep.2006.01.001; Shin-I T, 2008, HEPATOL RES, V38, P234, DOI 10.1111/j.1872-034X.2007.00262.x; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trosvik P, 2007, APPL ENVIRON MICROB, V73, P4975, DOI 10.1128/AEM.00128-07; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wildenberg A, 2003, J COMPUT BIOL, V10, P635, DOI 10.1089/10665270360688237; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhidkov I, 2011, NUCLEIC ACIDS RES, V39, pE47, DOI 10.1093/nar/gkq1354; Zimhony O, 2007, ANTIMICROB AGENTS CH, V51, P752, DOI 10.1128/AAC.01369-06	67	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54835	10.1371/journal.pone.0054835	http://dx.doi.org/10.1371/journal.pone.0054835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382983	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500033
J	O'Donnell, RK; Goldstein, WE; Perruzzi, C; Benjamin, LE; Aird, W				O'Donnell, Rebekah K.; Goldstein, Whitney E.; Perruzzi, Carole; Benjamin, Laura E.; Aird, William			Overexpression of MyrAkt1 in Endothelial Cells Leads to Erythropoietin- and BMP4-Independent Splenic Erythropoiesis in Mice	PLOS ONE			English	Article							BMP4-DEPENDENT STRESS ERYTHROPOIESIS; ERYTHROID PROGENITORS; REQUIRES; EXPRESSION; EXPANSION; ANEMIA; MOUSE; MODEL	Under steady state conditions, erythropoiesis occurs in the bone marrow. However, in mice, stress or tissue hypoxia results in increased erythropoiesis in the spleen. There is increasing evidence that the hematopoietic microenvironment, including endothelial cells, plays an important role in regulating erythropoiesis. Here, we show that short-term expression of constitutively active Akt in the endothelium of mice results in non-anemic stress erythropoiesis in the spleen. The initiation of this stress response was independent of erythropoietin and BMP4, and was observed in endothelial myrAkt1 mice reconstituted with wild-type bone marrow. Together, these data suggest that endothelial cell hyperactivation is a potentially novel pathway of inducing red cell production under stress.	[O'Donnell, Rebekah K.; Goldstein, Whitney E.; Perruzzi, Carole; Benjamin, Laura E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [O'Donnell, Rebekah K.; Goldstein, Whitney E.; Perruzzi, Carole; Benjamin, Laura E.; Aird, William] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Aird, William] Beth Israel Deaconess Med Ctr, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	O'Donnell, RK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	rebekah.k.odonnell@gmail.com		O'Donnell, Rebekah/0000-0001-5878-7510	National Institutes of Health [CA131152]; NATIONAL CANCER INSTITUTE [R01CA131152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (grant CA131152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancro MP, 2009, NAT REV IMMUNOL, V9, P657, DOI 10.1038/nri2621; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; Eckardt KU, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01525.x; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liesveld J, 2005, HEMATOLOGY, V10; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Ohneda O, 1997, BRIT J HAEMATOL, V98, P798, DOI 10.1046/j.1365-2141.1997.3163133.x; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Perry JM, 2009, BLOOD, V113, P911, DOI 10.1182/blood-2008-03-147892; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Porayette P, 2008, DEV BIOL, V317, P24, DOI 10.1016/j.ydbio.2008.01.047; Sheng Y, 2008, IMMUNOL LETT, V121, P33, DOI 10.1016/j.imlet.2008.08.001; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Wen XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026536; Yamashita T, 2008, BLOOD, V112, P1482, DOI 10.1182/blood-2007-11-122648	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55095	10.1371/journal.pone.0055095	http://dx.doi.org/10.1371/journal.pone.0055095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383068	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500057
J	Huang, JW; Lien, YC; Wu, HY; Yen, CJ; Pan, CC; Hung, TW; Su, CT; Chiang, CK; Cheng, HT; Hung, KY				Huang, Jenq-Wen; Lien, Yu-Chung; Wu, Hon-Yen; Yen, Chung-Jen; Pan, Chun-Chun; Hung, Tsai-Wei; Su, Chi-Ting; Chiang, Chih-Kang; Cheng, Hui-Teng; Hung, Kuan-Yu			Lean Body Mass Predicts Long-Term Survival in Chinese Patients on Peritoneal Dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; CREATININE KINETICS; MORTALITY; FAT	Background: Reduced lean body mass (LBM) is one of the main indicators in malnutrition inflammation syndrome among patients on dialysis. However, the influence of LBM on peritoneal dialysis (PD) patients' outcomes and the factors related to increasing LBM are seldom reported. Methods: We enrolled 103 incident PD patients between 2002 and 2003, and followed them until December 2011. Clinical characteristics, PD-associated parameters, residual renal function, and serum chemistry profiles of each patient were collected at 1 month and 1 year after initiating PD. LBM was estimated using creatinine index corrected with body weight. Multiple linear regression analysis, Kaplan-Meier survival analysis, and Cox regression proportional hazard analysis were used to define independent variables and compare survival between groups. Results: Using the median LBM value (70% for men and 64% for women), patients were divided into group 1 (n = 52; low LBM) and group 2 (n = 51; high LBM). Group 1 patients had higher rates of peritonitis (1.6 vs. 1.1/100 patient months; p<0.05) and hospitalization (14.6 vs. 9.7/100 patient months; p<0.05). Group 1 patients also had shorter overall survival and technique survival (p<0.01). Each percentage point increase in LBM reduced the hazard ratio for mortality by 8% after adjustment for diabetes, age, sex, and body mass index (BMI). Changes in residual renal function and protein catabolic rate were independently associated with changes in LBM in the first year of PD. Conclusions: LBM serves as a good parameter in addition to BMI to predict the survival of patients on PD. Preserving residual renal function and increasing protein intake can increase LBM.	[Huang, Jenq-Wen; Wu, Hon-Yen; Yen, Chung-Jen; Chiang, Chih-Kang; Hung, Kuan-Yu] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med & Hosp, Dept Integrated Diagnost & Therapeut, Taipei 10764, Taiwan; [Pan, Chun-Chun; Hung, Tsai-Wei] Natl Taiwan Univ, Coll Med & Hosp, Dept Nursing, Taipei 10764, Taiwan; [Lien, Yu-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, New Taipei City, Taiwan; [Wu, Hon-Yen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Su, Chi-Ting] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Yun Lin Branch, Yunlin Cty, Taiwan; [Cheng, Hui-Teng] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; Far Eastern Memorial Hospital; National Taiwan University	Cheng, HT (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan.	cheng78@hotmail.com; kyhung@ntu.edu.tw	CHENG, HUI-TENG/AAD-9899-2020	CHENG, HUI-TENG/0000-0003-1544-7473; HUNG, KUAN-YU/0000-0003-3472-5512; YEN, CHUNG-JEN/0000-0001-5372-3657; HUANG, JENQ-WEN/0000-0001-8011-2317; CHIANG, CHIH-KANG/0000-0001-9021-4616				[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; Borovnicar DJ, 1996, EUR J CLIN NUTR, V50, P607; DELIMA JJG, 1995, NEPHROL DIAL TRANSPL, V10, P1708; Dong J, 2008, KIDNEY INT, V73, P334, DOI 10.1038/sj.ki.5002644; Dong J, 2011, NEPHROL DIAL TRANSPL, V26, P3715, DOI 10.1093/ndt/gfr142; FORBES GB, 1976, AM J CLIN NUTR, V29, P1359, DOI 10.1093/ajcn/29.12.1359; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Huang CX, 2010, KIDNEY INT, V77, P624, DOI 10.1038/ki.2009.524; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Majchrzak KM, 2007, J RENAL NUTR, V17, P196, DOI 10.1053/j.jrn.2007.01.003; MITCH WE, 1980, CLIN SCI, V58, P327, DOI 10.1042/cs0580327; Moreau-Gaudry X, 2011, J RENAL NUTR, V21, P369, DOI 10.1053/j.jrn.2010.08.005; Noori N, 2010, AM J CLIN NUTR, V92, P1060, DOI 10.3945/ajcn.2010.29188; Rambod M, 2009, AM J KIDNEY DIS, V53, P298, DOI 10.1053/j.ajkd.2008.09.018; Szeto CC, 2000, KIDNEY INT, V58, P400, DOI 10.1046/j.1523-1755.2000.00179.x; Trivedi H, 2005, AM J NEPHROL, V25, P466, DOI 10.1159/000087876; Tzamaloukas AH, 2010, J RENAL NUTR, V20, P91, DOI 10.1053/j.jrn.2009.08.004	20	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54976	10.1371/journal.pone.0054976	http://dx.doi.org/10.1371/journal.pone.0054976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372806	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400049
J	Kim, DH; Kim, M; Kim, H; Kim, YL; Kang, SW; Yang, CW; Kim, NH; Kim, YS; Lee, JP				Kim, Do Hyoung; Kim, Myounghee; Kim, Ho; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Yon Su; Lee, Jung Pyo			Early Referral to a Nephrologist Improved Patient Survival: Prospective Cohort Study for End-Stage Renal Disease in Korea	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; ACCESS; CARE; HEMODIALYSIS; DETERMINANTS; PREDICTION; MORTALITY; COMORBIDITY; IMPACT	The timing of referral to a nephrologist may influence the outcome of chronic kidney disease patients, but its impact has not been evaluated thoroughly. The results of a recent study showing an association between early referral and patient survival are still being debated. A total of 1028 patients newly diagnosed as end-stage renal disease (ESRD) from July 2008 to October 2011 were enrolled. Early referral (ER) was defined as patients meeting with a nephrologist more than a year before dialysis and dialysis education were provided, and all others were considered late referral (LR). The relationship of referral pattern with mortality in ESRD patients was explored using a Cox proportional hazards regression models. Time from referral to dialysis was significantly longer in 599 ER patients than in 429 LR patients (62.3 +/- 58.9 versus 2.9 +/- 3.4 months, P<0.001). Emergency HD using a temporary vascular catheter was required in 485 (47.2%) out of all patients and in 262 (43.7%) of ER compared with 223 (52.0%) of LR (P = 0.009). After 2 years of follow-up, the survival rate in ER was better than that in LR (hazard ratio [HR] 2.38, 95% confidence interval [CI] 1.27-4.45, P = 0.007). In patients with diabetes nephropathy, patient survival was also significantly higher in ER than in LR (HR 4.74, 95% CI 1.73-13.00, P = 0.002). With increasing age, HR also increased. Timely referral to a nephrologist in the predialytic stage is associated with reduced mortality.	[Kim, Do Hyoung; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Myounghee] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Songnam, South Korea; [Kim, Ho] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Lee, Jung Pyo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Do Hyoung; Kim, Myounghee; Kim, Ho; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Yon Su; Lee, Jung Pyo] Clin Res Ctr End Stage Renal Dis Korea, Taegu, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU); Kyungpook National University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Seoul National University (SNU); Seoul National University Hospital	Lee, JP (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	nephrolee@gmail.com	Kim, Ho/AAS-2402-2021; Kim, Do Hyoung/AAE-7557-2022	Kim, Ho/0000-0001-7472-3752; Kim, Do Hyoung/0000-0002-8664-8830	Korea Healthcare Technology RD Project; Ministry for Health and Welfare, Republic of Korea [A102065]	Korea Healthcare Technology RD Project; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, COMPR PROSP STUD CLI; Astor BC, 2001, AM J KIDNEY DIS, V38, P494, DOI 10.1053/ajkd.2001.26833; Avorn J, 2002, J CLIN EPIDEMIOL, V55, P711, DOI 10.1016/S0895-4356(02)00415-8; Cass A, 2003, AM J KIDNEY DIS, V42, P1043, DOI 10.1016/j.ajkd.2003.07.006; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins AJ, 2010, AM J KIDNEY DIS, V55, p[1, A426], DOI DOI 10.1053/J.AJKD.2009.10.009; Curtis BM, 2002, CLIN NEPHROL, V58, P282; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; de Jager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652, DOI 10.1093/ndt/gfq438; Di Napoli A, 2010, J NEPHROL, V23, P603; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; Herget-Rosenthal S, 2010, INT J CLIN PRACT, V64, P1784, DOI 10.1111/j.1742-1241.2010.02535.x; Inaguma Daijo, 2006, Clin Exp Nephrol, V10, P274, DOI 10.1007/s10157-006-0439-2; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Lemaire X, 2009, BLOOD PURIFICAT, V28, P21, DOI 10.1159/000210034; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; NHIC, 2004, NAT HLTH INS STAT YB; Quaglia M, 2011, ARCH INTERN MED, V171, P2065, DOI 10.1001/archinternmed.2011.585; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Stehman-Breen CO, 2000, KIDNEY INT, V57, P639, DOI 10.1046/j.1523-1755.2000.t01-1-00885.x; Winkelmayer WC, 2007, AM J TRANSPLANT, V7, P872, DOI 10.1111/j.1600-6143.2006.01689.x; Winkelmayer WC, 2001, KIDNEY INT, V60, P1547, DOI 10.1046/j.1523-1755.2001.00958.x; Winkelmayer WC, 2011, ARCH INTERN MED, V171, P1371, DOI 10.1001/archinternmed.2011.360	29	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55323	10.1371/journal.pone.0055323	http://dx.doi.org/10.1371/journal.pone.0055323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372849	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400089
J	Krag, CL; Fillon, G; Gysbers, A; Hansen, HD; Neumann, M; Richter-Landsberg, C; Haass, C; Zalc, B; Lubetzki, C; Gai, WP; Halliday, GM; Kahle, PJ; Jensen, PH				Krag, Christine L.; Fillon, Gwenaelle; Gysbers, Amanda; Hansen, Hanne D.; Neumann, Manuela; Richter-Landsberg, Christiane; Haass, Christian; Zalc, Bernard; Lubetzki, Catherine; Gai, Wei-Ping; Halliday, Glenda M.; Kahle, Philipp J.; Jensen, Poul H.			FAS-Dependent Cell Death in alpha-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; GLIAL CYTOPLASMIC INCLUSIONS; MOUSE MODEL; PARKINSONS-DISEASE; RAT-BRAIN; NEURONAL DEGENERATION; PROTEIN TPPP/P25; EXPRESSION; APOPTOSIS; OVEREXPRESSION	Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically characterized by accumulation of the protein p25 alpha in cell bodies of oligodendrocytes followed by accumulation of aggregated alpha-synuclein in so-called glial cytoplasmic inclusions. p25 alpha is a stimulator of alpha-synuclein aggregation, and coexpression of alpha-synuclein and p25 alpha in the oligodendroglial OLN-t40-AS cell line causes alpha-synuclein aggregate-dependent toxicity. In this study, we investigated whether the FAS system is involved in alpha-synuclein aggregate dependent degeneration in oligodendrocytes and may play a role in multiple system atrophy. Using rat oligodendroglial OLN-t40-AS cells we demonstrate that the cytotoxicity caused by coexpressing alpha-synuclein and p25 alpha relies on stimulation of the death domain receptor FAS and caspase-8 activation. Using primary oligodendrocytes derived from PLP-alpha-synuclein transgenic mice we demonstrate that they exist in a sensitized state expressing pro-apoptotic FAS receptor, which makes them sensitive to FAS ligand-mediated apoptosis. Immunoblot analysis shows an increase in FAS in brain extracts from multiple system atrophy cases. Immunohistochemical analysis demonstrated enhanced FAS expression in multiple system atrophy brains notably in oligodendrocytes harboring the earliest stages of glial cytoplasmic inclusion formation. Oligodendroglial FAS expression is an early hallmark of oligodendroglial pathology in multiple system atrophy that mechanistically may be coupled to alpha-synuclein dependent degeneration and thus represent a potential target for protective intervention.	[Krag, Christine L.; Jensen, Poul H.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Fillon, Gwenaelle; Haass, Christian] Univ Munich, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, Munich, Germany; [Gysbers, Amanda; Halliday, Glenda M.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Hansen, Hanne D.; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Neumann, Manuela] Univ Zurich, Inst Neuropathol, Zurich, Switzerland; [Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, Dept Biol, D-26111 Oldenburg, Germany; [Zalc, Bernard; Lubetzki, Catherine] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, Paris, France; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Bedford Pk, SA 5042, Australia; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Ctr Neurosci, Bedford Pk, SA 5042, Australia; [Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Tubingen, Germany	Aarhus University; University of Munich; Neuroscience Research Australia; University of New South Wales Sydney; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; Carl von Ossietzky Universitat Oldenburg; UDICE-French Research Universities; Sorbonne Universite; Flinders University South Australia; Flinders University South Australia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany.	Philipp.Kahle@uni-tuebingen.de; phj@biokemi.au.dk	Halliday, Glenda M/E-8555-2011; Gai, Wei-Ping/A-3700-2008; Hansen, Hanne Demant/C-9029-2013; Neumann, Manuela/F-6558-2011	Halliday, Glenda M/0000-0003-0422-8398; Hansen, Hanne Demant/0000-0001-5564-7627; Neumann, Manuela/0000-0002-6232-4057; Jensen, Poul Henning/0000-0002-4439-9020	European Community's Seventh Framework Programme [241791 (MEFOPA), 238316 (Neurasync)]; Lundbeck Foundation; Deutsche Forschungsgemeinschaft [SFB 596, A1]; European consortium to develop PD gene therapy (NEUROPARK); Fondation pour la Recherche Medicale; Danish Medical Research Council, Aarhus University; Foundation of 1984 for treatment of Parkinson disease, Federal Ministry of Education and Research [01GI0299]; NHMRC Research Fellowships [630434, 535014]; National Health and Medical Research Council of Australia (NHMRC); Neuroscience Research Australia; University of New South Wales; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R24AA012725]; University of Sydney; Flinders Medical Centre Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme(European Commission); Lundbeck Foundation(Lundbeckfonden); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European consortium to develop PD gene therapy (NEUROPARK); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Danish Medical Research Council, Aarhus University(Danish Medical Research Council); Foundation of 1984 for treatment of Parkinson disease, Federal Ministry of Education and Research; NHMRC Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Research Australia; University of New South Wales; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Sydney(University of Sydney); Flinders Medical Centre Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241791 (MEFOPA), no 238316 (Neurasync), the Lundbeck Foundation, the Deutsche Forschungsgemeinschaft (SFB 596, project A1), the European consortium to develop PD gene therapy (NEUROPARK), the Fondation pour la Recherche Medicale, The Danish Medical Research Council, Aarhus University, the Foundation of 1984 for treatment of Parkinson disease, Federal Ministry of Education and Research (Project-No. 01GI0299). GMH and WPG have NHMRC Research Fellowships (630434 & 535014). Human brain samples were received thanks to support from the National Health and Medical Research Council of Australia (NHMRC), Neuroscience Research Australia, the University of New South Wales, the Schizophrenia Research Institute, the National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725, University of Sydney and the Flinders Medical Centre Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Ahmed Z, 2012, BRAIN PATHOL; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Fehlings M, 2012, J NEUROTRAUMA; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Jodo S, 2001, J BIOL CHEM, V276, P39938, DOI 10.1074/jbc.M107005200; Kahle PJ, 2002, J NEUROCHEM, V82, P449, DOI 10.1046/j.1471-4159.2002.01020.x; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kholodilov NG, 1999, J NEUROCHEM, V73, P2586, DOI 10.1046/j.1471-4159.1999.0732586.x; Kovacs GG, 2007, ACTA NEUROPATHOL, V113, P153, DOI 10.1007/s00401-006-0167-4; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Lantos PL, 1998, J NEUROPATH EXP NEUR, V57, P1099, DOI 10.1097/00005072-199812000-00001; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; LUBETZKI C, 1991, J NEUROCHEM, V56, P671, DOI 10.1111/j.1471-4159.1991.tb08202.x; Muzio M, 1998, INT J CLIN LAB RES, V28, P141, DOI 10.1007/s005990050035; Nakayama K, 2009, AM J PATHOL, V174, P1471, DOI 10.2353/ajpath.2009.080503; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Stemberger S, 2010, EXP NEUROL, V224, P459, DOI 10.1016/j.expneurol.2010.05.008; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wakabayashi K, 2006, NEUROPATHOLOGY, V26, P338, DOI 10.1111/j.1440-1789.2006.00713.x; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x	40	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55243	10.1371/journal.pone.0055243	http://dx.doi.org/10.1371/journal.pone.0055243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372841	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400081
J	Wulaningsih, W; Holmberg, L; Garmo, H; Zethelius, B; Wigertz, A; Carroll, P; Lambe, M; Hammar, N; Walldius, G; Jungner, I; Van Hemelrijck, M				Wulaningsih, Wahyu; Holmberg, Lars; Garmo, Hans; Zethelius, Bjoern; Wigertz, Annette; Carroll, Paul; Lambe, Mats; Hammar, Niklas; Walldius, Goeran; Jungner, Ingmar; Van Hemelrijck, Mieke			Serum Glucose and Fructosamine in Relation to Risk of Cancer	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; BREAST-CANCER; DIABETES-MELLITUS; COLORECTAL-CANCER; SOLUBLE RECEPTOR; APOLIPOPROTEIN-B; INSULIN; MORTALITY; COHORT; WOMEN	Background: Impaired glucose metabolism has been linked with increased cancer risk, but the association between serum glucose and cancer risk remains unclear. We used repeated measurements of glucose and fructosamine to get more insight into the association between the glucose metabolism and risk of cancer. Methods: We selected 11,998 persons (>20 years old) with four prospectively collected serum glucose and fructosamine measurements from the Apolipoprotein Mortality Risk (AMORIS) study. Multivariate Cox proportional hazards regression was used to assess standardized log of overall mean glucose and fructosamine in relation to cancer risk. Similar analyses were performed for tertiles of glucose and fructosamine and for different types of cancer. Results: A positive trend was observed between standardized log overall mean glucose and overall cancer risk (HR = 1.08; 95% CI: 1.02-1.14). Including standardized log fructosamine in the model resulted in a stronger association between glucose and cancer risk and aninverse association between fructosamine and cancer risk (HR = 1.17; 95% CI: 1.08-1.26 and HR: 0.89; 95% CI: 0.82-0.96, respectively). Cancer risks were highest among those in the highest tertile of glucose and lowest tertile of fructosamine. Similar findings were observed for prostate, lung, and colorectal cancer while none observed for breast cancer. Conclusion: The contrasting effect between glucose, fructosamine, and cancer risk suggests the existence of distinct groups among those with impaired glucose metabolism, resulting in different cancer risks based on individual metabolic profiles. Further studies are needed to clarify whether glucose is a proxy of other lifestyle-related or metabolic factors.	[Wulaningsih, Wahyu; Holmberg, Lars; Garmo, Hans; Van Hemelrijck, Mieke] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Holmberg, Lars] Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden; [Holmberg, Lars; Garmo, Hans; Wigertz, Annette; Lambe, Mats] Reg Canc Ctr, Uppsala, Sweden; [Zethelius, Bjoern] Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Zethelius, Bjoern] Med Prod Agcy Epidemiol, Uppsala, Sweden; [Carroll, Paul] St Thomas Hosp, Guys & St Thomas NHS Fdn Trust, Dept Endocrinol, London, England; [Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hammar, Niklas] Karolinska Inst, Inst Environm Med, Dept Epidemiol, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca Sverige, Sodertalje, Sweden; [Walldius, Goeran] Karolinska Inst, Inst Environm Med, Dept Epidemiol, S-10401 Stockholm, Sweden; [Jungner, Ingmar] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Jungner, Ingmar] CALAB Res, Stockholm, Sweden	University of London; King's College London; Uppsala University; Uppsala University Hospital; Uppsala University; Medical Products Agency; Guy's & St Thomas' NHS Foundation Trust; Karolinska Institutet; Karolinska Institutet; AstraZeneca; Karolinska Institutet; Karolinska Institutet	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England.	mieke.vanhemelrijck@kcl.ac.uk	Wulaningsih, Wahyu/AAW-4307-2020	Van Hemelrijck, Mieke/0000-0002-7317-0858; Wulaningsih, Wahyu/0000-0002-3822-1648; Lambe, Mats/0000-0002-4624-3767	Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London	Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London(National Institute for Health Research (NIHR))	This research was supported by the Experimental Cancer Medicine Centre at King's College London and also by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1983, BRIT MED J, V287, P863, DOI 10.1136/bmj.287.6396.863; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; De Michele G, 2008, IMMUNOPHARM IMMUNOT, V30, P925, DOI [10.1080/08923970802337718, 10.1080/08923970802337718 ]; DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group, 1998, BMJ, V317, P371; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Holme I, 2009, J INTERN MED, V266, P558, DOI 10.1111/j.1365-2796.2009.02133.x; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Jiao L, 2011, CANCER RES, V71, P3582, DOI 10.1158/0008-5472.CAN-10-2573; Jungner I, 2006, AM J CARDIOL, V97, P943, DOI 10.1016/j.amjcard.2005.10.062; Jungner I, 1998, CLIN CHEM, V44, P1641; Kabat GC, 2012, BRIT J CANCER, V106, P227, DOI 10.1038/bjc.2011.512; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; LAMB E, 1991, CLIN CHEM, V37, P2138; Lambe M, 2011, CANCER CAUSE CONTROL, V22, P1163, DOI 10.1007/s10552-011-9794-8; Misciagna G, 2004, EUR J EPIDEMIOL, V19, P425, DOI 10.1023/B:EJEP.0000027359.95727.24; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Platek M, 2005, CANCER EPIDEM BIOMAR, V14, P271; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rojas A, 2011, WORLD J DIABETES, V2, P108, DOI 10.4239/wjd.v2.i7.108; Sargeant LA, 2001, INT J EPIDEMIOL, V30, P547, DOI 10.1093/ije/30.3.547; Silbernagel G, 2011, DIABETES CARE, V34, P1355, DOI 10.2337/dc10-2010; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stocks T, 2008, INT J OBESITY, V32, P304, DOI 10.1038/sj.ijo.0803713; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Stopper H, 2003, CANCER LETT, V190, P151, DOI 10.1016/S0304-3835(02)00626-2; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Van Hemelrijck M, 2010, THESIS KINGS COLL LO; Walker K, 2011, BRIT J CANCER, V105, P1451, DOI 10.1038/bjc.2011.358; 1997, LANCET, V350, P1047	41	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54944	10.1371/journal.pone.0054944	http://dx.doi.org/10.1371/journal.pone.0054944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372798	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400044
J	Zheng, HX; Guo, JH; Jin, Y; Yang, F; He, JJ; Lv, L; Zhang, KS; Wu, Q; Liu, XT; Cai, XP				Zheng, Haixue; Guo, Jianhong; Jin, Ye; Yang, Fan; He, Jijun; Lv, Lv; Zhang, Kesan; Wu, Qiong; Liu, Xiangtao; Cai, Xuepeng			Engineering Foot-and-Mouth Disease Viruses with Improved Growth Properties for Vaccine Development	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SEROTYPE-A; REAL-TIME; DETERMINANTS; REPLICATION; PROTECTION; ARGENTINA; RESPONSES; STRAINS; REGION	Background: No licensed vaccine is currently available against serotype A foot-and-mouth disease (FMD) in China, despite the isolation of A/WH/CHA/09 in 2009, partly because this strain does not replicate well in baby hamster kidney (BHK) cells. Methodology/Principal Findings: A novel plasmid-based reverse genetics system was used to construct a chimeric strain by replacing the P1 gene in the vaccine strain O/CHA/99 with that from the epidemic stain A/WH/CHA/09. The chimeric virus displayed growth kinetics similar to those of O/CHA/99 and was selected for use as a candidate vaccine strain after 12 passages in BHK cells. Cattle were vaccinated with the inactivated vaccine and humoral immune responses were induced in most of the animals on day 7. A challenge infection with A/WH/CHA/09 on day 28 indicated that the group given a 4-mu g dose was fully protected and neither developed viremia nor seroconverted to a 3ABC antigen. Conclusions/Significance: Our data demonstrate that the chimeric virus not only propagates well in BHK cells and has excellent antigenic matching against serotype A FMD, but is also a potential marker vaccine to distinguish infection from vaccination. These results suggest that reverse genetics technology is a useful tool for engineering vaccines for the prevention and control of FMD.	[Zheng, Haixue; Guo, Jianhong; Jin, Ye; Yang, Fan; He, Jijun; Lv, Lv; Zhang, Kesan; Wu, Qiong; Liu, Xiangtao; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol,Minist Agr, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, XT (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol,Minist Agr, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Peoples R China.	hnxiangtao@hotmail.com		zheng, hai xue/0000-0001-6850-1379	National High Technology Research and Development Program of China (863 Program) [2011AA10A211-1]; High-level Technological Talent Program of Gansu province [1013JHTA008]; China Agriculture Research System [CARS-39]; International Atomic Energy Agency [16025/R0]; EPIZONE project [FOOD-CT-2006-016236]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); High-level Technological Talent Program of Gansu province; China Agriculture Research System; International Atomic Energy Agency(International Atomic Energy Agency); EPIZONE project	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2011AA10A211-1), the High-level Technological Talent Program of Gansu province (1013JHTA008), the China Agriculture Research System (CARS-39), the International Atomic Energy Agency (16025/R0), and the EPIZONE (FOOD-CT-2006-016236) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Barnett PV, 2004, VACCINE, V22, P1221, DOI 10.1016/j.vaccine.2003.09.024; Barnett PV, 2002, VACCINE, V20, P3197, DOI 10.1016/S0264-410X(02)00242-6; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Blignaut B, 2011, J GEN VIROL, V92, P849, DOI 10.1099/vir.0.027151-0; Bronsvoort BMD, 2004, J CLIN MICROBIOL, V42, P2186, DOI 10.1128/JCM.42.5.2186-2196.2004; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Chang YY, 2009, ACTA BIOCH BIOPH SIN, V41, P998, DOI 10.1093/abbs/gmp093; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; Cox SJ, 2003, VACCINE, V21, P1336, DOI 10.1016/S0264-410X(02)00691-6; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; Fowler VL, 2008, VACCINE, V26, P1982, DOI 10.1016/j.vaccine.2008.02.012; Guzman E, 2010, J VIROL, V84, P12375, DOI 10.1128/JVI.01545-10; Islam MA, 2001, VIRUS GENES, V23, P203, DOI 10.1023/A:1011821027235; Kitching RP, 2005, CURR TOP MICROBIOL, V288, P133; KITCHING RP, 1988, VACCINE, V6, P403, DOI 10.1016/0264-410X(88)90139-9; Klein Joern, 2006, BMC Vet Res, V2, P35, DOI 10.1186/1746-6148-2-35; Knowles NJ, 2009, TRANSBOUND EMERG DIS, V56, P157, DOI 10.1111/j.1865-1682.2009.01074.x; Konig GA, 2007, VET MICROBIOL, V124, P1, DOI 10.1016/j.vetmic.2007.03.015; Le VP, VET MICROBIOL; Lu ZJ, 2007, VET MICROBIOL, V125, P157, DOI 10.1016/j.vetmic.2007.05.017; Mattion N, 2004, VACCINE, V22, P4149, DOI 10.1016/j.vaccine.2004.06.040; Mohapatra JK, 2009, INFECT GENET EVOL, V9, P483, DOI 10.1016/j.meegid.2009.01.009; Muthuchelvan D, 2001, ACTA VIROL, V45, P159; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; Reed L. J., 1988, J HYG, V27, P493; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; RIEDER E, 1993, J VIROL, V67, P5139, DOI 10.1128/JVI.67.9.5139-5145.1993; Pulido MR, 2009, J VIROL, V83, P3475, DOI 10.1128/JVI.01836-08; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; Schumann KR, 2008, VIRUS GENES, V36, P401, DOI 10.1007/s11262-008-0206-4; Shaw AE, 2007, J VIROL METHODS, V143, P81, DOI 10.1016/j.jviromet.2007.02.009; Tosh C, 2002, J GEN VIROL, V83, P2455, DOI 10.1099/0022-1317-83-10-2455; Tosh C, 2002, ARCH VIROL, V147, P493, DOI 10.1007/s007050200002; van Rensburg HG, 2004, J GEN VIROL, V85, P61, DOI 10.1099/vir.0.19509-0	36	46	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55228	10.1371/journal.pone.0055228	http://dx.doi.org/10.1371/journal.pone.0055228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372840	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400080
J	Sanders, JM; Wampole, ME; Thakur, ML; Wickstrom, E				Sanders, Jeffrey M.; Wampole, Matthew E.; Thakur, Mathew L.; Wickstrom, Eric			Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics Study	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; RECEPTOR EXTRACELLULAR DOMAINS; FREE-ENERGY; CRYSTAL-STRUCTURE; TYROSINE KINASES; LIGAND-BINDING; ERBB RECEPTORS; EGF RECEPTOR; FORCE-FIELD; RAS-RAF	The epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase family that plays a role in multiple cellular processes. Activation of EGFR requires binding of a ligand on the extracellular domain to promote conformational changes leading to dimerization and transphosphorylation of intracellular kinase domains. Seven ligands are known to bind EGFR with affinities ranging from sub-nanomolar to near micromolar dissociation constants. In the case of EGFR, distinct conformational states assumed upon binding a ligand is thought to be a determining factor in activation of a downstream signaling network. Previous biochemical studies suggest the existence of both low affinity and high affinity EGFR ligands. While these studies have identified functional effects of ligand binding, high-resolution structural data are lacking. To gain a better understanding of the molecular basis of EGFR binding affinities, we docked each EGFR ligand to the putative active state extracellular domain dimer and 25.0 ns molecular dynamics simulations were performed. MM-PBSA/GBSA are efficient computational approaches to approximate free energies of protein-protein interactions and decompose the free energy at the amino acid level. We applied these methods to the last 6.0 ns of each ligand-receptor simulation. MM-PBSA calculations were able to successfully rank all seven of the EGFR ligands based on the two affinity classes: EGF>HB-EGF>TGF-alpha>BTC>EPR>EPG>AR. Results from energy decomposition identified several interactions that are common among binding ligands. These findings reveal that while several residues are conserved among the EGFR ligand family, no single set of residues determines the affinity class. Instead we found heterogeneous sets of interactions that were driven primarily by electrostatic and Van der Waals forces. These results not only illustrate the complexity of EGFR dynamics but also pave the way for structure-based design of therapeutics targeting EGF ligands or the receptor itself.	[Sanders, Jeffrey M.; Wampole, Matthew E.; Wickstrom, Eric] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Thakur, Mathew L.] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Thakur, Mathew L.; Wickstrom, Eric] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Wickstrom, E (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	eric@tesla.jci.tju.edu	wampole, matthew/AAF-9443-2019	Thakur, Mathew/0000-0003-2409-039X	US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-09-1-0577]; National Institutes of Health (NIH) [CA148565]; NIH [5P41RR006009]; NATIONAL CANCER INSTITUTE [R01CA148565] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER	US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by US Army Medical Research and Materiel Command (USAMRMC) grant W81XWH-09-1-0577 and National Institutes of Health (NIH) grant CA148565 to EW. Computations were performed on the HPC Blacklight of the Pittsburgh Supercomputer Center, supported by NIH grant 5P41RR006009, and on the HPC Harold of the USAMRMC Aberdeen Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blundell TL, 2000, BIOL CHEM, V381, P955, DOI 10.1515/BC.2000.117; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isayev O, 2007, J COMPUT CHEM, V28, P1598, DOI 10.1002/jcc.20696; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Louie GV, 1997, MOL CELL, V1, P67, DOI 10.1016/S1097-2765(00)80008-8; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Miura K, 2002, BIOCHEM BIOPH RES CO, V294, P1040, DOI 10.1016/S0006-291X(02)00585-5; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sato K, 2003, FEBS LETT, V553, P232, DOI 10.1016/S0014-5793(03)01005-6; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; TADAKI DK, 1993, J BIOL CHEM, V268, P10114; Tanizaki S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1865992; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Weis A, 2006, J MED CHEM, V49, P6596, DOI 10.1021/jm0608210; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Wereszczynski J, 2012, Q REV BIOPHYS, V45, P1, DOI 10.1017/S0033583511000096; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Zhao SL, 2011, J PHYS CHEM B, V115, P6971, DOI 10.1021/jp201949k	53	62	64	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54136	10.1371/journal.pone.0054136	http://dx.doi.org/10.1371/journal.pone.0054136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23382875	Green Published, gold			2022-12-25	WOS:000314023600033
J	Carmona-Catot, G; Magellan, K; Garcia-Berthou, E				Carmona-Catot, Gerard; Magellan, Kit; Garcia-Berthou, Emili			Temperature-Specific Competition between Invasive Mosquitofish and an Endangered Cyprinodontid Fish	PLOS ONE			English	Article							CLIMATE-CHANGE; LIFE-HISTORY; APHANIUS-IBERUS; SWIMMING PERFORMANCE; TRINIDADIAN GUPPY; ABIOTIC FACTORS; COEXISTENCE; BEHAVIOR; PISCES; COSTS	Condition-specific competition is widespread in nature. Species inhabiting heterogeneous environments tend to differ in competitive abilities depending on environmental stressors. Interactions between these factors can allow coexistence of competing species, which may be particularly important between invasive and native species. Here, we examine the effects of temperature on competitive interactions between invasive mosquitofish, Gambusia holbrooki, and an endemic Iberian toothcarp, Aphanius iberus. We compare the tendency to approach heterospecifics and food capture rates between these two species, and examine differences between sexes and species in aggressive interactions, at three different temperatures (19, 24 and 29 degrees C) in three laboratory experiments. Mosquitofish exhibit much more aggression than toothcarp. We show that mosquitofish have the capacity to competitively displace toothcarp through interference competition and this outcome is more likely at higher temperatures. We also show a reversal in the competitive hierarchy through reduced food capture rate by mosquitofish at lower temperatures and suggest that these two types of competition may act synergistically to deprive toothcarp of food at higher temperatures. Males of both species carry out more overtly aggressive acts than females, which is probably related to the marked sexual dimorphism and associated mating systems of these two species. Mosquitofish may thus impact heavily on toothcarp, and competition from mosquitofish, especially in warmer summer months, may lead to changes in abundance of the native species and displacement to non-preferred habitats. Globally increasing temperatures mean that highly invasive, warm-water mosquitofish may be able to colonize environments from which they are currently excluded through reduced physiological tolerance to low temperatures. Research into the effects of temperature on interactions between native and invasive species is thus of fundamental importance.	[Carmona-Catot, Gerard; Magellan, Kit; Garcia-Berthou, Emili] Univ Girona, Inst Aquat Ecol, Girona, Catalonia, Spain	Universitat de Girona	Carmona-Catot, G (corresponding author), Univ Girona, Inst Aquat Ecol, Girona, Catalonia, Spain.	carmona.catot@gmail.com	Magellan, Kit/B-5528-2012; García-Berthou, Emili/A-5392-2008	García-Berthou, Emili/0000-0001-8412-741X; Magellan, Kit/0000-0002-0860-5931	University of Girona [BR2010/10]; Spanish Ministry of Science [CGL2009-12877-C02-01, CSD2009-00065]	University of Girona; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Gerard Carmona-Catot held a doctoral fellowship (BR2010/10) from the University of Girona during the preparation of the manuscript. Financial support was provided by the Spanish Ministry of Science (projects CGL2009-12877-C02-01 and Consolider-Ingenio 2010 CSD2009-00065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Alcaraz C, 2007, ENVIRON BIOL FISH, V78, P193, DOI 10.1007/s10641-006-0018-0; Andersson Malte, 1994; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Benejam L, 2009, BIOL INVASIONS, V11, P2265, DOI 10.1007/s10530-008-9413-0; Botham MS, 2006, NATURWISSENSCHAFTEN, V93, P431, DOI 10.1007/s00114-006-0131-0; Caiola N, 2005, J APPL ICHTHYOL, V21, P358, DOI 10.1111/j.1439-0426.2005.00684.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carmona-Catot G, 2011, DIVERS DISTRIB, V17, P214, DOI 10.1111/j.1472-4642.2011.00743.x; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Cote IM, 2012, CURR ZOOL, V58, P1; DESTASO J, 1994, T AM FISH SOC, V123, P289, DOI 10.1577/1548-8659(1994)123<0289:IOWTOI>2.3.CO;2; Doadrio I., 2002, ATLAS LIBRO ROJO PEC; DUNSON WA, 1994, ESTUARIES, V17, P102, DOI 10.2307/1352338; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Fobert E, 2011, J FISH BIOL, V79, P1592, DOI 10.1111/j.1095-8649.2011.03083.x; Freyhof J, 2011, EUROPEAN RED LIST FR; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Hernandez M, 2002, AQUAC RES, V33, P933, DOI 10.1046/j.1365-2109.2002.00744.x; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Huntingford F.A., 1987, ANIMAL CONFLICT; JOHANSEN PH, 1980, CAN J ZOOL, V58, P586, DOI 10.1139/z80-082; Karplus I, 2007, J FISH BIOL, V71, P1023, DOI 10.1111/j.1095-8649.2007.01568.x; Krassoi FR, 2008, J ANIM ECOL, V77, P5, DOI 10.1111/j.1365-2656.2007.01316.x; La Peyre MKG, 2001, ECOLOGY, V82, P62, DOI 10.2307/2680086; Laha M, 2006, BIOL INVASIONS, V8, P719, DOI 10.1007/s10530-005-3426-8; Lang B, 2012, J ANIM ECOL, V81, P516, DOI 10.1111/j.1365-2656.2011.01931.x; Lapointe NWR, 2012, DIVERS DISTRIB, V18, P282, DOI 10.1111/j.1472-4642.2011.00858.x; Lowe S., 2000, ENCY BIOL INVASIONS; Magellan K, 2005, BEHAV ECOL SOCIOBIOL, V58, P366, DOI 10.1007/s00265-005-0950-6; Magellan K, 2006, ANIM BEHAV, V72, P75, DOI 10.1016/j.anbehav.2005.09.022; Magellan K, 2010, AFR ZOOL, V45, P18, DOI 10.3377/004.045.0115; Magurran AE, 2000, J FISH BIOL, V57, P839, DOI [10.1006/jfbi.2000.1391, 10.1111/j.1095-8649.2000.tb02196.x]; Meffe GK, 1989, ECOLOGY EVOLUTION LI; Moreno-Amich R, 1999, EFECTO REGULACION HI, P115; Navarro AR, 2012, MUSEO NACL CIENCIAS; Neat FC, 1998, ANIM BEHAV, V55, P875, DOI 10.1006/anbe.1997.0668; Oliva Paterna FJ, 2008, FARTET REGION MURCIA; Oliva-Paterna FJ, 2006, ENVIRON BIOL FISH, V75, P307, DOI 10.1007/s10641-006-0016-2; Oltra R, 2000, ENVIRON BIOL FISH, V57, P113, DOI 10.1023/A:1007579527064; Oyugi DO, 2012, REV FISH BIOL FISHER, V22, P499, DOI 10.1007/s11160-011-9243-5; Pilastro A, 2003, ANIM BEHAV, V65, P1161, DOI 10.1006/anbe.2003.2118; Portz DE, 2006, REV FISH BIOL FISHER, V16, P125, DOI 10.1007/s11160-006-9012-z; Priddis E, 2009, DIVERS DISTRIB, V15, P682, DOI 10.1111/j.1472-4642.2009.00573.x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Reddon AR, 2011, ANIM BEHAV, V82, P93, DOI 10.1016/j.anbehav.2011.04.003; Rincon PA, 2002, J FISH BIOL, V61, P1560, DOI 10.1006/jfbi.2002.2175; Rowe DK, 2007, J APPL ICHTHYOL, V23, P668, DOI 10.1111/j.1439-0426.2007.00912.x; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Seda JB, 2012, ETHOLOGY, V118, P411, DOI 10.1111/j.1439-0310.2012.02025.x; Sinclair ELE, 2011, J ZOOL, V283, P243, DOI 10.1111/j.1469-7998.2010.00776.x; Smith CC, 2006, ANIM BEHAV, V71, P401, DOI 10.1016/j.anbehav.2005.06.003; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Taniguchi Y, 2000, ECOLOGY, V81, P2027, DOI 10.2307/177290; Vargas MJ, 1997, NETH J ZOOL, V47, P143; Vargas MJ, 1996, HYDROBIOLOGIA, V341, P215, DOI 10.1007/BF00014686; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; WARNER SC, 1993, ECOLOGY, V74, P183, DOI 10.2307/1939513; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wilson RS, 2005, ANIM BEHAV, V70, P1387, DOI 10.1016/j.anbehav.2004.12.024	65	57	58	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54734	10.1371/journal.pone.0054734	http://dx.doi.org/10.1371/journal.pone.0054734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23382951	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500118
J	Vandenhoudt, HM; Langat, L; Menten, J; Odongo, F; Oswago, S; Luttah, G; Zeh, C; Crucitti, T; Laserson, K; Vulule, J; Buve, A				Vandenhoudt, Hilde M.; Langat, Lilian; Menten, Joris; Odongo, Fredrick; Oswago, Simon; Luttah, Geoffrey; Zeh, Clement; Crucitti, Tania; Laserson, Kayla; Vulule, John; Buve, Anne			Prevalence of HIV and Other Sexually Transmitted Infections among Female Sex Workers in Kisumu, Western Kenya, 1997 and 2008	PLOS ONE			English	Article							COMMERCIAL SEX; UNSAFE SEX; REGULAR PARTNERS; RISK BEHAVIORS; CONDOM USE; TRANSMISSION; PROSTITUTES; AFRICA; VIRUS; EPIDEMIC	Background: In 1997, a survey in Kisumu found a prevalence of HIV infection among female sex workers (FSW) of 75%. Only 50% reported using a condom with the last client. In 2008, we conducted another survey to collect data to inform an intervention targeting FSW in Kisumu. Methods: In 2008 FSW were recruited by respondent-driven sampling. Women completed a questionnaire and were tested for HIV and other sexually transmitted infections (STIs). Multiple logistic regression analysis was done to explore factors associated with HIV-infection, and with condom use. Prevalence of HIV infection was compared in the two surveys from 1997 and 2008. Multivariate analysis was used to assess whether a change in HIV prevalence between the two surveys could be explained by changes in socio-demographic characteristics and/or behavioral factors. Results: 481 FSW participated in the 2008 study. HIV prevalence was 56.5% (95% CI 52.0-61.6). Factors independently associated with HIV were age older than 29 years; being a widow; STI treatment in the past year; herpes simplex virus Type-2 infection; bacterial vaginosis; and trichomoniasis. Condom use with last client was reported by 75.0% (95% CI 70.9-78.9). Predictors of condom use with the last client were age older than 29 years; higher price paid by last client; ever having been tested for HIV. Predictors of unprotected sex were being drunk during last sex act; usually having sex during menses; and STI treatment in the past year. The odds ratio of HIV infection associated with year of survey was 0.49 (95% CI 0.33-0.75) after adjusting for socio-demographic and behavioral factors. Conclusions: The prevalence of HIV among FSW in Kisumu was found to be lower in 2008 than in 1997, while reported condom use was higher. However, access to HIV/STI prevention and care services needs to improve to further decrease HIV transmission between FSW and their clients.	[Vandenhoudt, Hilde M.; Langat, Lilian; Menten, Joris; Crucitti, Tania; Buve, Anne] Inst Trop Med, B-2000 Antwerp, Belgium; [Odongo, Fredrick; Oswago, Simon; Vulule, John] Kenya Govt Med Res Ctr, Kisian, Kenya; [Luttah, Geoffrey] Family Hlth Opt, Kisumu, Kenya; [Zeh, Clement; Laserson, Kayla] Ctr Dis Control & Prevent, Kisian, Kenya	Institute of Tropical Medicine (ITM); Kenya Medical Research Institute	Buve, A (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	abuve@itg.be	Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; 	Presidential Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention [5U62PSO24444-05]	Presidential Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention	This work was funded by the Presidential Emergency Plan for AIDS Relief through a cooperative agreement with the Centers for Disease Control and Prevention (grant number 5U62PSO24444-05). PEPFAR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Centers for Disease Control and Prevention in Atlanta reviewed the protocol and the manuscript. The IRB of the Centers for Disease Control and Prevention gave approval for the study.	[Anonymous], 2009, SAMPLING DESIGN ANAL; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Colvin M, 2008, ANAL HIV RESPONSES M; DCOSTA LJ, 1985, SEX TRANSM DIS, V12, P64, DOI 10.1097/00007435-198504000-00002; Diallo BL, 2010, REV EPIDEMIOL SANTE, V58, P245, DOI 10.1016/j.respe.2010.03.003; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Kenya National AIDS Control Council, 2009, KEN AN HIV PREV RESP; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Lau JTF, 2007, AIDS CARE, V19, P721, DOI 10.1080/09540120601084373; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Maleta K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-243; Ministry of Health Kenya, 2005, KEN NAT GUID RES DEV; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morris CN, 2009, AIDS BEHAV, V13, P860, DOI 10.1007/s10461-008-9431-z; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; PIOT P, 1987, J INFECT DIS, V155, P1108, DOI 10.1093/infdis/155.6.1108; PLUMMER FA, 1991, AIDS, V5, pS169; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; SIMONSEN JN, 1990, AIDS, V4, P139, DOI 10.1097/00002030-199002000-00007; StataCorp, 2007, STAT STAT SOFTW REL; Stoebenau K, 2009, AM J PUBLIC HEALTH, V99, P811, DOI 10.2105/AJPH.2007.118422; Uganda National AIDS Commission, 2009, UG HIV MOD TRANSM PR; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Volz E, 2007, RESPONDENT DRIVEN SA; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151	37	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54953	10.1371/journal.pone.0054953	http://dx.doi.org/10.1371/journal.pone.0054953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372801	Green Submitted, gold, Green Published			2022-12-25	WOS:000314021500149
J	Sekiguchi, T; Ito, R; Hayakawa, H; Sekiguchi, M				Sekiguchi, Takeshi; Ito, Riyoko; Hayakawa, Hiroshi; Sekiguchi, Mutsuo			Elimination and Utilization of Oxidized Guanine Nucleotides in the Synthesis of RNA and Its Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; ESCHERICHIA-COLI MUTT; PROTEIN HYDROLYZES; ADENYLATE KINASE; DNA; DAMAGE; RIBONUCLEOTIDE; MUTATIONS; GUANOSINE; ENZYME	Reactive oxygen species are produced as side products of oxygen utilization and can lead to the oxidation of nucleic acids and their precursor nucleotides. Among the various oxidized bases, 8-oxo-7,8-dihydroguanine seems to be the most critical during the transfer of genetic information because it can pair with both cytosine and adenine. During the de novo synthesis of guanine nucleotides, GMP is formed first, and it is converted to GDP by guanylate kinase. This enzyme hardly acts on an oxidized form of GMP(8-oxo-GMP) formed by the oxidation of GMP or by the cleavage of 8-oxo-GDP and 8-oxo-GTP by MutT protein. Although the formation of 8-oxo-GDP from 8-oxo-GMP is thus prevented, 8-oxo-GDP itself may be produced by the oxidation of GDP by reactive oxygen species. The 8-oxo-GDP thus formed can be converted to 8-oxo-GTP because nucleoside-diphosphate kinase and adenylate kinase, both of which catalyze the conversion of GDP to GTP, do not discriminate 8-oxo-GDP from normal GDP. The 8-oxo-GTP produced in this way and by the oxidation of GTP can be used for RNA synthesis. This misincorporation is prevented by MutT protein, which has the potential to cleave 8-oxo-GTP as well as 8-oxo-GDP to 8-oxo-GMP. When C-14-labeled 8-oxo-GTP was applied to CaCl2-permeabilized cells of a mutT(-) mutant strain, it could be incorporated into RNA at 4% of the rate for GTP. Escherichia coli cells appear to possess mechanisms to prevent misincorporation of 8-oxo-7,8-dihydroguanine into RNA.	[Sekiguchi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Ito, Riyoko; Hayakawa, Hiroshi; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Dept Biochem, Fukuoka 8140193, Japan; [Ito, Riyoko; Hayakawa, Hiroshi; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan	Kyushu University; Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Sekiguchi, M (corresponding author), Fukuoka Dent Coll, Dept Biochem, Fukuoka 8140193, Japan.	mseki@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, including the MEXT-supported Program for the Strategic Research Foundation at Private Universities and grants-in-aid for scientific research.	ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; Baker T. A., 1992, DNA REPLICATION, P55; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Boyer P.D, 1973, ENZYMES, P279; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Fowler RG, 2003, DNA REPAIR, V2, P159, DOI 10.1016/S1568-7864(02)00193-3; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; GENTRY D, 1993, J BIOL CHEM, V268, P14316; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; LAGERKVIST U, 1958, J BIOL CHEM, V233, P143; Lu Q, 1996, P NATL ACAD SCI USA, V93, P5720, DOI 10.1073/pnas.93.12.5720; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Nakatsu Y, 2006, OXIDATIVE STRESS, DISEASE AND CANCER, P221, DOI 10.1142/9781860948046_0006; OESCHGER MP, 1966, J BIOL CHEM, V241, P5452; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Sambrook J., 1989, MOL CLONING LAB MANU, P116; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x; Setoyama D, 2011, MUTAT RES-FUND MOL M, V707, P9, DOI 10.1016/j.mrfmmm.2010.12.001; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Willemoes M, 2005, ARCH BIOCHEM BIOPHYS, V444, P195, DOI 10.1016/j.abb.2005.10.003	30	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8128	8135		10.1074/jbc.M112.418723	http://dx.doi.org/10.1074/jbc.M112.418723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23376345	hybrid, Green Published			2022-12-25	WOS:000316564500013
J	Kim, BJ; Hong, SH; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Hong, Seok-Hyun; Kook, Yoon-Hoh; Kim, Bum-Joon			Molecular Evidence of Lateral Gene Transfer in rpoB Gene of Mycobacterium yongonense Strains via Multilocus Sequence Analysis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; NONTUBERCULOUS MYCOBACTERIA; AVIUM COMPLEX; RESTRICTION ANALYSIS; DIFFERENTIATION; HSP65; DNA; IDENTIFICATION	Recently, a novel species, Mycobacterium yongonense (DSM 45126(T)), was introduced and while it is phylogenetically related to Mycobacterium intracellulare, it has a distinct RNA polymerase beta-subunit gene (rpoB) sequence that is identical to that of Mycobacterium parascrofulaceum, which is a distantly related scotochromogen, which suggests the acquisition of the rpoB gene via a potential lateral gene transfer (LGT) event. The aims of this study are to prove the presence of the LGT event in the rpoB gene of the M. yongonense strains via multilocus sequence analysis (MLSA). In order to determine the potential of an LGT event in the rpoB gene of the M. yongonense, the MLSA based on full rpoB sequences (3447 or 3450 bp) and on partial sequences of five other targets [16S rRNA (1383 or 1395 bp), hsp65 (603 bp), dnaJ (192 bp), recA (1053 bp), and sodA (501 bp)] were conducted. Incongruences between the phylogenetic analysis of the full rpoB and the five other genes in a total of three M. yongonense strains [two clinical strains (MOTT-12 and MOTT-27) and one type strain (DSM 45126(T))] were observed, suggesting that rpoB gene of three M. yongonense strains may have been acquired very recently via an LGT event from M. parascrofulaceum, which is a distantly related scotochromogen.	[Kim, Byoung-Jun; Hong, Seok-Hyun; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, SNUMRC, Dept Microbiol & Immunol, Canc Res Inst,Coll Med,Inst Endem Dis, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, BJ (corresponding author), Seoul Natl Univ, SNUMRC, Dept Microbiol & Immunol, Canc Res Inst,Coll Med,Inst Endem Dis, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/J-2739-2012; Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A101205]	Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by grant A101205 from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; FROTHINGHAM R, 1993, J BACTERIOL, V175, P2818, DOI 10.1128/JB.175.10.2818-2825.1993; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim BJ, 2004, J CLIN MICROBIOL, V42, P1308, DOI 10.1128/JCM.42.3.1308-1312.2004; Kim BJ, 2001, J CLIN MICROBIOL, V39, P2102, DOI 10.1128/JCM.39.6.2102-2109.2001; Kim BJ, 2012, INT J SYST EVOL MICR; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kim HJ, 2006, J CLIN MICROBIOL, V44, P3855, DOI 10.1128/JCM.01214-06; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Morita Y, 2004, J MED MICROBIOL, V53, P813, DOI 10.1099/jmm.0.45601-0; Mun HS, 2007, MICROBIOL IMMUNOL, V51, P105, DOI 10.1111/j.1348-0421.2007.tb03880.x; Park JH, 2010, J MED MICROBIOL, V59, P1037, DOI 10.1099/jmm.0.020727-0; ROGALL T, 1990, J GEN MICROBIOL, V136, P1915, DOI 10.1099/00221287-136-9-1915; Ryoo SW, 2008, J CLIN LAB ANAL, V22, P415, DOI 10.1002/jcla.20278; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmon KE, 2011, EMERG INFECT DIS, V17, P1692, DOI 10.3201/eid1709.101667; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Turenne CY, 2004, INT J SYST EVOL MICR, V54, P1543, DOI 10.1099/ijs.0.02940-0	25	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e51846	10.1371/journal.pone.0051846	http://dx.doi.org/10.1371/journal.pone.0051846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382812	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600005
J	Li, NF; Li, HJ; Zhang, DL; Zhang, JH; Yao, XG; Wang, HM; Abulikemu, S; Zhou, KM; Zhang, XY				Li, Nan-Fang; Li, Hong-Jian; Zhang, De-Lian; Zhang, Ju-Hong; Yao, Xiao-Guang; Wang, Hong-Mei; Abulikemu, Suofeiya; Zhou, Ke-Ming; Zhang, Xiang-Yang			Genetic Variations in the KCNJ5 Gene in Primary Aldosteronism Patients from Xinjiang, China	PLOS ONE			English	Article							K+-CHANNEL; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; MESSENGER-RNA; MUTATIONS; POLYMORPHISMS; HYPERALDOSTERONISM; HYPERTENSION; ASSOCIATION; EXPRESSION	Background: Primary aldosteronism (PA) is the most common endocrine form of secondary hypertension, and one of the most common subtypes of sporadic PA is aldosterone-producing adenoma (APA). Recently, two somatic mutations of the KCNJ5 gene were implicated in APA, and two germline mutations were associated with familial hyperaldosteronism III. Objectives: This case-control study was designed to investigate the relationship between genetic variations in the KCNJ5 gene and sporadic PA patients in Xinjiang, China. Methods: Five common single nucleotide polymorphisms (SNPs) of the KCNJ5 gene (rs6590357, rs4937391, rs3740835, rs2604204, and rs11221497) were detected in patients with sporadic PA (n=235) and essential hypertension (EH; n=913) by the TaqMan polymerase chain reaction method. Results: The EH group and the PA group showed significant differences in the distributions of genotypes and alleles of rs4937391 and rs2604204 in total and male subjects (P<0.05), as well as rs3740835 in male subjects (P<0.05). However, only the association between the rs2604204 genotype and male sporadic PA remained significant after Bonferroni's correction (P<0.01). Furthermore, logistic regression analysis demonstrated that the CC genotype of rs2604204 was a risk factor for male patients with sporadic PA, after adjusting for age and body mass index (odds ratio=2.228, 95% CI: 1.300-3.819, P=0.004). Conclusion: The genetic variant rs2604204 of KCNJ5 is associated with sporadic PA in Chinese males, suggesting that KCNJ5 may be involved in the pathogenesis of sporadic PA in these particular patients	[Li, Nan-Fang; Zhang, De-Lian; Zhang, Ju-Hong; Yao, Xiao-Guang; Wang, Hong-Mei; Abulikemu, Suofeiya; Zhou, Ke-Ming] Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Ctr Diag Treatment & Res Hypertens Xinjiang, Urumqi, Peoples R China; [Li, Hong-Jian; Zhang, Xiang-Yang] Xinjiang Med Univ, Urumqi, Peoples R China	Xinjiang Medical University	Li, NF (corresponding author), Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Ctr Diag Treatment & Res Hypertens Xinjiang, Urumqi, Peoples R China.	lnanfang@yahoo.com.cn			National Natural Science Foundation of China [81160109, 81260129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81160109 and No. 81260129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Azizan EAB, 2012, HYPERTENSION, V59, P587, DOI 10.1161/HYPERTENSIONAHA.111.186239; Born-Frontsberg E, 2009, J CLIN ENDOCR METAB, V94, P1125, DOI 10.1210/jc.2008-2116; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Catena C, 2008, ARCH INTERN MED, V168, P80, DOI 10.1001/archinternmed.2007.33; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Gomez-Benito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025449; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jabbari J, 2011, CARDIOLOGY, V118, P116, DOI 10.1159/000323840; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Li NF, 2012, ANN CLIN BIOCHEM, V49, P369, DOI 10.1258/acb.2011.011129; Li NF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-124; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mulatero P, 2012, HYPERTENSION, V59, P235, DOI 10.1161/HYPERTENSIONAHA.111.183996; Murthy M, 2012, J HYPERTENS, V30, P1827, DOI 10.1097/HJH.0b013e328356139f; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; Scholl UI, 2012, P NATL ACAD SCI USA, V109, P2533, DOI 10.1073/pnas.1121407109; Sechi LA, 2006, JAMA-J AM MED ASSOC, V295, P2638, DOI 10.1001/jama.295.22.2638; Shimodaira M, 2010, EUR J ENDOCRINOL, V163, P671, DOI 10.1530/EJE-10-0428; Stowasser M, 2005, J CLIN ENDOCR METAB, V90, P5070, DOI 10.1210/jc.2005-0681; Taguchi R, 2012, J CLIN ENDOCR METAB, V97, P1311, DOI 10.1210/jc.2011-2885; Tiu SC, 2005, J CLIN ENDOCR METAB, V90, P72, DOI 10.1210/jc.2004-1149; Zhang C, 2009, HEART LUNG CIRC, V18, P257, DOI 10.1016/j.hlc.2008.12.002	31	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54051	10.1371/journal.pone.0054051	http://dx.doi.org/10.1371/journal.pone.0054051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382865	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600022
J	Sims, JT; Ganguly, SS; Bennett, H; Friend, JW; Tepe, J; Plattner, R				Sims, Jonathan T.; Ganguly, Sourik S.; Bennett, Holly; Friend, J. Woodrow; Tepe, Jessica; Plattner, Rina			Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-kappa B and HSP27/p38/AKT Pathways and by Inhibiting ABCB1	PLOS ONE			English	Article							BREAST-CANCER CELLS; MULTIDRUG-RESISTANCE; ABCG2 BCRP; C-ABL; TYROSINE KINASE; GENE-EXPRESSION; MELANOMA-CELLS; PROTEIN-KINASE; MESYLATE; TRANSCRIPTION	Despite advances in cancer detection and prevention, a diagnosis of metastatic disease remains a death sentence due to the fact that many cancers are either resistant to chemotherapy (conventional or targeted) or develop resistance during treatment, and residual chemoresistant cells are highly metastatic. Metastatic cancer cells resist the effects of chemotherapeutic agents by upregulating drug transporters, which efflux the drugs, and by activating proliferation and survival signaling pathways. Previously, we found that c-Abl and Arg non-receptor tyrosine kinases are activated in breast cancer, melanoma, and glioblastoma cells, and promote cancer progression. In this report, we demonstrate that the c-Abl/Arg inhibitor, imatinib (imatinib mesylate, STI571, Gleevec), reverses intrinsic and acquired resistance to the anthracycline, doxorubicin, by inducing G2/M arrest and promoting apoptosis in cancer cells expressing highly active c-Abl and Arg. Significantly, imatinib prevents intrinsic resistance by promoting doxorubicin-mediated NF-kappa B/p65 nuclear localization and repression of NF-kappa B targets in a STAT3-dependent manner, and by preventing activation of a novel STAT3/HSP27/p38/Akt survival pathway. In contrast, imatinib prevents acquired resistance by inhibiting upregulation of the ABC drug transporter, ABCB1, directly inhibiting ABCB1 function, and abrogating survival signaling. Thus, imatinib inhibits multiple novel chemoresistance pathways, which indicates that it may be effective in reversing intrinsic and acquired resistance in cancers containing highly active c-Abl and Arg, a critical step in effectively treating metastatic disease. Furthermore, since imatinib converts a master survival regulator, NF-kappa B, from a pro-survival into a pro-apoptotic factor, our data suggest that NF-kappa B inhibitors may be ineffective in sensitizing tumors containing activated c-Abl/Arg to anthracyclines, and instead might antagonize anthracycline-induced apoptosis.	[Sims, Jonathan T.; Ganguly, Sourik S.; Bennett, Holly; Friend, J. Woodrow; Tepe, Jessica; Plattner, Rina] Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of Kentucky	Plattner, R (corresponding author), Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	rplat2@uky.edu			NIH/NCI [R01CA116784]; NATIONAL CANCER INSTITUTE [R01CA116784] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by NIH/NCI R01CA116784. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Ashikawa K, 2004, BIOCHEM PHARMACOL, V67, P353, DOI 10.1016/j.bcp.2003.08.039; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Burger H, 2005, CANCER BIOL THER, V4, P747, DOI 10.4161/cbt.4.7.1826; Burger H, 2004, CELL CYCLE, V3, P1502, DOI 10.4161/cc.3.12.1331; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hafsi S, 2012, INT J ONCOL, V40, P639, DOI 10.3892/ijo.2011.1312; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; LEE JS, 1994, MOL PHARMACOL, V46, P627; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Mersin H, 2008, BREAST, V17, P341, DOI 10.1016/j.breast.2007.11.031; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; Paumi CM, 2003, BIOCHEMISTRY-US, V42, P5429, DOI 10.1021/bi027347u; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Pletz N, 2012, EXP DERMATOL, V21, P301, DOI 10.1111/j.1600-0625.2012.01440.x; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Ricci C, 2002, CANCER RES, V62, P5995; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Sims JT, 2009, CANCER CHEMOTH PHARM, V64, P629, DOI 10.1007/s00280-009-1004-y; Sims JT, 2009, BIOCHEM PHARMACOL, V78, P249, DOI 10.1016/j.bcp.2009.04.007; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tapia MA, 2007, CELL CYCLE, V6, P2284, DOI 10.4161/cc.6.18.4721; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Walsh N, 2010, BRIT J CANCER, V102, P1157, DOI 10.1038/sj.bjc.6605590; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576	59	81	86	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55509	10.1371/journal.pone.0055509	http://dx.doi.org/10.1371/journal.pone.0055509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383209	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600115
J	Solberg, MF; Skaala, O; Nilsen, F; Glover, KA				Solberg, Monica Favneboe; Skaala, Oystein; Nilsen, Frank; Glover, Kevin Alan			Does Domestication Cause Changes in Growth Reaction Norms? A Study of Farmed, Wild and Hybrid Atlantic Salmon Families Exposed to Environmental Stress	PLOS ONE			English	Article							HISTOCOMPATIBILITY CLASS-II; SALAR L.; RAINBOW-TROUT; PHENOTYPIC PLASTICITY; GENETIC-DIFFERENCES; PLASMA-CORTISOL; ONCORHYNCHUS-MYKISS; LOCAL ADAPTATION; RED JUNGLEFOWL; SELECTION	One of the most important traits linked with the successful domestication of animals is reducing their sensitivity to environmental stressors in the human controlled environment. In order to examine whether domestication selection in Atlantic salmon Salmo salar L., over approximately ten generations, has inadvertently selected for reduced responsiveness to stress, we compared the growth reaction norms of 29 wild, hybrid and domesticated families reared together under standard hatchery conditions (control) and in the presence of a stressor (reduced water level twice daily). The experiment was conducted for a 14 week period. Farmed salmon outgrew wild salmon 1:2.93 in the control tanks, and no overlap in mean weight was displayed between families representing the three groups. Thus, the elevation of the reaction norms differed among the groups. Overall, growth was approximately 25% lower in the stressed tanksl; however, farmed salmon outgrew wild salmon 1:3.42 under these conditions. That farmed salmon maintained a relatively higher growth rate than the wild salmon in the stressed tanks demonstrates a lower responsiveness to stress in the farmed salmon. Thus, flatter reaction norm slopes were displayed in the farmed salmon, demonstrating reduced plasticity for this trait under these specific experimental conditions. For all growth measurements, hybrid salmon displayed intermediate values. Wild salmon displayed higher heritability estimates for body weight than the hybrid and farmed salmon in both environments. This suggests reduced genetic variation for body weight in the farmed contra wild salmon studied here. While these results may be linked to the specific families and stocks investigated, and verification in other stocks and traits is needed, these data are consistent with the theoretical predictions of domestication.	[Solberg, Monica Favneboe; Skaala, Oystein; Glover, Kevin Alan] Inst Marine Res, Sect Populat Genet & Ecol, N-5024 Bergen, Norway; [Solberg, Monica Favneboe; Nilsen, Frank] Univ Bergen, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Glover, KA (corresponding author), Inst Marine Res, Sect Populat Genet & Ecol, POB 1870, N-5024 Bergen, Norway.	Kevin.Glover@imr.no		Solberg, Monica Favneboe/0000-0002-5844-9498	INTERACT [13159]; Research Council of Norway	INTERACT; Research Council of Norway(Research Council of Norway)	The project was conducted within the project INTERACT 13159 funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Awata S, 2011, AQUACULTURE, V314, P115, DOI 10.1016/j.aquaculture.2011.01.024; Bate D, 2012, LME4 LINEAR MIXED EF; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Besnier F, 2011, AQUACULT ENV INTERAC, V2, P75, DOI 10.3354/aei00032; Bidau CJ, 2009, GAYANA, V73, P55; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; BRONSON FH, 1984, BIOL REPROD, V31, P83, DOI 10.1095/biolreprod31.1.83; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Clifford SL, 1998, CAN J FISH AQUAT SCI, V55, P358, DOI 10.1139/cjfas-55-2-358; Clifford SL, 1998, J FISH BIOL, V52, P118, DOI 10.1111/j.1095-8649.1998.tb01557.x; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Darwish TL, 2009, CAN J FISH AQUAT SCI, V66, P83, DOI 10.1139/F08-185; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; FEVOLDEN SE, 1991, AQUACULTURE, V95, P53, DOI 10.1016/0044-8486(91)90072-F; Fevolden SE, 2002, AQUACULTURE, V205, P61, DOI 10.1016/S0044-8486(01)00660-3; FEVOLDEN SE, 1993, J FISH BIOL, V43, P919, DOI 10.1111/j.1095-8649.1993.tb01166.x; Fevolden SE, 1999, J FISH BIOL, V54, P900, DOI 10.1111/j.1095-8649.1999.tb02040.x; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, BEHAV ECOL, V8, P470, DOI 10.1093/beheco/8.5.470; Fleming IA, 1997, ICES J MAR SCI, V54, P1051, DOI 10.1006/jmsc.1997.0289; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Fox J., 2011, COMPANION APPL REGRE; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Fritts AL, 2007, CAN J FISH AQUAT SCI, V64, P813, DOI 10.1139/F07-057; GAVRILETS S, 1993, J EVOLUTION BIOL, V6, P49, DOI 10.1046/j.1420-9101.1993.6010049.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; GJEDREM T, 1975, AQUACULTURE, V6, P23, DOI 10.1016/0044-8486(75)90087-3; GJEDREM T, 1979, Z TIERZ ZUCHTUNGSBIO, V96, P56; Gjedrem T, 2006, DEV AQUATIC ANIMAL G, P22; GJERDE B, 1984, AQUACULTURE, V36, P97, DOI 10.1016/0044-8486(84)90057-7; GJERDE B, 1986, AQUACULTURE, V57, P37, DOI 10.1016/0044-8486(86)90179-1; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2006, AQUACULTURE, V254, P72, DOI 10.1016/j.aquaculture.2005.10.040; Glover KA, 2004, J FISH BIOL, V64, P1168, DOI 10.1111/j.0022-1112.2004.00376.x; Glover KA, 2004, AQUACULTURE, V232, P41, DOI 10.1016/S0044-8486(03)00454-X; Glover KA, 2001, J FISH BIOL, V59, P105, DOI 10.1111/j.1095-8649.2001.tb02341.x; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Gross MR, 1998, CAN J FISH AQUAT SCI, V55, P131, DOI 10.1139/cjfas-55-S1-131; Gulevich RG, 2004, PHYSIOL BEHAV, V82, P513, DOI 10.1016/j.physbeh.2004.04.062; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Herbinger CM, 1999, AQUACULTURE, V173, P105, DOI 10.1016/S0044-8486(98)00479-7; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; Houde ALS, 2010, CONSERV GENET, V11, P785, DOI 10.1007/s10592-009-9892-2; Jensen P, 2006, APPL ANIM BEHAV SCI, V97, P3, DOI 10.1016/j.applanim.2005.11.015; Jentoft S, 2005, COMP BIOCHEM PHYS A, V141, P353, DOI 10.1016/j.cbpb.2005.06.006; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kunzl C, 1999, HORM BEHAV, V35, P28, DOI 10.1006/hbeh.1998.1493; Lankin V, 1997, GENET SEL EVOL, V29, P73, DOI 10.1051/gse:19970105; Lankin VS, 1997, GENETIKA+, V33, P1119; Lankin VS, 2000, ZH VYSSH NERV DEYAT+, V50, P1016; Lindqvist C, 2009, BEHAV PROCESS, V81, P80, DOI 10.1016/j.beproc.2009.02.005; Lund RA, 1989, RES REPORT NORWEGIAN, V1, P1; Marchetti MP, 2003, ENVIRON BIOL FISH, V66, P9, DOI 10.1023/A:1023269221678; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1006/jmsc.1997.0286; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Mignon-Grasteau S, 2005, LIVEST PROD SCI, V93, P3, DOI 10.1016/j.livprodsci.2004.11.001; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Mjolnerod IB, 1997, HEREDITAS, V127, P239, DOI 10.1111/j.1601-5223.1997.t01-1-00239.x; Morris MRJ, 2011, EVOL APPL, V4, P444, DOI 10.1111/j.1752-4571.2010.00159.x; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Ottera H, 2004, REPORT I MARINE RES, V3, P1; PICKERING AD, 1993, AQUACULTURE, V111, P51, DOI 10.1016/0044-8486(93)90024-S; Pottinger TG, 1999, AQUACULTURE, V175, P351, DOI 10.1016/S0044-8486(99)00107-6; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reilly A, 1999, AQUACULTURE, V173, P459, DOI 10.1016/S0044-8486(98)00476-1; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Sanchez JA, 1996, HEREDITY, V77, P423, DOI 10.1038/hdy.1996.162; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Skaala O, 2005, J FISH BIOL, V67, P118, DOI 10.1111/j.0022-1112.2005.00843.x; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; SLETTAN A, 1995, ANIM GENET, V26, P281, DOI 10.1111/j.1365-2052.1995.tb03262.x; Solberg Monica F., 2012, BMC Research Notes, V5, P672, DOI 10.1186/1756-0500-5-672; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Taggart JB, 2007, MOL ECOL NOTES, V7, P412, DOI 10.1111/j.1471-8286.2006.01616.x; Tanck MWT, 2002, AQUACULTURE, V204, P419, DOI 10.1016/S0044-8486(01)00828-6; Thodesen J, 1999, AQUACULTURE, V180, P237, DOI 10.1016/S0044-8486(99)00204-5; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; van den Brandt J, 2000, CLIN EXP PHARMACOL P, V27, P793, DOI 10.1046/j.1440-1681.2000.03336.x; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; WOODWARD CC, 1987, T AM FISH SOC, V116, P574, DOI 10.1577/1548-8659(1987)116<574:PSRIWA>2.0.CO;2; Wynne JW, 2007, J FISH BIOL, V70, P45, DOI 10.1111/j.1095-8649.2007.01364.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	111	87	87	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54469	10.1371/journal.pone.0054469	http://dx.doi.org/10.1371/journal.pone.0054469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382901	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600028
J	Yajima, I; Colombo, S; Puig, I; Champeval, D; Kumasaka, M; Belloir, E; Bonaventure, J; Mark, M; Yamamoto, H; Taketo, MM; Choquet, P; Etchevers, HC; Beermann, F; Delmas, V; Monassier, L; Larue, L				Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Mark, Manuel; Yamamoto, Hiroaki; Taketo, Mark M.; Choquet, Philippe; Etchevers, Heather C.; Beermann, Friedrich; Delmas, Veronique; Monassier, Laurent; Larue, Lionel			A Subpopulation of Smooth Muscle Cells, Derived from Melanocyte-Competent Precursors, Prevents Patent Ductus Arteriosus	PLOS ONE			English	Article							CARDIAC NEURAL CREST; BETA-CATENIN GENE; MOUSE HEART; MICE; EXPRESSION; RECEPTOR; SYSTEM; CYCLOOXYGENASE-2; MUTATIONS; MYOSIN	Background: Patent ductus arteriosus is a life-threatening condition frequent in premature newborns but also present in some term infants. Current mouse models of this malformation generally lead to perinatal death, not reproducing the full phenotypic spectrum in humans, in whom genetic inheritance appears complex. The ductus arteriosus (DA), a temporary fetal vessel that bypasses the lungs by shunting the aortic arch to the pulmonary artery, is constituted by smooth muscle cells of distinct origins (SMC1 and SMC2) and many fewer melanocytes. To understand novel mechanisms preventing DA closure at birth, we evaluated the importance of cell fate specification in SMC that form the DA during embryonic development. Upon specific Tyr::Cre-driven activation of Wnt/beta-catenin signaling at the time of cell fate specification, melanocytes replaced the SMC2 population of the DA, suggesting that SMC2 and melanocytes have a common precursor. The number of SMC1 in the DA remained similar to that in controls, but insufficient to allow full DA closure at birth. Thus, there was no cellular compensation by SMC1 for the loss of SMC2. Mice in which only melanocytes were genetically ablated after specification from their potential common precursor with SMC2, demonstrated that differentiated melanocytes themselves do not affect DA closure. Loss of the SMC2 population, independent of the presence of melanocytes, is therefore a cause of patent ductus arteriosus and premature death in the first months of life. Our results indicate that patent ductus arteriosus can result from the insufficient differentiation, proliferation, or contractility of a specific smooth muscle subpopulation that shares a common neural crest precursor with cardiovascular melanocytes.	[Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Delmas, Veronique; Larue, Lionel] Inst Curie, F-91405 Orsay, France; [Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Delmas, Veronique; Larue, Lionel] CNRS, UMR 3347, F-91405 Orsay, France; [Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Delmas, Veronique; Larue, Lionel] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Mark, Manuel] IGBMC, Illkirch Graffenstaden, France; [Yamamoto, Hiroaki] Nagahama Univ, Inst Biosci & Technol, Nagahama, Japan; [Taketo, Mark M.] Kyoto Univ, Dept Pharmacol, Kyoto, Japan; [Choquet, Philippe] Univ Strasbourg, CNRS, Inst Mecan Fluides & Solides, Strasbourg, France; [Etchevers, Heather C.] INSERM, UMR S910, F-13258 Marseille, France; [Etchevers, Heather C.] Aix Marseille Univ, Fac Med, Marseille, France; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Monassier, Laurent] Fac Med, EA4438, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Larue, L (corresponding author), Inst Curie, F-91405 Orsay, France.	lionel.larue@curie.fr	YAJIMA, Ichiro/I-7467-2014; Etchevers, Heather C./B-5813-2012; Colombo, Sophie/AAD-1030-2019; CHOQUET, Philippe/H-5868-2019; Larue, Lionel/I-6532-2016; Larue, Lionel/F-7355-2013	Etchevers, Heather C./0000-0003-0201-3799; Colombo, Sophie/0000-0001-8945-5631; CHOQUET, Philippe/0000-0003-0514-0726; Puig Borreil, Isabel/0000-0001-5614-4298; Delmas, veronique/0000-0001-7368-3664	Region Ile-de-France; Fondation pour la Recherche Medicale; Ligue contre le Cancer (Comite de l'Oise); Nevus Outreach, Inc.; Naevus France-Europe; Ligue Nationale Contre le Cancer (Equipe labellisee) [EL2012.LNCC/LL]; INCa [2011-1-PL BIO-03-IC-1]; Canceropole IdF	Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue contre le Cancer (Comite de l'Oise); Nevus Outreach, Inc.; Naevus France-Europe; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Canceropole IdF(Region Ile-de-France)	We warmly thank Prof. Constantinesco for his help, and Drs. Stephane Zaffran and Gaelle Odelin for their constructive criticism. IY, SC and MK were supported by Region Ile-de-France, the Fondation pour la Recherche Medicale and the Ligue contre le Cancer (Comite de l'Oise), respectively. HCE was supported by Nevus Outreach, Inc. and Naevus 2000 France-Europe. We thank members of the animal colony and imaging facilities of the Institut Curie. We dedicate this manuscript to the memory of Christine Larue.; This work was supported grants from the Ligue Nationale Contre le Cancer (Equipe labellisee) # EL2012.LNCC/LL (http://www.ligue-cancer.net/), INCa #2011-1-PL BIO-03-IC-1 (http://www.e-cancer.fr/), and Canceropole IdF (http://www.canceropole-idf.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2003, CANCER RES, V63, P728; Balani K, 2009, J R SOC INTERFACE, V6, P1097, DOI 10.1098/rsif.2009.0174; Bergwerff M, 1999, ANAT EMBRYOL, V200, P559, DOI 10.1007/s004290050304; Bergwerff M, 1998, CIRC RES, V82, P221; Brault V, 2001, DEVELOPMENT, V128, P1253; Brito FC, 2008, PIGM CELL MELANOMA R, V21, P464, DOI 10.1111/j.1755-148X.2008.00459.x; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Choquet P, 2007, CR BIOL, V330, P821, DOI 10.1016/j.crvi.2007.08.002; COCEANI F, 1973, CAN J PHYSIOL PHARM, V51, P220, DOI 10.1139/y73-031; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Colombo S, 2007, PIGM CELL RES, V20, P305, DOI 10.1111/j.1600-0749.2007.00387.x; COTTON RB, 1978, J PEDIATR-US, V92, P467, DOI 10.1016/S0022-3476(78)80451-X; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Echtler K, 2010, NAT MED, V16, P75, DOI 10.1038/nm.2060; GERSONY WM, 1983, J PEDIATR-US, V102, P895, DOI 10.1016/S0022-3476(83)80022-5; Guyonneau L, 2002, PIGM CELL RES, V15, P305, DOI 10.1034/j.1600-0749.2002.02039.x; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HEYMANN MA, 1975, PHYSIOL REV, V55, P62, DOI 10.1152/physrev.1975.55.1.62; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Jaffre F, 2004, CIRCULATION, V110, P969, DOI 10.1161/01.CIR.0000139856.20505.57; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lei TC, 2002, PIGM CELL RES, V15, P426, DOI 10.1034/j.1600-0749.2002.02044.x; Levin MD, 2009, J CLIN INVEST, V119, P3420, DOI 10.1172/JCI39109; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MARMON LM, 1984, ANN THORAC SURG, V38, P146, DOI 10.1016/S0003-4975(10)62223-0; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Miano JM, 2006, ZEBRAFISH, V3, P455, DOI 10.1089/zeb.2006.3.455; Mjaatvedt CH, 2005, ANAT REC PART A, V285A, P748, DOI 10.1002/ar.a.20210; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; PORTER SD, 1994, DEVELOPMENT, V120, P2103; Puig I, 2009, J CLIN INVEST, V119, P3586, DOI 10.1172/JCI39929; Puig I, 2009, PIGM CELL MELANOMA R, V22, P331, DOI 10.1111/j.1755-148X.2009.00546.x; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schneider DJ, 2006, CIRCULATION, V114, P1873, DOI 10.1161/CIRCULATIONAHA.105.592063; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tshori S, 2006, J CLIN INVEST, V116, P2673, DOI 10.1172/JCI27643; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yajima I, 2006, GENESIS, V44, P34, DOI 10.1002/gene.20182; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	57	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53183	10.1371/journal.pone.0053183	http://dx.doi.org/10.1371/journal.pone.0053183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382837	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600011
J	Neogi, U; Heylen, E; Shet, A; Chandy, S; Shamsunder, R; Sonnerborg, A; Ekstrand, ML				Neogi, Ujjwal; Heylen, Elsa; Shet, Anita; Chandy, Sara; Shamsunder, Ranjani; Soennerborg, Anders; Ekstrand, Maria L.			Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study	PLOS ONE			English	Article							DRUG-RESISTANCE; VIROLOGICAL FAILURE; INFECTED PATIENTS; ADHERENCE; METAANALYSIS; SUPPRESSION; MUTATIONS; SETTINGS; PROGRAMS; OPTIONS	Background: Short term efficacy of combination antiretroviral therapy (cART) in resource-constrained settings is comparable to that found in western studies. However, long term data are limited. India has the third largest HIV infected population in the world but the long-term outcome of first line therapy according to the national guidelines has not been evaluated yet. Therefore, we conducted a long-term longitudinal analysis of the efficacy of the national first-line therapy in India from an observational cohort of Indian patients in two different clinical settings. Methodology/Principal Findings: A total 323 patients who had been on ART for a median of 23 months and achieved virological suppression <100 copies/ml by their study baseline visit, were included and followed for two years. Blood samples were collected every six months for viral load and CD4 count. Drug resistance genotyping was performed when the viral load was >2000 copies/mL. Adherence and treatment interruptions (>48 h) were assessed via self-report. In the studied patients, the median duration of viral suppression was 44 months; 15.8% of patients showed viral rebound, and 2.8% viral failure. Viral rebound or failure was significantly negatively related to perfect adherence (100% adherence and no treatment interruption >48 hrs). Virological re-suppression in the subsequent visit was observed in three patients without any change in therapy despite the presence of key mutations. Conclusion/Significance: Our study reports for the first time, a good long-term response to the first line therapy for a median of nearly four years although a less than perfect adherence increases the risk for treatment failure and subsequent drug resistance development. The empirical findings in this study also indicate the overall success of the Indian ART program in two different settings which likely are representative of other clinics that operate under the national guidelines.	[Neogi, Ujjwal; Soennerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Neogi, Ujjwal; Shamsunder, Ranjani] St Johns Med Coll, Dept Microbiol, Div Clin Virol, Bangalore, Karnataka, India; [Heylen, Elsa; Ekstrand, Maria L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shet, Anita] St Johns Med Coll Hosp, Dept Paediat, Bangalore, Karnataka, India; [Chandy, Sara] St Johns Med Coll Hosp, Dept Med, Bangalore, Karnataka, India	Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; University of California System; University of California San Francisco; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College	Neogi, U (corresponding author), Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.	ujjwal.neogi@ki.se	Sönnerborg, Anders/W-2011-2019; Neogi, Ujjwal/E-4274-2012; Neogi, Ujjwal/ABF-1172-2021	Sönnerborg, Anders/0000-0001-8928-3374; Neogi, Ujjwal/0000-0002-0844-3338; Shet, Anita/0000-0002-7204-8164	National Institute of Mental Health (NIMH) (Bethesda, MD, USA) [R01MH067513]; Swedish Physicians against AIDS fund [FOa2011-0014]; EU FP7 CHAIN grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067513, R01MH095659] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH) (Bethesda, MD, USA); Swedish Physicians against AIDS fund; EU FP7 CHAIN grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant R01MH067513 from the National Institute of Mental Health (NIMH) (Bethesda, MD, USA) to MLE and the Swedish Physicians against AIDS fund (FOa2011-0014) to UN. A Sonnerborg acknowledges the support received from EU FP7 CHAIN grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2009, CURR OPIN HIV AIDS, V4, P459, DOI 10.1097/COH.0b013e328331dea5; Aleman S, 2002, AIDS, V16, P1039, DOI 10.1097/00002030-200205030-00010; [Anonymous], PAT AL ANT THER; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Ekstrand ML, 2010, JAIDS-J ACQ IMM DEF, V53, P415, DOI 10.1097/QAI.0b013e3181ba3e4e; Ekstrand MLCS, 2008, AIDS 2008 17 INT AID, P361; El-Khatib Ziad, 2011, J AIDS Clin Res, V2; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Innes CCS, 2008, AIDS 2008 17 INT AID; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Konate I, 2011, JAIDS-J ACQ IMM DEF, V57, pS50, DOI 10.1097/QAI.0b013e3182207a3f; Kumarasamy N, 2005, AIDS, V19, P625, DOI 10.1097/01.aids.0000163940.85940.03; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Neogi U, 2011, AIDS, V25, P1123, DOI 10.1097/QAD.0b013e328346269f; Neogi U, 2010, AIDS RES HUM RETROV, V26, P1097, DOI 10.1089/aid.2010.0092; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Orrell C, 2007, ANTIVIR THER, V12, P83; Rashbaum Victoria, 2010, 2009 2010 ANN REPORT; Roge BT, 2004, HIV MED, V5, P344, DOI 10.1111/j.1468-1293.2004.00233.x; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shet A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-277; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Verhofstede C, 2007, J MED VIROL, V79, P1254, DOI 10.1002/jmv.20950; World Health Organization, 2010, ATR ITS MET DRINK WA, P1	31	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55421	10.1371/journal.pone.0055421	http://dx.doi.org/10.1371/journal.pone.0055421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383185	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800153
J	Nesnidal, MP; Helmkampf, M; Bruchhaus, I; El-Matbouli, M; Hausdorf, B				Nesnidal, Maximilian P.; Helmkampf, Martin; Bruchhaus, Iris; El-Matbouli, Mansour; Hausdorf, Bernhard			Agent of Whirling Disease Meets Orphan Worm: Phylogenomic Analyses Firmly Place Myxozoa in Cnidaria	PLOS ONE			English	Article							COMPOSITIONAL HETEROGENEITY; SEQUENCE ALIGNMENTS; ORIGIN; TREE; BUDDENBROCKIA; POSITION; RANDOMNESS; PROTISTS; METAZOA; PHYLUM	Myxozoa are microscopic obligate endoparasites with complex live cycles. Representatives are Myxobolus cerebralis, the causative agent of whirling disease in salmonids, and the enigmatic "orphan worm'' Buddenbrockia plumatellae parasitizing in Bryozoa. Originally, Myxozoa were classified as protists, but later several metazoan characteristics were reported. However, their phylogenetic relationships remained doubtful. Some molecular phylogenetic analyses placed them as sister group to or even within Bilateria, whereas the possession of polar capsules that are similar to nematocysts of Cnidaria and of minicollagen genes suggest a close relationship between Myxozoa and Cnidaria. EST data of Buddenbrockia also indicated a cnidarian origin of Myxozoa, but were not sufficient to reject a closer relationship to bilaterians. Phylogenomic analyses of new genomic sequences of Myxobolus cerebralis firmly place Myxozoa as sister group to Medusozoa within Cnidaria. Based on the new dataset, the alternative hypothesis that Myxozoa form a clade with Bilateria can be rejected using topology tests. Sensitivity analyses indicate that this result is not affected by long branch attraction artifacts or compositional bias.	[Nesnidal, Maximilian P.; Helmkampf, Martin; Hausdorf, Bernhard] Univ Hamburg, Zool Museum, Hamburg, Germany; [Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [El-Matbouli, Mansour] Univ Vet Med, Clin Div Fish Med, Vienna, Austria	University of Hamburg; Bernhard Nocht Institut fur Tropenmedizin; University of Veterinary Medicine Vienna	Hausdorf, B (corresponding author), Univ Hamburg, Zool Museum, Hamburg, Germany.	hausdorf@zoologie.uni-hamburg.de	Hausdorf, Bernhard/E-9829-2016; Helmkampf, Martin/ABD-8649-2020	Hausdorf, Bernhard/0000-0002-1604-1689; El-Matbouli, Mansour/0000-0001-8148-0218	Deutsche Forschungsgemeinschaft [HA 2763/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the priority program "Deep Metazoan Phylogeny'' of the Deutsche Forschungsgemeinschaft (http://www.dfg.de; grant number: HA 2763/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 1998, NATURE, V392, P346, DOI 10.1038/32801; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; CavalierSmith T, 1996, CAN J ZOOL, V74, P2031, DOI 10.1139/z96-231; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; El-Matbouli M, 2006, PARASITOLOGY, V132, P467, DOI 10.1017/S0031182005009522; Evans NM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-139; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; Grabner DS, 2010, PARASITOLOGY, V137, P629, DOI 10.1017/S0031182009991429; Hanelt B, 1996, MOL BIOL EVOL, V13, P1187, DOI 10.1093/oxfordjournals.molbev.a025683; Holland JW, 2011, P ROY SOC B-BIOL SCI, V278, P546, DOI 10.1098/rspb.2010.1301; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; Kim JH, 1999, MOL BIOL EVOL, V16, P423, DOI 10.1093/oxfordjournals.molbev.a026124; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lom J., 1990, P36; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Lom J, 1997, ACTA PROTOZOOL, V36, P83; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Monteiro AS, 2002, MOL BIOL EVOL, V19, P968, DOI 10.1093/oxfordjournals.molbev.a004155; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Okamura B, 2002, PARASITOLOGY, V124, P215, DOI 10.1017/S0031182001001184; Ott M, 2007, P ACM IEEE C SUP 200; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Roure B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-17; Schlegel M, 1996, ARCH PROTISTENKD, V147, P1; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siddall ME, 1999, CLADISTICS, V15, P9, DOI 10.1111/j.1096-0031.1999.tb00391.x; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMOTHERS JF, 1994, SCIENCE, V265, P1719, DOI 10.1126/science.8085160; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tops S, 2004, DIS AQUAT ORGAN, V60, P109, DOI 10.3354/dao060109; Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x; Zrzavy J, 2003, CLADISTICS, V19, P164, DOI 10.1016/S0748-3007(03)00007-0	48	46	46	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54576	10.1371/journal.pone.0054576	http://dx.doi.org/10.1371/journal.pone.0054576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382916	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800054
J	Banky, D; Ivan, G; Grolmusz, V				Banky, Daniel; Ivan, Gabor; Grolmusz, Vince			Equal Opportunity for Low-Degree Network Nodes: A PageRank-Based Method for Protein Target Identification in Metabolic Graphs	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MYCOBACTERIUM-TUBERCULOSIS; INHIBITORS; SYNTHASE; BIOSYNTHESIS; DATABASE; SUSCEPTIBILITY; PATHWAY; MODELS; GROWTH	Biological network data, such as metabolic-, signaling- or physical interaction graphs of proteins are increasingly available in public repositories for important species. Tools for the quantitative analysis of these networks are being developed today. Protein network-based drug target identification methods usually return protein hubs with large degrees in the networks as potentially important targets. Some known, important protein targets, however, are not hubs at all, and perturbing protein hubs in these networks may have several unwanted physiological effects, due to their interaction with numerous partners. Here, we show a novel method applicable in networks with directed edges (such as metabolic networks) that compensates for the low degree (non-hub) vertices in the network, and identifies important nodes, regardless of their hub properties. Our method computes the PageRank for the nodes of the network, and divides the PageRank by the in-degree (i.e., the number of incoming edges) of the node. This quotient is the same in all nodes in an undirected graph (even for large- and low-degree nodes, that is, for hubs and non-hubs as well), but may differ significantly from node to node in directed graphs. We suggest to assign importance to non-hub nodes with large PageRank/in-degree quotient. Consequently, our method gives high scores to nodes with large PageRank, relative to their degrees: therefore non-hub important nodes can easily be identified in large networks. We demonstrate that these relatively high PageRank scores have biological relevance: the method correctly finds numerous already validated drug targets in distinct organisms (Mycobacterium tuberculosis, Plasmodium falciparum and MRSA Staphylococcus aureus), and consequently, it may suggest new possible protein targets as well. Additionally, our scoring method was not chosen arbitrarily: its value for all nodes of all undirected graphs is constant; therefore its high value captures importance in the directed edge structure of the graph.	[Banky, Daniel; Ivan, Gabor; Grolmusz, Vince] Eotvos Lorand Univ, Prot Informat Technol Grp, Budapest, Hungary; [Banky, Daniel; Ivan, Gabor; Grolmusz, Vince] Uratim Ltd, Budapest, Hungary	Eotvos Lorand University	Grolmusz, V (corresponding author), Eotvos Lorand Univ, Prot Informat Technol Grp, Pazmany Peter Stny 1-C, Budapest, Hungary.	grolmusz@cs.elte.hu		Grolmusz, Vince/0000-0001-9456-8876	NKTH TB-INTER; OTKA [CNK 77780]; TAMOP [4.2.1./B-09/KMR-2010-0003]	NKTH TB-INTER(National Office for Research and Technology); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP	This work was supported by NKTH TB-INTER (www.nih.gov.hu), OTKA CNK 77780 (www.otka.hu), and the TAMOP 4.2.1./B-09/KMR-2010-0003 (http://kp.elte.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Agren D, 2009, FEBS LETT, V583, P330, DOI 10.1016/j.febslet.2008.12.019; Alhamadsheh MM, 2007, CHEM BIOL, V14, P513, DOI 10.1016/j.chembiol.2007.03.013; Aparicio IM, 2010, MOL BIOCHEM PARASIT, V172, P152, DOI 10.1016/j.molbiopara.2010.04.002; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Bange FC, 1996, INFECT IMMUN, V64, P1794, DOI 10.1128/IAI.64.5.1794-1799.1996; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brown AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006306; Choi KH, 2000, J BIOL CHEM, V275, P28201; Choubey V, 2007, ANTIMICROB AGENTS CH, V51, P696, DOI 10.1128/AAC.00919-06; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; De Las Rivas J, 2004, COMP FUNCT GENOM, V5, P173, DOI 10.1002/cfg.377; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Fortunato S, 2008, LECT NOTES COMPUT SC, V4936, P59, DOI 10.1007/978-3-540-78808-9_6; Gonzalez-Bulnes P, 2011, J BIOL CHEM, V286, P28940, DOI 10.1074/jbc.M111.268946; Grandoni JA, 1998, J ANTIMICROB CHEMOTH, V42, P475, DOI 10.1093/jac/42.4.475; Grolmusz V, 2012, ABS12051960 ARXIV CO; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Haley KP, 2012, MICROBES INFECT, V14, P217, DOI 10.1016/j.micinf.2011.11.001; Holme P, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.034801; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Hwang WC, 2008, CLIN PHARMACOL THER, V84, P563, DOI 10.1038/clpt.2008.129; Ideker T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100145; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lei T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046836; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Manhani KK, 2005, J MOL MODEL, V12, P42, DOI 10.1007/s00894-005-0002-1; McMillan PJ, 2005, MOL MICROBIOL, V55, P27, DOI 10.1111/j.1365-2958.2004.04398.x; McNamara PJ, 2000, INT J ANTIMICROB AG, V14, P117, DOI 10.1016/S0924-8579(99)00170-3; Muller IB, 2010, TRENDS PARASITOL, V26, P35, DOI 10.1016/j.pt.2009.10.006; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007656; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004406; OLAFSSON P, 1992, MOL BIOCHEM PARASIT, V56, P89, DOI 10.1016/0166-6851(92)90157-F; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Perra N, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036107; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Russell RB, 2008, NAT CHEM BIOL, V4, P666, DOI 10.1038/nchembio.119; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh V, 2011, MICROBIOL-SGM, V157, P38, DOI 10.1099/mic.0.042358-0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tonge PJ, 2007, CURR TOP MED CHEM, V7, P489, DOI 10.2174/156802607780059781; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2008, MOL MICROBIOL, V69, P1316, DOI 10.1111/j.1365-2958.2008.06365.x; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	53	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54204	10.1371/journal.pone.0054204	http://dx.doi.org/10.1371/journal.pone.0054204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382878	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200051
J	Gill, JK; Chatzidaki, A; Ursu, D; Sher, E; Millar, NS				Gill, JasKiran K.; Chatzidaki, Anna; Ursu, Daniel; Sher, Emanuele; Millar, Neil S.			Contrasting Properties of alpha 7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							TRANSMEMBRANE SITE; ION CHANNELS; IN-VITRO; ALPHA-7; MODULATORS; SUBUNIT; BINDING; RAT; POTENTIATION; ACTIVATION	Subtype-selective ligands are important tools for the pharmacological characterisation of neurotransmitter receptors. This is particularly the case for nicotinic acetylcholine receptors (nAChRs), given the heterogeneity of their subunit composition. In addition to agonists and antagonists that interact with the extracellular orthosteric nAChR binding site, a series of nAChR allosteric modulators have been identified that interact with a distinct transmembrane site. Here we report studies conducted with three pharmacologically distinct nicotinic ligands, an orthosteric agonist (compound B), a positive allosteric modulator (TQS) and an allosteric agonist (4BP-TQS). The primary focus of the work described in this study is to examine the suitability of these compounds for the characterisation of native neuronal receptors (both rat and human). However, initial experiments were conducted on recombinant nAChRs demonstrating the selectivity of these three compounds for alpha 7 nAChRs. In patch-clamp recordings on rat primary hippocampal neurons we found that all these compounds displayed pharmacological properties that mimicked closely those observed on recombinant alpha 7 nAChRs. However, it was not possible to detect functional responses with compound B, an orthosteric agonist, using a fluorescent intracellular calcium assay on either rat hippocampal neurons or with human induced pluripotent stem cell-derived neurons (iCell neurons). This is, presumably, due to the rapid desensitisation of alpha 7 nAChR that is induced by orthosteric agonists. In contrast, clear agonist-evoked responses were observed in fluorescence-based assays with the non-desensitising allosteric agonist 4BP-TQS and also when compound B was co-applied with the non-desensitising positive allosteric modulator TQS. In summary, we have demonstrated the suitability of subtype-selective orthosteric and allosteric ligands for the pharmacological identification and characterisation of native nAChRs and the usefulness of ligands that minimise receptor desensitisation for the characterisation of alpha 7 nAChRs in fluorescence-based assays.	[Gill, JasKiran K.; Chatzidaki, Anna; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Ursu, Daniel; Sher, Emanuele] Eli Lilly & Co Ltd, Lilly Res Ctr, Windlesham, Surrey, England	University of London; University College London; Eli Lilly	Millar, NS (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	n.millar@ucl.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F017146/1]; Eli Lilly Co. Ltd.	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eli Lilly Co. Ltd.(Eli Lilly)	The work was supported by PhD studentship awarded by the Biotechnology and Biological Sciences Research Council (BBSRC; BB/F017146/1)) with additional financial support from Eli Lilly & Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Cilia J, 2005, PSYCHOPHARMACOLOGY, V182, P214, DOI 10.1007/s00213-005-0069-5; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Croxen R, 2001, BRAIN, V124, P1362, DOI 10.1093/brain/124.7.1362; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; De Filippi G, 2002, SOC NEUR ABSTR, V137, P135; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Dunlop J, 2009, J PHARMACOL EXP THER, V328, P766, DOI 10.1124/jpet.108.146514; Elliott KJ, 1996, J MOL NEUROSCI, V7, P217, DOI 10.1007/BF02736842; Faghih R, 2008, J MED CHEM, V51, P701, DOI 10.1021/jm070256g; Gill JK, 2012, MOL PHARMACOL, V81, P710, DOI 10.1124/mol.111.076026; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hogg RC, 2005, BIOCHEM PHARMACOL, V70, P1267, DOI 10.1016/j.bcp.2005.06.010; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jindrichova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032073; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Mazurov AA, 2011, J MED CHEM, V54, P7943, DOI 10.1021/jm2007672; Medhurst SJ, 2008, J PAIN, V9, P580, DOI 10.1016/j.jpain.2008.01.336; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; O'Neill MJ, 2002, SOC NEUR ABSTR, V137, P136; Palczynska MM, 2012, MOL PHARM, DOI [10.1124/mol.1112.080259, DOI 10.1124/MOL.1112.080259]; Phillips E, 2001, PCT International Application, Patent No. [0160821, WO 01/60821 A1]; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Visanji NP, 2006, NEUROPHARMACOLOGY, V51, P506, DOI 10.1016/j.neuropharm.2006.04.015; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809	41	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55047	10.1371/journal.pone.0055047	http://dx.doi.org/10.1371/journal.pone.0055047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383051	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200016
J	Raykov, Z; Grekova, SP; Horlein, R; Leuchs, B; Giese, T; Giese, NA; Rommelaere, J; Zawatzky, R; Daeffler, L				Raykov, Zahari; Grekova, Svitlana P.; Hoerlein, Rita; Leuchs, Barbara; Giese, Thomas; Giese, Nathalia A.; Rommelaere, Jean; Zawatzky, Rainer; Daeffler, Laurent			TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NONSTRUCTURAL PROTEINS NS2; INTERFERON-PRODUCING CELLS; MINUTE VIRUS; RIG-I; CPG MOTIFS; KILHAM RAT; ACTIVATION; INFECTION; EXPRESSION	The oncotropism of Minute Virus of Mice (MVMp) is partially related to the stimulation of an antiviral response mediated by type-I interferons (IFNs) in normal but not in transformed mouse cells. The present work was undertaken to assess whether the oncotropism displayed against human cells by MVMp and its rat homolog H-1PV also depends on antiviral mechanisms and to identify the pattern recognition receptor (PRR) involved. Despite their low proliferation rate which represents a drawback for parvovirus multiplication, we used human peripheral blood mononuclear cells (hPBMCs) as normal model specifically because all known PRRs are functional in this mixed cell population and moreover because some of its subsets are among the main IFN producers upon infections in mammals. Human transformed models consisted in lines and tumor cells more or less permissive to both parvoviruses. Our results show that irrespective of their permissiveness, transformed cells do not produce IFNs nor develop an antiviral response upon parvovirus infection. However, MVMp- or H-1PV-infected hPBMCs trigger such defense mechanisms despite an absence of parvovirus replication and protein expression, pointing to the viral genome as the activating element. Substantial reduction of an inhibitory oligodeoxynucleotide (iODN) of the latter IFN production identified TLR-9 as a potential PRR for parvoviruses in hPBMCs. However, neither the iODN treatment nor an antibody-induced neutralization of the IFN-triggered effects restored parvovirus multiplication in these cells as expected by their weak proliferation in culture. Finally, given that a TLR-9 activation could also not be observed in parvovirus-infected human lines reported to be endowed with a functional TLR-9 pathway (Namalwa, Raji, and HEK293-TLR9(+/+)), our data suggest that transformed human cells do not sense MVMp or H-1PV either because of an absence of PRR expression or an intrinsic, or virus-driven defect in the endosomal sensing of the parvovirus genomes by TLR-9.	[Raykov, Zahari; Grekova, Svitlana P.; Hoerlein, Rita; Leuchs, Barbara; Rommelaere, Jean; Daeffler, Laurent] German Canc Res Ctr, Div F010, Infect & Canc Program, Heidelberg, Germany; [Raykov, Zahari; Grekova, Svitlana P.; Hoerlein, Rita; Leuchs, Barbara; Rommelaere, Jean; Daeffler, Laurent] German Canc Res Ctr, INSERM, U701, Heidelberg, Germany; [Zawatzky, Rainer] German Canc Res Ctr, Div F030, Infect & Canc Program, Dept Viral Transformat Mech, Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Giese, Nathalia A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Daeffler, L (corresponding author), German Canc Res Ctr, Div F010, Infect & Canc Program, Heidelberg, Germany.	l.daeffler@dkfz.de	Daeffler, Laurent/M-8914-2017; Daeffler, Laurent/S-6395-2019	Daeffler, laurent/0000-0001-5871-5082	DFG [RA 1891/2]; French Institut National de la Sante et de la Recherche Medicale (INSERM); German Cancer Research Center (DKFZ, Heidelberg)	DFG(German Research Foundation (DFG)); French Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Research Center (DKFZ, Heidelberg)	This work was supported by DFG grants RA 1891/2 to Z. Raykov and by funds provided by the French Institut National de la Sante et de la Recherche Medicale (INSERM) and the German Cancer Research Center (DKFZ, Heidelberg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova AL, 2009, MOL THER; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ashman RF, 2011, INT IMMUNOL, V23, P203, DOI 10.1093/intimm/dxq473; Bartel M, 2008, J PATHOL, V215, P195, DOI 10.1002/path.2348; Berns KI, 1996, CURR TOP MICROBIOL, V218, P1; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bodendorf U, 1999, J VIROL, V73, P7769, DOI 10.1128/JVI.73.9.7769-7779.1999; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Brockhaus K, 1996, J VIROL, V70, P7527, DOI 10.1128/JVI.70.11.7527-7534.1996; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Daeffler L, 2003, J VIROL, V77, P12466, DOI 10.1128/JVI.77.23.12466-12478.2003; Deleu L, 1999, J VIROL, V73, P3877, DOI 10.1128/JVI.73.5.3877-3885.1999; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Geletneky K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-99; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Grekova SP, 2012, CANC GENE THER; Grekova S, 2010, CANCER BIOL THER, V10, P1280, DOI 10.4161/cbt.10.12.13455; Grekova S, 2010, J VIROL, V84, P516, DOI 10.1128/JVI.01618-09; Grieger JC, 2012, METHOD ENZYMOL, V507, P229, DOI 10.1016/B978-0-12-386509-0.00012-0; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Henault M, 2005, J IMMUNOL METHODS, V300, P93, DOI 10.1016/j.jim.2005.02.012; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim Y, 2012, IMMUNOL CELL BIOL, V90, P655, DOI 10.1038/icb.2011.85; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Laredj LN, 2011, J VIROL, V85, P13133, DOI 10.1128/JVI.05407-11; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Malerba M, 2003, J VIROL, V77, P6683, DOI 10.1128/JVI.77.12.6683-6691.2003; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Mohr A, 2012, EUR J CELL BIOL, V91, P524, DOI 10.1016/j.ejcb.2011.09.005; Morales O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032197; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Nayak R, 2007, J VIROL, V81, P11908, DOI 10.1128/JVI.01132-07; Nuesch JP, 2012, CLIN CANC RES; Peng WM, 2007, HUM IMMUNOL, V68, P879, DOI 10.1016/j.humimm.2007.10.008; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Raykov Z, 2004, INT J CANCER, V109, P742, DOI 10.1002/ijc.20013; Raykov Z, 2008, INT J CANCER, V122, P2880, DOI 10.1002/ijc.23472; Rommelaere J, 2001, AUTONOMOUS PARVOVIRU; Rommelaere J, 2010, CYTOKINE GROWTH F R, V21, P185, DOI 10.1016/j.cytogfr.2010.02.011; Satomi H, 2002, CYTOKINE, V18, P108, DOI 10.1006/cyto.2002.1028; Schirrmacher V, 2005, CANCER IMMUNOL IMMUN, V54, P587, DOI 10.1007/s00262-004-0602-0; SCHLEHOFER JR, 1992, MED MICROBIOL IMMUN, V181, P153; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; Weitzman MD, 2011, METHODS MOL BIOL, V807, P1, DOI 10.1007/978-1-61779-370-7_1; Weng YJ, 2011, J HUAZHONG U SCI-MED, V31, P550, DOI 10.1007/s11596-011-0488-y; Wilden H, 2009, INT J ONCOL, V34, P971, DOI 10.3892/ijo_00000223; Younesi V, 2010, MICROBIOL IMMUNOL, V54, P534, DOI 10.1111/j.1348-0421.2010.00248.x; Yu SL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3803; Zaiss AK, 2008, GENE THER, V15, P808, DOI 10.1038/gt.2008.54; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131; Zipris D, 2007, J IMMUNOL, V178, P693, DOI 10.4049/jimmunol.178.2.693; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	74	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55086	10.1371/journal.pone.0055086	http://dx.doi.org/10.1371/journal.pone.0055086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383065	gold, Green Published, Green Submitted			2022-12-25	WOS:000315483200061
J	Martinez-Poveda, B; Garcia-Vilas, JA; Cardenas, C; Melgarejo, E; Quesada, AR; Medina, MA				Martinez-Poveda, Beatriz; Garcia-Vilas, Javier A.; Cardenas, Casimiro; Melgarejo, Esther; Quesada, Ana R.; Medina, Miguel A.			The Brominated Compound Aeroplysinin-1 Inhibits Proliferation and the Expression of Key Pro-Inflammatory Molecules in Human Endothelial and Monocyte Cells	PLOS ONE			English	Article							SPONGE VERONGIA-AEROPHOBA; IN-VITRO; ANGIOGENESIS ASSAYS; APLYSINA-AEROPHOBA; CHEMICAL DEFENSE; RECEPTOR; MMP-1; VIVO; MEMBRANE; DISEASE	Aeroplysinin-1 is a brominated antibiotic used by some sponges for defense against bacterial pathogen invasion. Aeroplysinin-1 has a wide spectrum of anti-tumoral action and behaves as a potent anti-angiogenic compound for bovine aortic endothelial cells. In this study, we demonstrate anti-angiogenic effects of aeroplysinin-1 on human endothelial cells. Furthermore, the response of angiogenesis related genes to aeroplysinin-1 treatment was studied in human endothelial cells by using gene arrays. The major changes were observed in thrombospondin 1 (TSP-1) and monocyte chemoattractant protein-1 (MCP-1), both of which were down-regulated. These inhibitory effects of aeroplysinin-1 were confirmed by using independent experimental approaches. To have a deeper insight on the anti-inflammatory effects of aeroplysinin-1 in endothelial cells, cytokine arrays were also used. This experimental approach confirmed effects on MCP-1 and TSP-1 and showed down-regulation of several other cytokines. Western blotting experiments confirmed down-regulation of ELTD1 (EGF, latrophilin and seven transmembrane domain-containing protein 1), interleukin 1 alpha and matrix metalloproteinase 1 (MMP-1). These results along with our observation of a dramatic inhibitory effect of aeroplysinin-1 on cyclooxygenase-2 protein expression levels in endothelial cells and a human monocyte cell line suggest that aeroplysinin-1 could be a novel anti-inflammatory compound with potential pharmacological interest.	[Martinez-Poveda, Beatriz; Garcia-Vilas, Javier A.; Cardenas, Casimiro; Melgarejo, Esther; Quesada, Ana R.; Medina, Miguel A.] Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, Malaga, Spain; [Quesada, Ana R.; Medina, Miguel A.] CIBER Enfermedades Raras CIBERER, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Medina, MA (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, Malaga, Spain.	medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Cardenas, Casimiro/L-1051-2014; Martinez-Poveda, Beatriz/T-6973-2017	Medina, Miguel Ángel/0000-0001-7275-6462; Cardenas, Casimiro/0000-0001-6259-8296; Martinez-Poveda, Beatriz/0000-0003-3927-3877; Rodriguez Quesada, Ana Maria/0000-0002-6419-8867	Spanish Ministry of Science and Innovation, ISCIII and FEDER [PS09/02216]; group BIO-267 Andalusian Government;  [PIE P08-CTS-3759];  [PIE CVI-6585]	Spanish Ministry of Science and Innovation, ISCIII and FEDER; group BIO-267 Andalusian Government; ; 	The authors' experimental work is supported by grants PS09/02216 (Spanish Ministry of Science and Innovation, ISCIII and FEDER), and PIE P08-CTS-3759, CVI-6585 and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras" is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Cardenas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023407; Chapman PT, 1997, ARTHRITIS RHEUM, V40, P955, DOI 10.1002/art.1780400525; Cipollone F, 2006, J CARDIOVASC PHARM, V47, pS26, DOI 10.1097/00005344-200605001-00006; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; CYBULSKY M I, 1987, Annales de l'Institut Pasteur Immunology, V138, P505; Debitus C, 1998, J MAR BIOTECHNOL, V6, P136; Fattorusso E, 1972, J Chem Soc Perkin 1, V1, P16; Forslow A, 2007, CELL MOL LIFE SCI, V64, P66, DOI 10.1007/s00018-006-6255-8; Garcia-Caballero M, 2011, J INVEST DERMATOL, V131, P1347, DOI 10.1038/jid.2010.416; Herouy Y, 2001, J DERMATOL SCI, V25, P198, DOI 10.1016/S0923-1811(00)00128-6; Hinterding K, 1998, BIOORGAN MED CHEM, V6, P1153, DOI 10.1016/S0968-0896(98)00070-4; Ikeda U, 2002, CLIN CARDIOL, V25, P143, DOI 10.1002/clc.4960250403; Koulman A, 1996, J NAT PROD, V59, P591, DOI 10.1021/np960167z; KREUTER MH, 1989, Z NATURFORSCH C, V44, P680; KREUTER MH, 1990, COMP BIOCHEM PHYS B, V97, P151, DOI 10.1016/0305-0491(90)90194-X; KREUTER MH, 1992, COMP BIOCHEM PHYS C, V101, P183, DOI 10.1016/0742-8413(92)90217-U; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; LEE WY, 1994, FASEB J, V8, P1081, DOI 10.1096/fasebj.8.13.7926375; Li DY, 2002, AM J PHYSIOL-HEART C, V283, pH1795, DOI 10.1152/ajpheart.00382.2002; Maes M, 2011, J AFFECT DISORD; Melgarejo E, 2007, CELL MOL LIFE SCI, V64, P2690, DOI 10.1007/s00018-007-7331-4; Melgarejo E, 2009, BRIT J PHARMACOL, V158, P1705, DOI 10.1111/j.1476-5381.2009.00452.x; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; NIEDER M, 1985, ARCH BIOCHEM BIOPHYS, V240, P121, DOI 10.1016/0003-9861(85)90014-1; Niu QX, 2008, CLIN EXP PHARMACOL P, V35, P89, DOI 10.1111/j.1440-1681.2007.04755.x; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Neto LRP, 2011, ANIM GENET, V42, P50, DOI 10.1111/j.1365-2052.2010.02120.x; Ray A, 2005, BBA-GENE STRUCT EXPR, V1732, P53, DOI 10.1016/j.bbaexp.2005.11.004; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Scarborough Robert M., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P73, DOI 10.2174/1568016033356698; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; TEEYAPANT R, 1993, Z NATURFORSCH C, V48, P939; Thoms C, 2006, J CHEM ECOL, V32, P97, DOI 10.1007/s10886-006-9355-x; Thoms C, 2004, Z NATURFORSCH C, V59, P113; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573; Zhou XY, 2004, THROMB RES, V113, P181, DOI 10.1016/j.thromres.2004.02.016	43	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55203	10.1371/journal.pone.0055203	http://dx.doi.org/10.1371/journal.pone.0055203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383109	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500065
J	Zavan, B; Ferroni, L; Giorgi, C; Calo, G; Brun, P; Cortivo, R; Abatangelo, G; Pinton, P				Zavan, Barbara; Ferroni, Letizia; Giorgi, Carlotta; Calo, Girolamo; Brun, Paola; Cortivo, Roberta; Abatangelo, Giovanni; Pinton, Paolo			Hyaluronic Acid Induces Activation of the kappa-Opioid Receptor	PLOS ONE			English	Article							KNEE; OSTEOARTHRITIS; VISCOSUPPLEMENTATION; MECHANISMS; EXPRESSION; AGONIST; CALCIUM; TRANSFORMATION; ANALGESIA; ARTHRITIS	Introduction: Nociceptive pain is one of the most common types of pain that originates from an injury involving nociceptors. Approximately 60% of the knee joint innervations are classified as nociceptive. The specific biological mechanism underlying the regulation of nociceptors is relevant for the treatment of symptoms affecting the knee joint. Intra-articular administration of exogenous hyaluronic acid (HA) in patients with osteoarthritis (OA) appears to be particularly effective in reducing pain and improving patient function. Methods: We performed an in vitro study conducted in CHO cells that expressed a panel of opioid receptors and in primary rat dorsal root ganglion (DRG) neurons to determine if HA induces the activation of opioid peptide receptors (OPr) using both aequorin and the fluorescent dye Fura-2/AM. Results: Selective agonists and antagonists for each OPr expressed on CHO cells were used to test the efficacy of our in vitro model followed by stimulation with HA. The results showed that HA induces stimulatory effects on the kappa receptor (KOP). These effects of HA were also confirmed in rat DRG neurons, which express endogenously the OPr. Conclusions: HA activates the KOP receptor in a concentration dependent manner, with a pEC(50) value of 7.57.	[Zavan, Barbara; Ferroni, Letizia; Brun, Paola; Cortivo, Roberta; Abatangelo, Giovanni] Univ Padua, Dept Biomed Sci, Padua, Italy; [Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Neurosci Ctr, I-44100 Ferrara, Italy	University of Padua; University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Zavan, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	barbara.zavan@unipd.it; pnp@unife.it	Brun, Paola/K-5729-2016; Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016	Pinton, Paolo/0000-0001-7108-6508; Giorgi, Carlotta/0000-0002-2494-7405; Brun, Paola/0000-0002-4204-3549; Ferroni, Letizia/0000-0002-5457-0338	University of Padova; University of Ferrara; Italian Ministry of Education, University and Research (COFIN); Italian Ministry of Health; Italian Association for Cancer Research (AIRC), Telethon	University of Padova; University of Ferrara; Italian Ministry of Education, University and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC), Telethon(Fondazione AIRC per la ricerca sul cancroFondazione Telethon)	This research was supported by local funds from the University of Padova to RC and GA. PP lab is supported by local funds from the University of Ferrara, Italian Association for Cancer Research (AIRC), Telethon, the Italian Ministry of Education, University and Research (COFIN) and Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2008, UPSALA J MED SCI, V113, P261, DOI 10.3109/2000-1967-233; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Barron MC, 2007, J AM OSTEOPATH ASSOC, V107, pES21; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Bellamy N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321; Bezzerri V, 2011, J IMMUNOL, V186, P4946, DOI 10.4049/jimmunol.1003535; Binder W, 1998, BRIT J PHARMACOL, V124, P647, DOI 10.1038/sj.bjp.0701874; Boettger MK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3394; Bot PT, 2008, CURR MED CHEM, V15, P786, DOI 10.2174/092986708783955554; Brough SJ, 2009, METHODS MOL BIOL, V552, P181, DOI 10.1007/978-1-60327-317-6_13; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; Camarda Valeria, 2013, Methods Mol Biol, V937, P293; Camarda V, 2009, N-S ARCH PHARMACOL, V379, P599, DOI 10.1007/s00210-009-0396-x; Connor-Ballard PA, 2009, AM J NURS, V109, P48, DOI 10.1097/01.NAJ.0000348604.47231.68; Das A, 2009, J FAM PRACTICE, V58; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; Demaria M, 2012, CELL DEATH DIFFER, V19, P1390, DOI 10.1038/cdd.2012.20; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; FRIEDMAN MJ, 1977, PSYCHOSOM MED, V39, P134, DOI 10.1097/00006842-197703000-00008; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Giorgi C, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-27; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gomis A, 2009, OSTEOARTHR CARTILAGE, V17, P798, DOI 10.1016/j.joca.2008.11.013; Grigg P, 2001, CELLS TISSUES ORGANS, V169, P218, DOI 10.1159/000047885; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; LAWRENCE AJ, 1992, EUR J CLIN PHARMACOL, V43, P351, DOI 10.1007/BF02220608; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; McCall J, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00011; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Peng JS, 2012, DRUG ALCOHOL DEPEN, V124, P223, DOI 10.1016/j.drugalcdep.2012.01.013; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Riedel W, 2001, Z RHEUMATOL, V60, P404, DOI 10.1007/s003930170003; Shen H, 2005, ARTHRITIS RHEUM-US, V52, P1402, DOI 10.1002/art.21141; Snyder SH, 2003, TRENDS PHARMACOL SCI, V24, P198, DOI 10.1016/S0165-6147(03)00066-X; Sorrentino G, 2012, CELL DEATH DIFFER; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; STEIN C, 1993, LANCET, V342, P321, DOI 10.1016/0140-6736(93)91471-W; Stein C, 1996, J CLIN INVEST, V98, P793, DOI 10.1172/JCI118852; Verkaar F, 2008, BIOTECHNOL ANN REV, V14, P253, DOI 10.1016/S1387-2656(08)00010-0; Waddell DD, 2007, DRUG AGING, V24, P629, DOI 10.2165/00002512-200724080-00002; Wilson JL, 1996, BRIT J PHARMACOL, V118, P1754, DOI 10.1111/j.1476-5381.1996.tb15601.x; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293	53	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55510	10.1371/journal.pone.0055510	http://dx.doi.org/10.1371/journal.pone.0055510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383210	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500077
J	Kang, M; Zhong, HJ; He, JF; Rutherford, S; Yang, F				Kang, Min; Zhong, Haojie; He, Jianfeng; Rutherford, Shannon; Yang, Fen			Using Google Trends for Influenza Surveillance in South China	PLOS ONE			English	Article								Background: Google Flu Trends was developed to estimate influenza activity in many countries; however there is currently no Google Flu Trends or other Internet search data used for influenza surveillance in China. Methods and Findings: Influenza surveillance data from 2008 through 2011 were obtained from provincial CDC influenza-like illness and virological surveillance systems of Guangdong, a province in south China. Internet search data were downloaded from the website of Google Trends. Pearson's correlation coefficients with 95% confidence intervals (95% CI) were calculated to compare surveillance data and internet search trends. The correlation between CDC ILI surveillance and CDC virus surveillance was 0.56 (95% CI: 0.43, 0.66). The strongest correlation was between the Google Trends term of Fever and ILI surveillance with a correlation coefficient of 0.73 (95% CI: 0.66, 0.79). When compared with influenza virological surveillance, the Google Trends term of Influenza A had the strongest correlation with a correlation coefficient of 0.64 (95% CI: 0.43, 0.79) in the 2009 H1N1 influenza pandemic period. Conclusions: This study shows that Google Trends in Chinese can be used as a complementary source of data for influenza surveillance in south China. More research in the future should develop new models using search trends in Chinese language to estimate local disease activity and detect early signals of outbreaks.	[Kang, Min; Zhong, Haojie; He, Jianfeng; Yang, Fen] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia	Griffith University	Kang, M (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	kangmin@yeah.net			key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province [A2010067]	key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province	This study was supported by the key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province Grant A2010067 (Research on patterns of transmission and intensity of epidemic of Pandemic Influenza H1N1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; [China internet Network information Center Center CiNi], 2011, CHINESE SEARCH ENGIN, P5; Cook AR, 2010, EMERG INFECT DIS, V16, P1647, DOI 10.3201/eid1610.100840; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Eurosurveillance editorial team, 2009, EURO SURVEILL, V14; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google org, 2011, GOOGLE FLU TRENDS; Google Trends Labs, 2009, ABOUT GOOGLE TRENDS; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Kelly H, 2009, EUROSURVEILLANCE, V14, P6; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Valdivia A, 2010, EUROSURVEILLANCE, V15, P2; Valdivia A, 2010, EMERG INFECT DIS, V16, P168, DOI 10.3201/eid1601.091308; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Orgnization, 2003, INFLUENZA FACT SHEET; Yang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038768; Zhang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023034	21	84	90	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55205	10.1371/journal.pone.0055205	http://dx.doi.org/10.1371/journal.pone.0055205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372837	gold, Green Published			2022-12-25	WOS:000315210400077
J	Harmon, B; Kozina, C; Maar, D; Carpenter, TS; Branda, CS; Negrete, OA; Carson, BD				Harmon, Brooke; Kozina, Carol; Maar, Dianna; Carpenter, Timothy S.; Branda, Catherine S.; Negrete, Oscar A.; Carson, Bryan D.			Identification of Critical Amino Acids within the Nucleoprotein of Tacaribe Virus Important for Anti-interferon Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; INFECTION; INHIBITION; INDUCTION; FEVER; HOST; RNA	The arenavirus nucleoprotein (NP) can suppress induction of type I interferon (IFN). This anti-IFN activity is thought to be shared by all arenaviruses with the exception of Tacaribe virus (TCRV). To identify the TCRV NP amino acid residues that prevent its IFN-countering ability, we created a series of NP chimeras between residues of TCRV NP and Pichinde virus (PICV) NP, an arenavirus NP with potent anti-IFN function. Chimera NP analysis revealed that a minimal four amino acid stretch derived from PICV NP could impart efficient anti-IFN activity to TCRV NP. Strikingly, the TCRV NP gene cloned and sequenced from viral stocks obtained through National Institutes of Health Biodefense and Emerging Infections (BEI) resources deviated from the reference sequence at this particular four-amino acid region, GPPT (GenBank KC329849) versus DLQL (GenBank NC004293), respectively at residues 389-392. When efficiently expressed in cells through codon-optimization, TCRV NP containing the GPPT residues rescued the antagonistic IFN function. Consistent with cell expression results, TCRV infection did not stimulate an IFN beta response early in infection in multiple cells types (e.g. A549, P388D1), and IRF-3 was not translocated to the nucleus in TCRV-infected A549 cells. Collectively, these data suggest that certain TCRV strain variants contain the important NP amino acids necessary for anti-IFN activity.	[Harmon, Brooke; Kozina, Carol; Maar, Dianna; Branda, Catherine S.; Negrete, Oscar A.] Sandia Natl Labs, Livermore, CA 94550 USA; [Carpenter, Timothy S.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Carson, Bryan D.] Sandia Natl Labs, Albuquerque, NM 87123 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories	Negrete, OA (corresponding author), Sandia Natl Labs, POB 969,MS9292, Livermore, CA 94551 USA.	onegret@sandia.gov		Carpenter, Timothy/0000-0001-7848-9983	Laboratory Directed Research and Development Grants; United States Department of Energy National Nuclear Security Administration [DE-AC04-94AL85000]	Laboratory Directed Research and Development Grants; United States Department of Energy National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE))	This work was supported by Laboratory Directed Research and Development Grants (to B. D. C. and O. A. N.).; Sandia National Laboratories is a multiprogram laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the United States Department of Energy National Nuclear Security Administration under contract DE-AC04-94AL85000.	Baird NL, 2012, J VIROL, V86, P11301, DOI 10.1128/JVI.01635-12; Borrow P, 2010, VIRUSES-BASEL, V2, P2443, DOI 10.3390/v2112443; Buchmeier M., 2007, FIELDS VIROL, V2, P1792; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Groseth A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001137; Groseth A, 2010, J VIROL, V84, P3603, DOI 10.1128/JVI.02429-09; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Harrison LH, 1999, CLIN INFECT DIS, V28, P1091, DOI 10.1086/514749; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Huang C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001659; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Liang YY, 2009, ANN NY ACAD SCI, V1171, pE65, DOI 10.1111/j.1749-6632.2009.05051.x; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Nunberg JH, 2012, VIRUSES-BASEL, V4, P83, DOI 10.3390/v4010083; Ogbu O., 2007, Journal of Vector Borne Diseases, V44, P1; Pythoud C, 2012, J VIROL, V86, P7728, DOI 10.1128/JVI.00187-12; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WEISSENBACHER MC, 1987, CURR TOP MICROBIOL, V134, P77; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	30	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8702	8711		10.1074/jbc.M112.444760	http://dx.doi.org/10.1074/jbc.M112.444760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382389	Green Published, hybrid			2022-12-25	WOS:000316564500070
J	Roiko, MS; Carruthers, VB				Roiko, Marijo S.; Carruthers, Vern B.			Functional Dissection of Toxoplasma gondii Perforin-like Protein 1 Reveals a Dual Domain Mode of Membrane Binding for Cytolysis and Parasite Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; HOST-CELL INVASION; LISTERIOLYSIN-O; MICRONEME DISCHARGE; PORE FORMATION; ATTACK; COMPLEMENT; MECHANISM; VIRULENCE; MOTILITY	The recently discovered role of a perforin-like protein (PLP1) for rapid host cell egress by the protozoan parasite Toxoplasma gondii expanded the functional diversity of pore-forming proteins. Whereas PLP1 was found to be necessary for rapid egress and pathogenesis, the sufficiency for and mechanism of membrane attack were yet unknown. Here we further dissected the PLP1 knock-out phenotype, the mechanism of PLP1 pore formation, and the role of each domain by genetic complementation. We found that PLP1 is sufficient for membrane disruption and has a conserved mechanism of pore formation through target membrane binding and oligomerization to form large, multimeric membrane-embedded complexes. The highly conserved, central MACPF domain and the beta-sheet-rich C-terminal domain were required for activity. Loss of the unique N-terminal extension reduced lytic activity and led to a delay in rapid egress, but did not significantly decrease virulence, suggesting that small amounts of lytic activity are sufficient for pathogenesis. We found that both N- and C-terminal domains have membrane binding activity, with the C-terminal domain being critical for function. This dual mode of membrane association may promote PLP1 activity and parasite egress in the diverse cell types in which this parasite replicates.	[Roiko, Marijo S.] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA; [Roiko, Marijo S.; Carruthers, Vern B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895	National Institutes of Health [R01AI046675]; Cellular and Molecular Biology Training Grant [T32 GM007315]; University of Michigan Rackham merit fellowship; Rackham student research grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Training Grant; University of Michigan Rackham merit fellowship(University of Michigan System); Rackham student research grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Operating Grant R01AI046675 (to V. B. C.) and Cellular and Molecular Biology Training Grant T32 GM007315. This work was also supported by a University of Michigan Rackham merit fellowship and Rackham student research grants (to M. S. R.).	Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; BJERRUM PJ, 1979, J MEMBRANE BIOL, V48, P43, DOI 10.1007/BF01869256; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Bouyain S, 2012, STRUCTURE, V20, P197, DOI 10.1016/j.str.2012.01.013; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Decatur AL, 2000, SCIENCE, V290, P992, DOI 10.1126/science.290.5493.992; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; ENDO T, 1987, J PROTOZOOL, V34, P291, DOI 10.1111/j.1550-7408.1987.tb03177.x; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Farrand S, 2008, BIOCHEMISTRY-US, V47, P7097, DOI 10.1021/bi8005835; Feil SC, 2012, STRUCTURE, V20, P248, DOI 10.1016/j.str.2011.11.017; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kafsack Bjorn F.C., 2010, Communicative & Integrative Biology, V3, P18; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Laliberte J, 2011, MOL BIOCHEM PARASIT, V177, P49, DOI 10.1016/j.molbiopara.2011.01.009; Lavine MD, 2007, CURR PHARM DESIGN, V13, P641, DOI 10.2174/138161207780162854; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lukoyanova N, 2008, TRENDS IMMUNOL, V29, P51, DOI 10.1016/j.it.2007.11.003; McDonald V, 2011, EXPERT REV ANTI-INFE, V9, P1077, DOI [10.1586/ERI.11.123, 10.1586/eri.11.123]; McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029; Muller-Eberhard H J, 1985, Biochem Soc Symp, V50, P235; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nagamune Kisaburo, 2008, V47, P70; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schnupf P, 2006, CELL MICROBIOL, V8, P353, DOI 10.1111/j.1462-5822.2005.00631.x; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Schreck SF, 2000, BBA-PROTEIN STRUCT M, V1482, P199, DOI 10.1016/S0167-4838(00)00155-2; Scibek JJ, 2002, BIOCHEMISTRY-US, V41, P14546, DOI 10.1021/bi026641j; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Sibley LD, 1999, IMMUNOBIOLOGY, V201, P210, DOI 10.1016/S0171-2985(99)80061-8; Singh S, 2012, MICROBES INFECT, V14, P820, DOI 10.1016/j.micinf.2012.05.007; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Van Den Steen P E, 2011, Verh K Acad Geneeskd Belg, V73, P123; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983	53	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8712	8725		10.1074/jbc.M113.450932	http://dx.doi.org/10.1074/jbc.M113.450932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23376275	Green Published, hybrid			2022-12-25	WOS:000316564500071
J	Baudoin, JP; Jerome, WG; Kubel, C; de Jonge, N				Baudoin, Jean-Pierre; Jerome, W. Gray; Kuebel, Christian; de Jonge, Niels			Whole-Cell Analysis of Low-Density Lipoprotein Uptake by Macrophages Using STEM Tomography	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; NANOPARTICLE UPTAKE; OXIDIZED LDL; CHOLESTEROL; LYSOSOMES; FLUORESCENCE; PROTEINS; FUSION	Nanoparticles of heavy materials such as gold can be used as markers in quantitative electron microscopic studies of protein distributions in cells with nanometer spatial resolution. Studying nanoparticles within the context of cells is also relevant for nanotoxicological research. Here, we report a method to quantify the locations and the number of nanoparticles, and of clusters of nanoparticles inside whole eukaryotic cells in three dimensions using scanning transmission electron microscopy (STEM) tomography. Whole-mount fixed cellular samples were prepared, avoiding sectioning or slicing. The level of membrane staining was kept much lower than is common practice in transmission electron microscopy (TEM),such that the nanoparticles could be detected throughout the entire cellular thickness. Tilt-series were recorded with a limited tilt-range of 80 degrees thereby preventing excessive beam broadening occurring at higher tilt angles. The 3D locations of the nanoparticles were nevertheless determined with high precision using computation. The obtained information differed from that obtained with conventional TEM tomography data since the nanoparticles were highlighted while only faint contrast was obtained on the cellular material. Similar as in fluorescence microscopy, a particular set of labels can be studied. This method was applied to study the fate of sequentially up-taken low-density lipoprotein (LDL) conjugated to gold nanoparticles in macrophages. Analysis of a 3D reconstruction revealed that newly up-taken LDL-gold was delivered to lysosomes containing previously up-taken LDL-gold thereby forming onion-like clusters.	[Baudoin, Jean-Pierre; de Jonge, Niels] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Jerome, W. Gray] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Kuebel, Christian] Karlsruhe Inst Technol, Inst Nanotechnol INT, Eggenstein Leopoldshaffe, Germany; [Kuebel, Christian] Karlsruhe Inst Technol, KNMF, Eggenstein Leopoldshaffe, Germany; [de Jonge, Niels] INM Leibniz Inst New Mat, Saarbrucken, Germany	Vanderbilt University; Vanderbilt University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Leibniz Institut fur Neue Materialien (INM)	de Jonge, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	niels.dejonge@inm-gmbh.de	Kübel, Christian/A-1720-2009; de Jonge, Niels/B-5677-2008	Kübel, Christian/0000-0001-5701-4006; de Jonge, Niels/0000-0002-3969-6821; BAUDOIN, Jean-Pierre/0000-0001-7361-5653	Office of Basic Energy Sciences, U.S. Department of Energy; Karlsruhe Nano Micro Facility, a Helmholtz research infrastructure at the Karlsruhe Institute of Technology; Vanderbilt Cell Imaging Shared Resource; National Institutes of Health [R01-GM081801]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081801] Funding Source: NIH RePORTER	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Karlsruhe Nano Micro Facility, a Helmholtz research infrastructure at the Karlsruhe Institute of Technology; Vanderbilt Cell Imaging Shared Resource; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy at the SHaRE user facility at Oak Ridge National Laboratory, sponsored by the Office of Basic Energy Sciences, U.S. Department of Energy, and at the Karlsruhe Nano Micro Facility, a Helmholtz research infrastructure at the Karlsruhe Institute of Technology, and at the Vanderbilt Cell Imaging Shared Resource. Research supported by National Institutes of Health grant R01-GM081801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2008, ULTRAMICROSCOPY, V109, P70, DOI 10.1016/j.ultramic.2008.08.005; Bright NA, 1997, J CELL SCI, V110, P2027; Bushby AJ, 2011, NAT PROTOC, V6, P845, DOI 10.1038/nprot.2011.332; Chithrani DB, 2010, NANOMED-NANOTECHNOL, V6, P161, DOI 10.1016/j.nano.2009.04.009; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; de Jonge N, 2010, ULTRAMICROSCOPY, V110, P1114, DOI 10.1016/j.ultramic.2010.04.001; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Dukes MJ, 2011, J STRUCT BIOL, V174, P552, DOI 10.1016/j.jsb.2011.03.013; Elsaesser A, 2010, NANOMEDICINE-UK, V5, P1447, DOI [10.2217/nnm.10.118, 10.2217/NNM.10.118]; Free P, 2009, CHEM COMMUN, P5009, DOI 10.1039/b910657j; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hohn K, 2011, HISTOCHEM CELL BIOL, V135, P1, DOI 10.1007/s00418-010-0765-z; Hoenger A, 2009, CURR OPIN CELL BIOL, V21, P89, DOI 10.1016/j.ceb.2008.12.003; Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/NMETH.1367, 10.1038/nmeth.1367]; Jerome WG, 2008, MICROSC MICROANAL, V14, P138, DOI 10.1017/S1431927608080069; Jerome WG, 2010, CLIN LIPIDOL, V5, P853, DOI 10.2217/CLP.10.70; Jerome WG, 2003, MICROSC MICROANAL, V9, P54, DOI 10.1017/S1431927603030010; Klein R M, 1992, Biotechnology, V24, P384; KLINKNER AM, 1995, J HISTOCHEM CYTOCHEM, V43, P1071, DOI 10.1177/43.10.7560885; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011; Levy R, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.4889; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2000, J CELL SCI, V113, P1515; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; Peckys DB, 2011, NANO LETT, V11, P1733, DOI 10.1021/nl200285r; Pierson J, 2009, HISTOCHEM CELL BIOL, V132, P253, DOI 10.1007/s00418-009-0622-0; Radermacher M., 1980, P 7 EUR C EL MICR, P132; Ring EA, 2011, J MICROSC-OXFORD, V243, P273, DOI 10.1111/j.1365-2818.2011.03501.x; Risco C, 2012, STRUCTURE, V20, P759, DOI 10.1016/j.str.2012.04.001; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Soman NR, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/18/185102; Sousa AA, 2007, J STRUCT BIOL, V159, P507, DOI 10.1016/j.jsb.2007.06.006; Tantra R, 2011, NANOTOXICOLOGY, V5, P381, DOI 10.3109/17435390.2010.512987; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Walling MA, 2009, INT J MOL SCI, V10, P441, DOI 10.3390/ijms10020441; Yakushevska AE, 2007, J STRUCT BIOL, V159, P381, DOI 10.1016/j.jsb.2007.04.006; Yancey PG, 2002, MICROSC MICROANAL, V8, P81, DOI 10.1017/S1431927601020013; Zhang Y, 2008, BIOESSAYS, V30, P606, DOI 10.1002/bies.20759	53	13	13	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55022	10.1371/journal.pone.0055022	http://dx.doi.org/10.1371/journal.pone.0055022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383042	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600057
J	Biino, G; Santimone, I; Minelli, C; Sorice, R; Frongia, B; Traglia, M; Ulivi, S; Di Castelnuovo, A; Gogele, M; Nutile, T; Francavilla, M; Sala, C; Pirastu, N; Cerletti, C; Iacoviello, L; Gasparini, P; Toniolo, D; Ciullo, M; Pramstaller, P; Pirastu, M; de Gaetano, G; Balduini, CL				Biino, Ginevra; Santimone, Iolanda; Minelli, Cosetta; Sorice, Rossella; Frongia, Bruno; Traglia, Michela; Ulivi, Sheila; Di Castelnuovo, Augusto; Goegele, Martin; Nutile, Teresa; Francavilla, Marcella; Sala, Cinzia; Pirastu, Nicola; Cerletti, Chiara; Iacoviello, Licia; Gasparini, Paolo; Toniolo, Daniela; Ciullo, Marina; Pramstaller, Peter; Pirastu, Mario; de Gaetano, Giovanni; Balduini, Carlo L.			Age- And Sex-Related Variations in Platelet Count in Italy: A Proposal of Reference Ranges Based on 40987 Subjects' Data	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; ISOLATED POPULATION; CELL COUNT; THROMBOCYTOPENIA; PARAMETERS; ETHNICITY; ISOLATE; TRAITS; LOCI	Background and Objectives: Although several studies demonstrated that platelet count is higher in women, decreases with age, and is influenced by genetic background, most clinical laboratories still use the reference interval 150-400 x 10(9) platelets/L for all subjects. The present study was to identify age- and sex-specific reference intervals for platelet count. Methods: We analysed electronic records of subjects enrolled in three population-based studies that investigated inhabitants of seven Italian areas including six geographic isolates. After exclusion of patients with malignancies, liver diseases, or inherited thrombocytopenias, which could affect platelet count, reference intervals were estimated from 40,987 subjects with the non parametric method computing the 2.5 degrees and 97.5 degrees percentiles. Results: Platelet count was similar in men and women until the age of 14, but subsequently women had steadily more platelets than men. The number of platelets decreases quickly in childhood, stabilizes in adulthood, and further decreases in oldness. The final result of this phenomenon is that platelet count in old age was reduced by 35% in men and by 25% in women compared with early infancy. Based on these findings, we estimated reference intervals for platelet count x 10(9)/L in children (176-452), adult men (141-362), adult women (156-405), old men (122-350) and, old women (140-379). Moreover, we calculated an "extended'' reference interval that takes into account the differences in platelet count observed in different geographic areas. Conclusions: The age-, sex-, and origin-related variability of platelet count is very wide, and the patient-adapted reference intervals we propose change the thresholds for diagnosing both thrombocytopenia and thrombocytosis in Italy.	[Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Biino, Ginevra; Frongia, Bruno; Francavilla, Marcella; Pirastu, Mario] Natl Res Council Italy, Inst Populat Genet, Sassari, Italy; [Santimone, Iolanda; Di Castelnuovo, Augusto; Iacoviello, Licia] Univ Cattolica, Fdn Ric & Cura Giovanni Paolo II, Res Labs, Lab Genet & Environm Epidemiol, Campobasso, Italy; [Minelli, Cosetta; Goegele, Martin; Pramstaller, Peter] EURAC Res, Inst Med Genet, Bolzano, Italy; [Sorice, Rossella; Nutile, Teresa; Ciullo, Marina] Natl Res Council Italy, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Traglia, Michela; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Ulivi, Sheila; Pirastu, Nicola; Gasparini, Paolo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Pirastu, Nicola; Gasparini, Paolo] Univ Trieste, Dept Reprod Sci, Trieste, Italy; [Cerletti, Chiara] Univ Cattolica, Fdn Ric & Cura Giovanni Paolo II, Res Labs, Lab Cell Biol & Pharmacol Thrombosis, Campobasso, Italy; [Pirastu, Mario] Shardna Life Sci, Cagliari, Italy; [de Gaetano, Giovanni] Univ Cattolica, Fdn Ric & Cura Giovanni Paolo II, Res Labs, Campobasso, Italy; [Balduini, Carlo L.] Univ Pavia, IRCCS, Fdn Policlin S Matteo, Dept Internal Med, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Consiglio Nazionale delle Ricerche (CNR); Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; European Academy of Bozen-Bolzano; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Burlo Garofolo; University of Trieste; Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Fondazione San Matteo; University of Pavia	Biino, G (corresponding author), Natl Res Council Italy, Inst Mol Genet, Pavia, Italy.	biino@igm.cnr.it	Ulivi, Sheila/H-3700-2013; Pramstaller, Peter P/C-2357-2008; Traglia, Michela/AAX-5816-2020; Francavilla, Matteo/L-6146-2013; Cerletti, Chiara/K-6447-2016; Siani, Alfonso/B-7925-2015; Di Castelnuovo, Augusto Filippo/AAC-2436-2022; Iacoviello, Licia/AGX-7071-2022; Pirastu, Nicola/G-4358-2011; Toniolo, Daniela/AAE-2969-2019; Iacoviello, Licia/K-4676-2016; Biino, Ginevra/B-5334-2013; Sala, Cinzia Felicita/AAN-1900-2020; Pirastu, Nicola/AHB-6226-2022; Ciullo, Marina/AAE-3041-2020; Gasparini, Paolo/B-6173-2014; Balduini, Carlo L/D-9299-2015	Ulivi, Sheila/0000-0003-3606-835X; Cerletti, Chiara/0000-0002-4759-3179; Di Castelnuovo, Augusto Filippo/0000-0001-9767-7998; Iacoviello, Licia/0000-0003-0514-5885; Toniolo, Daniela/0000-0001-9545-6032; Iacoviello, Licia/0000-0003-0514-5885; Biino, Ginevra/0000-0002-9936-946X; Ciullo, Marina/0000-0002-9621-9984; Balduini, Carlo L/0000-0001-6121-9311; Pramstaller, Peter P/0000-0002-9831-8302; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Pirastu, Nicola/0000-0002-5363-3886; s, hema/0000-0002-3440-9475; Gasparini, Paolo/0000-0002-0859-0856; NUTILE, TERESA/0000-0001-7062-8352; Gogele, Martin/0000-0003-4785-4348	Italian Ministry of Education, University and Research (MIUR) [5571/DSPAR/2002]; MIUR-Programma Triennale di Ricerca [D. 1588]; Pfizer Foundation, Rome; Instrumentation laboratory; Milan (Moli-sani Project); MIUR-FIRB [RBIN064YAT]; Assessorato Ricerca Regione Campania; Fondazione Banco di Napoli (Cilento National Park); Compagnia di San Paolo, Torino; Fondazione Cariplo; Ministry of Health; Ricerca Finalizzata; Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bozen/Bolzano; South Tyrolean Sparkasse Foundation (South Tyrol); FVG Regional government; Fondo Trieste; Ministry of Health (FVG); Ministry of Health (Carlantino)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); MIUR-Programma Triennale di Ricerca; Pfizer Foundation, Rome(Pfizer); Instrumentation laboratory; Milan (Moli-sani Project); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Assessorato Ricerca Regione Campania(Regione Campania); Fondazione Banco di Napoli (Cilento National Park); Compagnia di San Paolo, Torino(Compagnia di San Paolo); Fondazione Cariplo(Fondazione Cariplo); Ministry of Health; Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bozen/Bolzano; South Tyrolean Sparkasse Foundation (South Tyrol); FVG Regional government; Fondo Trieste; Ministry of Health (FVG); Ministry of Health (Carlantino)	This study was supported by grants from: Italian Ministry of Education, University and Research (MIUR) no: 5571/DSPAR/2002 (Ogliastra Genetic Park); MIUR-Programma Triennale di Ricerca (D. 1588), Pfizer Foundation, Rome and, "Instrumentation laboratory'', Milan (Moli-sani Project); MIUR-FIRB (RBIN064YAT), Assessorato Ricerca Regione Campania and Fondazione Banco di Napoli to MC (Cilento National Park); Compagnia di San Paolo, Torino, Fondazione Cariplo and, Ministry of Health, Ricerca Finalizzata 2008 to DT (INGI-VB); Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bozen/Bolzano and the South Tyrolean Sparkasse Foundation (South Tyrol); FVG Regional government, Fondo Trieste and the Ministry of Health (FVG and Carlantino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi P, 2007, INT J LAB HEMATOL, V29, P195, DOI 10.1111/j.1751-553X.2006.00843.x; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Beguin Y, 1999, HAEMATOLOGICA, V84, P541; Biino G, 2012, BRIT J HAEMATOL, V157, P384, DOI 10.1111/j.1365-2141.2011.08981.x; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Buckley MF, 2000, THROMB HAEMOSTASIS, V83, P480; Cheng Calvino Ka-Wing, 2004, Lab Hematol, V10, P42, DOI 10.1532/LH96.04010; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; Dacie J., 1991, PRACTICAL HEMATOLOGY, V7th; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; GILES C, 1981, BRIT J HAEMATOL, V48, P31; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; GRAHAM SS, 1987, AM J CLIN PATHOL, V87, P365, DOI 10.1093/ajcp/87.3.365; Ishiguro A, 1999, BRIT J HAEMATOL, V106, P884, DOI 10.1046/j.1365-2141.1999.01641.x; Kadikoylu G, 2006, J NATL MED ASSOC, V98, P398; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Nagata Y, 2003, GENE DEV, V17, P2864, DOI 10.1101/gad.1128003; National Committee for Clinical Laboratory Standards, 1990, PROC HANDL PROC BLOO; National Committee for Clinical Laboratory Standards, 1995, C28A NCCLS; National Committee for Clinical Laboratory Standards, 1991, PROC COLL DIAGN BLOO; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Peng LM, 2004, THROMB HAEMOSTASIS, V91, P367, DOI 10.1160/TH03-05-0276; PIRRIE R, 1952, J CLIN PATHOL, V5, P10, DOI 10.1136/jcp.5.1.10; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; REED AH, 1971, CLIN CHEM, V17, P275; Sandhaus LM, 2002, AM J CLIN PATHOL, V118, P235; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Solberg HE, 2004, CLIN CHEM LAB MED, V42, P710, DOI 10.1515/CCLM.2004.121; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stasi R, 2006, PLOS MED, V3, P388, DOI 10.1371/journal.pmed.0030024; STEVENS RF, 1977, BRIT J HAEMATOL, V37, P295, DOI 10.1111/j.1365-2141.1977.tb06847.x; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999	37	148	153	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54289	10.1371/journal.pone.0054289	http://dx.doi.org/10.1371/journal.pone.0054289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382888	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600027
J	Foster, BA; Gangavarapu, KJ; Mathew, G; Azabdaftari, G; Morrison, CD; Miller, A; Huss, WJ				Foster, Barbara A.; Gangavarapu, Kalyan J.; Mathew, Grinu; Azabdaftari, Gissou; Morrison, Carl D.; Miller, Austin; Huss, Wendy J.			Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme	PLOS ONE			English	Article							IN-VIVO; MALIGNANT PROSTATE; EPITHELIAL-CELLS; GENE-EXPRESSION; BENIGN; BASAL; MICE; ADENOCARCINOMA; PHENOTYPE; EFFLUX	Stem cell enrichment provides a tool to examine prostate stem cells obtained from benign and malignant tissue. Functional assays can enrich stem cells based on common stem cell phenotypes, such as high ATP binding cassette (ABC) transporter mediated efflux of Hoechst substrates (side population assay). This functional assay is based upon mechanisms that protect cells from environmental insult thus contributing to the survival and protection of the stem cell population. We have isolated and analyzed cells digested from twelve clinical prostate specimens based on the side population assay. Prostate stem cell properties of the isolated cells were tested by serial recombination with rat urogenital mesenchyme. Recombinants with side population cells demonstrate an increase in the frequency of human ductal growth and the number of glands per recombinant when compared to recombinants with non-side population cells. Isolated cells were capable of prostatic growth for up to three generations in the recombination assay with as little as 125 sorted prostate cells. The ability to reproducibly use cells isolated by fluorescence activated cell sorting from human prostate tissue is an essential step to a better understanding of human prostate stem cell biology. ABC transporter G2 (ABCG2) was expressed in recombinants from side population cells indicating the side population cells have self-renewal properties. Epithelial cell differentiation of recombinants was determined by immunohistochemical analysis for expression of the basal, luminal, and neuroendocrine markers, p63, androgen receptor, prostate specific antigen, and chromogranin A, respectively. Thus, the ABCG2 expressing side population demonstrates multipotency and self-renewal properties indicating stem cells are within this population.	[Foster, Barbara A.; Gangavarapu, Kalyan J.; Huss, Wendy J.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Mathew, Grinu] Indiana Univ Sch Med, IUPUI, Indianapolis, IN USA; [Azabdaftari, Gissou; Morrison, Carl D.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Miller, Austin] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Huss, Wendy J.] Roswell Pk Canc Inst, Dept Urol Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Huss, WJ (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	wendy.huss@roswellpark.org			NYSTEM [CO24292]; National Institutes of Health (NIH) [R01DK091240]; NIH [R01CA095367]; NCI Cancer Center Support Grant [CA016056]; NATIONAL CANCER INSTITUTE [R01CA095367, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091240] Funding Source: NIH RePORTER	NYSTEM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NYSTEM (CO24292) and National Institutes of Health (NIH) (R01DK091240) to WJH; NIH (R01CA095367) to BAF; the NCI Cancer Center Support Grant (CA016056) to RPCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Collins AT, 2001, J CELL SCI, V114, P3865; Foster BA, 2002, JACKS LAB BAR HARB M; Gangavarpu KJ, 2011, CURR PROTOC TOXICOL; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; GRIMWOOD RE, 1986, J INVEST DERMATOL, V87, P42, DOI 10.1111/1523-1747.ep12523552; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Haughney PC, 1998, BIOL REPROD, V59, P93, DOI 10.1095/biolreprod59.1.93; HAYASHI N, 1990, CANCER RES, V50, P4747; HAYASHI N, 1991, CANCER RES, V51, P4924; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hayward SW, 2001, CANCER RES, V61, P8135; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jiang M, 2010, STEM CELLS, V28, P344, DOI 10.1002/stem.284; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mathew G, 2009, CELL CYCLE, V8, P1053, DOI 10.4161/cc.8.7.8043; Morrison C, 2009, PROSTATE, V69, P770, DOI 10.1002/pros.20925; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roh M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002572; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Toivanen R, 2011, STEM CELLS, V29, P1310, DOI 10.1002/stem.668; Vander Griend DJ, 2009, PROSTATE, V69, P1557, DOI 10.1002/pros.21001; WONG YC, 1992, ACTA ANAT, V143, P139; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	37	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55062	10.1371/journal.pone.0055062	http://dx.doi.org/10.1371/journal.pone.0055062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383057	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600062
J	Hirsch, M; Wareham, RJ; Martin-Fernandez, ML; Hobson, MP; Rolfe, DJ				Hirsch, Michael; Wareham, Richard J.; Martin-Fernandez, Marisa L.; Hobson, Michael P.; Rolfe, Daniel J.			A Stochastic Model for Electron Multiplication Charge-Coupled Devices - From Theory to Practice	PLOS ONE			English	Article							LOCATION; SIGNALS	Electron multiplication charge-coupled devices (EMCCD) are widely used for photon counting experiments and measurements of low intensity light sources, and are extensively employed in biological fluorescence imaging applications. These devices have a complex statistical behaviour that is often not fully considered in the analysis of EMCCD data. Robust and optimal analysis of EMCCD images requires an understanding of their noise properties, in particular to exploit fully the advantages of Bayesian and maximum-likelihood analysis techniques, whose value is increasingly recognised in biological imaging for obtaining robust quantitative measurements from challenging data. To improve our own EMCCD analysis and as an effort to aid that of the wider bioimaging community, we present, explain and discuss a detailed physical model for EMCCD noise properties, giving a likelihood function for image counts in each pixel for a given incident intensity, and we explain how to measure the parameters for this model from various calibration images.	[Hirsch, Michael; Martin-Fernandez, Marisa L.; Rolfe, Daniel J.] STFC Rutherford Appleton Lab, Cent Laser Facil, Didcot, Oxon, England; [Wareham, Richard J.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Hobson, Michael P.] Univ Cambridge, Dept Phys, Cambridge, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Cambridge; University of Cambridge	Hirsch, M (corresponding author), STFC Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England.	Michael.Hirsch@stfc.ac.uk		martin-fernandez, marisa/0000-0001-5496-6300; Hirsch, Michael/0000-0001-6183-6256; Rolfe, Daniel/0000-0002-8394-8395	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; BBSRC [BB/G006911/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx) through grant BB/G006911/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Andor Technology, UNR SENS SIGN NOIS D; Andor Technology, LONG EMCCDS; Barrett HH, 2009, IEEE T NUCL SCI, V56, P725, DOI 10.1109/TNS.2009.2015308; Basden AG, 2003, MON NOT R ASTRON SOC, V345, P985, DOI 10.1046/j.1365-8711.2003.07020.x; Clarke DT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3635536; Daigle O, 2009, P SPIE, V5499; Daigle O, 2004, P SPIE, V5499; Diakonis P, 1983, SCI AM, V248; Feroz F, 2009, MON NOT R ASTRON SOC, V398; Hamamatsu Photonics, EL MULT CHARG COUPL; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Hughes J, 2010, ANN APPL STAT, V4, P830, DOI 10.1214/09-AOAS299; Korevaar MAN, 2011, PHYS MED BIOL, V56, P4785, DOI 10.1088/0031-9155/56/15/010; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/NMETH.1447, 10.1038/nmeth.1447]; Mullikin J, 1994, P SPIE, V2173; O'Grady A, 2006, P SOC PHOTO-OPT INS, V6093; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Plakhotnik T, 2006, IEEE T ELECTRON DEV, V53, P618, DOI 10.1109/TED.2006.870572; Robbins MS, 2003, IEEE T ELECT DEVICES, V50; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sharma D, 2006, IMAGING MICROSCOPY, V4; Tubbs RN, 2004, OBSERVATORY, V124; Tulloch S, 2004, P SPIE, V5492; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Zhang L, 2009, J PHYS B, V42	27	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53671	10.1371/journal.pone.0053671	http://dx.doi.org/10.1371/journal.pone.0053671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382848	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600017
J	Shionome, Y; Yan, L; Liu, S; Saeki, T; Ouchi, T				Shionome, Yoshimi; Yan, Li; Liu, Song; Saeki, Toshiaki; Ouchi, Toru			Integrity of p53 Associated Pathways Determines Induction of Apoptosis of Tumor Cells Resistant to Aurora-A Kinase Inhibitors	PLOS ONE			English	Article							CANCER-CELLS; OVARIAN-CANCER; OVEREXPRESSION; TRANSFORMATION; ACTIVATION; CARCINOMA; DISEASE	We have previously shown that mammary tumorigenesis in MMTV-Aurora-A mice is further enhanced when p53 is inactivated, demonstrating that integrity of p53 pathway determines phenotypes induced by this oncogenic kinase. In this study, we investigated the roles of genes involved in p53 pathway (p53, Puma, p21, Bax, and Chk2) in response to Aurora-A inhibitors, VX680 and MK-8745, and explored whether chemoresistant tumor cells would further undergo apoptosis with other therapeutic agents. Isogenic HCT116 cell lines were treated with VX680 or MK-8745. Cell cycle analysis, apoptosis, and tumorigenesity were studied. Chemoresistant cells were recovered from xenograft, and further induction of apoptosis was studied. Induction of apoptosis and aneuploidy with VX680 is much stronger than MK-8745. Xenograft assay indicates that tumor growth of HCT116 and HCT116 p53(-) cells are strongly inhibited by VX680, while that of other cell types are similarly inhibited by two compounds. Among the established cell lines recovered from xenografts, MK-8745-resistant clones contain elevated phosphorylation of mTOR and Akt. When further treated with inhibitors of both mTOR and Akt, those cells undergo apoptosis. These results indicate that p53-associated pathway plays a crucial role in regulating growth inhibition of tumor cells when treated with Aurora-A inhibitors. Combined treatment with Akt/mTOR inhibitors can further induce apoptosis of Aurora-A tumors.	[Shionome, Yoshimi; Ouchi, Toru] Univ Chicago, Dept Med, Natl Univ Hlth Sci, Pritzker Sch Med, Evanston, IL 60201 USA; [Yan, Li; Liu, Song] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Saeki, Toshiaki] Saitama Int Med Ctr, Dept Breast Oncol, Saitama, Japan; [Ouchi, Toru] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of Chicago; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Ouchi, T (corresponding author), Univ Chicago, Dept Med, Natl Univ Hlth Sci, Pritzker Sch Med, Evanston, IL 60201 USA.	Toru.Ouchi@RoswellPark.org			National Institutes of Health [R01CA79892, R01CA9063]; Breast Cancer Research Grant from Susan Komen Foundation;  [5P30CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA079892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Grant from Susan Komen Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants R01CA79892 and R01CA9063 from the National Institutes of Health, and a Breast Cancer Research Grant from Susan Komen Foundation (T.O.), and 5P30CA16056 (T.O. and S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Green MR, 2011, EXPERT OPIN DRUG DIS, V6, P291, DOI 10.1517/17460441.2011.555395; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Iqbal J, 2011, LEUKEMIA, V25, P348, DOI 10.1038/leu.2010.255; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li DH, 2003, CLIN CANCER RES, V9, P991; Meulenbeld HJ, 2012, EXPERT OPIN INV DRUG, V21, P383, DOI 10.1517/13543784.2012.652303; Nair JS, 2012, CELL CYCLE, V11, P807, DOI 10.4161/cc.11.4.19323; Pihan GA, 2001, CANCER RES, V61, P2212; Sanhaji M, 2011, ONCOTARGET, V2, P935; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Taga M, 2009, INT J BIOL SCI, V5, P444, DOI 10.7150/ijbs.5.444; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tanaka T, 1999, CANCER RES, V59, P2041; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Yan AX, 2011, DRUG DISCOV TODAY, V16, P260, DOI 10.1016/j.drudis.2010.12.003; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55457	10.1371/journal.pone.0055457	http://dx.doi.org/10.1371/journal.pone.0055457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383195	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600105
J	Cazares-Garcia, SV; Vazquez-Garciduenas, MS; Vazquez-Marrufo, G				Viridiana Cazares-Garcia, Saila; Soledad Vazquez-Garciduenas, Ma.; Vazquez-Marrufo, Gerardo			Structural and Phylogenetic Analysis of Laccases from Trichoderma: A Bioinformatic Approach	PLOS ONE			English	Article							MELANOCARPUS-ALBOMYCES LACCASE; MULTICOPPER OXIDASE GENES; CHESTNUT BLIGHT FUNGUS; MOLECULAR ANALYSIS; CRYSTAL-STRUCTURE; COPRINOPSIS-CINEREA; MULTIGENE FAMILY; EXPRESSION; COPPER; IDENTIFICATION	The genus Trichoderma includes species of great biotechnological value, both for their mycoparasitic activities and for their ability to produce extracellular hydrolytic enzymes. Although activity of extracellular laccase has previously been reported in Trichoderma spp., the possible number of isoenzymes is still unknown, as are the structural and functional characteristics of both the genes and the putative proteins. In this study, the system of laccases sensu stricto in the Trichoderma species, the genomes of which are publicly available, were analyzed using bioinformatic tools. The intron/exon structure of the genes and the identification of specific motifs in the sequence of amino acids of the proteins generated in silico allow for clear differentiation between extracellular and intracellular enzymes. Phylogenetic analysis suggests that the common ancestor of the genus possessed a functional gene for each one of these enzymes, which is a characteristic preserved in T. atroviride and T. virens. This analysis also reveals that T. harzianum and T. reesei only retained the intracellular activity, whereas T. asperellum added an extracellular isoenzyme acquired through horizontal gene transfer during the mycoparasitic process. The evolutionary analysis shows that in general, extracellular laccases are subjected to purifying selection, and intracellular laccases show neutral evolution. The data provided by the present study will enable the generation of experimental approximations to better understand the physiological role of laccases in the genus Trichoderma and to increase their biotechnological potential.	[Viridiana Cazares-Garcia, Saila; Vazquez-Marrufo, Gerardo] Univ Michoacana, Ctr Multidisciplinario Estudios Biotecnol, Fac Med Vet & Zootecnia, Morelia, Michoacan, Mexico; [Soledad Vazquez-Garciduenas, Ma.] Univ Michoacana, Div Estudios Posgrad, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo	Vazquez-Marrufo, G (corresponding author), Univ Michoacana, Ctr Multidisciplinario Estudios Biotecnol, Fac Med Vet & Zootecnia, Morelia, Michoacan, Mexico.	gvazquezmarrufo@yahoo.com.mx	Marrufo, Gerardo Vázquez-/AEN-6859-2022; Marrufo, Gerardo Vázquez-/ENE-8739-2022	Marrufo, Gerardo Vázquez-/0000-0003-4683-699X; Marrufo, Gerardo Vázquez-/0000-0003-4683-699X	Coordinacion de la Investigacion Cientifica-Universidad Michoacana de San Nicolas de Hidalgo (CIC-UMSNH), Research Support Program; CONACYT-Mexico	Coordinacion de la Investigacion Cientifica-Universidad Michoacana de San Nicolas de Hidalgo (CIC-UMSNH), Research Support Program; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors are grateful for the support of the Coordinacion de la Investigacion Cientifica-Universidad Michoacana de San Nicolas de Hidalgo (CIC-UMSNH), Research Support Program 2012. SVCG acknowledges a scholarship from CONACYT-Mexico for doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andberg M, 2009, FEBS J, V276, P6285, DOI 10.1111/j.1742-4658.2009.07336.x; ASSAVANIG A, 1992, APPL MICROBIOL BIOT, V38, P198, DOI 10.1007/BF00174468; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Ben-Menachem R, 2011, PROTEOMICS, V11, P4468, DOI 10.1002/pmic.201100199; Brandhorst T, 2000, J BIOL CHEM, V275, P7925, DOI 10.1074/jbc.275.11.7925; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Byun-McKay SA, 2007, TRENDS ECOL EVOL, V22, P338, DOI 10.1016/j.tree.2007.05.002; Canero DC, 2008, PHYTOPATHOLOGY, V98, P509, DOI 10.1094/PHYTO-98-5-0509; Catalano V, 2011, CURR GENET, V57, P13, DOI 10.1007/s00294-010-0322-2; Chakroun H, 2010, PROCESS BIOCHEM, V45, P507, DOI 10.1016/j.procbio.2009.11.009; CHOI GH, 1992, MOL PLANT MICROBE IN, V5, P119, DOI 10.1094/MPMI-5-119; Chung HJ, 2008, MOL PLANT MICROBE IN, V21, P1582, DOI 10.1094/MPMI-21-12-1582; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Courty PE, 2009, NEW PHYTOL, V182, P736, DOI 10.1111/j.1469-8137.2009.02774.x; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FernandezLarrea J, 1996, MOL GEN GENET, V252, P539, DOI 10.1007/s004380050261; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Ge HH, 2010, ACTA CRYSTALLOGR F, V66, P254, DOI 10.1107/S1744309110000084; GERMANN UA, 1988, J BIOL CHEM, V263, P885; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gochev V. K., 2007, Bulgarian Journal of Agricultural Science, V13, P171; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hoegger PJ, 2004, CURR GENET, V45, P9, DOI 10.1007/s00294-003-0452-x; Holker U, 2002, FOLIA MICROBIOL, V47, P423, DOI 10.1007/BF02818702; Hoshida H, 2001, J BIOSCI BIOENG, V92, P372, DOI 10.1263/jbb.92.372; Kallio JP, 2009, J MOL BIOL, V392, P895, DOI 10.1016/j.jmb.2009.06.053; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Krastanov A. I., 2007, Bulgarian Journal of Agricultural Science, V13, P349; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Lettera V, 2010, FUNGAL BIOL-UK, V114, P724, DOI 10.1016/j.funbio.2010.06.004; Levasseur A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-32; Li H, 2004, J AM CHEM SOC, V126, P8010, DOI 10.1021/ja049345y; Litvintseva AP, 2002, APPL ENVIRON MICROB, V68, P1305, DOI 10.1128/AEM.68.3.1305-1311.2002; Martin C, 2007, APPL MICROBIOL BIOT, V77, P613, DOI 10.1007/s00253-007-1207-2; Martin F, 1999, FUNGAL GENET BIOL, V27, P161, DOI 10.1006/fgbi.1999.1138; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mate D, 2011, CURR GENOMICS, V12, P113, DOI 10.2174/138920211795564322; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oda K, 2006, APPL ENVIRON MICROB, V72, P3448, DOI 10.1128/AEM.72.5.3448-3457.2006; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Poggeler S, 2011, CURR GENOMICS, V12, P95, DOI 10.2174/138920211795564368; Pokorny R, 2005, J BASIC MICROB, V45, P219, DOI 10.1002/jobm.200410354; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; Ramos JAT, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-78; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sadhasivam S, 2009, WORLD J MICROB BIOT, V25, P1733, DOI 10.1007/s11274-009-0069-4; Schouten A, 2002, MOL MICROBIOL, V43, P883, DOI 10.1046/j.1365-2958.2002.02801.x; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shraddha, 2011, Enzyme Res, V2011, P217861, DOI 10.4061/2011/217861; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; Sprockett DD, 2011, GENE, V479, P29, DOI 10.1016/j.gene.2011.02.009; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tetsch L, 2006, ANTON LEEUW INT J G, V90, P183, DOI 10.1007/s10482-006-9064-z; Vanhee C, 2011, J EXP BOT, V62, P497, DOI 10.1093/jxb/erq283; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	68	31	36	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55295	10.1371/journal.pone.0055295	http://dx.doi.org/10.1371/journal.pone.0055295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383142	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600084
J	Vital, C; Martins, EP				Vital, Cuauhcihuatl; Martins, Emilia P.			Socially-Central Zebrafish Influence Group Behavior More than Those on the Social Periphery	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; DANIO-RERIO; INFORMATION; EVOLUTION; CONSTRUCTION; RECOGNITION; ATTENTION; RESPONSES; NETWORKS; PREDATOR	Certain individuals are more effective than others at using individual experience to impact group behavior. Here, we tested whether pre-training of zebrafish that are at the focal central of social group dynamics ("Key" fish) has a stronger positive impact on group performance than does pre-training of less central ("Non-Key") fish. We used very short observation periods and social network statistics to identify Key and Non-Key individuals, trained these fish to respond to an aversive stimulus, and then measured group performance after returning these now-experienced fish to a social setting. Although Key and Non-Key fish evaded the stimulus equally quickly as individuals, groups with experienced Key fish escaped the aversive stimulus more quickly than did groups with experienced Non-Key fish. The impact depended on genetic background: PN zebrafish on the social extremes (more often males) influenced the group's baseline response to the aversive stimulus, whereas experienced Scientific Hatcheries' zebrafish (both males and females) influenced the change in response over repeated trials. These results suggest that social roles are an important feature of information transfer across a group, and set the stage for future research into the genetic and evolutionary basis of social learning.	[Vital, Cuauhcihuatl] Univ Autonoma Ciudad Juarez, Dept Vet Sci & Anim Husb, Ciudad Juarez, Chihuahua, Mexico; [Martins, Emilia P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Martins, Emilia P.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN USA	Universidad Autonoma de Ciudad Juarez; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Vital, C (corresponding author), Univ Autonoma Ciudad Juarez, Dept Vet Sci & Anim Husb, Ciudad Juarez, Chihuahua, Mexico.	cuauvital@gmail.com	Vital, Cuau/AAQ-8145-2020	Vital Garcia, Cuauhcihuatl/0000-0002-3634-2964; Martins, Emilia/0000-0002-8952-3240	National Science Foundation award [IOB-0543491]	National Science Foundation award(National Science Foundation (NSF))	This research was supported in part by a National Science Foundation award to EPM (IOB-0543491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barcellos LJG, 2010, J FISH BIOL, V76, P1032, DOI 10.1111/j.1095-8649.2010.02542.x; Barzilai-Nahon K, 2008, J AM SOC INF SCI TEC, V59, P1493, DOI 10.1002/asi.20857; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Bode NWF, 2011, ANIM BEHAV, V82, P29, DOI 10.1016/j.anbehav.2011.04.011; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Brown C, 2011, SOCIAL LEARNING FISH, P240; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Croft DP, 2003, FISH FISH, V4, P138, DOI 10.1046/j.1467-2979.2003.00113.x; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Fichtel C, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P37, DOI 10.1007/978-3-642-15355-6_3; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Forsman JT, 2011, ANIM BEHAV, V81, P879, DOI 10.1016/j.anbehav.2011.01.029; Gerlai Robert, 2012, Curr Top Behav Neurosci, V12, P3, DOI 10.1007/7854_2011_180; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Horner V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010625; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katz M, 2003, ANIMAL COGNITION, V6, P5; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kiflawi M, 2006, ENVIRON BIOL FISH, V76, P19, DOI 10.1007/s10641-006-9003-x; King AJ, 2009, COMMUNICATIVE INTEGR, V2, P3; King AP, 2003, ANIM BEHAV, V66, P817, DOI 10.1006/anbe.2003.2280; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland KN, 2004, LEARN BEHAV, V32, P4; Lindeyer CM, 2010, ANIM BEHAV, V79, P827, DOI 10.1016/j.anbehav.2009.12.024; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Manassa RP, 2012, ANIM COGN, V15, P559, DOI 10.1007/s10071-012-0484-z; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; Miller JL, 2008, ANIM BEHAV, V76, P931, DOI 10.1016/j.anbehav.2008.05.011; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Morrell LJ, 2008, ANIM BEHAV, V76, P855, DOI 10.1016/j.anbehav.2008.02.015; Oswald M, 2008, CAN J ZOOL, V86, P1085, DOI 10.1139/Z08-085; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Reader SM, 2000, ANIM BEHAV, V60, P175, DOI 10.1006/anbe.2000.1450; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Saltz JB, 2011, AM NAT, V177, P645, DOI 10.1086/659631; [SAS Institute S], 2009, SAS WIND; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Scheid C, 2007, J COMP PSYCHOL, V121, P380, DOI 10.1037/0735-7036.121.4.380; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Stewart A, 2012, NEUROPHARMACOLOGY, V62, P135, DOI 10.1016/j.neuropharm.2011.07.037; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; Vital C, 2011, J COMP PSYCHOL, V125, P278, DOI 10.1037/a0023906; Vital C, 2009, ETHOLOGY, V115, P347, DOI 10.1111/j.1439-0310.2009.01613.x; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; Wolf JBW, 2011, AM NAT, V177, P135, DOI 10.1086/657442	56	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55503	10.1371/journal.pone.0055503	http://dx.doi.org/10.1371/journal.pone.0055503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383208	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600114
J	Ono, N; Suzuki, S; Furusawa, C; Shimizu, H; Yomo, T				Ono, Naoaki; Suzuki, Shingo; Furusawa, Chikara; Shimizu, Hiroshi; Yomo, Tetsuya			Development of a Physical Model-Based Algorithm for the Detection of Single-Nucleotide Substitutions by Using Tiling Microarrays	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE MICROARRAYS; PROBE LEVEL DATA; DNA MICROARRAY; HYBRIDIZATION; SUMMARIES; SOFTWARE; ARRAYS; SNPS	High-density DNA microarrays are useful tools for analyzing sequence changes in DNA samples. Although microarray analysis provides informative signals from a large number of probes, the analysis and interpretation of these signals have certain inherent limitations, namely, complex dependency of signals on the probe sequences and the existence of false signals arising from non-specific binding between probe and target. In this study, we have developed a novel algorithm to detect the single-base substitutions by using microarray data based on a thermodynamic model of hybridization. We modified the thermodynamic model by introducing a penalty for mismatches that represent the effects of substitutions on hybridization affinity. This penalty results in significantly higher detection accuracy than other methods, indicating that the incorporation of hybridization free energy can improve the analysis of sequence variants by using microarray data.	[Ono, Naoaki] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan; [Suzuki, Shingo; Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan; [Shimizu, Hiroshi; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Yomo, Tetsuya] JST, ERATO, Suita, Osaka, Japan	Nara Institute of Science & Technology; RIKEN; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Furusawa, C (corresponding author), RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan.	chikara.furusawa@riken.jp	Furusawa, Chikara/ABB-6516-2021; Suzuki, Shingo/O-3651-2014; Furusawa, Chikara/N-6103-2015; Shimizu, Hiroshi/C-3688-2017	Furusawa, Chikara/0000-0003-3554-4975; Suzuki, Shingo/0000-0003-1332-3194; Furusawa, Chikara/0000-0003-3554-4975; Shimizu, Hiroshi/0000-0002-8986-0861; ONO, Naoaki/0000-0002-7722-055X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Global COE Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Binder H, 2005, LANGMUIR, V21, P9287, DOI 10.1021/la051231s; Furusawa C, 2009, BIOINFORMATICS, V25, P36, DOI 10.1093/bioinformatics/btn570; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hacia JG, 1999, J MED GENET, V36, P730, DOI 10.1136/jmg.36.10.730; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	25	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54571	10.1371/journal.pone.0054571	http://dx.doi.org/10.1371/journal.pone.0054571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382915	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500017
J	Ou, DB; Zeng, D; Jin, Y; Liu, XT; Teng, JW; Guo, WG; Wang, HT; Su, FF; He, Y; Zheng, QS				Ou, Dong-Bo; Zeng, Di; Jin, Yan; Liu, Xiong-Tao; Teng, Ji-Wei; Guo, Wan-Gang; Wang, Hong-Tao; Su, Fei-Fei; He, Yong; Zheng, Qiang-Sun			The Long-Term Differentiation of Embryonic Stem Cells into Cardiomyocytes: An Indirect Co-Culture Model	PLOS ONE			English	Article							GROWTH-FACTOR; IN-VITRO; PACEMAKER; ESTABLISHMENT; RESISTANCE; CULTURES; HEART; LINES; ACID	Background: Embryonic Stem Cells (ESCs) can differentiate into cardiomyocytes (CMs) in vitro but the differentiation level from ESCs is low. Here we describe a simple co-culture model by commercially available Millicell (TM) hanging cell culture inserts to control the long-term differentiation of ESCs into CMs. Methodology/Principal Findings: Mouse ESCs were cultured in hanging drops to form embryoid bodies (EBs) and treated with 0.1 mmol/L ascorbic acid to induce the differentiation of ESCs into CMs. In the indirect co-culture system, EBs were co-cultured with epidermal keratinocytes (EKs) or neonatal CMs (NCMs) by the hanging cell culture inserts (PET membranes with 1 mm pores). The molecular expressions and functional properties of ESC-derived CMs in prolonged culture course were evaluated. During time course of ESC differentiation, the percentages of EBs with contracting areas in NCMs co-culture were significantly higher than that without co-culture or in EKs co-culture. The functional maintenance of ESC-derived CMs were more prominent in NCMs co-culture model. Conclusions/Significance: These results indicate that NCMs co-culture promote ESC differentiation and has a further effect on cell growth and differentiation. We assume that the improvement of the differentiating efficiency of ESCs into CMs in the co-culture system do not result from the effect of co-culture directly on cell differentiation, but rather by signaling effects that influence the cells in proliferation and long-term function maintenance.	[Ou, Dong-Bo; Zeng, Di; Liu, Xiong-Tao; Teng, Ji-Wei; Guo, Wan-Gang; Wang, Hong-Tao; Su, Fei-Fei; He, Yong; Zheng, Qiang-Sun] Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710032, Peoples R China; [Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zheng, QS (corresponding author), Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710032, Peoples R China.	qiangsunzheng@gmail.com	Jin, Yan/I-4204-2013		National Natural Science Foundation of China [31271039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (no. 31271039). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; David R, 2009, CARDIOVASC RES, V84, P263, DOI 10.1093/cvr/cvp211; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Fahrenbach JP, 2007, J PHYSIOL-LONDON, V585, P565, DOI 10.1113/jphysiol.2007.144121; Gassanov N, 2004, FASEB J, V18, P1710, DOI 10.1096/fj.04-1619fje; GIBSON FM, 1995, BRIT J HAEMATOL, V90, P518, DOI 10.1111/j.1365-2141.1995.tb05578.x; Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x; Hatami L, 2007, INT J CARDIOL, V117, P80, DOI 10.1016/j.ijcard.2006.04.054; HOFLAND LJ, 1995, INT J CANCER, V60, P93, DOI 10.1002/ijc.2910600114; Houweling AC, 2002, ANAT RECORD, V266, P93, DOI 10.1002/ar.10042; Igelmund P, 1999, PFLUG ARCH EUR J PHY, V437, P669, DOI 10.1007/s004240050831; Kaichi S, 2010, CARDIOVASC RES, V88, P314, DOI 10.1093/cvr/cvq189; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Maltsev VA, 1999, CIRC RES, V84, P136, DOI 10.1161/01.RES.84.2.136; Martinez EC, 2010, TISSUE ENG PT A, V16, P1349, DOI [10.1089/ten.tea.2009.0399, 10.1089/ten.TEA.2009.0399]; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ou DB, 2011, J CELL BIOCHEM, V112, P3555, DOI 10.1002/jcb.23283; Ou DB, 2009, BIOESSAYS, V31, P246, DOI 10.1002/bies.200800179; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Roggia C, 2007, EXP CELL RES, V313, P921, DOI 10.1016/j.yexcr.2006.12.009; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x; Yoon J, 2005, ANN HEMATOL, V84, P715, DOI 10.1007/s00277-005-1068-7; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	34	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55233	10.1371/journal.pone.0055233	http://dx.doi.org/10.1371/journal.pone.0055233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383121	gold, Green Submitted, Green Published			2022-12-25	WOS:000315211500067
J	Miyamoto, N; Shinozaki, A; Fujiwara, Y				Miyamoto, Norio; Shinozaki, Ayuta; Fujiwara, Yoshihiro			Neuroanatomy of the Vestimentiferan Tubeworm Lamellibrachia satsuma Provides Insights into the Evolution of the Polychaete Nervous System	PLOS ONE			English	Article							NEREIS-DIVERSICOLOR; MOLECULAR EVIDENCE; MUSHROOM BODIES; COMMON ORIGIN; SIBOGLINIDAE; ANNELIDA; POGONOPHORANS; PHYLOGENY; IMMUNOHISTOCHEMISTRY; COMPLEXITY	Vestimentiferan tubeworms are marine invertebrates that inhabit chemosynthetic environments, and although recent molecular phylogenetic analyses have suggested that vestimentiferan tubeworms are derived from polychaete annelids, they show some morphological features that are different from other polychaetes. For example, vestimentiferans lack a digestive tract and have less body segments and comparative neuroanatomy can provide essential insight into the vestimentiferan body plan and its evolution. In the present study, we investigated the adult nervous system in the vestimentiferan Lamellibrachia satsuma using antibodies against synapsin, serotonin, FMRMamide and acetylated a-tubulin. We also examined the expressions of neural marker genes, elav and synaptotagmin to reveal the distribution of neuronal cell bodies. Brain anatomy shows simple organization in Lamellibrachia compared to other polychaetes. This simplification is probably due to the loss of the digestive tract, passing through the body between the brain and the subesophageal ganglion. In contrast, the ventral nerve cord shows a repeated organizational structure as in the other polychaetes, despite the absence of the multiple segmentation of the trunk. These results suggest that the brain anatomy is variable depending on the function and the condition of surrounding tissues, and that the formation of the rope ladder-like nervous system of the ventral nerve cord is independent from segmentation in polychaetes.	[Miyamoto, Norio; Shinozaki, Ayuta; Fujiwara, Yoshihiro] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Shinozaki, Ayuta; Fujiwara, Yoshihiro] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Hiroshima University	Miyamoto, N (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	nmiyamoto621@gmail.com		Miyamoto, Norio/0000-0002-3051-3945	JSPS [23870044]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a JSPS Grant-in-Aid for Research Activity Start-up (http://www.jsps.go.jp/; grant 23870044 to N. Miyamoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black MB, 1997, MAR BIOL, V130, P141, DOI 10.1007/s002270050233; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Bullock TH, 2002, INTEGR COMP BIOL, V42, P757, DOI 10.1093/icb/42.4.757; Cavanaugh C.M., 1985, Bulletin of the Biological Society of Washington, P373; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Gardiner Stephen L., 1993, P371; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; Hessling R, 2003, HYDROBIOLOGIA, V496, P225, DOI 10.1023/A:1026153016913; Heuer CM, 2008, CELL TISSUE RES, V331, P713, DOI 10.1007/s00441-007-0535-y; Heuer CM, 2009, ZOOMORPHOLOGY, V128, P219, DOI 10.1007/s00435-008-0063-7; Heuer CM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-13; Ivanov AV, 1963, POHONOPHORA; Jennings RM, 2005, MOL BIOL EVOL, V22, P210, DOI 10.1093/molbev/msi008; Jones M., 1985, B BIOL SOC WASH, V6, P117; JONES ML, 1989, BIOL BULL, V177, P254, DOI 10.2307/1541941; JONES ML, 1988, P BIOL SOC WASH, V101, P423; Karaseva NP, 2012, RUSS J MAR BIOL+, V38, P10, DOI 10.1134/S1063074012010075; Kaufman ZS, 2008, BIOL BULL+, V35, P318, DOI 10.1134/S106235900803014X; KOJIMA S, 1993, J MOL EVOL, V37, P66; Kojima S, 1998, MOL PHYLOGENET EVOL, V9, P255, DOI 10.1006/mpev.1997.0472; Kristof A, 2008, CURR BIOL, V18, P1129, DOI 10.1016/j.cub.2008.06.066; Loesel R, 2010, ACTA ZOOL-STOCKHOLM, V91, P29, DOI 10.1111/j.1463-6395.2009.00422.x; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Muller MC, 2000, J MORPHOL, V245, P87; Muller MCM, 2006, INTEGR COMP BIOL, V46, P125, DOI 10.1093/icb/icj017; Pleijel F, 2009, CR BIOL, V332, P140, DOI 10.1016/j.crvi.2008.10.007; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rouse GW, 1995, ZOOL SCR, V24, P269, DOI 10.1111/j.1463-6409.1995.tb00476.x; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Rousset V, 2004, CLADISTICS, V20, P518, DOI 10.1111/j.1096-0031.2004.00039.x; Schulze A, 2003, HYDROBIOLOGIA, V496, P199, DOI 10.1023/A:1026192715095; Schulze A, 2003, ZOOL SCR, V32, P321, DOI 10.1046/j.1463-6409.2003.00119.x; Shinozaki A, 2010, CAH BIOL MAR, V51, P467; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; VANDERLAND J, 1977, BIOL SKR DAN VID SEL, V21, P1; WEBB M, 1969, B MAR SCI, V19, P18	44	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55151	10.1371/journal.pone.0055151	http://dx.doi.org/10.1371/journal.pone.0055151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372830	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500157
J	Lamy, E; Herz, C; Lutz-Bonengel, S; Hertrampf, A; Marton, MR; Mersch-Sundermann, V				Lamy, Evelyn; Herz, Corinna; Lutz-Bonengel, Sabine; Hertrampf, Anke; Marton, Melinda-Rita; Mersch-Sundermann, Volker			The MAPK Pathway Signals Telomerase Modulation in Response to Isothiocyanate-Induced DNA Damage of Human Liver Cancer Cells	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; PROTEIN-KINASE-C; INHIBITS TELOMERASE; UP-REGULATION; HTERT GENE; APOPTOSIS; CHEMOPREVENTION; EXPRESSION; BETA; GROWTH	4-methylthiobutyl isothiocyanate (MTBITC), an aliphatic, sulphuric compound from Brassica vegetables, possesses in vitro and in vivo antitumor activity. Recently we demonstrated the potent growth inhibitory potential of the DNA damaging agent MTBITC in human liver cancer cells. Here we now show that MTBITC down regulates telomerase which sensitizes cells to apoptosis induction. This is mediated by MAPK activation but independent from production of reactive oxygen species (ROS). Within one hour, MTBITC induced DNA damage in cancer cells correlating to a transient increase in hTERT mRNA expression which then turned into telomerase suppression, evident at mRNA as well as enzyme activity level. To clarify the role of MAPK for telomerase regulation, liver cancer cells were pre-treated with MAPK-specific inhibitors prior to MTBITC exposure. This clearly showed that transient elevation of hTERT mRNA expression was predominantly mediated by the MAPK family member JNK. In contrast, activated ERK1/2 and P38, but not JNK, signalled to telomerase abrogation and consequent apoptosis induction. DNA damage by MTBITC was also strongly abolished by MAPK inhibition. Oxidative stress, as analysed by DCF fluorescence assay, electron spin resonance spectroscopy and formation of 4-hydroxynonenal was found as not relevant for this process. Furthermore, N-acetylcysteine pre-treatment did not impact MTBITC-induced telomerase suppression or depolarization of the mitochondrial membrane potential as marker for apoptosis. Our data therefore imply that upon DNA damage by MTBITC, MAPK are essential for telomerase regulation and consequent growth impairment in liver tumor cells and this detail probably plays an important role in understanding the potential chemotherapeutic efficacy of ITC.	[Lamy, Evelyn; Herz, Corinna; Hertrampf, Anke; Marton, Melinda-Rita; Mersch-Sundermann, Volker] Univ Med Ctr Freiburg, Dept Environm Hlth Sci, Freiburg, Germany; [Lutz-Bonengel, Sabine] Univ Med Ctr Freiburg, Inst Legal Med, Freiburg, Germany; [Hertrampf, Anke] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Marton, Melinda-Rita] Univ Politehn Bucuresti, Dept Chem Engn, Bucharest, Romania	University of Freiburg; University of Freiburg; University of Freiburg; Polytechnic University of Bucharest	Lamy, E (corresponding author), Univ Med Ctr Freiburg, Dept Environm Hlth Sci, Freiburg, Germany.	evelyn.lamy@uniklinik-freiburg.de		Herz, Corinna/0000-0003-3837-0544	European Social Fond; Ministry of Science, Research and Arts Baden-Wurttemberg, Germany; Sectorial Operational Programme "Human Resources Development" of the Romanian Ministry of Labour, Family and Social Protection [POSDRU/88/1.5/S/60203]; Mattern Foundation, Germany	European Social Fond; Ministry of Science, Research and Arts Baden-Wurttemberg, Germany; Sectorial Operational Programme "Human Resources Development" of the Romanian Ministry of Labour, Family and Social Protection; Mattern Foundation, Germany	E.L. is funded by an academic grant from the European Social Fond and the Ministry of Science, Research and Arts Baden-Wurttemberg, Germany. M-R.M. was partly funded for this project by the Sectorial Operational Programme "Human Resources Development 2007-2013'' of the Romanian Ministry of Labour, Family and Social Protection through the Financial Agreement POSDRU/88/1.5/S/60203. The study was partly supported by a grant from Mattern Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, CANCER LETT, V178, P187, DOI 10.1016/S0304-3835(01)00838-2; Alfonso-De Matte MY, 2002, CANCER RES, V62, P4575; Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Bianchini F, 2004, DRUG METAB REV, V36, P655, DOI 10.1081/DMR-200033468; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Clarke JD, 2011, J AGR FOOD CHEM, V59, P10955, DOI 10.1021/jf202887c; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GUGUENGUILLOUZO C, 1986, PROG LIVER DIS, V8, P33; Gunes C, 2000, CANCER RES, V60, P2116; Hecht SS, 1999, J NUTR, V129, p768S, DOI 10.1093/jn/129.3.768S; Hsin IL, MUTAT RES, V688, P72; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Klapper W, 2003, LEUKEMIA, V17, P2007, DOI 10.1038/sj.leu.2403086; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamy E, 2004, TOXICOL LETT, V146, P103, DOI 10.1016/j.toxlet.2003.07.001; Lamy E, 2009, ENVIRON MOL MUTAGEN, V50, P190, DOI 10.1002/em.20448; Lamy E, 2009, ENVIRON MOL MUTAGEN, V50, P164, DOI 10.1002/em.20470; Li H, 2007, ANN NY ACAD SCI, V1114, P56, DOI 10.1196/annals.1396.016; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Min NY, 2012, BIOCHEM BIOPH RES CO, V421, P91, DOI 10.1016/j.bbrc.2012.03.120; Moon DO, 2010, CANCER LETT, V295, P260, DOI 10.1016/j.canlet.2010.03.009; Moriarty TJ, 2002, LEUKEMIA, V16, P1112, DOI 10.1038/sj.leu.2402522; Mukherjee S, 2009, J ENVIRON PATHOL TOX, V28, P269, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.30; Mukherjee S, 2009, MOL CELL BIOCHEM, V330, P9, DOI 10.1007/s11010-009-0095-4; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamura Y, 2009, FORUM NUTR, V61, P170, DOI 10.1159/000212749; Pizzimenti S, 2006, FREE RADICAL BIO MED, V40, P1578, DOI 10.1016/j.freeradbiomed.2005.12.024; Pizzimenti S, 2010, J NUTR BIOCHEM, V21, P818, DOI 10.1016/j.jnutbio.2009.06.005; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Rose P, 2003, CELL MOL LIFE SCI, V60, P1489, DOI 10.1007/s00018-003-3150-4; Sato N, 2000, BRIT J CANCER, V82, P1819, DOI 10.1054/bjoc.2000.1117; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; STROM S, 1982, CANCER RES, V42, P4519; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Xi L, 2006, APOPTOSIS, V11, P789, DOI 10.1007/s10495-006-5701-2; Zanichelli F, 2012, APOPTOSIS, V17, P964, DOI 10.1007/s10495-012-0740-3; Zanichelli F, 2012, AGE, V34, P281, DOI 10.1007/s11357-011-9231-7; Zhang PS, 2003, FASEB J, V17, P767, DOI 10.1096/fj.02-0603fje	55	37	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53240	10.1371/journal.pone.0053240	http://dx.doi.org/10.1371/journal.pone.0053240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382840	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600014
J	Mohebbi, N; Perna, A; van der Wijst, J; Becker, HM; Capasso, G; Wagner, CA				Mohebbi, Nilufar; Perna, Angelica; van der Wijst, Jenny; Becker, Helen M.; Capasso, Giovambattista; Wagner, Carsten A.			Regulation of Two Renal Chloride Transporters, AE1 and Pendrin, by Electrolytes and Aldosterone	PLOS ONE			English	Article							ACID-BASE TRANSPORT; CL-/HCO3-EXCHANGER PENDRIN; INTERCALATED CELLS; COLLECTING DUCT; RAT-KIDNEY; MOUSE KIDNEY; MOLECULAR-MECHANISMS; METABOLIC-ACIDOSIS; H+-ATPASE; AMMONIUM-CHLORIDE	The renal handling of salt and protons and bicarbonate are intricately linked through shared transport mechanisms for sodium, chloride, protons, and bicarbonate. In the collecting duct, the regulated fine-tuning of salt and acid-base homeostasis is achieved by a series of transport proteins located in different cell types, intercalated and principal cells. Intercalated cells are considered to be of less importance for salt handling but recent evidence has suggested that the anion exchanger pendrin may participate in salt reabsorption and blood pressure regulation. Here, we examined the regulated expression of two functionally related but differentially expressed anion exchangers, AE1 and pendrin, by dietary electrolyte intake and aldosterone. Cortical expression of pendrin was regulated on mRNA and protein level. The combination of NaHCO3 and DOCA enhanced pendrin mRNA and protein levels, whereas DOCA or NaHCO3 alone had no effect. NaCl or KHCO3 increased pendrin mRNA, KCl decreased its mRNA abundance. On protein level, NH4Cl, NaCl, and KCl reduced pendrin expression, the other treatments were without effect. In contrast, AE1 mRNA or protein expression in kidney cortex was regulated by none of these treatments. In kidney medulla, NaHCO3/DOCA or NaHCO3 alone enhanced AE1 mRNA levels. AE1 protein abundance was increased by NH4Cl, NaHCO3/DOCA, and NaCl. Immunolocalization showed that during NH4Cl treatment the relative number of AE1 positive cells was increased and pendrin expressing cells reduced. Thus, pendrin and AE1 are differentially regulated with distinct mechanisms that separately affect mRNA and protein levels. Pendrin is regulated by acidosis and chloride intake, whereas AE1 is enhanced by acidosis, NaCl, and the combination of DOCA and NaHCO3.	[Mohebbi, Nilufar; Perna, Angelica; van der Wijst, Jenny; Becker, Helen M.; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Mohebbi, Nilufar; Perna, Angelica; van der Wijst, Jenny; Becker, Helen M.; Wagner, Carsten A.] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Mohebbi, Nilufar] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Perna, Angelica; Capasso, Giovambattista] Univ Naples 2, Dept Internal Med, Chair Nephrol, Naples, Italy	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; Universita della Campania Vanvitelli	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	Wagnerca@access.uzh.ch	van der Wijst, Jenny/D-9726-2016; Perna, Angelica/S-8292-2019; van der Wijst, Jenny/T-1620-2019	van der Wijst, Jenny/0000-0002-1547-516X; Perna, Angelica/0000-0002-7853-9159; van der Wijst, Jenny/0000-0002-1547-516X; Capasso, Giovambattista/0000-0003-3469-8614	Swiss National Science Foundation [31003A-138143/1]; 7th EU Framework project EUNEFRON; Second University of Naples	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th EU Framework project EUNEFRON; Second University of Naples	This study was supported by a grant from the Swiss National Science Foundation (31003A-138143/1) to CA Wagner, the 7th EU Framework project EUNEFRON to G Capasso and CA Wagner, and a student fellowship from the Second University of Naples to A Perna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler L, 2008, AM J PHYSIOL-CELL PH, V294, pC1261, DOI 10.1152/ajpcell.00486.2007; Alesutan I, 2011, CELL PHYSIOL BIOCHEM, V28, P553, DOI 10.1159/000335114; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Amlal H, 2011, CELL PHYSIOL BIOCHEM, V28, P521, DOI 10.1159/000335117; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Bonnici B, 2004, PFLUG ARCH EUR J PHY, V448, P16, DOI 10.1007/s00424-003-1227-4; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Christensen BM, 2004, AM J PHYSIOL-CELL PH, V286, pC952, DOI 10.1152/ajpcell.00266.2003; ELGER M, 1992, AM J PHYSIOL, V262, pF656, DOI 10.1152/ajprenal.1992.262.4.F656; Ellison DH, 2009, HYPERTENSION, V54, P196, DOI 10.1161/HYPERTENSIONAHA.109.129171; Frische S, 2003, AM J PHYSIOL-RENAL, V284, pF584, DOI 10.1152/ajprenal.00254.2002; Gao X, 2010, P NATL ACAD SCI US; Gimenez I, 2006, CURR OPIN NEPHROL HY, V15, P517, DOI 10.1097/01.mnh.0000242178.44576.b0; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hadchouel J, 2006, CELL METAB, V4, P335, DOI 10.1016/j.cmet.2006.10.007; Hadchouel J, 2011, CELL PHYSIOL BIOCHEM, V28, P505, DOI 10.1159/000335116; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Huber S, 1999, AM J PHYSIOL-RENAL, V277, pF841, DOI 10.1152/ajprenal.1999.277.6.F841; Jehle S, 2000, CLIN SCI, V99, P47, DOI 10.1042/CS19990317; Kim YH, 2007, AM J PHYSIOL-RENAL, V293, pF1314, DOI 10.1152/ajprenal.00155.2007; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mohebbi N, 2009, AM J PHYSIOL-RENAL, V297, pF499, DOI 10.1152/ajprenal.90489.2008; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; PACHA J, 1991, AM J PHYSIOL, V261, pF696, DOI 10.1152/ajprenal.1991.261.4.F696; Palmer LG, 2007, AM J PHYSIOL-RENAL, V292, pF966, DOI 10.1152/ajprenal.00191.2006; Pech V, 2006, AM J PHYSL RENAL PHY; Petrovic S, 2003, AM J PHYSIOL-RENAL, V284, pF103, DOI 10.1152/ajprenal.00205.2002; Procino G, 2011, CELL PHYSIOL BIOCHEM, V28, P683, DOI 10.1159/000335762; Purkerson JM, 2010, KIDNEY INT, V78, P993, DOI 10.1038/ki.2010.195; Quentin F, 2004, AM J PHYSIOL-RENAL, V287, pF1179, DOI 10.1152/ajprenal.00211.2004; Reimold FR, 2011, CELL PHYSIOL BIOCHEM, V28, P435, DOI 10.1159/000335106; Rodighiero S, 2011, CELL PHYSIOL BIOCHEM, V28, P559, DOI 10.1159/000335120; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Rozenfeld J, 2011, CELL PHYSIOL BIOCHEM, V28, P385, DOI 10.1159/000335100; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; SEBASTIAN A, 1976, J CLIN INVEST, V58, P454, DOI 10.1172/JCI108490; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; STONE DK, 1983, J CLIN INVEST, V72, P77, DOI 10.1172/JCI110986; STONE DK, 1983, J CLIN INVEST, V71, P1505, DOI 10.1172/JCI110905; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Van Huyen JPD, 2008, J AM SOC NEPHROL, V19, P1965, DOI 10.1681/ASN.2007070781; Verlander JW, 2006, AM J PHYSIOL-RENAL, V291, pF833, DOI 10.1152/ajprenal.00474.2005; VERLANDER JW, 1994, AM J PHYSIOL, V266, pF633, DOI 10.1152/ajprenal.1994.266.4.F633; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P513, DOI 10.1159/000335112; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P497, DOI 10.1159/000335111; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Welsh-Bacic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025240; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101	60	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55286	10.1371/journal.pone.0055286	http://dx.doi.org/10.1371/journal.pone.0055286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383138	Green Published, Green Accepted, gold			2022-12-25	WOS:000314610600082
J	Thay, B; Wai, SN; Oscarsson, J				Thay, Bernard; Wai, Sun Nyunt; Oscarsson, Jan			Staphylococcus aureus alpha-Toxin-Dependent Induction of Host Cell Death by Membrane-Derived Vesicles	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PLASMA-MEMBRANE; HEMOLYSIN; VIRULENCE; APOPTOSIS; PROTEINS; RELEASE; PATHWAY; HEAD	Staphylococcus aureus causes a wide spectrum of infections in humans, ranging from superficial cutaneous infections, infections in the circum-oral region, to life-threatening bacteremia. It was recently demonstrated that Gram-positive organisms such as S. aureus liberate membrane-derived vesicles (MVs), which analogously to outer membrane vesicles (OMVs) of Gram-negative bacteria can play a role in delivering virulence factors to host cells. In the present study we have shown that cholesterol-dependent fusion of S. aureus MVs with the plasma membrane represents a route for delivery of a key virulence factor, alpha-toxin (alpha-hemolysin; Hla) to human cells. Most S. aureus strains produce this 33-kDa pore-forming protein, which can lyse a wide range of human cells, and induce apoptosis in T-lymphocytes. Our results revealed a tight association of biologically active alpha-toxin with membrane-derived vesicles isolated from S. aureus strain 8325-4. Concomitantly, alpha-toxin contributed to HeLa cell cytotoxicity of MVs, and was the main vesicle-associated protein responsible for erythrocyte lysis. In contrast, MVs obtained from an isogenic hla mutant were significantly attenuated with regards to both causing lysis of erythrocytes and death of HeLa cells. This is to our knowledge the first recognition of an S. aureus MV-associated factor contributing to host cell cytotoxicity.	[Thay, Bernard; Oscarsson, Jan] Umea Univ, Dept Odontol, Umea, Sweden; [Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, Umea, Sweden; [Wai, Sun Nyunt] Umea Univ, UCMR, Umea, Sweden	Umea University; Umea University; Umea University	Wai, SN (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se; jan.oscarsson@odont.umu.se		Wai, Sun Nyunt/0000-0003-4793-4671; Thay, Bernard/0000-0001-5099-6844	Swedish Research Council; Swedish Research Council Formas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by grants from The Swedish Research Council (www.vr.se; SNW), and from the Swedish Research Council Formas (www.formas.se; JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldick T, 2009, MOL MICROBIOL, V71, P1496, DOI 10.1111/j.1365-2958.2009.06618.x; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; CROSSLEY KB, 1997, STAPHYLOCOCCI HUMAN; Dajcs JJ, 2002, DNA CELL BIOL, V21, P375, DOI 10.1089/10445490260099656; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dragneva Y, 2001, INFECT IMMUN, V69, P2630, DOI 10.1128/IAI.69.4.2630-2635.2001; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Giese B, 2009, INFECT IMMUN, V77, P3611, DOI 10.1128/IAI.01478-08; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Soderblom T, 2005, CELL MICROBIOL, V7, P779, DOI 10.1111/j.1462-5822.2005.00510.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Valeva A, 1996, EMBO J, V15, P1857, DOI 10.1002/j.1460-2075.1996.tb00536.x; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WALEV I, 1993, INFECT IMMUN, V61, P4972, DOI 10.1128/IAI.61.12.4972-4979.1993; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x	55	90	93	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54661	10.1371/journal.pone.0054661	http://dx.doi.org/10.1371/journal.pone.0054661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382935	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600032
J	Uehara, K; Morishita, T; Kubota, S; Funase, K				Uehara, Kazumasa; Morishita, Takuya; Kubota, Shinji; Funase, Kozo			Change in the Ipsilateral Motor Cortex Excitability Is Independent from a Muscle Contraction Phase during Unilateral Repetitive Isometric Contractions	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; UNIMANUAL FORCE GENERATION; DORSAL INTEROSSEOUS MUSCLE; INTERHEMISPHERIC INHIBITION; VOLUNTARY CONTRACTION; CORTICOSPINAL EXCITABILITY; EVOKED-POTENTIALS; FINGER MOVEMENTS; HAND MUSCLES; HUMAN-BRAIN	The aim of this study was to investigate the difference in a muscle contraction phase dependence between ipsilateral (ipsi)- and contralateral (contra)-primary motor cortex (M1) excitability during repetitive isometric contractions of unilateral index finger abduction using a transcranial magnetic stimulation (TMS) technique. Ten healthy right-handed subjects participated in this study. We instructed them to perform repetitive isometric contractions of the left index finger abduction following auditory cues at 1 Hz. The force outputs were set at 10, 30, and 50% of maximal voluntary contraction (MVC). Motor evoked potentials (MEP) were obtained from the right and left first dorsal interosseous muscles (FDI). To examine the muscle contraction phase dependence, TMS of ipsi-M1 or contra-M1 was triggered at eight different intervals (0, 20, 40, 60, 80, 100, 300, or 500 ms) after electromyogram (EMG) onset when each interval had reached the setup triggering level. Furthermore, to demonstrate the relationships between the integrated EMG (iEMG) in the active left FDI and the ipsi-M1 excitability, we assessed the correlation between the iEMG in the left FDI for the 100 ms preceding TMS onset and the MEP amplitude in the resting/active FDI for each force output condition. Although contra-M1 excitability was significantly changed after the EMG onset that depends on the muscle contraction phase, the modulation of ipsi-M1 excitability did not differ in response to any muscle contraction phase at the 10% of MVC condition. Also, we found that contra-M1 excitability was significantly correlated with iEMG in all force output conditions, but ipsi-M1 excitability was not at force output levels of below 30% of MVC. Consequently, the modulation of ipsi-M1 excitability was independent from the contraction phase of unilateral repetitive isometric contractions at least low force output.	[Uehara, Kazumasa; Morishita, Takuya; Kubota, Shinji; Funase, Kozo] Hiroshima Univ, Div Human Sci, Human Motor Control Lab, Grad Sch Integrated Arts & Sci, Hiroshima, Japan; [Uehara, Kazumasa; Morishita, Takuya] Japan Soc Promot Sci, Tokyo, Japan	Hiroshima University; Japan Society for the Promotion of Science	Funase, K (corresponding author), Hiroshima Univ, Div Human Sci, Human Motor Control Lab, Grad Sch Integrated Arts & Sci, Hiroshima, Japan.	funase@hiroshima-u.ac.jp	Morishita, Takuya/GLN-4074-2022	Morishita, Takuya/0000-0003-0039-1825; Uehara, Kazumasa/0000-0003-2350-8694	Japan Society for the Promotion of Science [24-393]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS fellows, 24-393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Duque J, 2005, CEREB CORTEX, V15, P588, DOI 10.1093/cercor/bhh160; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; Funase K, 1999, NEUROSCI LETT, V271, P25, DOI 10.1016/S0304-3940(99)00467-X; Hayashi MJ, 2008, CEREB CORTEX, V18, P2932, DOI 10.1093/cercor/bhn053; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; HORE J, 1976, J NEUROPHYSIOL, V39, P484, DOI 10.1152/jn.1976.39.3.484; Howatson G, 2011, EUR J NEUROSCI, V33, P978, DOI 10.1111/j.1460-9568.2010.07567.x; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Kasai T, 1999, MUSCLE NERVE, V22, P1419, DOI 10.1002/(SICI)1097-4598(199910)22:10<1419::AID-MUS12>3.0.CO;2-K; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P114, DOI 10.1016/S1388-2457(00)00503-4; MILLS KR, 1991, TRENDS NEUROSCI, V14, P401, DOI 10.1016/0166-2236(91)90029-T; Morishita T, 2012, J NEUROPHYSIOL, V107, P3086, DOI 10.1152/jn.00888.2011; Morishita T, 2011, BRAIN RES, V1371, P65, DOI 10.1016/j.brainres.2010.11.049; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Nirkko AC, 2001, NEUROIMAGE, V13, P825, DOI 10.1006/nimg.2000.0739; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; Post M, 2009, HUM BRAIN MAPP, V30, P1014, DOI 10.1002/hbm.20562; Rau C, 2003, CLIN NEUROPHYSIOL, V114, P1819, DOI 10.1016/S1388-2457(03)00174-3; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Sehm B, 2010, CEREB CORTEX, V20, P34, DOI 10.1093/cercor/bhp075; Sekiguchi H, 2007, EXP BRAIN RES, V178, P374, DOI 10.1007/s00221-006-0743-9; Sohn YH, 2003, EXP BRAIN RES, V148, P176, DOI 10.1007/s00221-002-1292-5; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Steinberg O, 2002, EUR J NEUROSCI, V15, P1371, DOI 10.1046/j.1460-9568.2002.01968.x; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; THOMPSON PD, 1991, ELECTROEN CLIN NEURO, V81, P397, DOI 10.1016/0168-5597(91)90029-W; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Uehara K, 2011, NEUROSCI LETT, V488, P22, DOI 10.1016/j.neulet.2010.10.073	36	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55083	10.1371/journal.pone.0055083	http://dx.doi.org/10.1371/journal.pone.0055083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383063	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600064
J	Armenteras, D; Rodriguez, N; Retana, J				Armenteras, Dolors; Rodriguez, Nelly; Retana, Javier			Landscape Dynamics in Northwestern Amazonia: An Assessment of Pastures, Fire and Illicit Crops as Drivers of Tropical Deforestation	PLOS ONE			English	Article							LAND-USE; FORESTS; CONSERVATION; PATTERNS; POLICY; MODIS; COCA	Many studies have identified drivers of deforestation throughout the tropics and, in most cases, have recognised differences in the level of threat. However, only a few have also looked at the temporal and spatial dynamics by which those drivers act, which is critical for assessing the conservation of biodiversity as well as for landscape planning. In this study, we analyse land cover change between 2000 and 2009 in north-western Colombian Amazonia to identify the interactions between the use of fire, cultivation of illicit crops and establishment of pastures, and their impacts on the loss of forest in the region. Yearly analyses were undertaken at randomly selected sample areas to quantify the average areas of transition of land cover types under different landscape compositions: forest-dominated mosaics, pasture mosaics, fire mosaics, and illicit crop mosaics. Our results indicate that despite the fact that forest areas were well-preserved, deforestation occurred at a low annual rate (0.06%). Conversion to pasture was the main factor responsible for forest loss (the area of pastures tripled within forest mosaics over 8 years), and this process was independent of the landscape matrix in which the forests were located. In fire mosaics, burning is a common tool for forest clearing and conversion to pasture. Thus, forests in fire mosaics were highly disturbed and frequently transformed from primary to secondary forests. The use of fire for illicit cropping was not detected, partly due to the small size of common illicit crops. Forest regeneration from pastures and secondary vegetation was observed in areas with large amounts of natural forest. Overall, assuming the continuation of the observed pasture conversion trend and the use of forest fire, we suggest that our results should be incorporated into a spatially explicit and integrated decision support tool to target and focus land-planning activities and policies.	[Armenteras, Dolors; Rodriguez, Nelly] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Lab Ecol Paisaje & Modelac Ecosistemas, Bogota, Colombia; [Retana, Javier] Univ Autonoma Barcelona, Ctr Recerca Ecol & Aplicac Forestals, Bellaterra, Barcelona, Spain; [Retana, Javier] Univ Autonoma Barcelona, Unitat Ecol, Bellaterra, Barcelona, Spain	Universidad Nacional de Colombia; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Armenteras, D (corresponding author), Univ Nacl Colombia, Fac Ciencias, Dept Biol, Lab Ecol Paisaje & Modelac Ecosistemas, Bogota, Colombia.	darmenterasp@unal.edu.co	ERASO, NELLY RODRIGUEZ/AGN-6951-2022; Armenteras, Dolors/A-4000-2010; ERASO, NELLY RODRIGUEZ/AAI-8005-2021; Retana, Javier/L-1214-2014	Armenteras, Dolors/0000-0003-0922-7298; Rodriguez Eraso, Nelly/0000-0001-7616-2493; Retana, Javier/0000-0002-7505-9467				Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Arce-Nazario JA, 2007, LANDSCAPE ECOL, V22, P89, DOI 10.1007/s10980-007-9123-5; Ariza Eduardo, 1998, ATLAS CULTURAL AMAZO; Armenteras D, 2006, ECOL INDIC, V6, P353, DOI 10.1016/j.ecolind.2005.03.014; Armenteras D, 2009, BIOL CONSERV, V142, P1411, DOI 10.1016/j.biocon.2009.02.002; Armenteras-Pascual D, 2011, AGR FOREST METEOROL, V151, P279, DOI 10.1016/j.agrformet.2010.11.002; Bradley AV, 2008, ECOL SOC, V13; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2008, AMBIO, V37, P522, DOI 10.1579/0044-7447-37.7.522; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Fearnside PM, 2007, BRAZ J ECOL, V10, P83; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Instituto Geografico Agustin Codazzi Comision Corografica, 2007, EC CONT COST MAR COL; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Key C.H, 2006, FIREMON FIRE EFFECTS; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Meidinger DV, 2003, 011 MIN FOR FOR SCI; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Nevle RJ, 2008, PALAEOGEOGR PALAEOCL, V264, P25, DOI 10.1016/j.palaeo.2008.03.008; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Rodriguez N, 2012, BIOTROPICA, V44, P123, DOI 10.1111/j.1744-7429.2011.00770.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Rudel TK, 2006, CONSERV BIOL, V20, P1604, DOI 10.1111/j.1523-1739.2006.00532.x; Soares BS, 2001, BIOSCIENCE, V51, P1059, DOI 10.1641/0006-3568(2001)051[1059:MTSTPO]2.0.CO;2; UNEP (United Nations Environment Program), 2010, LAT AM CAR ENV OUTL, V3; United Nations Office on Drugs and Crime-UNODC, 2009, COL MON CULT COC 200; UNODC, 2010, TRANSF SOC BIOF AS C; Vera-Diaz MD, 2008, ECOL ECON, V65, P420, DOI 10.1016/j.ecolecon.2007.07.015; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007	34	40	45	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54310	10.1371/journal.pone.0054310	http://dx.doi.org/10.1371/journal.pone.0054310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382890	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800044
J	Danhier, P; Copetti, T; De Preter, G; Leveque, P; Feron, O; Jordan, BF; Sonveaux, P; Gallez, B				Danhier, Pierre; Copetti, Tamara; De Preter, Geraldine; Leveque, Philippe; Feron, Olivier; Jordan, Benedicte F.; Sonveaux, Pierre; Gallez, Bernard			Influence of Cell Detachment on the Respiration Rate of Tumor and Endothelial Cells	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; OXYGEN-CONSUMPTION; MAMMALIAN-CELLS; IN-VITRO; MECHANISM; CANCER; SPECTROSCOPY; ADHERENT; DECREASE; ANOIKIS	Cell detachment is a procedure routinely performed in cell culture and a necessary step in many biochemical assays including the determination of oxygen consumption rates (OCR) in vitro. In vivo, cell detachment has been shown to exert profound metabolic influences notably in cancer but also in other pathologies, such as retinal detachment for example. In the present study, we developed and validated a new technique combining electron paramagnetic resonance (EPR) oximetry and the use of cytodex 1 and collagen-coated cytodex 3 dextran microbeads, which allowed the unprecedented comparison of the OCR of adherent and detached cells with high sensitivity. Hence, we demonstrated that both B16F10 melanoma cells and human umbilical vein endothelial cells (HUVEC) experience strong OCR decrease upon trypsin or collagenase treatments. The reduction of cell oxygen consumption was more pronounced with a trypsin compared to a collagenase treatment. Cells remaining in suspension also encounter a marked intracellular ATP depletion and an increase in the lactate production/glucose uptake ratio. These findings highlight the important influence exerted by cell adhesion/ detachment on cell respiration, which can be probed with the unprecedented experimental assay that was developed and validated in this study.	[Danhier, Pierre; De Preter, Geraldine; Leveque, Philippe; Jordan, Benedicte F.; Gallez, Bernard] Univ Catholique Louvain UCL, Biomed Magnet Resonance Res Grp, Louvain Drug Res Inst, Brussels, Belgium; [Copetti, Tamara; Feron, Olivier; Sonveaux, Pierre] Univ Catholique Louvain UCL, Inst Rech Expt & Clin IREC, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Gallez, B (corresponding author), Univ Catholique Louvain UCL, Biomed Magnet Resonance Res Grp, Louvain Drug Res Inst, Brussels, Belgium.	bernard.gallez@uclouvain.be	FERON, Olivier/AAM-6395-2020	FERON, Olivier/0000-0001-5360-0286; Sonveaux, Pierre/0000-0001-6484-8834; Danhier, Pierre/0000-0002-9028-8399	Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Fonds Joseph Maisin; Saint-Luc Foundation; Fondation contre le Cancer the "Actions de Recherches Concerte ' es-Communaute ' Franc [Belgique-ARC 09/14-020]; European Research Council [FP7/2007-2013]; ERC Independent Researcher Starting [243188]	Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Joseph Maisin; Saint-Luc Foundation; Fondation contre le Cancer the "Actions de Recherches Concerte ' es-Communaute ' Franc; European Research Council(European Research Council (ERC)European Commission); ERC Independent Researcher Starting	This work is supported by grants from the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), the Fonds Joseph Maisin, the Saint-Luc Foundation, the Fondation contre le Cancer, the "Actions de Recherches Concerte ' es-Communaute ' Franc, aise de Belgique-ARC 09/14-020'', and the European Research Council (FP7/2007-2013 ERC Independent Researcher Starting Grant No. 243188 TUMETABO to P. Sonveaux). B. F. Jordan and P. Sonveaux are Research Associates and P. Danhier is a Research Fellow of the FRS-FNRS. G. De Preter is a Televie Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1985, IN VITRO CELL DEV B, V21, P254; Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; Ansiaux R, 2006, CANCER RES, V66, P9698, DOI 10.1158/0008-5472.CAN-06-1854; BAUMANN H, 1979, J BIOL CHEM, V254, P3935; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cichon MA, 2010, J MOL CELL BIOL, V2, P113, DOI 10.1093/jmcb/mjp050; Clementi E, 1999, P NATL ACAD SCI USA, V96, P1559, DOI 10.1073/pnas.96.4.1559; Crokart N, 2005, CANCER RES, V65, P7911, DOI 10.1158/0008-5472.CAN-05-1288; Crokart N, 2007, CLIN CANCER RES, V13, P630, DOI 10.1158/1078-0432.CCR-06-0802; Diepart C, 2010, ANAL BIOCHEM, V396, P250, DOI 10.1016/j.ab.2009.09.029; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gallez B, 2004, NMR BIOMED, V17, P240, DOI 10.1002/nbm.900; Gottlieb E, 2009, NATURE, V461, P44, DOI 10.1038/461044a; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; HONDA BD, 1991, BIOCHEM CELL BIOL, V69, P728, DOI 10.1139/o91-109; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Jordan BF, 2002, CANCER RES, V62, P3555; Lahdesmaki I, 1999, ANAL CHEM, V71, P5248, DOI 10.1021/ac990712b; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Lindskog U, 1987, Dev Biol Stand, V66, P307; Mamchaoui K, 2000, AM J PHYSIOL-LUNG C, V278, P63; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MUKUNDAN NE, 1995, BIOCHEM BIOPH RES CO, V210, P113, DOI 10.1006/bbrc.1995.1634; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Presley T, 2006, BIOPHYS J, V91, P4623, DOI 10.1529/biophysj.106.090175; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Song YL, 2005, J PHYS D APPL PHYS, V38, P2682, DOI 10.1088/0022-3727/38/15/021; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Territo PR, 2000, ANAL BIOCHEM, V286, P156, DOI 10.1006/abio.2000.4774; Vaupel P, 1998, INT J RADIAT ONCOL, V42, P843, DOI 10.1016/S0360-3016(98)00324-1; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wang SF, 2007, INVEST OPHTH VIS SCI, V48, P1335, DOI 10.1167/iovs.06-0842; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, P36; ZECHEL K, 1980, ANAL BIOCHEM, V102, P203, DOI 10.1016/0003-2697(80)90339-5	40	27	27	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53324	10.1371/journal.pone.0053324	http://dx.doi.org/10.1371/journal.pone.0053324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382841	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800020
J	Feriotti, C; Loures, FV; de Araujo, EF; da Costa, TA; Calich, VLG				Feriotti, Claudia; Loures, Flavio V.; de Araujo, Eliseu Frank; da Costa, Tania Alves; Calich, Vera L. G.			Mannosyl-Recognizing Receptors Induce an M1-Like Phenotype in Macrophages of Susceptible Mice but an M2-Like Phenotype in Mice Resistant to a Fungal Infection	PLOS ONE			English	Article							PARACOCCIDIOIDES-BRASILIENSIS CONIDIA; TOLL-LIKE RECEPTORS; C-TYPE LECTINS; NITRIC-OXIDE; CELL-WALL; ALTERNATIVE ACTIVATION; CYTOKINE PRODUCTION; IMMUNE RECOGNITION; INNATE; PHAGOCYTOSIS	In addition to alpha1,3 glucan, mannan and mannan-linked proteins are expressed in the outer layer of Paracoccidioides brasiliensis yeasts. The recognition of mannosyl residues by multiple pathogen recognition receptors, such as the mannose receptor (MR), complement receptor 3 (CR3) and toll-like receptor 4 (TLR4) on macrophage membranes can influence macrophage activation and the mechanisms of innate immunity against fungal pathogens. The aim of this study was to clarify the role of these receptors in the interaction between P. brasiliensis and macrophages from resistant (A/J) and susceptible (B10,A) mice. Therefore, the phagocytic, fungicidal and secretory abilities of macrophages were evaluated in the presence of mannan and antibodies against MR, CR3 and TLR4. We verified that mannan increased and anti-MR antibody decreased the killing ability and nitric oxide production of macrophages. The specific blockade of MR, CR3 and TLR4 by monoclonal antibodies impaired fungal recognition and modulated the production of cytokines. Mannan or P. brasiliensis induced decreased expression of MR and TLR2 on A/J macrophages, whereas CR3, TLR4 and TLR2 were reduced on B10. A cells. Importantly, both mannan and P. brasiliensis induced the production of IL-12 by B10. A macrophages, whereas TGF-beta, TNF-alpha and IL-6 were produced by A/J cells. In addition, B10. A macrophages exhibited a prevalent expression of inducible NO-synthase and SOCS3 (suppressor of cytokine signaling-3), indicating a pro-inflammatory, "M1-like" differentiation. In contrast, the elevated expression of arginase-1, found in inflammatory zone-1 (FIZZ1), YM1 (CHI313, chitinase-like lectin), and SOCS1, typical markers of alternatively activated macrophages, indicates a prevalent "M2-like" differentiation of A/J macrophages. In conclusion, our data reveal that several mannosyl-recognizing receptors coordinate the apparently paradoxical innate response to paracoccidioidomycosis, in which resistance is initially mediated by alternatively activated phagocytes and tolerance to fungal growth, whereas susceptibility is linked to classically activated macrophages and the efficient control of fungal growth.	[Feriotti, Claudia; Loures, Flavio V.; de Araujo, Eliseu Frank; da Costa, Tania Alves; Calich, Vera L. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Calich, VLG (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	vlcalich@icb.usp.br	Calich, Vera/G-8367-2011; Feriotti, Claudia/AGG-1092-2022; Loures, Flávio Vieira/B-6913-2012	Calich, Vera/0000-0002-2170-5099; Loures, Flávio Vieira/0000-0001-7711-4063; Feriotti, Claudia/0000-0002-5184-5359	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/14518-2, 05/55327-8]; Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) [23038.027914/2009-32]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Research Grants 04/14518-2 and 05/55327-8, and Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) Grant 23038.027914/2009-32. The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645; Baida H, 1999, MICROBES INFECT, V1, P273, DOI 10.1016/S1286-4579(99)80022-7; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BONFIM CV, 2009, MED MYCOL, P1; Brandhorst TT, 2004, J IMMUNOL, V173, P7444, DOI 10.4049/jimmunol.173.12.7444; Briken V, 2011, J LEUKOCYTE BIOL, V90, P839, DOI 10.1189/jlb.0411203; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; CALICH VLG, 1979, CLIN IMMUNOL IMMUNOP, V12, P20, DOI 10.1016/0090-1229(79)90108-9; CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; CANO LE, 1992, INFECT IMMUN, V60, P2096, DOI 10.1128/IAI.60.5.2096-2100.1992; CANO LE, 1994, INFECT IMMUN, V62, P1494, DOI 10.1128/IAI.62.4.1494-1496.1994; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; CARBONELL LM, 1970, J BACTERIOL, V101, P636, DOI 10.1128/JB.101.2.636-642.1970; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Felonato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051071; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Jimenez MD, 2006, FEMS IMMUNOL MED MIC, V47, P56, DOI 10.1111/j.1574-695X.2006.00059.x; KANETSUNA F, 1972, J BACTERIOL, V110, P208, DOI 10.1128/JB.110.1.208-218.1972; KANETSUNA F, 1969, J BACTERIOL, V97, P1036, DOI 10.1128/JB.97.3.1036-1041.1969; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; KASHINO SS, 1990, MYCOPATHOLOGIA, V111, P173, DOI 10.1007/BF02282801; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levitz SA, 2004, MICROBES INFECT, V6, P1351, DOI 10.1016/j.micinf.2004.08.014; Levitz Stuart M, 2002, Nihon Ishinkin Gakkai Zasshi, V43, P133, DOI 10.3314/jjmm.43.133; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Loures FV, 2011, INFECT IMMUN, V79, P2470, DOI 10.1128/IAI.00375-10; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; Loures FV, 2009, J IMMUNOL, V183, P1279, DOI 10.4049/jimmunol.0801599; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McKenzie EJ, 2007, J IMMUNOL, V178, P4975, DOI 10.4049/jimmunol.178.8.4975; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakaira-Takahagi E, 2011, MED MYCOL, V49, P694, DOI 10.3109/13693786.2011.565485; Nascimento FRF, 2002, J IMMUNOL, V168, P4593, DOI 10.4049/jimmunol.168.9.4593; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pina A, 2008, J LEUKOCYTE BIOL, V83, P1088, DOI 10.1189/jlb.1107738; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Puccia R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00257; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SINGERVERMES LM, 1992, J MED VET MYCOL, V30, P261; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Toledo RG, 2010, MOL IMMUNOL, V48, P26, DOI 10.1016/j.molimm.2010.09.015; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; WRIGHT SD, 1983, J EXP MED, V158, P1338, DOI 10.1084/jem.158.4.1338; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020	69	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54845	10.1371/journal.pone.0054845	http://dx.doi.org/10.1371/journal.pone.0054845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382985	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800080
J	Vandenberghe, LH; Bell, P; Maguire, AM; Xiao, R; Hopkins, TB; Grant, R; Bennett, J; Wilson, JM				Vandenberghe, Luk H.; Bell, Peter; Maguire, Albert M.; Xiao, Ru; Hopkins, Tim B.; Grant, Rebecca; Bennett, Jean; Wilson, James M.			AAV9 Targets Cone Photoreceptors in the Nonhuman Primate Retina	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; GENE-TRANSFER; THERAPY; VECTOR; TRANSDUCTION; ROD; PIGMENTOSA; BINDING; ACHROMATOPSIA; DYSTROPHIES	Transduction of retinal pigment epithelial cells with an adeno-associated viral vector (AAV) based on serotype 2 has partially corrected retinal blindness in Leber congenital amaurosis type 2. However, many applications of gene therapy for retinal blindness rely on the efficient transduction of rod and cone photoreceptor which is difficult to achieve with first generation vector technology. To address this translational need, we evaluated rod and cone photoreceptor targeting of 4 novel AAV capsids (AAV7, AAV9, rh. 64R1 and rh. 8R) versus AAV2 and AAV8 in a foveated retina. Eyes of 20 nonhuman primates were injected subretinally in the proximity of the fovea. While numerous vectors efficiently transduced rods, only AAV9 targeted cones both centrally and peripherally efficiently at low doses, likely due to the abundance of galactosylated glycans, the primary receptor for AAV9, on cone photoreceptors. We conclude AAV9 is an ideal candidate for strategies that require restoration of cone photoreceptor function.	[Vandenberghe, Luk H.; Bell, Peter; Xiao, Ru; Grant, Rebecca; Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA USA; [Maguire, Albert M.; Hopkins, Tim B.; Bennett, Jean] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Vandenberghe, LH (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA.	luk_vandenberghe@meei.harvard.edu; wilsonjm@mail.med.upenn.edu	VANDENBERGHE, LUC H./ABH-1765-2020; Vandenberghe, Luk H./J-6395-2014; Wilson, James M/F-9220-2011	VANDENBERGHE, LUC H./0000-0002-3508-4924; Vandenberghe, Luk H./0000-0002-3508-4924; Wilson, James M/0000-0002-9630-3131	GlaxoSmithKline [NIH P30 DK47757]; Foundation Fighting Blindness; CHOP-PENN Pediatric Center for Retinal Degenerations; University of Pennsylvania; Evanina Mackall Foundation Trust at Scheie Eye Institute; Kirby Foundation; NATIONAL EYE INSTITUTE [DP1EY023177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047757] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008267] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Foundation Fighting Blindness(European Commission); CHOP-PENN Pediatric Center for Retinal Degenerations; University of Pennsylvania; Evanina Mackall Foundation Trust at Scheie Eye Institute; Kirby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the support of GlaxoSmithKline for a research grant and NIH P30 DK47757 (JMW). This work was also supported by the Foundation Fighting Blindness (LHV, JB), its CHOP-PENN Pediatric Center for Retinal Degenerations (JB), Transdisciplinary Award Program in Translational Medicine and Therapeutics (TAPITMAT) from the University of Pennsylvania (LHV, JB), Research to Prevent Blindness, the Paul and Evanina Mackall Foundation Trust at Scheie Eye Institute, and the F.M. Kirby Foundation (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bainbridge JWB, 2003, GENE THER, V10, P1336, DOI 10.1038/sj.gt.3301990; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2010, NEW ENGL J MED, V363, P1669, DOI 10.1056/NEJMcibr1007685; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Mussolino C, 2011, GENE THER, V18, P637, DOI 10.1038/gt.2011.3; Pang JJ, 2010, ADV EXP MED BIOL, V664, P639, DOI 10.1007/978-1-4419-1399-9_73; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Vandenberghe LH, 2009, GENE THER, V16, P1416, DOI 10.1038/gt.2009.101; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06	29	71	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53463	10.1371/journal.pone.0053463	http://dx.doi.org/10.1371/journal.pone.0053463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382846	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800022
J	Grade, S; Weng, YC; Snapyan, M; Kriz, J; Malva, JO; Saghatelyan, A				Grade, Sofia; Weng, Yuan C.; Snapyan, Marina; Kriz, Jasna; Malva, Joao O.; Saghatelyan, Armen			Brain-Derived Neurotrophic Factor Promotes Vasculature-Associated Migration of Neuronal Precursors toward the Ischemic Striatum	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ADULT OLFACTORY-BULB; CORTICAL INTERNEURON MIGRATION; TRANSIENT FOREBRAIN ISCHEMIA; CEREBRAL-ARTERY OCCLUSION; NEWLY GENERATED NEURONS; BLOOD-VESSELS FORM; SUBVENTRICULAR ZONE; NEUROBLAST MIGRATION; RAT-BRAIN	Stroke induces the recruitment of neuronal precursors from the subventricular zone (SVZ) into the ischemic striatum. In injured areas, de-routed neuroblasts use blood vessels as a physical scaffold to their migration, in a process that resembles the constitutive migration seen in the rostral migratory stream (RMS). The molecular mechanism underlying injury-induced vasculature-mediated migration of neuroblasts in the post-stroke striatum remains, however, elusive. Using adult mice we now demonstrate that endothelial cells in the ischemic striatum produce brain-derived neurotrophic factor (BDNF), a neurotrophin that promotes the vasculature-mediated migration of neuronal precursors in the RMS, and that recruited neuroblasts maintain expression of p75NTR, a low-affinity receptor for BDNF. Reactive astrocytes, which are widespread throughout the damaged area, ensheath blood vessels and express TrkB, a high-affinity receptor for BDNF. Despite the absence of BDNF mRNA, we observed strong BDNF immunolabeling in astrocytes, suggesting that these glial cells trap extracellular BDNF. Importantly, this pattern of expression is reminiscent of the adult RMS, where TrkB-expressing astrocytes bind and sequester vasculature-derived BDNF, leading to the entry of migrating cells into the stationary phase. Real-time imaging of cell migration in acute brain slices revealed a direct role for BDNF in promoting the migration of neuroblasts to ischemic areas. We also demonstrated that cells migrating in the ischemic striatum display higher exploratory behavior and longer stationary periods than cells migrating in the RMS. Our findings suggest that the mechanisms involved in the injury-induced vasculature-mediated migration of neuroblasts recapitulate, at least partially, those observed during constitutive migration in the RMS.	[Grade, Sofia; Snapyan, Marina; Saghatelyan, Armen] Inst Sante Mentale Quebec, Cellular Neurobiol Unit, Quebec City, PQ, Canada; [Grade, Sofia; Malva, Joao O.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Weng, Yuan C.; Kriz, Jasna] Univ Laval, Ctr Rech CHUL CHUQ, Quebec City, PQ, Canada; [Kriz, Jasna; Saghatelyan, Armen] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Malva, Joao O.] Univ Coimbra, Fac Med Polo 3, Ctr Res Environm Genet & Oncobiol CIMAGO, Coimbra, Portugal	Universidade de Coimbra; Laval University; Laval University; Universidade de Coimbra	Saghatelyan, A (corresponding author), Inst Sante Mentale Quebec, Cellular Neurobiol Unit, Quebec City, PQ, Canada.	armen.saghatelyan@crulrg.ulaval.ca	Grade, Sofia/Q-3967-2018; Grade, Sofia/AAM-6236-2021; Malva, Joao/L-3557-2014	Grade, Sofia/0000-0003-1873-5550; Malva, Joao/0000-0002-5438-4447; Saghatelyan, Armen/0000-0003-4962-0465	Canadian Institutes of Health Research (CIHR) [110947]; Fundacao Portuguesa para a Ciencia e a Tecnologia (FCT) [SFRH/BD/32953/2006]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); Canada Research Chair in postnatal neurogenesis [950-218183]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fundacao Portuguesa para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Canada Research Chair in postnatal neurogenesis	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to A.S. (MOP #110947), and student scholarships from Fundacao Portuguesa para a Ciencia e a Tecnologia (FCT; SFRH/BD/32953/2006) and Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT; merit scholarship program for foreign students) to S.G. A.S. is the recipient of a Canada Research Chair in postnatal neurogenesis (950-218183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, 1995, J NEUROSCI, V15, P5765; Andsberg G, 2001, EXP NEUROL, V169, P351, DOI 10.1006/exnr.2001.7646; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bath KG, 2012, DEV PSYCHOL IN PRESS; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; COMELLI MC, 1993, NEUROSCIENCE, V55, P473, DOI 10.1016/0306-4522(93)90517-J; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; Dougherty KD, 1999, J COMP NEUROL, V407, P77, DOI 10.1002/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S; Engel O, 2011, JOVE-J VIS EXP, DOI 10.3791/2423; Angelo MF, 2009, J NEUROSCI RES, V87, P1892, DOI 10.1002/jnr.21993; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Keiner S, 2009, J NEUROPATH EXP NEUR, V68, P83, DOI 10.1097/NEN.0b013e31819308e9; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220, DOI 10.1097/00004647-199911000-00006; LEE TH, 1995, J NEUROSCI RES, V41, P684, DOI 10.1002/jnr.490410515; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Narumiya S, 1998, BRAIN RES, V797, P278, DOI 10.1016/S0006-8993(98)00385-0; Nygren J, 2006, J NEUROSCI RES, V84, P626, DOI 10.1002/jnr.20956; Oderfeld-Nowak B, 2003, NEUROSCIENCE, V120, P31, DOI 10.1016/S0306-4522(03)00289-6; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Polleux F, 2002, DEVELOPMENT, V129, P3147; Reichardt LF, 2003, NATURE, V426, P25, DOI 10.1038/426025a; Saarelainen T, 2000, MOL CELL NEUROSCI, V16, P87, DOI 10.1006/mcne.2000.0863; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; TAKEDA A, 1993, NEUROSCIENCE, V55, P23, DOI 10.1016/0306-4522(93)90451-K; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Wong JYF, 1997, EXP NEUROL, V148, P83, DOI 10.1006/exnr.1997.6670; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zermeno V, 2009, INT J BIOL SCI, V5, P118; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	65	100	109	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55039	10.1371/journal.pone.0055039	http://dx.doi.org/10.1371/journal.pone.0055039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383048	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200015
J	Xavier, GM; Panousopoulos, L; Cobourne, MT				Xavier, Guilherme M.; Panousopoulos, Leonidas; Cobourne, Martyn T.			Scube3 Is Expressed in Multiple Tissues during Development but Is Dispensable for Embryonic Survival in the Mouse	PLOS ONE			English	Article							CELL-SURFACE GLYCOPROTEIN; FACTOR-RELATED GENE; HEDGEHOG SIGNAL; PROTEIN SCUBE1; CUB DOMAIN; ZEBRAFISH; SECRETION; RANGE; MICE	The vertebrate Scube family consists of three independent members Scube1-3; which encode secreted cell surface-associated membrane glycoproteins that share a domain organization of at least five recognizable motifs and the ability to both homo-and heterodimerize. There is recent biochemical evidence to suggest that Scube2 is directly involved in Hedgehog signaling, acting co-operatively with Dispatched to mediate the release in soluble form of cholesterol and palmitate-modified Hedgehog ligand during long-range activity. Indeed, in the zebrafish myotome, all three Scube proteins can subtly promote Hedgehog signal transduction in a non-cell autonomous manner. In order to further investigate the role of Scube genes during development, we have generated mice with targeted inactivation of Scube3. Despite a dynamic developmental expression pattern, with transcripts present in neuroectoderm, endoderm and endochondral tissues, particularly within the craniofacial region; an absence of Scube3 function results in no overt embryonic phenotype in the mouse. Mutant mice are born at expected Mendelian ratios, are both viable and fertile, and seemingly retain normal Hedgehog signaling activity in craniofacial tissues. These findings suggest that in the mouse, Scube3 is dispensable for normal development; however, they do not exclude the possibility of a co-operative role for Scube3 with other Scube members during embryogenesis or a potential role in adult tissue homeostasis over the long-term.	[Xavier, Guilherme M.; Panousopoulos, Leonidas; Cobourne, Martyn T.] Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [Cobourne, Martyn T.] Kings Coll London, Inst Dent, Dept Orthodonticsm, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Cobourne, MT (corresponding author), Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England.	martyn.cobourne@kcl.ac.uk	Cobourne, Martyn/R-1165-2019	Cobourne, Martyn/0000-0003-2857-0315	European Union [E07D400355BR]	European Union(European Commission)	Author GMX was funded by the European Union ALBAN Programme, Contract Grant Number E07D400355BR. http://www.welcomeurope.com/european-funds/alban-409+309.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron MJ, 2010, HUM MOL GENET, V19, P1230, DOI 10.1093/hmg/ddq001; Creanga A, 2012, GENE DEV, V26, P1312, DOI 10.1101/gad.191866.112; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Tu CF, 2006, CARDIOVASC RES, V71, P486, DOI 10.1016/j.cardiores.2006.04.010; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Xavier GM, 2009, J EXP ZOOL PART B, V312B, P518, DOI 10.1002/jez.b.21260; Xavier GM, 2011, J MOL HISTOL, V42, P383, DOI 10.1007/s10735-011-9341-7; Xavier GM, 2010, GENESIS, V48, P684, DOI 10.1002/dvg.20678; Yang HY, 2007, CARDIOVASC RES, V75, P139, DOI 10.1016/j.cardiores.2007.03.014; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	22	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55274	10.1371/journal.pone.0055274	http://dx.doi.org/10.1371/journal.pone.0055274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383134	Green Submitted, gold, Green Published			2022-12-25	WOS:000315483200018
J	Tu, CT; Chen, BS				Tu, Chien-Ta; Chen, Bor-Sen			New Measurement Methods of Network Robustness and Response Ability via Microarray Data	PLOS ONE			English	Article							H-INFINITY CONTROL; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; SYSTEMS; DESIGN; CANCER; CARCINOGENESIS; MECHANISMS; DIVERSE	"Robustness'', the network ability to maintain systematic performance in the face of intrinsic perturbations, and "response ability'', the network ability to respond to external stimuli or transduce them to downstream regulators, are two important complementary system characteristics that must be considered when discussing biological system performance. However, at present, these features cannot be measured directly for all network components in an experimental procedure. Therefore, we present two novel systematic measurement methods - Network Robustness Measurement (NRM) and Response Ability Measurement (RAM) - to estimate the network robustness and response ability of a gene regulatory network (GRN) or protein-protein interaction network (PPIN) based on the dynamic network model constructed by the corresponding microarray data. We demonstrate the efficiency of NRM and RAM in analyzing GRNs and PPINs, respectively, by considering aging- and cancer-related datasets. When applied to an aging-related GRN, our results indicate that such a network is more robust to intrinsic perturbations in the elderly than in the young, and is therefore less responsive to external stimuli. When applied to a PPIN of fibroblast and HeLa cells, we observe that the network of cancer cells possesses better robustness than that of normal cells. Moreover, the response ability of the PPIN calculated from the cancer cells is lower than that from healthy cells. Accordingly, we propose that generalized NRM and RAM methods represent effective tools for exploring and analyzing different systems-level dynamical properties via microarray data. Making use of such properties can facilitate prediction and application, providing useful information on clinical strategy, drug target selection, and design specifications of synthetic biology from a systems biology perspective.	[Tu, Chien-Ta; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017		National Science Council of Taiwan [NSC 99-2745-E-007-001-ASP, NSC 100-2745-E-007-001-ASP]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan with grants NSC 99-2745-E-007-001-ASP and NSC 100-2745-E-007-001-ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boyd SP, 1994, SOC IND APPL MATH, Vix; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen BS, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-66; Chen BS, 2004, IEEE T AUTOMAT CONTR, V49, P45, DOI 10.1109/TAC.2003.821400; CHEN BS, 1994, INT J CONTROL, V59, P439, DOI 10.1080/00207179408923085; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Doyle JC, 1992, FEEDBACK CONTROL THE; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Irmak MB, 2003, CANCER RES, V63, P6707; Johansson R., 1993, SYSTEM MODELING IDEN; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; Kuo B., 2009, AUTOMATIC CONTROL SY; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Lin CL, 2000, IEEE T NEURAL NETWOR, V11, P1078, DOI 10.1109/72.870041; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Schneider BL, 2004, CARCINOGENESIS, V25, P2033, DOI 10.1093/carcin/bgh204; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Troyanskaya OG, 2005, BRIEF BIOINFORM, V6, P34, DOI 10.1093/bib/6.1.34; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Yan J, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031909; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; Zhang WH, 2006, SIAM J CONTROL OPTIM, V44, P1973, DOI 10.1137/S0363012903423727; Zhu DX, 2005, BIOINFORMATICS, V21, P4014, DOI 10.1093/bioinformatics/bti655	45	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55230	10.1371/journal.pone.0055230	http://dx.doi.org/10.1371/journal.pone.0055230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383119	gold, Green Submitted, Green Published			2022-12-25	WOS:000315211500066
J	Sun, YL; Huang, LQ; Pelosi, P; Wang, CZ				Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu			A Lysine at the C-Terminus of an Odorant-Binding Protein is Involved in Binding Aldehyde Pheromone Components in Two Helicoverpa Species	PLOS ONE			English	Article							SWISS-MODEL; OLFACTORY RECEPTOR; SENSITIVE NEURONS; SEXUAL ATTRACTION; CRYSTAL-STRUCTURE; NMR STRUCTURE; RELEASE; MOTH; MECHANISM; INSECTS	Odorant-binding proteins (OBPs) are soluble proteins, whose role in olfaction of insects is being recognized as more and more important. We have cloned, expressed and purified an OBP (HarmOBP7) from the antennae of the moth Helicoverpa armigera. Western blot experiments indicate specific expression of this protein in the antennae of adults. HarmOBP7 binds both pheromone components Z-11-hexadecenal and Z-9-hexadecenal with good affinity. We have also performed a series of binding experiments with linear aldehydes, alcohols and esters, as well as with other compounds and found a requirement of medium size for best affinity. The affinity of OBP7, as well as that of a mutant lacking the last 6 residues does not substantially decrease in acidic conditions, but increases at basic pH values with no significant differences between wild-type and mutant. Binding to both pheromone components, instead, is negatively affected by the lack of the C-terminus. A second mutant, where one of the three lysine residues in the C-terminus (Lys123) was replaced by methionine showed reduced affinity to both pheromone components, as well as to their analogues, thus indicating that Lys123 is involved in binding these compounds, likely forming hydrogen bonds with the functional groups of the ligands.	[Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, CZ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	czwang@ioz.ac.cn	Rocco, Patricia/I-7460-2012	Rocco, Patricia/0000-0003-1412-7136; Sun, Ya-Lan/0000-0002-4468-1333	National Basic Research Program of China [2012CB114105]; National Natural Science Foundation of China [31130050, 30925026]; Key Technologies R&D Program of China [2012BAD19B05]; Chinese Academy of Sciences visiting professorship for senior international scientists [2009S2-32]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of China(National Key Technology R&D Program); Chinese Academy of Sciences visiting professorship for senior international scientists	This work was supported by National Basic Research Program of China (Grant No. 2012CB114105) and the National Natural Science Foundation of China (Grant No. 31130050; Grant No. 30925026), Key Technologies R&D Program of China (Grant No. 2012BAD19B05), and the Chinese Academy of Sciences visiting professorship for senior international scientists (Grant No. 2009S2-32), that supported a nine-month visit of PP at the Institute of Zoology, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo F, 2012, INSECT BIOCHEM MOLEC, V42, P708, DOI 10.1016/j.ibmb.2012.06.004; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; PELOSI P, 1982, BIOCHEM J, V201, P245, DOI 10.1042/bj2010245; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1990, CHEM SENSES, V15, P205, DOI 10.1093/chemse/15.2.205; PELOSI P, 1981, CHEM SENSES, V6, P77, DOI 10.1093/chemse/6.2.77; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tcatchoff L, 2006, FEBS LETT, V580, P2102, DOI 10.1016/j.febslet.2006.03.017; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015	37	20	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55132	10.1371/journal.pone.0055132	http://dx.doi.org/10.1371/journal.pone.0055132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372826	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400068
J	Zhao, SH; Zhou, Y; Wang, CH; Yang, Y; Wu, XB; Wei, Y; Zhu, L; Zhao, W; Zhang, QW; Wan, CS				Zhao, Suhui; Zhou, Ying; Wang, Chunhui; Yang, Yu; Wu, Xianbo; Wei, Yao; Zhu, Li; Zhao, Wei; Zhang, Qiwei; Wan, Chengsong			The N-Terminal Domain of EspF Induces Host Cell Apoptosis after Infection with Enterohaemorrhagic Escherichia coli O157:H7	PLOS ONE			English	Article							EFFECTOR; PROTEIN; MITOCHONDRIA; OPERON	Enterohemorrhagic Escherichia coli (EHEC) employs a type III secretion system (TTSS) to export the translocator and effector proteins required for mucosal colonization. As an important bacterial effector protein in locus of enterocyte effacement four, the EspF protein causes F-actin filament aggregations to form attaching and effacing (A/E) lesions, and induces the destruction of brush-border microvilli and cytoskeletal rearrangements to form pedestals. However, the molecular pathogenesis of A/E lesions due to EHEC O157:H7 infection is unclear. In this study, we constructed an espF-deficient mutant (Delta espF) with a 162-bp deletion in the N-terminal domain by using overlap extension PCR. The results showed that EHEC EspF translocated into intestinal epithelial cells, targeted mitochondria and induced apoptosis. The Delta espF mutant, compared to EHEC prototype Guangzhou strain, had lower cell attachment and effacement abilities, lower caspase-9/3 and lactate dehydrogenase levels, lower bacterial adhesion, weaker mitochondria apoptosis, and a higher mouse survival rate. Our results demonstrate the probable function of the EspF N-terminal domain, which targets mitochondria and binds mitochondria heat shock protein 70 to induce cell apoptosis via A/E lesions. These findings may be invaluable in clarifying the molecular pathogenesis of EspF of EHEC O157:H7.	[Zhao, Suhui; Zhou, Ying; Wang, Chunhui; Yang, Yu; Wu, Xianbo; Wei, Yao; Zhu, Li; Zhao, Wei; Zhang, Qiwei; Wan, Chengsong] So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zhang, QW (corresponding author), So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.	zhang.qiwei@yahoo.com; gzwcs@126.com	Zhao, Suhui/AAW-3259-2021; Zhang, Qiwei/D-9110-2012; Wu, Xianbo/AAL-2948-2020; Zhang, Qiwei/AAX-1977-2020	Zhao, Suhui/0000-0001-9170-9071; Zhang, Qiwei/0000-0002-2770-111X; 	Natural Science Foundation of Guangdong Province project [2010B031000005]; Guangdong Province 211 project [GWXY2010]	Natural Science Foundation of Guangdong Province project; Guangdong Province 211 project	This study was supported by the Natural Science Foundation of Guangdong Province project (2010B031000005) and Guangdong Province 211 project (GWXY2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitio O, 2012, STRUCTURE; ALJUMAILI I, 1992, FEMS MICROBIOL LETT, V93, P121; Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Campellone KG, 2012, J BIOL CHEM, V287, P20613, DOI 10.1074/jbc.M112.363473; Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FUJII J, 1994, INFECT IMMUN, V62, P3447, DOI 10.1128/IAI.62.8.3447-3453.1994; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kenny B, 2009, CURR OPIN MICROBIOL, V12, P1, DOI 10.1016/j.mib.2009.01.002; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lodato PB, 2009, MOL MICROBIOL, V71, P273, DOI 10.1111/j.1365-2958.2008.06530.x; MACLEOD DL, 1989, CAN J MICROBIOL, V35, P623, DOI 10.1139/m89-100; Marches O, 2006, J BACTERIOL, V188, P3110, DOI 10.1128/JB.188.8.3110-3115.2006; Mayer BJ, 2001, J CELL SCI, V114, P1253; McNamara BP, 1998, FEMS MICROBIOL LETT, V166, P71, DOI 10.1016/S0378-1097(98)00313-9; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ni XiaoPing, 2002, Chinese Journal of Zoonoses, V18, P74; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2005.00680.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Viswanathan VK, 2004, CELL MICROBIOL, V6, P987, DOI 10.1111/j.1462-5822.2004.00416.x; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Weflen AW, 2010, CELL MICROBIOL, V12, P919, DOI 10.1111/j.1462-5822.2010.01440.x; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; [苑丽霞 YUAN Lixia], 2008, [山西农业科学, Journal of Shanxi Agricultural Sciences], V36, P15; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	41	15	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55164	10.1371/journal.pone.0055164	http://dx.doi.org/10.1371/journal.pone.0055164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372831	Green Published, gold			2022-12-25	WOS:000315210400071
J	Delpu, Y; Lulka, H; Sicard, F; Saint-Laurent, N; Lopez, F; Hanoun, N; Buscail, L; Cordelier, P; Torrisani, J				Delpu, Yannick; Lulka, Hubert; Sicard, Flavie; Saint-Laurent, Nathalie; Lopez, Frederic; Hanoun, Naima; Buscail, Louis; Cordelier, Pierre; Torrisani, Jerome			The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool	PLOS ONE			English	Article							CELL-PROLIFERATION; GASTRIC-CANCER; TUMOR PROGRESSION; CARCINOGENESIS; MICRORNA-148A; METASTASIS; CARCINOMA	MicroRNAs are small non-coding RNAs that physiologically modulate proteins expression, and regulate numerous cellular mechanisms. Alteration of microRNA expression has been described in cancer and is associated to tumor initiation and progression. The microRNA 148a (miR-148a) is frequently down-regulated in cancer. We previously demonstrated that its down-regulation by DNA hypermethylation is an early event in pancreatic ductal adenocarcinoma (PDAC) carcinogenesis, suggesting a tumor suppressive function. Here, we investigate the potential role of miR-148a over-expression in PDAC as a therapeutic tool. We first report the consequences of miR-148a over-expression in PDAC cell lines. We demonstrate that miR-148a over-expression has no dramatic effect on cell proliferation and cell chemo-sensitivity in four well described PDAC cell lines. We also investigate the modulation of protein expression by a global proteomic approach (2D-DIGE). We show that despite its massive over-expression, miR-148a weakly modulates protein expression, thus preventing the identification of protein targets in PDAC cell lines. More importantly, in vivo data demonstrate that modulating miR-148a expression either in the epithelia tumor cells and/or in the tumor microenvironment does not impede tumor growth. Taken together, we demonstrate herein that miR-148a does not impact PDAC proliferation both in vitro and in vivo thus suggesting a weak potential as a therapeutic tool.	[Delpu, Yannick; Lulka, Hubert; Sicard, Flavie; Hanoun, Naima; Buscail, Louis; Cordelier, Pierre; Torrisani, Jerome] Univ Toulouse 3, INSERM UMR 1037, CRCT, Univ Hosp Ctr Rangeuil, F-31062 Toulouse, France; [Delpu, Yannick; Lulka, Hubert; Sicard, Flavie; Saint-Laurent, Nathalie; Lopez, Frederic; Hanoun, Naima; Buscail, Louis; Cordelier, Pierre; Torrisani, Jerome] Univ Toulouse 3, F-31062 Toulouse, France; [Buscail, Louis] Univ Hosp Ctr Rangueil Larrey, Dept Gastroenterol, Toulouse, France; [Saint-Laurent, Nathalie; Lopez, Frederic] Univ Hosp Ctr Rangueil, Basic & Clin Prote Grp, INSERM UMR 1037, Canc Res Ctr Toulouse, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Torrisani, J (corresponding author), Univ Toulouse 3, INSERM UMR 1037, CRCT, Univ Hosp Ctr Rangeuil, F-31062 Toulouse, France.	jerome.torrisani@inserm.fr	Nathalie, Saint-Laurent/G-5487-2017; Cordelier, Pierre/D-1150-2014; LULKA, Hubert/M-7382-2014; hanoun, naima NH/M-6408-2014; Torrisani, Jérôme/M-6203-2014	Cordelier, Pierre/0000-0003-2096-7967; Torrisani, Jérôme/0000-0001-6880-9357	Institut National de la Santee et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC); Toulouse Proteomics Infrastructure; "Association pour la Recherche sur le Cancer" (ARC-ARECA Program)	Institut National de la Santee et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Toulouse Proteomics Infrastructure; "Association pour la Recherche sur le Cancer" (ARC-ARECA Program)	This work was funded by the Institut National de la Santee et de la Recherche Medicale (INSERM, www.inserm.fr) and the Association pour la Recherche sur le Cancer (ARC, www.arc-cancer.net). Proteomics studies were supported by the Toulouse Proteomics Infrastructure with financial support of "Association pour la Recherche sur le Cancer" (ARC-ARECA Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Hanoun N, 2010, J HEPATOL, V53, P880, DOI 10.1016/j.jhep.2010.04.038; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hummel R, 2011, J GASTROINTEST SURG, V15, P429, DOI 10.1007/s11605-011-1418-9; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Vincent A, 2004, LANCET, V363, P1049; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482	28	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55513	10.1371/journal.pone.0055513	http://dx.doi.org/10.1371/journal.pone.0055513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383211	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600116
J	Curwin, AJ; LeBlanc, MA; Fairn, GD; McMaster, CR				Curwin, Amy J.; LeBlanc, Marissa A.; Fairn, Gregory D.; McMaster, Christopher R.			Localization of Lipid Raft Proteins to the Plasma Membrane Is a Major Function of the Phospholipid Transfer Protein Sec14	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; OXYSTEROL-BINDING-PROTEIN; YEAST GOLGI-COMPLEX; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; TRANSPORT; PHOSPHATIDYLCHOLINE; SPHINGOLIPIDS; PATHWAY; HOMEOSTASIS	The Sec14 protein domain is a conserved tertiary structure that binds hydrophobic ligands. The Sec14 protein from Saccharomyces cerevisiae is essential with studies of S. cerevisiae Sec14 cellular function facilitated by a sole temperature sensitive allele, sec14(ts). The sec14(ts) allele encodes a protein with a point mutation resulting in a single amino acid change, Sec14(G266D). In this study results from a genome-wide genetic screen, and pharmacological data, provide evidence that the Sec14(G266D) protein is present at a reduced level compared to wild type Sec14 due to its being targeted to the proteosome. Increased expression of the sec14(ts) allele ameliorated growth arrest, but did not restore the defects in membrane accumulation or vesicular transport known to be defective in sec14(ts) cells. We determined that trafficking and localization of two well characterized lipid raft resident proteins, Pma1 and Fus-Mid-GFP, were aberrant in sec14(ts) cells. Localization of both lipid raft proteins was restored upon increased expression of the sec14(ts) allele. We suggest that a major function provided by Sec14 is trafficking and localization of lipid raft proteins.	[Curwin, Amy J.; LeBlanc, Marissa A.; Fairn, Gregory D.; McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	Christopher.mcmaster@dal.ca	Curwin, Amy/O-8816-2015	Curwin, Amy/0000-0003-1086-2483; Fairn, Greg/0000-0001-6508-168X; McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes for Health Research [14124]; Canada Research Chairs Fund; Nova Scotia Health Research Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Fund(Canada Research Chairs); Nova Scotia Health Research Foundation	This work was supported by an operating grant (14124) from the Canadian Institutes for Health Research and the Canada Research Chairs Fund to CRM. MAL was the recipient of a Nova Scotia Health Research Foundation PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresta-Branco F, 2011, J BIOL CHEM, V286, P5043, DOI 10.1074/jbc.M110.154435; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Chang HJ, 2002, GENETICS, V162, P29; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Curwin AJ, 2009, J BIOL CHEM; Curwin AJ, 2008, FUTURE LIPIDOL, V3, P399, DOI 10.2217/17460875.3.4.399; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Howe AG, 2007, EUKARYOT CELL, V6, P1814, DOI 10.1128/EC.00087-07; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; LEE WC, 1992, MOL CELL BIOL, V12, P3865, DOI 10.1128/MCB.12.9.3865; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Mueller NS, 2012, MOL MEMBR BIOL, V29, P186, DOI 10.3109/09687688.2012.687461; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stolz J, 2002, J BIOL CHEM, V277, P44801, DOI 10.1074/jbc.M208023200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002	53	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55388	10.1371/journal.pone.0055388	http://dx.doi.org/10.1371/journal.pone.0055388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383173	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800146
J	Jia, YF; Liu, DZ; Xiao, DJ; Ma, XL; Han, SY; Zheng, Y; Sun, SH; Zhang, MX; Gao, HM; Cui, X; Wang, YS				Jia, Yanfei; Liu, Dezhi; Xiao, Dongjie; Ma, Xiaoli; Han, Shuyi; Zheng, Yan; Sun, Shanhui; Zhang, Maoxiu; Gao, Hongmei; Cui, Xia; Wang, Yunshan			Expression of AFP and STAT3 Is Involved in Arsenic Trioxide-Induced Apoptosis and Inhibition of Proliferation in AFP-Producing Gastric Cancer Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ALPHA-FETOPROTEIN; SIGNALING PATHWAY; TUMOR; CARCINOMA; GROWTH; TRANSDUCER; INDUCTION; ACTIVATOR; AS2O3	Alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC), represented by the production of AFP, has a more aggressive behavior than common gastric cancer. The underlying mechanisms are not well understood. Arsenic trioxide (As2O3) is used clinically to treat acute promyelocytic leukemia(APL) and has activity in vitro against several solid tumor cell lines, with induction of apoptosis and inhibition of proliferation the prime effects. Signal transducer and activator of transcription 3 (STAT3) has an important role in tumorigenesis of various primary cancers and cancer cell by upregulating cell-survival and downregulating tumor suppressor proteins. Here, we found decreased expression of AFP and STAT3 after induction of apoptosis by As2O3 in the AFPGC FU97 cells. Also, the level of the STAT3 target oncogene Bcl-2 was decreased with As2O3, and that of the tumor suppressor Bax was increased. Furthermore, STAT3 expression and depth of invasion and lymph node metastasis were associated. Survival of patients with gastric cancer was lower with AFP and STAT3 double overexpression than with overexpression of either alone. Downregulation of AFP and STAT3 expression plays an important role in As2O3-induced apoptosis of AFPGC cells, which suggests a new mechanism of As2O3-induced cell apoptosis. As2O3 may be a possible agent for AFPGC treatment.	[Jia, Yanfei; Xiao, Dongjie; Ma, Xiaoli; Han, Shuyi; Zheng, Yan; Sun, Shanhui; Zhang, Maoxiu; Gao, Hongmei; Cui, Xia; Wang, Yunshan] Shandong Univ, Cent Lab, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Jia, Yanfei; Wang, Yunshan] Shandong Univ, Jinan Cent Hosp, Shandong Prov Key Lab Tumor Target Mol, Jinan 250100, Peoples R China; [Liu, Dezhi] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong Normal University	Wang, YS (corresponding author), Shandong Univ, Cent Lab, Jinan Cent Hosp, Jinan 250100, Peoples R China.	sdjnwys@163.com			National Nature Science Foundation Grant of China (NSFC) [81000869, 81272588]	National Nature Science Foundation Grant of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is supported by National Nature Science Foundation Grant of China (NSFC, No. 81000869 and 81272588). (http://www.nsfc.gov.cn/Portal0/default166.htm.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Bowling BD, 2008, CANCER CHEMOTH PHARM, V63, P37, DOI 10.1007/s00280-008-0705-y; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dhar DK, 1999, ONCOLOGY-BASEL, V56, P122, DOI 10.1159/000011952; Dudich E, 1998, TUMOR BIOL, V19, P30, DOI 10.1159/000029972; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Florea AM, 2009, NEUROTOXICOLOGY, V30, P803, DOI 10.1016/j.neuro.2009.04.014; Gao F, 2002, WORLD J GASTROENTERO, V8, P36, DOI 10.3748/wjg.v8.i1.36; Gonda T, 1994, Gan To Kagaku Ryoho, V21, P1659; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hamanaka W, 2008, SURG TODAY, V38, P275, DOI 10.1007/s00595-007-3610-9; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hocking GR, 1995, PATHOLOGY, V27, P277, DOI 10.1080/00313029500169113; Hoshino K, 1996, Gan To Kagaku Ryoho, V23, P1197; Isonishi S, 2009, INT J CLIN ONCOL, V14, P70, DOI 10.1007/s10147-008-0800-4; Izdebska M, 2008, POSTEP HIG MED DOSW, V62, P463; Jiang Wei, 2006, ZHONG LIU JI CHU YU, V19, P21; Kataoka H, 2001, ONCOGENE, V20, P869, DOI 10.1038/sj.onc.1204160; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kono K, 2002, DIGEST SURG, V19, P359, DOI 10.1159/000065838; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li MS, 2009, CANCER LETT, V285, P190, DOI 10.1016/j.canlet.2009.05.014; Li MS, 2009, INT J CANCER, V124, P2845, DOI 10.1002/ijc.24272; Liu X, 2012, J SURG ONCOL, V102, P249; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; SAITO S, 1989, CANCER, V63, P544, DOI 10.1002/1097-0142(19890201)63:3<544::AID-CNCR2820630324>3.0.CO;2-2; Lafayette TCS, 2010, J PEDIAT HEMATOL ONC, V32, P229, DOI 10.1097/MPH.0b013e3181cf7ef3; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Siu KPY, 2002, LIFE SCI, V71, P275, DOI 10.1016/S0024-3205(02)01622-3; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Sumi D, 2010, TOXICOL APPL PHARM, V244, P385, DOI 10.1016/j.taap.2010.02.012; Ueno M, 2001, BJU INT, V88, P611, DOI 10.1046/j.1464-410X.2001.02357.x; Wang XW, 1998, INT J CANCER, V75, P596, DOI 10.1002/(SICI)1097-0215(19980209)75:4<596::AID-IJC17>3.0.CO;2-7; Wang YS, 2005, WORLD J GASTROENTERO, V11, P6053, DOI 10.3748/wjg.v11.i38.6053; Wetzler M, 2006, CLIN CANCER RES, V12, P6817, DOI 10.1158/1078-0432.CCR-06-1354; Wu DD, 2010, CANC GENETICS CYTOGE, V19, P890; Yabusaki H, 2000, Gan To Kagaku Ryoho, V27, P735; Yamagata Toshiyuki, 2004, Can Respir J, V11, P504; Yedjou C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-28; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158	47	18	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54774	10.1371/journal.pone.0054774	http://dx.doi.org/10.1371/journal.pone.0054774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382965	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800076
J	Phipps, WL; Willis, SG; Wolter, K; Naidoo, V				Phipps, W. Louis; Willis, Stephen G.; Wolter, Kerri; Naidoo, Vinny			Foraging Ranges of Immature African White-Backed Vultures (Gyps africanus) and Their Use of Protected Areas in Southern Africa	PLOS ONE			English	Article							CAPE VULTURES; GRIFFON VULTURES; LAND-USE; RANGING BEHAVIOR; POPULATION; CONSERVATION; COPROTHERES; PROVINCE; PERFORMANCE; PREDATION	Vultures in the Gyps genus are declining globally. Multiple threats related to human activity have caused widespread declines of vulture populations in Africa, especially outside protected areas. Addressing such threats requires the estimation of foraging ranges yet such estimates are lacking, even for widespread (but declining) species such as the African whitebacked vulture (Gyps africanus). We tracked six immature African white-backed vultures in South Africa using GPS-GSM units to study their movement patterns, their use of protected areas and the time they spent in the vicinity of supplementary feeding sites. All individuals foraged widely; their combined foraging ranges extended into six countries in southern Africa (mean (+/- SE) minimum convex polygon area = 269,103 +/- 187,187 km(2)) and three of the vultures travelled more than 900 km from the capture site. All six vultures spent the majority of their tracking periods outside protected areas. South African protected areas were very rarely visited whereas protected areas in northern Botswana and Zimbabwe were used more frequently. Two of the vultures visited supplementary feeding sites regularly, with consequent reduced ranging behaviour, suggesting that individuals could alter their foraging behaviour in response to such sites. We show that immature African white-backed vultures are capable of travelling throughout southern Africa, yet use protected areas to only a limited extent, making them susceptible to the full range of threats in the region. The standard approach of designating protected areas to conserve species is unlikely to ensure the protection of such wide-ranging species against threats in the wider landscape.	[Phipps, W. Louis] Univ Pretoria, Dept Paraclin Sci, Onderstepoort, Guateng, South Africa; [Phipps, W. Louis; Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Wolter, Kerri] Vulture Programme, Brits Dist, North West Prov, South Africa; [Naidoo, Vinny] Univ Pretoria, Biomed Res Ctr, Onderstepoort, Guateng, South Africa	University of Pretoria; Durham University; University of Pretoria	Willis, SG (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	s.g.willis@durham.ac.uk	Willis, Stephen G/F-8503-2015; Naidoo, Vinny/A-1508-2008	Willis, Stephen G/0000-0002-8656-5808; Naidoo, Vinny/0000-0003-2740-5983; Phipps, Louis/0000-0003-0400-2014	Leverhulme Trus; University of Pretoria; Mankwe Wildlife Reserve	Leverhulme Trus(Leverhulme Trust); University of Pretoria; Mankwe Wildlife Reserve	The Leverhulme Trust funded the project and WLP with a Study Abroad Studentship. The project was also funded in part by the Faculty of Veterinary Science at the University of Pretoria and Mankwe Wildlife Reserve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MD, 2000, OSTRICH, V71, P25, DOI 10.1080/00306525.2000.9639859; Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; Bamford AJ, 2009, S AFR J WILDL RES, V39, P202, DOI 10.3957/056.039.0201; Benson PC, 2004, OSTRICH, V75, P118, DOI 10.2989/00306520409485423; Beyer H, 2009, HAWTHS ANAL TOOLS AR; BirdLife International, 2013, SPEC FACTSH GYPS AFR; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BROWN CJ, 1988, OSTRICH, V59, P126, DOI 10.1080/00306525.1988.9633714; Brown L.H., 1982, BIRDS AFRICA, V1; Cronje H. P., 2002, Koedoe, V45, P79; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Diekmann M., 2004, VULTURE NEWS, V51, P34; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Herremans M, 2000, BIOL CONSERV, V94, P31, DOI 10.1016/S0006-3207(99)00166-4; HORNER MA, 1990, J MAMMAL, V71, P402, DOI 10.2307/1381953; HOUSTON D C, 1974, East African Wildlife Journal, V12, P63; HOUSTON DC, 1974, J ZOOL, V172, P35; HOUSTON DC, 1976, IBIS, V118, P14, DOI 10.1111/j.1474-919X.1976.tb02008.x; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; IUCN UNEP, 2003, UN LIST PROT AR 2003; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lindsey PA, 2009, J ZOOL, V277, P99, DOI 10.1111/j.1469-7998.2008.00529.x; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; Mapiye C, 2009, J ARID ENVIRON, V73, P529, DOI 10.1016/j.jaridenv.2009.01.003; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Mundy P., 1992, VULTURES AFRICA; Mundy PJ, 1997, ATLAS SO AFRICAN BIR, P160; Murn C, 2008, OSTRICH, V79, P191, DOI 10.2989/OSTRICH.2008.79.2.9.583; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Oschadleus Dieter, 2002, Vulture News, V46, P16; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; PARRY D, 1992, ENVIRON CONSERV, V19, P245, DOI 10.1017/S0376892900031040; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Piper SE, 1999, BIRD STUDY, V46, P230; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; ROBERTSON AS, 1986, BIOL CONSERV, V35, P63, DOI 10.1016/0006-3207(86)90027-3; Rodgers A.R., 2007, HOME RANGE TOOLS HRT; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; SCHOENER TW, 1981, THEOR POPUL BIOL, V20, P281, DOI 10.1016/0040-5809(81)90049-6; Schultz P, 2007, THESIS U CAPE TOWN; Simmons Robert E., 2007, Vulture News, V56, P41; South A. B., 2008, RANGES7 ANAL TRACKIN; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Tambling CJ, 2005, J APPL ECOL, V42, P431, DOI 10.1111/j.1365-2664.2005.01039.x; Thiollay JM, 2006, BIRD CONSERV INT, V16, P353, DOI 10.1017/S0959270906000487; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; van der Waal C, 2000, S AFR J WILDL RES, V30, P151; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	60	53	54	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52813	10.1371/journal.pone.0052813	http://dx.doi.org/10.1371/journal.pone.0052813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382824	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800012
J	Sakai, H; Sagara, A; Matsumoto, K; Hasegawa, S; Sato, K; Nishizaki, M; Shoji, T; Horie, S; Nakagawa, T; Tokuyama, S; Narita, M				Sakai, Hiroyasu; Sagara, Atsunobu; Matsumoto, Kenjiro; Hasegawa, Satoshi; Sato, Ken; Nishizaki, Maiko; Shoji, Tetsuro; Horie, Syunji; Nakagawa, Takayuki; Tokuyama, Shogo; Narita, Minoru			5-Fluorouracil Induces Diarrhea with Changes in the Expression of Inflammatory Cytokines and Aquaporins in Mouse Intestines	PLOS ONE			English	Article							WATER TRANSPORT; MUCOSITIS; COLON; MICE; CHANNELS; MODEL; MECHANISMS; FAMILY; CELLS	Although the mechanisms of 5-fluorouracil (5-FU)-induced diarrhea remain unclear, accumulating evidence has indicated that changes in the mucosal immune system and aquaporins (AQPs) may play a role in its pathogenesis. Therefore, we investigated the possible changes in the gene expression of inflammatory cytokines and AQPs in the intestines of mice with 5-FU-induced diarrhea. In the present study, the expressions of mRNAs that encode inflammatory cytokines, TNF-alpha, IL-1 beta, IL-6, Il-17A and IL-22, were significantly increased throughout the entire colon of mice that exhibited diarrhea following 5-FU administration. In contrast, the gene expression of IFN gamma was upregulated only in the distal colon. These increases were significantly reduced by the administration of etanercept. However, 5-FU-induced diarrhea was not recovered by etanercept. On the other hand, the genes for AQPs 4 and 8 were markedly present in the colon, and these expressions in the intestines were significantly decreased by treatment with 5-FU. These decreases were not reversed by etanercept. These findings suggest TNF-alpha neutralization had no effect on the acutely 5-FU-induced diarrhea and impaired AQPs but reduced dramatically several inflammatory cytokines.	[Sakai, Hiroyasu; Sagara, Atsunobu; Matsumoto, Kenjiro; Hasegawa, Satoshi; Sato, Ken; Nishizaki, Maiko; Shoji, Tetsuro; Narita, Minoru] Hoshi Univ, Dept Pharmacol, Tokyo 142, Japan; [Matsumoto, Kenjiro; Horie, Syunji] Josai Int Univ, Pharmacol Lab, Togane, Japan; [Nakagawa, Takayuki] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Tokuyama, Shogo] Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Kobe, Hyogo 65121, Japan; [Sakai, Hiroyasu; Matsumoto, Kenjiro; Nakagawa, Takayuki; Tokuyama, Shogo; Narita, Minoru] Japanese Soc Pharmaceut Palliat Care & Sci, Res Promot Comm, Tokyo, Japan	Hoshi University; Kyoto University; Kobe Gakuin University	Sakai, H (corresponding author), Hoshi Univ, Dept Pharmacol, Tokyo 142, Japan.	sakai@hoshi.ac.jp; narita@hoshi.ac.jp	Sagara, Atsunobu/AAM-5106-2020	Sakai, Hiroyasu/0000-0002-4501-2836; Nakagawa, Takayuki/0000-0003-1890-0843	KAKENHI [24790582]; Japan Society for the Promotion of Science	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KAKENHI (24790582) and by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2012, J CLIN IMMUNOL; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Busch M, 2012, INVEST OPHTHALMOL VI; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Laforenza U, 2012, MOL ASPECTS MED; Laforenza U, 2005, J NUTR, V135, P2329, DOI 10.1093/jn/135.10.2329; Logan R, 2009, CANCER CHEMOTH PHARM, V63, P239, DOI 10.1007/s00280-008-0732-8; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Ma TH, 1999, J PHYSIOL-LONDON, V517, P317, DOI 10.1111/j.1469-7793.1999.0317t.x; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Masyuk AI, 2002, GASTROENTEROLOGY, V122, P545, DOI 10.1053/gast.2002.31035; Matsuzaki Toshiyuki, 2004, Medical Electron Microscopy, V37, P71; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Ohashi Y, 2003, AM J OPHTHALMOL, V136, P291, DOI 10.1016/S0002-9394(03)00203-4; Okada S, 2003, FEBS LETT, V540, P157, DOI 10.1016/S0014-5793(03)00256-4; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Shen Y, 2011, J CELL MOL MED, V15, P1355, DOI 10.1111/j.1582-4934.2010.01103.x; Smith CL, 2008, NUTR CANCER, V60, P757, DOI 10.1080/01635580802192841; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Thi MM, 2008, J NEUROSCI RES, V86, P448, DOI 10.1002/jnr.21496; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Tritto S, 2007, BIOCHEM CELL BIOL, V85, P675, DOI 10.1139/O07-142; Verkman AS, 2002, J ANAT, V200, P617, DOI 10.1046/j.1469-7580.2002.00058.x; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG463, DOI 10.1152/ajpgi.2000.279.2.G463; Yamamoto T, 2007, LIFE SCI, V81, P115, DOI 10.1016/j.lfs.2007.04.036; Yang BX, 2005, AM J PHYSIOL-CELL PH, V288, pC1161, DOI 10.1152/ajpcell.00564.2004	39	46	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54788	10.1371/journal.pone.0054788	http://dx.doi.org/10.1371/journal.pone.0054788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382968	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800078
J	Yu, RJ; Huang, Y				Yu, Rongjun; Huang, Yi			A Nickel Ain't Worth a Dime Anymore: The Illusion of Money and the Rapid Encoding of Its True Value	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; FEEDBACK-RELATED NEGATIVITY; BRAIN POTENTIALS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; CINGULATE CORTEX; FINANCIAL REWARD; MONETARY REWARD; BAD OUTCOMES; RESPONSES	People often evaluate money based on its face value and overlook its real purchasing power, known as the money illusion. For example, the same 100 Chinese Yuan can buy many more goods in Tibet than in Beijing, but such difference in buying power is usually underestimated. Using event related potential combined with a gambling task, we sought to investigate the encoding of both the real value and the face value of money in the human brain. We found that the self-reported pleasantness of outcomes was modulated by both values. The feedback related negativity (FRN), which peaks around 250ms after feedback and is believed to be generated in the anterior cingulate cortex (ACC), was only modulated by the true value but not the face value of money. We conclude that the real value of money is rapidly encoded in the human brain even when participants exhibit the money illusion at the behavioral level.	[Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Yu, RJ (corresponding author), S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.	rongjun.yu@gmail.com	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Huang, Yi/0000-0002-9356-2306	Foundation for High-level Talents in Higher Education of Guangdong [C10454]	Foundation for High-level Talents in Higher Education of Guangdong	The authors acknowledge the Foundation for High-level Talents in Higher Education of Guangdong (No. C10454) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; CEBULA RJ, 1981, REG STUD, V15, P241, DOI 10.1080/09595238100185251; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Elliott R, 2008, EUR J NEUROSCI, V27, P2213, DOI 10.1111/j.1460-9568.2008.06202.x; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Foti D, 2011, HUM BRAIN MAPP, V32, P2207, DOI 10.1002/hbm.21182; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Harris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021074; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Luu P, 2009, BRAIN RES, V1247, P100, DOI 10.1016/j.brainres.2008.09.084; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Martin LE, 2009, NEUROREPORT, V20, P1140, DOI 10.1097/WNR.0b013e32832f0dca; Mayer ML, 2000, SOC SCI MED, V51, P395, DOI 10.1016/S0277-9536(99)00472-4; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Reinhardt U E, 1986, Mod Healthc, V16, P138; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; TOBIN J, 1972, AM ECON REV, V62, P1; Tyran JR, 2007, SCIENCE, V317, P1042, DOI 10.1126/science.1143917; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Weber B, 2009, P NATL ACAD SCI USA, V106, P5025, DOI 10.1073/pnas.0901490106; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yellen JL, 2006, ECON INQ, V44, P1, DOI 10.1093/ei/cbj002; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255	45	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55025	10.1371/journal.pone.0055025	http://dx.doi.org/10.1371/journal.pone.0055025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383044	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800106
J	Zu, HL; Wang, F; Ma, Y; Xue, YW				Zu, Hongliang; Wang, Feng; Ma, Yan; Xue, Yingwei			Stage-Stratified Analysis of Prognostic Significance of Tumor Size in Patients with Gastric Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; BORRMANN TYPE-IV; SURGICAL-TREATMENT; SURVIVAL; CARCINOMA; INDICATOR	Background: The prognostic significance of tumor size in gastric cancer is not well defined. The objective of this study was to identify the prognostic value of tumor size in patients with gastric cancer. Methods: We retrospectively reviewed a total of 1800 patients with gastric cancer admitted to our hospital between 1997 and 2007. These patients were divided into two groups according to tumor size: small size group (SSG, tumor <= 5 cm) and large size group (LSG, tumor >5 cm). We compared clinico-pathologic features of the two groups and investigated the prognostic factors by performing univariate, multivariate, and stage- stratified analyses according to tumor size. Results: LSG had more aggressive clinico-pathologic features than SSG. Tumor size was an independent prognostic indicator in patients with gastric cancer. In a stratified-pT, pN, and pTNM analysis, survival of patients with LSG was significantly worse than that of patients with SSG and advanced stage. Tumor size was not a significant predictor of survival in patients with early stage tumors. Large tumor size was associated with shorter survival in patients with stages N0, N1, N2, and N3, and stages I, II, III, and IV. Conclusions: Tumor size is a simple and practical prognostic factor in patients with gastric cancer. Tumor size could supplement clinical staging in the future.	[Zu, Hongliang; Wang, Feng; Ma, Yan; Xue, Yingwei] Harbin Med Univ, Affiliated Hosp 3, Dept Surg Gastroenterol, Harbin, Peoples R China	Harbin Medical University	Xue, YW (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Surg Gastroenterol, Harbin, Peoples R China.	xyw801@163.com			Heilongjiang province of Natural Science Foundation	Heilongjiang province of Natural Science Foundation	This study was aided by Heilongjiang province of Natural Science Foundation Major Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1997, ANN SURG ONCOL, V4, P137, DOI 10.1007/BF02303796; Aoyama T, 2011, GASTRIC CANCER, V14, P274, DOI 10.1007/s10120-011-0038-0; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Giuliani A, 2003, J EXP CLIN CANC RES, V22, P531; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kikuchi S, 2004, LANGENBECK ARCH SURG, V389, P69, DOI 10.1007/s00423-004-0462-2; Kikuchi Youichi, 1999, Gastric Cancer, V2, P173, DOI 10.1007/s101200050042; Kim DY, 2007, LANGENBECK ARCH SURG, V392, P131, DOI 10.1007/s00423-006-0114-9; Kim DY, 2006, WORLD J GASTROENTERO, V12, P1182, DOI 10.3748/wjg.v12.i8.1182; Kim DY, 2004, ACTA CHIR BELG, V104, P677, DOI 10.1080/00015458.2004.11679642; KITAMURA K, 1995, J SURG ONCOL, V58, P112, DOI 10.1002/jso.2930580208; Li C, 2009, J GASTROINTEST SURG, V13, P881, DOI 10.1007/s11605-009-0800-3; Liu XW, 2009, ANN SURG ONCOL, V16, P1875, DOI 10.1245/s10434-009-0449-x; Maehara Y, 1997, SURGERY, V121, P633, DOI 10.1016/S0039-6060(97)90051-9; MAEHARA Y, 1992, SURG GYNECOL OBSTET, V175, P13; MAEHARA Y, 1992, CANCER, V70, P392, DOI 10.1002/1097-0142(19920715)70:2<392::AID-CNCR2820700204>3.0.CO;2-P; Saito H, 2006, AM J SURG, V192, P296, DOI 10.1016/j.amjsurg.2006.03.004; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Smith DD, 2005, J CLIN ONCOL, V23, P7114, DOI 10.1200/JCO.2005.14.621; Wang X, 2008, J SURG ONCOL, V97, P236, DOI 10.1002/jso.20951; WU CW, 1994, CANCER, V73, P2059, DOI 10.1002/1097-0142(19940415)73:8<2059::AID-CNCR2820730808>3.0.CO;2-G; Yokota T, 2004, SCAND J GASTROENTERO, V39, P380, DOI 10.1080/00365520310008629; Yokota T, 2002, ANTICANCER RES, V22, P3673; Zhang M, 2010, J SURG ONCOL, V102, P64, DOI 10.1002/jso.21533	27	42	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54502	10.1371/journal.pone.0054502	http://dx.doi.org/10.1371/journal.pone.0054502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382906	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800051
J	Drain, PK; Losina, E; Parker, G; Giddy, J; Ross, D; Katz, JN; Coleman, SM; Bogart, LM; Freedberg, KA; Walensky, RP; Bassett, IV				Drain, Paul K.; Losina, Elena; Parker, Gary; Giddy, Janet; Ross, Douglas; Katz, Jeffrey N.; Coleman, Sharon M.; Bogart, Laura M.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.			Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MEDICAL-CARE; COLLABORATIVE ANALYSIS; FOOD INSECURITY; MORTALITY; INFECTION; ADULTS; AIDS; ERA; CONSEQUENCES	Background: After observing persistently low CD4 counts at initial HIV diagnosis in South Africa, we sought to determine risk factors for late-stage HIV disease presentation among adults. Methods: We surveyed adults prior to HIV testing at four outpatient clinics in Durban from August 2010 to November 2011. All HIV-infected adults were offered CD4 testing, and late-stage HIV disease was defined as a CD4 count<100 cells/mm(3). We used multivariate regression models to determine the effects of sex, emotional health, social support, distance from clinic, employment, perceived barriers to receiving healthcare, and foregoing healthcare to use money for food, clothing, or housing ("competing needs to healthcare'') on presentation with late-stage HIV disease. Results: Among 3,669 adults screened, 830 were enrolled, newly-diagnosed with HIV and obtained a CD4 result. Among those, 279 (33.6%) presented with late-stage HIV disease. In multivariate analyses, participants who lived >= 5 kilometers from the test site [adjusted odds ratio (AOR) 2.8, 95% CI 1.7-4.7], reported competing needs to healthcare (AOR 1.7, 95% CI 1.2-2.4), were male (AOR 1.7, 95% CI 1.2-2.3), worked outside the home (AOR 1.5, 95% CI 1.1-2.1), perceived health service delivery barriers (AOR 1.5, 95% CI 1.1-2.1), and/or had poor emotional health (AOR 1.4, 95% CI 1.0-1.9) had higher odds of late-stage HIV disease presentation. Conclusions: Independent risk factors for late-stage HIV disease presentation were from diverse domains, including geographic, economic, demographic, social, and psychosocial. These findings can inform various interventions, such as mobile testing or financial assistance, to reduce the risk of presentation with late-stage HIV disease.	[Drain, Paul K.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Drain, Paul K.; Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Drain, Paul K.; Losina, Elena; Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; [Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Bogart, Laura M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Coleman, Sharon M.; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Coleman, Sharon M.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Bogart, Laura M.] Boston Childrens Hosp, Boston, MA USA; [Parker, Gary; Giddy, Janet] McCord Hosp, Dept Med, Durban, South Africa; [Ross, Douglas] St Marys Hosp, Dept Med, Durban, South Africa	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University; Boston University; Harvard University; Boston Children's Hospital	Drain, PK (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	pdrain@partners.org	Bassett, Ingrid V./ABI-7674-2020	Bassett, Ingrid V./0000-0001-6920-6080; Drain, Paul/0000-0003-3300-3817; Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X	Harvard Institute for Global Health; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; National Institute of Allergy and Infectious Disease [K24 AI062476]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24 AR057827]; National Center for Research Resources [UL1 RR 025758]; Burke Global Health Fellowship; Claflin Distinguished Scholar Award; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, K24AI062476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445, R01MH090326] Funding Source: NIH RePORTER	Harvard Institute for Global Health; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Burke Global Health Fellowship; Claflin Distinguished Scholar Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Harvard Institute for Global Health (PKD); the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University R24 TW007988 (PKD); the National Institute of Mental Health R01 MH090326 (IVB) and R01 MH073445 (RPW); the National Institute of Allergy and Infectious Disease K24 AI062476 (KAF); the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Arthritis and Musculoskeletal and Skin Diseases K24 AR057827 (EL); the National Center for Research Resources (the Harvard Catalyst UL1 RR 025758); the Burke Global Health Fellowship (IVB); and the Claflin Distinguished Scholar Award (IVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS DAT TABL 2011; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS GLOB REP 2010; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; Mascolini M, 2011, S AFRICA RAISES THRE; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mills EJ, 2012, CLIN INFECT DIS, V54, P282, DOI 10.1093/cid/cir812; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; National Department of Health Republic of South Africa, 2010, NAT HIV COUNS TEST H; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ramirez-Avila L, 2012, AIDS BEHAV; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Samet JH, 1998, ARCH INTERN MED, V158, P734, DOI 10.1001/archinte.158.7.734; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; South Africa Department of Health, 2011, COMPR CAR MAN TREATM; Tadios Yonas, 2006, Ethiop Med J, V44, P237; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	49	52	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55305	10.1371/journal.pone.0055305	http://dx.doi.org/10.1371/journal.pone.0055305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383147	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500074
J	Pickett, LA; Yourshaw, M; Albornoz, V; Chen, ZJ; Solorzano-Vargas, RS; Nelson, SF; Martin, MG; Lindberg, I				Pickett, Lindsay A.; Yourshaw, Michael; Albornoz, Valeria; Chen, Zijun; Solorzano-Vargas, R. Sergio; Nelson, Stanley F.; Martin, Martin G.; Lindberg, Iris			Functional Consequences of a Novel Variant of PCSK1	PLOS ONE			English	Article							PROHORMONE CONVERTASE-1; PROPROTEIN CONVERTASES; PROTEIN FUNCTION; HUMAN GENOME; PC1; OBESITY; PROPEPTIDE; CLEAVAGE; FURIN; CELLS	Background: Common single nucleotide polymorphisms (SNPs) in proprotein convertase subtilisin/kexin type 1 with modest effects on PC1/3 in vitro have been associated with obesity in five genome-wide association studies and with diabetes in one genome-wide association study. We here present a novel SNP and compare its biosynthesis, secretion and catalytic activity to wild-type enzyme and to SNPs that have been linked to obesity. Methodology/Principal Findings: A novel PC1/3 variant introducing an Arg to Gln amino acid substitution at residue 80 (within the secondary cleavage site of the prodomain) (rs1799904) was studied. This novel variant was selected for analysis from the 1000 Genomes sequencing project based on its predicted deleterious effect on enzyme function and its comparatively more frequent allele frequency. The actual existence of the R80Q (rs1799904) variant was verified by Sanger sequencing. The effects of this novel variant on the biosynthesis, secretion, and catalytic activity were determined; the previously-described obesity risk SNPs N221D (rs6232), Q665E/S690T (rs6234/rs6235), and the Q665E and S690T SNPs (analyzed separately) were included for comparative purposes. The novel R80Q (rs1799904) variant described in this study resulted in significantly detrimental effects on both the maturation and in vitro catalytic activity of PC1/3. Conclusion/Significance: Our findings that this novel R80Q (rs1799904) variant both exhibits adverse effects on PC1/3 activity and is prevalent in the population suggests that further biochemical and genetic analysis to assess its contribution to the risk of metabolic disease within the general population is warranted.	[Yourshaw, Michael; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Chen, Zijun; Solorzano-Vargas, R. Sergio; Martin, Martin G.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA; [Chen, Zijun; Solorzano-Vargas, R. Sergio; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pickett, Lindsay A.; Albornoz, Valeria; Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lindberg, I (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Lindberg, Iris/Q-3825-2019; Nelson, Stanley F/D-4771-2009; Solorzano-Vargas, R Sergio/D-4869-2016; Martín, María/HDL-9512-2022; Yourshaw, Michael/F-9807-2015	Nelson, Stanley F/0000-0002-2082-3114; Yourshaw, Michael/0000-0001-7612-0437	National Institute of Diabetes and Digestive and Kidney Diseases [DK083762]; California Institute of Regenerative Medicine (CIRM) [RT2-01985]; National Institute of Drug Abuse [DA05084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084, R56DA005084] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (#DK083762) and the California Institute of Regenerative Medicine (CIRM), RT2-01985 to MGM; and a grant from the National Institute of Drug Abuse (#DA05084) to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bernard N, 2003, J NEUROCHEM, V85, P1592, DOI 10.1046/j.1471-4159.2003.01823.x; Bissonnette L, 2004, BIOCHEM J, V379, P757, DOI 10.1042/BJ20031902; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; Braman J, 1996, Methods Mol Biol, V57, P31; Coates LC, 1998, J NEUROCHEM, V70, P1670; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; Dong WJ, 1997, J NEUROSCI, V17, P563; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; GOODMAN LJ, 1994, BIOCHEM BIOPH RES CO, V201, P795, DOI 10.1006/bbrc.1994.1771; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Hoshino A., 2012, C SERIES NEUROPEPTID, V1, P1; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee SN, 2004, J ENDOCRINOL, V182, P353, DOI 10.1677/joe.0.1820353; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; MAINS RE, 1995, MOL ENDOCRINOL, V9, P3, DOI 10.1210/me.9.1.3; Mbikay M, 2011, MOL GENET METAB, V104, P682, DOI 10.1016/j.ymgme.2011.09.027; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muller L, 2000, J BIOL CHEM, V275, P39213, DOI 10.1074/jbc.M003547200; NG CP, 2003, NUCLEIC ACIDS RES, V31, P3812; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; NHLBI Exome Sequencing Project, 2011, EX VAR SERV; NIEHS Environmental Genome Project, 2011, NIEHS EX VAR SERV; Rabah N, 2006, J BIOL CHEM, V281, P7556, DOI 10.1074/jbc.M510607200; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rouille Y, 1997, J BIOL CHEM, V272, P32810, DOI 10.1074/jbc.272.52.32810; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; SEIDAH NG, 1991, GENOMICS, V11, P103, DOI 10.1016/0888-7543(91)90106-O; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; VINDROLA O, 1992, MOL ENDOCRINOL, V6, P1088, DOI 10.1210/me.6.7.1088; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHOU Y, 1995, J BIOL CHEM, V270, P24702, DOI 10.1074/jbc.270.42.24702; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; 2004, NATURE, V431, P931	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55065	10.1371/journal.pone.0055065	http://dx.doi.org/10.1371/journal.pone.0055065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383060	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500053
J	Strom, TS				Strom, Ted S.			A Numerical Analysis Model for the Interpretation of In Vivo Platelet Consumption Data	PLOS ONE			English	Article							WISKOTT-ALDRICH-SYNDROME; PRIMARY IMMUNE THROMBOCYTOPENIA; LONG-TERM; LIFE-SPAN; SPLENECTOMY; KINETICS; MICE; SURVIVAL; PURPURA; RECOVERY	Unlike anemias, most thrombocytopenias cannot be separated into those due to impaired production and those due to accelerated consumption. While rapid clearance of labeled platelets from the bloodstream can be followed in thrombocytopenic individuals, no model exists for quantitatively inferring from autologous or allogeneic platelet consumption data what changes in random consumption, lifespan dependent consumption, and platelet production rate may have caused the thrombocytopenia. Here we describe a numerical analysis model which resolves these issues. The model applies three parameter values (a random consumption rate constant, a lognormally-distributed platelet lifespan, and the standard deviation of the latter) to a matrix comprising a series of platelet cohorts which are sequentially produced and fractionally consumed in a series of time intervals. The cohort platelet counts achieved after equilibration of production and consumption both enumerate the population age distribution and sum to the population platelet count. Continued platelet consumption after production is halted then serves to model in vivo platelet consumption data, with consumption rate in the first such interval defining the equilibrium platelet production rate. We use a least squares fitting procedure to find parameter values which best fit observed platelet consumption data obtained in WT and thrombocytopenic WASP(-) mice. Equilibrium platelet age distributions are then 'grafted' into the matrix to allow modeling of the consumption of WT platelets in WASP(-) recipients, and vice versa. The optimal parameter values obtained indicate that random WT platelet consumption accounts for a larger fraction of platelet turnover than was previously suspected. Platelet WASP deficiency accelerates random consumption, and a trans effect of recipient WASP deficiency contributes to this. Application of the model to clinical data will allow distinctions to be made between thrombocytopenias due primarily to impaired platelet production and those due to acceleration of random or lifespan-dependent platelet consumption.	[Strom, Ted S.] Memphis Vet Adm Med Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Strom, Ted S.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center	Strom, TS (corresponding author), Memphis Vet Adm Med Ctr, Dept Pathol & Lab Med, Memphis, TN USA.	tstrom@uthsc.edu			NIAID [1R21AI079757-01A1]; Department of Veterans Affairs;  [R01AI071163]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071163, R21AI079757] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TS was supported by R01AI071163 (David J. Rawlings, Principal Investigator), by NIAID 1R21AI079757-01A1 (TS), and by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Andreansky S, 2005, EXP HEMATOL, V33, P443, DOI 10.1016/j.exphem.2004.12.006; Arnold DM, 2006, TRANSFUSION, V46, P257, DOI 10.1111/j.1537-2995.2006.00709.x; AuBuchon JP, 2005, TRANSFUSION, V45, P1143, DOI 10.1111/j.1537-2995.2005.00177.x; BALDINI MG, 1972, ANN NY ACAD SCI, V201, P437, DOI 10.1111/j.1749-6632.1972.tb16316.x; Chapman LM, 2012, J IMMUNOL, V189, P916, DOI 10.4049/jimmunol.1200580; DORNHORST AC, 1951, BLOOD, V6, P1284, DOI 10.1182/blood.V6.12.1284.1284; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Falet H, 2009, BLOOD, V114, P4729, DOI 10.1182/blood-2009-02-202721; FENAUX P, 1989, EUR J HAEMATOL, V42, P259; GROTTUM KA, 1969, BRIT J HAEMATOL, V17, P373, DOI 10.1111/j.1365-2141.1969.tb01383.x; Grozovsky R, 2010, CURR OPIN HEMATOL, V17, P585, DOI 10.1097/MOH.0b013e32833e7561; HANSON SR, 1985, BLOOD, V66, P1105; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; HEYNS AD, 1986, BLOOD, V67, P86; HILLZOBEL RL, 1986, AM J HEMATOL, V23, P231, DOI 10.1002/ajh.2830230307; Kajiwara M, 1999, BRIT J HAEMATOL, V107, P254, DOI 10.1046/j.1365-2141.1999.01694.x; Kauppi M, 2008, BLOOD, V112, P3148, DOI 10.1182/blood-2007-10-119677; Levin J, 2001, BLOOD, V98, P1019, DOI 10.1182/blood.V98.4.1019; LOTTER MG, 1986, J NUCL MED, V27, P1192; Marathe BM, 2009, EXP HEMATOL, V37, P1353, DOI 10.1016/j.exphem.2009.08.007; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Meyer O, 2012, TRANSFUS MED HEMOTH, V39, P5, DOI 10.1159/000335553; Mills J, 1946, J PHYSL SOC, V105; Mintz PD, 2005, TRANSFUSION, V45, p72S, DOI 10.1111/j.1537-2995.2005.00537.x; MULLEN CA, 1993, BLOOD, V82, P2961; MURPHY EA, 1971, THROMB DIATH HAEMOST, V26, P431, DOI 10.1055/s-0038-1653696; NAJEAN Y, 1991, BRIT J HAEMATOL, V79, P271, DOI 10.1111/j.1365-2141.1991.tb04532.x; OCHS HD, 1980, BLOOD, V55, P243; Panel on Diagnostic Application of Radioisotopes in Hematology International Committee for Standardization in Hematology, 1977, BLOOD, V50, P1137; Pons I, 2010, EUR J HAEMATOL, V85, P158, DOI 10.1111/j.1600-0609.2010.01468.x; Prislovsky A, 2012, PLATELETS; Prislovsky A, 2008, EXP HEMATOL, V36, P906; Roca M, 2011, AM J HEMATOL, V86, P909, DOI 10.1002/ajh.22147; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sarpatwari A, 2010, BRIT J HAEMATOL, V151, P477, DOI 10.1111/j.1365-2141.2010.08377.x; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; SHAO J, 1989, ANN STAT, V17, P1176, DOI 10.1214/aos/1176347263; Shcherbina A, 1999, BRIT J HAEMATOL, V106, P875, DOI 10.1046/j.1365-2141.1999.01637.x; Slichter SJ, 2004, TRANSFUS MED REV, V18, P153, DOI 10.1016/j.tmrv.2004.03.003; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snyder E, 2004, TRANSFUSION, V44, P1732, DOI 10.1111/j.0041-1132.2004.04145.x; Strom TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026657; TOMER A, 1991, J LAB CLIN MED, V118, P546; Wandall HH, 2008, BLOOD, V111, P3249, DOI 10.1182/blood-2007-06-097295	47	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55087	10.1371/journal.pone.0055087	http://dx.doi.org/10.1371/journal.pone.0055087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383066	Green Submitted, gold, Green Published			2022-12-25	WOS:000315211500055
J	Yeh, TM; Liu, SH; Lin, KC; Kuo, C; Kuo, SY; Huang, TY; Yen, YR; Wen, RK; Chen, LC; Fu, TF				Yeh, Trai-Ming; Liu, Shu-Hsiang; Lin, Kao-Chang; Kuo, Chieh; Kuo, Shu-Yun; Huang, Tzuu-Yuan; Yen, Yong-Ren; Wen, Rong-Kun; Chen, Lien-Cheng; Fu, Tsai-Feng			Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; HEMORRHAGIC-FEVER; SHOCK-SYNDROME; GROWTH-FACTOR; FACTOR MIF; TNF-ALPHA; IN-VITRO; KAPPA-B; COAGULATION; ACTIVATION	Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.	[Yeh, Trai-Ming] Natl Cheng Kung Univ Hosp, Dept Med Technol, Tainan, Taiwan; [Liu, Shu-Hsiang] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Liu, Shu-Hsiang] Natl Taipei Univ Nursing & Hlth Sci, Ctr Gen Educ, Taipei, Taiwan; [Lin, Kao-Chang] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Lin, Kao-Chang] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Kuo, Chieh] Sin Lau Christian Hosp, Dept Cardiol, Tainan, Taiwan; [Kuo, Shu-Yun; Fu, Tsai-Feng] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou, Taiwan; [Huang, Tzuu-Yuan] Sin Lau Christian Hosp, Dept Neurosurg, Tainan, Taiwan; [Yen, Yong-Ren] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Kuo, Shu-Yun; Wen, Rong-Kun; Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Chen, Lien-Cheng] Chung Hwa Univ Med Technol, Dept Med Technol, Tainan, Taiwan; [Chen, Lien-Cheng] Chung Hwa Univ Med Technol, Grad Inst Biol Sci & Technol, Tainan, Taiwan; [Chen, Lien-Cheng] Sin Lau Christian Hosp, Med Educ & Res Ctr, Tainan, Taiwan; [Chen, Lien-Cheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chen, Lien-Cheng] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Mackay Memorial Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Chi Nan University; Chung Shan Medical University; National Chi Nan University; Chung Hua University; Chung Hua University; Taipei Medical University; Chung Shan Medical University	Chen, LC (corresponding author), Chung Hwa Univ Med Technol, Dept Med Technol, Tainan, Taiwan.	clctcell@yahoo.com.tw; tffu@ncnu.edu.tw	Yeh, Trai-Ming/C-7193-2011	Yeh, Trai-Ming/0000-0003-3172-7432; Fu, Tsai-Feng/0000-0002-0343-3018	National Science Council Grant [101-2311-B-260-002, 101-2627-M-260-001-, 98-2311-B-260-001-MY3]; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program [TCVGH-NCNU1017904]	National Science Council Grant; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program	This work was supported by National Science Council Grant 101-2311-B-260-002, 101-2627-M-260-001- and 98-2311-B-260-001-MY3 (to T.-F.F) and grant from the Taichung Veterans General Hospital/National Chi Nan University Joint Research Program TCVGH-NCNU1017904 (to T.-F. F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bunyaratvej A, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 3, P32; Butthep P, 2006, PEDIATR INFECT DIS J, V25, P894, DOI 10.1097/01.inf.0000237918.85330.b9; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2003, J INFECT DIS, V187, pS385, DOI 10.1086/374752; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Charrad RS, 2002, BLOOD, V99, P290, DOI 10.1182/blood.V99.1.290; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Chen LC, 2009, J INFECTION, V58, P368, DOI 10.1016/j.jinf.2009.02.018; de Jong D, 2001, FERTIL STERIL, V75, P688, DOI 10.1016/S0015-0282(00)01789-1; DITTMAN WA, 1989, P NATL ACAD SCI USA, V86, P7179, DOI 10.1073/pnas.86.18.7179; Grey ST, 1998, INT J HEMATOL, V67, P53; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Huang YH, 2003, J MED VIROL, V70, P610, DOI 10.1002/jmv.10438; Huang YH, 2001, J MED VIROL, V63, P247, DOI 10.1002/1096-9071(200103)63:3&lt;247::AID-JMV1008&gt;3.0.CO;2-F; Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71; Ishii H, 2003, BLOOD, V101, P4765, DOI 10.1182/blood-2002-08-2428; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kim HK, 2007, BLOOD COAGUL FIBRIN, V18, P157, DOI 10.1097/MBC.0b013e32801481cb; Krishnamurti C, 2002, AM J TROP MED HYG, V66, P435, DOI 10.4269/ajtmh.2002.66.435; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin SJ, 2007, J CELL BIOCHEM, V101, P642, DOI 10.1002/jcb.21206; Mairuhu ATA, 2003, LANCET INFECT DIS, V3, P33, DOI 10.1016/S1473-3099(03)00487-0; MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; Nan BC, 2005, THROMB RES, V115, P417, DOI 10.1016/j.thromres.2004.10.010; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; OHJI T, 1995, THROMB HAEMOSTASIS, V73, P812; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shyu LY, 2012, THROMB RES, V129, P43, DOI 10.1016/j.thromres.2011.08.011; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42, DOI 10.1055/s-0037-1612941; Uehara S, 2001, THROMB RES, V104, P325, DOI 10.1016/S0049-3848(01)00358-9; Van de Wouwer M, 2004, CRIT CARE MED, V32, pS254, DOI 10.1097/01.CCM.0000128036.64448.9e; van Gorp ECM, 2002, J MED VIROL, V67, P549, DOI 10.1002/jmv.10137; van Gorp ECM, 2001, BRIT J HAEMATOL, V113, P94, DOI 10.1046/j.1365-2141.2001.02710.x; Wakabayashi K, 2012, MOD RHEUMATOL, V22, P59, DOI 10.1007/s10165-011-0466-z; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd	47	23	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55018	10.1371/journal.pone.0055018	http://dx.doi.org/10.1371/journal.pone.0055018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383040	gold, Green Submitted, Green Published			2022-12-25	WOS:000315211500048
J	Zhang, XY; Yao, DX; Wang, QH; Xu, WY; Wei, Q; Wang, CC; Liu, CL; Zhang, CJ; Yan, H; Ling, Y; Su, Z; Li, FG				Zhang, Xueyan; Yao, Dongxia; Wang, Qianhua; Xu, Wenying; Wei, Qiang; Wang, Chunchao; Liu, Chuanliang; Zhang, Chaojun; Yan, Hong; Ling, Yi; Su, Zhen; Li, Fuguang			mRNA-seq Analysis of the Gossypium arboreum transcriptome Reveals Tissue Selective Signaling in Response to Water Stress during Seedling Stage	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE RESOLUTION; GENE-EXPRESSION PROFILES; ABSCISIC-ACID; SALT-STRESS; COTTON PLANTS; HIGH SALINITY; OSMOTIC ADJUSTMENT; ARABIDOPSIS ROOTS; ION HOMEOSTASIS; ABIOTIC STRESS	The cotton diploid species, Gossypium arboreum, shows important properties of stress tolerance and good genetic stability. In this study, through mRNA-seq, we de novo assembled the unigenes of multiple samples with 3h H2O, NaCl, or PEG treatments in leaf, stem and root tissues and successfully obtained 123,579 transcripts of G. arboreum, 89,128 of which were with hits through BLAST against known cotton ESTs and draft genome of G. raimondii. About 36,961 transcripts (including 1,958 possible transcription factor members) were identified with differential expression under water stresses. Principal component analysis of differential expression levels in multiple samples suggested tissue selective signalling responding to water stresses. Venn diagram analysis showed the specificity and intersection of transcripts' response to NaCl and PEG treatments in different tissues. Self-organized mapping and hierarchical cluster analysis of the data also revealed strong tissue selectivity of transcripts under salt and osmotic stresses. In addition, the enriched gene ontology (GO) terms for the selected tissue groups were differed, including some unique enriched GO terms such as photosynthesis and tetrapyrrole binding only in leaf tissues, while the stem-specific genes showed unique GO terms related to plant-type cell wall biogenesis, and root-specific genes showed unique GO terms such as monooxygenase activity. Furthermore, there were multiple hormone cross-talks in response to osmotic and salt stress. In summary, our multidimensional mRNA sequencing revealed tissue selective signalling and hormone crosstalk in response to salt and osmotic stresses in G. arboreum. To our knowledge, this is the first such report of spatial resolution of transcriptome analysis in G. arboreum. Our study will potentially advance understanding of possible transcriptional networks associated with water stress in cotton and other crop species.	[Zhang, Xueyan; Wang, Qianhua; Liu, Chuanliang; Zhang, Chaojun; Li, Fuguang] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Yao, Dongxia; Xu, Wenying; Wei, Qiang; Wang, Chunchao; Yan, Hong; Ling, Yi; Su, Zhen] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; China Agricultural University	Su, Z (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zhensu@cau.edu.cn; aylifug@hotmail.com			National Science Fund for Distinguished Young Scholars [31125020]; National Natural Science Foundation of China [31171276, 90817006]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31125020), the National Natural Science Foundation of China (31171276 and 90817006), and the Innovation Scientists and Technicians Troop Construction Projects of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; ACKERSON RC, 1982, PLANT PHYSIOL, V69, P609, DOI 10.1104/pp.69.3.609; ACKERSON RC, 1981, PLANT PHYSIOL, V67, P489, DOI 10.1104/pp.67.3.489; Akhtar J, 2010, PAK J BOT, V42, P2857; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barozai MYK, 2012, MOL BIOL REP, V39, P1011, DOI 10.1007/s11033-011-0826-y; BERLIN J, 1982, PLANT PHYSIOL, V70, P238, DOI 10.1104/pp.70.1.238; Bharambe P. R., 1980, Journal of Maharashtra Agricultural Universities, V5, P201; BOYER JS, 1965, PLANT PHYSIOL, V40, P229, DOI 10.1104/pp.40.2.229; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dinneny JR, 2010, PLANT CELL ENVIRON, V33, P543, DOI 10.1111/j.1365-3040.2009.02055.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL; Galvan-Ampudia SC, 2011, CURR OPIN PLANT BIOL, V14, P1; Gomez-Cadenas A, 1998, PHYSIOL PLANTARUM, V103, P475, DOI 10.1034/j.1399-3054.1998.1030405.x; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hossain MA, 2011, PLANT PHYSIOL, V156, P430, DOI 10.1104/pp.111.172254; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; JORDAN WR, 1975, PLANT PHYSIOL, V56, P595, DOI 10.1104/pp.56.5.595; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin H, 1997, CROP SCI, V37, P190, DOI 10.2135/cropsci1997.0011183X003700010032x; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Maqbool A, 2010, BIOTECHNOL PROGR, V26, P21, DOI 10.1002/btpr.306; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; OOSTERHUIS DM, 1987, PLANT PHYSIOL, V84, P1154, DOI 10.1104/pp.84.4.1154; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; RADIN JW, 1984, PLANT PHYSIOL, V76, P392, DOI 10.1104/pp.76.2.392; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; RK B.O, 2009, J PLANT ENV SCI, P16; Rodriguez-Uribe L, 2011, PLANT SCI, V180, P461, DOI 10.1016/j.plantsci.2010.10.009; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sattar S, 2010, J ANIM PLANT SCI, V20, P87; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; SEXTON PD, 1982, AGRON J, V74, P699, DOI 10.2134/agronj1982.00021962007400040025x; Shinozaki K, 1999, Tanpakushitsu Kakusan Koso, V44, P2186; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; TIMPA JD, 1986, PLANT PHYSIOL, V82, P724, DOI 10.1104/pp.82.3.724; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Ueda A, 2006, THEOR APPL GENET, V112, P1286, DOI 10.1007/s00122-006-0231-4; VIEIRADASILVA J, 1974, P NATL ACAD SCI USA, V71, P3243; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wee CW, 2010, BIOTECHNOL LETT, V32, P1361, DOI 10.1007/s10529-010-0307-8; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilhelm BT, 2010, NAT PROTOC, V5, P255, DOI 10.1038/nprot.2009.229; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	85	15	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54762	10.1371/journal.pone.0054762	http://dx.doi.org/10.1371/journal.pone.0054762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382961	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500025
J	He, DM; Zhang, YQ; Liu, XF; Guo, SM; Zhao, DH; Zhu, YJ; Li, HD; Kong, L				He, Dengming; Zhang, Yuqi; Liu, Xiaofeng; Guo, Shimin; Zhao, Donghong; Zhu, Yunjie; Li, Huaidong; Kong, Li			Epidemiological and Clinical Features of Plasmodium falciparum Malaria in United Nations Personnel in Western Bahr el Ghazal State, South Sudan	PLOS ONE			English	Article							TRAVELERS	Western Bahr el Ghazal State is located in northwestern South Sudan, which is a tropical area subject to Plasmodium falciparum malaria epidemics. The aim of this study is to explore the epidemiological and clinical features of Plasmodium falciparum malaria in United Nations personnel stationed in this area. From July 2006 to June 2009, epidemiological data and medical records of 678 patients with Plasmodium falciparum malaria at the U.N. level 2 hospital were analyzed. The U.N. personnel were divided into individuals not immune to Plasmodium falciparum and individuals semi-immune to Plasmodium falciparum. The patients were divided into a chemoprophylaxis group (non-immune individuals who complied with the chemoprophylaxis regimen, 582 cases) and a no/incomplete chemoprophylaxis group (non-immune individuals who either did not fully comply with chemoprophylaxis or did not use it at all and semi-immune individuals who did not use chemoprophylaxis, 96 cases). Overall morbidity was about 11.3%. There was a significant difference in the morbidity of semi-immune and non-immune individuals (1.3% vs. 15.1%, P<0.001). Out of the total, 82.9% of cases occurred during the rainy season. The incidence of fever in the chemoprophylaxis group was significantly lower than in the no/incomplete chemoprophylaxis group (36.8% vs. 96.9%, P<0.001). Significant differences were observed between the two groups with respect to all other malaria-like symptoms except gastrointestinal symptoms, serum glucose level, platelet count, and alanine aminotransferase level. The incidence of complications was 1.2% (chemoprophylaxis group) and 44.8% (no/incomplete chemoprophylaxis group). The most common complication was thrombocytopenia, which was seen in 40.6% of the no/incomplete chemoprophylaxis group. In summary, Plasmodium falciparum malaria mainly occurred in rainy season. Gastrointestinal symptoms are an important precursor of malaria. Blood smears and rapid diagnostic tests should be performed after the onset of gastrointestinal symptoms. Appropriate chemoprophylaxis is necessary for reducing the severity of malaria.	[He, Dengming; Zhang, Yuqi; Zhu, Yunjie; Li, Huaidong; Kong, Li] 88th Hosp Chinese PLA, Dept Infect Dis, Tai An, Shandong, Peoples R China; [Liu, Xiaofeng; Zhao, Donghong] Gen Hosp Jinan Mil Command, Dept Gastroenterol Dis, Jinan, Shandong, Peoples R China; [Guo, Shimin] 150th Hosp Chinese PLA, Dept Infect Dis, Luoyang, Henan Province, Peoples R China; [He, Dengming; Zhang, Yuqi; Liu, Xiaofeng; Guo, Shimin; Zhao, Donghong; Zhu, Yunjie; Li, Huaidong; Kong, Li] Level 2 Hosp United Nations Mission Sudan UNMIS, Wau City, Western Bahr El, Sudan		He, DM (corresponding author), 88th Hosp Chinese PLA, Dept Infect Dis, Tai An, Shandong, Peoples R China.	hedengming@gmail.com						A-Elbasit IE, 2006, TROP MED INT HEALTH, V11, P604, DOI 10.1111/j.1365-3156.2006.01616.x; [Anonymous], 2010, WORLD MAL REP 2010, P54; [Anonymous], 2010, GUID TREATM MAL, P13; Beg MA, 2008, INT J INFECT DIS, V12, P37, DOI 10.1016/j.ijid.2007.04.006; Ciminera P, 2007, AM J TROP MED HYG, V76, P275, DOI 10.4269/ajtmh.2007.76.275; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; GENTON B, 2001, TRAVELERS MALARIA, P371; Guthmann JP, 2002, T ROYAL SOC TROPICAL, V96; Kamya MR, 2007, PLOS CLIN TRIALS, V2; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Moody A, 2002, CLIN MICROBIOLOGY RE, V15; Sadanand Saheli, 2010, Yale Journal of Biology and Medicine, V83, P185	13	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55220	10.1371/journal.pone.0055220	http://dx.doi.org/10.1371/journal.pone.0055220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372839	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400079
J	Mosoyan, G; Nagi, C; Marukian, S; Teixeira, A; Simonian, A; Resnick-Silverman, L; DiFeo, A; Johnston, D; Reynolds, SR; Roses, DF; Mosoian, A				Mosoyan, Goar; Nagi, Chandandeep; Marukian, Svetlana; Teixeira, Avelino; Simonian, Anait; Resnick-Silverman, Lois; DiFeo, Analisa; Johnston, Dean; Reynolds, Sandra R.; Roses, Daniel F.; Mosoian, Arevik			Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; TP53 MUTATIONS; P53 EXPRESSION; LUNG-CANCER; PROTEIN; GENE; GROWTH; ASSOCIATION; RISK; SUSCEPTIBILITY	Background: Breast cancer cell lines are widely used tools to investigate breast cancer biology and to develop new therapies. Breast cancer tissue contains molecularly heterogeneous cell populations. Thus, it is important to understand which cell lines best represent the primary tumor and have similarly diverse phenotype. Here, we describe the development of five breast cancer cell lines from a single patient's breast cancer tissue. We characterize the molecular profiles, tumorigenicity and metastatic ability in vivo of all five cell lines and compare their responsiveness to 4-hydroxytamoxifen (4-OHT) treatment. Methods: Five breast cancer cell lines were derived from a single patient's primary breast cancer tissue. Expression of different antigens including HER2, estrogen receptor (ER), CK8/18, CD44 and CD24 was determined by flow cytometry, western blotting and immunohistochemistry (IHC). In addition, a Fuorescent In Situ Hybridization (FISH) assay for HER2 gene amplification and p53 genotyping was performed on all cell lines. A xenograft model in nude mice was utilized to assess the tumorigenic and metastatic abilities of the breast cancer cells. Results: We have isolated, cloned and established five new breast cancer cell lines with different tumorigenicity and metastatic abilities from a single primary breast cancer. Although all the cell lines expressed low levels of ER, their growth was estrogen-independent and all had high-levels of expression of mutated non-functional p53. The HER2 gene was rearranged in all cell lines. Low doses of 4-OHT induced proliferation of these breast cancer cell lines. Conclusions: All five breast cancer cell lines have different antigenic expression profiles, tumorigenicity and organ specific metastatic abilities although they derive from a single tumor. None of the studied markers correlated with tumorigenic potential. These new cell lines could serve as a model for detailed genomic and proteomic analyses to identify mechanisms of organ-specific metastasis of breast cancer.	[Mosoyan, Goar; Teixeira, Avelino; Simonian, Anait; Mosoian, Arevik] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Nagi, Chandandeep] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Marukian, Svetlana] HemoShear, Charlottesville, VA USA; [Resnick-Silverman, Lois] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [DiFeo, Analisa] Case Western Reserve Univ, Dept Case, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Johnston, Dean] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA; [Reynolds, Sandra R.] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Roses, Daniel F.] NYU, Sch Med, Dept Surg, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University	Mosoian, A (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	arevik.mosoian@mssm.edu		DiFeo, Analisa/0000-0001-8319-6763	Dr. Leo A. Shifrin and Roslyn Myers Breast Cancer Discovery Fund; Dorothy Rodbell Cohen Cancer Research Program; Lehman Brothers Foundation	Dr. Leo A. Shifrin and Roslyn Myers Breast Cancer Discovery Fund; Dorothy Rodbell Cohen Cancer Research Program; Lehman Brothers Foundation	This work was supported by the Dr. Leo A. Shifrin and Roslyn Myers Breast Cancer Discovery Fund (to JCB) and the Dorothy Rodbell Cohen Cancer Research Program and Lehman Brothers Foundation (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Bailey ST, 2012, P NATL ACAD SCI USA, V109, P18060, DOI 10.1073/pnas.1018858109; Birnbaum D, 2004, INT J ONCOL, V25, P249; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; D'Assoro AB, 2010, INT J ONCOL, V37, P1167, DOI 10.3892/ijo_00000768; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Endo K, 2000, J HEPATOL, V32, P78, DOI 10.1016/S0168-8278(00)80192-0; Fernandez-Cuesta L, 2010, BREAST CANC RES TREA; FERNANDEZCUESTA L, 2010, INT J CANC; Gaudet MM, 2008, BREAST CANCER RES TR, V108, P93, DOI 10.1007/s10549-007-9573-0; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Hayashi N., 2011, INT J CLIN ONCOL; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Ignatiadis M, 2007, J CLIN ONCOL, V25, P5194, DOI 10.1200/JCO.2007.11.7762; Jha P, 2011, EXP MOL PATHOL, V90, P167, DOI 10.1016/j.yexmp.2010.11.002; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kerstens HMJ, 2000, J HISTOCHEM CYTOCHEM, V48, P709, DOI 10.1177/002215540004800515; Konduri SD, 2010, P NATL ACAD SCI USA, V107, P15081, DOI 10.1073/pnas.1009575107; Korkaya H, 2008, ONCOGENE; Lee EB, 2010, J KOREAN MED SCI, V25, P698, DOI 10.3346/jkms.2010.25.5.698; LESOONWOOD LA, 1995, HUM GENE THER, V6, P395, DOI 10.1089/hum.1995.6.4-395; Li Y, 2010, MOL ENDOCRINOL, V24, P969, DOI 10.1210/me.2009-0148; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Lyon E, 2001, CLIN CHEM, V47, P844; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Ozeki C, 2011, J BIOL CHEM, V286, P18251, DOI 10.1074/jbc.M110.208587; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; REDDEL RR, 1985, CANCER RES, V45, P1525; Ricks-Santi L, 2010, PROSTATE, V70, P1739, DOI 10.1002/pros.21209; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Sangha N, 2008, NEOPLASIA, V10, P1362, DOI 10.1593/neo.08784; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z; Wei FX, 2010, CELL SIGNAL, V22, P1783, DOI 10.1016/j.cellsig.2010.07.007; Weigelt B, 2009, BREAST CANC RES TREA; Xiao Y, 2009, CLIN CHEM, V55, P1307, DOI 10.1373/clinchem.2008.120576; Zolota V, 2002, UROL ONCOL, V7, P13, DOI 10.1016/S1078-1439(01)00129-6	45	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55145	10.1371/journal.pone.0055145	http://dx.doi.org/10.1371/journal.pone.0055145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372829	gold, Green Published			2022-12-25	WOS:000315210400070
J	Ryu, WS; Kim, CK; Kim, BJ; Lee, SH				Ryu, Wi-Sun; Kim, Chi Kyung; Kim, Beom Joon; Lee, Seung-Hoon			Serum Uric Acid Levels and Cerebral Microbleeds in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							BLOOD-PRESSURE; BRAIN-INJURY; RISK-FACTOR; ASSOCIATION; PREVALENCE; HEMORRHAGE; DEMENTIA; DEATH	Unlike experimental studies indicating a neuroprotective property of uric acid, clinical studies have shown that elevated levels of uric acid are associated with a risk of ischemic stroke. However, the association of uric acid with cerebral hemorrhage has seldom been tested. We aimed to elucidate the association between uric acid and cerebral microbleeds (CMBs), a hemorrhage-prone cerebral microangiopathy. Seven hundred twenty-four patients with ischemic stroke who were consecutively admitted to our hospital were included in this study. We collected demographic, clinical, and laboratory data, including uric acid level, and examined the presence of CMBs using T2*-weighted gradient-echo MRI. We used logistic regression analysis to examine an independent association between uric acid and CMBs. Two-hundred twenty-six patients had CMBs (31.2%). After adjusting for possible confounders, elevated uric acid was independently associated with the presence of CMBs (the highest quartile vs. lowest quartile, adjusted odd ratio [OR], 1.98; 95% confidence interval [CI], 1.16-3.39). This association retained in patients with deep or infratentorial CMBs (with or without lobar CMBs) but not among those with lobar CMBs. In addition, this association was robust among patients with hypertension (the highest quartile vs. lowest quartile, adjusted OR, 2.74; 95% CI, 1.43-5.24). In contrast, we did not find the association in patients without hypertension. We demonstrated that serum uric acid is independently associated with the presence of CMBs. In particular, the relation between uric acid and CMBs was robust in hypertensive patients.	[Ryu, Wi-Sun; Kim, Chi Kyung; Lee, Seung-Hoon] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Ryu, Wi-Sun; Kim, Chi Kyung; Lee, Seung-Hoon] Seoul Natl Univ Hosp, Clin Res Inst, Clin Res Ctr Stroke, Seoul 110744, South Korea; [Kim, Beom Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, SH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	sb0516@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Kim, Beom Joon/C-2904-2011	Kim, Beom Joon/0000-0002-2719-3012; Ryu, Wi-Sun/0000-0002-2823-5253; Kim, Beom Joon/0000-0003-2320-7621	Korea Health 21 R&D Project, Ministry of Health and Welfare [A111014]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2011-0026315]	Korea Health 21 R&D Project, Ministry of Health and Welfare; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants of the Korea Health 21 R&D Project, Ministry of Health and Welfare (A111014), and by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology (2011-0026315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro Sergio, 2008, Expert Rev Neurother, V8, P259, DOI 10.1586/14737175.8.2.259; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Benavente Oscar, 2005, Curr Cardiol Rep, V7, P23, DOI 10.1007/s11886-005-0006-6; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; BRITTON M, 1986, STROKE, V17, P861, DOI 10.1161/01.STR.17.5.861; Chamorro A, 2004, MED HYPOTHESES, V62, P173, DOI 10.1016/S0306-9877(03)00324-4; Cho AH, 2009, NEUROLOGY, V73, P1645, DOI 10.1212/WNL.0b013e3181c1defa; Christensen H, 2002, ACTA NEUROL SCAND, V106, P142, DOI 10.1034/j.1600-0404.2002.01356.x; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Dimitroula HV, 2008, NEUROLOGIST, V14, P238, DOI 10.1097/NRL.0b013e31815c666b; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fito M, 1997, EUR J CLIN CHEM CLIN, V35, P787; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Jeon SB, 2009, NEUROLOGY, V73, P1638, DOI 10.1212/WNL.0b013e3181bd110f; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Karagiannis A, 2007, CIRC J, V71, P1120, DOI 10.1253/circj.71.1120; Kim DE, 2002, ARCH NEUROL-CHICAGO, V59, P425, DOI 10.1001/archneur.59.3.425; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Langlois M, 2003, ATHEROSCLEROSIS, V168, P163, DOI 10.1016/S0021-9150(03)00093-5; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Lee SH, 2006, NEUROLOGY, V66, P430, DOI 10.1212/01.wnl.0000196471.04165.2b; Lee SH, 2004, NEUROLOGY, V63, P16, DOI 10.1212/01.WNL.0000132525.36804.A1; Lee SH, 2004, NEUROLOGY, V62, P72, DOI 10.1212/01.WNL.0000101463.50798.0D; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Patetsios P, 2001, AM J CARDIOL, V88, P188, DOI 10.1016/S0002-9149(01)01621-6; Pipkin FB, 2004, J HYPERTENS, V22, P237, DOI 10.1097/00004872-200402000-00002; Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349; RAO GN, 1991, J BIOL CHEM, V266, P8604; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Ueno H, 2008, AM J NEURORADIOL, V29, P1483, DOI 10.3174/ajnr.A1120; van den Boom R, 2005, NEUROLOGY, V64, P1288, DOI 10.1212/01.WNL.0000156946.44593.24; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2004, J NEUROL, V251, P584, DOI 10.1007/s00415-004-0371-x; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1	41	12	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55210	10.1371/journal.pone.0055210	http://dx.doi.org/10.1371/journal.pone.0055210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372838	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400078
J	Lu, DY; Liu, JP; Jiao, JQ; Long, B; Li, Q; Tan, WQ; Li, PF				Lu, Daoyuan; Liu, Jinping; Jiao, Jianqin; Long, Bo; Li, Qian; Tan, Weiqi; Li, Peifeng			Transcription Factor Foxo3a Prevents Apoptosis by Regulating Calcium through the Apoptosis Repressor with Caspase Recruitment Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL-RAT CARDIOMYOCYTES; HYPOXIA-INDUCED APOPTOSIS; PROTEIN-KINASE CK2; CELL-DEATH; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; ENDOPLASMIC-RETICULUM; NA+-CA2+ EXCHANGER; PRESSURE-OVERLOAD	Apoptosis can occur in the myocardium under a variety of pathological conditions, including myocardial infarction and heart failure. The forkhead family of transcription factor Foxo3a plays a pivotal role in apoptosis; however, its role in regulating cardiac apoptosis remains to be fully elucidated. We showed that enforced expression of Foxo3a inhibits cardiomyocyte apoptosis, whereas knockdown of endogenous Foxo3a sensitizes cardiomyocytes to undergo apoptosis. The apoptosis repressor with caspase recruitment domain (ARC) is a potent anti-apoptotic protein. Here, we demonstrate that it attenuates the release of calcium from the sarcoplasmic reticulum and inhibits calcium elevations in the cytoplasm and mitochondria provoked by oxidative stress in cardiomyocytes. Furthermore, Foxo3a is shown to maintain cytoplasmic and mitochondrial calcium homeostasis through ARC. We observed that Foxo3a knock-out mice exhibited enlarged myocardial infarction sizes upon ischemia/reperfusion, and ARC transgenic mice demonstrated reduced myocardial infarction and balanced calcium levels in mitochondria and sarcoplasmic reticulum. Moreover, we showed that Foxo3a activates ARC expression by directly binding to its promoter. This study reveals that Foxo3a maintains calcium homeostasis and inhibits cardiac apoptosis through trans-activation of the ARC promoter. These findings provided novel evidence that Foxo3a and ARC constitute an anti-apoptotic pathway that regulates calcium homeostasis in the heart.	[Lu, Daoyuan; Liu, Jinping; Jiao, Jianqin; Long, Bo; Li, Qian; Tan, Weiqi] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China; [Li, Peifeng] Univ Illinois, Coll Med, Chicago, IL 60612 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, PF (corresponding author), Univ Illinois, Coll Med, Chicago, IL 60612 USA.	peifli@uic.edu	Long, Bo/AGX-8013-2022; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021; Long, Bo/GQH-5131-2022	Li, Peifeng/0000-0002-0969-9407; 	National Institutes of Health [1R01HL102202, 5R21HL092315]; National Natural Science Foundation of China [31010103911, 81070119]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092315, R01HL102202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HL102202 and 5R21HL092315. This work was also supported by National Natural Science Foundation of China Grants 31010103911 and 81070119.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen HP, 2009, EUR J PHARMACOL, V603, P86, DOI 10.1016/j.ejphar.2008.12.003; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Ekhterae D, 1999, CIRC RES, V85, pE70; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Jo DG, 2004, MOL CELL BIOL, V24, P9763, DOI 10.1128/MCB.24.22.9763-9770.2004; Jo H, 2006, J MOL CELL CARDIOL, V40, P394, DOI 10.1016/j.yjmcc.2005.12.012; Kabbara AA, 2001, J PHYSIOL-LONDON, V534, P87, DOI 10.1111/j.1469-7793.2001.00087.x; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kohlhaas M, 2010, CIRCULATION, V122, P2273, DOI 10.1161/CIRCULATIONAHA.110.968057; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; Long XL, 2004, J MOL CELL CARDIOL, V37, P63, DOI 10.1016/j.yjmcc.2004.04.001; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Morris TE, 1997, FREE RADICAL BIO MED, V22, P37, DOI 10.1016/S0891-5849(96)00238-9; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Neuss M, 2001, J BIOL CHEM, V276, P33915, DOI 10.1074/jbc.M104080200; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pacher P, 2001, BIOL SIGNAL RECEPT, V10, P200; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Pyo JO, 2008, J BIOL CHEM, V283, P30707, DOI 10.1074/jbc.M804209200; Reeve JLV, 2005, J CELL MOL MED, V9, P609, DOI 10.1111/j.1582-4934.2005.tb00492.x; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shannon TR, 2003, CIRC RES, V93, P40, DOI 10.1161/01.RES.0000079967.11815.19; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Stamm C, 2002, CIRCULATION, V106, pI290, DOI 10.1161/01.cir.0000032896.55215.a0; Tajima M, 1999, CIRCULATION, V99, P127, DOI 10.1161/01.CIR.99.1.127; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Webster KA, 1999, J CLIN INVEST, V104, P239; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657	57	34	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8491	8504		10.1074/jbc.M112.442061	http://dx.doi.org/10.1074/jbc.M112.442061			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382383	Green Published, hybrid			2022-12-25	WOS:000316564500046
J	De Ioris, MA; Prete, A; Cozza, R; Podda, M; Manzitti, C; Pession, A; Schiavello, E; Contoli, B; Balter, R; Fagioli, F; Bisogno, G; Amoroso, L; Locatelli, F; Luksch, R				De Ioris, Maria Antonietta; Prete, Arcangelo; Cozza, Raffaele; Podda, Marta; Manzitti, Carla; Pession, Andrea; Schiavello, Elisabetta; Contoli, Benedetta; Balter, Rita; Fagioli, Franca; Bisogno, Gianni; Amoroso, Loredana; Locatelli, Franco; Luksch, Roberto			Ewing Sarcoma of the Bone in Children under 6 Years of Age	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; FAMILY TUMORS; IFOSFAMIDE; ETOPOSIDE; CYCLOPHOSPHAMIDE; OSTEOSARCOMA; CHEMOTHERAPY; EXPERIENCE; YOUNGER; IMPACT	Background: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study was to report the clinical characteristics and outcome of children under 6 years of age affected by ESFT of the bone in Italy. Methods: The records of all the children diagnosed with osseous ESFT in centres members of the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) from 1990 to 2008 were reviewed. The Kaplan-Meier method was used for estimating overall and progression-free survival (OS, PFS) curves; multivariate analyses were performed using Cox proportional hazards regression model. Results: This study includes 62 patients. An axial primary localization was present in 66% of patients, with the primary site in the chest wall in 34%. Fourteen (23%) patients presented metastatic disease. The 5-year OS and PFS were 73% (95% confidence interval, CI, 58-83%) and 72% (95% CI 57-83%) for patients with localized disease and 38% (95% CI 17-60%) and 21% (95% CI 5-45%) for patients with metastatic disease. Metastatic spread, skull/pelvis/spine primary localization, progression during treatment and no surgery predicted worse survival (P < 0.01), while patients treated in the last decade had better survival (P = 0.002). In fact, the 5-year OS and PFS for patients diagnosed in the period 2000-2008 were 89% (95% CI 71-96%) and 86% (95% CI 66-94%), respectively. Conclusion: The axial localization is the most common site of ESFT in pre-scholar children. Patients treated in the most recent period have an excellent outcome.	[De Ioris, Maria Antonietta; Cozza, Raffaele; Locatelli, Franco] Osped Pediat Bambino Gesu IRCCS, Haematol Oncol Dept, Rome, Italy; [Prete, Arcangelo; Pession, Andrea] Univ Bologna, Paediat Haematol Oncol Dept, Bologna, Italy; [Podda, Marta; Schiavello, Elisabetta; Luksch, Roberto] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Manzitti, Carla; Amoroso, Loredana] Ist Giannina Gaslini IRCCS, Paediat Haematol Oncol Dept, Genoa, Italy; [Contoli, Benedetta] Osped Pediat Bambino Gesu IRCCS, Epidemiol Unit, Rome, Italy; [Balter, Rita] Univ Verona, Paediat Haematol Oncol Dept, I-37100 Verona, Italy; [Fagioli, Franca] Regina Margherita Hosp, Paediat Haematol Oncol Dept, Turin, Italy; [Bisogno, Gianni] Univ Padua, Paediat Haematol Oncol Dept, Padua, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Bambino Gesu; University of Bologna; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Bambino Gesu; University of Verona; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Padua; University of Pavia	De Ioris, MA (corresponding author), Osped Pediat Bambino Gesu IRCCS, Haematol Oncol Dept, Rome, Italy.	deioris@opbg.net	Schiavello, Elisabetta/K-8091-2016; Podda, Marta Giorgia/I-1921-2017; Contoli, Benedetta/AAB-2696-2022; Manzitti, Carla/K-2080-2018; Amoroso, Loredana/AAB-3000-2020; DE IORIS, MARIA ANTONIETTA/AAA-9588-2022; Luksch, Roberto/K-2206-2016; Fagioli, Franca/AAC-2181-2022; Pession, Andrea/O-3200-2013; Bisogno, Gianni/K-9282-2016	Schiavello, Elisabetta/0000-0002-8049-7445; Podda, Marta Giorgia/0000-0002-0855-2526; Manzitti, Carla/0000-0002-1501-5518; Amoroso, Loredana/0000-0003-1950-4754; DE IORIS, MARIA ANTONIETTA/0000-0002-2113-4505; Luksch, Roberto/0000-0002-7203-4176; Pession, Andrea/0000-0002-0379-9562; Bisogno, Gianni/0000-0003-4462-5523; FAGIOLI, FRANCA/0000-0002-9257-900X; Cozza, Raffaele/0000-0002-8502-3310; Contoli, Benedetta/0000-0003-0479-7822; Prete, Arcangelo/0000-0002-6823-3797				Abate ME, 2010, PEDIATR BLOOD CANCER, V55, P652, DOI 10.1002/pbc.22567; Abudu A, 1999, BRIT J CANCER, V79, P1185, DOI 10.1038/sj.bjc.6690190; Ahrens S, 1999, MED PEDIATR ONCOL, V32, P186, DOI 10.1002/(SICI)1096-911X(199903)32:3<186::AID-MPO5>3.0.CO;2-D; Bacci G, 1999, ONCOL REP, V6, P807; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; de Alava E, 2000, CANCER-AM CANCER SOC, V89, P783, DOI 10.1002/1097-0142(20000815)89:4<783::AID-CNCR10>3.0.CO;2-Q; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Ferrari S, 2011, ANN ONCOL, V22, P1221, DOI 10.1093/annonc/mdq573; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Jenkin RD, 2002, MED PEDIATR ONCOL, V39, P586, DOI 10.1002/mpo.10212; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krasin MJ, 2005, CANCER-AM CANCER SOC, V104, P367, DOI 10.1002/cncr.21160; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Luksch R, 2001, HAEMATOLOGICA, V86, P753; Milano GM, 2006, CANCER, V106, P1838, DOI 10.1002/cncr.21780; Paulussen M, 2001, J CLIN ONCOL, V19, P1818, DOI 10.1200/JCO.2001.19.6.1818; Paulussen M, 2008, J CLIN ONCOL, V26, P4385, DOI 10.1200/JCO.2008.16.5720; Picci P, 1997, J CLIN ONCOL, V15, P1; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Rodriguez-Galindo C, 2007, CANCER-AM CANCER SOC, V110, P375, DOI 10.1002/cncr.22821; Rosito P, 1999, CANCER-AM CANCER SOC, V86, P421, DOI 10.1002/(SICI)1097-0142(19990801)86:3<421::AID-CNCR10>3.0.CO;2-O; Stiller CA, 2006, EUR J CANCER, V42, P2124, DOI 10.1016/j.ejca.2006.05.015; van den Berg H, 2008, J PEDIATR ORTHOPED, V28, P29, DOI 10.1097/BPO.0b013e3181558cb5; van den Berg H, 2008, PEDIATR BLOOD CANCER, V50, P761, DOI 10.1002/pbc.21292; Wei G, 2000, CANCER-AM CANCER SOC, V89, P793, DOI 10.1002/1097-0142(20000815)89:4<793::AID-CNCR11>3.0.CO;2-M; Worch J, 2010, PEDIATR BLOOD CANCER, V55, P285, DOI 10.1002/pbc.22509	28	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53223	10.1371/journal.pone.0053223	http://dx.doi.org/10.1371/journal.pone.0053223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382839	Green Published, gold			2022-12-25	WOS:000314610600013
J	Liu, SF; Jia, XF; Li, CS; Han, XF; Yan, WH; Xing, Y				Liu, Sufang; Jia, Xiaofeng; Li, Changsheng; Han, Xuefei; Yan, Wenhai; Xing, Ying			CXCR7 Silencing Attenuates Cell Adaptive Response to Stromal Cell Derived Factor 1 alpha after Hypoxia	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; RECEPTOR CXCR7; IN-VITRO; MIGRATION; EXPRESSION; FACTOR-1-ALPHA; ANGIOGENESIS; ACTIVATION; SURVIVAL; BRAIN	Previous studies have shown that chemotactic factor stromal-cell derived factor 1 alpha (SDF1 alpha) promotes cell recovery from hypoxic injury via its main receptor C-X-C chemokine receptor type (CXCR) 4. However, the role of its new receptor CXCR7 on cell repair against hypoxia and cell response to SDF1 alpha remains largely unknown. In this study, neurons induced from hippocampal progenitor cells were pre-conditioned in hypoxia for 4h and subsequently monitored to investigate the function of SDF1 alpha on cell repair after hypoxia. Neurons were assessed for their cell morphology, actin filament polymerization and migration capability. SDF1 alpha protein levels increased significantly 1 h after hypoxia compared to control (P<0.01), and it reached a peak at 24 h after hypoxia. Moreover, addition of SDF1 alpha promoted neurite outgrowth and actin filament polymerization both in normoxic and hypoxic cells compared to untreated cells. Cell migration showed a time-dependent increase with SDF1 alpha stimulation in both groups, and hypoxic cells illustrated a significant augment at 0.5 h, 1 h and 12 h after SDF1 alpha application compared to normoxic cells (P<0.01). CXCR7 expression also increased with time dependence after hypoxia and demonstrated a two-fold upregulation compared to control at 24 h after hypoxia. With CXCR7 silencing, axon elongation and actin filament polymerization induced by SDF1 alpha were inhibited sharply both in normoxic and hypoxic cells. CXCR7 silencing also leads to reduced hypoxic cell migration at 0.5 h, 1 h, 12 h, 24 h and 36 h after SDF1 alpha application (P<0.01), but it failed to reduce normoxic cell migration induced by SDF1 alpha at 0.5 h, 1 h and 12 h (P>0.05). 24 h SDF1 alpha stimulation led to higher ERK1/2 phosphorylation compared to control, and ERK1/2 phosphorylation increased more in hypoxic cells than that in normoxic cells. This study suggested that CXCR7 plays an important role on cell repair processing induced by SDF1 alpha, and CXCR7 silencing attenuates cell adaptive response to acute SDF1 alpha stimulation (<= 12 h) after hypoxia.	[Liu, Sufang; Han, Xuefei; Yan, Wenhai; Xing, Ying] Zhengzhou Univ, Dept Physiol, Sch Med, Zhengzhou, Henan Province, Peoples R China; [Liu, Sufang; Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Jia, Xiaofeng] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA; [Jia, Xiaofeng; Li, Changsheng] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Li, Changsheng] Henan Anticanc Hosp, Dept Anesthesiol, Zhengzhou, Henan Province, Peoples R China	Zhengzhou University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Xing, Y (corresponding author), Zhengzhou Univ, Dept Physiol, Sch Med, Zhengzhou, Henan Province, Peoples R China.	xingyingprofessor@gmail.com	Liu, Sufang/Q-9869-2018; Jia, Xiaofeng/B-2145-2008; Liu, Sufang/AAF-7275-2021	Liu, Sufang/0000-0003-2677-1295; Jia, Xiaofeng/0000-0003-1445-8525; 	State Natural Science Funds Commission	State Natural Science Funds Commission	The authors appreciate State Natural Science Funds Commission for their funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ortega JA, 2010, CEREB CORTEX, V20, P2132, DOI 10.1093/cercor/bhp275; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bakondi B, 2011, STEM CELLS DEV, V20, P1021, DOI 10.1089/scd.2010.0198; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Biswas I, 2012, BLOOD CELL MOL DIS, V49, P92, DOI 10.1016/j.bcmd.2012.05.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; Feast A, 2012, EPILEPSIA, V53, P1349, DOI 10.1111/j.1528-1167.2012.03591.x; Gillard SE, 2002, J NEUROIMMUNOL, V124, P16, DOI 10.1016/S0165-5728(02)00005-X; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; Kremer KN, 2011, J IMMUNOL, V187, P1440, DOI 10.4049/jimmunol.1100820; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li Q, 2008, J NEUROSCI RES, V86, P1227, DOI 10.1002/jnr.21597; Lin SC, 2012, J CLIN ENDOCR METAB, V97, pE1515, DOI 10.1210/jc.2012-1450; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schneider C, 2012, BRAIN DEV-JPN, V34, P261, DOI 10.1016/j.braindev.2011.07.006; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Timotijevic G, 2012, INT J BIOCHEM CELL B, V44, P838, DOI 10.1016/j.biocel.2012.03.014; Tiveron MC, 2010, J NEUROIMMUNOL; WANG FZ, 1995, ACTA PHARM SINIC, V16, P419; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wang YT, 2012, CURR DRUG TARGETS, V13, P166, DOI 10.2174/138945012799201603; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Yang K, 2012, BRAIN STRUCT FUNCT; Yu T, 2010, J NEUROSCI RES, V88, P2775, DOI 10.1002/jnr.22454; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482	43	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55290	10.1371/journal.pone.0055290	http://dx.doi.org/10.1371/journal.pone.0055290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383139	Green Published, gold			2022-12-25	WOS:000314610600083
J	Paustian, C; Taylor, P; Johnson, T; Xu, M; Ramirez, N; Rosenthal, KS; Shu, SY; Cohen, PA; Czerniecki, BJ; Koski, GK				Paustian, Christopher; Taylor, Patricia; Johnson, Terrence; Xu, Min; Ramirez, Nancy; Rosenthal, Kenneth S.; Shu, Suyu; Cohen, Peter A.; Czerniecki, Brian J.; Koski, Gary K.			Extracellular ATP and Toll-Like Receptor 2 Agonists Trigger in Human Monocytes an Activation Program That Favors T Helper 17	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; SERUM-FREE CONDITIONS; GROWTH-FACTOR-BETA; TH17 CELLS; IN-VIVO; ADAPTIVE IMMUNITY; CD14(+) MONOCYTES; CALCIUM IONOPHORE; IL-12 PRODUCTION; HOST-DEFENSE	Strategically-paired Toll-like receptor (TLR) ligands induce a unique dendritic cell (DC) phenotype that polarizes Th1 responses. We therefore investigated pairing single TLR ligands with a non TLR-mediated danger signal to cooperatively induce distinct DC properties from cultured human monocytes. Adenosine triphosphate (ATP) and the TLR2 ligand lipoteichoic acid (LTA) selectively and synergistically induced expression of IL-23 and IL-1 beta from cultured monocytes as determined by ELISA assays. Flow cytometric analysis revealed that a sizable sub-population of treated cells acquired DC-like properties including activated surface phenotype with trans-well assays showing enhanced migration towards CCR7 ligands. Such activated cells also preferentially deviated, in an IL-23 and IL-1-dependent manner, CD4(pos) T lymphocyte responses toward the IL-22(hi), IL-17(hi)/IFN-gamma(lo) Th17 phenotype in standard in vitro allogeneic sensitization assays. Although pharmacological activation of either ionotropic or cAMP-dependent pathways acted in synergy with LTA to enhance IL-23, only inhibition of the cAMP-dependent pathway antagonized ATP-enhanced cytokine production. ATP plus atypical lipopolysaccharide from P. gingivalis (signaling through TLR2) was slightly superior to E. coli-derived LPS (TLR4 ligand) for inducing the high IL-23-secreting DC-like phenotype, but greatly inferior for inducing IL-12 p70 production when paired with IFN-gamma, a distinction reflected in activated DCs' ability to deviate lymphocytes toward Th1. Collectively, our data suggest TLR2 ligands encountered by innate immune cells in an environment with physiologically-relevant levels of extracellular ATP can induce a distinct activation state favoring IL-23- and IL-1 beta-dependent Th17 type response.	[Paustian, Christopher; Johnson, Terrence; Ramirez, Nancy; Koski, Gary K.] Kent State Univ, Dept Biol Sci, Program Biomed Sci, Kent, OH 44242 USA; [Taylor, Patricia; Rosenthal, Kenneth S.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA; [Xu, Min; Czerniecki, Brian J.] Univ Penn, Harrison Dept Surg Res, Philadelphia, PA 19104 USA; [Shu, Suyu; Cohen, Peter A.] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44106 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Northeast Ohio Medical University (NEOMED); University of Pennsylvania; Cleveland Clinic Foundation	Koski, GK (corresponding author), Kent State Univ, Dept Biol Sci, Program Biomed Sci, Kent, OH 44242 USA.	dendritic_cell@hotmail.com			NIH [R01 CA100163]; National Institutes of Health/National Center for Research Resources Cleveland Clinical and Translational Science Award [1RR024989]; American Cancer Society (ACS) Research Scholars Grant [RSG-09-187-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA100163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Research Resources Cleveland Clinical and Translational Science Award; American Cancer Society (ACS) Research Scholars Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH R01 CA100163 (G.K.) and in part by the National Institutes of Health/National Center for Research Resources Cleveland Clinical and Translational Science Award 1RR024989 and the American Cancer Society (ACS) Research Scholars Grant # RSG-09-187-01-LIB (G.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Berchtold S, 1999, FEBS LETT, V458, P424, DOI 10.1016/S0014-5793(99)01197-7; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Duraisingham SS, 2009, J IMMUNOL, V183, P2242, DOI 10.4049/jimmunol.0900474; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; FORBES GM, 1994, LANCET, V343, P258, DOI 10.1016/S0140-6736(94)91111-8; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Islander U, 2010, INFECT IMMUN, V78, P381, DOI 10.1128/IAI.00724-09; Iwase T, 2010, J CLIN MICROBIOL, V48, P1949, DOI 10.1128/JCM.01941-09; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Koski GK, 2001, EUR J IMMUNOL, V31, P3773, DOI 10.1002/1521-4141(200112)31:12<3773::AID-IMMU3773>3.0.CO;2-W; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Liu FL, 2007, RHEUMATOLOGY, V46, P1266, DOI 10.1093/rheumatology/kem055; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Lyakh LA, 2000, J IMMUNOL, V165, P3647, DOI 10.4049/jimmunol.165.7.3647; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Maio EA, 2006, NAT IMMUNOL, V6, P569; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Rachmilewitz Jacob, 2010, Self Nonself, V1, P250; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tokudome Shinkan, 2006, Asian Pac J Cancer Prev, V7, P163; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu SW, 2006, SURGERY, V140, P170, DOI 10.1016/j.surg.2006.03.006; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	72	18	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54804	10.1371/journal.pone.0054804	http://dx.doi.org/10.1371/journal.pone.0054804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382974	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600043
J	Chang, ZY; Yeh, MK; Chiang, CH; Chen, YH; Lu, DW				Chang, Zhi-Yang; Yeh, Ming-Kung; Chiang, Chiao-Hsi; Chen, Yi-Hao; Lu, Da-Wen			Erythropoietin Protects Adult Retinal Ganglion Cells against NMDA-, Trophic Factor Withdrawal-, and TNF-alpha-Induced Damage	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; OPTIC-NERVE FIBERS; EXPERIMENTAL GLAUCOMA; INDUCED APOPTOSIS; IN-VITRO; MEDIATED NEUROPROTECTION; NEUROTROPHIC FACTOR; AXONAL-TRANSPORT; VITREOUS FLUID; MOUSE MODEL	Purpose: This study aimed to evaluate the neuroprotective effect of EPO in the presence of N-methyl-D-aspartate (NMDA)-, trophic factor withdrawal (TFW)-, and tumor necrosis factor-alpha (TNF-alpha)-induced toxicity on total, small, and large retinal ganglion cells (RGCs). Methods: Retinal cells from adult rats were cultured in a medium containing brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), basic fibroblast growth factor (bFGF), and forskolin. Expression of RGC markers and EPOR was examined using immunocytochemistry. RGCs were classified according to their morphological properties. Cytotoxicity was induced by NMDA, TFW, or TNF-alpha. RGC survival was assessed by counting thy-1 and neurofilament-L double-positive cells. Results: EPO offered dose-dependent (EC50 = 5.7 ng/mL) protection against NMDA toxicity for small RGCs; protection was not significant for large RGCs. Time-course analysis showed that the presence of EPO either before or after NMDA exposure gave effective protection. For both small and large RGCs undergoing trophic factor withdrawal, EPO at concentrations of 1, 10, or 100 ng/mL improved survival. However, EPO had to be administered soon after the onset of injury to provide effective protection. For TNF-alpha-induced toxicity, survival of small RGCs was seen only for the highest examined concentration (100 ng/mL) of EPO, whereas large RGCs were protected at concentrations of 1, 10, or 100 ng/mL of EPO. Time-course analysis showed that pretreatment with EPO provided protection only for large RGCs; early post-treatment with EPO protected both small and large RGCs. Inhibitors of signal transduction and activators of transcription such as (STAT)-5, mitogen-activated protein kinases (MAPK)/extracellular-regulated kinase (ERK), and phosphatidyl inositol-3 kinase (PI3K)/Akt impaired the protective effect of EPO on RGCs exposed to different insults. Conclusion: EPO provided neuroprotection to cultured adult rat RGCs; however, the degree of protection varied with the type of toxic insult, RGC subtype, and timing of EPO treatment.	[Chang, Zhi-Yang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yeh, Ming-Kung] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Chiang, Chiao-Hsi] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Chen, Yi-Hao; Lu, Da-Wen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Lu, DW (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	p310849@ms23.hinet.net	Chiang, Chiao-Hsi/AAS-9777-2021		National Science Council [NSC98-2314-B016-006-MY3, NSC98-2320-B016-003-MY3]; Tri-service General Hospital [TSGH-C99-086]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-service General Hospital	This work was supported by grants from the National Science Council (NSC98-2314-B016-006-MY3 and NSC98-2320-B016-003-MY3) and a grant from the Tri-service General Hospital (TSGH-C99-086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brooks Dennis E., 1999, Veterinary Ophthalmology, V2, P3; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; Chang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033983; Chang ZY, 2008, EXPERT OPIN DRUG DEL, V5, P1313, DOI 10.1517/17425240802544159 ; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dong CJ, 2008, INVEST OPHTH VIS SCI, V49, P4515, DOI 10.1167/iovs.08-2078; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; Garcia M, 2003, INVEST OPHTH VIS SCI, V44, P4532, DOI 10.1167/iovs.03-0419; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Heidinger V, 1997, BRAIN RES, V767, P279, DOI 10.1016/S0006-8993(97)00605-7; Hernandez C, 2006, DIABETES CARE, V29, P2028, DOI 10.2337/dc06-0556; Huxlin KR, 1997, J COMP NEUROL, V385, P309; Jehle T, 2009, OPHTHALMOLOGE; Kashiwagi F, 2000, INVEST OPHTH VIS SCI, V41, P2373; Katsura Y, 2005, DIABETES CARE, V28, P2252, DOI 10.2337/diacare.28.9.2252; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; Klocker N, 2000, J NEUROSCI, V20, P6962, DOI 10.1523/JNEUROSCI.20-18-06962.2000; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Ma CHE, 2010, CELL TISSUE RES, V339, P297, DOI 10.1007/s00441-009-0897-4; Manabe S, 2003, INVEST OPHTH VIS SCI, V44, P385, DOI 10.1167/iovs.02-0187; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Osborne NN, 2009, ACTA OPHTHALMOL, V87, P450, DOI 10.1111/j.1755-3768.2008.01459.x; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Pregi N, 2009, EXP CELL RES, V315, P419, DOI 10.1016/j.yexcr.2008.11.005; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; WATANABE M, 1995, J NEUROBIOL, V27, P189, DOI 10.1002/neu.480270206; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Zhang JF, 2008, ACTA PHARMACOL SIN, V29, P1383, DOI 10.1111/j.1745-7254.2008.00885.x; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200	53	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55291	10.1371/journal.pone.0055291	http://dx.doi.org/10.1371/journal.pone.0055291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383140	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800139
J	Jayaraman, S; Patel, A; Jayaraman, A; Patel, V; Holterman, M; Prabhakar, B				Jayaraman, Sundararajan; Patel, Akshay; Jayaraman, Arathi; Patel, Vasu; Holterman, Mark; Prabhakar, Bellur			Transcriptome Analysis of Epigenetically Modulated Genome Indicates Signature Genes in Manifestation of Type 1 Diabetes and Its Prevention in NOD Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; MIGRATION-INHIBITION; MACROPHAGE-MIGRATION; NEUTROPHIL ELASTASE; TH17 CELLS; TNF-ALPHA; EXPRESSION; MOUSE; MODEL; IDENTIFICATION	Classic genetic studies implicated several genes including immune response genes in the risk of developing type 1 diabetes in humans. However, recent evidence including discordant diabetes incidence among monozygotic twins suggested a role for epigenetics in disease manifestation. NOD mice spontaneously develop type 1 diabetes like humans and serve as an excellent model system to study the mechanisms of type 1 diabetes as well as the efficacy of maneuvers to manipulate the disease. Using this preclinical model, we have recently demonstrated that pharmacological inhibition of histone deacetylases can lead to histone hyperacetylation, selective up-regulation of interferon-gamma and its transactivator Tbx21/Tbet, and amelioration of autoimmune diabetes. In the current study, we show that chromatin remodeling can render splenocytes incapable of transferring diabetes into immunodeficient NOD. scid mice. To elucidate the underlying mechanisms of drug-mediated protection against type 1 diabetes, we performed global gene expression profiling of splenocytes using high throughput microarray technology. This unbiased transcriptome analysis unraveled the exaggerated expression of a novel set of closely related inflammatory genes in splenocytes of acutely diabetic mice and their repression in mice cured of diabetes by chromatin remodeling. Analysis of gene expression by qRT-PCR using RNA derived from spleens and pancreata of cured mice validated the suppression of most of these genes, indicating an inverse correlation between the high levels of these inflammatory genes and protection against diabetes in NOD mice. In addition, higher-level expression of genes involved in insulin sensitivity, erythropoiesis, hemangioblast generation, and cellular redox control was evident in spleens of cured mice, indicating their possible contribution to protection against type 1 diabetes. Taken together, these results are consistent with the involvement of epistatic mechanisms in the manifestation of autoimmune diabetes and further indicate the utility of chromatin remodeling in curing this complex autoimmune disorder.	[Jayaraman, Sundararajan; Patel, Akshay; Jayaraman, Arathi; Patel, Vasu; Holterman, Mark] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Prabhakar, Bellur] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jayaraman, S (corresponding author), Univ Illinois, Dept Surg, Chicago, IL 60680 USA.	anue2468@uic.edu		Jayaraman, Sundararajan/0000-0002-7026-5958				Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; BAXTER AG, 1991, EUR J IMMUNOL, V21, P2051, DOI 10.1002/eji.1830210912; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; BLOOM BR, 1969, P NATL ACAD SCI USA, V64, P1176, DOI 10.1073/pnas.64.4.1176; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Cantor J, 2005, J IMMUNOL, V175, P7738, DOI 10.4049/jimmunol.175.11.7738; Chen YG, 2007, DIABETES, V56, P424, DOI 10.2337/db06-1303; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Eaves IA, 2002, GENOME RES, V12, P232, DOI 10.1101/gr.214102. Article published online before print in January 2002; Eckenrode SE, 2004, DIABETES, V53, P366, DOI 10.2337/diabetes.53.2.366; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hancock Wayne W, 2011, Handb Exp Pharmacol, V206, P103, DOI 10.1007/978-3-642-21631-2_6; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Irie J, 2008, J IMMUNOL, V180, P1071, DOI 10.4049/jimmunol.180.2.1071; JAYARAMAN S, 1979, DEV COMP IMMUNOL, V3, P67, DOI 10.1016/S0145-305X(79)80007-5; JAYARAMAN S, 1977, DEV COMP IMMUNOL, V1, P133, DOI 10.1016/S0145-305X(77)80006-2; Jayaraman S, 2012, CIRC RES, V110, P1039, DOI 10.1161/CIRCRESAHA.112.268375; Jayaraman S, 2011, EPIGENOMICS-UK, V3, P639, DOI [10.2217/EPI.11.78, 10.2217/epi.11.78]; Jayaraman S, 2010, J IMMUNOL, V184, P3008, DOI 10.4049/jimmunol.0903615; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Kleemann R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/610479; Knip M, 2011, HORM RES PAEDIAT, V76, P57, DOI 10.1159/000329169; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lee LF, 2008, P NATL ACAD SCI USA, V105, P10107, DOI 10.1073/pnas.0803336105; Makino S, 1980, Jikken Dobutsu, V29, P1; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyazaki T, 2007, CELL CYCLE, V6, P1419; Ounissi-Benkalha H, 2008, TRENDS MOL MED, V14, P268, DOI 10.1016/j.molmed.2008.04.002; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; Patel T, 2011, IMMUNOL CELL BIOL, V89, P640, DOI 10.1038/icb.2010.144; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Rajput A, 2004, J AUTOIMMUN, V23, P311, DOI 10.1016/j.jaut.2004.09.002; Regnault B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-63; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; ROJASESPINOSA O, 1975, BIOCHIM BIOPHYS ACTA, V403, P161, DOI 10.1016/0005-2744(75)90019-4; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Sobel DO, 2002, J AUTOIMMUN, V19, P129, DOI 10.1006/jaut.2002.0604; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tong C, 2010, J DIABETES, V2, P267, DOI 10.1111/j.1753-0407.2010.00088.x; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Xu HX, 2001, GENOMICS, V76, P2, DOI 10.1006/geno.2001.6600	52	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55074	10.1371/journal.pone.0055074	http://dx.doi.org/10.1371/journal.pone.0055074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383062	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800109
J	Liu, H; Chatel, S; Simard, C; Syam, N; Salle, L; Probst, V; Morel, J; Millat, G; Lopez, M; Abriel, H; Schott, JJ; Guinamard, R; Bouvagnet, P				Liu, Hui; Chatel, Stephanie; Simard, Christophe; Syam, Ninda; Salle, Laurent; Probst, Vincent; Morel, Julie; Millat, Gilles; Lopez, Michel; Abriel, Hugues; Schott, Jean-Jacques; Guinamard, Romain; Bouvagnet, Patrice			Molecular Genetics and Functional Anomalies in a Series of 248 Brugada Cases with 11 Mutations in the TRPM4 Channel	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; ST-SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; BUNDLE-BRANCH BLOCK; J-WAVE SYNDROMES; CONDUCTION; DEPOLARIZATION; SUBSTRATE	Brugada syndrome (BrS) is a condition defined by ST-segment alteration in right precordial leads and a risk of sudden death. Because BrS is often associated with right bundle branch block and the TRPM4 gene is involved in conduction blocks, we screened TRPM4 for anomalies in BrS cases. The DNA of 248 BrS cases with no SCN5A mutations were screened for TRPM4 mutations. Among this cohort, 20 patients had 11 TRPM4 mutations. Two mutations were previously associated with cardiac conduction blocks and 9 were new mutations (5 absent from similar to 149000 control alleles and 4 statistically more prevalent in this BrS cohort than in control alleles). In addition to Brugada, three patients had a bifascicular block and 2 had a complete right bundle branch block. Functional and biochemical studies of 4 selected mutants revealed that these mutations resulted in either a decreased expression (p. Pro779Arg and p. Lys914X) or an increased expression (p. Thr873Ile and p.Leu1075Pro) of TRPM4 channel. TRPM4 mutations account for about 6% of BrS. Consequences of these mutations are diverse on channel electrophysiological and cellular expression. Because of its effect on the resting membrane potential, reduction or increase of TRPM4 channel function may both reduce the availability of sodium channel and thus lead to BrS.	[Liu, Hui; Millat, Gilles; Bouvagnet, Patrice] Hosp Civils Lyon, Grp Hosp Est, Lab Cardiogenet, Bron, France; [Liu, Hui; Bouvagnet, Patrice] Univ Lyon 1, Lab Cardiogenet, Equipe Accueil 4173, F-69365 Lyon, France; [Bouvagnet, Patrice] Hosp Civils Lyon, Grp Hosp Est, Serv Cardiol Pediat, Bron, France; [Chatel, Stephanie; Probst, Vincent; Schott, Jean-Jacques] Inst Natl Sante & Rech Med, Inst Thorax, UMR 915, Nantes, France; [Chatel, Stephanie; Probst, Vincent; Schott, Jean-Jacques] Ctr Natl Rech Sci, Equipe Rech Labellisee 3147, Inst Thorax, Nantes, France; [Chatel, Stephanie; Probst, Vincent; Schott, Jean-Jacques] Univ Nantes, Inst Thorax, Nantes, France; [Schott, Jean-Jacques] CHU Nantes, Serv Cardiol, Inst Thorax, F-44035 Nantes 01, France; [Simard, Christophe; Salle, Laurent; Morel, Julie; Guinamard, Romain] Univ Caen, Ctr Hosp Univ Caen, Equipe Accueil 4650, Grp Signalisat Elect & Imagerie Les Ischem Reperf, F-14032 Caen, France; [Syam, Ninda; Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Lopez, Michel] Hop St Luc, Serv Cardiol, Lyon, France; [Millat, Gilles] Univ Lyon 1, Lab Neurocardiol, EA 4612, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Bern; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bouvagnet, P (corresponding author), Hosp Civils Lyon, Grp Hosp Est, Lab Cardiogenet, Bron, France.	patrice.bouvagnet@chu-lyon.fr	probst, vincent/D-4996-2015; CHATEL, Stephanie/D-2536-2015; MILLAT, Gilles/GWZ-2688-2022; Abriel, Hugues/B-9800-2009; Schott, jean-Jacques/F-8842-2013	probst, vincent/0000-0002-5492-8619; CHATEL, Stephanie/0000-0003-0677-5627; Abriel, Hugues/0000-0003-0465-5138; Schott, jean-Jacques/0000-0002-9578-9475	Projet Hospitalier de Recherche Clinique; Foundation Renaud Febvre; Etards, France; Swiss National Science Foundation TransCure [310030, 120707]	Projet Hospitalier de Recherche Clinique; Foundation Renaud Febvre; Etards, France; Swiss National Science Foundation TransCure	This work was supported by grants from Projet Hospitalier de Recherche Clinique 2008 and Foundation Renaud Febvre, les Etards, France to PB, and Swiss National Science Foundation TransCure and 310030 120707 grants to HA. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Antzelevitch C, 2003, J AM COLL CARDIOL, V41, P1665, DOI 10.1016/S0735-1097(03)00310-3; Brugada J, 2002, CIRCULATION, V105, P73, DOI 10.1161/hc0102.101354; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Giudicessi JR, 2011, HEART RHYTHM, V8, P1024, DOI 10.1016/j.hrthm.2011.02.021; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guinamard R, 2006, TRENDS CARDIOVAS MED, V16, P245, DOI 10.1016/j.tcm.2006.04.007; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Hedley PL, 2009, HUM MUTAT, V30, P1256, DOI 10.1002/humu.21066; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kattygnarath D, 2011, CIRC-CARDIOVASC GENE, V4, P261, DOI 10.1161/CIRCGENETICS.110.959130; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Medeiros-Domingo A, 2010, HEART RHYTHM, V7, P1466, DOI 10.1016/j.hrthm.2010.06.016; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Ohkubo K, 2010, INT HEART J, V51, P17, DOI 10.1536/ihj.51.17; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P1320, DOI 10.1046/j.1540-8167.2000.01320.x; SPEAR JF, 1974, CIRC RES, V35, P782, DOI 10.1161/01.RES.35.5.782; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599	28	92	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54131	10.1371/journal.pone.0054131	http://dx.doi.org/10.1371/journal.pone.0054131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382873	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800033
J	Rudolph, M; Kroll, F; Beery, M; Marinda, E; Sobiecki, JF; Douglas, G; Orr, G				Rudolph, Michael; Kroll, Florian; Beery, Moira; Marinda, Edmore; Sobiecki, Jean-Francois; Douglas, Geoffrey; Orr, Gary			A Pilot Study Assessing the Impact of a Fortified Supplementary Food on the Health and Well-Being of Creche Children and Adult TB Patients in South Africa	PLOS ONE			English	Article							VITAMIN-A; TUBERCULOSIS; MALNUTRITION; IMMUNITY; NUTRITION; DISEASES; DIETARY	The South African population faces many of the global concerns relating to micronutrient deficiency and the impact this has on health and well-being. Moreover, there is a high prevalence of HIV infection, compounded by a high level of co-infection with TB. This pilot study evaluates the impact of a fortified supplementary food on the health and well-being of a cohort of creche children, aged 3 to 6, and adult TB patients drawn from the Presidential Node of Alexandra, Johannesburg, South Africa. A further aim of this study was to evaluate the sensitivity and validity of non-invasive indicators of nutritional status in a field-based population sample. The investigational product, e'Pap, is supported by extensive anecdotal evidence that whole grain cereals with food-style nutrients constitute an effective supplementary food for those suffering from the effects of food insecurity, poor health and well-being, and coping with TB and HIV infection. The results indicate a beneficial effect of e'Pap for both study populations, and particularly for adult TB patients, whose baseline data reflected severe food insecurity and malnutrition in the majority of cases. There is evidence to suggest statistically significant improvements in key micronutrient levels, well-being and energy, hand-grip strength, the Bioelectrical Impedance Analysis (BIA) Illness Marker, and certain clinical indicators. Although Body Mass Index (BMI) and Mid Upper Arm Circumference (MUAC) are frequently used as standard measures to evaluate the efficacy of nutritional interventions, these indicators were not sufficiently sensitive in this study. Nor does weight gain necessarily indicate improved nutritional status. Hand-grip strength, lean body mass, and the BIA Illness Marker seem to be more useful indicators of change in nutritional status.	[Rudolph, Michael; Kroll, Florian; Beery, Moira] Univ Witwatersrand, Siyakhana Initiat, Hlth Consortium, Johannesburg, Gauteng, South Africa; [Marinda, Edmore] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, Gauteng, South Africa; [Sobiecki, Jean-Francois] Univ Johannesburg, Ctr Anthropol Res, Fac Humanities, Gauteng, South Africa; [Douglas, Geoffrey; Orr, Gary] Hlth Empowerment Nutr, Malvern, Worcs, England	University of Witwatersrand; University of Witwatersrand; University of Johannesburg	Douglas, G (corresponding author), Hlth Empowerment Nutr, Malvern, Worcs, England.	geoff@hetn.org			BHP Billiton; Health Empowerment Through Nutrition; South African National Tuberculosis Association; Society of St Vincent de Paul; Econocom Foods; Cytoplan (United Kingdom); FoodState (South Africa); Sportron (South Africa); Eli Lilly; Lundbeck; Astra Zeneca	BHP Billiton; Health Empowerment Through Nutrition; South African National Tuberculosis Association; Society of St Vincent de Paul; Econocom Foods; Cytoplan (United Kingdom); FoodState (South Africa); Sportron (South Africa); Eli Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Astra Zeneca(AstraZeneca)	This study was funded by BHP Billiton-www.bhpbilliton.com, Health Empowerment Through Nutrition-www.hetn.org, Econocom Foods-www.epap.co. za, South African National Tuberculosis Association-www.santa.org.za, Society of St Vincent de Paul-www.ssvpglobal.org. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by BHP Billiton and Econocom Foods. Econocom Foods produces e'pap. GAD has received speaking grants and honoraria from Cytoplan (United Kingdom), FoodState (South Africa) and Sportron (South Africa). GO has received educational sponsorships from Eli Lilly, Lundbeck, and Astra Zeneca and was a previous employee of Bristol Myers Squibb Pharmaceuticals (United Kingdom) Ltd. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ABUL HT, 1995, MOL CELL BIOCHEM, V146, P139, DOI 10.1007/BF00944606; Academy of Science of South Africa, 2007, HIV AIDS TB NUTR; Ambrus JL, 2004, EXP BIOL MED, V229, P464, DOI 10.1177/153537020422900603; [Anonymous], 2004, HIV AIDS GUID NUTR C; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; BURK R F, 1985, American Journal of Clinical Nutrition, V41, P1091, DOI 10.1093/ajcn/41.5.1091; Chandra RK, 2004, INT J VITAM NUTR RES, V74, P144, DOI 10.1024/0300-9831.74.2.144; Committee on Food Protection Food and Nutrition Board National Research, 1973, PHYT TOX OCC NAT FOO; Cook JT, 2004, J NUTR, V134, P1432; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; Gorbach S., 1999, NUTR CLIN CARE, V2, P95; Hanekom WA, 1999, CLIN DIAGN LAB IMMUN, V6, P204, DOI 10.1128/CDLI.6.2.204-208.1999; Human Sciences Research Council, 2008, S AFR NAT HIV PREV H; Hurrell RF, 2003, J NUTR, V133, p2973S, DOI 10.1093/jn/133.9.2973S; Karyadi E, 2002, AM J CLIN NUTR, V75, P720, DOI 10.1093/ajcn/75.4.720; Kemp FW, 2002, NUTR RES, V22, P45, DOI 10.1016/S0271-5317(01)00373-6; Labadarios D, 2000, NATL FOOD CONSUMPTIO; Labadarios D., 2007, NATL FOOD CONSUMPTIO; Manary M, 2010, MALAWI MED J, V22, P46; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Metcalfe N, 2005, T ROY SOC TROP MED H, V99, P115, DOI 10.1016/j.trstmh.2004.06.007; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Piwoz EG, 2000, HIV AIDS NUTR REV LI; Ryan AS, 1996, CLIN DERMATOL, V14, P389, DOI 10.1016/0738-081X(96)00068-5; Seyedrezazadeh E, 2008, RESPIROLOGY, V13, P294, DOI 10.1111/j.1440-1843.2007.01200.x; Sguassero Y, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005039.pub3; Steyn NP, 2008, S AFR J CLIN NUTR, V21, P22; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846	33	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55544	10.1371/journal.pone.0055544	http://dx.doi.org/10.1371/journal.pone.0055544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383220	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800163
J	Klein, D; Misawa, R; Bravo-Egana, V; Vargas, N; Rosero, S; Piroso, J; Ichii, H; Umland, O; Jiang, ZJ; Tsinoremas, N; Ricordi, C; Inverardi, L; Dominguez-Bendala, J; Pastori, RL				Klein, Dagmar; Misawa, Ryosuke; Bravo-Egana, Valia; Vargas, Nancy; Rosero, Samuel; Piroso, Julieta; Ichii, Hirohito; Umland, Oliver; Jiang Zhijie; Tsinoremas, Nicholas; Ricordi, Camillo; Inverardi, Luca; Dominguez-Bendala, Juan; Pastori, Ricardo L.			MicroRNA Expression in Alpha and Beta Cells of Human Pancreatic Islets	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; INSULIN-SECRETION; ANIMAL MICRORNAS; HIGH-THROUGHPUT; RAT ISLETS; C-MAF; RNA; PURIFICATION	microRNAs (miRNAs) play an important role in pancreatic development and adult beta-cell physiology. Our hypothesis is based on the assumption that each islet cell type has a specific pattern of miRNA expression. We sought to determine the profile of miRNA expression in alpha- and beta-cells, the main components of pancreatic islets, because this analysis may lead to a better understanding of islet gene regulatory pathways. Highly enriched (>98%) subsets of human alpha- and beta-cells were obtained by flow cytometric sorting after intracellular staining with c-peptide and glucagon antibody. The method of sorting based on intracellular staining is possible because miRNAs are stable after fixation. MiRNA expression levels were determined by quantitative high throughput PCR-based miRNA array platform screening. Most of the miRNAs were preferentially expressed in beta-cells. From the total of 667 miRNAs screened, the Significant Analysis of Microarray identified 141 miRNAs, of which only 7 were expressed more in alpha-cells (alpha-miRNAs) and 134 were expressed more in beta-cells (beta-miRNAs). Bioinformatic analysis identified potential targets of beta-miRNAs analyzing the Beta Cell Gene Atlas, described in the T1Dbase, the web platform, supporting the type 1 diabetes (T1D) community. cMaf, a transcription factor regulating glucagon expression expressed selectively in alpha-cells (TF alpha) is targeted by beta-miRNAs; miR-200c, miR-125b and miR-182. Min6 cells treated with inhibitors of these miRNAs show an increased expression of cMaf RNA. Conversely, over expression of miR-200c, miR-125b or miR-182 in the mouse alpha cell line alpha TC6 decreases the level of cMAF mRNA and protein. MiR-200c also inhibits the expression of Zfpm2, a TF alpha that inhibits the PI3K signaling pathway, at both RNA and protein levels. In conclusion, we identified miRNAs differentially expressed in pancreatic alpha- and beta-cells and their potential transcription factor targets that could add new insights into different aspects of islet biology and pathophysiology.	[Klein, Dagmar; Misawa, Ryosuke; Bravo-Egana, Valia; Vargas, Nancy; Rosero, Samuel; Piroso, Julieta; Ichii, Hirohito; Umland, Oliver; Ricordi, Camillo; Inverardi, Luca; Dominguez-Bendala, Juan; Pastori, Ricardo L.] Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33124 USA; [Jiang Zhijie; Tsinoremas, Nicholas] Univ Miami, Ctr Computat Sci, Miami, FL USA; [Tsinoremas, Nicholas; Inverardi, Luca; Pastori, Ricardo L.] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL USA; [Ricordi, Camillo; Dominguez-Bendala, Juan] Univ Miami, Leonard M Miller Sch Med, Dept Surg Sci, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami	Pastori, RL (corresponding author), Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33124 USA.	rpastori@med.miami.edu	RICORDI, CAMILLO/AAA-4740-2019; Ichii, Hirohito/AAV-8256-2021; Dominguez-Bendala, Juan/AAE-8296-2019	Ricordi, Camillo/0000-0001-8092-7153; Ichii, Hirohito/0000-0002-3635-5773	National Institutes of Health [5U01DK070460-07]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was possible thanks to the generous support of the Diabetes Research Institute Foundation (DRIF) (www.diabetesresearch.org). The DRIF funds work conducted at the Diabetes Research Institute with the goal of achieving a cure for type 1 diabetes in the fastest, safest and most efficient way possible. Funding is internal and as such is not associated with grant numbers. This work was also supported in part by the National Institutes of Health, grant 5U01DK070460-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kalis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029166; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Kohler M, 2012, INTEGR BIOL-UK, V4, P209, DOI 10.1039/c2ib00125j; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kredo-Russo S, 2012, EXP DIABETES RES, DOI 10.1155/2012/695214; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; PIPELEERS DG, 1981, DIABETOLOGIA, V20, P654; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Roggli E., 2012, DIABETES; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; RUSSELL TR, 1984, CYTOMETRY, V5, P539, DOI 10.1002/cyto.990050517; Schuit F, 2012, DIABETES, V61, P969, DOI 10.2337/db11-1564; Stange Geert, 2003, Methods Mol Med, V83, P15; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDEWINKEL M, 1982, BIOCHEM BIOPH RES CO, V107, P525, DOI 10.1016/0006-291X(82)91523-6; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907	53	100	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55064	10.1371/journal.pone.0055064	http://dx.doi.org/10.1371/journal.pone.0055064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383059	Green Published, gold			2022-12-25	WOS:000315483200041
J	Berg, C; Backstrom, T; Winberg, S; Lindberg, R; Brandt, I				Berg, Cecilia; Backstrom, Tobias; Winberg, Svante; Lindberg, Richard; Brandt, Ingvar			Developmental Exposure to Fluoxetine Modulates the Serotonin System in Hypothalamus	PLOS ONE			English	Article							SEWAGE-TREATMENT PLANTS; REUPTAKE INHIBITORS; XENOPUS-TROPICALIS; IN-UTERO; BRAIN; ANTIDEPRESSANTS; MONOAMINES; PREGNANCY; BEHAVIOR; STEROIDS	The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLU, Prozac (R)) is commonly prescribed for depression in pregnant women. This results in SSRI exposure of the developing fetus. However, there are knowledge gaps regarding the impact of SSRI exposure during development. Given the role of serotonin in brain development and its cross-talk with sex hormone function, we investigated effects of developmental exposure to pharmacologically relevant concentrations of FLU (3 and 30 nM (measured)) on brain neurotransmitter levels, gonadal differentiation, aromatase activity in brain and gonads, and the thyroid system, using the Xenopus tropicalis model. Tadpoles were chronically exposed (8 weeks) until metamorphosis. At metamorphosis brains were cryosectioned and levels of serotonin, dopamine, norepinephrine, and their metabolites 5-hydroxyindoleacetic acid, 3,4-dihydroxyphenylacetic acid, and homovanillic acid were measured in discrete regions (telencephalon, hypothalamus and the reticular formation) of the cryosections using high-performance liquid chromatography. Exposure to 30 nM FLU increased the concentration of 5-hydroxyindoleacetic acid in hypothalamus compared with controls. FLU exposure did not affect survival, time to metamorphosis, thyroid histology, gonadal sex differentiation, or aromatase activity implying that the effect on the serotonergic neurotransmitter system in the hypothalamus region was specific. The FLU concentration that impacted the serotonin system is lower than the concentration measured in umbilical cord serum, suggesting that the serotonin system of the developing brain is highly sensitive to in utero exposure to FLU. To our knowledge this is the first study showing effects of developmental FLU exposure on brain neurochemistry. Given that SSRIs are present in the aquatic environment the current results warrant further investigation into the neurobehavioral effects of SSRIs in aquatic wildlife.	[Berg, Cecilia; Backstrom, Tobias; Brandt, Ingvar] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Winberg, Svante] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lindberg, Richard] Umea Univ, Dept Chem, Umea, Sweden	Uppsala University; Uppsala University; Umea University	Berg, C (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.	Cecilia.Berg@ebc.uu.se	Winberg, Svante/ABB-6458-2021; Lindberg, Richard/C-8882-2013	Winberg, Svante/0000-0003-4252-3144; Brandt, Ingvar/0000-0002-5386-2400; Backstrom, Tobias/0000-0003-1984-9533	Research Council Formas; Carl Trygger Foundation; MistraPharma; Swedish Foundation for Strategic Environmental Research (Mistra)	Research Council Formas(Swedish Research Council Formas); Carl Trygger Foundation; MistraPharma; Swedish Foundation for Strategic Environmental Research (Mistra)(Swedish Foundation for Strategic Research)	This work was funded by the Research Council Formas, the Carl Trygger Foundation and MistraPharma, a research programme supported by the Swedish Foundation for Strategic Environmental Research (Mistra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg Cecilia, 2012, Methods Mol Biol, V889, P73, DOI 10.1007/978-1-61779-867-2_6; Berg C, 2009, J TOXICOL ENV HEAL A, V72, P219, DOI 10.1080/15287390802539079; Bethea CL, 2002, FRONT NEUROENDOCRIN, V23, P41, DOI 10.1006/frne.2001.0225; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Davidson S, 2009, PEDIATR RES, V65, P236, DOI 10.1203/PDR.0b013e318193594a; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Feenstra MGP, 1996, PHARMACOL BIOCHEM BE, V55, P647, DOI 10.1016/S0091-3057(96)00276-6; Foran CM, 2004, ARCH ENVIRON CON TOX, V46, P511, DOI 10.1007/s00244-003-3042-5; Gentile S, 2011, J AFFECT DISORDERS, V128, P1, DOI 10.1016/j.jad.2010.02.125; GOLSTEIN J, 1983, EUR J PHARMACOL, V91, P239, DOI 10.1016/0014-2999(83)90471-5; Gyllenhammar I, 2009, AQUAT TOXICOL, V91, P102, DOI 10.1016/j.aquatox.2008.10.005; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; HILAKIVI LA, 1987, PSYCHOPHARMACOLOGY, V91, P403, DOI 10.1007/BF00216004; Hoglund E, 2000, J EXP BIOL, V203, P1711; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; KING JA, 1981, GEN COMP ENDOCR, V44, P20, DOI 10.1016/0016-6480(81)90351-8; Kloas W, 2006, J CHROMATOGR A, V1130, P16, DOI 10.1016/j.chroma.2006.04.001; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Lister A, 2009, AQUAT TOXICOL, V95, P320, DOI 10.1016/j.aquatox.2009.04.011; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Muller JC, 2012, REPROD TOXICOL, V34, P80, DOI 10.1016/j.reprotox.2012.04.001; Nielsen Rene Ernst, 2007, Ugeskr Laeger, V169, P1442; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2005, PEDIATRICS, V115, P411, DOI 10.1542/peds.2004-0420; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; OECD, 2009, TEST NO 231 AMPH MET; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Parent A, 1984, HDB CHEM NEUROANAT 1, V2; Pawluski JL, 2012, NEUROENDOCRINOLOGY, V95, P39, DOI 10.1159/000329293; Pettersson I, 2007, ENVIRON TOXICOL CHEM, V26, P1005, DOI 10.1897/06-464R.1; Pope C, 2006, DEV BIOL, V297, P172, DOI 10.1016/j.ydbio.2006.05.005; Resko JA, 1997, CELL MOL NEUROBIOL, V17, P627, DOI 10.1023/A:1022534019718; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Tsai CL, 2000, J NEUROENDOCRINOL, V12, P894, DOI 10.1046/j.1365-2826.2000.00536.x; UEDA S, 1984, ANAT EMBRYOL, V169, P219, DOI 10.1007/BF00315627; Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Vigh B, 1998, MICROSC RES TECHNIQ, V41, P57, DOI 10.1002/(SICI)1097-0029(19980401)41:1<57::AID-JEMT6>3.0.CO;2-R; Vijayakumar M, 1999, NEUROCHEM RES, V24, P345, DOI 10.1023/A:1020992314534; Ward RM, 2000, PEDIATRICS, V105, P880	52	27	27	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55053	10.1371/journal.pone.0055053	http://dx.doi.org/10.1371/journal.pone.0055053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383055	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500052
J	Ganesh, S; Rogal, SS; Yadav, D; Humar, A; Behari, J				Ganesh, Swaytha; Rogal, Shari S.; Yadav, Dhiraj; Humar, Abhinav; Behari, Jaideep			Risk Factors for Frequent Readmissions and Barriers to Transplantation in Patients with Cirrhosis	PLOS ONE			English	Article							QUALITY-OF-CARE; LIVER-DISEASE; HEPATIC-ENCEPHALOPATHY; DIABETES-MELLITUS; HOSPITALIZATION; SURVIVAL; MODEL; DISPARITIES; RACE	Background: Hospital readmission rate is receiving increasing regulatory scrutiny. Patients with cirrhosis have high hospital readmissions rates but the relationship between frequent readmissions and barriers to transplantation remains unexplored. The goal of this study was to determine risk factors for frequent readmissions among patients with cirrhosis and identify barriers to transplantation in this population. Methods: We retrospectively reviewed medical records of 587 patients with a confirmed diagnosis of cirrhosis admitted to a large tertiary care center between May 1, 2008 and May 1, 2009. Demographics, clinical factors, and outcomes were recorded. Multivariate logistic regression was performed to identify risk factors for high readmission rates. Transplant-related factors were assessed for patients in the high readmission group. Results: The 587 patients included in the study had 1557 admissions during the study period. A subset of 87 (15%) patients with 5 or more admissions accounted for 672 (43%) admissions. The factors associated with frequent admissions were nonwhite race (OR = 2.45, p = 0.01), diabetes (OR = 2.04, p = 0.01), higher Model for End-Stage Liver Disease (MELD) score (OR = 35.10, p<0.0001 for MELD>30) and younger age (OR = 0.98, p = 0.02). Among the 87 patients with >= 5 admissions, only 14 (16%) underwent liver transplantation during the study period. Substance abuse, medical co-morbidities, and low (<15) MELD scores were barriers to transplantation in this group. Conclusions: A small group of patients with cirrhosis account for a disproportionately high number of hospital admissions. Interventions targeting this high-risk group may decrease frequent hospital readmissions and increase access to transplantation.	[Ganesh, Swaytha; Rogal, Shari S.; Yadav, Dhiraj; Behari, Jaideep] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Humar, Abhinav] Univ Pittsburgh, Dept Surg, Div Transplantat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Behari, J (corresponding author), Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	beharij@upmc.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Berg CL, 2011, HEPATOLOGY, V54, P1313, DOI 10.1002/hep.24494; Berman K, 2011, CLIN GASTROENTEROL H, V9, P254, DOI 10.1016/j.cgh.2010.10.035; Davis SK, 2003, AM J PUBLIC HEALTH, V93, P447, DOI 10.2105/AJPH.93.3.447; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Hannan EL, 2011, JACC-CARDIOVASC INTE, V4, P569, DOI 10.1016/j.jcin.2011.01.010; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kanwal F, 2010, CLIN GASTROENTEROL H, V8, P709, DOI 10.1016/j.cgh.2010.03.028; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Laditka JN, 2006, ETHNIC HEALTH, V11, P247, DOI 10.1080/13557850600565640; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Punamiya SJ, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/398291; Sanchez W, 2006, GASTROENTEROLOGY, V130, pA810, DOI 10.1053/j.gastro.2005.11.055; Sigal SH, 2006, AM J GASTROENTEROL, V101, P1490, DOI 10.1111/j.1572-0241.2006.00649.x; Terra C, 2005, GASTROENTEROLOGY, V129, P1944, DOI 10.1053/j.gastro.2005.09.024; Thuluvath PJ, 2006, AM J GASTROENTEROL, V101, P2244, DOI 10.1111/j.1572-0241.2006.00800.x; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; Volk ML, 2010, GASTROENTEROLOGY, V139, P14, DOI 10.1053/j.gastro.2010.05.017	23	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55140	10.1371/journal.pone.0055140	http://dx.doi.org/10.1371/journal.pone.0055140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383085	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500060
J	Tajerian, M; Alvarado, S; Millecamps, M; Vachon, P; Crosby, C; Bushnell, MC; Szyf, M; Stone, LS				Tajerian, Maral; Alvarado, Sebastian; Millecamps, Magali; Vachon, Pascal; Crosby, Cecilia; Bushnell, M. Catherine; Szyf, Moshe; Stone, Laura S.			Peripheral Nerve Injury Is Associated with Chronic, Reversible Changes in Global DNA Methylation in the Mouse Prefrontal Cortex	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; LOW-BACK-PAIN; NEUROPATHIC PAIN; LUMINOMETRIC METHYLATION; HISTONE DEACETYLASES; PERSISTENT PAIN; RAT MODEL; BRAIN; HYPOMETHYLATION; EXPRESSION	Changes in brain structure and cortical function are associated with many chronic pain conditions including low back pain and fibromyalgia. The magnitude of these changes correlates with the duration and/or the intensity of chronic pain. Most studies report changes in common areas involved in pain modulation, including the prefrontal cortex (PFC), and pain-related pathological changes in the PFC can be reversed with effective treatment. While the mechanisms underlying these changes are unknown, they must be dynamically regulated. Epigenetic modulation of gene expression in response to experience and environment is reversible and dynamic. Epigenetic modulation by DNA methylation is associated with abnormal behavior and pathological gene expression in the central nervous system. DNA methylation might also be involved in mediating the pathologies associated with chronic pain in the brain. We therefore tested a) whether alterations in DNA methylation are found in the brain long after chronic neuropathic pain is induced in the periphery using the spared nerve injury modal and b) whether these injury-associated changes are reversible by interventions that reverse the pathologies associated with chronic pain. Six months following peripheral nerve injury, abnormal sensory thresholds and increased anxiety were accompanied by decreased global methylation in the PFC and the amygdala but not in the visual cortex or the thalamus. Environmental enrichment attenuated nerve injury-induced hypersensitivity and reversed the changes in global PFC methylation. Furthermore, global PFC methylation correlated with mechanical and thermal sensitivity in neuropathic mice. In summary, induction of chronic pain by peripheral nerve injury is associated with epigenetic changes in the brain. These changes are detected long after the original injury, at a long distance from the site of injury and are reversible with environmental manipulation. Changes in brain structure and cortical function that are associated with chronic pain conditions may therefore be mediated by epigenetic mechanisms.	[Tajerian, Maral; Millecamps, Magali; Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Fac Med, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Dept Anesthesiol, Montreal, PQ, Canada; [Tajerian, Maral; Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Alvarado, Sebastian; Crosby, Cecilia; Szyf, Moshe; Stone, Laura S.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Alvarado, Sebastian; Crosby, Cecilia; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Millecamps, Magali; Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Vachon, Pascal] Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca; laura.s.stone@mcgill.ca	Alvarado, Sebastian/S-7607-2018	Alvarado, Sebastian/0000-0001-5866-4043; Tajerian, Maral/0000-0002-4598-1012	Canadian Institutes for Health Research [MOP-102586, MOP-42411]; Eli Lilly Canada Inc	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Eli Lilly Canada Inc(Eli Lilly)	Funding was received by Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca) MOP-102586 to L.S.S., MOP-42411 to M.S., and a grant from Eli Lilly Canada Inc to M.C.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; BONICA JJ, 1979, PAIN, V6, P247, DOI 10.1016/0304-3959(79)90046-0; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Chiechio S, 2010, TRENDS PHARMACOL SCI, V31, P153, DOI 10.1016/j.tips.2009.12.003; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; ESPADA J, 2007, NUCL ACIDS RES; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Karimi M, 2006, EPIGENETICS-US, V1, P45; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kashiwagi K, 2011, NUCLEIC ACIDS RES, V39, P874, DOI 10.1093/nar/gkq870; Kiguchi N, 2011, J PHARM EXP THER; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; SCHUFFENHAUER S, 1995, HUM GENET, V96, P562, DOI 10.1007/BF00197412; Schweinhardt P, 2010, J CLIN INVEST, V120, P3788, DOI 10.1172/JCI43498; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Stefanska B, 2011, CANC RES; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tajerian M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-65; Tochiki KK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-14; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	42	96	99	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55259	10.1371/journal.pone.0055259	http://dx.doi.org/10.1371/journal.pone.0055259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383129	Green Published, gold			2022-12-25	WOS:000315211500068
J	Upadhya, R; Campbell, LT; Donlin, MJ; Aurora, R; Lodge, JK				Upadhya, Rajendra; Campbell, Leona T.; Donlin, Maureen J.; Aurora, Rajeev; Lodge, Jennifer K.			Global Transcriptome Profile of Cryptococcus neoformans during Exposure to Hydrogen Peroxide Induced Oxidative Stress	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYMES; CYTOCHROME-C PEROXIDASE; ANTIFUNGAL DRUG-RESISTANCE; TO-CELL SPREAD; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; FUNGAL PATHOGEN; NITROSATIVE STRESS; GENE-EXPRESSION; NITRIC-OXIDE	The ability of the opportunistic fungal pathogen Cryptococcus neoformans to resist oxidative stress is one of its most important virulence related traits. To cope with the deleterious effect of cellular damage caused by the oxidative burst inside the macrophages, C. neoformans has developed multilayered redundant molecular responses to neutralize the stress, to repair the damage and to eventually grow inside the hostile environment of the phagosome. We used microarray analysis of cells treated with hydrogen peroxide (H2O2) at multiple time points in a nutrient defined medium to identify a transcriptional signature associated with oxidative stress. We discovered that the composition of the medium in which fungal cells were grown and treated had a profound effect on their capacity to degrade exogenous H2O2. We determined the kinetics of H2O2 breakdown by growing yeast cells under different conditions and accordingly selected an appropriate media composition and range of time points for isolating RNA for hybridization. Microarray analysis revealed a robust transient transcriptional response and the intensity of the global response was consistent with the kinetics of H2O2 breakdown by treated cells. Gene ontology analysis of differentially expressed genes related to oxidation-reduction, metabolic process and protein catabolic processes identified potential roles of mitochondrial function and protein ubiquitination in oxidative stress resistance. Interestingly, the metabolic pathway adaptation of C. neoformans to H2O2 treatment was remarkably distinct from the response of other fungal organisms to oxidative stress. We also identified the induction of an antifungal drug resistance response upon the treatment of C. neoformans with H2O2. These results highlight the complexity of the oxidative stress response and offer possible new avenues for improving our understanding of mechanisms of oxidative stress resistance in C. neoformans.	[Upadhya, Rajendra; Campbell, Leona T.; Lodge, Jennifer K.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Donlin, Maureen J.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Donlin, Maureen J.; Aurora, Rajeev] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Washington University (WUSTL); Saint Louis University; Saint Louis University	Lodge, JK (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	lodgej@wusm.wustl.edu	Donlin, Maureen J./M-4709-2019	Aurora, Rajeev/0000-0002-6609-6055; Lodge, Jennifer/0000-0002-2526-1210; Donlin, Maureen/0000-0001-7312-079X	NIH NIAID [R01AI050184]; NIH NHLBI [R01HL088905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050184] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH NIAID R01AI050184 and NIH NHLBI R01HL088905 grants to JKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Alonso-Monge R, 2009, MICROBIOL-SGM, V155, P413, DOI 10.1099/mic.0.023309-0; Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Brown SM, 2010, EUKARYOT CELL, V9, P971, DOI 10.1128/EC.00271-09; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Charizanis C, 1999, MOL GEN GENET, V262, P437, DOI 10.1007/s004380051103; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cuellar-Cruz M, 2008, EUKARYOT CELL, V7, P814, DOI 10.1128/EC.00011-08; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerik KJ, 2008, EUKARYOT CELL, V7, P1685, DOI 10.1128/EC.00146-08; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Guerrero-Castillo S, 2011, J BIOENERG BIOMEMBR, V43, P323, DOI 10.1007/s10863-011-9356-5; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.micro.46.1.565; Hasenberg M, 2011, INT J MED MICROBIOL, V301, P436, DOI 10.1016/j.ijmm.2011.04.012; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hiraishi H, 2006, BIOSCI BIOTECH BIOCH, V70, P2762, DOI 10.1271/bbb.60250; Honjoh K, 2010, AMINO ACIDS, V38, P1173, DOI 10.1007/s00726-009-0328-6; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hwang GW, 2008, LIFE SCI, V82, P1182, DOI 10.1016/j.lfs.2008.04.002; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Jin JHQ, 2003, MICROBIOL-SGM, V149, P3371, DOI 10.1099/mic.0.26644-0; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim SH, 2005, ANAL CHEM, V77, P6828, DOI 10.1021/ac0507340; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kwon M, 2003, BBA-GEN SUBJECTS, V1623, P1, DOI 10.1016/S0304-4165(03)00151-X; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; Lopes Joao, 2010, Open Microbiol J, V4, P75, DOI 10.2174/1874285801004010075; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Mak S, 2010, ENVIRON HEALTH PERSP, V118, P653, DOI 10.1289/ehp.0901448; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; Missall TA, 2005, MICROBIOL-SGM, V151, P2573, DOI 10.1099/mic.0.28132-0; Missall TA, 2005, MOL MICROBIOL, V57, P847, DOI 10.1111/j.1365-2958.2005.04735.x; Missall TA, 2005, EUKARYOT CELL, V4, P487, DOI 10.1128/EC.4.2.487-489.2005; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Missall TA, 2004, MOL MICROBIOL, V51, P1447, DOI 10.1111/j.1365-2958.2004.03921.x; Morgan Brian A., 2007, V44, P253; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Reed SH, 2007, DNA REPAIR, V6, P149, DOI 10.1016/j.dnarep.2006.10.026; Roetzer A, 2011, FEBS LETT, V585, P319, DOI 10.1016/j.febslet.2010.12.006; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Soriano FX, 2009, MOL CELLS, V27, P279, DOI 10.1007/s10059-009-0050-y; Sorrell Tania C., 1997, Revista Iberoamericana de Micologia, V14, P42; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; Toffaletti DL, 2004, CURR GENET, V46, P193, DOI 10.1007/s00294-004-0521-9; Toffaletti DL, 2003, MICROBIOL-SGM, V149, P1041, DOI 10.1099/mic.0.26021-0; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Venkateswarlu K, 1997, ANTIMICROB AGENTS CH, V41, P748, DOI 10.1128/AAC.41.4.748; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x	88	47	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55110	10.1371/journal.pone.0055110	http://dx.doi.org/10.1371/journal.pone.0055110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383070	Green Published, gold			2022-12-25	WOS:000315211500058
J	Harper, AR; Mayosi, BM; Rodriguez, A; Rahman, T; Hall, D; Mamasoula, C; Avery, PJ; Keavney, BD				Harper, Andrew R.; Mayosi, Bongani M.; Rodriguez, Antony; Rahman, Thahira; Hall, Darroch; Mamasoula, Chrysovalanto; Avery, Peter J.; Keavney, Bernard D.			Common Variation Neighbouring Micro-RNA 22 Is Associated with Increased Left Ventricular Mass	PLOS ONE			English	Article							BLOOD-PRESSURE; LIPOTOXIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; MEDIAL THICKNESS; GENE; FAMILY; CARDIOMYOCYTES; POLYMORPHISMS; METAANALYSIS; EXPRESSION	Aims: Previous genome-wide linkage analysis has suggested that chromosomal region 17p13.3 may harbour genes influencing left ventricular mass (LVM) in man. To date, the genetic factors accounting for LVM variability remain largely unknown but a non-coding RNA gene within this region, micro-RNA 22 (miR-22), has been implicated in cardiac hypertrophy and heart failure in animal models. We thus investigated the relationship between common genetic polymorphisms surrounding miR-22 and left ventricular mass in a family-based association study. Methods and Results: We studied a cohort of 255 families comprising 1,425 individuals ascertained via a hypertensive proband. Ten single nucleotide polymorphisms which together tagged common genetic variation surrounding the miR-22 gene were genotyped. There was evidence of association between the rs7223247 polymorphism, which lies within the 3'UTR of a gene of unknown function, TLCD2, immediately downstream from miR-22, and left ventricular mass determined by Sokolow-Lyon voltage (Bonferroni corrected p-value = 0.038). The T allele at rs7223247 was associated with an 0.272 standard deviation higher Sokolow-Lyon voltage. Genotype was responsible for similar to 1% of the population variability in LVM. Conclusions: Genotype at the rs7223247 polymorphism affects left ventricular mass determined by Sokolow-Lyon voltage. The neighbouring genes miR-22 and TLCD2 are strong candidates to account for this observation.	[Harper, Andrew R.] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Harper, Andrew R.; Rahman, Thahira; Hall, Darroch; Mamasoula, Chrysovalanto; Keavney, Bernard D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Rodriguez, Antony] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Avery, Peter J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Cape Town; University of Cape Town; Baylor College of Medicine; Newcastle University - UK	Keavney, BD (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	b.d.keavney@ncl.ac.uk	Harper, Andrew/B-7044-2017	Harper, Andrew/0000-0001-5327-0328; Keavney, Bernard/0000-0001-9573-0812; Mayosi, Bongani/0000-0001-6641-8950	British Heart Foundation [RG/08/012/25941]	British Heart Foundation(British Heart Foundation)	The study was funded by the British Heart Foundation (Grant: RG/08/012/25941) (URL:http://www.bhf.org.uk/annualreview09/BHF-Grant-Awards-2009.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036694; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Cunnington MS, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-135; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; Getz GS, 2008, J LIPID RES, V49, P2077, DOI 10.1194/jlr.E800015-JLR200; Gurha P., 2012, CIRCULATION; Hall D, 2011, J HYPERTENS, V29, P690, DOI 10.1097/HJH.0b013e3283440115; Hong KW, 2012, EUR HEART J, V33, P1250, DOI 10.1093/eurheartj/ehr267; Jazbutyte V, 2012, AGE DORDR; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Keavney B, 2000, J HUM HYPERTENS, V14, P361, DOI 10.1038/sj.jhh.1001020; LEVY D, 1994, CIRCULATION, V90, P1786, DOI 10.1161/01.CIR.90.4.1786; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96; Mayosi BM, 2003, EUR J HUM GENET, V11, P395, DOI 10.1038/sj.ejhg.5200967; Mayosi BM, 2002, EUR HEART J, V23, P1963, DOI 10.1053/euhj.2002.3288; Mayosi BM, 2008, EUR HEART J, V29, P525, DOI 10.1093/eurheartj/ehn028; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Palomino-Doza J, 2008, HYPERTENSION, V52, P980, DOI 10.1161/HYPERTENSIONAHA.108.113282; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Rahman TJ, 2011, CIRC-CARDIOVASC GENE, V4, P156, DOI 10.1161/CIRCGENETICS.110.958496; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shah S, 2011, CIRC-CARDIOVASC GENE, V4, P626, DOI 10.1161/CIRCGENETICS.111.960203; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852	32	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55061	10.1371/journal.pone.0055061	http://dx.doi.org/10.1371/journal.pone.0055061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372812	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400055
J	Jones, KH; Ford, DV; Jones, PA; John, A; Middleton, RM; Lockhart-Jones, H; Peng, J; Osborne, LA; Noble, JG				Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Osborne, Lisa A.; Noble, J. Gareth			The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register	PLOS ONE			English	Article							SCALE MSIS-29	Introduction: The MSIS-29 was developed to assess the physical and psychological impact of MS. The aims of this study were to use the responses to the MSIS-29 via the web portal of the UK MS Register to: examine the internal properties of the scale delivered via the internet, profile the cohort, and assess how well the scale measures impact of disability on the potential workforce. Methods: Between May 2011 and April 2012, 4558 people with MS completed the MSIS-29(v.1). The responses were collated with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS(v.20). Results: Internal consistency was high (Cronbach's alpha 0.97 MSIS-29-PHYS, 0.92 MSIS-29-PSYCH). The mean MSIS-29-PHYS score was 60.5 (50.6%) with a median of 62 and the mean MSIS-29-PSYCH score was 24.8 (43.8%) with a median of 24. Physical scores increased with age and disease duration (p<0.001, p<0.001), but there was a weak negative relationship between psychological scores and age (p<0.001). The odds of people having an employment status of sick/disabled were 7.2 (CI 5.5, 9.4, p<0.001) for people with a moderate physical score, and 22.3 (CI 17.0, 29.3, p<0.001) for people with a high physical score (relative to having a low physical score). Conclusions: This largest known study of its kind has demonstrated how the MSIS-29 can be administered via the internet to characterise a cohort, and to predict the likely impact of disability on taking an active part in the workforce, as a reasonable proxy for the effects of MS on general activities. The findings examining MSIS-29-PHYS and MSIS-29-PSYCH scores against age support the use of two sub-scales, not a combined score. These results underline the importance of using a scale such as this to monitor disability levels regularly in guiding MS care to enable people to be as active as possible.	[Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Osborne, Lisa A.] Swansea Univ, Coll Human & Hlth Sci, Long Term & Chron Condit Ctr, Swansea, W Glam, Wales	Swansea University; Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Jones, Kerina/0000-0001-8164-3718; Ford, David/0000-0001-6551-721X; Noble, Gareth/0000-0002-4588-049X; Middleton, Rodden/0000-0002-2130-4420; John, Ann/0000-0002-5657-6995	MS Society of Great Britain and Northern Ireland; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish	MS Society of Great Britain and Northern Ireland; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study is funded by the MS Society of Great Britain and Northern Ireland (http://www.mssociety.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ETH REV RES DAT; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; European Medicines Agency, 2012, EMACHMP7718152011; Ford DV, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-73; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Gray OM, 2009, MULT SCLER, V15, P75, DOI 10.1177/1352458508096872; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart J, 2009, HLTH TECHNOLOGY ASSE, V13; Hobart JC, 2005, J NEUROL NEUROSUR PS, V76, P1539, DOI 10.1136/jnnp.2005.064584; Hoogervorst ELJ, 2004, MULT SCLER, V10, P569, DOI 10.1191/1352458504ms1078oa; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; McGuigan C, 2004, J NEUROL NEUROSUR PS, V75, P266; Multiple Sclerosis International Federation website, ATL MS DAT PROF COUN; Noble JG, 2012, MULT SCLER J, V18, P1718, DOI 10.1177/1352458512457847; Office for National Statistics, NOM OFF LAB MARK STA; Osborne LA, INT J HEALT IN PRESS; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Riazi A, 2002, J NEUROL NEUROSUR PS, V73, P701, DOI 10.1136/jnnp.73.6.701; van der Linden FAH, 2005, J NEUROL NEUROSUR PS, V76, P1677, DOI 10.1136/jnnp.2005.065227; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zajicek JP, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-88; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	26	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55422	10.1371/journal.pone.0055422	http://dx.doi.org/10.1371/journal.pone.0055422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23383186	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600101
J	Ye, XF; Lian, QQ; Eckenhoff, MF; Eckenhoff, RG; Pan, JZ				Ye, Xuefei; Lian, Qingquan; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.; Pan, Jonathan Z.			Differential General Anesthetic Effects on Microglial Cytokine Expression	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; RANDOMIZED CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; INTERFERON-GAMMA; ENDOTOXEMIC RATS; ISOFLURANE; SURGERY; LIPOPOLYSACCHARIDE; INFLAMMATION; DESFLURANE	Post-operative cognitive dysfunction has been widely observed, especially in older patients. An association of postoperative cognitive dysfunction with the neurodegenerative diseases, such as Alzheimer's disease, has been suggested. Neuroinflammation contributes to Alzheimer pathology, through elevated pro-inflammatory cytokines and microglial activation in the CNS leading to neuronal damage, synaptic disruption and ultimately cognitive dysfunction. We compare the effects of three different, clinically-used, anesthetics on microglial activation with, and without, the prototypical inflammatory trigger, lipopolysaccharide (LPS). Microglial BV-2 cell cultures were first exposed to isoflurane, sevoflurane (each at 2 concentrations) or propofol for 6 h, and cytokine levels measured in lysates and media. The same experiments were repeated after 1 h LPS pre-treatment. We found; 1) anesthetics alone have either no or only a small effect on cytokine expression; 2) LPS provoked a large increase in microglia cytokine expression; 3) the inhaled anesthetics either had no effect on LPS-evoked responses or enhanced it; 4) propofol nearly eliminated the LPS pro-inflammatory cytokine response and improved cell survival as reflected by lactate dehydrogenase release. These data suggest that propofol may be a preferred anesthetic when it is desirable to minimize neuroinflammation.	[Ye, Xuefei; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.; Pan, Jonathan Z.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Ye, Xuefei; Lian, Qingquan] Wenzhou Med Coll, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Zhejiang, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Wenzhou Medical University	Eckenhoff, RG (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Eckenhoff, Roderic/0000-0002-5581-746X	Austin Lamont Endowment, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania	Austin Lamont Endowment, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania	This work was funded by the Austin Lamont Endowment, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SD, 2008, J TRAUMA, V65, P170, DOI 10.1097/TA.0b013e31805824ca; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boost KA, 2006, INT J MOL MED, V17, P1139; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hocker J, 2009, ANESTHESIOLOGY, V110, P1068, DOI 10.1097/ALN.0b013e31819dad92; Hofstetter C, 2007, ACTA ANAESTH SCAND, V51, P893, DOI 10.1111/j.1399-6576.2007.01353.x; Kim JA, 2009, ANESTHESIOLOGY, V111, P566, DOI 10.1097/ALN.0b013e3181af5b3d; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Liu Y, 2012, AM J MED SCI; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Rortgen D, 2010, BRIT J ANAESTH, V104, P167, DOI 10.1093/bja/aep369; Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718; Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x; Schlachetzki JCM, 2009, CURR ALZHEIMER RES, V6, P554, DOI 10.2174/156720509790147179; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Tang JXX, 2011, CURR OPIN ANESTHESIO, V24, P389, DOI 10.1097/ACO.0b013e32834871c5; Tang JX, 2012, ANN SURG; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xu X, 2008, NEUROSCIENCE, V154, P1002, DOI 10.1016/j.neuroscience.2008.04.013; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664	37	68	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52887	10.1371/journal.pone.0052887	http://dx.doi.org/10.1371/journal.pone.0052887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382826	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600008
J	Clay, Z; de Waal, FBM				Clay, Zanna; de Waal, Frans B. M.			Bonobos Respond to Distress in Others: Consolation across the Age Spectrum	PLOS ONE			English	Article							POST-CONFLICT BEHAVIOR; POSTCONFLICT 3RD-PARTY AFFILIATION; RECONCILIATION; CHIMPANZEES; EMPATHY; CHILDREN; ATTACHMENT; MONKEYS; MOTHERS	How animals respond to conflict provides key insights into the evolution of socio-cognitive and emotional capacities. Evidence from apes has shown that, after social conflicts, bystanders approach victims of aggression to offer stress-alleviating contact behavior, a phenomenon known as consolation. This other-orientated behavior depends on sensitivity to the other's emotional state, whereby the consoler acts to ameliorate the other's situation. We examined post-conflict interactions in bonobos (Pan paniscus) to identify the determinants of consolation and reconciliation. Thirty-six semi-free bonobos of all ages were observed at the Lola ya Bonobo Sanctuary, DR Congo, using standardized Post-conflict/Matched Control methods. Across age and sex classes, bonobos consoled victims and reconciled after conflicts using a suite of affiliative and socio-sexual behaviors including embracing, touching, and mounting. Juveniles were more likely to console than adults, challenging the assumption that comfort-giving rests on advanced cognitive mechanisms that emerge only with age. Mother-reared individuals were more likely to console than orphans, highlighting the role of rearing in emotional development. Consistent with previous studies, bystanders were more likely to console relatives or closely bonded partners. Effects of kinship, affiliation and rearing were similarly indicated in patterns of reconciliation. Nearby bystanders were significantly more likely to contact victims than more distal ones, and consolation was more likely in non-food contexts than during feeding. The results did not provide convincing evidence that bystander contacts served for self-protection or as substitutes for reconciliation. Overall, results indicate that a suite of social, developmental and contextual factors underlie consolation and reconciliation in bonobos and that a sensitivity to the emotions of others and the ability to provide appropriate consolatory behaviors emerges early in development.	[Clay, Zanna; de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Clay, Z (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	zannaclay@emory.edu			Living Links Center; Yerkes National Primate Research Center; Emory's College for Arts Sciences; Ministry of Research; Ministry of Environment in the Democratic Republic of Congo [MIN.RS/SG/004/2009]	Living Links Center; Yerkes National Primate Research Center; Emory's College for Arts Sciences; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Environment in the Democratic Republic of Congo	Funding for the study has come from the Living Links Center, part of the Yerkes National Primate Research Center, and Emory's College for Arts & Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Pitshou Nsele Kayanga for assistance in data collection. We are grateful to Claudine Andre, Fanny Mehl, Dominique Morel, Valery Dhanani and Pierrot Mbonzo for their collaboration and to the Ministry of Research and the Ministry of Environment in the Democratic Republic of Congo for supporting our research ( research permit: MIN.RS/SG/004/2009). We thank all the staff of Lola ya Bonobo for their support, particularly to Stany Mokando, Jean-Claude Nzumbi and Philippe Kunaka. We thank Brian Hare for his ongoing support and Tim Eppley for valuable practical assistance. We are grateful to Noah Snyder-Mackler for statistical assistance. We thank Kim Bard, Philippe Rochat and Malini Suchak for insightful comments; Robert O'Reilly and Nigel Lo for their support in data management, and two anonymous reviewers for their valuable comments.	Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Byrne R, 2008, J CONSCIOUSNESS STUD, V15, P10; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Clay Z, 2011, ETHOLOGY, V117, P1158, DOI 10.1111/j.1439-0310.2011.01975.x; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; De Bellis MD, 2005, CHILD MALTREATMENT, V10, P150, DOI 10.1177/1077559505275116; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; de Waal FBM, 2011, EMPATHY; De Waal Frans B. M., 1996, P80; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DeWaal FBM, 1997, ANN NY ACAD SCI, V807, P317; Eisenberg N, 1992, REV PERSONALITY SOCI, P119; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fuentes A, 2002, PRIMATES, V43, P223, DOI 10.1007/BF02629650; Furuichi T, 2008, BONOBOS BEHAV ECOLOG; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Harlow H. F., 1965, P287; Hastings RP, 2006, AM J MENT RETARD, V111, P48, DOI 10.1352/0895-8017(2006)111[48:MDAEEC]2.0.CO;2; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Mallavarapu S, 2006, AM J PRIMATOL, V68, P789, DOI 10.1002/ajp.20279; MINEKA S, 1978, PSYCHOL BULL, V85, P1376, DOI 10.1037/0033-2909.85.6.1376; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Radke-Yarrow M., 1984, DEV MAINTENANCE PROS, P81, DOI 10.1007/978-1-4613-2645-8; RADKEYARROW M, 1994, CHILD DEV, V65, P1405, DOI 10.1111/j.1467-8624.1994.tb00825.x; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Romero T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022173; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Rosati AG, 2012, ANIM BEHAV IN PRESS; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Suomi SJ, 2008, INTEGR PSYCHOL BEHAV, V42, P354, DOI 10.1007/s12124-008-9072-9; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Tabachnick BG, 2001, MULTIVARIATE STAT; TIZARD B, 1978, J CHILD PSYCHOL PSYC, V19, P99, DOI 10.1111/j.1469-7610.1978.tb00453.x; van IJzendoorn MH, 2009, DEV PSYCHOBIOL, V51, P173, DOI 10.1002/dev.20356; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P1038, DOI 10.1037/0012-1649.28.6.1038; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	62	91	91	4	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55206	10.1371/journal.pone.0055206	http://dx.doi.org/10.1371/journal.pone.0055206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383110	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800130
J	Duce, SL; D'Alessandro, M; Du, YM; Jagpal, B; Gilbert, FJ; Crichton, L; Barker, S; Collinson, JM; Miedzybrodzka, Z				Duce, Suzanne L.; D'Alessandro, Mariella; Du, Yimeng; Jagpal, Baljit; Gilbert, Fiona J.; Crichton, Lena; Barker, Simon; Collinson, J. Martin; Miedzybrodzka, Zosia			3D MRI Analysis of the Lower Legs of Treated Idiopathic Congenital Talipes Equinovarus (Clubfoot)	PLOS ONE			English	Article							3-DIMENSIONAL MRI; PONSETI METHOD; LIMB LENGTH; FOOT; ABNORMALITIES; ANGIOGRAPHY; DISCREPANCY; DEFORMITY	Idiopathic congenital talipes equinovarus (CTEV) is the commonest form of clubfoot. Its exact cause is unknown, although it is related to limb development. The aim of this study was to quantify the anatomy of the muscle, subcutaneous fat, tibia, fibula and arteries in the lower legs of teenagers and young adults with CTEV using 3D magnetic resonance imaging (MRI), and thus to investigate the anatomical differences between CTEV participants and controls. Methodology/Principal Findings: The lower legs of six CTEV (2 bilateral, 4 unilateral) and five control young adults (age 1228) were imaged using a 3T MRI Philips scanner. 5 of the CTEV participants had undergone soft-tissue and capsular release surgery. 3D T1-weighted and 3D magnetic resonance angiography (MRA) images were acquired. Segmentation software was used for volumetric, anatomical and image analysis. Kolmogorov-Smirnov tests were performed. The volumes of the lower affected leg, muscle, tibia and fibula in unilateral CTEV participants were consistently smaller compared to their contralateral unaffected leg, this was most pronounced in muscle. The proportion of muscle in affected CTEV legs was significantly reduced compared with control and unaffected CTEV legs, whilst proportion of muscular fat increased. No spatial abnormalities in the location or branching of arteries were detected, but hypoplastic anomalies were observed. Conclusions/Significance: Combining 3D MRI and MRA is effective for quantitatively characterizing CTEV anatomy. Reduction in leg muscle volume appears to be a sensitive marker. Since 5/6 CTEV cases had soft-tissue surgery, further work is required to confirm that the treatment did not affect the MRI features observed. We propose that the proportion of muscle and intra-muscular fat within the lower leg could provide a valuable addition to current clinical CTEV classification. These measures could be useful for clinical care and guiding treatment pathways, as well as treatment research and clinical audit.	[Duce, Suzanne L.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [D'Alessandro, Mariella] Clin Genet Ctr, Aberdeen, Scotland; [Du, Yimeng] Univ Dundee, Div Mech Engn & Mechatron, Dundee, Scotland; [Jagpal, Baljit; Gilbert, Fiona J.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Crichton, Lena] Aberdeen Matern Hosp, Aberdeen, Scotland; [Barker, Simon] Royal Aberdeen Childrens Hosp, Dept Paediat Orthopaed Surg, Aberdeen, Scotland; [Collinson, J. Martin] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Miedzybrodzka, Zosia] Dept Med Genet, Aberdeen, Scotland	University of Dundee; University of Dundee; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Duce, SL (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	s.duce@dundee.ac.uk	Collinson, Jon Martin/I-9997-2019	Gilbert, Fiona/0000-0002-0124-9962	Medical Research Council [G0800901, 87379]; Welcome Trust [WT081039]; Chief Scientist Office, Scotland; MRC [G0800901] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust(Wellcome Trust); Chief Scientist Office, Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Medical Research Council project grant reference G0800901 (Grant ID: 87379). The authors also acknowledge the Welcome Trust (WT081039, SLD) and Chief Scientist Office, Scotland (MDA) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MRI PICTURE PROTON; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Barker SL, 2012, SURG-J R COLL SURG E, V10, P84, DOI 10.1016/j.surge.2011.01.002; Bohm M, 1929, J BONE JOINT SURG, V11, P229; Cahuzac JP, 1999, J BONE JOINT SURG BR, V81B, P97, DOI 10.1302/0301-620X.81B1.9053; Dobbs MB, 2004, J BONE JOINT SURG AM, V86A, P599, DOI 10.2106/00004623-200403000-00022; Duce S, 2010, J ANAT, V216, P108, DOI 10.1111/j.1469-7580.2009.01163.x; Dyer PJ, 2006, J BONE JOINT SURG BR, V88B, P1082, DOI 10.1302/0301-620X.88B8.17482; GREIDER TD, 1982, J BONE JOINT SURG AM, V64, P837, DOI 10.2106/00004623-198264060-00005; Gutzeit A, 2011, EUR RADIOL, V21, P1979, DOI 10.1007/s00330-011-2132-4; HARROLD AJ, 1983, J BONE JOINT SURG BR, V65, P8, DOI 10.1302/0301-620X.65B1.6822607; Ippolito E, 2009, J CHILD ORTHOP, V3, P171, DOI 10.1007/s11832-009-0179-4; Itohara T, 2005, EUR J RADIOL, V53, P78, DOI 10.1016/j.ejrad.2004.03.003; Kamegaya M, 2000, CLIN ORTHOP RELAT R, P218; Katz DA, 2003, J PEDIATR ORTHOPED, V23, P84, DOI 10.1097/00004694-200301000-00017; Kruse L, 2009, CLIN ORTHOP RELAT R, V467, P1250, DOI 10.1007/s11999-008-0673-x; LITTLE DG, 1995, AUST NZ J SURG, V65, P409, DOI 10.1111/j.1445-2197.1995.tb01770.x; Merrill LJ, 2011, CLIN ORTHOP RELAT R, V469, P1442, DOI 10.1007/s11999-010-1657-1; Miedzybrodzka Z, 2003, J ANAT, V202, P37, DOI 10.1046/j.1469-7580.2003.00147.x; Noonan Kenneth J, 2004, Iowa Orthop J, V24, P60; O'Connor PJ, 1998, SKELETAL RADIOL, V27, P440, DOI 10.1007/s002560050414; Pekindil G, 2001, EUR J RADIOL, V37, P123, DOI 10.1016/S0720-048X(00)00275-8; Pirani S, 2001, J PEDIATR ORTHOPED, V21, P719, DOI 10.1097/00004694-200111000-00004; PONSETI IV, 1992, J BONE JOINT SURG AM, V74A, P448, DOI 10.2106/00004623-199274030-00021; Richards BS, 2007, J PEDIATR ORTHOPED, V27, P214, DOI 10.1097/BPO.0b013e31803179c0; Saito S, 2004, J PEDIATR ORTHOP B, V13, P99, DOI 10.1097/00009957-200403000-00007; Sarrafian S, 1993, ANATOMY FOOT ANKLE D; Shimode K, 2005, J PEDIATR ORTHOP B, V14, P280, DOI 10.1097/01202412-200507000-00009; SODRE H, 1990, J PEDIATR ORTHOPED, V10, P101; Staheli L, 2009, GLOBAL HELP, V27; Wang C, 1999, PEDIATR RADIOL, V29, P262, DOI 10.1007/s002470050585; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P464, DOI 10.1302/0301-620X.46B3.464	32	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54100	10.1371/journal.pone.0054100	http://dx.doi.org/10.1371/journal.pone.0054100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382871	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800032
J	Fry, JP; Laestadius, LI; Grechis, C; Nachman, KE; Neff, RA				Fry, Jillian P.; Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.			Investigating the Role of State and Local Health Departments in Addressing Public Health Concerns Related to Industrial Food Animal Production Sites	PLOS ONE			English	Article							EASTERN NORTH-CAROLINA; FEEDING OPERATIONS; ENVIRONMENTAL INJUSTICE; RESPIRATORY HEALTH; SWINE OPERATIONS; HOG INDUSTRY; RESIDENTS; COMMUNITY; EXPOSURE; EMISSIONS	Objectives: Evidence of community health concerns stemming from industrial food animal production (IFAP) facilities continues to accumulate. This study examined the role of local and state health departments in responding to and preventing community-driven concerns associated with IFAP. Methods: We conducted semi-structured qualitative interviews with state and county health department staff and community members in eight states with high densities or rapid growth of IFAP operations. We investigated the extent to which health concerns associated with IFAP sites are reported to health departments, the nature of health departments' responses, and barriers to involvement. Results: Health departments' roles in these matters are limited by political barriers, lack of jurisdiction, and finite resources, expertise, and staff. Community members reported difficulties in engaging health departments on these issues. Conclusions: Our investigation suggests that health departments frequently lack resources or jurisdiction to respond to health concerns related to IFAP sites, resulting in limited engagement. Since agencies with jurisdiction over IFAP frequently lack a health focus, increased health department engagement may better protect public health.	[Fry, Jillian P.; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Fry, Jillian P.; Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Livable Future, Baltimore, MD USA; [Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fry, JP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	jfry@jhsph.edu	Laestadius, Linnea/AAC-1911-2019	Laestadius, Linnea/0000-0003-3272-9317; Neff, Roni/0000-0002-0010-2635; Nachman, Keeve/0000-0003-4925-4151				American Public Health Association, 10 ESS PUBL HLTH SER; Association of State and Territorial Health Officials, 2012, BUDG CUTS CONT AFF H; Avery RC, 2004, ARCH ENVIRON HEALTH, V59, P101, DOI 10.3200/AEOH.59.2.101-108; Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839; Cartiglia N., 2022, 17 TRENT WORKSH ADV; Centner TJ, 2011, J ANIM SCI, V89, P4364, DOI 10.2527/jas.2011-4256; Donham KJ, 2010, J ANIM SCI, V88, pE102, DOI 10.2527/jas.2009-2554; Erwin PC, 2011, AM J PUBLIC HEALTH, V101, P609, DOI 10.2105/AJPH.2009.177451; Graham JP, 2010, J WATER HEALTH, V8, P646, DOI 10.2166/wh.2010.075; Horton RA., 2009, AM J PUBLIC HEALTH, V99, pS610, DOI [10.2105/ajph.2008.148924, 10.2105/AJPH.2008.148924., DOI 10.2105/AJPH.2008.148924, 10.2105/AJPH.2008.148924]; Hyde JK, 2012, AM J PREV MED, V42, pS29, DOI 10.1016/j.amepre.2012.01.021; Johns Hopkins Bloomberg School of Public Health, 2008, NE MID PROF ENV PUBL; Juzych Nadia Shalauta, 2007, Am J Public Health, V97 Suppl 1, pS163, DOI 10.2105/AJPH.2006.096453; Kanarek N, 2006, J PUBLIC HEALTH MAN, V12, P522; Kufel JSZ, 2011, AM J PUBLIC HEALTH, V101, P1495, DOI 10.2105/AJPH.2011.300137; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586; Missouri Department of Health and Senior Services, 2003, HLTH CONS FIN REP EX; Mitloehner FM, 2008, J AGRIC SAF HEALTH, V14, P163, DOI 10.13031/2013.24349; National Association of County and City Health Officials, 2012, LOC HLTH DEP JOB LOS; National Conference of State Legislatures, 2008, NAT C STAT LEG CONC; Nimmermark S, 2004, ANN AGR ENV MED, V11, P163; Osterberg D, 2004, AM J PUBLIC HEALTH, V94, P1703, DOI 10.2105/AJPH.94.10.1703; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; Resnick BA, 2009, J PUBLIC HEALTH MAN, pS40, DOI 10.1097/PHH.0b013e3181b3492d; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; Schiffman SS, 2001, AGR FOREST METEOROL, V108, P213, DOI 10.1016/S0168-1923(01)00239-8; SCHIFFMAN SS, 1995, BRAIN RES BULL, V37, P369, DOI 10.1016/0361-9230(95)00015-1; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Thu K, 1997, J AGR SAF HLTH, V3, P13, DOI DOI 10.13031/2013.17747; Thu K M, 2002, J Agric Saf Health, V8, P175; Trabue S, 2010, ATMOS ENVIRON, V44, P3538, DOI 10.1016/j.atmosenv.2010.06.009; US Census Bureau, 2010, INC POV HLTH INS COV; US Centers for Disease Control and Prevention, 1980, NAT SURV ASTHM US 19; US Department of Agriculture, CENS AGR HIST ARCH; US Department of Agriculture, CENS AGR QUICK STATS; US Department of Agriculture, 2009, EC INF B, VEIB-43; US Environmental Protection Agency, 2012, FY 2012 OFF ENF COMP; Williams DL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-72; Wilson SM, 2007, ATMOS ENVIRON, V41, P4977, DOI 10.1016/j.atmosenv.2006.12.055; Wilson SM, 2002, ENVIRON HEALTH PERSP, V110, P195, DOI 10.1289/ehp.02110s2195; Wing S, 2002, ENVIRON HEALTH PERSP, V110, P437, DOI 10.1289/ehp.02110437; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439	45	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54720	10.1371/journal.pone.0054720	http://dx.doi.org/10.1371/journal.pone.0054720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382947	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800069
J	Lai, JY; Ma, DHK; Lai, MH; Li, YT; Chang, RJ; Chen, LM				Lai, Jui-Yang; Ma, David Hui-Kang; Lai, Meng-Heng; Li, Ya-Ting; Chang, Ren-Jie; Chen, Li-Mei			Characterization of Cross-Linked Porous Gelatin Carriers and Their Interaction with Corneal Endothelium: Biopolymer Concentration Effect	PLOS ONE			English	Article							HYALURONIC-ACID HYDROGELS; PIGMENT EPITHELIAL-CELLS; SHEET TRANSPLANTATION; DELIVERY CARRIERS; IN-VITRO; SCAFFOLDS; RECONSTRUCTION; SURFACES; FABRICATION; ATTACHMENT	Cell sheet-mediated tissue regeneration is a promising approach for corneal reconstruction. However, the fragility of bioengineered corneal endothelial cell (CEC) monolayers allows us to take advantage of cross-linked porous gelatin hydrogels as cell sheet carriers for intraocular delivery. The aim of this study was to further investigate the effects of biopolymer concentrations (5-15 wt%) on the characteristic and safety of hydrogel discs fabricated by a simple stirring process combined with freeze-drying method. Results of scanning electron microscopy, porosity measurements, and ninhydrin assays showed that, with increasing solid content, the pore size, porosity, and cross-linking index of carbodiimide treated samples significantly decreased from 508 +/- 30 to 292 +/- 42 mu m, 59.8 +/- 1.1 to 33.2 +/- 1.9%, and 56.2 +/- 1.6 to 34.3 +/- 1.8%, respectively. The variation in biopolymer concentrations and degrees of cross-linking greatly affects the Young's modulus and swelling ratio of the gelatin carriers. Differential scanning calorimetry measurements and glucose permeation studies indicated that for the samples with a highest solid content, the highest pore wall thickness and the lowest fraction of mobile water may inhibit solute transport. When the biopolymer concentration is in the range of 5-10 wt%, the hydrogels have high freezable water content (0.89-0.93) and concentration of permeated glucose (591.3-615.5 mu g/ml). These features are beneficial to the in vitro cultivation of CECs without limiting proliferation and changing expression of ion channel and pump genes such as ATP1A1, VDAC2, and AQP1. In vivo studies by analyzing the rabbit CEC morphology and count also demonstrate that the implanted gelatin discs with the highest solid content may cause unfavorable tissue-material interactions. It is concluded that the characteristics of cross-linked porous gelatin hydrogel carriers and their triggered biological responses are in relation to biopolymer concentration effects.	[Lai, Jui-Yang; Lai, Meng-Heng; Li, Ya-Ting; Chang, Ren-Jie; Chen, Li-Mei] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan; [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan, Taiwan; [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Ma, David Hui-Kang] Chang Gung Mem Hosp, Dept Ophthalmol, Limbal Stem Cell Lab, Tao Yuan, Taiwan; [Ma, David Hui-Kang] Chang Gung Univ, Dept Chinese Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lai, JY (corresponding author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan.	jylai@mail.cgu.edu.tw	Lai, Jui-Yang/I-1166-2017	Lai, Jui-Yang/0000-0002-9227-8549	Chang Gung Memorial Hospital [CMRPD190431]; National Science Council of the Republic of China [NSC100-2628-E-182-004-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant CMRPD190431 from the Chang Gung Memorial Hospital and grant NSC100-2628-E-182-004-MY3 from the National Science Council of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao B, 2011, MACROMOL BIOSCI, V11, P427, DOI 10.1002/mabi.201000389; Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4; CRAWFORD KM, 1995, INVEST OPHTH VIS SCI, V36, P1317; Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]; Elbert DL, 2011, ACTA BIOMATER, V7, P31, DOI 10.1016/j.actbio.2010.07.028; Faroongsarng D, 2008, INT J PHARMACEUT, V352, P152, DOI 10.1016/j.ijpharm.2007.10.022; Goh YQ, 2008, J MATER SCI-MATER M, V19, P2445, DOI 10.1007/s10856-008-3366-9; Gutierrez MC, 2007, ADV FUNCT MATER, V17, P3505, DOI 10.1002/adfm.200700093; Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c; Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000; Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005; Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8; Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060; Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441; Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575; Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753; Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012; Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873; Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a; Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085; Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256; Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024; Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3; Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f; Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980; Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442; Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; Lai JY, 2005, AM J OPHTHALMOL, V139, P1123, DOI 10.1016/j.ajo.2004.11.052; Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695; Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034; Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W; Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Nitschke M, 2007, J BIOMED MATER RES A, V80A, P1003, DOI 10.1002/jbm.a.31098; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o; Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Zhang F, 2011, INT J BIOL MACROMOL, V48, P474, DOI 10.1016/j.ijbiomac.2011.01.012	46	75	77	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54058	10.1371/journal.pone.0054058	http://dx.doi.org/10.1371/journal.pone.0054058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382866	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800030
J	Lilja, AM; Luo, Y; Yu, QS; Rojdner, J; Li, YZ; Marini, AM; Marutle, A; Nordberg, A; Greig, NH				Lilja, Anna M.; Luo, Yu; Yu, Qian-sheng; Rojdner, Jennie; Li, Yazhou; Marini, Ann M.; Marutle, Amelia; Nordberg, Agneta; Greig, Nigel H.			Neurotrophic and Neuroprotective Actions of (-)- and (+)-Phenserine, Candidate Drugs for Alzheimer's Disease	PLOS ONE			English	Article							BRAIN; PROTEIN; NEUROGENESIS; DOUBLECORTIN; HIPPOCAMPAL; PATHWAYS; NEURONS; BIOLOGY; DEATH; MEK2	Neuronal dysfunction and demise together with a reduction in neurogenesis are cardinal features of Alzheimer's disease (AD) induced by a combination of oxidative stress, toxic amyloid-beta peptide (A beta) and a loss of trophic factor support. Amelioration of these was assessed with the Ab lowering A beta experimental drugs (+)-phenserine and (-)-phenserine in neuronal cultures, and actions in mice were evaluated with (+)-phenserine. Both experimental drugs together with the metabolite N1-norphenserine induced neurotrophic actions in human SH-SY5Y cells that were mediated by the protein kinase C (PKC) and extracellular signal-regulated kinases (ERK) pathways, were evident in cells expressing amyloid precursor protein Swedish mutation (APP(SWE)), and retained in the presence of A beta and oxidative stress challenge. (+)-Phenserine, together with its (2) enantiomer as well as its N1- and N8-norphenserine and N1,N8-bisnorphenserine metabolites, likewise provided neuroprotective activity against oxidative stress and glutamate toxicity via the PKC and ERK pathways. These neurotrophic and neuroprotective actions were evident in primary cultures of subventricular zone (SVZ) neural progenitor cells, whose neurosphere size and survival were augmented by (+)-phenserine. Translation of these effects in vivo was assessed in wild type and AD APP(swe) transgenic (Tg2576) mice by doublecortin (DCX) immunohistochemical analysis of neurogenesis in the SVZ, which was significantly elevated by 16 day systemic (+)-phenserine treatment, in the presence of a (+)-phenserine-induced elevation in brain-derived neurotrophic factor (BDNF).	[Lilja, Anna M.; Rojdner, Jennie; Marutle, Amelia; Nordberg, Agneta] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Neurobiol Ctr, Stockholm, Sweden; [Lilja, Anna M.; Yu, Qian-sheng; Li, Yazhou; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Neurosci Lab, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Luo, Yu] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH USA; [Rojdner, Jennie; Nordberg, Agneta] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA	Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; Karolinska Institutet; Karolinska University Hospital; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Lilja, AM (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Neurobiol Ctr, Stockholm, Sweden.	anna.lilja@ki.se; greign@grc.nia.nih.gov	nordberg, agneta/ABD-2479-2021	Nordberg, Agneta/0000-0001-7345-5151; Luo, Yu/0000-0002-7939-5505	Swedish Medical Research Council [05817]; Stockholm County Council-Karolinska Institutet (ALF grant); Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power; Brain Foundation; Gun and Bertil Stohnes Foundation; Foundation for Old Servants; Magnus Bergvalls Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggma "stare Foundation, KI Foundations; Karolinska Institutet agreement with Johnson Johnson; Alzheimer Association Sweden; Karolinska Institutet KID; Erik and Edith Fernstroms Foundation, Karolinska Insitutet; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council-Karolinska Institutet (ALF grant); Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power; Brain Foundation; Gun and Bertil Stohnes Foundation; Foundation for Old Servants; Magnus Bergvalls Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggma "stare Foundation, KI Foundations; Karolinska Institutet agreement with Johnson Johnson; Alzheimer Association Sweden; Karolinska Institutet KID(Karolinska Institutet); Erik and Edith Fernstroms Foundation, Karolinska Insitutet; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research study was partly funded by the Swedish Medical Research Council (Project no. 05817), Stockholm County Council-Karolinska Institutet (ALF grant), the Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power, the Brain Foundation, Gun and Bertil Stohnes Foundation, the Foundation for Old Servants, the Magnus Bergvalls Foundation, The Dementia Association, The Lars Hierta Memorial Foundation, Olle Engkvist Byggma "stare Foundation, KI Foundations, Karolinska Institutet agreement with Johnson & Johnson, and Alzheimer Association Sweden. A. M. L was supported by a PhD scholarship from Karolinska Institutet KID-funding, as well as Erik and Edith Fernstroms Foundation, Karolinska Insitutet for her stay at National Institutes of Health. This work was also supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Becker RE, 2012, ALZHEIMERS DEMENT; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Claeysen S, 2012, CELL SIGNAL; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Corbett A, 2012, EXPERT OPIN EMERG DR, V17, P147, DOI 10.1517/14728214.2012.675327; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Jonsson L, 2009, PHARMACOECONOMICS, V27, P391, DOI 10.2165/00019053-200927050-00004; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Lahiri Debomoy K., 2006, Current Alzheimer Research, V3, P475, DOI 10.2174/156720506779025224; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LAMBERT DG, 1990, PROG BRAIN RES, V84, P31; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maccecchini ML, 2012, J NEUROL NEUROSURG P; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Perry EK, 2012, NEUROBIOL DIS; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Pouryamout L, 2012, DRUGS, V72, P789, DOI 10.2165/11631830-000000000-00000; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Sambamurti Kumar, 2006, Current Alzheimer Research, V3, P81, DOI 10.2174/156720506775697142; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Skarpen E, 2008, FASEB J, V22, P466, DOI 10.1096/fj.07-8650com; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Sugaya K, 2007, CURR ALZHEIMER RES, V4, P370, DOI 10.2174/156720507781788936; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Wicklund L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015600; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Yu QS, 2013, ANTIINFLAMM IN PRESS; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	59	39	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54887	10.1371/journal.pone.0054887	http://dx.doi.org/10.1371/journal.pone.0054887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382994	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800087
J	Loh, NY; Bentley, L; Dimke, H; Verkaart, S; Tammaro, P; Gorvin, CM; Stechman, MJ; Ahmad, BN; Hannan, FM; Piret, SE; Evans, H; Bellantuono, I; Hough, TA; Fraser, WD; Hoenderop, JGJ; Ashcroft, FM; Brown, SDM; Bindels, RJM; Cox, RD; Thakker, RV				Loh, Nellie Y.; Bentley, Liz; Dimke, Henrik; Verkaart, Sjoerd; Tammaro, Paolo; Gorvin, Caroline M.; Stechman, Michael J.; Ahmad, Bushra N.; Hannan, Fadil M.; Piret, Sian E.; Evans, Holly; Bellantuono, Ilaria; Hough, Tertius A.; Fraser, William D.; Hoenderop, Joost G. J.; Ashcroft, Frances M.; Brown, Steve D. M.; Bindels, Rene J. M.; Cox, Roger D.; Thakker, Rajesh V.			Autosomal Dominant Hypercalciuria in a Mouse Model Due to a Mutation of the Epithelial Calcium Channel, TRPV5	PLOS ONE			English	Article							CA2+ CHANNEL; SENSING RECEPTOR; IDIOPATHIC HYPERCALCIURIA; ABSORPTIVE HYPERCALCIURIA; TRANSPORT PROTEINS; PLASMA-MEMBRANE; BONE-RESORPTION; XENOPUS OOCYTES; KNOCKOUT MICE; VITAMIN-D	Hypercalciuria is a major cause of nephrolithiasis, and is a common and complex disorder involving genetic and environmental factors. Identification of genetic factors for monogenic forms of hypercalciuria is hampered by the limited availability of large families, and to facilitate such studies, we screened for hypercalciuria in mice from an N-ethyl-N-nitrosourea mutagenesis programme. We identified a mouse with autosomal dominant hypercalciuria (HCALC1). Linkage studies mapped the Hcalc1 locus to a 11.94 Mb region on chromosome 6 containing the transient receptor potential cation channel, subfamily V, members 5 (Trpv5) and 6 (Trpv6) genes. DNA sequence analysis of coding regions, intron-exon boundaries and promoters of Trpv5 and Trpv6 identified a novel T to C transition in codon 682 of TRPV5, mutating a conserved serine to a proline (S682P). Compared to wild-type littermates, heterozygous (Trpv5(682P/+)) and homozygous (Trpv5(682P/682P)) mutant mice had hypercalciuria, polyuria, hyperphosphaturia and a more acidic urine, and similar to 10% of males developed tubulointerstitial nephritis. Trpv5(682P/682P) mice also had normal plasma parathyroid hormone but increased 1,25-dihydroxyvitamin D-3 concentrations without increased bone resorption, consistent with a renal defect for the hypercalciuria. Expression of the S682P mutation in human embryonic kidney cells revealed that TRPV5-S682P-expressing cells had a lower baseline intracellular calcium concentration than wild-type TRPV5-expressing cells, suggesting an altered calcium permeability. Immunohistological studies revealed a selective decrease in TRPV5-expression from the renal distal convoluted tubules of Trpv5(682P/+) and Trpv5(682P/682P) mice consistent with a trafficking defect. In addition, Trpv5(682P/682P) mice had a reduction in renal expression of the intracellular calcium-binding protein, calbindin-D-28K, consistent with a specific defect in TRPV5-mediated renal calcium reabsorption. Thus, our findings indicate that the TRPV5 S682P mutant is functionally significant and study of HCALC1, a novel model for autosomal dominant hypercalciuria, may help further our understanding of renal calcium reabsorption and hypercalciuria.	[Loh, Nellie Y.; Gorvin, Caroline M.; Stechman, Michael J.; Ahmad, Bushra N.; Hannan, Fadil M.; Piret, Sian E.; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, OCDEM, Nuffield Dept Med,Acad Endocrine Unit, Oxford, England; [Bentley, Liz; Hough, Tertius A.; Brown, Steve D. M.; Cox, Roger D.] MRC, Mammalian Genet Unit, Harwell, Oxon, England; [Bentley, Liz; Hough, Tertius A.; Brown, Steve D. M.; Cox, Roger D.] MRC, Mary Lyon Ctr, Harwell, Oxon, England; [Dimke, Henrik; Verkaart, Sjoerd; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Tammaro, Paolo; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Evans, Holly; Bellantuono, Ilaria] Univ Sheffield, Sch Med, Acad Unit Bone Biol, Sheffield, S Yorkshire, England; [Fraser, William D.] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	University of Oxford; Radboud University Nijmegen; University of Oxford; University of Sheffield; University of East Anglia	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, OCDEM, Nuffield Dept Med,Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Hoenderop, Joost G.J./H-8047-2014; Dimke, Henrik/M-3319-2019; Bindels, René JM/B-9824-2013; Gorvin, Caroline/T-2406-2019; Dimke, Henrik/G-7970-2011	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Gorvin, Caroline/0000-0002-1361-9174; Dimke, Henrik/0000-0002-9170-2168; Tammaro, Paolo/0000-0002-6183-8187; Bellantuono, Ilaria/0000-0001-9994-6987; Hannan, Fadil/0000-0002-2975-5170; Thakker, Rajesh/0000-0002-1438-3220; Cox, Roger/0000-0001-7170-5014; Piret, Sian/0000-0002-3586-7654	European Union; EuReGene Framework Programme 6; Medical Research Council UK; Kidney Research UK; Wellcome Trust; Glaxo SmithKline; University of Oxford; European Young Investigator award; Dutch Kidney Foundation [C05.2134]; GlaxoSmithKline; MRC [G0600702, G9825289, MC_UP_1502/1, MC_U142684172, MC_U142661184, G1000467] Funding Source: UKRI; Kidney Research UK [RP52/2012] Funding Source: researchfish; Medical Research Council [G1000467, G9825289, MC_U142661184, G0600702, MC_U142684172, MC_UP_1502/1] Funding Source: researchfish	European Union(European Commission); EuReGene Framework Programme 6; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Wellcome Trust(Wellcome Trust); Glaxo SmithKline(GlaxoSmithKline); University of Oxford; European Young Investigator award; Dutch Kidney Foundation; GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by grants from the European Union, EuReGene Framework Programme 6, the Medical Research Council UK, Kidney Research UK, the Wellcome Trust, Glaxo SmithKline, and the University of Oxford, European Young Investigator award, and the Dutch Kidney Foundation C05.2134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ENU mutagenesis programme at the MRC unit at Harwell had originally received funding from GlaxoSmithKline. However, there has been no further funding from GlaxoSmithKline for similar to 10 years, and the authors acknowledged their funding at the set up as a matter of courtesy. The data and materials are freely available without commercial links. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Chamoux E, 2010, J BIOL CHEM, V285, P25354, DOI 10.1074/jbc.M109.075234; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Coleman RA, 2000, AM J PHYSIOL-RENAL, V279, pF874, DOI 10.1152/ajprenal.2000.279.5.F874; Eknoyan G, 1999, ATLAS DIS KIDNEY, V2, P61; Embark HM, 2004, CELL PHYSIOL BIOCHEM, V14, P203, DOI 10.1159/000080329; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Gloor JM, 1999, ATLAS DIS KIDNEY, V2, P81; Goldfarb DS, 2005, KIDNEY INT, V67, P1053, DOI 10.1111/j.1523-1755.2005.00170.x; Gong M, 2006, CLIN SCI, V110, P315, DOI 10.1042/CS20050208; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmeister MV, 2011, ADV EXP MED BIOL, V704, P277, DOI 10.1007/978-94-007-0265-3_15; Hong CJ, PLOS ONE, V5; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Lieben Liesbet, 2012, Front Endocrinol (Lausanne), V3, P99, DOI 10.3389/fendo.2012.00099; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Loh NY, 2000, J CELL SCI, V113, P2715; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Muller D, 2002, NEPHROL DIAL TRANSPL, V17, P1614, DOI 10.1093/ndt/17.9.1614; Na T, 2009, AM J PHYSIOL-RENAL, V296, pF1042, DOI 10.1152/ajprenal.90771.2008; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Noveroske JK, 2000, MAMM GENOME, V11, P478, DOI 10.1007/s003350010093; PAK CYC, 1975, NEW ENGL J MED, V292, P497, DOI 10.1056/NEJM197503062921002; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Reed BY, 1999, J CLIN ENDOCR METAB, V84, P3907, DOI 10.1210/jc.84.11.3907; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Renkema KY, 2005, J AM SOC NEPHROL, V16, P3188, DOI 10.1681/ASN.2005060632; Rio DC, 2010, COLD SPRING HARB PRO; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Slingerland AS, 2006, REV ENDOCR METAB DIS, V7, P171, DOI 10.1007/s11154-006-9014-0; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Stechman MJ, 2009, PEDIATR NEPHROL, V24, P2321, DOI 10.1007/s00467-008-0807-0; Suzuki Y, 2008, HUM MOL GENET, V17, P1613, DOI 10.1093/hmg/ddn048; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; VanBaal J, 1996, AM J PHYSIOL-RENAL, V271, pF985, DOI 10.1152/ajprenal.1996.271.5.F985; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vezzoli G, 2011, KIDNEY INT, V80, P587, DOI 10.1038/ki.2010.430; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005; Wu F, 2009, NEPHRON PHYSIOL, V112, pP53, DOI 10.1159/000225944	62	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55412	10.1371/journal.pone.0055412	http://dx.doi.org/10.1371/journal.pone.0055412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383183	Green Published, gold, Green Accepted			2022-12-25	WOS:000315563800152
J	Raterman, EL; Welch, RA				Raterman, Erica L.; Welch, Rodney A.			Chemoreceptors of Escherichia coli CFT073 Play Redundant Roles in Chemotaxis toward Urine	PLOS ONE			English	Article							AMINO-ACIDS; TRACT-INFECTIONS; COLONIZATION; SUGARS; AEROTAXIS; EXCRETION; VIRULENCE; CAFFEINE; MOTILITY; GENES	Community-acquired urinary tract infections (UTIs) are commonly caused by uropathogenic Escherichia coli (UPEC). We hypothesize that chemotaxis toward ligands present in urine could direct UPEC into and up the urinary tract. Wild-type E. coli CFT073 and chemoreceptor mutants with tsr, tar, or aer deletions were tested for chemotaxis toward human urine in the capillary tube assay. Wild-type CFT073 was attracted toward urine, and Tsr and Tar were the chemoreceptors mainly responsible for mediating this response. The individual components of urine including L-amino acids, D-amino acids and various organic compounds were also tested in the capillary assay with wild-type CFT073. Our results indicate that CFT073 is attracted toward some L- amino acids and possibly toward some D-amino acids but not other common compounds found in urine such as urea, creatinine and glucuronic acid. In the murine model of UTI, the loss of any two chemoreceptors did not affect the ability of the bacteria to compete with the wild-type strain. Our data suggest that the presence of any strong attractant and its associated chemoreceptor might be sufficient for colonization of the urinary tract and that amino acids are the main chemoattractants for E. coli strain CFT073 in this niche.	[Raterman, Erica L.; Welch, Rodney A.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Welch, RA (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	rawelch@wisc.edu			National Institutes of Health [R01 DK063250-06]; National Research Service [AI55397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Institutes of Health Grant R01 DK063250-06 and by the National Institutes of Health, National Research Service Award AI55397. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; ADLER J, 1974, P NATL ACAD SCI USA, V71, P2895, DOI 10.1073/pnas.71.7.2895; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Alphen LBv, 2008, CELL MICROBIOL, V10, P53; ARMSTRONG D W, 1991, Amino Acids (Vienna), V1, P97, DOI 10.1007/BF00808096; Bacheller CD, 1997, MED CLIN N AM, V81, P719, DOI 10.1016/S0025-7125(05)70542-3; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; BLACK RA, 1983, J BACTERIOL, V153, P1187, DOI 10.1128/JB.153.3.1187-1195.1983; BRAUN P, 1955, Acta Med Acad Sci Hung, V7, P147; BRUCKNER H, 1994, AMINO ACIDS, V6, P205, DOI 10.1007/BF00805848; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Chambaz A, 2001, INT J SPORTS MED, V22, P366, DOI 10.1055/s-2001-15646; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donnenberg M.S., 1996, URINARY TRACT INFECT, P135; Eisenbach M, 2007, J CELL PHYSIOL, V213, P574, DOI 10.1002/jcp.21238; Freter R, 1981, Ciba Found Symp, V80, P36; Gosink KK, 2006, J BACTERIOL, V188, P3487, DOI 10.1128/JB.188.10.3487-3493.2006; Greco FA, 2009, AMINOACIDURIA; Huang Y, 1998, BIOL PHARM BULL, V21, P156, DOI 10.1248/bpb.21.156; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kato S, 2010, J CHROMATOGR B; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lane MC, 2006, J BACTERIOL, V188, P5618, DOI 10.1128/JB.00449-06; LEE A, 1986, INFECT IMMUN, V51, P536, DOI 10.1128/IAI.51.2.536-546.1986; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lux R, 1999, MOL BIOL CELL, V10, P1133, DOI 10.1091/mbc.10.4.1133; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Moran VH, 2001, J ENDOCRINOL, V170, P157, DOI 10.1677/joe.0.1700157; MUNION GL, 1983, J SURG RES, V35, P507, DOI 10.1016/0022-4804(83)90040-9; MURAD F, 1972, NEW ENGL J MED, V286, P1382, DOI 10.1056/NEJM197206292862604; Orenstein R, 1999, AM FAM PHYSICIAN, V59, P1225; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; PeaceHealth, CAT UR; Putnam D. F., 1971, COMPOSITION CONCENTR; Redford P, 2006, INFECT IMMUN, V74, P4030, DOI 10.1128/IAI.01984-05; Schwan WR, 2008, INT J MED MICROBIOL, V298, P441, DOI 10.1016/j.ijmm.2007.05.009; Slocum RH, 1991, TECHNIQUES DIAGNOSTI, P87; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Weimann A, 2005, J MASS SPECTROM, V40, P307, DOI 10.1002/jms.785; Yamamoto Shingo, 2007, Journal of Infection and Chemotherapy, V13, P68, DOI 10.1007/s10156-007-0506-y; Yao J, 2007, J BACTERIOL, V189, P6415, DOI 10.1128/JB.00398-07; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; YOUNG SE, 1967, CANCER RES, V27, P15; Zhang HW, 1999, ANAL CHEM, V71, P3955, DOI 10.1021/ac990162h	50	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54133	10.1371/journal.pone.0054133	http://dx.doi.org/10.1371/journal.pone.0054133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382874	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800034
J	Barnett, J; Vasileiou, K; Gowland, MH; Raats, MM; Lucas, JS				Barnett, Julie; Vasileiou, Konstantina; Gowland, M. Hazel; Raats, Monique M.; Lucas, Jane S.			Beyond Labelling: What Strategies Do Nut Allergic Individuals Employ to Make Food Choices? A Qualitative Study	PLOS ONE			English	Article							PEANUT ALLERGY; PSYCHOLOGICAL BURDEN; OF-LIFE; CHILDREN; PREVALENCE; PARENTS; ADOLESCENTS; ADULTS; RISK	Objective: Food labelling is an important tool that assists people with peanut and tree nut allergies to avoid allergens. Nonetheless, other strategies are also developed and used in food choice decision making. In this paper, we examined the strategies that nut allergic individuals deploy to make safe food choices in addition to a reliance on food labelling. Methods: Three qualitative methods: an accompanied shop, in-depth semi-structured interviews, and the product choice reasoning task - were used with 32 patients that had a clinical history of reactions to peanuts and/or tree nuts consistent with IgE-mediated food allergy. Thematic analysis was applied to the transcribed data. Results: Three main strategies were identified that informed the risk assessments and food choice practices of nut allergic individuals. These pertained to: (1) qualities of product such as the product category or the country of origin, (2) past experience of consuming a food product, and (3) sensory appreciation of risk. Risk reasoning and risk management behaviours were often contingent on the context and other physiological and socio-psychological needs which often competed with risk considerations. Conclusions: Understanding and taking into account the complexity of strategies and the influences of contextual factors will allow healthcare practitioners, allergy nutritionists, and caregivers to advise and educate patients more effectively in choosing foods safely. Governmental bodies and policy makers could also benefit from an understanding of these food choice strategies when risk management policies are designed and developed.	[Barnett, Julie; Vasileiou, Konstantina] Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England; [Gowland, M. Hazel] Allergy Act, Farnborough, Hants, England; [Raats, Monique M.] Univ Surrey, Fac Arts & Human Sci, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Lucas, Jane S.] Univ Southampton, Fac Med, Univ Hosp Southampton NHS Fdn Trust, Southampton SO9 5NH, Hants, England	Brunel University; University of Surrey; University of Southampton; University Hospital Southampton NHS Foundation Trust	Barnett, J (corresponding author), Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England.	Julie.Barnett@brunel.ac.uk	Raats, Monique/G-5348-2012; Lucas, Jane S/C-3620-2013	Raats, Monique/0000-0002-8057-2783; Barnett, Julie/0000-0001-5740-0863; Vasileiou, Konstantina/0000-0001-5047-3920; Gowland, M Hazel/0000-0002-5513-5979; Lucas, Jane/0000-0001-8701-9975	United Kingdom Food Standards Agency [T07058]; Anaphylaxis Campaign	United Kingdom Food Standards Agency; Anaphylaxis Campaign	This study was funded by the United Kingdom Food Standards Agency under project code T07058 (http://www.food.gov.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided comment on a full draft of this paper.; We acknowledge the support of the Anaphylaxis Campaign and also the contribution of Jo Leftwich and Kate Muncer who collected the data on which the analysis is based.	Al-Muhsen S, 2003, CAN MED ASSOC J, V168, P1279; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Barnett J, 2011, ALLERGY, V66, P969, DOI 10.1111/j.1398-9995.2011.02563.x; Barnett J, 2010, T07058 FOOD STAND AG; Barnett Julie, 2012, Clin Transl Allergy, V2, P12, DOI 10.1186/2045-7022-2-12; Barnett J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-734; Ben-Shoshan M, 2009, J ALLERGY CLIN IMMUN, V123, P783, DOI 10.1016/j.jaci.2009.02.004; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Connors M, 2001, APPETITE, V36, P189, DOI 10.1006/appe.2001.0400; Cornelisse-Vermaat JR, 2008, EUR J PUBLIC HEALTH, V18, P115, DOI 10.1093/eurpub/ckm032; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; Enright G, 2010, QUALITATIVE RES EXPL; Ericsson K. A., 1984, PROTOCOL ANAL VERBAL; Falk LW, 1996, J NUTR EDUC, V28, P257; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; Gallagher M, 2011, CLIN EXP ALLERGY, V41, P869, DOI 10.1111/j.1365-2222.2011.03743.x; Gallagher M, 2009, ALLERGY, V64, P1117, DOI 10.1111/j.1398-9995.2009.02065.x; Green JM, 2003, HEALTH RISK SOC, V5, P33, DOI 10.1080/1369857031000065998; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Higginson C. S., 2002, Nutrition & Food Science, V32, P92, DOI 10.1108/00346650210423392; Horlick-Jones T, 2007, HEALTH RISK SOC, V9, P83, DOI 10.1080/13698570601181623; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P634, DOI [10.1111/j.1365-2222.1997.tb01190.x, 10.1046/j.1365-2222.1997.d01-559.x]; Joshi P, 2002, J ALLERGY CLIN IMMUN, V109, P1019, DOI 10.1067/mai.2002.123305; Leftwich J, 2011, CLIN EXP ALLERGY, V41, P243, DOI 10.1111/j.1365-2222.2010.03649.x; Lupton DA, 2005, SOCIOL HEALTH ILL, V27, P448, DOI 10.1111/j.1467-9566.2005.00451.x; Macadam Clare, 2012, Clin Transl Allergy, V2, P3, DOI 10.1186/2045-7022-2-3; Nielsen J, 2002, NORD C COMP HUM INT; Noimark L, 2009, PEDIATR ALLERGY IMMU, V20, P500, DOI 10.1111/j.1399-3038.2008.00796.x; Otnes Cele C., 1995, J RETAIL CONSUM SERV, V2, P97; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pieretti MM, 2009, J ALLERGY CLIN IMMUN, V124, P337, DOI 10.1016/j.jaci.2009.05.032; Primeau MN, 2000, CLIN EXP ALLERGY, V30, P1135, DOI 10.1046/j.1365-2222.2000.00889.x; Pumphrey RSH, 2007, J ALLERGY CLIN IMMUN, V119, P1018, DOI 10.1016/j.jaci.2007.01.021; QSR International Pty Ltd, 2020, NVIVO; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Sampson HA, 1996, BRIT MED J, V312, P1050; Sampson HA, 2002, NEW ENGL J MED, V346, P1294, DOI 10.1056/NEJMcp012667; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; Sommer I, 2012, ALLERGY, V67, P1319, DOI 10.1111/j.1398-9995.2012.02883.x; Teufel M, 2007, WORLD J GASTROENTERO, V13, P3456, DOI 10.3748/wjg.v13.i25.3456; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x	48	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55293	10.1371/journal.pone.0055293	http://dx.doi.org/10.1371/journal.pone.0055293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383141	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000315483200010
J	Lin, HC; Gean, PW; Wang, CC; Chan, YH; Chen, PS				Lin, Hui-Ching; Gean, Po-Wu; Wang, Chao-Chuan; Chan, Yun-Han; Chen, Po See			The Amygdala Excitatory/Inhibitory Balance in a Valproate-Induced Rat Autism Model	PLOS ONE			English	Article							PRENATAL EXPOSURE; ANIMAL-MODEL; SYNAPTIC PLASTICITY; SOCIAL-BEHAVIOR; IN-VIVO; BRAIN; FEAR; ACID; CHILDREN; ADOLESCENTS	The amygdala is an important structure contributing to socio-emotional behavior. However, the role of the amygdala in autism remains inconclusive. In this study, we used the 28-35 days valproate (VPA)-induced rat model of autism to observe the autistic phenotypes and evaluate their synaptic characteristics in the lateral nucleus (LA) of the amygdala. The VPA-treated offspring demonstrated less social interaction, increased anxiety, enhanced fear learning and impaired fear memory extinction. Slice preparation and electrophysiological recordings of the amygdala showed significantly enhanced long-term potentiation (LTP) while stimulating the thalamic-amygdala pathway of the LA. In addition, the pair pulse facilitation (PPF) at 30- and 60-ms intervals decreased significantly. Whole-cell recordings of the LA pyramidal neurons showed an increased miniature excitatory postsynaptic current (EPSC) frequency and amplitude. The relative contributions of the AMPA receptor and NMDA receptor to the EPSCs did not differ significantly between groups. These results suggested that the enhancement of the presynaptic efficiency of excitatory synaptic transmission might be associated with hyperexcitibility and enhanced LTP in LA pyramidal neurons. Disruption of the synaptic excitatory/inhibitory (E/I) balance in the LA of VPA-treated rats might play certain roles in the development of behaviors in the rat that may be relevant to autism. Further experiments to demonstrate the direct link are warranted.	[Lin, Hui-Ching] Natl Yang Ming Univ, Sch Med, Dept & Inst Physiol, Taipei 112, Taiwan; [Lin, Hui-Ching] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Gean, Po-Wu; Chan, Yun-Han] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Wang, Chao-Chuan] Kaohsiung Med Univ, Coll Med, Dept Anat, Kaohsiung, Taiwan; [Chan, Yun-Han] Ctr Drug Evaluat, Taipei, Taiwan; [Chen, Po See] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan 70101, Taiwan; [Chen, Po See] Natl Cheng Kung Univ, Addict Res Ctr, Tainan 70101, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chen, PS (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan 70101, Taiwan.	chenps@mail.ncku.edu.tw	Chen, Po See/AAA-6492-2021	Lin, Hui-Ching/0000-0002-1639-9293	National Science Council, Taiwan [NSC 99-2628-B-006-013, NSC 96-2314-B-006-056, NSC 100-2320-B-010-033-MY2]; Aim for the Top University Plan from the National Cheng Kung University; Aim for the Top University Plan from the National Yang-Ming University; National Cheng Kung Hospital [NCKUH-10005008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan from the National Cheng Kung University; Aim for the Top University Plan from the National Yang-Ming University; National Cheng Kung Hospital	Funding provided by the National Science Council, Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7; NSC 99-2628-B-006-013, NSC 96-2314-B-006-056, NSC 100-2320-B-010-033-MY2); Aim for the Top University Plan from the National Cheng Kung University (http://top-en.ncku.edu.tw/bin/home.php); Aim for the Top University Plan from the National Yang-Ming University (http://www.ym.edu.tw/top/eng/index.html); and National Cheng Kung Hospital (http://www.hosp.ncku.edu.tw/nckm/english/HomeStyle.aspx?Type=11&ContentPage=0; NCKUH-10005008). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2006, PROG BRAIN RES, V156, P363, DOI 10.1016/S0079-6123(06)56020-0; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barad M, 2006, BIOL PSYCHIAT, V60, P322, DOI 10.1016/j.biopsych.2006.05.029; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Becker B, 2012, BIOL PSYCHIAT, V72, P70, DOI 10.1016/j.biopsych.2011.11.024; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Blair RJR, 2006, J CHILD PSYCHOL PSYC, V47, P262, DOI 10.1111/j.1469-7610.2006.01596.x; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Chiao JY, 2008, J COGNITIVE NEUROSCI, V20, P2167, DOI 10.1162/jocn.2008.20151; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Cottraux J, 2005, CURR OPIN PSYCHIATR, V18, P51; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Damsa C, 2005, CURR OPIN PSYCHIATR, V18, P55; Du J, 2008, J NEUROSCI, V28, P68, DOI 10.1523/JNEUROSCI.3080-07.2008; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Evans DW, 2005, CHILD PSYCHIAT HUM D, V36, P3, DOI 10.1007/s10578-004-3619-x; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Gadziola MA, 2012, J NEUROPHYSIOL, V107, P1047, DOI 10.1152/jn.00422.2011; Genton P, 2006, DRUG SAFETY, V29, P1, DOI 10.2165/00002018-200629010-00001; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; HERITCH AJ, 1990, J PSYCHIAT RES, V24, P251, DOI 10.1016/0022-3956(90)90014-H; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kataoka S, 2011, INT J NEURO IN PRESS; Keightley ML, 2007, SOC COGN AFFECT NEUR, V2, P292, DOI 10.1093/scan/nsm024; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kleinhans NM, 2010, NEUROPSYCHOLOGIA, V48, P3665, DOI 10.1016/j.neuropsychologia.2010.07.022; Kuzmanovic B., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lin HC, 2011, J NEUROSCI, V31, P8851, DOI 10.1523/JNEUROSCI.0979-11.2011; Lin HC, 2010, INT J NEUROPSYCHOPH, V13, P335, DOI 10.1017/S1461145709990678; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Miyazaki K, 2005, INT J DEV NEUROSCI, V23, P287, DOI 10.1016/j.ijdevneu.2004.05.004; Muscatell KA, 2012, NEUROIMAGE, V60, P1771, DOI 10.1016/j.neuroimage.2012.01.080; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nelson ED, 2011, J NEUROPHYSIOL, V106, P193, DOI 10.1152/jn.00751.2010; Pejic T, 2011, SOCIAL COGN IN PRESS; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rojas DC, 2004, AM J PSYCHIAT, V161, P2038, DOI 10.1176/appi.ajp.161.11.2038; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Schneider T, 2007, PSYCHOPHARMACOLOGY, V193, P547, DOI 10.1007/s00213-007-0795-y; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Todd RM, 2009, NAT NEUROSCI, V12, P1217, DOI 10.1038/nn1009-1217; Tsuchiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003892; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walcott EC, 2011, J NEUROSCI, V31, P13097, DOI 10.1523/JNEUROSCI.1341-11.2011; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Whalley K, 2012, NAT REV NEUROSCI, V13, DOI 10.1038/nrn3163; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x	75	44	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55248	10.1371/journal.pone.0055248	http://dx.doi.org/10.1371/journal.pone.0055248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383124	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200059
J	Batary, P; Sutcliffe, L; Dormann, CF; Tscharntke, T				Batary, Perer; Sutcliffe, Laura; Dormann, Carsten F.; Tscharntke, Teja			Organic Farming Favours Insect-Pollinated over Non-Insect Pollinated Forbs in Meadows and Wheat Fields	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; PROMOTING BIODIVERSITY; FARMLAND BIODIVERSITY; LANDSCAPE COMPLEXITY; CEREAL FIELDS; DIVERSITY; PLANT; BEES; MANAGEMENT; CROPS	The aim of this study was to determine the relative effects of landscape-scale management intensity, local management intensity and edge effect on diversity patterns of insect-pollinated vs. non-insect pollinated forbs in meadows and wheat fields. Nine landscapes were selected differing in percent intensively used agricultural area (IAA), each with a pair of organic and conventional winter wheat fields and a pair of organic and conventional meadows. Within fields, forbs were surveyed at the edge and in the interior. Both diversity and cover of forbs were positively affected by organic management in meadows and wheat fields. This effect, however, differed significantly between pollination types for species richness in both agroecosystem types (i.e. wheat fields and meadows) and for cover in meadows. Thus, we show for the first time in a comprehensive analysis that insect-pollinated plants benefit more from organic management than non-insect pollinated plants regardless of agroecosystem type and landscape complexity. These benefits were more pronounced in meadows than wheat fields. Finally, the community composition of insect-pollinated and non-insect-pollinated forbs differed considerably between management types. In summary, our findings in both agroecosystem types indicate that organic management generally supports a higher species richness and cover of insect-pollinated plants, which is likely to be favourable for the density and diversity of bees and other pollinators.	[Batary, Perer; Sutcliffe, Laura; Tscharntke, Teja] Univ Gottingen, D-37073 Gottingen, Germany; [Batary, Perer] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Dormann, Carsten F.] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Dormann, Carsten F.] Univ Freiburg, D-79106 Freiburg, Germany	University of Gottingen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg	Batary, P (corresponding author), Univ Gottingen, D-37073 Gottingen, Germany.	pbatary@gmail.com	Tscharntke, Teja/N-5123-2014; Sutcliffe, Laura/AAF-6241-2020; Batáry, Péter/A-2349-2008	Batáry, Péter/0000-0002-1017-6996; Dormann, Carsten/0000-0002-9835-1794	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [DFG BA 4438/1-1]; University of Gottingen	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Gottingen	P.B. was supported by the Alexander von Humboldt Foundation and during the preparation of the paper by the Deutsche Forschungsgemeinschaft (DFG BA 4438/1-1). The publication was funded by the University of Gottingen in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengot L, 2011, AGR ECOSYST ENVIRON, V142, P311, DOI 10.1016/j.agee.2011.06.001; Batary P, 2012, AGR ECOSYST ENVIRON, V146, P130, DOI 10.1016/j.agee.2011.10.018; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2010, AGR ECOSYST ENVIRON, V136, P35, DOI 10.1016/j.agee.2009.11.004; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Caballero-Lopez B, 2010, AGR ECOSYST ENVIRON, V137, P288, DOI 10.1016/j.agee.2010.02.014; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6; Ekroos J, 2010, AGR ECOSYST ENVIRON, V135, P288, DOI 10.1016/j.agee.2009.10.007; Flohre A, 2011, ECOL APPL, V21, P1772, DOI 10.1890/10-0645.1; Gabriel D, 2005, PERSPECT PLANT ECOL, V7, P85, DOI 10.1016/j.ppees.2005.04.001; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Guerrero I, 2010, AGR ECOSYST ENVIRON, V138, P103, DOI 10.1016/j.agee.2010.04.006; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Jose-Maria L, 2011, AGR ECOSYST ENVIRON, V145, P77, DOI 10.1016/j.agee.2010.12.020; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Klotz F., 2002, BIOLFLOR DATENBANK B; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Kovacs-Hostyanszki A, 2011, AGR ECOSYST ENVIRON, V141, P296, DOI 10.1016/j.agee.2011.03.004; Krauss J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019502; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Oksanen J., 2011, VEGAN PACKAGE COMMUN; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pinheiro J., 2011, NLME PACKAGE LINEAR; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Power EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038073; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; Romero A, 2008, AGR ECOSYST ENVIRON, V124, P97, DOI 10.1016/j.agee.2007.08.002; Smith H. G., 2010, Aspects of Applied Biology, P225; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Whittingham MJ, 2011, J APPL ECOL, V48, P509, DOI 10.1111/j.1365-2664.2011.01987.x	42	28	30	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54818	10.1371/journal.pone.0054818	http://dx.doi.org/10.1371/journal.pone.0054818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382979	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500031
J	de Andres, MC; Kingham, E; Imagawa, K; Gonzalez, A; Roach, HI; Wilson, DI; Oreffo, ROC				de Andres, Maria C.; Kingham, Emmajayne; Imagawa, Kei; Gonzalez, Antonio; Roach, Helmtrud I.; Wilson, David I.; Oreffo, Richard O. C.			Epigenetic Regulation during Fetal Femur Development: DNA Methylation Matters	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MARROW STROMAL CELLS; ADULT HUMAN BONE; GENE-TRANSCRIPTION; OSTEOCALCIN GENE; CPG SITES; EXPRESSION; MICE; ACTIVATION; PROMOTER	Epigenetic modifications are heritable changes in gene expression without changes in DNA sequence. DNA methylation has been implicated in the control of several cellular processes including differentiation, gene regulation, development, genomic imprinting and X-chromosome inactivation. Methylated cytosine residues at CpG dinucleotides are commonly associated with gene repression; conversely, strategic loss of methylation during development could lead to activation of lineage-specific genes. Evidence is emerging that bone development and growth are programmed; although, interestingly, bone is constantly remodelled throughout life. Using human embryonic stem cells, human fetal bone cells (HFBCs), adult chondrocytes and STRO-1(+) marrow stromal cells from human bone marrow, we have examined a spectrum of developmental stages of femur development and the role of DNA methylation therein. Using pyrosequencing methodology we analysed the status of methylation of genes implicated in bone biology; furthermore, we correlated these methylation levels with gene expression levels using qRT-PCR and protein distribution during fetal development evaluated using immunohistochemistry. We found that during fetal femur development DNA methylation inversely correlates with expression of genes including iNOS (NOS2) and COL9A1, but not catabolic genes including MMP13 and IL1B. Furthermore, significant demethylation was evident in the osteocalcin promoter between the fetal and adult developmental stages. Increased TET1 expression and decreased expression of DNA (cytosine-5(-))-methyltransferase 1 (DNMT1) in adult chondrocytes compared to HFBCs could contribute to the loss of methylation observed during fetal development. HFBC multipotency confirms these cells to be an ideal developmental system for investigation of DNA methylation regulation. In conclusion, these findings demonstrate the role of epigenetic regulation, specifically DNA methylation, in bone development, informing and opening new possibilities in development of strategies for bone repair/tissue engineering.	[de Andres, Maria C.; Kingham, Emmajayne; Imagawa, Kei; Roach, Helmtrud I.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Southampton, Hants, England; [de Andres, Maria C.; Kingham, Emmajayne; Imagawa, Kei; Roach, Helmtrud I.; Wilson, David I.; Oreffo, Richard O. C.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat Human Dev &, Southampton, Hants, England; [de Andres, Maria C.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Imagawa, Kei] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Oreffo, Richard O. C.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southampton; University of Southampton; Complexo Hospitalario Universitario de Santiago de Compostela; Tohoku University; King Saud University	Oreffo, ROC (corresponding author), Univ Southampton, Bone & Joint Res Grp, Southampton, Hants, England.	roco@soton.ac.uk	Gonzalez, Antonio/C-4444-2008; Wilson, David/A-6264-2010; de Andrés González, M del Carmen/ABD-7612-2021; de+Andrés, María/AAP-1473-2020; Oreffo, Richard OC/A-4615-2011	Gonzalez, Antonio/0000-0002-2624-0606; Wilson, David/0000-0001-8779-2060; de Andrés González, M del Carmen/0000-0003-2260-6356; Oreffo, Richard OC/0000-0001-5995-6726	Wessex Medical Research [M19, BBSRC G006970/1]; Programa Sara Borrell, Instituto de Salud Carlos III, Spain; Comprehensive Local Research Network (National Institute for Health Research Clinical Research Network); Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish; BBSRC [BB/G010579/1] Funding Source: UKRI	Wessex Medical Research; Programa Sara Borrell, Instituto de Salud Carlos III, Spain; Comprehensive Local Research Network (National Institute for Health Research Clinical Research Network); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Grant support from Wessex Medical Research (M19; HIR and RO) and BBSRC G006970/1 (RO). MCA was supported by Programa Sara Borrell, Instituto de Salud Carlos III, Spain. Recruitment for fetal tissues was supported by funding from Comprehensive Local Research Network (National Institute for Health Research Clinical Research Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6; Alizadeh BZ, 2005, ARTHRITIS RHEUM-US, V52, P1437, DOI 10.1002/art.21020; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Arnsdorf EJ, 2010, J BIOMECH, V43, P2881, DOI 10.1016/j.jbiomech.2010.07.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BROWN JP, 1984, LANCET, V1, P1091; CHARTRAIN NA, 1994, J BIOL CHEM, V269, P6765; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; CLARK BD, 1986, NUCLEIC ACIDS RES, V14, P7897, DOI 10.1093/nar/14.20.7897; COLLINOSDOBY P, 1995, J CELL BIOCHEM, V57, P399, DOI 10.1002/jcb.240570305; Corbett SA, 1999, J BONE JOINT SURG BR, V81B, P531, DOI 10.1302/0301-620X.81B3.8852; Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597; da Silva MA, 2009, J ORTHOP RES, V27, P593, DOI 10.1002/jor.20799; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006; Diwan AD, 2000, J BONE MINER RES, V15, P342, DOI 10.1359/jbmr.2000.15.2.342; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; El-Serafi AT, 2011, DIFFERENTIATION, V81, P35, DOI 10.1016/j.diff.2010.09.183; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Hashimoto K, 2007, EPIGENETICS-US, V2, P86, DOI 10.4161/epi.2.2.4203; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Krattinger N, 2011, EUR CELLS MATER, V21, P46, DOI 10.22203/eCM.v021a04; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lanham SA, 2011, EUR CELLS MATER, V22, P332; Lanham Stuart A, 2011, Eur Cell Mater, V22, P321; LEVINE A, 1992, P NATL ACAD SCI USA, V89, P10119, DOI 10.1073/pnas.89.21.10119; Lu TY, 2009, J CELL BIOCHEM, V108, P315, DOI 10.1002/jcb.22256; Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368; Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001; PALMER RMJ, 1993, BIOCHEM BIOPH RES CO, V193, P398, DOI 10.1006/bbrc.1993.1637; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sengupta PK, 1998, BBA-GENE STRUCT EXPR, V1443, P75, DOI 10.1016/S0167-4781(98)00188-2; Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345; Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tardif G, 1997, BIOCHEM J, V323, P13, DOI 10.1042/bj3230013; Turner CH, 1997, BONE, V21, P487, DOI 10.1016/S8756-3282(97)00202-0; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Vickaryous N, 2005, REPROD FERT DEVELOP, V17, P335, DOI 10.1071/RD04133; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Wang FS, 2004, BONE, V35, P114, DOI 10.1016/j.bone.2004.02.012; Wang FS, 2004, ENDOCRINOLOGY, V145, P2148, DOI 10.1210/en.2003-1074; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Zaragoza C, 2006, J CELL SCI, V119, P1896, DOI 10.1242/jcs.02895; Zhang P, 2003, J BIOL CHEM, V278, P117, DOI 10.1074/jbc.M208049200; Zhu W, 2001, J BONE MINER RES, V16, P535, DOI 10.1359/jbmr.2001.16.3.535	63	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54957	10.1371/journal.pone.0054957	http://dx.doi.org/10.1371/journal.pone.0054957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383012	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315211500039
J	Mohanraj, L; Kim, HS; Li, W; Cai, Q; Kim, KE; Shin, HJ; Lee, YJ; Lee, WJ; Kim, JH; Oh, Y				Mohanraj, Lathika; Kim, Ho-Seong; Li, Wei; Cai, Qing; Kim, Ki Eun; Shin, Hye-Jung; Lee, Yong-Jae; Lee, Woo Jung; Kim, Jung Hyun; Oh, Youngman			IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis	PLOS ONE			English	Article							FACTOR-KAPPA-B; VISCERAL FAT ACCUMULATION; IGF-BINDING PROTEIN-3; BODY-MASS INDEX; GROWTH-FACTOR-I; ADIPOSE-TISSUE; CROSS-TALK; OBESITY; DISEASE; ACTIVATION	Metabolic syndrome is associated with visceral obesity, insulin resistance and an increased risk of cardiovascular diseases. Visceral fat tissue primarily consists of adipocytes that secrete cytokines leading to a state of systemic inflammation in obese conditions. One of the IGF-independent functions of IGFBP-3 is its role as an anti-inflammatory molecule. Our study in obese adolescents show a decrease in total IGFBP-3 levels and increase in proteolyzed IGFBP-3 in circulation when compared to their normal counterparts and establishes a positive correlation between IGFBP-3 proteolysis and adiposity parameters as well as insulin resistance. In human adipocytes, we show that IGFBP-3 inhibits TNF-alpha-induced NF-kappa B activity in an IGF-independent manner, thereby restoring the deregulated insulin signaling and negating TNF-alpha-induced inhibition of glucose uptake. IGFBP-3 further inhibits TNF-alpha, CRP and high glucose-induced NF-kappa B activity in human aortic endothelial cells (HAECs) and subsequently suppresses monocyte adhesion to HAEC through the IGFBP-3 receptor. In conclusion, these findings suggest that reduced levels of IGFBP-3 in circulation and reduced expression of IGFBP-3 in macrophages in obesity may result in suppression of its anti-inflammatory functions and therefore IGFBP-3 may present itself as a therapeutic for obesity-induced insulin resistance and for events occurring in the early stages of atherosclerosis.	[Mohanraj, Lathika; Cai, Qing; Oh, Youngman] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA; [Kim, Ho-Seong; Lee, Woo Jung; Kim, Jung Hyun] Yonsei Univ, Coll Med, Inst Endocrinol, Dept Pediat, Seoul, South Korea; [Li, Wei; Oh, Youngman] Biocure Pharma LLC, Richmond, VA USA; [Kim, Ki Eun] CHA Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Shin, Hye-Jung] Natl Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Yong-Jae] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea	Virginia Commonwealth University; Yonsei University; Yonsei University Health System; Pochon Cha University; National Medical Center - Korea; Yonsei University; Yonsei University Health System	Oh, Y (corresponding author), Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA.	yoh@mcvh-vcu.edu		Kim, Ho-Seong/0000-0003-1135-099X; Mohanraj, Lathika/0000-0002-5504-1518	United States Department of Defense (DOD) [PC061151]; Yonsei University College of Medicine-MSD Grant [6-2006-0151]	United States Department of Defense (DOD)(United States Department of Defense); Yonsei University College of Medicine-MSD Grant	This work was supported by United States Department of Defense (DOD) grant (PC061151) to YO and the Yonsei University College of Medicine-MSD Grant (6-2006-0151) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini MG, 2004, J PEDIATR ENDOCR MET, V17, P749; Bang P, 1997, ENDOCRINOLOGY, V138, P3912, DOI 10.1210/en.138.9.3912; BANG P, 1994, J CLIN ENDOCR METAB, V78, P1119, DOI 10.1210/jc.78.5.1119; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P4943, DOI 10.1210/jc.86.10.4943; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Collard TJ, 2006, INT J ONCOL, V29, P1279; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; DUBUC PU, 1976, METABOLISM, V25, P1567, DOI 10.1016/0026-0495(76)90109-8; Firth Sue M., 1995, Progress in Growth Factor Research, V6, P223, DOI 10.1016/0955-2235(95)00009-7; Gatenby VK, 2010, EXPERT OPIN THER TAR, V14, P1333, DOI 10.1517/14728222.2010.528930; Gomez JM, 2004, GROWTH HORM IGF RES, V14, P91, DOI 10.1016/j.ghir.2003.11.004; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Han JF, 2011, CANCER LETT, V307, P200, DOI 10.1016/j.canlet.2011.04.004; HOSSENLOPP P, 1990, J CLIN ENDOCR METAB, V71, P797, DOI 10.1210/jcem-71-4-797; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jialal I, 2001, Am J Clin Pathol, V116 Suppl, pS108; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; KANAI H, 1990, HYPERTENSION, V16, P484, DOI 10.1161/01.HYP.16.5.484; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kaplan RC, 2007, J CLIN ENDOCR METAB, V92, P1319, DOI 10.1210/jc.2006-1631; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kim HS, 2007, PEDIATR RES, V61, P159, DOI 10.1203/pdr.0b013e31802d8a30; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Maile LA, 1999, GROWTH HORM IGF RES, V9, P85, DOI 10.1054/ghir.1999.0096; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Maury E, 2009, J CLIN ENDOCR METAB, V94, P1393, DOI 10.1210/jc.2008-2196; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; OH YM, 1993, J BIOL CHEM, V268, P14964; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Palau N, 2012, ENDOCRINOLOGY, V153, P177, DOI 10.1210/en.2011-0181; Schuler-Luttmann, 2000, Arterioscler Thromb Vasc Biol, V20, pE10; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Skolnik Edward Y., 1996, Cytokine and Growth Factor Reviews, V7, P161, DOI 10.1016/1359-6101(96)00021-4; Spilcke-Liss E, 2011, CLIN ENDOCRINOL OXF; Tikellis C, 2008, ATHEROSCLEROSIS, V199, P55, DOI 10.1016/j.atherosclerosis.2007.10.038; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita S, 1996, DIABETES CARE, V19, P287, DOI 10.2337/diacare.19.3.287	52	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55084	10.1371/journal.pone.0055084	http://dx.doi.org/10.1371/journal.pone.0055084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383064	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500054
J	Gane, S; Georganakis, D; Maniati, K; Vamvakias, M; Ragoussis, N; Skoulakis, EMC; Turin, L				Gane, Simon; Georganakis, Dimitris; Maniati, Klio; Vamvakias, Manolis; Ragoussis, Nikitas; Skoulakis, Efthimios M. C.; Turin, Luca			Molecular Vibration-Sensing Component in Human Olfaction	PLOS ONE			English	Article							ODOR RELATIONSHIP; MUSK; DISCRIMINATION; EXCHANGE	Whether olfaction recognizes odorants by their shape, their molecular vibrations, or both remains an open and controversial question. A convenient way to address it is to test for odor character differences between deuterated and undeuterated odorant isotopomers, since these have identical ground-state conformations but different vibrational modes. In a previous paper (Franco et al. (2011) Proc Natl Acad Sci USA 108: 9, 3797-802) we showed that fruit flies can recognize the presence of deuterium in odorants by a vibrational mechanism. Here we address the question of whether humans too can distinguish deuterated and undeuterated odorants. A previous report (Keller and Vosshall (2004) Nat Neurosci 7:4, 337-8) indicated that naive subjects are incapable of distinguishing acetophenone and d-8 acetophenone. Here we confirm and extend those results to trained subjects and gas-chromatography [GC]-pure odorants. However, we also show that subjects easily distinguish deuterated and undeuterated musk odorants purified to GC-pure standard. These results are consistent with a vibrational component in human olfaction.	[Gane, Simon] UCL, Royal Natl Throat Nose & Ear Hosp, London, England; [Georganakis, Dimitris; Vamvakias, Manolis; Ragoussis, Nikitas] Vioryl SA, Afidnes, Greece; [Maniati, Klio; Skoulakis, Efthimios M. C.; Turin, Luca] Biomed Sci Res Ctr Alexander Fleming, Div Neurobiol, Vari, Greece	University College London Hospitals NHS Foundation Trust; University of London; University College London; Alexander Fleming Biomedical Sciences Research Center	Turin, L (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Neurobiol, Vari, Greece.	turin@fleming.gr	Franco, Maribel/AAE-8375-2019		UCL; NanoIRC; Greek Ministry of Education and Research; National Institute for Health Research [ACF-2008-18-025] Funding Source: researchfish	UCL; NanoIRC; Greek Ministry of Education and Research; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Ian Smith for valuable help and advice with gas chromatography, Christina Koutsoudaki for perfumer evaluations of the deuterated musks, Haido Bardouki for analytical chemistry and Andreas Mores for NMR. SG thanks UCL and the NanoIRC for support.; Funded by the Greek Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS CJ, 1985, J PHYS C SOLID STATE, V18, P1313, DOI 10.1088/0022-3719/18/7/003; AMOORE JE, 1964, ANN NY ACAD SCI, V116, P457, DOI 10.1111/j.1749-6632.1964.tb45075.x; Baur A, 1891, BER DTSCH CHEM GES, V24, P2832; Bedoukian PZ, 1967, BIOCHEMISTRY-US, V24, P5907; BERSUKER IB, 1991, NEW J CHEM, V15, P307; BESTMANN HJ, 1989, NATURWISSENSCHAFTEN, V76, P422, DOI 10.1007/BF00366167; Bittner ER, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767067; Brookes JC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038101; Chang PY, 2012, PHYS CHEM CHEM PHYS; CHASTRETTE M, 1995, EUR J MED CHEM, V30, P679, DOI 10.1016/0223-5234(96)88285-7; Dyson GM., 1938, CHEM IND, V57, P647, DOI [10.1002/jctb.5000572802, DOI 10.1002/JCTB.5000572802]; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Gautschi M, 2001, CHIMIA, V55, P379; Gilbert AN, 1996, CHEM SENSES, V21, P411, DOI 10.1093/chemse/21.4.411; Haffenden LJW, 2001, FOOD CHEM, V73, P67, DOI 10.1016/S0308-8146(00)00287-9; HARA J, 1977, EXPERIENTIA, V33, P618, DOI 10.1007/BF01946534; Franco MI, 2011, P NATL ACAD SCI USA, V108, pE350, DOI 10.1073/pnas.1107618108; Ishikawa Y, 2000, INT J QUANTUM CHEM, V79, P109, DOI 10.1002/1097-461X(2000)79:2<109::AID-QUA6>3.0.CO;2-G; Junk T, 1997, CHEM SOC REV, V26, P401, DOI 10.1039/cs9972600401; Keller A, 2004, NAT NEUROSCI, V7, P337, DOI 10.1038/nn1215; KLOPPING HL, 1971, J AGR FOOD CHEM, V19, P999, DOI 10.1021/jf60177a002; Maegawa T, 2008, ANGEW CHEM INT EDIT, V47, P5394, DOI 10.1002/anie.200800941; Mookherjee BD, 1982, FRAGRANCE CHEM; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Nojima S, 2008, J CHEM ECOL, V34, P418, DOI 10.1007/s10886-008-9437-z; Pauling L., 1946, CHEM ENG NEWS, V24, P1064; Rossiter KJ, 1996, CHEM REV, V96, P3201, DOI 10.1021/cr950068a; Sell CS, 2006, ANGEW CHEM INT EDIT, V45, P6254, DOI 10.1002/anie.200600782; Socrates G., 2004, INFRARED RAMAN CHARA; Surburg H., 2016, COMMON FRAGRANCE FLA; Takane SY, 2004, ORG BIOMOL CHEM, V2, P3250, DOI 10.1039/b409802a; Turin L, 2002, J THEOR BIOL, V216, P367, DOI 10.1006/jtbi.2001.2504; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Turin L, 2003, HDB OLFACTION GUSTAT, P275; Turin L, 2009, CHEM TECHNOLOGY FLAV, P261; Wade D, 1999, CHEM-BIOL INTERACT, V117, P191, DOI 10.1016/S0009-2797(98)00097-0; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; Williams AS, 1999, SYNTHESIS-STUTTGART, P1707; WRIGHT RH, 1961, NATURE, V190, P1101, DOI 10.1038/1901101a0; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x	40	70	71	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55780	10.1371/journal.pone.0055780	http://dx.doi.org/10.1371/journal.pone.0055780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372854	Green Published, gold			2022-12-25	WOS:000315210400094
J	Glatz, G; Gogl, G; Alexa, A; Remenyi, A				Glatz, Gabor; Gogl, Gergo; Alexa, Anita; Remenyi, Attila			Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOCKING INTERACTIONS; PB1 DOMAIN; MEK5 PB1; DIFFERENTIAL REGULATION; PROTEIN-KINASES; GENE-EXPRESSION; MAP; SITES; BMK1/ERK5; MOTIFS	Mitogen-activated protein kinase (MAPK) activation depends on a linear binding motif found in all MAPK kinases (MKK). In addition, the PB1 (Phox and Bem1) domain of MKK5 is required for extracellular signal regulated kinase 5 (ERK5) activation. We present the crystal structure of ERK5 in complex with an MKK5 construct comprised of the PB1 domain and the linear binding motif. We show that ERK5 has distinct protein-protein interaction surfaces compared with ERK2, which is the closest ERK5 paralog. The two MAPKs have characteristically different physiological functions and their distinct protein-protein interaction surface topography enables them to bind different sets of activators and substrates. Structural and biochemical characterization revealed that the MKK5 PB1 domain cooperates with the MAPK binding linear motif to achieve substrate specific binding, and it also enables co-recruitment of the upstream activating enzyme and the downstream substrate into one signaling competent complex. Studies on present day MAPKs and MKKs hint on the way protein kinase networks may evolve. In particular, they suggest how paralogous enzymes with similar catalytic properties could acquire novel signaling roles by merely changing the way they make physical links to other proteins.	[Glatz, Gabor; Gogl, Gergo; Alexa, Anita; Remenyi, Attila] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Eotvos Lorand University	Remenyi, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	remenyi@elte.hu	Remenyi, Attila/N-1345-2016; Gogl, Gergo/ABH-4309-2020	Gogl, Gergo/0000-0002-8597-3711; Remenyi, Attila/0000-0002-8345-1311; Alexa, Anita/0000-0002-5740-7835	Hungarian Scientific Research Fund [OTKA NK81950, NKTH-OTKA H07A 74216]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (OTKA NK81950 and NKTH-OTKA H07A 74216).	Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Barsyte-Lovejoy D, 2004, BIOCHEM J, V381, P693, DOI 10.1042/BJ20031940; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Gogl G., 2012, ACTA CRYS D IN PRESS; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hu Q, 2007, BIOCHEMISTRY-US, V46, P13478, DOI 10.1021/bi701341n; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026999; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Ma WF, 2010, STRUCTURE, V18, P1502, DOI 10.1016/j.str.2010.08.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milanesi L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S20; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Nakamura K, 2007, MOL CELL BIOL, V27, P4566, DOI 10.1128/MCB.00125-07; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Piserchio A, 2011, BIOCHEMISTRY-US, V50, P3660, DOI 10.1021/bi2000559; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won AP, 2011, P NATL ACAD SCI USA, V108, P9809, DOI 10.1073/pnas.1016337108; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	58	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8596	8609		10.1074/jbc.M113.452235	http://dx.doi.org/10.1074/jbc.M113.452235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23382384	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000316564500060
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			Cdc45 Protein-Single-stranded DNA Interaction Is Important for Stalling the Helicase during Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA; S-PHASE; CHROMOSOME-REPLICATION; STRUCTURAL BASIS; DAMAGE RESPONSE; MCM2-7 HELICASE; GINS; COMPLEX; INITIATION; KINASE	Replicative polymerase stalling is coordinated with replicative helicase stalling in eukaryotes, but the mechanism underlying this coordination is not known. Cdc45 activates the Mcm2-7 helicase. We report here that Cdc45 from budding yeast binds tightly to long (>= 40 nucleotides) genomic single-stranded DNA (ssDNA) and that 60mer ssDNA specifically disrupts the interaction between Cdc45 and Mcm2-7. We identified a mutant of Cdc45 that does not bind to ssDNA. When this mutant of cdc45 is expressed in budding yeast cells exposed to hydroxyurea, cell growth is severely inhibited, and excess RPA accumulates at or near an origin. Chromatin immunoprecipitation suggests that helicase movement is uncoupled from polymerase movement for mutant cells exposed to hydroxyurea. These data suggest that Cdc45-ssDNA interaction is important for stalling the helicase during replication stress.	[Bruck, Irina; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	daniel.kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745	National Science Foundation [1121534]; Direct For Biological Sciences [1265431] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1121534 (to D. L. K.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Handa T, 2012, MOL BIOL CELL, V23, P3240, DOI 10.1091/mbc.E12-05-0339; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kang YH, 2012, P NATL ACAD SCI USA, V109, P6042, DOI 10.1073/pnas.1203734109; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krastanova I, 2012, J BIOL CHEM, V287, P4121, DOI 10.1074/jbc.M111.285395; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lundblad V, 2001, CURR PROTOC MOL BIOL; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023	55	30	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7550	7563		10.1074/jbc.M112.440941	http://dx.doi.org/10.1074/jbc.M112.440941			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382391	Green Published, hybrid			2022-12-25	WOS:000316455300012
J	Czimmerer, Z; Hulvely, J; Simandi, Z; Varallyay, E; Havelda, Z; Szabo, E; Varga, A; Balazs, D; Balogh, M; Horvath, A; Domokos, B; Torok, Z; Nagy, L; Balint, BL				Czimmerer, Zsolt; Hulvely, Julianna; Simandi, Zoltan; Varallyay, Eva; Havelda, Zoltan; Szabo, Erzsebet; Varga, Attila; Balazs Dezso; Balogh, Maria; Horvath, Attila; Domokos, Balint; Torok, Zsolt; Nagy, Laszlo; Balint, Balint L.			A Versatile Method to Design Stem-Loop Primer-Based Quantitative PCR Assays for Detecting Small Regulatory RNA Molecules	PLOS ONE			English	Article							RT-PCR; MICRORNAS; QUANTIFICATION; REPRESSION; DISCOVERY; CANCER	Short regulatory RNA-s have been identified as key regulators of gene expression in eukaryotes. They have been involved in the regulation of both physiological and pathological processes such as embryonal development, immunoregulation and cancer. One of their relevant characteristics is their high stability, which makes them excellent candidates for use as biomarkers. Their number is constantly increasing as next generation sequencing methods reveal more and more details of their synthesis. These novel findings aim for new detection methods for the individual short regulatory RNA-s in order to be able to confirm the primary data and characterize newly identified subtypes in different biological conditions. We have developed a flexible method to design RT-qPCR assays that are very sensitive and robust. The newly designed assays were tested extensively in samples from plant, mouse and even human formalin fixed paraffin embedded tissues. Moreover, we have shown that these assays are able to quantify endogenously generated shRNA molecules. The assay design method is freely available for anyone who wishes to use a robust and flexible system for the quantitative analysis of matured regulatory RNA-s.	[Czimmerer, Zsolt; Simandi, Zoltan; Szabo, Erzsebet; Horvath, Attila; Nagy, Laszlo; Balint, Balint L.] Univ Debrecen, Dept Biochem & Mol Biol, Res Ctr Mol Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Hulvely, Julianna; Varga, Attila; Horvath, Attila; Domokos, Balint; Torok, Zsolt] Astrid Res Ltd, Debrecen, Hungary; [Varallyay, Eva; Havelda, Zoltan] Agr Biotechnol Ctr, Plant Dev Biol Grp, H-2101 Godollo, Hungary; [Balazs Dezso] Univ Debrecen, Inst Pathol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Nagy, Laszlo] Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Balogh, Maria; Balint, Balint L.] Univ Debrecen, Ctr Clin Genom & Personalized Med, Res Ctr Mol Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Balint, Balint L.] UD Genomed Ltd, Debrecen, Hungary; [Torok, Zsolt] Univ Debrecen, Dept Comp Graph & Image Proc, Ctr Arts Humanities & Sci, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Balint, BL (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Res Ctr Mol Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.	lbalint@med.unideb.hu	SIMANDI, Zoltan/A-9619-2012; Nagy, Laszlo/A-3814-2008; Horvath, Attila/AAA-9075-2020; Varallyay, Eva/D-5196-2012	SIMANDI, Zoltan/0000-0001-8894-1259; Nagy, Laszlo/0000-0001-6653-2155; Balint, Balint/0000-0002-6163-7190; Varallyay, Eva/0000-0002-9085-942X; Havelda, Zoltan/0000-0002-6349-7646; Horvath, Attila/0000-0002-6127-8925; Dezso, Balazs/0000-0002-7871-0219	European Union; European Social Fund;  [TAMOP-4.2.2/B-10/1-2010-0024]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); 	BLB is a Szodoray Fellow of the University of Debrecen. ZC is a pre-doctoral fellow supported by the TAMOP-4.2.2/B-10/1-2010-0024 project co-financed by the European Union and the European Social Fund. Some of the reagents used for measurements were provided kindly by Roche Hungary and UDGenomed Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Du LQ, 2011, J MOL CELL BIOL, V3, P176, DOI 10.1093/jmcb/mjq058; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	24	77	79	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55168	10.1371/journal.pone.0055168	http://dx.doi.org/10.1371/journal.pone.0055168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383094	Green Published, Green Accepted, gold			2022-12-25	WOS:000314610600070
J	Repetto, D; Aramu, S; Erba, EB; Sharma, N; Grasso, S; Russo, I; Jensen, ON; Cabodi, S; Turco, E; Di Stefano, P; Defilippi, P				Repetto, Daniele; Aramu, Simona; Erba, Elisabetta Boeri; Sharma, Nanaocha; Grasso, Silvia; Russo, Isabella; Jensen, Ole N.; Cabodi, Sara; Turco, Emilia; Di Stefano, Paola; Defilippi, Paola			Mapping of p140Cap Phosphorylation Sites: The EPLYA and EGLYA Motifs Have a Key Role in Tyrosine Phosphorylation and Csk Binding, and Are Substrates of the Abl Kinase	PLOS ONE			English	Article							HELICOBACTER-PYLORI CAGA; FAMILY KINASES; PROTEIN; SRC; MECHANISMS; EVOLUTION	Protein phosphorylation tightly regulates specific binding of effector proteins that control many diverse biological functions of cells (e.g. signaling, migration and proliferation). p140Cap is an adaptor protein, specifically expressed in brain, testis and epithelial cells, that undergoes phosphorylation and tunes its interactions with other regulatory molecules via post-translation modification. In this work, using mass spectrometry, we found that p140Cap is in vivo phosphorylated on tyrosine (Y) within the peptide GEGLpYADPYGLLHEGR (from now on referred to as EGLYA) as well as on three serine residues. Consistently, EGLYA has the highest score of in silico prediction of p140Cap phosphorylation. To further investigate the p140Cap function, we performed site specific mutagenesis on tyrosines inserted in EGLYA and EPLYA, a second sequence with the same highest score of phosphorylation. The mutant protein, in which both EPLYA/EGLYA tyrosines were converted to phenylalanine, was no longer tyrosine phosphorylated, despite the presence of other tyrosine residues in p140Cap sequence. Moreover, this mutant lost its ability to bind the C-terminal Src kinase (Csk), previously shown to interact with p140Cap by Far Western analysis. In addition, we found that in vitro and in HEK-293 cells, the Abelson kinase is the major kinase involved in p140Cap tyrosine phosphorylation on the EPLYA and EGLYA sequences. Overall, these data represent an original attempt to in vivo characterise phosphorylated residues of p140Cap. Elucidating the function of p140Cap will provide novel insights into its biological activity not only in normal cells, but also in tumors.	[Repetto, Daniele; Aramu, Simona; Sharma, Nanaocha; Grasso, Silvia; Russo, Isabella; Cabodi, Sara; Turco, Emilia; Di Stefano, Paola; Defilippi, Paola] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Erba, Elisabetta Boeri] Univ J Fourier, Inst Biol Struct JP Ebel, Grenoble, France; [Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Turin; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Southern Denmark	Di Stefano, P (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	paola.distefano@unito.it; paola.defilippi@unito.it	DEFILIPPI, Paola/L-2232-2014; Erba, Elisabetta Boeri/J-1058-2014; Jensen, Ole N/J-1763-2012	Erba, Elisabetta Boeri/0000-0002-5910-4707; Jensen, Ole N/0000-0003-1862-8528; Cabodi, Sara/0000-0003-1248-6549; Defilippi, Paola/0000-0001-6427-4906	Associazione Italiana Ricerca Cancro (AIRC); Ministero Universita Ricerca (MIUR); University of Torino Compagnia San Paolo, Torino; Regione Piemonte; Progetto Druidi	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Universita Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Torino Compagnia San Paolo, Torino; Regione Piemonte(Regione Piemonte); Progetto Druidi	This study was funded by Associazione Italiana Ricerca Cancro (AIRC), Ministero Universita Ricerca (MIUR) and University of Torino Compagnia San Paolo, Torino; Progetto d'Ateneo. The authors also received financial support from the following: Regione Piemonte, Progetto Druidi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Casnici C, 2011, HYBRIDOMA, V30, P261, DOI 10.1089/hyb.2010.0122; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Damiano L, 2012, P140CAP SUPPRESSES; DeGiorgis JA, 2005, J PROTEOME RES, V4, P306, DOI 10.1021/pr0498436; Di Stefano P, 2004, MOL BIOL CELL, V15, P787, DOI 10.1091/mbc.E03-09-0689; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Ia KK, 2010, GROWTH FACTORS, V28, P329, DOI 10.3109/08977194.2010.484424; Ito H, 2008, J NEUROCHEM, V107, P61, DOI 10.1111/j.1471-4159.2008.05585.x; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Koegl M, 1995, ONCOGENE, V11, P2317; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Miller Martin L., 2009, V527, P299, DOI 10.1007/978-1-60327-834-8_22; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Safari F, 2011, P NATL ACAD SCI USA, V108, P14938, DOI 10.1073/pnas.1107740108; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Thingholm Tine E., 2009, V527, P47, DOI 10.1007/978-1-60327-834-8_4	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54931	10.1371/journal.pone.0054931	http://dx.doi.org/10.1371/journal.pone.0054931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383002	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600052
J	Simon, AB; Griffeth, VEM; Wong, EC; Buxton, RB				Simon, Aaron B.; Griffeth, Valerie E. M.; Wong, Eric C.; Buxton, Richard B.			A Novel Method of Combining Blood Oxygenation and Blood Flow Sensitive Magnetic Resonance Imaging Techniques to Measure the Cerebral Blood Flow and Oxygen Metabolism Responses to an Unknown Neural Stimulus	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; OXIDATIVE-METABOLISM; NOISE-REDUCTION; TISSUE SIGNAL; MOTOR CORTEX; HUMAN BRAIN; FMRI; ACTIVATION; DYNAMICS	Simultaneous implementation of magnetic resonance imaging methods for Arterial Spin Labeling (ASL) and Blood Oxygenation Level Dependent (BOLD) imaging makes it possible to quantitatively measure the changes in cerebral blood flow (CBF) and cerebral oxygen metabolism (CMRO2) that occur in response to neural stimuli. To date, however, the range of neural stimuli amenable to quantitative analysis is limited to those that may be presented in a simple block or event related design such that measurements may be repeated and averaged to improve precision. Here we examined the feasibility of using the relationship between cerebral blood flow and the BOLD signal to improve dynamic estimates of blood flow fluctuations as well as to estimate metabolic-hemodynamic coupling under conditions where a stimulus pattern is unknown. We found that by combining the information contained in simultaneously acquired BOLD and ASL signals through a method we term BOLD Constrained Perfusion (BCP) estimation, we could significantly improve the precision of our estimates of the hemodynamic response to a visual stimulus and, under the conditions of a calibrated BOLD experiment, accurately determine the ratio of the oxygen metabolic response to the hemodynamic response. Importantly we were able to accomplish this without utilizing a priori knowledge of the temporal nature of the neural stimulus, suggesting that BOLD Constrained Perfusion estimation may make it feasible to quantitatively study the cerebral metabolic and hemodynamic responses to more natural stimuli that cannot be easily repeated or averaged.	[Simon, Aaron B.; Griffeth, Valerie E. M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Simon, Aaron B.; Griffeth, Valerie E. M.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Wong, Eric C.; Buxton, Richard B.] Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Buxton, Richard B.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Buxton, RB (corresponding author), Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA.	rbuxton@ucsd.edu			National Institutes of Health [NS-36722]; GE healthcare [A-44 20114049]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036722, R21NS081405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE healthcare(General ElectricGE Healthcare); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS-36722 and Grant A-44 20114049 from GE healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: 1) Research grant from GE healthcare; 2) Patent Application (Invention Disclosure filed). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Blockley NP, 2012, NEUROIMAGE, V60, P279, DOI 10.1016/j.neuroimage.2011.11.081; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton Richard B, 2010, Front Neuroenergetics, V2, P8, DOI 10.3389/fnene.2010.00008; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Chen JJ, 2010, NEUROIMAGE, V53, P383, DOI 10.1016/j.neuroimage.2010.07.003; Chen JJ, 2009, NEUROIMAGE, V46, P559, DOI 10.1016/j.neuroimage.2009.03.015; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DIXON WT, 1991, MAGN RESON MED, V18, P257, DOI 10.1002/mrm.1910180202; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P1856, DOI 10.1038/jcbfm.2009.107; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Fukunaga M, 2008, J CEREBR BLOOD F MET, V28, P1377, DOI 10.1038/jcbfm.2008.25; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Griffeth VEM, 2011, NEUROIMAGE, V58, P198, DOI 10.1016/j.neuroimage.2011.05.077; Griffeth VEM, 2011, NEUROIMAGE, V57, P809, DOI 10.1016/j.neuroimage.2011.04.064; Griffeth VEM, 2012, P INT SOC MAG RESON, V20, P1; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Liau J, 2008, NEUROIMAGE, V42, P296, DOI 10.1016/j.neuroimage.2008.04.177; Liu TT, 2005, NEUROIMAGE, V24, P207, DOI 10.1016/j.neuroimage.2004.09.047; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Owen DG, 2008, PAIN, V136, P85, DOI 10.1016/j.pain.2007.06.021; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Press WH., 2002, NUMERICAL RECIPES C, V2; Restom K, 2006, NEUROIMAGE, V31, P1104, DOI 10.1016/j.neuroimage.2006.01.026; St Lawrence KS, 2005, MAGN RESON MED, V53, P735, DOI 10.1002/mrm.20396; Uludag K, 2008, MAGN RESON IMAGING, V26, P863, DOI 10.1016/j.mri.2008.01.049; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Wong E, 1998, MAGNETIC RESONANCE I; Wong EC, 2005, J MAGN RESON IMAGING, V22, P727, DOI 10.1002/jmri.20459; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	51	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54816	10.1371/journal.pone.0054816	http://dx.doi.org/10.1371/journal.pone.0054816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382977	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600045
J	Spindler, EC; Boyle, NR; Hancock, REW; Gill, RT				Spindler, Eileen C.; Boyle, Nanette R.; Hancock, Robert E. W.; Gill, Ryan T.			Genome-Wide Identification of Genes Conferring Energy Related Resistance to a Synthetic Antimicrobial Peptide (Bac8c)	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; BACTERIA; MECHANISMS	A fundamental issue in the design and development of antimicrobials is the lack of understanding of complex modes of action and how this complexity affects potential pathways for resistance evolution. Bac8c (RIWVIWRR-NH2) is an 8 amino acid antimicrobial peptide (AMP) that has been shown to have enhanced activity against a range of pathogenic Gram-positive and Gram-negative bacteria, as well as yeast. We have previously demonstrated that Bac8c appears to interfere with multiple targets, at least in part through the disruption of cytoplasmic membrane related functions, and that resistance to this peptide does not easily develop using standard laboratory methods. Here, we applied a genomics approach, SCalar Analysis of Library Enrichement (SCALEs), to map the effect of gene overexpression onto Bac8c resistance in parallel for all genes and gene combinations (up to similar to 10 adjacent genes) in the E. coli genome (a total of similar to 500,000 individual clones were mapped). Our efforts identified an elaborate network of genes for which overexpression leads to low-level resistance to Bac8c (including biofilm formation, multi-drug transporters, etc). This data was analyzed to provide insights into the complex relationships between mechanisms of action and potential routes by which resistance to this synthetic AMP can develop.	[Spindler, Eileen C.; Boyle, Nanette R.; Gill, Ryan T.] Univ Colorado Boulder, Dept Biol & Chem Engn, Boulder, CO 80302 USA; [Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada	University of Colorado System; University of Colorado Boulder; University of British Columbia	Gill, RT (corresponding author), Univ Colorado Boulder, Dept Biol & Chem Engn, Boulder, CO 80302 USA.	rtg@colorado.edu	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding to REWH from the Canadian Institutes of Health Research is gratefully acknowledged. REWH holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BODANSZKY M, 1969, SCIENCE, V163, P352, DOI 10.1126/science.163.3865.352; Bonomo J, 2008, METAB ENG, V10, P109, DOI 10.1016/j.ymben.2007.10.002; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cloete TE, 2003, INT BIODETER BIODEGR, V51, P277, DOI 10.1016/S0964-8305(03)00042-8; Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Gall S, 2008, METAB ENG, V10, P382, DOI 10.1016/j.ymben.2008.08.003; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2010, MEMBRANE ACTIVE PEPT, P3; HEITKAMP M, 1981, BIOCHIM BIOPHYS ACTA, V676, P345, DOI 10.1016/0304-4165(81)90169-0; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Lynch MD, 2004, METAB ENG, V6, P177, DOI 10.1016/j.ymben.2004.01.002; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Sambrook J, 2001, MOL CLONING LAB MANU, P561; Sambrook J, 2001, MOL CLONING LAB MANU; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Warnecke TE, 2008, METAB ENG, V10, P154, DOI 10.1016/j.ymben.2008.04.004; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274	30	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55052	10.1371/journal.pone.0055052	http://dx.doi.org/10.1371/journal.pone.0055052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383054	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600061
J	Verma, D; Kawarabayasi, Y; Miyazaki, K; Satyanarayana, T				Verma, Digvijay; Kawarabayasi, Yutaka; Miyazaki, Kentaro; Satyanarayana, Tulasi			Cloning, Expression and Characteristics of a Novel Alkalistable and Thermostable Xylanase Encoding Gene (Mxyl) Retrieved from Compost-Soil Metagenome	PLOS ONE			English	Article							ENVIRONMENTAL DNA; SEQUENCE; XYLOOLIGOSACCHARIDES; BINDING; ENZYME; IDENTIFICATION; PURIFICATION; DOMAINS; STRAIN	Background: The alkalistable and thermostable xylanases are in high demand for pulp bleaching in paper industry and generating xylooligosaccharides by hydrolyzing xylan component of agro-residues. The compost-soil samples, one of the hot environments, are expected to be a rich source of microbes with thermostable enzymes. Methodology/Principal Findings: Metagenomic DNA from hot environmental samples could be a rich source of novel biocatalysts. While screening metagenomic library constructed from DNA extracted from the compost-soil in the p18GFP vector, a clone (TSDV-MX1) was detected that exhibited clear zone of xylan hydrolysis on RBB xylan plate. The sequencing of 6.321 kb DNA insert and its BLAST analysis detected the presence of xylanase gene that comprised 1077 bp. The deduced protein sequence (358 amino acids) displayed homology with glycosyl hydrolase (GH) family 11 xylanases. The gene was subcloned into pET28a vector and expressed in E. coli BL21 (DE3). The recombinant xylanase (rMxyl) exhibited activity over a broad range of pH and temperature with optima at pH 9.0 and 80 degrees C. The recombinant xylanase is highly thermostable having T1/2 of 2 h at 80 degrees C and 15 min at 90 degrees C. Conclusion/Significance: This is the first report on the retrieval of xylanase gene through metagenomic approach that encodes an enzyme with alkalistability and thermostability. The recombinant xylanase has a potential application in paper and pulp industry in pulp bleaching and generating xylooligosaccharides from the abundantly available agro-residues.	[Verma, Digvijay; Satyanarayana, Tulasi] Univ Delhi, Dept Microbiol, New Delhi, India; [Kawarabayasi, Yutaka] Kyushu Univ, Fac Agr, Lab Funct Genom Extremophiles, Fukuoka 812, Japan; [Kawarabayasi, Yutaka] Natl Inst Adv Ind Sci & Technol, Inst Hearth Res, Amagasaki, Hyogo, Japan; [Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Miyazaki, Kentaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Hokkaido 1138654, Japan	University of Delhi; Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Satyanarayana, T (corresponding author), Univ Delhi, Dept Microbiol, South Campus, New Delhi, India.	tsnarayana@gmail.com	Miyazaki, Kentaro/F-7022-2010	Miyazaki, Kentaro/0000-0002-4349-566X; Verma, Digvijay/0000-0002-6177-8399	Department of Biotechnology, Govt. of India [BT/PR-8492/BCE/08/497/2006]; Grants-in-Aid for Scientific Research [24119515] Funding Source: KAKEN	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Department of Biotechnology, Govt. of India (BT/PR-8492/BCE/08/497/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archana A, 1997, ENZYME MICROB TECH, V21, P12, DOI 10.1016/S0141-0229(96)00207-4; Brennan Y, 2004, APPL ENVIRON MICROB, V70, P3609, DOI 10.1128/AEM.70.6.3609-3617.2004; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; COUGHLAN MP, 1993, BIOTECHNOL APPL BIOC, V17, P259; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; GRUPPEN H, 1992, J CEREAL SCI, V16, P53, DOI 10.1016/S0733-5210(09)80079-9; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hori H, 1985, BIOSYNTHESIS BIODEGR, P109; Hu Y, 2008, APPL MICROBIOL BIOT, V80, P823, DOI 10.1007/s00253-008-1636-6; Jalal A, 2009, J BIOSCI BIOENG, V107, P360, DOI 10.1016/j.jbiosc.2008.12.005; JunGang Li, 2010, Microb Cell Fact, V9, P83, DOI 10.1186/1475-2859-9-83; Khandeparkar R, 2007, BIORESOURCE TECHNOL, V98, P897, DOI 10.1016/j.biortech.2006.02.037; KHASIN A, 1993, APPL ENVIRON MICROB, V59, P1725, DOI 10.1128/AEM.59.6.1725-1730.1993; KORMELINK FJM, 1993, APPL MICROBIOL BIOT, V38, P688, DOI 10.1007/BF00182811; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Lee CC, 2006, EXTREMOPHILES, V10, P295, DOI 10.1007/s00792-005-0499-3; Li N, 2008, APPL MICROBIOL BIOT, V80, P231, DOI 10.1007/s00253-008-1533-z; Li RP, 2009, WORLD J MICROB BIOT, V25, P2071, DOI 10.1007/s11274-009-0111-6; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Liu WL, 2010, APPL BIOCHEM BIOTECH, V162, P1, DOI 10.1007/s12010-009-8719-4; Maalej I, 2009, APPL BIOCHEM BIOTECH, V158, P200, DOI 10.1007/s12010-008-8317-x; Mamo G, 2007, EXTREMOPHILES, V11, P169, DOI 10.1007/s00792-006-0023-4; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; MATHRANI IM, 1992, APPL MICROBIOL BIOT, V38, P23, DOI 10.1007/BF00169413; Matteotti C, 2012, PROTEIN EXPRES PURIF, V83, P117, DOI 10.1016/j.pep.2012.03.009; Menon V, 2010, BIORESOURCE TECHNOL, V101, P5366, DOI 10.1016/j.biortech.2010.01.150; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ng IS, 2009, EXTREMOPHILES, V13, P425, DOI 10.1007/s00792-009-0228-4; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Romanowska I, 2006, APPL MICROBIOL BIOT, V69, P665, DOI 10.1007/s00253-005-0011-0; SAKKA K, 1993, BIOSCI BIOTECH BIOCH, V57, P273, DOI 10.1271/bbb.57.273; Sharma A, 2007, WORLD J MICROB BIOT, V23, P483, DOI 10.1007/s11274-006-9250-1; Shi P, 2011, APPL ENVIRON MICROB, V76, P3620; Shibuya H, 2000, BIOCHEM J, V349, P651, DOI 10.1042/0264-6021:3490651; Sun JY, 2007, FOOD CHEM, V104, P1055, DOI 10.1016/j.foodchem.2007.01.028; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Sunna A, 1997, EXTREMOPHILES, V1, P2, DOI 10.1007/s007920050009; UCHINO F, 1983, AGR BIOL CHEM TOKYO, V47, P965, DOI 10.1080/00021369.1983.10865774; Vazquez MJ, 2000, TRENDS FOOD SCI TECH, V11, P387, DOI 10.1016/S0924-2244(01)00031-0; Verma D, 2012, BIORESOURCE TECHNOL, V107, P333, DOI 10.1016/j.biortech.2011.12.055; Verma D, 2011, APPL BIOCHEM BIOTECH, V165, P454, DOI 10.1007/s12010-011-9264-5; Vieira DS, 2009, MOL PHYS, V107, P59, DOI 10.1080/00268970902717959; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Wang YR, 2007, AQUACULTURE, V267, P328, DOI 10.1016/j.aquaculture.2007.03.005; WINTERHALTER C, 1995, APPL ENVIRON MICROB, V61, P1810, DOI 10.1128/AEM.61.5.1810-1815.1995; Woldesenbet F, 2012, APPL BIOCHEM BIOTECH, V167, P100, DOI 10.1007/s12010-012-9663-2; Yamada K, 2008, ENVIRON MICROBIOL, V10, P978, DOI 10.1111/j.1462-2920.2007.01518.x; Yang YL, 2010, AFR J MICROBIOL RES, V4, P2249; Yoon Hyang-Sik, 2004, Agricultural Chemistry and Biotechnology, V47, P157; Yoon KH, 2009, J MICROBIOL BIOTECHN, V19, P1514, DOI 10.4014/jmb.0907.07004; Yu EY, 2011, APPL MICROBIOL BIOT, V90, P573, DOI 10.1007/s00253-011-3132-7; Yuhong Z, 2009, J MICROBIOL BIOTECHN, V158, P200; Zhang GM, 2007, APPL MICROBIOL BIOT, V74, P339, DOI 10.1007/s00253-006-0648-3; Zhao YY, 2011, APPL BIOCHEM BIOTECH, V165, P35, DOI 10.1007/s12010-011-9231-1	58	60	67	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52459	10.1371/journal.pone.0052459	http://dx.doi.org/10.1371/journal.pone.0052459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382818	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600006
J	Zhu, JW; Wu, XJ; Lu, ZF; Luo, D; Cai, SQ; Zheng, M				Zhu, Jian-Wei; Wu, Xian-Jie; Lu, Zhong-Fa; Luo, Dan; Cai, Sui-Qing; Zheng, Min			Role of VEGF Receptors in Normal and Psoriatic Human Keratinocytes: Evidence from Irradiation with Different UV Sources	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; HUMAN EPIDERMAL-KERATINOCYTES; ULTRAVIOLET-B; TYROSINE KINASE; SKIN INFLAMMATION; FACTOR EXPRESSION; ACTIVATION; RADIATION; CELLS	Vascular endothelial growth factor (VEGF) promotes angiogenesis and plays important roles both in physiological and pathological conditions. VEGF receptors (VEGFRs) are high-affinity receptors for VEGF and are originally considered specific to endothelial cells. We previously reported that VEGFRs were also constitutively expressed in normal human keratinocytes and overexpressed in psoriatic epidermis. In addition, UVB can activate VEGFRs in normal keratinocytes, and the activated VEGFR-2 signaling is involved in the pro-survival mechanism. Here, we show that VEGFRs were also upregulated and activated by UVA in normal human keratinocytes via PKC, and interestingly, both the activated VEGFR-1 and VEGFR-2 protected against UVA-induced cell death. As VEGFRs were over-expressed in psoriatic epidermis, we further investigated whether narrowband UVB (NB-UVB) phototherapy or topical halomethasone monohydrate 0.05% cream could affect their expression. Surprisingly, the over-expressed VEGFRs in psoriatic epidermis were significantly attenuated by both treatments. During NB-UVB therapy, VEGFRs declined first in the basal, and then gradually in the upper psoriatic epidermis. VEGFRs were activated in psoriatic epidermis, their activation was enhanced by NB-UVB, but turned undetectable after whole therapy. This process was quite different from that by halomethasone, in which VEGFRs and phospho-VEGFRs decreased in a gradual, homogeneous manner. Our findings further suggest that UV-induced activation of VEGFRs serves as a pro-survival signal for keratinocytes. In addition, VEGFRs may be involved in the pathological process of psoriasis, and UV phototherapy is effective for psoriasis by directly modulating the expression of VEGFRs.	[Zhu, Jian-Wei; Wu, Xian-Jie; Lu, Zhong-Fa; Cai, Sui-Qing; Zheng, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Dan] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Nanjing Medical University	Zheng, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China.	minz@zju.edu.cn			National Natural Science Fundation of China (NSFC) [30972643, 81171497, 81171521]	National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grant 30972643, 81171497 and 81171521 from the National Natural Science Fundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman A, 2009, CLIN EXP DERMATOL, V34, pE202, DOI 10.1111/j.1365-2230.2008.02991.x; Arun SN, 2011, ONCOGENE, V30, P1586, DOI 10.1038/onc.2010.540; Barbagallo J, 2001, CUTIS, V68, P345; Battie C, 2012, INDIAN J DERMATOL VE, V78, P9, DOI 10.4103/0378-6323.97350; Brauchle M, 1996, J BIOL CHEM, V271, P21793, DOI 10.1074/jbc.271.36.21793; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Decraene D, 2004, J INVEST DERMATOL, V122, P484, DOI 10.1046/j.0022-202X.2004.22215.x; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 1997, J INVEST DERMATOL, V108, P263, DOI 10.1111/1523-1747.ep12286453; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Flisiak I, 2010, CYTOKINE, V52, P225, DOI 10.1016/j.cyto.2010.09.012; Fuh G, 2000, J BIOL CHEM, V275, P26690; Gille J, 2000, J INVEST DERMATOL, V115, P30, DOI 10.1046/j.1523-1747.2000.00020.x; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; He YY, 2004, J BIOL CHEM, V279, P53867, DOI 10.1074/jbc.M405781200; Herve MAJ, 2006, J ENDOCRINOL, V188, P91, DOI 10.1677/joe.1.06184; Hirakawa S, 2005, BLOOD, V105, P2392, DOI 10.1182/blood-2004-06-2435; JEANMOUGIN M, 1987, ANN DERMATOL VENER, V114, P671; Kim EJ, 2005, EXP DERMATOL, V14, P625, DOI 10.1111/j.0906-6705.2005.00345.x; Kosmadaki MG, 2003, FASEB J, V17, P446, DOI 10.1096/fj.02-0379fje; Lapolla W, 2011, J AM ACAD DERMATOL, V64, P936, DOI 10.1016/j.jaad.2009.12.054; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lee EJ, 2010, FREE RADICAL BIO MED, V48, P1133, DOI 10.1016/j.freeradbiomed.2010.01.034; Li CM, 2011, MOL CELL BIOCHEM, V346, P173, DOI 10.1007/s11010-010-0602-7; Man XY, 2009, CLIN EXP DERMATOL, V34, P396, DOI 10.1111/j.1365-2230.2008.03104.x; Man XY, 2008, J CELL MOL MED, V12, P649, DOI 10.1111/j.1582-4934.2007.00112.x; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; MATSUI MS, 1994, PHOTOCHEM PHOTOBIOL, V59, P53; Matsui MS, 1996, PHOTODERMATOL PHOTO, V12, P103, DOI 10.1111/j.1600-0781.1996.tb00185.x; Mildner M, 1999, PHOTOCHEM PHOTOBIOL, V70, P674, DOI 10.1562/0031-8655(1999)070<0674:UAURDR>2.3.CO;2; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nofal A, 2009, J EUR ACAD DERMATOL, V23, P803, DOI 10.1111/j.1468-3083.2009.03181.x; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Ravnbak MH, 2007, ARCH DERMATOL RES, V299, P25, DOI 10.1007/s00403-006-0728-3; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; SEETHARAM L, 1995, ONCOGENE, V10, P135; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Supp DM, 2000, J INVEST DERMATOL, V114, P5, DOI 10.1046/j.1523-1747.2000.00824.x; Syed DN, 2012, PHOTOCHEM PHOTOBIOL, V88, P1184, DOI 10.1111/j.1751-1097.2012.01115.x; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Umeda J, 2003, FASEB J, V17, P610, DOI 10.1096/fj.02-0597com; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Weninger W, 1996, LAB INVEST, V75, P647; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033; Zhu JW, 2012, INT J BIOCHEM CELL B, V44, P246, DOI 10.1016/j.biocel.2011.10.022	60	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55463	10.1371/journal.pone.0055463	http://dx.doi.org/10.1371/journal.pone.0055463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383198	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600107
J	Bandiera, S; Cartault, F; Jannot, AS; Hatem, E; Girard, M; Rifai, L; Loiseau, C; Munnich, A; Lyonnet, S; Henrion-Caude, A				Bandiera, Simonetta; Cartault, Francois; Jannot, Anne-Sophie; Hatem, Elie; Girard, Muriel; Rifai, Laila; Loiseau, Clemence; Munnich, Arnold; Lyonnet, Stanislas; Henrion-Caude, Alexandra			Genetic Variations Creating MicroRNA Target Sites in the FXN 3 '-UTR Affect Frataxin Expression in Friedreich Ataxia	PLOS ONE			English	Article							TRIPLET REPEAT EXPANSION; WEB SERVER; DISEASE; PREDICTION; RESOURCE; 3'UTR	Friedreich's ataxia (FRDA) is a severe neurodegenerative disease caused by GAA repeat expansion within the first intron of the frataxin gene. It has been suggested that the repeat is responsible for the disease severity due to impaired transcription thereby reducing expression of the protein. However, genotype-phenotype correlation is imperfect, and the influence of other gene regions of the frataxin gene is unknown. We hypothesized that FRDA patients may harbor specific regulatory variants in the 3'-UTR. We sequenced the 3'-UTR region of the frataxin gene in a cohort of 57 FRDA individuals and 58 controls. Seven single nucleotide polymorphisms (SNPs) out of 19 were polymorphic in our case-control sample. These SNPs defined several haplotypes with one reaching 89% of homozygosity in patients versus 24% in controls. In another cohort of 47 FRDA Reunionese patients, 94% patients were found to be homozygous for this haplotype. We found that this FRDA 3'-UTR conferred a 1.2-fold decrease in the expression of a reporter gene versus the alternative haplotype configuration. We established that differential targeting by miRNA could account for this functional variability. We specifically demonstrated the involvement of miR-124 (i.e hsa-mir-124-3p) in the down-regulation of FRDA-3'-UTR. Our results suggest for the first time that post-transcriptional regulation of frataxin occurs through the 3'-UTR and involves miRNA targeting. We propose that the involvement of miRNAs in a FRDA-specific regulation of frataxin may provide a rationale to increase residual levels of frataxin through miRNA-inhibitory molecules.	[Bandiera, Simonetta; Jannot, Anne-Sophie; Girard, Muriel; Munnich, Arnold; Lyonnet, Stanislas; Henrion-Caude, Alexandra] Univ Paris Descartes Sorbonne Cite, INSERM, U781, Hop Necker Enfants Malad,Inst Imagine, Paris, France; [Cartault, Francois; Hatem, Elie; Loiseau, Clemence] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Cartault, Francois] Ctr Hosp Reg La Reunion, Dept Genet, St Denis, Reunion, France; [Rifai, Laila] Natl Inst Hlth, Dept Med Genet, Rabat, Morocco	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Reunion	Henrion-Caude, A (corresponding author), Univ Paris Descartes Sorbonne Cite, INSERM, U781, Hop Necker Enfants Malad,Inst Imagine, Paris, France.	alexandra.caude@inserm.fr	Lyonnet, Stanislas/H-5483-2017; Girard, Muriel/B-7156-2018; Caude, Alexandra A Henrion/I-2778-2016	Lyonnet, Stanislas/0000-0001-5426-9417; Girard, Muriel/0000-0003-0050-1035; Caude, Alexandra A Henrion/0000-0002-8170-2260; Jannot, Anne-Sophie/0000-0002-8001-8539; Bandiera, Simonetta/0000-0002-7368-8155	AFAF (French association against Friedreich ataxia); AFAF	AFAF (French association against Friedreich ataxia); AFAF	This work was financially supported by the AFAF (French association against Friedreich ataxia, http://www.afaf.asso.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the AFAF, particularly to Juliette Dieusaert and Marianne Kerdougli for financial support of this work. We thank Patrick Munier for technical help. We sincerely thank Pr Josue Feingold for helpful discussion, and Pr Jean-Paul Bonnefont and Dr Benoit Funalot, Hopital Necker, Paris, the Centre de Ressources Biologiques, CHR Felix Guyon, Saint-Denis, La Reunion, and the Centre de Reference des Maladies neuromusculaires et neurologiques rares du CHR de la Reunion for providing genomic DNA.	Acquaviva F, 2008, CEREBELLUM, V7, P360, DOI 10.1007/s12311-008-0036-x; Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bilen J, 2006, CELL CYCLE, V5, P2835, DOI 10.4161/cc.5.24.3579; Boehm T, 2011, NEUROL SCI, V32, P327, DOI 10.1007/s10072-010-0326-1; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chattopadhyay B, 2004, ANN HUM GENET, V68, P189, DOI 10.1046/j.1529-8817.2003.00087.x; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griseri P, 2007, HUM MUTAT, V28, P168, DOI 10.1002/humu.20397; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Juvonen V, 2002, HUM GENET, V110, P36, DOI 10.1007/s00439-001-0642-x; Kelly M, 2011, J MOL CELL CARDIOL, V51, P848, DOI 10.1016/j.yjmcc.2011.07.001; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Mahishi LH, 2012, J NEUROSCI, V32, P9369, DOI 10.1523/JNEUROSCI.0059-12.2012; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Pelletier C, 2011, CELL CYCLE, V10, P90, DOI 10.4161/cc.10.1.14359; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Rufini A, 2011, HUM MOL GENET, V20, P1253, DOI 10.1093/hmg/ddq566; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Sonntag KC, 2012, EXP NEUROL, V235, P427, DOI 10.1016/j.expneurol.2011.11.035; Yang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S4	38	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54791	10.1371/journal.pone.0054791	http://dx.doi.org/10.1371/journal.pone.0054791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382970	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800079
J	Bremner, AJ; Hill, EL; Pratt, M; Rigato, S; Spence, C				Bremner, Andrew J.; Hill, Elisabeth L.; Pratt, Michelle; Rigato, Silvia; Spence, Charles			Bodily Illusions in Young Children: Developmental Change in Visual and Proprioceptive Contributions to Perceived Hand Position	PLOS ONE			English	Article							LIMB POSITION; INTERMODAL PERCEPTION; LOCALIZATION; INTEGRATION; INFORMATION; MOVEMENT; INFANCY; MIRROR; SPACE; TOUCH	We examined the visual capture of perceived hand position in forty-five 5-to 7-year-olds and in fifteen young adults, using a mirror illusion task. In this task, participants see their left hand on both the left and right (by virtue of a mirror placed at the midline facing the left arm, and obscuring the right). The accuracy of participants' reaching was measured when proprioceptive and visual cues to the location of the right arm were put into conflict (by placing the arms at different distances from the mirror), and also when only proprioceptive information was available (i.e., when the mirror was covered). Children in all age-groups (and adults) made reaching errors in the mirror condition in accordance with the visually-specified illusory starting position of their hand indicating a visual capture of perceived hand position. Data analysis indicated that visual capture increased substantially up until 6 years of age. These findings are interpreted with respect to the development of the visual guidance of action in early childhood.	[Bremner, Andrew J.; Hill, Elisabeth L.; Pratt, Michelle; Rigato, Silvia] Univ London, Dept Psychol, Sensorimotor Dev Res Unit, London, England; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University of Oxford	Bremner, AJ (corresponding author), Univ London, Dept Psychol, Sensorimotor Dev Res Unit, London, England.	a.bremner@gold.ac.uk	Bremner, Andrew J/G-8500-2014	Bremner, Andrew J/0000-0002-4119-3748; Hill, Elisabeth/0000-0003-3130-1271	British Academy [SG42169]; European Research Council under the European Community's Seventh Framework Programme [FP7/2007-2013]; ERC [241242]	British Academy; European Research Council under the European Community's Seventh Framework Programme(European Commission); ERC(European Research Council (ERC)European Commission)	This research was supported by British Academy grant SG42169 (http://www.britac.ac.uk/) awarded to ELH, AJB and CS, and an award from the European Research Council (http://erc.europa.eu/) under the European Community's Seventh Framework Programme (FP7/2007-2013) (ERC Grant agreement no. 241242) to AJB and ELH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRICK LE, 1985, DEV PSYCHOL, V21, P963, DOI 10.1037/0012-1649.21.6.963; BIRCH HG, 1967, MONOGR SOC RES CHILD, V32, P1, DOI 10.2307/1165792; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bremner AJ, 2013, HAND ORGAN MIND; Bremner AJ, 2008, TRENDS COGN SCI, V12, P298, DOI 10.1016/j.tics.2008.05.003; Bremner AJ, 2008, J EXP PSYCHOL GEN, V137, P149, DOI 10.1037/0096-3445.137.1.149; Brown LE, 2003, EXP BRAIN RES, V153, P266, DOI 10.1007/s00221-003-1601-7; BUTTERWORTH G, 1988, BRIT J DEV PSYCHOL, V6, P303, DOI 10.1111/j.2044-835X.1988.tb01103.x; Cowie D, 2013, PSYCHOL SCI IN PRESS; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Godoi D, 2008, DEV PSYCHOBIOL, V50, P77, DOI 10.1002/dev.20272; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; HAY L, 1979, J MOTOR BEHAV, V11, P189, DOI 10.1080/00222895.1979.10735187; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2005, EXP BRAIN RES, V166, P489, DOI 10.1007/s00221-005-2389-4; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Martin MGF, 1995, BODY SELF, P267; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Nardini M, 2012, MUTISENSORY DEV, P137; Nardini M, 2010, P NATL ACAD SCI USA, V107, P17041, DOI 10.1073/pnas.1001699107; Pagel B, 2009, DEVELOPMENTAL SCI, V12, P929, DOI 10.1111/j.1467-7687.2009.00845.x; POPPEL E, 1973, NATURE, V243, P231, DOI 10.1038/243231a0; Renshaw S, 1930, PEDAGOG SEMIN J GEN, V38, P223; Rochat P, 1997, EARLY DEV PARENTING, V6, P105; Rochat P, 1998, EXP BRAIN RES, V123, P102, DOI 10.1007/s002210050550; Schmuckler MA, 2001, CHILD DEV, V72, P949, DOI 10.1111/1467-8624.00327; Schmuckler MA, 1996, INFANT BEHAV DEV, V19, P221, DOI 10.1016/S0163-6383(96)90021-1; Smyth MM, 2004, Q J EXP PSYCHOL-A, V57, P269, DOI 10.1080/02724980343000215; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Spence C., 2004, CROSSMODAL SPACE CRO; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van der Meer A L, 1997, Eur J Paediatr Neurol, V1, P103; VONHOFSTEN C, 1988, NEUROPSYCHOLOGIA, V26, P805, DOI 10.1016/0028-3932(88)90051-6; WANN JP, 1992, EXP BRAIN RES, V91, P162; WARREN DH, 1970, PERCEPT PSYCHOPHYS, V8, P430, DOI 10.3758/BF03207040	39	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51887	10.1371/journal.pone.0051887	http://dx.doi.org/10.1371/journal.pone.0051887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382813	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315563800007
J	Dobon, A; Wulff, BBH; Canet, JV; Fort, P; Tornero, P				Dobon, Albor; Wulff, Brande B. H.; Vicente Canet, Juan; Fort, Patrocinio; Tornero, Pablo			An Allele of Arabidopsis COI1 with Hypo- and Hypermorphic Phenotypes in Plant Growth, Defence and Fertility	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; DISEASE RESISTANCE; SIGNALING PATHWAYS; METHYL JASMONATE; PHYTOTOXIN CORONATINE; TRANSCRIPTION FACTOR; GENETIC-ANALYSIS; CROSS-TALK; THALIANA	Resistance to biotrophic pathogens is largely dependent on the hormone salicylic acid (SA) while jasmonic acid (JA) regulates resistance against necrotrophs. JA negatively regulates SA and is, in itself, negatively regulated by SA. A key component of the JA signal transduction pathway is its receptor, the COI1 gene. Mutations in this gene can affect all the JA phenotypes, whereas mutations in other genes, either in JA signal transduction or in JA biosynthesis, lack this general effect. To identify components of the part of the resistance against biotrophs independent of SA, a mutagenised population of NahG plants (severely depleted of SA) was screened for suppression of susceptibility. The screen resulted in the identification of intragenic and extragenic suppressors, and the results presented here correspond to the characterization of one extragenic suppressor, coi1-40. coi1-40 is quite different from previously described coi1 alleles, and it represents a strategy for enhancing resistance to biotrophs with low levels of SA, likely suppressing NahG by increasing the perception to the remaining SA. The phenotypes of coi1-40 lead us to speculate about a modular function for COI1, since we have recovered a mutation in COI1 which has a number of JA-related phenotypes reduced while others are equal to or above wild type levels.	[Dobon, Albor; Wulff, Brande B. H.; Vicente Canet, Juan; Fort, Patrocinio; Tornero, Pablo] Univ Politecn Valencia, CSIC, IBMCP, CPI, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Tornero, P (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, CPI, E-46071 Valencia, Spain.	ptornero@ibmcp.upv.es	Wulff, Brande B/N-4273-2013; Wulff, Brande BH/C-7465-2013	Wulff, Brande BH/0000-0003-4044-4346; Tornero, Pablo/0000-0001-9755-7726	"Ministerio de Economia y Competitividad" (MINECO) of Spain [BIO201018896]; Generalitat Valenciana [ACOMP/2012/105]; JAE-CSIC Fellowship; FPI-MINECO; European Molecular Biology Organization; Human Frontier Science Program	"Ministerio de Economia y Competitividad" (MINECO) of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); JAE-CSIC Fellowship; FPI-MINECO(Spanish Government); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by grant BIO201018896 from "Ministerio de Economia y Competitividad" (MINECO) of Spain and by grant ACOMP/2012/105 from "Generalitat Valenciana" to PT, a JAE-CSIC Fellowship to JVC, a FPI-MINECO to AD, and Fellowships from the European Molecular Biology Organization and the Human Frontier Science Program to BBHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Canet JV, 2010, PLANT BIOTECHNOL J, V8, P126, DOI 10.1111/j.1467-7652.2009.00468.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DeFraia CT, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-28; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dobon A, 2011, PLANTA, V234, P671, DOI 10.1007/s00425-011-1436-6; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Fernandez-Arbaizar A, 2012, PLANT CELL PHYSIOL, V53, P53, DOI 10.1093/pcp/pcr174; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Genoud T, 1999, TRENDS PLANT SCI, V4, P503, DOI 10.1016/S1360-1385(99)01498-3; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; He YJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003018; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; JOHNSON C. M. et al., 1957, Plant and Soil, V8, P337, DOI 10.1007/BF01666323; JURGENS G, 1991, DEVELOPMENT, P27; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; MITTAL S, 1995, MOL PLANT MICROBE IN, V8, P165, DOI 10.1094/MPMI-8-0165; Nawrath C, 2006, MULTIGENIC AND INDUCED SYSTEMIC RESISTANCE IN PLANTS, P143, DOI 10.1007/0-387-23266-4_7; Payne CT, 2000, GENETICS, V156, P1349; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; ROSS AF, 1961, VIROLOGY, V14, P340, DOI 10.1016/0042-6822(61)90319-1; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Sun JQ, 2009, PLANT CELL, V21, P1495, DOI 10.1105/tpc.108.064303; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Ton J, 2002, PLANT J, V29, P11, DOI 10.1046/j.1365-313x.2002.01190.x; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Traw MB, 2003, PLANT PHYSIOL, V133, P1367, DOI 10.1104/pp.103.027086; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819	74	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55115	10.1371/journal.pone.0055115	http://dx.doi.org/10.1371/journal.pone.0055115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383073	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800112
J	He, Z; Ferguson, SA; Cui, L; Greenfield, LJ; Paule, MG				He, Zhen; Ferguson, Sherry A.; Cui, Li; Greenfield, L. John, Jr.; Paule, Merle G.			Role of Neural Stem Cell Activity in Postweaning Development of the Sexually Dimorphic Nucleus of the Preoptic Area in Rats	PLOS ONE			English	Article							SEX-DIFFERENCES; GLOBAL-ISCHEMIA; BED NUCLEUS; BRAIN; HYPOTHALAMUS; NEUROGENESIS; APOPTOSIS; DIFFERENTIATION; MIGRATION; FEMALE	The sexually dimorphic nucleus of the preoptic area (SDN-POA) has received increased attention due to its apparent sensitivity to estrogen-like compounds found in food and food containers. The mechanisms that regulate SDN-POA volume remain unclear as is the extent of postweaning development of the SDN-POA. Here we demonstrate that the female Sprague-Dawley SDN-POA volume increased from weaning to adulthood, although this increase was not statistically significant as it was in males. The number of cells positive for Ki67, a marker of cell proliferation, in both the SDN-POA and the hypothalamus was significantly higher at weaning than at adulthood in male rats. In contrast, the number of Ki67-positive cells was significantly higher in the hypothalamus but not in the SDN-POA (p>0.05) at weaning than at adulthood in female rats. A subset of the Ki67-positive cells in the SDN-POA displayed the morphology of dividing cells. Nestin-immunoreactivity delineated a potential macroscopic neural stem cell niche in the rostral end of the 3rd ventricle. In conclusion, stem cells may partially account for the sexually dimorphic postweaning development of the SDN-POA.	[He, Zhen; Ferguson, Sherry A.; Paule, Merle G.] US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [He, Zhen; Cui, Li; Greenfield, L. John, Jr.] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA	US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences	He, Z (corresponding author), US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	zhen.he@fda.hhs.gov	he, zhen/F-5133-2013	he, zhen/0000-0001-9972-9114; Ferguson, Sherry/0000-0002-5120-0219	National Center for Toxicological Research/FDA [Protocol P00710, Protocol P00706]; National Institutes of Health [R01-NS049389]; UAMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049389] Funding Source: NIH RePORTER	National Center for Toxicological Research/FDA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Center for Toxicological Research/FDA (Protocol P00710 to ZH and Protocol P00706 to SAF). LC was supported by National Institutes of Health, Grant R01-NS049389 and UAMS institutional funds to LJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Bodo C, 2008, ENDOCRINOLOGY, V149, P4142, DOI 10.1210/en.2008-0183; Budefeld T, 2008, DEV NEUROBIOL, V68, P981, DOI 10.1002/dneu.20638; Chung WCJ, 2000, J NEUROBIOL, V43, P234, DOI 10.1002/(SICI)1097-4695(20000605)43:3<234::AID-NEU2>3.3.CO;2-V; Dahiya S, 2011, J NEUROPATH EXP NEUR, V70, P622, DOI 10.1097/NEN.0b013e31822200aa; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; Dugger BN, 2008, NEUROENDOCRINOLOGY, V88, P17, DOI 10.1159/000119740; Edelmann M, 2007, DEV NEUROBIOL, V67, P1371, DOI 10.1002/dneu.20507; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Gilmore RF, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-5; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; Gorski RA, 1989, NEUROLOGY NEUROBIOLO, V50, P33; He Z, 2005, NEUROREPORT, V16, P1541, DOI 10.1097/01.wnr.0000179074.32035.46; He Z, 2005, CURR NEUROVASC RES, V2, P365, DOI 10.2174/156720205774962674; He Z, 2004, CURR NEUROVASC RES, V1, P399, DOI 10.2174/1567202043361893; He Z, 1997, NUTR RES, V17, P305, DOI 10.1016/S0271-5317(96)00260-6; He Z, 2006, CURR NEUROVASC RES, V3, P181, DOI 10.2174/156720206778018802; He Z, 2012, NEUROTOXICOL TERATOL, V34, P329, DOI 10.1016/j.ntt.2012.03.004; He Z, 2011, ACS CHEM NEUROSCI, V2, P600, DOI 10.1021/cn2000487; He Z, 2009, CURR NEUROVASC RES, V6, P54, DOI 10.2174/156720209787466055; Henderson RG, 1999, J NEUROBIOL, V41, P252, DOI 10.1002/(SICI)1097-4695(19991105)41:2<252::AID-NEU8>3.0.CO;2-W; HOFMAN MA, 1989, J ANAT, V164, P55; JACOBSON CD, 1985, DEV BRAIN RES, V21, P7, DOI 10.1016/0165-3806(85)90019-7; Kato Y, 2012, NEUROSCI LETT, V516, P290, DOI 10.1016/j.neulet.2012.04.017; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Meredith JM, 2001, J NEUROSCI METH, V104, P113, DOI 10.1016/S0165-0270(00)00331-9; Orikasa C, 2010, NEUROSCI RES, V68, P9, DOI 10.1016/j.neures.2010.05.008; Orikasa C, 2010, J COMP NEUROL, V518, P3618, DOI 10.1002/cne.22419; Park JJ, 1996, J NEUROBIOL, V30, P315, DOI 10.1002/(SICI)1097-4695(199607)30:3<315::AID-NEU1>3.0.CO;2-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; PFEIFFER B, 1989, BRAIN RES, V476, P120, DOI 10.1016/0006-8993(89)91543-6; Prince KN, 1998, BRAIN RES BULL, V47, P349, DOI 10.1016/S0361-9230(98)00118-X; Roselli CE, 2007, ENDOCRINOLOGY, V148, P4450, DOI 10.1210/en.2007-0454; Sakuma Y, 2009, J NEUROENDOCRINOL, V21, P410, DOI 10.1111/j.1365-2826.2009.01856.x; Sickel MJ, 2000, J NEUROENDOCRINOL, V12, P397; Tsukahara S, 2009, J NEUROENDOCRINOL, V21, P370, DOI 10.1111/j.1365-2826.2009.01855.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weiss S, 1996, J NEUROSCI, V16, P7599; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yamamoto Masako, 2005, Journal of Toxicological Sciences, V30, P7; YOUNG JK, 1982, BRAIN RES, V239, P233, DOI 10.1016/0006-8993(82)90844-7	45	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54927	10.1371/journal.pone.0054927	http://dx.doi.org/10.1371/journal.pone.0054927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383001	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800089
J	Liou, LB; Tsai, WP; Chang, CJ; Chao, WJ; Chen, MH				Liou, Lieh-bang; Tsai, Wen-pin; Chang, Chee J.; Chao, Wan-ju; Chen, Meng-hsin			Blood Monocyte Chemotactic Protein-1 (MCP-1) and Adapted Disease Activity Score28-MCP-1: Favorable Indicators for Rheumatoid Arthritis Activity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG PENTRAXIN PTX3; ERYTHROCYTE SEDIMENTATION-RATE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SERUM-AMYLOID-P; RECOGNITION RECEPTOR PTX3; ACTIVITY SCORE DAS28; CHEMOATTRACTANT PROTEIN-1; METHOTREXATE THERAPY; MONOCLONAL-ANTIBODY	We assessed blood pentraxin 3 (PTX3) and macrophage chemotactic factor-1 (MCP-1) levels as indicators of disease activity in rheumatoid arthritis (RA) patients, because data on disease activity score 28 (DAS28)-erythrocyte sedimentation rate (ESR) and DAS28-C-reactive protein (CRP) are still imperfect. Methods: In 111 patients with RA, we examined longitudinal and cross-sectional correlations of blood PTX3, MCP-1, CRP, and ESR levels with measures of clinical arthritic activity, namely, swollen joint count (SJC), tender joint count (TJC), visual analog scale for general health (GH), DAS28, and adapted DAS28-MCP-1. Results: Blood MCP-1, but not PTX3, was significantly correlated with SJC, TJC, DAS28, and DAS28-CRP. DAS28-MCP-1 was strongly correlated with DAS28 (r = 0.984, P<0.001) and DAS28-CRP (r = 0.971, P<0.001), and modestly correlated with CRP (r = 0.350, P<0.001), and ESR (r = 0.386, P<0.001). Similarly, the duration of arthritic symptoms, but not sex, was significantly correlated with variables of arthritic activity. In particular, DAS28-MCP-1 significantly correlated with DAS28 during a 6-month period (r = 0.944, P<0.001; r = 0.951, P<0.001; r = 0.862, P<0.001; and r = 0.865, P<0.001 for month 0, 1, 3, and 6, respectively). Conclusion: Blood MCP-1 and adapted DAS28-MCP-1, but not blood PTX3, may be useful in monitoring RA activity.	[Liou, Lieh-bang; Chao, Wan-ju; Chen, Meng-hsin] Chang Gung Mem Hosp Lin Kou, Dept Rheumatol Allergy & Immunol, Kwei San Hsiang, Tao Yuan County, Taiwan; [Liou, Lieh-bang] Chang Gung Univ, Coll Med, Kwei San Hsiang, Tao Yuan County, Taiwan; [Tsai, Wen-pin] Chang Gung Mem Hosp Kee Lung, Dept Rheumatol Allergy & Immunol, Kee Lung City, Taiwan; [Chang, Chee J.] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Kwei San Hsiang, Tao Yuan County, Taiwan; [Chang, Chee J.] Chang Gung Univ, Inst Clin Med Sci, Kwei San Hsiang, Tao Yuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Liou, LB (corresponding author), Chang Gung Mem Hosp Lin Kou, Dept Rheumatol Allergy & Immunol, Kwei San Hsiang, Tao Yuan County, Taiwan.	b890121@cgmh.org.tw		Chang, Chee Jen/0000-0002-7725-7555	Chang Gung Medical Foundation Research Grant [CMRPG 360171-2]	Chang Gung Medical Foundation Research Grant	This work was supported by Chang Gung Medical Foundation Research Grant (CMRPG 360171-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2009, ARTHRITIS RHEUM, V60, P1242, DOI 10.1002/art.24433; ALLES VV, 1994, BLOOD, V84, P3483; Baldini M, 2012, ARTHRITIS RHEUM-US, V64, P854, DOI 10.1002/art.33411; Baruah P, 2006, BLOOD, V107, P151, DOI 10.1182/blood-2005-03-1112; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; Bevelacqua V, 2006, INT J MOL MED, V18, P415; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Cader MZ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-187; Chen HS, 2007, RHEUMATOLOGY, V46, P539, DOI 10.1093/rheumatology/kel343; Crowson CS, 2009, J RHEUMATOL, V36, P1606, DOI 10.3899/jrheum.081188; den Broeder AA, 2002, ANN RHEUM DIS, V61, P311, DOI 10.1136/ard.61.4.311; Dessein PH, 2004, J RHEUMATOL, V31, P1095; Ellingsen T, 2001, J RHEUMATOL, V28, P41; Gardiner PV, 2005, ANN RHEUM DIS, V64, P506, DOI 10.1136/ard.2004.025015; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hensor EMA, 2010, RHEUMATOLOGY, V49, P1521, DOI 10.1093/rheumatology/keq117; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Keenan RT, 2008, CLIN EXP RHEUMATOL, V26, P814; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kim J, 2009, CLIN EXP RHEUMATOL, V27, P773; Klimiuk PA, 2005, J RHEUMATOL, V32, P1666; Kou CF, 2008, CLIN RHEUMATOL, V27, P231; Kravitz MS, 2005, J CLIN IMMUNOL, V25, P582, DOI 10.1007/s10875-005-7828-2; Kremer JM, 2003, ARTHRITIS RHEUM, V48, P1493, DOI 10.1002/art.11142; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEE GW, 1993, J IMMUNOL, V150, P1804; Liou LB, 2003, CLIN EXP RHEUMATOL, V21, P437; Liu FC, 2008, CLIN RHEUMATOL, V27, P463, DOI 10.1007/s10067-007-0729-4; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Mamehara Akira, 2010, Kobe J Med Sci, V56, pE98; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Nyhall-Wahlin BM, 2011, SCAND J RHEUMATOL, V40, P81, DOI 10.3109/03009742.2010.509103; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Pincus T, 2009, RHEUM DIS CLIN N AM, V35, P731, DOI 10.1016/j.rdc.2009.10.007; Pope JE, 2011, SCAND J RHEUMATOL, V40, P232, DOI 10.3109/03009742.2010.517548; Pransen J, 2005, ANN RHEUM DIS, V64, P1294; Prevoo ML, 1995, ARTHRITIS RHEUM, V39, P44; Rajasekhar L, 2004, CLIN EXP RHEUMATOL, V22, P597; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Sato Y, 2005, J THORAC CARDIOV SUR, V130, P346, DOI 10.1016/j.jtcvs.2004.12.028; Taylor WJ, 2008, RHEUMATOLOGY, V47, P514, DOI 10.1093/rheumatology/ken004; Toussirot E, 2000, HUM IMMUNOL, V61, P303, DOI 10.1016/S0198-8859(99)00126-3; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; van Tuyl LHD, 2010, ARTHRIT CARE RES, V62, P108, DOI 10.1002/acr.20021; Ward MM, 2004, J RHEUMATOL, V31, P884; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Wolfe F, 1997, J RHEUMATOL, V24, P1477; Wolfe F, 2009, J RHEUMATOL, V36, P1568, DOI 10.3899/jrheum.090386; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	60	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55346	10.1371/journal.pone.0055346	http://dx.doi.org/10.1371/journal.pone.0055346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383162	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800144
J	Guo, FJ; Li, YL; Wang, JJ; Li, YD; Li, YH; Li, GC				Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng			Stanniocalcin1 (STC1) Inhibits Cell Proliferation and Invasion of Cervical Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; REGULATOR; APOPTOSIS; HYPOXIA; PROTEIN; MARKER; MUSCLE; GROWTH	STC1 is a glycoprotein hormone involved in calcium/phosphate (Pi) homeostasis. There is mounting evidence that STC1 is tightly associated with the development of cancer. But the function of STC1 in cancer is not fully understood. Here, we found that STC1 is down-regulated in Clinical tissues of cervical cancer compared to the adjacent normal cervical tissues (15 cases). Subsequently, the expression of STC1 was knocked down by RNA interference in cervical cancer CaSki cells and the low expression promoted cell growth, migration and invasion. We also found that STC1 overexpression inhibited cell proliferation and invasion of cervical cancer cells. Moreover, STC1 overexpression sensitized CaSki cells to drugs. Further, we showed that NF-kappa B p65 protein directly bound to STC1 promoter and activated the expression of STC1 in cervical cancer cells. Thus, these results provided evidence that STC1 inhibited cell proliferation and invasion through NF-kappa B p65 activation in cervical cancer.	[Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng] Cent S Univ, Xiangya Med Sch, Canc Res Inst, Changsha, Hunan, Peoples R China; [Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China; [Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng] Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Guo, Fengjie] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China	Central South University; Tianjin Medical University	Li, GC (corresponding author), Cent S Univ, Xiangya Med Sch, Canc Res Inst, Changsha, Hunan, Peoples R China.	libsun@163.com			National Natural Science Foundation of China [30672352]; Innovation Project of Postgraduate Education of Central South University [2340-74334000006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Postgraduate Education of Central South University	This work was supported by a grant from the National Natural Science Foundation of China (No. 30672352) and Innovation Project of Postgraduate Education of Central South University (No. 2340-74334000006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; Diaz-Padilla I, 2012, CANCER TREAT REV, V38, P767, DOI 10.1016/j.ctrv.2012.02.001; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Fujiwara Y, 2000, INT J ONCOL, V16, P799; Fukasawa M, 2004, J BIOCHEM, V136, P273, DOI 10.1093/jb/mvh137; Gerritsen ME, 2002, PHYSIOL GENOMICS, V10, P13, DOI 10.1152/physiolgenomics.00035.2002; Guo FJ, 2010, ONCOL REP, V23, P1449, DOI 10.3892/or_00000783; Hasilo CP, 2005, AM J PHYSIOL-ENDOC M, V289, pE634, DOI 10.1152/ajpendo.00098.2005; Ismail RS, 2000, CANCER RES, V60, P6744; Jiang WQ, 2000, J ENDOCRINOL, V165, P457, DOI 10.1677/joe.0.1650457; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Law AYS, 2008, EXP CELL RES, V314, P2975, DOI 10.1016/j.yexcr.2008.07.002; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Law AYS, 2011, J CELL BIOCHEM, V112, P2089, DOI 10.1002/jcb.23127; Li X, 2007, CANCER RES, V67, P8716, DOI 10.1158/0008-5472.CAN-06-3731; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; del Campo JM, 2008, GYNECOL ONCOL, V110, pS72, DOI 10.1016/j.ygyno.2008.04.016; McCudden CR, 2004, MOL CELL ENDOCRINOL, V213, P167, DOI 10.1016/j.mce.2003.10.042; Okabe H, 2001, CANCER RES, V61, P2129; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Tamura S, 2011, ANTICANCER RES, V31, P325; Thompson JS, 2010, APOPTOSIS, V15, P705, DOI 10.1007/s10495-010-0487-7; Tohmiya Y, 2004, TOHOKU J EXP MED, V204, P125, DOI 10.1620/tjem.204.125; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yoshiko Y, 2004, PEPTIDES, V25, P1663, DOI 10.1016/j.peptides.2004.04.015; Zaidi D, 2006, AM J PHYSIOL-ENDOC M, V291, pE974, DOI 10.1152/ajpendo.00601.2005	33	27	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53989	10.1371/journal.pone.0053989	http://dx.doi.org/10.1371/journal.pone.0053989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382863	Green Submitted, Green Published, gold			2022-12-25	WOS:000315483200056
J	Knaupp, AS; Keleher, S; Yang, L; Dai, WW; Bottomley, SP; Pearce, MC				Knaupp, Anja S.; Keleher, Shani; Yang, Li; Dai, Weiwen; Bottomley, Stephen P.; Pearce, Mary C.			The Roles of Helix I and Strand 5A in the Folding, Function and Misfolding of alpha(1)-Antitrypsin	PLOS ONE			English	Article							SERPIN POLYMERIZATION; CONFORMATIONAL-CHANGES; METASTABLE SERPIN; MOLECULAR-BASIS; F-HELIX; MECHANISM; ALPHA-1-ANTITRYPSIN; STABILITY; DISEASE; ALPHA(1)-ANTICHYMOTRYPSIN	alpha(1)-Antitrypsin, the archetypal member of the serpin superfamily, is a metastable protein prone to polymerization when exposed to stressors such as elevated temperature, low denaturant concentrations or through the presence of deleterious mutations which, in a physiological context, are often associated with disease. Experimental evidence suggests that alpha(1)-Antitrypsin can polymerize via several alternative mechanisms in vitro. In these polymerization mechanisms different parts of the molecule are proposed to undergo conformational change. Both strand 5 and helix I are proposed to adopt different conformations when forming the various polymers, and possess a number of highly conserved residues however their role in the folding and misfolding of alpha(1)-Antitrypsin has never been examined. We have therefore created a range of alpha(1)-Antitypsin variants in order to explore the role of these conserved residues in serpin folding, misfolding, stability and function. Our data suggest that key residues in helix I mediate efficient folding from the folding intermediate and residues in strand 5A ensure native state stability in order to prevent misfolding. Additionally, our data indicate that helix I is involved in the inhibitory process and that both structural elements undergo differing conformational rearrangements during unfolding and misfolding. These findings suggest that the ability of alpha(1)-Antitrypsin to adopt different types of polymers under different denaturing conditions may be due to subtle conformational differences in the transiently populated structures adopted prior to the I and M* states.	[Knaupp, Anja S.; Keleher, Shani; Yang, Li; Dai, Weiwen; Bottomley, Stephen P.; Pearce, Mary C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Bottomley, SP (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	steve.bottomley@monash.edu; mary.pearce@monash.edu		Knaupp, Anja/0000-0003-0493-7872	NHMRC National Health and Medical Research Council Program Grant; PRF fellowship from the NHMRC; AlphaOne Foundation	NHMRC National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); PRF fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); AlphaOne Foundation	This project was supported by a NHMRC National Health and Medical Research Council Program Grant, a PRF fellowship from the NHMRC to SPB, and an Postdoctoral Fellowship from the AlphaOne Foundation to MCP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; Cabrita LD, 2002, BIOCHEMISTRY-US, V41, P4575, DOI 10.1021/bi0158932; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 2004, METHODS, V32, P150, DOI 10.1016/S1046-2023(03)00206-8; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Devlin GL, 2005, FRONT BIOSCI-LANDMRK, V10, P288, DOI 10.2741/1528; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Huntington JA, 2010, BIOL CHEM, V391, P973, DOI 10.1515/BC.2010.085; Im H, 1999, J BIOL CHEM, V274, P11072, DOI 10.1074/jbc.274.16.11072; Im H, 2000, PROTEIN SCI, V9, P934, DOI 10.1110/ps.9.5.934; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; James EL, 1998, ARCH BIOCHEM BIOPHYS, V356, P296, DOI 10.1006/abbi.1998.0751; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Knaupp AS, 2011, J MOL BIOL, V413, P888, DOI 10.1016/j.jmb.2011.09.013; Knaupp AS, 2010, J MOL BIOL, V396, P375, DOI 10.1016/j.jmb.2009.11.048; Koloczek H, 1996, J PROTEIN CHEM, V15, P447, DOI 10.1007/BF01886851; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; Levina V, 2009, PROTEIN EXPR PURIF; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Pearce MC, 2000, J BIOL CHEM, V275, P28513, DOI 10.1074/jbc.M004310200; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; Tew DJ, 2001, J MOL BIOL, V313, P1161, DOI 10.1006/jmbi.2001.5104; Tsutsui Y, 2012, P NATL ACAD SCI US; Tsutsui Y, 2007, J MOL BIOL, V371, P245, DOI 10.1016/j.jmb.2007.05.039; Tsutsui Y, 2012, P NATL ACAD SCI USA, V109, P4467, DOI 10.1073/pnas.1109125109; Whisstock JC, 2000, J MOL BIOL, V296, P685, DOI 10.1006/jmbi.1999.3520; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	37	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54766	10.1371/journal.pone.0054766	http://dx.doi.org/10.1371/journal.pone.0054766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382962	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200060
J	Wu, CL; Lu, J; Wang, MH; Lv, X; Chen, Y; Kung, HF; Zee, B; Cheng, XW; He, ML				Wu, Chun-Li; Lu, Juan; Wang, Maggie Haitian; Lv, Xing; Chen, Ying; Kung, Hsiang-fu; Zee, Benny; Cheng, Xiao-wen; He, Ming-Liang			Cross Sectional Survey of Influenza Antibodies before and during the 2009 Pandemic in Shenzhen, China	PLOS ONE			English	Article							H1N1 INFLUENZA; VIRUS INFECTION; EMERGENCE; RESIDENTS; A(H1N1); TITERS	Much information is available for the 2009 H1N1 influenza immunity response, but little is known about the antibody change in seasonal influenza before and during the novel influenza A pandemic. In this study, we conducted a cross-sectional serological survey of 4 types of major seasonal influenza in March and September 2009 on a full range of age groups, to investigate seasonal influenza immunity response before and during the outbreak of the sH1N1 influenza in Shenzhen - the largest migration city in China. We found that the 0-5 age group had an increased antibody level for all types of seasonal influenza during the pandemic compared to the pre-outbreak level, in contrast with almost all other age groups, in which the antibody level decreased. Also, distinct from the antibodies of A/H3N2, B/Yamagata and B/Victoria that decreased significantly during the 2009 H1N1 pandemic, the antibody of A/H1N1 showed no statistical difference from the pre-outbreak level. The results suggest that the antibodies against the 2009 sH1N1 cross-reacted with seasonal H1N1. Moreover, the 0-5 age group was under attack by both seasonal and 2009 H1N1 influenza during the pandemic, hence vaccination merely against a new strain of flu might not be enough to protect the youngest group.	[Wu, Chun-Li; Lv, Xing; Cheng, Xiao-wen] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Lu, Juan] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Wang, Maggie Haitian; Zee, Benny] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Biostat, Hong Kong, Hong Kong, Peoples R China; [Lu, Juan; Chen, Ying; Kung, Hsiang-fu; He, Ming-Liang] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [He, Ming-Liang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Southern Medical University - China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	He, ML (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	mlhe7788@gmail.com	Wang, Maggie Haitian/F-5954-2017; Zee, Benny Chung Ying/G-5606-2017; HE, Ming-Liang/AFK-4738-2022; HE, Ming-Liang/AAG-3397-2022	Wang, Maggie Haitian/0000-0003-1223-4595; Zee, Benny Chung Ying/0000-0002-7238-845X; HE, Mingliang/0000-0002-9942-9151; He, Ming-Liang/0000-0002-4317-2836	Chinese University of Hong Kong [2041755]; Food and Health Bureau; government of Hong Kong Special Administrative Region, China [CU-10-01-01]	Chinese University of Hong Kong(Chinese University of Hong Kong); Food and Health Bureau; government of Hong Kong Special Administrative Region, China	This work was supported by the Chinese University of Hong Kong [Direct Grant 2041755] and The Food and Health Bureau, the government of Hong Kong Special Administrative Region, China [Commissioned Grant of Research Fund for Control of Infectious Diseases (CU-10-01-01)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUGH M, 1978, AVIAN DIS, V22, P362, DOI 10.2307/1589552; Cheng XW, 2008, J MED VIROL, V80, P1058, DOI 10.1002/jmv.21130; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kendal AP, 1982, CONCEPTS PROCEDURES; Klein SL, 2010, BIOL SEX DIFFER, V1, P5; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nauta JJP, 2006, VACCINE, V24, P6645, DOI 10.1016/j.vaccine.2006.05.052; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2009, EUROSURVEILLANCE, V14, P1; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Xie X, 2012, EPIDEMIOL INFECT, V140, P788, DOI 10.1017/S0950268811001312; Zhang XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025822; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53847	10.1371/journal.pone.0053847	http://dx.doi.org/10.1371/journal.pone.0053847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382854	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200017
J	Hawse, JR; Subramaniam, M; Cicek, M; Wu, XL; Gingery, A; Grygo, SB; Sun, ZF; Pitel, KS; Lingle, WL; Goetz, MP; Ingle, JN; Spelsberg, TC				Hawse, John R.; Subramaniam, Malayannan; Cicek, Muzaffer; Wu, Xianglin; Gingery, Anne; Grygo, Sarah B.; Sun, Zhifu; Pitel, Kevin S.; Lingle, Wilma L.; Goetz, Matthew P.; Ingle, James N.; Spelsberg, Thomas C.			Endoxifen's Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens	PLOS ONE			English	Article							BREAST-CANCER-CELLS; ESTROGEN-RECEPTOR; TAMOXIFEN METABOLITE; RANDOMIZED-TRIALS; CYP2D6 GENOTYPE; INHIBITORS; THERAPY; GROWTH; ALPHA	Endoxifen, a cytochrome P450 mediated tamoxifen metabolite, is being developed as a drug for the treatment of estrogen receptor (ER) positive breast cancer. Endoxifen is known to be a potent anti-estrogen and its mechanisms of action are still being elucidated. Here, we demonstrate that endoxifen-mediated recruitment of ER alpha to known target genes differs from that of 4-hydroxy-tamoxifen (4HT) and ICI-182,780 (ICI). Global gene expression profiling of MCF7 cells revealed substantial differences in the transcriptome following treatment with 4HT, endoxifen and ICI, both in the presence and absence of estrogen. Alterations in endoxifen concentrations also dramatically altered the gene expression profiles of MCF7 cells, even in the presence of clinically relevant concentrations of tamoxifen and its metabolites, 4HT and N-desmethyl-tamoxifen (NDT). Pathway analysis of differentially regulated genes revealed substantial differences related to endoxifen concentrations including significant induction of cell cycle arrest and markers of apoptosis following treatment with high, but not low, concentrations of endoxifen. Taken together, these data demonstrate that endoxifen's mechanism of action is different from that of 4HT and ICI and provide mechanistic insight into the potential importance of endoxifen in the suppression of breast cancer growth and progression.	[Hawse, John R.; Subramaniam, Malayannan; Cicek, Muzaffer; Wu, Xianglin; Gingery, Anne; Grygo, Sarah B.; Pitel, Kevin S.; Spelsberg, Thomas C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Sun, Zhifu] Mayo Clin, Bioinformat Core, Div Biomed Stat & Informat, Rochester, MN USA; [Lingle, Wilma L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Goetz, Matthew P.; Ingle, James N.] Mayo Clin, Dept Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Hawse, JR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	hawse.john@mayo.edu	Goetz, Matthew P/AAH-2333-2020	Gingery, Anne/0000-0002-1690-7382; Harrington, Jon/0000-0003-1293-5201; Sun, Zhifu/0000-0001-8461-7523	Breast Cancer Research Foundation; Mayo Clinic Breast Cancer [SPORE: P50CA116201]; National Center for Advancing Translational Sciences; Mayo Foundation; Paul Calabresi K12 award NCI [CA90628]; CTSA Grant [UL1 TR000135]; Susan G. Komen for the Cure [KG100142]; NATIONAL CANCER INSTITUTE [P50CA116201, K12CA090628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Mayo Clinic Breast Cancer; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; Paul Calabresi K12 award NCI; CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a Breast Cancer Research Foundation grant (JNI), Susan G. Komen for the Cure KG100142 (JRH), the Mayo Clinic Breast Cancer SPORE: P50CA116201 (JNI), a generous gift from Bruce and Martha Atwater (TCS, JRH, MPG, JNI), a Paul Calabresi K12 award NCI CA90628 (JRH), a CTSA Grant: UL1 TR000135 supporting JRH from the National Center for Advancing Translational Sciences and the Mayo Foundation (TCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Clarke R, 2001, PHARMACOL REV, V53, P25; COEZY E, 1982, CANCER RES, V42, P317; Crewe HK, 2004, BRIT J CLIN PHARMACO, V58, pS744, DOI 10.1111/j.1365-2125.2004.02282.x; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Early Breast Cancer Trialists' Collaborative Group, 1998, LANCET, V351, P1451; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Jordan V C, 1982, Breast Cancer Res Treat, V2, P123, DOI 10.1007/BF01806449; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; Lim YC, 2005, CANCER CHEMOTH PHARM, V55, P471, DOI 10.1007/s00280-004-0926-7; Lim YC, 2006, J PHARMACOL EXP THER, V318, P503, DOI 10.1124/jpet.105.100511; Madlensky L, 2011, CLIN PHARMACOL THER, V89, P718, DOI 10.1038/clpt.2011.32; MAUVAISJARVIS P, 1986, CANCER RES, V46, P1521; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933	23	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54613	10.1371/journal.pone.0054613	http://dx.doi.org/10.1371/journal.pone.0054613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382923	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500020
J	Pajevic, S; Basser, PJ				Pajevic, Sinisa; Basser, Peter J.			An Optimum Principle Predicts the Distribution of Axon Diameters in Normal White Matter	PLOS ONE			English	Article							STATISTICAL SOFTWARE; CEREBRAL-CORTEX; NERVE-FIBER; SCALING LAW; GRAY-MATTER; INFORMATION; TRANSMISSION; RELIABILITY; CAPACITY	Many important functional properties affecting nerve conduction are influenced by axon diameter. It is also known that the axon diameter distribution (ADD) in normal nerve fascicles is heterogeneous and skewed. A recent attempt to model and explain the parametric form of these distributions was based on biomechanical principles. Here we explore a neurophysiologically-based hypothesis that the observed ADD can be obtained by optimizing the information flow through a fascicle subject to reasonable anatomical and metabolic constraints. Specifically, we use a variational framework to find an optimal distribution based on the fascicle's channel capacity and informative upper bound (IUB), subject to constraints of fixed available fascicle cross-sectional area and fixed number of axons, to derive two novel probability density functions, which we then compare to other previously used distributions. We show, using experimental histological data, that the distributions based on this optimum principle outperform other distributions. Moreover, the new distribution that optimizes the IUB is extremely robust in fitting ADD data obtained histologically, making it well-suited for use in MRI techniques to measure ADDs in vivo, e.g., AxCaliber MRI.	[Pajevic, Sinisa] NIH, Math & Stat Comp Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Basser, Peter J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Tissue Biophys & Biomimet, Program Pediat Imaging & Tissue Sci, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pajevic, S (corresponding author), NIH, Math & Stat Comp Lab, Div Computat Biosci, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA.	pajevic@nih.gov			Intramural Research Program of the Division of Computational Bioscience in the Center for Information Technology, National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000275] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Computational Bioscience in the Center for Information Technology, National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	SP was supported by the Intramural Research Program of the Division of Computational Bioscience in the Center for Information Technology, National Institutes of Health (NIH). PJB was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1975, BIOL CYBERN, V19, P121, DOI 10.1007/BF00337250; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aitchison J., 1963, LOGNORMAL DISTRIBUTI; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Basser Peter J., 2004, Journal of Integrative Neuroscience, V3, P227, DOI 10.1142/S0219635204000427; Blair EA, 1933, AM J PHYSIOL, V106, P524, DOI 10.1152/ajplegacy.1933.106.3.524; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Gov NS, 2009, EUR PHYS J E, V29, P337, DOI 10.1140/epje/i2009-10476-8; He JH, 2006, CHAOS SOLITON FRACT, V27, P864, DOI 10.1016/j.chaos.2005.04.081; HEATH DF, 1967, NATURE, V213, P1159, DOI 10.1038/2131159a0; Hildebrand F.B., 1965, METHODS APPL MATH; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; JACOBSON H, 1950, SCIENCE, V112, P143, DOI 10.1126/science.112.2901.143; JACOBSON H, 1951, SCIENCE, V113, P292, DOI 10.1126/science.113.2933.292; Keeling KB, 2007, COMPUT STAT DATA AN, V51, P3811, DOI 10.1016/j.csda.2006.02.013; LASS Y, 1975, BIOL CYBERN, V19, P61, DOI 10.1007/BF00364102; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; MacKAY DONALD M., 1952, BULL MATH BIOPHYS, V14, P127, DOI 10.1007/BF02477711; Odeh OO, 2010, AM J AGR ECON, V92, P1472, DOI 10.1093/ajae/aaq068; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pajevic S, 2008, 2008 NEUR M PLANN SO, P8179; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; PUMPHREY R. J., 1938, JOUR EXP BIOL, V15, P453; RAPOPORT A, 1960, INFORM CONTR, V3, P335; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; Tasaki I, 1939, AM J PHYSIOL, V127, P211, DOI 10.1152/ajplegacy.1939.127.2.211; Tasaki I, 1943, JAPANESE J MED SCI 3, V9, P189; Tasaki I, 2008, COMMUNICATION; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	36	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54095	10.1371/journal.pone.0054095	http://dx.doi.org/10.1371/journal.pone.0054095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382870	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500009
J	Kai, K; Iwamoto, T; Kobayashi, T; Arima, Y; Takamoto, Y; Ohnishi, N; Bartholomeusz, C; Horii, R; Akiyama, F; Hortobagyi, GN; Pusztai, L; Saya, H; Ueno, NT				Kai, K.; Iwamoto, T.; Kobayashi, T.; Arima, Y.; Takamoto, Y.; Ohnishi, N.; Bartholomeusz, C.; Horii, R.; Akiyama, F.; Hortobagyi, G. N.; Pusztai, L.; Saya, H.; Ueno, N. T.			Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells	ONCOGENE			English	Article						Ink4a/Arf; HRAS(G12V); Triple-negative breast cancer; Intratumoral heterogeneity; Tumor-initiating cell	TUMOR-INITIATING CELLS; HEPATIC STELLATE CELLS; GENE-EXPRESSION; STEM-CELLS; MOLECULAR CHARACTERIZATION; MESENCHYMAL TRANSITION; RAS ACTIVATION; CLAUDIN-LOW; IDENTIFICATION; MODEL	Intratumoral heterogeneity within individual breast tumors is a well-known phenomenon that may contribute to drug resistance. This heterogeneity is dependent on several factors, such as types of oncogenic drivers and tumor precursor cells. The purpose of our study was to engineer a mouse mammary tumor model with intratumoral heterogeneity by using defined genetic perturbations. To achieve this, we used mice with knockout (-/-) of Ink4a/Arf, a tumor suppressor locus; these mice are known to be susceptible to non-mammary tumors such as fibrosarcoma. To induce mammary tumors, we retrovirally introduced an oncogene, HRAS(G12V), into Ink4a/Arf(-/-) mammary cells in vitro, and those cells were inoculated into syngeneic mice mammary fat pads. We observed 100% tumorigenesis. The tumors formed were negative for estrogen receptor, progesterone receptor and HER2. Further, they had pathological features similar to those of human triple-negative breast cancer (TNBC) (for example, pushing borders, central necrosis). The tumors were found to be heterogeneous and included two subpopulations: CD49f(-) quiescent cells and CD49f(-) cells. Contrary to our expectation, CD49f(-) quiescent cells had high tumor-initiating potential and CD49f(-) cells had relatively low tumor-initiating potential. Gene expression analysis revealed that CD49f(-) quiescent cells overexpressed epithelial-to-mesenchymal transition-driving genes, reminiscent of tumor-initiating cells and claudin-low breast cancer. Our animal model with intratumoral heterogeneity, derived from defined genetic perturbations, allows us to test novel molecular targeted drugs in a setting that mimics the intratumoral heterogeneity of human TNBC.	[Kai, K.; Bartholomeusz, C.; Pusztai, L.; Ueno, N. T.] Univ Texas MD Anderson Canc Ctr, Breast Canc Translat Res Lab, Houston, TX 77030 USA; [Kai, K.; Iwamoto, T.; Bartholomeusz, C.; Hortobagyi, G. N.; Pusztai, L.; Ueno, N. T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Kai, K.; Kobayashi, T.; Arima, Y.; Takamoto, Y.; Ohnishi, N.; Saya, H.] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Horii, R.; Akiyama, F.] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Keio University; Japanese Foundation for Cancer Research	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan.	hsaya@a5.keio.jp; nueno@mdanderson.org	Saya, Hideyuki/J-4325-2013; Pusztai, Lajos/AAB-2901-2019	Arima, Yoshimi/0000-0002-2384-1406; Saya, Hideyuki/0000-0001-6610-1902	Japan Society for the Promotion of Science, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; US National Institutes of Health through MD Anderson's Cancer Center Support Grant [5 P30 CA016672-36, R01 CA123318-01A1]; Nellie B Connally Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA123318] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health through MD Anderson's Cancer Center Support Grant; Nellie B Connally Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N Suzuki, Y Ito and S Hayashi for excellent animal husbandry, I Ishimatsu for expert assistance with histology and K Hashimoto for expert help in the flow cytometry lab. We thank T Suda and MC Hung for invaluable discussions. Thanks are also owed to M Fujiwara for expert help with microarray analysis, T Ishimoto for technical help with confocal microscopy and SC Patterson for editorial assistance. This work was supported by grants from the Japan Society for the Promotion of Science, Japan (to KK and HS). KK was supported by the program 'Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation' by the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was also supported in part by the US National Institutes of Health through MD Anderson's Cancer Center Support Grant (5 P30 CA016672-36), grant R01 CA123318-01A1 (to NTU) and by the Nellie B Connally Breast Cancer Research Fund and a donation from Mr and Mrs Sidney J Jansma, Jr.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bartholomeusz C, 2012, MOL CANCER THER, V11, P360, DOI 10.1158/1535-7163.MCT-11-0400; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cardiff RD, 2010, J MAMMARY GLAND BIOL, V15, P225, DOI 10.1007/s10911-010-9184-y; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cho JJ, 2000, GASTROENTEROLOGY, V118, P1169, DOI 10.1016/S0016-5085(00)70370-2; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cui XS, 2000, ONCOGENE, V19, P5988, DOI 10.1038/sj.onc.1203993; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2003, CANCER RES, V63, P5821; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	47	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 23	2014	33	4					440	448		10.1038/onc.2012.609	http://dx.doi.org/10.1038/onc.2012.609			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	296VX	23376849	Green Accepted			2022-12-25	WOS:000330214600005
J	Arshad, M; Ye, ZD; Gu, XF; Wong, CK; Liu, Y; Li, D; Zhou, LK; Zhang, Y; Bay, WP; Yu, VC; Li, P				Arshad, Muhammad; Ye, Zhongde; Gu, Xiaofeng; Wong, Chung Kai; Liu, Yang; Li, De; Zhou, Linkang; Zhang, Yi; Bay, Wan Ping; Yu, Victor C.; Li, Peng			RNF13, a RING Finger Protein, Mediates Endoplasmic Reticulum Stress-induced Apoptosis through the Inositol-requiring Enzyme (IRE1 alpha)/c-Jun NH2-terminal Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER; ACTIVATION; JNK; TRANSLOCATION; DEATH; STEP; BIM	Disturbance of homeostasis at endoplasmic reticulum (ER) causes stress to cells that in turn triggers an adaptive signaling pathway termed unfolded protein response for the purpose of restoring normal cellular physiology or initiating signaling events leading to apoptosis. Identification of those genes that are involved in the unfolded protein response-mediated apoptotic signaling pathway would be valuable toward elucidating the molecular mechanism underlying the relationship between ER stress and apoptosis. We initiated a genetic screen by using the retroviral insertion mutation system to search for genes whose inactivation confers resistance to apoptosis induction by staurosporine. Using this approach, RING finger protein 13 (RNF13) was identified. Interestingly, RNF13 is highly enriched in ER. RNF13 knockdown cells are resistant to apoptosis and JNK activation triggered by ER stress. Conversely, overexpression of RNF13 induces JNK activation and caspase-dependent apoptosis. The RING and transmembrane domains of RNF13 are both required for its effects on JNK activation and apoptosis. Moreover, systematic analysis of the involvement of individual signaling components in the ER stress pathway using knockdown approach reveals that RNF13 acts upstream of the IRE1 alpha-TRAF2 signaling axis for JNK activation and apoptosis. Finally, RNF13 co-immunoprecipitates with IRE1 alpha, and the intact RING domain is also required for mediating its interaction. Together, our data support a model that RNF13 is a critical mediator for facilitating ER stress-induced apoptosis through the activation of the IRE1 alpha-TRAF2-JNK signaling pathway.	[Arshad, Muhammad; Ye, Zhongde; Gu, Xiaofeng; Liu, Yang; Zhou, Linkang; Li, Peng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Wong, Chung Kai] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong 100044, Hong Kong, Peoples R China; [Li, De] Tsinghua Univ, Ctr Biomed Anal, Beijing 100084, Peoples R China; [Zhang, Yi] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Bay, Wan Ping; Yu, Victor C.] Natl Univ Singapore, Dept Pharm, Singapore 119077, Singapore; [Arshad, Muhammad] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad 44000, Pakistan	Tsinghua University; Hong Kong University of Science & Technology; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; International Islamic University, Pakistan	Li, P (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn	Yu, Victor/A-7899-2015; Zhou, Linkang/AAH-9911-2020; Zhou, Linkang/C-8812-2015	Yu, Victor/0000-0003-3270-4734; Zhou, Linkang/0000-0002-7009-5776; Zhang, Yi/0000-0003-2785-1780; LIU, Yang/0000-0002-4428-3562	National Natural Science Foundation of China [30670418]; National High Technology Research and Development Program from the Ministry of Science and Technology of China [2010AA023002]; Singapore Ministry of Health National Medical Research Council [NMRC/1317/2011]; National University of Singapore [R148-000-121-133]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA023002] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Natural Science Foundation of China Grant 30670418 (to P. L.) and National High Technology Research and Development Program Grant 2010AA023002 from the Ministry of Science and Technology of China.; Supported by grants from Singapore Ministry of Health National Medical Research Council under its Individual Research Grant (NMRC/1317/2011) and National University of Singapore (R148-000-121-133). A Minjiang Scholar Chair Professor at School of Life Sciences, Xiamen University, China.	Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hoeflich KP, 1999, ONCOGENE, V18, P5814, DOI 10.1038/sj.onc.1202975; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li JQ, 2004, J CELL SCI, V117, P4673, DOI 10.1242/jcs.01339; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Plonne D, 1999, ANAL BIOCHEM, V276, P88, DOI 10.1006/abio.1999.4311; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito S, 2005, PHYSIOL GENOMICS, V22, P8, DOI 10.1152/physiolgenomics.00142.2004; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tranque P, 1996, P NATL ACAD SCI USA, V93, P3105, DOI 10.1073/pnas.93.7.3105; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang Q, 2010, FEBS J, V277, P466, DOI 10.1111/j.1742-4658.2009.07498.x; Zhang Q, 2009, CELL RES, V19, P348, DOI 10.1038/cr.2008.285	28	34	36	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8726	8736		10.1074/jbc.M112.368829	http://dx.doi.org/10.1074/jbc.M112.368829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378536	Green Published, hybrid			2022-12-25	WOS:000316564500072
J	Aistleitner, K; Heinz, C; Hormann, A; Heinz, E; Montanaro, J; Schulz, F; Maier, E; Pichler, P; Benz, R; Horn, M				Aistleitner, Karin; Heinz, Christian; Hoermann, Alexandra; Heinz, Eva; Montanaro, Jacqueline; Schulz, Frederik; Maier, Elke; Pichler, Peter; Benz, Roland; Horn, Matthias			Identification and Characterization of a Novel Porin Family Highlights a Major Difference in the Outer Membrane of Chlamydial Symbionts and Pathogens	PLOS ONE			English	Article							SINGLE-CHANNEL ANALYSIS; MATRIX PROTEIN PORIN; PROTOCHLAMYDIA-AMOEBOPHILA; ESCHERICHIA-COLI; DEVELOPMENTAL CYCLE; SIGNAL PEPTIDES; CELL-WALL; TRACHOMATIS; PSITTACI; EXPRESSION	The Chlamydiae constitute an evolutionary well separated group of intracellular bacteria comprising important pathogens of humans as well as symbionts of protozoa. The amoeba symbiont Protochlamydia amoebophila lacks a homologue of the most abundant outer membrane protein of the Chlamydiaceae, the major outer membrane protein MOMP, highlighting a major difference between environmental chlamydiae and their pathogenic counterparts. We recently identified a novel family of putative porins encoded in the genome of P. amoebophila by in silico analysis. Two of these Protochlamydia outer membrane proteins, PomS (pc1489) and PomT (pc1077), are highly abundant in outer membrane preparations of this organism. Here we show that all four members of this putative porin family are toxic when expressed in the heterologous host Escherichia coli. Immunofluorescence analysis using antibodies against heterologously expressed PomT and PomS purified directly from elementary bodies, respectively, demonstrated the location of both proteins in the outer membrane of P. amoebophila. The location of the most abundant protein PomS was further confirmed by immuno-transmission electron microscopy. We could show that pomS is transcribed, and the corresponding protein is present in the outer membrane throughout the complete developmental cycle, suggesting an essential role for P. amoebophila. Lipid bilayer measurements demonstrated that PomS functions as a porin with anion-selectivity and a pore size similar to the Chlamydiaceae MOMP. Taken together, our results suggest that PomS, possibly in concert with PomT and other members of this porin family, is the functional equivalent of MOMP in P. amoebophila. This work contributes to our understanding of the adaptations of symbiotic and pathogenic chlamydiae to their different eukaryotic hosts.	[Aistleitner, Karin; Heinz, Christian; Hoermann, Alexandra; Heinz, Eva; Montanaro, Jacqueline; Schulz, Frederik; Horn, Matthias] Univ Vienna, Dept Microbial Ecol, Vienna, Austria; [Maier, Elke] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forschungsgemeinschaft, Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Pichler, Peter] Christian Doppler Lab Mass Spectrometry, Vienna, Austria; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany	University of Vienna; German Research Foundation (DFG); University of Wurzburg; University of Bremen	Horn, M (corresponding author), Univ Vienna, Dept Microbial Ecol, Vienna, Austria.	horn@microbial-ecology.net	Heinz, Eva/I-2053-2014; Horn, Matthias/G-1136-2011	Heinz, Eva/0000-0003-4413-3756; Horn, Matthias/0000-0002-8309-5855; Benz, Roland/0000-0002-9510-9265	German Science Foundation [BE 865/16]; Austrian Science Fund (FWF) [Y277-B03]; Austrian Science Fund (FWF) [Y 277] Funding Source: researchfish	German Science Foundation(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the German Science Foundation to RB (BE 865/16) and the Austrian Science Fund (FWF) to MH (Y277-B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abeyrathne PD, 2007, CAN J MICROBIOL, V53, P526, DOI 10.1139/W07-007; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Alphen W V, 1977, J Bacteriol, V131, P623; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bagos PG., 2004, WSEAS T BIOL BIOMED, V2, P186; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; Benz R, 2001, PORINS STRUCTURE FUC; Benz R., 1994, BACTERIAL CELL WALL; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Borges V, 2010, J MICROBIOL METH, V82, P256, DOI 10.1016/j.mimet.2010.06.013; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CALDWELL HD, 1982, INFECT IMMUN, V38, P745, DOI 10.1128/IAI.38.2.745-754.1982; Collier TS, 2010, ANAL CHEM, V82, P8696, DOI 10.1021/ac101978b; Collingro A, 2005, INT J SYST EVOL MICR, V55, P1863, DOI 10.1099/ijs.0.63572-0; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; EVERETT KDE, 1995, J BACTERIOL, V177, P877, DOI 10.1128/jb.177.4.877-882.1995; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; HATCH TP, 1981, J BACTERIOL, V146, P426, DOI 10.1128/JB.146.1.426-429.1981; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hatch TP, 1996, J BACTERIOL, V178, P1; HATCH TP, 1984, J BACTERIOL, V157, P13, DOI 10.1128/JB.157.1.13-20.1984; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Heinz E, 2010, PROTEOMICS, V10, P4363, DOI 10.1002/pmic.201000302; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANN REV MIC IN PRESS, V62; Hughes ES, 2001, INFECT IMMUN, V69, P1671, DOI 10.1128/IAI.69.3.1671-1678.2001; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KOEHLER JE, 1992, MOL MICROBIOL, V6, P1087; Kubo A, 2000, MOL MICROBIOL, V38, P772, DOI 10.1046/j.1365-2958.2000.02167.x; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MCCAFFERTY MC, 1995, INFECT IMMUN, V63, P2387, DOI 10.1128/IAI.63.6.2387-2389.1995; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; NEWHALL WJ, 1987, INFECT IMMUN, V55, P162, DOI 10.1128/IAI.55.1.162-168.1987; NEWHALL WJ, 1983, J BACTERIOL, V154, P998, DOI 10.1128/JB.154.2.998-1001.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997; PEELING R, 1984, INFECT IMMUN, V46, P484, DOI 10.1128/IAI.46.2.484-488.1984; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; RAULSTON JE, 1995, MOL MICROBIOL, V15, P607, DOI 10.1111/j.1365-2958.1995.tb02370.x; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; RITTER K, 1991, J IMMUNOL METHODS, V137, P209, DOI 10.1016/0022-1759(91)90026-C; SALARI SH, 1981, J GEN MICROBIOL, V123, P197; SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751; SEN K, 1988, J BIOL CHEM, V263, P1182; Stephens RS, 1999, CHLAMYDIA, P9; STEPHENS RS, 1982, J IMMUNOL, V128, P1083; Stothard DR, 1998, INFECT IMMUN, V66, P3618, DOI 10.1128/IAI.66.8.3618-3625.1998; SU H, 1991, INFECT IMMUN, V59, P2843, DOI 10.1128/IAI.59.8.2843-2845.1991; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; TAN TW, 1990, INFECT IMMUN, V58, P3101, DOI 10.1128/IAI.58.9.3101-3108.1990; Tanzer RJ, 2001, J BACTERIOL, V183, P2686, DOI 10.1128/JB.183.8.2686-2690.2001; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; WARD ME, 1984, J GEN MICROBIOL, V130, P1765; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; WELTE W, 1995, KIDNEY INT, V48, P930, DOI 10.1038/ki.1995.374; Wyllie S, 1998, INFECT IMMUN, V66, P5202, DOI 10.1128/IAI.66.11.5202-5207.1998; Wyllie S, 1999, FEBS LETT, V445, P192, DOI 10.1016/S0014-5793(99)00121-0; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	86	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55010	10.1371/journal.pone.0055010	http://dx.doi.org/10.1371/journal.pone.0055010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383036	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600055
J	Honarvar, B; Moghadami, M; Moattari, A; Emami, A; Odoomi, N; Lankarani, KB				Honarvar, Behnam; Moghadami, Mohsen; Moattari, Afagh; Emami, Amir; Odoomi, Neda; Lankarani, Kamran Bagheri			Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign	PLOS ONE			English	Article							CHILDBEARING AGE; INFECTION; IMMUNITY; ELIMINATION; POPULATION; UNIVERSITY; PROGRESS	Objective: Nonimmune pregnant women are at risk of developing congenital rubella syndrome and measles complications. We aimed to identify pregnant women susceptible to rubella or measles in order to determine the need for immunity screening and supplemental immunization in women of childbearing age. Method: This seroprevalence survey was conducted by convenience sampling in obstetric hospitals affiliated with Shiraz University of Medical Sciences (southern Iran). Serum IgG levels were measured by ELISA. Result: Mean age of the 175 pregnant women was 27.3 +/- 5.3 (range 16 to 42) years. The geometric mean concentration of anti-rubella IgG was 14.9 IU/mL (CI 95%,14.1-15.5), and that of anti-measles IgG was 13.8 IU/mL (CI 95%, 13-14.5). One hundred sixty-eight women (96%) had a protective serologic level (>11 IU/mL) of IgG against rubella, and 143 (81.7%) had a protective level against measles. Except for a significant inverse correlation that was showed by univariate analysis between anti-rubella IgG and the women's age (P = 0.01), immunity did not correlate with demographic or obstetric characteristics or medical history. There was no significant correlation between anti-rubella and anti-measles IgG levels (P = 0.25). Conclusion: Nearly a decade after Iran's nationwide measles-rubella vaccination campaign for the population aged 5-25 years, most pregnant women up to 34 years of age had humoral immunity against rubella. We recommend rubella immunity screening or catch-up immunization for women older than 35 years who wish to become pregnant, and measles immunity screening and appropriate vaccination for all women of childbearing age.	[Honarvar, Behnam; Lankarani, Kamran Bagheri] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran; [Moghadami, Mohsen] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Shiraz, Iran; [Moattari, Afagh; Emami, Amir] Shiraz Univ Med Sci, Dept Virol, Sch Med, Shiraz, Iran; [Odoomi, Neda] Shiraz Univ Med Sci, Dept Hlth, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Honarvar, B (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran.	honarvarbh32@yahoo.com	Lankarani, Kamran B/P-5336-2019; Moattari, Afagh/U-8143-2017; moghadami, mohsen/T-6539-2018; Honarvar, Behnam/K-1623-2013; Lankarani, Kamran Bagheri/P-2066-2017; Emami, Amir/H-1024-2016; lankarani, kamran b/D-5901-2012	Lankarani, Kamran B/0000-0002-7524-9017; Moattari, Afagh/0000-0003-4394-9622; moghadami, mohsen/0000-0001-8015-0313; Honarvar, Behnam/0000-0002-1081-5778; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Emami, Amir/0000-0002-4510-1820; 	Health Policy Research Center [HP-90-2]; Shiraz University of Medical Sciences, Shiraz, Iran	Health Policy Research Center; Shiraz University of Medical Sciences, Shiraz, Iran	This study was implemented by authors and based on priorities that have been announced by Health Policy Research Center affiliated with Shiraz University of Medical Sciences. The Health Policy Research Center sponsored this study by grunt number of HP-90-2. However, This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the Health Policy Research Center affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. We thank the pregnant women and their partners for their consent to participate in this study, and the obstetrics clinic staff members at Hafez and Zeinabieh Hospitals in Shiraz for providing a comfortable environment for the interviews that was respectful of participants' privacy. We also thank K. Shashok (AuthorAID in the Eastern Mediterranean) for improving the use of English in the manuscript.	Aksakal FN, 2007, JPN J INFECT DIS, V60, P157; Ali ME, 1997, INT J GYNECOL OBSTET, V59, P109, DOI 10.1016/S0020-7292(97)00196-3; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; Anselem O, 2011, PRESSE MED, V40, P1001, DOI 10.1016/j.lpm.2011.07.002; BABOONIAN C, 1983, BRIT J OBSTET GYNAEC, V90, P1168, DOI 10.1111/j.1471-0528.1983.tb06466.x; Byrne L, 2012, VACCINE, V30, P161, DOI 10.1016/j.vaccine.2011.11.045; Chiba ME, 2003, J INFECTION, V47, P40, DOI 10.1016/S0163-4453(03)00045-8; Dayan GH, 2005, EPIDEMIOL INFECT, V133, P861, DOI 10.1017/S0950268805004437; de Oliveira SA, 2011, J INFECT DIS, V204, pS664, DOI 10.1093/infdis/jir356; EBERHARTPHILLIPS JE, 1993, OBSTET GYNECOL, V82, P797; Enders M, 2007, BUNDESGESUNDHEITSBLA, V50, P1393, DOI 10.1007/s00103-007-0195-9; Esteghamati A, 2007, PEDIATR INFECT DIS J, V26, P1137, DOI 10.1097/INF.0b013e3181462090; Ghazizadeh SH, 2004, TXB PUBLIC HLTH, V3, P1317; Hamdan HZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-217; Hamkar R, 2006, AM J INFECT CONTROL, V34, P588, DOI 10.1016/j.ajic.2005.11.005; Karakoc GB, 2003, EUR J EPIDEMIOL, V18, P81, DOI 10.1023/A:1022538407514; Kennedy Colleen M, 2006, Infect Dis Obstet Gynecol, V2006, P13890; Lin CC, 2011, BJOG-INT J OBSTET GY, V118, P706, DOI 10.1111/j.1471-0528.2011.02903.x; Mahmoudi M, 2007, MED J MASHHAD U MED, V50, P177; Majlessi F., 2008, Eastern Mediterranean Health Journal, V14, P590; Miller EM, 2009, AM J HUM BIOL, V21, P401, DOI 10.1002/ajhb.20882; Mora-García Gustavo J, 2011, Rev. salud pública, V13, P288; Onakewhor JU, 2011, NIGER J CLIN PRACT, V14, P140, DOI 10.4103/1119-3077.84002; Pehlivan E, 2007, PUBLIC HEALTH, V121, P462, DOI 10.1016/j.puhe.2006.09.021; Pourabbas B, 2008, INT J INFECT DIS, V12, P43, DOI 10.1016/j.ijid.2007.03.013; Qian Xiao-hua, 2010, Zhongguo Yi Miao He Mian Yi, V16, P146; Rasmussen SA, 2012, BIRTH DEFECTS RES A, V94, P123, DOI 10.1002/bdra.22887; Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155; Sadighi J, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-44; Sathanandan D, 2005, AUST NZ J OBSTET GYN, V45, P435, DOI 10.1111/j.1479-828X.2005.00467.x; Sauerbrei A, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P10, DOI 10.1007/s00103-003-0689-z; Seker S, 2004, SAUDI MED J, V25, P575; Shoda A, 2011, BJOG-INT J OBSTET GY, V118, P88, DOI 10.1111/j.1471-0528.2010.02764.x; Tabatabaei M, 2006, PRINCIPLES DIS PREVE, P77; WHO, RUB; World Health Organization, 2011, MEASL FACT SHEET 286; Wysokinska T, 2004, VACCINE, V22, P1899, DOI 10.1016/j.vaccine.2003.11.004; Yekta Z., 2009, Eastern Mediterranean Health Journal, V15, P516; Zahraei SM, 2011, J INFECT DIS, V204, pS305, DOI 10.1093/infdis/jir076	39	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55043	10.1371/journal.pone.0055043	http://dx.doi.org/10.1371/journal.pone.0055043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383049	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600059
J	Balique, F; Colson, P; Barry, AO; Nappez, C; Ferretti, A; Al Moussawi, K; Ngounga, T; Lepidi, H; Ghigo, E; Mege, JL; Lecoq, H; Raoult, D				Balique, Fanny; Colson, Philippe; Barry, Abdoulaye Oury; Nappez, Claude; Ferretti, Audrey; Al Moussawi, Khatoun; Ngounga, Tatsiana; Lepidi, Hubert; Ghigo, Eric; Mege, Jean-Louis; Lecoq, Herve; Raoult, Didier			Tobacco Mosaic Virus in the Lungs of Mice following Intra-Tracheal Inoculation	PLOS ONE			English	Article							PLANT-VIRUS; FRANKLINIELLA-OCCIDENTALIS; INSECT VECTOR; RNA; PROTEIN; CELL; TRANSMISSION; IMMUNIZATION; PROTECTION; INFECTION	Plant viruses are generally considered incapable of infecting vertebrates. Accordingly, they are not considered harmful for humans. However, a few studies questioned the certainty of this paradigm. Tobacco mosaic virus (TMV) RNA has been detected in human samples and TMV RNA translation has been described in animal cells. We sought to determine if TMV is detectable, persists, and remains viable in the lung tissues of mice following intratracheal inoculation, and we attempted to inoculate mouse macrophages with TMV. In the animal model, mice were intratracheally inoculated with 10(11) viral particles and were sacrificed at different time points. The virus was detected in the mouse lungs using immunohistochemistry, electron microscopy, real-time RT-PCR and sequencing, and its viability was studied with an infectivity assay on plants. In the cellular model, the culture medium of murine bone marrow derived macrophages (BMDM) was inoculated with different concentrations of TMV, and the virus was detected with real-time RT-PCR and immunofluorescence. In addition, anti-TMV antibodies were detected in mouse sera with ELISA. We showed that infectious TMV could enter and persist in mouse lungs via the intratracheal route. Over 14 days, the TMV RNA level decreased by 5 log(10) copies/ml in the mouse lungs and by 3.5 log(10) in macrophages recovered from bronchoalveolar lavage. TMV was localized to lung tissue, and its infectivity was observed on plants until 3 days after inoculation. In addition, anti-TMV antibody seroconversions were observed in the sera from mice 7 days after inoculation. In the cellular model, we observed that TMV persisted over 15 days after inoculation and it was visualized in the cytoplasm of the BMDM. This work shows that a plant virus, Tobacco mosaic virus, could persist and enter in cells in mammals, which raises questions about the potential interactions between TMV and human hosts.	[Balique, Fanny; Colson, Philippe; Barry, Abdoulaye Oury; Nappez, Claude; Al Moussawi, Khatoun; Ngounga, Tatsiana; Lepidi, Hubert; Ghigo, Eric; Mege, Jean-Louis; Raoult, Didier] Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect,URMITE, UM CNRS IRD INSERM 3R198 U1095 63 7278, Marseille, France; [Colson, Philippe; Ferretti, Audrey; Mege, Jean-Louis; Raoult, Didier] CHU Timone, Assistance Publ Hop Marseille, Federat Bacteriol Hyg Virol, Marseille, France; [Balique, Fanny; Lecoq, Herve] INRA, UR 407, F-84143 Montfavet, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE	Colson, P (corresponding author), Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect,URMITE, UM CNRS IRD INSERM 3R198 U1095 63 7278, Marseille, France.	philippe.colson@univ-amu.fr	RAOULT, Didier/A-8434-2008; MEGE, JEAN-LOUIS/O-6063-2016; Eric, Ghigo/N-9427-2016; Colson, Philippe/P-6355-2014	RAOULT, Didier/0000-0002-0633-5974; Colson, Philippe/0000-0001-6285-0308	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	Recurrent funding from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, ARCH VIROL, V154, P1967, DOI 10.1007/s00705-009-0506-6; Balique F, 2012, J CLIN VIROL, V55, P374, DOI 10.1016/j.jcv.2012.08.012; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bothwell PW, 1960, LANCET, V1; Bousbia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011298; Brennan FR, 1999, J VIROL, V73, P930, DOI 10.1128/JVI.73.2.930-938.1999; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; Colson P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010041; de Medeiros RB, 2005, P NATL ACAD SCI USA, V102, P1175, DOI 10.1073/pnas.0406668102; DIMITRIADIS GJ, 1975, NUCLEIC ACIDS RES, V2, P1719, DOI 10.1093/nar/2.10.1719; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; ERICKSON JO, 1953, J IMMUNOL, V71, P30; ERICKSON JO, 1957, J IMMUNOL, V78, P94; Fujiyama K, 2006, J BIOSCI BIOENG, V101, P398, DOI 10.1263/jbb.101.398; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Harrison BD, 1999, PHILOS T ROY SOC B, V354, P521, DOI 10.1098/rstb.1999.0403; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Karasev AV, 2005, VACCINE, V23, P1875, DOI 10.1016/j.vaccine.2004.11.021; KATSILAMBROS L, 1960, LANCET, V2, P934; KITAJIMA EW, 1983, INTERVIROLOGY, V19, P129, DOI 10.1159/000149347; KNOWLAND J, 1974, GENETICS, V78, P383; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; LaScola B, 1997, INFECT IMMUN, V65, P2443, DOI 10.1128/IAI.65.6.2443-2447.1997; LECLAIR RA, 1967, AM REV RESPIR DIS, V95, P510; Li L, 2012, BIOSCIENCE REP, V32, P171, DOI 10.1042/BSR20110069; McCormick AA, 2006, BIOCONJUGATE CHEM, V17, P1330, DOI 10.1021/bc060124m; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Modelska A, 1998, P NATL ACAD SCI USA, V95, P2481, DOI 10.1073/pnas.95.5.2481; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Pascual DW, 2007, P NATL ACAD SCI USA, V104, P10757, DOI 10.1073/pnas.0704516104; Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017; Rogers SO, 2004, MED HYPOTHESES, V63, P773, DOI 10.1016/j.mehy.2004.04.004; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; SALOMON R, 1982, J GEN VIROL, V62, P343, DOI 10.1099/0022-1317-62-2-343; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Wahyuni W. S., 2008, J BIOSCIENCE, V15, P118, DOI DOI 10.4308/HJB.15.3.118; Wales SQ, 2004, CLIN DIAGN LAB IMMUN, V11, P42, DOI 10.1128/CDLI.11.1.42-49.2004; WETTER C, 1975, NATURWISSENSCHAFTEN, V62, P533, DOI 10.1007/BF00609072; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	45	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54993	10.1371/journal.pone.0054993	http://dx.doi.org/10.1371/journal.pone.0054993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383021	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800091
J	Dentzien-Dias, PC; Poinar, G; de Figueiredo, AEQ; Pacheco, ACL; Horn, BLD; Schultz, CL				Dentzien-Dias, Paula C.; Poinar, George, Jr.; de Figueiredo, Ana Emilia Q.; Pacheco, Ana Carolina L.; Horn, Bruno L. D.; Schultz, Cesar L.			Tapeworm Eggs in a 270 Million-Year-Old Shark Coprolite	PLOS ONE			English	Article							BASIN	Remains of parasites in vertebrates are rare from the Mesozoic and Paleozoic. Once most parasites that live in - or pass through - the gastrointestinal tract of vertebrates, fossil feces (coprolites) or even intestinal contents (enterolites) can eventually preserve their remains. Here we announce the discovery of a spiral shark coprolite from the Paleozoic bearing a cluster of 93 small oval-elliptical smooth-shelled structures, interpreted as eggs of a tapeworm. The eggs were found in a thin section of an elasmobranch coprolite. Most of the eggs are filled by pyrite and some have a special polar swelling (operculum), suggesting they are non-erupted eggs. One of the eggs contains a probable developing larva. The eggs are approximately 145-155 mu m in length and 88-100 mu m in width and vary little in size within the cluster. The depositional and morphological features of the eggs closely resemble those of cestodes. Not only do the individual eggs have features of extant tapeworms, but their deposition all together in an elongate segment is typical to modern tapeworm eggs deposited in mature segments (proglottids). This is the earliest fossil record of tapeworm parasitism of vertebrates and establishes a timeline for the evolution of cestodes. This discovery shows that the fossil record of vertebrate intestinal parasites is much older than was hitherto known and that the interaction between tapeworms and vertebrates occurred at least since the Middle-Late Permian.	[Dentzien-Dias, Paula C.] Univ Fed Rio Grande, Inst Oceanog, Lab Paleontol & Paleoceanog, Rio Grande, Brazil; [Poinar, George, Jr.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [de Figueiredo, Ana Emilia Q.; Horn, Bruno L. D.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Pacheco, Ana Carolina L.] Univ Fed Piaui, Picos, Piaui, Brazil	Universidade Federal do Rio Grande; Oregon State University; Universidade Federal do Rio Grande do Sul; Universidade Federal do Piaui	Dentzien-Dias, PC (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Lab Paleontol & Paleoceanog, Rio Grande, Brazil.	pauladentzien@gmail.com	Schultz, Cesar/I-4127-2013; Dentzien-Dias, Paula/AAZ-3945-2020; Quezado de Figueiredo, Ana Emilia/L-8057-2015	Schultz, Cesar/0000-0001-7121-0409; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (CNPq); Edital MCT/CNPq [478914/2006-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Edital MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (CNPq) through a study grant (PCD-D, AEQF and BH) and the Project 478914/2006-7 (Edital MCT/CNPq 02/2006 - Universal). This work was also partially funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) through scholarships granted to AEQF, BH and CLS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avantin F, 2007, PALEOPARASITOLOGIE C, P203; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P47, DOI 10.1590/S0074-02762003000900009; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Bouchet F, 1996, CR ACAD SCI III-VIE, V319, P147; Caira JN, 2004, CRC MAR BIOL SER, P523; Caira JN, 2005, MARINE PARASITOLOGY, P92; Campbell RA, 1998, FOLIA PARASIT, V45, P47; Chin K., 2007, MICROSC MICROANAL, V13, P50, DOI DOI 10.1017/S143192760707540X; Cisneros JC, 2012, P NATL ACAD SCI USA, V109, P1584, DOI 10.1073/pnas.1115975109; Cisneros JC, 2011, SCIENCE, V331, P1603, DOI 10.1126/science.1200305; Conn DB, 2008, FOLIA PARASIT, V55, P42, DOI 10.14411/fp.2008.006; Dentzien-Dias PC, 2012, J S AM EARTH SCI, V40, P53, DOI 10.1016/j.jsames.2012.09.008; Erasmus DA, 1972, BIOL TREMATODES; FERREIRA LF, 1979, C BRAS PAR 1979, P56; Goncalves MLC, 2003, MEM I OSWALDO CRUZ, V98, P103, DOI 10.1590/S0074-02762003000900016; Halstead L.B., 1990, P381; Hoberg EP, 1999, SYST PARASITOL, V42, P1, DOI 10.1023/A:1006099009495; Holz M, 2010, J S AM EARTH SCI, V29, P381, DOI 10.1016/j.jsames.2009.04.004; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Langer M.C., 1998, J AFR EARTH SCI, V27, P158; Levine N.D., 1978, TXB VET PARASITOLOGY; Moravec F, 2007, FOLIA PARASIT, V54, P239, DOI 10.14411/fp.2007.033; Neumayer L., 1904, Palaeontogr, Vli, P121; Poinar G, 2006, PARASITOLOGY, V133, P245, DOI 10.1017/S0031182006000138; Poinar G, 2008, WHAT BUGGED THE DINOSAURS INSECTS, DISEASE, AND DEATH IN THE CRETACEOUS, P102; Reinhard K.J., 1992, ARCHAEOLOGICAL METHO, P245; Reinhard KJ, 1998, MUMMIES DIS ANCIENT, P377; Rohde K., 2005, Marine parasitology, DOI 10.1079/9780643090255.0000; Schell S. C., 1970, KNOW TREMATODES; Smith RMH, 2011, PALAEOGEOGR PALAEOCL, V312, P40, DOI 10.1016/j.palaeo.2011.09.006; Smyth JD, 1969, PHYSL CESTODES; Southwell T, 1925, MONOGRAPH TETRAPHYLL; SPENCER FM, 1961, COLOR ATLAS INTESTIN; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Yamaguti S., 1959, CESTODES VERTEBRATES, VII; Yamaguti S., 1961, SYSTEMA HELMINTHUM N, VIII; Zangere R., 1976, Palaeontographica Abt A, V154, P107	37	71	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55007	10.1371/journal.pone.0055007	http://dx.doi.org/10.1371/journal.pone.0055007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383033	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800103
J	Jacobs, SR; Elliott, KH; Gaston, AJ				Jacobs, Shoshanah R.; Elliott, Kyle Hamish; Gaston, Anthony J.			Parents are a Drag: Long-Lived Birds Share the Cost of Increased Foraging Effort with Their Offspring, but Males Pass on More of the Costs than Females	PLOS ONE			English	Article							THICK-BILLED MURRES; GUILLEMOTS URIA-LOMVIA; BODY CONDITION; BRUNNICHS GUILLEMOTS; ARCTIC SEABIRD; PLASMA-CORTICOSTERONE; MONOMORPHIC SEABIRD; REPRODUCTIVE COSTS; ATLANTIC PUFFINS; ANTARCTIC PETREL	Life history theory predicts that parents will balance benefits from investment in current offspring against benefits from future reproductive investments. Long-lived organisms are therefore less likely to increase parental effort when environmental conditions deteriorate. To investigate the effect of decreased foraging capacity on parental behaviour of long-lived monogamous seabirds, we experimentally increased energy costs for chick-rearing thick-billed murres (Uria lomvia). Handicapped birds had lighter chicks and lower provisioning rates, supporting the prediction that long-lived animals would pass some of the costs of impaired foraging ability on to their offspring. Nonetheless, handicapped birds spent less time underwater, had longer inter-dive surface intervals, had lower body mass, showed lower resighting probabilities in subsequent years and consumed fewer risky prey items. Corticosterone levels were similar between control and handicapped birds. Apparently, adults shared some of the costs of impaired foraging, but those costs were not measurable in all metrics. Handicapped males had higher plasma neutral lipid concentrations (higher energy mobilisation) and their chicks exhibited lower growth rates than handicapped females, suggesting different sex-specific investment strategies. Unlike other studies of auks, partners did not compensate for handicapping, despite good foraging conditions for unhandicapped birds. In conclusion, parental murres and their offspring shared the costs of experimentally increased foraging constraints, with females investing more than males.	[Jacobs, Shoshanah R.] Dept Integrated Biol, Guelph, ON, Canada; [Elliott, Kyle Hamish] Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada; [Gaston, Anthony J.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada	University of Manitoba; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Elliott, KH (corresponding author), Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada.	urialomvia@gmail.com	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993	University of Ottawa Doctoral Research Award; Northern Scientific Training Program; Weinberger Award for Environmental Research; Heather Glendinning McMurter Award for Environmental Research; Maas Family Scholarship; NSERC PGSM and Vanier Awards; Natural Sciences and Engineering Research Council Northern Research Internship; Mountain Equipment Co-op Studentship; Arctic Institute of North America; American Ornithologists' Union Research Grant; Society of Canadian Ornithologists/Bird Studies Canada Taverner; American Museum of Natural History Frank M. Chapman Award; Science and technology Branch of Environment Canada, the University of Manitoba	University of Ottawa Doctoral Research Award; Northern Scientific Training Program; Weinberger Award for Environmental Research; Heather Glendinning McMurter Award for Environmental Research; Maas Family Scholarship; NSERC PGSM and Vanier Awards; Natural Sciences and Engineering Research Council Northern Research Internship; Mountain Equipment Co-op Studentship; Arctic Institute of North America; American Ornithologists' Union Research Grant; Society of Canadian Ornithologists/Bird Studies Canada Taverner; American Museum of Natural History Frank M. Chapman Award; Science and technology Branch of Environment Canada, the University of Manitoba	SRJ benefited from the University of Ottawa Doctoral Research Award, Northern Scientific Training Program, Weinberger Award for Environmental Research, Heather Glendinning McMurter Award for Environmental Research, and Maas Family Scholarship. KHE benefited from funding provided by NSERC PGSM and Vanier Awards, Natural Sciences and Engineering Research Council Northern Research Internship, Northern Scientific Training Program, Mountain Equipment Co-op Studentship, Arctic Institute of North America Grant-in-aid, American Ornithologists' Union Research Grant, Society of Canadian Ornithologists/Bird Studies Canada Taverner and James L. Baillie Awards and an American Museum of Natural History Frank M. Chapman Award. Additional financial support came from Science and technology Branch of Environment Canada, the University of Manitoba and 2007-08 International Polar Year. R. Armstrong at the Nunavut Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Angelier F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P283, DOI 10.1086/512585; Angelier F, 2009, J EXP BIOL, V212, P2824, DOI 10.1242/jeb.027722; Baillie SM, 2004, WATERBIRDS, V27, P102, DOI 10.1675/1524-4695(2004)027[0102:ROAPTA]2.0.CO;2; Barrett RT, 1996, ICES J MAR SCI, V53, P713, DOI 10.1006/jmsc.1996.0090; BARRETT RT, 1992, COLON WATERBIRD, V15, P24, DOI 10.2307/1521351; Beaulieu M, 2010, J EXP BIOL, V213, P33, DOI 10.1242/jeb.035378; Beaulieu M, 2009, ANIM BEHAV, V78, P313, DOI 10.1016/j.anbehav.2009.05.006; Benvenuti S, 2002, POLAR BIOL, V25, P474, DOI 10.1007/s00300-002-0372-0; Bijleveld AI, 2009, BEHAV ECOL, V20, P736, DOI 10.1093/beheco/arp054; Blem C.R., 1990, Current Ornithology, V7, P59; BLEM CR, 1976, AM ZOOL, V16, P671; Burke CM, 2008, WATERBIRDS, V31, P372, DOI 10.1675/1524-4695-31.3.372; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; CLARK CW, 1990, EVOL ECOL, V4, P21, DOI 10.1007/BF02270712; CROLL DA, 1991, CONDOR, V93, P496, DOI 10.2307/1368181; Davoren GK, 2003, MAR ECOL PROG SER, V258, P253, DOI 10.3354/meps258253; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; DRENT RH, 1980, ARDEA, V68, P225; Elliott KH, 2005, IBIS, V147, P783, DOI 10.1111/j.1474-919x.2005.00462.x; Elliott KH, 2008, J FIELD ORNITHOL, V79, P298, DOI 10.1111/j.1557-9263.2008.00177.x; Elliott KH, 2007, CAN J ZOOL, V85, P352, DOI 10.1139/Z07-012; Elliott KH, 2012, MAR ECOL PROG SER, V466, P1, DOI 10.3354/meps09975; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Elliott KH, 2009, MAR BIOL, V156, P1809, DOI 10.1007/s00227-009-1214-1; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Elliott Kyle Hamish, 2008, Marine Ornithology, V36, P25; Elliott KH, 2008, ANIM BEHAV, V75, P1311, DOI 10.1016/j.anbehav.2007.10.026; Elliott KH, 2008, MAR ECOL PROG SER, V354, P289, DOI 10.3354/meps07221; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Elliott KH, 2009, WATERBIRDS, V32, P183, DOI 10.1675/063.032.0123; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erikstad KE, 1997, BEHAV ECOL SOCIOBIOL, V40, P95, DOI 10.1007/s002650050320; FISHER HI, 1975, AUK, V92, P433, DOI 10.2307/4084599; Pereira RJG, 2009, J WILDLIFE MANAGE, V73, P772, DOI 10.2193/2008-184; Gaston AJ, 2006, J AVIAN BIOL, V37, P101; Gaston AJ, 2006, IBIS, V148, P106, DOI 10.1111/j.1474-919X.2006.00489.x; Gaston AJ, 2005, J ANIM ECOL, V74, P832, DOI 10.1111/j.1365-2656.2005.00982.x; Gaston AJ, 2003, ARCTIC, V56, P227; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; Gaston AT, 2009, CONDOR, V111, P111, DOI 10.1525/cond.2009.080077; Gill VA, 2002, IBIS, V144, P268, DOI 10.1046/j.1474-919X.2002.00043.x; Gladbach A, 2009, POLAR BIOL, V32, P1315, DOI 10.1007/s00300-009-0628-z; Golet GH, 2004, ECOL MONOGR, V74, P353, DOI 10.1890/02-4029; Granadeiro JP, 2004, J SEA RES, V52, P227, DOI 10.1016/j.seares.2004.01.005; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Hamer KC, 2006, BEHAV ECOL, V17, P132, DOI 10.1093/beheco/arj008; Harding AMA, 2009, ANIM BEHAV, V78, P321, DOI 10.1016/j.anbehav.2009.05.009; Harding AMA, 2007, ECOLOGY, V88, P2024, DOI 10.1890/06-1695.1; Harding AMA, 2009, FUNCT ECOL, V23, P348, DOI 10.1111/j.1365-2435.2008.01488.x; HEDGREN S, 1981, ORNIS SCAND, V12, P51, DOI 10.2307/3675904; Hipfner JM, 2006, CAN J ZOOL, V84, P931, DOI 10.1139/Z06-066; Hipfner JM, 1997, CONDOR, V99, P353, DOI 10.2307/1369941; Hipfner JM, 1999, ECOLOGY, V80, P1289, DOI 10.2307/177075; Hipfner JM, 2001, AUK, V118, P1076, DOI 10.1642/0004-8038(2001)118[1076:FRCORI]2.0.CO;2; Ito M, 2010, AQUAT BIOL, V8, P279, DOI 10.3354/ab00229; Jacobs SR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P85, DOI 10.1086/663832; Jacobs SR, 2011, COMP BIOCHEM PHYS B, V158, P77, DOI 10.1016/j.cbpb.2010.09.011; Jacobs SR, 2009, J AVIAN BIOL, V40, P327, DOI 10.1111/j.1600-048X.2008.04625.x; JACOBSEN KO, 1995, ECOLOGY, V76, P1636, DOI 10.2307/1938164; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; JENNIEIERMANN S, 1992, PHYSIOL ZOOL, V65, P112, DOI 10.1086/physzool.65.1.30158242; Jensen BH, 2001, FISH PHYSIOL BIOCHEM, V25, P141, DOI 10.1023/A:1020564121935; Keedwell RJ, 2003, J FIELD ORNITHOL, V74, P217, DOI 10.1648/0273-8570-74.3.217; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Landys MTM, 2004, HORM BEHAV, V46, P574, DOI 10.1016/j.yhbeh.2004.06.006; Landys-Ciannelli MM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P101, DOI 10.1086/338285; Lewis S, 2006, J ANIM ECOL, V75, P1304, DOI 10.1111/j.1365-2656.2006.01152.x; Lewis S, 2009, OIKOS, V118, P521, DOI 10.1111/j.1600-0706.2009.17308.x; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; MAUCK RA, 1995, ANIM BEHAV, V49, P999, DOI 10.1006/anbe.1995.0129; McWilliams SR, 2004, J AVIAN BIOL, V35, P377, DOI 10.1111/j.0908-8857.2004.03378.x; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Paredes R, 2005, ANIM BEHAV, V69, P197, DOI 10.1016/j.anbehav.2003.12.029; Paredes R, 2006, BEHAVIOUR, V143, P451, DOI 10.1163/156853906776240641; PARTRIDGE L, 1988, SCIENCE, V241, P1449, DOI 10.1126/science.241.4872.1449; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; RICKLEFS RE, 1992, ANIM BEHAV, V43, P895, DOI 10.1016/0003-3472(92)90003-R; RICKLEFS RE, 1984, ORNIS SCAND, V15, P162, DOI 10.2307/3675957; RICKLEFS RE, 1981, AUK, V98, P361; Robin JP, 2001, J AVIAN BIOL, V32, P303, DOI 10.1111/j.0908-8857.2001.320403.x; Robin JP, 1998, AM J PHYSIOL-REG I, V274, pR746, DOI 10.1152/ajpregu.1998.274.3.R746; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; SAETHER BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P147, DOI 10.1007/BF00216594; Takahashi A, 2003, FUNCT ECOL, V17, P590, DOI 10.1046/j.1365-2435.2003.00772.x; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; Thaxter CB, 2010, J EXP BIOL, V213, P1018, DOI 10.1242/jeb.037390; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Tremblay Y, 2003, J EXP BIOL, V206, P1929, DOI 10.1242/jeb.00363; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; WANLESS S, 1988, CONDOR, V90, P816, DOI 10.2307/1368838; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilhelm SI, 2004, ATLANTIC SEABIRDS, V6, P47; Winkler DW, 1995, AUK, V112, P737; [No title captured]	101	20	20	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54594	10.1371/journal.pone.0054594	http://dx.doi.org/10.1371/journal.pone.0054594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382921	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800056
J	Miyazaki, K; Itoh, N; Ohyama, S; Kadota, K; Oishi, K				Miyazaki, Koyomi; Itoh, Nanako; Ohyama, Sumika; Kadota, Koji; Oishi, Katsutaka			Continuous Exposure to a Novel Stressor Based on Water Aversion Induces Abnormal Circadian Locomotor Rhythms and Sleep-Wake Cycles in Mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; GLYCOGEN-SYNTHASE KINASE-3-BETA; BODY-TEMPERATURE; CHRONIC INSOMNIA; DEPRIVATION; RATS; BEHAVIOR; CORTICOSTERONE; RESTRICTION; EXPRESSION	Psychological stressors prominently affect diurnal rhythms, including locomotor activity, sleep, blood pressure, and body temperature, in humans. Here, we found that a novel continuous stress imposed by the perpetual avoidance of water on a wheel (PAWW) affected several physiological diurnal rhythms in mice. One week of PAWW stress decayed robust circadian locomotor rhythmicity, while locomotor activity was evident even during the light period when the mice are normally asleep. Daytime activity was significantly upregulated, whereas nighttime activity was downregulated, resulting in a low amplitude of activity. Total daily activity gradually decreased with increasing exposure to PAWW stress. The mice could be exposed to PAWW stress for over 3 weeks without adaptation. Furthermore, continuous PAWW stress enhanced food intake, but decreased body weight and plasma leptin levels, indicating that sleep loss and PAWW stress altered the energy balance in these mice. The diurnal rhythm of corticosterone levels was not severely affected. The body temperature rhythm was diurnal in the stressed mice, but significantly dysregulated during the dark period. Plasma catecholamines were elevated in the stressed mice. Continuous PAWW stress reduced the duration of daytime sleep, especially during the first half of the light period, and increased nighttime sleepiness. Continuous PAWW stress also simultaneously obscured sleep/wake and locomotor activity rhythms compared with control mice. These sleep architecture phenotypes under stress are similar to those of patients with insomnia. The stressed mice could be entrained to the light/dark cycle, and when they were transferred to constant darkness, they exhibited a free-running circadian rhythm with a timing of activity onset predicted by the phase of their entrained rhythms. Circadian gene expression in the liver and muscle was unaltered, indicating that the peripheral clocks in these tissues remained intact.	[Miyazaki, Koyomi; Itoh, Nanako; Ohyama, Sumika; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan; [Kadota, Koji] Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Miyazaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan.	k-miyazaki@aist.go.jp	Miyazaki, Koyomi/L-6539-2018; Oishi, Katsutaka/L-6906-2018; , Kadota/AAP-2804-2020; Kadota, Koji/C-9168-2011	Miyazaki, Koyomi/0000-0002-5464-1095; Oishi, Katsutaka/0000-0002-4870-0837; , Kadota/0000-0002-3907-4336; Kadota, Koji/0000-0002-3907-4336	AIST; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23607040]; Yamada Bee Farm Grant for Honeybee Research; Grants-in-Aid for Scientific Research [23617040] Funding Source: KAKEN	AIST; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Bee Farm Grant for Honeybee Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by operational subsidies from AIST, and a Grant-in Aid for Scientific Research KAKENHI 23607040 to K. Miyazaki from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The study was also partially funded by a Yamada Bee Farm Grant for Honeybee Research (http://grant.bee-lab.jp/) to K. Oishi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnum CJ, 2007, J NEUROENDOCRINOL, V19, P632, DOI 10.1111/j.1365-2826.2007.01571.x; Basta M, 2007, SLEEP MED CLIN, V2, P279, DOI 10.1016/j.jsmc.2007.04.002; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Gold PW, 2005, P NATL ACAD SCI USA, V102, P8303, DOI 10.1073/pnas.0503069102; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Grandin LD, 2006, CLIN PSYCHOL REV, V26, P679, DOI 10.1016/j.cpr.2006.07.001; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Gronli J, 2004, BEHAV BRAIN RES, V150, P139, DOI 10.1016/S0166-4328(03)00252-3; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Ibuka N, 1980, Waking Sleeping, V4, P167; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Jiang WG, 2011, BRAIN RES, V1399, P25, DOI 10.1016/j.brainres.2011.05.001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kim Y, 2007, P NATL ACAD SCI USA, V104, P10697, DOI 10.1073/pnas.0610351104; Kinn AM, 2008, PHYSIOL BEHAV, V95, P553, DOI 10.1016/j.physbeh.2008.07.031; Kinoshita C, 2012, NEUROREPORT, V23, P98, DOI 10.1097/WNR.0b013e32834e7ec2; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; Kronfeld-Schor N, 2012, NEUROPHARMACOLOGY, V62, P101, DOI 10.1016/j.neuropharm.2011.08.020; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lack LC, 2008, SLEEP MED REV, V12, P307, DOI 10.1016/j.smrv.2008.02.003; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Lopez-Rodriguez F, 2004, NEUROPSYCHOPHARMACOL, V29, P1105, DOI 10.1038/sj.npp.1300406; Masaki M, 2012, MOL NUTR FOOD RES, V56, P304, DOI 10.1002/mnfr.201100181; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Meerlo, 1996, Stress, V1, P21; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Miyazaki K, 2010, GENES CELLS, V15, P351, DOI 10.1111/j.1365-2443.2010.01384.x; Mochizuki T, 2006, AM J PHYSIOL-REG I, V291, pR533, DOI 10.1152/ajpregu.00887.2005; Ohkura N, 2007, CHRONOBIOL INT, V24, P651, DOI 10.1080/07420520701534673; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Oishi K, 2010, NEUROENDOCRINOL LETT, V31, P198; Pandi-Perumal SR, 2005, EXP GERONTOL, V40, P911, DOI 10.1016/j.exger.2005.08.009; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Shirayama M, 2003, SLEEP MED, V4, P427, DOI 10.1016/S1389-9457(03)00101-1; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Storch C, 2004, J NEUROSCI METH, V133, P173, DOI 10.1016/j.jneumeth.2003.10.008; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TSAI LL, 1992, SLEEP, V15, P537, DOI 10.1093/sleep/15.6.537; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ushijima K, 2006, BEHAV BRAIN RES, V173, P326, DOI 10.1016/j.bbr.2006.06.038; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787	44	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55452	10.1371/journal.pone.0055452	http://dx.doi.org/10.1371/journal.pone.0055452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383193	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800157
J	Tsai, CH; Tung, KY; Su, MW; Chiang, BL; Chew, FT; Kuo, NW; Lee, YL				Tsai, Ching-Hui; Tung, Kuan-Yen; Su, Ming-Wei; Chiang, Bor-Luen; Chew, Fook Tim; Kuo, Nai-Wei; Lee, Yungling Leo			Interleukin-13 Genetic Variants, Household Carpet Use and Childhood Asthma	PLOS ONE			English	Article							MITE ALLERGEN; PROMOTER POLYMORPHISM; BRONCHITIC SYMPTOMS; TOBACCO-SMOKE; TOTAL IGE; CHILDREN; ASSOCIATION; IL-13; IL13; EXPOSURE	Interleukin (IL)-13 genetic polymorphisms have shown adverse effects on respiratory health. However, few studies have explored the interactive effects between IL-13 haplotypes and environmental exposures on childhood asthma. The aims of our study are to evaluate the effects of IL-13 genetic variants on asthma phenotypes, and explore the potential interaction between IL-13 and household environmental exposures among Taiwanese children. We investigated 3,577 children in the Taiwan Children Health Study from 14 Taiwanese communities. Data regarding children's exposure and disease status were obtained from parents using a structured questionnaire. Four SNPs were tagged accounting for 100% of the variations in IL-13. Multiple logistic regression models with false-discovery rate (FDR) adjustments were fitted to estimate the effects of IL-13 variants on asthma phenotypes. SNP rs1800925, SNP rs20541 and SNP rs848 were significantly associated with increased risks on childhood wheeze with FDR of 0.03, 0.04 and 0.04, respectively. Children carrying two copies of h1011 haplotype showed increased susceptibility to wheeze. Compared to those without carpet use and h1011 haplotype, children carrying h1011 haplotype and using carpet at home had significantly synergistic risks of wheeze (OR, 2.5; 95% CI, 1.4-4.4; p for interaction, 0.01) and late-onset asthma (OR, 4.7; 95% CI, 2.0-10.9; p for interaction, 0.02). In conclusions, IL-13 genetic variants showed significant adverse effects on asthma phenotypes among children. The results also suggested that asthma pathogenesis might be mediated by household carpet use.	[Tsai, Ching-Hui; Tung, Kuan-Yen; Su, Ming-Wei; Kuo, Nai-Wei; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Tung, Kuan-Yen; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chew, Fook Tim] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National University of Singapore	Lee, YL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	leolee@ntu.edu.tw	Lee, Yungling/S-7011-2018; Chew, Fook Tim/E-7259-2010	Lee, Yungling/0000-0002-2234-9479; Chew, Fook Tim/0000-0003-1337-5146; CHIANG, BOR-LUEN/0000-0002-6705-0286; Tsai, Chinghui/0000-0003-0998-8230	National Science Council [96-2314-B-006-053, 98-2314-B-002-138-MY3, 101-2314-B-002-113-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council (Grant # 96-2314-B-006-053, # 98-2314-B-002-138-MY3 and # 101-2314-B-002-113-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHANYEUNG M, 1995, AM J RESP CRIT CARE, V152, P1805, DOI 10.1164/ajrccm.152.6.8520740; Chen YC, 2011, INT J HYG E IN PRESS; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DeMeo DL, 2002, GENET EPIDEMIOL, V23, P335, DOI 10.1002/gepi.10182; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Heinzmann A, 2003, J ALLERGY CLIN IMMUN, V112, P735, DOI 10.1016/S0091-6749(03)01887-6; HENDERSON FW, 1995, AM J RESP CRIT CARE, V151, P1786, DOI 10.1164/ajrccm.151.6.7767521; Hummelshoj T, 2003, EUR J IMMUNOGENET, V30, P355, DOI 10.1046/j.1365-2370.2003.00416.x; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; Hwang BF, 2010, CHEST, V138, P956, DOI 10.1378/chest.09-2600; Kim HB, 2006, J HUM GENET, V51, P1055, DOI 10.1007/s10038-006-0061-x; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Martinez Fernando D, 2007, Proc Am Thorac Soc, V4, P26, DOI 10.1513/pats.200607-144JG; Maziak W, 2003, ALLERGY, V58, P572, DOI 10.1034/j.1398-9995.2003.00161.x; Mihrshahi S, 2002, ALLERGY, V57, P137, DOI 10.1034/j.1398-9995.2002.5720999.x; Ogbuanu Ikechukwu U, 2010, Allergy Asthma Clin Immunol, V6, P6, DOI 10.1186/1710-1492-6-6; Osborne J., 2006, SAS US GROUP INT P, V190, P1; Park HW, 2009, RESP MED, V103, P284, DOI 10.1016/j.rmed.2008.08.009; Sadeghnejad A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-2; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Sorensen M, 2009, PEDIAT ALLERG IMM-UK, V20, P614, DOI 10.1111/j.1399-3038.2009.00855.x; Spee-van der Wekke J, 1998, J EPIDEMIOL COMMUN H, V52, P359, DOI 10.1136/jech.52.6.359; Spertini F, 2010, ALLERGY, V65, P623, DOI 10.1111/j.1398-9995.2009.02230.x; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Takkouche B, 2008, ALLERGY, V63, P857, DOI 10.1111/j.1398-9995.2008.01732.x; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Tranter DC, 2009, J OCCUP ENVIRON HYG, V6, P582, DOI 10.1080/15459620903103454; Tsai CH, 2011, OCCUPATIONAL ENV MED; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; Vojta PJ, 2001, ENVIRON HEALTH PERSP, V109, P815, DOI 10.2307/3454824; Wang IJ, 2011, EUR RESPIR J, V37, P1371, DOI 10.1183/09031936.00137210; Weiss K B, 1994, Pediatr Allergy Immunol, V5, P7, DOI 10.1111/j.1399-3038.1994.tb00341.x; Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	47	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51970	10.1371/journal.pone.0051970	http://dx.doi.org/10.1371/journal.pone.0051970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382814	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800008
J	Breitenstein, A; Wyss, CA; Spescha, RD; Franzeck, FC; Hof, D; Riwanto, M; Hasun, M; Akhmedov, A; von Eckardstein, A; Maier, W; Landmesser, U; Luscher, TF; Camici, GG				Breitenstein, Alexander; Wyss, Christophe A.; Spescha, Remo D.; Franzeck, Fabian C.; Hof, Danielle; Riwanto, Meliana; Hasun, Matthias; Akhmedov, Alexander; von Eckardstein, Arnold; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.			Peripheral Blood Monocyte Sirt1 Expression Is Reduced in Patients with Coronary Artery Disease	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; MYOCARDIAL-INFARCTION; THROMBUS FORMATION; ATHEROSCLEROSIS; HDL; OVEREXPRESSION; BIOLOGY; SERUM; RISK; MICE	Background: Inflammation plays a key role in atherosclerosis. Sirt1 regulates transcription factors involved in inflammatory processes and blunts atherosclerosis in mice. However, its role in humans remains to be defined. This study was therefore designed to investigate the role of Sirt1 in the development of atherosclerosis. Methods and Results: 48 male subjects admitted for cardiac catheterization were subdivided into healthy subjects, patients with stable coronary artery disease (CAD), and with acute coronary syndromes (ACS). Monocytes were isolated and Sirt1 mRNA levels were determined. Sirt1 gene expression was higher in healthy subjects as compared to patients with CAD or ACS (P<0.05), respectively. Interestingly, HDL levels correlated positively with Sirt1 expression. Thus, HDL from the three groups was isolated and incubated with THP-1 monocytes to determine the effects of HDL on Sirt1 protein in controlled experimental conditions. HDL from healthy subjects stimulated Sirt1 expression in THP-1 monocytes to a higher degree than HDL from CAD and ACS patients (P<0.05). Paraoxonase-1 (PON-1), a HDL-associated enzyme, showed a reduced activity in HDL isolated from CAD and ACS patients as compared to the controls (P<0.001). Conclusions: Monocytic Sirt1 expression is reduced in patients with stable CAD and ACS. Experiments on THP-1 monocytes suggest that this effect is HDL-dependent and is mediated by a reduced activity of HDL-associated enzyme PON1.	[Breitenstein, Alexander; Wyss, Christophe A.; Hasun, Matthias; Akhmedov, Alexander; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Breitenstein, Alexander; Wyss, Christophe A.; Spescha, Remo D.; Franzeck, Fabian C.; Hof, Danielle; Riwanto, Meliana; Hasun, Matthias; Akhmedov, Alexander; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Breitenstein, Alexander; Wyss, Christophe A.; Spescha, Remo D.; Franzeck, Fabian C.; Hof, Danielle; Riwanto, Meliana; Hasun, Matthias; Akhmedov, Alexander; von Eckardstein, Arnold; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Ctr Integrat Human Physiol ZHIP, Zurich, Switzerland; [von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Camici, GG (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland.	giovannic@access.uzh.ch	Camici, Giovanni/H-1631-2018	Camici, Giovanni/0000-0002-0523-0695	Swiss National Science Foundation; Bonizzi-Theler Foundation; Velux Foundation; Wolfermann Nageli Foundation; MERCATOR Foundation; Swiss Heart Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler Foundation; Velux Foundation(Velux Fonden); Wolfermann Nageli Foundation; MERCATOR Foundation; Swiss Heart Foundation	This study was supported by the Swiss National Science Foundation, Bonizzi-Theler Foundation, Velux Foundation, Wolfermann Nageli Foundation, MERCATOR Foundation, and the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Breitenstein A, 2008, ARTERIOSCL THROM VAS, V28, P2231, DOI 10.1161/ATVBAHA.108.171272; Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339; Camici GG, 2006, CIRCULATION, V114, P1512, DOI 10.1161/CIRCULATIONAHA.106.638460; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Mackness B, 2006, ARTERIOSCL THROM VAS, V26, P1545, DOI 10.1161/01.ATV.0000222924.62641.aa; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027081	19	56	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53106	10.1371/journal.pone.0053106	http://dx.doi.org/10.1371/journal.pone.0053106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382833	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000315483200046
J	Liu, CX; Wang, LQ; Li, WR; Zhang, XM; Tian, YZ; Zhang, N; He, SG; Chen, T; Huang, JC; Liu, MJ				Liu, Chenxi; Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun			Highly Efficient Generation of Transgenic Sheep by Lentivirus Accompanying the Alteration of Methylation Status	PLOS ONE			English	Article							GENE-TRANSFER; STEM-CELLS; PREIMPLANTATION EMBRYOS; MAMMALIAN-CELLS; FARM-ANIMALS; COPY NUMBER; VECTORS; EXPRESSION; PIGS; MICE	Background: Low efficiency of gene transfer and silence of transgene expression are the critical factors hampering the development of transgenic livestock. Recently, transfer of recombinant lentivirus has been demonstrated to be an efficient transgene delivery method in various animals. However, the lentiviral transgenesis and the methylation status of transgene in sheep have not been well addressed. Methodology/Principle Findings: EGFP transgenic sheep were generated by injecting recombinant lentivirus into zygotes. Of the 13 lambs born, 8 carried the EGFP transgene, and its chromosomal integration was identified in all tested tissues. Western blotting showed that GFP was expressed in all transgenic founders and their various tissues. Analysis of CpG methylation status of CMV promoter by bisulfate sequencing unraveled remarkable variation of methylation levels in transgenic sheep. The average methylation levels ranged from 37.6% to 79.1% in the transgenic individuals and 34.7% to 83% in the tested tissues. Correlative analysis of methylation status with GFP expression revealed that the GFP expression level was inversely correlated with methylation density. The similar phenomenon was also observed in tested tissues. Transgene integration determined by Southern blotting presented multiple integrants ranging from 2 to 6 copies in the genome of transgenic sheep. Conclusions/Significance: Injection of lentiviral transgene into zygotes could be a promising efficient gene delivery system to generate transgenic sheep and achieved widespread transgene expression. The promoter of integrants transferred by lentiviral vector was subjected to dramatic alteration of methylation status and the transgene expression level was inversely correlative with promoter methylation density. Our work illustrated for the first time that generation of transgenic sheep by injecting recombinant lentivirus into zygote could be an efficient tool to improve sheep performance by genetic modification.	[Liu, Chenxi; Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun] Xinjiang Lab Anim Biotechnol, Urumqi, Xinjiang, Peoples R China; [Liu, Chenxi; Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun] Minist Agr, Key Lab Genet Breeding & Reprod Grass Feeding Liv, Urumqi, Xinjiang, Peoples R China; [Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun] Xinjiang Acad Anim Sci, Anim Biotechnol Res Ctr, Urumqi, Xinjiang, Peoples R China; [Liu, Chenxi] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Xinjiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Xinjiang University	Liu, MJ (corresponding author), Xinjiang Lab Anim Biotechnol, Urumqi, Xinjiang, Peoples R China.	mingjun_1@sina.com	贺, 三刚/GYJ-3892-2022		National Key Program for Transgenic Sheep Breeding [2008ZX08006-003]	National Key Program for Transgenic Sheep Breeding	The studies were supported by the grant of "National Key Program for Transgenic Sheep Breeding". Grant numbers: 2008ZX08006-003. http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Glud AN, 2010, ACTA NEUROBIOL EXP, V70, P308; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hofmann A, 2004, BIOL REPROD, V71, P405, DOI 10.1095/biolreprod.104.028472; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mohamedali A, 2004, MOL THER, V10, P249, DOI 10.1016/j.ymthe.2004.05.002; Niemann H, 2004, P NATL ACAD SCI USA, V101, P7211, DOI 10.1073/pnas.0402011101; Pfeifer A, 2004, TRANSGENIC RES, V13, P513, DOI 10.1007/s11248-004-2735-5; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Reichenbach M, 2010, TRANSGENIC RES, V19, P549, DOI 10.1007/s11248-009-9333-5; Ritchie WA, 2009, MOL REPROD DEV, V76, P61, DOI 10.1002/mrd.20930; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rudolph NS, 1999, TRENDS BIOTECHNOL, V17, P367, DOI 10.1016/S0167-7799(99)01341-4; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; Schweizer J, 1998, DNA CELL BIOL, V17, P427, DOI 10.1089/dna.1998.17.427; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; Tessanne K, 2012, MOL REPROD DEV, V79, P176, DOI 10.1002/mrd.22007; Wang Y, 2010, TRANSGENIC RES, V19, P775, DOI 10.1007/s11248-009-9355-z; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Yang SH, 2008, GENESIS, V46, P711, DOI 10.1002/dvg.20435; Zielske SP, 2004, MOL THER, V9, P923, DOI 10.1016/j.ymthe.2004.02.017	35	15	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54614	10.1371/journal.pone.0054614	http://dx.doi.org/10.1371/journal.pone.0054614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382924	gold, Green Submitted, Green Published			2022-12-25	WOS:000315483200032
J	Gomez, FA; Tobar, JA; Henriquez, V; Sola, M; Altamirano, C; Marshall, SH				Gomez, Fernando A.; Tobar, Jaime A.; Henriquez, Vitalia; Sola, Mariel; Altamirano, Claudia; Marshall, Sergio H.			Evidence of the Presence of a Functional Dot/Icm Type IV-B Secretion System in the Fish Bacterial Pathogen Piscirickettsia salmonis	PLOS ONE			English	Article							PHAGOSOME-LYSOSOME FUSION; LEGIONELLA-PNEUMOPHILA; COXIELLA-BURNETII; RAINBOW-TROUT; AGROBACTERIUM-TUMEFACIENS; HELICOBACTER-PYLORI; PROTEIN SECRETION; VIRULENCE GENES; DOTA PROTEIN; CELL-LINE	Piscirickettsia salmonis is a fish bacterial pathogen that has severely challenged the sustainability of the Chilean salmon industry since its appearance in 1989. As this Gram-negative bacterium has been poorly characterized, relevant aspects of its life cycle, virulence and pathogenesis must be identified in order to properly design prophylactic procedures. This report provides evidence of the functional presence in P. salmonis of four genes homologous to those described for Dot/Icm Type IV Secretion Systems. The Dot/Icm System, the major virulence mechanism of phylogenetically related pathogens Legionella pneumophila and Coxiella burnetii, is responsible for their intracellular survival and multiplication, conditions that may also apply to P. salmonis. Our results demonstrate that the four P. salmonis dot/icm homologues (dotB, dotA, icmK and icmE) are expressed both during in vitro tissue culture cells infection and growing in cell-free media, suggestive of their putative constitutive expression. Additionally, as it happens in other referential bacterial systems, temporal acidification of cell-free media results in over expression of all four P. salmonis genes, a well-known strategy by which SSTIV-containing bacteria inhibit phagosome-lysosome fusion to survive. These findings are very important to understand the virulence mechanisms of P. salmonis in order to design new prophylactic alternatives to control the disease.	[Gomez, Fernando A.; Henriquez, Vitalia; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile; [Henriquez, Vitalia; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile; [Tobar, Jaime A.; Sola, Mariel] Lab Centrovet, Santiago, Chile; [Marshall, Sergio H.] Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Santiago, Chile; [Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Marshall, SH (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile.	smarshal@ucv.cl		Altamirano, Claudia/0000-0002-6389-086X; Gomez, Fernando/0000-0002-8191-2153; Henriquez, Vitalia/0000-0002-3447-4031; marshall, sergio/0000-0003-0438-8252	FONDECYT [1120584]; Conicyt Doctoral Scholarship	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt Doctoral Scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT grant 1120584 for Sergio H. Marshall and by a Conicyt Doctoral Scholarship for Fernando A. Gomez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendras FE, 1997, CAN J VET RES, V61, P66; Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; Angelini A, 2008, PROTEINS, V72, P1212, DOI 10.1002/prot.22014; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Arkush KD, 2005, DIS AQUAT ORGAN, V63, P139, DOI 10.3354/dao063139; Athanassopoulou F, 2004, J APPL ICHTHYOL, V20, P525, DOI 10.1111/j.1439-0426.2004.00571.x; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Birkbeck TH, 2004, INFECT IMMUN, V72, P3693, DOI 10.1128/IAI.72.6.3693-3694.2004; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Bravo S., 1989, CHILE PESQUERO, V54, P47; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Carle A, 2006, INFECT IMMUN, V74, P108, DOI 10.1128/IAI.74.1.108-117.2006; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Flores-Herrera O, 2003, MENSAJE BIOQUIMICO, VXXVII; Fryer JL, 2003, J FISH DIS, V26, P251, DOI 10.1046/j.1365-2761.2003.00460.x; FRYER JL, 1990, FISH PATHOL, V25, P107, DOI 10.3147/jsfp.25.107; Fryer JL, 1997, EMERG INFECT DIS, V3, P137, DOI 10.3201/eid0302.970206; Funato K, 1997, J BIOL CHEM, V272, P16147, DOI 10.1074/jbc.272.26.16147; Gal-Mor O, 2002, J BACTERIOL, V184, P3823, DOI 10.1128/JB.184.14.3823-3833.2002; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Gangwar D, 2009, MALARIA J, V18, P8; Gomez F, 2009, ARCH MED VET, V41, P261, DOI 10.4067/S0301-732X2009000300011; Gomez FA, 2011, FEMS MICROBIOL LETT, V317, P83, DOI 10.1111/j.1574-6968.2011.02218.x; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Joiner KA, 1997, J CLIN INVEST, V99, P1814, DOI 10.1172/JCI119347; Jones KM, 2007, J BACTERIOL, V189, P2133, DOI 10.1128/JB.00116-06; Krause S, 2000, P NATL ACAD SCI USA, V97, P3067, DOI 10.1073/pnas.050578697; Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN JS, 1995, INFECT IMMUN, V63, P1409, DOI 10.1128/IAI.63.4.1409-1414.1995; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall S, 1998, APPL ENVIRON MICROB, V64, P3066; Marshall SH, 2012, RES MICROBIOL, V163, P557, DOI 10.1016/j.resmic.2012.08.002; Marshall SH, 2011, FEMS MICROBIOL LETT, V314, P18, DOI 10.1111/j.1574-6968.2010.02132.x; Mauel MJ, 2008, J VET DIAGN INVEST, V20, P213, DOI 10.1177/104063870802000211; Mauel MJ, 2003, DIS AQUAT ORGAN, V53, P249, DOI 10.3354/dao053249; Mauel MJ, 1999, DIS AQUAT ORGAN, V35, P115, DOI 10.3354/dao035115; McCarthy UM, 2008, FISH SHELLFISH IMMUN, V25, P477, DOI 10.1016/j.fsi.2008.07.005; Mikalsen J, 2008, FEMS MICROBIOL LETT, V278, P43, DOI 10.1111/j.1574-6968.2007.00977.x; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Olsen A. B., 1993, NORSK FISKEOPPDRETT, V12, P40; Pena Andrea A, 2010, BMC Res Notes, V3, P101, DOI 10.1186/1756-0500-3-101; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rajas V, 2009, J CELL BIOCHEM, V108, P631, DOI 10.1002/jcb.22295; Rashkova S, 1997, J BACTERIOL, V179, P583, DOI 10.1128/jb.179.3.583-591.1997; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rojas V, 2010, J CELL BIOCHEM, V110, P468, DOI 10.1002/jcb.22560; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Sauer JD, 2005, INFECT IMMUN, V73, P4494, DOI 10.1128/IAI.73.8.4494-4504.2005; Scaturro M, 2009, J MICROBIOL, V47, P768, DOI 10.1007/s12275-009-0103-0; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Segal G, 1999, MOL MICROBIOL, V33, P669, DOI 10.1046/j.1365-2958.1999.01512.x; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sexton JA, 2005, MOL MICROBIOL, V57, P70, DOI 10.1111/j.1365-2958.2005.04667.x; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Tobar JA, 2004, J IMMUNOL, V173, P4058, DOI 10.4049/jimmunol.173.6.4058; Tobar JA, 2011, VACCINE, V317, P83; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Rojas MV, 2008, MICROB PATHOGENESIS, V44, P370, DOI 10.1016/j.micpath.2007.10.012; Vincent CD, 2006, J BACTERIOL, V188, P8231, DOI 10.1128/JB.00937-06; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Yanez AJ, 2012, DIS AQUAT ORGAN, V97, P197, DOI 10.3354/dao02403; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	73	50	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54934	10.1371/journal.pone.0054934	http://dx.doi.org/10.1371/journal.pone.0054934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383004	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500036
J	Pechlaner, R; Knoflach, M; Matosevic, B; Ruecker, M; Schmidauer, C; Kiechl, S; Willeit, J				Pechlaner, Raimund; Knoflach, Michael; Matosevic, Benjamin; Ruecker, Michael; Schmidauer, Christoph; Kiechl, Stefan; Willeit, Johann			Recanalization of Extracranial Internal Carotid Artery Occlusion after i.v. Thrombolysis for Acute Ischemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; THERAPY	Background: Although extracranial internal carotid artery (e-ICA) occlusion is a common pathology in patients undergoing intravenous thrombolysis for treatment of acute ischemic stroke, no data on e-ICA recanalization rate or potential effects on outcome are yet available. Methods and Results: This study included 52 consecutive patients with e-ICA occlusion and ischemic stroke undergoing standard intravenous thrombolysis. The rate of e-ICA recanalization was 30.8% [95% CI, 18.2-43.3], documented at 3.5 [2.0-11.8] (median [IQR]) days after stroke, as compared to 8.6% [95% CI, 3.5-13.7] in a series of 116 consecutive patients with symptomatic e-ICA occlusion not undergoing thrombolysis (P < 0.001 for difference). Functional outcome three months after stroke did not significantly differ for those with or without e-ICA recanalization following intravenous thrombolysis (modified Rankin scale <= 2: 31.3% vs. 22.2%, odds ratio 1.6 [95% CI, 0.4-5.9], P = 0.506). In patients with e-ICA occlusion of atherothrombotic origin, recanalization resulted in most instances in residual high-grade stenosis (13 of 14). Conclusions: Recanalization of e-ICA occlusion after stroke thrombolysis occurred in about one third of patients. Although e-ICA recanalization had no significant effect on patient outcome, control sonography in the early days after thrombolysis is recommended for the detection of potential residual e-ICA stenosis.	[Pechlaner, Raimund; Knoflach, Michael; Matosevic, Benjamin; Ruecker, Michael; Schmidauer, Christoph; Kiechl, Stefan; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Tyrol, Austria	Medical University of Innsbruck	Willeit, J (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Tyrol, Austria.	Johann.Willeit@i-med.ac.at		Pechlaner, Raimund/0000-0001-9006-5606; Knoflach, Michael/0000-0001-5576-6562				Christou I, 2001, INT ANGIOL, V20, P208; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Georgiadis D, 2004, NEUROLOGY, V63, P22, DOI 10.1212/01.WNL.0000132524.82310.91; Linfante I, 2002, STROKE, V33, P2066, DOI 10.1161/01.STR.0000021001.18101.A5; Mokin M, 2012, STROKE, V43, P2362, DOI 10.1161/STROKEAHA.112.655621; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; Paciaroni M, 2005, CEREBROVASC DIS, V20, P108, DOI 10.1159/000086800; Papanagiotou P, 2011, J AM COLL CARDIOL, V58, P2363, DOI 10.1016/j.jacc.2011.08.044; Ruecker M, 2012, NEUROLOGY, V79, P31, DOI 10.1212/WNL.0b013e31825dcdf0; Seet RC, 2012, ARCH NEUROL-CHICAGO, V24, P1; WOLPERT SM, 1993, AM J NEURORADIOL, V14, P3; Zangerle A, 2007, NEUROLOGY, V68, P39, DOI 10.1212/01.wnl.0000250341.38014.d2	12	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55318	10.1371/journal.pone.0055318	http://dx.doi.org/10.1371/journal.pone.0055318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383152	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500075
J	Wei, QX; Claus, R; Hielscher, T; Mertens, D; Raval, A; Oakes, CC; Tanner, SM; de la Chapelle, A; Byrd, JC; Stilgenbauer, S; Plass, C				Wei, Quan-Xiang; Claus, Rainer; Hielscher, Thomas; Mertens, Daniel; Raval, Aparna; Oakes, Christopher C.; Tanner, Stephan M.; de la Chapelle, Albert; Byrd, John C.; Stilgenbauer, Stephan; Plass, Christoph			Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							COLON-CANCER PATIENTS; GENE-EXPRESSION; MONOALLELIC EXPRESSION; COLORECTAL-CANCER; DOWN-REGULATION; METHYLATION; EPIMUTATION; GENOME; TGFBR1; DNA	We previously reported a rare germline variant (c.1-6531) that resulted in allele-specific expression (ASE) of death-associated protein kinase 1 (DAPK1) and predisposition to chronic lymphocytic leukemia (CLL). We investigated a cohort of CLL patients lacking this mutation for the presence of ASE of DAPK1. We developed a novel strategy that combines single-nucleotide primer extension (SNuPE) with MALDI-TOF mass spectrometry, and detected germline DAPK1 ASE in 17 out of 120 (14.2%) CLL patients associated with a trend towards younger age at diagnosis. ASE was absent in 63 healthy controls. Germline cells of CLL patients with ASE showed increased levels of DNA methylation in the promoter region, however, neither genetic nor further epigenetic aberrations could be identified in the DAPK1 5' upstream regulatory region, within distinct exons or in the 3'-UTR. We identified B-lymphoid malignancy related cell line models harboring allelic imbalance and found that allele-specific methylation in DAPK1 is associated with ASE. Our data indicate that ASE at the DAPK1 gene locus is a recurrent event, mediated by epigenetic mechanisms and potentially predisposing to CLL.	[Wei, Quan-Xiang; Claus, Rainer; Oakes, Christopher C.; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Claus, Rainer] Univ Freiburg, Med Ctr, Dept Hematol Oncol, Freiburg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Mertens, Daniel] German Canc Res Ctr, Cooperat Unit Mech Leukemogenesis, Heidelberg, Germany; [Mertens, Daniel; Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Raval, Aparna] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA; [Tanner, Stephan M.; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Byrd, John C.] Ohio State Univ, Dept Internal Med, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Stanford University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Claus, R (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany.	r.claus@dkfz.de	Mertens, Daniel/F-4681-2011; Oakes, Christopher C/H-7288-2014; Plass, Christoph/H-7192-2014; Stilgenbauer, Stephan/ABE-6609-2020; Claus, Rainer/AAZ-5606-2020	Mertens, Daniel/0000-0003-0227-7188; Oakes, Christopher C/0000-0001-8000-9694; Claus, Rainer/0000-0003-2617-8766	German Cancer Aid (Deutsche Krebshilfe); National Cancer Institute [P01 CA1019563, P50 CA140158, P30-CA016058-35]; German Research Council (DFG) [CL 427/2-1]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA101956, P50CA140158, P01CA081534] Funding Source: NIH RePORTER	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Council (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the German Cancer Aid (Deutsche Krebshilfe) and The National Cancer Institute grants P01 CA101956 (to CP and JCB), P50 CA140158 (to JCB and ADC), and P30-CA016058-35 (OSU CCC). RC received a fellowship from the German Research Council (DFG, CL 427/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Crowther-Swanepoel D, 2009, HAEMATOL-HEMATOL J, V94, P606, DOI 10.3324/haematol.2009.006296; DAVIES L, 1993, J AM STAT ASSOC, V88, P782, DOI 10.2307/2290763; Davies P, 1993, J AM STAT ASSOC, V88, P782; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Horsthemke B, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573b; Howlader N, 2011, SEER CANC STAT REV 1; Huang WH, 2009, BIOL PSYCHIAT, V65, P702, DOI 10.1016/j.biopsych.2008.11.024; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lynch HT, 2008, CANCER GENET CYTOGEN, V186, P95, DOI 10.1016/j.cancergencyto.2008.06.014; Martin DIK, 2005, ANN NY ACAD SCI, V1054, P68, DOI 10.1196/annals.1345.009; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Palacios R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004150; Pinheiro H, 2010, HUM MOL GENET, V19, P943, DOI 10.1093/hmg/ddp537; R Core Team, 2022, R LANG ENV STAT COMP; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Rohde C, BMC BIOINFORMATICS, V11, P230; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Snell C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1858; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yuille MR, 2000, BRIT J HAEMATOL, V109, P794, DOI 10.1046/j.1365-2141.2000.02111.x; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55261	10.1371/journal.pone.0055261	http://dx.doi.org/10.1371/journal.pone.0055261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383130	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500069
J	Papi, A; Storci, G; Guarnieri, T; De Carolis, S; Bertoni, S; Avenia, N; Sanguinetti, A; Sidoni, A; Santini, D; Ceccarelli, C; Taffurelli, M; Orlandi, M; Bonafe, M				Papi, Alessio; Storci, Gianluca; Guarnieri, Tiziana; De Carolis, Sabrina; Bertoni, Sara; Avenia, Nicola; Sanguinetti, Alessandro; Sidoni, Angelo; Santini, Donatella; Ceccarelli, Claudio; Taffurelli, Mario; Orlandi, Marina; Bonafe, Massimiliano			Peroxisome Proliferator Activated Receptor-alpha/Hypoxia Inducible Factor-1 alpha Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells	PLOS ONE			English	Article							NF-KAPPA-B; PPAR-GAMMA; IN-VITRO; SIGNALING PATHWAYS; SELF-RENEWAL; RXR-GAMMA; TUMOR; PROTEIN; GROWTH; IDENTIFICATION	Aims: Cancer stem cell biology is tightly connected to the regulation of the pro-inflammatory cytokine network. The concept of cancer stem cells "inflammatory addiction'' leads to envisage the potential role of anti-inflammatory molecules as new anti-cancer targets. Here we report on the relationship between nuclear receptors activity and the modulation of the pro-inflammatory phenotype in breast cancer stem cells. Methods: Breast cancer stem cells were expanded as mammospheres from normal and tumor human breast tissues and from tumorigenic (MCF7) and non tumorigenic (MCF10) human breast cell lines. Mammospheres were exposed to the supernatant of breast tumor and normal mammary gland tissue fibroblasts. Results: In mammospheres exposed to the breast tumor fibroblasts supernatant, autocrine tumor necrosis factor-alpha signalling engenders the functional interplay between peroxisome proliferator activated receptor-alpha and hypoxia inducible factor-1 alpha (PPAR alpha/HIF1 alpha). The two proteins promote mammospheres formation and enhance each other expression via miRNA130b/miRNA17-5p-dependent mechanism which is antagonized by PPAR gamma. Further, the PPAR alpha/HIF1 alpha interplay regulates the expression of the pro-inflammatory cytokine interleukin-6, the hypoxia survival factor carbonic anhydrase IX and the plasma lipid carrier apolipoprotein E. Conclusion: Our data demonstrate the importance of exploring the role of nuclear receptors (PPAR alpha/PPAR gamma) in the regulation of pro-inflammatory pathways, with the aim to thwart breast cancer stem cells functioning.	[Papi, Alessio; Guarnieri, Tiziana; Ceccarelli, Claudio; Orlandi, Marina] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Storci, Gianluca; De Carolis, Sabrina; Bonafe, Massimiliano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Storci, Gianluca; Guarnieri, Tiziana; Bertoni, Sara; Bonafe, Massimiliano] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy; [Guarnieri, Tiziana] Natl Biostruct & Biosyst Inst INBB, Rome, Italy; [Avenia, Nicola; Sanguinetti, Alessandro] Univ Perugia, Dept Surg Sci Radiol & Dent, I-06100 Perugia, Italy; [Sidoni, Angelo] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Santini, Donatella] St Orsola Malpighi Univ Hosp, Dept Radiol & Histocytopathol, Bologna, Italy; [Taffurelli, Mario] Univ Bologna, Dept Clin & Surg Sci, Bologna, Italy	University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Perugia; University of Perugia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Papi, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.	alessio.papi2@unibo.it; massimiliano.bonafe@unibo.it	ceccarelli, claudio/AAS-6105-2020; PAPI, ALESSIO/AAR-6808-2020; Guarnieri, Tiziana/A-9534-2016; Storci, Gianluca/AED-6195-2022; Avenia, Nicola/AAL-4546-2021; Santini, Donatella/AAO-1490-2021; SIDONI, Angelo/K-8171-2016	ceccarelli, claudio/0000-0003-0743-2087; PAPI, ALESSIO/0000-0002-2490-3090; Guarnieri, Tiziana/0000-0002-5069-5010; Storci, Gianluca/0000-0001-5145-3091; Santini, Donatella/0000-0002-1692-6348; SIDONI, Angelo/0000-0002-8458-5901; DE CAROLIS, SABRINA/0000-0001-5785-2624	Project of National Interest (PRIN) of Ministry of Education (Italy) [2008KTRN38]; Cornelia and Roberts Pallotti legacy; Fundamental Oriented Research of TG	Project of National Interest (PRIN) of Ministry of Education (Italy)(Ministry of Education, Universities and Research (MIUR)); Cornelia and Roberts Pallotti legacy; Fundamental Oriented Research of TG	This work has been supported by grant Project of National Interest (PRIN) of Ministry of Education (Italy), code project: 2008KTRN38 and title project: "Clinical, diagnostic and therapeutic implications of studies on breast cancer stem cells'', Cornelia and Roberts Pallotti legacy to MB and MT and by Fundamental Oriented Research of TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alikhani N, 2012, ONCOGENE; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Bonafe M, 2012, BIOESSAYS, V34, P40, DOI 10.1002/bies.201100104; Bonofiglio D, 2009, AM J PATHOL, V175, P1270, DOI 10.2353/ajpath.2009.081078; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Chang NW, 2009, CLIN CHIM ACTA, V401, P144, DOI 10.1016/j.cca.2008.12.005; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Galzio R, 2012, J CELL BIOCHEM, V113, P3342, DOI 10.1002/jcb.24210; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Ha SA, 2009, J CELL MOL MED, V13, P3868, DOI 10.1111/j.1582-4934.2009.00652.x; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Moysich KB, 2000, MOL CARCINOGEN, V27, P2, DOI 10.1002/(SICI)1098-2744(200001)27:1<2::AID-MC2>3.0.CO;2-W; Nakayama-Ichiyama Shoko, 2011, Br J Haematol, V153, P419, DOI 10.1111/j.1365-2141.2011.08625.x; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Nwankwo JO, 2001, PROSTAG LEUKOTR ESS, V64, P241, DOI 10.1054/plef.2001.0266; Papi A, 2012, CELL DEATH DIFFER, V19, P1208, DOI 10.1038/cdd.2011.207; Papi A, 2010, CANCER LETT, V297, P65, DOI 10.1016/j.canlet.2010.04.026; Papi A, 2009, J NEUROCHEM, V109, P1779, DOI 10.1111/j.1471-4159.2009.06111.x; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pfaff N, 2011, EMBO REP, V12, P1153, DOI 10.1038/embor.2011.176; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; SOULE HD, 1990, CANCER RES, V50, P6075; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Svastova E, 2012, J BIOL CHEM, V287, P3392, DOI 10.1074/jbc.M111.286062; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takubo K, 2012, INT J HEMATOL, V95, P478, DOI 10.1007/s12185-012-1071-4; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Twu YC, 2011, EUR J IMMUNOL, V41, P335, DOI 10.1002/eji.201040639; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072; Zhang JZ, 2010, INT J TOXICOL, V29, P496, DOI 10.1177/1091581810376674; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	62	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54968	10.1371/journal.pone.0054968	http://dx.doi.org/10.1371/journal.pone.0054968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372804	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400047
J	Ishida, Y; Park, JH; Mao, LL; Yamaguchi, Y; Inouye, M				Ishida, Yojiro; Park, Jung-Ho; Mao, Lili; Yamaguchi, Yoshihiro; Inouye, Masayori			Replacement of All Arginine Residues with Canavanine in MazF-bs mRNA Interferase Changes Its Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-ANTITOXIN SYSTEMS; UNNATURAL AMINO-ACIDS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENETIC-CODE; PROTEINS	Replacement of a specific amino acid residue in a protein with nonnatural analogues is highly challenging because of their cellular toxicity. We demonstrate for the first time the replacement of all arginine (Arg) residues in a protein with canavanine (Can), a toxic Arg analogue. All Arg residues in the 5-base specific (UACAU) mRNA interferase from Bacillus subtilis (MazF-bs(arg)) were replaced with Can by using the single-protein production system in Escherichia coli. The resulting MazF-bs(can) gained a 6-base recognition sequence, UACAUA, for RNA cleavage instead of the 5-base sequence, UACAU, for MazF-bs(arg). Mass spectrometry analysis confirmed that all Arg residues were replaced with Can. The present system offers a novel approach to create new functional proteins by replacing a specific amino acid in a protein with its analogues.	[Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@cabm.rutgers.edu		Park, Jung-Ho/0000-0003-0441-4457; Yamaguchi, Yoshihiro/0000-0003-4663-6963	National Institutes of Health [RO1GM081567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM081567.	Angaji SA, 2010, J GENET, V89, P527; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Gogos A, 2003, PROTEINS, V53, P320, DOI 10.1002/prot.10457; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; ROSENTHAL GA, 1989, J BIOL CHEM, V264, P13693; ROSENTHAL GA, 1989, J BIOL CHEM, V264, P9768; ROSENTHAL GA, 1991, J BIOL CHEM, V266, P15684; Stigers DJ, 2011, CHEM COMMUN, V47, P1839, DOI 10.1039/c0cc02879g; Suzuki M, 2006, J BIOL CHEM, V281, P37559, DOI 10.1074/jbc.M608806200; Vaiphei ST, 2010, APPL ENVIRON MICROB, V76, P6063, DOI 10.1128/AEM.00815-10; Yamaguchi Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1621; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200	22	12	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7564	7571		10.1074/jbc.M112.434969	http://dx.doi.org/10.1074/jbc.M112.434969			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23378533	hybrid, Green Published			2022-12-25	WOS:000316455300013
J	Decano, JL; Moran, AM; Giordano, N; Ruiz-Opazo, N; Herrera, VLM				Decano, Julius L.; Moran, Ann Marie; Giordano, Nicholas; Ruiz-Opazo, Nelson; Herrera, Victoria L. M.			Analysis of CD45-[CD34+/KDR+] Endothelial Progenitor Cells as Juvenile Protective Factors in a Rat Model of Ischemic-Hemorrhagic Stroke	PLOS ONE			English	Article							INJURY; NEOVASCULARIZATION; MOBILIZATION; RELEVANCE; CAPACITY	Background: Identification of juvenile protective factors (JPFs) which are altered with age and contribute to adult-onset diseases could identify novel pathways for reversing the effects of age, an accepted non-modifiable risk factor to adult-onset diseases. Since endothelial progenitor cells (EPCs) have been observed to be altered in stroke, hypertension and hypercholesterolemia, said EPCs are candidate JPFs for adult-onset stroke. A priori, if EPC aging plays a 'master-switch JPF-role' in stroke pathogenesis, juvenile EPC therapy alone should delay stroke-onset. Using a hypertensive, transgenic-hyperlipidemic rat model of spontaneous ischemic-hemorrhagic stroke, spTg25, we tested the hypothesis that freshly isolated juvenile EPCs are JPFs that can attenuate stroke progression and delay stroke onset. Methodology/Principal Findings: FACS analysis revealed that CD45- [CD34+/KDR+] EPCs decrease with progression to stroke in spTg25 rats, exhibit differential expression of the dual endodthelin-1/VEGFsp receptor (DEspR) and undergo differential DEspR-subtype specific changes in number and in vitro angiogenic tube-incorporation. In vivo EPC infusion of male, juvenile non-expanded CD45-[CD34+/KDR+] EPCs into female stroke-prone rats prior to stroke attenuated delayed stroke onset (P<0.003). Detection of Y-chromosome DNA in brain microvessels of EPC-treated female spTg25 rats indicates integration of male EPCs into female rat brain microvessels. Gradient-echo MRI showed delay of ischemic-hemorrhagic lesions in EPC-treated rats. Real-time RT-PCR pathway-specific array-analysis revealed age-associated gene expression changes in CD45-[CD34+/KDR]EPC subtypes, which were accelerated in stroke-prone rats. Pro-angiogenic genes implicated in intimal hyperplasia were increased in stroke-prone rat EPCs (P<0.0001), suggesting a maladaptive endothelial repair system which acts like a double-edged sword repairing while predisposing to age-associated intimal hyperplasia. Conclusions/Significance: Altogether, the data demonstrate that CD45-[CD34/KDR+]EPCs are juvenile protective factors for ischemic hemorrhagic stroke as modeled in the spTg25-rat model. The ability to delay stroke onset emphasizes the importance of EPC-mediated roles in vascular health for ischemic-hemorrhagic stroke, a high unmet need.	[Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University; Boston University	Herrera, VLM (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	vherrera@bu.edu		Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332	National Institutes of Health [RO1 AG032649]; NATIONAL INSTITUTE ON AGING [R01AG032649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health RO1 AG032649 to VLMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 1997, J ANDROL, V18, P289; Bergerat A, 2011, MOL MED, V17, P588, DOI 10.2119/molmed.2010.00228; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Decano JL, 2009, CIRCULATION, V119, P1501, DOI 10.1161/CIRCULATIONAHA.108.833327; del Zoppo GJ, 2009, CEREBROVASC DIS, V27, P65, DOI 10.1159/000200442; Desai A, 2009, ARTERIOSCL THROM VAS, V29, P121, DOI 10.1161/ATVBAHA.108.174573; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Gennaro G, 2003, CIRCULATION, V107, P230, DOI 10.1161/01.CIR.0000050652.47145.4C; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; Hunter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036893; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Navarro-Sobrino M, 2010, MICROVASC RES, V80, P317, DOI 10.1016/j.mvr.2010.05.008; Payne GW, 2006, MICROCIRCULATION, V13, P275, DOI 10.1080/10739680600618710; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Taguchi A, 2011, J CEREBR BLOOD F MET, V31, P855, DOI 10.1038/jcbfm.2010.165; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; VRACKO R, 1970, J CELL BIOL, V47, P281, DOI 10.1083/jcb.47.1.281; Williamson K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00030; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11	23	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55222	10.1371/journal.pone.0055222	http://dx.doi.org/10.1371/journal.pone.0055222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383116	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600076
J	Izaurralde, RC; Rice, CW; Wielopolski, L; Ebinger, MH; Reeves, JB; Thomson, AM; Harris, R; Francis, B; Mitra, S; Rappaport, AG; Etchevers, JD; Sayre, KD; Govaerts, B; McCarty, GW				Izaurralde, Roberto C.; Rice, Charles W.; Wielopolski, Lucian; Ebinger, Michael H.; Reeves, James B., III; Thomson, Allison M.; Harris, Ronny; Francis, Barry; Mitra, Sudeep; Rappaport, Aaron G.; Etchevers, Jorge D.; Sayre, Kenneth D.; Govaerts, Bram; McCarty, Gregory W.			Evaluation of Three Field-Based Methods for Quantifying Soil Carbon	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; INDUCED BREAKDOWN SPECTROSCOPY; MITIGATION; STORAGE	Three advanced technologies to measure soil carbon (C) density (g C m(-2)) are deployed in the field and the results compared against those obtained by the dry combustion (DC) method. The advanced methods are: a) Laser Induced Breakdown Spectroscopy (LIBS), b) Diffuse Reflectance Fourier Transform Infrared Spectroscopy (DRIFTS), and c) Inelastic Neutron Scattering (INS). The measurements and soil samples were acquired at Beltsville, MD, USA and at Centro International para el Mejoramiento del Maiz y el Trigo (CIMMYT) at El Batan, Mexico. At Beltsville, soil samples were extracted at three depth intervals (0-5, 5-15, and 15-30 cm) and processed for analysis in the field with the LIBS and DRIFTS instruments. The INS instrument determined soil C density to a depth of 30 cm via scanning and stationary measurements. Subsequently, soil core samples were analyzed in the laboratory for soil bulk density (kg m(-3)), C concentration (g kg(-1)) by DC, and results reported as soil C density (kg m(-2)). Results from each technique were derived independently and contributed to a blind test against results from the reference (DC) method. A similar procedure was employed at CIMMYT in Mexico employing but only with the LIBS and DRIFTS instruments. Following conversion to common units, we found that the LIBS, DRIFTS, and INS results can be compared directly with those obtained by the DC method. The first two methods and the standard DC require soil sampling and need soil bulk density information to convert soil C concentrations to soil C densities while the INS method does not require soil sampling. We conclude that, in comparison with the DC method, the three instruments (a) showed acceptable performances although further work is needed to improve calibration techniques and (b) demonstrated their portability and their capacity to perform under field conditions.	[Izaurralde, Roberto C.; Thomson, Allison M.; Rappaport, Aaron G.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Izaurralde, Roberto C.; Thomson, Allison M.; Rappaport, Aaron G.] Univ Maryland, College Pk, MD 20742 USA; [Rice, Charles W.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Wielopolski, Lucian; Mitra, Sudeep] Brookhaven Natl Lab, Dept Environm Sci, Upton, NY 11973 USA; [Ebinger, Michael H.; Harris, Ronny] Los Alamos Natl Lab, Los Alamos, NM USA; [Reeves, James B., III; Francis, Barry] ARS, EMBUL, USDA, Beltsville, MD USA; [Etchevers, Jorge D.] Rappaport & Associates, Joint Global Change Res Inst, College Pk, MD USA; [Sayre, Kenneth D.] Colegio Postgrad, Nat Resources Inst, Soil Fertil Lab, Texcoco, State Of Mexico, Mexico; [Govaerts, Bram] CIMMYT, Mexico City, DF, Mexico; [McCarty, Gregory W.] ARS, HRSL, USDA, BARC W, Beltsville, MD USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; Kansas State University; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Agriculture (USDA); Colegio de Postgraduados - Mexico; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); United States Department of Agriculture (USDA)	Izaurralde, RC (corresponding author), Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA.	cesar.izaurralde@pnnl.gov	Izaurralde, Roberto César/E-5257-2019; Thomson, Allison/GRO-3207-2022; Thomson, Allison M/B-1254-2010	Thomson, Allison M/0000-0001-5326-1755; Govaerts, Bram/0000-0002-6109-7286; ETCHEVERS, J. D./0000-0003-4663-6306; Izaurralde, Roberto/0000-0002-8797-9500	United States Agency for International Development, Global Climate Change Office; United States Department of Energy's Office of Science, Biological and Environmental Research (BER); Consortium of Agricultural Soils Mitigation of Greenhouse Gases (CASMGS); Robertson Foundation; Div Of Biological Infrastructure [1043393] Funding Source: National Science Foundation; Office Of The Director [0903806] Funding Source: National Science Foundation	United States Agency for International Development, Global Climate Change Office(United States Agency for International Development (USAID)); United States Department of Energy's Office of Science, Biological and Environmental Research (BER)(United States Department of Energy (DOE)); Consortium of Agricultural Soils Mitigation of Greenhouse Gases (CASMGS); Robertson Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The authors acknowledge the financial support of the United States Agency for International Development, Global Climate Change Office, the United States Department of Energy's Office of Science, Biological and Environmental Research (BER) funding to the Consortium for Research on Enhancing Carbon Sequestration in Terrestrial Ecosystems (CSiTE), the USDA CSREES through its support of the Consortium of Agricultural Soils Mitigation of Greenhouse Gases (CASMGS), and the Robertson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jowder O, 1999, J AGR FOOD CHEM, V47, P3210, DOI 10.1021/jf981196d; Bertelli D, 2007, FOOD CHEM, V101, P1565, DOI 10.1016/j.foodchem.2006.04.010; Brown D.J., 2010, EOS T AGU, V91, P441, DOI DOI 10.1029/2010EO470001; Carayannis E., 2011, PLANET EARTH 2011 GL, P467; Chatterjee A, 2009, CRIT REV PLANT SCI, V28, P164, DOI 10.1080/07352680902776556; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Cremers DA, 2001, J ENVIRON QUAL, V30, P2202, DOI 10.2134/jeq2001.2202; Csikai J, 1987, HDB FAST NEUTRON GEN; Ebinger MH, 2003, SOIL SCI SOC AM J, V67, P1616, DOI 10.2136/sssaj2003.1616; Ebinger MH, 2010, United States Patent No, Patent No. [7,692, 789 B1, 7692789]; Gish TJ, 2004, PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON GROUND PENETRATING RADAR, VOLS 1 AND 2, P493; Govaerts B, 2006, SOIL TILL RES, V87, P163, DOI 10.1016/j.still.2005.03.005; Govaerts B, 2009, SOIL TILL RES, V103, P222, DOI 10.1016/j.still.2008.05.018; Harmon RS, 2005, GEOCHEM-EXPLOR ENV A, V5, P21, DOI 10.1144/1467-7873/03-059; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; Izaurralde R. C., 2006, Carbon sequestration in soils of Latin America, P457; Izaurralde RC, 2005, CLIMATE CHANGE AND GLOBAL FOOD SECURITY, P467; Izaurralde RC, 2001, ADV AGRON, V70, P1; Izaurralde RC, 1998, ADV SOIL S, P433; Janik LJ, 1998, AUST J EXP AGR, V38, P681, DOI 10.1071/EA97144; Janzen HH, 1998, SOIL TILL RES, V47, P181, DOI 10.1016/S0167-1987(98)00105-6; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Macauley-Patrick S, 2003, BIOTECHNOL LETT, V25, P257, DOI 10.1023/A:1022351001284; McCarty GW, 2006, SOIL SCI, V171, P94, DOI 10.1097/01.ss.0000187377.84391.54; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; Moenke-Blankenburg L., 1989, LASER MICROANALYSIS; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; RADZIEMSKI LJ, 1989, LASER INDUCED PLASMA, P295; Reeves JB, 2001, J AGR FOOD CHEM, V49, P766, DOI 10.1021/jf0011283; Rusak DA, 1997, CRIT REV ANAL CHEM, V27, P257, DOI 10.1080/10408349708050587; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Wielopolski L, 2011, GEODERMA, V160, P394, DOI 10.1016/j.geoderma.2010.10.009; Wielopolski L., 2004, 722002004 BNL; Wielopolski L, 2008, SOIL SCI SOC AM J, V72, P1269, DOI 10.2136/sssaj2007.0177; Wielopolski L, 2010, FOREST ECOL MANAG, V260, P1132, DOI 10.1016/j.foreco.2010.06.039; Wielopolski L, 2010, SOIL SCI SOC AM J, V74, P812, DOI 10.2136/sssaj2009.0205	37	17	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55560	10.1371/journal.pone.0055560	http://dx.doi.org/10.1371/journal.pone.0055560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383225	Green Published, gold			2022-12-25	WOS:000314610600126
J	Klagges, C; Campoy, JA; Quero-Garcia, J; Guzman, A; Mansur, L; Gratacos, E; Silva, H; Rosyara, UR; Iezzoni, A; Meisel, LA; Dirlewanger, E				Klagges, Carolina; Antonio Campoy, Jose; Quero-Garcia, Jose; Guzman, Alejandra; Mansur, Levi; Gratacos, Eduardo; Silva, Herman; Rosyara, Umesh R.; Iezzoni, Amy; Meisel, Lee A.; Dirlewanger, Elisabeth			Construction and Comparative Analyses of Highly Dense Linkage Maps of Two Sweet Cherry Intra-Specific Progenies of Commercial Cultivars	PLOS ONE			English	Article							ROSACEAE; MICROSATELLITE; DATABASE; PEACH	Despite the agronomical importance and high synteny with other Prunus species, breeding improvements for cherry have been slow compared to other temperate fruits, such as apple or peach. However, the recent release of the peach genome v1.0 by the International Peach Genome Initiative and the sequencing of cherry accessions to identify Single Nucleotide Polymorphisms (SNPs) provide an excellent basis for the advancement of cherry genetic and genomic studies. The availability of dense genetic linkage maps in phenotyped segregating progenies would be a valuable tool for breeders and geneticists. Using two sweet cherry (Prunus avium L.) intra-specific progenies derived from crosses between 'Black Tartarian' x 'Kordia' (BTxK) and 'Regina' x 'Lapins'(RxL), high-density genetic maps of the four parental lines and the two segregating populations were constructed. For BTxK and RxL, 89 and 121 F-1 plants were used for linkage mapping, respectively. A total of 5,696 SNP markers were tested in each progeny. As a result of these analyses, 723 and 687 markers were mapped into eight linkage groups (LGs) in BTxK and RxL, respectively. The resulting maps spanned 752.9 and 639.9 cM with an average distance of 1.1 and 0.9 cM between adjacent markers in BTxK and RxL, respectively. The maps displayed high synteny and co-linearity between each other, with the Prunus bin map, and with the peach genome v1.0 for all eight LGs (LG1-LG8). These maps provide a useful tool for investigating traits of interest in sweet cherry and represent a qualitative advance in the understanding of the cherry genome and its synteny with other members of the Rosaceae family.	[Klagges, Carolina; Meisel, Lee A.] Univ Andres Bello, Ctr Biotecnol Vegetal, Fac Ciencias Biol, Santiago, Chile; [Antonio Campoy, Jose; Quero-Garcia, Jose; Dirlewanger, Elisabeth] INRA, UR419, UREF, Villenave Dornon, France; [Guzman, Alejandra; Mansur, Levi; Gratacos, Eduardo] Pontificia Univ Catolica Valparaiso, Fac Agron, Estn Expt La Palma, Quillota, Chile; [Silva, Herman] Univ Chile, Fac Ciencias Agron, Dept Agr Prod, Lab Genom Func & Bioinformat, Santiago, Chile; [Rosyara, Umesh R.; Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Meisel, Lee A.] Univ Chile, INTA, Santiago, Chile	Universidad Andres Bello; INRAE; Pontificia Universidad Catolica de Valparaiso; Universidad de Chile; Michigan State University; Universidad de Chile	Meisel, LA (corresponding author), Univ Andres Bello, Ctr Biotecnol Vegetal, Fac Ciencias Biol, Santiago, Chile.	lmeisel@inta.uchile.cl; edirlewan@bordeaux.inra.fr	Campoy, José A/L-2699-2015; Meisel, Lee Ann/J-6755-2012; Silva, Herman P/C-7252-2012	Campoy, José A/0000-0002-6018-5698; Meisel, Lee Ann/0000-0002-4806-6864; Silva, Herman P/0000-0003-1007-7442; Dirlewanger, Elisabeth/0000-0003-3244-5197	INNOVA Chile CORFO project [07CN13PBT-167]; INRA's Department of "Genetic and Plant Breeding"; Universidad Andres Bello [DI-78-12/I]; USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project "RosBREED: Enabling marker-assisted breeding in Rosaceae" [2009-51181-05808]; CONICYT [1120261, 1121021, 21120115, 24121484]; "Programa de Formacion Postdoctoral de Personal Investigador" of the "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia", Spain; Conseil Regional d'Aquitaine [01 00122000568]	INNOVA Chile CORFO project; INRA's Department of "Genetic and Plant Breeding"; Universidad Andres Bello; USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project "RosBREED: Enabling marker-assisted breeding in Rosaceae"; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); "Programa de Formacion Postdoctoral de Personal Investigador" of the "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia", Spain; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was funded by 07CN13PBT-167 INNOVA Chile CORFO project, and by INRA's Department of "Genetic and Plant Breeding" and the Conseil Regional d'Aquitaine 2011 project "convention 2011-12 01 00122000568" for analyses performed in France. Additional funding was provided by Universidad Andres Bello DI-78-12/I project, the USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project "RosBREED: Enabling marker-assisted breeding in Rosaceae" (2009-51181-05808), CONICYT Fondecyt/regular number 1120261 and CONICYT Fondecyt/regular number 1121021. CK holds a CONICYT doctoral fellowship (21120115 and 24121484). JC is holder of a postdoctoral fellowship from the "Programa de Formacion Postdoctoral de Personal Investigador" of the "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia", Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arus P, 2012, TREE GENET GENOMES, V8, P531, DOI 10.1007/s11295-012-0493-8; Bargioni G, 1996, SWEET CHERRY SCIONS, P73; Brettin TS, 2000, J HERED, V91, P75, DOI 10.1093/jhered/91.1.75; Cabrera A, 2012, TREE GENET GENOMES, V8, P237, DOI 10.1007/s11295-011-0436-9; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Dirlewanger E, 2008, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.2008.795.13; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 1998, THEOR APPL GENET, V97, P888, DOI 10.1007/s001220050969; Dirlewanger E., 2007, Fruits and nuts, P103; Faust M., 1997, Horticultural Reviews, V19, P263; Gratacos E, 2008, ACTA HORTIC, P239, DOI 10.17660/ActaHortic.2008.795.32; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Iezzoni A., 1991, GENETIC RESOURCES TE, V290, P111, DOI [10.17660/ActaHortic.1991.290.4, DOI 10.17660/ACTAHORTIC.1991.290.4]; Iezzoni A. F., 2008, P151, DOI 10.1007/978-1-4020-6907-9_5; Illumina, 2008, GENOMESTUDIO GEN MOD; Illumina, 2010, UND ILL QUAL SCOR; Illumina I, 2010, INF GEN DAT AN GUID; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Kappel F, 1996, HORTSCIENCE, V31, P443, DOI 10.21273/HORTSCI.31.3.443; Kappel F, 2012, HANDB PLANT BREED, V8, P459, DOI 10.1007/978-1-4419-0763-9_13; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Luedeling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020155; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; OLDEN EJ, 1968, HEREDITAS-GENETISK A, V59, P327; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Peace C, 2012, PLOS ONE IN PRESS; PROEBSTING EL, 1987, HORTSCIENCE, V22, P227; Sherman W, 2002, CLIMATIC ADAPTATION, P411; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Sosinski B., 2010, 5 INT GEN C NOV STEL; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; Tavassolian I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-551; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Van Ooijen J., 2006, SOFTWARE CALCULATION; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Webster A. D., 1996, P127; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8	44	54	55	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54743	10.1371/journal.pone.0054743	http://dx.doi.org/10.1371/journal.pone.0054743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382953	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600037
J	Robin, S; Arese, M; Forte, E; Sarti, P; Kolaj-Robin, O; Giuffre, A; Soulimane, T				Robin, Sylvain; Arese, Marzia; Forte, Elena; Sarti, Paolo; Kolaj-Robin, Olga; Giuffre, Alessandro; Soulimane, Tewfik			Functional Dissection of the Multi-Domain Di-Heme Cytochrome c(550) from Thermus thermophilus	PLOS ONE			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; SULFITE-OXIDIZING ENZYMES; SWISS-MODEL; BIOCHEMICAL-CHARACTERIZATION; FLAVOCYTOCHROME-C; MOLECULAR-BIOLOGY; CAA(3) OXIDASE; METABOLISM; COMPLEX; C(4)	In bacteria, oxidation of sulfite to sulfate, the most common strategy for sulfite detoxification, is mainly accomplished by the molybdenum-containing sulfite: acceptor oxidoreductases (SORs). Bacterial SORs are very diverse proteins; they can exist as monomers or homodimers of their core subunit, as well as heterodimers with an additional cytochrome c subunit. We have previously described the homodimeric SOR from Thermus thermophilus HB8 (SORTTHB8), identified its physiological electron acceptor, cytochrome c(550), and demonstrated the key role of the latter in coupling sulfite oxidation to aerobic respiration. Herein, the role of this di-heme cytochrome c was further investigated. The cytochrome was shown to be composed of two conformationally independent domains, each containing one heme moiety. Each domain was separately cloned, expressed in E. coli and purified to homogeneity. Stopped-flow experiments showed that: i) the N-terminal domain is the only one accepting electrons from SORTTHB8; ii) the N- and C-terminal domains are in rapid redox equilibrium and iii) both domains are able to transfer electrons further to cytochrome c(552), the physiological substrate of the ba(3) and caa(3) terminal oxidases. These findings show that cytochrome c(550) functions as a electron shuttle, without working as an electron wire with one heme acting as the electron entry and the other as the electron exit site. Although contribution of the cytochrome c(550) C-terminal domain to T. thermophilus sulfur respiration seems to be dispensable, we suggest that di-heme composition of the cytochrome physiologically enables storage of the two electrons generated from sulfite oxidation, thereof ensuring efficient contribution of sulfite detoxification to the respiratory chain-mediated energy generation.	[Robin, Sylvain; Kolaj-Robin, Olga; Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Mat & Surface Sci Inst, Limerick, Ireland; [Arese, Marzia; Forte, Elena; Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, Fdn Cenci Bolognetti, Rome, Italy; [Arese, Marzia; Forte, Elena; Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Sarti, Paolo; Giuffre, Alessandro] Ist Biol & Patol Mol, Consiglio Nazl Ric, Rome, Italy	University of Limerick; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Giuffre, A (corresponding author), Ist Biol & Patol Mol, Consiglio Nazl Ric, Rome, Italy.	alessandro.giuffre@uniroma1.it; tewfik.soulimane@ul.ie	Forte, Elena/K-6015-2015; Giuffrè, Alessandro/K-4341-2015	Giuffrè, Alessandro/0000-0001-5301-0681; ARESE, Marzia/0000-0002-6140-2287; Sarti, Paolo/0000-0002-8219-4827; FORTE, Elena/0000-0001-9049-6916	Science Foundation Ireland [BICF685]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [FIRB RBFR08F41U_001, FIRB RBIN06E9Z8]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	Work partially supported by Science Foundation Ireland (BICF685) to TF and Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (FIRB RBFR08F41U_001 to AG and FIRB RBIN06E9Z8 to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel C, 2003, STRUCTURE, V11, P547, DOI 10.1016/S0969-2126(03)00072-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Brune DC, 1995, ANOXYGENIC PHOTOSYNT, P847, DOI 10.1007/0-306-47954-0_39; Chang HY, 2010, BIOCHEMISTRY-US, V49, P7494, DOI 10.1021/bi1004574; CHARLES AM, 1965, BIOCHEM BIOPH RES CO, V19, P686, DOI 10.1016/0006-291X(65)90311-6; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; COHEN HJ, 1971, J BIOL CHEM, V246, P367; CONRAD LS, 1995, EUR J BIOCHEM, V231, P133, DOI 10.1111/j.1432-1033.1995.tb20679.x; Cook AM, 2006, ADV EXP MED BIOL, V583, P3; D'Errico G, 2006, J BACTERIOL, V188, P694, DOI 10.1128/JB.188.2.694-701.2006; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; Di Rocco G, 2008, J BIOL INORG CHEM, V13, P789, DOI 10.1007/s00775-008-0366-7; Di Salle A, 2006, EXTREMOPHILES, V10, P587, DOI 10.1007/s00792-006-0534-z; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Emesh S, 2009, BIOCHEMISTRY-US, V48, P2156, DOI 10.1021/bi801553q; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gerscher S, 1998, BIOSPECTROSCOPY, V4, P365, DOI 10.1002/(SICI)1520-6343(1998)4:6<365::AID-BSPY2>3.0.CO;2-C; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heitmann D, 2005, BIOCHEMISTRY-US, V44, P12411, DOI 10.1021/bi0509999; Higuchi M, 2009, PHOTOSYNTH RES, V102, P77, DOI 10.1007/s11120-009-9492-5; Janzon J, 2007, IUBMB LIFE, V59, P563, DOI 10.1080/15216540701242482; Kadziola A, 1997, STRUCTURE, V5, P203, DOI 10.1016/S0969-2126(97)00179-2; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2011, BBA-BIOENERGETICS, V1807, P1, DOI 10.1016/j.bbabio.2010.09.004; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Low L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00058; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Mooser D, 2005, BBA-BIOENERGETICS, V1708, P262, DOI 10.1016/j.bbabio.2005.03.008; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; PETTIGREW GW, 1988, BIOCHEM J, V252, P427, DOI 10.1042/bj2520427; Raffalt AC, 2009, J INORG BIOCHEM, V103, P717, DOI 10.1016/j.jinorgbio.2009.01.004; Reichenbecher W, 1999, ARCH MICROBIOL, V172, P387, DOI 10.1007/s002030050775; Robin S, 2011, J BACTERIOL, V193, P3988, DOI 10.1128/JB.05186-11; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SOROKIN DY, 1995, MICROBIOLOGY+, V64, P295; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; Soulimane T, 2002, PRACTICAL GUIDE MEMB, P229; VANBEEUMEN JJ, 1991, J BIOL CHEM, V266, P12921; Wilson JJ, 2009, BBA-BIOENERGETICS, V1787, P1516, DOI 10.1016/j.bbabio.2009.07.005	53	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55129	10.1371/journal.pone.0055129	http://dx.doi.org/10.1371/journal.pone.0055129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383080	Green Published, gold			2022-12-25	WOS:000314610600067
J	Wu, XY; Ma, J				Wu, Xinyi; Ma, Jun			The Formation Mechanism of Defects, Spiral Wave in the Network of Neurons	PLOS ONE			English	Article							SPATIOTEMPORAL CHAOS; PATTERN-FORMATION; VENTRICULAR-FIBRILLATION; TARGET WAVES; TRANSITION; MODEL; SUPPRESSION; NOISE; TACHYCARDIA; TURBULENCE	A regular network of neurons is constructed by using the Morris-Lecar (ML) neuron with the ion channels being considered, and the potential mechnism of the formation of a spiral wave is investigated in detail. Several spiral waves are initiated by blocking the target wave with artificial defects and/or partial blocking (poisoning) in ion channels. Furthermore, possible conditions for spiral wave formation and the effect of partial channel blocking are discussed completely. Our results are summarized as follows. 1) The emergence of a target wave depends on the transmembrane currents with diversity, which mapped from the external forcing current and this kind of diversity is associated with spatial heterogeneity in the media. 2) Distinct spiral wave could be induced to occupy the network when the target wave is broken by partially blocking the ion channels of a fraction of neurons (local poisoned area), and these generated spiral waves are similar with the spiral waves induced by artificial defects. It is confirmed that partial channel blocking of some neurons in the network could play a similar role in breaking a target wave as do artificial defects; 3) Channel noise and additive Gaussian white noise are also considered, and it is confirmed that spiral waves are also induced in the network in the presence of noise. According to the results mentioned above, we conclude that appropriate poisoning in ion channels of neurons in the network acts as 'defects' on the evolution of the spatiotemporal pattern, and accounts for the emergence of a spiral wave in the network of neurons. These results could be helpful to understand the potential cause of the formation and development of spiral waves in the cortex of a neuronal system.	[Wu, Xinyi; Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China	Lanzhou University of Technology	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.	hyperchaos@163.com	Ma, Jun/G-2376-2010; Wu, xinyi/AGX-5050-2022	Ma, Jun/0000-0002-6127-000X; 	National Nature Science of Foundation of China [11265008]	National Nature Science of Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Nature Science of Foundation of China under the Grant No.11265008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARANSON I, 1995, PHYSICA D, V85, P142, DOI 10.1016/0167-2789(95)00113-I; Bordyugov G, 2007, PHYSICA D, V228, P49, DOI 10.1016/j.physd.2007.02.005; Cai MC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016208; Cao ZJ, 2007, CHAOS, V17, DOI 10.1063/1.2713688; Christini DJ, 2002, CHAOS, V12, P732, DOI 10.1063/1.1504061; Christoph J, 2002, CHAOS, V12, P215, DOI 10.1063/1.1449956; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Crotti P, 2011, THESIS; Erichsen R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061917; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gao JH, 2007, PHYS LETT A, V371, P96, DOI 10.1016/j.physleta.2007.06.018; Gollub JP, 1999, REV MOD PHYS, V71, pS396, DOI 10.1103/RevModPhys.71.S396; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; HAGAN PS, 1982, SIAM J APPL MATH, V42, P762, DOI 10.1137/0142054; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; HILDEBRAND M, 1995, PHYS REV LETT, V75, P1503, DOI 10.1103/PhysRevLett.75.1503; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Hu G, 1998, PHYS REV LETT, V80, P1884, DOI 10.1103/PhysRevLett.80.1884; Huang L, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013500022; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jensen FG, 2002, CHAOS, V12, P16, DOI 10.1063/1.1429968; Jiang LL, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103001; KAPRAL R, 1995, PHYSICA D, V86, P149, DOI 10.1016/0167-2789(95)00096-M; KEYNES RD, 1973, J PHYSIOL-LONDON, V229, P409, DOI 10.1113/jphysiol.1973.sp010146; Kistler WM, 1998, PHYSICA D, V114, P273, DOI 10.1016/S0167-2789(97)00195-4; Kremmydas GP, 2002, CHAOS SOLITON FRACT, V13, P1659, DOI 10.1016/S0960-0779(01)00173-4; Liao XH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056204; Liu FC, 2007, CHINESE PHYS, V16, P2640, DOI 10.1088/1009-1963/16/9/024; Lou Q, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026213; Ma J, 2006, COMMUN THEOR PHYS, V45, P121; Ma J, 2007, CHINESE J CHEM PHYS, V20, P53, DOI 10.1360/cjcp2007.20(1).53.6; Ma J, 2013, SCI CHINA PHYS MECH, V56, P952, DOI 10.1007/s11433-013-5070-0; Ma J, 2010, APPL MATH COMPUT, V217, P3844, DOI 10.1016/j.amc.2010.09.043; Ma J, 2010, COMMUN THEOR PHYS, V54, P583, DOI 10.1088/0253-6102/54/3/38; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Nie HC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056204; Ouyang Q, 2000, PHYS REV LETT, V84, P1047, DOI 10.1103/PhysRevLett.84.1047; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pivik L., 1995, IEEE T CIRCUITS-I, V42, P638; Puwal S, 2009, IEEE T BIO-MED ENG, V56, P532, DOI 10.1109/TBME.2008.2003279; Qian Y, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/10/108201; Rinzel J., 1989, METHODS NEURONAL MOD, P251; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Samie FH, 2000, CIRC RES, V86, P684, DOI 10.1161/01.RES.86.6.684; Samie FH, 2001, CARDIOVASC RES, V50, P242, DOI 10.1016/S0008-6363(00)00289-3; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Schmid G, 2004, PHYS BIOL, V1, P61, DOI 10.1088/1478-3967/1/2/002; Schulze TP, 1999, PHYSICA D, V132, P520, DOI 10.1016/S0167-2789(99)00108-6; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; Sinha S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015101; Smith G.D., 2002, INTERD APPL, VVolume 20, P285; Stich M, 2006, PHYSICA D, V215, P38, DOI 10.1016/j.physd.2006.01.011; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Yagisita H, 1998, PHYSICA D, V124, P126, DOI 10.1016/S0167-2789(98)00182-1; Yuan GY, 2005, EUROPHYS LETT, V72, P908, DOI 10.1209/epl/i2004-10553-2; Zhang H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188301; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; Zykov VS, 2009, PHYSICA D, V238, P931, DOI 10.1016/j.physd.2008.06.009	63	49	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55403	10.1371/journal.pone.0055403	http://dx.doi.org/10.1371/journal.pone.0055403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383179	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600099
J	Ding, AY; Li, Q; Zhou, IY; Ma, SJ; Tong, GH; McAlonan, GM; Wu, EX				Ding, Abby Y.; Li, Qi; Zhou, Iris Y.; Ma, Samantha J.; Tong, Gehua; McAlonan, Grainne M.; Wu, Ed X.			MR Diffusion Tensor Imaging Detects Rapid Microstructural Changes in Amygdala and Hippocampus Following Fear Conditioning in Mice	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VOXEL-BASED ANALYSIS; WHITE-MATTER; STRUCTURAL PLASTICITY; ANTERIOR CINGULATE; IMMUNE CHALLENGE; GRAY-MATTER; BRAIN; INTEGRITY; NEUROGENESIS	Background: Following fear conditioning (FC), ex vivo evidence suggests that early dynamics of cellular and molecular plasticity in amygdala and hippocampal circuits mediate responses to fear. Such altered dynamics in fear circuits are thought to be etiologically related to anxiety disorders including posttraumatic stress disorder (PTSD). Consistent with this, neuroimaging studies of individuals with established PTSD in the months after trauma have revealed changes in brain regions responsible for processing fear. However, whether early changes in fear circuits can be captured in vivo is not known. Methods: We hypothesized that in vivo magnetic resonance diffusion tensor imaging (DTI) would be sensitive to rapid microstructural changes elicited by FC in an experimental mouse PTSD model. We employed a repeated measures paired design to compare in vivo DTI measurements before, one hour after, and one day after FC-exposed mice (n = 18). Results: Using voxel-wise repeated measures analysis, fractional anisotropy (FA) significantly increased then decreased in amygdala, decreased then increased in hippocampus, and was increasing in cingulum and adjacent gray matter one hour and one day post-FC respectively. These findings demonstrate that DTI is sensitive to early changes in brain microstructure following FC, and that FC elicits distinct, rapid in vivo responses in amygdala and hippocampus. Conclusions: Our results indicate that DTI can detect rapid microstructural changes in brain regions known to mediate fear conditioning in vivo. DTI indices could be explored as a translational tool to capture potential early biological changes in individuals at risk for developing PTSD.	[Ding, Abby Y.; Zhou, Iris Y.; Ma, Samantha J.; Tong, Gehua; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Ding, Abby Y.; Zhou, Iris Y.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Li, Qi; McAlonan, Grainne M.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Li, Qi; McAlonan, Grainne M.] Univ Hong Kong, Ctr Reprod Growth & Dev, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [McAlonan, Grainne M.] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of London; King's College London	McAlonan, GM (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	grainne.mcalonan@kcl.ac.uk; ewu@eee.hku.hk	Zhou, Iris Yuwen/A-2089-2017; Zhou, Yuwen/D-8009-2013; Wu, Ed Xuekui/C-1579-2009; McAlonan, Grainne/G-1541-2011	Zhou, Iris Yuwen/0000-0002-4351-7398; Wu, Ed Xuekui/0000-0001-5581-1546; McAlonan, Grainne/0000-0002-4466-2343; Ma, Samantha J./0000-0003-3127-455X	Hong Kong Research Grant Council [HKU7837/11M, 7747/10]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was fully supported by Hong Kong Research Grant Council (HKU7837/11M and 7747/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Avery SN, 2012, NEUROIMAGE, V59, P887, DOI 10.1016/j.neuroimage.2011.09.065; Barnes P, 2005, BEHAV BRAIN RES, V157, P107, DOI 10.1016/j.bbr.2004.06.014; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Bremner J Douglas, 2005, J Trauma Dissociation, V6, P51, DOI 10.1300/J229v06n02_06; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chahboune H, 2007, NMR BIOMED, V20, P375, DOI 10.1002/nbm.1130; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Groof G, 2010, NMR BIOMED, V23, P873, DOI 10.1002/nbm.1551; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Ding AY, 2012, MAGN RESON IMAGING, V30, P993, DOI 10.1016/j.mri.2012.02.012; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Fatemi SH, 2009, EUR NEUROPSYCHOPHARM, V19, P648, DOI 10.1016/j.euroneuro.2009.03.004; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Hui ES, 2007, P ANN INT IEEE EMBS, P4312, DOI 10.1109/IEMBS.2007.4353290; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; JOB RFS, 1995, BEHAV NEUROSCI, V109, P106, DOI 10.1037/0735-7044.109.1.106; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; Johansen-Berg H, 2012, NEURON, V73, P1058, DOI 10.1016/j.neuron.2012.03.001; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2011, NEUROIMAGE; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li Q, 2010, NEUROIMAGE, V52, P1, DOI 10.1016/j.neuroimage.2010.04.015; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; McFarlane AC, 2000, J CLIN PSYCHIAT, V61, P15; Mei B, 2005, BRAIN RES BULL, V67, P1, DOI 10.1016/j.brainresbull.2005.03.023; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; Mori S, 1999, ANAT REC, V257, P102; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pelletier JG, 2005, LEARN MEMORY, V12, P96, DOI 10.1101/lm.88605; Pham J, 2009, J NEUROSCI METH, V178, P323, DOI 10.1016/j.jneumeth.2008.12.021; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Sanchez I, 1996, J NEUROSCI, V16, P5095; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shalev AY, 2011, ARCH GEN PSYCHIAT; SHORT KR, 1993, PHARMACOL BIOCHEM BE, V45, P827, DOI 10.1016/0091-3057(93)90128-G; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P558, DOI 10.1016/j.neubiorev.2007.01.001; Steckler T, 2005, HDB STRESS BRAIN ELS; Su TP, 2009, J PSYCHIATR RES, V43, P1078, DOI 10.1016/j.jpsychires.2009.03.010; Tanev Kaloyan, 2003, Curr Psychiatry Rep, V5, P369; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vermetten E, 2002, DEPRESS ANXIETY, V15, P126, DOI 10.1002/da.10016; Vestergaard-Poulsen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020653; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wu EX, 2007, MAGN RESON IMAGING, V25, P1048, DOI 10.1016/j.mri.2006.12.008; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Wu EX, 2003, MAGNET RESON MED, V49, P765, DOI 10.1002/mrm.10425; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang L, 2012, METHODS MOL BIOL, V829, P453, DOI 10.1007/978-1-61779-458-2_29	106	45	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51704	10.1371/journal.pone.0051704	http://dx.doi.org/10.1371/journal.pone.0051704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382811	gold, Green Published			2022-12-25	WOS:000315563800006
J	Kim, M; Grimmig, T; Grimm, M; Lazariotou, M; Meier, E; Rosenwald, A; Tsaur, I; Blaheta, R; Heemann, U; Germer, CT; Waaga-Gasser, AM; Gasser, M				Kim, Mia; Grimmig, Tanja; Grimm, Martin; Lazariotou, Maria; Meier, Eva; Rosenwald, Andreas; Tsaur, Igor; Blaheta, Roman; Heemann, Uwe; Germer, Christoph-Thomas; Waaga-Gasser, Ana Maria; Gasser, Martin			Expression of Foxp3 in Colorectal Cancer but Not in Treg Cells Correlates with Disease Progression in Patients with Colorectal Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; INDUCTION; MECHANISM; CARCINOMA; REJECTION; SURVIVAL; IMMUNITY	Background: Regulatory T cells (Treg) expressing the transcription factor forkhead-box protein P3 (Foxp3) have been identified to counteract anti-tumor immune responses during tumor progression. Besides, Foxp3 presentation by cancer cells itself may also allow them to evade from effector T-cell responses, resulting in a survival benefit of the tumor. For colorectal cancer (CRC) the clinical relevance of Foxp3 has not been evaluated in detail. Therefore the aim of this study was to study its impact in colorectal cancer (CRC). Methods and Findings: Gene and protein analysis of tumor tissues from patients with CRC was performed to quantify the expression of Foxp3 in tumor infiltrating Treg and colon cancer cells. The results were correlated with clinicopathological parameters and patients overall survival. Serial morphological analysis demonstrated Foxp3 to be expressed in cancer cells. High Foxp3 expression of the cancer cells was associated with poor prognosis compared to patients with low Foxp3 expression. In contrast, low and high Foxp3 level in tumor infiltrating Treg cells demonstrated no significant differences in overall patient survival. Conclusions: Our findings strongly suggest that Foxp3 expression mediated by cancer cells rather than by Treg cells contribute to disease progression.	[Kim, Mia; Germer, Christoph-Thomas; Gasser, Martin] Univ Wurzburg, Dept Surg 1, D-97070 Wurzburg, Germany; [Grimmig, Tanja; Lazariotou, Maria; Meier, Eva; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97070 Wurzburg, Germany; [Grimm, Martin] Univ Tubingen, Dept Oral & Maxillofacial Plast Surg, Tubingen, Germany; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany; [Tsaur, Igor; Blaheta, Roman] Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany; [Heemann, Uwe] Univ Munich, Dept Nephrol, Klinikum Rechts Isar, Munich, Germany	University of Wurzburg; University of Wurzburg; Eberhard Karls University of Tubingen; University of Wurzburg; Goethe University Frankfurt; Technical University of Munich; University of Munich	Waaga-Gasser, AM (corresponding author), Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97070 Wurzburg, Germany.	waaga-gasser@chirurgie.uni-wuerzburg.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523; Kim, Mia/0000-0002-0706-8281				Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Greene Frederick L, 2003, Semin Surg Oncol, V21, P23, DOI 10.1002/ssu.10018; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ho-Pun-Cheung A, 2009, ANAL BIOCHEM, V388, P348, DOI 10.1016/j.ab.2009.03.001; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Ladoire S, 2011, BREAST CANCER RES TR, V125, P65, DOI 10.1007/s10549-010-0831-1; Lee WS, 2010, CANCER-AM CANCER SOC, V116, P5188, DOI 10.1002/cncr.25293; Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Onizuka S, 1999, CANCER RES, V59, P3128; Sack MJ, 1997, DIAGN CYTOPATHOL, V16, P132, DOI 10.1002/(SICI)1097-0339(199702)16:2<132::AID-DC7>3.0.CO;2-J; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shimizu J, 1999, J IMMUNOL, V163, P5211; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Tao H, 2012, LUNG CANCER, V75, P95, DOI 10.1016/j.lungcan.2011.06.002; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Wang WH, 2010, WORLD J GASTROENTERO, V16, P5502, DOI 10.3748/wjg.v16.i43.5502; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Whiteside TL, 2006, CANC TREAT, V130, P103; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	33	56	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53630	10.1371/journal.pone.0053630	http://dx.doi.org/10.1371/journal.pone.0053630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382847	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800023
J	Long, Y; Wang, YB; Ji, GX; Yan, LF; Hu, F; Gu, AH				Long, Yan; Wang, Yubang; Ji, Guixiang; Yan, Lifeng; Hu, Fan; Gu, Aihua			Neurotoxicity of Perfluorooctane Sulfonate to Hippocampal Cells in Adult Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; NEONATAL EXPOSURE; MOUSE MODEL; PFOS; MEMORY	Perfluorooctane sulfonate (PFOS) is a ubiquitous pollutant and found in the environment and in biota. The neurotoxicity of PFOS has received much concern among its various toxic effects when given during developing period of brain. However, little is known about the neurotoxic effects and potential mechanisms of PFOS in the mature brain. Our study demonstrated the neurotoxicity and the potential mechanisms of PFOS in the hippocampus of adult mice for the first time. The impairments of spatial learning and memory were observed by water maze studies after exposure to PFOS for three months. Significant apoptosis was found in hippocampal cells after PFOS exposure, accompanied with a increase of glutamate in the hippocampus and decreases of dopamine (DA) and 3,4-dihydrophenylacetic acid (DOPAC) in Caudate Putamen in the 10.75 mg/kg PFOS group. By two-dimensional fluorescence difference in gel electrophoresis (2D-DIGE) analysis, seven related proteins in the hippocampus that responded to PFOS exposure were identified, among which, Mib1 protein (an E3 ubiquitin-protein ligase), Herc5 (hect domain and RLD 5 isoform 2) and Tyro3 (TYRO3 protein tyrosine kinase 3) were found down-regulated, while Sdha (Succinate dehydrogenase flavoprotein subunit), Gzma (Isoform HF1 of Granzyme A precursor), Plau (Urokinase-type plasminogen activator precursor) and Lig4 (DNA ligase 4) were found up-regulated in the 10.75 mg/kg PFOS-treated group compare with control group. Furthermore, we also found that (i) increased expression of caspase-3 protein and decreased expression of Bcl-2, Bcl-XL and survivin proteins, (ii) the increased glutamate release in the hippocampus. All these might contribute to the dysfunction of hippocampus which finally account for the impairments of spatial learning and memory in adult mice.	[Long, Yan] China Pharmaceut Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Wang, Yubang] Nanjing Med Univ, Sch Publ Hlth, Safety Assessment & Res Ctr Drugs Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wang, Yubang; Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Ji, Guixiang] Minist Environm Protect, Nanjing Inst Environm Sci, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China; [Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Gu, AH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China.	aihuagu@njmu.edu.cn			National Science Foundation of China [81172694, 30901210, 81102494]; Natural Science Foundation of Jiangsu Province [BK2010431]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Safety Assessment and Research Center for Drugs of Jiangsu Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; Safety Assessment and Research Center for Drugs of Jiangsu Province	This study was supported by the National Science Foundation of China (Grant No. 81172694, No. 30901210 and No. 81102494), the Natural Science Foundation of Jiangsu Province (Grant No. BK2010431). This project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supports and animals feeding provided by the Safety Assessment and Research Center for Drugs of Jiangsu Province are gratefully acknowledged. Thanks also to Shanghai Applied Protein Technology Co. Ltd for technical assistance.	Ambrose ML, 2001, ALCOHOL CLIN EXP RES, V25, P185, DOI 10.1111/j.1530-0277.2001.tb02197.x; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Austin ME, 2003, ENVIRON HEALTH PERSP, V111, P1485, DOI 10.1289/ehp.6128; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Calafat AM, 2006, ENVIRON SCI TECHNOL, V40, P2128, DOI 10.1021/es0517973; Candas M, 2003, MOL CELL PROTEOMICS, V2, P19, DOI 10.1074/mcp.M200069-MCP200; Chang SC, 2009, REPROD TOXICOL, V27, P387, DOI 10.1016/j.reprotox.2009.01.005; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Davis MA, 2006, J PHARMACOL EXP THER, V318, P589, DOI 10.1124/jpet.105.100032; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Fuentes S, 2007, TOXICOLOGY, V242, P123, DOI 10.1016/j.tox.2007.09.012; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Johansson N, 2009, TOXICOL SCI, V108, P412, DOI 10.1093/toxsci/kfp029; Kajii Y, 1996, BIOL CELL, V88, P45, DOI 10.1016/S0248-4900(97)86830-X; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kannan K, 2001, ENVIRON SCI TECHNOL, V35, P1593, DOI 10.1021/es001873w; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Lee YJ, 2013, CHEMOSPHERE, V90, P1597, DOI 10.1016/j.chemosphere.2012.08.033; MEIRI N, 1994, P NATL ACAD SCI USA, V91, P3196, DOI 10.1073/pnas.91.8.3196; Mondal D, 2012, ENVIRON HEALTH PERSP, V120, P752, DOI 10.1289/ehp.1104538; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Olsen GW, 2008, ENVIRON SCI TECHNOL, V42, P4989, DOI 10.1021/es800071x; Raiteri L, 2003, BRIT J PHARMACOL, V138, P1021, DOI 10.1038/sj.bjp.0705142; Renner R, 2001, ENVIRON SCI TECHNOL, V35, p154A, DOI 10.1021/es012317k; Shankaran M, 2006, J PHARMACOL EXP THER, V319, P1172, DOI 10.1124/jpet.106.110510; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Terry AV, 2009, FRONT NEUROSCI, P267; Yasuhara S, 2003, J HISTOCHEM CYTOCHEM, V51, P873, DOI 10.1177/002215540305100703; Zeng HC, 2011, NEUROTOXICOLOGY, V32, P130, DOI 10.1016/j.neuro.2010.10.001	32	51	55	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54176	10.1371/journal.pone.0054176	http://dx.doi.org/10.1371/journal.pone.0054176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382877	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800036
J	Nguyen, T; Rich, A; Dahl, R				Tan Nguyen; Rich, Audrey; Dahl, Richard			MiR-24 Promotes the Survival of Hematopoietic Cells	PLOS ONE			English	Article							UP-REGULATION; MYELOID-LEUKEMIA; APOPTOSIS; EXPRESSION; MICRORNAS; DIFFERENTIATION; PROGENITORS; INHIBITION; BCL-X(L); PATHWAYS	The microRNA, miR-24, inhibits B cell development and promotes myeloid development of hematopoietic progenitors. Differential regulation of cell survival in myeloid and lymphoid cells by miR-24 may explain how miR-249s affects hematopoietic progenitors. MiR-24 is reported to regulate apoptosis, either positively or negatively depending on cell context. However, no role for miR-24 in regulating cell death has been previously described in blood cells. To examine miR-249s effect on survival, we expressed miR-24 via retrovirus in hematopoietic cells and induced cell death with cytokine or serum withdrawal. We observed that miR-24 enhanced survival of myeloid and B cell lines as well as primary hematopoietic cells. Additionally, antagonizing miR-24 with shRNA in hematopoietic cells made them more sensitive to apoptotic stimuli, suggesting miR-24 functions normally to promote blood cell survival. Since we did not observe preferential protection of myeloid over B cells, miR-249s pro-survival effect does not explain its promotion of myelopoiesis. Moreover, expression of pro-survival protein, Bcl-xL, did not mimic miR-249s impact on cellular differentiation, further supporting this conclusion. Our results indicate that miR-24 is a critical regulator of hematopoietic cell survival. This observation has implications for leukemogenesis. Several miRNAs that regulate apoptosis have been shown to function as either tumor suppressors or oncogenes during leukemogenesis. MiR-24 is expressed highly in primary acute myelogenous leukemia, suggesting that its pro-survival activity could contribute to the transformation of hematopoietic cells.	[Tan Nguyen; Dahl, Richard] Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN USA; [Rich, Audrey] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Dahl, Richard] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of New Mexico; University of New Mexico's Health Sciences Center; University of Notre Dame	Dahl, R (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN USA.	richdahl@iupui.edu		Dahl, Richard/0000-0002-6341-5604	American Cancer Society [RSG-06-170-01-LIB]; Indiana University School of Medicine	American Cancer Society(American Cancer Society); Indiana University School of Medicine	This study was funded by the American Cancer Society (RSG-06-170-01-LIB), and a Biomedical Enhancement Grant from the Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; FRIEDMAN AD, 1991, BLOOD, V78, P2426; Gaines P, 2005, J LEUKOCYTE BIOL, V77, P669, DOI 10.1189/jlb.1004567; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin SC, 2010, ORAL ONCOL, V46, P204, DOI 10.1016/j.oraloncology.2009.12.005; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; MERINO R, 1995, J IMMUNOL, V155, P3830; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Singh R, 2012, J CELL SCI; Srivastava N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2861; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567	31	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55406	10.1371/journal.pone.0055406	http://dx.doi.org/10.1371/journal.pone.0055406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383180	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800149
J	Xie, SL; Zhu, MG; Lv, GY; Geng, YJ; Chen, GF; Ma, J; Wang, GY				Xie, Shuli; Zhu, Mingguang; Lv, Guoyue; Geng, Yajun; Chen, Guofu; Ma, Jian; Wang, Guangyi			Overexpression of Ras Homologous C (RhoC) Induces Malignant Transformation of Hepatocytes In Vitro and in Nude Mouse Xenografts	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; CELL INVASION; HEPATITIS-B; PROLIFERATION; EXPRESSION; GENE; METASTASIS; PROTEINS; GTPASES	Ras homologous C (RhoC) is expressed in various cancers, including hepatocellular carcinoma (HCC). In this study, we first analyzed RhoC expression in 46 HCC tissue specimens and found that RhoC expression was significantly increased in HCC tissues compared to the adjacent normal liver tissues. Next, we investigated the role of RhoC in malignant transformation of normal hepatocytes. The HL7702 cell line was stably transfected with a RhoC expression vector and then subjected to cell proliferation, differentiation, colony formation, migration and invasion assays, as well as nude mouse xenograft assays. Gene expressions in these cells were determined using RT-PCR and Western blot. Overexpression of RhoC significantly promoted proliferation and anchorage-independent growth of HL7702 cells, but suppressed cell differentiation, as compared with the parental cells and the empty vector-transfected control cells. Moreover, RhoC overexpression induced migration and invasion of HL7702 cells in vitro. Molecularly, RhoC increased the expression of cell cycle-related genes, matrix metalloprotease 2 (MMP2), MMP9 and vascular endothelial growth factor (VEGF). In addition, RhoC-transfected cells formed tumors in nude mice, whereas vector-transfected HL7702 cells did not form any tumors in nude mice. This study demonstrated the role of RhoC overexpression in malignant transformation of normal human hepatocytes, suggesting that RhoC may function as an oncogene in hepatocytes.	[Xie, Shuli; Lv, Guoyue; Geng, Yajun; Chen, Guofu; Ma, Jian; Wang, Guangyi] Jilin Univ, Hosp 1, Dept Gen Surg, Changchun 130023, Jilin, Peoples R China; [Zhu, Mingguang] Jilin Univ, Sch Basic Med Sci, Dept Immunol, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Wang, GY (corresponding author), Jilin Univ, Hosp 1, Dept Gen Surg, Changchun 130023, Jilin, Peoples R China.	xieshuli6310@hotmail.com						Abedin ZR, 2010, CELL CYCLE, V9, P2456, DOI 10.4161/cc.9.12.12055; Abraham MT, 2001, LARYNGOSCOPE, V111, P1285, DOI 10.1097/00005537-200107000-00027; Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Baranwal S, 2011, CURR DRUG TARGETS, V12, P1194, DOI 10.2174/138945011795906534; Bauvois B., 2011, BIOCHIM BIOPHYS ACTA, V1825, P29; Bostrom Pia, 2009, BMC Res Notes, V2, P140, DOI 10.1186/1756-0500-2-140; Chen LL, 2010, ACTA PHARMACOL SIN, V31, P1165, DOI 10.1038/aps.2010.94; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Deshpande A, 2009, CELL CYCLE, V8, P3592, DOI 10.4161/cc.8.21.9993; Faried A, 2006, EUR J CANCER, V42, P1455, DOI 10.1016/j.ejca.2006.02.012; Farley J, 2011, GYNECOL ONCOL, V121, P395, DOI 10.1016/j.ygyno.2010.11.023; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Frame MC, 2002, CURR OPIN GENET DEV, V12, P36, DOI 10.1016/S0959-437X(01)00261-1; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Okabe H, 2001, CANCER RES, V61, P2129; Perez R, 2003, J GASTROINTEST SURG, V7, P884, DOI 10.1016/j.gassur.2003.08.001; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Sun HW, 2007, WORLD J GASTROENTERO, V13, P3517, DOI 10.3748/wjg.v13.i25.3517; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vecchiarelli-Federico LM, 2010, CANCER RES, V70, P863, DOI 10.1158/0008-5472.CAN-09-3592; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang W, 2003, WORLD J GASTROENTERO, V9, P1950, DOI 10.3748/wjg.v9.i9.1950; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xie SL, 2012, MED ONCOL, V29, P1802, DOI 10.1007/s12032-011-0003-0; Xie SY., 2009, THESIS; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x	42	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54493	10.1371/journal.pone.0054493	http://dx.doi.org/10.1371/journal.pone.0054493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382905	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800050
J	Colombo, E; Franceschetti, S; Avanzini, G; Mantegazza, M				Colombo, Elisa; Franceschetti, Silvana; Avanzini, Giuliano; Mantegazza, Massimo			Phenytoin Inhibits the Persistent Sodium Current in Neocortical Neurons by Modifying Its Inactivation Properties	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MAMMALIAN CNS NEURONS; GATED NA+ CHANNELS; PYRAMIDAL NEURONS; SLOW INACTIVATION; MOLECULAR DETERMINANTS; SENSORIMOTOR CORTEX; STATUS EPILEPTICUS; LOCAL-ANESTHETICS; SINGLE-CHANNEL	The persistent Na+ current (I-NaP) is important for neuronal functions and can play a role in several pathologies, although it is small compared to the transient Na+ current (I-NaT). Notably, I-NaP is not a real persistent current because it undergoes inactivation with kinetics in the order of tens of seconds, but this property has often been overlooked. Na+ channel blockers, drugs used for treating epilepsy and other diseases, can inhibit I-NaP, but the mechanism of this action and the conditions in which I-NaP can be actually inhibited have not been completely clarified yet. We evaluated the action of phenytoin (PHT), a prototype anti-epileptic Na+ channel blocker, on I-NaP inactivation in pyramidal neurons of rat sensorimotor cortical slices at different concentrations, from 5 to 100 mu M. PHT did not modify I-NaP evoked with depolarizing voltage ramps of 50 or 100 mVs(-1), but decreased I-NaP evoked by slower voltage ramps (10 mVs(-1)). However, at all of the tested concentrations, PHT decreased I-NaP evoked by faster ramps when they were preceded by inactivating pre-pulses. Moreover, PHT shifted towards negative potentials the voltage-dependence of I-NaP inactivation and accelerated its kinetics of development also at depolarized potentials (+40 mV), not consistently with a simple inactivated state stabilizer. Therefore, our study shows a prominent PHT effect on I-NaP inactivation rather than an open channel block, which is instead often implied. I-NaP is inhibited by PHT only in conditions that induce major I-NaP inactivation. These results highlight the importance of I-NaP inactivation not only for physiological functions but also as drug target, which could be shared by other therapeutic drugs. Through this action PHT can reduce I-NaP-induced long-lasting pathological depolarisations and intracellular sodium overload, whereas shorter I-NaP actions should not be modified. These properties set the conditions of efficacy and the limits of PHT as I-NaP inhibitor.	[Colombo, Elisa; Franceschetti, Silvana; Avanzini, Giuliano; Mantegazza, Massimo] Fdn IRCCS Neurol Inst C Besta, Epilepsy Ctr, Dept Neurophysiopathol, Milan, Italy; [Mantegazza, Massimo] CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France; [Mantegazza, Massimo] Univ Nice Sophia Antipolis, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Mantegazza, M (corresponding author), Fdn IRCCS Neurol Inst C Besta, Epilepsy Ctr, Dept Neurophysiopathol, Milan, Italy.	mantegazza@ipmc.cnrs.fr	Mantegazza, Massimo/J-8802-2016; Franceschetti, Silvana/K-3438-2016	Mantegazza, Massimo/0000-0002-1070-7929; Franceschetti, Silvana/0000-0002-1921-6755	European Integrated Project EPICURE [EFP6-037315]; Mariani Foundation; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale	European Integrated Project EPICURE; Mariani Foundation; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was supported in part by the European Integrated Project EPICURE EFP6-037315 http://www.epicureproject.eu (to MM, GA and SF), the Mariani Foundation www.fondazione-mariani.org (to SF), the Federation pour la Recherche sur le Cerveau http://www.frc.asso.fr/(to MM) and the Fondation pour la Recherche Medicale, http://www.frm.org (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; ALZHEIMER C, 1994, J PHYSIOL-LONDON, V479, P199, DOI 10.1113/jphysiol.1994.sp020288; Aracri P, 2006, J NEUROPHYSIOL, V95, P3460, DOI 10.1152/jn.00588.2005; Artinian J, 2011, J NEUROSCI, V31, P10811, DOI 10.1523/JNEUROSCI.0388-11.2011; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Avanzini G, 2007, EPILEPSIA, V48, P51, DOI 10.1111/j.1528-1167.2007.01067.x; Carlier E, 2006, J PHYSIOL-LONDON, V577, P141, DOI 10.1113/jphysiol.2006.118026; Cestele S, 2008, J NEUROSCI, V28, P7273, DOI 10.1523/JNEUROSCI.4453-07.2008; CHAO TI, 1995, NEUROREPORT, V6, P1778, DOI 10.1097/00001756-199509000-00017; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Enomoto A, 2006, J NEUROSCI, V26, P3412, DOI 10.1523/JNEUROSCI.5274-05.2006; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; FRANCESCHETTI S, 1995, BRAIN RES, V696, P127, DOI 10.1016/0006-8993(95)00807-3; Fung ML, 2000, CLIN EXP PHARMACOL P, V27, P569, DOI 10.1046/j.1440-1681.2000.03309.x; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Harnmarstrom AKM, 2002, EUR BIOPHYS J BIOPHY, V31, P323, DOI 10.1007/s00249-002-0218-2; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Kiernan MC, 2009, EXP NEUROL, V218, P1, DOI 10.1016/j.expneurol.2009.03.039; Kole MHP, 2011, NEURON, V71, P671, DOI 10.1016/j.neuron.2011.06.024; KUO CC, 1994, MOL PHARMACOL, V46, P716; Kuo CC, 1997, MOL PHARMACOL, V51, P1077, DOI 10.1124/mol.51.6.1077; Lampl I, 1998, J PHARMACOL EXP THER, V284, P228; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Magistretti J, 1998, BIOPHYS J, V74, P831, DOI 10.1016/S0006-3495(98)74007-X; Magistretti J, 1999, J GEN PHYSIOL, V114, P491, DOI 10.1085/jgp.114.4.491; Mantegazza M, 2005, J NEUROSCI, V25, P3341, DOI 10.1523/JNEUROSCI.0104-05.2005; Mantegazza M, 1998, J PHYSIOL-LONDON, V507, P105, DOI 10.1111/j.1469-7793.1998.105bu.x; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Mantegazza M, 2010, EPILEPSY RES, V92, P1, DOI 10.1016/j.eplepsyres.2010.08.003; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marini Carla, 2010, Expert Rev Clin Pharmacol, V3, P371, DOI 10.1586/ecp.10.20; Martella G, 2005, EPILEPSIA, V46, P624, DOI 10.1111/j.1528-1167.2005.34904.x; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Niespodziany I, 2004, NEUROREPORT, V15, P1049, DOI 10.1097/00001756-200404290-00023; Osorio N, 2010, J PHYSIOL-LONDON, V588, P651, DOI 10.1113/jphysiol.2010.183798; QUANDT FN, 1988, MOL PHARMACOL, V34, P557; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101; Segal MM, 1997, J NEUROPHYSIOL, V77, P3021, DOI 10.1152/jn.1997.77.6.3021; Stafstrom Carl E, 2007, Epilepsy Curr, V7, P15, DOI 10.1111/j.1535-7511.2007.00156.x; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; Sun GC, 2007, EPILEPSIA, V48, P774, DOI 10.1111/j.1528-1167.2007.01001.x; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Taverna S, 1999, J PHARMACOL EXP THER, V288, P960; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vreugdenhil M, 2004, EUR J NEUROSCI, V19, P2769, DOI 10.1111/j.1460-9568.2004.03400.x; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005	56	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55329	10.1371/journal.pone.0055329	http://dx.doi.org/10.1371/journal.pone.0055329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383157	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200047
J	Claeyssen, E; Dorion, S; Clendenning, A; He, JZ; Wally, O; Chen, JK; Auslender, EL; Moisan, MC; Jolicoeur, M; Rivoal, J				Claeyssen, Eric; Dorion, Sonia; Clendenning, Audrey; He, Jiang Zhou; Wally, Owen; Chen, Jingkui; Auslender, Evgenia L.; Moisan, Marie-Claude; Jolicoeur, Mario; Rivoal, Jean			The Futile Cycling of Hexose Phosphates Could Account for the Fact That Hexokinase Exerts a High Control on Glucose Phosphorylation but Not on Glycolytic Rate in Transgenic Potato (Solanum tuberosum) Roots	PLOS ONE			English	Article							NIGRA SUSPENSION CELLS; HIGHER-PLANT CELLS; CASTOR-OIL SEEDS; SUCROSE SYNTHASE; FRUCTOSE-6-PHOSPHATE 1-PHOSPHOTRANSFERASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; AGROBACTERIUM-RHIZOGENES; CARBOHYDRATE-METABOLISM; ANTISENSE REPRESSION; MATHEMATICAL-MODEL	The metabolism of potato (Solanum tuberosum) roots constitutively over-and underexpressing hexokinase (HK, EC 2.7.1.1) was examined. An 11-fold variation in HK activity resulted in altered root growth, with antisense roots growing better than sense roots. Quantification of sugars, organic acids and amino acids in transgenic roots demonstrated that the manipulation of HK activity had very little effect on the intracellular pools of these metabolites. However, adenylate and free Pi levels were negatively affected by an increase in HK activity. The flux control coefficient of HK over the phosphorylation of glucose was measured for the first time in plants. Its value varied with HK level. It reached 1.71 at or below normal HK activity value and was much lower (0.32) at very high HK levels. Measurements of glycolytic flux and O-2 uptake rates demonstrated that the differences in glucose phosphorylation did not affect significantly glycolytic and respiratory metabolism. We hypothesized that these results could be explained by the existence of a futile cycle between the pools of hexose-Ps and carbohydrates. This view is supported by several lines of evidence. Firstly, activities of enzymes capable of catalyzing these reactions were detected in roots, including a hexose-P phosphatase. Secondly, metabolic tracer experiments using C-14-glucose as precursor showed the formation of C-14-fructose and C-14-sucrose. We conclude that futile cycling of hexose-P could be partially responsible for the differences in energetic status in roots with high and low HK activity and possibly cause the observed alterations in growth in transgenic roots. The involvement of HK and futile cycles in the control of glucose-6P metabolism is discussed.	[Claeyssen, Eric; Dorion, Sonia; Clendenning, Audrey; He, Jiang Zhou; Wally, Owen; Auslender, Evgenia L.; Moisan, Marie-Claude; Rivoal, Jean] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [Chen, Jingkui; Jolicoeur, Mario] Ecole Polytech Montreal, Dept Chem Engn, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Polytechnique Montreal	Rivoal, J (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada.	jean.rivoal@umontreal.ca	Rivoal, Jean/J-6544-2014	Rivoal, Jean/0000-0002-8991-0566	Natural Science and Engineering Research Council of Canada; China Scholarship Council; Fonds de Bourses en Sciences Biologiques of the Universite de Montreal; Canada Research Chair in Applied Metabolic Engineering	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); China Scholarship Council(China Scholarship Council); Fonds de Bourses en Sciences Biologiques of the Universite de Montreal; Canada Research Chair in Applied Metabolic Engineering(Canada Research Chairs)	This research was supported by a Natural Science and Engineering Research Council of Canada Discovery grant to JR (http://www.nserc-crsng.gc.ca). JZH was supported by a State Scholarship Fund from the China Scholarship Council (www.csc.edu.cn). ELA was supported by an Undergraduate Student Research Award from the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). MCM was supported in part by a grant from the Fonds de Bourses en Sciences Biologiques of the Universite de Montreal. MJ is supported by the Canada Research Chair in Applied Metabolic Engineering (http.//www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AP, 2005, PLANT PHYSIOL, V138, P2220, DOI 10.1104/pp.105.062083; Aon MA, 1998, BIOTECHNOL BIOENG, V59, P203, DOI 10.1002/(SICI)1097-0290(19980720)59:2<203::AID-BIT8>3.3.CO;2-T; Baque S, 1998, DIABETES, V47, P1392, DOI 10.2337/diabetes.47.9.1392; BORCHERT S, 1993, PLANT PHYSIOL, V101, P303, DOI 10.1104/pp.101.1.303; Bouny JM, 1996, PLANT PHYSIOL, V111, P187, DOI 10.1104/pp.111.1.187; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carswell C, 1996, PLANT PHYSIOL, V110, P105, DOI 10.1104/pp.110.1.105; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Claeyssen E, 2006, PROTEIN EXPRES PURIF, V47, P329, DOI 10.1016/j.pep.2005.11.003; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; DIEUAIDENOUBHANI M, 1995, J BIOL CHEM, V270, P13147, DOI 10.1074/jbc.270.22.13147; Dorion S, 2005, PLANT SCI, V168, P183, DOI 10.1016/j.plantsci.2004.07.029; Dorion S, 2012, PLANTA IN PRESS; Dorion S, 2009, ACTA PHYSIOL PLANT, V31, P855, DOI 10.1007/s11738-009-0292-5; DUFF SMG, 1989, PLANT PHYSIOL, V90, P734, DOI 10.1104/pp.90.2.734; DUFF SMG, 1989, PLANT PHYSIOL, V90, P1275, DOI 10.1104/pp.90.4.1275; Ernandes JR, 1998, YEAST, V14, P255, DOI 10.1002/(SICI)1097-0061(199802)14:3<255::AID-YEA228>3.0.CO;2-N; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Fernie AR, 2002, PLANT CELL ENVIRON, V25, P1219, DOI 10.1046/j.1365-3040.2002.00918.x; Fernie AR, 2001, PLANTA, V212, P250, DOI 10.1007/s004250000386; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Gmati D, 2005, BIOTECHNOL BIOENG, V89, P138, DOI 10.1002/bit.20293; GOUT E, 1992, J BIOL CHEM, V267, P13903; HAWKER JS, 1966, BIOCHEM J, V99, P102, DOI 10.1042/bj0990102; Hodgson RJ, 1998, ARCH BIOCHEM BIOPHYS, V355, P189, DOI 10.1006/abbi.1998.0725; Iynedjian PB, 1998, TRENDS BIOCHEM SCI, V23, P467, DOI 10.1016/S0968-0004(98)01317-6; JOURNET EP, 1986, J BIOL CHEM, V261, P3193; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kelly G, 2012, PLANT PHYSIOL, V159, P47, DOI 10.1104/pp.112.196105; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Klein D, 1998, PLANTA, V205, P223, DOI 10.1007/s004250050315; KLEIN RR, 1993, PLANTA, V190, P498, DOI 10.1007/BF00224789; Kristo P, 1996, EUR J BIOCHEM, V237, P240, DOI 10.1111/j.1432-1033.1996.0240n.x; Kulma A, 2004, PLANT J, V37, P654, DOI 10.1111/j.1365-313X.2003.01992.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELENDEZHEVIA E, 1992, MOL CELL BIOCHEM, V115, P1; Menu T, 2004, PLANT CELL ENVIRON, V27, P89, DOI 10.1046/j.0016-8025.2003.01128.x; Moisan MC, 2011, BOTANY, V89, P289, DOI [10.1139/B11-016, 10.1139/b11-016]; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MOORE L, 1979, PLASMID, V2, P617, DOI 10.1016/0147-619X(79)90059-3; MOORHEAD GBG, 1994, ARCH BIOCHEM BIOPHYS, V312, P326, DOI 10.1006/abbi.1994.1316; Moraes TF, 2000, EUR J BIOCHEM, V267, P4465, DOI 10.1046/j.1432-1327.2000.01495.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nguyen-Quoc B, 2001, J EXP BOT, V52, P881, DOI 10.1093/jexbot/52.358.881; PETIT A, 1983, MOL GEN GENET, V190, P204, DOI 10.1007/BF00330641; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Plaxton WC, 2002, ARCH BIOCHEM BIOPHYS, V400, P54, DOI 10.1006/abbi.2002.2782; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Plaxton WC, 1990, METHODS PLANT BIOCH, P145; Puigjaner J, 1997, FEBS LETT, V418, P47, DOI 10.1016/S0014-5793(97)01347-1; RAPOPORT TA, 1974, EUR J BIOCHEM, V42, P107, DOI 10.1111/j.1432-1033.1974.tb03320.x; RENZ A, 1993, PLANTA, V190, P156; RENZ A, 1993, PLANTA, V190, P166; RIVOAL J, 1989, PLANT PHYSIOL BIOCH, V27, P43; RIVOAL J, 1994, PLANT PHYSIOL, V106, P1179, DOI 10.1104/pp.106.3.1179; RIVOAL J, 1993, PLANT PHYSIOL, V101, P553, DOI 10.1104/pp.101.2.553; Rohwer JM, 2001, BIOCHEM J, V358, P437, DOI 10.1042/0264-6021:3580437; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; Salla S, 1996, GRAEF ARCH CLIN EXP, V234, P521, DOI 10.1007/BF00184862; SALON C, 1988, J BIOL CHEM, V263, P12278; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; SWEET IR, 1995, AM J PHYSIOL-ENDOC M, V268, pE775, DOI 10.1152/ajpendo.1995.268.4.E775; Sweetlove LJ, 2002, PLANTA, V214, P741, DOI 10.1007/s004250100666; Sweetlove LJ, 1996, BIOCHEM J, V320, P487, DOI 10.1042/bj3200487; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang GQ, 1999, PLANT MOL BIOL, V41, P465, DOI 10.1023/A:1006327606696; Tesfaye M, 2001, PLANT PHYSIOL, V127, P1836, DOI 10.1104/pp.010376; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339, DOI 10.1104/pp.101.2.339; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Toroser D, 2000, PLANT PHYSIOL, V123, P403, DOI 10.1104/pp.123.1.403; TORRES NV, 1988, FEBS LETT, V233, P83, DOI 10.1016/0014-5793(88)81360-7; Trethewey RN, 1998, PLANT J, V15, P109, DOI 10.1046/j.1365-313X.1998.00190.x; Troncoso-Ponce MA, 2011, J PLANT PHYSIOL, V168, P299, DOI 10.1016/j.jplph.2010.07.018; Veramendi J, 1999, PLANT PHYSIOL, V121, P123, DOI 10.1104/pp.121.1.123; Veramendi J, 2002, PLANT MOL BIOL, V49, P491, DOI 10.1023/A:1015528014562; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wood SM, 2002, CAN J BOT, V80, P983, DOI [10.1139/B02-085, 10.1139/b02-085]	85	11	12	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e53898	10.1371/journal.pone.0053898	http://dx.doi.org/10.1371/journal.pone.0053898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382859	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000315211500008
J	Petit, E; LaTouf, WG; Coppi, MV; Warnick, TA; Currie, D; Romashko, I; Deshpande, S; Haas, K; Alvelo-Maurosa, JG; Wardman, C; Schnell, DJ; Leschine, SB; Blanchard, JL				Petit, Elsa; LaTouf, W. Greg; Coppi, Maddalena V.; Warnick, Thomas A.; Currie, Devin; Romashko, Igor; Deshpande, Supriya; Haas, Kelly; Alvelo-Maurosa, Jesus G.; Wardman, Colin; Schnell, Danny J.; Leschine, Susan B.; Blanchard, Jeffrey L.			Involvement of a Bacterial Microcompartment in the Metabolism of Fucose and Rhamnose by Clostridium phytofermentans	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; SEROVAR TYPHIMURIUM LT2; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; POLYHEDRAL BODIES; ORGANELLES; OPERON; GENES; PROTEIN; IDENTIFICATION	Background: Clostridium phytofermentans, an anaerobic soil bacterium, can directly convert plant biomass into biofuels. The genome of C. phytofermentans contains three loci with genes encoding shell proteins of bacterial microcompartments (BMC), organelles composed entirely of proteins. Methodology and Principal Findings: One of the BMC loci has homology to a BMC-encoding locus implicated in the conversion of fucose to propanol and propionate in a human gut commensal, Roseburia inulinivorans. We hypothesized that it had a similar role in C. phytofermentans. When C. phytofermentans was grown on fucose, the major products identified were ethanol, propanol and propionate. Transmission electron microscopy of fucose-and rhamnose-grown cultures revealed polyhedral structures, presumably BMCs. Microarray analysis indicated that during growth on fucose, operons coding for the BMC locus, fucose dissimilatory enzymes, and an ATP-binding cassette transporter became the dominant transcripts. These data are consistent with fucose fermentation producing a 1,2-propanediol intermediate that is further metabolized in the microcompartment encoded in the BMC locus. Growth on another deoxyhexose sugar, rhamnose, resulted in the expression of the same BMC locus and similar fermentation products. However, a different set of dissimilatory enzymes and transport system genes were induced. Quite surprisingly, growth on fucose or rhamnose also led to the expression of a diverse array of complex plant polysaccharide-degrading enzymes. Conclusions/Significance: Based on physiological, genomic, and microarray analyses, we propose a model for the fermentation of fucose and rhamnose in C. phytofermentans that includes enzymes encoded in the same BMC locus. Comparative genomic analysis suggests that this BMC may be present in other clostridial species.	[Petit, Elsa; LaTouf, W. Greg; Coppi, Maddalena V.; Warnick, Thomas A.; Currie, Devin; Romashko, Igor; Deshpande, Supriya; Haas, Kelly; Alvelo-Maurosa, Jesus G.; Wardman, Colin; Leschine, Susan B.; Blanchard, Jeffrey L.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Petit, Elsa; Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Leschine, Susan B.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	blanchard@microbio.umass.edu	Wardman, Colin/S-8924-2019; Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678; Haas, Kelly/0000-0002-6232-0056; Wardman, Colin/0000-0002-1067-213X	U.S. Department of Energy [DE-FG02-02ER15330]; Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station [MAS00923, MAS009582]; Qteros; UMass College of Natural Sciences and Mathematics Excellence Initiatives; Commonwealth College Research Grant; Life Sciences Junior Fellowship; Howard Hughes Medical Institute Award; National Science Foundation [NSF BBS 8714235]	U.S. Department of Energy(United States Department of Energy (DOE)); Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Qteros; UMass College of Natural Sciences and Mathematics Excellence Initiatives; Commonwealth College Research Grant; Life Sciences Junior Fellowship; Howard Hughes Medical Institute Award(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF))	This research was supported by U.S. Department of Energy grant DE-FG02-02ER15330 and Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station Project No. MAS00923 to SL and Project No. MAS009582 to JB, a Sponsored Research Agreement between Qteros and JB and SL, UMass College of Natural Sciences and Mathematics Excellence Initiatives funding to EP, a Commonwealth College Research Grant to IR, a Life Sciences Junior Fellowship to DC, a Howard Hughes Medical Institute Award to the University of Massachusetts Amherst and a National Science Foundation grant NSF BBS 8714235 to the University of Massachusetts Amherst Central Microscopy Facility. One of the funders, Qteros, was involved in identifying microbial fermentation products presented in Fig 1 using HPLC and GC. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADIA J, 1989, FEMS MICROBIOL LETT, V65, P253, DOI 10.1016/0378-1097(89)90226-7; BADIA J, 1985, J BACTERIOL, V161, P435; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bolstad BM, 2005, STAT BIOL HEALTH, P33; BORONAT A, 1981, J BACTERIOL, V147, P181, DOI 10.1128/JB.147.1.181-185.1981; CHEN YM, 1987, J BACTERIOL, V169, P3712, DOI 10.1128/jb.169.8.3712-3719.1987; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; Choi IG, 1998, J BIOCHEM MOL BIOL, V31, P130; CODD GA, 1976, PLANTA, V130, P323, DOI 10.1007/BF00387840; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorham J, 2008, BIOFUELS TECHNOLOGY, V1; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen TE, 1961, P IOWA ACAD SCI, V68, P89; Ju YH, 2010, BIOTECHNOL LETT, V32, P299, DOI 10.1007/s10529-009-0154-7; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; MAYER C, 2005, HEXOSE PENTOSE HEXIT; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Park D, 2007, GLYCOBIOLOGY, V17, P955, DOI 10.1093/glycob/cwm066; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Persson B, 1994, MED BIOCH, V22, P15; POHLSCHRODER M, 1995, J BACTERIOL, V177, P6625, DOI 10.1128/jb.177.22.6625-6629.1995; Raynaud C, 2003, P NATL ACAD SCI USA, V100, P5010, DOI 10.1073/pnas.0734105100; Richardson JS, 2004, J BACTERIOL, V186, P8433, DOI 10.1128/JB.186.24.8433-8442.2004; Rivas R, 2001, J MICROBIOL METH, V47, P59, DOI 10.1016/S0167-7012(01)00292-5; Rondo M, 1995, J BACTERIOL, P5434; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; TOBIN JF, 1987, J MOL BIOL, V196, P789, DOI 10.1016/0022-2836(87)90405-0; Vallet A, 2009, APPL MICROBIOL BIOT, V82, P87, DOI 10.1007/s00253-008-1721-x; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]; YAMADA M, 1988, J MOL BIOL, V203, P569, DOI 10.1016/0022-2836(88)90193-3; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	51	83	83	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54337	10.1371/journal.pone.0054337	http://dx.doi.org/10.1371/journal.pone.0054337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382892	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500010
J	Castro, V; Grisdale-Helland, B; Helland, SJ; Torgersen, J; Kristensen, T; Claireaux, G; Farrell, AP; Takle, H				Castro, Vicente; Grisdale-Helland, Barbara; Helland, Stale J.; Torgersen, Jacob; Kristensen, Torstein; Claireaux, Guy; Farrell, Anthony P.; Takle, Harald			Cardiac Molecular-Acclimation Mechanisms in Response to Swimming-Induced Exercise in Atlantic Salmon	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RAINBOW-TROUT; SKELETAL-MUSCLE; ERYTHROPOIETIN RECEPTOR; OXIDATIVE CAPACITY; PROTEIN EXPRESSION; TRAINING IMPROVES; OXYGEN-TRANSPORT	Cardiac muscle is a principal target organ for exercise-induced acclimation mechanisms in fish and mammals, given that sustained aerobic exercise training improves cardiac output. Yet, the molecular mechanisms underlying such cardiac acclimation have been scarcely investigated in teleosts. Consequently, we studied mechanisms related to cardiac growth, contractility, vascularization, energy metabolism and myokine production in Atlantic salmon pre-smolts resulting from 10 weeks exercise-training at three different swimming intensities: 0.32 (control), 0.65 (medium intensity) and 1.31 (high intensity) body lengths s(-1). Cardiac responses were characterized using growth, immunofluorescence and qPCR analysis of a large number of target genes encoding proteins with significant and well-characterized function. The overall stimulatory effect of exercise on cardiac muscle was dependent on training intensity, with changes elicited by high intensity training being of greater magnitude than either medium intensity or control. Higher protein levels of PCNA were indicative of cardiac growth being driven by cardiomyocyte hyperplasia, while elevated cardiac mRNA levels of MEF2C, GATA4 and ACTA1 suggested cardiomyocyte hypertrophy. In addition, up-regulation of EC coupling-related genes suggested that exercised hearts may have improved contractile function, while higher mRNA levels of EPO and VEGF were suggestive of a more efficient oxygen supply network. Furthermore, higher mRNA levels of PPAR alpha, PGC1 alpha and CPT1 all suggested a higher capacity for lipid oxidation, which along with a significant enlargement of mitochondrial size in cardiac myocytes of the compact layer of fish exercised at high intensity, suggested an enhanced energetic support system. Training also elevated transcription of a set of myokines and other gene products related to the inflammatory process, such as TNF alpha, NF kappa B, COX2, IL1RA and TNF decoy receptor. This study provides the first characterization of the underlying molecular acclimation mechanisms in the heart of exercise-trained fish, which resemble those reported for mammalian physiological cardiac growth.	[Castro, Vicente; Torgersen, Jacob; Takle, Harald] Nofima AS, As, Norway; [Castro, Vicente; Helland, Stale J.] Norwegian Univ Life Sci UMB, Inst Anim Sci, As, Norway; [Grisdale-Helland, Barbara; Helland, Stale J.] Aquaculture Prot Ctr, As, Norway; [Grisdale-Helland, Barbara; Helland, Stale J.] Nofima AS, Sunndalsora, Norway; [Kristensen, Torstein] Norwegian Inst Water Res, Bodo, Norway; [Claireaux, Guy] Univ Bretagne Occidentale, Lab Sci Environm Marin LEMAR, Plouzane, France; [Claireaux, Guy] IFREMER, Unite Physiol Fonct Organismes, Plouzane, France; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Takle, Harald] AVS Chile SA, Puerto Varas, Chile	Nofima; Norwegian University of Life Sciences; Nofima; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Ifremer; University of British Columbia; University of British Columbia	Takle, H (corresponding author), Nofima AS, As, Norway.	harald.takle@nofima.no		Kristensen, Torstein/0000-0002-2640-4260	Fishery and Aquaculture Industry Research Fund (FHF); Research Council of Norway [190067]	Fishery and Aquaculture Industry Research Fund (FHF); Research Council of Norway(Research Council of Norway)	This study was funded by the Fishery and Aquaculture Industry Research Fund (FHF) and the Research Council of Norway (Grant number: 190067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Anttila K, 2011, J FISH BIOL, V78, P552, DOI 10.1111/j.1095-8649.2010.02871.x; Anttila K, 2008, J COMP PHYSIOL B, V178, P465, DOI 10.1007/s00360-007-0239-3; Anttila K, 2006, J EXP BIOL, V209, P2971, DOI 10.1242/jeb.02341; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Bailey JR, 1997, COMP BIOCHEM PHYS B, V118, P607, DOI 10.1016/S0305-0491(97)00226-5; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bethke J, 2012, J FISH DIS IN PRESS; BLOOR CM, 1970, LAB INVEST, V22, P160; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Castro V, 2011, COMP BIOCHEM PHYS A, V160, P278, DOI 10.1016/j.cbpa.2011.06.013; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Chou CF, 2004, BLOOD, V104, P1498, DOI 10.1182/blood-2003-10-3404; Clark RJ, 1998, J EXP BIOL, V201, P1541; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; DAVIE PS, 1986, J EXP ZOOL, V237, P159, DOI 10.1002/jez.1402370203; Davison W, 1997, COMP BIOCHEM PHYS A, V117, P67, DOI 10.1016/S0300-9629(96)00284-8; Doyama K, 1996, INT J CARDIOL, V54, P217, DOI 10.1016/0167-5273(96)02607-1; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; Farrell AP, 2003, J EXP BIOL, V206, P487, DOI 10.1242/jeb.00100; FARRELL AP, 1991, FISH PHYSIOL BIOCHEM, V9, P303, DOI 10.1007/BF02265151; FARRELL AP, 1990, CAN J ZOOL, V68, P1174, DOI 10.1139/z90-174; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gallaugher PE, 2001, J EXP BIOL, V204, P2861; Gamperl AK, 2004, J EXP BIOL, V207, P2539, DOI 10.1242/jeb.01057; Gwechenberger M, 1999, CIRCULATION, V99, P546, DOI 10.1161/01.CIR.99.4.546; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Heggelund J, 2011, NORD J PSYCHIAT, V65, P269, DOI 10.3109/08039488.2011.560278; Helgerud J, 2011, INT J SPORTS MED, V32, P677, DOI 10.1055/s-0031-1275742; HOCHACHKA P, 1961, CAN J ZOOLOG, V39, P767, DOI 10.1139/z61-073; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; HOULIHAN DF, 1987, CAN J FISH AQUAT SCI, V44, P1614, DOI 10.1139/f87-195; Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, pH1290, DOI 10.1152/ajpheart.00820.2005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jobling M., 1993, AQUACULT INT, V1, P95, DOI [10.1007/BF00692614, DOI 10.1007/BF00692614]; KAPADIA S, 1995, J CLIN INVEST, V96, P1042, DOI 10.1172/JCI118090; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Khovanskiy I.Y., 1993, J ICHTHYOL, V33, P36; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; McClelland GB, 2005, J EXP BIOL, V208, P515, DOI 10.1242/jeb.01423; Moran M, 2003, PFLUG ARCH EUR J PHY, V446, P161, DOI 10.1007/s00424-003-1019-x; MOYES CD, 1992, CAN J ZOOL, V70, P1246, DOI 10.1139/z92-172; Moyes CD, 1996, COMP BIOCHEM PHYS A, V113, P69, DOI 10.1016/0300-9629(95)02057-8; Patey CP, 1997, CAN J ZOOL, V75, P324, DOI 10.1139/z97-041; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pelster B, 2003, AM J PHYSIOL-REG I, V285, pR339, DOI 10.1152/ajpregu.00110.2003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; SABORIDO A, 1995, PFLUG ARCH EUR J PHY, V429, P364, DOI 10.1007/BF00374151; Sachdev S, 2008, FREE RADICAL BIO MED, V44, P215, DOI 10.1016/j.freeradbiomed.2007.07.019; Sanger A. M., 2000, BASIC APPL MYOL, V10, P297; SANGER AM, 1992, ENVIRON BIOL FISH, V33, P97, DOI 10.1007/BF00002557; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Shiels HA, 2002, J EXP BIOL, V205, P3631; Shiels HA, 2002, COMP BIOCHEM PHYS A, V132, P811, DOI 10.1016/S1095-6433(02)00050-8; Simonot DL, 2009, J FISH BIOL, V75, P1762, DOI 10.1111/j.1095-8649.2009.02427.x; Simonot DL, 2007, J EXP BIOL, V210, P2574, DOI 10.1242/jeb.004028; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; THORARENSEN H, 1993, J EXP BIOL, V179, P115; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; TOMANEK RJ, 1970, ANAT RECORD, V167, P55, DOI 10.1002/ar.1091670106; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; Vornanen M, 2002, COMP BIOCHEM PHYS A, V132, P827, DOI 10.1016/S1095-6433(02)00051-X; WALKER MG, 1978, J FISH BIOL, V13, P475, DOI 10.1111/j.1095-8649.1978.tb03457.x; WEST TG, 1993, J EXP BIOL, V177, P63; YAMAUCHITAKIHARA K, 1995, CIRCULATION, V91, P1520, DOI 10.1161/01.CIR.91.5.1520; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	76	39	40	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55056	10.1371/journal.pone.0055056	http://dx.doi.org/10.1371/journal.pone.0055056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372811	Green Published, gold			2022-12-25	WOS:000315210400054
J	Finley, A; Chen, Z; Esposito, E; Cuzzocrea, S; Sabbadini, R; Salvemini, D				Finley, Amanda; Chen, Zhoumou; Esposito, Emanuela; Cuzzocrea, Salvatore; Sabbadini, Roger; Salvemini, Daniela			Sphingosine 1-Phosphate Mediates Hyperalgesia via a Neutrophil-Dependent Mechanism	PLOS ONE			English	Article							NF-KAPPA-B; MORPHINE ANTINOCICEPTIVE TOLERANCE; COLLAGEN-INDUCED ARTHRITIS; HUMAN ENDOTHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; RAT SENSORY NEURONS; NERVE GROWTH-FACTOR; S1P(1) ANTAGONIST; SPINAL CERAMIDE; SPHINGOSINE-1-PHOSPHATE RECEPTOR	Novel classes of pain-relieving molecules are needed to fill the void between non-steroidal anti-inflammatory agents and narcotics. We have recently shown that intraplantar administration of sphingosine 1-phosphate (S1P) in rats causes peripheral sensitization and hyperalgesia through the S1P(1) receptor subtype (S1PR(1)): the mechanism(s) involved are largely unknown and were thus explored in the present study. Intraplantar injection of carrageenan in rats led to a time-dependent development of thermal hyperalgesia that was associated with pronounced edema and infiltration of neutrophils in paw tissues. Inhibition of 1) S1P formation with SK-I, a sphingosine kinase inhibitor, 2) S1P bioavailability with the S1P blocking antibody Sphingomab, LT1002 (but not its negative control, LT1017) or 3) S1P actions through S1PR(1) with the selective S1PR1 antagonist, W146 (but not its inactive enantiomer, W140) blocked thermal hyperalgesia and infiltration of neutrophils. Taken together, these findings identify S1P as an important contributor to inflammatory pain acting through S1PR(1) to elicit hyperalgesia in a neutrophil-dependant manner. In addition and in further support, we demonstrate that the development of thermal hyperalgesia following intraplantar injection of S1P or SEW2871 (an S1PR(1) agonist) was also associated with neutrophilic infiltration in paw tissues as these events were attenuated by fucoidan, an inhibitor of neutrophilic infiltration. Importantly, FTY720, an FDA-approved S1P receptor modulator known to block S1P-S1PR(1) signaling, attenuated carrageenan-induced thermal hyperalgesia and associated neutrophil infiltration. Targeting the S1P/S1PR(1) axis opens a therapeutic strategy for the development of novel non-narcotic anti-hyperalgesic agents.	[Finley, Amanda; Chen, Zhoumou; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Sabbadini, Roger] San Diego State Univ, Lpath Inc, San Diego, CA 92182 USA; [Sabbadini, Roger] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	Saint Louis University; University of Messina; California State University System; San Diego State University; California State University System; San Diego State University	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	salvemd@slu.edu		Esposito, Emanuela/0000-0002-2663-6387; Cuzzocrea, Salvatore/0000-0001-6131-3690	National Institutes of Health National Institute on Drug Abuse [R01 DA024074]; National Institutes of Health predoctoral fellowship [5T32GM008306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024074] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institutes of Health National Institute on Drug Abuse (Grant R01 DA024074) to DS and a National Institutes of Health predoctoral fellowship (Grant 5T32GM008306) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Bennett G, 1998, PAIN, V77, P315, DOI 10.1016/S0304-3959(98)00114-6; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Bryant L, 2009, NEUROSCI LETT, V463, P49, DOI 10.1016/j.neulet.2009.07.051; CHI XX, 2010, J NEUROPHYSIOL; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cuzzocrea S, 2000, FASEB J, V14, P1061, DOI 10.1096/fasebj.14.9.1061; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Doyle T, 2011, NEUROSCI LETT, V499, P4, DOI 10.1016/j.neulet.2011.05.018; Doyle T, 2011, PAIN, V152, P643, DOI 10.1016/j.pain.2010.12.011; French KJ, 2003, CANCER RES, V63, P5962; Fujii Y, 2012, J IMMUNOL, V188, P206, DOI 10.4049/jimmunol.1101537; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jia YT, 2007, J IMMUNOL, V179, P7808, DOI 10.4049/jimmunol.179.11.7808; Jongsma M, 2006, BRIT J PHARMACOL, V149, P277, DOI 10.1038/sj.bjp.0706872; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Koide Y, 2002, J MED CHEM, V45, P4629, DOI 10.1021/jm020080c; Kress M., 2012, TRENDS PHARMACOL SCI; Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9; Kulms D, 2006, VITAM HORM, V74, P283, DOI 10.1016/S0083-6729(06)74011-0; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Lee HY, 2004, AM J PHYSIOL-CELL PH, V287, pC1657, DOI 10.1152/ajpcell.00172.2004; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; LEVINE JD, 1985, J NEUROSCI, V5, P3025; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; LEY K, 1993, BLOOD, V81, P177; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Lin CI, 2007, BIOCHEM BIOPH RES CO, V355, P895, DOI 10.1016/j.bbrc.2007.02.043; Mair N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017268; Matsuura M, 2000, INT J IMMUNOPHARMACO, V22, P323, DOI 10.1016/S0192-0561(99)00088-0; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; National CfHS, 2006, HEALTH UNITED STATES; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Russell FA, 2009, PAIN, V142, P264, DOI 10.1016/j.pain.2009.01.021; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Salvemini D, 1998, DRUG NEWS PERSPECT, V11, P204; Salvemini D, 2001, BRIT J PHARMACOL, V132, P815, DOI 10.1038/sj.bjp.0703841; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Semenov AV, 1998, VOP MED KHIM, V44, P135; Shimamura K, 2004, EUR J PHARMACOL, V486, P141, DOI 10.1016/j.ejphar.2003.12.022; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TONNESEN MG, 1989, J INVEST DERMATOL, V93, pS53, DOI 10.1111/1523-1747.ep12581069; Trifilieff A, 2009, N-S ARCH PHARMACOL, V380, P303, DOI 10.1007/s00210-009-0438-4; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Welch SP, 2012, BIOCHEM PHARMACOL, V84, P1551, DOI 10.1016/j.bcp.2012.08.010; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xie WR, 2012, NEUROSCI LETT, V515, P61, DOI 10.1016/j.neulet.2012.03.019; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006	67	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55255	10.1371/journal.pone.0055255	http://dx.doi.org/10.1371/journal.pone.0055255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372844	gold, Green Submitted, Green Published			2022-12-25	WOS:000315210400084
J	Lee, H; Lee, J; Hwang, SS; Kim, S; Chin, HJ; Han, JS; Heo, NJ				Lee, Hajeong; Lee, Jeonghwan; Hwang, Seung-sik; Kim, Sejoong; Chin, Ho Jun; Han, Jin Suk; Heo, Nam Ju			Potassium Intake and the Prevalence of Metabolic Syndrome: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; THIAZIDE DIURETICS; DIETARY POTASSIUM; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; MAGNESIUM INTAKE; ORAL POTASSIUM; ADULTS; RISK	Lower potassium intake is considered to be correlated with diabetes incidence. However, few studies have investigated the effect of potassium intake on metabolic syndrome (MetS). Data was taken from the Korean National Health and Nutritional Examination Survey (2008-2010) using weighted adjustment. MetS was defined as per the revised National Cholesterol Education Program criteria. Homeostasis model assessment indices were calculated to diagnosis insulin resistance (IR). A total of 16,637 participants (44 +/- 0.25 years) were included. Women ingested lower amounts of potassium (2.71 +/- 0.02 g/day) than men (3.45 +/- 0.03 g/day). A curvilinear association between potassium intake and MetS prevalence was found among women. Women with less than the Adequate Intake (4.7 g/day) of potassium had an 11% risk reduction for MetS (adjusted odds ratio [OR], 0.89; 95% confidence interval [CI], 0.82-0.96; P = 0.004) and a 10% risk reduction for IR (OR, 0.90; 95% CI, 0.82-0.99; P = 0.026) for every 1 g/day potassium increase. Compared with the reference group (3.5-4.5 g/day), potassium intake was inversely associated with an increased risk of MetS (1.5-2.5 g/day; OR, 1.29; 95% CI, 1.02-1.63; P = 0.035; < 1.5 g/day; OR, 1.40; 95% CI, 1.06-1.85; P = 0.017) and IR (< 1.5 g/day; OR, 1.36; 95% CI, 1.05-1.76; P = 0.021). This relationship was more prominent in postmenopausal women, but not observed among men. Higher potassium intake is significantly associated with a lower MetS prevalence in women, and IR is believed to be connected.	[Lee, Hajeong; Lee, Jeonghwan; Han, Jin Suk] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Hwang, Seung-sik] Inha Univ, Sch Med, Dept Social & Prevent Med, Inchon, South Korea; [Kim, Sejoong; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Heo, Nam Ju] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Inha University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Heo, NJ (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea.	julie082007@naver.com	Lee, Jeonghwan/C-5214-2011; Kim, Sejoong/J-5356-2015	Lee, Jeonghwan/0000-0003-3199-635X; Kim, Sejoong/0000-0002-7238-9962				ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Bar-Or, 2004, DIETARY REFERENCE IN; Chatterjee R, 2012, DIABETOLOGIA, V55, P1295, DOI 10.1007/s00125-012-2487-3; Chatterjee R, 2010, ARCH INTERN MED, V170, P1745, DOI 10.1001/archinternmed.2010.362; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; GRIMM RH, 1990, NEW ENGL J MED, V322, P569, DOI 10.1056/NEJM199003013220901; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; He FJ, 2008, PHYSIOL PLANTARUM, V133, P725, DOI 10.1111/j.1399-3054.2007.01033.x; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Hu G, 2005, DIABETOLOGIA, V48, P1477, DOI 10.1007/s00125-005-1824-1; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kannel William B, 2002, J Gend Specif Med, V5, P27; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Kim ES, 2003, TOHOKU J EXP MED, V200, P7, DOI 10.1620/tjem.200.7; Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001; Larsson SC, 2011, AM J EPIDEMIOL, V174, P35, DOI 10.1093/aje/kwr051; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mirmiran P, 2012, PUBLIC HEALTH NUTR, V15, P693, DOI 10.1017/S1368980011002941; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; NORBIATO G, 1984, EUR J CLIN INVEST, V14, P414, DOI 10.1111/j.1365-2362.1984.tb01205.x; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; Reungjui S, 2008, CURR OPIN NEPHROL HY, V17, P470, DOI 10.1097/MNH.0b013e328305b9a5; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; Sowers MR, 2005, J CLIN ENDOCR METAB, V90, P6064, DOI 10.1210/jc.2005-0765; Tasevska N, 2006, J NUTR, V136, P1334, DOI 10.1093/jn/136.5.1334; van Mierlo LAJ, 2010, ARCH INTERN MED, V170, P1501, DOI 10.1001/archinternmed.2010.284; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	41	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55106	10.1371/journal.pone.0055106	http://dx.doi.org/10.1371/journal.pone.0055106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372822	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400064
J	Wilson, S; Marra, PP; Sillett, TS				Wilson, Scott; Marra, Peter P.; Sillett, T. Scott			The Effects of Experimental Irrigation on Plant Productivity, Insect Abundance and the Non-Breeding Season Performance of a Migratory Songbird	PLOS ONE			English	Article							TROPICAL DRY FOREST; HABITAT QUALITY; NEOTROPICAL MIGRANT; AMERICAN REDSTARTS; DECIDUOUS FOREST; LEAF PHENOLOGY; RAINFALL; TREES; WATER; BIRD	Migratory bird populations are often limited by food during the non-breeding season. Correlative evidence suggests that food abundance on territories varies among years in relation to rainfall, which affects plant productivity and arthropod biomass. At the Font Hill Nature Preserve in Jamaica, we used an irrigation experiment to test the hypothesis that rainfall affects the condition of wintering American redstarts (Setophaga ruticilla) via intermediate effects on plant productivity and arthropod abundance. Experimental plots were irrigated in late February and early March to simulate a mid-season pulse of 200 mm of rain. Irrigation maintained soil moisture levels near saturation and had immediate effects on plant productivity. Cumulative leaf abscission over the dry season was 50% lower on experimental plots resulting in greater canopy cover, and we observed significantly higher ground level shoot growth and the flushing of new leaves on about 58% of logwood (Haematoxylon campechianum) individuals. Arthropod biomass was 1.5 times higher on irrigated plots, but there was considerable inter-plot variability within a treatment and a strong seasonal decline in biomass. Consequently, we found no significant effect of irrigation on arthropod abundance or redstart condition. We suspect that the lack of an irrigation effect for taxa higher on the trophic chain was due to the small spatial scale of the treatment relative to the scale at which these taxa operate. Although redstart condition was not affected, we did observe turnover from subordinate to dominant territorial individuals on experimental plots suggesting a perceived difference in habitat quality that influenced individual behavior.	[Wilson, Scott; Marra, Peter P.; Sillett, T. Scott] Smithsonian Conservat Biol Inst, Natl Zool Pk, Migratory Bird Ctr, Washington, DC USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Wilson, S (corresponding author), Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada.	scottd.wilson@ec.gc.ca	Sillett, Scott/N-2240-2017; Wilson, Scott/AAC-7144-2021	Sillett, Scott/0000-0002-7486-0076; Marra, Peter/0000-0002-0508-7577	National Science Foundation [DEB 0717243]; Smithsonian Institution; Canadian Natural Sciences and Engineering Research Council; Direct For Biological Sciences [1242584] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation (grant DEB 0717243) to PPM and TSS, the Smithsonian Institution, and a Canadian Natural Sciences and Engineering Research Council grant to SW. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams CD., 1971, FLOWERING PLANTS JAM, V7, P109; Angelier F, 2011, J AVIAN BIOL, V42, P335, DOI 10.1111/j.1600-048X.2011.05369.x; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; BORCHERT R, 1994, TREES-STRUCT FUNCT, V8, P198, DOI 10.1007/BF00196847; Borchert R, 2002, BIOTROPICA, V34, P27, DOI 10.1111/j.1744-7429.2002.tb00239.x; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; CARPENTER FL, 1983, P NATL ACAD SCI-BIOL, V80, P7259, DOI 10.1073/pnas.80.23.7259; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Hannon SJ, 2009, OIKOS, V118, P1035, DOI 10.1111/j.1600-0706.2008.17383.x; Hayden B, 2010, J TROP ECOL, V26, P237, DOI 10.1017/S0266467409990563; Holbrook N. Michele, 1995, P243, DOI 10.1017/CBO9780511753398.010; JANZEN DH, 1967, EVOLUTION, V21, P620, DOI 10.1111/j.1558-5646.1967.tb03416.x; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Kendall C., 1998, ISOTOPE TRACERS CATC, DOI [10.1016/c2009-0-10239-8, DOI 10.1016/C2009-0-10239-8, 10.1016/C2009-0-10239-8]; Latta SC, 2002, ECOLOGY, V83, P2502, DOI 10.1890/0012-9658(2002)083[2502:DAPROC]2.0.CO;2; Latta SC, 2012, J FIELD ORNITHOL, V83, P107, DOI 10.1111/j.1557-9263.2012.00361.x; MARRA PP, 1993, AUK, V110, P565, DOI 10.2307/4088420; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MEDINA E, 1985, MEDIO AMBIENTE, V7, P91; Myers BA, 1998, AUST J ECOL, V23, P329, DOI 10.1111/j.1442-9993.1998.tb00738.x; OLIVARES E, 1992, J VEG SCI, V3, P383, DOI 10.2307/3235764; Paine CET, 2009, J TROP ECOL, V25, P171, DOI 10.1017/S0266467408005798; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; REICH PB, 1982, ECOLOGY, V63, P294, DOI 10.2307/1938945; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rojas-Jimenez K, 2007, TREE PHYSIOL, V27, P1561, DOI 10.1093/treephys/27.11.1561; Sherry T. W., 1997, BIRDS N AM; Sherry Thomas W., 2005, P414; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Smith JAM, 2010, ECOLOGY, V91, P2874, DOI 10.1890/09-2212.1; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; STUTCHBURY BJ, 1994, AUK, V111, P63, DOI 10.2307/4088505; TANAKA LK, 1982, BIOTROPICA, V14, P114, DOI 10.2307/2387740; Temeles EJ, 2005, AUK, V122, P187, DOI 10.1642/0004-8038(2005)122[0187:FATEOS]2.0.CO;2; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; WOLDA H, 1992, P K NED AKAD WETENSC, V95, P535; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; WRIGHT SJ, 1990, ECOLOGY, V71, P1165, DOI 10.2307/1937384; Yavitt JB, 2008, J TROP ECOL, V24, P19, DOI 10.1017/S0266467407004713	48	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55114	10.1371/journal.pone.0055114	http://dx.doi.org/10.1371/journal.pone.0055114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372825	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400067
J	Du, Y; Shen, J; Hsu, JL; Han, Z; Hsu, MC; Yang, CC; Kuo, HP; Wang, YN; Yamaguchi, H; Miller, SA; Hung, MC				Du, Y.; Shen, J.; Hsu, J. L.; Han, Z.; Hsu, M-C; Yang, C-C; Kuo, H-P; Wang, Y-N; Yamaguchi, H.; Miller, S. A.; Hung, M-C			Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking	ONCOGENE			English	Article						EGF receptor; Golgi and nuclear translocation; microtubules; syntaxin 6	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; MEMBRANE; LOCALIZATION; PROTEIN; PHOSPHORYLATION; EXPRESSION; TRANSPORT; ENDOCYTOSIS; MECHANISM	Receptor tyrosine kinases (RTKs) are cell surface receptors that initiate signal cascades in response to ligand stimulation. Abnormal expression and dysregulated intracellular trafficking of RTKs have been shown to be involved in tumorigenesis. Recent evidence shows that these cell surface receptors translocate from cell surface to different cellular compartments, including the Golgi, mitochondria, endoplasmic reticulum (ER) and the nucleus, to regulate physiological and pathological functions. Although some trafficking mechanisms have been resolved, the mechanism of intracellular trafficking from cell surface to the Golgi is not yet completely understood. Here we report a mechanism of Golgi translocation of epidermal growth factor receptor (EGFR) in which EGF-induced EGFR travels to the Golgi via microtubule-dependent movement by interacting with dynein and fuses with the Golgi through syntaxin 6-mediated membrane fusion. We also demonstrate that the microtubule-and syntaxin 6-mediated Golgi translocation of EGFR is necessary for its consequent nuclear translocation and nuclear functions. Thus, together with previous studies, the microtubule-and syntaxin 6-mediated trafficking pathway from cell surface to the Golgi, ER and the nucleus defines a comprehensive trafficking route for EGFR to travel from cell surface to the Golgi and the nucleus.	[Du, Y.; Shen, J.; Hsu, J. L.; Han, Z.; Hsu, M-C; Yang, C-C; Kuo, H-P; Wang, Y-N; Yamaguchi, H.; Miller, S. A.; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Du, Y.; Shen, J.; Yang, C-C; Kuo, H-P; Hung, M-C] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX USA; [Hsu, J. L.; Wang, Y-N; Hung, M-C] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Hsu, J. L.; Wang, Y-N; Hung, M-C] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Hsu, J. L.; Wang, Y-N; Hung, M-C] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hsu, MC/AAE-5310-2020; Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Wang, Ying-Nai/0000-0002-5275-6729	National Institutes of Health [CA109311, CA099031]; Cancer Research Center of Excellence, Taiwan [D0H101-TD-C-111-005]; Private University Grant, Taiwan [NSC99-2632-B-039-001-MY3]; Program for Stem Cell and Regenerative Medicine Frontier Research, Taiwan [NSC100-2321-B-039-002]; International Research-Intensive Centers of Excellence in Taiwan, Taiwan [NSC101-2911-I-002-303]; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Institutes of Health through MD Anderson's Cancer Center Support Grant; Center for Biological Pathways [CA016672]; Patel Memorial Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA109311, P01CA099031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Center of Excellence, Taiwan; Private University Grant, Taiwan; Program for Stem Cell and Regenerative Medicine Frontier Research, Taiwan; International Research-Intensive Centers of Excellence in Taiwan, Taiwan; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biological Pathways; Patel Memorial Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr B Storrie (University of Arkansas for Medical Sciences) for providing the GalNac T2-GFP plasmid. This study was partially supported by the following grants: National Institutes of Health Grants CA109311 and CA099031 (to MC Hung); Cancer Research Center of Excellence (D0H101-TD-C-111-005, Taiwan); Private University Grant (NSC99-2632-B-039-001-MY3, Taiwan); Program for Stem Cell and Regenerative Medicine Frontier Research (NSC100-2321-B-039-002, Taiwan); International Research-Intensive Centers of Excellence in Taiwan (NSC101-2911-I-002-303, Taiwan); The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Institutes of Health through MD Anderson's Cancer Center Support Grant and the Center for Biological Pathways (CA016672); Patel Memorial Breast Cancer Research Fund.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Allan VJ, 1999, CURR OPIN CELL BIOL, V11, P476, DOI 10.1016/S0955-0674(99)80068-4; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; Cao XY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-26; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dittmann K, 2010, STRAHLENTHER ONKOL, V186, P1, DOI 10.1007/s00066-009-2026-4; Klaus HD, 2008, INT J RADIAT ONCOL, V70, P203, DOI 10.1016/j.ijrobp.2007.08.065; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; KAMIO T, 1990, HUM PATHOL, V21, P277, DOI 10.1016/0046-8177(90)90227-V; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M; Mittar S, 2009, EXP CELL RES, V315, P877, DOI 10.1016/j.yexcr.2008.12.020; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; ROBERTSON BJ, 1992, ARCH BIOCHEM BIOPHYS, V292, P190, DOI 10.1016/0003-9861(92)90067-7; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Srinivasan R, 2000, CANCER RES, V60, P1483; Stachowiak MK, 1996, MOL BRAIN RES, V38, P161, DOI 10.1016/0169-328X(96)00010-1; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yarden Y, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.013	60	36	38	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					756	770		10.1038/onc.2013.1	http://dx.doi.org/10.1038/onc.2013.1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23376851	Green Accepted			2022-12-25	WOS:000331129200010
J	Illigens, BMW; Gibbons, CH				Illigens, Ben M. W.; Gibbons, Christopher H.			A Human Model of Small Fiber Neuropathy to Study Wound Healing	PLOS ONE			English	Article							REFLEX-RELATED VASODILATION; CUTANEOUS WOUNDS; TOPICAL CAPSAICIN; GROWTH-FACTOR; DOUBLE-BLIND; SKIN BIOPSY; INNERVATION; FOOT; QUANTIFICATION; REGENERATION	The aim of this study was to develop a human model of acute wound healing that isolated the effects of small fiber neuropathy on the healing process. Twenty-five healthy subjects had the transient receptor vanilloid 1 agonist capsaicin and placebo creams topically applied to contralateral areas on the skin of the thigh for 48 hours. Subjects had shallow (1.2 millimeter) and deep (>3 millimeter) punch skin biopsies from each thigh on days 1 and 14. Biopsy wound healing was monitored photographically until closure. Intra-epidermal and sweat-gland nerve fiber densities were measured for each biopsy. Shallow wounds in capsaicin-treated sites healed more slowly than in placebo treated skin with biopsies taken on day 1 (P<0.001) and day 14 (P<0.001). Deep biopsies in the capsaicin and placebo areas healed at similar rates at both time points. Nerve fiber densities were reduced only in capsaicin treated regions (P<0.01). In conclusion, topical application of capsaicin causes a small fiber neuropathy and is associated with a delay in healing of shallow, but not deep wounds. This novel human model may prove valuable in the study of wound healing in patients with neuropathy.	[Illigens, Ben M. W.; Gibbons, Christopher H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gibbons, CH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	cgibbons@bidmc.harvard.edu			National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS) [K23 NS050209]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS050209] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS) K23 NS050209 (CHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Berghoff M, 2002, J APPL PHYSIOL, V92, P780, DOI 10.1152/japplphysiol.01167.2000; BIESBROECK R, 1995, ADV THER, V12, P111; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Caselli A, 2003, NEUROLOGY, V60, P297, DOI 10.1212/01.WNL.0000040250.31755.F9; Chan F C, 2007, J Wound Care, V16, P359; Dabby R, 2007, J PERIPHER NERV SYST, V12, P98, DOI 10.1111/j.1529-8027.2007.00128.x; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Fuchs E, 1998, Harvey Lect, V94, P47; Gibbons CH, 2006, NEUROLOGY, V66, P256, DOI 10.1212/01.wnl.0000194314.86486.a2; Gibbons CH, 2010, ANN NEUROL, V68, P888, DOI 10.1002/ana.22126; Gibbons CH, 2010, MUSCLE NERVE, V42, P112, DOI 10.1002/mus.21626; Gibbons CH, 2009, NEUROLOGY, V72, P1479, DOI 10.1212/WNL.0b013e3181a2e8b8; Hamdy O, 2001, DIABETES CARE, V24, P344, DOI 10.2337/diacare.24.2.344; Jacobsen JN, 2010, APMIS, V118, P753, DOI 10.1111/j.1600-0463.2010.02654.x; Kramer HH, 2004, DIABETES, V53, P769, DOI 10.2337/diabetes.53.3.769; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Lai Xinan, 2002, Chin J Traumatol, V5, P176; Laing T, 2010, J SURG RES, V161, P336, DOI 10.1016/j.jss.2009.01.024; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; LOW PA, 1995, PAIN, V62, P163, DOI 10.1016/0304-3959(94)00261-C; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinez-Martinez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036421; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Miller SJ, 1998, J INVEST DERMATOL, V110, P13, DOI 10.1046/j.1523-1747.1998.00087.x; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; O'Sullivan JB, 2010, IRJMEDSCI; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P857; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P883; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P911; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6; Wang NS, 2011, J HISTOCHEM CYTOCHEM, V59, P382, DOI 10.1369/0022155410396931; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198	38	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54760	10.1371/journal.pone.0054760	http://dx.doi.org/10.1371/journal.pone.0054760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382960	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600039
J	Rudnicki, J; Zysko, D; Kozlowski, D; Kuliczkowski, W; Kozluk, E; Lelonek, M; Piatkowska, A; Gajek, J; Negrusz-Kawecka, M; Agrawal, AK				Rudnicki, Jerzy; Zysko, Dorota; Kozlowski, Dariusz; Kuliczkowski, Wiktor; Kozluk, Edward; Lelonek, Malgorzata; Piatkowska, Agnieszka; Gajek, Jacek; Negrusz-Kawecka, Marta; Agrawal, Anil Kumar			The Choice of Surgical Specialization by Medical Students and Their Syncopal History	PLOS ONE			English	Article							QUALITY-OF-LIFE; VASOVAGAL SYNCOPE; MENSTRUAL-CYCLE; SURGERY; CAREERS; GENDER; RISK	Background: The aim of the study was to assess whether medical students' fainting outside the university or while witnessing surgical procedures and/or autopsies influenced their choice of a specialization. Materials and Methods: The study group consisted of 605 medical students (from fourth to sixth year of study) from five medical universities in Poland (325 women, 212 men and 8 responders of an unspecified gender). The median age of subjects studied was 23 years, and the interquartile range was 23-24 years. The students at each university were chosen randomly by the author who worked there and had contact with them. An anonymous questionnaire was developed to gather information regarding demographics, the specialization which each student wanted to choose, the syncope occurrence in the medical history, the syncope and presyncope occurrence during surgery and autopsy as well as the syncopal events' characteristics. Results: The group of 15% of women and 30% of men declared to have pursued the surgical specialization (P<0.001), 29% of women and 56% of men declared the intention to pursue an invasive specialization (P<0.001). As many as 36.0% of women studied and 13.1% of men studied reported syncopal spells outside university (P<0.001). Only 41 students (6.8%) reported that syncope or presyncope in any studied circumstances had an impact on their specialization choice. The multivariate analysis showed that the choice of surgical specialization is related to the male gender and the absence of syncopal spells outside the university. Conclusions: Syncopal and presyncopal spells may affect the professional choices of the medical students. The male gender and a lack of syncope occurrence outside operating room are related to the choice of surgical specialization.	[Rudnicki, Jerzy] Wroclaw Med Univ, Dept Minimally Invas Surg & Proctol, Wroclaw, Poland; [Zysko, Dorota] Wroclaw Med Univ, Teaching Dept Emergency Med Serv, Wroclaw, Poland; [Kozlowski, Dariusz] Med Univ Gdansk, Dept Cardiol, Gdansk, Poland; [Kuliczkowski, Wiktor] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland; [Kozluk, Edward; Piatkowska, Agnieszka] Warsaw Med Univ, Dept Cardiol, Warsaw, Poland; [Lelonek, Malgorzata] Med Univ Lodz, Dept Cardiol, Lodz, Poland; [Gajek, Jacek; Negrusz-Kawecka, Marta] Wroclaw Med Univ, Dept Cardiol, Wroclaw, Poland; [Agrawal, Anil Kumar] Wroclaw Med Univ, Dept Gen & Oncol Surg 2, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Medical University of Warsaw; Medical University Lodz; Wroclaw Medical University; Wroclaw Medical University	Zysko, D (corresponding author), Wroclaw Med Univ, Teaching Dept Emergency Med Serv, Wroclaw, Poland.	dzysko@wp.pl	Lelonek, Malgorzata/S-9339-2016; Gajek, Jacek/AAD-8948-2020; Kozluk, Edward/B-6950-2019	Gajek, Jacek/0000-0002-0038-1750; Negrusz-Kawecka, Marta/0000-0003-0764-1495; Lelonek, Malgorzata/0000-0003-0756-5541; Piatkowska, Agnieszka/0000-0001-8234-2773; Kozluk, Edward/0000-0002-7829-653X; Kuliczkowski, Wiktor/0000-0001-6284-0820; Rudnicki, Jerzy/0000-0001-8575-7595				Baron-Esquivias G, 2005, INT J CARDIOL, V102, P315, DOI 10.1016/j.ijcard.2004.10.019; Baxter N, 1996, AM J SURG, V172, P373, DOI 10.1016/S0002-9610(96)00185-7; Colman N, 2004, CLIN AUTON RES, V14, P9, DOI 10.1007/s10286-004-1003-3; Convertino VA, 1998, AM J PHYSIOL-REG I, V275, pR1909, DOI 10.1152/ajpregu.1998.275.6.R1909; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; Ganzeboom KS, 2006, J CARDIOVASC ELECTR, V17, P1172, DOI 10.1111/j.1540-8167.2006.00595.x; Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; Giada F, 2005, EUROPACE, V7, P465, DOI 10.1016/j.eupc.2005.05.008; Glynn RW, 2010, SURG-J R COLL SURG E, V8, P187, DOI 10.1016/j.surge.2009.11.005; Jamjoom AAB, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-14; Lefevre JH, 2010, J VISC SURG, V147, pE181, DOI 10.1016/j.jviscsurg.2010.08.004; Meendering JR, 2005, AM J PHYSIOL-HEART C, V289, pH631, DOI 10.1152/ajpheart.00029.2005; Rudnicki J, 2011, PACE, V34, P1486, DOI 10.1111/j.1540-8159.2011.03169.x; Santhouse J, 2007, EPILEPSIA, V48, P1019, DOI 10.1111/j.1528-1167.2006.00971.x; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; Tambyraja AL, 2008, WORLD J SURG, V32, P960, DOI 10.1007/s00268-008-9529-5; Zysko D, 2010, RATUNEK, V4, P28; Zysko D, 2012, ARCH GYNECOL OBSTET, V286, P429, DOI 10.1007/s00404-012-2308-4	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55236	10.1371/journal.pone.0055236	http://dx.doi.org/10.1371/journal.pone.0055236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383122	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600079
J	Zwerling, A; Benedetti, A; Cojocariu, M; McIntosh, F; Pietrangelo, F; Behr, MA; Schwartzman, K; Menzies, D; Pai, M				Zwerling, Alice; Benedetti, Andrea; Cojocariu, Mihaela; McIntosh, Fiona; Pietrangelo, Filomena; Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar			Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability?	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LATENT TUBERCULOSIS INFECTION; WITHIN-SUBJECT VARIABILITY; CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; GUIDELINES; DIAGNOSIS; SETTINGS; RISK	Background: Although North American hospitals are switching from tuberculin testing (TST) to interferon-gamma release assays (IGRAs), data are limited on the association between occupational exposure and serial QuantiFERON-TB Gold In-Tube (QFT) results in healthcare workers (HCWs). Methods: In a cohort of Canadian HCWs, TST and QFT were performed at study enrolment (TST1 and QFT1) and 1 year later (TST2 and QFT2). Conversion and reversion rates were estimated, and correlation with TB exposure was assessed. Results: Among 258 HCWs, median age was 36.8 years, 188/258 (73%) were female and 183/258 (71%) were Canadian-born. In 245 subjects with a negative QFT1 we found a QFT conversion rate of 5.3% (13/245, 95% CI 2.9-8.9%). Using more stringent definitions, QFT conversion rates ranged from 2.0 to 5.3%. No TST conversions were found among the 241 HCWs with negative TST1, and no measure of recent TB exposure was associated with QFT conversions. In the 13 HCWs with a positive QFT1, 62% reverted. Conclusion: Using the conventional QFT conversion definition, we found a higher than expected rate of conversion. Recent occupational exposures were not associated with QFT conversions, and no TST conversions occurred in this cohort, suggesting the 'conversions' may not reflect new TB infection.	[Zwerling, Alice; Benedetti, Andrea; Behr, Marcel A.; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Zwerling, Alice; Benedetti, Andrea; Cojocariu, Mihaela; Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Benedetti, Andrea; Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada; [Pietrangelo, Filomena] McGill Univ, Ctr Hlth, Dept Occupat Hlth & Safety, Montreal, PQ, Canada; [Cojocariu, Mihaela; McIntosh, Fiona] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Pai, M (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research (CIHR) [81362]; Fonds de recherche du Quebec-Sante	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant 81362. AZ received a doctoral fellowship from CIHR, and MP received a New Investigator Award from CIHR. MP also received a salary award from Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 2008, Canada Communicable Disease Report, V34, P1; Bartalesi F, 2012, J INFECTION; Belknap R, 2010, AM J RESP CRIT CARE, V181; Chiappini E, 2012, CLIN THER, V34, P1041, DOI 10.1016/j.clinthera.2012.03.006; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; Cummings KJ, 2009, INFECT CONT HOSP EP, V30, P1123, DOI 10.1086/644754; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Denkinger CM, 2012, J CLIN MICROBIOL; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11; DORMAN S, 2009, AM J RESP CRIT CARE, pA1010; Fong KS, 2012, CHEST, V142, P55, DOI 10.1378/chest.11-0992; Gandra S, 2011, INFECT CONT HOSP EP, V32, P518, DOI 10.1086/659957; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Joshi M, 2012, CAN RESPIR J, V19, P84, DOI 10.1155/2012/576324; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Loddenkemper R, 2012, CHEST, V142, P10, DOI 10.1378/chest.12-0045; Long R., 2007, CANADIAN TUBERCULOSI, V6th; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2000, ANN INTERN MED, V133, P779, DOI 10.7326/0003-4819-133-10-200011210-00010; Menzies D, 1998, INT J TUBERC LUNG D, V2, pS98; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe J, 2012, AM J RESP CRIT CARE; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2012, CAN RESPIR J, V19, P81, DOI 10.1155/2012/420392; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; PHAC, 2009, TUB CAN 2009 PRER; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Schablon Anja, 2010, GMS Krankenhhyg Interdiszip, V5, DOI 10.3205/dgkh000148; SSSQ, 2009, EP TUB QUEB 2004 200; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Whitworth WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043790; World Health Organization, 2009, WHO POL TB INF CONTR; Zwerling A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043014; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	46	58	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54748	10.1371/journal.pone.0054748	http://dx.doi.org/10.1371/journal.pone.0054748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382955	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600038
J	Badro, DA; Douaihy, B; Haber, M; Youhanna, SC; Salloum, A; Ghassibe-Sabbagh, M; Johnsrud, B; Khazen, G; Matisoo-Smith, E; Soria-Hernanz, DF; Wells, RS; Tyler-Smith, C; Platt, DE; Zalloua, PA				Badro, Danielle A.; Douaihy, Bouchra; Haber, Marc; Youhanna, Sonia C.; Salloum, Angelique; Ghassibe-Sabbagh, Michella; Johnsrud, Brian; Khazen, Georges; Matisoo-Smith, Elizabeth; Soria-Hernanz, David F.; Wells, R. Spencer; Tyler-Smith, Chris; Platt, Daniel E.; Zalloua, Pierre A.		Genographic Consortium	Y-Chromosome and mtDNA Genetics Reveal Significant Contrasts in Affinities of Modern Middle Eastern Populations with European and African Populations	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL REGION SEQUENCES; MODERN HUMAN ORIGINS; SUB-SAHARAN; MEDITERRANEAN AREA; ALLELE FREQUENCIES; ARABIAN PENINSULA; HUMAN MIGRATIONS; HUMAN-EVOLUTION; HAPLOGROUP-J	The Middle East was a funnel of human expansion out of Africa, a staging area for the Neolithic Agricultural Revolution, and the home to some of the earliest world empires. Post LGM expansions into the region and subsequent population movements created a striking genetic mosaic with distinct sex-based genetic differentiation. While prior studies have examined the mtDNA and Y-chromosome contrast in focal populations in the Middle East, none have undertaken a broad-spectrum survey including North and sub-Saharan Africa, Europe, and Middle Eastern populations. In this study 5,174 mtDNA and 4,658 Y-chromosome samples were investigated using PCA, MDS, mean-linkage clustering, AMOVA, and Fisher exact tests of F-ST's, R-ST's, and haplogroup frequencies. Geographic differentiation in affinities of Middle Eastern populations with Africa and Europe showed distinct contrasts between mtDNA and Y-chromosome data. Specifically, Lebanon's mtDNA shows a very strong association to Europe, while Yemen shows very strong affinity with Egypt and North and East Africa. Previous Y-chromosome results showed a Levantine coastal-inland contrast marked by J1 and J2, and a very strong North African component was evident throughout the Middle East. Neither of these patterns were observed in the mtDNA. While J2 has penetrated into Europe, the pattern of Y-chromosome diversity in Lebanon does not show the widespread affinities with Europe indicated by the mtDNA data. Lastly, while each population shows evidence of connections with expansions that now define the Middle East, Africa, and Europe, many of the populations in the Middle East show distinctive mtDNA and Y-haplogroup characteristics that indicate long standing settlement with relatively little impact from and movement into other populations.	[Badro, Danielle A.; Douaihy, Bouchra; Haber, Marc; Youhanna, Sonia C.; Salloum, Angelique; Ghassibe-Sabbagh, Michella; Khazen, Georges; Zalloua, Pierre A.] Lebanese Amer Univ, Beirut, Lebanon; [Haber, Marc; Soria-Hernanz, David F.] Univ Pompeu Fabra, Dept Ciencies Salut & Vida, Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Johnsrud, Brian] Stanford Univ, Stanford, CA 94305 USA; [Matisoo-Smith, Elizabeth] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Soria-Hernanz, David F.; Wells, R. Spencer] Natl Geog Soc, Genog Project, Washington, DC USA; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, England; [Platt, Daniel E.] IBM TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Zalloua, Pierre A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Lebanese American University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Stanford University; University of Otago; National Geographic Society; Wellcome Trust Sanger Institute; International Business Machines (IBM); Harvard University; Harvard T.H. Chan School of Public Health	Zalloua, PA (corresponding author), Lebanese Amer Univ, Beirut, Lebanon.	pierre.zalloua@lau.edu.lb	Haber, Marc/D-2553-2012; Khazen, Georges/AAC-2923-2020; Haber, Marc/Y-5090-2019; Cooper, Alan/E-8171-2012; Santos, Fabrício Rodrigues/H-2370-2011; Haak, Wolfgang/C-2362-2014; Comas, David/D-5382-2014; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Balanovsky, Oleg/G-1549-2014; Ghassibe, Michella/A-7256-2011	Haber, Marc/0000-0003-1000-1448; Haber, Marc/0000-0003-1000-1448; Cooper, Alan/0000-0002-7738-7851; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Haak, Wolfgang/0000-0003-2475-2007; Comas, David/0000-0002-5075-0956; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; Douaihy, Bouchra/0000-0001-7600-3409; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Quintana-Murci, Lluis/0000-0003-2429-6320; Royyuru, Ajay/0000-0003-4440-4755; Khazen, Geroges/0000-0002-9244-2978; zalloua, pierre/0000-0002-8494-5081; Badro, Danielle A/0000-0003-4487-9144; youhanna, sonia/0000-0002-9376-8478; mele, marta/0000-0001-8874-6453	National Geographic Society; Waitt Family Foundation; IBM	National Geographic Society(National Geographic Society); Waitt Family Foundation; IBM(International Business Machines (IBM))	The Genographic Project is supported by funding from the National Geographic Society, IBM and the Waitt Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Alshamali F, 2009, HUM HERED, V68, P45, DOI 10.1159/000210448; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Athey T. W., 2005, J GENET GENEAL, V1, P1; Athey TW., 2006, J GENET GENEAL, V2, P34; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; BARYOSEF O, 1992, PHILOS T ROY SOC B, V337, P193, DOI 10.1098/rstb.1992.0097; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Cerny V, 2008, AM J PHYS ANTHROPOL, V136, P128, DOI 10.1002/ajpa.20784; Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028; Chiaroni J, 2008, ANTIQUITY, V82, P281, DOI 10.1017/S0003598X00096800; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; El-Sibai M, 2009, ANN HUM GENET, V73, P568, DOI 10.1111/j.1469-1809.2009.00538.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fattovich R, 1997, ENCY PRECOLONIAL AFR, P479; Ferri G, 2008, FORENSIC SCI INT, V175, P250, DOI 10.1016/j.forsciint.2007.06.007; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Gonzalez AM, 2008, ANN HUM BIOL, V35, P212, DOI 10.1080/03014460801946538; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Irwin J, 2008, INT J LEGAL MED, V122, P87, DOI 10.1007/s00414-007-0173-7; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lewis Bernard, 1990, RACE SLAVERY MIDDLE; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; NEI M, 1993, MOL BIOL EVOL, V10, P927; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2009, ANN HUM GENET, V73, P438, DOI 10.1111/j.1469-1809.2009.00526.x; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Petrejcikova E, 2011, FORENSIC SCI INT-GEN, V5, pE53, DOI 10.1016/j.fsigen.2010.08.003; Pilkington MM, 2008, MOL BIOL EVOL, V25, P517, DOI 10.1093/molbev/msm279; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REYNOLDS J, 1983, GENETICS, V105, P767; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Rowold DJ, 2007, J HUM GENET, V52, P436, DOI 10.1007/s10038-007-0132-7; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Saunier JL, 2009, FORENSIC SCI INT-GEN, V3, pE97, DOI 10.1016/j.fsigen.2008.09.004; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Segal Ronald, 2002, ISLAMS BLACK SLAVES; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; SLATKIN M, 1995, GENETICS, V139, P457; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Tchernov E., 1994, LATE QUATERNARY CHRO, P333; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	78	38	38	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54616	10.1371/journal.pone.0054616	http://dx.doi.org/10.1371/journal.pone.0054616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382925	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800057
J	Celec, P; Tretinarova, D; Minarik, G; Ficek, A; Szemes, T; Lakatosova, S; Schmidtova, E; Turna, J; Kadasi, L; Ostatnikova, D				Celec, Peter; Tretinarova, Denisa; Minarik, Gabriel; Ficek, Andrej; Szemes, Tomas; Lakatosova, Silvia; Schmidtova, Eva; Turna, Jan; Kadasi, Ludevit; Ostatnikova, Daniela			Genetic Polymorphisms Related to Testosterone Metabolism in Intellectually Gifted Boys	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; QUANTITATIVE TRAIT LOCUS; GENOME-WIDE SCAN; PROSTATE-CANCER; SEX-DIFFERENCES; CAG REPEAT; ENVIRONMENTAL-INFLUENCES; 5-YEAR-OLD CHILDREN; COGNITIVE FUNCTION; INTELLIGENCE	Prepubertal testosterone levels are lower in intellectually gifted boys. The aim of this pilot study was to analyze potential genetic factors related to testosterone metabolism in control and gifted boys. Intellectually gifted (IQ>130; n = 95) and control (n = 67) boys were genotyped. Polymorphisms of interests were chosen in genes including androgen and estrogen receptors, 5-alpha reductase, aromatase and sex hormone binding globulin. Significant differences between control and gifted boys in genotype distributions were found for ESR2 (rs928554) and SHBG (rs1799941). A significantly lower number of CAG repeats in the AR gene were found in gifted boys. Our results support the role of genetic factors related to testosterone metabolism in intellectual giftedness. Increased androgen signaling might explain previous results of lower testosterone levels in intellectually gifted boys and add to the understanding of variability in cognitive abilities.	[Celec, Peter; Minarik, Gabriel] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Celec, Peter] Comenius Univ, Inst Pathophysiol, Bratislava, Slovakia; [Celec, Peter; Tretinarova, Denisa; Minarik, Gabriel; Ficek, Andrej; Szemes, Tomas; Turna, Jan; Kadasi, Ludevit] Comenius Univ, Dept Mol Biol, Bratislava, Slovakia; [Minarik, Gabriel; Ficek, Andrej; Kadasi, Ludevit] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; [Lakatosova, Silvia; Schmidtova, Eva; Ostatnikova, Daniela] Comenius Univ, Inst Physiol, Bratislava, Slovakia	Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; Slovak Academy of Sciences	Celec, P (corresponding author), Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia.	petercelec@gmail.com	Kadasi, Ludevit/A-4677-2013; Ficek, Andrej/O-5139-2018; Minarik, Gabriel/A-3493-2013; Turňa, Ján/T-2942-2019; Celec, Peter/I-7103-2012; Ostatnikova, Daniela/AAD-1359-2019	Turňa, Ján/0000-0001-5813-566X; Celec, Peter/0000-0001-5883-3580; Szemes, Tomas/0000-0002-0900-2534; Ficek, Andrej/0000-0001-7526-2361; Ostatnikova, Daniela/0000-0002-4960-5057	Framework Programme for Research and Technology Development; Building of Centre of Excellency for Sudden Cerebral Vascular Events; Comenius University Faculty of Medicine in Bratislava [ITMS: 26240120023]; European Regional Development Fund	Framework Programme for Research and Technology Development; Building of Centre of Excellency for Sudden Cerebral Vascular Events; Comenius University Faculty of Medicine in Bratislava; European Regional Development Fund(European Commission)	This work was funded by the Framework Programme for Research and Technology Development, project: Building of Centre of Excellency for Sudden Cerebral Vascular Events, Comenius University Faculty of Medicine in Bratislava (ITMS: 26240120023), cofinanced by European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azurmendi A, 2005, HORM BEHAV, V48, P187, DOI 10.1016/j.yhbeh.2005.03.003; Azurmendi A, 2006, HORM BEHAV, V50, P132, DOI 10.1016/j.yhbeh.2006.02.004; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P3681, DOI 10.1210/jc.84.10.3681; Bartels M, 2002, BEHAV GENET, V32, P237, DOI 10.1023/A:1019772628912; Beilin J, 2000, J MOL ENDOCRINOL, V25, P85, DOI 10.1677/jme.0.0250085; BENBOW CP, 1988, BEHAV BRAIN SCI, V11, P169, DOI 10.1017/S0140525X00049244; Bouchard TJ, 1998, HUM BIOL, V70, P257; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Buyske S, 2006, BEHAV GENET, V36, P65, DOI 10.1007/s10519-005-9008-9; Celec P, 2009, J PSYCHOPHYSIOL, V23, P1, DOI 10.1027/0269-8803.23.1.1; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Dick DM, 2007, BEHAV GENET, V37, P265, DOI 10.1007/s10519-006-9131-2; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Giton F, 2006, CLIN CHEM, V52, P474, DOI 10.1373/clinchem.2005.052126; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Henningsson S, 2009, PSYCHONEUROENDOCRINO, V34, P752, DOI 10.1016/j.psyneuen.2008.12.007; IRVINE RA, 1995, CANCER RES, V55, P1937; Irwing P, 2005, BRIT J PSYCHOL, V96, P505, DOI 10.1348/000712605X53542; Kutlu N, 2001, INT J NEUROSCI, V111, P1, DOI 10.3109/00207450108986548; Luciano M, 2006, BEHAV GENET, V36, P45, DOI 10.1007/s10519-005-9003-1; Matsumoto Y, 2009, BEHAV BRAIN RES, V205, P234, DOI 10.1016/j.bbr.2009.06.034; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; Ostatnikova D, 2007, NEUROPSYCHOLOGIA, V45, P1378, DOI 10.1016/j.neuropsychologia.2006.10.018; Paus T, 2010, HORM BEHAV, V57, P63, DOI 10.1016/j.yhbeh.2009.08.004; Plomin R, 2001, BEHAV GENET, V31, P497, DOI 10.1023/A:1013385125887; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Seshadri S, 2007, BMC MED GENET, V8, P14; Thakur MK, 2007, NEUROCHEM INT, V50, P314, DOI 10.1016/j.neuint.2006.08.019; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van Leeuwen M, 2008, LEARN INDIVID DIFFER, V18, P76, DOI 10.1016/j.lindif.2007.04.006; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130	33	12	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54751	10.1371/journal.pone.0054751	http://dx.doi.org/10.1371/journal.pone.0054751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382957	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800074
J	Wen, J; Chen, ZB; Cai, XD				Wen, Ji; Chen, Zhibin; Cai, Xiaodong			A Biophysical Model for Identifying Splicing Regulatory Elements and Their Interactions	PLOS ONE			English	Article							PRE-MESSENGER-RNA; TRACT BINDING-PROTEIN; MUSCLEBLIND PROTEINS; MYOTONIC-DYSTROPHY; EXON DEFINITION; GENE-REGULATION; CIS-REGULATION; IN-VIVO; IDENTIFICATION; SPECIFICITY	Alternative splicing (AS) of precursor mRNA (pre-mRNA) is a crucial step in the expression of most eukaryotic genes. Splicing factors (SFs) play an important role in AS regulation by binding to the cis-regulatory elements on the pre-mRNA. Although many splicing factors (SFs) and their binding sites have been identified, their combinatorial regulatory effects remain to be elucidated. In this paper, we derive a biophysical model for AS regulation that integrates combinatorial signals of cis-acting splicing regulatory elements (SREs) and their interactions. We also develop a systematic framework for model inference. Applying the biophysical model to a human RNA-Seq data set, we demonstrate that our model can explain 49.1%-66.5% variance of the data, which is comparable to the best result achieved by biophysical models for transcription. In total, we identified 119 SRE pairs between different regions of cassette exons that may regulate exon or intron definition in splicing, and 77 SRE pairs from the same region that may arise from a long motif or two different SREs bound by different SFs. Particularly, putative binding sites of polypyrimidine tract-binding protein (PTB), heterogeneous nuclear ribonucleoprotein (hnRNP) F/H and E/K are identified as interacting SRE pairs, and have been shown to be consistent with the interaction models proposed in previous experimental results. These results show that our biophysical model and inference method provide a means of quantitative modeling of splicing regulation and is a useful tool for identifying SREs and their interactions. The software package for model inference is available under an open source license.	[Wen, Ji; Cai, Xiaodong] Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; [Chen, Zhibin] Univ Miami, Dept Microbiol & Immunol, Miami, FL USA	University of Miami; University of Miami	Cai, XD (corresponding author), Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA.	x.cai@miami.edu		Wen, Ji/0000-0002-3327-5591	National Science Foundation [CCF-0746882]; Division of Computing and Communication Foundations [0746882] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation under grant CCF-0746882 to XC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown JWS, 1998, ANNU REV PLANT PHYS, V49, P77, DOI 10.1146/annurev.arplant.49.1.77; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Das Debopriya, 2007, Methods Mol Biol, V377, P95; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Das D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000269; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2012, J R STAT SOC B, V74, P37, DOI 10.1111/j.1467-9868.2011.01005.x; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Friedman BA, 2008, GENOME RES, V18, P1643, DOI 10.1101/gr.080085.108; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; GORLACH M, 1994, J BIOL CHEM, V269, P23074; HASTIE T, 2009, SPRINGER SERIES STAT; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hori T, 2005, NUCLEIC ACIDS RES, V33, P190, DOI 10.1093/nar/gki153; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; Ke SD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r84; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Merritt H, 1997, PLANT J, V12, P937, DOI 10.1046/j.1365-313X.1997.12040937.x; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Peng R, 2002, RNA, V8, P1334, DOI 10.1017/S1355838202022070; Perez I, 1997, RNA, V3, P764; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Reid DC, 2009, RNA, V15, P2385, DOI 10.1261/rna.1821809; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Suyama M, 2010, NUCLEIC ACIDS RES, V38, P7916, DOI 10.1093/nar/gkq705; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HW, 2010, NUCLEIC ACIDS RES, V38, P3760, DOI 10.1093/nar/gkq028; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen J, 2010, NUCLEIC ACIDS RES, V38, P7895, DOI 10.1093/nar/gkq679; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	96	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54885	10.1371/journal.pone.0054885	http://dx.doi.org/10.1371/journal.pone.0054885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382993	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800086
J	Xia, Z; Huynh, T; Ren, PY; Zhou, RH				Xia, Zhen; Tien Huynh; Ren, Pengyu; Zhou, Ruhong			Large Domain Motions in Ago Protein Controlled by the Guide DNA-Strand Seed Region Determine the Ago-DNA-mRNA Complex Recognition Process	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; POSTTRANSCRIPTIONAL REGULATION; FORCE-FIELD; EWALD SUMS; MICRORNAS; CHARMM; ARGONAUTE; ENERGY; INTERFERENCE; MECHANISM	The recognition mechanism and cleavage activity of argonaute (Ago), miRNA, and mRNA complexes are the core processes to the small non-coding RNA world. The 59 nucleation at the 'seed' region (position 2-8) of miRNA was believed to play a significant role in guiding the recognition of target mRNAs to the given miRNA family. In this paper, we have performed allatom molecular dynamics simulations of the related and recently revealed Ago-DNA: mRNA ternary complexes to study the dynamics of the guide-target recognition and the effect of mutations by introducing "damaging" C? C mismatches at different positions in the seed region of the DNA-RNA duplex. Our simulations show that the A-form-like helix duplex gradually distorts as the number of seed mismatches increases and the complex can survive no more than two such mismatches. Severe distortions of the guide-target heteroduplex are observed in the ruinous 4-sites mismatch mutant, which give rise to a bending motion of the PAZ domain along the L1/L2 "hinge-like" connection segment, resulting in the opening of the nucleic-acid-binding channel. These long-range interactions between the seed region and PAZ domain, moderated by the L1/L2 segments, reveal the central role of the seed region in the guide-target strands recognition: it not only determines the guide-target heteroduplex's nucleation and propagation, but also regulates the dynamic motions of Ago domains around the nucleic-acid-binding channel.	[Xia, Zhen; Tien Huynh; Zhou, Ruhong] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, New York, NY 10598 USA; [Xia, Zhen; Ren, Pengyu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhou, Ruhong] Columbia Univ, Dept Chem, New York, NY 10027 USA	International Business Machines (IBM); University of Texas System; University of Texas Austin; Columbia University	Zhou, RH (corresponding author), IBM Thomas J Watson Res Ctr, Computat Biol Ctr, New York, NY 10598 USA.	ruhongz@us.ibm.com	Xia, Zhen/B-3391-2014; Ren, Pengyu/Q-6872-2017	Ren, Pengyu/0000-0002-5613-1910; Zhou, Ruhong/0000-0001-8624-5591	IBM Blue Gene Science program	IBM Blue Gene Science program(International Business Machines (IBM))	This work was supported by the IBM Blue Gene Science program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; De Guire V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq354; Denning EJ, 2011, J COMPUT CHEM, V32, P1929, DOI 10.1002/jcc.21777; Deserno M, 1998, J CHEM PHYS, V109, P7694, DOI 10.1063/1.477415; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kumar S, 2008, IBM J RES DEV, V52, P177, DOI 10.1147/rd.521.0177; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Ming D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-470; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Neria E, 1996, J CHEM PHYS, V105, P10812, DOI 10.1063/1.472889; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Priyakumar UD, 2008, J PHYS CHEM B, V112, P1515, DOI 10.1021/jp709827m; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; van der Spoel D., 2005, GROMACS USER MANUAL; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wang YH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000866; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xia Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00569; Xia Z, 2012, BIOPHYS J, V102, P1453, DOI 10.1016/j.bpj.2012.01.043; Xia Z, 2009, BIOPHYS J, V96, P1761, DOI 10.1016/j.bpj.2008.11.047; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	52	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54620	10.1371/journal.pone.0054620	http://dx.doi.org/10.1371/journal.pone.0054620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382927	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200039
J	Kock, A; O'Riain, MJ; Mauff, K; Meyer, M; Kotze, D; Griffiths, C				Kock, Alison; O'Riain, M. Justin; Mauff, Katya; Meyer, Michael; Kotze, Deon; Griffiths, Charles			Residency, Habitat Use and Sexual Segregation of White Sharks, Carcharodon carcharias in False Bay, South Africa	PLOS ONE			English	Article							FORAGING BEHAVIOR; GUADALUPE ISLAND; FARALLON-ISLANDS; PATTERNS; CONSERVATION; MIGRATION; MOVEMENTS; PREDATOR; MANAGEMENT; FISH	White sharks (Carcharodon carcharias) are threatened apex predators and identification of their critical habitats and how these are used are essential to ensuring improved local and ultimately global white shark protection. In this study we investigated habitat use by white sharks in False Bay, South Africa, using acoustic telemetry. 56 sharks (39 female, 17 male), ranging in size from 1.7-5 m TL, were tagged with acoustic transmitters and monitored on an array of 30 receivers for 975 days. To investigate the effects of season, sex and size on habitat use we used a generalized linear mixed effects model. Tagged sharks were detected in the Bay in all months and across all years, but their use of the Bay varied significantly with the season and the sex of the shark. In autumn and winter males and females aggregated around the Cape fur seal colony at Seal Island, where they fed predominantly on young of the year seals. In spring and summer there was marked sexual segregation, with females frequenting the Inshore areas and males seldom being detected. The shift from the Island in autumn and winter to the Inshore region in spring and summer by females mirrors the seasonal peak in abundance of juvenile seals and of migratory teleost and elasmobranch species respectively. This study provides the first evidence of sexual segregation at a fine spatial scale and demonstrates that sexual segregation in white sharks is not restricted to adults, but is apparent for juveniles and sub-adults too. Overall, the results confirm False Bay as a critical area for white shark conservation as both sexes, across a range of sizes, frequent the Bay on an annual basis. The finding that female sharks aggregate in the Inshore regions when recreational use peaks highlights the need for ongoing shark-human conflict mitigation strategies.	[Kock, Alison; O'Riain, M. Justin; Griffiths, Charles] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa; [Kock, Alison] Shark Spotters, Cape Town, South Africa; [Mauff, Katya] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Meyer, Michael; Kotze, Deon] Oceans & Coasts Branch, Dept Environm Affairs, Cape Town, South Africa	University of Cape Town; University of Cape Town; Department of Environment, Forestry & Fisheries	Kock, A (corresponding author), Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa.	alison@sharkspotters.org.za		O'Riain, M. Justin/0000-0001-5233-8327; Kock, Alison/0000-0001-9981-1652	National Research Foundation; National Research Foundation (South Africa); Save Our Seas Foundation	National Research Foundation; National Research Foundation (South Africa)(National Research Foundation - South Africa); Save Our Seas Foundation	Bursary funding for AAK was provided for her MSc research from the National Research Foundation and for her PhD research through a grant to CG from the National Research Foundation (South Africa) (http://www.nrf.ac.za) SEAChange Programme. The Department of Environmental Affairs provided additional research equipment and ship time. The Save Our Seas Foundation provided a grant to AAK to conduct this research. The funders had no role in study design, analysis and decision to publish. MM and DK (employees of the Department of Environmental Affairs who supplied research equipment and ship time) assisted in collection of the data and contribution of materials. Both also reviewed the manuscript before publication.	Anderson SG, 2003, LASER FOCUS WORLD, V39, P89; Andrews KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012549; ATKINS GR, 1970, T ROY SOC S AFR, V39, P139, DOI 10.1080/00359197009519109; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bozogan H., 1987, PSYCHOMETRIKA, V52, P345; Bruce B., 2008, SHARKS OPEN OCEAN BI, P69, DOI DOI 10.1002/9781444302516; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce B. D, 2005, SITE FIDELITY RESIDE; Bruce Barry D., 2012, P225; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Clark BM, 1996, MAR ECOL PROG SER, V131, P35, DOI 10.3354/meps131035; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cliff G, 2006, WWF S AFRICA REPORT; De Vos A, 2010, THESIS U CAPE TOWN S; Dicken ML, 2006, AFR J MAR SCI, V28, P603, DOI 10.2989/18142320609504210; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier Michael L., 2012, P133; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dudley Sheldon F.J., 2012, P511; Fergusson I, 2005, IUCN 2011 IUCN RED L; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2004, CRC MAR BIOL SER, P487; Hussey Nigel E., 2012, P27; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; KIME DE, 1982, COMP BIOCHEM PHYS B, V71, P675, DOI 10.1016/0305-0491(82)90480-1; KLIMLEY AP, 1992, COPEIA, P680; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Kock AA, 2012, GLOBAL PERSPECTIVES, P447; Lacroix GL, 2000, ADV FISH TELEMETRY, P37; LAMBERTH SJ, 1995, S AFR J MARINE SCI, V15, P157; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; Malcolm H., 2001, REV BIOL STATUS WHIT; McCullagh P, 1989, GEN LINEAR MODELS; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; MUSICK JA, 2000, FISHERIES, V25; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pyle P, 1996, GREAT WHITE SHARKS, P281, DOI 10.1016/B978-012415031-7/50027-6; Robbins RL, 2007, J FISH BIOL, V70, P1350, DOI 10.1111/j.1095-8649.2007.01414.x; Robbins Rachel L., 2012, P287; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Sims David W., 2005, P127; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; SPARGO PE, 1991, T ROY SOC S AFR, V47, P363; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; van Herwerden L., 1989, OCEAN SHORELINE MANA, V12, P331, DOI https://doi.org/10.1016/0951-8312(89)90067-2; Ward-Paige CA, 2012, J FISH BIOL, V80, P1844, DOI 10.1111/j.1095-8649.2012.03246.x; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016	64	89	89	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55048	10.1371/journal.pone.0055048	http://dx.doi.org/10.1371/journal.pone.0055048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383052	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500051
J	Khireddine, I; Le Ray, C; Dupont, C; Rudigoz, RC; Bouvier-Colle, MH; Deneux-Tharaux, C				Khireddine, Imane; Le Ray, Camille; Dupont, Corinne; Rudigoz, Rene-Charles; Bouvier-Colle, Marie-Helene; Deneux-Tharaux, Catherine			Induction of Labor and Risk of Postpartum Hemorrhage in Low Risk Parturients	PLOS ONE			English	Article							ELECTIVE INDUCTION; EXPECTANT MANAGEMENT; NULLIPAROUS WOMEN; OXYTOCIN; PREGNANCIES; POPULATION; GESTATION	Objective: Labor induction is an increasingly common procedure, even among women at low risk, although evidence to assess its risks remains sparse. Our objective was to assess the association between induction of labor and postpartum hemorrhage (PPH) in low-risk parturients, globally and according to its indications and methods. Method: Population-based case-control study of low-risk women who gave birth in 106 French maternity units between December 2004 and November 2006, including 4450 women with PPH, 1125 of them severe, and 1744 controls. Indications for labor induction were standard or non-standard, according to national guidelines. Induction methods were oxytocin or prostaglandins. Multilevel multivariable logistic regression modelling was used to test the independent association between induction and PPH, quantified as odds ratios. Results: After adjustment for all potential confounders, labor induction was associated with a significantly higher risk of PPH (adjusted odds ratio, AOR1.22, 95%CI 1.04-1.42). This excess risk was found for induction with both oxytocin (AOR 1.52, 95%CI 1.19-1.93 for all and 1.57, 95%CI 1.11-2.20 for severe PPH) and prostaglandins (AOR 1.21, 95%CI 0.97-1.51 for all and 1.42, 95%CI 1.04-1.94 for severe PPH). Standard indicated induction was significantly associated with PPH (AOR1.28, 95%CI 1.06-1.55) while no significant association was found for non-standard indicated inductions. Conclusion: Even in low risk women, induction of labor, regardless of the method used, is associated with a higher risk of PPH than spontaneous labor. However, there was no excess risk of PPH in women who underwent induction of labor for non-standard indications. This raises the hypothesis that the higher risk of PPH associated with labor induction may be limited to unfavorable obstetrical situations.	[Khireddine, Imane; Le Ray, Camille; Bouvier-Colle, Marie-Helene; Deneux-Tharaux, Catherine] Univ Paris 06, INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France; [Le Ray, Camille] Univ Paris 05, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Sorbonne Paris Cite, Paris, France; [Dupont, Corinne; Rudigoz, Rene-Charles] Univ Lyon 1, Aurore Perinatal Network, Hop Croix Rousse, Hosp Civils Lyon,EA 4129, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Deneux-Tharaux, C (corresponding author), Univ Paris 06, INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France.	catherine.deneux-tharaux@inserm.fr	DUPONT, Corinne/ABD-5045-2020; deneux-tharaux, catherine/R-1111-2016	deneux-tharaux, catherine/0000-0002-6561-3321; Le Ray, Camille/0000-0003-0891-1063	French Ministry of Health under its Clinical Research Hospital Program [27-35]; Caisse Nationale d'Assurance Maladie (CNAMTS); l'Institut de Recherche en Sante Publique (IRESP)	French Ministry of Health under its Clinical Research Hospital Program; Caisse Nationale d'Assurance Maladie (CNAMTS); l'Institut de Recherche en Sante Publique (IRESP)	The project was funded by the French Ministry of Health under its Clinical Research Hospital Program (contract no.27-35) and the Caisse Nationale d'Assurance Maladie (CNAMTS). IK was supported by a grant from l'Institut de Recherche en Sante Publique (IRESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Al-Zirqi I, 2009, AM J OBSTET GYNECOL, V201; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Bouvier-Colle MH, 2011, J GYNECOL OBST BIO R, V40, P87, DOI 10.1016/j.jgyn.2010.12.007; Caughey AB, 2009, ANN INTERN MED, V151, P252, DOI 10.7326/0003-4819-151-4-200908180-00007; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Deneux-Tharaux C, 2010, BJOG-INT J OBSTET GY, V117, P1278, DOI 10.1111/j.1471-0528.2010.02648.x; Dunne C, 2009, J OBSTET GYNAECOL CA, V31, P1124, DOI 10.1016/S1701-2163(16)34372-9; Gelisen O, 2005, EUR J OBSTET GYN R B, V120, P164, DOI 10.1016/j.ejogrb.2004.08.013; Goffinet F, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P638; Goldman JB, 1999, OBSTET GYNECOL, V93, P271, DOI 10.1016/S0029-7844(98)00359-7; Grotegut CA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.023; Guerra GV, 2011, B WORLD HEALTH ORGAN, V89, P657, DOI 10.2471/BLT.08.061226; Haute Autorite de Sante, 2008, DECL ART TRAV PART 3; Hussain AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S5; Kelly AJ, 2003, COCHRANE DB SYST REV, V2003; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Le Ray C, 2007, ACTA OBSTET GYN SCAN, V86, P657, DOI 10.1080/00016340701245427; Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26; Magalhaes JKRS, 2009, REPROD SCI, V16, P501, DOI 10.1177/1933719108329954; Mamelle N, 2004, Gynecol Obstet Fertil, V32 Spec No 1, P4; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; National Institute for Health and Clinical Excellence, 2008, IND LAB, V2nd; Nicholson JM, 2004, AM J OBSTET GYNECOL, V191, P1516, DOI 10.1016/j.ajog.2004.07.002; Osmundson S, 2011, OBSTET GYNECOL, V117, P583, DOI 10.1097/AOG.0b013e31820caf12; Osmundson SS, 2010, OBSTET GYNECOL, V116, P601, DOI 10.1097/AOG.0b013e3181eb6e9b; Robinson C, 2003, AM J OBSTET GYNECOL, V188, P497, DOI 10.1067/mob.2003.22; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; Zhang J, 2002, J REPROD MED, V47, P120; Zimbeck M, 2009, EUR J OBSTET GYN R B, V146, P149, DOI 10.1016/j.ejogrb.2009.07.017	33	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54858	10.1371/journal.pone.0054858	http://dx.doi.org/10.1371/journal.pone.0054858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23382990	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400036
J	Timoneda, O; Balcells, I; Nunez, JI; Egea, R; Vera, G; Castello, A; Tomas, A; Sanchez, A				Timoneda, Oriol; Balcells, Ingrid; Ignacio Nunez, Jose; Egea, Raquel; Vera, Gonzalo; Castello, Anna; Tomas, Anna; Sanchez, Armand			miRNA Expression Profile Analysis in Kidney of Different Porcine Breeds	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; PHYLOGENETIC-RELATIONSHIPS; PIG DOMESTICATION; WEB SERVER; MICRORNA; DNA; IDENTIFICATION; TARGETS; CANCER; GENES	microRNAs (miRNAs) are important post-transcriptional regulators in eukaryotes that target mRNAs repressing their expression. The uncertain process of pig domestication, with different origin focuses, and the selection process that commercial breeds suffered, have generated a wide spectrum of breeds with clear genetic and phenotypic variability. The aim of this work was to define the miRNAs expression profile in kidney of several porcine breeds. Small RNA libraries from kidney were elaborated and high-throughput sequenced with the 454 Genome Sequencer FLX (Roche). Pigs used were classified into three groups: the European origin group (Iberian breed and European Wild Boar ancestor), European commercial breeds (Landrace, Large White and Pietrain breeds) and breeds with Asian origin (Meishan and Vietnamese breeds). A total of 229 miRNAs were described in the pig kidney miRNA profile, including 110 miRNAs out of the 257 previously described pig miRNAs and 119 orthologous miRNAs. The most expressed miRNAs in pig kidney microRNAome were Hsa-miR-200b-3p, Ssc-miR-125b and Ssc-miR-23b. Moreover, 5 novel porcine miRNAs and 3 orthologous miRNAs could be validated through RT-qPCR. miRNA sequence variation was determined in 116 miRNAs, evidencing the presence of isomiRs. 125 miRNAs were differentially expressed between breed groups. The identification of breed-specific miRNAs, which could be potentially associated to certain phenotypes, is becoming a new tool for the study of the genetic variability underlying complex traits and furthermore, it adds a new layer of complexity to the interesting process of pig evolution.	[Timoneda, Oriol; Balcells, Ingrid; Egea, Raquel; Vera, Gonzalo; Castello, Anna; Sanchez, Armand] Univ Autonoma Barcelona, Ctr Recerca AgriGenom CRAG, Dept Genet Anim, Bellaterra, Spain; [Ignacio Nunez, Jose] UAB, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Spain; [Tomas, Anna] FISIB, Program Infect & Immun, Bunyola, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Autonomous University of Barcelona; IRTA	Timoneda, O (corresponding author), Univ Autonoma Barcelona, Ctr Recerca AgriGenom CRAG, Dept Genet Anim, Campus UAB, Bellaterra, Spain.	oriol.timoneda@cragenomica.es	Vera, Gonzalo/L-1895-2014; Egea, Raquel/F-9355-2016; Nuñez, Jose I/M-7141-2018; Farré, Anna Castelló/K-9637-2015; Sanchez, Armand/L-7905-2015	Vera, Gonzalo/0000-0001-6990-0216; Egea, Raquel/0000-0002-6201-4112; Nuñez, Jose I/0000-0001-9890-7695; Farré, Anna Castelló/0000-0001-8497-6251; Sanchez, Armand/0000-0001-9160-1124	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion [CSD2007-00036]; FPI PhD fellowship from Spanish Government;  [AGL2007-66371-C02-01];  [AGL2010-22358-C02-01]	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion; FPI PhD fellowship from Spanish Government; ; 	This work was supported by the projects AGL2007-66371-C02-01 and AGL2010-22358-C02-01 and by the Consolider-Ingenio 2010 program (CSD2007-00036) from Ministerio de Ciencia e Innovacion. OT is recipient of FPI PhD fellowship from Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2003, ANIM GENET, V34, P319, DOI 10.1046/j.1365-2052.2003.01010.x; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bockmeyer CL, 2011, BREAST CANC RES TREA; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Clop A, 2004, GENET SEL EVOL, V36, P97, DOI 10.1051/gse:2003053; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Gao Y, 2011, GENET MOL RES, V10, P779, DOI 10.4238/vol10-2gmr1170; Giuffra E, 2000, GENETICS, V154, P1785; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HY, 2012, ANIMAL GENETICS; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Li S, 2011, DNA CELL BIOL, V30, P1073, DOI 10.1089/dna.2011.1267; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lian C, 2012, FEBS J; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ojeda A, 2011, HEREDITY, V106, P330, DOI 10.1038/hdy.2010.61; Patel N, 2011, J NUCL ACIDS INVESTI, V2, pe1; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Tang XQ, 2011, METHODS MOL BIOL, V732, P69, DOI 10.1007/978-1-61779-083-6_6; Tarver JE, 2012, BIOESSAYS, V34, P857, DOI 10.1002/bies.201200055; Taub MA, 2010, GENOME MED, V2, DOI 10.1186/gm208; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou Y, 2012, REPROD DOMESTIC ANIM; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	81	24	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55402	10.1371/journal.pone.0055402	http://dx.doi.org/10.1371/journal.pone.0055402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372853	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400093
J	Sun, XX; Ai, MD; Wang, Y; Shen, SS; Gu, Y; Jin, Y; Zhou, ZY; Long, YQ; Yu, Q				Sun, Xiaoxiao; Ai, Midan; Wang, Ying; Shen, Shensi; Gu, Yuan; Jin, Yi; Zhou, Zuyu; Long, Yaqiu; Yu, Qiang			Selective Induction of Tumor Cell Apoptosis by a Novel P450-mediated Reactive Oxygen Species (ROS) Inducer Methyl 3-(4-Nitrophenyl) Propiolate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PHENETHYL ISOTHIOCYANATE; OXIDATIVE STRESS; REDOX REGULATION; CANCER; GENERATION; P53; METABOLISM; CYTOTOXICITY; ACTIVATION	Induction of tumor cell apoptosis has been recognized as a valid anticancer strategy. However, therapeutic selectivity between tumor and normal cells has always been a challenge. Here, we report a novel anti-cancer compound methyl 3-(4-nitrophenyl) propiolate (NPP) preferentially induces apoptosis in tumor cells through P450-catalyzed reactive oxygen species (ROS) production. A compound sensitivity study on multiple cell lines shows that tumor cells with high basal ROS levels, low antioxidant capacities, and p53 mutations are especially sensitive to NPP. Knockdown of p53 sensitized non-transformed cells to NPP-induced cell death. Additionally, by comparing NPP with other ROS inducers, we show that the susceptibility of tumor cells to the ROS-induced cell death is influenced by the mode, amount, duration, and perhaps location of ROS production. Our studies not only discovered a unique anticancer drug candidate but also shed new light on the understanding of ROS generation and function and the potential application of a ROS-promoting strategy in cancer treatment.	[Sun, Xiaoxiao; Ai, Midan; Wang, Ying; Shen, Shensi; Gu, Yuan; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 201203, Peoples R China; [Jin, Yi; Zhou, Zuyu; Long, Yaqiu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Yu, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, 555 Zhchongzhi Rd, Shanghai 201203, Peoples R China.	qyu@sibs.ac.cn	Sun, Xiaoxiao/AAR-9563-2021; SHEN, Shensi/AAW-2735-2020	Sun, Xiaoxiao/0000-0002-9689-9385; SHEN, Shensi/0000-0002-5087-8220; Gu, Yuan/0000-0003-1401-6233	China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program [2013ZX09102015]; China Ministry of Science and Technology Research [2013ZX10002010-009]; China National Natural Science Foundation [31129004, 91129701, 91213304]; National Science and Technology 973 Grants [2012CB910704, 2013CB910900]	China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program; China Ministry of Science and Technology Research(Ministry of Science and Technology, China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology 973 Grants	This work was supported by China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program Grant 2013ZX09102015; by China Ministry of Science and Technology Research Grant 2013ZX10002010-009; by China National Natural Science Foundation Grants 31129004, 91129701, and 91213304; and by National Science and Technology 973 Grants 2012CB910704 and 2013CB910900.	Agostinelli E, 2006, AMINO ACIDS, V31, P341, DOI 10.1007/s00726-005-0271-8; Bhana S, 2008, MUTAGENESIS, V23, P43, DOI 10.1093/mutage/gem041; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Cai L, 2003, CELL RES, V13, P93, DOI 10.1038/sj.cr.7290154; Celik H, 2008, J PHARM PHARM SCI, V11, P68; Cerna D, 2012, J BIOL CHEM, V287, P22408, DOI 10.1074/jbc.M112.357301; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Constan AA, 1999, TOXICOL APPL PHARM, V160, P120, DOI 10.1006/taap.1999.8756; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Fischer U, 2005, CELL DEATH DIFFER, V12, P942, DOI 10.1038/sj.cdd.4401556; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Hodson PV, 2007, AQUAT TOXICOL, V81, P275, DOI 10.1016/j.aquatox.2006.12.012; Hsieh JL, 2003, CLIN CANCER RES, V9, P338; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Joseph P, 1998, BRIT J CANCER, V77, P709, DOI 10.1038/bjc.1998.117; Kamdem LK, 2010, BRIT J CLIN PHARMACO, V70, P854, DOI 10.1111/j.1365-2125.2010.03791.x; Khan D, 2008, CHEM-BIOL INTERACT, V175, P231, DOI 10.1016/j.cbi.2008.05.024; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mao L, 2009, MOL CELL BIOL, V29, P5426, DOI 10.1128/MCB.00105-09; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; Omiecinski CJ, 1999, TOXICOL SCI, V48, P151, DOI 10.1093/toxsci/48.2.151; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Park JY, 2003, ANTIMICROB AGENTS CH, V47, P3464, DOI 10.1128/AAC.47.11.3464-3469.2003; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; ROBERTSON IGC, 1993, BIOCHEM PHARMACOL, V45, P2159, DOI 10.1016/0006-2952(93)90031-Q; Seliskar M, 2007, BBA-GEN SUBJECTS, V1770, P458, DOI 10.1016/j.bbagen.2006.09.016; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Xu K, 2001, BIOCHEM PHARMACOL, V61, P165, DOI 10.1016/S0006-2952(00)00526-8	51	38	40	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8826	8837		10.1074/jbc.M112.429316	http://dx.doi.org/10.1074/jbc.M112.429316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23382387	Green Published, hybrid			2022-12-25	WOS:000316862200005
J	Gong, P; Wang, YX; Liu, GV; Zhang, J; Wang, ZY				Gong, Peng; Wang, Yingxin; Liu, Gavin; Zhang, Jing; Wang, Zhongyu			New Insight into Ki67 Expression at the Invasive Front in Breast Cancer	PLOS ONE			English	Article							PHASE-II; KI-67	Purpose: To investigate the distribution of Ki67+ cells in breast cancer in relation to clinical-pathological parameters and prognosis. Materials and Methods: Ki67 expression status was detected in 1,086 breast cancer specimens using immunohistochemistry staining and examining the relationship between the Ki67+ cells' location. Subsequently, clinical-pathological parameters and prognosis were determined. Results: In total, Ki67 protein expression was found in 781 (71.92%) of the 1,086 breast cancer specimens. Among the 781 Ki67+ cases, 461 were defined as diffuse type and 320 were defined as borderline type. After universal correlation analysis, significant differences were observed in age, histological grade, metastatic nodes, postoperative distant metastasis, and molecular subtype between Ki67+ and Ki67- cases (P = 0.01, 0.001, 0.001, 0.001, and 0.001, respectively). After subgroup analysis, the borderline cases were found to be characterized by a high distant metastasis rate compared to the diffuse cases as well as the Ki67- cases (P = 0.001). No differences were observed between diffuse type or Ki67- cases (P = 0.105). Multivariate analysis showed that age, tumor size, histological grade, lymph node metastasis, molecular subtype, and the Ki67 distribution pattern were observed to be related to postoperative distant metastasis (all P<0.05). Furthermore, borderline type was shown to attain a significantly more distant bone and liver metastasis and worse disease-specific survival than the other types (P = 0.001). In the Cox regression test, the Ki67 distribution pattern was detected as an independent prognostic factor (P = 0.001). Conclusion: The distribution pattern of Ki67 may be a new independent prognostic factor for breast cancer.	[Gong, Peng; Wang, Yingxin; Liu, Gavin; Zhang, Jing; Wang, Zhongyu] Dalian Med Univ, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China	Dalian Medical University	Gong, P (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China.	gongpengdalian@163.com		WANG, YINGXIN/0000-0001-9032-9990	China National Natural Science Foundation [81102029, 81172047]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was funded by the China National Natural Science Foundation (No. 81102029 and 81172047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonanni B, 2012, J CLIN ONCOL, V30, P2593, DOI 10.1200/JCO.2011.39.3769; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Campana LG, 2012, BREAST CANCER RES TR, V134, P1169, DOI 10.1007/s10549-012-2095-4; Delpech Y, 2012, BREAST CANCER RES TR, V135, P619, DOI 10.1007/s10549-012-2194-2; Dilaveri CA, 2012, INT J WOMENS HEALTH, V4, P35, DOI 10.2147/IJWH.S27624; Dowling EC, 2010, J MED SCREEN, V17, P139, DOI 10.1258/jms.2010.010033; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Fredslund SO, 2012, INT J CIRCUMPOL HEAL, V71, P1; Koo DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039880; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; Sanchez-Rovira P, 2012, CLIN TRANSL ONCOL, V14, P430, DOI 10.1007/s12094-012-0820-4; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sinicropi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040092; Strehl JD, 2011, BREAST CARE, V6, P258, DOI 10.1159/000331339; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Wang L, 2011, ANN SURG ONCOL, V18, P1553, DOI 10.1245/s10434-010-1519-9; Wojnar A, 2011, ANTICANCER RES, V31, P3027; Wu QJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042607	18	24	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54912	10.1371/journal.pone.0054912	http://dx.doi.org/10.1371/journal.pone.0054912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382998	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600050
J	Wang, XJ; Zielinski, MC; Misawa, R; Wen, P; Wang, TY; Wang, CZ; Witkowski, P; Hara, M				Wang, Xiaojun; Zielinski, Mark C.; Misawa, Ryosuke; Wen, Patrick; Wang, Tian-Yuan; Wang, Cheng-Zhang; Witkowski, Piotr; Hara, Manami			Quantitative Analysis of Pancreatic Polypeptide Cell Distribution in the Human Pancreas	PLOS ONE			English	Article							ISLET ARCHITECTURE; GHRELIN; QUANTIFICATION; GALLBLADDER; SURVIVAL; CANCER; RICH	The pancreatic islet is mainly composed of beta-, alpha- and delta-cells with small numbers of pancreatic polypeptide (PP) and epsilon cells. It is known that there is a region in the head of the pancreas that is rich in PP-cells. In the present study, we examined the distribution of PP-cells, and assessed the influence of the PP-cell rich region to quantify the total islet mass. Pancreatic tissues were collected from donors with no history of diabetes or pancreatic diseases (n = 12). A stereological approach with a computer-assisted large-scale analysis of whole pancreatic sections was applied to quantify the entire distribution of endocrine cells within a given section. The initial whole pancreas analysis showed that a PP-cell rich region was largely restricted to the uncinate process with a clear boundary. The distinct distribution of PP-cells includes irregularly shaped clusters composed solely of PP-cells. Furthermore, in the PP-cell rich region, beta- and alpha- cell mass is significantly reduced compared to surrounding PP-cell poor regions. The results suggest that the analysis of the head region should distinguish the PP-cell rich region, which is best examined separately. This study presents an important implication for the regional selection and interpretation of the results.	[Wang, Xiaojun; Misawa, Ryosuke; Witkowski, Piotr] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Wang, Xiaojun] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China; [Zielinski, Mark C.; Wen, Patrick; Wang, Tian-Yuan; Wang, Cheng-Zhang; Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; Army Medical University; University of Chicago	Hara, M (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@uchicago.edu	Hara, Masayuki/AAH-4361-2019; Wen, Patrick/AAE-3776-2022	Zielinski, Mark/0000-0002-6950-6689	US Public Health Service Grant [DK-081527, DK-042086, DK-20595, DK-072473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081527, P60DK020595, P30DK042086, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	US Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study is supported by US Public Health Service Grant DK-081527, DK-042086 and DK-20595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, and a gift from the Kovler Family Foundation (M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN TE, 1982, AM J PHYSIOL, V243, pG204, DOI 10.1152/ajpgi.1982.243.3.G204; Andralojc KM, 2009, DIABETOLOGIA, V52, P486, DOI 10.1007/s00125-008-1238-y; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Bouvier AM, 2010, PANCREAS, V39, P1243, DOI 10.1097/MPA.0b013e3181e1d5b3; Chandra J, 2012, CLIN RADIOL; Cui YF, 2012, ENDOCR-RELAT CANCER, V19, pF9, DOI 10.1530/ERC-12-0105; Floyd J C Jr, 1976, Recent Prog Horm Res, V33, P519; GEPTS W, 1977, DIABETOLOGIA, V13, P27, DOI 10.1007/BF00996324; GERSELL DJ, 1979, DIABETES, V28, P11, DOI 10.2337/diabetes.28.1.11; GREENBERG GR, 1978, LANCET, V2, P1280; Hasselby JP, 2012, APMIS, V120, P157, DOI 10.1111/j.1600-0463.2011.02831.x; HAZELWOOD RL, 1993, P SOC EXP BIOL MED, V202, P44; HEITZ P, 1976, VIRCHOWS ARCH B, V21, P259; Jacobsson H, 2012, CLIN NUCL MED, V37, P362, DOI 10.1097/RLU.0b013e3182485110; Kahleova H, 2012, J DIABETES COMPLICAT, V26, P442, DOI 10.1016/j.jdiacomp.2012.05.003; Kilimnik G, 2012, ISLETS, V4, P167, DOI 10.4161/isl.19256; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim A, 2011, JOVE-J VIS EXP, DOI 10.3791/2471; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; LIN TM, 1977, AM J PHYSIOL, V232, pE311, DOI 10.1152/ajpendo.1977.232.3.E311; MALAISSELAGAE F, 1979, DIABETOLOGIA, V17, P361, DOI 10.1007/BF01236270; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Nathan H, 2009, J SURG ONCOL, V99, P87, DOI 10.1002/jso.21189; ORCI L, 1978, LANCET, V2, P1200; RAHIER J, 1983, J CLIN ENDOCR METAB, V56, P441, DOI 10.1210/jcem-56-3-441; Sata N, 2009, J HEPATO-BILIARY-PAN, V16, P485, DOI 10.1007/s00534-009-0077-7; SCHWARTZ TW, 1979, SCAND J GASTROENTERO, V14, P93; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Ueberberg B, 2009, HORM METAB RES, V41, P814, DOI 10.1055/s-0029-1233462; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vignjevic S, 2012, CELLS TISSUES ORGANS, V196, P362, DOI 10.1159/000335469; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8	36	44	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55501	10.1371/journal.pone.0055501	http://dx.doi.org/10.1371/journal.pone.0055501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383206	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600113
J	Zhou, YF; Liao, SS; Luo, YY; Tang, JG; Wang, JL; Lei, LF; Chi, JW; Du, J; Jiang, H; Xia, K; Tang, BS; Shen, L				Zhou, Ya-Fang; Liao, Shu-Sheng; Luo, Ying-Ying; Tang, Jian-Guang; Wang, Jun-Ling; Lei, Li-Fang; Chi, Jing-Wei; Du, Juan; Jiang, Hong; Xia, Kun; Tang, Bei-Sha; Shen, Lu			SUMO-1 Modification on K166 of PolyQ-Expanded aTaxin-3 Strengthens Its Stability and Increases Its Cytotoxicity	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; COVALENT MODIFICATION; ANDROGEN RECEPTOR; MUTANT-HUNTINGTIN; PROTEIN; AGGREGATION; SUMOYLATION; RANGAP1; GENE; HETEROGENEITY	Post-translational modification by SUMO was proposed to modulate the pathogenesis of several neurodegenerative diseases. Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is an autosomal dominant neurodegenerative disease caused by polyQ-expanded ataxin-3. We have previously shown that ataxin-3 was a new target of SUMOylation in vitro and in vivo. Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis. Our findings revealed the role of ataxin-3 SUMOylation in SCA3/MJD pathogenesis.	[Zhou, Ya-Fang; Liao, Shu-Sheng; Luo, Ying-Ying; Wang, Jun-Ling; Lei, Li-Fang; Du, Juan; Jiang, Hong; Tang, Bei-Sha; Shen, Lu] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Jian-Guang] Cent S Univ, Xiangya Hosp 2, Dept Neurol, Changsha, Hunan, Peoples R China; [Chi, Jing-Wei; Jiang, Hong; Xia, Kun; Tang, Bei-Sha] Cent S Univ, Natl Lab Med Genet China, Changsha, Hunan, Peoples R China; [Tang, Bei-Sha; Shen, Lu] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Shen, L (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	shenlu2505@yahoo.com.cn	XIA, KUN/AAO-3525-2020		National Natural Sciences Foundation of China [30470619, 30971034, 81000543]; Distinguished Youth Foundation of Hunan Province [2007JJ1005]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Youth Foundation of Hunan Province	This work was supported by the National Natural Sciences Foundation of China (No: 30470619, 30971034, 81000543), Distinguished Youth Foundation of Hunan Province (No: 2007JJ1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Breuer P, 2010, J BIOL CHEM, V285, P6532, DOI 10.1074/jbc.M109.036335; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CANCEL G, 1995, AM J HUM GENET, V57, P809; Cecchin CR, 2007, COMMUNITY GENET, V10, P19, DOI 10.1159/000096276; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 2005, MOL BIOL CELL, V16, P5115, DOI 10.1091/mbc.E05-06-0536; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hughes RE, 2002, CURR BIOL, V12, pR141, DOI 10.1016/S0960-9822(02)00709-1; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pennuto M, 2009, HUM MOL GENET, V18, pR40, DOI 10.1093/hmg/ddn412; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen Lu, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P242; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; Tang JG, 2006, PROG BIOCHEM BIOPHYS, V33, P1037	42	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54214	10.1371/journal.pone.0054214	http://dx.doi.org/10.1371/journal.pone.0054214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382880	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600025
J	Grainger, S; Hryniuk, A; Lohnes, D				Grainger, Stephanie; Hryniuk, Alexa; Lohnes, David			Cdx1 and Cdx2 Exhibit Transcriptional Specificity in the Intestine	PLOS ONE			English	Article							HOMEOBOX GENE CDX1; DIFFERENTIAL REGULATION; GASTROINTESTINAL-TRACT; EMBRYONIC INTESTINE; EPITHELIAL-CELLS; PROTEINS CDX1; MOUSE EMBRYO; COLON-CANCER; MUTANT MICE; HOX GENES	The caudal-related homeodomain transcription factors Cdx1 and Cdx2 are expressed in the developing endoderm with expression persisting into adulthood. Cdx1(-)/(-) mutants are viable and fertile and display no overt intestinal phenotype. Cdx2 null mutants are peri-implantation lethal; however, conditional mutation approaches have revealed that Cdx2 is required for patterning the intestinal epithelium and specification of the colon. Cdx2 is also necessary for homeostasis of the intestinal tract in the adult, where Cdx1 and Cdx2 appear to functionally overlap in the distal colon, but not during intestinal development. Cdx1 and Cdx2 exhibit complete overlap of expression in the intestine, although they differ in their relative levels, with Cdx1 maximal in the distal colon and Cdx2 peaking in the proximal cecum. Moreover, Cdx1 protein is graded along the crypt-villus axis, being abundant in the crypts and diminishing towards the villi. Cdx2 is expressed uniformly along this axis, but is differentially phosphorylated; the functional relevance of these expression domains and phosphorylation is currently unknown. Cdx1 and Cdx2 have been suggested to exhibit functional specificity in the intestinal tract. In the present study, using cell-based models, we found that relative to Cdx1, Cdx2 was significantly less potent at effecting a transcriptional response from the Cdx1 promoter, a known Cdx target gene. We subsequently assessed this relationship in vivo using a "gene swap'' approach and found that Cdx2 cannot substitute for Cdx1 in this autoregulatory loop. This is in marked contrast with the ability of Cdx2 to support Cdx1 expression and function in paraxial mesoderm and vertebral patterning, thus providing novel in vivo evidence of context-dependent transcriptional specificity between these transcription factors.	[Grainger, Stephanie; Hryniuk, Alexa; Lohnes, David] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa	Lohnes, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	dlohnes@uottawa.ca	Grainger, Stephanie/AAT-4518-2020	Grainger, Stephanie/0000-0001-6889-7174; , Alexa/0000-0002-6778-2006	Canadian Institutes of Health Research [MOP14412]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP14412 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhoury F, 2005, AM J PHYSIOL-GASTR L, V289, pG285, DOI 10.1152/ajpgi.00037.2005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Beland M, 2004, MOL CELL BIOL, V24, P5028, DOI 10.1128/MCB.24.11.5028-5038.2004; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Bonhomme C, 2008, ONCOGENE, V27, P4497, DOI 10.1038/onc.2008.78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; CULLING CFA, 1975, J CLIN PATHOL, V28, P656, DOI 10.1136/jcp.28.8.656; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gaunt SJ, 2008, DEVELOPMENT, V135, P2511, DOI 10.1242/dev.015909; Gautier-Stein A, 2003, NUCLEIC ACIDS RES, V31, P5238, DOI 10.1093/nar/gkg747; Grainger S, 2012, DEV BIOL, V361, P1, DOI 10.1016/j.ydbio.2011.09.034; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Grainger S, 2009, DEV BIOL, V331, P528, DOI 10.1016/j.ydbio.2009.05.526; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; JAMES R, 1991, J BIOL CHEM, V266, P3246; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kakizaki F, 2010, GASTROENTEROLOGY, V138, P627, DOI 10.1053/j.gastro.2009.10.047; Koslowski M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-77; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lee YJ, 1999, J BIOL CHEM, V274, P1566, DOI 10.1074/jbc.274.3.1566; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lynch JP, 2008, NEOPLASIA, V10, P8, DOI 10.1593/neo.07703; Ma L, 2012, AM J PHYSIOL-GASTR L, V302, pG123, DOI 10.1152/ajpgi.00102.2011; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Munoz J, 2012, EMBO J; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Santagati F, 2005, DEVELOPMENT, V132, P4927, DOI 10.1242/dev.02078; SAVORY JGA, 2011, DEVELOPMENT; Savory JGA, 2011, DEVELOPMENT, V138, P1361, DOI 10.1242/dev.056622; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Subramanian V, 1998, DIFFERENTIATION, V64, P11, DOI 10.1046/j.1432-0436.1998.6410011.x; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Taylor JK, 1997, NUCLEIC ACIDS RES, V25, P2293, DOI 10.1093/nar/25.12.2293; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Verzi MP, 2011, MOL CELL BIOL; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010	56	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54757	10.1371/journal.pone.0054757	http://dx.doi.org/10.1371/journal.pone.0054757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382958	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800075
J	Klein, E; Moeller, K; Glauche, V; Weiller, C; Willmes, K				Klein, Elise; Moeller, Korbinian; Glauche, Volkmar; Weiller, Cornelius; Willmes, Klaus			Processing Pathways in Mental Arithmetic-Evidence from Probabilistic Fiber Tracking	PLOS ONE			English	Article							MULTI-DIGIT ADDITION; WORKING-MEMORY; STRUCTURAL CONNECTIVITY; NUMBER REPRESENTATION; INTRAPARIETAL SULCUS; SYMBOL MANIPULATION; LANGUAGE PATHWAYS; BRAIN ACTIVATION; PARIETAL CORTEX; ANGULAR GYRUS	Numerical cognition is a case of multi-modular and distributed cerebral processing. So far neither the anatomo-functional connections between the cortex areas involved nor their integration into established frameworks such as the differentiation between dorsal and ventral processing streams have been specified. The current study addressed this issue combining a re-analysis of previously published fMRI data with probabilistic fiber tracking data from an independent sample. We aimed at differentiating neural correlates and connectivity for relatively easy and more difficult addition problems in healthy adults and their association with either rather verbally mediated fact retrieval or magnitude manipulations, respectively. The present data suggest that magnitude-and fact retrieval-related processing seem to be subserved by two largely separate networks, both of them comprising dorsal and ventral connections. Importantly, these networks not only differ in localization of activation but also in the connections between the cortical areas involved. However, it has to be noted that even though seemingly distinct anatomically, these networks operate as a functionally integrated circuit for mental calculation as revealed by a parametric analysis of brain activation.	[Klein, Elise; Willmes, Klaus] Rhein Westfal TH Aachen, Univ Hosp, Sect Neuropsychol, Dept Neurol, Aachen, Germany; [Klein, Elise; Willmes, Klaus] Univ Hosp RWTH Aachen, Interdisciplinary Ctr Clin Res, Neurofunct Imaging Lab, Aachen, Germany; [Klein, Elise; Moeller, Korbinian] IWM KMRC, Knowledge Media Res Ctr, Tubingen, Germany; [Glauche, Volkmar; Weiller, Cornelius] Univ Med Ctr Freiburg, Dept Neurol, Freiburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien; University of Freiburg	Klein, E (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Sect Neuropsychol, Dept Neurol, Aachen, Germany.	e.klein@iwm-kmrc.de	Moeller, Korbinian/AAC-6387-2020; Willmes, Klaus F/A-1268-2014	Willmes, Klaus F/0000-0002-9012-0553				Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P302, DOI 10.1080/14640746608400047; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brysbaert M, 1998, COGNITION, V66, P51, DOI 10.1016/S0010-0277(98)00006-7; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Chassy P, 2011, CEREB CORTEX, DOI 101093/cercor/bhr219; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Delazer Margarete, 2004, Cortex, V40, P166, DOI 10.1016/S0010-9452(08)70936-5; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Imbo I, 2007, PSYCHOL RES-PSYCH FO, V71, P467, DOI 10.1007/s00426-006-0044-8; Imbo I, 2007, Q J EXP PSYCHOL, V60, P708, DOI 10.1080/17470210600762447; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Ischebeck A, 2006, NEUROIMAGE, V30, P1365, DOI 10.1016/j.neuroimage.2005.11.016; Kazui H, 2000, PSYCHIAT CLIN NEUROS, V54, P479, DOI 10.1046/j.1440-1819.2000.00739.x; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-70; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-42; Klein E, 2010, ACTA PSYCHOL, V135, P67, DOI 10.1016/j.actpsy.2010.06.002; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Krueger F, 2011, HUM BRAIN MAPP, V32, P1419, DOI 10.1002/hbm.21119; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Menon V, 2000, COGNITIVE BRAIN RES, V9, P343, DOI 10.1016/S0926-6410(00)00010-0; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MILNER AD, 1996, VISUAL BRAIN ACTION; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Montojo CA, 2008, NEURON, V59, P173, DOI 10.1016/j.neuron.2008.05.012; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Noel MP, 1998, PSYCHOL BELG, V38, P231; Oishi K, 2011, MRI ATLAS HUMAN WHIT, VSecond; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Parsons S., 2005, DOES NUMERACY MATTER; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Qin YL, 2004, P NATL ACAD SCI USA, V101, P5686, DOI 10.1073/pnas.0401227101; Ratinckx E, 2002, NEUROPSYCHOLOGY, V16, P217, DOI 10.1037//0894-4105.16.2.217; Ratinckx E, 2001, THESIS U GHENT; Ratinckx E, 2006, CORTEX, V42, P1128, DOI 10.1016/S0010-9452(08)70225-9; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rusconi E, 2007, COGNITIVE ASPECTS OF BILINGUALISM, P153, DOI 10.1007/978-1-4020-5935-3_5; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Venkatraman V, 2006, J COGNITIVE NEUROSCI, V18, P64, DOI 10.1162/089892906775250030; Weiller C, 2011, BRAIN LANG, V118, P29, DOI 10.1016/j.bandl.2011.01.005; Weis S, 2011, HUM BRAIN MAPP, V32, P1544, DOI 10.1002/hbm.21126; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Whalen J, 2002, COGN NEUROPSYCHOL, V19, P505, DOI 10.1080/02643290244000086; Willmes Klaus, 2008, Handb Clin Neurol, V88, P339, DOI 10.1016/S0072-9752(07)88017-1; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95; Wood G, 2008, BRAIN RES, V1187, P154, DOI 10.1016/j.brainres.2007.09.094; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; Zaunmuller L, 2009, NEUROPSYCHOL REHABIL, V19, P422, DOI 10.1080/09602010802296378	89	78	79	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55455	10.1371/journal.pone.0055455	http://dx.doi.org/10.1371/journal.pone.0055455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383194	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800158
J	Kota, KP; Eaton, B; Lane, D; Ulrich, M; Ulrich, R; Peyser, BD; Robinson, CG; Jaissle, JG; Pegoraro, G; Bavari, S; Panchal, RG				Kota, Krishna P.; Eaton, Brett; Lane, Douglas; Ulrich, Melanie; Ulrich, Ricky; Peyser, Brian D.; Robinson, Camenzind G.; Jaissle, James G.; Pegoraro, Gianluca; Bavari, Sina; Panchal, Rekha G.			Integrating High-Content Imaging and Chemical Genetics to Probe Host Cellular Pathways Critical for Yersinia Pestis Infection	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; PNEUMONIC PLAGUE; MACROPHAGES; INVASION; MICE; PATHOGENESIS; APOPTOSIS; RNAI; PHENOTHIAZINES	The molecular machinery that regulates the entry and survival of Yersinia pestis in host macrophages is poorly understood. Here, we report the development of automated high-content imaging assays to quantitate the internalization of virulent Y. pestis CO92 by macrophages and the subsequent activation of host NF-kappa B. Implementation of these assays in a focused chemical screen identified kinase inhibitors that inhibited both of these processes. Rac-2-ethoxy-3 octadecanamido-1-propylphosphocholine (a protein Kinase C inhibitor), wortmannin (a PI3K inhibitor), and parthenolide (an I kappa B kinase inhibitor), inhibited pathogen-induced NF-kappa B activation and reduced bacterial entry and survival within macrophages. Parthenolide inhibited NF-kappa B activation in response to stimulation with Pam3CSK4 (a TLR2 agonist), E. coli LPS (a TLR4 agonist) or Y. pestis infection, while the PI3K and PKC inhibitors were selective only for Y. pestis infection. Together, our results suggest that phagocytosis is the major stimulus for NF-kappa B activation in response to Y. pestis infection, and that Y. pestis entry into macrophages may involve the participation of protein kinases such as PI3K and PKC. More importantly, the automated image-based screening platform described here can be applied to the study of other bacteria in general and, in combination with chemical genetic screening, can be used to identify host cell functions facilitating the identification of novel antibacterial therapeutics.	[Eaton, Brett; Ulrich, Melanie; Ulrich, Ricky; Bavari, Sina; Panchal, Rekha G.] USA, Med Res Inst Infect Dis, Dept Target Discovery & Cellular Microbiol, Frederick, MD USA; [Kota, Krishna P.; Pegoraro, Gianluca] Perkin Elmer, Waltham, MA USA; [Lane, Douglas; Peyser, Brian D.] NCI Frederick, SAIC Frederick, Target Struct Based Drug Discovery Grp, Frederick, MD USA; [Robinson, Camenzind G.] USA, Med Res Inst Infect Dis, Div Pathol, Frederick, MD USA; [Jaissle, James G.] USA, Med Res Inst Infect Dis, Diagnost Syst Div, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Panchal, RG (corresponding author), USA, Med Res Inst Infect Dis, Dept Target Discovery & Cellular Microbiol, Frederick, MD USA.	rekha.panchal@amedd.army.mil	Robinson, Camenzind G/O-5097-2018; Kota, Krishna/GPF-8474-2022; Bavari, Sina/L-3642-2019; Peyser, Brian/ABB-8010-2020; Eaton, Brett/G-1796-2019; Panchal, Rekha/None; Pegoraro, Gianluca/K-4233-2016	Robinson, Camenzind G/0000-0002-7277-692X; Bavari, Sina/0000-0001-8424-5635; Peyser, Brian/0000-0002-3455-5181; Eaton, Brett/0000-0002-3060-2913; Panchal, Rekha/0000-0001-8621-9078; Pegoraro, Gianluca/0000-0003-2843-9464	Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA) [JSTO-CBD 2.10019_09_RD_B]; National Cancer Institute, National Institutes of Health [N01-CO-12400]; Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute	Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)	This project was funded by the Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA) JSTO-CBD 2.10019_09_RD_B (to RGP). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. This research was supported, in part, by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; Bartfeld S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-21; Basu LR, 2005, MICROBIOL RES, V160, P95, DOI 10.1016/j.micres.2004.10.002; Benedek O, 2004, MICROB PATHOGENESIS, V37, P47, DOI 10.1016/j.micpath.2004.04.001; Bosio CM, 2005, J IMMUNOL, V175, P6750, DOI 10.4049/jimmunol.175.10.6750; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Caie PD, 2010, MOL CANCER THER, V9, P1913, DOI 10.1158/1535-7163.MCT-09-1148; Chan YY, 2007, ANTIMICROB AGENTS CH, V51, P623, DOI 10.1128/AAC.01033-06; Christensen DR, 2006, CLIN CHEM, V52, P141, DOI 10.1373/clinchem.2005.052522; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; DREVETS DA, 1995, J IMMUNOL METHODS, V187, P69, DOI 10.1016/0022-1759(95)00168-A; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Jenkins AL, 2009, J MICROBIOL METH, V77, P316, DOI 10.1016/j.mimet.2009.02.013; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kristiansen JE, 1997, J ANTIMICROB CHEMOTH, V40, P319, DOI 10.1093/jac/40.3.319; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Low J, 2008, CURR OPIN DRUG DISC, V11, P338; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Neish AS, 2011, TRENDS MICROBIOL, V19, P596, DOI 10.1016/j.tim.2011.08.004; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Ponnusamy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042211; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; ROSENSHINE I, 1992, INFECT IMMUN, V60, P2211, DOI 10.1128/IAI.60.6.2211-2217.1992; Saadane A, 2007, AM J RESP CELL MOL, V36, P728, DOI 10.1165/rcmb.2006-0323OC; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Scibelli A, 2007, VET J, V173, P482, DOI 10.1016/j.tvjl.2006.01.010; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Zhang Y, 2005, CURR TOP MICROBIOL, V289, P151; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003	51	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55167	10.1371/journal.pone.0055167	http://dx.doi.org/10.1371/journal.pone.0055167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383093	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800125
J	Liu, YL; Tsai, IC; Chang, CW; Liao, YF; Liu, GY; Hung, HC				Liu, Yi-Liang; Tsai, I-Chen; Chang, Chia-Wei; Liao, Ya-Fan; Liu, Guang-Yaw; Hung, Hui-Chih			Functional Roles of the Non-Catalytic Calcium-Binding Sites in the N-Terminal Domain of Human Peptidylarginine Deiminase 4	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ARGININE DEIMINASE; GENE ORGANIZATION; DEVELOPMENTALLY IMMATURE; CITRULLINATED PROTEINS; HISTONE DEIMINATION; EXPRESSION ANALYSIS; MULTIPLE-SCLEROSIS; MOLECULAR-CLONING; CDNA CLONING	This study investigated the functional roles of the N-terminal Ca2+ ion-binding sites, in terms of enzyme catalysis and stability, of peptidylarginine deiminase 4 (PAD4). Amino acid residues located in the N-terminal Ca2+-binding site of PAD4 were mutated to disrupt the binding of Ca2+ ions. Kinetic data suggest that Asp155, Asp157 and Asp179, which directly coordinate Ca3 and Ca4, are essential for catalysis in PAD4. For D155A, D157A and D179A, the k(cat)/K-m,(BAEE) values were 0.02, 0.63 and 0.01 s(-1) mM(-1) (20.8 s(-1) mM(-1) for WT), respectively. Asn153 and Asp176 are directly coordinated with Ca3 and indirectly coordinated with Ca5 via a water molecule. However, N153A displayed low enzymatic activity with a k(cat) value of 0.3 s(-1) (13.3 s(-1) for wild-type), whereas D176A retained some catalytic power with a kcat of 9.7 s(-1). Asp168 is the direct ligand for Ca5, and Ca5 coordination by Glu252 is mediated by two water molecules. However, mutation of these two residues to Ala did not cause a reduction in the kcat/Km, BAEE values, which indicates that the binding of Ca5 may not be required for PAD4 enzymatic activity. The possible conformational changes of these PAD4 mutants were examined. Thermal stability analysis of the PAD4 mutants in the absence or presence of Ca2+ indicated that the conformational stability of the enzyme is highly dependent on Ca2+ ions. In addition, the results of urea-induced denaturation for the N153, D155, D157 and D179 series mutants further suggest that the binding of Ca2+ ions in the N-terminal Ca2+-binding site stabilizes the overall conformational stability of PAD4. Therefore, our data strongly suggest that the N-terminal Ca2+ ions play critical roles in the full activation of the PAD4 enzyme.	[Liu, Yi-Liang; Tsai, I-Chen; Chang, Chia-Wei; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yi-Liang; Tsai, I-Chen; Chang, Chia-Wei; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liao, Ya-Fan] Chaoyang Univ Technol, Grad Inst Biochem Sci & Biotechnol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Chaoyang University of Technology; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Liu, GY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, ROC [NSC-101-2311-B-005-016]; Ministry of Education, Taiwan	National Science Council, ROC(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the National Science Council, ROC (NSC-101-2311-B-005-016 to H.-C. H.) (http://web1.nsc.gov.tw/) and in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 1999, NEUROSCI LETT, V274, P53, DOI 10.1016/S0304-3940(99)00678-3; Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 1998, BIOCHEM BIOPH RES CO, V243, P641, DOI 10.1006/bbrc.1998.8148; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; delPino MMS, 1997, BIOCHEMISTRY-US, V36, P5560, DOI 10.1021/bi963133z; Guerrin M, 2003, BIOCHEM J, V370, P167, DOI 10.1042/BJ20020870; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Ishida-Yamamoto A, 2002, J INVEST DERMATOL, V118, P282, DOI 10.1046/j.0022-202x.2001.01671.x; Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7; Ishigami A, 2010, GERIATR GERONTOL INT, V10, pS53, DOI 10.1111/j.1447-0594.2010.00593.x; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knuckley B, 2007, BIOCHEMISTRY-US, V46, P6578, DOI 10.1021/bi700095s; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Liao YF, 2005, ANAL BIOCHEM, V347, P176, DOI 10.1016/j.ab.2005.09.027; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021314; Lu XF, 2004, J AM CHEM SOC, V126, P5374, DOI 10.1021/ja049543p; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Mizoguchi M, 1998, J HISTOCHEM CYTOCHEM, V46, P1303, DOI 10.1177/002215549804601110; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nakayama-Hamada M, 2005, BIOCHEM BIOPH RES CO, V327, P192, DOI 10.1016/j.bbrc.2004.11.152; Nijenhuis S, 2004, CLIN CHIM ACTA, V350, P17, DOI 10.1016/j.cccn.2004.07.016; Pace C N, 1986, Methods Enzymol, V131, P266; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Senshu T, 1999, J DERMATOL SCI, V21, P113, DOI 10.1016/S0923-1811(99)00026-2; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Suzuki A, 2005, BIOCHEM BIOPH RES CO, V333, P418, DOI 10.1016/j.bbrc.2005.05.137; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Zhang JY, 2004, ACTA BIOCHIM POL, V51, P1051	44	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51660	10.1371/journal.pone.0051660	http://dx.doi.org/10.1371/journal.pone.0051660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382808	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800005
J	Sikoglu, EM; Jensen, JE; Vitaliano, G; Navarro, AAL; Renshaw, PF; Frazier, JA; Moore, CM				Sikoglu, Elif M.; Jensen, J. Eric; Vitaliano, Gordana; Navarro, Ana A. Liso; Renshaw, Perry F.; Frazier, Jean A.; Moore, Constance M.			Bioenergetic Measurements in Children with Bipolar Disorder: A Pilot P-31 Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							BRAIN PHOSPHORUS-METABOLISM; MITOCHONDRIAL DYSFUNCTION; INTRACELLULAR PH; RATING-SCALE; CORTEX	Background: Research exploring Bipolar Disorder (BD) phenotypes and mitochondrial dysfunction, particularly in younger subjects, has been insufficient to date. Previous studies have found abnormal cerebral pH levels in adults with BD, which may be directly linked to abnormal mitochondrial activity. To date no such studies have been reported in children with BD. Methods: Phosphorus Magnetic Resonance Spectroscopy (P-31 MRS) was used to determine pH, phopshocreatine (PCr) and inorganic phosphate (Pi) levels in 8 subjects with BD and 8 healthy comparison subjects (HCS) ages 11 to 20 years old. Results: There was no significant difference in pH between the patients and HCS. However, frontal pH values for patients with BD increased with age, contrary to studies of HCS and the pH values in the frontal lobe correlated negatively with the YMRS values. Global Pi was significantly lower in subjects with BD compared with HCS. There were no significant differences in PCr between the groups. Global PCr-to-Pi ratio (PCr/Pi) was significantly higher in subjects with BD compared with HCS. Conclusions: The change in Pi levels for the patients with BD coupled with the no difference in PCr levels, suggest an altered mitochondrial phosphorylation. However, our findings require further investigation of the underlying mechanisms with the notion that a mitochondrial dysfunction may manifest itself differently in children than that in adults. Limitations: Further investigations with larger patient populations are necessary to draw further conclusions.	[Sikoglu, Elif M.; Navarro, Ana A. Liso; Frazier, Jean A.; Moore, Constance M.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Jensen, J. Eric; Vitaliano, Gordana] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Renshaw, Perry F.] Univ Utah, Deparment Psychiat, Salt Lake City, UT USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; McLean Hospital; Utah System of Higher Education; University of Utah	Moore, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA.	Constance.Moore@umassmed.edu	Renshaw, Perry/O-1384-2018		National Institute for Mental Health [MH082335]; Stanley Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073998, R21MH082335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The National Institute for Mental Health (CMM: MH082335) and the Stanley Medical Research Institute (PFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbiroli B, 1998, BIOCHIMIE, V80, P847, DOI 10.1016/S0300-9084(00)88879-3; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450; Hamakawa H, 2004, PSYCHIAT CLIN NEUROS, V58, P82, DOI 10.1111/j.1440-1819.2004.01197.x; KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R; Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Mato S, 2010, GLIA, V58, P1739, DOI 10.1002/glia.21044; Moore CM, 2007, J AM ACAD CHILD PSY, V46, P524, DOI 10.1097/chi.0b013e31802f5f2c; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; PETTEGREW JW, 1991, ARCH GEN PSYCHIAT, V48, P563; Poznanski E.O., 1996, CHILDRENS DEPRESSION; POZNANSKI EO, 1979, PEDIATRICS, V64, P442; Quiroz JA, 2008, NEUROPSYCHOPHARMACOL, V33, P2551, DOI 10.1038/sj.npp.1301671; Rae C, 2003, DEV NEUROSCI-BASEL, V25, P324, DOI 10.1159/000073509; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Yildiz A, 2005, PSYCHIAT RES-NEUROIM, V138, P51, DOI 10.1016/j.pscychresns.2003.10.005; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	23	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54536	10.1371/journal.pone.0054536	http://dx.doi.org/10.1371/journal.pone.0054536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382910	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800053
J	Silk, AD; Gast, CE; Davies, PS; Fakhari, FD; Vanderbeek, GE; Mori, M; Wong, MH				Silk, Alain D.; Gast, Charles E.; Davies, Paige S.; Fakhari, Farnaz D.; Vanderbeek, Gretchen E.; Mori, Motomi; Wong, Melissa H.			Fusion between Hematopoietic and Epithelial Cells in Adult Human Intestine	PLOS ONE			English	Article							MARROW-DERIVED CELLS; BONE-MARROW; PURKINJE NEURONS; STEM-CELLS; VASCULAR ENDOTHELIUM; HEPATOCYTES; LIVER; INFLAMMATION	Following transplantation of hematopoietic lineage cells, genetic markers unique to the transplanted cells have been detected in non-hematopoietic recipient cells of human liver, vascular endothelium, intestinal epithelium and brain. The underlying mechanisms by which this occurs are unclear. Evidence from mice suggests it is due in part to fusion between cells of hematopoietic and non-hematopoietic origins; however, direct evidence for this in humans is scant. Here, by quantitative and statistical analysis of X-and Y-chromosome numbers in epithelial and non-epithelial intestinal cells from gender-mismatched hematopoietic cell transplant patients, we provide evidence that transplanted cells of the hematopoietic lineage incorporate into human intestinal epithelium through cell fusion. This is the first definitive identification of cell fusion between hematopoietic cells and any epithelial cell type in humans, and provides the basis for further understanding the physiological and potential pathological consequences of cell fusion in humans.	[Silk, Alain D.; Davies, Paige S.; Fakhari, Farnaz D.; Vanderbeek, Gretchen E.; Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Silk, Alain D.; Davies, Paige S.; Mori, Motomi; Wong, Melissa H.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Gast, Charles E.] Oregon Hlth & Sci Univ, Program Cell & Mol Biol, Portland, OR 97201 USA; [Mori, Motomi] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Wong, MH (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	wongme@ohsu.edu			NIH [R01CA118235]; National Cancer Institute of the National Institutes of Health [T32CA106195]; NCI CCSG [R01CA118235, T32CA106195, P30CA069533]; NATIONAL CANCER INSTITUTE [R01CA118235, T32CA106195, P30CA069533, R21CA172334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01CA118235 to M. H. W. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number T32CA106195. Funding for this work was also provided by NCI CCSG P30CA069533 to the Biostatistics Shared Resource of the Knight Cancer Institute, T32CA106195 to A. D. S, and R01CA118235 to M. H. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Diaz D, 2012, CELL TRANSPLANT; Fujino H, 2007, FASEB J, V21, P3499, DOI 10.1096/fj.06-6109com; HAM A W, 1979; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kemp K, 2012, BRAIN; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Quintana-Bustamante O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033945; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Yilmaz Y, 2005, BONE MARROW TRANSPL, V35, P1021, DOI 10.1038/sj.bmt.1704939	25	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55572	10.1371/journal.pone.0055572	http://dx.doi.org/10.1371/journal.pone.0055572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383228	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800167
J	Siskova, Z; Reynolds, RA; O'Connor, V; Perry, VH				Siskova, Zuzana; Reynolds, Richard A.; O'Connor, Vincent; Perry, V. Hugh			Brain Region Specific Pre-Synaptic and Post-Synaptic Degeneration Are Early Components of Neuropathology in Prion Disease	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; SYNAPTIC DEGENERATION; DENDRITIC SPINE; NERVOUS-SYSTEM; AUTOPHAGY; MICE; ABNORMALITIES	Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functional deficits and contributes to the devastating clinical outcome. The synaptic compartment is the first to succumb in several neurodegenerative diseases linked with protein misfolding but the mechanisms underpinning this are poorly defined. In our current study we document that a focal intrahippocampal injection of the mouse-adapted 22L scrapie strain produces a complex, region-specific pathology in the brain. Our findings reveal that early synaptic changes in the stratum radiatum of the hippocampus, identical to those observed with the ME7 strain, occur when 22L strain is introduced into the hippocampus. The pathology was defined by degenerating Type I pre-synaptic elements progressively enveloped by the post-synaptic density of the dendritic spine. In contrast, the pathology in the cerebellum suggested that dendritic disintegration rather than pre-synaptic abnormalities dominate the early degenerative changes associated with the Purkinje cells. Indeed, both of the major synaptic inputs into the cerebellum, which arise from the parallel and climbing fibers, remained intact even at late stage disease. Immunolabeling with pathway selective antibodies reinforced these findings. These observations demonstrate that neuronal vulnerability to pathological protein misfolding is strongly dependent on the structure and function of the target neurons.	[Siskova, Zuzana; Reynolds, Richard A.; O'Connor, Vincent; Perry, V. Hugh] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Siskova, Zuzana] Univ Bonn, Deutsch Zentrum Neurodegenerat Erkrankungen, Bonn, Germany	University of Southampton; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Siskova, Z (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	Zuzana.Siskova@dzne.de	Perry, V. Hugh/Y-2935-2019		UK Medical Research Council (MRC) [G0501636]; Medical Research Council [G0501636] Funding Source: researchfish; MRC [G0501636] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) grant G0501636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski JJ, 2003, J NEUROSCI, V23, P3469; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; BRAAK H, 1989, J NEUROL SCI, V93, P277, DOI 10.1016/0022-510X(89)90197-4; Cantalupo C, 2010, CORTEX, V46, P821, DOI 10.1016/j.cortex.2009.10.004; Cataldo AM, 1996, ADV EXP MED BIOL, V389, P271; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; FERRER I, 1988, CLIN NEUROPATHOL, V7, P22; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Frey D, 2000, J NEUROSCI, V20, P2534; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gillingwater TH, 2006, BRAIN, V129, P1546, DOI 10.1093/brain/awl101; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Harvey RJ, 2005, EUR J NEUROSCI, V21, P1777, DOI 10.1111/j.1460-9568.2005.04010.x; Ironside JW, 1996, NEUROPATH APPL NEURO, V22, P446, DOI 10.1111/j.1365-2990.1996.tb00919.x; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jeffrey M, 2011, ACTA NEUROPATHOL, V121, P113, DOI 10.1007/s00401-010-0700-3; KIM YS, 1987, J GEN VIROL, V68, P695, DOI 10.1099/0022-1317-68-3-695; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Saab CY, 2003, BRAIN RES REV, V42, P85, DOI 10.1016/S0165-0173(03)00151-6; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7	34	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55004	10.1371/journal.pone.0055004	http://dx.doi.org/10.1371/journal.pone.0055004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383030	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800100
J	Sherman, SP; Pyle, AD				Sherman, Sean P.; Pyle, April D.			Small Molecule Screening with Laser Cytometry Can Be Used to Identify Pro-Survival Molecules in Human Embryonic Stem Cells	PLOS ONE			English	Article							ENHANCES SURVIVAL; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; CULTURE; GROWTH; LINES	Differentiated cells from human embryonic stem cells (hESCs) provide an unlimited source of cells for use in regenerative medicine. The recent derivation of human induced pluripotent cells (hiPSCs) provides a potential supply of pluripotent cells that avoid immune rejection and could provide patient-tailored therapy. In addition, the use of pluripotent cells for drug screening could enable routine toxicity testing and evaluation of underlying disease mechanisms. However, prior to establishment of patient specific cells for cell therapy it is important to understand the basic regulation of cell fate decisions in hESCs. One critical issue that hinders the use of these cells is the fact that hESCs survive poorly upon dissociation, which limits genetic manipulation because of poor cloning efficiency of individual hESCs, and hampers production of large-scale culture of hESCs. To address the problems associated with poor growth in culture and our lack of understanding of what regulates hESC signaling, we successfully developed a screening platform that allows for large scale screening for small molecules that regulate survival. In this work we developed the first large scale platform for hESC screening using laser scanning cytometry and were able to validate this platform by identifying the pro-survival molecule HA-1077. These small molecules provide targets for both improving our basic understanding of hESC survival as well as a tool to improve our ability to expand and genetically manipulate hESCs for use in regenerative applications.	[Sherman, Sean P.; Pyle, April D.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Pyle, April D.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Pyle, AD (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	apyle@mednet.ucla.edu		Sherman, Sean/0000-0002-6295-0680	CIRM [T1-00005, TG2-01169]; MIMG Warsaw Fellowship; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064855] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); MIMG Warsaw Fellowship; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by CIRM Predoctoral training grants (T1-00005 and TG2-01169) and MIMG Warsaw Fellowship to S.P.S. and by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA funding to A.D.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Bai H, 2012, STEM CELL RES, V8, P26, DOI 10.1016/j.scr.2011.08.002; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Barbaric I, 2011, CRYOBIOLOGY, V63, P298, DOI 10.1016/j.cryobiol.2011.10.002; Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Inniss K, 2006, STEM CELLS DEV, V15, P789, DOI 10.1089/scd.2006.15.789; Kamei KI, 2009, LAB CHIP, V9, P555, DOI 10.1039/b809105f; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Sherman SP, 2011, METHODS MOL BIOL, V767, P283, DOI 10.1007/978-1-61779-201-4_21; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xu Y., 2010, P NATL ACAD SCI US; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	23	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54948	10.1371/journal.pone.0054948	http://dx.doi.org/10.1371/journal.pone.0054948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383009	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200055
J	Tikhonenko, M; Lydic, TA; Opreanu, M; Calzi, SL; Bozack, S; McSorley, KM; Sochacki, AL; Faber, MS; Hazra, S; Duclos, S; Guberski, D; Reid, GE; Grant, MB; Busik, JV				Tikhonenko, Maria; Lydic, Todd A.; Opreanu, Madalina; Calzi, Sergio Li; Bozack, Svetlana; McSorley, Kelly M.; Sochacki, Andrew L.; Faber, Matthew S.; Hazra, Sugata; Duclos, Shane; Guberski, Dennis; Reid, Gavin E.; Grant, Maria B.; Busik, Julia V.			N-3 Polyunsaturated Fatty Acids Prevent Diabetic Retinopathy by Inhibition of Retinal Vascular Damage and Enhanced Endothelial Progenitor Cell Reparative Function	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DOCOSAHEXAENOIC ACID; STEM-CELLS; DISEASE; COMPLICATIONS; ACTIVATION; MELLITUS; CERAMIDE; PATHWAY; DEATH	Objective: The vasodegenerative phase of diabetic retinopathy is characterized by not only retinal vascular degeneration but also inadequate vascular repair due to compromised bone marrow derived endothelial progenitor cells (EPCs). We propose that n-3 polyunsaturated fatty acid (PUFA) deficiency in diabetes results in activation of the central enzyme of sphingolipid metabolism, acid sphingomyelinase (ASM) and that ASM represents a molecular metabolic link connecting the initial damage in the retina and the dysfunction of EPCs. Research Design and Methods: Type 2 diabetic rats on control or docosahexaenoic acid (DHA)-rich diet were studied. The number of acellular capillaries in the retinas was assessed by trypsin digest. mRNA levels of interleukin (IL)-1 beta, IL-6, intracellular adhesion molecule (ICAM)-1 in the retinas from diabetic animals were compared to controls and ASM protein was assessed by western analysis. EPCs were isolated from blood and bone marrow and their numbers and ability to form colonies in vitro, ASM activity and lipid profiles were determined. Results: DHA-rich diet prevented diabetes-induced increase in the number of retinal acellular capillaries and significantly enhanced the life span of type 2 diabetic animals. DHA-rich diet blocked upregulation of ASM and other inflammatory markers in diabetic retina and prevented the increase in ASM activity in EPCs, normalized the numbers of circulating EPCs and improved EPC colony formation. Conclusions: In a type 2 diabetes animal model, DHA-rich diet fully prevented retinal vascular pathology through inhibition of ASM in both retina and EPCs, leading to a concomitant suppression of retinal inflammation and correction of EPC number and function.	[Tikhonenko, Maria; Lydic, Todd A.; Opreanu, Madalina; Bozack, Svetlana; McSorley, Kelly M.; Sochacki, Andrew L.; Faber, Matthew S.; Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Opreanu, Madalina; Bozack, Svetlana] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Reid, Gavin E.] Michigan State Univ, Dept Chem & Biochem & Mol Biol, E Lansing, MI 48824 USA; [Duclos, Shane; Guberski, Dennis] Biomed Res Models Inc, Worcester, MA USA; [Calzi, Sergio Li; Hazra, Sugata; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	Michigan State University; Michigan State University; Michigan State University; State University System of Florida; University of Florida	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	busik@msu.edu	Busik, Julia V/A-2698-2010; Lydic, Todd A./ADB-0177-2022	Busik, Julia V/0000-0003-3453-7124; Faber, Matthew/0000-0002-5583-5115; Reid, Gavin/0000-0002-9675-1444	National Institutes of Health [EY 016077, RR 025386, DK090730, EY 012601, EY 007739]; Michigan Experimental Agricaltural Station [MICL02163]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025386] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016077, R01EY007739, P30EY011373, R29EY007739, R01EY012601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Experimental Agricaltural Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (EY 016077 to JB, RR 025386 to GR and JB, DK090730 to MG and JB, EY 012601 and EY 007739 to MG) and Michigan Experimental Agricaltural Station MICL02163 to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2006, METABOLISM, V55, P168, DOI 10.1016/j.metabol.2005.08.009; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Bodin S, 2005, MOL BIOL CELL, V16, P5773, DOI 10.1091/mbc.E05-04-0358; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Churdchomjan W, BMC ENDOCR DISORD, V10, P5; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Decsi T, 2002, PROSTAG LEUKOTR ESS, V67, P203, DOI 10.1054/plef.2002.0420; Estrada R, 2004, J MASS SPECTROM, V39, P1531, DOI 10.1002/jms.759; Estrada R, 2004, J MASS SPECTROM, V39, P412, DOI 10.1002/jms.603; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FUTTERMAN S, 1968, INVEST OPHTH VISUAL, V7, P105; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Humpert PM, 2008, MOL MED, V14, P301, DOI 10.2119/2007-00052.Humpert; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kielczewski JL, 2011, INVEST OPHTH VIS SCI, V52, P8278, DOI 10.1167/iovs.11-8167; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Li MF, 2011, DIABETES-METAB RES, V27, P185, DOI 10.1002/dmrr.1159; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Opreanu M, 2011, DIABETES, V60, P2370, DOI 10.2337/db10-0550; Opreanu M, 2010, INVEST OPHTH VIS SCI, V51, P3253, DOI 10.1167/iovs.09-4731; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Reslewic S, 2005, APPL ENVIRON MICROB, V71, P5511, DOI 10.1128/AEM.71.9.5511-5522.2005; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Tirabassi RS, 2004, ILAR J, V45, P292, DOI 10.1093/ilar.45.3.292; Tooke JE, 1999, DIABETIC MED, V16, P710, DOI 10.1046/j.1464-5491.1999.00099.x; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; YANG ZH, 1993, J BIOL CHEM, V268, P20520; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225	54	65	69	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55177	10.1371/journal.pone.0055177	http://dx.doi.org/10.1371/journal.pone.0055177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383097	Green Published, gold			2022-12-25	WOS:000315483200045
J	Ting, NC; Jansen, J; Nagappan, J; Ishak, Z; Chin, CW; Tan, SG; Cheah, SC; Singh, R				Ting, Ngoot-Chin; Jansen, Johannes; Nagappan, Jayanthi; Ishak, Zamzuri; Chin, Cheuk-Weng; Tan, Soon-Guan; Cheah, Suan-Choo; Singh, Rajinder			Identification of QTLs Associated with Callogenesis and Embryogenesis in Oil Palm Using Genetic Linkage Maps Improved with SSR Markers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TISSUE-CULTURE RESPONSE; NUCLEAR-DNA CONTENT; INITIATION; CALLUS	Clonal reproduction of oil palm by means of tissue culture is a very inefficient process. Tissue culturability is known to be genotype dependent with some genotypes being more amenable to tissue culture than others. In this study, genetic linkage maps enriched with simple sequence repeat (SSR) markers were developed for dura (ENL48) and pisifera (ML161), the two fruit forms of oil palm, Elaeis guineensis. The SSR markers were mapped onto earlier reported parental maps based on amplified fragment length polymorphism (AFLP) and restriction fragment length polymorphism (RFLP) markers. The new linkage map of ENL48 contains 148 markers (33 AFLPs, 38 RFLPs and 77 SSRs) in 23 linkage groups (LGs), covering a total map length of 798.0 cM. The ML161 map contains 240 markers (50 AFLPs, 71 RFLPs and 119 SSRs) in 24 LGs covering a total of 1,328.1 cM. Using the improved maps, two quantitative trait loci (QTLs) associated with tissue culturability were identified each for callusing rate and embryogenesis rate. A QTL for callogenesis was identified in LGD4b of ENL48 and explained 17.5% of the phenotypic variation. For embryogenesis rate, a QTL was detected on LGP16b in ML161 and explained 20.1% of the variation. This study is the first attempt to identify QTL associated with tissue culture amenity in oil palm which is an important step towards understanding the molecular processes underlying clonal regeneration of oil palm.	[Ting, Ngoot-Chin; Nagappan, Jayanthi; Ishak, Zamzuri; Cheah, Suan-Choo; Singh, Rajinder] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia; [Jansen, Johannes] Univ Wageningen & Res Ctr, Ac Wageningen, Netherlands; [Chin, Cheuk-Weng] Fed Land Dev Author Malaysia Agr Serv Sdn Bhd, Fed Land Dev Author Malaysia Biotechnol Ctr, Kuala Lumpur, Malaysia; [Tan, Soon-Guan] Univ Putra Malaysia, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia	Malaysian Palm Oil Board; Wageningen University & Research; Universiti Putra Malaysia	Singh, R (corresponding author), Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia.	rajinder@mpob.gov.my	Tan, S G/B-2448-2010; Tan, Soon Guan/V-1782-2019; Singh, Rajinder/P-9179-2015	Tan, S G/0000-0001-9960-4493; Tan, Soon Guan/0000-0001-9960-4493; Singh, Rajinder/0000-0001-9933-4884; Ting, Ngoot Chin/0000-0002-4910-6020	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [MMBPP 04-03-T0045-TC3.2]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This project is funded by the Ministry of Science, Technology and Innovation (MOSTI), Malaysia under the project code MMBPP 04-03-T0045-TC3.2. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwee SSRS, 2010, PROC ADVANCES IN OIL, P45; BenAmer IM, 1997, THEOR APPL GENET, V94, P1047, DOI 10.1007/s001220050513; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Billotte N, 2010, THEOR APPL GENET, V120, P1673, DOI 10.1007/s00122-010-1284-y; Bolibok H, 2007, CELL MOL BIOL LETT, V12, P523, DOI 10.2478/s11658-007-0023-0; Bolibok H, 2006, EUPHYTICA, V149, P73, DOI 10.1007/s10681-005-9055-6; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Cheah S. C, 1993, 1991 P INT PALM OIL, P144; Chin CW, 1996, PROC OIL PALM PLANTI, P71; Chua KL, 2006, THESIS; Corley R.H.V., 1997, PLANTATION MANAGEMEN, P279; Corley RHV, 1998, PROC INT OIL PALM CO, P1; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hardon J., 1987, IMPROVING VEGETATIVE; Ho YW, 2009, P NAT C OIL PALM, P86; Jansen J, 2005, GENETICS, V170, P2013, DOI 10.1534/genetics.105.041822; KEYES GJ, 1980, THEOR APPL GENET, V58, P265, DOI 10.1007/BF00265178; KOMATSUDA T, 1993, THEOR APPL GENET, V86, P713, DOI 10.1007/BF00222661; Krakowsky MD, 2006, THEOR APPL GENET, V113, P821, DOI 10.1007/s00122-006-0334-y; Kushairi A, 2010, PAPER PRESENTED AT T; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; MacKay JJ, 2006, TREE GENET GENOMES, V2, P1, DOI 10.1007/s11295-005-0020-2; Madon M, 2008, J OIL PALM RES, V20, P447; Mano Y, 2002, THEOR APPL GENET, V105, P708, DOI 10.1007/s00122-002-0992-3; Mohd Basri W, 2009, PAPER PRESENTED AT T; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ong-Abdullah M, 2006, OIL PALM B, V53, P36; SINGH R, 2011, FURTHER ADV OIL PALM, P202; Singh R, 2008, BIOLOGIA, V63, P227, DOI 10.2478/s11756-008-0041-z; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Soh AC, 2011, J OIL PALM RES, V23, P935; TaguchiShiobara F, 1997, THEOR APPL GENET, V95, P828, DOI 10.1007/s001220050632; Tarmizi AH, 2010, FURTHER ADVANCES IN, P102; Ting NC, 2006, PERTANIKA J TROP AGR, V29, P35; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VSNI, 2020, GENSTAT WINDOWS, V21; Wooi K. C., 1995, P 1993 ISOPB INT S R, P21; Zaki NM, 2010, SAINS MALAYS, V39, P909	43	30	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53076	10.1371/journal.pone.0053076	http://dx.doi.org/10.1371/journal.pone.0053076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382832	gold, Green Published, Green Submitted			2022-12-25	WOS:000315483200036
J	Ali, WH; Chen, Q; Delgiorno, KE; Su, WJ; Hall, JC; Hongu, T; Tian, H; Kanaho, Y; Di Paolo, G; Crawford, HC; Frohman, MA				Ali, Wahida H.; Chen, Qin; Delgiorno, Kathleen E.; Su, Wenjuan; Hall, Jason C.; Hongu, Tsunaki; Tian, Huasong; Kanaho, Yasunori; Di Paolo, Gilbert; Crawford, Howard C.; Frohman, Michael A.			Deficiencies of the Lipid-Signaling Enzymes Phospholipase D1 and D2 Alter Cytoskeletal Organization, Macrophage Phagocytosis, and Cytokine-Stimulated Neutrophil Recruitment	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; YERSINIA-PSEUDOTUBERCULOSIS; ACTIN CYTOSKELETON; FOCAL ADHESIONS; SURFACE-CHARGE; ACTIVATION; GAMMA; RHO	Cell migration and phagocytosis ensue from extracellular-initiated signaling cascades that orchestrate dynamic reorganization of the actin cytoskeleton. The reorganization is mediated by effector proteins recruited to the site of activity by locally-generated lipid second messengers. Phosphatidic acid (PA), a membrane phospholipid generated by multiple enzyme families including Phospholipase D (PLD), has been proposed to function in this role. Here, we show that macrophages prepared from mice lacking either of the classical PLD isoforms PLD1 or PLD2, or wild-type macrophages whose PLD activity has been pharmacologically inhibited, display isoform-specific actin cytoskeleton abnormalities that likely underlie decreases observed in phagocytic capacity. Unexpectedly, PA continued to be detected on the phagosome in the absence of either isoform and even when all PLD activity was eliminated. However, a disorganized phagocytic cup was observed as visualized by imaging PA, F-actin, Rac1, an organizer of the F-actin network, and DOCK2, a Rac1 activator, suggesting that PLD-mediated PA production during phagocytosis is specifically critical for the integrity of the process. The abnormal F-actin reorganization additionally impacted neutrophil migration and extravasation from the vasculature into interstitial tissues. Although both PLD1 and PLD2 were important in these processes, we also observed isoform-specific functions. PLD1-driven processes in particular were observed to be critical in transmigration of macrophages exiting the vasculature during immune responses such as those seen in acute pancreatitis or irritant-induced skin vascularization.	[Ali, Wahida H.; Chen, Qin; Delgiorno, Kathleen E.; Su, Wenjuan; Hall, Jason C.; Crawford, Howard C.; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Ali, Wahida H.; Chen, Qin; Delgiorno, Kathleen E.; Su, Wenjuan; Hall, Jason C.; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Ali, Wahida H.; Delgiorno, Kathleen E.; Hall, Jason C.; Crawford, Howard C.; Frohman, Michael A.] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Hongu, Tsunaki; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Hongu, Tsunaki; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan; [Tian, Huasong; Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tsukuba; University of Tsukuba; Columbia University	Frohman, MA (corresponding author), SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA.	michael@pharm.stonybrook.edu	DelGiorno, Kathy/AAJ-9911-2021	DelGiorno, Kathy/0000-0002-5749-8394; Hanel, Wahida/0000-0003-0196-8040	NIH [GM084251]; NATIONAL CANCER INSTITUTE [R01CA159222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100109, R01GM084251, T32GM007518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (www.nih.gov/) through an R01 award (GM084251). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Bombardelli L, 2010, GASTROENTEROLOGY, V138, P2531, DOI 10.1053/j.gastro.2010.02.043; Botelho RJ, 2011, CURR BIOL, V21, pR533, DOI 10.1016/j.cub.2011.05.053; Botelho RJ, 2009, J BIOL CHEM, V284, P28522, DOI 10.1074/jbc.M109.009514; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Dart AE, 2012, J CELL SCI, V125, P2825, DOI 10.1242/jcs.106583; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Grinstein S, 2010, AM J PHYSIOL-CELL PH, V299, pC876, DOI 10.1152/ajpcell.00342.2010; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Martin A, 1996, J BIOL CHEM, V271, P17397, DOI 10.1074/jbc.271.29.17397; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Okada M, 2012, BIOCH BIOPHYS RES CO; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Pleskot R, 2010, PLANT J, V62, P494, DOI 10.1111/j.1365-313X.2010.04168.x; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Schwarz K, 2011, J NEUROSCI, V31, P15996, DOI 10.1523/JNEUROSCI.2965-11.2011; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Zhang Y, 2011, INFECT IMMUN; Zhang Y, 2008, INFECT IMMUN, V76, P4299, DOI 10.1128/IAI.00183-08; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	62	49	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55325	10.1371/journal.pone.0055325	http://dx.doi.org/10.1371/journal.pone.0055325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383154	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500076
J	Cai, MS; Li, ML; Wang, KZ; Wang, S; Lu, Q; Yan, JH; Mossman, KL; Lin, RT; Zheng, CF				Cai, Mingsheng; Li, Meili; Wang, Kezhen; Wang, Shuai; Lu, Qiong; Yan, Jinghua; Mossman, Karen L.; Lin, Rongtuan; Zheng, Chunfu			The Herpes Simplex Virus 1-Encoded Envelope Glycoprotein B Activates NF-kappa B through the Toll-Like Receptor 2 and MyD88/TRAF6-Dependent Signaling Pathway	PLOS ONE			English	Article							CUTTING EDGE; HEPARAN-SULFATE; CELL ACTIVATION; RECOGNITION; INNATE; TLR2; CD14; CYTOKINE; BINDING; PROTEIN	The innate immune response plays a critical role in the host defense against invading pathogens, and TLR2, a member of the Toll-like receptor (TLR) family, has been implicated in the immune response and initiation of inflammatory cytokine secretion against several human viruses. Previous studies have demonstrated that infectious and ultraviolet-inactivated herpes simplex virus 1 (HSV-1) virions lead to the activation of nuclear factor kappa B (NF-kappa B) and secretion of proinflammatory cytokines via TLR2. However, except for the envelope glycoprotein gH and gL, whether there are other determinants of HSV-1 responsible for TLR2 mediated biological effects is not known yet. Here, we demonstrated that the HSV-1-encoded envelope glycoprotein gB displays as molecular target recognized by TLR2. gB coimmunoprecipitated with TLR2, TLR1 and TLR6 in transfected and infected human embryonic kidney (HEK) 293T cells. Treatment of TLR2-transfected HEK293T (HEK293T-TLR2) cells with purified gB results in the activation of NF-kappa B reporter, and this activation requires the recruitment of the adaptor molecules myeloid differentiation primary-response protein 88 (MyD88) and tumor necrosis factor receptor-associated factor 6 (TRAF6) but not CD14. Furthermore, activation of NF-kB was abrogated by anti-gB and anti-TLR2 blocking antibodies. In addition, the expression of interleukin-8 induced by gB was abrogated by the treatment of the human monocytic cell line THP-1 with anti-TLR2 blocking antibody or by the incubation of gB with anti-gB antibody. Taken together, these results indicate the importance and potency of HSV-1 gB as one of pathogen-associated molecular patterns (PAMPs) molecule recognized by TLR2 with immediate kinetics.	[Wang, Kezhen; Wang, Shuai; Zheng, Chunfu] Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China; [Cai, Mingsheng; Wang, Kezhen; Wang, Shuai; Zheng, Chunfu] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China; [Cai, Mingsheng; Li, Meili] Guangzhou Med Univ, Dept Pathogen Biol & Immunol, Guangzhou, Guangdong, Peoples R China; [Cai, Mingsheng] Foshan Sci & Technol Univ, Dept Vet Med, Foshan, Peoples R China; [Lu, Qiong; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Mossman, Karen L.] McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Lin, Rongtuan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Lin, Rongtuan] McGill Univ, Dept Med, Montreal, PQ, Canada	Soochow University - China; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Guangzhou Medical University; Foshan University; Chinese Academy of Sciences; Institute of Microbiology, CAS; McMaster University; Lady Davis Institute; McGill University; McGill University	Zheng, CF (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China.	zheng.alan@hotmail.com	Lin, Rongtuan/A-1442-2008; zheng, Chunfu/F-2404-2012	Lin, Rongtuan/0000-0002-2238-3503; zheng, Chunfu/0000-0002-8797-1322	National Natural Science Foundation of China [81171584, 31200120]; Major State Basic Research Development Program of China (973 Program) [2010CB530105, 2011CB504802]; Medical Scientific Research Foundation of Guangdong Province, China [B2012165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (81171584 and 31200120); the Major State Basic Research Development Program of China (973 Program) (2010CB530105 and 2011CB504802); Medical Scientific Research Foundation of Guangdong Province, China (B2012165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Knipe DM, 2007, FIELDS VIROLOGY; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kopp M, 2002, J VIROL, V76, P8820, DOI 10.1128/JVI.76.17.8820-8833.2002; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Leoni V, 2012, J VIROL, V86, P6555, DOI 10.1128/JVI.00295-12; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Li Y, 2011, ARCH VIROL, V156, P2267, DOI 10.1007/s00705-011-1094-9; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu XQ, 2008, P NATL ACAD SCI USA, V105, P11335, DOI 10.1073/pnas.0801617105; Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Michaud F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013742; Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Sugawara S, 2001, INFECT IMMUN, V69, P4951, DOI 10.1128/IAI.69.8.4951-4957.2001; Wang JP, 2005, J VIROL, V79, P12658, DOI 10.1128/JVI.79.20.12658-12666.2005; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Xing JJ, 2011, J VIROL, V85, P1881, DOI 10.1128/JVI.01730-10; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	51	66	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54586	10.1371/journal.pone.0054586	http://dx.doi.org/10.1371/journal.pone.0054586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382920	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500019
J	Martin, DH; Boro, A; Schafer, BW				Martin, David Herrero; Boro, Aleksandar; Schaefer, Beat W.			Cell-Based Small-Molecule Compound Screen Identifies Fenretinide as Potential Therapeutic for Translocation-Positive Rhabdomyosarcoma	PLOS ONE			English	Article							EWINGS-SARCOMA FAMILY; CHILDRENS ONCOLOGY GROUP; SOFT-TISSUE SARCOMA; IN-VIVO; N-(4-HYDROXYPHENYL) RETINAMIDE; INTERGROUP RHABDOMYOSARCOMA; ALVEOLAR RHABDOMYOSARCOMA; NEUROBLASTOMA-CELLS; INDUCED APOPTOSIS; DOWN-REGULATION	A subset of paediatric sarcomas are characterized by chromosomal translocations encoding specific oncogenic transcription factors. Such fusion proteins represent tumor specific therapeutic targets although so far it has not been possible to directly inhibit their activity by small-molecule compounds. In this study, we hypothesized that screening a small-molecule library might identify already existing drugs that are able to modulate the transcriptional activity of PAX3/FOXO1, the fusion protein specifically found in the pediatric tumor alveolar rhabdomyosarcoma (aRMS). Towards this end, we established a reporter cell line based on the well characterized PAX3/FOXO1 target gene AP2 beta. A library enriched in mostly FDA approved drugs was screened using specific luciferase activity as read-out and normalized for cell viability. The most effective inhibitor identified from this screen was Fenretinide. Treatment with this compound resulted in down-regulation of PAX3/FOXO1 mRNA and protein levels as well as in reduced expression of several of its direct target genes, but not of wild-type FOXO1, in a dose-and time-dependent manner. Moreover, fenretinide induced reactive oxygen species and apoptosis as shown by caspase 9 and PARP cleavage and upregulated miR-9. Importantly, it demonstrated a significant anti-tumor effect in vivo. These results are similar to earlier reports for two other pediatric tumors, namely neuroblastoma and Ewing sarcoma, where fenretinide is under clinical development. Our results suggest that fenretinide might represent a novel treatment option also for translocation-positive rhabdomyosarcoma.	[Schaefer, Beat W.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich	Schafer, BW (corresponding author), Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch		Schafer, Beat/0000-0001-5988-2915	Cancer Research Switzerland [OCS2264-08-2008]; Swiss Foundation Child and Cancer	Cancer Research Switzerland; Swiss Foundation Child and Cancer	This work was supported by grants from Cancer Research Switzerland (OCS2264-08-2008) and the Swiss Foundation Child and Cancer (http://www.kindundkrebs.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Amstutz R, 2008, CANCER RES, V68, P3767, DOI 10.1158/0008-5472.CAN-07-2447; Ayyanathan K, 2000, CANCER RES, V60, P5803; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Begum S, 2005, ONCOGENE, V24, P1860, DOI 10.1038/sj.onc.1208315; Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Brien DO, 2012, HISTOL HISTOPATHOL, V27, P13, DOI 10.14670/HH-27.13; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; CROUCH GD, 1991, CANCER RES, V51, P4882; DELIA D, 1995, BLOOD, V85, P359, DOI 10.1182/blood.V85.2.359.bloodjournal852359; Denli AM, 2009, NAT STRUCT MOL BIOL, V16, P346, DOI 10.1038/nsmb0409-346; Ebauer M, 2007, ONCOGENE, V26, P7267, DOI 10.1038/sj.onc.1210525; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Ferrari N, 2003, CLIN CANCER RES, V9, P6020; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; FORMELLI F, 1993, CANCER RES, V53, P5374; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gopal AK, 2004, BLOOD, V103, P3516, DOI 10.1182/blood-2003-08-2795; Goto H, 2003, INT J HEMATOL, V78, P219, DOI 10.1007/BF02983798; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hecker RM, 2010, ONCOGENE, V29, P3942, DOI 10.1038/onc.2010.145; Heerema-McKenney A, 2008, AM J SURG PATHOL, V32, P1513, DOI 10.1097/PAS.0b013e31817a909a; HOUGHTON JA, 1982, J NATL CANCER I, V68, P437; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Karmakar Surajit, 2011, World J Oncol, V2, P53; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Koscielniak E, 1999, J CLIN ONCOL, V17, P3706, DOI 10.1200/JCO.1999.17.12.3706; Kutty RK, 2010, MOL VIS, V16, P1475; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; Malone W, 2003, EXPERT OPIN INV DRUG, V12, P1829, DOI 10.1517/eoid.12.11.1829.21882; MARIOTTI A, 1994, J NATL CANCER I, V86, P1245, DOI 10.1093/jnci/86.16.1245; Melguizo C, 2011, ONCOL REP, V26, P755, DOI 10.3892/or.2011.1347; Meyer WH, 2004, CANCER TREAT REV, V30, P269, DOI 10.1016/j.ctrv.2003.11.001; Myatt SS, 2008, ONCOGENE, V27, P985, DOI 10.1038/sj.onc.1210705; Myatt SS, 2005, CLIN CANCER RES, V11, P3136, DOI 10.1158/1078-0432.CCR-04-2050; Oesch S, 2009, MOL CANCER THER, V8, P1838, DOI 10.1158/1535-7163.MCT-08-1147; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Pappo AS, 1999, J CLIN ONCOL, V17, P3487, DOI 10.1200/JCO.1999.17.11.3487; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reynolds CP, 2001, HEMATOL ONCOL CLIN N, V15, P867, DOI 10.1016/S0889-8588(05)70256-2; Ricaud S, 2005, EXP CELL RES, V311, P192, DOI 10.1016/j.yexcr.2005.09.011; Roeb W, 2008, CELL CYCLE, V7, P837, DOI 10.4161/cc.7.7.5652; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943; Smith LM, 2001, J CLIN ONCOL, V19, P4058, DOI 10.1200/JCO.2001.19.20.4058; Smith ME, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-34; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Tosetti F, 2003, MOL PHARMACOL, V63, P565, DOI 10.1124/mol.63.3.565; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271; Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; White DE, 2010, BRIT J CANCER, V103, P1380, DOI 10.1038/sj.bjc.6605896; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	63	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55072	10.1371/journal.pone.0055072	http://dx.doi.org/10.1371/journal.pone.0055072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372815	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400058
J	Trung, LQ; Espinoza, JL; Takami, A; Nakao, S				Trung, Ly Quoc; Espinoza, J. Luis; Takami, Akiyoshi; Nakao, Shinji			Resveratrol Induces Cell Cycle Arrest and Apoptosis in Malignant NK Cells via JAK2/STAT3 Pathway Inhibition	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NATURAL-KILLER-CELLS; CONSTITUTIVE ACTIVATION; CARCINOMA-CELLS; L-ASPARAGINASE; NASAL-TYPE; MOLECULAR TARGETS; CANCER CELLS; HUMAN TUMORS; STAT3	Natural killer (NK) cell malignancies, particularly aggressive NK cell leukaemias and lymphomas, have poor prognoses. Although recent regimens with L-asparaginase substantially improved outcomes, novel therapeutic approaches are still needed to enhance clinical response. Resveratrol, a naturally occurring polyphenol, has been extensively studied for its anti-inflammatory, cardioprotective and anti-cancer activities. In this study, we investigated the potential anti-tumour activities of resveratrol against the NK cell lines KHYG-1, NKL, NK-92 and NK-YS. Resveratrol induced robust G0/G1 cell cycle arrest, significantly suppressed cell proliferation and induced apoptosis in a dose-and time-dependent manner for all four cell lines. In addition, resveratrol suppressed constitutively active STAT3 in all the cell lines and inhibited JAK2 phosphorylation but had no effect on other upstream mediators of STAT3 activation, such as PTEN, TYK2, and JAK1. Resveratrol also induced downregulation of the anti-apoptotic proteins MCL1 and survivin, two downstream effectors of the STAT3 pathway. Finally, resveratrol induced synergistic effect on the apoptotic and antiproliferative activities of L-asparaginase against KHYG-1, NKL and NK-92 cells. These results suggest that resveratrol may have therapeutic potential against NK cell malignancies. Furthermore, our finding that resveratrol is a bonafide JAK2 inhibitor extends its potential benefits to other diseases with dysregulated JAK2 signaling.	[Trung, Ly Quoc; Espinoza, J. Luis; Nakao, Shinji] Kanazawa Univ, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Takami, Akiyoshi] Kanazawa Univ Hosp, Dept Haematol & Oncol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Espinoza, JL (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan.	luis1.esp2.cd@outlook.com	Espinoza, J. Luis/L-1586-2013	Espinoza, J. Luis/0000-0002-1794-6666; Takami, Akiyoshi/0000-0002-1822-9976	Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports and Technology; Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku GanKikin Fund (Kanazawa, Japan)	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku GanKikin Fund (Kanazawa, Japan)	This study was supported by grants from the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports and Technology, as well as funds from the Mitani Research and Development Assistance Organization (Kanazawa, Japan), the Japan Leukemia Research Fund (Tokyo, Japan) and the Hokkoku GanKikin Fund (Kanazawa, Japan). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ai WZY, 2012, BRIT J HAEMATOL, V156, P626, DOI 10.1111/j.1365-2141.2011.08982.x; Albani D, 2009, J NEUROCHEM, V110, P1445, DOI 10.1111/j.1471-4159.2009.06228.x; Ando M, 2005, BRIT J HAEMATOL, V130, P860, DOI 10.1111/j.1365-2141.2005.05694.x; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Bai L, 2008, MOL CELL BIOCHEM, V307, P129, DOI 10.1007/s11010-007-9592-5; Bjorklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Buettner R, 2002, CLIN CANCER RES, V8, P945; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Chen Y, 2004, SURGERY, V136, P57, DOI 10.1016/j.surg.2004.01.017; Cheung MMC, 2003, SEMIN HEMATOL, V40, P221, DOI 10.1016/S0037-1963(03)00136-7; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Coppo P, 2009, LEUKEMIA, V23, P1667, DOI 10.1038/leu.2009.91; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; Della Ragione F, 1998, BIOCHEM BIOPH RES CO, V250, P53, DOI 10.1006/bbrc.1998.9263; Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Grund EM, 2005, J IMMUNOL METHODS, V296, P31, DOI 10.1016/j.jim.2004.10.008; Gui W, 2011, MED ONCOL, V28, pS367, DOI 10.1007/s12032-010-9756-0; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Ham MF, 2010, INT J HEMATOL, V92, P681, DOI 10.1007/s12185-010-0738-y; Hsieh TC, 2011, INT J CANCER, V129, P2732, DOI 10.1002/ijc.25930; Jaccard A, 2009, ANN ONCOL, V20, P110, DOI 10.1093/annonc/mdn542; Jager R, 2010, HAEMATOL-HEMATOL J, V95, P526, DOI 10.3324/haematol.2009.019570; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwong YL, 2005, LEUKEMIA, V19, P2186, DOI 10.1038/sj.leu.2403955; Kwong YL, 2011, J CLIN EXP HEMATOP, V51, P21; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Li T, 2010, INT IMMUNOPHARMACOL, V10, P18, DOI 10.1016/j.intimp.2009.09.009; Liu BQ, 2010, BIOCHEM BIOPH RES CO, V391, P778, DOI 10.1016/j.bbrc.2009.11.137; Luzi C, 2004, BIOCHEM PHARMACOL, V68, P2019, DOI 10.1016/j.bcp.2004.07.002; Madan E, 2008, BIOCHEM BIOPH RES CO, V377, P1232, DOI 10.1016/j.bbrc.2008.10.158; Markasz L, 2007, MOL CANCER THER, V6, P644, DOI 10.1158/1535-7163.MCT-06-0358; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mora LB, 2002, CANCER RES, V62, P6659; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Ng SB, 2011, J PATHOL, V223, P496, DOI 10.1002/path.2823; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Podhorecka M, 2011, ANN HEMATOL, V90, P173, DOI 10.1007/s00277-010-1045-7; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sakajiri S, 2001, JPN J CANCER RES, V92, P1048, DOI 10.1111/j.1349-7006.2001.tb01059.x; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Suzuki R, 2010, INT J HEMATOL, V92, P697, DOI 10.1007/s12185-010-0726-2; Trincheri NF, 2008, CARCINOGENESIS, V29, P381, DOI 10.1093/carcin/bgm271; Tsuchiyama J, 1998, BLOOD, V92, P1374, DOI 10.1182/blood.V92.4.1374.416a33_1374_1383; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Wieczorek M, 2012, CYTOKINE GROWTH FACT; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; Yasuda H, 2009, EUR J HAEMATOL, V82, P39, DOI 10.1111/j.1600-0609.2008.01152.x; Yin WH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-15; Yong WB, 2009, ANN HEMATOL, V88, P647, DOI 10.1007/s00277-008-0669-3; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071	64	74	75	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55183	10.1371/journal.pone.0055183	http://dx.doi.org/10.1371/journal.pone.0055183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372833	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400073
J	Cao-Ehlker, X; Zong, XG; Hammelmann, V; Gruner, C; Fenske, S; Michalakis, S; Wahl-Schott, C; Biel, M				Cao-Ehlker, Xiaochun; Zong, Xiangang; Hammelmann, Verena; Gruner, Christian; Fenske, Stefanie; Michalakis, Stylianos; Wahl-Schott, Christian; Biel, Martin			Up-regulation of Hyperpolarization-activated Cyclic Nucleotide-gated Channel 3 (HCN3) by Specific Interaction with K+ Channel Tetramerization Domain-containing Protein 3 (KCTD3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACEMAKER CHANNEL; CATION CHANNEL; WD-REPEAT; TRIP8B; TRAFFICKING; SUBUNIT; LOCALIZATION; MODULATION; EXPRESSION; FAMILY	Most ion channels consist of the principal ion-permeating core subunit(s) and accessory proteins that are assembled with the channel core. The biological functions of the latter proteins are diverse and include the regulation of the biophysical properties of the ion channel, its connection to signaling pathways and the control of its cell surface expression. There is recent evidence that native hyperpolarization-activated cyclic nucleotide-gated channel complexes (HCN1-4) also contain accessory subunits, among which TRIP8b (tetratricopeptide repeat-containing Rab8b-interacting protein) has been most extensively studied. Here, we identify KCTD3, a so far uncharacterized member of the potassium channel tetramerization-domain containing (KCTD) protein family as an HCN3-interacting protein. KCTD3 is widely expressed in brain and some non-neuronal tissues and colocalizes with HCN3 in specific regions of the brain including hypothalamus. Within the HCN channel family, KCTD3 specifically binds to HCN3 and leads to a profound up-regulation of cell surface expression and current density of this channel. HCN3 can also functionally interact with TRIP8b; however, we found no evidence for channel complexes containing both TRIP8b and KCTD3. The C terminus of HCN3 is crucially required for functional interaction with KCTD3. Replacement of the cytosolic C terminus of HCN2 by the corresponding domain of HCN3 renders HCN2 sensitive to regulation by KCTD3. The C-terminal-half of KCTD3 is sufficient for binding to HCN3. However, the complete protein including the N-terminal tetramerization domain is needed for HCN3 current up-regulation. Together, our experiments indicate that KCTD3 is an accessory subunit of native HCN3 complexes.	Univ Munich, Ctr Integrated Prot Sci CIPS M, D-81377 Munich, Germany; Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany	University of Munich; University of Munich	Biel, M (corresponding author), Univ Munich, Dept Pharm, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de	Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019; Biel, Martin/G-1175-2014; Wahl-Schott, Christian A/J-2623-2015	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Fenske, Stefanie/0000-0002-6994-8401	Deutsche Forschungsgemeinschaft (DFG); Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 870 (SFB 870)]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was support by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Sonderforschungsbereich 870 (SFB 870).	Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Barbuti A, 2007, J MOL CELL CARDIOL, V42, P71, DOI 10.1016/j.yjmcc.2006.09.018; Baruscotti M, 2010, J MOL CELL CARDIOL, V48, P55, DOI 10.1016/j.yjmcc.2009.06.019; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hammelmann V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017078; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Hurtado R, 2010, KIDNEY INT, V77, P500, DOI 10.1038/ki.2009.483; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kimura K, 2004, GENES CELLS, V9, P631, DOI 10.1111/j.1356-9597.2004.00752.x; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Michalakis S, 2011, J NEUROSCI, V31, P133, DOI 10.1523/JNEUROSCI.4735-10.2011; Michels G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001511; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	56	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7580	7589		10.1074/jbc.M112.434803	http://dx.doi.org/10.1074/jbc.M112.434803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382386	Green Published, hybrid			2022-12-25	WOS:000316455300015
J	Rossi, N; Mantelatto, FL				Rossi, Natalia; Mantelatto, Fernando Luis			Molecular Analysis of the Freshwater Prawn Macrobrachium olfersii (Decapoda, Palaemonidae) Supports the Existence of a Single Species throughout Its Distribution	PLOS ONE			English	Article							POPULATION-GENETICS; MITOCHONDRIAL-DNA; 1868 CRUSTACEA; RIVER SHRIMP; PHYLOGENY; DIVERGENCE; EVOLUTION; MODEL; MORPHOTYPES; SYSTEMATICS	Macrobrachium olfersii is an amphidromous freshwater prawn, widespread along the eastern coasts of the Americas. This species shows great morphological modifications during ontogenesis, and several studies have verified the existence of a wide intraspecific variation. Because of this condition, the species is often misidentified, and several synonyms have been documented. To elucidate these aspects, individuals of M. olfersii from different populations along its range of distribution were investigated. The taxonomic limit was established, and the degree of genetic variability of this species was described. We extracted DNA from 53 specimens of M. olfersii, M. americanum, M. digueti and M. faustinum, which resulted in 84 new sequences (22 of 16S mtDNA, 45 of Cythocrome Oxidase I (COI) mtDNA, and 17 of Histone (H3) nDNA). Sequences of three genes (single and concatenated) from these species were used in the Maximum Likelihood and Bayesian Inference phylogenetic analyses and COI sequences from M. olfersii were used in population analysis. The genetic variation was evaluated through the alignment of 554 bp from the 16S, 638 bp from the COI, and 338 bp from the H3. The rates of genetic divergence among populations were lower at the intraspecific level. This was confirmed by the haplotype net, which showed a continuous gene flow among populations. Although a wide distribution and high morphological intraspecific variation often suggest the existence of more than one species, genetic similarity of Caribbean and Brazilian populations of M. olfersii supported them as a single species.	[Rossi, Natalia; Mantelatto, Fernando Luis] Univ Sao Paulo, Lab Bioecol & Crustacean Systemat LBSC, Program Comparat Biol, Dept Biol,Fac Philosophy Sci & Letters Ribeirao P, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Rossi, N (corresponding author), Univ Sao Paulo, Lab Bioecol & Crustacean Systemat LBSC, Program Comparat Biol, Dept Biol,Fac Philosophy Sci & Letters Ribeirao P, BR-14049 Ribeirao Preto, SP, Brazil.	nataliarossi.bio@gmail.com; flmantel@usp.br	Rossi, Natalia/B-5877-2011; Mantelatto, Fernando/N-9536-2019; Mantelatto, Fernando/GQI-1333-2022; Fapesp, Biota/F-8655-2017	Rossi, Natalia/0000-0002-1706-2238; Mantelatto, Fernando/0000-0002-8497-187X; Mantelatto, Fernando/0000-0002-8497-187X; Fapesp, Biota/0000-0002-9887-8449	Fundacaco de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/12409-5, Tematico Biota 2010/50188-8, Colecoes Cientificas 2009/54931-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472746/2004-9, 473050/2007-2, 491490/2004-6, 490353/2007-0, 471011/2011-8, PQ 301261/2004-0, 302748/2010-5]	Fundacaco de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This contribution is part of a multidisciplinary research project Tematico BIOTA - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), which aims to produce a fine-scale assessment of the marine/estuarine decapod biodiversity. This research is also part of the MSc Dissertation of NR and was supported by a fellowship from the Fundacaco de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2009/12409-5). Partial support for visits to European museums was provided by the Senckenberg Naturmuseum und Forschungsinstitut to NR. Additional support for this study was also provided by FAPESP (Tematico Biota 2010/50188-8; Colecoes Cientificas 2009/54931-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Research Grants 472746/2004-9, 473050/2007-2, 491490/2004-6, 490353/2007-0, 471011/2011-8; Research Scholarships PQ 301261/2004-0, 302748/2010-5) to FLM. The ongoing PhD fellowship to NR was awarded by CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar Dib, 2001, Revista Brasileira de Zoologia, V18, P529, DOI 10.1590/S0101-81752001000200024; ANDERSON G, 1980, CRUSTACEANA, V39, P90, DOI 10.1163/156854080X00319; Ashelby CW, 2012, ZOOL SCR, V41, P293, DOI 10.1111/j.1463-6409.2012.00535.x; Baker N, 2008, FRESHWATER BIOL, V53, P1592, DOI 10.1111/j.1365-2427.2008.01996.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barros M.P., 1995, BIOCI NCIAS, V3, P239; Bauer RT, 2008, J CRUSTACEAN BIOL, V28, P622, DOI 10.1651/08-2977.1; Bauer Raymond T., 2011, V15, P145; Bowles DE, 2000, J CRUSTACEAN BIOL, V20, P158, DOI 10.1651/0278-0372(2000)020[0158:MDCPIT]2.0.CO;2; Boxshall GA, 2000, ADV ECOL RES, V31, P61, DOI 10.1016/S0065-2504(00)31007-8; Bracken Heather D., 2009, Arthropod Systematics & Phylogeny, V67, P99; Chace F. A., 1969, Bulletin United States National Museum, V292, P1; CHOUDHURY P C, 1970, Crustaceana (Leiden), V18, P113, DOI 10.1163/156854070X00743; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Crandall KA, 2000, P ROY SOC B-BIOL SCI, V267, P1679, DOI 10.1098/rspb.2000.1195; Crandall KA, 1996, SYST BIOL, V45, P1; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; DUGGER D M, 1975, Crustaceana (Leiden), V29, P1, DOI 10.1163/156854075X00018; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GAMBA A L, 1982, Caribbean Journal of Science, V18, P23; GAMBA AL, 1987, B MAR SCI, V40, P454; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HEDGPETH JOEL W., 1949, TEXAS JOUR SCI, V1, P28; Holthuis L. B., 1952, Occasional Papers of the Allan Hancock Foundation, VNo. 12, P1; HOLTHUIS L B, 1970, Crustaceana (Leiden), V19, P211, DOI 10.1163/156854070X00545; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JALIHAL DR, 1993, CRUSTACEANA, V65, P363, DOI 10.1163/156854093X00793; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Liu MY, 2007, ZOOL STUD, V46, P272; Mantelatto F.L., 2009, CRUSTACEAN ISSUES DE, P567, DOI [10.1201/9781420092592-38, DOI 10.1201/9781420092592-C29]; Mantelatto FL, 2007, ZOOL J LINN SOC-LOND, V150, P211, DOI 10.1111/j.1096-3642.2007.00298.x; Mantelatto FL, 2009, ZOOTAXA, P20, DOI 10.11646/zootaxa.2133.1.2; Mathews LM, 2006, MOL ECOL, V15, P4049, DOI 10.1111/j.1365-294X.2006.03077.x; Melo GAS., 2003, MANUAL IDENTIFICA O, P289; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P44; Moraes-Riodades PMC, 2004, AQUACULTURE, V236, P297, DOI 10.1016/j.aquaculture.2004.02.015; Morrison CL, 2004, MOL PHYLOGENET EVOL, V30, P563, DOI 10.1016/S1055-7903(03)00252-5; Mossolin EC, 2003, CRUSTACEANA, V76, P363, DOI 10.1163/156854003765911748; Mossolin EC, 2002, J CRUSTACEAN BIOL, V22, P367, DOI 10.1651/0278-0372(2002)022[0367:RBOMOD]2.0.CO;2; Muller YMR, 2003, J CRUSTACEAN BIOL, V23, P869, DOI 10.1651/C-2408; Munasinghe DHN, 2010, J NATL SCI FOUND SRI, V38, P193, DOI 10.4038/jnsfsr.v38i3.2309; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Murphy NP, 2004, AUST J ZOOL, V52, P549, DOI 10.1071/ZO03062; Ng PKL, 2010, ZOOL STUD, V49, P544; Ortmann A.E., 1897, REV MUSEU PAULISTA, V2, P173; Page TJ, 2008, J N AM BENTHOL SOC, V27, P68, DOI 10.1899/07-044R.1; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Pileggi LG, 2012, IHERINGIA SER ZOOL, V102, P426, DOI 10.1590/S0073-47212012005000012; Pileggi LG, 2010, INVERTEBR SYST, V24, P194, DOI 10.1071/IS09043; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ranbaut A, 2007, FIGTREE; RATHBUN M. J., 1900, P WASHINGTON ACAD SC, V2, P133; Robles Rafael, 2009, Crustacean Issues, V18, P309; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sawaya M. P., 1946, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo Zoologica, VNo. 11, P393; Schnabel KE, 2011, MOL PHYLOGENET EVOL, V58, P157, DOI 10.1016/j.ympev.2010.11.011; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Schwander T, 2011, TRENDS ECOL EVOL, V26, P143, DOI 10.1016/j.tree.2010.12.010; Short JW, 2004, HYDROBIOLOGIA, V525, P1, DOI 10.1023/B:HYDR.0000038871.50730.95; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Templeton A.R., 1994, Experientia Supplementum (Basel), V69, P455; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torati LS, 2012, J CRUSTACEAN BIOL, V32, P625, DOI 10.1163/193724012X635322; Valencia Diego M., 2007, Zootaxa, V1456, P1; Vergamini FG, 2011, CONTRIB ZOOL, V80, P67, DOI 10.1163/18759866-08001003; Villalobos F.A., 1969, FAO FISHERIES REPORT, V57, P1055; von Rintelen K, 2012, MOL PHYLOGENET EVOL, V63, P82, DOI 10.1016/j.ympev.2011.12.015; Williams A.B., 1984, pi; Wortham JL, 2012, J CRUSTACEAN BIOL, V32, P545, DOI 10.1163/193724012X637311; Wowor D, 2009, MOL PHYLOGENET EVOL, V52, P340, DOI 10.1016/j.ympev.2009.01.002; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	82	41	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54698	10.1371/journal.pone.0054698	http://dx.doi.org/10.1371/journal.pone.0054698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382941	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600035
J	Yu, MM; Jiang, Q; Gu, XJ; Ju, LL; Ji, Y; Wu, KH; Jiang, HX				Yu, Minmin; Jiang, Qian; Gu, Xiaojun; Ju, Lili; Ji, Ying; Wu, Kaihua; Jiang, Hongxiu			Correlation between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta	PLOS ONE			English	Article							HBV INTRAUTERINE INFECTION; DNA; SPERMATOZOA; HBCAG; PATHOGENESIS; MECHANISM; BARRIER; OVA	Background: The aim of this study was to investigate the correlation between the expression of hepatitis B surface antigen (HBsAg) in human ovary and placenta and the vertical transmission of hepatitis B virus (HBV). Methodology/Principal Fidnings: Ovarian and placental tissue specimens of pregnant women infected with HBV were collected during cesarean section and immunostained for HBsAg. The sera of the corresponding newborns were tested for HBV markers and HBV DNA. HBsAg was detected in 15 out of 33 (45%) placental tissues and was further detected in capillary endothelial cells in 4 specimens (26%), of which 3 (75%) corresponding infants were infected with HBV in utero. Out of the 33 ovarian tissues, 7 (21%) were positive for HBsAg, of which 2 (28%) showed HBsAg in ovarian follicles and the 2 corresponding infants (100%) had intrauterine HBV infection. Conclusions/Significance: HBsAg expression in cells of the ovarian follicle or placental capillary endothelium signal a higher risk for intrauterine HBV infection.	[Yu, Minmin; Ju, Lili; Ji, Ying; Wu, Kaihua; Jiang, Hongxiu] Southeast Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Jiang, Qian] Yixing Peoples Hosp, Dept Obstet & Gynecol, Yixing, Jiangsu, Peoples R China; [Gu, Xiaojun] Southeast Univ, Affiliated Hosp 2, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yu, MM (corresponding author), Southeast Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China.	yuminmin324@126.com; 999gu@163.com			Natural Science Foundation of Jiangsu Province [BK2008070]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Natural Science Foundation of Jiangsu Province (Grant No. BK2008070). We are grateful to associate professor Lanxia Liu and Hongmei Zhang in our hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BA, 2005, MOL REPROD DEV, V70, P30, DOI 10.1002/mrd.20185; Amarapurkar Deepak N, 2002, Ann Hepatol, V1, P192; Bai GQ, 2011, ARCH GYNECOL OBSTET, V283, P317, DOI 10.1007/s00404-010-1366-8; Bai H, 2007, WORLD J GASTROENTERO, V13, P3625, DOI 10.3748/wjg.v13.i26.3625; Bhat P, 2007, J VIROL, V81, P7200, DOI 10.1128/JVI.02371-06; Chen LZ, 2005, WORLD J GASTROENTERO, V11, P5565, DOI 10.3748/wjg.v11.i35.5565; Chunyan Y, 2000, J HEPATOL, V8, P124; DAVISON F, 1987, J HEPATOL, V4, P37, DOI 10.1016/S0168-8278(87)80007-7; Gatta A, 2008, CLIN EXP RHEUMATOL, V26, pS33; HADCHOUEL M, 1985, J MED VIROL, V16, P61, DOI 10.1002/jmv.1890160109; Han Steven-Huy B, 2004, Clin Liver Dis, V8, P403, DOI 10.1016/j.cld.2004.02.003; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Lang Z W, 1993, Zhonghua Yi Xue Za Zhi, V73, P329; Li XM, 2004, WORLD J GASTROENTERO, V10, P3215; LIN CY, 1993, NEPHRON, V63, P58, DOI 10.1159/000187144; Lou H, 2010, J INT MED RES, V38, P214, DOI 10.1177/147323001003800125; Ma J, 2000, Zhonghua Fu Chan Ke Za Zhi, V35, P654; Ranger-Rogez S, 2002, PATHOL BIOL, V50, P568, DOI 10.1016/S0369-8114(02)00351-6; URSELL PC, 1984, HUM PATHOL, V15, P481, DOI 10.1016/S0046-8177(84)80085-4; Wang An-hui, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P51; Xia Guo-liang, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P362; Ye F, 2006, AM J OBSTET GYNECOL, V194, P387, DOI 10.1016/j.ajog.2005.07.011; Ye F, 2005, WORLD J GASTROENTERO, V11, P5718, DOI 10.3748/wjg.v11.i36.5718; Zhang SL, 2004, WORLD J GASTROENTERO, V10, P437	24	18	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54246	10.1371/journal.pone.0054246	http://dx.doi.org/10.1371/journal.pone.0054246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382883	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600026
J	Allam, SR; Kruger, B; Mehrotra, A; Schiano, T; Schroppel, B; Murphy, B				Allam, Sridhar R.; Krueger, Bernd; Mehrotra, Anita; Schiano, Thomas; Schroeppel, Bernd; Murphy, Barbara			The Association of IL28B Polymorphism and Graft Survival in Patients with Hepatitis C Undergoing Liver Transplantation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; SPONTANEOUS CLEARANCE; PEGYLATED INTERFERON; RIBAVIRIN THERAPY; UNITED-STATES; VIRUS; EXPRESSION; INFECTION; GENOTYPE	Hepatitis C virus (HCV) infection is the leading cause of liver transplantation (LT) in Western countries. Polymorphism in the IL28B gene region has a major impact on the natural history and response to antiviral treatment in HCV. We investigated whether IL28B polymorphism was associated with graft survival in patients with or without HCV undergoing LT. 1,060 adult patients (age >18 years) underwent LT between years 2000 and 2008. Patients with previous LT, living donor LT and patients dying or requiring retransplants within 30 days of LT were excluded. DNA samples of 620 (84%) recipients and 377 (51%) donors were available for genotyping of IL28B rs12979860C>T. Donor IL28B genotypes had no significant differences in graft survival irrespective of HCV status. There was no difference in graft outcome in the non-HCV cohort (n = 293) based on recipient IL28B genotype. In the HCV group (n = 327), recipients with CC or CT genotype had better graft survival compared to TT genotype (62% vs. 48%, p = 0.02). HCV recipients with CC or CT genotype had delayed time to clinically relevant HCV recurrence compared to TT (10.4 vs. 6.7 months, p = 0.002). The beneficial effect of the CC/CT genotype on HCV recurrence and graft survival was independent of antiviral treatment. In conclusion, our study demonstrated that in contrast to donor IL28B genotype recipient IL28B was associated with graft survival and clinically relevant HCV recurrence in HCV infected recipients. No effect of IL28B genotype was manifest in non-HCV LT recipients.	[Allam, Sridhar R.; Mehrotra, Anita; Schroeppel, Bernd; Murphy, Barbara] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Krueger, Bernd] Heidelberg Univ, Med Fak Mannheim, Univ Med Mannheim, Med Klin 5, Mannheim, Germany; [Schiano, Thomas] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Schiano, Thomas] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Murphy, B (corresponding author), Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA.	Barbara.Murphy@mssm.edu	Allam, Sridhar/AAQ-8582-2020; Krüger, Bernd/F-5781-2011	Allam, Sridhar/0000-0001-6051-9443; 	American Society of Transplant Surgeons (ASTS) - Pfizer mid-level faculty award; National Institutes of Health (NIH) [UL1RR029887]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER	American Society of Transplant Surgeons (ASTS) - Pfizer mid-level faculty award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by American Society of Transplant Surgeons (ASTS) - Pfizer mid-level faculty award (B. S.), and National Institutes of Health (NIH) grant UL1RR029887 (B.M.). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; Cisneros E, 2012, TRANSPLANTATION, V94, P275, DOI 10.1097/TP.0b013e31825668f6; Coto-Llerena M, 2011, AM J TRANSPLANT, V11, P1051, DOI 10.1111/j.1600-6143.2011.03491.x; Coto-Llerena M, 2012, J HEPATOL, V56, P355, DOI 10.1016/j.jhep.2011.07.027; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Duarte-Rojo A, 2012, TRANSPLANTATION, V94, P197, DOI 10.1097/TP.0b013e3182547551; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghobrial RM, 2001, ANN SURG, V234, P384, DOI 10.1097/00000658-200109000-00012; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Kemmer N, 2007, TRANSPL P, V39, P1477, DOI 10.1016/j.transproceed.2006.11.012; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lange CM, 2011, J HEPATOL, V55, P322, DOI 10.1016/j.jhep.2010.10.037; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Shebl FM, 2010, GASTROENTEROLOGY, V139, P1422, DOI 10.1053/j.gastro.2010.07.055; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thuluvath PJ, 2007, LIVER TRANSPLANT, V13, P719, DOI 10.1002/lt.21123; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; U.S. Department of Health and Human Services HRaSA Healthcare Systems Bureau Division of Transplantation, 2008, 2008 ANN REP US ORG; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Veldt BJ, 2008, AM J TRANSPLANT, V8, P2426, DOI 10.1111/j.1600-6143.2008.02362.x; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54854	10.1371/journal.pone.0054854	http://dx.doi.org/10.1371/journal.pone.0054854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382988	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800082
J	Colleoni, F; Padmanabhan, N; Yung, HW; Watson, ED; Cetin, I; van Patot, MCT; Burton, GJ; Murray, AJ				Colleoni, Francesca; Padmanabhan, Nisha; Yung, Hong-wa; Watson, Erica D.; Cetin, Irene; van Patot, Martha C. Tissot; Burton, Graham J.; Murray, Andrew J.			Suppression of Mitochondrial Electron Transport Chain Function in the Hypoxic Human Placenta: A Role for miRNA-210 and Protein Synthesis Inhibition	PLOS ONE			English	Article							HIGH-ALTITUDE HYPOXIA; OXIDATIVE STRESS; NITRIC-OXIDE; METABOLIC ADAPTATION; GROWTH RESTRICTION; SKELETAL-MUSCLE; OXYGEN; MICRORNA-210; PREECLAMPSIA; RESPIRATION	Fetal growth is critically dependent on energy metabolism in the placenta, which drives active exchange of nutrients. Placental oxygen levels are therefore vital, and chronic hypoxia during pregnancy impairs fetal growth. Here we tested the hypothesis that placental hypoxia alters mitochondrial electron transport chain (ETS) function, and sought to identify underlying mechanisms. We cultured human placental cells under different oxygen concentrations. Mitochondrial respiration was measured, alongside levels of ETS complexes. Additionally, we studied placentas from sea-level and high-altitude pregnancies. After 4 d at 1% O-2 (1.01 KPa), complex I-supported respiration was 57% and 37% lower, in trophoblast-like JEG3 cells and fibroblasts, respectively, compared with controls cultured at 21% O-2 (21.24 KPa); complex IV-supported respiration was 22% and 30% lower. Correspondingly, complex I levels were 45% lower in placentas from high-altitude pregnancies than those from sea-level pregnancies. Expression of HIF-responsive microRNA-210 was increased in hypoxic fibroblasts and high-altitude placentas, whilst expression of its targets, iron-sulfur cluster scaffold (ISCU) and cytochrome c oxidase assembly protein (COX10), decreased. Moreover, protein synthesis inhibition, a feature of the high-altitude placenta, also suppressed ETS complex protein levels. Our results demonstrate that mitochondrial function is altered in hypoxic human placentas, with specific suppression of complexes I and IV compromising energy metabolism and potentially contributing to impaired fetal growth.	[Colleoni, Francesca; Padmanabhan, Nisha; Yung, Hong-wa; Watson, Erica D.; van Patot, Martha C. Tissot; Burton, Graham J.; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Colleoni, Francesca; Padmanabhan, Nisha; Yung, Hong-wa; Watson, Erica D.; van Patot, Martha C. Tissot; Burton, Graham J.; Murray, Andrew J.] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Cetin, Irene] Univ Milan, Unit Obstet & Gynecol, Dept Clin Sci Luigi Sacco, Milan, Italy	University of Cambridge; University of Cambridge; University of Milan; Luigi Sacco Hospital	Colleoni, F (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	fc316@cam.ac.uk	cetin, irene/K-6112-2016; Padmanabhan, Nisha/ABE-4879-2020	cetin, irene/0000-0002-9217-3034; Padmanabhan, Nisha/0000-0003-1253-2162; Murray, Andrew/0000-0002-0929-9315; Watson, Erica/0000-0003-4496-2271; Tissot van Patot, Martha/0000-0002-2934-366X	Research Councils UK; Wellcome Trust [084804/2/08/Z]; Action Medical Research [SP4545]; Action Medical Research [1776] Funding Source: researchfish	Research Councils UK(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; Action Medical Research	Dr Murray thanks the Research Councils UK for supporting his academic fellowship and Prof Burton gratefully acknowledges support for his research from the Wellcome Trust (084804/2/08/Z). This study was primarily supported by Action Medical Research, project grant number SP4545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Colleoni F, 2012, PLACENTA, V33, P122, DOI 10.1016/j.placenta.2011.11.019; Gandley RE, 2008, HYPERTENSION, V52, P387, DOI 10.1161/HYPERTENSIONAHA.107.107532; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Illsley NP, 2010, INT J DEV BIOL, V54, P409, DOI 10.1387/ijdb.082798ni; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lee DC, 2011, AM J PATHOL, V179, P590, DOI 10.1016/j.ajpath.2011.04.035; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Many A, 2000, AM J PATHOL, V156, P321, DOI 10.1016/S0002-9440(10)64733-5; MATSUO H, 1994, ENDOCRINOLOGY, V135, P1135, DOI 10.1210/en.135.3.1135; Melillo G, 1997, J BIOL CHEM, V272, P12236, DOI 10.1074/jbc.272.18.12236; Moore LG, 2003, HIGH ALT MED BIOL, V4, P141, DOI 10.1089/152702903322022767; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Murray AJ, 2012, PLACENTA, V33, pE16, DOI 10.1016/j.placenta.2012.06.006; Murray AJ, 2007, CURR OPIN CLIN NUTR, V10, P704, DOI 10.1097/MCO.0b013e3282f0ecbe; Murray AJ, 2009, GENOME MED, V1, DOI 10.1186/gm117; Palmer SK, 1999, AM J OBSTET GYNECOL, V180, P1161, DOI 10.1016/S0002-9378(99)70611-3; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rennie J.M., 2002, FETAL MATERN MED REV, V13, P157, DOI [10.1017/S0965539502000311, DOI 10.1017/S0965539502000311]; Simon MC, 2006, CELL METAB, V3, P150, DOI 10.1016/j.cmet.2006.02.007; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	51	83	87	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55194	10.1371/journal.pone.0055194	http://dx.doi.org/10.1371/journal.pone.0055194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383105	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800127
J	Denner, J; Eschricht, M; Lauck, M; Semaan, M; Schlaermann, P; Ryu, H; Akyuz, L				Denner, Joachim; Eschricht, Magdalena; Lauck, Michael; Semaan, Marwan; Schlaermann, Philipp; Ryu, Hyunmi; Akyuez, Levent			Modulation of Cytokine Release and Gene Expression by the Immunosuppressive Domain of gp41 of HIV-1	PLOS ONE			English	Article							PROTEIN-KINASE-C; SYNTHETIC PEPTIDE; SEQUENCE IDENTITY; ENVELOPE PROTEIN; LYMPHOCYTE-PROLIFERATION; IMMUNE-RESPONSE; INNATE IMMUNITY; HUMAN MONOCYTES; IL-6 LEVELS; VIRUS	The transmembrane envelope protein gp41 of the human immunodeficiency virus HIV-1 plays an important role during infection allowing fusion of the viral and cellular membrane. In addition, there is increasing evidence that gp41 may contribute to the immunodeficiency induced by HIV-1. Recombinant gp41 and a synthetic peptide corresponding to a highly conserved domain in gp41, the immunosuppressive (isu) domain, have been shown to inhibit mitogen-induced activation of human peripheral blood mononuclear cells (PBMCs) and to increase release of IL-6 and IL-10 from these cells. We recently reported that a single mutation in the isu domain of gp41 abrogated the immunosuppressive properties and that HIV-1 sequences containing such abrogating mutations had never been isolated from infected individuals. Here, we studied the influence of the isu peptide on the release of 66 cytokines and the expression of 27,000 genes in PBMCs. Incubation of PBMCs with isu peptide homopolymers increased the expression of 16 cytokines among them IL-6 and IL-10, and decreased that of IL-2 and CXCL9. Interestingly, the extend of cytokine modulation was donor-dependent. Among the genes up-regulated were IL-6, IL-8, IL-10 but also MMP-1, TREM-1 and IL-1beta. Most importantly, genes involved in innate immunity such as FCN1 and SEPP1 were found down-regulated. Many changes in cytokine expression demonstrated in our experiments were also found in HIV-1 infected individuals. These data indicate that the isu domain of gp41 has a broad impact on gene expression and cytokine release and therefore may be involved in HIV-1 induced immunopathogenesis.	[Denner, Joachim; Eschricht, Magdalena; Lauck, Michael; Semaan, Marwan; Schlaermann, Philipp; Ryu, Hyunmi; Akyuez, Levent] Robert Koch Inst, Berlin, Germany	Robert Koch Institute	Denner, J (corresponding author), Robert Koch Inst, Berlin, Germany.	Denner@rki.de	Schlaermann, Philipp/AAN-4861-2020	Schlaermann, Philipp/0000-0001-8586-6417	German AIDS Foundation; Berliner Sparkassenstiftung Medizin	German AIDS Foundation; Berliner Sparkassenstiftung Medizin	The authors thank the German AIDS Foundation (http://www.aids-stiftung.de/) and the Berliner Sparkassenstiftung Medizin (http://www.berliner-sparkassenstiftung-medizin.de/) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAVENA C, 1995, BIOL TRACE ELEM RES, V47, P133, DOI 10.1007/BF02790110; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; Barcova M, 1999, PFLUG ARCH EUR J PHY, V437, P538, DOI 10.1007/s004240050815; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; BREEN EC, 1990, J IMMUNOL, V144, P480; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; Denner J, 1998, ANN NY ACAD SCI, V862, P75, DOI 10.1111/j.1749-6632.1998.tb09119.x; Denner J, 1996, J ACQ IMMUN DEF SYND, V12, P442, DOI 10.1097/00042560-199608150-00002; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; Denner J, 2000, J HUMAN VIROL, V3, P81; Denner J, 1995, J CANCER RES CLIN, V121, P35; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DWORKIN BM, 1994, CHEM-BIOL INTERACT, V91, P181, DOI 10.1016/0009-2797(94)90038-8; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Ghorpade A, 2001, J VIROL, V75, P6572, DOI 10.1128/JVI.75.14.6572-6583.2001; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Gomez-Pina V, 2012, J LEUKOCYTE BIOL, V91, P933, DOI 10.1189/jlb.0711340; GOTTLIEB RA, 1990, J IMMUNOL, V145, P2566; HARAGUCHI S, 1995, IMMUNOL TODAY, V16, P595, DOI 10.1016/0167-5699(95)80083-2; Haraguchi S, 2008, IMMUNOL RES, V41, P46, DOI 10.1007/s12026-007-0039-6; Hartman AL, 2008, J VIROL, V82, P5348, DOI 10.1128/JVI.00215-08; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; HONDA M, 1990, J IMMUNOL, V145, P4059; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Hulkkonen J, 2001, ARTHRITIS RHEUM, V44, P176, DOI 10.1002/1529-0131(200101)44:1<176::AID-ANR23>3.0.CO;2-K; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; KADOTA J, 1991, MICROBIOL IMMUNOL, V35, P443, DOI 10.1111/j.1348-0421.1991.tb01575.x; Koutsonikolis A, 1997, IMMUNOL LETT, V55, P109, DOI 10.1016/S0165-2478(97)02695-3; Lane BR, 2001, J VIROL, V75, P5812, DOI 10.1128/JVI.75.13.5812-5822.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Moss WJ, 2004, INT J BIOCHEM CELL B, V36, P1380, DOI 10.1016/j.biocel.2004.01.019; Nagase H, 2000, MATRIX METALLOPROTEI; Nicholas J, 2005, J INTERF CYTOK RES, V25, P373, DOI 10.1089/jir.2005.25.373; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; OOSTENDORP RAJ, 1993, CRIT REV ONCOL HEMAT, V14, P189, DOI 10.1016/1040-8428(93)90009-S; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; RUEGG CL, 1989, J VIROL, V63, P3250, DOI 10.1128/JVI.63.8.3250-3256.1989; RUEGG CL, 1990, J IMMUNOL, V144, P3928; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Speth C, 2000, AIDS, V14, P629, DOI 10.1097/00002030-200004140-00001; Stone CA, 2010, NUTR REV, V68, P671, DOI 10.1111/j.1753-4887.2010.00337.x; TAKESHITA S, 1995, CELL IMMUNOL, V165, P234, DOI 10.1006/cimm.1995.1210; Tan JQ, 1997, J IMMUNOL, V158, P475; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10	60	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55199	10.1371/journal.pone.0055199	http://dx.doi.org/10.1371/journal.pone.0055199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383108	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800129
J	Drehmer, M; Duncan, BB; Kac, G; Schmidt, MI				Drehmer, Michele; Duncan, Bruce Bartholow; Kac, Gilberto; Schmidt, Maria Ines			Association of Second and Third Trimester Weight Gain in Pregnancy with Maternal and Fetal Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; RISK; WOMEN; RECOMMENDATIONS; BIRTH; MACROSOMIA; OVERWEIGHT; DIETARY; OBESITY; PATTERN	Objective: To investigate the association between weekly weight gain, during the second and third trimesters, classified according to the 2009 Institute of Medicine (IOM/NRC) recommendations, and maternal and fetal outcomes. Methods: Gestational weight gain was evaluated in 2,244 pregnant women of the Brazilian Study of Gestational Diabetes (Estudo Brasileiro do Diabetes Gestacional - EBDG). Outcomes were cesarean delivery, preterm birth and small or large for gestational age birth (SGA, LGA). Associations between inadequate weight gain and outcomes were estimated using robust Poisson regression adjusting for pre-pregnancy body mass index, trimester-specific weight gain, age, height, skin color, parity, education, smoking, alcohol consumption, gestational diabetes and hypertensive disorders in pregnancy. Results: In fully adjusted models, in the second trimester, insufficient weight gain was associated with SGA (relative risk [RR] 1.72, 95% confidence interval [CI] 1.26-2.33), and excessive weight gain with LGA (RR 1.64, 95% CI 1.16-2.31); in third trimester, excessive weight gain with preterm birth (RR 1.70, 95% CI 1.08-2.70) and cesarean delivery (RR 1.21, 95% CI 1.03-1.44). Women with less than recommended gestational weight gain in the 2nd trimester had a lesser risk of cesarean deliveries (RR 0.82, 95% CI 0.71-0.96) than women with adequate gestational weight gain in this trimester. Conclusion: Though insufficient weight gain in the 3rd trimester was not associated with adverse outcomes, other deviations from recommended weight gain during second and third trimester were associated with adverse pregnancy outcomes. These findings support, in part, the 2009 IOM/NRC recommendations for nutritional monitoring during pregnancy.	[Drehmer, Michele; Duncan, Bruce Bartholow; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Dept Social Med, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Kac, Gilberto] Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, Josue de Castro Nutr Inst, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro	Drehmer, M (corresponding author), Univ Fed Rio Grande do Sul, Dept Social Med, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil.	michele.drehmer@gmail.com	Kac, Gilberto/H-6862-2012; Drehmer, Michele/I-1105-2012; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022; Duncan, Bruce B/L-4140-2016; Schmidt, Maria/V-3196-2019	Kac, Gilberto/0000-0001-8603-9077; Schmidt, Maria Inês/0000-0002-3837-0731; Duncan, Bruce B/0000-0002-7491-2630; 	National Support Program for Centers of Excellence (PRONEX); Brazilian National Council of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)	National Support Program for Centers of Excellence (PRONEX); Brazilian National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was funded by the National Support Program for Centers of Excellence (PRONEX)(http://www.cnpq.br/web/guest/historia), the Brazilian National Council of Technological and Scientific Development (CNPq)(http://www.cnpq.br/web/guest) and the Coordination for the Improvement of Higher Level Personnel (CAPES)(http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P170, DOI 10.1016/0029-7844(95)00119-C; Abrams Barbara, 2000, American Journal of Clinical Nutrition, V71, p1233S; American College of Obstetrics and Gynecology, 1986, MAN PREECL, P91; Amorim AR, 2008, MATERN CHILD NUTR, V4, P1, DOI 10.1111/j.1740-8709.2007.00093.x; Artal R, 2010, OBSTET GYNECOL, V115, P152, DOI 10.1097/AOG.0b013e3181c51908; Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef; Bertoldi Nucci L, 2001, Cad Saude Publica, V17, P1367, DOI 10.1590/S0102-311X2001000600020; Bodnar LM, 2011, AM J EPIDEMIOL, V174, P136, DOI 10.1093/aje/kwr064; Carmichael S, 1997, AM J PUBLIC HEALTH, V87, P1984, DOI 10.2105/AJPH.87.12.1984; Claesson IM, 2008, BJOG-INT J OBSTET GY, V115, P44, DOI 10.1111/j.1471-0528.2007.01531.x; COGSWELL ME, 1995, AM J OBSTET GYNECOL, V172, P705, DOI 10.1016/0002-9378(95)90598-7; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a; Drehmer M, 2010, CAD SAUDE PUBLICA, V26, P1024, DOI 10.1590/S0102-311X2010000500024; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; Hedderson MM, 2006, OBSTET GYNECOL, V108, P1153, DOI 10.1097/01.AOG.0000242568.75785.68; Hickey CA, 1996, OBSTET GYNECOL, V88, P490, DOI 10.1016/0029-7844(96)00262-1; IBGE Diretoria de Pesquisas, 2010, COORD TRAB REND PESQ; IOM (Institute of Medicine) and NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC; Kabali C, 2007, INT J GYNECOL OBSTET, V97, P100, DOI 10.1016/j.ijgo.2007.02.001; Kaiser PS, 2001, OBSTET GYNECOL, V97, P39, DOI 10.1016/S0029-7844(00)01078-4; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Rode L, 2007, OBSTET GYNECOL, V109, P1309, DOI 10.1097/01.AOG.0000266556.69952.de; Schieve LA, 1999, EPIDEMIOLOGY, V10, P141, DOI 10.1097/00001648-199903000-00010; SCHMIDT MI, 1993, REV SAUDE PUBL, V27, P271, DOI 10.1590/S0034-89101993000400007; Schmidt MI, 2001, DIABETES CARE, V24, P1151, DOI 10.2337/diacare.24.7.1151; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; SIEGARIZ AM, 1994, OBSTET GYNECOL, V84, P565; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stotland NE, 2004, OBSTET GYNECOL, V104, P671, DOI 10.1097/01.AOG.0000139515.97799.f6; Strauss RS, 1999, J NUTR, V129, P988, DOI 10.1093/jn/129.5.988; Tanentsapf I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-81; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; *WHO, 1994, PREV DIAB MELL REP W; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	37	70	78	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54704	10.1371/journal.pone.0054704	http://dx.doi.org/10.1371/journal.pone.0054704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382944	Green Published, gold			2022-12-25	WOS:000315563800066
J	Kathania, M; Zadeh, M; Lightfoot, YL; Roman, RM; Sahay, B; Abbott, JR; Mohamadzadeh, M				Kathania, Mahesh; Zadeh, Mojgan; Lightfoot, Yaima L.; Roman, Robert M.; Sahay, Bikash; Abbott, Jeffrey R.; Mohamadzadeh, Mansour			Colonic Immune Stimulation by Targeted Oral Vaccine	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTHRAX PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; DENDRITIC CELLS; T-CELLS; MUCOSAL; IMMUNIZATION; RECEPTORS; DELIVERY; MICE	Background: Currently, sufficient data exist to support the use of lactobacilli as candidates for the development of new oral targeted vaccines. To this end, we have previously shown that Lactobacillus gasseri expressing the protective antigen (PA) component of anthrax toxin genetically fused to a dendritic cell (DC)-binding peptide (DCpep) induced efficacious humoral and T cell-mediated immune responses against Bacillus anthracis Sterne challenge. Methodology/Principal Finding: In the present study, we investigated the effects of a dose dependent treatment of mice with L. gasseri expressing the PA-DCpep fusion protein on intestinal and systemic immune responses and confirmed its safety. Treatment of mice with different doses of L. gasseri expressing PA-DCpep stimulated colonic immune responses, resulting in the activation of innate immune cells, including dendritic cells, which induced robust Th1, Th17, CD4(+)Foxp3(+) and CD8(+)Foxp3(+) T cell immune responses. Notably, high doses of L. gasseri expressing PA-DCpep (10(12) CFU) were not toxic to the mice. Treatment of mice with L. gasseri expressing PA-DCpep triggered phenotypic maturation and the release of proinflammatory cytokines by dendritic cells and macrophages. Moreover, treatment of mice with L. gasseri expressing PA-DCpep enhanced antibody immune responses, including IgA, IgG(1), IgG(2b), IgG(2c) and IgG(3). L. gasseri expressing PA-DCpep also increased the gene expression of numerous pattern recognition receptors, including Toll-like receptors, C-type lectin receptors and NOD-like receptors. Conclusion/Significance: These findings suggest that L. gasseri expressing PA-DCpep has substantial immunopotentiating properties, as it can induce humoral and T cell-mediated immune responses upon oral administration and may be used as a safe oral vaccine against anthrax challenge.	[Kathania, Mahesh; Zadeh, Mojgan; Lightfoot, Yaima L.; Roman, Robert M.; Sahay, Bikash; Abbott, Jeffrey R.; Mohamadzadeh, Mansour] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Mohamadzadeh, Mansour] Univ Florida, Div Hepatol Gastroenterol & Nutr, Gainesville, FL USA; [Mohamadzadeh, Mansour] Univ Florida, Dept Med, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mohamadzadeh, M (corresponding author), Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA.	m.zadeh@ufl.edu	Kathania, Mahesh/AAA-5766-2021; Abbott, Jeffrey/AAI-2817-2020	Abbott, Jeffrey/0000-0002-7830-435X; Sahay, Bikash/0000-0003-0905-733X; Kathania, Mahesh/0000-0002-4784-8581	National Institutes of Health [1R01AI098833-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant 1R01AI098833-01. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Dickinson EC, 1998, SURGERY, V124, P284, DOI 10.1016/S0039-6060(98)70132-1; Erskine CL, 2011, J IMMUNOL, V187, P316, DOI 10.4049/jimmunol.1100658; Flick-Smith HC, 2002, INFECT IMMUN, V70, P2022, DOI 10.1128/IAI.70.4.2022-2028.2002; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mercenier A, 2003, CURR PHARM DESIGN, V9, P175, DOI 10.2174/1381612033392224; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P1155, DOI 10.1586/14760584.7.8.1155; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P163, DOI 10.1586/14760584.7.2.163; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Mohamadzadeh M, 2010, FUTURE MICROBIOL, V5, P1289, DOI 10.2217/FMB.10.78; Pouwels PH, 1998, INT J FOOD MICROBIOL, V41, P155, DOI 10.1016/S0168-1605(98)00048-8; Roberts M, 2000, INFECT IMMUN, V68, P6041, DOI 10.1128/IAI.68.10.6041-6043.2000; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saklani-Jusforgues H, 2003, INFECT IMMUN, V71, P1083, DOI 10.1128/IAI.71.3.1083-1090.2003; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stevenson A, 2003, FEMS IMMUNOL MED MIC, V37, P121, DOI 10.1016/S0928-8244(03)00068-3; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840	34	24	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55143	10.1371/journal.pone.0055143	http://dx.doi.org/10.1371/journal.pone.0055143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383086	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800120
J	Tang, Q; Cao, B; Wu, HY; Cheng, G				Tang, Qiong; Cao, Bin; Wu, Haiyan; Cheng, Gang			Cholesterol-Peptide Hybrids to Form Liposome-Like Vesicles for Gene Delivery	PLOS ONE			English	Article							DNA; THERAPY; OLIGOPEPTIDES; HISTIDINE; POLYMERS	In this paper, four amphiphilic cholesterol-peptide conjugates (Ch-R5H5, Ch-R3H3, Ch-R5 and Ch-R5) were designed and synthesized, and their properties in gene delivery were evaluated in vitro with an aim of developing more efficient gene delivery carriers. These amphiphilic cholesterol-peptide conjugates are composed of hydrophobic cholesterol and positively charged peptides. They were able to self-assemble into micelles at low concentrations and their critical micelle concentrations in phosphate buffered saline (pH 7.4) are <= 85 mu g/mL. Amphiphilic cholesterol-peptide conjugates condensed DNA more efficiently than a hydrophilic cationic oligoarginine (R10) peptide with no hydrophobic segment. Their transfection efficiencies were at least two orders of magnitude greater than that of R10 peptide in HEK-293 cells. Moreover, the introduction of histidine residues in cholesterol-peptide conjugates led to higher gene expression efficiency compared with cholesterol-peptides without histidine (Ch-R5 and Ch-R3), and the luciferase expression level was comparable or even higher than that induced by PEI at its optimal N/P ratio. In particular, Ch-R5H5 condensed DNA into smaller nanoparticles than Ch-R3H3 at higher N/P ratios, and the minimum size of Ch-R5H5/DNA complexes was 180 nm with zeta potential of 23 mV, achieved at the N/P ratio of 30. This liposome-like vesicle may be a promising gene delivery carrier for intravenous therapy.	[Tang, Qiong; Cao, Bin; Wu, Haiyan; Cheng, Gang] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Cheng, Gang] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED)	Cheng, G (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	gc@uakron.edu			National Science Foundation [NSF DMR-12062923]; University of Akron Research Foundation	National Science Foundation(National Science Foundation (NSF)); University of Akron Research Foundation	This work is supported by National Science Foundation (NSF DMR-12062923) and University of Akron Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2003, BIOCONJUGATE CHEM, V14, P979, DOI 10.1021/bc034067y; BEHR JP, 1993, ACCOUNTS CHEM RES, V26, P274, DOI 10.1021/ar00029a008; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; Chen MM, 2011, CARBOHYD POLYM, V84, P1244, DOI 10.1016/j.carbpol.2011.01.012; Chen QR, 2002, NUCLEIC ACIDS RES, V30, P1338, DOI 10.1093/nar/30.6.1338; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Dominguez A, 1997, J CHEM EDUC, V74, P1227, DOI 10.1021/ed074p1227; Guo XD, 2008, BIOMATERIALS, V29, P4838, DOI 10.1016/j.biomaterials.2008.07.053; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Mitchell P, 1998, LANCET, V351, P346, DOI 10.1016/S0140-6736(05)78325-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; Obata Y, 2010, J CONTROL RELEASE, V142, P267, DOI 10.1016/j.jconrel.2009.10.023; Pathak Atul, 2009, Biotechnology Journal, V4, P1559, DOI 10.1002/biot.200900161; Patil SN, 2008, J ORG CHEM, V73, P4476, DOI 10.1021/jo702762u; Pichon C, 2001, ADV DRUG DELIVER REV, V53, P75, DOI 10.1016/S0169-409X(01)00221-6; Preuss M, 2003, ORG BIOMOL CHEM, V1, P2430, DOI 10.1039/b302361c; Read ML, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni085; Saccardo P, 2009, BIOTECHNOL ADV, V27, P432, DOI 10.1016/j.biotechadv.2009.03.004; Sennato S, 2005, BBA-BIOMEMBRANES, V1714, P11, DOI 10.1016/j.bbamem.2005.06.004; Seow WY, 2009, ADV MATER, V21, P86, DOI 10.1002/adma.200800928; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Tang Q, 2012, LANGMUIR, V28, P16126, DOI 10.1021/la303299s; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wiradharma N, 2008, ADV FUNCT MATER, V18, P943, DOI 10.1002/adfm.200700884; Yudovin-Farber I, 2007, MAT SCI ENG C-BIO S, V27, P595, DOI 10.1016/j.msec.2006.05.044	31	28	31	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54460	10.1371/journal.pone.0054460	http://dx.doi.org/10.1371/journal.pone.0054460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382899	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800049
J	Xie, XQ; White, EP; Mehnert, JM				Xie, Xiaoqi; White, Eileen P.; Mehnert, Janice M.			Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma	PLOS ONE			English	Article							PHASE-II TRIAL; SIGNALING PATHWAYS; CANCER CELLS; METASTATIC MELANOMA; MOUSE MODELS; DOUBLE-BLIND; IN-VITRO; SURVIVAL; TEMSIROLIMUS; COMPLEX	The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway promotes melanoma tumor growth and survival while suppressing autophagy, a catabolic process through which cells collect and recycle cellular components to sustain energy homeostasis in starvation. Conversely, inhibitors of the PI3K/AKT/mTOR pathway, in particular the mTOR inhibitor temsirolimus (CCI-779), induce autophagy, which can promote tumor survival and thus, these agents potentially limit their own efficacy. We hypothesized that inhibition of autophagy in combination with mTOR inhibition would block this tumor survival mechanism and hence improve the cytotoxicity of mTOR inhibitors in melanoma. Here we found that melanoma cell lines of multiple genotypes exhibit high basal levels of autophagy. Knockdown of expression of the essential autophagy gene product ATG7 resulted in cell death, indicating that survival of melanoma cells is autophagy-dependent. We also found that the lysosomotropic agent and autophagy inhibitor hydroxychloroquine (HCQ) synergizes with CCI-779 and led to melanoma cell death via apoptosis. Combination treatment with CCI-779 and HCQ suppressed melanoma growth and induced cell death both in 3-dimensional (3D) spheroid cultures and in tumor xenografts. These data suggest that coordinate inhibition of the mTOR and autophagy pathways promotes apoptosis and could be a new therapeutic paradigm for the treatment of melanoma.	[Xie, Xiaoqi; White, Eileen P.; Mehnert, Janice M.] Canc Inst New Jersey, New Brunswick, NJ USA; [Xie, Xiaoqi; Mehnert, Janice M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Med Oncol, Piscataway, NJ 08854 USA; [White, Eileen P.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [White, Eileen P.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	White, EP (corresponding author), Canc Inst New Jersey, New Brunswick, NJ USA.	whiteei@umdnj.edu; mehnerja@umdnj.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	V Foundation for Cancer Research; Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE [R01CA163591, R01CA130893] Funding Source: NIH RePORTER	V Foundation for Cancer Research; Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Translational Grant from the V Foundation for Cancer Research and by an IMPACT Pilot Award from The Cancer Institute of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazy K, 2011, AACR ANN M 2011, V2011, P4500; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Armstrong JL, 2011, CLIN CANCER RES, V17, P2216, DOI 10.1158/1078-0432.CCR-10-3003; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Beevers CS, 2006, INT J CANCER, V119, P757, DOI 10.1002/ijc.21932; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hui B, 2012, CANCER; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladoire S, 2012, AUTOPHAGY, V8, P1175, DOI 10.4161/auto.20353; Lazova R, 2012, CLIN CANCER RES, V18, P370, DOI 10.1158/1078-0432.CCR-11-1282; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Ma XH, 2011, CLIN CANC RES; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Margolin K, 2005, CANCER-AM CANCER SOC, V104, P1045, DOI 10.1002/cncr.21265; Margolin KA, 2012, CLIN CANCER RES, V18, P1129, DOI 10.1158/1078-0432.CCR-11-2488; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Marino ML, 2012, J BIOL CHEM; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109; Mehnert JM, 2012, CURRENT ONCOLOGY REP; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Miracco C, 2010, HUM PATHOL, V41, P503, DOI 10.1016/j.humpath.2009.09.004; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Munster T, 2002, ARTHRITIS RHEUM-US, V46, P1460, DOI 10.1002/art.10307; Populo H, 2011, PIGM CELL MELANOMA R, V24, P254, DOI 10.1111/j.1755-148X.2010.00796.x; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rosich L, 2012, CLIN CANC RES OFFICI; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Verschooten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048264; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; White E, 2012, NATURE REV CANC; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028	72	111	114	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55096	10.1371/journal.pone.0055096	http://dx.doi.org/10.1371/journal.pone.0055096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383069	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800110
J	Park, M; Costa, ELV; Maciel, AT; Silva, DPE; Friedrich, N; Barbosa, EVS; Hirota, AS; Schettino, G; Azevedo, LCP				Park, Marcelo; Vieira Costa, Eduardo Leite; Maciel, Alexandre Toledo; Prudencio e Silva, Debora; Friedrich, Natalia; Santos Barbosa, Edzangela Vasconcelos; Hirota, Adriana Sayuri; Schettino, Guilherme; Pontes Azevedo, Luciano Cesar			Determinants of Oxygen and Carbon Dioxide Transfer during Extracorporeal Membrane Oxygenation in an Experimental Model of Multiple Organ Dysfunction Syndrome	PLOS ONE			English	Article							IONIZED CALCIUM; AFFINITY	Extracorporeal membrane oxygenation (ECMO) has gained renewed interest in the treatment of respiratory failure since the advent of the modern polymethylpentene membranes. Limited information exists, however, on the performance of these membranes in terms of gas transfers during multiple organ failure (MOF). We investigated determinants of oxygen and carbon dioxide transfer as well as biochemical alterations after the circulation of blood through the circuit in a pig model under ECMO support before and after induction of MOF. A predefined sequence of blood and sweep flows was tested before and after the induction of MOF with fecal peritonitis and saline lavage lung injury. In the multivariate analysis, oxygen transfer had a positive association with blood flow (slope = 66, p<0.001) and a negative association with premembrane PaCO2 (slope = -0.96, P = 0.001) and SatO(2) (slope = 21.7, p<0.001). Carbon dioxide transfer had a positive association with blood flow (slope = 17, p<0.001), gas flow (slope = 33, p<0.001), pre-membrane PaCO2 (slope = 1.2, p<0.001) and a negative association with the hemoglobin (slope = -3.478, P = 0.042). We found an increase in pH in the baseline from 7.50[7.46,7.54] to 7.60[7.55,7.65] (p<0.001), and during the MOF from 7.19[6.92,7.32] to 7.41[7.13,7.5] (p<0.001). Likewise, the PCO2 fell in the baseline from 35 [32,39] to 25 [22,27] mmHg (p<0.001), and during the MOF from 59 [47,91] to 34 [28,45] mmHg (p<0.001). In conclusion, both oxygen and carbon dioxide transfers were significantly determined by blood flow. Oxygen transfer was modulated by the pre-membrane SatO(2) and CO2, while carbon dioxide transfer was affected by the gas flow, pre-membrane CO2 and hemoglobin.	[Park, Marcelo; Vieira Costa, Eduardo Leite; Maciel, Alexandre Toledo; Schettino, Guilherme; Pontes Azevedo, Luciano Cesar] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Park, Marcelo; Vieira Costa, Eduardo Leite; Maciel, Alexandre Toledo; Prudencio e Silva, Debora; Friedrich, Natalia; Santos Barbosa, Edzangela Vasconcelos; Hirota, Adriana Sayuri; Pontes Azevedo, Luciano Cesar] Univ Sao Paulo, Sch Med, Hosp Clin, Intens Care Unit, Sao Paulo, Brazil	Hospital Sirio Libanes; Universidade de Sao Paulo	Park, M (corresponding author), Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil.	marcelo.park@hc.fm.usp.br	Costa, Eduardo/K-5841-2012; Azevedo, Luciano CP/H-2652-2012	Costa, Eduardo/0000-0002-6941-3626; Azevedo, Luciano CP/0000-0001-6759-3910	Brazil	Brazil	The authors received a donation of PLS systems from MAQUET cardiovascular from Brazil, and Marcelo Park, Luciano Cesar Pontes Azevedo, Eduardo Leite Vieira Costa and Guilherme Pinto Paula Schettino were lecturers from three Brazilian courses of mechanical ventilation sponsored for MAQUET cardiovascular from Brazil. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and material.	Bosticardo GM, 2010, NEPHROL DIAL TRANSPL, V25, P3458, DOI 10.1093/ndt/gfq422; Almeida JRD, 2010, J TRAUMA, V69, P375, DOI 10.1097/TA.0b013e3181e12b3a; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; DOUGLAS AR, 1988, J APPL PHYSIOL, V65, P473; FIGGE J, 1991, J LAB CLIN MED, V117, P453; Kellum JA, 1998, SHOCK, V9, P364, DOI 10.1097/00024382-199805000-00009; KOLOBOW T, 1977, T AM SOC ART INT ORG, V23, P17; MELIONES JN, 1991, CRIT CARE MED, V19, P1247, DOI 10.1097/00003246-199110000-00006; Morgan T John, 2009, Clin Biochem Rev, V30, P41; MULHAUSEN RO, 1970, CIRCULATION, V42, P195, DOI 10.1161/01.CIR.42.2.195; Nguyen MK, 2006, J APPL PHYSIOL, V100, P1293, DOI 10.1152/japplphysiol.01274.2005; Noah MA, 2011, JAMA; Patroniti N, 2011, INTENS CARE MED, V37, P1447, DOI 10.1007/s00134-011-2301-6; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pontes De Azevedo LC, 2007, CLINICS, V62, P491, DOI 10.1590/S1807-59322007000400017; R Development Core Team, 2009, R FDN STAT COMP; RIGGS TE, 1973, J CLIN INVEST, V52, P2660, DOI 10.1172/JCI107459; Rosario AL, 2011, SHOCK; Sethi S, 2011, ANN CARD ANAESTH, V14, P156, DOI [10.4103/0971-9784.81576, 10.4103/0971-9784.84030]; Sidebotham D, 2009, J CARDIOTHORAC VASC; SIGGAARDANDERSEN O, 1977, SCAND J CLIN LAB INV, V37, P15, DOI 10.3109/00365517709098927; Zimmermann AK, 2007, J BIOMED MATER RES B, V80B, P433, DOI 10.1002/jbm.b.30614	22	26	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54954	10.1371/journal.pone.0054954	http://dx.doi.org/10.1371/journal.pone.0054954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383011	gold, Green Submitted, Green Published			2022-12-25	WOS:000315483200021
J	Park, SH; Chen, WC; Hoffman, C; Marsh, LM; West, J; Grunig, G				Park, Sung-Hyun; Chen, Wen-Chi; Hoffman, Carol; Marsh, Leigh M.; West, James; Grunig, Gabriele			Modification of Hemodynamic and Immune Responses to Exposure with a Weak Antigen by the Expression of a Hypomorphic BMPR2 Gene	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; REGULATORY T-CELLS; PROTEIN-RECEPTOR-II; TGF-BETA; AIRWAY INFLAMMATION; CYTOKINE PRODUCTION; ENDOTHELIAL INJURY; MUSCLE-CELLS; IFN-GAMMA; MUTATION	Background: Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much greater risk for developing pulmonary arterial hypertension (PAH). However, not all carriers of a mutation in the BMPR2 gene suffer from PAH. We have previously shown that prolonged T helper 2 (Th2) responses in the lungs to a mild antigen delivered via the airways induce severe pulmonary arterial remodeling, but no pulmonary hypertension. The current studies were designed to test the idea that Th2 responses to a mild antigen together with the expression of a hypomorphic BMPR2 gene would trigger pulmonary hypertension. Methodology/Principal Findings: Mice that expressed a hypomorphic BMPR2 transgene (transgene-positive) and transgene-negative mice were either exposed to saline, or primed and exposed to a mild antigen (Ovalbumin) over a prolonged period of time. Only transgene-positive but not transgene-negative mice exposed to antigen developed significantly increased right ventricular systolic pressures, while both groups showed pulmonary artery remodeling with severe muscularization and airway inflammation to a similar degree. Antigen exposure resulted in a smaller increase in the percentage of Interleukin (IL)-13 positive T cells in the lymph nodes, and in a smaller increase in resistin-like-molecule (RELM)alpha expression and a decreased ratio of expression of IL-33 relative to its receptor (IL-1-receptor-like 1, IL1RL1-ST2) in the right ventricles of transgene-positive mice compared to transgene-negative animals. Furthermore, only antigen-challenged transgene-positive mice showed a significant increase in Interferon (IFN)gamma positive T cells over saline-exposed controls. Conclusions/Significance: Our study suggests that exposure with a mild Th2 antigen can trigger pulmonary hypertension on the background of the expression of a hypomorphic BMPR2 gene and that conversely, the expression of the hypomorphic BMPR2 gene can alter the immune response to a mild, inhaled antigen.	[Park, Sung-Hyun; Chen, Wen-Chi; Hoffman, Carol; Grunig, Gabriele] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Marsh, Leigh M.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [West, James] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Grunig, Gabriele] NYU, Sch Med, Dept Med, Div Pulm Med, New York, NY USA	New York University; Ludwig Boltzmann Institute; Vanderbilt University; New York University	Grunig, G (corresponding author), NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA.	ggrunig1@earthlink.net	Marsh, Leigh/AAB-5125-2021; West, James/E-2960-2010	Marsh, Leigh/0000-0002-1754-9249; West, James/0000-0002-6004-0202	National Institutes of Health [1R21HL092370-01, 1R01 HL095764-01, R01HL082694]; American Heart Association [0855943D]; Stony Wold - Herbert Fund, New York; NIEHS Center [5P30ES00260-47]; Cancer Center Support Grant [5P30CA016087-31]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092370, R01HL082694, R01HL095797, R01HL095764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stony Wold - Herbert Fund, New York; NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was funded in part by the National Institutes of Health 1R21HL092370-01 (G. G.), 1R01 HL095764-01 (GG); R01HL082694 (J.W.); American Heart Association, Founders affiliate (0855943D, G. G.); Stony Wold - Herbert Fund, New York; (S. H. P.). The NIEHS Center Grant 5P30ES00260-47 and the Cancer Center Support Grant (C. C. S. G.) 5P30CA016087-31 provided Core Facility support. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Austin ED, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-6; Baum JR, 2012, AM J PHYSIOL-HEART C, V302, pH790, DOI 10.1152/ajpheart.00498.2011; Chen WC, 2012, J VISUALIZE IN PRESS; Crnkovic S, 2011, RESP PHYSIOL NEUROBI, V179, P342, DOI 10.1016/j.resp.2011.09.016; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hoffman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027629; Hoffmann J, 2011, EUR RESPIR J, V37, P1400, DOI 10.1183/09031936.00043310; Johnson JA, 2012, AM J PHYSIOL-LUNG C, V302, pL474, DOI 10.1152/ajplung.00202.2011; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu D, 2012, EUR RESPIR J, V39, P597, DOI 10.1183/09031936.00072911; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Munitz A, 2012, AM J RESP CELL MOL, V46, P703, DOI 10.1165/rcmb.2011-0391OC; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Mushaben EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032468; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Newman JH, 2004, J AM COLL CARDIOL, V43, p33S, DOI 10.1016/j.jacc.2004.02.028; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Perros F, 2005, SEMIN RESP CRIT CARE, V26, P355, DOI 10.1055/s-2005-916149; Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pfarr N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-99; Phillips JA, 2008, GENET MED, V10, P359, DOI 10.1097/GIM.0b013e318172dcdf; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rastogi D, 2004, PEDIATR PULM, V37, P50, DOI 10.1002/ppul.10363; Reynolds LA, 2012, J IMMUNOL, V189, P1113, DOI 10.4049/jimmunol.1200991; Rosenzweig EB, 2008, J HEART LUNG TRANSPL, V27, P668, DOI 10.1016/j.healun.2008.02.009; Said SI, 2010, EUR RESPIR J, V35, P730, DOI 10.1183/09031936.00097109; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Serre K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020731; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC; Talati M, 2010, AM J PHYSIOL-LUNG C, V299, pL363, DOI 10.1152/ajplung.00295.2009; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Upton PD, 2009, CURR OPIN PHARMACOL, V9, P274, DOI 10.1016/j.coph.2009.02.007; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; West J, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-45; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zaiman A, 2005, AM J RESP CELL MOL, V33, P425, DOI 10.1165/rcmb.F307	63	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55180	10.1371/journal.pone.0055180	http://dx.doi.org/10.1371/journal.pone.0055180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383100	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200042
J	Doesburg, SM; Ibrahim, GM; Smith, ML; Sharma, R; Viljoen, A; Chu, B; Rutka, JT; Snead, OC; Pang, EW				Doesburg, Sam M.; Ibrahim, George M.; Smith, Mary Lou; Sharma, Rohit; Viljoen, Amrita; Chu, Bill; Rutka, James T.; Snead, O. Carter, III; Pang, Elizabeth W.			Altered Rolandic Gamma-Band Activation Associated with Motor Impairment and Ictal Network Desynchronization in Childhood Epilepsy	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; EPILEPTOGENIC NETWORKS; NEURAL SYNCHRONY; DYNAMICS; EEG; POWER; BRAIN; COMMUNICATION; CONNECTIVITY; COHERENCE	Epilepsy is associated with an abnormal expression of neural oscillations and their synchronization across brain regions. Oscillatory brain activation and synchronization also play an important role in cognition, perception and motor control. Childhood epilepsy is associated with a variety of cognitive and motor deficits, but the relationship between altered functional brain responses in various frequency ranges and functional impairment in these children remains poorly understood. We investigated functional magnetoencephalographic (MEG) responses from motor cortex in multiple functionally relevant frequency bands following median nerve stimulation in twelve children with epilepsy, including four children with motor impairments. We demonstrated that children with motor impairments exhibit an excessive gamma-band response from Rolandic cortex, and that the magnitude of this Rolandic gamma response is negatively associated with motor function. Abnormal responses from motor cortex were also associated with ictal desynchronization of oscillations within Rolandic cortex measured using intracranial EEG (iEEG). These results provide the evidence that ictal disruption of motor networks is associated with an altered functional response from motor cortex, which is in turn associated with motor impairment.	[Doesburg, Sam M.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Doesburg, Sam M.; Smith, Mary Lou; Snead, O. Carter, III; Pang, Elizabeth W.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Doesburg, Sam M.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Ibrahim, George M.; Rutka, James T.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Ibrahim, George M.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Smith, Mary Lou; Sharma, Rohit; Viljoen, Amrita; Chu, Bill; Snead, O. Carter, III; Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Smith, Mary Lou] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Doesburg, SM (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sam.doesburg@sickkids.ca			Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for Epilepsy Surgery Research; University of Toronto Surgeon-Scientist Program; Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program	Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for Epilepsy Surgery Research; University of Toronto Surgeon-Scientist Program; Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program	This work was supported by the Hospital for Sick Children, Foundation Student Scholarship Program, the Hospital for Sick Children Centre for Brain and Behavior, the Ontario Brain Institute, the Wiley Family and Jack Beqaj Funds for Epilepsy Surgery Research, the University of Toronto Surgeon-Scientist Program, and the Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; Bartolomei F, 2005, CLIN NEUROPHYSIOL, V116, P2473, DOI 10.1016/j.clinph.2005.05.013; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Benifla M, 2009, J NEUROSURG-PEDIATR, V4, P199, DOI 10.3171/2009.3.PEDS08459; Berg AT, 2011, EPILEPSIA, V52, P7, DOI 10.1111/j.1528-1167.2010.02905.x; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Chu B, 2007, NEW FRONTIERS BIOMAG, V1300; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Ibrahim GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039326; Jacobs J, 2008, EPILEPSIA, V49, P1893, DOI 10.1111/j.1528-1167.2008.01656.x; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Kulandaivel K, 2011, EPILEPSY BEHAV, V20, P700, DOI 10.1016/j.yebeh.2011.02.021; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Matthew C.G., 1964, GROOVED PEGBOARD INS; Moazami-Goudarzi M, 2008, NEUROIMAGE, V41, P985, DOI 10.1016/j.neuroimage.2008.03.032; Ochi A, 2007, EPILEPSIA, V48, P286, DOI 10.1111/j.1528-1167.2007.00923.x; Oishi M, 2003, J NEUROL NEUROSUR PS, V74, P1649, DOI 10.1136/jnnp.74.12.1649; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Reitan RM., 1969, MANUAL ADM NEUROPSYC; Ribary U, 2005, PROG BRAIN RES, V150, P127, DOI 10.1016/S0079-6123(05)50010-4; Sarnthein J, 2006, BRAIN, V129, P55, DOI 10.1093/brain/awh631; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Sharma R, 2007, NEW FRONTIERS BIOMAG, V1300; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang Y, 2011, J NEUROSCI, V31, P13204, DOI 10.1523/JNEUROSCI.6227-10.2011; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Womelsdorf T, 2006, J PHYSIOL-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005	45	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54943	10.1371/journal.pone.0054943	http://dx.doi.org/10.1371/journal.pone.0054943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383007	Green Submitted, gold, Green Published			2022-12-25	WOS:000315211500037
J	Ransom, JI; Hobbs, NT; Bruemmer, J				Ransom, Jason I.; Hobbs, N. Thompson; Bruemmer, Jason			Contraception can Lead to Trophic Asynchrony between Birth Pulse and Resources	PLOS ONE			English	Article							PORCINE ZONAE-PELLUCIDAE; CLIMATE-CHANGE; IMMUNIZATION; PHENOLOGY; IMMUNOCONTRACEPTION; MARES; MECHANISMS; FERTILITY; ADJUVANTS	Abiotic inputs such as photoperiod and temperature can regulate reproductive cyclicity in many species. When humans perturb this process by intervening in reproductive cycles, the ecological consequences may be profound. Trophic mismatches between birth pulse and resources in wildlife species may cascade toward decreased survival and threaten the viability of small populations. We followed feral horses (Equus caballus) in three populations for a longitudinal study of the transient immunocontraceptive porcine zona pellucida (PZP), and found that repeated vaccinations extended the duration of infertility far beyond the targeted period. After the targeted years of infertility, the probability of parturition from post-treated females was 25.6% compared to 64.1% for untreated females, when the data were constrained only to females that had demonstrated fertility prior to the study. Estimated time to parturition increased 411.3 days per year of consecutive historical treatment. Births from untreated females in these temperate latitude populations were observed to peak in the middle of May, indicating peak conception occurred around the previous summer solstice. When the post-treated females did conceive and give birth, parturition was an estimated 31.5 days later than births from untreated females, resulting in asynchrony with peak forage availability. The latest neonate born to a post-treated female arrived 7.5 months after the peak in births from untreated females, indicating conception occurred within 24-31 days of the winter solstice. These results demonstrate surprising physiological plasticity for temperate latitude horses, and indicate that while photoperiod and temperature are powerful inputs driving the biological rhythms of conception and birth in horses, these inputs may not limit their ability to conceive under perturbed conditions. The protracted infertility observed in PZP-treated horses may be of benefit for managing overabundant wildlife, but also suggests caution for use in small refugia or rare species.	[Ransom, Jason I.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Hobbs, N. Thompson] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Bruemmer, Jason] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University	Ransom, JI (corresponding author), Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO USA.	Jason_I_Ransom@nps.gov	Ransom, Jason/AAT-4025-2020; Hobbs, Tom/C-5263-2016	Ransom, Jason/0000-0002-5930-4004; Bruemmer, Jason/0000-0002-4236-756X	United States Geological Survey (USGS) Wildlife Program	United States Geological Survey (USGS) Wildlife Program	The late F.J. Singer acquired funding and initiated the precursor to this project with the assistance of L. Coates-Markle and A.J. Kane. This research was funded by the United States Geological Survey (USGS) Wildlife Program and conducted through a cooperative effort between the USGS Fort Collins Science Center, Bureau of Land Management, United States Department of Agriculture Animal and Plant Health Inspection Service, and Colorado State University. No agency administration or funding program had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the United States Government.	Berger J., 1986, WILD HORSES GREAT BA; Card C, 1993, EQUINE REPROD, P567; DUNBAR BS, 1989, FERTIL STERIL, V52, P311; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Feh C, 2012, INT WILD EQ C, P69; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; GARROTT RA, 1992, J WILDLIFE MANAGE, V56, P456, DOI 10.2307/3808859; Ginther OJ, 2001, ANIM REPROD, V1, P31; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Gray ME, 2010, REPRODUCTION, V139, P45, DOI 10.1530/REP-08-0456; Grubaugh W, 1982, J Reprod Fertil Suppl, V32, P293; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hone J., 2007, WILDLIFE DAMAGE CONT; HOWELL CE, 1951, J ANIM SCI, V10, P789, DOI 10.2527/jas1951.104789x; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Kirkpatrick JF, 2002, REPRODUCTION, P197; LIU IKM, 1989, J REPROD FERTIL, V85, P19, DOI 10.1530/jrf.0.0850019; Lyda RO, 2005, J ZOO WILDLIFE MED, V36, P610, DOI 10.1638/04104.1; Madosky JM, 2010, APPL ANIM BEHAV SCI, V128, P50, DOI 10.1016/j.applanim.2010.09.013; MAHIBROWN CA, 1985, BIOL REPROD, V32, P761, DOI 10.1095/biolreprod32.4.761; Munson Linda, 2005, P66; National Research Council, 2007, NUTR REQ HORS; Nunez CMV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013635; Nunez CMV, 2009, APPL ANIM BEHAV SCI, V117, P74, DOI 10.1016/j.applanim.2008.12.001; Palmer E, 1982, J Reprod Fertil Suppl, V32, P275; Palmer E, 1998, REPROD DOMEST ANIM, V33, P205, DOI 10.1111/j.1439-0531.1998.tb01343.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Powell D. M., 2001, Journal of Applied Animal Welfare Science, V4, P271, DOI 10.1207/S15327604JAWS0404_04; Ransom JI, 2011, WILDLIFE SOC B, V35, P343, DOI 10.1002/wsb.66; Ransom JI, 2010, APPL ANIM BEHAV SCI, V124, P51, DOI 10.1016/j.applanim.2010.01.015; Ransom JI, 2012, POPULATION ECOLOGY F; Reitor RJ, 1983, PINEAL; Roelle JE, 2010, US GEOLOGICAL SURVEY; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stoops MA, 2006, REPROD FERT DEVELOP, V18, P667, DOI 10.1071/RD05045; Tan B, 2011, IEEE J-STARS, V4, P361, DOI 10.1109/JSTARS.2010.2075916; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Turner A, 2002, REPRODUCTION, P187; Turner JW, 2002, REPRODUCTION, P177; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Waring G, 1983, HORSE BEHAV; WOOD DM, 1981, BIOL REPROD, V25, P439, DOI 10.1095/biolreprod25.2.439	44	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54972	10.1371/journal.pone.0054972	http://dx.doi.org/10.1371/journal.pone.0054972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383018	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500043
J	Song, YX; Ye, X; Ye, LQ; Li, BJ; Wang, LJ; Hua, YY				Song, Yingxiang; Ye, Xiao; Ye, Leqin; Li, Bijun; Wang, Lijun; Hua, Yanyin			Disturbed Subjective Sleep in Chinese Females with Type 2 Diabetes on Insulin Therapy	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; RESISTANCE; QUALITY; APNEA; DURATION; MELLITUS; IMPACT; RISK; ASSOCIATIONS	Objective:The aim of this study is to investigate the prevalence and determine the possible risk factors of poor sleep quality in Chinese type 2 diabetes patients with insulin treatment. Methods: 140 type 2 diabetes patients with insulin treatments were enrolled in our study. General characteristics and laboratory testing such glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), post-prandial plasma glucose (PPG) were measured. Every patient completed Chinese version of Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI global score>5 was defined as poor sleep quality. Results: Global PSQI score was significantly higher in female type 2 diabetes patients with insulin treatment than male (7.52 vs 6.08, P<0.05). After adjusting for age, BMI, FPG, PPG, HbA1c and duration of diabetes, female is still an independent risk factor for poor sleep quality [OR = 2.55, 95% confidence interval (CI) = 1.24-5.27, P = 0.01]. Conclusion: The results suggest that we found poor sleep quality in female Chinese type 2 diabetes patients with insulin treatment and these findings may contribute to sleep disorder control in female type 2 diabetes.	[Song, Yingxiang; Ye, Xiao; Ye, Leqin; Li, Bijun; Wang, Lijun; Hua, Yanyin] Zhejiang Prov Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital	Hua, YY (corresponding author), Zhejiang Prov Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China.	Yanyin_hua@sina.com						Bidulescu A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-581; Bloomgarden ZT, 1999, DIABETES CARE, V22, P1739, DOI 10.2337/diacare.22.10.1739; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Liu R, 2011, SLEEP MED, V12, P914, DOI 10.1016/j.sleep.2011.04.006; Natl Ctr Sleep Disorders Res, 1999, SLEEP, V22, pS402; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Perciaccante Antonio, 2006, BMC Cardiovasc Disord, V6, P19, DOI 10.1186/1471-2261-6-19; Rajendran A, 2012, DIABETES METAB J, V36, P70, DOI 10.4093/dmj.2012.36.1.70; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Tasali E, 2008, J CLIN ENDOCR METAB, V93, P3878, DOI 10.1210/jc.2008-0925; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Terzano MG, 2004, SLEEP MED, V5, P67, DOI 10.1016/j.sleep.2003.09.006; Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6; Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041; van Dijk M, 2011, DIABETOLOGIA, V54, P1967, DOI 10.1007/s00125-011-2184-7; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; Yang SH, 2010, NEW ENGL J MED, V362, P2425; Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a	27	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54951	10.1371/journal.pone.0054951	http://dx.doi.org/10.1371/journal.pone.0054951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383010	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500038
J	Ferguson, JL; Chao, WCH; Lee, E; Friedman, KL				Ferguson, Jenifer L.; Chao, William Chong Hang; Lee, Ethan; Friedman, Katherine L.			The Anaphase Promoting Complex Contributes to the Degradation of the S. cerevisiae Telomerase Recruitment Subunit Est1p	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST TELOMERASE; DEPENDENT DEGRADATION; REVERSE-TRANSCRIPTASE; CYCLIN PROTEOLYSIS; CATALYTIC SUBUNIT; DESTRUCTION BOX; MITOTIC EXIT; G1 CYCLINS; AURORA-A	Telomerase is a multi-subunit enzyme that reverse transcribes telomere repeats onto the ends of linear eukaryotic chromosomes and is therefore critical for genome stability. S. cerevisiae telomerase activity is cell-cycle regulated; telomeres are not elongated during G1 phase. Previous work has shown that Est1 protein levels are low during G1 phase, preventing telomerase complex assembly. However, the pathway targeting Est1p for degradation remained uncharacterized. Here, we show that Est1p stability through the cell cycle mirrors that of Clb2p, a known target of the Anaphase Promoting Complex (APC). Indeed, Est1p is stabilized by mutations in both essential and non-essential components of the APC. Mutations of putative Destruction boxes (D-boxes), regions shown to be important for recognition of known APC substrates, stabilize Est1p, suggesting that Est1p is likely to be targeted for degradation directly by the APC. However, we do not detect degradation or ubiquitination of recombinant Est1p by the APC in vitro, suggesting either that the recombinant protein lacks necessary post-translational modification and/or conformation, or that the APC affects Est1p degradation by an indirect mechanism. Together, these studies shed light on the regulation of yeast telomerase assembly and demonstrate a new connection between telomere maintenance and cell cycle regulation pathways.	[Ferguson, Jenifer L.; Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Chao, William Chong Hang] Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Vanderbilt University	Friedman, KL (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	katherine.friedman@vanderbilt.edu			Vanderbilt University; National Institutes of Health (NIH) [GM080393]; ICR; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080393] Funding Source: NIH RePORTER	Vanderbilt University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICR; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Vanderbilt University and a National Institutes of Health (NIH) grant GM080393 to KLF. WCHC was funded by an ICR studentship. Flow Cytometry experiments were performed in the VMC Flow Cytometry Shared Resource and supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Baumer M, 2000, FEBS LETT, V468, P142, DOI 10.1016/S0014-5793(00)01208-4; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; DELANGE T, 2005, TELOMERES; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grossberger R, 1999, J BIOL CHEM, V274, P14500, DOI 10.1074/jbc.274.20.14500; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Irniger S, 1997, J CELL SCI, V110, P1523; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser P, 2005, METHOD ENZYMOL, V399, P243, DOI 10.1016/S0076-6879(05)99016-2; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Larose S, 2007, J BIOL CHEM, V282, P4373, DOI 10.1074/jbc.M607145200; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lendvay TS, 1996, GENETICS, V144, P1399; LEW DJ, 1992, CELL, V69, P317, DOI 10.1016/0092-8674(92)90412-6; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lubin JW, 2012, RNA, V18, P1597, DOI 10.1261/rna.034447.112; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Martina M, 2012, MOL CELL BIOL, V32, P1604, DOI 10.1128/MCB.06547-11; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Page AM, 2005, GENETICS, V170, P1045, DOI 10.1534/genetics.104.040105; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Pfleger CM, 2000, GENE DEV, V14, P655; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rose MD., 1990, METHODS YEAST GENETI; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Seto AG, 2002, GENE DEV, V16, P2800, DOI 10.1101/gad.1029302; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tuzon CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002060; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wu Y, 2011, P NATL ACAD SCI USA, V108, P20362, DOI 10.1073/pnas.1100281108; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	86	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55055	10.1371/journal.pone.0055055	http://dx.doi.org/10.1371/journal.pone.0055055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372810	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400053
J	Guzik-Lendrum, S; Heissler, SM; Billington, N; Takagi, Y; Yang, Y; Knight, PJ; Homsher, E; Sellers, JR				Guzik-Lendrum, Stephanie; Heissler, Sarah M.; Billington, Neil; Takagi, Yasuharu; Yang, Yi; Knight, Peter J.; Homsher, Earl; Sellers, James R.			Mammalian Myosin-18A, a Highly Divergent Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; PHOSPHORYLATION-DEPENDENT REGULATION; REGULATORY LIGHT-CHAIN; PDZ-CONTAINING MYOSIN; SMOOTH-MUSCLE MYOSIN; HEAVY-MEROMYOSIN; ADENOSINE-TRIPHOSPHATASE; KINETIC MECHANISM; BINDING-SITE; ACTIN	The Mus musculus myosin-18A gene is expressed as two alternatively spliced isoforms, alpha and beta, with reported roles in Golgi localization, in maintenance of cytoskeleton, and as receptors for immunological surfactant proteins. Both myosin-18A isoforms feature a myosin motor domain, a single predicted IQ motif, and a long coiled-coil reminiscent of myosin-2. The myosin-18A alpha isoform, additionally, has an N-terminal PDZ domain. Recombinant heavy meromyosin- and subfragment-1 (S1)-like constructs for both myosin-18A alpha and -18 beta species were purified from the baculovirus/Sf9 cell expression system. These constructs bound both essential and regulatory light chains, indicating an additional noncanonical light chain binding site in the neck. Myosin-18A alpha-S1 and -18A beta-S1 molecules bound actin weakly with K-d values of 4.9 and 54 mu M, respectively. The actin binding data could be modeled by assuming an equilibrium between two myosin conformations, a competent and an incompetent form to bind actin. Actin binding was unchanged by presence of nucleotide. Both myosin-18A isoforms bound N-methylanthraniloyl- nucleotides, but the rate of ATP hydrolysis was very slow (<0.002 s(-1)) and not significantly enhanced by actin. Phosphorylation of the regulatory light chain had no effect on ATP hydrolysis, and neither did the addition of tropomyosin or of GOLPH3, a myosin-18A binding partner. Electron microscopy of myosin-18A-S1 showed that the lever is strongly angled with respect to the long axis of the motor domain, suggesting a pre-power stroke conformation regardless of the presence of ATP. These data lead us to conclude that myosin-18A does not operate as a traditional molecular motor in cells.	[Homsher, Earl; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Yang, Yi] Hunan Agr Univ, Coll Vet Med, Lab Funct Prote, Changsha 410128, Hunan, Peoples R China; [Knight, Peter J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Homsher, Earl] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Hunan Agricultural University; University of Leeds; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3523, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov		Billington, Neil/0000-0003-2306-0228	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, ZIAHL001786] Funding Source: NIH RePORTER	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Fang Zhang for technical assistance with myosin-18A experiments and protein purification, Melanie Barzik and John A. Hammer III (NHLBI, National Institutes of Health) for providing a full-length clone of mouse myosin-18A alpha and -beta as starting points for cloning in this project, and Kathryn Callahan (NIDDK, National Institutes of Health) for assistance with filter binding assays. We thank the NHLBI Proteomics Core Facility, which provided excellent service. We thank the Electron Microscopy Core Facility of the NHLBI for support and the use of facilities.	ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Beach JR, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-52; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Brown JH, 2011, P NATL ACAD SCI USA, V108, P114, DOI 10.1073/pnas.1016288107; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; JANSON LW, 1992, CELL MOTIL CYTOSKEL, V22, P274, DOI 10.1002/cm.970220407; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nakano T, 2005, GENE CHROMOSOME CANC, V43, P162, DOI 10.1002/gcc.20180; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Onishi H, 1997, BIOCHEMISTRY-US, V36, P3767, DOI 10.1021/bi9630772; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Preller M, 2011, J BIOL CHEM, V286, P35051, DOI 10.1074/jbc.M111.265298; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SELLERS JR, 1993, METHOD CELL BIOL, V39, P23, DOI 10.1016/S0091-679X(08)60159-4; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Sweeney HL, 2000, J BIOL CHEM, V275, P41273, DOI 10.1074/jbc.M008310200; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; Uchimura T, 2002, CELL STRUCT FUNCT, V27, P479, DOI 10.1247/csf.27.479; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422; Yanaihara N, 2004, INT J CANCER, V112, P150, DOI 10.1002/ijc.20339; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	71	44	45	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9532	9548		10.1074/jbc.M112.441238	http://dx.doi.org/10.1074/jbc.M112.441238			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23382379	Green Published, hybrid			2022-12-25	WOS:000316862200068
J	Bogani, C; Bartalucci, N; Martinelli, S; Tozzi, L; Guglielmelli, P; Bosi, A; Vannucchi, AM				Bogani, Costanza; Bartalucci, Niccolo; Martinelli, Serena; Tozzi, Lorenzo; Guglielmelli, Paola; Bosi, Alberto; Vannucchi, Alessandro M.		Associazione Italiana Ric Canc AGI	mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms	PLOS ONE			English	Article							POLYCYTHEMIA-VERA; PRIMARY MYELOFIBROSIS; HEMATOPOIETIC STEM; EXPRESSION; MUTATION; PATHOGENESIS; JAK2(V617F); JAK2V617F; THERAPY; RUXOLITINIB	Background: Dysregulated signaling of the JAK/STAT pathway is a common feature of chronic myeloproliferative neoplasms (MPN), usually associated with JAK2V617F mutation. Recent clinical trials with JAK2 inhibitors showed significant improvements in splenomegaly and constitutional symptoms in patients with myelofibrosis but meaningful molecular responses were not documented. Accordingly, there remains a need for exploring new treatment strategies of MPN. A potential additional target for treatment is represented by the PI3K/AKT/mammalian target of rapamycin (mTOR) pathway that has been found constitutively activated in MPN cells; proof-of-evidence of efficacy of the mTOR inhibitor RAD001 has been obtained recently in a Phase I/II trial in patients with myelofibrosis. The aim of the study was to characterize the effects in vitro of mTOR inhibitors, used alone and in combination with JAK2 inhibitors, against MPN cells. Findings: Mouse and human JAK2V617F mutated cell lines and primary hematopoietic progenitors from MPN patients were challenged with an allosteric (RAD001) and an ATP-competitive (PP242) mTOR inhibitor and two JAK2 inhibitors (AZD1480 and ruxolitinib). mTOR inhibitors effectively reduced proliferation and colony formation of cell lines through a slowed cell division mediated by changes in cell cycle transition to the S-phase. mTOR inhibitors also impaired the proliferation and prevented colony formation from MPN hematopoietic progenitors at doses significantly lower than healthy controls. JAK2 inhibitors produced similar antiproliferative effects in MPN cell lines and primary cells but were more potent inducers of apoptosis, as also supported by differential effects on cyclinD1, PIM1 and BcLxL expression levels. Co-treatment of mTOR inhibitor with JAK2 inhibitor resulted in synergistic activity against the proliferation of JAK2V617F mutated cell lines and significantly reduced erythropoietin-independent colony growth in patients with polycythemia vera. Conclusions/Significance: These findings support mTOR inhibitors as novel potential drugs for the treatment of MPN and advocate for clinical trials exploiting the combination of mTOR and JAK2 inhibitor.	[Bogani, Costanza; Bartalucci, Niccolo; Martinelli, Serena; Tozzi, Lorenzo; Guglielmelli, Paola; Bosi, Alberto; Vannucchi, Alessandro M.; Associazione Italiana Ric Canc AGI] Univ Florence, Sect Hematol, Dept Med & Surg Care, Florence, Italy	University of Florence	Vannucchi, AM (corresponding author), Univ Florence, Sect Hematol, Dept Med & Surg Care, Florence, Italy.	amvannucchi@unifi.it	Vannucchi, Alessandro M./K-7499-2016; Bartalucci, Niccolò/AAB-3612-2019; Guglielmelli, Paola/K-7509-2016	Vannucchi, Alessandro M./0000-0001-5755-0730; Bartalucci, Niccolò/0000-0002-9328-3948; Guglielmelli, Paola/0000-0003-1809-284X; Tozzi, Lorenzo/0000-0002-0679-5030; martinelli, serena/0000-0003-4992-2252; BOSI, ALBERTO/0000-0002-5486-4838	Associazione Italiana per la Ricerca sul Cancro-"AIRC 5 per Mille"; Ministero Italiano della Universita e della Ricerca (MIUR) [FIRB-RBAP11CZLK]	Associazione Italiana per la Ricerca sul Cancro-"AIRC 5 per Mille"(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a special grant from Associazione Italiana per la Ricerca sul Cancro-"AIRC 5 per Mille''- to AGIMM, "AIRC-Gruppo Italiano Malattie Mieloproliferative''. Supported by Ministero Italiano della Universita e della Ricerca (MIUR), project FIRB-RBAP11CZLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Beer PA, 2008, BLOOD, V112, P141, DOI 10.1182/blood-2008-01-131664; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Drayer AL, 2006, STEM CELLS, V24, P105, DOI 10.1634/stemcells.2005-0062; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ghaffari S, 2006, BLOOD, V107, P1888, DOI 10.1182/blood-2005-06-2304; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Guglielmelli P, 2011, BLOOD, V118, P2069, DOI 10.1182/blood-2011-01-330563; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li G, 2010, LEUKEMIA, V24, P1397, DOI 10.1038/leu.2010.131; Li G, 2009, BLOOD, V114, p3902A; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu PCC, 2009, CLIN CANCER RES, V15, P6891, DOI 10.1158/1078-0432.CCR-09-1298; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Maruani DM, 2012, ONCOGENE; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Pardanani A, 2011, LEUKEMIA, V25, P1834, DOI 10.1038/leu.2011.161; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Pardanani AD, 2008, BLOOD, V112, P43, DOI 10.1182/blood.V112.11.97.97; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Vannucchi AM, 2008, BLOOD, V112, P844, DOI 10.1182/blood-2008-01-135897; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Vannucchi AM, 2005, AM J PATHOL, V167, P849, DOI 10.1016/S0002-9440(10)62056-1; Verstovsek S, 2010, BLOOD, V116, P313, DOI 10.1182/blood.V116.21.313.313; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	57	65	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54826	10.1371/journal.pone.0054826	http://dx.doi.org/10.1371/journal.pone.0054826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382981	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600046
J	Valencia-Cruz, AI; Uribe-Figueroa, LI; Galindo-Murillo, R; Baca-Lopez, K; Gutierrez, AG; Vazquez-Aguirre, A; Ruiz-Azuara, L; Hernandez-Lemus, E; Mejia, C				Idan Valencia-Cruz, Alejandra; Uribe-Figueroa, Laura I.; Galindo-Murillo, Rodrigo; Baca-Lopez, Karol; Gutierrez, Anllely G.; Vazquez-Aguirre, Adriana; Ruiz-Azuara, Lena; Hernandez-Lemus, Enrique; Mejia, Carmen			Whole Genome Gene Expression Analysis Reveals Casiopeina-Induced Apoptosis Pathways	PLOS ONE			English	Article							CELLS IN-VITRO; MIXED CHELATE; HELA-CELLS; MECHANISM; COMPLEX; INHIBITION; DEATH; CYTOTOXICITY; GLUTATHIONE; GENERATION	Copper-based chemotherapeutic compounds Casiopeinas, have been presented as able to promote selective programmed cell death in cancer cells, thus being proper candidates for targeted cancer therapy. DNA fragmentation and apoptosis-in a process mediated by reactive oxygen species-for a number of tumor cells, have been argued to be the main mechanisms. However, a detailed functional mechanism (a model) is still to be defined and interrogated for a wide variety of cellular conditions before establishing settings and parameters needed for their wide clinical application. In order to shorten the gap in this respect, we present a model proposal centered in the role played by intrinsic (or mitochondrial) apoptosis triggered by oxidative stress caused by the chemotherapeutic agent. This model has been inferred based on genome wide expression profiling in cervix cancer (HeLa) cells, as well as statistical and computational tests, validated via functional experiments (both in the same HeLa cells and also in a Neuroblastoma model, the CHP-212 cell line) and assessed by means of data mining studies.	[Idan Valencia-Cruz, Alejandra; Uribe-Figueroa, Laura I.] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Idan Valencia-Cruz, Alejandra; Uribe-Figueroa, Laura I.] Natl Inst Genom Med, Microarray Core Facil, Mexico City, DF, Mexico; [Galindo-Murillo, Rodrigo] Univ Nacl Autonoma Mexico, Inst Chem, Dept Chem Phys, Mexico City 04510, DF, Mexico; [Galindo-Murillo, Rodrigo] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA; [Baca-Lopez, Karol] Autonomous Univ State Mexico, Sch Sci, Toluca, Mexico; [Gutierrez, Anllely G.; Vazquez-Aguirre, Adriana] Univ Nacl Autonoma Mexico, Inst Biomed Res, Genom Med & Environm Toxicol Dept, Mexico City 04510, DF, Mexico; [Ruiz-Azuara, Lena] Univ Nacl Autonoma Mexico, Sch Chem, Nucl & Inorgan Chem Dept, Mexico City 04510, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Utah System of Higher Education; University of Utah; Universidad Autonoma del Estado de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez-Lemus, E (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx; Maria.C.Mejia@uv.es		Ruiz-Azuara, Lena/0000-0003-3035-4507; Hernandez-Lemus, Enrique/0000-0002-1872-1397	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [PIUTE10-92, PICSA10-61]; Universidad Nacional Autonoma de Mexico [PAPIIT-UNAM 204511]; National Institute of Genomic Medicine	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); National Institute of Genomic Medicine	The authors gratefully acknowledge support by grants: PIUTE10-92 and PICSA10-61 from the Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF), and PAPIIT-UNAM 204511 from the Universidad Nacional Autonoma de Mexico, as well as federal funding from the National Institute of Genomic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemon-Medina R, 2008, TOXICOL IN VITRO, V22, P710, DOI 10.1016/j.tiv.2007.11.011; Alemon-Medina R, 2007, CANCER CHEMOTH PHARM, V60, P219, DOI 10.1007/s00280-006-0364-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baca-Lopez K, 2009, REV MEX FIS, V55, P456; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Garcia-Ramos JC, 2012, DALTON T, V41, P10164, DOI 10.1039/c2dt30224a; Carvallo-Chaigneau F, 2008, BIOMETALS, V21, P17, DOI 10.1007/s10534-007-9089-4; Chikira M, 2002, J INORG BIOCHEM, V89, P163, DOI 10.1016/S0162-0134(02)00378-1; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P12; De Vizcaya-Ruiz A, 2000, TOXICOL IN VITRO, V14, P1, DOI 10.1016/S0887-2333(99)00082-X; Deighton RF, 2010, PROTEOMICS, V10, P1307, DOI 10.1002/pmic.200900112; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Bravo-Gomez ME, 2009, J INORG BIOCHEM, V103, P299, DOI 10.1016/j.jinorgbio.2008.10.006; FranceLanord V, 1997, J NEUROCHEM, V69, P1612; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Gutierrez AG, 2013, MITOCHONDRI IN PRESS; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez-Esquivel L, 2006, TOXICOL APPL PHARM, V212, P79, DOI 10.1016/j.taap.2005.06.023; Hernandez-Lemus E., 2012, THYROID CANC DIAGNOS; JOUINI M, 1986, J INORG BIOCHEM, V26, P269, DOI 10.1016/0162-0134(86)80051-4; Kachadourian R, 2010, TOXICOLOGY, V268, P176, DOI 10.1016/j.tox.2009.12.010; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kim JW, 2012, J INT MED RES, V40, P486, DOI 10.1177/147323001204000210; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Leal-Garcia M, 2007, BASIC CLIN PHARMACOL, V101, P151, DOI 10.1111/j.1742-7843.2007.00038.x; Lim YB, 2008, J BIOL CHEM, V283, P33110, DOI 10.1074/jbc.M804255200; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Marin-Hernandez A, 2012, ARCH TOXICOL, V86, P753, DOI 10.1007/s00204-012-0809-3; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Mejia C, 2008, PATHOL ONCOL RES, V14, P467, DOI 10.1007/s12253-008-9060-x; Moshe Y, 2011, J BIOL CHEM, V286, P16647, DOI 10.1074/jbc.M111.223339; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Rivero-Muller A, 2007, CHEM-BIOL INTERACT, V165, P189, DOI 10.1016/j.cbi.2006.12.002; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shtyrlin VG, 2012, DALTON T, V41, P1216, DOI 10.1039/c1dt11309g; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Speisky H, 2008, BIOORGAN MED CHEM, V16, P6568, DOI 10.1016/j.bmc.2008.05.026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Trejo-Solis C, 2005, NEOPLASIA, V7, P563, DOI 10.1593/neo.04607; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0	49	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54664	10.1371/journal.pone.0054664	http://dx.doi.org/10.1371/journal.pone.0054664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382936	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600033
J	Sun, Q; Zhang, Y; Zhu, SL; Tian, HF; Huang, GH; Cui, H; Li, XL; Yan, DM; Zhu, Z; Li, J; Zheng, P; Jiang, HF; Zhang, B; Tan, XJ; Zhu, H; An, HQ; Xu, WB				Sun, Qiang; Zhang, Yong; Zhu, Shuangli; Tian, Huifang; Huang, Guohong; Cui, Hui; Li, Xiaolei; Yan, Dongmei; Zhu, Zhen; Li, Jing; Zheng, Peng; Jiang, Huafang; Zhang, Bo; Tan, Xiaojuan; Zhu, Hui; An, Hongqiu; Xu, Wenbo			Transmission of Human Enterovirus 85 Recombinants Containing New Unknown Serotype HEV-B Donor Sequences in Xinjiang Uighur Autonomous Region, China	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; ACUTE FLACCID PARALYSIS; COMPLETE GENOME SEQUENCE; MOLECULAR-IDENTIFICATION; ASEPTIC-MENINGITIS; PROTEIN; ECHOVIRUS-19; OUTBREAK; STRAIN; CHILD	Background: Human enterovirus 85 (HEV85), whose prototype strain (Strain BAN00-10353/BAN/2000) was isolated in Bangladesh in 2000, is a recently identified serotype within the human enterovirus B (HEV-B) species. At present, only one nucleotide sequence of HEV85 (the complete genome sequence of the prototype strain) is available in the GenBank database. Principal Findings: In this study, we report the genetic characteristics of 33 HEV85 isolates that circulated in the Xinjiang Uighur autonomous region of China in 2011. Sequence analysis revealed that all these Chinese HEV85 isolates belong to 2 transmission chains, and intertypic recombination was found with the new unknown serotype HEV-B donor sequences. Two HEV85 isolates recovered from a patient presenting acute flaccid paralysis and one of his contacts were temperature-insensitive strains, and some nucleotide substitutions in the non-coding regions and in the 2C or 3D coding regions may have affected the temperature sensitivity of HEV85 strains. Conclusions: The Chinese HEV85 recombinant described in this study trapped a new unknown serotype HEV-B donor sequence, indicating that new unknown HEV-B serotypes exist or circulate in Xinjiang of China. Our study also indicated that HEV85 is a prevalent and common enterovirus serotype in Xinjiang.	[Sun, Qiang; Zhang, Yong; Zhu, Shuangli; Huang, Guohong; Li, Xiaolei; Yan, Dongmei; Zhu, Zhen; Li, Jing; Zheng, Peng; Jiang, Huafang; Zhang, Bo; Tan, Xiaojuan; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Key Lab Med Virol & Viral Dis, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Tian, Huifang] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Cui, Hui] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Urumqi, Xinjiang Uygur, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Key Lab Med Virol & Viral Dis, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [30900063, 81101303]; National Key Technology R&D Program of China [2008BAI56B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	This study was supported by the National Natural Science Foundation of China (Project Nos. 30900063 and 81101303) and the National Key Technology R&D Program of China (Project No. 2008BAI56B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 2009, J INFECT DIS, V199, P391, DOI 10.1086/596052; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Avellon A, 2006, EMERG INFECT DIS, V12, P1609, DOI 10.3201/eid1210.060353; Bailly JL, 2004, VIRUS RES, V99, P147, DOI 10.1016/j.virusres.2003.11.006; Bergamini G, 2000, RNA, V6, P1781, DOI 10.1017/S1355838200001679; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Faustini A, 2006, INT J INFECT DIS, V10, P291, DOI 10.1016/j.ijid.2005.06.008; GEORGESCU MM, 1995, J VIROL, V69, P5278, DOI 10.1128/JVI.69.9.5278-5286.1995; Harvala H, 2011, J VIROL, V85, P4480, DOI 10.1128/JVI.02285-10; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lewthwaite P, 2010, EMERG INFECT DIS, V16, P1780, DOI 10.3201/eid1611.100672; dos Santos GPL, 2011, J MED VIROL, V83, P2164, DOI 10.1002/jmv.22235; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Norder L, 2002, J GEN VIROL, V83, P1721, DOI 10.1099/0022-1317-83-7-1721; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2007, ARCH VIROL, V152, P1587, DOI 10.1007/s00705-007-0978-1; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Oberste MS, 2001, J GEN VIROL, V82, P409, DOI 10.1099/0022-1317-82-2-409; Piralla A, 2010, EMERG INFECT DIS, V16, P1018, DOI 10.3201/eid1606.091533; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Starlin R, 2001, CLIN INFECT DIS, V33, P730, DOI 10.1086/322624; Sun Q, 2012, J VIROL, V86, P10228, DOI 10.1128/JVI.01567-12; Svitkin YV, 2001, RNA, V7, P1743; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Wang JT, 2012, ARCH VIROL, V157, P1593, DOI 10.1007/s00705-012-1332-9; World Health Organization, 2004, WHOIVB0410; Yamashita T, 2010, J GEN VIROL, V91, P1063, DOI 10.1099/vir.0.016014-0; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y., 2010, MANAGEMENT WORLD, V2, P1; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	43	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55480	10.1371/journal.pone.0055480	http://dx.doi.org/10.1371/journal.pone.0055480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383202	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600111
J	Hatakeyama, K; Suwabe, K; Tomita, RN; Kato, T; Nunome, T; Fukuoka, H; Matsumoto, S				Hatakeyama, Katsunori; Suwabe, Keita; Tomita, Rubens Norio; Kato, Takeyuki; Nunome, Tsukasa; Fukuoka, Hiroyuki; Matsumoto, Satoru			Identification and Characterization of Crr1a, a Gene for Resistance to Clubroot Disease (Plasmodiophora brassicae Woronin) in Brassica rapa L.	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; CHINESE-CABBAGE; CONFERRING RESISTANCE; ARABIDOPSIS-THALIANA; FULL-LENGTH; TRANSCRIPTS; LOCUS; COLONIZATION; POPULATIONS; CULTIVARS	Clubroot disease, caused by the obligate biotrophic protist Plasmodiophora brassicae Woronin, is one of the most economically important diseases of Brassica crops in the world. Although many clubroot resistance (CR) loci have been identified through genetic analysis and QTL mapping, the molecular mechanisms of defense responses against P. brassicae remain unknown. Fine mapping of the Crr1 locus, which was originally identified as a single locus, revealed that it comprises two gene loci, Crr1a and Crr1b. Here we report the map-based cloning and characterization of Crr1a, which confers resistance to clubroot in Brassica rapa. Crr1a(G004), cloned from the resistant line G004, encodes a Toll-Interleukin-1 receptor/nucleotide-binding site/leucine-rich repeat (TIR-NB-LRR) protein expressed in the stele and cortex of hypocotyl and roots, where secondary infection of the pathogen occurs, but not in root hairs, where primary infection occurs. Gain-of-function analysis proved that Crr1a(G004) alone conferred resistance to isolate Ano-01 in susceptible Arabidopsis and B. rapa. In comparison, the susceptible allele Crr1a(A9709) encodes a truncated NB-LRR protein, which lacked more than half of the TIR domain on account of the insertion of a solo-long terminal repeat (LTR) in exon 1 and included several substitutions and insertion-deletions in the LRR domain. This study provides a basis for further molecular analysis of defense mechanisms against P. brassicae and will contribute to the breeding of resistant cultivars of Brassica vegetables by marker-assisted selection. Data deposition The sequence reported in this paper has been deposited in the GenBank database (accession no. AB605024).	[Hatakeyama, Katsunori; Tomita, Rubens Norio; Kato, Takeyuki; Nunome, Tsukasa; Fukuoka, Hiroyuki; Matsumoto, Satoru] NARO Inst Vegetable & Tea Sci, Vegetable Breeding & Genome Res Div, Tsu, Mie, Japan; [Suwabe, Keita; Kato, Takeyuki] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan	Mie University	Matsumoto, S (corresponding author), NARO Inst Vegetable & Tea Sci, Vegetable Breeding & Genome Res Div, Tsu, Mie, Japan.	ssmats@affrc.go.jp			MEXT KAKENHI [19380008, 24580015]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grant number 19380008, 24580015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, DNA RES, V18, P277, DOI 10.1093/dnares/dsr018; Ariizumi T, 2002, PLANT CELL REP, V21, P90, DOI 10.1007/s00299-002-0487-3; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; BUCZACKI ST, 1975, T BRIT MYCOL SOC, V65, P295, DOI 10.1016/S0007-1536(75)80013-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dixon GR, 2009, J PLANT GROWTH REGUL, V28, P194, DOI 10.1007/s00344-009-9090-y; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Hatakeyama K, 2004, BREEDING SCI, V54, P197, DOI 10.1270/jsbbs.54.197; Hayashida N, 2008, J JPN SOC HORTIC SCI, V77, P150, DOI 10.2503/jjshs1.77.150; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Hiramoto T., 2011, PLANT CELL REP, P1; Ikegami H., 1981, GROWTH PLASMODIOPHOR; JONES DR, 1982, PLANT PATHOL, V31, P239, DOI 10.1111/j.1365-3059.1982.tb01274.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jubault M, 2008, THEOR APPL GENET, V117, P191, DOI 10.1007/s00122-008-0765-8; Kato T, 2012, BREEDING SCI, V62, P282, DOI 10.1270/jsbbs.62.282; Kobelt P, 2000, MYCOL RES, V104, P220, DOI 10.1017/S0953756299001781; KROLL TK, 1983, PHYTOPATHOL Z, V108, P97; Kuginuki Y, 1999, EUR J PLANT PATHOL, V105, P327, DOI 10.1023/A:1008705413127; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Manzanares-Dauleux MJ, 2001, PLANT PATHOL, V50, P165, DOI 10.1046/j.1365-3059.2001.00557.x; Matsumoto E, 1998, EUPHYTICA, V104, P79, DOI 10.1023/A:1018370418201; Matsumoto E, 2005, J JPN SOC HORTIC SCI, V74, P367, DOI 10.2503/jjshs.74.367; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Niwa R, 2011, PROTIST, V162, P423, DOI 10.1016/j.protis.2011.02.005; Piao ZY, 2009, J PLANT GROWTH REGUL, V28, P252, DOI 10.1007/s00344-009-9093-8; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Saito M, 2006, THEOR APPL GENET, V114, P81, DOI 10.1007/s00122-006-0412-1; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Siemens J, 2009, J PLANT GROWTH REGUL, V28, P245, DOI 10.1007/s00344-009-9091-x; Some A, 1996, PLANT PATHOL, V45, P432, DOI 10.1046/j.1365-3059.1996.d01-155.x; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Suwabe K, 2012, BREEDING SCI, V62, P170, DOI 10.1270/jsbbs.62.170; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Takasaki T, 1997, BREEDING SCI, V47, P127; Tanaka Shuhei, 2006, Journal of General Plant Pathology, V72, P205, DOI 10.1007/s10327-006-0276-x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; WILLIAMS PH, 1966, PHYTOPATHOLOGY, V56, P624; Yoshikawa H., 1981, Chinese cabbage. Proceedings of the first international symposium., P405; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474	49	106	125	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54745	10.1371/journal.pone.0054745	http://dx.doi.org/10.1371/journal.pone.0054745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382954	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800073
J	Thonpho, A; Rojvirat, P; Jitrapakdee, S; MacDonald, MJ				Thonpho, Ansaya; Rojvirat, Pinnara; Jitrapakdee, Sarawut; MacDonald, Michael J.			Characterization of the Distal Promoter of the Human Pyruvate Carboxylase Gene in Pancreatic Beta Cells	PLOS ONE			English	Article							NUCLEAR-FACTOR-Y; GLYCEROL PHOSPHATE DEHYDROGENASE; STIMULATED INSULIN-SECRETION; NF-Y; TRANSCRIPTIONAL REGULATION; PROXIMAL PROMOTER; CCAAT BOXES; RAT; REGIONS; BINDING	Pyruvate carboxylase (PC) is an enzyme that plays a crucial role in many biosynthetic pathways in various tissues including glucose-stimulated insulin secretion. In the present study, we identify promoter usage of the human PC gene in pancreatic beta cells. The data show that in the human, two alternative promoters, proximal and distal, are responsible for the production of multiple mRNA isoforms as in the rat and mouse. RT-PCR analysis performed with cDNA prepared from human liver and islets showed that the distal promoter, but not the proximal promoter, of the human PC gene is active in pancreatic beta cells. A 1108 bp fragment of the human PC distal promoter was cloned and analyzed. It contains no TATA box but possesses two CCAAT boxes, and other putative transcription factor binding sites, similar to those of the distal promoter of rat PC gene. To localize the positive regulatory region in the human PC distal promoter, 5'-truncated and the 25-bp and 15-bp internal deletion mutants of the human PC distal promoter were generated and used in transient transfections in INS-1 832/13 insulinoma and HEK293T (kidney) cell lines. The results indicated that positions -340 to -315 of the human PC distal promoter serve as (an) activator element(s) for cell-specific transcription factor, while the CCAAT box at -71/-67, a binding site for nuclear factor Y (NF-Y), as well as a GC box at -54/-39 of the human PC distal promoter act as activator sequences for basal transcription.	[Thonpho, Ansaya; Rojvirat, Pinnara; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Mol Metab Res Grp, Bangkok 10400, Thailand; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI USA	Mahidol University; University of Wisconsin System; University of Wisconsin Madison	Jitrapakdee, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Mol Metab Res Grp, Bangkok 10400, Thailand.	sarawut.jit@mahidol.ac.th; mjmacdon@wisc.edu		MacDonald, Michael/0000-0002-0201-9245	Thailand Research Fund [BRG5480002]; Faculty of Science, Mahidol University; NIH [DK28348]; Royal Golden Jubilee-PhD program from the Thailand Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK028348, R01DK028348] Funding Source: NIH RePORTER	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Golden Jubilee-PhD program from the Thailand Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Thailand Research Fund (BRG5480002) and the Faculty of Science, Mahidol University to SJ and NIH grant DK28348 to MJM. AT was supported by a Royal Golden Jubilee-PhD program from the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernadt CT, 2005, GENE EXPRESSION, V12, P193, DOI 10.3727/000000005783992052; Boonsaen T, 2007, BIOCHEM J, V405, P359, DOI 10.1042/BJ20070276; Carbone MA, 1998, AM J HUM GENET, V62, P1312, DOI 10.1086/301884; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Eggers A, 1998, J BIOL CHEM, V273, P18499, DOI 10.1074/jbc.273.29.18499; Ferre-D'Amare A.R., 1992, EMBO J, V13, P181; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hazelton SR, 2008, J DAIRY SCI, V91, P91, DOI 10.3168/jds.2007-0542; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hou Y, 2010, INT J BIOL SCI, V6, P655; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958; Jitrapakdee S, 2001, BIOCHEM BIOPH RES CO, V287, P411, DOI 10.1006/bbrc.2001.5599; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; JITRAPAKDEE S, 1997, J BIOL CHEM, V272, P20520; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; MacDonald MJ, 2012, HORM METAB IN PRESS; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nicolas M, 2003, BIOCHEM J, V371, P265, DOI 10.1042/BJ20021166; PAPAZAFIRI P, 1991, J BIOL CHEM, V266, P5790; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; Rojvirat P, 2011, BBA-GENE REGUL MECH, V1809, P541, DOI 10.1016/j.bbagrm.2011.06.011; Shi Q, 2001, HYPERTENSION, V38, P332, DOI 10.1161/01.HYP.38.3.332; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067; Wang D, 2008, MOL GENET METAB, V95, P31, DOI 10.1016/j.ymgme.2008.06.006; WEXLER ID, 1994, BBA-MOL BASIS DIS, V1227, P46, DOI 10.1016/0925-4439(94)90105-8; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9	37	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55139	10.1371/journal.pone.0055139	http://dx.doi.org/10.1371/journal.pone.0055139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383084	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800119
J	Reuter, M; van Vliet, AHM				Reuter, Mark; van Vliet, Arnoud H. M.			Signal Balancing by the CetABC and CetZ Chemoreceptors Controls Energy Taxis in Campylobacter jejuni	PLOS ONE			English	Article							CHEMOTACTIC BEHAVIOR; RESPIRATORY OXIDASES; GENOME SEQUENCE; GROWTH; SYSTEM; DOMAIN; IDENTIFICATION; METABOLISM; AEROTAXIS; PROTEINS	The coupling of environmental sensing to flagella-mediated directed motility allows bacteria to move to optimum environments for growth and survival, either by sensing external stimuli (chemotaxis) or monitoring internal metabolic status (energy taxis). Sensing is mediated by transducer-like proteins (Tlp), either located in the membrane or in the cytoplasm, which commonly influence motility via the CheA-CheY chemotaxis pathway. In this study we have investigated the role of PAS-domain-containing intracellular Tlp-sensors in energy taxis of the food-borne pathogen Campylobacter jejuni, using plate-and tube-based assays utilising the conversion of the redox indicator dyes triphenyl tetrazolium chloride (TTC) and resazurin. Inactivation of the genes encoding the Campylobacter Energy Taxis system (CetA (Tlp9) and CetB (Aer2)) in C. jejuni strain NCTC 11168 resulted in reduced taxis. Inactivation of the cj1191c gene, encoding the CetB homolog CetC (Aer1), did not affect taxis per se, but the cetC gene complemented a cetB mutant in trans, indicating that CetC can form a functional signal transduction complex with CetA in the absence of CetB. Inactivation of both CetB and CetC resulted in greatly reduced taxis confirming the role of CetC in energy taxis. Inactivation of the cj1110c gene, encoding Tlp8 (CetZ), a cytoplasmic sensor with two PAS-domains, resulted in increased taxis, a phenotype opposite to that of CetAB. Inactivation of the cheA gene resulted in the same overall phenotype as the cetAB mutant in both wild-type and cetZ backgrounds, suggesting that both systems use the CheA system for signal transduction. Absence of both CetAB and CetZ resulted in the cetAB taxis phenotype, suggesting that CetZ is subordinate to CetAB. In conclusion, we present evidence that C. jejuni balances the input from two counteracting PAS-domain-containing sensory systems to position itself for optimal usage of energy resources.	[Reuter, Mark; van Vliet, Arnoud H. M.] Inst Food Res, Gut Hlth & Food Safety Programme, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	van Vliet, AHM (corresponding author), Inst Food Res, Gut Hlth & Food Safety Programme, Norwich Res Pk, Norwich, Norfolk, England.	arnoud.vanvliet@ifr.ac.uk	van Vliet, Arnoud HM/B-5155-2013	van Vliet, Arnoud/0000-0003-0203-1305	Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Biology and Complexity of Foodborne Bacterial Pathogens) [IFR/08/3]; Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Gut Health and Food Safety) [BB/J004529/1]; BBSRC [BBS/E/F/00044403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044403] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Biology and Complexity of Foodborne Bacterial Pathogens)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Gut Health and Food Safety)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk) through the Institute Strategic Programmes IFR/08/3 (Biology and Complexity of Foodborne Bacterial Pathogens) and BB/J004529/1 (Gut Health and Food Safety) to the Institute of Food Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre G, 2010, MICROBIOL-SGM, V156, P2283, DOI 10.1099/mic.0.039214-0; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Elliott KT, 2008, MOL MICROBIOL, V69, P1091, DOI 10.1111/j.1365-2958.2008.06357.x; Elliott KT, 2009, J BACTERIOL, V191, P375, DOI 10.1128/JB.00578-08; ERB RE, 1950, J DAIRY SCI, V33, P853, DOI 10.3168/jds.S0022-0302(50)91981-3; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Hendrixson DR, 2001, MOL MICROBIOL, V40, P214, DOI 10.1046/j.1365-2958.2001.02376.x; Holmes K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-214; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Howitt MR, 2011, MBIO, V2, DOI 10.1128/mBio.00098-11; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Jackson RJ, 2007, J BACTERIOL, V189, P1604, DOI 10.1128/JB.00897-06; Jacobs-Reitsma W, 2008, CAMPYLOBACTER, 3RD EDITION, P627; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kelly DJ, 2008, CAMPYLOBACTER, 3RD EDITION, P41; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Marchant J, 2002, TRENDS MICROBIOL, V10, P155, DOI 10.1016/S0966-842X(02)02323-5; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Schweinitzer T, 2010, ARCH MICROBIOL, V192, P507, DOI 10.1007/s00203-010-0575-7; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; TENGERDY RP, 1967, APPL MICROBIOL, V15, P954, DOI 10.1128/AEM.15.4.954-955.1967; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; Van Vliet AHM, 1998, METHOD MICROBIOL, V27, P407; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wright JA, 2009, MICROBIOL-SGM, V155, P80, DOI 10.1099/mic.0.021790-0; Wuichet K, 2007, METHOD ENZYMOL, V422, P3, DOI 10.1016/S0076-6879(06)22001-9; Xie ZH, 2010, P NATL ACAD SCI USA, V107, P2235, DOI 10.1073/pnas.0910055107	46	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54390	10.1371/journal.pone.0054390	http://dx.doi.org/10.1371/journal.pone.0054390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382896	Green Submitted, Green Published, gold			2022-12-25	WOS:000315483200053
J	Vieux-Rochas, M; Bouhali, K; Mantero, S; Garaffo, G; Provero, P; Astigiano, S; Barbieri, O; Caratozzolo, MF; Tullo, A; Guerrini, L; Lallemand, Y; Robert, B; Levi, G; Merlo, GR				Vieux-Rochas, Maxence; Bouhali, Kamal; Mantero, Stefano; Garaffo, Giulia; Provero, Paolo; Astigiano, Simonetta; Barbieri, Ottavia; Caratozzolo, Mariano F.; Tullo, Apollonia; Guerrini, Luisa; Lallemand, Yvan; Robert, Benoit; Levi, Giovanni; Merlo, Giorgio R.			BMP-Mediated Functional Cooperation between Dlx5;Dlx6 and Msx1;Msx2 during Mammalian Limb Development	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; EARLY TOOTH DEVELOPMENT; VERTEBRATE LIMB; MOUSE LIMB; HOMEOBOX GENES; CLEFT-PALATE; REGULATORY INTERACTIONS; SIGNALING PATHWAYS; DLX HOMEOPROTEINS; MURINE SKULL	The Dlx and Msx homeodomain transcription factors play important roles in the control of limb development. The combined disruption of Msx1 and Msx2, as well as that of Dlx5 and Dlx6, lead to limb patterning defects with anomalies in digit number and shape. Msx1; Msx2 double mutants are characterized by the loss of derivatives of the anterior limb mesoderm which is not observed in either of the simple mutants. Dlx5; Dlx6 double mutants exhibit hindlimb ectrodactyly. While the morphogenetic action of Msx genes seems to involve the BMP molecules, the mode of action of Dlx genes still remains elusive. Here, examining the limb phenotypes of combined Dlx and Msx mutants we reveal a new Dlx-Msx regulatory loop directly involving BMPs. In Msx1; Dlx5; Dlx6 triple mutant mice (TKO), beside the expected ectrodactyly, we also observe the hallmark morphological anomalies of Msx1; Msx2 double mutants suggesting an epistatic role of Dlx5 and Dlx6 over Msx2. In Msx2; Dlx5; Dlx6 TKO mice we only observe an aggravation of the ectrodactyly defect without changes in the number of the individual components of the limb. Using a combination of qPCR, ChIP and bioinformatic analyses, we identify two Dlx/Msx regulatory pathways: 1) in the anterior limb mesoderm a non-cell autonomous Msx-Dlx regulatory loop involves BMP molecules through the AER and 2) in AER cells and, at later stages, in the limb mesoderm the regulation of Msx2 by Dlx5 and Dlx6 occurs also cell autonomously. These data bring new elements to decipher the complex AER-mesoderm dialogue that takes place during limb development and provide clues to understanding the etiology of congenital limb malformations.	[Vieux-Rochas, Maxence; Bouhali, Kamal; Levi, Giovanni] Museum Natl Hist Nat, CNRS, Evolut Regulat Endocriniennes UMR 7221, Paris, France; [Mantero, Stefano; Garaffo, Giulia; Provero, Paolo; Merlo, Giorgio R.] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Astigiano, Simonetta; Barbieri, Ottavia] Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Ist Ricovero & Cura Carattere Sci, Genoa, Italy; [Barbieri, Ottavia] Univ Genoa, Dept Expt Med, Genoa, Italy; [Caratozzolo, Mariano F.; Tullo, Apollonia] CNR, Inst Biomed Technol, Bari, Italy; [Guerrini, Luisa] Univ Milan, Dept Biosci, Milan, Italy; [Lallemand, Yvan; Robert, Benoit] Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, Paris, France; [Merlo, Giorgio R.] Univ Turin, Dulbecco Telethon Inst, Turin, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Turin	Merlo, GR (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	gmerlo@dti.telethon.it	Tullo, Apollonia/AAX-1079-2020; Astigiano, Simonetta/AAG-7766-2019; Provero, Paolo/AAC-1930-2019; Mantero, Stefano/AAE-5515-2021	Tullo, Apollonia/0000-0002-5081-4745; Astigiano, Simonetta/0000-0002-8200-0666; Bouhali, Kamal/0000-0002-3497-5303; Mantero, Stefano/0000-0003-0608-2724; Levi, Giovanni/0000-0002-7041-6787; Caratozzolo, Mariano Francesco/0000-0002-9559-4598	Italian Telethon Foundation [GGP11097, GP0218Y01]; Fondazione per la Ricerca Biomedica (Torino, Italy); Compagnia di San Paolo (Torino, Italy); Institut Pasteur; Centre National de la Recherche Scientifique (France); Agence Nationale de la Recherche (France)	Italian Telethon Foundation(Fondazione Telethon); Fondazione per la Ricerca Biomedica (Torino, Italy); Compagnia di San Paolo (Torino, Italy)(Compagnia di San Paolo); Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (France)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	Giorgio R. Merlo is supported by the Italian Telethon Foundation (GGP11097), the Fondazione per la Ricerca Biomedica (Torino, Italy), and the Compagnia di San Paolo (Torino, Italy). Ottavia Barbieri is supported by the Italian Telethon Foundation (GP0218Y01). Benoit Robert is supported by Institut Pasteur and the Centre National de la Recherche Scientifique (France). Benoit Robert and Giovanni Levi are supported by the Agence Nationale de la Recherche (France) grant "GENDACTYL." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Ahn K, 2001, DEVELOPMENT, V128, P4449; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Allard P, 2009, SEMIN CELL DEV BIOL, V20, P479, DOI 10.1016/j.semcdb.2008.10.011; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bastida MF, 2008, CURR OPIN GENET DEV, V18, P374, DOI 10.1016/j.gde.2008.06.009; Bei M, 2000, DEVELOPMENT, V127, P4711; Bei M, 1998, DEVELOPMENT, V125, P4325; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bensoussan-Trigano V, 2011, DEV DYNAM, V240, P1190, DOI 10.1002/dvdy.22619; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Chen HX, 2002, INT J DEV BIOL, V46, P937; Chen YP, 1996, DEVELOPMENT, V122, P3035; Chung IH, 2010, GENESIS, V48, P645, DOI 10.1002/dvg.20671; Cygan JA, 1997, DEVELOPMENT, V124, P5021; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; FERRARI D, 1995, MECH DEVELOP, V52, P257, DOI 10.1016/0925-4773(95)98113-O; Guerrini L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/864904; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; JONES CM, 1991, DEVELOPMENT, V111, P531; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Lallemand Y, 2009, DEV BIOL, V331, P189, DOI 10.1016/j.ydbio.2009.04.038; Levi G, 2003, MOL CELL NEUROSCI, V22, P530, DOI 10.1016/S1044-7431(02)00041-6; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Merlo GR, 2007, J MOL HISTOL, V38, P347, DOI 10.1007/s10735-007-9109-2; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Muraglia A, 2008, EUR J CELL BIOL, V87, P751, DOI 10.1016/j.ejcb.2008.04.004; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Paina S, 2011, J NEUROSCI, V31, P2675, DOI 10.1523/JNEUROSCI.3110-10.2011; Pan ZZ, 2002, BIOCHEM BIOPH RES CO, V290, P955, DOI 10.1006/bbrc.2001.6294; Panganiban G, 2002, DEVELOPMENT, V129, P4371; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Perera M, 2004, MOL CELL NEUROSCI, V25, P153, DOI 10.1016/j.mcn.2003.10.004; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Pizette S, 2001, DEVELOPMENT, V128, P4463; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Qiu Q, 2009, GENESIS, V47, P224, DOI 10.1002/dvg.20430; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Robert B, 2006, DEV DYNAM, V235, P2337, DOI 10.1002/dvdy.20890; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shamseldin HE, 2012, J MED GENET, V49, P16, DOI 10.1136/jmedgenet-2011-100556; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; SUMOY L, 1995, DEV BIOL, V170, P230, DOI 10.1006/dbio.1995.1210; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Vieux-Rochas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000510; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; ZELLER R, 2004, SCI STKE, V259, pPE53; Zeller R, 2010, CURR OPIN GENET DEV, V20, P384, DOI 10.1016/j.gde.2010.04.014; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhao X, 2000, MECH DEVELOP, V99, P29, DOI 10.1016/S0925-4773(00)00467-6; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	90	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e51700	10.1371/journal.pone.0051700	http://dx.doi.org/10.1371/journal.pone.0051700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382810	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200011
J	Zaugg, I; Benrey, B; Bacher, S				Zaugg, Isabelle; Benrey, Betty; Bacher, Sven			Bottom-Up and Top-Down Effects Influence Bruchid Beetle Individual Performance but Not Population Densities in the Field	PLOS ONE			English	Article							ACANTHOSCELIDES-OBTECTUS SAY; HOST-PLANT GENOTYPE; INSECT HERBIVORE; RELATIVE ROLES; BEAN WEEVIL; DINARMUS-BASALIS; PARASITOID WASP; QUALITY AFFECTS; SEX-RATIOS; COLEOPTERA	Plant quality (bottom-up) and natural enemies (top-down) can influence the individual performance of herbivorous insects on their host plants, but few studies measured at the same time the influence on population densities in the field. We investigated if plant quality of different wild common bean populations, Phaseolus vulgaris L. (Fabaceae), affects the performance of the bean weevil, Acanthoscelides obtectus (Say) (Coleoptera: Bruchidae), and one of its enemies, the ectoparasitoid Dinarmus basalis (Rondani) (Hymenoptera: Pteromalidae), in controlled laboratory experiments. Additionally, we examined if parasitoids influence the beetles' development and if increased individual beetle and parasitoid fitness lead to higher field population densities. We show that bean quality and parasitoids affected individual bean weevil performance under laboratory and field conditions. In the presence of parasitoids, fewer and smaller beetles emerged. However, beetle and parasitoid performance were not correlated. Increased individual performance was not leading to higher population densities; we found no correlations between measured performance components and beetle field infestation levels or parasitism rates. We conclude that bottom-up or top-down effects measured at the individual level do not always translate into population effects; therefore it is important to discriminate between effects acting on individual insects and those acting on populations.	[Zaugg, Isabelle; Bacher, Sven] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland; [Benrey, Betty] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Fribourg; University of Neuchatel	Bacher, S (corresponding author), Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland.	sven.bacher@unifr.ch	Benrey, Betty/AAL-1374-2020; Bacher, Sven/F-5431-2010	Benrey, Betty/0000-0002-3230-4450; Bacher, Sven/0000-0001-5147-7165	National Center of Competence in Research (NCCR)	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This study was funded by the National Center of Competence in Research (NCCR), "Plant Survival." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 1998, GENET RESOUR CROP EV, V45, P235, DOI 10.1023/A:1008636132108; Aebi A, 2004, MOL ECOL NOTES, V4, P707, DOI 10.1111/j.1471-8286.2004.00766.x; Alvarez N, 2005, J ZOOL SYST EVOL RES, V43, P29, DOI 10.1111/j.1439-0469.2004.00286.x; Alvarez N, 2006, ECOL ENTOMOL, V31, P582, DOI 10.1111/j.1365-2311.2006.00817.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bacher S, 1997, J INSECT PHYSIOL, V43, P945, DOI 10.1016/S0022-1910(97)00058-9; Ball SL, 1996, ECOLOGY, V77, P1116, DOI 10.2307/2265580; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Benrey B, 1998, BIOL CONTROL, V11, P130, DOI 10.1006/bcon.1997.0590; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bowler DE, 2011, OECOLOGIA, V166, P111, DOI 10.1007/s00442-010-1820-0; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Bull JC, 2008, J ANIM ECOL, V77, P1296, DOI 10.1111/j.1365-2656.2008.01449.x; CARDONA C, 1990, ENTOMOL EXP APPL, V56, P197, DOI 10.1007/BF00163462; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Dicke M, 2003, BASIC APPL ECOL, V4, P3, DOI 10.1078/1439-1791-00129; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; FOX LR, 1990, OECOLOGIA, V83, P414, DOI 10.1007/BF00317569; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Hansson C, 2004, ZOOTAXA, P1; Hartweck LM, 1997, THEOR APPL GENET, V95, P1012, DOI 10.1007/s001220050655; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; Harvey JA, 2007, ECOL ENTOMOL, V32, P15, DOI 10.1111/j.1365-2311.2006.00838.x; Harvey JA, 2012, J INSECT PHYSIOL, V58, P1463, DOI 10.1016/j.jinsphys.2012.08.013; Harvey JA, 2011, OECOLOGIA, V166, P421, DOI 10.1007/s00442-010-1861-4; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; HOWE R. W., 1964, BULL ENTOMOL RES, V55, P437, DOI 10.1017/S0007485300049580; Huignard J, 1996, BIOL CONTROL BRUCHID; Hunter MD, 1997, P NATL ACAD SCI USA, V94, P9176, DOI 10.1073/pnas.94.17.9176; HUNTER MD, 1992, ECOLOGY, V73, P724; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; KINGSOLVER JM, 1968, P ENTOMOL SOC WASH, V70, P4; KISTLER RA, 1985, ENVIRON ENTOMOL, V14, P507, DOI 10.1093/ee/14.4.507; KOHLER SL, 1989, ECOLOGY, V70, P1811, DOI 10.2307/1938114; Kos M, 2011, FUNCT ECOL, V25, P1113, DOI 10.1111/j.1365-2435.2011.01871.x; Lacoume S, 2006, J INSECT PHYSIOL, V52, P249, DOI 10.1016/j.jinsphys.2005.11.003; LaSalle John, 1995, P315; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Mayhew PJ, 1997, OECOLOGIA, V110, P218, DOI 10.1007/s004420050153; MEYHOFER R, 1994, PHYSIOL ENTOMOL, V19, P349, DOI 10.1111/j.1365-3032.1994.tb01062.x; MINNEY BHP, 1990, J INSECT PHYSIOL, V36, P757, DOI 10.1016/0022-1910(90)90049-L; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Newton E, 2009, ECOL ENTOMOL, V34, P614, DOI 10.1111/j.1365-2311.2009.01111.x; Nishimura K, 1997, FUNCT ECOL, V11, P336, DOI 10.1046/j.1365-2435.1997.00092.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OSBORN TC, 1988, SCIENCE, V240, P207, DOI 10.1126/science.240.4849.207; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Price PW, 2005, J ANIM ECOL, V74, P917, DOI 10.1111/j.1365-2656.2005.00989.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richmond DS, 2004, ECOL ENTOMOL, V29, P353, DOI 10.1111/j.1365-2311.2004.00598.x; Romero J, 1999, COLEOPTS BULL, V53, P87; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Sarfraz M, 2009, BIOL CONTROL, V51, P34, DOI 10.1016/j.biocontrol.2009.07.004; Schadler M, 2010, ENTOMOL EXP APPL, V135, P162, DOI 10.1111/j.1570-7458.2010.00976.x; Schmale I, 2001, BIOL CONTROL, V21, P134, DOI 10.1006/bcon.2000.0911; SCHOONHOVEN AV, 1983, J ECON ENTOMOL, V76, P1255, DOI 10.1093/jee/76.6.1255; Singer MS, 2005, ECOL LETT, V8, P1247, DOI 10.1111/j.1461-0248.2005.00835.x; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; STAMOPOULOS DC, 1988, J APPL ENTOMOL, V105, P317, DOI 10.1111/j.1439-0418.1988.tb00193.x; Stenberg JA, 2012, BIOL CONTROL, V60, P54, DOI 10.1016/j.biocontrol.2011.09.004; Teder T, 2002, ECOL ENTOMOL, V27, P94, DOI 10.1046/j.0307-6946.2001.00381.x; Teixeira IRV, 2002, J STORED PROD RES, V39, P131; Teixeira IRV, 2012, INSECT SCI, V19, P102, DOI 10.1111/j.1744-7917.2011.01425.x; THIERY D, 1984, J STORED PROD RES, V20, P177, DOI 10.1016/0022-474X(84)90001-8; THIERY D, 1994, J CHEM ECOL, V20, P1867, DOI 10.1007/BF02066228; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; Velten G, 2008, BIOL CONTROL, V47, P133, DOI 10.1016/j.biocontrol.2008.07.009; Velten G, 2007, BIOL CONTROL, V43, P78, DOI 10.1016/j.biocontrol.2007.05.003; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Walker M, 2008, J ANIM ECOL, V77, P1063, DOI 10.1111/j.1365-2656.2008.01406.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Zaugg I, 2013, THEOR APPL GENET, V126, P647, DOI 10.1007/s00122-012-2008-2	83	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55317	10.1371/journal.pone.0055317	http://dx.doi.org/10.1371/journal.pone.0055317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383151	gold, Green Published			2022-12-25	WOS:000315483200013
J	Bai, LL; Yin, WB; Chen, YH; Niu, LL; Sun, YR; Zhao, SM; Yang, FQ; Wang, RRC; Wu, Q; Zhang, XQ; Hu, ZM				Bai, Li-Li; Yin, Wei-Bo; Chen, Yu-Hong; Niu, Li-Li; Sun, Yong-Ru; Zhao, Shi-Min; Yang, Fu-Quan; Wang, Richard R. -C.; Wu, Qing; Zhang, Xiang-Qi; Hu, Zan-Min			A New Strategy to Produce a Defensin: Stable Production of Mutated NP-1 in Nitrate Reductase-Deficient Chlorella ellipsoidea	PLOS ONE			English	Article							N-TERMINAL METHIONINE; ANTIMICROBIAL PEPTIDES; GROWTH-HORMONE; EXPRESSION; GENE; PURIFICATION; CHLOROPLAST; PROTEINS; ALGA	Defensins are small cationic peptides that could be used as the potential substitute for antibiotics. However, there is no efficient method for producing defensins. In this study, we developed a new strategy to produce defensin in nitrate reductase (NR)-deficient C. ellipsoidea (nrm-4). We constructed a plant expression vector carrying mutated NP-1 gene (mNP-1), a mature alpha-defensin NP-1 gene from rabbit with an additional initiator codon in the 5'-terminus, in which the selection markers were NptII and NR genes. We transferred mNP-1 into nrm-4 using electroporation and obtained many transgenic lines with high efficiency under selection chemicals G418 and NaNO3. The mNP-1 was characterized using N-terminal sequencing after being isolated from transgenic lines. Excitingly, mNP-1 was produced at high levels (approximately 11.42 mg/l) even after 15 generations of continuous fermentation. In addition, mNP-1 had strong activity against Escherichia coli at 5 mu g/ml. This research developed a new method for producing defensins using genetic engineering.	[Bai, Li-Li; Yin, Wei-Bo; Chen, Yu-Hong; Sun, Yong-Ru; Zhao, Shi-Min; Zhang, Xiang-Qi; Hu, Zan-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Niu, Li-Li; Yang, Fu-Quan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China; [Wang, Richard R. -C.] Utah State Univ, FRRL, USDA ARS, Logan, UT 84322 USA; [Wu, Qing] Polo Biol Sci Pk Co Ltd, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Hu, ZM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	zmhu@genetics.ac.cn	Wang, Richard Ruey-Chyi/S-3053-2018	Wang, Richard Ruey-Chyi/0000-0003-3622-2572	Ministry of Science and Technology of China [2011AA10A212, 2011CB200902]; Chinese Academy of Sciences [Yz200947, KSCX2-YW-R-2]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by "863" Program number 2011AA10A212 (to ZMH), "973" Program number 2011CB200902 (to YHC) from the Ministry of Science and Technology of China and the projects numbers Yz200947 and KSCX2-YW-R-2 (to ZMH) from Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balous A, 1991, MANUAL CLIN MICROBIO, P1138; Befus AD, 1999, J IMMUNOL, V163, P947; BORENSTEIN LA, 1991, INFECT IMMUN, V59, P1368, DOI 10.1128/IAI.59.4.1368-1377.1991; Chebolu S, 2009, CURR TOP MICROBIOL, V332, P33, DOI 10.1007/978-3-540-70868-1_3; Chen HH, 2006, IEEE VEH TECHNOL MAG, V1, P2, DOI 10.1109/MVT.2006.307302; Chen Y, 2001, CURR GENET, V39, P365, DOI 10.1007/s002940100205; Cipakova I, 2005, PROTEIN PEPTIDE LETT, V12, P551, DOI 10.2174/0929866054395761; Corrales-Garcia LL, 2011, AMINO ACIDS, V40, P5, DOI 10.1007/s00726-010-0493-7; Dawson HN, 1997, CURR MICROBIOL, V35, P356, DOI 10.1007/s002849900268; ENDO H, 1974, AGR BIOL CHEM TOKYO, V38, P9, DOI 10.1080/00021369.1974.10861121; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Fuchs C, 2002, J BIOTECHNOL, V93, P243, DOI 10.1016/S0168-1656(01)00402-3; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; GANZ T, 1989, J IMMUNOL, V143, P1358; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hawkins RL, 1999, CURR MICROBIOL, V38, P335, DOI 10.1007/PL00006813; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; JARVIS EE, 1991, CURR GENET, V19, P317, DOI 10.1007/BF00355062; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kim DH, 2002, MAR BIOTECHNOL, V4, P63, DOI 10.1007/s1012601-0070-x; LEHRER RI, 1985, J VIROL, V54, P467, DOI 10.1128/JVI.54.2.467-472.1985; Liao YD, 2004, PROTEIN SCI, V13, P1802, DOI 10.1110/ps.04679104; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; MARUYAMA M, 1994, BIOTECHNOL TECH, V8, P821, DOI 10.1007/BF00152891; MIYASAKI KT, 1990, ORAL MICROBIOL IMMUN, V5, P315, DOI 10.1111/j.1399-302X.1990.tb00432.x; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; Nozdrachev A D, 2006, Neurosci Behav Physiol, V36, P313, DOI 10.1007/s11055-006-0018-8; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; Potvin G, 2010, BIOTECHNOL ADV, V28, P910, DOI 10.1016/j.biotechadv.2010.08.006; Raj PA, 2000, BIOCHEM J, V347, P633, DOI 10.1042/0264-6021:3470633; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; SELSTED ME, 1985, INFECT IMMUN, V49, P202, DOI 10.1128/IAI.49.1.202-206.1985; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; TAYLOR MG, 1993, PLANT CELL REP, V12, P491, DOI 10.1007/BF00236093; Ting ZW, 2011, AFR J BIOTECHNOL, V10, P9218; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Wang YQ, 2005, J APPL PHYCOL, V17, P281, DOI 10.1007/s10811-005-5559-7; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Zelitch I, 1971, PHOTOSYNTHESIS PHOTO, P275; Zhou L, 2007, PROTEOMICS, V7, P3194, DOI 10.1002/pmic.200700137	45	38	40	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54966	10.1371/journal.pone.0054966	http://dx.doi.org/10.1371/journal.pone.0054966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383016	gold, Green Submitted, Green Published			2022-12-25	WOS:000315211500041
J	Brun, J; Dieudonne, FX; Marty, C; Muller, J; Schule, R; Patino-Garcia, A; Lecanda, F; Fromigue, O; Marie, PJ				Brun, Julia; Dieudonne, Francois-Xavier; Marty, Caroline; Mueller, Judith; Schuele, Roland; Patino-Garcia, Ana; Lecanda, Fernando; Fromigue, Olivia; Marie, Pierre J.			FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo	PLOS ONE			English	Article							ONLY PROTEIN FHL2; BETA-CATENIN; CELL-DIFFERENTIATION; OXIDATIVE STRESS; LIM; EXPRESSION; INTERACTS; COACTIVATOR; DISEASE; DOMAIN	Background: The molecular mechanisms that are involved in the growth and invasiveness of osteosarcoma, an aggressive and invasive primary bone tumor, are not fully understood. The transcriptional co-factor FHL2 (four and a half LIM domains protein 2) acts as an oncoprotein or as a tumor suppressor depending on the tissue context. In this study, we investigated the role of FHL2 in tumorigenesis in osteosarcoma model. Methodology/Principal Findings: Western blot analyses showed that FHL2 is expressed above normal in most human and murine osteosarcoma cells. Tissue microarray analysis revealed that FHL2 protein expression is high in human osteosarcoma and correlates with osteosarcoma aggressiveness. In murine osteosarcoma cells, FHL2 silencing using shRNA decreased canonical Wnt/beta-catenin signaling and reduced the expression of Wnt responsive genes as well as of the key Wnt molecules Wnt5a and Wnt10b. This effect resulted in inhibition of osteosarcoma cell proliferation, invasion and migration in vitro. Using xenograft experiments, we showed that FHL2 silencing markedly reduced tumor growth and lung metastasis occurence in mice. The anti-oncogenic effect of FHL2 silencing in vivo was associated with reduced cell proliferation and decreased Wnt signaling in the tumors. Conclusion/Significance: Our findings demonstrate that FHL2 acts as an oncogene in osteosarcoma cells and contributes to tumorigenesis through Wnt signaling. More importantly, FHL2 depletion greatly reduces tumor cell growth and metastasis, which raises the potential therapeutic interest of targeting FHL2 to efficiently impact primary bone tumors.	[Brun, Julia; Dieudonne, Francois-Xavier; Marty, Caroline; Fromigue, Olivia; Marie, Pierre J.] INSERM, UMR 606, Paris, France; [Brun, Julia; Dieudonne, Francois-Xavier; Marty, Caroline; Fromigue, Olivia; Marie, Pierre J.] Univ Paris Diderot, Paris, France; [Mueller, Judith; Schuele, Roland] Univ Freiburg Klinikum, Urol Klink Frauenklin, Freiburg, Germany; [Mueller, Judith; Schuele, Roland] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Patino-Garcia, Ana; Lecanda, Fernando] Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Navarra	Marie, PJ (corresponding author), INSERM, UMR 606, Paris, France.	pierre.marie@inserm.fr	Patiño-Garcia, Ana/I-4299-2012; Fromigue, Olivia/B-8225-2013	Patiño-Garcia, Ana/0000-0002-4066-8203; Fromigue, Olivia/0000-0002-3050-6155	DIM Stem Pole Ile de France (Paris, France)	DIM Stem Pole Ile de France (Paris, France)	Julia Brun is a recipient of a Ph.D. Award from the DIM Stem Pole Ile de France (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bruland OS, 2005, CLIN CANCER RES, V11, P4666, DOI 10.1158/1078-0432.CCR-05-0165; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; Dieudonne FX, 2010, CANCER RES, V70, P5399, DOI 10.1158/0008-5472.CAN-10-0090; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Entz-Werle N, 2007, NEOPLASIA, V9, P678, DOI 10.1593/neo.07367; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gullotti L, 2011, LAB INVEST, V91, P1695, DOI 10.1038/labinvest.2011.109; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Himelstein Bruce P., 1998, Current Opinion in Oncology, V10, P326, DOI 10.1097/00001622-199807000-00009; Jaffe N, 2009, CANCER TREAT RES, V152, P239, DOI 10.1007/978-1-4419-0284-9_12; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Khanna C, 2001, CANCER RES, V61, P3750; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Kleiber K, 2007, ANTICANCER RES, V27, P55; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Labalette C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010371; Lai CF, 2006, J BONE MINER RES, V21, P17, DOI 10.1359/JBMR.050915; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; McQueen P, 2011, EXPERT REV ANTICANC, V11, P1223, DOI [10.1586/era.11.94, 10.1586/ERA.11.94]; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Ng CF, 2011, CANCER LETT, V304, P97, DOI 10.1016/j.canlet.2011.02.001; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Tanahashi H, 2000, HUM MOL GENET, V9, P2281, DOI 10.1093/oxfordjournals.hmg.a018919; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang WJ, 2011, EUR J CANCER, V47, P121, DOI 10.1016/j.ejca.2010.07.045	54	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55034	10.1371/journal.pone.0055034	http://dx.doi.org/10.1371/journal.pone.0055034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383046	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500049
J	Fischer, MD; Goldmann, T; Wallrapp, C; Muhlfriedel, R; Beck, SC; Stern-Schneider, G; Ueffing, M; Wolfrum, U; Seeliger, MW				Fischer, M. Dominik; Goldmann, Tobias; Wallrapp, Christine; Muehlfriedel, Regine; Beck, Susanne C.; Stern-Schneider, Gabi; Ueffing, Marius; Wolfrum, Uwe; Seeliger, Mathias W.			Successful Subretinal Delivery and Monitoring of MicroBeads in Mice	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; GLUCAGON-LIKE PEPTIDE-1; OPTICAL COHERENCE TOMOGRAPHY; MESENCHYMAL STEM-CELLS; MAMMALIAN PHOTORECEPTOR CELLS; SCANNING LASER OPHTHALMOSCOPY; LEBERS CONGENITAL AMAUROSIS; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; ANIMAL-MODELS	Background: To monitor viability of implanted genetically engineered and microencapsulated human stem cells (MicroBeads) in the mouse eye, and to study the impact of the beads and/or xenogenic cells on retinal integrity. Methodology/Principal Findings: MicroBeads were implanted into the subretinal space of SV126 wild type mice using an ab externo approach. Viability of microencapsulated cells was monitored by noninvasive retinal imaging (Spectralis (TM) HRA+OCT). Retinal integrity was also assessed with retinal imaging and upon the end of the study by light and electron microscopy. The implanted GFP-marked cells encapsulated in subretinal MicroBeads remained viable over a period of up to 4 months. Retinal integrity and viability appeared unaltered apart from the focal damage due to the surgical implantation, GFAP upregulation, and opsin mistargeting in the immediate surrounding tissue. Conclusions/Significance: The accessibility for routine surgery and its immune privileged state make the eye an ideal target for release system implants for therapeutic substances, including neurotrophic and anti-angiogenic compounds or protein based biosimilars. Microencapsulated human stem cells (MicroBeads) promise to overcome limitations inherent with single factor release systems, as they are able to produce physiologic combinations of bioactive compounds.	[Fischer, M. Dominik] Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Tubingen, Germany; [Fischer, M. Dominik] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX2 6AW, England; [Goldmann, Tobias; Stern-Schneider, Gabi; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Cell & Matrix Biol, Mainz, Germany; [Wallrapp, Christine] CellMed AG, Alzenau, Germany; [Muehlfriedel, Regine; Beck, Susanne C.; Seeliger, Mathias W.] Univ Tubingen, Div Ocular Neurodegenerat, Tubingen, Germany; [Muehlfriedel, Regine; Beck, Susanne C.; Ueffing, Marius; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oxford; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fischer, MD (corresponding author), Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Tubingen, Germany.	Dominik.Fischer@merton.ox.ac.uk		Goldmann, Tobias/0000-0001-9754-9144	DFG [Se837/5-2, Se837/6-1, Se837/7-1]; BMBF [0314106]; EU [LSHG-CT-512036, EU HEALTH-F2-2008-200234]; Kerstan Foundation; Hochbaum Foundation; Fortuene Program University of Tuebingen; FAUN-Stiftung, Nurnberg; MRC [MR/K003690/1] Funding Source: UKRI; Medical Research Council [MR/K003690/1] Funding Source: researchfish	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Kerstan Foundation(European Commission); Hochbaum Foundation; Fortuene Program University of Tuebingen; FAUN-Stiftung, Nurnberg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by DFG grants Se837/5-2, Se837/6-1, Se837/7-1; BMBF grant 0314106; EU grants LSHG-CT-512036, EU HEALTH-F2-2008-200234; Kerstan Foundation; Hochbaum Foundation; Fortuene Program University of Tuebingen; FAUN-Stiftung, Nurnberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beltran WA, 2008, ADV EXP MED BIOL, V613, P45; Beltran WA, 2007, EXP EYE RES, V84, P753, DOI 10.1016/j.exer.2006.12.019; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gekeler F, 2007, GRAEF ARCH CLIN EXP, V245, P230, DOI 10.1007/s00417-006-0339-x; Glage S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-18; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Helb HM, 2010, ACTA OPHTHALMOL, V88, P842, DOI 10.1111/j.1755-3768.2009.01602.x; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Jaissle GB, 2010, GRAEF ARCH CLIN EXP, V248, P1063, DOI 10.1007/s00417-009-1253-9; Klinge PM, 2011, NEUROSCI LETT, V497, P6, DOI 10.1016/j.neulet.2011.03.092; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mao H, 2012, HUM GENE THER; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Schwahn HN, 2001, GRAEF ARCH CLIN EXP, V239, P961, DOI 10.1007/s004170100368; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Thanos CG, 2004, TISSUE ENG, V10, P1617, DOI 10.1089/ten.2004.10.1617; VERDERBER L, 1995, INVEST OPHTH VIS SCI, V36, P1137; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Weber Christian, 2007, Open Biomed Eng J, V1, P64, DOI 10.2174/1874120700701010064; Weber Christian, 2007, Open Biomed Eng J, V1, P38, DOI 10.2174/1874120700701010038; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Zhang R, 2011, ACTA OPHTHALMOL, V89, pE320, DOI 10.1111/j.1755-3768.2010.02044.x; Zhang R, 2011, RETINA-J RET VIT DIS, V31, P785, DOI 10.1097/IAE.0b013e3181f27509; Zhang R, 2010, ACTA OPHTHALMOL, V88, pe348, DOI 10.1111/j.1755-3768.2009.01762.x	37	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55173	10.1371/journal.pone.0055173	http://dx.doi.org/10.1371/journal.pone.0055173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383096	gold, Green Submitted, Green Published			2022-12-25	WOS:000315211500061
J	Rico-Leo, EM; Alvarez-Barrientos, A; Fernandez-Salguero, PM				Rico-Leo, Eva M.; Alvarez-Barrientos, Alberto; Fernandez-Salguero, Pedro M.			Dioxin Receptor Expression Inhibits Basal and Transforming Growth Factor beta-induced Epithelial-to-mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR SNAIL; CONSTITUTIVE EXPRESSION; VAV3 PROTOONCOGENE; CELL PLASTICITY; GENE-EXPRESSION; TARGET GENE; FACTOR SLUG; CADHERIN; MECHANISM	Recent studies have emphasized the role of the dioxin receptor (AhR) in maintaining cell morphology, adhesion, and migration. These novel AhR functions depend on the cell phenotype, and although AhR expression maintains mesenchymal fibroblasts migration, it inhibits keratinocytes motility. These observations prompted us to investigate whether AhR modulates the epithelial-to-mesenchymal transition (EMT). For this, we have used primary AhR(+/+) and AhR(-/-) keratinocytes and NMuMG cells engineered to knock down AhR levels (sh-AhR) or to express a constitutively active receptor (CA-AhR). Both AhR(-/-) keratinocytes and sh-AhR NMuMG cells had increased migration, reduced levels of epithelial markers E-cadherin and beta-catenin, and increased expression of mesenchymal markers Snail, Slug/Snai2, vimentin, fibronectin, and alpha-smooth muscle actin. Consistently, AhR(+/+) and CA-AhR NMuMG cells had reduced migration and enhanced expression of epithelial markers. AhR activation by the agonist FICZ (6-formylindolo[3,2-b] carbazole) inhibited NMuMG migration, whereas the antagonist alpha-naphthoflavone induced migration as did AhR knockdown. Exogenous TGF beta exacerbated the promigratory mesenchymal phenotype in both AhR-expressing and AhR-depleted cells, although the effects on the latter were more pronounced. Rescuing AhR expression in sh-AhR cells reduced Snail and Slug/Snai2 levels and cell migration and restored E-cadherin levels. Interference of AhR in human HaCaT cells further supported its role in EMT. Interestingly, co-immunoprecipitation and immunofluorescence assays showed that AhR associates in common protein complexes with E-cadherin and beta-catenin, suggesting the implication of AhR in cell-cell adhesion. Thus, basal or TGF beta-induced AhR down-modulation could be relevant in the acquisition of a motile EMT phenotype in both normal and transformed epithelial cells.	[Rico-Leo, Eva M.; Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain; [Alvarez-Barrientos, Alberto] Univ Extremadura, Serv Tecn Aplicadas Biociencias, E-06071 Badajoz, Spain	Universidad de Extremadura; Universidad de Extremadura	Fernandez-Salguero, PM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain.	pmfersal@unex.es	Alvarez-Barrientos, Alberto/L-9299-2014; Fernandez-Salguero, Pedro M./J-8437-2014	Alvarez-Barrientos, Alberto/0000-0003-4761-0212; Fernandez-Salguero, Pedro M./0000-0003-2839-5027	Spanish Ministry of Science and Innovation [SAF2008-00462, BFU2011-22678]; Red Tematica de Investigacion Cooperativa en Cancer; Fondo de Investigaciones Sanitarias; Carlos III Institute; Spanish Ministry of Health [RD06/0020/1016, RD12/0036/0032]; Junta de Extremadura [GRU10008]; European Union FEDER (Fondo Europeo de Desarrollo Regional) program; Servicio de Tecnicas Aplicadas a las Biociencias of the Universidad de Extremadura	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Carlos III Institute(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Junta de Extremadura; European Union FEDER (Fondo Europeo de Desarrollo Regional) program; Servicio de Tecnicas Aplicadas a las Biociencias of the Universidad de Extremadura	This work was funded by grants from the Spanish Ministry of Science and Innovation (SAF2008-00462 and BFU2011-22678), the Red Tematica de Investigacion Cooperativa en Cancer, Fondo de Investigaciones Sanitarias, Carlos III Institute, Spanish Ministry of Health (RD06/0020/1016 and RD12/0036/0032), and the Junta de Extremadura (GRU10008). All Spanish funding was co-sponsored by the European Union FEDER (Fondo Europeo de Desarrollo Regional) program.; We are very grateful to Drs. Alberto Munoz, Xose R. Bustelo, and Jesus M. Paramio for technical assistance with TER measurements, retroviral transduction, and primary keratinocytes cultures, respectively. We also thank Drs. Antonio Garcia de Herreros for the NMuMG cells and the anti-Snail antibody, Yoshiaki Fujii-Kuriyama for the CA-AhR construct, and Miguel Quintanilla for the HaCaT cell line. The technical help of Eva Barrasa is greatly appreciated. Support of the Servicio de Tecnicas Aplicadas a las Biociencias of the Universidad de Extremadura is greatly acknowledged.	ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Bergander L, 2003, DRUG METAB DISPOS, V31, P233, DOI 10.1124/dmd.31.2.233; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Roman AC, 2011, GENOME RES, V21, P422, DOI 10.1101/gr.111203.110; Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Cho YC, 2004, TOXICOL APPL PHARM, V199, P220, DOI 10.1016/j.taap.2003.12.025; Diry M, 2006, ONCOGENE, V25, P5570, DOI 10.1038/sj.onc.1209553; Dohr O, 1997, MOL PHARMACOL, V51, P703, DOI 10.1124/mol.51.5.703; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Fernandez-Salguero PM, 2010, CELL ADHES MIGR, V4, P172, DOI 10.4161/cam.4.2.10387; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; MERCHANT M, 1993, TOXICOL APPL PHARM, V120, P179, DOI 10.1006/taap.1993.1101; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Mulero-Navarro S, 2006, CARCINOGENESIS, V27, P1099, DOI 10.1093/carcin/bgi344; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pohjanvirta R, 2012, AH RECEPTOR BIOL TOX; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Puga A, 2002, TOXICOLOGY, V181, P171, DOI 10.1016/S0300-483X(02)00276-7; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Roman A.C., 2012, AH RECEPTOR BIOL TOX, P485; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932; Santiago-Josefat B, 2003, J MOL BIOL, V333, P249, DOI 10.1016/j.jmb.2003.08.020; Seifert A, 2009, TOXICOL LETT, V184, P26, DOI 10.1016/j.toxlet.2008.10.026; Temchura VV, 2005, EUR J IMMUNOL, V35, P2738, DOI 10.1002/eji.200425641; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313	61	43	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7841	7856		10.1074/jbc.M112.425009	http://dx.doi.org/10.1074/jbc.M112.425009			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382382	Green Published, hybrid			2022-12-25	WOS:000316455300038
J	Chen, HH; Wang, HM; Fan, KH; Lin, CY; Yen, TC; Liao, CT; Chen, IH; Kang, CJ; Huang, SF				Chen, Hsuan-Ho; Wang, Hung-Ming; Fan, Kang-Hsing; Lin, Chien-Yu; Yen, Tzu-Chen; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu			Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; POSITRON-EMISSION-TOMOGRAPHY; ACUTE-PHASE PROTEINS; SCC-ANTIGEN; NECK-CANCER; NEOADJUVANT CHEMOTHERAPY; F-18 FLUORODEOXYGLUCOSE; TREATMENT RESPONSE; COLORECTAL-CANCER; CERVICAL-CANCER	The levels of squamous cell carcinoma antigen (SCC-Ag) and C-reactive protein (CRP) can be used to predict tumor invasion, lymph node metastasis, staging and survival in patients with oral cavity cancer. The present study analyzed the relationship between pre-treatment levels of SCC-Ag and CRP in relation to clinicopathological factors in patients with pharyngolaryngeal cancer (PLC) and determined whether elevated levels of CRP and SCC-Ag were associated with tumor metabolic activity via [18F] fluorodeoxyglucose positron emission tomography (FDG-PET). We retrospectively recruited one hundred and six PLC patients between June 2008 and December 2011. All patients received computed tomography (CT)/magnetic resonance imaging (MRI) and FDG-PET staging analyses, and the serum levels of SCC-Ag and CRP in these patients were measured prior to treatment. A SCC-Ag level >= 2.0 ng/ml and a CRP level >= 5.0 mg/L were significantly associated with clinical stage (P < 0.001), clinical tumor status (P < 0.001), and clinical nodal status (P < 0.001). The elevation of both SCC-Ag and CRP levels was correlated with the standardized uptake value (SUV) max of the tumor (>= 8.6 mg/L) and lymph nodes (>= 5.7 ng/ml) (P = 0.019). The present study demonstrated that the presence of high levels of both pre-treatment SCC-Ag and CRP acts as a predictor of clinical stage, clinical tumor status, and clinical nodal status in patients with PLC. Moreover, elevated levels of SCC-Ag and CRP were associated with a high metabolic rate as well as the proliferative activity measured according to the SUVmax of the tumor and lymph nodes. Therefore, elevated levels of these two factors have the potential to serve as biomarkers for the prediction of tumor aggressiveness in cases of PLC.	[Chen, Hsuan-Ho; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan; [Chen, Hsuan-Ho; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Mem Hosp, Dept Head & Neck Surg, Linkou, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Div Hematol Oncol, Linkou, Taiwan; [Fan, Kang-Hsing; Lin, Chien-Yu] Chang Gung Mem Hosp, Linkou, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Linkou, Taiwan; [Chen, Hsuan-Ho; Wang, Hung-Ming; Fan, Kang-Hsing; Lin, Chien-Yu; Yen, Tzu-Chen; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Linkou, Taiwan; [Chen, Hsuan-Ho; Wang, Hung-Ming; Fan, Kang-Hsing; Lin, Chien-Yu; Yen, Tzu-Chen; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Univ, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, SF (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan.	shiangfu.huang@gmail.com	Fan, K/GXH-3734-2022	Fan, Kang-Hsing/0000-0002-0910-7803				Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Chen HH, 2011, CLIN OTOLARYNGOL, V36, P147, DOI 10.1111/j.1749-4486.2011.02274.x; Chen PH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-101; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Department-of-Health, 2009, CANC REG ANN REP TAI; Dhankhar R, 2011, CLIN LAB, V57, P795; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Emoto T, 2008, BIOCHEM BIOPH RES CO, V370, P495, DOI 10.1016/j.bbrc.2008.03.132; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; GALLO O, 1995, EUR ARCH OTO-RHINO-L, V252, P159; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Huang SF, 2012, ANN SURG ONCOL; Huang SF, 2008, CANCER, V112, P1066, DOI 10.1002/cncr.23278; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Jablonska Ewa, 1997, Pathol Oncol Res, V3, P126; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Khandavilli SD, 2009, ORAL ONCOL, V45, P912, DOI 10.1016/j.oraloncology.2009.03.015; Kidd EA, 2007, CANCER, V110, P1738, DOI 10.1002/cncr.22974; Kim SY, 2007, J NUCL MED, V48, P752, DOI 10.2967/jnumed.107.039610; Kimura Y, 2000, CANCER LETT, V155, P163, DOI 10.1016/S0304-3835(00)00423-7; Krimmel M, 1998, J CRANIO MAXILL SURG, V26, P243, DOI 10.1016/S1010-5182(98)80020-6; Kulpa J, 2004, NEOPLASMA, V51, P103; Lachowicz MA, 1999, CLIN OTOLARYNGOL, V24, P270, DOI 10.1046/j.1365-2273.1999.00239.x; LARA PC, 1995, CANCER, V76, P758, DOI 10.1002/1097-0142(19950901)76:5<758::AID-CNCR2820760508>3.0.CO;2-9; Liao CT, 2008, ANN SURG ONCOL, V15, P915, DOI 10.1245/s10434-007-9761-5; Liao CT, 2010, INT J RADIAT ONCOL, V77, P421, DOI 10.1016/j.ijrobp.2009.05.002; Liao CT, 2009, INT J RADIAT ONCOL, V74, P1054, DOI 10.1016/j.ijrobp.2008.09.045; Lin WH, 2011, LARYNGOSCOPE, V121, P971, DOI 10.1002/lary.21721; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Molina R, 1996, TUMOR BIOL, V17, P81, DOI 10.1159/000217970; Nakamura K, 2010, GYNECOL ONCOL, V119, P81, DOI 10.1016/j.ygyno.2010.04.020; Ng SH, 2005, J NUCL MED, V46, P1136; Ng SH, 2006, J CLIN ONCOL, V24, P4371, DOI 10.1200/JCO.2006.05.7349; NGAN HYS, 1990, GYNECOL ONCOL, V37, P260, DOI 10.1016/0090-8258(90)90344-K; Oka M, 1996, CANCER RES, V56, P2776; Pectasides D, 1996, AM J CLIN ONCOL-CANC, V19, P271, DOI 10.1097/00000421-199606000-00013; SCAMBIA G, 1991, AM J OBSTET GYNECOL, V164, P631, DOI 10.1016/S0002-9378(11)80037-2; Schoder H, 2006, J NUCL MED, V47, P755; Schwarz JK, 2007, JAMA-J AM MED ASSOC, V298, P2289, DOI 10.1001/jama.298.19.2289; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Sueoka K, 2005, INT J ONCOL, V27, P1345; Takeda A, 2002, BIOL CHEM, V383, P1231, DOI 10.1515/BC.2002.136; Tartour E, 1997, CANCER, V79, P1401, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1401::AID-CNCR18>3.3.CO;2-H; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201, DOI 10.1200/JCO.1999.17.10.3201; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wensing BM, 2006, LARYNGOSCOPE, V116, P809, DOI 10.1097/01.mlg.0000209151.78362.d0; Yasumatsu R, 2001, CANCER LETT, V167, P205, DOI 10.1016/S0304-3835(01)00445-1; Zeng YC, 2012, TUMOR BIOL, V33, P891, DOI 10.1007/s13277-012-0330-6; Zhang BT, 2010, ACTA OTO-LARYNGOL, V130, P756, DOI 10.3109/00016480903402981	54	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55327	10.1371/journal.pone.0055327	http://dx.doi.org/10.1371/journal.pone.0055327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383155	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600088
J	Chen, ML; Xiao, JF; Zhang, Z; Liu, JX; Wu, JY; Yu, J				Chen, Meili; Xiao, Jingfa; Zhang, Zhang; Liu, Jingxing; Wu, Jiayan; Yu, Jun			Identification of Human HK Genes and Gene Expression Regulation Study in Cancer from Transcriptomics Data Analysis	PLOS ONE			English	Article							HOUSEKEEPING GENES; TGF-BETA; MICROARRAY; REPRODUCIBILITY; NORMALIZATION; DISCOVERIES; COMPENDIUM; STABILITY; DENSITY	The regulation of gene expression is essential for eukaryotes, as it drives the processes of cellular differentiation and morphogenesis, leading to the creation of different cell types in multicellular organisms. RNA-Sequencing (RNA-Seq) provides researchers with a powerful toolbox for characterization and quantification of transcriptome. Many different human tissue/cell transcriptome datasets coming from RNA-Seq technology are available on public data resource. The fundamental issue here is how to develop an effective analysis method to estimate expression pattern similarities between different tumor tissues and their corresponding normal tissues. We define the gene expression pattern from three directions: 1) expression breadth, which reflects gene expression on/off status, and mainly concerns ubiquitously expressed genes; 2) low/high or constant/variable expression genes, based on gene expression level and variation; and 3) the regulation of gene expression at the gene structure level. The cluster analysis indicates that gene expression pattern is higher related to physiological condition rather than tissue spatial distance. Two sets of human housekeeping (HK) genes are defined according to cell/tissue types, respectively. To characterize the gene expression pattern in gene expression level and variation, we firstly apply improved K-means algorithm and a gene expression variance model. We find that cancer-associated HK genes (a HK gene is specific in cancer group, while not in normal group) are expressed higher and more variable in cancer condition than in normal condition. Cancer-associated HK genes prefer to AT-rich genes, and they are enriched in cell cycle regulation related functions and constitute some cancer signatures. The expression of large genes is also avoided in cancer group. These studies will help us understand which cell type-specific patterns of gene expression differ among different cell types, and particularly for cancer.	[Chen, Meili; Xiao, Jingfa; Zhang, Zhang; Liu, Jingxing; Wu, Jiayan; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Meili; Liu, Jingxing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, JY (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	wujy@big.ac.cn; junyu@big.ac.cn		wu, jia yan/0000-0001-6048-405X	National Programs for High Technology Research and Development [2012AA020409]; Ministry of Science and Technology of the People's Republic of China; National Science Foundation of China [31101063, 31271386, 31000584]	National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant (2012AA020409) from National Programs for High Technology Research and Development (863 Program), the Ministry of Science and Technology of the People's Republic of China; and grants from the National Science Foundation of China (No. 31101063, No. 31271386 and No, 31000584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Howard BE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S6; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Klebanov L, 2006, STAT APPL GENET MOL, V5; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; Martinez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010398; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Qiu X, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-120; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Thellin O, 1999, J BIOTECHNOL, V75, P5; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wang DP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-20; Wang D, 2011, COMPUT BIOL CHEM, V35, P126, DOI 10.1016/j.compbiolchem.2011.04.006; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 2003, NAT REV GENET, V4, P741, DOI 10.1038/nrg1160; Warnefors M, 2011, GENOME BIOL EVOL, V3, P667, DOI 10.1093/gbe/evr019; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zheng-Bradley X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r124; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zhu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010144	57	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54082	10.1371/journal.pone.0054082	http://dx.doi.org/10.1371/journal.pone.0054082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382867	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600023
J	Eskens, BJM; Mooij, HL; Cleutjens, JPM; Roos, JMA; Cobelens, JE; Vink, H; VanTeeffelen, JWGE				Eskens, Bart J. M.; Mooij, Hans L.; Cleutjens, Jack P. M.; Roos, Jozef M. A.; Cobelens, Johanna E.; Vink, Hans; VanTeeffelen, Jurgen W. G. E.			Rapid Insulin-Mediated Increase in Microvascular Glycocalyx Accessibility in Skeletal Muscle May Contribute to Insulin-Mediated Glucose Disposal in Rats	PLOS ONE			English	Article							ENDOTHELIAL-CELL GLYCOCALYX; CAPILLARY-TUBE HEMATOCRIT; FREE LAYER; BARRIER PROPERTIES; TIME-COURSE; RECRUITMENT; PERFUSION; PERMEABILITY; SENSITIVITY; RESISTANCE	It has been demonstrated that insulin-mediated recruitment of microvascular blood volume is associated with insulin sensitivity. We hypothesize that insulin rapidly stimulates penetration of red blood cells (RBC) and plasma into the glycocalyx and thereby promotes insulin-mediated glucose uptake by increasing intracapillary blood volume. Experiments were performed in rats; the role of the glycocalyx was assessed by enzymatic degradation using a bolus of hyaluronidase. First, the effect of insulin on glycocalyx accessibility was assessed by measuring the depth of penetration of RBCs into the glycocalyx in microvessels of the gastrocnemius muscle with Sidestream Dark-field imaging. Secondly, peripheral insulin sensitivity was determined using intravenous insulin tolerance tests (IVITT). In addition, in a smaller set of experiments, intravital microscopy of capillary hemodynamics in cremaster muscle and histological analysis of the distribution of fluorescently labeled 40 kDa dextrans (D40) in hindlimb muscle was used to evaluate insulin-mediated increases in capillary blood volume. Insulin increased glycocalyx penetration of RBCs by 0.34 +/- 0.44 mu m (P < 0.05) within 10 minutes, and this effect of insulin was greatly impaired in hyaluronidase treated rats. Further, hyaluronidase treated rats showed a 35 +/- 25% reduction in whole-body insulin-mediated glucose disposal compared to control rats. Insulin-mediated increases in capillary blood volume were reflected by a rapid increase in capillary tube hematocrit from 21.1 +/- 10.1% to 29.0 +/- 9.8% (P < 0.05), and an increase in D40 intensity in individual capillaries of 134 +/- 138% compared to baseline at the end of the IVITT. These effects of insulin were virtually abolished in hyaluronidase treated animals. In conclusion, insulin rapidly increases glycocalyx accessibility for circulating blood in muscle, and this is associated with an increased blood volume in individual capillaries. Hyaluronidase treatment of the glycocalyx abolishes the effects of insulin on capillary blood volume and impairs insulin-mediated glucose disposal.	[Eskens, Bart J. M.; Mooij, Hans L.; Roos, Jozef M. A.; Cobelens, Johanna E.; Vink, Hans; VanTeeffelen, Jurgen W. G. E.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [Mooij, Hans L.; Vink, Hans] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Cleutjens, Jack P. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Eskens, BJM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands.	B.Eskens@maastrichtuniversity.nl	Cleutjens, Jack P.M./F-6242-2012	Cleutjens, Jack P.M./0000-0002-4346-1785	Dutch Diabetes Research Foundation [2006.00.027]; Netherlands Heart Foundation [2005T037]; Center for Translational Molecular Medicine [01C-104-04-PREDICCT]	Dutch Diabetes Research Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Center for Translational Molecular Medicine	The study was supported by the Dutch Diabetes Research Foundation (grant number 2006.00.027), the Netherlands Heart Foundation (grant number 2005T037) and the Center for Translational Molecular Medicine (Work package 01C-104-04-PREDICCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINMOKUN A, 1992, DIABETIC MED, V9, P432, DOI 10.1111/j.1464-5491.1992.tb01813.x; Baron AD, 1996, AM J PHYSIOL-ENDOC M, V271, pE1067, DOI 10.1152/ajpendo.1996.271.6.E1067; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Barrett EJ, 2011, AM J PHYSIOL-ENDOC M, V301, pE252, DOI 10.1152/ajpendo.00186.2011; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borghouts LB, 1999, EUR J APPL PHYSIOL O, V80, P461, DOI 10.1007/s004210050618; Brands J, 2010, AM J PHYSIOL-HEART C, V298, pH515, DOI 10.1152/ajpheart.01306.2008; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Cabrales P, 2007, J APPL PHYSIOL, V102, P2251, DOI 10.1152/japplphysiol.01155.2006; Chiu JD, 2008, DIABETES, V57, P828, DOI 10.2337/db07-1444; Clark MG, 2008, AM J PHYSIOL-ENDOC M, V295, pE732, DOI 10.1152/ajpendo.90477.2008; Clark MG, 2008, J APPL PHYSIOL, V104, P889, DOI 10.1152/japplphysiol.00779.2007; Clerk LH, 2004, DIABETES-METAB RES, V20, P3, DOI 10.1002/dmrr.414; Clerk LH, 2002, DIABETES, V51, P1138, DOI 10.2337/diabetes.51.4.1138; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Constantinescu AA, 2001, AM J PHYSIOL-HEART C, V280, pH1051, DOI 10.1152/ajpheart.2001.280.3.H1051; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; DESJARDINS C, 1987, AM J PHYSIOL, V252, pH494, DOI 10.1152/ajpheart.1987.252.3.H494; Dominighini A, 2010, CLIN HEMORHEOL MICRO, V44, P217, DOI 10.3233/CH-2010-1265; DULING BR, 1987, NEWS PHYSIOL SCI, V2, P66; Eggleston EM, 2007, DIABETES, V56, P2958, DOI 10.2337/db07-0670; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Gudbjornsdottir S, 2003, J CLIN ENDOCR METAB, V88, P4559, DOI 10.1210/jc.2003-030434; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Herkner H, 2003, EUR J CLIN INVEST, V33, P141, DOI 10.1046/j.1365-2362.2003.01106.x; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JARETT L, 1975, P NATL ACAD SCI USA, V72, P3526, DOI 10.1073/pnas.72.9.3526; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim S, 2009, BIORHEOLOGY, V46, P181, DOI 10.3233/BIR-2009-0530; KLITZMAN B, 1979, AM J PHYSIOL, V237, pH481, DOI 10.1152/ajpheart.1979.237.4.H481; Li JA, 2002, MICROVASC RES, V64, P38, DOI 10.1006/mvre.2002.2399; Meijer RI, 2012, MICROCIRCULATION, V19, P494, DOI 10.1111/j.1549-8719.2012.00174.x; Muniyappa R, 2007, CURR OPIN CLIN NUTR, V10, P523, DOI 10.1097/MCO.0b013e32819f8ecd; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Ong PK, 2010, AM J PHYSIOL-HEART C, V298, pH1870, DOI 10.1152/ajpheart.01182.2009; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; SARELIUS IH, 1982, AM J PHYSIOL, V243, pH1018, DOI 10.1152/ajpheart.1982.243.6.H1018; Schrauwen-Hinderling VB, 2003, J CLIN ENDOCR METAB, V88, P1610, DOI 10.1210/jc.2002-021464; Sheikh MY, 2009, DIGEST DIS SCI, V54, P2706, DOI 10.1007/s10620-008-0664-5; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; TOBERMEYER BK, 1981, LAB ANIM, V15, P111, DOI 10.1258/002367781780959071; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Van Teeffelen JWGE, 2008, J PHYSIOL-LONDON, V586, P3207, DOI 10.1113/jphysiol.2008.152975; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; VanTeeffelen JWGE, 2010, CARDIOVASC RES, V87, P311, DOI 10.1093/cvr/cvq114; VanTeeffelen JWGE, 2005, AM J PHYSIOL-HEART C, V289, pH447, DOI 10.1152/ajpheart.01298.2004; Vincent MA, 2005, CLIN EXP PHARMACOL P, V32, P302, DOI 10.1111/j.1440-1681.2005.04188.x; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vink H., 2012, BIORHEOLOGY, V49, P172; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Wheatley CM, 2004, AM J PHYSIOL-ENDOC M, V287, pE804, DOI 10.1152/ajpendo.00077.2004; YANG YJ, 1989, J CLIN INVEST, V84, P1620, DOI 10.1172/JCI114339; Zhang L, 2004, DIABETES, V53, P447, DOI 10.2337/diabetes.53.2.447; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	59	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55399	10.1371/journal.pone.0055399	http://dx.doi.org/10.1371/journal.pone.0055399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383178	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600098
J	Kalber, TL; Campbell-Washburn, AE; Siow, BM; Sage, E; Price, AN; Ordidge, KL; Walker-Samuel, S; Janes, SM; Lythgoe, MF				Kalber, Tammy L.; Campbell-Washburn, Adrienne E.; Siow, Bernard M.; Sage, Elizabeth; Price, Anthony N.; Ordidge, Katherine L.; Walker-Samuel, Simon; Janes, Sam M.; Lythgoe, Mark F.			Primed Infusion with Delayed Equilibrium of Gd.DTPA for Enhanced Imaging of Small Pulmonary Metastases	PLOS ONE			English	Article							EARLY LUNG-CANCER; MAGNETIC-RESONANCE; MRI; TUMOR; MICROENVIRONMENT; PERMEABILITY; TOMOGRAPHY; VALIDATION; DENSITY; NODULES	Objective: To use primed infusions of the magnetic resonance imaging (MRI) contrast agent Gd.DTPA (Magnevist), to achieve an equilibrium between blood and tissue (eqMRI). This may increase tumor Gd concentrations as a novel cancer imaging methodology for the enhancement of small tumor nodules within the low signal-to-noise background of the lung. Methods: A primed infusion with a delay before equilibrium (eqMRI) of the Gd(III) chelator Gd.DTPA, via the intraperitoneal route, was used to evaluate gadolinium tumor enhancement as a function of a bolus injection, which is applied routinely in the clinic, compared to gadolinium maintained at equilibrium. A double gated (respiration and cardiac) spin-echo sequence at 9.4T was used to evaluate whole lungs pre contrast and then at 15 (representative of bolus enhancement), 25 and 35 minutes (representative of eqMRI). This was carried out in two lung metastasis models representative of high and low tumor cell seeding. Lungs containing discrete tumor nodes where inflation fixed and taken for haematoxylin and eosin staining as well as CD34 staining for correlation to MRI. Results: We demonstrate that sustained Gd enhancement, afforded by Gd equilibrium, increases the detection of pulmonary metastases compared to bolus enhancement and those tumors which enhance at equilibrium are sub-millimetre in size (<0.7 mm(2)) with a similar morphology to early bronchoalveolar cell carcinomas. Conclusion: As Gd-chelates are routinely used in the clinic for detecting tumors by MRI, this methodology is readily transferable to the clinic and advances MRI as a methodology for the detection of small pulmonary tumors.	[Kalber, Tammy L.; Campbell-Washburn, Adrienne E.; Siow, Bernard M.; Price, Anthony N.; Ordidge, Katherine L.; Walker-Samuel, Simon; Lythgoe, Mark F.] UCL, Div Med, UCL Ctr Adv Biomed Imaging, London, England; [Kalber, Tammy L.; Campbell-Washburn, Adrienne E.; Siow, Bernard M.; Price, Anthony N.; Ordidge, Katherine L.; Walker-Samuel, Simon; Lythgoe, Mark F.] UCL, Inst Child Hlth, London, England; [Kalber, Tammy L.; Sage, Elizabeth; Ordidge, Katherine L.; Janes, Sam M.] UCL, Dept Med, Ctr Resp Res, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Kalber, TL (corresponding author), UCL, Div Med, UCL Ctr Adv Biomed Imaging, London, England.	t.kalber@ucl.ac.uk	Siow, Bernard/ABC-4414-2020	Siow, Bernard/0000-0002-8687-8783; Campbell-Washburn, Adrienne/0000-0002-7169-5693; Price, Anthony/0000-0002-6907-7554; Kalber, Tammy/0000-0002-3378-3748; Lythgoe, Mark/0000-0002-4945-0171; Janes, Sam/0000-0002-6634-5939	Nanotech Grand Challenge Engineering and Physical Sciences Research Council (EPSRC) [EP/G06262072/1]; British Heart Foundation; King's College London; University College London Comprehensive Cancer Imaging Centre CR-UK EPSRC; Medical Research Council (MRC); Medical Research Council Capacity Building Studentship; Department of Health's NIHR Biomedical Research Centres funding scheme; Department of Health (England)	Nanotech Grand Challenge Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); King's College London; University College London Comprehensive Cancer Imaging Centre CR-UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Capacity Building Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Department of Health (England)	The main funding for this study was provided by the Nanotech Grand Challenge Engineering and Physical Sciences Research Council (EPSRC) grant (EP/G06262072/1 - http://www.epsrc.ac.uk), the British Heart Foundation, the King's College London and University College London Comprehensive Cancer Imaging Centre CR-UK & EPSRC, in association with the Medical Research Council (MRC) and Department of Health (England), and a Medical Research Council Capacity Building Studentship (KLO). This study was partly undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. SMJ is a Wellcome Trust Senior fellow in Clinical Science (WT091730MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Branca RT, 2010, P NATL ACAD SCI USA, V107, P3693, DOI 10.1073/pnas.1000386107; Campbell AE, 2011, J CARDIOVASC MAGN S1, V13, pO60; Driehuys B, 2007, TOXICOL PATHOL, V35, P49, DOI 10.1080/01926230601132048; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Fan XB, 2004, MAGNET RESON MED, V51, P487, DOI 10.1002/mrm.10737; Fleming JB, 2003, J CELL BIOCHEM, V90, P492, DOI 10.1002/jcb.10644; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; FROST JK, 1984, AM REV RESPIR DIS, V130, P549; Fukumura D, 1997, AM J PATHOL, V151, P679; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garbow JR, 2004, CANCER RES, V64, P2740, DOI 10.1158/0008-5472.CAN-03-3258; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; GUPTA NC, 1992, RADIOLOGY, V184, P441, DOI 10.1148/radiology.184.2.1620844; Hatabu H, 1999, EUR J RADIOL, V29, P114, DOI 10.1016/S0720-048X(98)00174-0; Hatabu H, 1999, EUR J RADIOL, V29, P245, DOI 10.1016/S0720-048X(98)00169-7; Hoekstra CJ, 2005, J CLIN ONCOL, V23, P8362, DOI 10.1200/JCO.2005.01.1189; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Kennel SJ, 2000, MED PHYS, V27, P1101, DOI 10.1118/1.598974; Kokuryo D, 2012, MAGN RESON MED, V67, P156, DOI 10.1002/mrm.23005; KUBOTA K, 1990, J NUCL MED, V31, P1927; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; Padhani AR, 1999, BRIT J RADIOL, V72, P427, DOI 10.1259/bjr.72.857.10505003; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; Parker GJM, 2003, P 11 ISMRM TOR; Patz EF, 2001, RADIOLOGY, V221, P587, DOI 10.1148/radiol.2213001643; Price AN, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-44; RINCK PA, 1984, FORTSCHR RONTG NEUEN, V140, P239, DOI 10.1055/s-2008-1052964; RUNGE VM, 1988, MAGN RESON IMAGING, V6, P595, DOI 10.1016/0730-725X(88)90135-X; Saam BT, 2000, MAGN RESON MED, V44, P174, DOI 10.1002/1522-2594(200008)44:2<174::AID-MRM2>3.0.CO;2-4; Salerno M, 2001, EUR J RADIOL, V40, P33, DOI 10.1016/S0720-048X(01)00347-3; Semelka RC, 2001, RADIOLOGY, V218, P27, DOI 10.1148/radiology.218.1.r01ja2427; Song JW, 2009, LUNG CANCER, V65, P333, DOI 10.1016/j.lungcan.2008.12.004; Spiro SG, 2012, RESPIROLOGY, V17, P237, DOI 10.1111/j.1440-1843.2011.02114.x; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Tidwell VK, 2012, MAGN RESON MED, V67, P572, DOI 10.1002/mrm.22951; TOFTS PS, 1994, MAGN RESON IMAGING, V12, P81, DOI 10.1016/0730-725X(94)92355-8; Togao O, 2010, MAGN RESON MED, V64, P1491, DOI 10.1002/mrm.22521; VAUPEL P, 1989, CANCER RES, V49, P6449; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54903	10.1371/journal.pone.0054903	http://dx.doi.org/10.1371/journal.pone.0054903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382996	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600048
J	Kataria, H; Wadhwa, R; Kaul, SC; Kaur, G				Kataria, Hardeep; Wadhwa, Renu; Kaul, Sunil C.; Kaur, Gurcharan			Withania somnifera Water Extract as a Potential Candidate for Differentiation Based Therapy of Human Neuroblastomas	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; HEAT-SHOCK RESPONSE; POLYSIALIC ACID; CYCLIN D1; RETINOIC ACID; MATRIX METALLOPROTEINASES; NEURITE OUTGROWTH; NERVOUS-SYSTEM; CANCER-CELLS; TUMOR-CELLS	Neuroblastoma is an aggressive childhood disease of the sympathetic nervous system. Treatments are often ineffective and have serious side effects. Conventional therapy of neuroblastoma includes the differentiation agents. Unlike chemo-radiotherapy, differentiation therapy shows minimal side effects on normal cells, because normal non-malignant cells are already differentiated. Keeping in view the limited toxicity of Withania somnifera (Ashwagandha), the current study was aimed to investigate the efficacy of Ashwagandha water extract (ASH-WEX) for anti-proliferative potential in neuroblastoma and its underlying signalling mechanisms. ASH-WEX significantly reduced cell proliferation and induced cell differentiation as indicated by morphological changes and NF200 expression in human IMR-32 neuroblastoma cells. The induction of differentiation was accompanied by HSP70 and mortalin induction as well as pancytoplasmic translocation of the mortalin in ASH-WEX treated cells. Furthermore, the ASH-WEX treatment lead to induction of neural cell adhesion molecule (NCAM) expression and reduction in its polysialylation, thus elucidating its anti-migratory potential, which was also supported by downregulation of MMP 2 and 9 activity. ASH-WEX treatment led to cell cycle arrest at G0/G1 phase and increase in early apoptotic population. Modulation of cell cycle marker Cyclin D1, anti-apoptotic marker bcl-xl and Akt-P provide evidence that ASH-WEX may prove to be a promising phytotherapeutic intervention in neuroblatoma related malignancies.	[Kataria, Hardeep; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST)	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Kaur, Gurcharan/V-6033-2019; Wadhwa, Renu/L-8898-2018; Kataria, Hardeep/AAI-8411-2020; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Kataria, Hardeep/0000-0001-8413-0600	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by grants from the Department of Biotechnology, Government of India to Guru Nanak Dev University, under DBT-AIST, Japan collaboration program. H. K. is supported by fellowship grant from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; Armstrong JL, 2007, BRIT J CANCER, V96, P1675, DOI 10.1038/sj.bjc.6603779; Armstrong JL, 2005, BRIT J CANCER, V92, P696, DOI 10.1038/sj.bjc.6602398; BLACK MM, 1991, J NEUROSCI, V11, P1163; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Cesi V, 2002, CELL DEATH DIFFER, V9, P1232, DOI 10.1038/sj.cdd.4401103; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Deb S, 1996, J NEUROCHEM, V66, P1641; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DOLE MG, 1995, CANCER RES, V55, P2576; Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Fukuda M, 1996, CANCER RES, V56, P2237; Gallagher HC, 2000, J NEUROSCI RES, V61, P636, DOI 10.1002/1097-4547(20000915)61:6<636::AID-JNR7>3.3.CO;2-6; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Gupta Girdhari Lal, 2007, Indian J Physiol Pharmacol, V51, P345; HEIKKILA JJ, 1993, DEV GENET, V14, P87, DOI 10.1002/dvg.1020140202; Hildebrandt H, 1998, CANCER RES, V58, P779; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huerta S, 2001, SURGERY, V130, P834, DOI 10.1067/msy.2001.116415; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Katayama M, 1997, EXP CELL RES, V236, P412, DOI 10.1006/excr.1997.3757; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kuboyama T, 2002, NEUROREPORT, V13, P1715, DOI 10.1097/00001756-200210070-00005; Kumar S, 2010, PHYTOTHER RES, V24, P1567, DOI 10.1002/ptr.3261; Loones MT, 2000, CELL STRESS CHAPERON, V5, P291, DOI 10.1379/1466-1268(2000)005<0291:TDOHSP>2.0.CO;2; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Matthay KK, 2007, J CLIN ONCOL, V25, P1054, DOI 10.1200/JCO.2006.09.3484; McClellan KA, 2006, CELL CYCLE, V5, P1506, DOI 10.4161/cc.5.14.2980; Misra L, 2008, PHYTOCHEMISTRY, V69, P1000, DOI 10.1016/j.phytochem.2007.10.024; Misra L, 2012, J ASIAN NAT PROD RES, V14, P39, DOI 10.1080/10286020.2011.622719; Miyazaki T, 2008, GLYCOBIOLOGY, V18, P187, DOI 10.1093/glycob/cwm132; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Mulabagal V, 2009, PHYTOTHER RES, V23, P987, DOI 10.1002/ptr.2736; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Njar Vincent C O, 2006, Med Chem, V2, P431, DOI 10.2174/157340606777724022; Noujaim D, 2002, ONCOGENE, V21, P4549, DOI 10.1038/sj.onc.1205552; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Pestell RG, 1999, ENDOCR REV, V20, P501, DOI 10.1210/er.20.4.501; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; RAY SD, 1994, ARCH BIOCHEM BIOPHYS, V311, P180, DOI 10.1006/abbi.1994.1224; REICHARDT LF, 1989, DEV NEUROSCI-BASEL, V11, P332, DOI 10.1159/000111910; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Sallinen SL, 1999, J PATHOL, V188, P289; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Singh AP, 2012, INT J ONCOL, V40, P99, DOI 10.3892/ijo.2011.1225; Spix C, 2006, EUR J CANCER, V42, P2081, DOI 10.1016/j.ejca.2006.05.008; Sukumari-Ramesh S, 2011, INT J DEV NEUROSCI, V29, P701, DOI 10.1016/j.ijdevneu.2011.06.002; Sumrejkanchanakij P, 2006, BIOCHEM BIOPH RES CO, V340, P302, DOI 10.1016/j.bbrc.2005.11.181; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Takahashi K, 2011, MOL CELL NEUROSCI, V48, P217, DOI 10.1016/j.mcn.2011.08.002; Takashima S, 1998, J BIOL CHEM, V273, P7675, DOI 10.1074/jbc.273.13.7675; Tanaka F, 2000, CANCER RES, V60, P3072; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; WADHWA R, 1995, INT J ONCOL, V7, P69; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yoshida Y, 1996, J BIOL CHEM, V271, P30167, DOI 10.1074/jbc.271.47.30167	80	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55316	10.1371/journal.pone.0055316	http://dx.doi.org/10.1371/journal.pone.0055316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383150	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600087
J	Merino, S; Knirel, YA; Regue, M; Tomas, JM				Merino, Susana; Knirel, Yuriy A.; Regue, Miguel; Tomas, Juan M.			Experimental Identification of Actinobacillus pleuropneumoniae Strains L20 and JL03 Heptosyltransferases, Evidence for a New Heptosyltransferase Signature Sequence	PLOS ONE			English	Article							CORE BIOSYNTHESIS GENE; CAPSULAR POLYSACCHARIDES; VIRULENCE FACTORS; LIPOPOLYSACCHARIDE; EXPRESSION; OLIGOSACCHARIDES; PATHOGENESIS; TEMPERATURE; SEROTYPES; PREVALENT	We experimentally identified the activities of six predicted heptosyltransferases in Actinobacillus pleuropneumoniae genome serotype 5b strain L20 and serotype 3 strain JL03. The initial identification was based on a bioinformatic analysis of the amino acid similarity between these putative heptosyltrasferases with others of known function from enteric bacteria and Aeromonas. The putative functions of all the Actinobacillus pleuropneumoniae heptosyltrasferases were determined by using surrogate LPS acceptor molecules from well-defined A. hydrophyla AH-3 and A. salmonicida A450 mutants. Our results show that heptosyltransferases APL_0981 and APJL_1001 are responsible for the transfer of the terminal outer core D-glycero-D-manno-heptose (D,D-Hep) residue although they are not currently included in the CAZY glycosyltransferase 9 family. The WahF heptosyltransferase group signature sequence [S(T/S)(GA)XXH] differs from the heptosyltransferases consensus signature sequence [D(TS)(GA)XXH], because of the substitution of D-261 for S-261, being unique.	[Merino, Susana; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia; [Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014; Knirel, Yuriy A/E-2058-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; 	Plan Nacional de I+D+i grant (Ministerio de Educacion, Ciencia y Deporte); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)	Plan Nacional de I+D+i grant (Ministerio de Educacion, Ciencia y Deporte); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya)	This work was supported by Plan Nacional de I+D+i grant (Ministerio de Educacion, Ciencia y Deporte) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baltes N, 2007, VET MICROBIOL, V123, P110, DOI 10.1016/j.vetmic.2007.03.026; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Canals R, 2006, INFECT IMMUN, V74, P537, DOI 10.1128/IAI.74.1.537-548.2006; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73, DOI 10.1017/S1466252300000074; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; Foote SJ, 2008, J BACTERIOL, V190, P1495, DOI 10.1128/JB.01845-07; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gottschalk M, 2006, DIS SWINE, P563; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Gronow S, 2005, J BACTERIOL, V187, P6242, DOI 10.1128/JB.187.17.6242-6247.2005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haesebrouck F, 1997, VET MICROBIOL, V58, P239, DOI 10.1016/S0378-1135(97)00162-4; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Hiratsuka K, 2005, J BACTERIOL, V187, P5156, DOI 10.1128/JB.187.15.5156-5165.2005; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003; Jacobsen MJ, 1996, VET MICROBIOL, V49, P159, DOI 10.1016/0378-1135(95)00184-0; Jacques M, 2004, CAN J VET RES, V68, P81; Jacques M, 1996, TRENDS MICROBIOL, V4, P408, DOI 10.1016/0966-842X(96)10054-8; Jacques M, 1998, FEMS MICROBIOL REV, V22, P45, DOI 10.1016/S0168-6445(98)00007-2; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; MacLean LL, 2004, INFECT IMMUN, V72, P5925, DOI 10.1128/IAI.72.10.5925-5930.2004; MERINO S, 1992, INFECT IMMUN, V60, P4343, DOI 10.1128/IAI.60.10.4343-4349.1992; Michael FS, 2004, CARBOHYD RES, V339, P1973, DOI 10.1016/j.carres.2004.04.019; Moreau F, 2008, BIOORG MED CHEM LETT, V18, P4022, DOI 10.1016/j.bmcl.2008.05.117; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Perry MB, 2004, CARBOHYD RES, V339, P1399, DOI 10.1016/j.carres.2004.03.011; PRADEL E, 1991, J BACTERIOL, V173, P6428, DOI 10.1128/jb.173.20.6428-6431.1991; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Ramjeet M, 2008, MOL MICROBIOL, V70, P221, DOI 10.1111/j.1365-2958.2008.06409.x; Rioux S, 2000, MICROB PATHOGENESIS, V28, P279, DOI 10.1006/mpat.1999.0347; Sambrook J., 1989, MOL CLONING LAB MANU, V2; St Michael F, 2005, GLYCOBIOLOGY, V15, P323, DOI 10.1093/glycob/cwi015; St Michael F, 2005, CARBOHYD RES, V340, P59, DOI 10.1016/j.carres.2004.10.017; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Ward CK, 1998, INFECT IMMUN, V66, P3326, DOI 10.1128/IAI.66.7.3326-3336.1998; WARD CK, 1994, J IMMUNOL, V153, P2110; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Zhan BJ, 2010, J BACTERIOL, V192, P5846, DOI 10.1128/JB.00867-10	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55546	10.1371/journal.pone.0055546	http://dx.doi.org/10.1371/journal.pone.0055546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383222	Green Published, gold			2022-12-25	WOS:000315563800164
J	Oliver, MJ; Irwin, A; Moline, MA; Fraser, W; Patterson, D; Schofield, O; Kohut, J				Oliver, Matthew J.; Irwin, Andrew; Moline, Mark A.; Fraser, William; Patterson, Donna; Schofield, Oscar; Kohut, Josh			Adelie Penguin Foraging Location Predicted by Tidal Regime Switching	PLOS ONE			English	Article							SAN-JUAN ISLANDS; DIVING BEHAVIOR; CLIMATE-CHANGE; SPHENISCUS MAGELLANICUS; DELAWARE BAY; PHYTOPLANKTON; ZOOPLANKTON; VARIABILITY; CHANNEL; WEST	Penguin foraging and breeding success depend on broad-scale environmental and local-scale hydrographic features of their habitat. We investigated the effect of local tidal currents on a population of Adelie penguins on Humble Is., Antarctica. We used satellite-tagged penguins, an autonomous underwater vehicle, and historical tidal records to model of penguin foraging locations over ten seasons. The bearing of tidal currents did not oscillate daily, but rather between diurnal and semidiurnal tidal regimes. Adelie penguins foraging locations changed in response to tidal regime switching, and not to daily tidal patterns. The hydrography and foraging patterns of Adelie penguins during these switching tidal regimes suggest that they are responding to changing prey availability, as they are concentrated and dispersed in nearby Palmer Deep by variable tidal forcing on weekly timescales, providing a link between local currents and the ecology of this predator.	[Oliver, Matthew J.; Moline, Mark A.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Irwin, Andrew] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada; [Fraser, William; Patterson, Donna] Polar Oceans Res Grp, Sheridan, MT USA; [Schofield, Oscar; Kohut, Josh] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA	University of Delaware; Mount Allison University; Rutgers State University New Brunswick	Oliver, MJ (corresponding author), Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA.	moliver@udel.edu	Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131; Irwin, Andrew/0000-0001-7784-2319	National Aeronautics and Space Administration [NNG06GH75G1/3]; National Science Foundation Office of Polar Programs [ANT-0823101, ANT-1019839]; Gordon and Betty Moore Foundation; Directorate For Geosciences [1440435, 1019838] Funding Source: National Science Foundation	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	These efforts were only possible with funding support provided by the National Aeronautics and Space Administration Biodiversity program (NNG06GH75G1/3 to M. Oliver, http://www.nasa.gov/), the National Science Foundation Office of Polar Programs (ANT-0823101 to Co-PI O. Schofield; ANT-1019839 to M. Moline, http://www.nsf.gov/), and the Gordon and Betty Moore Foundation, http://www.moore.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; ALLDREDGE AL, 1980, ESTUAR COAST MAR SCI, V10, P31, DOI 10.1016/S0302-3524(80)80047-8; Amos A, 1993, ANTARCT J US, V28, P162; Argo data management, 2008, ARG US MAN VERS 2 1; BARLOW JP, 1955, BIOL BULL, V109, P211, DOI 10.2307/1538722; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BENGTSON JL, 1993, ANTARCT SCI, V5, P9, DOI 10.1017/S0954102093000033; BOWDEN KF, 1963, AIR WATER POLLUT, V7, P343; BOWMAN MJ, 1981, J MAR RES, V39, P587; Cimino MA, 2013, GLOBAL CHANGE BIOL, V19, P136, DOI 10.1111/gcb.12016; Clarke J., 1994, CCAMLR SCI, V1, P155; CLOERN JE, 1991, J MAR RES, V49, P203, DOI 10.1357/002224091784968611; Cotte C, 2005, MAR ECOL PROG SER, V288, P199, DOI 10.3354/meps288199; CROLL DA, 1991, CONDOR, V93, P777, DOI 10.2307/1368216; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 2001, ANTARCT SCI, V13, P289, DOI 10.1017/S0954102001000414; Emslie SD, 1998, ANTARCT SCI, V10, P257, DOI 10.1017/S0954102098000352; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; EPIFANIO CE, 1987, J CRUSTACEAN BIOL, V7, P513, DOI 10.2307/1548299; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Franks PJS, 1996, J MAR RES, V54, P631, DOI 10.1357/0022240963213718; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Freitas C, 2010, ARGOSFILTER ARGOS LO; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Garrett C. J. R., 1978, ATMOS OCEAN, V16, P403, DOI [10.1080/07055900.1978.9649046, DOI 10.1080/07055900.1978.9649046]; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gille ST, 2010, J CLIMATE, P4749; Gregory Paul R., 2001, Aquatic Mammals, V27, P105; Holm HJ, 2002, WATERBIRDS, V25, P312; Hunt GL, 1997, ICES J MAR SCI, V54, P600; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Jones PL, 2008, J EXP MAR BIOL ECOL, V361, P98, DOI 10.1016/j.jembe.2008.05.004; Kahl LA, 2010, INTEGR COMP BIOL, V50, P1041, DOI 10.1093/icb/icq098; Kato A, 2003, POLAR BIOL, V26, P389, DOI 10.1007/s00300-003-0493-0; Kils U, 1982, SWIMMING BEHAV SWIMM; Lascara CM, 1999, DEEP-SEA RES PT I, V46, P951, DOI 10.1016/S0967-0637(98)00099-5; Loder J.W., 1985, P NIN EUR MAR BIOL S, P3; Luque SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015850; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Moline MA, 1996, MAR ECOL PROG SER, V145, P143, DOI 10.3354/meps145143; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; NAITO Y, 1990, CONDOR, V92, P582, DOI 10.2307/1368676; PINGREE RD, 1985, ESTUAR COAST SHELF S, V20, P1, DOI 10.1016/0272-7714(85)90115-5; Prezelin BB, 2004, J MAR RES, V62, P419, DOI 10.1357/0022240041446173; Prezelin BB, 2000, J MAR RES, V58, P165, DOI 10.1357/002224000321511133; RALSTON SL, 1986, J EXP MAR BIOL ECOL, V98, P35, DOI 10.1016/0022-0981(86)90074-2; Rey AR, 2010, J ORNITHOL, V151, P933, DOI 10.1007/s10336-010-0531-y; ROWE PM, 1994, MAR ECOL PROG SER, V110, P115, DOI 10.3354/meps110115; ROWE PM, 1994, MAR ECOL PROG SER, V110, P105, DOI 10.3354/meps110105; Schofield O, 2007, J FIELD ROBOT, V24, P473, DOI 10.1002/rob.20200; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Vlietstra LS, 2005, FISH OCEANOGR, V14, P196, DOI 10.1111/j.1365-2419.2005.00369.x; Williams T.D., 1995, PENGUINS; Wilson RP, 2001, J AVIAN BIOL, V32, P83, DOI 10.1034/j.1600-048X.2001.320113.x; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; WOOLDRIDGE T, 1980, ESTUAR COAST MAR SCI, V11, P107, DOI 10.1016/S0302-3524(80)80033-8; Zamon JE, 2001, FISH OCEANOGR, V10, P353, DOI 10.1046/j.1365-2419.2001.00180.x; Zamon JE, 2002, MAR ECOL PROG SER, V226, P193, DOI 10.3354/meps226193; Zar JH, 1999, BIOSTATISTICAL ANAL	62	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55163	10.1371/journal.pone.0055163	http://dx.doi.org/10.1371/journal.pone.0055163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383091	Green Published, gold			2022-12-25	WOS:000315563800124
J	Olsen, AMS; Fosbol, EL; Lindhardsen, J; Andersson, C; Folke, F; Nielsen, MB; Kober, L; Hansen, PR; Torp-Pedersen, C; Gislason, GH				Olsen, Anne-Marie Schjerning; Fosbol, Emil L.; Lindhardsen, Jesper; Andersson, Charlotte; Folke, Fredrik; Nielsen, Mia B.; Kober, Lars; Hansen, Peter R.; Torp-Pedersen, Christian; Gislason, Gunnar H.			Cause-Specific Cardiovascular Risk Associated with Nonsteroidal Anti-Inflammatory Drugs among Myocardial Infarction Patients - A Nationwide Study	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; MORTALITY; DEATH; INHIBITION; VALIDITY; VALIDATION; PREDICTION; DIAGNOSIS	Background: Non steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial infarction (MI). We examined cause-specific mortality and morbidity associated with NSAIDs in a nationwide cohort of MI patients. Methods and Results: By individual-level linkage of nationwide registries of hospitalization and drug dispensing from pharmacies in Denmark, patients aged >30 years admitted with first-time MI during 1997-2009 and their subsequent NSAID use were identified. The risk of three cardiovascular specific endpoints: cardiovascular death, the composite of coronary death and nonfatal MI, and the composite of fatal and nonfatal stroke, associated with NSAID use was analyzed by Cox proportional hazard analyses. Of 97,698 patients included 44.0% received NSAIDs during follow-up. Overall use of NSAIDs was associated with an increased risk of cardiovascular death (hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.36-1.49). In particular use of the nonselective NSAID diclofenac and the selective cyclooxygenase-2 inhibitor rofecoxib was associated with increased risk of cardiovascular death (HR 1.96 [1.79-2.15] and HR1.66 [1.44-1.91], respectively) with a dose dependent increase in risk. Use of ibuprofen was associated with increased risk of cardiovascular death (HR 1.34[1.26-1.44]), whereas naproxen was associated with the lowest risk of (e.g., HR 1.27[1.01-1.59]. Conclusion: Use of individual NSAIDs is associated with different cause-specific cardiovascular risk and in particular rofecoxib and diclofenac were associated with increased cardiovascular morbidity and mortality. These results support caution with use of all NSAIDs in patients with prior MI.	[Olsen, Anne-Marie Schjerning; Fosbol, Emil L.; Lindhardsen, Jesper; Andersson, Charlotte; Folke, Fredrik; Nielsen, Mia B.; Hansen, Peter R.; Torp-Pedersen, Christian; Gislason, Gunnar H.] Copenhagen Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Kober, Lars] Rigshosp, Copenhagen Univ Hosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Fosbol, Emil L.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	University of Copenhagen; Rigshospitalet; University of Copenhagen; Duke University	Olsen, AMS (corresponding author), Copenhagen Univ Hosp, Dept Cardiol, Hellerup, Denmark.	amschjerning@gmail.com	Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013; Andersson, Charlotte/P-4849-2014; Hansen, Peter Riis/AAR-7659-2020; Folke, Fredrik/P-3601-2014	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X; Kober, Lars/0000-0002-6635-1466; Fosbol, Emil/0000-0002-2048-4167; Folke, Fredrik/0000-0002-2284-7857	Department of Cardiology; Copenhagen University Hospital Gentofte, Denmark [DK-2900]; FUKAP; Novo Nordisk Foundation	Department of Cardiology; Copenhagen University Hospital Gentofte, Denmark; FUKAP; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was supported by the Department of Cardiology, Copenhagen University Hospital Gentofte, DK-2900, Denmark, FUKAP. The funding source had no influence on study design, interpretation of the results or the decision to submit the article. Dr. Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Antman EM, 2005, CIRCULATION, V112, P759, DOI 10.1161/CIRCULATIONAHA.105.568451; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Fosbol EL, 2010, CIRC-CARDIOVASC QUAL, V3, P395, DOI 10.1161/CIRCOUTCOMES.109.861104; Gaist D, 1997, DAN MED BULL, V44, P445; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Madsen JK, 1997, CIRCULATION, V96, P748; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Minuz P, 2008, J AM COLL CARDIOL, V52, P1637, DOI 10.1016/j.jacc.2008.08.042; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Psaty BM, 2007, NEW ENGL J MED, V356, P328, DOI 10.1056/NEJMp068286; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Ross JS, 2010, ARCH INTERN MED, V170, P2035, DOI 10.1001/archinternmed.2010.461; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3	28	38	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54309	10.1371/journal.pone.0054309	http://dx.doi.org/10.1371/journal.pone.0054309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382889	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800043
J	Simon-Areces, J; Acaz-Fonseca, E; Ruiz-Palmero, I; Garcia-Segura, LM; Arevalo, MA				Simon-Areces, Julia; Acaz-Fonseca, Estefania; Ruiz-Palmero, Isabel; Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles			A CRM1-Mediated Nuclear Export Signal Is Essential for Cytoplasmic Localization of Neurogenin 3 in Neurons	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; DETERMINATION GENES; PANCREAS; SPECIFICATION; EXPRESSION; TRANSPORT; PROTEINS; CRM1; DIFFERENTIATION; IDENTITY	Neurogenin 3 (Ngn3), a proneural gene, regulates dendritogenesis and synaptogenesis in mouse hippocampal neurons. Ngn3 is transiently exported from the cell nucleus to the cytoplasm when neuronal polarity is initiated, suggesting that the nucleo-cytoplasmic transport of the protein is important for its action on neuronal development. In this study, we identified for the first time a functional nuclear export sequence (NES2; (131)YIWALTQTLRIA(142)) in Ngn3. The green fluorescent protein (EGFP)-NES2 fusion protein was localized in the cytoplasm and its nucleo-cytoplasmic shuttling was blocked by the CRM1 specific export inhibitor leptomycin B. Mutation of a leucine residue to alanine (L135A) in the NES2 motif resulted in both cytoplasmic and nuclear localization of the EGFP-NES2 fusion protein and in the nuclear accumulation of ectopic full-length myc-Ngn3. In addition, point mutation of the leucine 135 counteracted the effects of Ngn3 on neuronal morphology and synaptic inputs indicating that the cytoplasmic localization of Ngn3 is important for neuronal development. Pharmacological perturbation of the cytoskeleton revealed that cytoplasmic Ngn3 is associated with microtubules.	[Simon-Areces, Julia; Acaz-Fonseca, Estefania; Ruiz-Palmero, Isabel; Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Arevalo, MA (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	arevalo@cajal.csic.es	Garcia-Segura, Luis M/U-3711-2017; Arevalo, Maria-Angeles/J-7000-2014; Acaz-Fonseca, Estefania/S-5884-2016	Garcia-Segura, Luis M/0000-0002-2450-2916; Arevalo, Maria-Angeles/0000-0002-4303-9576; Acaz-Fonseca, Estefania/0000-0003-2549-6420; Ruiz Palmero, Isabel/0000-0002-8721-4591	Ministerio de Ciencia e Innovacion, Spain [BFU2011-30217-C03-01]; Comunidad de Madrid [CCG08-CSIC/SAL-3617]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	The authors acknowledge financial support from the Ministerio de Ciencia e Innovacion, Spain (BFU2011-30217-C03-01) and from Comunidad de Madrid (CCG08-CSIC/SAL-3617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Dehmelt L, 2005, GENOME BIOL, V6; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Fode C, 2000, GENE DEV, V14, P67; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868; Lejonklou MH, 2009, PANCREAS, V38, P259, DOI 10.1097/MPA.0b013e3181930818; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma WX, 2009, MOL CELL NEUROSCI, V40, P187, DOI 10.1016/j.mcn.2008.10.006; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Pelling M, 2011, DEV BIOL, V349, P406, DOI 10.1016/j.ydbio.2010.11.007; Rubio-Cabezas O, 2011, DIABETES, V60, P1349, DOI 10.2337/db10-1008; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Simon-Areces J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021825; Simon-Areces J, 2010, J COMP NEUROL, V518, P1814, DOI 10.1002/cne.22304; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Zhang MJ, 1998, BIOCHEM BIOPH RES CO, V243, P113, DOI 10.1006/bbrc.1997.8070	41	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55237	10.1371/journal.pone.0055237	http://dx.doi.org/10.1371/journal.pone.0055237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383123	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800134
J	Zhu, YD; Warin, RF; Soroka, DN; Chen, HD; Sang, SM				Zhu, Yingdong; Warin, Renaud F.; Soroka, Dominique N.; Chen, Huadong; Sang, Shengmin			Metabolites of Ginger Component [6]-Shogaol Remain Bioactive in Cancer Cells and Have Low Toxicity in Normal Cells: Chemical Synthesis and Biological Evaluation	PLOS ONE			English	Article							PREVENTION; INSTITUTE; FOOD	Our previous study found that [6]-shogaol, a major bioactive component in ginger, is extensively metabolized in cancer cells and in mice. It is unclear whether these metabolites retain bioactivity. The aim of the current study is to synthesize the major metabolites of [6]-shogaol and evaluate their inhibition of growth and induction of apoptosis in human cancer cells. Twelve metabolites of [6]-shogaol (M1, M2, and M4-M13) were successfully synthesized using simple and easily accessible chemical methods. Growth inhibition assays showed that most metabolites of [6]-shogaol had measurable activities against human cancer cells HCT-116 and H-1299. In particular, metabolite M2 greatly retained the biological activities of [6]-shogaol, with an IC50 of 24.43 mu M in HCT-116 human colon cancer cells and an IC50 of 25.82 mu M in H-1299 human lung cancer cells. Also exhibiting a relatively high potency was thiol-conjugate M13, with IC50 values of 45.47 and 47.77 mu M toward HCT-116 and H-1299 cells, respectively. The toxicity evaluation of the synthetic metabolites (M1, M2, and M4-M13) against human normal fibroblast colon cells CCD-18Co and human normal lung cells IMR-90 demonstrated a detoxifying metabolic biotransformation of [6]-shogaol. The most active metabolite M2 had almost no toxicity to CCD-18Co and IMR-90 normal cells with IC(50)s of 99.18 and 98.30 mu M, respectively. TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) assay indicated that apoptosis was triggered by metabolites M2, M13, and its two diastereomers M13-1 and M13-2. There was no significant difference between the apoptotic effect of [6]-shogaol and the effect of M2 and M13 after 6 hour treatment.	[Zhu, Yingdong; Warin, Renaud F.; Soroka, Dominique N.; Chen, Huadong; Sang, Shengmin] North Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, Kannapolis, NC USA	University of North Carolina; North Carolina A&T State University	Sang, SM (corresponding author), North Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, North Carolina Res Campus, Kannapolis, NC USA.	ssang@ncat.edu	Chen, Huadong/H-2272-2013		National Institutes of Health [CA138277, CA138277S1]; NATIONAL CANCER INSTITUTE [R21CA138277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA138277 and CA138277S1 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; Chen HD, 2012, DRUG METAB DISPOS, V40, P742, DOI 10.1124/dmd.111.043331; Constantino MG, 1998, QUIM NOVA, V21, P719, DOI 10.1590/S0100-40421998000600009; Crowell JA, 2005, EUR J CANCER, V41, P1889, DOI 10.1016/j.ejca.2005.04.016; Haniadka R, 2012, J ALTERN COMPLEM MED, V18, P440, DOI 10.1089/acm.2010.0737; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; Karakaya S, 2004, CRIT REV FOOD SCI, V44, P453, DOI 10.1080/10408690490886683; Key TJ, BR J CANC, V104, P6; Kim JS, 2008, ARCH PHARM RES, V31, P415, DOI 10.1007/s12272-001-1172-y; Kubra IR, 2012, CRIT REV FOOD SCI, V52, P651, DOI 10.1080/10408398.2010.505689; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001; SOWDEN JC, 1962, J ORG CHEM, V27, P1791, DOI 10.1021/jo01052a074; Stan SD, 2008, J CELL BIOCHEM, V104, P339, DOI 10.1002/jcb.21623; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Toyota M, 2005, ORG LETT, V7, P3929, DOI 10.1021/ol051411t; Wild CP, 2001, BRIT J NUTR, V86, pS37, DOI 10.1079/BJN2001338; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Wu H, 2010, MOL NUTR FOOD RES, V54, P1296, DOI 10.1002/mnfr.200900409	20	37	37	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54677	10.1371/journal.pone.0054677	http://dx.doi.org/10.1371/journal.pone.0054677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382939	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800063
J	Rocco, A; Kierzek, AM; McFadden, J				Rocco, Andrea; Kierzek, Andrzej M.; McFadden, Johnjoe			Slow Protein Fluctuations Explain the Emergence of Growth Phenotypes and Persistence in Clonal Bacterial Populations	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; SINGLE-CELL; HETEROGENEITY; TRANSCRIPTOME; METABOLISM; BIOFILMS; DORMANCY; NOISE; CYCLE	One of the most challenging problems in microbiology is to understand how a small fraction of microbes that resists killing by antibiotics can emerge in a population of genetically identical cells, the phenomenon known as persistence or drug tolerance. Its characteristic signature is the biphasic kill curve, whereby microbes exposed to a bactericidal agent are initially killed very rapidly but then much more slowly. Here we relate this problem to the more general problem of understanding the emergence of distinct growth phenotypes in clonal populations. We address the problem mathematically by adopting the framework of the phenomenon of so-called weak ergodicity breaking, well known in dynamical physical systems, which we extend to the biological context. We show analytically and by direct stochastic simulations that distinct growth phenotypes can emerge as a consequence of slow-down of stochastic fluctuations in the expression of a gene controlling growth rate. In the regime of fast gene transcription, the system is ergodic, the growth rate distribution is unimodal, and accounts for one phenotype only. In contrast, at slow transcription and fast translation, weakly non-ergodic components emerge, the population distribution of growth rates becomes bimodal, and two distinct growth phenotypes are identified. When coupled to the well-established growth rate dependence of antibiotic killing, this model describes the observed fast and slow killing phases, and reproduces much of the phenomenology of bacterial persistence. The model has major implications for efforts to develop control strategies for persistent infections.	[Rocco, Andrea; Kierzek, Andrzej M.; McFadden, Johnjoe] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Rocco, A (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	a.rocco@surrey.ac.uk	Rocco, Andrea/N-7076-2017	Rocco, Andrea/0000-0002-0974-5522; McFadden, Johnjoe/0000-0003-2145-0046; Kierzek, Andrzej/0000-0002-2605-9057	Wellcome Trust [088677]; Biotechnology and Biological Sciences Research Council [BB/J002097/1] Funding Source: researchfish; BBSRC [BB/J002097/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge support from The Wellcome Trust (ref: 088677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BOUCHAUD JP, 1992, J PHYS I, V2, P1705, DOI 10.1051/jp1:1992238; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cooper S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-10; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dannenberg JH, 2010, CELL, V141, P18, DOI 10.1016/j.cell.2010.03.020; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorfman J. R., 1999, CAMBRIDGE LECT NOTES, V14; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kubitschek HE, 1968, ANL7535; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Mattsson AE, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155101; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rebenshtok A, 2008, J STAT PHYS, V133, P565, DOI 10.1007/s10955-008-9610-3; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Trott J, 2012, MOL BIOSYST, V8, P744, DOI 10.1039/c1mb05398a; Valluri SR, 2000, CAN J PHYS, V78, P823, DOI 10.1139/cjp-78-9-823; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Waddington C., 1957, STRATEGY GENES; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Weber M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-11; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	40	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54272	10.1371/journal.pone.0054272	http://dx.doi.org/10.1371/journal.pone.0054272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382887	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200054
J	Okamura, K; Dummer, P; Kopp, J; Qiu, LR; Levi, M; Faubel, S; Blaine, J				Okamura, Kayo; Dummer, Patrick; Kopp, Jeffrey; Qiu, Liru; Levi, Moshe; Faubel, Sarah; Blaine, Judith			Endocytosis of Albumin by Podocytes Elicits an Inflammatory Response and Induces Apoptotic Cell Death	PLOS ONE			English	Article							PROXIMAL TUBULE CELLS; ENDOPLASMIC-RETICULUM STRESS; GLOMERULAR-FILTRATION-RATE; RISK POPULATION COHORTS; KAPPA-B ACTIVATION; COLLABORATIVE METAANALYSIS; DEPENDENT PATHWAY; EPITHELIAL-CELLS; KIDNEY-FUNCTION; NADPH OXIDASE	The presence of albuminuria is strongly associated with progression of chronic kidney disease. While albuminuria has been shown to injure renal proximal tubular cells, the effects of albumin on podocytes have been less well studied. We have addressed the hypothesis that exposure of podocytes to albumin initiates an injury response. We studied transformed human-urine derived podocytes-like epithelial cells (HUPECS, or podocytes). Upon differentiation, these cells retain certain characteristics of differentiated podocytes, including expression of synaptopodin, CD2AP, and nestin. We exposed podocytes to recombinant human albumin, which lacks lipids and proteins that bind serum albumin; this reagent allowed a direct examination of the effects of albumin. Podocytes endocytosed fluoresceinated albumin and this process was inhibited at 4 degrees C, suggesting an energy-dependent process. Exposure to albumin at concentrations of 5 and 10 mg/ml was associated with increased cell death in a dose-dependent manner. The mechanism of cell death may involve apoptosis, as caspase 3/7 were activated and the pan-caspase inhibitor z-VAD reduced cell death. Albumin exposure also increased nuclear factor (NF)-mu B activation and increased transcription and release of interleukin (IL-) 1 beta, tumor necrosis factor (TNF), and IL-6. We extended these findings to an in vivo model. Glomeruli isolated from mice with nephrotic syndrome also had increased expression of IL-1 beta and TNF RNA. These data suggest that while podocyte injury begets albuminuria, albumin in the glomerular ultrafiltrate may also beget podocyte injury. Thus, an additional mechanism by which anti-proteinuric therapies are beneficial in the treatment of glomerular diseases may be a reduction in injury to the podocyte by albumin.	[Okamura, Kayo; Qiu, Liru; Levi, Moshe; Faubel, Sarah; Blaine, Judith] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Dummer, Patrick; Kopp, Jeffrey] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Blaine, J (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.	Judith.Blaine@ucdenver.edu	qiu, liru/AAA-4648-2022; Kopp, Jeffrey B/O-2681-2015	qiu, liru/0000-0002-1583-7183; Kopp, Jeffrey B/0000-0001-9052-186X; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health K08 grant [DK080989]; Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK099544, P30DK048520, K08DK080989] Funding Source: NIH RePORTER	National Institutes of Health K08 grant; Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health K08 grant (DK080989) to JB and by the Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Cao W, 2011, J HYPERTENS, V29, P1411, DOI 10.1097/HJH.0b013e32834786f0; Chang AM, 2012, NEPHROL DIAL TRANSPL, V27, P1330, DOI 10.1093/ndt/gfr483; Chen S, 2011, CELL CALCIUM, V50, P523, DOI 10.1016/j.ceca.2011.08.008; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; He FF, 2011, GENE, V484, P18, DOI 10.1016/j.gene.2011.05.025; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Nicotera P, 1999, BIOL CHEM, V380, P1035, DOI 10.1515/BC.1999.129; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Peti-Peterdi J, 2009, AM J PHYSIOL-RENAL, V296, pF1255, DOI 10.1152/ajprenal.00144.2009; Prabakaran T, 2012, NEPHROL DIAL TRANSPL, V27, P3156, DOI 10.1093/ndt/gfr794; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sandoval RM, 2012, J AM SOC NEPHROL, V23, P447, DOI 10.1681/ASN.2011070666; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Tanner GA, 2009, AM J PHYSIOL-RENAL, V296, pF1258, DOI 10.1152/ajprenal.90638.2008; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x	36	64	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54817	10.1371/journal.pone.0054817	http://dx.doi.org/10.1371/journal.pone.0054817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382978	Green Submitted, gold, Green Published			2022-12-25	WOS:000315211500030
J	Shi, TX; Li, RY; Zhao, ZK; Ding, GD; Long, Y; Meng, JL; Xu, FS; Shi, L				Shi, Taoxiong; Li, Ruiyuan; Zhao, Zunkang; Ding, Guangda; Long, Yan; Meng, Jinling; Xu, Fangsen; Shi, Lei			QTL for Yield Traits and Their Association with Functional Genes in Response to Phosphorus Deficiency in Brassica napus	PLOS ONE			English	Article							ORYZA-SATIVA L.; OILSEED RAPE; ARABIDOPSIS-THALIANA; MAPPING QTLS; SEED YIELD; SOIL-PHOSPHORUS; COMPLEX TRAITS; USE EFFICIENCY; LOCI ANALYSIS; ROOT HAIR	Background: Oilseed rape (Brassica napus L.) is one of the most important oil crops. A primary limitation to the cultivation of this crop is the lack of available phosphorus (P) in soils. To elucidate the genetic control of P deficiency tolerance in Brassica napus, quantitative trait locus (QTL) for seed yield and yield related-traits in response to P deficiency were identified using a double haploid mapping population (TN DH) derived from a cross between a P-efficient cultivar, Ningyou 7 and a P-inefficient cultivar, Tapidor. Results: Three field trials were conducted to determine seed yield (SY), plant height (PH), number of primary branches (BN), height to the first primary branch (FBH), relative first primary branch height (RBH), pod number per plant (PN), seed number per pod (SN) and seed weight of 1,000 seeds (SW) in 188 lines of TN DH population exposed to low P (LP) and optimal P (OP) conditions. P deficiency decreased PH, BN, SN, PN and SY, and increased FBH and RBH with no effect on SW. Three reproducible LP-specific QTL regions were identified on chromosomes A2, A3 and A5 that controlled SN, PN and SW respectively. In addition, six reproducible constitutive regions were also mapped with two each for SY-LP on A2, and FBH-LP on C6 and one each for PH-LP and SW-LP on A3. About 30 markers derived from 19 orthologous genes involved in Arabidopsis P homeostasis were mapped on 24 QTL regions by comparative mapping between Arabidopsis and Brassica napus. Among these genes, GPT1, MGD2 and SIZ1 were associated with two major loci regulating SY-LP and other yield-related traits on A2 between 77.1 and 95.0 cM. Conclusion: The stable QTLs detected under LP conditions and their candidate genes may provide useful information for marker-assisted selection in breeding high-yield B. napus varieties with improved P efficiency.	[Shi, Taoxiong; Li, Ruiyuan; Zhao, Zunkang; Ding, Guangda; Long, Yan; Meng, Jinling; Xu, Fangsen; Shi, Lei] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Shi, Taoxiong; Li, Ruiyuan; Zhao, Zunkang; Ding, Guangda; Long, Yan; Meng, Jinling; Xu, Fangsen; Shi, Lei] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Shi, Taoxiong; Zhao, Zunkang; Ding, Guangda; Xu, Fangsen; Shi, Lei] Huazhong Agr Univ, Key Lab Arable Land Conservat Middle & Lower Reac, Minist Agr, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Shi, L (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	leish@mail.hzau.edu.cn	Ding, Guangda/ABG-3651-2020; Ding, Guangda/AAH-5026-2021	Ding, Guangda/0000-0003-3702-5087; 	Natural Science Funds for Distinguished Young Scholar in Hubei Province [2011CDA090]; National Basic Research and Development Program [2011CB100301]; Fundamental Research Funds for the Central Universities [2012PY006]	Natural Science Funds for Distinguished Young Scholar in Hubei Province; National Basic Research and Development Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors sincerely thank funding agencies, the Natural Science Funds for Distinguished Young Scholar in Hubei Province (2011CDA090), the National Basic Research and Development Program (2011CB100301) and the Fundamental Research Funds for the Central Universities (2012PY006) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; CHURCHILL GA, 1994, GENETICS, V138, P963; Ding GD, 2012, ANN BOT-LONDON, V109, P747, DOI 10.1093/aob/mcr323; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; Duan HY, 2009, J PLANT NUTR, V32, P1148, DOI 10.1080/01904160902943171; Fageria NK, 2008, J PLANT NUTR, V31, P1121, DOI 10.1080/01904160802116068; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Hammond JP, 2011, PLANT PHYSIOL, V156, P1230, DOI 10.1104/pp.111.175612; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Li YD, 2005, EUPHYTICA, V142, P137, DOI 10.1007/s10681-005-1192-4; Li YY, 2007, AUST J AGR RES, V58, P759, DOI 10.1071/AR06350; Li YY, 2006, EUPHYTICA, V152, P25, DOI 10.1007/s10681-006-9173-9; Liang QA, 2010, ANN BOT-LONDON, V106, P223, DOI 10.1093/aob/mcq097; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Long Y, 2011, GENETICS, V189, P1093, DOI 10.1534/genetics.111.131615; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Ming F, 2000, CHINESE SCI BULL, V45, P520, DOI 10.1007/BF02887097; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Ni JJ, 1998, THEOR APPL GENET, V97, P1361, DOI 10.1007/s001220051030; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Quijada PA, 2006, THEOR APPL GENET, V113, P549, DOI 10.1007/s00122-006-0323-1; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shi TaoXiong, 2010, Plant Nutrition and Fertilizer Science, V16, P959; Su JY, 2009, PLANT SCI, V176, P824, DOI 10.1016/j.plantsci.2009.03.006; Su JY, 2006, PLANT SOIL, V281, P25, DOI 10.1007/s11104-005-3771-5; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Van Ooijen J.W., 2006, JOINMAP4 SOFTWARE CA; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wu J, 2008, PLANT SOIL, V310, P25, DOI 10.1007/s11104-008-9625-1; Yan XL, 2004, PLANT SOIL, V265, P17, DOI 10.1007/s11104-005-0693-1; Yang M, 2011, PLANT SOIL, V339, P97, DOI 10.1007/s11104-010-0516-x; Yang M, 2010, THEOR APPL GENET, V121, P181, DOI 10.1007/s00122-010-1301-1; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao JJ, 2008, PLANT CELL ENVIRON, V31, P887, DOI 10.1111/j.1365-3040.2008.01791.x; Zhu JM, 2005, PLANT SOIL, V270, P299, DOI 10.1007/s11104-004-1697-y	53	30	37	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54559	10.1371/journal.pone.0054559	http://dx.doi.org/10.1371/journal.pone.0054559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382913	Green Published, gold, Green Submitted			2022-12-25	WOS:000315211500016
J	Zukewich, J; Kurella, V; Doebeli, M; Hauert, C				Zukewich, Joshua; Kurella, Venu; Doebeli, Michael; Hauert, Christoph			Consolidating Birth-Death and Death-Birth Processes in Structured Populations	PLOS ONE			English	Article							EVOLUTIONARY STABILITY; PRISONERS-DILEMMA; COOPERATION; GAMES	Network models extend evolutionary game theory to settings with spatial or social structure and have provided key insights on the mechanisms underlying the evolution of cooperation. However, network models have also proven sensitive to seemingly small details of the model architecture. Here we investigate two popular biologically motivated models of evolution in finite populations: Death-Birth (DB) and Birth-Death (BD) processes. In both cases reproduction is proportional to fitness and death is random; the only difference is the order of the two events at each time step. Although superficially similar, under DB cooperation may be favoured in structured populations, while under BD it never is. This is especially troubling as natural populations do not follow a strict one birth then one death regimen (or vice versa); such constraints are introduced to make models more tractable. Whether structure can promote the evolution of cooperation should not hinge on a simplifying assumption. Here, we propose a mixed rule where in each time step DB is used with probability delta and BD is used with probability 1-delta. We derive the conditions for selection favouring cooperation under the mixed rule for all social dilemmas. We find that the only qualitatively different outcome occurs when using just BD (delta=0). This case admits a natural interpretation in terms of kin competition counterbalancing the effect of kin selection. Finally we show that, for any mixed BD-DB update and under weak selection, cooperation is never inhibited by population structure for any social dilemma, including the Snowdrift Game.	[Zukewich, Joshua; Kurella, Venu; Doebeli, Michael; Hauert, Christoph] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Zukewich, J (corresponding author), Univ British Columbia, Dept Math, Vancouver, BC, Canada.	jzuke@math.ubc.ca	Hauert, Christoph/E-5369-2011	Hauert, Christoph/0000-0002-1239-281X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	MD and CH acknowledge financial support by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2006, J THEOR BIOL, V240, P627, DOI 10.1016/j.jtbi.2005.10.024; Hofbauer J., 1988, THEORY EVOLUTION DYN; Maynard Smith J., 1982, pi; Moran P., 1962, STAT PROCESSES EVOLU; Morita S, 2008, PROG THEOR PHYS, V119, P29, DOI 10.1143/PTP.119.29; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ohtsuki H, 2008, J THEOR BIOL, V251, P698, DOI 10.1016/j.jtbi.2008.01.005; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tarnita CE, 2011, P NATL ACAD SCI USA, V108, P2334, DOI 10.1073/pnas.1016008108; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971	25	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54639	10.1371/journal.pone.0054639	http://dx.doi.org/10.1371/journal.pone.0054639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382931	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500022
J	Contreras, E; Rausell, C; Real, MD				Contreras, Estefania; Rausell, Carolina; Real, M. Dolores			Proteome Response of Tribolium castaneum Larvae to Bacillus thuringiensis Toxin Producing Strains	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; COLORADO POTATO BEETLE; GENE-EXPRESSION; CHORISTONEURA-FUMIFERANA; MAINTENANCE PHASES; DOWN-REGULATION; CRY1AB TOXIN; HEMOLYMPH; IDENTIFICATION; INITIATION	Susceptibility of Tribolium castaneum (Tc) larvae was determined against spore-crystal mixtures of five coleopteran specific and one lepidopteran specific Bacillus thuringiensis Cry toxin producing strains and those containing the structurally unrelated Cry3Ba and Cry23Aa/Cry37Aa proteins were found toxic (LC50 values 13.53 and 6.30 mu g spore-crystal mixture/mu L flour disc, respectively). Using iTRAQ combined with LC-MS/MS allowed the discovery of seven novel differentially expressed proteins in early response of Tc larvae to the two active spore-crystal mixtures. Proteins showing a statistically significant change in treated larvae compared to non-intoxicated larvae fell into two major categories; up-regulated proteins were involved in host defense (odorant binding protein C12, apolipophorin-III and chemosensory protein 18) and down-regulated proteins were linked to metabolic pathways affecting larval metabolism and development (pyruvate dehydrogenase Ea subunit, cuticular protein, ribosomal protein L13a and apolipoprotein LI-II). Among increased proteins, Odorant binding protein C12 showed the highest change, 4-fold increase in both toxin treatments. The protein displayed amino acid sequence and structural homology to Tenebrio molitor 12 kDa hemolymph protein b precursor, a non-olfactory odorant binding protein. Analysis of mRNA expression and mortality assays in Odorant binding protein C12 silenced larvae were consistent with a general immune defense function of non-olfactory odorant binding proteins. Regarding down-regulated proteins, at the transcriptional level, pyruvate dehydrogenase and cuticular genes were decreased in Tc larvae exposed to the Cry3Ba producing strain compared to the Cry23Aa/Cry37Aa producing strain, which may contribute to the developmental arrest that we observed with larvae fed the Cry3Ba producing strain. Results demonstrated a distinct host transcriptional regulation depending upon the Cry toxin treatment. Knowledge on how insects respond to Bt intoxication will allow designing more effective management strategies for pest control.	[Contreras, Estefania; Rausell, Carolina; Real, M. Dolores] Univ Valencia, Fac Ciencias Biol, Dept Genet, Valencia, Spain	University of Valencia	Rausell, C (corresponding author), Univ Valencia, Fac Ciencias Biol, Dept Genet, Valencia, Spain.	carolina.rausell@uv.es	Rausell, Carolina/ABG-4542-2020; Contreras, Estefania/AAZ-4659-2020; Rausell, Carolina/ABG-9554-2020; Real, M. Dolores/ABD-4252-2021	Contreras, Estefania/0000-0002-1822-6839; Rausell, Carolina/0000-0002-5849-9102; Real, M. Dolores/0000-0003-3188-9335	Ministerio de Ciencia e Innovacion [BIO 2007-67860, AGL2010-22300-C03-03]; Conselleria Valenciana d'Educacio i Ciencia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Valenciana d'Educacio i Ciencia	This work was supported by "Ministerio de Ciencia e Innovacion'' (BIO 2007-67860, AGL2010-22300-C03-03) and E. Contreras was awarded with a grant from the Conselleria Valenciana d'Educacio i Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Armbruster P, 2009, J MED ENTOMOL, V46, P271, DOI 10.1603/033.046.0211; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Crickmore N, 2012, BACILLUS THURINGIENS; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; DONOVAN WP, 2002, Patent No. 549839; Finney DJ, 1947, PROBIT ANAL STAT TRE; Graham LA, 2003, MOL CELL PROTEOMICS, V2, P541, DOI 10.1074/mcp.M300018-MCP200; Graham LA, 2001, INSECT BIOCHEM MOLEC, V31, P691, DOI 10.1016/S0965-1748(00)00177-6; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Hand SC, 2011, J INSECT PHYSIOL, V57, P584, DOI 10.1016/j.jinsphys.2011.02.010; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; Levy F, 2004, BIOCHIMIE, V86, P607, DOI 10.1016/j.biochi.2004.07.007; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Oppert B, 2011, PEST MANAG SCI, V67, P568, DOI 10.1002/ps.2099; Oppert B, 2010, J STORED PROD RES, V46, P143, DOI 10.1016/j.jspr.2010.01.003; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sayed A, 2010, INSECT MOL BIOL, V19, P381, DOI 10.1111/j.1365-2583.2010.00998.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song KH, 2006, COMP BIOCHEM PHYS D, V1, P260, DOI 10.1016/j.cbd.2006.01.001; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; van Frankenhuyzen K., 2009, BACILLUS THURINGIENS; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wang CT, 2007, J INVERTEBR PATHOL, V96, P230, DOI 10.1016/j.jip.2007.05.012; Xie YS, 1996, CAN ENTOMOL, V128, P865, DOI 10.4039/Ent128865-5; Yocum GD, 2009, EUR J ENTOMOL, V106, P471, DOI 10.14411/eje.2009.059; Yocum GD, 2009, J INSECT PHYSIOL, V55, P32, DOI 10.1016/j.jinsphys.2008.10.003; Yuan C, 2011, BIOCONTROL SCI TECHN, V21, P139, DOI 10.1080/09583157.2010.527318; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029084, 10.1371/journal.pone.0031868]; Zhang X, 2008, COMP BIOCHEM PHYS B, V149, P581, DOI 10.1016/j.cbpb.2007.12.006; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	56	43	44	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55330	10.1371/journal.pone.0055330	http://dx.doi.org/10.1371/journal.pone.0055330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372850	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400090
J	Samson, T; van Buul, JD; Kroon, J; Welch, C; Bakker, EN; Matlung, HL; van den Berg, TK; Sharek, L; Doerschuk, C; Hahn, K; Burridge, K				Samson, Thomas; van Buul, Jaap D.; Kroon, Jeffrey; Welch, Christopher; Bakker, Erik N.; Matlung, Hanke L.; van den Berg, Timo K.; Sharek, Lisa; Doerschuk, Claire; Hahn, Klaus; Burridge, Keith			The Guanine-Nucleotide Exchange Factor SGEF Plays a Crucial Role in the Formation of Atherosclerosis	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; ENDOTHELIAL-CELLS; LEUKOCYTE TRANSMIGRATION; ADHERENT LEUKOCYTES; DOCKING STRUCTURE; DEFICIENCY; MIGRATION; ICAM-1; MICE; INFLAMMATION	The passage of leukocytes across the endothelium and into arterial walls is a critical step in the development of atherosclerosis. Previously, we showed in vitro that the RhoG guanine nucleotide exchange factor SGEF (Arhgef26) contributes to the formation of ICAM-1-induced endothelial docking structures that facilitate leukocyte transendothelial migration. To further explore the in vivo role of this protein during inflammation, we generated SGEF-deficient mice. When crossed with ApoE null mice and fed a Western diet, mice lacking SGEF showed a significant decrease in the formation of atherosclerosis in multiple aortic areas. A fluorescent biosensor revealed local activation of RhoG around bead-clustered ICAM-1 in mouse aortic endothelial cells. Notably, this activation was decreased in cells from SGEF-deficient aortas compared to wild type. In addition, scanning electron microscopy of intimal surfaces of SGEF(-/-) mouse aortas revealed reduced docking structures around beads that were coated with ICAM-1 antibody. Similarly, under conditions of flow, these beads adhered less stably to the luminal surface of carotid arteries from SGEF(-/-) mice. Taken together, these results show for the first time that a Rho-GEF, namely SGEF, contributes to the formation of atherosclerosis by promoting endothelial docking structures and thereby retention of leukocytes at athero-prone sites of inflammation experiencing high shear flow. SGEF may therefore provide a novel therapeutic target for inhibiting the development of atherosclerosis.	[Samson, Thomas; Sharek, Lisa; Burridge, Keith] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Samson, Thomas; Sharek, Lisa; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [van Buul, Jaap D.; Kroon, Jeffrey] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Welch, Christopher; Hahn, Klaus] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Bakker, Erik N.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Matlung, Hanke L.; van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Dept Blood Cell Res, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Doerschuk, Claire] Univ N Carolina, Chapel Hill, NC USA; [Burridge, Keith] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	van Buul, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl; keith_burridge@med.unc.edu	van Buul, Jaap D/AAJ-4371-2021; Kroon, Jeffrey/AAL-2588-2021; Matlung, Hanke/ABH-5649-2020; van den Berg, Timo K/AAC-2479-2022; Stefanadis, Christodoulos/ABH-2232-2020	van Buul, Jaap D/0000-0003-0054-7949; Kroon, Jeffrey/0000-0001-9983-6614; Bakker, Erik/0000-0003-2819-5818; Hahn, Klaus/0000-0002-1970-7562; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institute of Health [GM029860, HL080166, GM057464, F30HL094020-02, T32-GM-80079]; American Heart Association [0825379E]; Dutch Heart Foundation [2005T039]; Landsteiner Foundation for Blood Transfusion Research [1028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166, F30HL094020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM057464, R55GM057464, R01GM029860] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Dutch Heart Foundation(Netherlands Heart Foundation); Landsteiner Foundation for Blood Transfusion Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health to KB (GM029860 and HL080166) and KH (GM057464). TS was supported by a fellowship from the American Heart Association (0825379E). Fellowships from the National Institute of Health (F30HL094020-02 and T32-GM-80079) supported CW. JDvB is supported by the Dutch Heart Foundation (grant no. 2005T039) and Landsteiner Foundation for Blood Transfusion Research (project no. 1028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chi Z, 2007, CELL ADHES MIGR, V1, P171, DOI 10.4161/cam.1.4.5321; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395	28	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55202	10.1371/journal.pone.0055202	http://dx.doi.org/10.1371/journal.pone.0055202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372835	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400075
J	Stoy, S; Sandahl, TD; Dige, AK; Agnholt, J; Rasmussen, TK; Gronbaek, H; Deleuran, B; Vilstrup, H				Stoy, Sidsel; Sandahl, Thomas Damgaard; Dige, Anders Kirch; Agnholt, Jorgen; Rasmussen, Tue Kruse; Gronbaek, Henning; Deleuran, Bent; Vilstrup, Hendrik			Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course	PLOS ONE			English	Article							INNATE IMMUNITY; IL-22; HEPATOCYTES; SURVIVAL; LIPOPOLYSACCHARIDE; REGENERATION; PATHOGENESIS; CIRRHOSIS; THERAPY	Background: Alcoholic hepatitis (AH) has a severe prognosis due to hepatic inflammatory injury. The cytokine interleukin-22 (IL-22) is reported to exert anti-apoptotic and proliferative effects, but IL-22 has not been studied during the course of AH. IL-22 is mainly produced by CD4(+) (helper) T cells, including Th17 cells. In addition, Th17 cells produce the proinflammatory cytokine IL-17A, which has been implicated in AH. Aims: We aimed to study the levels of circulating IL-22- and IL-17A-producing T helper cells and plasma cytokines in patients with AH and to examine the observations in relation to the short-term disease course. Methods: We collected blood samples from 21 consecutive patients with severe AH on days 0, 14 and 30 after diagnosis, and included 10 stable alcoholic cirrhosis patients and 10 healthy subjects as controls. Analyses were performed using flow cytometry and ELISA. Results: We found higher frequencies of IL-22-producing T helper cells in AH patients (median 1.7%) than in cirrhosis patients (1.0%, p = 0.03) and healthy controls (1.0%, p = 0.01), and a 1.5-fold increase in the plasma concentration of IL-17A in AH compared with healthy controls (p < 0.01). Those patients who markedly improved their Glasgow Alcoholic Hepatitis Score demonstrated a 2-fold higher frequency of IL-22-producing T helper cells at baseline and during follow-up than patients whose condition deteriorated (p = 0.04). Conclusions: The frequency of IL-22-producing T helper cells was increased in AH patients and most so in those whose condition seemed to improve. T cell differentiation toward an IL-22-producing phenotype may thus be favourable in AH.	[Stoy, Sidsel; Sandahl, Thomas Damgaard; Dige, Anders Kirch; Agnholt, Jorgen; Gronbaek, Henning; Vilstrup, Hendrik] Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, DK-8000 Aarhus, Denmark; [Rasmussen, Tue Kruse; Deleuran, Bent] Aarhus Univ, Inst Biomed, Aarhus, Denmark	Aarhus University; Aarhus University	Stoy, S (corresponding author), Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, DK-8000 Aarhus, Denmark.	stoy@studmed.au.dk	Gronbaek, Henning/AAJ-3202-2020	Gronbaek, Henning/0000-0001-8998-7910; Agnholt, Jorgen/0000-0003-2822-6442; Deleuran, Bent/0000-0002-7079-1587; Sandahl, Thomas Damgaard/0000-0001-9807-6852	Novo nordisk foundation; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish	Novo nordisk foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding: The Novo nordisk foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Dudakov JA, 2012, SCIENCE, V1, P1; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Foster RG, 2011, DIGEST DIS SCI, V20, P20; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045625; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kong X, 2012, HEPATOLOGY, V2, P25744; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lefkowitch Jay H, 2005, Clin Liver Dis, V9, P37, DOI 10.1016/j.cld.2004.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; Mookerjee RP, 2007, HEPATOLOGY, V46, P831, DOI 10.1002/hep.21737; Park O, 2011, HEPATOLOGY, V54, P252, DOI 10.1002/hep.24339; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rasmussen TK, 2010, J RHEUMATOL, V37, P2014, DOI 10.3899/jrheum.100259; Ren XD, 2010, AM J PHYSIOL-GASTR L, V298, pG74, DOI 10.1152/ajpgi.00075.2009; Sandahl TD, 2011, J HEPATOL, V54, P760, DOI 10.1016/j.jhep.2010.07.016; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; THEODOSSI A, 1982, GUT, V23, P75, DOI 10.1136/gut.23.1.75; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Wei CC, 2003, GENES IMMUN, V4, P204, DOI 10.1038/sj.gene.6363947; Whitfield K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007339.pub2; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Xiang X, 2011, IMMUNOL CELL BIOL, V27, P79; Xing WW, 2011, CYTOKINE, V56, P174, DOI 10.1016/j.cyto.2011.07.022; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang Y, 2011, GASTROENTEROLOGY, V141, P1897, DOI 10.1053/j.gastro.2011.06.051; Zhao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018909; Ziol M, 2001, J HEPATOL, V34, P254, DOI 10.1016/S0168-8278(00)00047-7	43	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55101	10.1371/journal.pone.0055101	http://dx.doi.org/10.1371/journal.pone.0055101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372820	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400062
J	Yue, YF; Yang, HY; Wu, K; Yang, LJ; Chen, JY; Huang, XW; Pan, Y; Ruan, YQ; Zhao, YJ; Shi, XA; Sun, QM; Li, QH				Yue, Yaofei; Yang, Hongying; Wu, Kun; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Ruan, Youqing; Zhao, Yujiao; Shi, Xinan; Sun, Qiangming; Li, Qihan			Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; INVASIVE CERVICAL-CANCER; MINOR CAPSID PROTEIN; WORLDWIDE PERSPECTIVE; SEQUENCE ANALYSIS; JAPANESE WOMEN; HIGH-RISK; PREVALENCE; VARIANTS; METAANALYSIS	HPV account for most of the incidence of cervical cancer. Approximately 90% of anal cancers and a smaller subset (<50%) of other cancers (oropharyngeal, penile, vaginal, vulvar) are also attributed to HPV. The L1 protein comprising HPV vaccine formulations elicits high-titre neutralizing antibodies and confers type restricted protection. The L2 protein is a promising candidate for a broadly protective HPV vaccine. In our previous study, we found the most prevalent high-risk HPV infectious serotypes were HPV-16 and HPV-58 among women of Southwest China. To explore gene polymorphisms and intratypic variations of HPV-16 and HPV-58 L1/L2 genes originating in Southwest China, HPV-16 (L1: n = 31, L2: n = 28) and HPV-58 (L1: n = 21, L2: n = 21) L1/L2 genes were sequenced and compared to others described and submitted to GenBank. Phylogenetic trees were then constructed by Neighbor-Joining and the Kimura 2-parameters methods (MEGA software), followed by an analysis of the diversity of secondary structure. Then selection pressures acting on the L1/L2 genes were estimated by PAML software. Twenty-nine single nucleotide changes were observed in HPV-16 L1 sequences with 16/29 non-synonymous mutations and 13/29 synonymous mutations (six in alpha helix and two in beta turns). Seventeen single nucleotide changes were observed in HPV-16 L2 sequences with 8/17 non-synonymous mutations (one in beta turn) and 9/17 synonymous mutations. Twenty-four single nucleotide changes were observed in HPV-58 L1 sequences with 10/24 non-synonymous mutations and 14/24 synonymous mutations (eight in alpha helix and four in beta turn). Seven single nucleotide changes were observed in HPV-58 L2 sequences with 4/7 non-synonymous mutations and 3/7 synonymous mutations. The result of selective pressure analysis showed that most of these mutations were of positive selection. This study may help understand the intrinsic geographical relatedness and biological differences of HPV-16/HPV-58 and contributes further to research on their infectivity, pathogenicity, and vaccine strategy.	[Yue, Yaofei; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Zhao, Yujiao; Sun, Qiangming; Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Yue, Yaofei; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Zhao, Yujiao; Sun, Qiangming; Li, Qihan] Peking Union Med Coll, Kunming, Peoples R China; [Yue, Yaofei; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Zhao, Yujiao; Sun, Qiangming; Li, Qihan] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; [Yang, Hongying; Ruan, Youqing] Kunming Med Univ, Affiliated Hosp 3, Yunnan Prov Tumor Hosp, Kunming, Peoples R China; [Wu, Kun] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China; [Shi, Xinan] Southwest Guizhou Vocat & Tech Coll Nationalities, Xingyi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Kunming Medical University; Kunming Medical University; Xingyi Normal University for Nationalities	Sun, QM (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	msun08@yahoo.com; imbcams.lq@gmail.com	Sun, Qiangming/GYE-2002-2022	Zhao, Yujiao/0000-0001-9142-4332	National Natural Science Foundation of China [81171946]; Natural Science Foundation of Yunnan Province [2009ZC187M, 2011CA016]; Special Research Fund for the Doctoral Program of Higher Education of China [20111106120055]; Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Special Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This research was supported by the National Natural Science Foundation of China (grant no. 81171946), the Natural Science Foundation of Yunnan Province (grant no. 2009ZC187M and grant no. 2011CA016), the Special Research Fund for the Doctoral Program of Higher Education of China (grant no. 20111106120055) and the Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2008, J MICROBIOL BIOTECHN, V18, P788; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Camara GNL, 2003, MEM I OSWALDO CRUZ, V98, P879, DOI 10.1590/S0074-02762003000700003; Cerqueira DM, 2007, ARCH VIROL, V152, P75, DOI 10.1007/s00705-006-0828-6; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;232::AID-JMV18&gt;3.0.CO;2-7; Chaturvedi AK, 2005, J MED VIROL, V75, P105, DOI 10.1002/jmv.20244; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Ding TA, 2010, GYNECOL ONCOL, V119, P436, DOI 10.1016/j.ygyno.2010.08.032; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1982, Q REV BIOL, V57, P379, DOI 10.1086/412935; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frati E, 2011, INFECT GENET EVOL, V11, P2119, DOI 10.1016/j.meegid.2011.06.014; Fukui A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-199; Garbuglia AR, 2007, NEW MICROBIOL, V30, P377; Hamza AA, 2012, SYST APPL MICROBIOL, V35, P183, DOI 10.1016/j.syapm.2011.12.005; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Huang SX, 1997, INT J CANCER, V70, P408, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;408::AID-IJC6&gt;3.0.CO;2-#; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Karanam B, 2009, IMMUNOL CELL BIOL, V87, P287, DOI 10.1038/icb.2009.13; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Lai CH, 2008, INT J CANCER, V123, P1685, DOI 10.1002/ijc.23679; Lai HC, 1999, INT J CANCER, V84, P553, DOI 10.1002/(SICI)1097-0215(19991222)84:6&lt;553::AID-IJC2&gt;3.0.CO;2-4; Lin QQ, 1998, INT J CANCER, V75, P484, DOI 10.1002/(SICI)1097-0215(19980130)75:3<484::AID-IJC25>3.0.CO;2-7; Liu JH, 2004, GYNECOL ONCOL, V94, P803, DOI 10.1016/j.ygyno.2004.06.005; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Pista A, 2007, J MED VIROL, V79, P1889, DOI 10.1002/jmv.21002; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Sasagawa T, 2001, CANCER EPIDEM BIOMAR, V10, P45; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Sun ZR, 2010, INT J GYNECOL OBSTET, V109, P105, DOI 10.1016/j.ijgo.2009.11.026; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; Wu YP, 2006, J CLIN VIROL, V35, P264, DOI 10.1016/j.jcv.2005.07.011; Xin CY, 2001, CANCER LETT, V170, P19, DOI 10.1016/S0304-3835(01)00570-5; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yue YaoFei, 2012, Chinese Journal of Obstetrics and Gynecology and Pediatrics, V8, P467; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	49	20	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55204	10.1371/journal.pone.0055204	http://dx.doi.org/10.1371/journal.pone.0055204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372836	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400076
J	Hoshino, D; Nagano, M; Saitoh, A; Koshikawa, N; Suzuki, T; Seiki, M				Hoshino, Daisuke; Nagano, Makoto; Saitoh, Anri; Koshikawa, Naohiko; Suzuki, Takashi; Seiki, Motoharu			The Phosphoinositide-Binding Protein ZF21 Regulates ECM Degradation by Invadopodia	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; TUMOR-CELL INVASION; FOCAL ADHESION KINASE; CANCER METASTASIS; MIGRATION; MT1-MMP; PHOSPHORYLATION; MOTILITY; DOMAIN; MICROENVIRONMENT	During the process of tumor invasion, cells require footholds on extracellular matrices (ECM) that are created by forming focal adhesions (FAs) using integrins. On the other hand, cells must degrade the ECM barrier using extracellular proteases including MMPs in the direction of cell movement. Degradation occurs at the leading edges or invadopodia of cells, which are enriched in proteases and adhesion molecules. Recently, we showed that the phosphoinositide-binding protein ZF21 regulates FA disassembly. ZF21 increased cell migration by promoting the turnover of FAs. In addition, ZF21 promotes experimental tumor metastasis to lung in mice and its depletion suppresses it. However, it is not known whether ZF21 regulates cancer cell invasion in addition to its activity on FAs. In this study, we demonstrate that ZF21 also regulates invasion of tumor cells, whereas it does not affect the overall production of MMP-2, MMP-9, and MT1-MMP by the cells. Also, we observe that the ECM-degrading activity specifically at the invadopodia is severely abrogated. In the ZF21 depleted cells MT1-MMP cannot accumulate to the invadopodia and thereby cannot contribute to the ECM degradation. Thus, this study demonstrates that ZF21 is a key player regulating multiple aspects of cancer cell migration and invasion. Possible mechanisms regulating ECM degradation at the invadopodia are discussed.	[Hoshino, Daisuke; Saitoh, Anri; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo, Japan; [Nagano, Makoto] Setsunan Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Hirakata, Osaka 57301, Japan; [Suzuki, Takashi] Osaka Univ, Grad Sch Engn Sci, Div Math Sci, Toyonaka, Osaka 560, Japan	University of Tokyo; Setsunan University; Osaka University	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo, Japan.	mseiki@ims.u-tokyo.ac.jp	Nagano, Makoto/J-7050-2015; Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Nagano, Makoto/0000-0002-1948-1591; Koshikawa, Naohiko/0000-0002-4539-888X	CREST project from JST; MEXT [22220014, 23790109]	CREST project from JST; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a CREST project (to T.S., and M.S.) from JST, by a Grant-in-Aid for Scientific Research (S) (to M.S., number 22220014) from MEXT, and by a Grant-in-Aid for Young Scientists (B) (to M.N., number 23790109) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; de Oliveira MV, 2009, FEBS LETT, V583, P2975, DOI 10.1016/j.febslet.2009.08.022; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hoshino D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002964; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Liu SC, 2000, J CELL SCI, V113, P3563; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Nagano M, 2011, J BIOL CHEM, V286, P31598, DOI 10.1074/jbc.M110.199430; Nagano Makoto, 2011, Cell Adh Migr, V5, P23, DOI 10.4161/cam.5.1.13492; Nagano M, 2010, J BIOL CHEM, V285, P21013, DOI 10.1074/jbc.M110.106443; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ouyang MX, 2008, J BIOL CHEM, V283, P17740, DOI 10.1074/jbc.M709872200; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e50825	10.1371/journal.pone.0050825	http://dx.doi.org/10.1371/journal.pone.0050825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382803	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600003
J	Jagu, S; Kwak, K; Karanam, B; Huh, WK; Damotharan, V; Chivukula, SV; Roden, RBS				Jagu, Subhashini; Kwak, Kihyuck; Karanam, Balasubramanyam; Huh, Warner K.; Damotharan, Vijayarangam; Chivukula, Sudha V.; Roden, Richard B. S.			Optimization of Multimeric Human Papillomavirus L2 Vaccines	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; CROSS-NEUTRALIZATION EPITOPE; VIRUS-LIKE PARTICLES; DOUBLE-BLIND; YOUNG-WOMEN; TYPE-16; HPV; IMMUNIZATION; ANTIBODIES; INFECTION	We sought to define the protective epitopes within the amino terminus of human papillomavirus (HPV) type 16 minor capsid protein L2. Passive transfer of mice with rabbit antisera to HPV16 L2 peptides 17-36, 32-51 and 65-81 provided significant protection against vaginal HPV16 challenge, whereas antisera to 47-66, 108-120 or 373-392 did not. Vaccination with L1 virus-like particles induces a high titer, but generally type-restricted neutralizing antibody response. Conversely, vaccination with L2 11-88, especially multimers thereof, induces antibodies that neutralize a broad range of papillomavirus types, albeit at lower titers than for L1 VLP. With the intent of enhancing the immunogenicity and the breadth of protection by focusing the immune response to the key protective epitopes, we designed L2 fusion proteins consisting of residues similar to 11-88 of eight divergent mucosal HPV types 6, 16, 18, 31, 39, 51, 56, 73 (11-88 x 8) or residues, similar to 13-47 of fifteen HPV types (13-47 x 15). The 11-88 x 8 was significantly more immunogenic than 13-47 x 15 in Balb/c mice regardless of the adjuvant used, suggesting the value of including the 65-81 protective epitope in the vaccine. Since the L2 47-66 peptide antiserum failed to elicit significant protection, we generated an 11-88 x 8 construct deleted for this region in each subunit (11-88 x 8 Delta). Mice were vaccinated with 11-88 x 8 and 11-88 x 8 Delta to determine if deletion of this non-protective epitope enhanced the neutralizing antibody response. However, 11-88 x 8 Delta was significantly less immunogenic than 11-88 x 8, and even the addition of a known T helper epitope, PADRE, to the construct (11-88 x 8 Delta PADRE) failed to recover the immunogenicity of 11-88 x 8 in C57BL/6 mice, suggesting that while L2 47-66 is not a critical protective or T helper epitope, it nevertheless contributes to the immunogenicity of the L2 11- 8868 multimer vaccine.	[Jagu, Subhashini; Kwak, Kihyuck; Karanam, Balasubramanyam; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA; [Huh, Warner K.] Univ Alabama Birmingham, Dept Gynecol Oncol, Birmingham, AL USA; [Damotharan, Vijayarangam; Chivukula, Sudha V.] Shantha Biotech Ltd, Hyderabad, Andhra Pradesh, India	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Sanofi-Aventis	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	roden@jhmi.edu	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589	Public Health Service grant [CA133749, CA118790, P50 CA098252, RC2 CA148499]; American Cancer Society RSG [116279]; Sanofi Pasteur/Shantha Biotechnics; NATIONAL CANCER INSTITUTE [R01CA133749, RC2CA148499, R01CA118790, P50CA098252] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); American Cancer Society RSG(American Cancer Society); Sanofi Pasteur/Shantha Biotechnics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Public Health Service grants CA133749, CA118790, P50 CA098252 and RC2 CA148499, and by the American Cancer Society RSG 116279 and Sanofi Pasteur/Shantha Biotechnics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bronnimann MP, 2012, J VIROL; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Campo MS, 2010, J VIROL, V84, P1214, DOI 10.1128/JVI.01927-09; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; CHANDRACHUD LM, 1995, VIROLOGY, V211, P204, DOI 10.1006/viro.1995.1392; CHRISTENSEN ND, 1991, VIROLOGY, V181, P572, DOI 10.1016/0042-6822(91)90890-N; Embers ME, 2002, J VIROL, V76, P9798, DOI 10.1128/JVI.76.19.9798-9805.2002; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kawana K, 1998, VIROLOGY, V245, P353, DOI 10.1006/viro.1998.9168; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kawana K, 2003, VACCINE, V21, P4256, DOI 10.1016/S0264-410X(03)00454-7; Kawana K, 2001, VACCINE, V19, P1496, DOI 10.1016/S0264-410X(00)00367-4; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Mustafa AS, 2006, TUBERCULOSIS, V86, P115, DOI 10.1016/j.tube.2005.05.001; Nakao S, 2012, VIROLOGY, V434, P110, DOI 10.1016/j.virol.2012.09.006; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Rosa DS, 2004, IMMUNOL LETT, V92, P259, DOI 10.1016/j.imlet.2004.01.006; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Rubio I, 2009, VACCINE, V27, P1949, DOI 10.1016/j.vaccine.2009.01.102; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Varsani A, 2003, J VIROL, V77, P8386, DOI 10.1128/JVI.77.15.8386-8393.2003; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	42	46	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55538	10.1371/journal.pone.0055538	http://dx.doi.org/10.1371/journal.pone.0055538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383218	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600122
J	Nubel, U; Nachtnebel, M; Falkenhorst, G; Benzler, J; Hecht, J; Kube, M; Brocker, F; Moelling, K; Buhrer, C; Gastmeier, P; Piening, B; Behnke, M; Dehnert, M; Layer, F; Witte, W; Eckmanns, T				Nuebel, Ulrich; Nachtnebel, Matthias; Falkenhorst, Gerhard; Benzler, Justus; Hecht, Jochen; Kube, Michael; Broecker, Felix; Moelling, Karin; Buehrer, Christoph; Gastmeier, Petra; Piening, Brar; Behnke, Michael; Dehnert, Manuel; Layer, Franziska; Witte, Wolfgang; Eckmanns, Tim			MRSA Transmission on a Neonatal Intensive Care Unit: Epidemiological and Genome-Based Phylogenetic Analyses	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HIV-1 TRANSMISSION; SPREAD; INFECTION; OUTBREAK; LESSONS	Background: Methicillin-resistant Staphylococcus aureus (MRSA) may cause prolonged outbreaks of infections in neonatal intensive care units (NICUs). While the specific factors favouring MRSA spread on neonatal wards are not well understood, colonized infants, their relatives, or health-care workers may all be sources for MRSA transmission. Whole-genome sequencing may provide a new tool for elucidating transmission pathways of MRSA at a local scale. Methods and Findings: We applied whole-genome sequencing to trace MRSA spread in a NICU and performed a case-control study to identify risk factors for MRSA transmission. MRSA genomes had accumulated sequence variation sufficiently fast to reflect epidemiological linkage among individual patients, between infants and their mothers, and between infants and staff members, such that the relevance of individual nurses' nasal MRSA colonization for prolonged transmission could be evaluated. In addition to confirming previously reported risk factors, we identified an increased risk of transmission from infants with as yet unknown MRSA colonisation, in contrast to known MRSA-positive infants. Conclusions: The integration of epidemiological (temporal, spatial) and genomic data enabled the phylogenetic testing of several hypotheses on specific MRSA transmission routes within a neonatal intensive-care unit. The pronounced risk of transmission emanating from undetected MRSA carriers suggested that increasing the frequency or speed of microbiological diagnostics could help to reduce transmission of MRSA.	[Nuebel, Ulrich; Layer, Franziska; Witte, Wolfgang] Robert Koch Inst, Dept Infect Dis, Unit Nosocomial Infect, Wernigerode, Germany; [Nachtnebel, Matthias; Falkenhorst, Gerhard; Benzler, Justus; Dehnert, Manuel; Eckmanns, Tim] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Nachtnebel, Matthias] Robert Koch Inst, Berlin, Germany; [Nachtnebel, Matthias] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Hecht, Jochen; Kube, Michael; Broecker, Felix; Moelling, Karin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Hecht, Jochen] Charite, Med Ctr, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Moelling, Karin] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Buehrer, Christoph] Charite, Dept Neonatol, Med Ctr, D-13353 Berlin, Germany; [Gastmeier, Petra; Piening, Brar; Behnke, Michael] Charite, Med Ctr, Inst Hyg & Environm Med, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nubel, U (corresponding author), Robert Koch Inst, Dept Infect Dis, Unit Nosocomial Infect, Wernigerode, Germany.	nuebelu@rki.de	Piening, Brar/E-2622-2014	Piening, Brar/0000-0002-4478-5597; Gastmeier, Petra/0000-0001-5520-4287; Layer, Franziska/0000-0002-4613-6478; nachtnebel, matthias/0000-0001-7077-5694; Behnke, Michael/0000-0002-3993-9651	European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control, Stockholm, Sweden; Institute of Medical Virology, University of Zurich, Switzerland	European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control, Stockholm, Sweden; Institute of Medical Virology, University of Zurich, Switzerland	MN received a fellowship from the European Programme for Intervention Epidemiology Training (EPIET), provided by the European Centre for Disease Prevention and Control, Stockholm, Sweden. The study was partially funded by a grant from the Institute of Medical Virology, University of Zurich, Switzerland (to KM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; DREWS MB, 1995, J HOSP INFECT, V30, P65, DOI 10.1016/0195-6701(95)90250-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Garcia Robin, 2011, Adv Neonatal Care, V11, P200, DOI 10.1097/ANC.0b013e31821bab47; Geva A, 2011, PEDIATRICS, V128, pE1173, DOI 10.1542/peds.2010-2562; Gould IM, 2009, EPIDEMIOL INFECT, V137, P1242, DOI 10.1017/S0950268809002234; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Khandavilli S, 2009, J HOSP INFECT, V71, P29, DOI 10.1016/j.jhin.2008.09.011; Khoury J, 2005, INFECT CONT HOSP EP, V26, P616, DOI 10.1086/502590; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Maraqa NF, 2011, AM J INFECT CONTROL, V39, P35, DOI 10.1016/j.ajic.2010.07.013; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Nubel U, 2011, INT J MED MICROBIOL, V301, P614, DOI 10.1016/j.ijmm.2011.09.007; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Rachinger A, 2011, AIDS, V25, P1035, DOI 10.1097/QAD.0b013e3283467020; Saiman L, 2003, INFECT CONT HOSP EP, V24, P317, DOI 10.1086/502217; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Senn L, 2011, J HOSP INFECT, V79, P202, DOI 10.1016/j.jhin.2011.04.021; Shopsin B, 2001, EMERG INFECT DIS, V7, P323, DOI 10.3201/eid0702.010236; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vergnano S, 2011, PEDIATR INFECT DIS J, V30, P850, DOI 10.1097/INF.0b013e318224546d; Waterhouse M, 2011, J HOSP INFECT, V78, P92, DOI 10.1016/j.jhin.2011.01.016; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	33	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54898	10.1371/journal.pone.0054898	http://dx.doi.org/10.1371/journal.pone.0054898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382995	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600047
J	Joeng, KS; Long, FX				Joeng, Kyu Sang; Long, Fanxin			Constitutive Activation of Gli2 Impairs Bone Formation in Postnatal Growing Mice	PLOS ONE			English	Article							INDIAN-HEDGEHOG; CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; ENDOCHONDRAL OSSIFICATION; GROWTH-PLATE; IHH; CARTILAGE; PROTEIN; PTHRP; PROLIFERATION	Indian hedgehog (Ihh) signaling is indispensable for osteoblast differentiation during endochondral bone development in the mouse embryo. We have previously shown that the Gli2 transcription activator critically mediates Ihh function in osteoblastogenesis. To explore the possibility that activation of Hedgehog (Hh) signaling may enhance bone formation, we generated mice that expressed a constitutively active form of Gli2 in the Osx-lineage cells. Unexpectedly, these mice exhibited severe osteopenia due to a marked decrease in osteoblast number and function, although bone resorption was not affected. Quantitative analyses of the molecular markers indicated that osteoblast differentiation was impaired in the mutant mouse. However, the osteoblast-lineage cells isolated from these mice exhibited more robust osteoblast differentiation than normal in vitro. Similarly, pharmacological stimulation of Hh signaling enhanced osteoblast differentiation from Osx-expressing cells isolated from the wild-type mouse. Thus, even though Hh signaling directly promotes osteoblast differentiation in vitro, constitutive activation of this pathway impairs bone formation in vivo, perhaps through an indirect mechanism.	[Joeng, Kyu Sang; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Joeng, Kyu Sang; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	flong@wustl.edu			National Institutes of Health [R01 DK065789]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study is funded by National Institutes of Health R01 DK065789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Heller E, 2012, CANCER RES, V72, P897, DOI 10.1158/0008-5472.CAN-11-2681; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kesper DA, 2010, DEV DYNAM, V239, P1818, DOI 10.1002/dvdy.22301; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010	24	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55134	10.1371/journal.pone.0055134	http://dx.doi.org/10.1371/journal.pone.0055134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383082	gold, Green Published			2022-12-25	WOS:000315563800117
J	Kuhnen, CM; Samanez-Larkin, GR; Knutson, B				Kuhnen, Camelia M.; Samanez-Larkin, Gregory R.; Knutson, Brian			Serotonergic Genotypes, Neuroticism, and Financial Choices	PLOS ONE			English	Article							GENETIC-VARIATION; TESTOSTERONE; POLYMORPHISM; PERSONALITY; ASSOCIATION; DECISIONS; AGE	Life financial outcomes carry a significant heritable component, but the mechanisms by which genes influence financial choices remain unclear. Focusing on a polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR), we found that individuals possessing the short allele of this gene invested less in equities, were less engaged in actively making investment decisions, and had fewer credit lines. Short allele carriers also showed higher levels of the personality trait neuroticism, despite not differing from others with respect to cognitive skills, education, or wealth. Mediation analysis suggested that the presence of the 5-HTTLPR short allele decreased real life measures of financial risk taking through its influence on neuroticism. These findings show that 5-HTTLPR short allele carriers avoid risky and complex financial choices due to negative emotional reactions, and have implications for understanding and managing individual differences in financial choice.	[Kuhnen, Camelia M.] Northwestern Univ, Kellogg Sch Management, Dept Finance, Evanston, IL 60208 USA; [Samanez-Larkin, Gregory R.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Northwestern University; Vanderbilt University; Stanford University	Kuhnen, CM (corresponding author), Northwestern Univ, Kellogg Sch Management, Dept Finance, Evanston, IL 60208 USA.	c-kuhnen@kellogg.northwestern.edu	Samanez-Larkin, Gregory/A-1139-2007	Samanez-Larkin, Gregory/0000-0001-7846-3804; Knutson, Brian/0000-0002-7669-426X	FINRA Investor Education Foundation; National Institute on Aging [AG030778]; Zell Center for Risk Research at the Kellogg School of Management; NATIONAL INSTITUTE ON AGING [F31AG032804, K99AG042596, R21AG030778] Funding Source: NIH RePORTER	FINRA Investor Education Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Zell Center for Risk Research at the Kellogg School of Management; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received funding from the FINRA Investor Education Foundation, the National Institute on Aging (AG030778) and the Zell Center for Risk Research at the Kellogg School of Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, BROOKINGS PAP ECO AC, P51, DOI 10.1353/eca.0.0067; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Barnea A, 2010, J FINANC ECON, V98, P583, DOI 10.1016/j.jfineco.2010.08.001; Beauchamp JP, 2011, J ECON PERSPECT, V25, P57, DOI 10.1257/jep.25.4.57; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Brav A, 2005, J FINANC ECON, V77, P483, DOI 10.1016/j.jfineco.2004.07.004; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; Cronqvist H, 2010, ORIGINS SAVINGS BEHA; De Neve JE, 2010, GENES EC HAPPINESS; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Frydman C, 2011, P ROY SOC B-BIOL SCI, V278, P2053, DOI 10.1098/rspb.2010.2304; Grinblatt M, J FINANCE IN PRESS; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024390; Korniotis G, REV EC STAT IN PRESS; Kraus MW, 2009, J PERS SOC PSYCHOL, V97, P992, DOI 10.1037/a0016357; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kuhnen CM, 2011, J FINANC QUANT ANAL, V46, P605, DOI 10.1017/S0022109011000123; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Loewenstein G, 2003, SER AFFECTIVE SCI, P619; Malmendier U, J FINANCE IN PRESS; Malmendier U, 2011, Q J ECON, V126, P373, DOI 10.1093/qje/qjq004; Puri M, 2007, J FINANC ECON, V86, P7199; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Repin DV, 2005, AM ECON REV, V95; Roiser JP, 2009, J NEUROSCI, V29, P5985, DOI 10.1523/JNEUROSCI.0407-09.2009; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Wechsler D., 1997, WECHSLER ADULT INTEL; WRIGHT WF, 1992, ORGAN BEHAV HUM DEC, V52, P276, DOI 10.1016/0749-5978(92)90039-A; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312	49	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54632	10.1371/journal.pone.0054632	http://dx.doi.org/10.1371/journal.pone.0054632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382929	Green Published, gold			2022-12-25	WOS:000315563800059
J	Schelleman, H; Bilker, WB; Kimmel, SE; Daniel, GW; Newcomb, C; Guevara, JP; Cziraky, MJ; Strom, BL; Hennessy, S				Schelleman, Hedi; Bilker, Warren B.; Kimmel, Stephen E.; Daniel, Gregory W.; Newcomb, Craig; Guevara, James P.; Cziraky, Mark J.; Strom, Brian L.; Hennessy, Sean			Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; POSITIVE PREDICTIVE-VALUE; MIDDLE-AGED ADULTS; DIAGNOSTIC CODES; ADHD MEDICATIONS; STROKE; VALIDATION; ACCURACY; 1ST-EVER; DEATH	Main Objective: To compare the incidence rates of serious cardiovascular events in adult initiators of amphetamines or atomoxetine to rates in non-users. Methods: This was a retrospective cohort study of new amphetamines (n = 38,586) or atomoxetine (n = 20,995) users. Each medication user was matched to up to four non-users on age, gender, data source, and state (n = 238,183). The following events were primary outcomes of interest 1) sudden death or ventricular arrhythmia, 2) stroke, 3) myocardial infarction, 4) a composite endpoint of stroke or myocardial infarction. Cox proportional hazard regression was used to calculate propensity-adjusted hazard ratios for amphetamines versus matched non-users and atomoxetine versus matched non-users, with intracluster dependence within matched sets accounted for using a robust sandwich estimator. Results: The propensity-score adjusted hazard ratio for amphetamines use versus non-use was 1.18 (95% CI: 0.55-2.54) for sudden death/ventricular arrhythmia, 0.80 (95% CI: 0.44-1.47) for stroke, 0.75 (95% CI: 0.42-1.35) for myocardial infarction, and 0.78 (95% CI: 0.51-1.19) for stroke/myocardial infarction. The propensity-score adjusted hazard ratio for atomoxetine use versus non-use was 0.41 (95% CI: 0.10-1.75) for sudden death/ventricular arrhythmia, 1.30 (95% CI: 0.52-3.29) for stroke, 0.56 (95% CI: 0.16-2.00) for myocardial infarction, and 0.92 (95% CI: 0.44-1.92) for stroke/myocardial infarction. Conclusions: Initiation of amphetamines or atomoxetine was not associated with an elevated risk of serious cardiovascular events. However, some of the confidence intervals do not exclude modest elevated risks, e.g. for sudden death/ventricular arrhythmia.	[Schelleman, Hedi; Bilker, Warren B.; Kimmel, Stephen E.; Newcomb, Craig; Guevara, James P.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schelleman, Hedi; Bilker, Warren B.; Kimmel, Stephen E.; Newcomb, Craig; Guevara, James P.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Bilker, Warren B.; Kimmel, Stephen E.; Guevara, James P.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiololgy Res & Training, Philadelphia, PA 19104 USA; [Kimmel, Stephen E.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kimmel, Stephen E.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Therapeut Effectiveness Res, Philadelphia, PA 19104 USA; [Daniel, Gregory W.] Brookings Inst, Engelberg Ctr Hlth Care Reform, Washington, DC 20036 USA; [Guevara, James P.] Childrens Hosp Philadelphia, PolicyLab, Ctr Bridge Res Practice & Policy, Philadelphia, PA 19104 USA; [Cziraky, Mark J.] HealthCore Inc, Wilmington, DE USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Brookings Institution; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; HealthCore, Inc	Hennessy, S (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	hennessy@upenn.edu	Bilker, Warren/AAS-3515-2021	Guevara, James/0000-0003-1665-4503	Shire Development Inc.; National Institutes of Health [CTSA UL1RR024134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	Shire Development Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded through a sponsored research agreement with Shire Development Inc., with infrastructure support provided by the National Institutes of Health (CTSA UL1RR024134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors were responsible for all aspects of the study and independently performed and analyzed the study, and wrote the manuscript. The authors had the right to publish the results and determine the paper's final wording. Shire approved the protocol and was given the opportunity to provide nonbinding written comments on a draft of this manuscript.	Abildstrom S. Z., 1999, CARDIAC ELECTROPHYSI, V3, P177, DOI DOI 10.1023/A:1009971104937; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; COX DR, 1972, J R STAT SOC B, V34, P187; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Hammerness PG, 2011, CURR PSYCHIAT REP, V13, P357, DOI 10.1007/s11920-011-0213-3; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P934, DOI 10.1002/pds.1992; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Nissen SE, 2006, NEW ENGL J MED, V354, P1445, DOI 10.1056/NEJMp068049; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pladevall M, 1996, INT J EPIDEMIOL, V25, P948, DOI 10.1093/ije/25.5.948; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schelleman H, 2012, AM J PSYCHIAT, V169, P178, DOI 10.1176/appi.ajp.2011.11010125; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Wahl PM, 2010, THROMB HAEMOSTASIS, V103, P1203, DOI 10.1160/TH09-08-0595; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523	23	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52991	10.1371/journal.pone.0052991	http://dx.doi.org/10.1371/journal.pone.0052991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382829	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800015
J	Wang, J; Chen, YL; Gao, N; Wang, YS; Tian, YP; Wu, JM; Zhang, JL; Zhu, JP; Fan, DY; An, J				Wang, Juan; Chen, Yanlei; Gao, Na; Wang, Yisong; Tian, Yanping; Wu, Jiangman; Zhang, Junlei; Zhu, Junping; Fan, Dongying; An, Jing			Inhibitory Effect of Glutathione on Oxidative Liver Injury Induced by Dengue Virus Serotype 2 Infections in Mice	PLOS ONE			English	Article							INFLUENZA-A VIRUS; INDUCED LETHAL DISEASE; N-ACETYLCYSTEINE; MOUSE MODEL; REDUCED GLUTATHIONE; HIV-INFECTION; IN-VITRO; REPLICATION; CELLS; GSH	The pathogenesis of dengue virus (DV) infection has not been completely defined and change of redox status mediated by depletion of glutathione (GSH) in host cell is a common result of viral infection. Our previous study has demonstrated that DV serotype 2 (DV2) infection alters host intracellular GSH levels, and exogenous GSH inhibits viral production by modulating the activity of NF-kappa B in HepG2 cells. GSH is the most powerful intracellular antioxidant and involved in viral infections. Thus, this study was to investigate whether DV2 infection can induce alteration in redox balance and effect of GSH on the disease in HepG2 xenografts SCID mice. Our results revealed that mice infected with DV2 showed alterations in oxidative stress by increasing the level of malondialdehyde (MDA), an end product of lipid peroxidation, and GSSG/GSH ratio. DV2-infected mice also showed a decrease in the activity of catalase (CAT) and total superoxide dismutase (T-SOD) in the serum and/or observed organs, especially the liver. Moreover, DV2 infection resulted in elevated serum levels of the cytokines tumor necrosis factor-alpha and interlukin-6 and obvious histopathological changes in the liver. The administration of exogenous GSH significantly reversed all of the aforementioned pathological changes and prevented significant liver damage. Furthermore, in vitro treatment of HepG2 cells with antioxidants such as GSH inhibited viral entry as well as the production of reactive oxygen species in HepG2 cells. These results suggest that GSH prevents DV2-induced oxidative stress and liver injury in mice by inhibiting proinflammatory cytokine production, and GSH and may be a promising therapeutic agent for prevention of oxidative liver damage during DV infection.	[Wang, Juan; Chen, Yanlei; Gao, Na; Wang, Yisong; Wu, Jiangman; Zhu, Junping; Fan, Dongying; An, Jing] Capital Med Univ, Dept Microbiol, Sch Basic Med Sci, Beijing, Peoples R China; [Tian, Yanping; Zhang, Junlei] Third Mil Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China	Capital Medical University; Army Medical University	An, J (corresponding author), Capital Med Univ, Dept Microbiol, Sch Basic Med Sci, Beijing, Peoples R China.	anjing@ccmu.edu.cn			National Key Programs on Basic Research of China [2011CB504703]; National Natural Science Foundation of China [81271839, 30800983]; Funding Project of Beijing Municipal Commission of Education [SQKM201210025005]; Military Major Project [BWS11]	National Key Programs on Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project of Beijing Municipal Commission of Education; Military Major Project	This work was supported by grants from the National Key Programs on Basic Research of China (2011CB504703, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (81271839, 30800983, http://www.nsfc.gov.cn/), Funding Project of Beijing Municipal Commission of Education (SQKM201210025005, http://www.bjedu.gov.cn/) and the Military Major Project(BWS11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Coaccioli S, 2010, CLIN TER, V161, P55; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; De Rosa SC, 2000, EUR J CLIN INVEST, V30, P915, DOI 10.1046/j.1365-2362.2000.00736.x; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; DROGE W, 1994, FASEB J, V8, P1131; Fierbinteanu-Braticevici C, 2009, ROM J MORPHOL EMBRYO, V50, P407; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54, DOI 10.1002/jlb.62.1.54; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652; HENNET T, 1992, J GEN VIROL, V73, P39, DOI 10.1099/0022-1317-73-1-39; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A; Mahmuduzzaman M, 2011, Mymensingh Med J, V20, P349; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Palamara AT, 1996, AIDS RES HUM RETROV, V12, P1373, DOI 10.1089/aid.1996.12.1373; PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A; Papi A, 2008, J BIOL CHEM, V283, P28595, DOI 10.1074/jbc.M805766200; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; SCHOLZ RW, 1989, ANN NY ACAD SCI, V570, P514; Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108; Treitinger Aricio, 2004, Braz J Infect Dis, V8, P363, DOI 10.1590/S1413-86702004000500005; Ungheri D, 2000, INT J IMMUNOPATH PH, V13, P123; World Health Organization, 2012, DENGUE DENGUE HEMORR; YOSHIOKA T, 1979, AM J OBSTET GYNECOL, V135, P372, DOI 10.1016/0002-9378(79)90708-7	41	53	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55407	10.1371/journal.pone.0055407	http://dx.doi.org/10.1371/journal.pone.0055407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383181	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800150
J	Koh, GCKW; Schreiber, MF; Bautista, R; Maude, RR; Dunachie, S; Limmathurotsakul, D; Day, NPJ; Dougan, G; Peacock, SJ				Koh, Gavin C. K. W.; Schreiber, M. Fernanda; Bautista, Ruben; Maude, Rapeephan R.; Dunachie, Susanna; Limmathurotsakul, Direk; Day, Nicholas P. J.; Dougan, Gordon; Peacock, Sharon J.			Host Responses to Melioidosis and Tuberculosis Are Both Dominated by Interferon-Mediated Signaling	PLOS ONE			English	Article							RECOGNITION; BEADARRAY; SIGNATURE; INFECTION; INSIGHTS; DATABASE; GAMMA; MICE; CD14	Melioidosis (Burkholderia pseudomallei infection) is a common cause of community-acquired sepsis in Northeast Thailand and northern Australia. B. pseudomallei is a soil saprophyte endemic to Southeast Asia and northern Australia. The clinical presentation of melioidosis may mimic tuberculosis (both cause chronic suppurative lesions unresponsive to conventional antibiotics and both commonly affect the lungs). The two diseases have overlapping risk profiles (e.g., diabetes, corticosteroid use), and both B. pseudomallei and Mycobacterium tuberculosis are intracellular pathogens. There are however important differences: the majority of melioidosis cases are acute, not chronic, and present with severe sepsis and a mortality rate that approaches 50% despite appropriate antimicrobial therapy. By contrast, tuberculosis is characteristically a chronic illness with mortality <2% with appropriate antimicrobial chemotherapy. We examined the gene expression profiles of total peripheral leukocytes in two cohorts of patients, one with acute melioidosis (30 patients and 30 controls) and another with tuberculosis (20 patients and 24 controls). Interferon-mediated responses dominate the host response to both infections, and both type 1 and type 2 interferon responses are important. An 86-gene signature previously thought to be specific for tuberculosis is also found in melioidosis. We conclude that the host responses to melioidosis and to tuberculosis are similar: both are dominated by interferon-signalling pathways and this similarity means gene expression signatures from whole blood do not distinguish between these two diseases.	[Koh, Gavin C. K. W.; Schreiber, M. Fernanda; Bautista, Ruben; Dougan, Gordon; Peacock, Sharon J.] Wellcome Trust Sanger Inst, Cambridge, England; [Koh, Gavin C. K. W.; Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Koh, Gavin C. K. W.; Maude, Rapeephan R.; Dunachie, Susanna; Limmathurotsakul, Direk; Day, Nicholas P. J.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Koh, Gavin C. K. W.] Birmingham Heartlands Hosp, Dept Infect & Trop Dis, Birmingham B9 5ST, W Midlands, England; [Peacock, Sharon J.] Mahidol Univ, Dept Microbiol, Bangkok 10700, Thailand	Wellcome Trust Sanger Institute; University of Cambridge; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Heart of England NHS Foundation Trust; University of Birmingham; Mahidol University	Koh, GCKW (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	gavin.koh@gmail.com	Maude, Rapeephan/AHB-3558-2022; Peacock, Sharon J/ABE-6331-2020	Dunachie, Susanna/0000-0001-5665-6293; Peacock, Sharon/0000-0002-1718-2782; Koh, Gavin/0000-0002-7336-1566; Maude, Rapeephan/0000-0002-3383-3629; Limmathurotsakul, Direk/0000-0001-7240-5320	Wellcome Trust of Great Britain [086532/Z/08/Z, 089275/Z/09/Z]; NIHR Cambridge Biomedical Research Centre; National Institute for Health Research [CL-2008-13-010] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Wellcome Trust of Great Britain (grants 086532/Z/08/Z and 089275/Z/09/Z, www.wellcome.ac.uk). SJP is supported by the NIHR Cambridge Biomedical Research Centre (www.cambridge-brc.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Breitbach K, 2009, INFECT IMMUN; Brewer C. A., 2003, CARTOGR GEOGR INF SC, V30, P5, DOI [10.1559/152304003100010929, DOI 10.1559/152304003100010929]; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Cairns JM, 2008, BIOINFORMATICS, V24, P2921, DOI 10.1093/bioinformatics/btn557; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Chierakul W, 2005, AM J TROP MED HYG, V73, P1165, DOI 10.4269/ajtmh.2005.73.1165; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gutierrez O, 2004, FEBS LETT, V568, P79, DOI 10.1016/j.febslet.2004.04.095; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hebenstreit D, CYTOKINE GROWTH FACT, V17, P173; Jung ID, 2011, CANCER RES, V71, P2858, DOI 10.1158/0008-5472.CAN-10-3487; Khoo JJ, 2011, J INTERF CYTOK RES, V31, P13, DOI 10.1089/jir.2010.0095; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; Koh GCKW, 2010, ANTIMICROB AGENTS CH, V54, P4520, DOI 10.1128/AAC.00805-10; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Neuwirth E, 2007, RCOLORBREWER COLORBR; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Propst KL, 2010, ANTIMICROB AGENTS CH, V54, P1785, DOI 10.1128/AAC.01513-09; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53	44	73	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54961	10.1371/journal.pone.0054961	http://dx.doi.org/10.1371/journal.pone.0054961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383015	gold, Green Published			2022-12-25	WOS:000315483200033
J	Pruvost, I; Dubos, F; Chazard, E; Hue, V; Duhamel, A; Martinot, A				Pruvost, Isabelle; Dubos, Francois; Chazard, Emmanuel; Hue, Valerie; Duhamel, Alain; Martinot, Alain			The Value of Body Weight Measurement to Assess Dehydration in Children	PLOS ONE			English	Article							ROTAVIRUS DISEASE; CLINICAL SIGNS; MANAGEMENT	Dehydration secondary to gastroenteritis is one of the most common reasons for office visits and hospital admissions. The indicator most commonly used to estimate dehydration status is acute weight loss. Post-illness weight gain is considered as the gold-standard to determine the true level of dehydration and is widely used to estimate weight loss in research. To determine the value of post-illness weight gain as a gold standard for acute dehydration, we conducted a prospective cohort study in which 293 children, aged 1 month to 2 years, with acute diarrhea were followed for 7 days during a 3-year period. The main outcome measures were an accurate pre-illness weight (if available within 8 days before the diarrhea), post-illness weight, and theoretical weight (predicted from the child's individual growth chart). Post-illness weight was measured for 231 (79%) and both theoretical and post-illness weights were obtained for 111 (39%). Only 62 (21%) had an accurate pre-illness weight. The correlation between post-illness and theoretical weight was excellent (0.978), but bootstrapped linear regression analysis showed that post-illness weight underestimated theoretical weight by 0.48 kg (95% CI: 0.06-0.79, p<0.02). The mean difference in the fluid deficit calculated was 4.0% of body weight (95% CI: 3.2-4.7, p<0.0001). Theoretical weight overestimated accurate pre-illness weight by 0.21 kg (95% CI: 0.08-0.34, p = 0.002). Postillness weight underestimated pre-illness weight by 0.19 kg (95% CI: 0.03-0.36, p = 0.02). The prevalence of 5% dehydration according to post-illness weight (21%) was significantly lower than the prevalence estimated by either theoretical weight (60%) or clinical assessment (66%, p<0.0001). These data suggest that post-illness weight is of little value as a gold standard to determine the true level of dehydration. The performance of dehydration signs or scales determined by using post-illness weight as a gold standard has to be reconsidered.	[Pruvost, Isabelle; Dubos, Francois; Duhamel, Alain; Martinot, Alain] Univ Lille Nord France, UDSL, Lille, France; [Dubos, Francois; Duhamel, Alain; Martinot, Alain] Publ Hlth Epidemiol & Qual Care EA2694, Lille, France; [Pruvost, Isabelle; Dubos, Francois; Hue, Valerie; Martinot, Alain] CHU Lille, Paediat Emergency & Infect Dis Unit, F-59037 Lille, France; [Chazard, Emmanuel; Duhamel, Alain] CHU Lille, Dept Biostat, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Martinot, A (corresponding author), Univ Lille Nord France, UDSL, Lille, France.	alain.martinot@chru-lille.fr	Duhamel, Alain/A-4899-2013; Martinot, Alain/M-6780-2016; Dubos, Francois/AGD-5638-2022	Martinot, Alain/0000-0002-2146-8273; dubos, francois/0000-0003-2151-1638	Sanofi-Pasteur MSD pharmaceuticals, France	Sanofi-Pasteur MSD pharmaceuticals, France	The study was supported by grants from Sanofi-Pasteur MSD pharmaceuticals, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Duggan C, 1996, J PEDIATR GASTR NUTR, V22, P56, DOI 10.1097/00005176-199601000-00009; Frifdman JN, 2004, J PEDIATR-US, V145, P201, DOI 10.1016/j.jpeds.2004.05.035; GLASS RI, 1991, J PEDIATR-US, V118, pS27, DOI 10.1016/S0022-3476(05)81422-2; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; MACKENZIE A, 1989, LANCET, V2, P605; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Porter SC, 2003, ANN EMERG MED, V41, P196, DOI 10.1067/mem.2003.5; SAAVEDRA JM, 1991, AM J DIS CHILD, V145, P296, DOI 10.1001/archpedi.1991.02160030064022; Soriano-Gabarro M, 2006, PEDIATR INFECT DIS J, V25, pS7, DOI 10.1097/01.inf.0000197622.98559.01; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Teach SJ, 1997, CLIN PEDIATR, V36, P395, DOI 10.1177/000992289703600703; Vega RM, 1997, PEDIATR EMERG CARE, V13, P179, DOI 10.1097/00006565-199706000-00001; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Yilmaz K, 2002, J PAEDIATR CHILD H, V38, P226, DOI 10.1046/j.1440-1754.2002.00792.x	17	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55063	10.1371/journal.pone.0055063	http://dx.doi.org/10.1371/journal.pone.0055063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383058	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200031
J	McCarthy, JM; Franke, M; Resenberger, UK; Waldron, S; Simpson, JC; Tatzelt, J; Appelhans, D; Rogers, MS				McCarthy, James M.; Franke, Markus; Resenberger, Ulrike K.; Waldron, Sibeal; Simpson, Jeremy C.; Tatzelt, Joerg; Appelhans, Dietmar; Rogers, Mark S.			Anti- Prion Drug mPPIg5 Inhibits PrPC Conversion to PrPSc	PLOS ONE			English	Article							BRANCHED POLYAMINES; AMYLOID PEPTIDES; DENDRIMERS; PROTEIN; ACCUMULATION; AGGREGATION; ALZHEIMERS; VESICLES	Prion diseases, also known as transmissible spongiform encephalopathies, are a group of fatal neurodegenerative diseases that include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle and Creutzfeldt-Jakob disease (CJD) in humans. The 'protein only hypothesis' advocates that PrPSc, an abnormal isoform of the cellular protein PrPC, is the main and possibly sole component of prion infectious agents. Currently, no effective therapy exists for these diseases at the symptomatic phase for either humans or animals, though a number of compounds have demonstrated the ability to eliminate PrPSc in cell culture models. Of particular interest are synthetic polymers known as dendrimers which possess the unique ability to eliminate PrPSc in both an intracellular and in vitro setting. The efficacy and mode of action of the novel anti-prion dendrimer mPPIg5 was investigated through the creation of a number of innovative bio-assays based upon the scrapie cell assay. These assays were used to demonstrate that mPPIg5 is a highly effective anti-prion drug which acts, at least in part, through the inhibition of PrPC to PrPSc conversion. Understanding how a drug works is a vital component in maximising its performance. By establishing the efficacy and method of action of mPPIg5, this study will help determine which drugs are most likely to enhance this effect and also aid the design of dendrimers with anti-prion capabilities for the future.	[McCarthy, James M.; Waldron, Sibeal; Simpson, Jeremy C.; Rogers, Mark S.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Franke, Markus; Appelhans, Dietmar] Leibniz Inst Polymer Res Dresden, Dresden, Germany; [Resenberger, Ulrike K.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Tatzelt, Joerg] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	University College Dublin; Leibniz Institut fur Polymerforschung Dresden; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	McCarthy, JM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	jim.mccarthy@ucd.ie	Rogers, Mark/M-4524-2013	Rogers, Mark/0000-0002-5288-0295; Simpson, Jeremy/0000-0002-7956-7805; Tatzelt, Jorg/0000-0001-5017-5528	University College Dublin; Irish Research Council for Science, Engineering & Technology (IRCSET); European Union [COST TD0802, FOOD-CT-2004-506579]; Irish Department of Agriculture, Food and Rural Development [FIRM 01-RD-D-160]; Saxon Ministry for Science and Art; German Ministry for Education and Science; DFG [SFB 596]	University College Dublin; Irish Research Council for Science, Engineering & Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); European Union(European Commission); Irish Department of Agriculture, Food and Rural Development; Saxon Ministry for Science and Art; German Ministry for Education and Science; DFG(German Research Foundation (DFG))	This work was supported by funding from University College Dublin, the Irish Research Council for Science, Engineering & Technology (IRCSET) the European Union (Dendrimers in Biomedical Applications - COST TD0802, Neuroprion - FOOD-CT-2004-506579), the Irish Department of Agriculture, Food and Rural Development (FIRM 01-R&D-D-160), the Saxon Ministry for Science and Art and The German Ministry for Education and Science, as well as the DFG SFB 596 (to Jorg Tatzelt and Ulrike K. Resenberger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fischer M, 2010, BIOMACROMOLECULES, V11, P1314, DOI 10.1021/bm100101s; Ghaemmaghami S, 2010, J BIOL CHEM, V285, P10415, DOI 10.1074/jbc.M109.045112; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Heegaard PMH, 2007, MACROMOL BIOSCI, V7, P1047, DOI 10.1002/mabi.200700051; Heegaard PMH, 2004, FEBS LETT, V577, P127, DOI 10.1016/j.febslet.2004.09.073; Janaszewska A, 2012, NEW J CHEM, V36, P350, DOI 10.1039/c1nj20444k; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Klajnert B, 2006, BIOMACROMOLECULES, V7, P2186, DOI 10.1021/bm060229s; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V339, P577, DOI 10.1016/j.bbrc.2005.11.053; Klajnert B, 2008, CHEM-EUR J, V14, P7030, DOI 10.1002/chem.200800342; Klajnert B, 2007, BIOCHEM BIOPH RES CO, V364, P20, DOI 10.1016/j.bbrc.2007.09.083; Klajnert B, 2007, MACROMOL BIOSCI, V7, P1065, DOI 10.1002/mabi.200700049; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lim YB, 2010, BIOMATERIALS, V31, P2025, DOI 10.1016/j.biomaterials.2009.11.085; Masel J, 2000, BIOPHYS CHEM, V88, P47, DOI 10.1016/S0301-4622(00)00197-6; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Miesbauer M, 2009, J BIOL CHEM, V284, P24384, DOI 10.1074/jbc.M109.023135; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Nishina KA, 2007, ANAL BIOCHEM, V363, P318, DOI 10.1016/j.ab.2007.01.032; Perez AP, 2011, INT J NANOMED, V6, P2715, DOI 10.2147/IJN.S25235; Pless DD, 1996, J CELL BIOCHEM, V62, P27, DOI 10.1002/(SICI)1097-4644(199607)62:1<27::AID-JCB4>3.0.CO;2-3; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Solassol J, 2004, J GEN VIROL, V85, P1791, DOI 10.1099/vir.0.19726-0; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Waldron S, 2008, THESIS U COLL DUBLIN; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Yam AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009316	42	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55282	10.1371/journal.pone.0055282	http://dx.doi.org/10.1371/journal.pone.0055282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383136	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500071
J	van Dijk, JH; Sutcliffe, CG; Hamangaba, F; Bositis, C; Watson, DC; Moss, WJ				van Dijk, Janneke H.; Sutcliffe, Catherine G.; Hamangaba, Francis; Bositis, Christopher; Watson, Douglas C.; Moss, William J.			Effectiveness of Efavirenz-Based Regimens in Young HIV-Infected Children Treated for Tuberculosis: A Treatment Option for Resource-Limited Settings	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ANTITUBERCULAR THERAPY; PLASMA-CONCENTRATIONS; EQUIVALENCE TRIAL; INITIAL TREATMENT; AFRICAN CHILDREN; HIGH PREVALENCE; NEVIRAPINE; RIFAMPICIN; EFFICACY	Background: Antiretroviral treatment (ART) options for young children co-infected with HIV and tuberculosis are limited in resource-poor settings due to limited data on the use of efavirenz (EFV). Using available pharmacokinetic data, an EFV dosing schedule was developed for young co-infected children and implemented as the standard of care at Macha Hospital in Southern Province, Zambia. Treatment outcomes in children younger than 3 years of age or weighing less than 10 kg receiving either EFV-based ART plus anti-tuberculous treatment or nevirapine-based (NVP) ART were compared. Methods: Treatment outcomes were measured in a cohort of HIV-infected children seeking care at Macha Hospital in rural Zambia from 2007 to 2010. Informationon the diagnosis and treatment of tuberculosis was abstracted from medical records. Results: Forty-five children treated for tuberculosis initiated an EFV-based regimen and 69 children initiated a NVP-based regimen, 7 of whom also were treated for tuberculosis. Children receiving both regimens were comparable in age, but children receiving EFV started ART with a lower CD4(+) T-cell percentage and weight-for-age z-score. Children receiving EFV experienced increases in both CD4(+) T-cell percentage and weight-for-age z-score during follow-up, such that levels were comparable to children receiving NVP after two years of ART. Cumulative survival after 12 months of ART did not differ between groups (NVP:87%; EFV:80%; p = 0.25). Eleven children experienced virologic failure during follow-up. The adjusted hazard ratio of virologic failure comparing EFV to NVP was 0.25 (95% CI:0.05,1.24) and 0.13 (95% CI:0.03,0.62) using thresholds of 5000 and 400 copies/mL, respectively. Five children receiving EFV were reported to have had convulsions after ART initiation compared to only one child receiving NVP (p = 0.04). Conclusions: Despite poorer health at ART initiation, children treated for tuberculosis and receiving EFV-based regimens showed significant improvements comparable to children receiving NVP-based regimens. EFV-based regimens should be considered for young HIV-infected children co-infected with tuberculosis in resource-limited settings.	[van Dijk, Janneke H.; Hamangaba, Francis] Macha Hosp, Macha Res Trust, Choma, Zambia; [van Dijk, Janneke H.] Erasmus Univ, Dept Immunol & Infect Dis, Rotterdam, Netherlands; [Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Bositis, Christopher] Greater Lawrence Family Hlth Ctr, Lawrence, MA USA; [Watson, Douglas C.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	Erasmus University Rotterdam; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	wmoss@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [U62/CCU322428]; Global AIDS Program	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global AIDS Program	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement U62/CCU322428 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The findings and conclusions included in its content are solely the responsibility of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihingsanon A, 2008, ANTIVIR THER, V13, P529; Barlow-Mosha L, 2009, 16 C RETR OPP INF 8; Bobat R, 2008, 4 IAS C HIV PATH TRE; Bolton C, 2012, C RETR OPP INF 2012; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Capparelli E, 2009, 16 C RETR OPP INF 8; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cohen K, 2008, J ANTIMICROB CHEMOTH, V61, P389, DOI 10.1093/jac/dkm484; Coutinho AB, 2005, J OCUL PHARMACOL TH, V21, P166, DOI 10.1089/jop.2005.21.166; FDA, 2012, SUST PRESCR INF; Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hirt D, 2009, ANTIMICROB AGENTS CH, V53, P4407, DOI 10.1128/AAC.01594-08; Jeena PM, 1998, AIDS, V12, P1185, DOI 10.1097/00002030-199810000-00011; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lapphra K, 2008, INT J INFECT DIS, V12, pE33, DOI 10.1016/j.ijid.2007.10.008; Maartens G, 2009, ANTIVIR THER, V14, P1039, DOI 10.3851/IMP1455; Manosuthi W, 2006, CLIN INFECT DIS, V43, P253, DOI 10.1086/505210; McIlleron H, 2011, ANTIVIR THER, V16, P417, DOI 10.3851/IMP1757; McKinney RE, 2007, PEDIATRICS, V120, pE416, DOI 10.1542/peds.2006-0925; Meyers TM, 2011, PEDIATR INFECT DIS J, V30, P974, DOI 10.1097/INF.0b013e31822539f6; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Oudijk JM, 2009, 5 IAS C HIV PATH TRE; Puthanakit T, 2007, PEDIATR INFECT DIS J, V26, P953, DOI 10.1097/INF.0b013e318125720a; Ramachandran G, 2006, JAIDS-J ACQ IMM DEF, V42, P36; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Ren Y, 2007, JAIDS-J ACQ IMM DEF, V45, P133, DOI 10.1097/QAI.0b013e31805c9d52; Scherpbier HJ, 2007, PEDIATRICS, V119, pE705, DOI 10.1542/peds.2006-1367; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; Strehlau R, 2011, PEDIATR INFECT DIS J, V30, P1001, DOI 10.1097/INF.0b013e318223b680; Swaminathan S, 2011, CLIN INFECT DIS, V53, P716, DOI 10.1093/cid/cir447; Teglas JP, 2001, AIDS, V15, P241, DOI 10.1097/00002030-200101260-00014; The HIV-CAUSAL Collaboration, 2012, EFF EF VERS NEV CONT; UNAIDS, 2012, TOG WE WILL END AIDS; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Vibhagool A, 2004, CURR MED RES OPIN, V20, P1103, DOI 10.1185/030079904125004006; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; von Hentig N, 2006, EUR J MED RES, V11, P377; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; WHO, WHO CHILD GROWTH STA; *WHO, 2008, WHO TECHN REF GROUP; WHO, 2001, IRON DEFICIENCY ANAE; Wintergerst U, 2008, J ANTIMICROB CHEMOTH, V61, P1336, DOI 10.1093/jac/dkn112; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, ANT THER HIV INF INF; Yotebieng M, 2010, AIDS, V24, P1341, DOI 10.1097/QAD.0b013e328339e576	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55111	10.1371/journal.pone.0055111	http://dx.doi.org/10.1371/journal.pone.0055111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372824	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400066
J	Ray, KC; Moss, ME; Franklin, JL; Weaver, CJ; Higginbotham, J; Song, Y; Revetta, FL; Blaine, SA; Bridges, LR; Guess, KE; Coffey, RJ; Crawford, HC; Washington, MK; Means, AL				Ray, K. C.; Moss, M. E.; Franklin, J. L.; Weaver, C. J.; Higginbotham, J.; Song, Y.; Revetta, F. L.; Blaine, S. A.; Bridges, L. R.; Guess, K. E.; Coffey, R. J.; Crawford, H. C.; Washington, M. K.; Means, A. L.			Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia	ONCOGENE			English	Article						pancreatic ductal adenocarcinoma; inflammation; transdifferentiation; EGFR	DUCTAL ADENOCARCINOMA; FACTOR RECEPTOR; K-RAS; EPITHELIAL-CELLS; ACINAR-CELLS; EGF RECEPTOR; CANCER; MICE; EXPRESSION; CARCINOMA	Pancreatic cancer remains as one of the most deadly cancers with few treatment options at late stages and little information about how it develops through earlier stages. Activating mutation of the Kras gene has been implicated in, but is not sufficient for, tumorigenesis. In mouse models of pancreatic cancer, loss of tumor suppressor genes in conjunction with Kras mutation leads to gradual stochastic acquisition of neoplastic precursors and carcinomas, whereas many cells remain phenotypically unaltered in younger mice. Here, we demonstrate that two oncogenic events, mutation of Kras and production of the growth factor heparin-binding epidermal growth factor-like growth factor (HB-EGF), are sufficient for rapid and complete neoplastic transformation of the exocrine pancreas. We found that macrophages are the major source of HB-EGF production in pancreatic cancer tissue samples, and that macrophages are present in high density and in close association with human pancreatic cancer lesions. In a mouse model, high macrophage density was observed at the earliest stages of neoplastic transformation. The consequence of elevated HB-EGF signaling was investigated without the confounding effects of other macrophage-produced factors via transgenic overexpression of the active form of HB-EGF. In this model, HB-EGF was sufficient to promote Kras-initiated tumorigenesis, inducing rapid and complete neoplastic transformation of the entire exocrine pancreas shortly after birth. HB-EGF overexpression and Kras(G12D) together, but neither alone, increased proliferation with increased cyclinD1 and decreased Cdkn2a/2d (p16/p19(Ink4A/Arf)). These findings establish the importance of oncogenic synergy in cancer initiation and promotion, and establish a molecular link between inflammation and the earliest stages of tumor induction.	[Ray, K. C.; Moss, M. E.; Weaver, C. J.; Blaine, S. A.; Bridges, L. R.; Guess, K. E.; Means, A. L.] Vanderbilt Univ, Med Ctr, Div Surg Oncol, Nashville, TN 37232 USA; [Franklin, J. L.; Higginbotham, J.; Coffey, R. J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Franklin, J. L.; Coffey, R. J.; Means, A. L.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Song, Y.; Crawford, H. C.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Revetta, F. L.; Washington, M. K.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Crawford, H. C.] Vet Affairs Med Ctr, Dept Res, Northport, NY USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Means, AL (corresponding author), Vanderbilt Univ, Med Ctr, Div Surg Oncol, D2300 Med Ctr North,1161 21st Ave S, Nashville, TN 37232 USA.	anna.means@vanderbilt.edu		Moss, M Elizabeth/0000-0002-9761-7263	NIH [CA123061, P30DK058404, P50CA095103, CA136754]; VA Merit; Knapp Chair in Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA159222, R01CA136754, R21CA123061, P50CA095103, R01CA046413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit(US Department of Veterans Affairs); Knapp Chair in Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R Daniel Beauchamp for support and helpful discussions, Steven D Leach, Barbara Fingleton and Harold L Moses for critically reading the manuscript, and Heidi Moreno and Christian Kis for technical assistance. This work was supported by NIH grants CA123061 (ALM), P30DK058404 and P50CA095103 (MKW), CA136754, VA Merit, and the Knapp Chair in Pancreatic Cancer Research (HCC).	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Blaine SA, 2009, AM J PHYSIOL-GASTR L, V297, pG434, DOI 10.1152/ajpgi.00152.2009; Brand RE, 2007, GUT, V56, P1460, DOI 10.1136/gut.2006.108456; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; DOYLE CM, 1978, DEV BIOL, V65, P11, DOI 10.1016/0012-1606(78)90175-6; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Ito Y, 2001, INT J PANCREATOL, V29, P47, DOI 10.1385/IJGC:29:1:47; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Luttges J, 1999, VIRCHOWS ARCH, V435, P461, DOI 10.1007/s004280050428; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Mohammed A, 2010, CANCER PREV RES, V3, P1417, DOI 10.1158/1940-6207.CAPR-10-0038; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Oldham SM, 1998, ONCOGENE, V16, P2565, DOI 10.1038/sj.onc.1201784; Ray KC, 2009, GASTROENTEROLOGY, V137, P1785, DOI 10.1053/j.gastro.2009.07.067; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Zhu ZW, 2000, BIOCHEM BIOPH RES CO, V273, P1019, DOI 10.1006/bbrc.2000.3033	46	29	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					823	831		10.1038/onc.2013.3	http://dx.doi.org/10.1038/onc.2013.3			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23376846	Green Accepted			2022-12-25	WOS:000331626900003
J	Gerber, S; Lizak, C; Michaud, G; Bucher, M; Darbre, T; Aebi, M; Reymond, JL; Locher, KP				Gerber, Sabina; Lizak, Christian; Michaud, Gaelle; Bucher, Monika; Darbre, Tamis; Aebi, Markus; Reymond, Jean-Louis; Locher, Kaspar P.			Mechanism of Bacterial Oligosaccharyltransferase IN VITRO QUANTIFICATION OF SEQUON BINDING AND CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; HYDROXY AMINO-ACID; PROTEIN GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; CONSENSUS SEQUENCE; SITE; GLYCOPROTEINS; MANGANESE; CELLS; SPECIFICITY	N-Linked glycosylation is an essential post-translational protein modification in the eukaryotic cell. The initial transfer of an oligosaccharide from a lipid carrier onto asparagine residues within a consensus sequon is catalyzed by oligosaccharyltransferase (OST). The first X-ray structure of a complete bacterial OST enzyme, Campylobacter lari PglB, was recently determined. To understand the mechanism of PglB, we have quantified sequon binding and glycosylation turnover in vitro using purified enzyme and fluorescently labeled, synthetic peptide substrates. Using fluorescence anisotropy, we determined a dissociation constant of 1.0 mu M and a strict requirement for divalent metal ions for consensus (DQNAT) sequon binding. Using in-gel fluorescence detection, we quantified exceedingly low glycosylation rates that remained undetected using in vivo assays. We found that an alanine in the -2 sequon position, converting the bacterial sequon to a eukaryotic one, resulted in strongly lowered sequon binding, with in vitro turnover reduced 50,000-fold. A threonine is preferred over serine in the +2 sequon position, reflected by a 4-fold higher affinity and a 1.2-fold higher glycosylation rate. The interaction of the +2 sequon position with PglB is modulated by isoleucine 572. Our study demonstrates an intricate interplay of peptide and metal binding as the first step of protein N-glycosylation.	[Gerber, Sabina; Lizak, Christian; Bucher, Monika; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland; [Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Michaud, Gaelle; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, Schafmattstr 20, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Reymond, Jean-Louis/0000-0003-2724-2942	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 200020_125020, SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the NCCR Structural Biology Zurich (to K. P. L.) and Swiss National Science Foundation Grants SNF 200020_125020 (to J. L. R.) and SNF 31003A-131075/1 (to K. P. L.).	BAUSE E, 1982, BIOCHEM J, V203, P761, DOI 10.1042/bj2030761; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1984, BIOCHEM SOC T, V12, P514, DOI 10.1042/bst0120514; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; DAS RC, 1980, P NATL ACAD SCI-BIOL, V77, P3811, DOI 10.1073/pnas.77.7.3811; DAVISON W, 1993, EARTH-SCI REV, V34, P119, DOI 10.1016/0012-8252(93)90029-7; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gawlitzek M, 2009, BIOTECHNOL BIOENG, V103, P1164, DOI 10.1002/bit.22348; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; Ihssen J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-67; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Jervis AJ, 2012, J BACTERIOL, V194, P2355, DOI 10.1128/JB.00042-12; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; MAJZURAWSKA M, 1989, ANAL CHIM ACTA, V218, P47, DOI 10.1016/S0003-2670(00)80281-0; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; SUGIYAMA T, 1995, AM J PHYSIOL-CELL PH, V269, pC698, DOI 10.1152/ajpcell.1995.269.3.C698; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weisinger JR, 1998, LANCET, V352, P391, DOI 10.1016/S0140-6736(97)10535-9; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	55	65	65	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8849	8861		10.1074/jbc.M112.445940	http://dx.doi.org/10.1074/jbc.M112.445940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23382388	Green Published, hybrid			2022-12-25	WOS:000316862200007
J	Hand, D; Wallis, C; Colyer, A; Penn, CW				Hand, Daniel; Wallis, Corrin; Colyer, Alison; Penn, Charles W.			Pyrosequencing the Canine Faecal Microbiota: Breadth and Depth of Biodiversity	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL DIVERSITY; CETOBACTERIUM-SOMERAE; ILYOBACTER-POLYTROPUS; SP-NOV; DOGS; COMMUNITIES; HEALTH; DNA; DEGRADATION	Mammalian intestinal microbiota remain poorly understood despite decades of interest and investigation by culture-based and other long-established methodologies. Using high-throughput sequencing technology we now report a detailed analysis of canine faecal microbiota. The study group of animals comprised eleven healthy adult miniature Schnauzer dogs of mixed sex and age, some closely related and all housed in kennel and pen accommodation on the same premises with similar feeding and exercise regimes. DNA was extracted from faecal specimens and subjected to PCR amplification of 16S rDNA, followed by sequencing of the 59 region that included variable regions V1 and V2. Barcoded amplicons were sequenced by Roche-454 FLX high-throughput pyrosequencing. Sequences were assigned to taxa using the Ribosomal Database Project Bayesian classifier and revealed dominance of Fusobacterium and Bacteroidetes phyla. Differences between animals in the proportions of different taxa, among 10,000 reads per animal, were clear and not supportive of the concept of a "core microbiota''. Despite this variability in prominent genera, littermates were shown to have a more similar faecal microbial composition than unrelated dogs. Diversity of the microbiota was also assessed by assignment of sequence reads into operational taxonomic units (OTUs) at the level of 97% sequence identity. The OTU data were then subjected to rarefaction analysis and determination of Chao1 richness estimates. The data indicated that faecal microbiota comprised possibly as many as 500 to 1500 OTUs.	[Hand, Daniel; Penn, Charles W.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wallis, Corrin; Colyer, Alison] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	University of Birmingham; Mars; WALTHAM Petcare Science Institute	Penn, CW (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	c.w.penn@bham.ac.uk			UK Biotechnology and Biological Sciences Research Council; WALTHAM Centre for Pet Nutrition	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); WALTHAM Centre for Pet Nutrition	This work was co-funded by the UK Biotechnology and Biological Sciences Research Council and the WALTHAM Centre for Pet Nutrition. The study was undertaken to support the development of a fundamental understanding of the canine gastrointestinal microbiota using 454-pyrosequencing. Scientists at the WALTHAM Centre for Pet Nutrition including co-authors Corrin Wallis and Alison Colyer contributed to the study design, data collection and analysis, the decision to publish and preparation of the manuscript. The work has no direct commercial value and is submitted in good faith within the conventions of scientific integrity and peer review. http://www.bbsrc.ac.uk/ http://www.waltham.com/.	BALISH E, 1977, APPL ENVIRON MICROB, V34, P207, DOI 10.1128/AEM.34.2.207-221.1977; Beasley SS, 2006, J APPL MICROBIOL, V101, P131, DOI 10.1111/j.1365-2672.2006.02884.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Callaway TR, 2010, J ANIM SCI; CHAO A, 1984, SCAND J STAT, V11, P265; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Finegold SM, 2003, SYST APPL MICROBIOL, V26, P177, DOI 10.1078/072320203322346010; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Green BD, 2006, CURR OPIN BIOTECH, V17, P236, DOI 10.1016/j.copbio.2006.05.004; Greetham HL, 2002, J APPL MICROBIOL, V93, P640, DOI 10.1046/j.1365-2672.2002.01724.x; Greetham HL, 2003, THESIS READING U SCH; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hughes JB, 2005, METHOD ENZYMOL, V397, P292, DOI 10.1016/S0076-6879(05)97017-1; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Martin-Orue SM, 2002, BRIT J NUTR, V87, P533, DOI [10.1079/BJNBJN2002573, 10.1079/BJN2002573]; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Probert H M, 2002, Curr Issues Intest Microbiol, V3, P23; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shah HN, 2009, ANAEROBE, V15, P179, DOI 10.1016/j.anaerobe.2009.08.003; Sikorski J, 2010, STAND GENOMIC SCI, V3, P304, DOI 10.4056/sigs.1273360; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; STIEB M, 1984, ARCH MICROBIOL, V140, P139, DOI 10.1007/BF00454916; Strauss J, 2008, ANAEROBE, V14, P301, DOI 10.1016/j.anaerobe.2008.12.003; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Suchodolski JS, 2009, VET MICROBIOL; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walter Jens, 2002, Microbial Ecology in Health and Disease, V14, P129, DOI 10.1080/089106002320644294; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wiedemann S, 2006, J ANIM SCI, V84, P135, DOI 10.2527/2006.841135x; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Youssef NH, 2008, J MICROBIOL METH, V75, P86, DOI 10.1016/j.mimet.2008.05.009; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	70	49	50	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53115	10.1371/journal.pone.0053115	http://dx.doi.org/10.1371/journal.pone.0053115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382835	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600010
J	Kolbert, CP; Feddersen, RM; Rakhshan, F; Grill, DE; Simon, G; Middha, S; Jang, JS; Simon, V; Schultz, DA; Zschunke, M; Lingle, W; Carr, JM; Thompson, EA; Oberg, AL; Eckloff, BW; Wieben, ED; Li, P; Yang, P; Jen, J				Kolbert, Christopher P.; Feddersen, Rod M.; Rakhshan, Fariborz; Grill, Diane E.; Simon, Gyorgy; Middha, Sumit; Jang, Jin Sung; Simon, Vernadette; Schultz, Debra A.; Zschunke, Michael; Lingle, Wilma; Carr, Jennifer M.; Thompson, E. Aubrey; Oberg, Ann L.; Eckloff, Bruce W.; Wieben, Eric D.; Li, Peter; Yang, Ping; Jen, Jin			Multi-Platform Analysis of MicroRNA Expression Measurements in RNA from Fresh Frozen and FFPE Tissues	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; HEART-FAILURE; LUNG-CANCER; C-ELEGANS; TRANSLATION; LIN-14; TRANSCRIPTOME; TECHNOLOGY; INITIATION	MicroRNAs play a role in regulating diverse biological processes and have considerable utility as molecular markers for diagnosis and monitoring of human disease. Several technologies are available commercially for measuring microRNA expression. However, cross-platform comparisons do not necessarily correlate well, making it difficult to determine which platform most closely represents the true microRNA expression level in a tissue. To address this issue, we have analyzed RNA derived from cell lines, as well as fresh frozen and formalin-fixed paraffin embedded tissues, using Affymetrix, Agilent, and Illumina microRNA arrays, NanoString counting, and Illumina Next Generation Sequencing. We compared the performance within-and between the different platforms, and then verified these results with those of quantitative PCR data. Our results demonstrate that the within-platform reproducibility for each method is consistently high and although the gene expression profiles from each platform show unique traits, comparison of genes that were commonly detectable showed that detection of microRNA transcripts was similar across multiple platforms.	[Kolbert, Christopher P.; Feddersen, Rod M.; Rakhshan, Fariborz; Jang, Jin Sung; Simon, Vernadette; Schultz, Debra A.; Jen, Jin] Mayo Clin, Med Genome Facil Gene Express Core, Rochester, MN 55905 USA; [Grill, Diane E.; Simon, Gyorgy; Middha, Sumit; Oberg, Ann L.; Li, Peter] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Zschunke, Michael; Lingle, Wilma] Mayo Clin, Rochester, MN USA; [Carr, Jennifer M.; Thompson, E. Aubrey] Mayo Clin, Jacksonville, FL 32224 USA; [Eckloff, Bruce W.; Wieben, Eric D.] Mayo Clin, Med Genome Facil Sequencing Core, Rochester, MN USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kolbert, CP (corresponding author), Mayo Clin, Med Genome Facil Gene Express Core, Rochester, MN 55905 USA.	Kolbert.christopher@mayo.edu; jen.jin@mayo.edu		Middha, Sumit/0000-0003-4135-6268	Mayo Clinic Cancer Center; Center for Individualized Medicine; Research Core Oversight Subcommittee	Mayo Clinic Cancer Center; Center for Individualized Medicine; Research Core Oversight Subcommittee	We thank the Mayo Clinic Cancer Center, Center for Individualized Medicine, and the Research Core Oversight Subcommittee for support of this work. We thank Dr. Don Baldwin for helpful technical discussions.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hasemeier B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-90; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lau NC., 2001, SCIENCE, V294, P858, DOI [DOI 10.1126/SCIENCE.1065062, 10.1126/science.1065062, DOI 10.1126/science.1065062]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	37	76	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52517	10.1371/journal.pone.0052517	http://dx.doi.org/10.1371/journal.pone.0052517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382819	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600007
J	Merkl, C; Saalfrank, A; Riesen, N; Kuhn, R; Pertek, A; Eser, S; Hardt, MS; Kind, A; Saur, D; Wurst, W; Iglesias, A; Schnieke, A				Merkl, Claudia; Saalfrank, Anja; Riesen, Nathalie; Kuehn, Ralf; Pertek, Anna; Eser, Stefan; Hardt, Markus Sebastian; Kind, Alexander; Saur, Dieter; Wurst, Wolfgang; Iglesias, Antonio; Schnieke, Angelika			Efficient Generation of Rat Induced Pluripotent Stem Cells Using a Non-Viral Inducible Vector	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; IN-VITRO DIFFERENTIATION; GENE KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; GENOMIC INTEGRATION; PHI-C31 INTEGRASE; MAMMALIAN-CELLS; PHAGE INTEGRASE; EXPRESSION; TETRACYCLINE	Current methods of generating rat induced pluripotent stem cells are based on viral transduction of pluripotency inducing genes (Oct4, Sox2, c-myc and Klf4) into somatic cells. These activate endogenous pluripotency genes and reprogram the identity of the cell to an undifferentiated state. Epigenetic silencing of exogenous genes has to occur to allow normal iPS cell differentiation. To gain more control over the expression of exogenous reprogramming factors, we used a novel doxycycline-inducible plasmid vector encoding Oct4, Sox2, c-Myc and Klf4. To ensure efficient and controlled generation of iPS cells by plasmid transfection we equipped the reprogramming vector with a bacteriophage phi C31 attB site and used a phi C31 integrase expression vector to enhance vector integration. A series of doxycycline-independent rat iPS cell lines were established. These were characterized by immunocytochemical detection of Oct4, SSEA1 and SSEA4, alkaline phosphatase staining, methylation analysis of the endogenous Oct4 promoter and RT-PCR analysis of endogenous rat pluripotency genes. We also determined the number of vector integrations and the extent to which reprogramming factor gene expression was controlled. Protocols were developed to generate embryoid bodies and rat iPS cells demonstrated as pluripotent by generating derivatives of all three embryonic germ layers in vitro, and teratoma formation in vivo. All data suggest that our rat iPS cells, generated by plasmid based reprogramming, are similar to rat ES cells. Methods of DNA transfection, protein transduction and feeder-free monolayer culture of rat iPS cells were established to enable future applications.	[Merkl, Claudia; Saalfrank, Anja; Riesen, Nathalie; Hardt, Markus Sebastian; Kind, Alexander; Schnieke, Angelika] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany; [Eser, Stefan; Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar 2, D-80290 Munich, Germany; [Kuehn, Ralf; Pertek, Anna; Wurst, Wolfgang] Helmholtz Ctr Munich, Inst Dev Genet, Munich, Germany; [Kuehn, Ralf; Wurst, Wolfgang] Tech Univ Munich, D-80290 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV, Munich, Germany; [Iglesias, Antonio] L Hoffmann La Roche Ltd, Small Mol Res Discovery Technol, Pharma Res & Early Dev, Basel, Switzerland	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Roche Holding	Schnieke, A (corresponding author), Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany.	schnieke@wzw.tum.de	Kühn, Ralf/U-1278-2017; Saur, Dieter/O-8355-2015	Kühn, Ralf/0000-0003-1694-9803; Saur, Dieter/0000-0001-5874-0210; Wurst, Wolfgang/0000-0003-4422-7410; Schnieke, Angelika/0000-0002-5761-9635	German Ministry of Education and Research [FKZ 01 GN 0806]; F. Hoffmann-La Roche Ltd.	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This work was supported by the German Ministry of Education and Research (FKZ 01 GN 0806) and F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. set the overall goal of the project, but had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript. The manuscript was approved in its final form by F. Hoffmann-La Roche Ltd.; AI is an employee of Small Molecules Research - Discovery Technologies, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd. - a pharmaceutical company involved in biomedical research and manufacture of medical products. This work was supported, in part, by F. Hoffmann-La Roche Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; Chalberg TW, 2005, INVEST OPHTH VIS SCI, V46, P2140, DOI 10.1167/iovs.04-1252; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; Crowe J, 1995, MOL BIOTECHNOL, V4, P247, DOI 10.1007/BF02779018; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008; Hirabayashi M, 2010, MOL REPROD DEV, V77, P474, DOI 10.1002/mrd.21181; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yamamoto S, 2011, TRANSGENIC RES; Ye L, 2010, P NATL ACAD SCI USA, V107, P19467, DOI 10.1073/pnas.1012677107	45	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55170	10.1371/journal.pone.0055170	http://dx.doi.org/10.1371/journal.pone.0055170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383095	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600071
J	Wasser, L; Day, R; Chasmer, L; Taylor, A				Wasser, Leah; Day, Rick; Chasmer, Laura; Taylor, Alan			Influence of Vegetation Structure on Lidar-derived Canopy Height and Fractional Cover in Forested Riparian Buffers During Leaf-Off and Leaf-On Conditions	PLOS ONE			English	Article							AIRBORNE SCANNING LASER; SMALL-FOOTPRINT; WATER-QUALITY; FLYING ALTITUDES; STAND; DENSITY; MANAGEMENT; INTENSITY; PARAMETERS; ELEVATION	Estimates of canopy height (H) and fractional canopy cover (FC) derived from lidar data collected during leaf-on and leaf-off conditions are compared with field measurements from 80 forested riparian buffer plots. The purpose is to determine if existing lidar data flown in leaf-off conditions for applications such as terrain mapping can effectively estimate forested riparian buffer H and FC within a range of riparian vegetation types. Results illustrate that: 1) leaf-off and leaf-on lidar percentile estimates are similar to measured heights in all plots except those dominated by deciduous compound-leaved trees where lidar underestimates H during leaf off periods; 2) canopy height models (CHMs) underestimate H by a larger margin compared to percentile methods and are influenced by vegetation type (conifer needle, deciduous simple leaf or deciduous compound leaf) and canopy height variability, 3) lidar estimates of FC are within 10% of plot measurements during leaf-on periods, but are underestimated during leaf-off periods except in mixed and conifer plots; and 4) depth of laser pulse penetration lower in the canopy is more variable compared to top of the canopy penetration which may influence within canopy vegetation structure estimates. This study demonstrates that leaf-off lidar data can be used to estimate forested riparian buffer canopy height within diverse vegetation conditions and fractional canopy cover within mixed and conifer forests when leaf-on lidar data are not available.	[Wasser, Leah; Taylor, Alan] Penn State Univ, University Pk, PA 16802 USA; [Wasser, Leah] Natl Ecol Observ Network, Boulder, CO USA; [Day, Rick] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Chasmer, Laura] Wilfrid Laurier Univ, Cold Reg Res Ctr, Waterloo, ON N2L 3C5, Canada; [Taylor, Alan] Penn State Univ, Dept Geog, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wilfrid Laurier University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wasser, L (corresponding author), Penn State Univ, University Pk, PA 16802 USA.	leahwasser@gmail.com		Wasser, Leah/0000-0002-8177-6550	National Consortium for Rural Geospatial Innovations in America; Penn State Geospatial Technology Program housed in the Department of Crop and Soil Sciences at Penn State; Penn State Forest Vegetation Dynamics Laboratory	National Consortium for Rural Geospatial Innovations in America; Penn State Geospatial Technology Program housed in the Department of Crop and Soil Sciences at Penn State; Penn State Forest Vegetation Dynamics Laboratory	LAW has been supported in part by a grant from the National Consortium for Rural Geospatial Innovations in America (www.ruralgis.org) and the Penn State Geospatial Technology Program housed in the Department of Crop and Soil Sciences at Penn State and by the Penn State Forest Vegetation Dynamics Laboratory (http://www.geog.psu.edu/research/physical-geography/vegetation-dynamics-lab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2005, INT J REMOTE SENS, V26, P3889, DOI 10.1080/01431160500181671; Arroyo LA, 2010, FOREST ECOL MANAG, V259, P598, DOI 10.1016/j.foreco.2009.11.018; Bain M. B., 2000, ENVIRON SCI POLICY, V3, P89, DOI DOI 10.1016/S1462-9011(00)00029-0; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Brandtberg T, 2003, REMOTE SENS ENVIRON, V85, P290, DOI 10.1016/S0034-4257(03)00008-7; Brandtberg T, 2007, ISPRS J PHOTOGRAMM, V61, P325, DOI 10.1016/j.isprsjprs.2006.10.006; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; Brooks R, 2009, ENVIRON MONIT ASSESS, V150, P101, DOI 10.1007/s10661-008-0673-z; Chasmer L, 2008, REMOTE SENS ENVIRON, V112, P4344, DOI 10.1016/j.rse.2008.08.003; Chen JM, 2006, AGR FOREST METEOROL, V140, P257, DOI 10.1016/j.agrformet.2006.08.005; Claggett PR, 2010, J AM WATER RESOUR AS, V46, P334, DOI 10.1111/j.1752-1688.2010.00424.x; Crew R, 2007, RIPARIAN FOREST WETL; DeWalle DR, 2010, J AM WATER RESOUR AS, V46, P323, DOI 10.1111/j.1752-1688.2010.00423.x; Farve R, 2010, EVALUATION LASER REN; Gaveau DLA, 2003, CAN J REMOTE SENS, V29, P650, DOI 10.5589/m03-023; Goetz SJ, 2006, J AM WATER RESOUR AS, V42, P133, DOI 10.1111/j.1752-1688.2006.tb03829.x; Goodwin NR, 2006, REMOTE SENS ENVIRON, V103, P140, DOI 10.1016/j.rse.2006.03.003; Hall RK, 2009, ENVIRON MONIT ASSESS, V159, P63, DOI 10.1007/s10661-008-0613-y; Hawbaker TJ, 2010, FOREST SCI, V56, P313; Hill RA, 2009, ISPRS J PHOTOGRAMM, V64, P223, DOI 10.1016/j.isprsjprs.2008.12.004; Hopkinson C, 2009, REMOTE SENS ENVIRON, V113, P275, DOI 10.1016/j.rse.2008.09.012; Hopkinson C, 2007, CAN J REMOTE SENS, V33, P312, DOI 10.5589/m07-029; Hopkinson C, 2006, CAN J REMOTE SENS, V32, P139, DOI 10.5589/m06-006; Hopkinson C, 2005, CAN J REMOTE SENS, V31, P191, DOI 10.5589/m05-007; Hyer EJ, 2004, AGR FOREST METEOROL, V122, P157, DOI 10.1016/j.agrformet.2003.09.013; Ishii HT, 2004, FOREST SCI, V50, P342; Johansen K, 2010, REMOTE SENS ENVIRON, V114, P2679, DOI 10.1016/j.rse.2010.06.004; Kim S, 2009, REMOTE SENS ENVIRON, V113, P1575, DOI 10.1016/j.rse.2009.03.017; Korpela I, 2011, MAPPING UNDERSTORY T, P6; Korpela I, 2010, SILVA FENN, V44, P319, DOI 10.14214/sf.156; Lattin PD, 2004, J AM WATER RESOUR AS, V40, P215, DOI 10.1111/j.1752-1688.2004.tb01020.x; Leblanc SG, 2005, AGR FOREST METEOROL, V129, P187, DOI 10.1016/j.agrformet.2004.09.006; Lowrance R, 1997, ENVIRON MANAGE, V21, P687, DOI 10.1007/s002679900060; Magnussen S, 2010, REMOTE SENS ENVIRON, V114, P700, DOI 10.1016/j.rse.2009.11.007; Malhado ACM, 2010, GLOBAL ECOL BIOGEOGR, V19, P852, DOI 10.1111/j.1466-8238.2010.00567.x; Mayer P.M., 2005, RIPARIAN BUFFER WIDT; Morsdorf F, 2008, INT J REMOTE SENS, V29, P1387, DOI 10.1080/01431160701736349; Morsdorf F, 2005, P ISPRS WG 3 3 3 4 3; Morsdorf F, 2006, REMOTE SENS ENVIRON, V104, P50, DOI 10.1016/j.rse.2006.04.019; Naesset E, 2005, REMOTE SENS ENVIRON, V98, P356, DOI 10.1016/j.rse.2005.07.012; Naesset E, 1997, REMOTE SENS ENVIRON, V61, P246, DOI 10.1016/S0034-4257(97)00041-2; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Naesset E, 2004, REMOTE SENS ENVIRON, V91, P243, DOI 10.1016/j.rse.2004.03.009; Naesset E, 2002, REMOTE SENS ENVIRON, V79, P105, DOI 10.1016/S0034-4257(01)00243-7; Naesset E, 2011, SAMPLING MAPPING FOR, P297; Naesset E, 2009, REMOTE SENS ENVIRON, V113, P148, DOI 10.1016/j.rse.2008.09.001; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Niinemets U, 1998, PLANT ECOL, V134, P1, DOI 10.1023/A:1009773704558; Nilsson M, 1996, REMOTE SENS ENVIRON, V56, P1, DOI 10.1016/0034-4257(95)00224-3; Orka HO, 2010, REMOTE SENS ENVIRON, V114, P1445, DOI 10.1016/j.rse.2010.01.024; Orka HO, 2009, REMOTE SENS ENVIRON, V113, P1163, DOI 10.1016/j.rse.2009.02.002; Perry CD, 1999, J WATER RES PL-ASCE, V125, P117, DOI 10.1061/(ASCE)0733-9496(1999)125:3(117); PETERSEN RC, 1992, FRESHWATER BIOL, V27, P295, DOI 10.1111/j.1365-2427.1992.tb00541.x; Schuft MJ, 1999, PHOTOGRAMM ENG REM S, V65, P1157; Seavy NE, 2009, ECOL APPL, V19, P1848, DOI 10.1890/08-1124.1; Smith AMS, 2009, CAN J REMOTE SENS, V35, P447, DOI 10.5589/m09-038; Smith TA, 2008, SOUTHEAST NAT, V7, P277, DOI 10.1656/1528-7092(2008)7[277:EOVMOB]2.0.CO;2; Snyder CD, 2003, LANDSCAPE ECOL, V18, P647, DOI 10.1023/B:LAND.0000004178.41511.da; Snyder MN, 2005, J AM WATER RESOUR AS, V41, P659, DOI 10.1111/j.1752-1688.2005.tb03762.x; Song J.H., 2002, INT ARCH PHOTOGRAMM, V34, P259; Speiran GK, 2010, J AM WATER RESOUR AS, V46, P246, DOI 10.1111/j.1752-1688.2010.00427.x; Sumida A, 1997, ANN BOT-LONDON, V80, P759, DOI 10.1006/anbo.1997.0519; Sutton AJ, 2010, WATER AIR SOIL POLL, V208, P101, DOI 10.1007/s11270-009-0152-3; USTIN SL, 1991, IEEE T GEOSCI REMOTE, V29, P843, DOI 10.1109/TGRS.1991.1019468; Valladares F., 2007, FUNCTIONAL PLANT ECO, P101, DOI DOI 10.1201/9781420007626.CH4; Vidon P, 2010, HYDROL PROCESS, V24, P1532, DOI 10.1002/hyp.7740; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Warman L, 2011, OIKOS, V120, P813, DOI 10.1111/j.1600-0706.2010.19344.x	69	81	81	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54776	10.1371/journal.pone.0054776	http://dx.doi.org/10.1371/journal.pone.0054776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382966	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600041
J	Gerhold, KA; Pellegrino, M; Tsunozaki, M; Morita, T; Leitch, DB; Tsuruda, PR; Brem, RB; Catania, KC; Bautista, DM				Gerhold, Kristin A.; Pellegrino, Maurizio; Tsunozaki, Makoto; Morita, Takeshi; Leitch, Duncan B.; Tsuruda, Pamela R.; Brem, Rachel B.; Catania, Kenneth C.; Bautista, Diana M.			The Star-Nosed Mole Reveals Clues to the Molecular Basis of Mammalian Touch	PLOS ONE			English	Article							CHANNEL; CELL; EXPRESSION; NEURONS; INNERVATION; NOCICEPTION; PREDICTION; CIRCUITS; ORGAN; COLD	Little is known about the molecular mechanisms underlying mammalian touch transduction. To identify novel candidate transducers, we examined the molecular and cellular basis of touch in one of the most sensitive tactile organs in the animal kingdom, the star of the star-nosed mole. Our findings demonstrate that the trigeminal ganglia innervating the star are enriched in tactile-sensitive neurons, resulting in a higher proportion of light touch fibers and lower proportion of nociceptors compared to the dorsal root ganglia innervating the rest of the body. We exploit this difference using transcriptome analysis of the star-nosed mole sensory ganglia to identify novel candidate mammalian touch and pain transducers. The most enriched candidates are also expressed in mouse somatosesensory ganglia, suggesting they may mediate transduction in diverse species and are not unique to moles. These findings highlight the utility of examining diverse and specialized species to address fundamental questions in mammalian biology.	[Gerhold, Kristin A.; Pellegrino, Maurizio; Tsunozaki, Makoto; Morita, Takeshi; Tsuruda, Pamela R.; Brem, Rachel B.; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gerhold, Kristin A.; Morita, Takeshi; Bautista, Diana M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Leitch, Duncan B.; Catania, Kenneth C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Vanderbilt University	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X; Morita, Takeshi/0000-0002-8570-6744	U.S. National Institutes of Health [DOD007123A]; Pew Scholars Program; McKnight Scholars Fund; NSF [0844743]; Division Of Integrative Organismal Systems [0844743] Funding Source: National Science Foundation	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; McKnight Scholars Fund; NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors are supported by a U.S. National Institutes of Health Innovator Award DOD007123A, the Pew Scholars Program, and the McKnight Scholars Fund (to DMB) and NSF grant 0844743 (to KCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Catania KC, 2005, NATURE, V433, P519, DOI 10.1038/nature03250; Catania KC, 1996, J COMP NEUROL, V365, P343; CATANIA KC, 1995, J COMP NEUROL, V351, P536, DOI 10.1002/cne.903510405; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Guo T, 2011, NAT NEUROSCI, V14, P31, DOI 10.1038/nn.2710; Heine S, 2011, J NEUROSCI, V31, P11184, DOI 10.1523/JNEUROSCI.6159-10.2011; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krogh A, 1929, SCIENCE, V70, P200, DOI 10.1126/science.70.1809.200; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinez-Salgado C, 2007, J NEUROPHYSIOL, V98, P3802, DOI 10.1152/jn.00860.2007; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	39	32	33	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55001	10.1371/journal.pone.0055001	http://dx.doi.org/10.1371/journal.pone.0055001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383028	gold, Green Published			2022-12-25	WOS:000315563800098
J	Hirata, H; Ueno, K; Shahryari, V; Deng, GR; Tanaka, Y; Tabatabai, ZL; Hinoda, Y; Dahiya, R				Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Deng, Guoren; Tanaka, Yuichiro; Tabatabai, Z. Laura; Hinoda, Yuji; Dahiya, Rajvir			MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer	PLOS ONE			English	Article							SUPPRESSOR GENE; METASTASIS; MIR-182; PROGRESSION; EXPRESSION; RECK; OVEREXPRESSION; AGGRESSIVENESS; PATHWAY; CLUSTER	Recently miR-182 has been reported to be over-expressed in prostate cancer (PC) tissues, however detailed functional analysis of miR-182-5p has not been carried out. The purpose of this study was to: 1. analyze the function of miR-182-5p in prostate cancer, 2. assess its usefulness as a tumor marker, 3. identify miR-182-5p target genes in PC, 4. investigate the potential for miR-182-5p inhibitor to be used in PC treatment. Initially we found that miR-182-5p expression was significantly higher in prostate cancer tissues and cell lines compared to normal prostate tissues and cells. Moreover high miR-182-5p expression was associated with shorter overall survival in PC patients. To study the functional significance of miR-182-5p, we knocked down miR-182-5p with miR-182-5p inhibitor. After miR-182-5p knock-down, prostate cancer cell proliferation, migration and invasion were decreased. We identified FOXF2, RECK and MTSS1 as potential target genes of miR-182-5p using several algorithms which was confirmed by 3'UTR luciferase assay and Western analysis. Knock-down of miR-182-5p also significantly decreased in vivo prostate tumor growth. In conclusion this is the first report documenting that over-expression of miR-182-5p is associated with prostate cancer progression and potentially useful as a prognostic biomarker. Also knock down of miR-182-5p in order to increase expression of tumor suppressor genes FOXF2, RECK and MTSS1 may be of therapeutic benefit in prostate cancer treatment.	[Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Deng, Guoren; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; [Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Deng, Guoren; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Tabatabai, Z. Laura] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Hinoda, Yuji] Yamaguchi Univ, Dept Oncol & Lab Med, Grad Sch Med, Yamaguchi, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Yamaguchi University	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [RO1CA138642, RO1CA130860, RO1CA160079]; VA Merit Review grants; VA Program Project; Yamada Science Foundation; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079, R01CA130860] Funding Source: NIH RePORTER; Veterans Affairs [IP1BX001604] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review grants(US Department of Veterans Affairs); VA Program Project; Yamada Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by National Center for Research Resources of the National Institutes of Health through Grant Number RO1CA138642, RO1CA130860, RO1CA160079, VA Merit Review grants, VA Program Project and Yamada Science Foundation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; Cheng L, 2001, CANCER-AM CANCER SOC, V91, P66, DOI 10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Clark JCM, 2011, CANCER-AM CANCER SOC, V117, P3517, DOI 10.1002/cncr.25757; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Li N, 2012, FEBS LETT, V586, P722, DOI 10.1016/j.febslet.2012.01.025; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Mustafa N, 2011, EXP THER MED, V2, P157, DOI 10.3892/etm.2010.184; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rabien A, 2012, PROSTATE, V72, P948, DOI 10.1002/pros.21498; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-14; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Roemeling S, 2006, J UROLOGY, V175, P1332, DOI 10.1016/S0022-5347(05)00698-1; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shukla S, 2005, NUTR CANCER, V53, P18, DOI 10.1207/s15327914nc5301_3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yoshida Y, 2012, ONCOGENE, V31, P4128, DOI 10.1038/onc.2011.570; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679	36	126	133	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55502	10.1371/journal.pone.0055502	http://dx.doi.org/10.1371/journal.pone.0055502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383207	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800161
J	Wang, YC; Srivathsan, A; Feng, CC; Salim, A; Shekelle, M				Wang, Yi-Chen; Srivathsan, Amrita; Feng, Chen-Chieh; Salim, Agus; Shekelle, Myron			Asian Primate Species Richness Correlates with Rainfall	PLOS ONE			English	Article							SUNDA SHELF; DIVERSITY; PATTERNS; PRODUCTIVITY; ISLANDS; BIOGEOGRAPHY; PHYLOGENY; ECOLOGY; LINE	Previous studies of meta-analyses found significantly positive correlations between primate species richness and rainfall for Africa, Madagascar and the Neotropics, with the exception of Asia, leaving the open question whether that anomaly is the result of sampling bias, biogeography, or some other factor. This study re-examines the question using modelled data, with primate species richness data from the Southeast Asian Mammals Databank and rainfall data from the Climatic Research Unit. Data processing with Geographical Information Systems resulted in 390 sample points. Reduced major axis and ordinary least squares regressions were employed to examine the relationship for six regions, including the whole study area of Southeast Asia, and the subareas of Huxley West, Huxley East, Mainland Southeast Asia, Borneo, and Sumatra. The results showed a significant positive relationship between primate species richness and mean annual rainfall for Southeast Asia (r = 0.26, P<0.001). Comparing the results for the large islands and Mainland Southeast Asia showed that Sumatra had the highest correlation (r = 0.58; P<0.05). After controlling for the major biogeographic effect associated with Huxley's Line, our results showed that primate species richness is positively associated with mean annual rainfall in Southeast Asia. Our findings contrast to prior studies of meta-analyses that showed no relationship between rainfall and primate species richness in Asia, and thereby bring Asia into agreement with results showing significant positive correlations between rainfall and primate species richness everywhere else in the world. The inference is that previous anomalous results for Asia were result of sampling bias in the meta-analysis.	[Wang, Yi-Chen; Feng, Chen-Chieh] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [Srivathsan, Amrita] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Salim, Agus] Hatfield Consultants, N Vancouver, BC, Canada; [Shekelle, Myron] Portland State Univ, Dept Biol, Museum Vertebrate Biol, Portland, OR 97207 USA	National University of Singapore; National University of Singapore; Portland State University	Shekelle, M (corresponding author), Portland State Univ, Dept Biol, Museum Vertebrate Biol, Portland, OR 97207 USA.	shekelle@tarsier.org	Wang, Yi-Chen/F-6885-2012; Feng, Chen-Chieh/F-9993-2012; Srivathsan, Amrita/F-6256-2013; Salim, Agus/P-1407-2014; Zimmermann, Elke/D-2281-2015	Wang, Yi-Chen/0000-0002-3034-7377; Feng, Chen-Chieh/0000-0003-0410-714X; Salim, Agus/0000-0003-3999-7701; 	Faculty of Science, National University of Singapore	Faculty of Science, National University of Singapore(National University of Singapore)	The Faculty of Science, National University of Singapore provided funding support for Shekelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Blackburn TM, 1996, ECOGRAPHY, V19, P369, DOI 10.1111/j.1600-0587.1996.tb00247.x; Boitani L, 2006, SE ASIAN MAMMAL DATA; Catullo G, 2008, BIOL CONSERV, V141, P2730, DOI 10.1016/j.biocon.2008.08.019; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chuan G.K., 2005, PHYS GEOGRAPHY SE AS, P80; Cowlishaw G., 2000, PRIMATE CONSERVATION; ESRI, 2010, ARCGIS 10; Esselstyn JA, 2010, J BIOGEOGR, V37, P2054, DOI 10.1111/j.1365-2699.2010.02378.x; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Ganzhorn JU, 1997, BIOTROPICA, V29, P331, DOI 10.1111/j.1744-7429.1997.tb00434.x; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Harcourt AH, 1999, GLOBAL ECOL BIOGEOGR, V8, P55, DOI 10.1046/j.1365-2699.1999.00125.x; Harrison T, 2006, DEV PRIMATOL, P331; Hassel-Finnegan HM, 2009, THESIS STONY BROOK U; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; HEANEY LR, 1984, OECOLOGIA, V61, P11, DOI 10.1007/BF00379083; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huxley TH, 1868, P ZOOL SOC LOND, P296; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; Kozak KH, 2012, ECOLOGY, V93, pS167, DOI 10.1890/11-0542.1; Lawes MJ, 2000, J BIOGEOGR, V27, P1421, DOI 10.1046/j.1365-2699.2000.00510.x; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; MAC ARTHUR ROBERT H., 1967; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Mittermeier R.A., 1988, P145; Moody A, 2000, J BIOGEOGR, V27, P711, DOI 10.1046/j.1365-2699.2000.00435.x; Osborne P. L., 2000, TROPICAL ECOSYSTEMS; Pan XB, 2012, SCIENCE, V335, DOI [10.1126/science.1214786, 10.1126/science.1215042]; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Raven HC., 1935, B AM MUS NAT HIST, V68, P177; Reed KE, 2004, YEARB PHYS ANTHROPOL, V47, P2, DOI 10.1002/ajpa.20153; REED KE, 1995, P NATL ACAD SCI USA, V92, P7874, DOI 10.1073/pnas.92.17.7874; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIMPSON GG, 1977, P AM PHILOS SOC, V121, P107; Smith BT, 2012, ECOL LETT, V15, P1318, DOI 10.1111/j.1461-0248.2012.01855.x; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Stevens RD, 2006, P ROY SOC B-BIOL SCI, V273, P2283, DOI 10.1098/rspb.2006.3596; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Wilson D. E., 2005, MAMMAL SPECIES WORLD	45	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54995	10.1371/journal.pone.0054995	http://dx.doi.org/10.1371/journal.pone.0054995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383023	gold, Green Published			2022-12-25	WOS:000315563800093
J	Warner, SE; Pickering, P; Panagiotopoulou, O; Pfau, T; Ren, L; Hutchinson, JR				Warner, Sharon Elaine; Pickering, Phillip; Panagiotopoulou, Olga; Pfau, Thilo; Ren, Lei; Hutchinson, John Richard			Size-Related Changes in Foot Impact Mechanics in Hoofed Mammals	PLOS ONE			English	Article							DYNAMIC SIMILARITY; IMPULSIVE FORCES; LIMB BONES; PREVALENCE; ALLOMETRY; LAMENESS; BIOMECHANICS; ATTENUATION; PATTERNS; WALKING	Foot-ground impact is mechanically challenging for all animals, but how do large animals mitigate increased mass during foot impact? We hypothesized that impact force amplitude scales according to isometry in animals of increasing size through allometric scaling of related impact parameters. To test this, we measured limb kinetics and kinematics in 11 species of hoofed mammals ranging from 18-3157 kg body mass. We found impact force amplitude to be maintained proportional to size in hoofed mammals, but that other features of foot impact exhibit differential scaling patterns depending on the limb; forelimb parameters typically exhibit higher intercepts with lower scaling exponents than hind limb parameters. Our explorations of the size-related consequences of foot impact advance understanding of how body size influences limb morphology and function, foot design and locomotor behaviour.	[Warner, Sharon Elaine; Pickering, Phillip; Panagiotopoulou, Olga; Hutchinson, John Richard] Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Pfau, Thilo] Royal Vet Coll, Hatfield, Herts, England; [Ren, Lei] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Greater Manches, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Manchester	Warner, SE (corresponding author), Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England.	swarner@rvc.ac.uk	Panagiotopoulou, Olga/ABA-6654-2021; Hutchinson, John/AAH-1593-2020; Panagiotopoulou, Olga/M-5476-2013	Panagiotopoulou, Olga/0000-0002-6457-448X; Panagiotopoulou, Olga/0000-0002-6457-448X; Hutchinson, John/0000-0002-6767-7038	Biotechnology and Biological Sciences Research Council [BB/F01169/1, BB/H002782/1]; Biotechnology and Biological Sciences Research Council [BB/F000863/1] Funding Source: researchfish; BBSRC [BB/H002782/1, BB/F000863/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), grants BB/F01169/1 and BB/H002782/1 to JRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1979, J ZOOL, V189, P305; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; BIEWENER AA, 1983, J EXP BIOL, V105, P147; Blum Y, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026006; Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Buchner HHF, 1997, J BIOMECH, V30, P653, DOI 10.1016/S0021-9290(97)00005-5; Bullimore SR, 2008, J THEOR BIOL, V250, P339, DOI 10.1016/j.jtbi.2007.09.038; Bullimore SR, 2004, P ROY SOC B-BIOL SCI, V271, P285, DOI 10.1098/rspb.2003.2611; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; COLLINS JJ, 1989, CLIN BIOMECH, V4, P179, DOI 10.1016/0268-0033(89)90023-5; Currey J.D., 2002, BONES STRUCTURE MECH; Denoth J., 1986, BIOMECHANICS RUNNING; FARLEY CT, 1993, J EXP BIOL, V185, P71; Gustas P, 2004, EQUINE VET J, V36, P737, DOI 10.2746/0425164044848136; Gustas P, 2001, Equine Vet J Suppl, P11; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Herr HM, 2002, J EXP BIOL, V205, P959; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Johnston C., 1991, EQUINE EXERCISE PHYS, V3, P167; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Manske T, 2002, PREV VET MED, V54, P247, DOI 10.1016/S0167-5877(02)00018-1; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; Michilsens F, 2009, J ZOOL, V279, P236, DOI 10.1111/j.1469-7998.2009.00611.x; More HL, 2010, P ROY SOC B-BIOL SCI, V277, P3563, DOI 10.1098/rspb.2010.0898; Mouttotou N, 1997, VET REC, V141, P115, DOI 10.1136/vr.141.5.115; Murray RD, 1996, VET REC, V138, P586, DOI 10.1136/vr.138.24.586; Parsons KJ, 2011, EQUINE VET J, V43, P216, DOI 10.1111/j.2042-3306.2010.00149.x; PRATT DJ, 1989, CLIN BIOMECH, V4, P51, DOI 10.1016/0268-0033(89)90068-5; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Ren L, 2010, P NATL ACAD SCI USA, V107, P7078, DOI 10.1073/pnas.0911396107; SIMON SR, 1972, J BIOMECH, V5, P267, DOI 10.1016/0021-9290(72)90042-5; Wakeling JM, 2001, J APPL PHYSIOL, V91, P1307, DOI 10.1152/jappl.2001.91.3.1307; Wassink GJ, 2003, VET REC, V152, P351, DOI 10.1136/vr.152.12.351; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7	40	13	13	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54784	10.1371/journal.pone.0054784	http://dx.doi.org/10.1371/journal.pone.0054784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382967	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800077
J	Wyszko, E; Szymanski, M; Zeichhardt, H; Muller, F; Barciszewski, J; Erdmann, VA				Wyszko, Eliza; Szymanski, Maciej; Zeichhardt, Heinz; Mueller, Florian; Barciszewski, Jan; Erdmann, Volker A.			Spiegelzymes: Sequence Specific Hydrolysis of L-RNA with Mirror Image Hammerhead Ribozymes and DNAzymes	PLOS ONE			English	Article							IN-VITRO; ANTICOAGULANT; THERAPEUTICS; SELECTION; APTAMERS; LIGANDS; BIND; 1ST	In this manuscript we describe for the first time mirror image catalytic nucleic acids (Spiegelzymes), which hydrolyze sequence specifically L-ribonucleic acid molecules. The mirror image nucleic acid ribozymes designed are based upon the known hammerhead ribozyme and DNAzyme structures that contain L-ribose or L-deoxyribose instead of the naturally occurring D-ribose or D-deoxyribose, respectively. Both Spiegelzymes show similar hydrolytic activities with the same L-RNA target molecules and they also exhibit extra ordinary stabilities when tested with three different human sera. In this respect they are very similar to Spiegelmers (mirror image aptamers), which we had previously developed and for which it has been shown that they are non-toxic and non-immunogenic. Since we are also able to demonstrate that the hammerhead and DNAzyme Spiegelzymes can also hydrolyze mirror image oligonucleotide sequences, like they occur in Spiegelmers, in vivo, it seems reasonable to assume that Spiegelzymes may in principle be used as an antidote against Spiegelmers. Since the Spiegelzymes contain the same building blocks as the Spiegelmers, it can be expected that they will have similar favorable biological characteristics concerning toxicity and immunogenety. In trying to understand the mechanism of action of the Spiegelzymes described in this study, we have initiated for the first time a model building system with L-nucleic acids. The models for L-hammerhead ribozyme and L-DNAzyme interaction with the same L-RNA target will be presented.	[Wyszko, Eliza; Szymanski, Maciej; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Zeichhardt, Heinz] Charite, Inst Virol, D-13353 Berlin, Germany; [Mueller, Florian] Pentafolium Soft, Rosengarten, Germany; [Erdmann, Volker A.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Erdmann, VA (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.	vae@zedat.fu-berlin.de	Barciszewski, Jan/N-9283-2019	Barciszewski, Jan/0000-0001-7766-5594; Wyszko, Eliza/0000-0001-9524-0960; Szymanski, Maciej/0000-0001-7694-6706	Foreign Office of the Free University of Berlin; Berlin RNA Network; Federal Ministry of Science (BMBF); Deutsche Forschungsgemeinschaft [SFB Transregio 19]; Polish Ministry of Sciences of Higher Education	Foreign Office of the Free University of Berlin; Berlin RNA Network; Federal Ministry of Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Polish Ministry of Sciences of Higher Education	This study was supported by the Foreign Office of the Free University of Berlin. The authors are also grateful for additional financial support from the Berlin RNA Network, the Federal Ministry of Science (BMBF), the Deutsche Forschungsgemeinschaft for funding of the SFB Transregio 19 (project C1) and the Polish Ministry of Sciences of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker R C, 2007, Hamostaseologie, V27, P378; Bolik S, 2007, RNA, V13, P1877, DOI 10.1261/rna.564507; Burgess DJ, 2012, NAT REV CANCER, V12, P508, DOI 10.1038/nrc3328; Cai H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003960; Carothers J.M., 2006, APTAMER HDB FUNCTION, V1st, P1; Dass CR, 2008, MOL CANCER THER, V7, P243, DOI 10.1158/1535-7163.MCT-07-0510; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Eulberg D, 2006, APTAMER HDB FUNCTION; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Gaglione M, 2010, MINI-REV MED CHEM, V10, P578, DOI 10.2174/138955710791384036; Hammann C, 2002, CHEMBIOCHEM, V3, P691; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Mangasarian A, 2011, 5 ANN INT PARTN C MI; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Ninichuk V, 2008, AM J PATHOL, V172, P628, DOI 10.2353/ajpath.2008.070601; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; RUFFNER DE, 1989, GENE, V82, P31, DOI 10.1016/0378-1119(89)90027-9; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Rypniewski W, 2006, ACTA CRYSTALLOGR D, V62, P659, DOI 10.1107/S090744490601359X; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scott WG, 2010, RNA TECHNOL, P305, DOI 10.1007/978-3-642-12168-5_14; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vallazza M, 2004, ACTA CRYSTALLOGR D, V60, P1, DOI 10.1107/S0907444903027690; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wang J, 2009, CHEMBIOCHEM, V10, P2171, DOI 10.1002/cbic.200900408; Wedekind JE, 1998, ANNU REV BIOPH BIOM, V27, P475, DOI 10.1146/annurev.biophys.27.1.475; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; Zaborowska Z, 2005, FEBS LETT, V579, P554, DOI 10.1016/j.febslet.2004.12.008	34	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54741	10.1371/journal.pone.0054741	http://dx.doi.org/10.1371/journal.pone.0054741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382952	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800072
J	Ansarullah; Lu, Y; Holstein, M; DeRuyter, B; Rabinovitch, A; Guo, ZG				Ansarullah; Lu, Yan; Holstein, Martha; DeRuyter, Brittany; Rabinovitch, Alex; Guo, Zhiguang			Stimulating beta-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; NONOBESE DIABETIC MICE; GLYCEMIC CONTROL; GLUCOSE-TOLERANCE; SITAGLIPTIN; REPLICATION; INCRETIN; BIOLOGY	Background: Activating G-protein coupled receptor 119 (GPR119) by its agonists can stimulate glucagon like peptide-1 (GLP-1) release. GLP-1 is rapidly degraded and inactivated by dipeptidylpeptidase-IV (DPP-IV). We studied the efficiency of combining PSN632408, a GPR119 agonist, with sitagliptin, a DPP-IV inhibitor, on beta-cell regeneration in diabetic mice. Materials & Methods: Diabetes in C57BL/6 mice was induced by streptozotocin. PSN632408 and sitagliptin alone or in combination were administered to diabetic mice for 7 weeks along with BrdU daily. Nonfasting blood glucose levels were monitored. After treatment, oral glucose tolerance test (OGTT), plasma active GLP-1 levels, beta-cell mass along with alpha- and beta-cell replication, and beta-cell neogenesis were evaluated. Results: Normoglycemia was not achieved in vehicle-treated mice. By contrast, 32% (6 of 19) of PSN632408-treated diabetic mice, 36% (5 of 14) sitagliptin-treated diabetic mice, and 59% (13 of 22) diabetic mice treated with PSN632408 and sitagliptin combination achieved normoglycemia after 7 weeks treatment. Combination therapy significantly increased plasma active GLP-1 levels, improved glucose clearance, stimulated both alpha- and beta-cell replication, and augmented beta-cell mass. Furthermore, treatment with combination therapy induced beta-cell neogenesis from pancreatic duct-derived cells. Conclusion: Our results demonstrate that combining a GPR119 agonist with a DPP-IV inhibitor may offer a novel therapeutic strategy for stimulating beta-cell regeneration and reversing diabetes.	[Ansarullah; Lu, Yan; Holstein, Martha; DeRuyter, Brittany; Rabinovitch, Alex; Guo, Zhiguang] Sanford Res USD, Children Hlth Res Ctr, Sanford Project, Sioux Falls, SD 57105 USA; [Rabinovitch, Alex; Guo, Zhiguang] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA; [Guo, Zhiguang] Univ S Dakota, Sanford Sch Med, Dept Surg, Sioux Falls, SD USA	Sanford Health; University of South Dakota; University of South Dakota	Guo, ZG (corresponding author), Sanford Res USD, Children Hlth Res Ctr, Sanford Project, Sioux Falls, SD 57105 USA.	zhiguang.guo@sanfordhealth.org	Ansarullah, ./CAH-0894-2022	, Ansarullah/0000-0002-3415-7319				Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Brubaker PL, 2010, ENDOCRINOLOGY, V151, P1984, DOI 10.1210/en.2010-0115; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Drucker D, 2007, NAT REV DRUG DISCOV, V6, P109, DOI 10.1038/nrd2245; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Furuta Y, 2010, DIABETES OBES METAB, V12, P421, DOI 10.1111/j.1463-1326.2009.01180.x; Gao J, 2011, TRANSPL INT; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Herman GA, 2006, J CLIN PHARMACOL, V46, P876, DOI 10.1177/0091270006289850; Idris I, 2007, DIABETES OBES METAB, V9, P153, DOI 10.1111/j.1463-1326.2007.00705.x; In't Veld P, 2010, DIABETES, V59, P1702, DOI 10.2337/db09-1698; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Karasik A, 2008, CURR MED RES OPIN, V24, P489, DOI 10.1185/030079908X261069 ; Lee SH, 2011, ISLETS, V3, P358, DOI 10.4161/isl.3.6.17923; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Prasadan K, 2002, DIABETES, V51, P3229, DOI 10.2337/diabetes.51.11.3229; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; Rosenstock Julio, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P98, DOI 10.1097/MED.0b013e3280a02f65; Sakamoto Y, 2006, BIOCHEM BIOPH RES CO, V351, P474, DOI 10.1016/j.bbrc.2006.10.076; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Suarez-Pinzon WL, 2009, DIABETOLOGIA, V52, P1680, DOI 10.1007/s00125-009-1390-z; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian L, 2011, TRANSPL INT, V24, P856, DOI 10.1111/j.1432-2277.2011.01275.x; Tian L, 2010, ENDOCRINOLOGY, V151, P3049, DOI 10.1210/en.2010-0068; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670	41	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53345	10.1371/journal.pone.0053345	http://dx.doi.org/10.1371/journal.pone.0053345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382843	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200058
J	Easton, AH; Goulson, D				Easton, Amy H.; Goulson, Dave			The Neonicotinoid Insecticide Imidacloprid Repels Pollinating Flies and Beetles at Field-Realistic Concentrations	PLOS ONE			English	Article							BUMBLEBEE NEST DENSITY; COLONY GROWTH; PESTICIDES; SCALE; BEES	Neonicotinoids are widely used systemic insecticides which, when applied to flowering crops, are translocated to the nectar and pollen where they may impact upon pollinators. Given global concerns over pollinator declines, this potential impact has recently received much attention. Field exposure of pollinators to neonicotinoids depends on the concentrations present in flowering crops and the degree to which pollinators choose to feed upon them. Here we describe a simple experiment using paired yellow pan traps with or without insecticide to assess whether the commonly used neonicotinoid imidacloprid repels or attracts flying insects. Both Diptera and Coleoptera exhibited marked avoidance of traps containing imidacloprid at a field-realistic dose of 1 mu g L-1, with Diptera avoiding concentrations as low as 0.01 mu g L-1. This is to our knowledge the first evidence for any biological activity at such low concentrations, which are below the limits of laboratory detection using most commonly available techniques. Catch of spiders in pan traps was also slightly reduced by the highest concentrations of imidacloprid used (1 mu g L-1), but catch was increased by lower concentrations. It remains to be seen if the repellent effect on insects occurs when neonicotinoids are present in real flowers, but if so then this could have implications for exposure of pollinators to neonicotinoids and for crop pollination.	[Easton, Amy H.; Goulson, Dave] Univ Stirling, Sch Nat Sci, Stirling, Scotland	University of Stirling	Goulson, D (corresponding author), Univ Stirling, Sch Nat Sci, Stirling, Scotland.	dave.goulson@stir.ac.uk	Goulson, David/A-2462-2010	Goulson, David/0000-0003-4421-2876				[Anonymous], 2011, UK NAT EC ASS SYNTH; AOAC Official Method 2007.01, 2007, J AOAC INT, V90, P485; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Tomizawa M., 1999, NICOTINOID INSECTICI, P271, DOI [10.1007/978-4-431-67933-2_13, DOI 10.1007/978-4-431-67933-2_13]; Vrdoljak SM, 2012, J INSECT CONSERV, V16, P345, DOI 10.1007/s10841-011-9420-9; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	26	42	44	1	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54819	10.1371/journal.pone.0054819	http://dx.doi.org/10.1371/journal.pone.0054819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382980	Green Published, gold, Green Accepted			2022-12-25	WOS:000315211500032
J	Sakkiah, S; Arooj, M; Kumar, MR; Eom, SH; Lee, KW				Sakkiah, Sugunadevi; Arooj, Mahreen; Kumar, Manian Rajesh; Eom, Soo Hyun; Lee, Keun Woo			Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; INCREASED DOSAGE; SIR2; ACETYLATION; ACTIVATION; STRESS; GENE	The ability to identify the site of a protein that can bind with high affinity to small, drug-like compounds has been an important goal in drug design. Sirtuin 2 (SIRT2), histone deacetylase protein family, plays a central role in the regulation of various pathways. Hence, identification of drug for SIRT2 has attracted great interest in the drug discovery community. To elucidate the molecular basis of the small molecules interactions to inhibit the SIRT2 function we employed the molecular docking, molecular dynamics simulations, and the molecular mechanism Poisson-Boltzmann/ surface area (MM-PBSA) calculations. Five well know inhibitors such as suramin, mol-6, sirtinol, 67, and nf675 were selected to establish the nature of the binding mode of the inhibitors in the SIRT2 active site. The molecular docking and dynamics simulations results revealed that the hydrogen bonds between Arg97 and Gln167 are crucial to inhibit the function of SIRT2. In addition, the MM-PBSA calculations revealed that binding of inhibitors to SIRT2 is mainly driven by van der Waals/non-polar interactions. Although the five inhibitors are very different in structure, shape, and electrostatic potential, they are able to fit in the same binding pocket. These findings from this study provide insights to elucidate the binding pattern of SIRT2 inhibitors and help in the rational structure-based design of novel SIRT2 inhibitors with improved potency and better resistance profile.	[Sakkiah, Sugunadevi; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Sakkiah, Sugunadevi; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Kwangju, South Korea; [Sakkiah, Sugunadevi; Kumar, Manian Rajesh] Chonnam Natl Univ, Dept Chem, Kwangju, South Korea; [Sakkiah, Sugunadevi; Kumar, Manian Rajesh] Chonnam Natl Univ, Inst Basic Sci, Kwangju, South Korea; [Arooj, Mahreen; Lee, Keun Woo] Gyeongsang Natl Univ, Res Inst Nat Sci, Plant Mol Biol & Biotechnol Res Ctr, Syst & Synthet Agrobiotech Ctr,Div Appl Life Sci, Jinju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Gyeongsang National University	Lee, KW (corresponding author), Gyeongsang Natl Univ, Res Inst Nat Sci, Plant Mol Biol & Biotechnol Res Ctr, Syst & Synthet Agrobiotech Ctr,Div Appl Life Sci, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Sakkiah, Suguna Devi/0000-0002-8337-9348; Arooj, Mahreen/0000-0003-1975-5289	Basic Science Research Program [2012R1A1A4A01013657]; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education, Science and Technology (MEST) of the Republic of Korea; Rural Development Administration (RDA) of the Republic of Korea [PJ008038]	Basic Science Research Program; Pioneer Research Center Program; Management of Climate Change Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of the Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of the Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arguelho MLPM, 2010, QUIM NOVA, V33, P1291, DOI 10.1590/S0100-40422010000600014; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Choi SH, 2012, BIOORG MED CHEM LETT, V22, P2789, DOI 10.1016/j.bmcl.2012.02.089; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Eroglu E, 2007, INT J MOL SCI, V8, P145, DOI 10.3390/i8020145; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gaussian, 2004, REV C 03; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Neugebauer RC, 2008, J MED CHEM, V51, P1203, DOI 10.1021/jm700972e; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Sakkiah S, 2012, CHEM BIOL DRUG DES, V80, P315, DOI 10.1111/j.1747-0285.2012.01406.x; Sakkiah S, 2012, J BIOMOL STRUCT DYN, V30, P235, DOI 10.1080/07391102.2012.680026; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Singh R.K., 2011, INT J CHEMTECH RES, V3, P1571; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tervo AJ, 2004, J MED CHEM, V47, P6292, DOI 10.1021/jm049933m; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x	41	28	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e51429	10.1371/journal.pone.0051429	http://dx.doi.org/10.1371/journal.pone.0051429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382805	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500002
J	Zhu, P; Zhu, Q; Zhang, YL; Ma, XJ; Li, ZZ; Li, J; Chen, JZ; Luo, L; Ring, HJZ; Ring, BZ; Su, L				Zhu, Peng; Zhu, Qian; Zhang, Yilei; Ma, Xuejun; Li, Zizhao; Li, Jie; Chen, Jiazhong; Luo, Le; Ring, Huijun Z.; Ring, Brian Z.; Su, Li			ABCB1 Variation and Treatment Response in AIDS Patients: Initial Results of the Henan Cohort	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; P-GLYCOPROTEIN; ANTIRETROVIRAL TREATMENT; PLASMA-CONCENTRATIONS; POLYMORPHISMS; METABOLISM; CYP2B6; PHARMACOGENETICS; VARIANTS; BLOOD	HIV/AIDS has the highest mortality among infectious diseases in China. In ongoing efforts to alleviate this crisis, the national government has placed great emphasis on efforts in Henan province where HIV-infected former plasma donors in the 1990s contributed to AIDS becoming a public health crisis. Concomitant with a national initiative focusing the use of phamacogenetics for the better prediction of treatment response, we studied genetic variants with known pharmacokinetic phenotypes in a set of 298 HAART-treated (highly active antiretroviral therapy) patients infected with HIV from the Henan cohort. We measured the association of response to treatment, assessed as changes in CD4+ T cell counts after antiretroviral therapy, of five polymorphisms in four genes (CYP2B6, ABCB1/MDR1, ABCG2, and ABCC4) in which variation has been suggested to affect the pharmacokinetics of drugs commonly employed to treat HIV/AIDS. We show that genotyping for ABCB1 variations (rs1045642 and rs2032582) may help predict HIV treatment response. We found variations in this gene have a significant association with outcome as measured by CD4+ T cell counts in a discovery subset (N=197; odds ratio (OR)=1.58; 95% CI 1.02-2.45), these results were confirmed in a validation subset of the cohort (N=78; OR=2.81; 95% CI 1.32-5.96). Exploratory analysis suggests that this effect may be specific to NVP (nevirapine) or 3TC (lamivudine) response. This publication represents the first genetic analysis in a continuing effort to study and assist the patients in a very large, unique, and historically significant HIV-AIDS cohort. Genotyping of AIDS patients for ABCB1 variation may help predict outcome and potentially could help guide treatment strategies.	[Zhu, Peng; Zhang, Yilei; Su, Li] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Ring, Huijun Z.; Ring, Brian Z.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China; [Chen, Jiazhong] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Peoples R China; [Zhu, Qian; Li, Jie] Henan Ctr Dis Prevent & Control, Inst AIDS STD Prevent & Control, Zhengzhou, Peoples R China; [Ma, Xuejun; Luo, Le] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Li, Zizhao] Hlth Dept Henan Prov, Zhengzhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Ring, BZ (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China.	bzring@mail.hust.edu.cn; lisu@mail.hust.edu.cn	Zhang, Yilei/I-8997-2014	Zhang, Yilei/0000-0003-1407-0301	China Mega-Project for Infectious Diseases [2009ZX10017-016, 2011ZX10004-001, 2012ZX10004-215]	China Mega-Project for Infectious Diseases	This study was funded by grants from the China Mega-Project for Infectious Diseases (2009ZX10017-016, 2011ZX10004-001 and 2012ZX10004-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; [Anonymous], 2011, MIN HLTH AIDS PREV C; Chen CL, 2002, DRUG METAB DISPOS, V30, P1523, DOI 10.1124/dmd.30.12.1523; Chen J, 2010, THER DRUG MONIT, V32, P573, DOI 10.1097/FTD.0b013e3181ea953c; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; di Iulio J, 2009, PHARMACOGENET GENOM, V19, P300, DOI 10.1097/FPC.0b013e328328d577; Estrela RC, 2009, PHARMACOGENOMICS, V10, P311, DOI 10.2217/14622416.10.2.311; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gisslen M, 1997, J INFECT DIS, V175, P434, DOI 10.1093/infdis/175.2.434; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Kim HS, 2007, BRIT J CLIN PHARMACO, V64, P645, DOI 10.1111/j.1365-2125.2007.02944.x; Koralage Nadeeja, 2004, BMJ, V328, P975, DOI 10.1136/bmj.328.7446.975-a; Kwara A, 2009, AIDS, V23, P2101, DOI 10.1097/QAD.0b013e3283319908; Kwara A, 2009, BRIT J CLIN PHARMACO, V67, P427, DOI 10.1111/j.1365-2125.2009.03368.x; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Li JY, 2005, CELL RES, V15, P843, DOI 10.1038/sj.cr.7290356; PILERI SA, 1991, HISTOPATHOLOGY, V19, P131, DOI 10.1111/j.1365-2559.1991.tb00003.x; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Smith MZ, 2012, CURR HIV-AIDS REP, V9, P5, DOI 10.1007/s11904-011-0108-2; Stormer E, 2002, PHARMACEUT RES, V19, P1038, DOI 10.1023/A:1016430825740; Sun XH, 2010, INT J EPIDEMIOL, V39, pII4, DOI 10.1093/ije/dyq217; UNAIDS, 2011, HIV AS PAC GETT ZER, P27; Veal GJ, 1995, GEN PHARMACOL, V26, P1469, DOI 10.1016/0306-3623(95)00047-X; Weinberg Jennifer L, 2010, Virtual Mentor, V12, P202, DOI 10.1001/virtualmentor.2010.12.3.cprl1-1003; WHO, 2010, ANT THER HIV INF AD; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhou ZX, 2006, ANTIMICROB AGENTS CH, V50, P2686, DOI 10.1128/AAC.01637-05	31	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55197	10.1371/journal.pone.0055197	http://dx.doi.org/10.1371/journal.pone.0055197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372834	Green Submitted, gold, Green Published			2022-12-25	WOS:000315210400074
J	Cheng, JC; Klausen, C; Leung, PCK				Cheng, Jung-Chien; Klausen, Christian; Leung, Peter C. K.			Overexpression of Wild-Type but Not C134W Mutant FOXL2 Enhances GnRH-Induced Cell Apoptosis by Increasing GnRH Receptor Expression in Human Granulosa Cell Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; EPICANTHUS INVERSUS SYNDROME; HORMONE (GNRH)-I; FOLLICULAR DEVELOPMENT; GROWTH INHIBITION; CANCER-CELLS; OVARY; GENE; BLEPHAROPHIMOSIS; INTERACTS	The etiology of granulosa cell tumors (GCTs) is largely unknown. The primary mode of treatment is surgical, however not all women are cured by surgery alone. Thus, it is important to develop improved treatments through a greater understanding of the molecular mechanisms that contribute to this disease. Recently, it has been shown that a FOXL2 402C>G (C134W) mutation is present in 97% of human adult-type GCTs, suggesting an important role for this mutation in the development of GCTs. We have shown previously that gonadotropin-releasing hormone (GnRH)-I and -II induce apoptosis in cultured normal human granulosa cells. Moreover, it has been reported that FOXL2 can bind to the promoter of the mouse GnRH receptor gene and regulate its transcription. Thus, we hypothesized that C134W mutant FOXL2 could modulate the pro-apoptotic effects of GnRH via aberrant regulation of GnRH receptor levels. Using KGN cells, a human GCT-derived cell line which harbors the FOXL2 402C>G mutation, we show that treatment with GnRH-I and -II induces cell apoptosis, and that small interfering RNA-mediated depletion of GnRH receptor abolishes these effects. Overexpression of wild-type FOXL2 increases both mRNA and protein levels of GnRH receptor and consequently enhances GnRH-induced apoptosis. Importantly, neither the expression levels of GnRH receptor nor GnRH-induced apoptosis were affected by overexpression of the C134W mutant FOXL2. Interestingly, knockdown of endogenous FOXL2 down-regulates GnRHR expression in normal human granulosa cells with wild-type FOXL2, but not in KGN cells. These results suggest that the FOXL2 402C>G mutation may contribute to the development of human adult-type GCTs by reducing the expression of GnRH receptor, thus conferring resistance to GnRH-induced cell apoptosis.	[Cheng, Jung-Chien; Klausen, Christian; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	peter.leung@ubc.ca	Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research; Child & Family Research Institute; BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship	This work was supported by an operating grant from the Canadian Institutes of Health Research to PCKL. PCKL is the recipient of a Child & Family Research Institute Senior Investigator Award. JCC is the recipient of BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Cheng CK, 2002, MOL ENDOCRINOL, V16, P1552, DOI 10.1210/me.16.7.1552; Choi JH, 2006, J CLIN ENDOCR METAB, V91, P4562, DOI 10.1210/jc.2006-1147; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Hong IS, 2008, J CLIN ENDOCR METAB, V93, P3179, DOI 10.1210/jc.2008-0127; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim KY, 2006, ENDOCR-RELAT CANCER, V13, P211, DOI 10.1677/erc.1.01033; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Ngan ESW, 1999, ENDOCRINOLOGY, V140, P2452, DOI 10.1210/endo.140.6.6759; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Park DW, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-81; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Poon SL, 2009, MOL ENDOCRINOL, V23, P1646, DOI 10.1210/me.2009-0147; Rosario R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046270; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stromme PS, 1996, ACTA OPHTHALMOL SCAN, V74, P45; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	30	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55099	10.1371/journal.pone.0055099	http://dx.doi.org/10.1371/journal.pone.0055099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372819	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500154
J	Demichelis, VT; Vilcaes, AA; Iglesias-Bartolome, R; Ruggiero, FM; Daniotti, JL				Demichelis, Vanina Torres; Vilcaes, Aldo A.; Iglesias-Bartolome, Ramiro; Ruggiero, Fernando M.; Daniotti, Jose L.			Targeted Delivery of Immunotoxin by Antibody to Ganglioside GD3: A Novel Drug Delivery Route for Tumor Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; CHO-K1 CELLS; EXPRESSION; MELANOMA; CYTOTOXICITY; SELECTIVITY; SYNTHASE; PROTEIN	Gangliosides are sialic acid-containing glycolipids expressed on plasma membranes from nearly all vertebrate cells. The expression of ganglioside GD3, which plays essential roles in normal brain development, decreases in adults but is up regulated in neuroectodermal and epithelial derived cancers. R24 antibody, directed against ganglioside GD3, is a validated tumor target which is specifically endocytosed and accumulated in endosomes. Here, we exploit the internalization feature of the R24 antibody for the selective delivery of saporin, a ribosome-inactivating protein, to GD3-expressing cells [human (SK-Mel-28) and mouse (B16) melanoma cells and Chinese hamster ovary (CHO)-K1 cells]. This immunotoxin showed a specific cytotoxicity on tumor cells grew on 2D monolayers, which was further evident by the lack of any effect on GD3-negative cells. To estimate the potential antitumor activity of R24-saporin complex, we also evaluated the effect of the immunotoxin on the clonogenic growth of SK-Mel-28 and CHO-K1(GD3+) cells cultured in attachment-free conditions. A drastic growth inhibition (>80-90%) of the cell colonies was reached after 3 days of immunotoxin treatment. By the contrary, colonies continue to growth at the same concentration of the immuntoxin, but in the absence of R24 antibody, or in the absence of both immunotoxin and R24, undoubtedly indicating the specificity of the effect observed. Thus, the ganglioside GD3 emerge as a novel and attractive class of cell surface molecule for targeted delivery of cytotoxic agents and, therefore, provides a rationale for future therapeutic intervention in cancer.	[Demichelis, Vanina Torres; Vilcaes, Aldo A.; Iglesias-Bartolome, Ramiro; Ruggiero, Fernando M.; Daniotti, Jose L.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar	Iglesias-Bartolome, Ramiro/H-4460-2014	Iglesias-Bartolome, Ramiro/0000-0002-0792-1254	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT)	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC) (www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the technical assistance of G. Schachner, S. Deza, C. Sampedro and C. Mas. Rab5-GFP and Lamp1-GFP were generously supplied by J. Bonifacino (NICHD, National Institute of Health, Bethesda, MD, USA). V.T.D. and A.A.V. are recipients of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina) Fellowships. F.M.R. is recipient of Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) Fellowship. J.L.D. is Career Investigator of CONICET.	Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; Daniotti JL, 2002, NEUROCHEM RES, V27, P1421, DOI 10.1023/A:1021684018665; Daniotti JL, 1997, INT J DEV NEUROSCI, V15, P767, DOI 10.1016/S0736-5748(97)00027-0; GRAVOTTA D, 1989, J NEUROCHEM, V52, P768, DOI 10.1111/j.1471-4159.1989.tb02521.x; Guillemard V, 2004, ONCOGENE, V23, P3613, DOI 10.1038/sj.onc.1207463; Guillemard V, 2001, CANCER RES, V61, P694; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Lee FT, 2001, CANCER RES, V61, P4474; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; Nasi ML, 1997, MELANOMA RES, V7, pS155; Polito I, 2004, LEUKEMIA, V18, P1215, DOI 10.1038/sj.leu.2403378; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; RAVINDRANATH M H, 1991, International Reviews of Immunology, V7, P303, DOI 10.3109/08830189109114877; SCHENGRUND CL, 1988, NEUROCHEM PATHOL, V8, P189; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; Thomas PB, 2002, J PEDIATR SURG, V37, P539, DOI 10.1053/jpsu.2002.30856	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55304	10.1371/journal.pone.0055304	http://dx.doi.org/10.1371/journal.pone.0055304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383146	Green Published, gold			2022-12-25	WOS:000314610600085
J	Kennedy, PGE; Montague, P; Scott, F; Grinfeld, E; Ashrafi, GH; Breuer, J; Rowan, EG				Kennedy, Peter G. E.; Montague, Paul; Scott, Fiona; Grinfeld, Esther; Ashrafi, G. H.; Breuer, Judith; Rowan, Edward G.			Varicella-Zoster Viruses Associated with Post-Herpetic Neuralgia Induce Sodium Current Density Increases in the ND7-23 Nav-1.8 Neuroblastoma Cell Line	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXPRESSION; INFECTION; CHANNELS; NEURONS; LATENCY; PAIN; MODEL; GENE	Post-herpetic neuralgia (PHN) is the most significant complication of herpes zoster caused by reactivation of latent Varicella-Zoster virus (VZV). We undertook a heterologous infection in vitro study to determine whether PHN-associated VZV isolates induce changes in sodium ion channel currents known to be associated with neuropathic pain. Twenty VZV isolates were studied blind from 11 PHN and 9 non-PHN subjects. Viruses were propagated in the MeWo cell line from which cell-free virus was harvested and applied to the ND7/23-Nav1.8 rat DRG x mouse neuroblastoma hybrid cell line which showed constitutive expression of the exogenous Nav 1.8, and endogenous expression of Nav 1.6 and Nav 1.7 genes all encoding sodium ion channels the dysregulation of which is associated with a range of neuropathic pain syndromes. After 72 hrs all three classes of VZV gene transcripts were detected in the absence of infectious virus. Single cell sodium ion channel recording was performed after 72 hr by voltage-clamping. PHN-associated VZV significantly increased sodium current amplitude in the cell line when compared with non-PHN VZV, wild-type (Dumas) or vaccine VZV strains ((POka, Merck and GSK). These sodium current increases were unaffected by acyclovir pre-treatment but were abolished by exposure to Tetrodotoxin (TTX) which blocks the TTX-sensitive fast Nav 1.6 and Nav 1.7 channels but not the TTX-resistant slow Nav 1.8 channel. PHN-associated VZV sodium current increases were therefore mediated in part by the Nav 1.6 and Nav 1.7 sodium ion channels. An additional observation was a modest increase in message levels of both Nav1.6 and Nav1.7 mRNA but not Nav 1.8 in PHN virally infected cells.	[Kennedy, Peter G. E.; Montague, Paul; Grinfeld, Esther] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & life Sci, Glasgow, Lanark, Scotland; [Scott, Fiona; Breuer, Judith] UCL, Div Infect & Immun, London WC1E 6BT, England; [Ashrafi, G. H.] Kingston Univ London, Kingston Upon Thames, Surrey, England; [Rowan, Edward G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of London; University College London; Kingston University; University of Strathclyde	Kennedy, PGE (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & life Sci, Glasgow, Lanark, Scotland.	Peter.Kennedy@glasgow.ac.uk		Rowan, Edward/0000-0002-9960-3308; Breuer, Judith/0000-0001-8246-0534; Ashrafi, G. Hossein/0000-0002-4516-5111	Chief Scientist Office of Scottish Government; Wellcome Trust [081703]; University College London/University College London Hospitals National Institute for Health Research Comprehensive Biomedical Research Centre; Sanofi Pasteur MSD; MRC [G0700814] Funding Source: UKRI; Medical Research Council [G0700814] Funding Source: researchfish; Chief Scientist Office [CZB/4/737] Funding Source: researchfish	Chief Scientist Office of Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); University College London/University College London Hospitals National Institute for Health Research Comprehensive Biomedical Research Centre; Sanofi Pasteur MSD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by a grant from The Chief Scientist Office of the Scottish Government. FS was supported by Wellcome Trust grant no 081703. JB receives funding from the University College London/University College London Hospitals National Institute for Health Research Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JB receives funding from Sanofi Pasteur MSD for viral genotyping of rashes following vaccination, however this funding was not for this specific study. PGEK has acted as an adviser on shingles vaccination to Sanofi Pasteur MSD. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ashrafi GH, 2010, VIRUS GENES, V41, P192, DOI 10.1007/s11262-010-0515-2; BOURDONWOUTERS C, 1990, J NEUROSCI RES, V26, P90, DOI 10.1002/jnr.490260111; Bradley BM, 2003, J NEUROVIROL, V9, P194; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dabby R, 2012, CURR NEUROL NEUROSCI, V12, P76, DOI 10.1007/s11910-011-0233-8; Dalziel RG, 2004, BRAIN RES REV, V46, P234, DOI 10.1016/j.brainresrev.2004.07.008; Finnen RL, 2006, J VIROL, V80, P10325, DOI 10.1128/JVI.00939-06; Fleetwood-Walker SM, 1999, J GEN VIROL, V80, P2433, DOI 10.1099/0022-1317-80-9-2433; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Garry EM, 2005, PAIN, V118, P97, DOI 10.1016/j.pain.2005.08.003; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Hamza MA, 2007, NEUROSCI LETT, V413, P31, DOI 10.1016/j.neulet.2006.11.063; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Hasnie FS, 2007, NEUROSCIENCE, V144, P1495, DOI 10.1016/j.neuroscience.2006.11.029; KENNEDY PGE, 1994, VIROLOGY, V205, P558, DOI 10.1006/viro.1994.1679; Kennedy PGE, 2002, REV MED VIROL, V12, P327, DOI 10.1002/rmv.362; Kennedy PGE, 1998, P NATL ACAD SCI USA, V95, P4658, DOI 10.1073/pnas.95.8.4658; Kinchington PR, 2011, J NEUROVIROL, V17, P590, DOI 10.1007/s13365-011-0069-7; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; MAHALINGAM R, 1995, J NEUROVIROL, V1, P130, DOI 10.3109/13550289509111018; Markman JD, 2006, J PAIN, V7, pS38, DOI 10.1016/j.jpain.2005.09.008; McCarthy KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000640; Medhurst SJ, 2008, PAIN, V138, P61, DOI 10.1016/j.pain.2007.11.006; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Peng WP, 2003, J VIROL, V77, P10714, DOI 10.1128/JVI.77.19.10714-10718.2003; Quan D, 2006, ARCH NEUROL-CHICAGO, V63, P940, DOI 10.1001/archneur.63.7.noc60049; Quinlivan ML, 2011, J CLIN VIROL, V50, P130, DOI 10.1016/j.jcv.2010.10.014; Schunemann S, 1999, ACTA VIROL, V43, P337; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Storey N, 2002, J CELL BIOL, V158, P1251, DOI 10.1083/jcb.200204010; Szpara ML, 2010, J NEUROIMMUNE PHARM, V5, P418, DOI 10.1007/s11481-010-9212-0; VAFAI A, 1988, P NATL ACAD SCI USA, V85, P2767, DOI 10.1073/pnas.85.8.2767; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zhou XP, 2003, J PHARMACOL EXP THER, V306, P498, DOI 10.1124/jpet.103.051086	38	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e51570	10.1371/journal.pone.0051570	http://dx.doi.org/10.1371/journal.pone.0051570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382806	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000314610600004
J	Shahab, U; Moinuddin; Ahmad, S; Dixit, K; Habib, S; Alam, K; Ali, A				Shahab, Uzma; Moinuddin; Ahmad, Saheem; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif			Genotoxic Effect of N-Hydroxy-4-Acetylaminobiphenyl on Human DNA: Implications in Bladder Cancer	PLOS ONE			English	Article							URINARY-BLADDER; ADDUCTS; 4-AMINOBIPHENYL-DNA; CELLS; IMMUNOGENICITY; QUANTITATION; METABOLITE; CHEMICALS; EXPOSURE; SMOKERS	Background: The interaction of environmental chemicals and their metabolites with biological macromolecules can result in cytotoxic and genotoxic effects. 4-Aminobiphenyl (4-ABP) and several other related arylamines have been shown to be causally involved in the induction of human urinary bladder cancers. The genotoxic and the carcinogenic effects of 4-ABP are exhibited only when it is metabolically converted to a reactive electrophile, the aryl nitrenium ions, which subsequently binds to DNA and induce lesions. Although several studies have reported the formation of 4-ABP-DNA adducts, no extensive work has been done to investigate the immunogenicity of 4-ABP-modified DNA and its possible involvement in the generation of antibodies in bladder cancer patients. Methodology/Principal Findings: Human DNA was modified by N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP), a reactive metabolite of 4-ABP. Structural perturbations in the N-OH-AABP modified DNA were assessed by ultraviolet, fluorescence, and circular dichroic spectroscopy as well as by agarose gel electrophoresis. Genotoxicity of N-OH-AABP modified DNA was ascertained by comet assay. High performance liquid chromatography (HPLC) analysis of native and modified DNA samples confirmed the formation of N-(deoxyguanosine-8-yl)-4-aminobiphenyl (dG-C8-4ABP) in the N-OH-AABP damaged DNA. The experimentally induced antibodies against N-OH-AABP-modified DNA exhibited much better recognition of the DNA isolated from bladder cancer patients as compared to the DNA obtained from healthy individuals in competitive binding ELISA. Conclusions/Significance: This work shows epitope sharing between the DNA isolated from bladder cancer patients and the N-OH-AABP-modified DNA implicating the role of 4-ABP metabolites in the DNA damage and neo-antigenic epitope generation that could lead to the induction of antibodies in bladder cancer patients.	[Shahab, Uzma; Moinuddin; Ahmad, Saheem; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif] Aligarh Muslim Univ, Fac Med, Dept Biochem, JN Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Moinuddin (corresponding author), Aligarh Muslim Univ, Fac Med, Dept Biochem, JN Med Coll, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	Shahab, Uzma/AAR-4332-2021; Ahmad, Saheem/R-7016-2017; Ahmad, Saheem/T-2609-2019	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Alam, Khursheed/0000-0001-9729-9966	ICMR grant [18/11/18/2008-ECD-I]; University (Aligarh Muslim University)	ICMR grant; University (Aligarh Muslim University)	This work was partly funded by the ICMR grant no. Immuno 18/11/18/2008-ECD-I (which now stands completed) and the funds from the University (Aligarh Muslim University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; ALATRASH J, 1995, CHEM RES TOXICOL, V8, P747, DOI 10.1021/tx00047a015; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; Beland FA, 1999, CHEM RES TOXICOL, V12, P68, DOI 10.1021/tx980172y; BELAND FA, 1983, ENVIRON HEALTH PERSP, V49, P125, DOI 10.2307/3429589; BRYANT MS, 1987, CANCER RES, V47, P602; Burger MS, 2001, ENVIRON MOL MUTAGEN, V38, P1, DOI 10.1002/em.1044; BUTLER MA, 1989, CANCER RES, V49, P25; Curigliano G, 1996, CARCINOGENESIS, V17, P911, DOI 10.1093/carcin/17.5.911; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; HATCHER JF, 1995, CARCINOGENESIS, V16, P295, DOI 10.1093/carcin/16.2.295; HAUGEN DA, 1982, ANAL CHEM, V54, P32, DOI 10.1021/ac00238a012; IARC, 1986, IARC SCI PUBLICATION, V38; KADLUBAR FF, 1985, ACS SYM SER, V283, P341; KADLUBAR FF, 1977, CANCER RES, V37, P805; KING C, 1995, FOOD CHEM TOXICOL, V33, P757, DOI 10.1016/0278-6915(95)00043-2; KING CM, 1974, CANCER RES, V34, P1503; LAI CC, 1985, CARCINOGENESIS, V6, P1037, DOI 10.1093/carcin/6.7.1037; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MILLER JA, 1970, CANCER RES, V30, P559; Moinuddin, 2014, ENVIRON TOXICOL, V29, P568, DOI 10.1002/tox.21782; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Poirier MC, 1995, CARCINOGENESIS, V16, P2917, DOI 10.1093/carcin/16.12.2917; POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C; Schulte PA, 1988, CARCINOGENIC MUTAGEN, P23; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shahab U, 2012, IUBMB LIFE, V64, P340, DOI 10.1002/iub.1008; STEINECK G, 1990, AM J IND MED, V17, P371, DOI 10.1002/ajim.4700170310; Swaminathan S, 2000, COMPREHENSIVE TXB GE, P289; TALASKA G, 1991, P NATL ACAD SCI USA, V88, P5350, DOI 10.1073/pnas.88.12.5350; Torino JL, 2001, CARCINOGENESIS, V22, P147, DOI 10.1093/carcin/22.1.147; VINEIS P, 1994, ENVIRON HEALTH PERSP, V102, P7, DOI 10.2307/3432143	32	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53205	10.1371/journal.pone.0053205	http://dx.doi.org/10.1371/journal.pone.0053205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382838	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600012
J	Wang, ZY; Zhang, XW; Chen, SY; Wang, DF; Wu, J; Liang, TM; Liu, C				Wang, Zhuyao; Zhang, Xiwen; Chen, Siyu; Wang, Danfeng; Wu, Jun; Liang, Tingming; Liu, Chang			Lithium Chloride Inhibits Vascular Smooth Muscle Cell Proliferation and Migration and Alleviates Injury-Induced Neointimal Hyperplasia via Induction of PGC-1 alpha	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; INFLAMMATION; ATHEROSCLEROSIS; PHOSPHORYLATION; CYCLE	The proliferation and migration of vascular smooth muscle cells (VSMCs) contributes importantly to the development of instent restenosis. Lithium has recently been shown to have beneficial effects on the cardiovascular system, but its actions in VSMCs and the direct molecular target responsible for its action remains unknown. On the other hand, PGC-1 alpha is a transcriptional coactivator which negatively regulates the pathological activation of VSMCs. Therefore, the purpose of the present study is to determine if lithium chloride (LiCl) retards VSMC proliferation and migration and if PGC-1 alpha mediates the effects of lithium on VSMCs. We found that pretreatment of LiCl increased PGC-1 alpha protein expression and nuclear translocation in a dose-dependent manner. MTT and EdU incorporation assays indicated that LiCl inhibited serum-induced VSMC proliferation. Similarly, deceleration of VSMC migration was confirmed by wound healing and transwell assays. LiCl also suppressed ROS generation and cell cycle progression. At the molecular level, LiCl reduced the protein expression levels or phosphorylation of key regulators involved in the cell cycle re-entry, adhesion, inflammation and motility. In addition, in vivo administration of LiCl alleviated the pathophysiological changes in balloon injury-induced neointima hyperplasia. More importantly, knockdown of PGC-1 alpha by siRNA significantly attenuated the beneficial effects of LiCl on VSMCs both in vitro and in vivo. Taken together, our results suggest that LiCl has great potentials in the prevention and treatment of cardiovascular diseases related to VSMC abnormal proliferation and migration. In addition, PGC-1 alpha may serve as a promising drug target to regulate cardiovascular physiological homeostasis.	[Wang, Zhuyao; Chen, Siyu; Wang, Danfeng; Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Zhuyao; Chen, Siyu; Wang, Danfeng; Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiwen] Nanjing Med Univ, Dept Cardiol, Huaian Peoples Hosp 1, Huaian, Jiangsu, Peoples R China; [Wu, Jun] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Nanjing Medical University; Nanjing Medical University	Liu, C (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	changliu@njnu.edu.cn	Liang, Tingming/ACL-6141-2022	Chen, Siyu/0000-0002-3809-1062	National Basic Research Program of China [2012CB947600]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET); National Natural Science Foundation of China [31171137, 31271261]; Key Project of Chinese Ministry of Education [211062]; Research Fund for the Doctoral Program of Higher Education of China [20103207110007]; Fok Ying Tong Education Foundation [121022]; Major Program of Educational Commission of Jiangsu Province [09KJA180004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); Major Program of Educational Commission of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Basic Research Program of China (973 Program) (2012CB947600), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET), the National Natural Science Foundation of China (31171137, 31271261), the Key Project of Chinese Ministry of Education (211062), the Research Fund for the Doctoral Program of Higher Education of China (20103207110007), the Fok Ying Tong Education Foundation (121022), the Major Program of Educational Commission of Jiangsu Province (09KJA180004) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; [Anonymous], 2004, NAT REV DRUG DISCOV, V3, P101, DOI 10.1038/nrd1315; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Choi SE, 2010, VASC PHARMACOL, V53, P264, DOI 10.1016/j.vph.2010.09.004; De Meyer I, 2011, BRIT J PHARMACOL, V162, P1410, DOI 10.1111/j.1476-5381.2010.01152.x; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; GORDON D, 1986, CIRC RES, V59, P633, DOI 10.1161/01.RES.59.6.633; Holm PW, 2009, ANN MED, V41, P257, DOI 10.1080/07853890802516507; Hsueh WA, 1999, AM J CARDIOL, V84, p21J; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Jiang XH, 2010, MOL CELL ENDOCRINOL, V315, P74, DOI 10.1016/j.mce.2009.09.018; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Komatsu R, 1998, CIRCULATION, V98, P224, DOI 10.1161/01.CIR.98.3.224; Kornowski R, 1997, CIRCULATION, V95, P1366; Lee HJ, 2008, FEBS LETT, V582, P627, DOI 10.1016/j.febslet.2008.01.033; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Licht RW, 2012, CNS NEUROSCI THER, V18, P219, DOI 10.1111/j.1755-5949.2011.00260.x; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; O'Neal JH, 2010, HDB REHABILITATION P, P195; Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101; Shao L, 2005, BIOL PSYCHIAT, V58, P879, DOI 10.1016/j.biopsych.2005.04.052; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Struewing IT, 2007, FEBS J, V274, P2749, DOI 10.1111/j.1742-4658.2007.05809.x; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Wang Y, 2009, BRIT J PHARMACOL, V157, P1004, DOI 10.1111/j.1476-5381.2009.00284.x; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014; Zhang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001137; Zhu L, 2009, IEEE PHOTONICS J, V1, P1, DOI 10.1109/JPHOT.2009.2020963	37	28	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55471	10.1371/journal.pone.0055471	http://dx.doi.org/10.1371/journal.pone.0055471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383200	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600109
J	Dang, BN; Westbrook, RA; Black, WC; Rodriguez-Barradas, MC; Giordano, TP				Dang, Bich N.; Westbrook, Robert A.; Black, William C.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.			Examining the Link between Patient Satisfaction and Adherence to HIV Care: A Structural Equation Model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SCREENING-TEST; UNITED-STATES; METAANALYSIS; RETENTION; QUESTION; ASSOCIATION; GUIDELINES; AMERICA; ENTRY	Introduction Analogous to the business model of customer satisfaction and retention, patient satisfaction could serve as an innovative, patient-centered focus for increasing retention in HIV care and adherence to HAART, and ultimately HIV suppression. Objective: To test, through structural equation modeling (SEM), a model of HIV suppression in which patient satisfaction influences HIV suppression indirectly through retention in HIV care and adherence to HAART. Methods: We conducted a cross-sectional study of adults receiving HIV care at two clinics in Texas. Patient satisfaction was based on two validated items, one adapted from the Consumer Assessment of Healthcare Providers and Systems survey ("Would you recommend this clinic to other patients with HIV?) and one adapted from the Delighted-Terrible Scale, ("Overall, how do you feel about the care you got at this clinic in the last 12 months?''). A validated, single-item question measured adherence to HAART over the past 4 weeks. Retention in HIV care was based on visit constancy in the year prior to the survey. HIV suppression was defined as plasma HIV RNA,48 copies/mL at the time of the survey. We used SEM to test hypothesized relationships. Results: The analyses included 489 patients (94% of eligible patients). The patient satisfaction score had a mean of 8.5 (median 9.2) on a 0- to 10-point scale. A total of 46% reported "excellent'' adherence, 76% had adequate retention, and 70% had HIV suppression. In SEM analyses, patient satisfaction with care influences retention in HIV care and adherence to HAART, which in turn serve as key determinants of HIV suppression (all p,. 0001). Conclusions: Patient satisfaction may have direct effects on retention in HIV care and adherence to HAART. Interventions to improve the care experience, without necessarily targeting objective clinical performance measures, could serve as an innovative method for optimizing HIV outcomes.	[Dang, Bich N.; Giordano, Thomas P.] Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dang, Bich N.; Giordano, Thomas P.] Harris Hlth Syst, Houston, TX USA; [Westbrook, Robert A.] Rice Univ, Jesse H Jones Grad Sch Business, Houston, TX USA; [Black, William C.] Louisiana State Univ, EJ Ourso Coll Business, Baton Rouge, LA 70803 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Louisiana State University System; Louisiana State University	Dang, BN (corresponding author), Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA.	bndang@bcm.edu		Giordano, Thomas/0000-0002-9346-5530	Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Houston VA Health Services Research and Development Center of Excellence	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and the Houston VA Health Services Research and Development Center of Excellence (HFP90-020). This material was also supported in part by the facilities and resources of Harris Health System, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; ANDREWS FM, 1976, SOC INDIC RES, V3, P1, DOI 10.1007/BF00286161; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Baker R, 1996, BRIT J GEN PRACT, V46, P601; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Browne M. W., 1993, SOCIOL METHOD RES, P136; CAHPS clinician & group survey adult primary care instrument, CAHPS CLIN GROUP SUR; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; COPE DW, 1986, J GEN INTERN MED, V1, P394, DOI 10.1007/BF02596425; Crow R, 2002, Health Technol Assess, V6, P1; Dang BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042980; Davies AR, 1981, R2711HHS RAND CORP; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Giordano TP, 2010, AIDS PATIENT CARE ST, V24, P287, DOI 10.1089/apc.2009.0332; Hair J., 2010, MULTIVARIATE DATA AN, V7; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kane RL, 2005, UNDERSTANDING HLTH C; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Markus KA, 2010, STRUCT EQU MODELING, V17, P654, DOI 10.1080/10705511.2010.510068; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mittal V., 2010, MSI FAST FORWARD SER; MORRELL DC, 1986, BMJ-BRIT MED J, V292, P870, DOI 10.1136/bmj.292.6524.870; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; National Council on Patient Information and Education, 2007, ENH PRESCR MED ADH N; Netemeyer R.G., 2003, SCALING PROCEDURES I; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rumptz MH, 2007, AIDS PATIENT CARE ST, V21, pS30, DOI 10.1089/apc.2007.9989; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Watkins CL, 2007, CLIN REHABIL, V21, P846, DOI 10.1177/0269215507079846; Wilson IB, 2010, JAIDS-J ACQ IMM DEF, V53, P338, DOI 10.1097/QAI.0b013e3181c7a245; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; Yedidia MJ, 2003, JAMA-J AM MED ASSOC, V290, P1157, DOI 10.1001/jama.290.9.1157	46	101	106	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54729	10.1371/journal.pone.0054729	http://dx.doi.org/10.1371/journal.pone.0054729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382948	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800070
J	Kishimoto, N; Nagai, J; Kinoshita, T; Ueno, K; Ohashi, Y; Mitsuhara, I				Kishimoto, Naoki; Nagai, Jun-ichi; Kinoshita, Takehito; Ueno, Keiichiro; Ohashi, Yuko; Mitsuhara, Ichiro			DNA Elements Reducing Transcriptional Gene Silencing Revealed by a Novel Screening Strategy	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; TOBACCO PLANTS; ARABIDOPSIS-THALIANA; TRANSGENIC RICE; CELL-DEATH; METHYLATION; EXPRESSION; INACTIVATION; ACCUMULATION; MECHANISMS	Transcriptional gene silencing (TGS)-a phenomenon observed in endogenous genes/transgenes in eukaryotes-is a huge hindrance to transgenic technology and occurs mainly when the genes involved share sequence homology in their promoter regions. TGS depends on chromosomal position, suggesting the existence of genomic elements that suppress TGS. However, no systematic approach to identify such DNA elements has yet been reported. Here, we developed a successful novel screening strategy to identify such elements (anti-silencing regions-ASRs), based on their ability to protect a flanked transgene from TGS. A silenced transgenic tobacco plant in which a subsequently introduced transgene undergoes obligatory promoter-homology dependent TGS in trans allowed the ability of DNA elements to prevent TGS to be used as the screening criterion. We also identified ASRs in a genomic library from a different plant species (Lotus japonicus: a perennial legume); the ASRs include portions of Ty1/copia retrotransposon-like and pararetrovirus-like sequences; the retrotransposon-like sequences also showed interspecies anti-TGS activity in a TGS-induction system in Arabidopsis. Anti-TGS elements could provide effective tools to reduce TGS and ensure proper regulation of transgene expression. Furthermore, the screening strategy described here will also facilitate the efficient identification of new classes of anti-TGS elements.	[Kishimoto, Naoki] NIAS, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Nagai, Jun-ichi] Kagoshima Prefectural Inst Agr Dev KIAD, Tokunoshima Branch, Isen, Kagoshima, Japan; [Kinoshita, Takehito] Saga Prefectural Agr Res Ctr, Vegetable Flower & Ornamental Plant Div, Saga, Japan; [Ueno, Keiichiro] KIAD, Kumage Branch, Nishinoomote City, Kagoshima, Japan; [Ohashi, Yuko; Mitsuhara, Ichiro] NIAS, Div Plant Sci, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Mitsuhara, I (corresponding author), NIAS, Div Plant Sci, Tsukuba, Ibaraki, Japan.	mituhara@affrc.go.jp		Mitsuhara, Ichiro/0000-0001-8750-5017	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN)	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN)	This work was supported, in part, by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALLIS C.D., 2007, EPIGENETICS; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Brasset E, 2010, GENE, V450, P25, DOI 10.1016/j.gene.2009.09.015; Buchmann RC, 2009, J VIROL, V83, P5005, DOI 10.1128/JVI.01771-08; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; Fukuoka H, 2000, PLANT CELL REP, V19, P815, DOI 10.1007/s002990000191; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Hagan ND, 2003, PLANT BIOTECHNOL J, V1, P479, DOI 10.1046/j.1467-7652.2003.00043.x; Hisahara S, 1998, J CELL SCI, V111, P667; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kawahigashi H, 2007, J AGR FOOD CHEM, V55, P1241, DOI 10.1021/jf062339w; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kobayashi M, 2010, MOL PLANT MICROBE IN, V23, P1032, DOI 10.1094/MPMI-23-8-1032; Lisch D, 2011, INT REV CEL MOL BIO, V292, P119, DOI 10.1016/B978-0-12-386033-0.00003-7; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Matzke MA, 1999, GENETICA, V107, P271, DOI 10.1023/A:1003921710672; Matzke Marjori A, 2002, Adv Genet, V46, P235; Mitsuhara I, 1999, CURR BIOL, V9, P775, DOI 10.1016/S0960-9822(99)80341-8; Mitsuhara I, 2002, GENETICS, V160, P343; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Mitsuhara I., 2006, PLANT BIOTECHNOLOGY, V23, P63, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.23.63; Mochizuki A, 1999, ENTOMOL EXP APPL, V93, P173, DOI 10.1023/A:1003849003354; Ohmido N, 2010, CHROMOSOME RES, V18, P287, DOI 10.1007/s10577-009-9103-5; Park YD, 1996, PLANT J, V9, P183, DOI 10.1046/j.1365-313X.1996.09020183.x; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Sasaki K, 2006, PLANT MOL BIOL, V62, P753, DOI 10.1007/s11103-006-9055-5; Seo S, 2011, PLANT PHYSIOL, V155, P502, DOI 10.1104/pp.110.162412; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P687, DOI 10.1093/nar/18.3.687; Sokal RR, 1995, BIOMETRY; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Thierry D, 1996, PLANT MOL BIOL, V32, P1075, DOI 10.1007/BF00041391; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wassenegger M, 2002, INT REV CYTOL, V219, P61; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wolffe AP, 1997, CURR BIOL, V7, pR796, DOI 10.1016/S0960-9822(06)00408-8; Zar JH, 1999, BIOSTATISTICAL ANAL	42	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54670	10.1371/journal.pone.0054670	http://dx.doi.org/10.1371/journal.pone.0054670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382937	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800062
J	Wurpel, DJ; Beatson, SA; Totsika, M; Petty, NK; Schembri, MA				Wurpel, Daniel J.; Beatson, Scott A.; Totsika, Makrina; Petty, Nicola K.; Schembri, Mark A.			Chaperone-Usher Fimbriae of Escherichia coli	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACTERIAL ADHESINS; PHASE VARIATION; COMMON PILUS; P-PILI; GENE; COMMENSAL; IDENTIFICATION; ADHERENCE; STRAINS	Chaperone-usher (CU) fimbriae are adhesive surface organelles common to many Gram-negative bacteria. Escherichia coli genomes contain a large variety of characterised and putative CU fimbrial operons, however, the classification and annotation of individual loci remains problematic. Here we describe a classification model based on usher phylogeny and genomic locus position to categorise the CU fimbrial types of E. coli. Using the BLASTp algorithm, an iterative usher protein search was performed to identify CU fimbrial operons from 35 E. coli (and one Escherichia fergusonnii) genomes representing different pathogenic and phylogenic lineages, as well as 132 Escherichia spp. plasmids. A total of 458 CU fimbrial operons were identified, which represent 38 distinct fimbrial types based on genomic locus position and usher phylogeny. The majority of fimbrial operon types occupied a specific locus position on the E. coli chromosome; exceptions were associated with mobile genetic elements. A group of core-associated E. coli CU fimbriae were defined and include the Type 1, Yad, Yeh, Yfc, Mat, F9 and Ybg fimbriae. These genes were present as intact or disrupted operons at the same genetic locus in almost all genomes examined. Evaluation of the distribution and prevalence of CU fimbrial types among different pathogenic and phylogenic groups provides an overview of group specific fimbrial profiles and insight into the ancestry and evolution of CU fimbriae in E. coli.	[Wurpel, Daniel J.; Beatson, Scott A.; Totsika, Makrina; Petty, Nicola K.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	University of Queensland	Beatson, SA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	s.beatson@uq.edu.au; m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Totsika, Makrina/A-8993-2011	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Totsika, Makrina/0000-0003-2468-0293; Petty, Nicola/0000-0001-6528-9886	Australian National Health and Medical Research Council [631654, APP1012076]; Australian Research Council (ARC) [FT100100662]; ARC Australian Research [DP0881247]; ARC Discovery Early Career [DE130101169]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC Australian Research(Australian Research Council); ARC Discovery Early Career(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council (631654 and APP1012076). MAS is the recipient of an Australian Research Council (ARC) Future Fellowship (FT100100662). SAB is the recipient of an ARC Australian Research Fellowship (DP0881247). MT is the recipient of an ARC Discovery Early Career Researcher Award(DE130101169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; Bergsten G, 2004, J INFECT DIS, V189, P1734, DOI 10.1086/383278; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HEDGES SR, 1995, TRENDS MICROBIOL, V3, P266, DOI 10.1016/S0966-842X(00)88941-6; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Holden N, 2007, INFECT IMMUN, V75, P3325, DOI 10.1128/IAI.01989-06; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; Khan AS, 2000, INFECT IMMUN, V68, P3541, DOI 10.1128/IAI.68.6.3541-3547.2000; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; KORHONEN TK, 1986, INFECT IMMUN, V54, P322, DOI 10.1128/IAI.54.2.322-327.1986; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; KYOGASHIMA M, 1989, ARCH BIOCHEM BIOPHYS, V270, P391, DOI 10.1016/0003-9861(89)90042-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEBOUGUENEC C, 1993, INFECT IMMUN, V61, P5106, DOI 10.1128/IAI.61.12.5106-5114.1993; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lugering A, 2003, MICROBIOL-SGM, V149, P1387, DOI 10.1099/mic.0.26266-0; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mu XQ, 2006, P NATL ACAD SCI USA, V103, P9861, DOI 10.1073/pnas.0509620103; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; ORSKOV I, 1990, CURR TOP MICROBIOL, V151, P71; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; OTTOW JCG, 1975, ANNU REV MICROBIOL, V29, P79, DOI 10.1146/annurev.mi.29.100175.000455; PARKKINEN J, 1986, INFECT IMMUN, V54, P37, DOI 10.1128/IAI.54.1.37-42.1986; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Roberts JA, 2004, J UROLOGY, V171, P1682, DOI 10.1097/01.ju.0000116123.05160.43; Sakellaris H, 1996, MOL MICROBIOL, V21, P529, DOI 10.1111/j.1365-2958.1996.tb02562.x; Sakellaris H, 1999, P NATL ACAD SCI USA, V96, P12828, DOI 10.1073/pnas.96.22.12828; Saldana Z, 2009, J BACTERIOL, V191, P3451, DOI 10.1128/JB.01539-08; Salih O, 2008, J MOL BIOL, V379, P174, DOI 10.1016/j.jmb.2008.03.056; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; SAVARINO SJ, 1994, J BACTERIOL, V176, P4949, DOI 10.1128/jb.176.16.4949-4957.1994; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Spurbeck RR, 2011, INFECT IMMUN, V79, P4753, DOI 10.1128/IAI.05621-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Totsika M, 2008, MOL MICROBIOL, V67, P996, DOI 10.1111/j.1365-2958.2007.06098.x; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Verger D, 2007, PLOS PATHOG, V3, P674, DOI 10.1371/journal.ppat.0030073; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Yue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038596; Zavialov A, 2003, ACTA CRYSTALLOGR D, V59, P359, DOI 10.1107/S0907444902021054; Zavialov AV, 2007, MOL MICROBIOL, V64, P153, DOI 10.1111/j.1365-2958.2007.05644.x; Zavialvo AV, 2005, BIOCHEM J, V389, P685, DOI 10.1042/BJ20050426; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zhaxybayeva O, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-402; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	91	111	114	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52835	10.1371/journal.pone.0052835	http://dx.doi.org/10.1371/journal.pone.0052835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382825	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800013
J	Yang, XF; Norma-Rashid, Y; Lourenco, WR; Zhu, MS				Yang, Xiaofeng; Norma-Rashid, Yusoff; Lourenco, Wilson R.; Zhu, Mingsheng			True Lateral Eye Numbers for Extant Buthids: A New Discovery on an Old Character	PLOS ONE			English	Article							MESOBUTHUS SCORPIONES BUTHIDAE; GENUS; CHINA; SYSTEMATICS	This study reports the results of a re-analysis of the number of lateral eyes in extant buthids. Specimens studied were confined mostly to those from China and the adjacent areas. 353 specimens belonging to 20 species (subspecies) and 8 genera were rechecked and found to have 5 pairs of lateral eyes contrary to earlier published works which reported the presence of 3 pairs of lateral eyes only. Combined with reported examples collected through reference investigation including 63 species from 16 genera, our study here shows a total of 79 species from 21 genera of scorpions spanning Asia and Africa had 5 pairs of lateral eyes. Reasons for not observing the presence of the extra lateral eyes are discussed and new protocols for examining specimens including using UV light are proposed to aid lateral eye recognition. Besides, a majority of genera in Buthidae are suggested to be in "Five-eye" model and a re-examination of all previously published taxonomic studies of buthid species is highly recommended.	[Yang, Xiaofeng; Zhu, Mingsheng] Hebei Univ, Coll Life Sci, Baoding, Hebei Province, Peoples R China; [Norma-Rashid, Yusoff] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Norma-Rashid, Yusoff] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lourenco, Wilson R.] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France	Hebei University; Universiti Malaya; Harvard University; Museum National d'Histoire Naturelle (MNHN)	Yang, XF (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Hebei Province, Peoples R China.	YangxiaofengChina@yahoo.com	Norma-Rashid, Y/B-8028-2010	Norma-Rashid, Y/0000-0002-1450-1995				Birula A. A., 1911, Revue Russe d'Entomologie, V11; Birula A.A., 1904, ANNUAIRE MUSEE ZOOLO, V9, P20; Birula A.A., 1897, ANNUAIRE MUSEE ZOOLO, V2, P377; Birula A.A., 1917, MEMOIRES MUSEE CAUCA, V5, P1; Di ZY, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.82.715; Fet V, 2000, CATALOG OF THE SCORP; Fet Victor, 2003, Euscorpius, V4, P1; Finnegan S., 1932, Journal of the Linnean Society London, VVol. 38, P91; FLEISSNER G, 1977, J COMP PHYSIOL, V118, P101, DOI 10.1007/BF00612340; FLEISSNER G, 1974, J COMP PHYSIOL, V91, P399, DOI 10.1007/BF00694470; Kishida K, 1933, REPORT OF THE FIRST, V1, P49; Kjellesvig-Waering E. N., 1986, RESTUDY FOSSIL SCORP; Koch CL, 1837, UBERSICHT DES ARACHN; Kovaiik F, 2004, EUSCORPIUS, V16, P1, DOI DOI 10.18590/EUSCORPIUS.2004.VOL2004; Lankester E. R., 1883, Q J MICROSC SCI, V23, P177; Lankester ER, 1885, T ZOOL SOC LONDON, V11, P372; Lourenco W. R., 2010, Boletin de la S.E.A., P307; Lourenco W. R., 2005, CHINA BOLETIN SOCIED, V36, P57; Lourenco Wilson R., 2004, Revista Iberica de Aracnologia, V10, P225; Lourenco Wilson R., 2012, Boletin de la SEA, V50, P187; Lourenco Wilson R., 2010, Journal of Hebei University Natural Science Edition, V30, P307; Lourenco Wilson R., 2009, Boletin de la SEA, V44, P71; Lourenco Wilson R., 2008, Acta Zootaxonomica Sinica, V33, P264; Lourenco Wilson R., 2006, Boletin de la SEA, P59; Lourenco WR, 2005, ZOOTAXA, P1; Lowe G., 2009, EUSCORPIUS, V90, P1, DOI [10.18590/euscorpius.2009.vol2009.iss90.1, DOI 10.18590/EUSCORPIUS.2009.VOL2009.ISS90.1]; Lowe G, 2010, NORTHERN OMAN EUSCOR, P1; MAQSOOD JAVED S. M., 2010, EUSCORPIUS, V98, P1; Mirshamsi O, 2011, ZOOTAXA, P1; Mirza Zeeshan A., 2010, Journal of Threatened Taxa, V2, P789; Navidpour S, 2009, J ARACHNOL, V37, P45, DOI 10.1636/H08-44.1; Polis GA, 1990, BIOL SCORPIONS, pxxiii; Prendini L, 2004, J ARACHNOL, V32, P109, DOI 10.1636/H03-17; Prendini L, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)408<0001:DOTMOP>2.0.CO;2; Prendini L, 2004, ANN ENTOMOL SOC AM, V97, P37, DOI 10.1603/0013-8746(2004)097[0037:SOTGPK]2.0.CO;2; Prendini L, 2010, ZOOL J LINN SOC-LOND, V159, P673, DOI 10.1111/j.1096-3642.2009.00608.x; Qi Jian-Xin, 2004, Revista Iberica de Aracnologia, V10, P137; Qi JX, 2007, CR BIOL, V330, P80, DOI 10.1016/j.crvi.2006.09.005; Rein JO, 2012, THE SCORPION FILES; SCHLIWA M, 1980, CELL TISSUE RES, V206, P95, DOI 10.1007/BF00233611; Soleglad Michael E., 2003, Euscorpius, V11, P1; Spreitzer A, 2003, ZOOL ANZ, V242, P137, DOI 10.1078/0044-5231-00098; Stockwell SA, 1989, THESIS; Sun D, 2011, J ARACHNOL, V39, P59, DOI 10.1636/Ha10-36.1; Sun D, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.37.301; Sun D, 2010, J ARACHNOL, V38, P35, DOI 10.1636/Ha09-39.1; Sureshan P. M., 2007, Zoos Print Journal, V22, P2903; Teruel R, 2010, NEW HOTTENTOTTA BIRU, P1; Tikader BK, 1983, FAUNA OF INDIA SCORP, VIII; VACHON MAX, 1958, VIDENSK MEDDEL DANSK NATURHIST FOR KOBENHAVN, V120, P121; Zambre A. M., 2010, Boletin de la S.E.A., P115; Zambre Amod M., 2011, Euscorpius, V107, P1; Zambre Amod M., 2009, Journal of Threatened Taxa, V1, P621	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55125	10.1371/journal.pone.0055125	http://dx.doi.org/10.1371/journal.pone.0055125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383077	Green Published, gold			2022-12-25	WOS:000315563800114
J	Panouilleres, M; Gaveau, V; Socasau, C; Urquizar, C; Pelisson, D				Panouilleres, Muriel; Gaveau, Valerie; Socasau, Camille; Urquizar, Christian; Pelisson, Denis			Brain Processing of Visual Information during Fast Eye Movements Maintains Motor Performance	PLOS ONE			English	Article							SACCADE GAIN ADAPTATION; ADAPTIVE-CONTROL; SENSORIMOTOR ADAPTATION; ERROR; MECHANISMS; PLASTICITY; SYSTEM; SIGNALS; HUMANS; LOCALIZATION	Movement accuracy depends crucially on the ability to detect errors while actions are being performed. When inaccuracies occur repeatedly, both an immediate motor correction and a progressive adaptation of the motor command can unfold. Of all the movements in the motor repertoire of humans, saccadic eye movements are the fastest. Due to the high speed of saccades, and to the impairment of visual perception during saccades, a phenomenon called "saccadic suppression", it is widely believed that the adaptive mechanisms maintaining saccadic performance depend critically on visual error signals acquired after saccade completion. Here, we demonstrate that, contrary to this widespread view, saccadic adaptation can be based entirely on visual information presented during saccades. Our results show that visual error signals introduced during saccade execution-by shifting a visual target at saccade onset and blanking it at saccade offset-induce the same level of adaptation as error signals, presented for the same duration, but after saccade completion. In addition, they reveal that this processing of intra-saccadic visual information for adaptation depends critically on visual information presented during the deceleration phase, but not the acceleration phase, of the saccade. These findings demonstrate that the human central nervous system can use short intra-saccadic glimpses of visual information for motor adaptation, and they call for a reappraisal of current models of saccadic adaptation.	[Panouilleres, Muriel; Gaveau, Valerie; Urquizar, Christian; Pelisson, Denis] CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France; [Panouilleres, Muriel; Gaveau, Valerie; Socasau, Camille; Urquizar, Christian; Pelisson, Denis] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Panouilleres, M (corresponding author), CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France.	muriel.panouilleres@inserm.fr	Pelisson, Denis/H-2916-2017; GAVEAU, Valérie VG/H-4779-2017	Pelisson, Denis/0000-0002-9114-7758; GAVEAU, Valérie VG/0000-0002-2255-5766; Panouilleres, Muriel/0000-0003-0264-2093	Institut National de la Sante et de la Recherche Medicale (INSERM) [U1028]; Region Rhone-Alpes [CLUSTER 11]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM) U1028 and by Region Rhone-Alpes (CLUSTER 11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL LA, 1978, ANN NEUROL, V4, P313, DOI 10.1002/ana.410040405; Alabyane N, 2004, INVEST OPHTH VIS SCI, V45, P123, DOI 10.1167/iovs.03-0570; Anand S, 2002, EXP BRAIN RES, V142, P335, DOI 10.1007/s00221-001-0937-0; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; BECKER W, 1969, VISION RES, V9, P1247, DOI 10.1016/0042-6989(69)90112-6; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Cameron BD, 2009, EXP BRAIN RES, V195, P445, DOI 10.1007/s00221-009-1812-7; Catz N, 2008, P NATL ACAD SCI USA, V105, P7309, DOI 10.1073/pnas.0706032105; Collins T, 2012, J NEUROPHYS IN PRESS; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; Eggert T, 1999, EXP BRAIN RES, V129, P161, DOI 10.1007/s002210050947; Ethier V, 2008, J NEUROSCI, V28, P13929, DOI 10.1523/JNEUROSCI.3470-08.2008; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Gaveau V, 2003, NEUROREPORT, V14, P875, DOI 10.1097/00001756-200305060-00020; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; Hamker FH, 2011, PHILOS T R SOC B, V366, P554, DOI 10.1098/rstb.2010.0229; Hernandez TD, 2008, J VISION, V8, DOI 10.1167/8.8.3; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Iwamoto Y, 2010, EXP BRAIN RES, V204, P145, DOI 10.1007/s00221-010-2314-3; Jing T, 2009, ANN NY ACAD SCI, V1164, P166, DOI 10.1111/j.1749-6632.2009.03853.x; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; KOMMERELL G, 1976, INVEST OPHTH VISUAL, V15, P657; Krekelberg B, 2010, CURR BIOL, V20, pR228, DOI 10.1016/j.cub.2009.12.018; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Noto CT, 1999, J NEUROPHYSIOL, V81, P2798, DOI 10.1152/jn.1999.81.6.2798; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; Panouilleres M, 2012, HUM BRAIN MAPP, V33, P1512, DOI 10.1002/hbm.21301; Panouilleres M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017329; Panouilleres M, 2009, J NEUROPHYSIOL, V101, P1550, DOI 10.1152/jn.90988.2008; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; PRABLANC C, 1978, VISION RES, V18, P557, DOI 10.1016/0042-6989(78)90202-X; Prsa M, 2011, EUR J NEUROSCI, V33, P2114, DOI 10.1111/j.1460-9568.2011.07693.x; Prsa M, 2010, J NEUROSCI, V30, P15834, DOI 10.1523/JNEUROSCI.3901-10.2010; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Schnier F, 2012, J NEUROPHYS IN PRESS; Schnier F, 2011, J NEUROPHYSIOL, V106, P1399, DOI 10.1152/jn.00236.2011; Seeberger T, 2002, BRAIN RES, V956, P374, DOI 10.1016/S0006-8993(02)03577-1; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; STRAUBE A, 1995, VISION RES, V35, P3451, DOI 10.1016/0042-6989(95)00076-Q; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54641	10.1371/journal.pone.0054641	http://dx.doi.org/10.1371/journal.pone.0054641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382932	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200014
J	Li, ZQ; Cheng, DJ; Mon, H; Zhu, L; Xu, J; Tatsuke, T; Lee, JM; Xia, QY; Kusakabe, T				Li, Zhiqing; Cheng, Daojun; Mon, Hiroaki; Zhu, Li; Xu, Jian; Tatsuke, Tsuneyuki; Lee, Jae Man; Xia, Qingyou; Kusakabe, Takahiro			Cell Cycle-Dependent Recruitment of Polycomb Proteins to the ASNS Promoter Counteracts C/ebp-Mediated Transcriptional Activation in Bombyx mori	PLOS ONE			English	Article							ASPARAGINE SYNTHETASE GENE; H3 LYSINE-27 METHYLATION; AMINO-ACID DEPRIVATION; DNA METHYLATION; DROSOPHILA; SILKWORM; CANCER; COMPLEX; BINDING; EXPRESSION	Epigenetic modifiers and transcription factors contribute to developmentally programmed gene expression. Here, we establish a functional link between epigenetic regulation by Polycomb group (PcG) proteins and transcriptional regulation by C/ebp that orchestrates the correct expression of Bombyx mori asparagine synthetase (BmASNS), a gene involved in the biosynthesis of asparagine. We show that the cis-regulatory elements of YY1-binding motifs and the CpG island present on the BmASNS promoter are required for the recruitment of PcG proteins and the subsequent deposition of the epigenetic repression mark H3K27me3. RNAi-mediated knockdown of PcG genes leads to derepression of the BmASNS gene via the recruitment of activators, including BmC/ebp, to the promoter. Intriguingly, we find that PcG proteins and BmC/ebp can dynamically modulate the transcriptional output of the BmASNS target in a cell cycle-dependent manner. It will be essential to suppress BmASNS expression by PcG proteins at the G2/M phase of the cell cycle in the presence of BmC/ebp activator. Thus, our results provide a novel insight into the molecular mechanism underlying the recruitment and regulation of the PcG system at a discrete gene locus in Bombyx mori.	[Li, Zhiqing; Mon, Hiroaki; Zhu, Li; Xu, Jian; Tatsuke, Tsuneyuki; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan; [Cheng, Daojun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Kyushu University; Southwest University - China	Kusakabe, T (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan.	kusakabe@agr.kyushu-u.ac.jp	Tatsuke, Tsuneyuki/I-3714-2019; Zhu, Li/S-7517-2018; Xu, Jian/G-6684-2015	Tatsuke, Tsuneyuki/0000-0003-2322-4528; Zhu, Li/0000-0002-4919-1894; Xu, Jian/0000-0003-1816-4129; Li, Zhiqing/0000-0001-8323-3245	Japan Society for the Promotion of Science [22248004, 23580077]; National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) No. 22248004 and 23580077 from the Japan Society for the Promotion of Science to TK and JML, and also by grants from the National Basic Research Program of China (No. 2012CB114600) and the National Hi-Tech Research and Development Program of China (No. 2011AA100306) to QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; GRECO A, 1989, MOL CELL BIOL, V9, P2350, DOI 10.1128/MCB.9.6.2350; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034330; Li ZQ, 2012, MOL BIOL REP, V39, P5575, DOI 10.1007/s11033-011-1362-5; Lorenzi PL, 2008, MOL CANCER THER, V7, P3123, DOI 10.1158/1535-7163.MCT-08-0589; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Mitsunobu H, 2012, INSECT MOL BIOL, V21, P9, DOI 10.1111/j.1365-2583.2011.01115.x; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Mon H, 2003, BIOCHEM BIOPH RES CO, V312, P684, DOI 10.1016/j.bbrc.2003.10.169; Mon H, 2012, J INSECT SC IN PRESS; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhou D, 2011, BBA-GENE REGUL MECH, V1809, P549, DOI 10.1016/j.bbagrm.2011.07.003	39	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e52320	10.1371/journal.pone.0052320	http://dx.doi.org/10.1371/journal.pone.0052320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382816	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500004
J	Bidwell, GL; Perkins, E; Hughes, J; Khan, M; James, JR; Raucher, D				Bidwell, Gene L., III; Perkins, Eddie; Hughes, Joshua; Khan, Majid; James, Judy R.; Raucher, Drazen			Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma Model	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; ELASTIN-LIKE POLYPEPTIDE; CANCER-CELL-PROLIFERATION; DRUG-DELIVERY; GLIOBLASTOMA-MULTIFORME; GENETIC ALTERATIONS; SOLID TUMORS; PEPTIDE; DIFFERENTIATION; ACCUMULATION	Treatment of glioblastoma is complicated by the tumors' high resistance to chemotherapy, poor penetration of drugs across the blood brain barrier, and damaging effects of chemotherapy and radiation to normal neural tissue. To overcome these limitations, a thermally responsive polypeptide was developed for targeted delivery of therapeutic peptides to brain tumors using focused hyperthermia. The peptide carrier is based on elastin-like polypeptide (ELP), which is a thermally responsive biopolymer that forms aggregates above a characteristic transition temperature. ELP was modified with cell penetrating peptides (CPPs) to enhance delivery to brain tumors and mediate uptake across the tumor cells' plasma membranes and with a peptide inhibitor of c-Myc (H1). In rats with intracerebral gliomas, brain tumor targeting of ELP following systemic administration was enhanced up to 5-fold by the use of CPPs. When the lead CPP-ELP-fused c-Myc inhibitor was combined with focused hyperthermia of the tumors, an additional 3 fold increase in tumor polypeptide levels was observed, and 80% reduction in tumor volume, delayed onset of tumor-associated neurological deficits, and at least doubled median survival time including complete regression in 80% of animals was achieved. This work demonstrates that a c-Myc inhibitory peptide can be effectively delivered to brain tumors.	[Bidwell, Gene L., III; Khan, Majid] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; [Bidwell, Gene L., III; Perkins, Eddie; Raucher, Drazen] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Perkins, Eddie; Hughes, Joshua] Univ Mississippi, Med Ctr, Dept Neurosurg, Jackson, MS 39216 USA; [Perkins, Eddie] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Khan, Majid; James, Judy R.] Univ Mississippi, Med Ctr, Dept Radiol, Jackson, MS 39216 USA; [Raucher, Drazen] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Raucher, D (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA.	draucher@umc.edu	Raucher, Drazen/AAE-4540-2022	Khan, Majid/0000-0002-3807-1387; Hughes, Joshua/0000-0003-0362-302X; Bidwell, Gene/0000-0001-9104-150X	Department of Defense Breast Cancer Research Program fellowship [W81XWH-08-1-0647]; National Science Foundation [CBET-0931041]; National Institutes of Health (NIH) National Cancer Institute [R21 CA139589-01]; NIH from the MFGN INBRE Program of the National Center for Research Resources [RR016476]; NATIONAL CANCER INSTITUTE [R21CA139589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program fellowship(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH from the MFGN INBRE Program of the National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for these studies was provided by a Department of Defense Breast Cancer Research Program fellowship [W81XWH-08-1-0647] to GLB, National Science Foundation grant [CBET-0931041] to DR, and National Institutes of Health (NIH) National Cancer Institute grant [R21 CA139589-01] to DR. The authors thank the Mississippi Functional Genomics Network (MFGN) Genomics Facility, which is supported by NIH Grant # RR016476 from the MFGN INBRE Program of the National Center for Research Resources, for access to and assistance with slide scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bidwell GL, 2012, CANCER LETT, V319, P136, DOI 10.1016/j.canlet.2011.12.042; Bidwell GL, 2010, ADV DRUG DELIVER REV, V62, P1486, DOI 10.1016/j.addr.2010.05.003; Bidwell GL, 2010, PEPTIDES, V31, P834, DOI 10.1016/j.peptides.2010.02.007; Bidwell GL, 2009, EXPERT OPIN DRUG DEL, V6, P1033, DOI 10.1517/17425240903143745; Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015; Bidwell GL, 2006, BIOCHEM PHARMACOL, V71, P248, DOI 10.1016/j.bcp.2005.10.041; Bidwell GL, 2005, MOL CANCER THER, V4, P1076, DOI 10.1158/1535-7163.MCT-04-0253; Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1; DRAEGER LJ, 1994, J BIOL CHEM, V269, P1785; Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444; Gorin F, 2004, ACTA NEUROPATHOL, V107, P235, DOI 10.1007/s00401-003-0803-1; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7; Hou Lewis C, 2006, Neurosurg Focus, V20, pE5; Jolesz FA, 2008, J MAGN RESON IMAGING, V27, P391, DOI 10.1002/jmri.21261; Jolesz FA, 2009, ANNU REV MED, V60, P417, DOI 10.1146/annurev.med.60.041707.170303; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; Lefranc F, 2006, EXPERT REV ANTICANC, V6, P719, DOI 10.1586/14737140.6.5.719; Lipka E, 1996, J CONTROL RELEASE, V39, P121, DOI 10.1016/0168-3659(95)00145-X; Liu WE, 2006, J CONTROL RELEASE, V116, P170, DOI 10.1016/j.jconrel.2006.06.026; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Marquet F, 2009, PHYS MED BIOL, V54, P2597, DOI 10.1088/0031-9155/54/9/001; Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jconrel.2005.08.007; Massodi I, 2010, INT J CANCER, V126, P533, DOI 10.1002/ijc.24725; Massodi I, 2009, MOLECULES, V14, P1999, DOI 10.3390/molecules14061999; Meyer DE, 2001, CANCER RES, V61, P1548; ORIAN JM, 1992, BRIT J CANCER, V66, P106, DOI 10.1038/bjc.1992.225; Panicker SP, 2010, ONCOTARGET, V1, P289; Partanen A, 2012, INT J HYPERTHER, V28, P320, DOI 10.3109/02656736.2012.680173; Paul I, 2012, ONCOGENE; Pourquier P, 1998, BIOCHEM PHARMACOL, V55, P1963, DOI 10.1016/S0006-2952(98)00006-9; Raucher D, 2009, EXPERT OPIN DRUG DEL, V6, P1049, DOI 10.1517/17425240903158909; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; Talmadge JE, 1998, ADV DRUG DELIVER REV, V33, P241, DOI 10.1016/S0169-409X(98)00032-5; Thuroff S, 2003, J ENDOUROL, V17, P673, DOI 10.1089/089277903322518699; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang X, 2002, CHINESE MED J-PEKING, V115, P1332; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	42	80	83	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55104	10.1371/journal.pone.0055104	http://dx.doi.org/10.1371/journal.pone.0055104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372821	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400063
J	Ventura, T; Manor, R; Aflalo, ED; Chalifa-Caspi, V; Weil, S; Sharabi, O; Sagi, A				Ventura, Tomer; Manor, Rivka; Aflalo, Eliahu D.; Chalifa-Caspi, Vered; Weil, Simy; Sharabi, Omri; Sagi, Amir			Post-Embryonic Transcriptomes of the Prawn Macrobrachium rosenbergii: Multigenic Succession through Metamorphosis	PLOS ONE			English	Article							METHYL FARNESOATE; LIFE-CYCLE; MICROARRAY ANALYSIS; GENE-EXPRESSION; HEDGEHOG; LARVAL; GENOMICS; ANNOTATION; BLAST2GO; TOOL	Like many metazoans, the freshwater prawn Macrobrachium rosenbergii begins its post-embryonic life with a set of morphologically distinct planktonic larval stages, followed by a benthic post-larval stage during which the maturing organism differs from the larvae both ecologically and physiologically. Understanding of the molecular basis underlying morphogenesis in crustaceans is limited to the observation that methyl farnesoate, the non-epoxidated form of the insect juvenile hormone, acts as the active crustacean juvenoid. Molt steroids were also linked to morphogenesis and several other molecular pathways, such as Hedgehog and Wnt, are known to underlie morphogenesis in all metazoans examined and, as such, are thought to do the same in crustaceans. Using next generation sequencing, we deep-sequenced the transcriptomes of several larval and post-larval stages. De novo assembly, followed by bioinformatics analysis, revealed that many novel transcripts are over-expressed in either larvae-or post-larvae-stage prawn, shedding light on the molecular basis underlying M. rosenbergii metamorphosis. Fast larval molting rates and periodic morphological changes were reflected in over-expression of transcripts annotated to the cell cycle, DNA replication and morphogenic pathways (i.e., Hedgehog and Wnt). Further characterization of transcripts assigned to morphogenic pathways by real-time RT-PCR reconfirmed their over-expression in larvae, albeit with a more complex expression pattern when examined in the individual developmental stages. The expression level of an orthologue of cytochrome P450, 15A1, known to epoxidize methyl farnesoate in insects, was increased in the late larval and early post-larval stages, in accordance with the role of methyl farnesoate in crustacean metamorphosis. This study exemplifies the applicability of a high-throughput sequencing approach for studying complex traits, including metamorphosis, providing new insight into this unexplored area of crustacean research.	[Ventura, Tomer; Manor, Rivka; Aflalo, Eliahu D.; Weil, Simy; Sharabi, Omri; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ventura, Tomer; Manor, Rivka; Aflalo, Eliahu D.; Chalifa-Caspi, Vered; Weil, Simy; Sharabi, Omri; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	Ventura, T./H-9832-2019	Ventura, T./0000-0002-0777-2367; Sagi, Amir/0000-0002-4229-1059; Chalifa-Caspi, Vered/0000-0001-6030-5816; Aflalo, Eli/0000-0003-1385-2387	Tiran, Ltd. through BGNegev; National Institute for Biotechnology in the Negev (NIBN); Wolfson Family Charitable Trust	Tiran, Ltd. through BGNegev; National Institute for Biotechnology in the Negev (NIBN); Wolfson Family Charitable Trust	This study was funded by grants from Tiran, Ltd. through BGNegev and the National Institute for Biotechnology in the Negev (NIBN) and the Wolfson Family Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 1998, BIOL BULL, V195, P112, DOI 10.2307/1542818; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Conaco C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-209; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; FAO, 2009, MACR ROS SPEC FACT S; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Guerrero FD, 2009, J MED ENTOMOL, V46, P257, DOI 10.1603/033.046.0210; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Laufer H, 2001, AM ZOOL, V41, P442, DOI 10.1668/0003-1569(2001)041[0442:UCLFMF]2.0.CO;2; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Lemos D, 2002, AQUACULTURE, V214, P363, DOI 10.1016/S0044-8486(02)00253-3; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Medina M, 2009, MOL ECOL, V18, P763, DOI 10.1111/j.1365-294X.2008.04079.x; MOHLER J, 1988, GENETICS, V120, P1061; Retaux S, 2010, INTEGR COMP BIOL, V50, P98, DOI 10.1093/icb/icq032; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; SAGI A, 1991, COMP BIOCHEM PHYS B, V99, P879, DOI 10.1016/0305-0491(91)90157-9; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; UNO Y, 1969, Journal of the Tokyo University of Fisheries, V55, P179; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Wong YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033323; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	38	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55322	10.1371/journal.pone.0055322	http://dx.doi.org/10.1371/journal.pone.0055322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372848	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400088
J	Pielarski, KN; van Stegen, B; Andreyeva, A; Nieweg, K; Jungling, K; Redies, C; Gottmann, K				Pielarski, Kim N.; van Stegen, Bernd; Andreyeva, Aksana; Nieweg, Katja; Juengling, Kay; Redies, Christoph; Gottmann, Kurt			Asymmetric N-Cadherin Expression Results in Synapse Dysfunction, Synapse Elimination, and Axon Retraction in Cultured Mouse Neurons	PLOS ONE			English	Article							REGULATES DENDRITIC SPINE; EMBRYONIC STEM-CELLS; BETA-CATENIN; ADHESION; DIFFERENTIATION; MECHANISMS; RECEPTOR; LOCALIZATION; SUPERFAMILY; CONNECTIONS	Synapse elimination and pruning of axon collaterals are crucial developmental events in the refinement of neuronal circuits. While a control of synapse formation by adhesion molecules is well established, the involvement of adhesion molecules in developmental synapse loss is poorly characterized. To investigate the consequences of mis-match expression of a homophilic synaptic adhesion molecule, we analysed an asymmetric, exclusively postsynaptic expression of N-cadherin. This was induced by transfecting individual neurons in cultures of N-cadherin knockout mouse neurons with a N-cadherin expression vector. 2 days after transfection, patch-clamp analysis of AMPA receptor-mediated miniature postsynaptic currents revealed an impaired synaptic function without a reduction in the number of presynaptic vesicle clusters. Longterm asymmetric expression of N-cadherin for 8 days subsequently led to synapse elimination as indicated by a loss of colocalization of presynaptic vesicles and postsynaptic PSD95 protein. We further studied long-term asymmetric N-cadherin expression by conditional, Cre-induced knockout of N-cadherin in individual neurons in cultures of N-cadherin expressing cortical mouse neurons. This resulted in a strong retraction of axonal processes in individual neurons that lacked N-cadherin protein. Moreover, an in vivo asymmetric expression of N-cadherin in the developmentally transient cortico-tectal projection was indicated by in-situ hybridization with layer V neurons lacking N-cadherin expression. Thus, mis-match expression of N-cadherin might contribute to selective synaptic connectivity.	[Pielarski, Kim N.; van Stegen, Bernd; Andreyeva, Aksana; Nieweg, Katja; Juengling, Kay; Gottmann, Kurt] Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany; [Redies, Christoph] Univ Jena, Sch Med, Jena Univ Hosp, Inst Anat 1, Jena, Germany	Heinrich Heine University Dusseldorf; Friedrich Schiller University of Jena	Gottmann, K (corresponding author), Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany.	Kurt.Gottmann@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding from Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva A, 2012, BRAIN, V135, P2140, DOI 10.1093/brain/aws120; Baba K, 2007, BRAIN RES, V1140, P205, DOI 10.1016/j.brainres.2006.09.113; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Cork RJ, 1998, J COMP NEUROL, V394, P205; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DOHERTY P, 1991, J CELL SCI, P13; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiederling A, 2011, NEUROSCI LETT, V501, P167, DOI 10.1016/j.neulet.2011.07.009; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; Gil OD, 2002, J COMP NEUROL, V453, P372, DOI 10.1002/cne.10424; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Huntley GW, 1999, J COMP NEUROL, V407, P453; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Jungling K, 2003, FASEB J, V17, P2100, DOI 10.1096/fj.03-0118fje; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mohrmann R, 2003, NEUROSCIENCE, V117, P7, DOI 10.1016/S0306-4522(02)00835-7; Moore R, 1999, INT J DEV BIOL, V43, P831; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Mysore SP, 2008, FRONT NEUROSCI-SWITZ, V2, P168, DOI 10.3389/neuro.01.035.2008; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Obst-Pernberg K, 2001, NEUROSCIENCE, V106, P505, DOI 10.1016/S0306-4522(01)00292-5; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Piechotta K, 2006, CELL TISSUE RES, V326, P617, DOI 10.1007/s00441-006-0267-4; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; SIDDIQUI TJ, 2010, CURR OPIN NEUROBIOL, V21, P1; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugiura H, 2009, NEUROSCIENTIST, V15, P90, DOI 10.1177/1073858408324024; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	71	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54105	10.1371/journal.pone.0054105	http://dx.doi.org/10.1371/journal.pone.0054105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382872	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600024
J	Takata, F; Dohgu, S; Yamauchi, A; Matsumoto, J; Machida, T; Fujishita, K; Shibata, K; Shinozaki, Y; Sato, K; Kataoka, Y; Koizumi, S				Takata, Fuyuko; Dohgu, Shinya; Yamauchi, Atsushi; Matsumoto, Junichi; Machida, Takashi; Fujishita, Kayoko; Shibata, Keisuke; Shinozaki, Youichi; Sato, Kaoru; Kataoka, Yasufumi; Koizumi, Schuichi			In Vitro Blood-Brain Barrier Models Using Brain Capillary Endothelial Cells Isolated from Neonatal and Adult Rats Retain Age-Related Barrier Properties	PLOS ONE			English	Article							P-GLYCOPROTEIN; EFFLUX TRANSPORT; VALPROIC ACID; EXPRESSION; PERICYTES; CULTURES; PENETRATION; OSELTAMIVIR; OCCLUDIN; INVITRO	The blood-brain barrier (BBB) restricts the entry of circulating drugs and xenobiotics into the brain, and thus its permeability to substances is a critical factor that determines their central effects. The infant brain is vulnerable to neurotoxic substances partly due to the immature BBB. The employment of in vitro BBB models to evaluate permeability of compounds provides higher throughput than that of in vivo animal experiments. However, existing in vitro BBB models have not been able to simulate the intrinsic neonatal BBB. To establish a neonatal BBB model that mimics age-related BBB properties, the neonatal and adult in vitro BBB models were constructed with brain endothelial cells isolated from 2- and 8-week-old rats, respectively. To evaluate BBB functions, transendothelial electrical resistance, permeability of sodium fluorescein and Evans blue-albumin, and transport of rhodamine123 were measured. Radiolabelled drugs were used for BBB permeability studies in the neonatal and adult BBB models (in vitro) and in age-matched rats (in vivo). The neonatal BBB model showed lower barrier and p-glycoprotein (P-gp) functions than the adult BBB model; these were well associated with lower expressions of the barrier-related proteins and P-gp, and a different distribution pattern of immunostained barrier-related proteins. Verapamil (a P-gp inhibitor) significantly increased the influx of rhodamine 123, supporting functional P-gp expression in the neonatal BBB model. Valproic acid, but not nicotine, showed higher BBB permeability in the neonatal BBB model, which was well in accordance with the in vivo BBB property. We established a neonatal BBB model in vitro. This could allow us to assess the age-dependent BBB permeability of drugs.	[Takata, Fuyuko; Dohgu, Shinya; Yamauchi, Atsushi; Matsumoto, Junichi; Machida, Takashi; Kataoka, Yasufumi] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka 81401, Japan; [Takata, Fuyuko; Kataoka, Yasufumi] PharmaCo Cell Co Ltd, BBB Lab, Nagasaki, Japan; [Fujishita, Kayoko; Shibata, Keisuke; Shinozaki, Youichi; Koizumi, Schuichi] Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan; [Shibata, Keisuke; Shinozaki, Youichi; Koizumi, Schuichi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Sato, Kaoru] Natl Inst Hlth Sci, Div Pharmacol, Tokyo, Japan	Fukuoka University; University of Yamanashi; Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan	Koizumi, S (corresponding author), Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan.	skoizumi@yamanashi.ac.jp	Shinozaki, Youichi/AAC-9431-2019; Koizumi, Schuichi/E-8568-2010; Dohgu, Shinya/AAK-9992-2020; Shinozaki, Youichi/E-8594-2010	Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106; Shinozaki, Youichi/0000-0002-6448-1304	Food Safety Commission Japan [1003]; Japan Society for the Promotion of Science [21240034, 22590255, 21790102, 23790113, 21790257, 21790255]; central research institute of Fukuoka University [112505]; Grants-in-Aid for Scientific Research [22590255, 21700422, 22590163] Funding Source: KAKEN	Food Safety Commission Japan(Food Safety Commission of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); central research institute of Fukuoka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid ((to SK) 1003) from Food Safety Commission Japan (http://www.fsc.go.jp/english/index.html), a Grant-in Aid for Scientific Research ((to SK)(A) 21240034), Grants-in-Aid for Scientific Research ((to YK)(C) 22590255), Grants-in-Aid for Young Scientists ((to FT)(B) 21790102, (to FT)(B) 23790113, (to SD)(B) 21790257, (to AY)(B) 21790255) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/), and Funds ((to SD) no. 112505) from the central research institute of Fukuoka University (http://www.adm.fukuoka-u.ac.jp/fu844/home2/Ronso/Ronso-top/Ronso_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Banks WA, 2000, AM J PHYSIOL-ENDOC M, V278, pE1158, DOI 10.1152/ajpendo.2000.278.6.E1158; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Costa LG, 2004, PHARMACOL REV, V56, P103, DOI 10.1124/pr.56.1.5; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dohgu S, 2007, CELL MOL NEUROBIOL, V27, P889, DOI 10.1007/s10571-007-9209-2; Dohgu S, 2011, MICROVASC RES, V81, P103, DOI 10.1016/j.mvr.2010.10.004; Ek CJ, 2012, NEUROTOXICOLOGY; FERGUSON RK, 1969, EXP BRAIN RES, V7, P181; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Gibbs JP, 2004, EPILEPSY RES, V58, P53, DOI 10.1016/j.eplepsyres.2003.12.008; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Kakee A, 2002, MICROVASC RES, V63, P233, DOI 10.1006/mvre.2001.2378; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Matsuoka Y, 1999, J NEUROBIOL, V39, P383, DOI 10.1002/(SICI)1097-4695(19990605)39:3<383::AID-NEU5>3.0.CO;2-4; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mooradian AD, 2003, MECH AGEING DEV, V124, P143, DOI 10.1016/S0047-6374(02)00041-6; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Ose A, 2008, DRUG METAB DISPOS, V36, P427, DOI 10.1124/dmd.107.018556; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Shayo M, 1997, LIFE SCI, V60, pPL115, DOI 10.1016/S0024-3205(96)00685-6; Szabo C A, 1997, Neurobiology (Bp), V5, P1; Takashima T, 2011, J NUCL MED, V52, P950, DOI 10.2967/jnumed.110.083949; Takata F, 2008, NEUROSCI LETT, V441, P163, DOI 10.1016/j.neulet.2008.06.030; Takata F, 2009, NEUROSCI LETT, V449, P71, DOI 10.1016/j.neulet.2008.10.082; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Urayama Akihiko, 2003, Drug Metab Pharmacokinet, V18, P310, DOI 10.2133/dmpk.18.310; Winneke G, 2011, J NEUROL SCI, V308, P9, DOI 10.1016/j.jns.2011.05.020	34	38	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55166	10.1371/journal.pone.0055166	http://dx.doi.org/10.1371/journal.pone.0055166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383092	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600069
J	Campbell, AD; Lawn, S; McGarry, LC; Welch, HC; Ozanne, BW; Norman, JC				Campbell, Andrew D.; Lawn, Samuel; McGarry, Lynn C.; Welch, Heidi C.; Ozanne, Bradford W.; Norman, Jim C.			P-Rex1 Cooperates with PDGFR beta to Drive Cellular Migration in 3D Microenvironments	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; HUMAN ONCOGENE; RHO-GTPASES; RAC; GROWTH; GENES; PERICYTES; MELANOMA; INVASION; PROTEIN	Expression of the Rac-guanine nucleotide exchange factor (RacGEF), P-Rex1 is a key determinant of progression to metastasis in a number of human cancers. In accordance with this proposed role in cancer cell invasion and metastasis, we find that ectopic expression of P-Rex1 in an immortalised human fibroblast cell line is sufficient to drive multiple migratory and invasive phenotypes. The invasive phenotype is greatly enhanced by the presence of a gradient of serum or platelet-derived growth factor, and is dependent upon the expression of functional PDGF receptor beta. Consistently, the invasiveness of WM852 melanoma cells, which endogenously express P-Rex1 and PDGFR beta, is opposed by siRNA of either of these proteins. Furthermore, the current model of P-Rex1 activation is advanced through demonstration of P-Rex1 and PDGFR beta as components of the same macromolecular complex. These data suggest that P-Rex1 has an influence on physiological migratory processes, such as invasion of cancer cells, both through effects upon classical Rac1-driven motility and a novel association with RTK signalling complexes.	[Campbell, Andrew D.; Lawn, Samuel; McGarry, Lynn C.; Ozanne, Bradford W.; Norman, Jim C.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Welch, Heidi C.] Babraham Inst, Cambridge, England	Beatson Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Norman, JC (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	j.norman@beatson.gla.ac.uk		Welch, Heidi/0000-0001-7865-7000; NORMAN, Jim/0000-0002-0098-3014	Cancer Research UK; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0411, BB/I02154X/1] Funding Source: researchfish; BBSRC [BB/I02154X/1, BBS/E/B/000C0411] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by generous support from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eriksson A, 1992, GROWTH FACTORS, V6, DOI 10.3109/08977199209008867; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RODECK U, 1991, J INVEST DERMATOL, V97, P20, DOI 10.1111/1523-1747.ep12477822; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Scott LA, 2004, MOL CELL BIOL, V24, P1540, DOI 10.1128/MCB.24.4.1540-1559.2004; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Shi H, 2000, CANCER RES, V71, P5067; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Weiner OD, 2002, CURR BIOL, V12, pR429, DOI 10.1016/S0960-9822(02)00917-X; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Woodward AM, 2001, CELL BIOL INT, V25, P205, DOI 10.1006/cbir.2000.0635; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	39	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53982	10.1371/journal.pone.0053982	http://dx.doi.org/10.1371/journal.pone.0053982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382862	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000315563800028
J	Dion, C; Singh, K; Ozaki, T; Lesk, MR; Costantino, S				Dion, Carolyne; Singh, Kanwarpal; Ozaki, Tsuneyuki; Lesk, Mark R.; Costantino, Santiago			Analysis of Pulsatile Retinal Movements by Spectral-Domain Low-Coherence Interferometry: Influence of Age and Glaucoma on the Pulse Wave	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; FREQUENCY-ANALYSIS; AMPLITUDE	Recent studies have shown that ocular hemodynamics and eye tissue biomechanical properties play an important role in the pathophysiology of glaucoma. Nevertheless, better, non-invasive methods to assess these characteristics in vivo are essential for a thorough understanding of degenerative mechanisms. Here, we propose to measure ocular tissue movements induced by cardiac pulsations and study the ocular pulse waveform as an indicator of tissue compliance. Using a novel, low-cost and non-invasive device based on spectral-domain low coherence interferometry (SD-LCI), we demonstrate the potential of this technique to differentiate ocular hemodynamic and biomechanical properties. We measured the axial movement of the retina driven by the pulsatile ocular blood flow in 11 young healthy individuals, 12 older healthy individuals and 15 older treated glaucoma patients using our custom-made SD-OCT apparatus. The cardiac pulse was simultaneously measured through the use of an oximeter to allow comparison. Spectral components up to the second harmonic were obtained and analyzed. For the different cohorts, we computed a few parameters that characterize the three groups of individuals by analyzing the movement of the retinal tissue at two locations, using this simple, low-cost interferometric device. Our pilot study indicates that spectral analysis of the fundus pulsation has potential for the study of ocular biomechanical and vascular properties, as well as for the study of ocular disease.	[Dion, Carolyne; Singh, Kanwarpal; Ozaki, Tsuneyuki] Inst Natl Rech Sci Energie Mat & Telecommun, Varennes, PQ, Canada; [Dion, Carolyne; Singh, Kanwarpal; Ozaki, Tsuneyuki; Lesk, Mark R.; Costantino, Santiago] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Lesk, Mark R.; Costantino, Santiago] Univ Montreal, Fac Med, Dept Ophthalmol, Montreal, PQ H3C 3J7, Canada; [Costantino, Santiago] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Universite de Montreal; Universite de Montreal	Costantino, S (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada.	santiago.costantino@umontreal.ca	Singh, Kanwarpal/P-3789-2019; Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635; Singh, Kanwarpal/0000-0002-6884-8089; Ozaki, Tsuneyuki/0000-0001-8857-3900	Ministere du Developpement Economique de l'Innovation et de l'Exportation du Quebec; Fonds Quebecois de la Recherchesur la Nature et les Technologies; Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec; le Fonds de Recherche en Ophthalmologie de Universite de Montreal; Natural Sciences and Engineering Research Council of Canada	Ministere du Developpement Economique de l'Innovation et de l'Exportation du Quebec; Fonds Quebecois de la Recherchesur la Nature et les Technologies(FQRNT); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); le Fonds de Recherche en Ophthalmologie de Universite de Montreal; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The study was supported by the Ministere du Developpement Economique de l'Innovation et de l'Exportation du Quebec, the Fonds Quebecois de la Recherchesur la Nature et les Technologies, the Canadian Institutes of Health Research, the Fonds de la Recherche en Sante du Quebec, le Fonds de Recherche en Ophthalmologie de Universite de Montreal and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolger C, 1999, VISION RES, V39, P1911, DOI 10.1016/S0042-6989(98)00322-8; BOSLEY TM, 1993, STROKE, V24, P6, DOI 10.1161/01.STR.24.1.6; Delori FC, 2007, J OPT SOC AM A, V24, P1250, DOI 10.1364/JOSAA.24.001250; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Dragostinoff N, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251049; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; FINDLAY JM, 1971, KYBERNETIK, V8, P207, DOI 10.1007/BF00288749; FINKELSTEIN SM, 1988, HYPERTENSION, V12, P380, DOI 10.1161/01.HYP.12.4.380; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garzozi HJ, 2001, ISRAEL MED ASSOC J, V3, P443; Hodapp E, 1993, CLIN DECISIONS GLAUC; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; JAMES CB, 1991, BRIT J OPHTHALMOL, V75, P466, DOI 10.1136/bjo.75.8.466; Kasprzak H, 2007, OPT PURA APL, V40, P7; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kerr J, 1998, AM J OPHTHALMOL, V126, P42, DOI 10.1016/S0002-9394(98)00074-9; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; KRAKAU CET, 1995, ACTA OPHTHALMOL SCAN, V73, P472; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Lesk MR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1568, DOI 10.1001/archopht.124.11.1568; Mangouritsas G, 2008, ACTA OPHTHALMOLOGICA; NICHOLS WW, 1977, CIRC RES, V40, P451, DOI 10.1161/01.RES.40.5.451; Nowak W, 2008, OPT APPL, V38, P469; Plumb RD, 2011, BRIT J DIABETES VASC, V11, P243; Schmidt KG, 1997, EYE, V11, P485, DOI 10.1038/eye.1997.131; Silver D M, 1994, Surv Ophthalmol, V38 Suppl, pS72, DOI 10.1016/0039-6257(94)90049-3; Singh K, 2012, INVESTIGATIVE OPHTHA; Singh K, EXPT EYE RES, V91, P63; Singh K, INVESTIGATIVE OPHTHA, V52, P8927; Witte S, 2009, OPT EXPRESS, V17, P11335, DOI 10.1364/OE.17.011335; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309	32	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54207	10.1371/journal.pone.0054207	http://dx.doi.org/10.1371/journal.pone.0054207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382879	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800037
J	Gerasimova, A; Chavez, L; Li, B; Seumois, G; Greenbaum, J; Rao, A; Vijayanand, P; Peters, B				Gerasimova, Anna; Chavez, Lukas; Li, Bin; Seumois, Gregory; Greenbaum, Jason; Rao, Anjana; Vijayanand, Pandurangan; Peters, Bjoern			Predicting Cell Types and Genetic Variations Contributing to Disease by Combining GWAS and Epigenetic Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HISTONE MODIFICATIONS; CHILDHOOD ASTHMA; CHROMATIN STATES; SEQ DATA; EXPRESSION; ENHANCERS; VARIANTS; POPULATION; DIFFERENTIATION	Genome-wide association studies (GWASs) identify single nucleotide polymorphisms (SNPs) that are enriched in individuals suffering from a given disease. Most disease-associated SNPs fall into non-coding regions, so that it is not straightforward to infer phenotype or function; moreover, many SNPs are in tight genetic linkage, so that a SNP identified as associated with a particular disease may not itself be causal, but rather signify the presence of a linked SNP that is functionally relevant to disease pathogenesis. Here, we present an analysis method that takes advantage of the recent rapid accumulation of epigenomics data to address these problems for some SNPs. Using asthma as a prototypic example; we show that non-coding disease-associated SNPs are enriched in genomic regions that function as regulators of transcription, such as enhancers and promoters. Identifying enhancers based on the presence of the histone modification marks such as H3K4me1 in different cell types, we show that the location of enhancers is highly cell-type specific. We use these findings to predict which SNPs are likely to be directly contributing to disease based on their presence in regulatory regions, and in which cell types their effect is expected to be detectable. Moreover, we can also predict which cell types contribute to a disease based on overlap of the disease-associated SNPs with the locations of enhancers present in a given cell type. Finally, we suggest that it will be possible to re-analyze GWAS studies with much higher power by limiting the SNPs considered to those in coding or regulatory regions of cell types relevant to a given disease.	[Gerasimova, Anna; Chavez, Lukas; Li, Bin; Seumois, Gregory; Greenbaum, Jason; Rao, Anjana; Vijayanand, Pandurangan; Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	La Jolla Institute for Immunology	Gerasimova, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	agerasimova@liai.org		Chavez, Lukas/0000-0002-8718-8848; Seumois, Gregory/0000-0002-8164-6852	United States National Institutes of Health (NIH) [R01 HL114093, NIH U19 AI100275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100275] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by United States National Institutes of Health (NIH) R01 HL114093 and NIH U19 AI100275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; Chanock S, 2012, GENOME RES, V22, P1612, DOI 10.1101/gr.144980.112; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Miller EK, 2011, VACCINE, V29, P3431, DOI 10.1016/j.vaccine.2011.02.071; Milosavljevic A, 2011, TRENDS GENET, V27, P242, DOI 10.1016/j.tig.2011.03.001; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mondul AM, 2011, HUM MOL GENET, V20, P4724, DOI 10.1093/hmg/ddr387; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54359	10.1371/journal.pone.0054359	http://dx.doi.org/10.1371/journal.pone.0054359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382893	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000315563800046
J	Glessner, JT; Smith, AV; Panossian, S; Kim, CE; Takahashi, N; Thomas, KA; Wang, FX; Seidler, K; Harris, TB; Launer, LJ; Keating, B; Connolly, J; Sleiman, PMA; Buxbaum, JD; Grant, SFA; Gudnason, V; Hakonarson, H				Glessner, Joseph T.; Smith, Albert Vernon; Panossian, Saarene; Kim, Cecilia E.; Takahashi, Nagahide; Thomas, Kelly A.; Wang, Fengxiang; Seidler, Kallyn; Harris, Tamara B.; Launer, Lenore J.; Keating, Brendan; Connolly, John; Sleiman, Patrick M. A.; Buxbaum, Joseph D.; Grant, Struan F. A.; Gudnason, Vilmundur; Hakonarson, Hakon			Copy Number Variations in Alternative Splicing Gene Networks Impact Lifespan	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; COMMON VARIANTS; EXCEPTIONAL LONGEVITY; SEQUENCE VARIANTS; ASSOCIATION; GENOTYPE; RISK; AGE; INSIGHTS; PATHWAY	Longevity has a strong genetic component evidenced by family-based studies. Lipoprotein metabolism, FOXO proteins, and insulin/IGF-1 signaling pathways in model systems have shown polygenic variations predisposing to shorter lifespan. To test the hypothesis that rare variants could influence lifespan, we compared the rates of CNVs in healthy children (0-18 years of age) with individuals 67 years or older. CNVs at a significantly higher frequency in the pediatric cohort were considered risk variants impacting lifespan, while those enriched in the geriatric cohort were considered longevity protective variants. We performed a whole-genome CNV analysis on 7,313 children and 2,701 adults of European ancestry genotyped with 302,108 SNP probes. Positive findings were evaluated in an independent cohort of 2,079 pediatric and 4,692 geriatric subjects. We detected 8 deletions and 10 duplications that were enriched in the pediatric group (P = 3.33 x 10(-8)-1.6 x 10(-2) unadjusted), while only one duplication was enriched in the geriatric cohort (P = 6.3 x 10(-4)). Population stratification correction resulted in 5 deletions and 3 duplications remaining significant (P = 5.16 x 10(-5)-4.26 x 10(-2)) in the replication cohort. Three deletions and four duplications were significant combined (combined P = 3.7 x 10(-4)-3.9 x 10(-2)). All associated loci were experimentally validated using qPCR. Evaluation of these genes for pathway enrichment demonstrated similar to 50% are involved in alternative splicing (P = 0.0077 Benjamini and Hochberg corrected). We conclude that genetic variations disrupting RNA splicing could have long-term biological effects impacting lifespan.	[Glessner, Joseph T.; Panossian, Saarene; Kim, Cecilia E.; Thomas, Kelly A.; Wang, Fengxiang; Seidler, Kallyn; Keating, Brendan; Connolly, John; Sleiman, Patrick M. A.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Heart Prevent Clin, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Res Inst, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Takahashi, Nagahide; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, New York, NY USA; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icelandic Heart Association; Icelandic Heart Association; University of Iceland; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Buxbaum, Joseph D/G-6001-2010; Takahashi, Nagahide/AAR-6268-2020; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Smith, Albert Vernon/K-5150-2015	Takahashi, Nagahide/0000-0002-7711-0297; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Glessner, Joseph/0000-0001-5131-2811; Smith, Albert Vernon/0000-0003-1942-5845; Buxbaum, Joseph/0000-0001-8898-8313; Connolly, John/0000-0003-4396-1226	Institutional Development; Children's Hospital of Philadelphia; Cotswold Foundation; National Institutes of Health (NIH) [N01-AG12100]; National Institute on Aging (NIA); Althingi; NIA Intramural Research Program Laboratory of Neurogenetics; National Human Genome Research Institute (NHGRI) [U01HG004608]; National Institute for General Medical Sciences (NIGMS); Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy [D1A RH00025]; Wisconsin Department of Commerce Technology Development [TDF FYO10718]; NIH [U01HG004438]; eMERGE Administrative Coordinating Center [U01HG004603]; National Center for Biotechnology Information (NCBI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004603, U01HG004438, U01HG004608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, N01AG012100, ZIAAG007270] Funding Source: NIH RePORTER	Institutional Development; Children's Hospital of Philadelphia; Cotswold Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi; NIA Intramural Research Program Laboratory of Neurogenetics; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy; Wisconsin Department of Commerce Technology Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); eMERGE Administrative Coordinating Center; National Center for Biotechnology Information (NCBI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia; by a Research Development Award from the Cotswold Foundation. The AGES-Reykjavik is funded by National Institutes of Health (NIH) contract number N01-AG12100, the National Institute on Aging (NIA) Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). Genotyping was conducted at the NIA Intramural Research Program Laboratory of Neurogenetics. The replication cohort for the older person dataset used for the analyses was obtained from the database of Genotype and Phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000170.v1.p1. Samples and associated phenotype data for the "GWAS on Cataract and HDL in the PMRP'' project were accessed via an authorized data access request by Hakon Hakonarson and Struan F.A. Grant. Funding support for the Personalized Medicine Research Project (PMRP) was provided through a cooperative agreement (U01HG004608) with the National Human Genome Research Institute (NHGRI), with additional funding from the National Institute for General Medical Sciences (NIGMS) The samples used for PMRP analyses were obtained with funding from Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy grant number D1A RH00025, and Wisconsin Department of Commerce Technology Development Fund contract number TDF FYO10718. Funding support for genotyping, which was performed at Johns Hopkins University, was provided by the NIH (U01HG004438). Assistance with phenotype harmonization and genotype cleaning was provided by the eMERGE Administrative Coordinating Center (U01HG004603) and the National Center for Biotechnology Information (NCBI). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000170.v1.p1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Newman AB, 2010, J GERONTOL A-BIOL, V65, P478, DOI 10.1093/gerona/glq028; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Sebastiani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008210; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53846	10.1371/journal.pone.0053846	http://dx.doi.org/10.1371/journal.pone.0053846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382853	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800025
J	McIntyre, NJ; Fluck, RJ; McIntyre, CW; Fakis, A; Taal, MW				McIntyre, Natasha J.; Fluck, Richard J.; McIntyre, Christopher W.; Fakis, Apostolos; Taal, Maarten W.			Determinants of Arterial Stiffness in Chronic Kidney Disease Stage 3	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; SKIN-AUTOFLUORESCENCE; CARDIOVASCULAR EVENTS; AORTIC STIFFNESS; BLOOD-PRESSURE; RISK; MORTALITY; PREDICTOR; SURVIVAL; INDEX	Background: Early chronic kidney disease (CKD) is associated with increased cardiovascular (CV) risk but underlying mechanisms remain uncertain. Arterial stiffness (AS) is associated with increased CV risk in advanced CKD, but it is unclear whether AS is relevant to CV disease (CVD) in early CKD. Study Design: Cross-sectional. Setting and participants: 1717 patients with previous estimated glomerular filtration rate (eGFR) 59-30 mL/min/1.73 m(2); mean age 73 +/- 9y, were recruited from 32 general practices in primary care. Outcomes: Increased arterial stiffness. Measurements: Medical history was obtained and participants underwent clinical assessment, urine and serum biochemistry testing. Carotid to femoral pulse wave velocity (PWV) was determined as a measure of AS, using a Vicorder (TM) device. Results: Univariate analysis revealed significant correlations between PWV and risk factors for CVD including age (r = 0.456; p<0.001), mean arterial pressure (MAP) (r = 0.228; p<0.001), body mass index (r = 20.122; p<0.001), log urinary albumin to creatinine ratio (r = 0.124; p<0.001), Waist to Hip ratio (r = 0.124, p<0.001), eGFR (r = 20.074; p = 0.002), log high sensitivity c-reactive protein (r = 0.066; p = 0.006), HDL (r = -0.062; p = 0.01) and total cholesterol (r = -0.057; p = 0.02). PWV was higher in males (9.6 m/sec vs. 10.3 m/sec; p<0.001), diabetics (9.8 m/sec vs. 10.3 m/sec; p<0.001), and those with previous CV events (CVE) (9.8 m/s vs. 10.3 m/sec; p<0.001). Multivariable analysis identified age, MAP and diabetes as strongest independent determinants of higher PWV (adjusted R-2 = 0.29). An interactive term indicated that PWV increased to a greater extent with age in males versus females. Albuminuria was a weaker determinant of PWV and eGFR did not enter the model. Limitations: Data derived from one study visit, with absence of normal controls. Conclusion: In this cohort, age and traditional CV risk factors were the strongest determinants of AS. Albuminuria was a relatively weak determinant of AS and eGFR was not an independent determinant. Long-term follow-up will investigate AS as an independent risk factor for CVE in this cohort.	[McIntyre, Natasha J.; Fluck, Richard J.; McIntyre, Christopher W.; Fakis, Apostolos; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [McIntyre, Christopher W.] Univ Nottingham, Dept Vasc Med, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Taal, MW (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	maarten.taal1@nhs.net	McIntyre, Christopher W/O-8927-2014	Taal, Maarten/0000-0002-9065-212X; Fakis, Apostolos/0000-0003-1220-3692	Kidney Research UK; British Renal Society; Roche Products plc	Kidney Research UK(Kidney Research UK (KRUK)); British Renal Society; Roche Products plc	This study was supported by a fellowship grant from Kidney Research UK and the British Renal Society, as well as an unrestricted educational grant from Roche Products plc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As regards potential competing interests the authors would like to clarify that the support from Roche Products plc was in the form of an unrestricted educational grant. Specifically this means that Roche played no role whatever in the initiation, design or conduct of the study and have no ownership of the data. The authors are not obligated to provide Roche with any publications prior to submission and are not required to seek approval from Roche for any publications. The authors are therefore able to confirm unequivocally that the sponsorship from Roche does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 1999, J HYPERTENS, V17, P237, DOI 10.1097/00004872-199917020-00008; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Briet M, 2006, KIDNEY INT, V69, P350, DOI 10.1038/sj.ki.5000047; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; de Lusignan S, 2011, NEPHRON CLIN PRACT, V117, pC213, DOI 10.1159/000320341; Evans PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034699; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hartog JWL, 2009, TRANSPLANTATION, V87, P1069, DOI 10.1097/TP.0b013e31819d3173; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lilitkarntakul P, 2012, DIABETES CARE, V35, P1774, DOI 10.2337/dc11-2345; Lilitkarntakul P, 2011, ATHEROSCLEROSIS, V216, P217, DOI 10.1016/j.atherosclerosis.2011.01.045; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McIntyre NJ, 2011, NEPHRON CLIN PRACT, V119, pC269, DOI 10.1159/000329109; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Mitchell GF, 2004, HYPERTENSION, V43, P151, DOI 10.1161/01.HYP.0000114581.77705.29; Mourad JJ, 2001, KIDNEY INT, V59, P1834, DOI 10.1046/j.1523-1755.2001.0590051834.x; Orr JS, 2008, HYPERTENSION, V51, P1519, DOI 10.1161/HYPERTENSIONAHA.108.112946; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; The National Institute for Health and Clincal Excellence, 2008, CHRON KIDN DIS NAT C; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Wang MC, 2005, AM J KIDNEY DIS, V45, P494, DOI 10.1053/j.ajkd.2004.11.011; World Health Organization, 2006, DEF DIAGN DIAB MELL	44	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55444	10.1371/journal.pone.0055444	http://dx.doi.org/10.1371/journal.pone.0055444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383192	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800156
J	Wang, JH; Li, LF; Zhang, KQ; Yu, Y; Li, B; Li, J; Yan, Z; Hu, ZL; Yen, Y; Wu, MC; Jiang, XQ; Qian, QJ				Wang, Jinghan; Li, Linfang; Zhang, Keqiang; Yu, Yong; Li, Bin; Li, Jiang; Yan, Zi; Hu, Zhenli; Yen, Yun; Wu, Mengchao; Jiang, Xiaoqing; Qian, Qijun			Characterization of Two Novel Cell Lines with Distinct Heterogeneity Derived from a Single Human Bile Duct Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER-CELLS; E-CADHERIN; MATRIX METALLOPROTEINASES; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; RISK-FACTORS; HUMAN BREAST; TUMOR; METASTASIS	Background: Intratumoral heterogeneity reflects subclonal diversity and accounts for a variety of clinically defined phenotypes including the development of drug resistance and recurrence. However, intratumoral heterogeneity of bile duct carcinoma (BDC) is rarely studied. Methods: Two highly heterogeneous cell lines named EH-CA1a and EH-CA1b were established from a primary tumor tissue of a pathologically proven BDC. Distinct heterogeneity and underlying mechanisms of two cell lines in karyotype, colony formation, tumorgenicity, and sensitivity to chemoradiotherapy were intensively studied. Results: Both cell lines showed typical morphology of cancer cells. EH-CA1a cells grew as free-floating aggregates, while EH-CA1b cells grew adherently as a monolayer. EH-CA1 alpha cells had higher cloning efficiencies and were able to keep proliferating under hypoxic condition. Coincidentally, hypoxia-induced factor-1a (HIF1 alpha) and vascular endothelial growth factor (VEGF) mRNA were significantly higher in EH-CA1a cells than in EH-CA1b cells. Both cell lines were tumorigenic in nude mouse, however, EH-CA1a cells showed more aggressive characteristics. Most importantly, the EH-CA1a cells showed much more resistance against radiation and chemotherapy with gemcitabine. Metastasis-related genes including matrix metalloproteinase 2 (MMP-2), MMP-9, epithelial-mesenchymal transition (EMT) markers such as Vimentin, Snail, and Twist, are more highly expressed in EH-CA1a cells than in EH-CA1b cells. Moreover, the percentage of cells expressing cancer stem cell-like marker, CD133, in EH-CA1a cells is much higher than that in EH-CA1b cells. Moreover, knockdown of CD133 in both EH-CA1a and EH-CA1b cells significantly reduced their invasive potential and increased their sensitivities to radiation and gemcitabine, suggesting the differential expression of CD133 protein may partially account for the difference in malignancy between these two cancer cells. Conclusion: Establishment of these two cell lines will not only shed light on intratumoral heterogeneities of BDC, but also potentially facilitate the development of novel therapeutic approaches of BDC.	[Wang, Jinghan; Li, Linfang; Yu, Yong; Li, Bin; Li, Jiang; Yan, Zi; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Viral & Gene Therapy, Shanghai, Peoples R China; [Wang, Jinghan; Jiang, Xiaoqing] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg 1, Shanghai, Peoples R China; [Zhang, Keqiang; Yen, Yun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Hu, Zhenli] Second Mil Med Univ, Changhai Hosp, Dept Resp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; City of Hope; Beckman Research Institute of City of Hope; Naval Medical University	Jiang, XQ (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg 1, Shanghai, Peoples R China.	jxq1225@sina.com; qianqj@sino-gene.cn	Yen, Yun/H-9591-2016; Zhang, Keqiang/P-7082-2019		National Science Funds for Distinguished Young Scholar [30925037]; National Natural Science Foundation of China [30921006]	National Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Science Funds for Distinguished Young Scholar (No. 30925037) and supported by the Science Fund for Creative Research Group of National Natural Science Foundation of China (No. 30921006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic T, 2011, TRANSL RES, V157, P19, DOI 10.1016/j.trsl.2010.09.004; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boral Debasish, 2012, Front Biosci (Elite Ed), V4, P2502; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Chung JY, 2009, CLIN CANCER RES, V15, P660, DOI 10.1158/1078-0432.CCR-08-1084; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grosse-Gehling P, 2012, J PATHOL; Hambly RJ, 1997, BREAST CANCER RES TR, V43, P247, DOI 10.1023/A:1005756632293; Hui EP, 2002, CLIN CANCER RES, V8, P2595; KELLER G, 1995, AM J PATHOL, V147, P593; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kubo T, 2012, CANC SCI; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Li ZX, 2008, INT J DERMATOL, V47, P207, DOI 10.1111/j.1365-4632.2007.03318.x; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu YP, 2012, CANC RES; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Poomphakwaen K, 2009, ASIAN PAC J CANCER P, V10, P251; Sato J, 2011, J HEPATO-BIL-PAN SCI, V18, P700, DOI 10.1007/s00534-011-0376-7; SEABRIGH.M, 1971, LANCET, V2, P971; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sprenger T, 2012, CANCER; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang XF, 2010, CANCER SCI, V101, P759, DOI 10.1111/j.1349-7006.2009.01435.x; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yoshimoto M, 2012, GENE CHROMOSOME CANC, V51, P149, DOI 10.1002/gcc.20939; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang Bai-He, 2006, Hepatobiliary Pancreat Dis Int, V5, P278	49	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54377	10.1371/journal.pone.0054377	http://dx.doi.org/10.1371/journal.pone.0054377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382894	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800047
J	Verstraete, B; Janssens, S; Smets, E; Dessein, S				Verstraete, Brecht; Janssens, Steven; Smets, Erik; Dessein, Steven			Symbiotic beta-Proteobacteria beyond Legumes: Burkholderia in Rubiaceae	PLOS ONE			English	Article							ENDOSYMBIONTS; ENDOPHYTES; NODULATION; DIVERSITY	Symbiotic beta-proteobacteria not only occur in root nodules of legumes but are also found in leaves of certain Rubiaceae. The discovery of bacteria in plants formerly not implicated in endosymbiosis suggests a wider occurrence of plant-microbe interactions. Several beta-proteobacteria of the genus Burkholderia are detected in close association with tropical plants. This interaction has occurred three times independently, which suggest a recent and open plant-bacteria association. The presence or absence of Burkholderia endophytes is consistent on genus level and therefore implies a predictive value for the discovery of bacteria. Only a single Burkholderia species is found in association with a given plant species. However, the endophyte species are promiscuous and can be found in association with several plant species. Most of the endophytes are part of the plant-associated beneficial and environmental group, but others are closely related to B. glathei. This soil bacteria, together with related nodulating and non-nodulating endophytes, is therefore transferred to a newly defined and larger PBE group within the genus Burkholderia.	[Verstraete, Brecht; Janssens, Steven; Smets, Erik] Katholieke Univ Leuven, Louvain, Belgium; [Smets, Erik] Leiden Univ, Nat Biodivers Ctr, Leiden, Netherlands; [Dessein, Steven] Natl Bot Garden Belgium, Meise, Belgium	KU Leuven; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Verstraete, B (corresponding author), Katholieke Univ Leuven, Louvain, Belgium.	brecht.verstraete@bio.kuleuven.be	Smets, Erik F/A-9875-2011; Verstraete, Brecht/E-4141-2015; Dessein, Steven/I-9147-2014	Smets, Erik F/0000-0002-9416-983X; Verstraete, Brecht/0000-0001-9332-7798; Dessein, Steven/0000-0002-3179-4005	Research Foundation - Flanders (FWO) [G.0343.09N]; King Leopold-III Fund for Nature Exploration and Conservation; Agency for Innovation by Science and Technology (IWT) [91158]	Research Foundation - Flanders (FWO)(FWO); King Leopold-III Fund for Nature Exploration and Conservation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported financially by the Research Foundation - Flanders (FWO, G.0343.09N) and by the King Leopold-III Fund for Nature Exploration and Conservation. BV holds a PhD research grant from the Agency for Innovation by Science and Technology (IWT, no. 91158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollback J.P., 2006, SIMMAP VERSION 1 0 P; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Caballero-Mellado J, 2007, APPL ENVIRON MICROB, V73, P5308, DOI 10.1128/AEM.00324-07; Carlier AL, 2012, ENVIRON MICROBIOL, V14, P2757, DOI 10.1111/j.1462-2920.2012.02763.x; Chen WM, 2003, J BACTERIOL, V185, P7266, DOI 10.1128/JB.185.24.7266-7272.2003; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Couvreur TLP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010473; Drummond A., 2011, GENEIOUS V5 5; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Lemaire B, 2012, FEMS MICROBIOL ECOL, V81, P364, DOI 10.1111/j.1574-6941.2012.01356.x; Lemaire B, 2012, APPL ENVIRON MICROB, V78, P284, DOI 10.1128/AEM.06130-11; Lemaire B, 2011, J MICROBIOL, V49, P935, DOI 10.1007/s12275-011-1163-5; Lemaire B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024430; Lemaire B, 2011, RES MICROBIOL, V162, P528, DOI 10.1016/j.resmic.2011.04.003; Lemaire B, 2012, INT J SYST EVOL MICR, V62, P202, DOI 10.1099/ijs.0.028019-0; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Van Oevelen S, 2004, INT J SYST EVOL MICR, V54, P2237, DOI 10.1099/ijs.0.63188-0; Van Oevelen S, 2002, INT J SYST EVOL MICR, V52, P2023, DOI [10.1099/ijs.0.02103-0, 10.1099/00207713-52-6-2023]; Van Oevelen Sandra, 2001, Systematics and Geography of Plants, V71, P557, DOI 10.2307/3668700; Verstraete B, BOT J LINN IN PRESS; Verstraete B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019265	29	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55260	10.1371/journal.pone.0055260	http://dx.doi.org/10.1371/journal.pone.0055260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372845	gold, Green Submitted, Green Published			2022-12-25	WOS:000315210400085
J	Gervasi, S; Gondhalekar, C; Olson, DH; Blaustein, AR				Gervasi, Stephanie; Gondhalekar, Carmen; Olson, Deanna H.; Blaustein, Andrew R.			Host Identity Matters in the Amphibian-Batrachochytrium dendrobatidis System: Fine-Scale Patterns of Variation in Responses to a Multi-Host Pathogen	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; INTERSPECIFIC VARIATION; PEPTIDE DEFENSES; CHYTRIDIOMYCOSIS; SUSCEPTIBILITY; DYNAMICS; TRANSMISSION; BIODIVERSITY; DECLINES; ECOLOGY	Species composition within ecological assemblages can drive disease dynamics including pathogen invasion, spread, and persistence. In multi-host pathogen systems, interspecific variation in responses to infection creates important context dependency when predicting the outcome of disease. Here, we examine the responses of three sympatric host species to a single fungal pathogen, Batrachochytrium dendrobatidis, which is associated with worldwide amphibian population declines and extinctions. Using an experimental approach, we show that amphibian species from three different genera display significant differences in patterns of pathgen-induced mortality as well as the magnitude and temporal dynamics of infection load. We exposed amphibians to one of four inoculation dose treatments at both larval and post- metamorphic stages and quantified infection load on day 8 and day 15 post-inoculation. Of the three species examined, only one (the Pacific treefrog; Pseudacris regilla) displayed "dose-dependent" responses; survival was reduced and infection load was elevated as inoculation dose was increased. We observed a reduction in survival but no differences in infection load across pathogen treatments in Cascades frogs (Rana cascadae). Western toads (Anaxyrus boreas) displayed differences in infection load but no differences in survival across pathogen treatments. Within species, responses to the pathogen varied with life history stage, and the most heavily infected species at the larval stage was different from the most heavily infected species at the post-metamorphic stage. Temporal changes in infection load were species and life history stage-specific. We show that variation in susceptibility to this multi-host pathogen is complex when viewed at a fine-scale and may be mediated through intrinsic host traits.	[Gervasi, Stephanie; Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Olson, Deanna H.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Blaustein, Andrew R.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Gervasi, S (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	gervasis@science.oregonstate.edu			United States Forest Service (Pacific Northwest Research Station); Robert and Clarice MacVicar Animal Health Scholar Award through Oregon State University	United States Forest Service (Pacific Northwest Research Station)(United States Department of Agriculture (USDA)United States Forest Service); Robert and Clarice MacVicar Animal Health Scholar Award through Oregon State University	Funding for this study was provided by the United States Forest Service (Pacific Northwest Research Station; http://www.fs.fed.us/pnw/) and the Robert and Clarice MacVicar Animal Health Scholar Award (issued through Oregon State University to SG). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Begon Michael, 2008, P12; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; BLAUSTEIN AR, 1988, BEHAV GENET, V18, P449, DOI 10.1007/BF01065514; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; COX DR, 1972, J R STAT SOC B, V34, P187; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daszak P, 2002, CONSERVATION MEDICINE, P40; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gosner K. L., 1960, Herpetologica, V16, P183; GROSHOLZ ED, 1992, ECOLOGY, V73, P507, DOI 10.2307/1940756; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; McMahon TA, P NATL ACAD IN PRESS; Olsen V, 2004, DIS AQUAT ORGAN, V61, P85, DOI 10.3354/dao061085; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Roedder Dennis, 2009, Diversity, V1, P52; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Venesky MD, 2009, INTEGR COMP BIOL, V49, pE176; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	53	67	70	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54490	10.1371/journal.pone.0054490	http://dx.doi.org/10.1371/journal.pone.0054490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23382904	Green Published, gold			2022-12-25	WOS:000314023600060
J	Geng, Y; Chandrasekaran, S; Hsu, JW; Gidwani, M; Hughes, AD; King, MR				Geng, Yue; Chandrasekaran, Siddarth; Hsu, Jong-Wei; Gidwani, Mishka; Hughes, Andrew D.; King, Michael R.			Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; E-SELECTIN; MESENCHYMAL TRANSITION; EXPRESSION; METASTASIS; CHEMOTHERAPY; ENDOTHELIUM; RESISTANCE; APOPTOSIS; CAPTURE	Hematogeneous metastasis can occur via a cascade of circulating tumor cell adhesion events to the endothelial lining of the vasculature, i.e. the metastatic cascade. Interestingly, the pro-inflammatory cytokines IL-6 and TNF-alpha, which play an important role in potentiating the inflammatory cascade, are significantly elevated in metastatic breast cancer (BCa) patients. Despite their high metastatic potential, human breast carcinoma cells MDA-MB-231 lack interactions with E-selectin functionalized surfaces under physiological shear stresses. We hypothesized that human plasma, 3-D tumor spheroid culture, and cytokine-supplemented culture media could induce a phenotypic switch that allows BCa cells to interact with E-selectin coated surfaces under physiological flow. Flow cytometry, immunofluorescence imaging, and flow-based cell adhesion assay were utilized to investigate the phenotypic changes of MDA-MB-231 cells with various treatments. Our results indicate that plasma, IL-6, and TNF-alpha promote breast cancer cell growth as aggregates and induce adhesive recruitment of BCa cells on E-selectin coated surfaces under flow. 3-D tumor spheroid culture exhibits the most significant increases in the interactions between BCa and E-selectin coated surfaces by upregulating CD44V4 and sLe(x) expression. Furthermore, we show that IL-6 and TNF-alpha concentrations in blood may regulate the recruitment of BCa cells to the inflamed endothelium. Finally, we propose a mechanism that could explain the invasiveness of 'triple-negative' breast cancer cell line MDA-MB-231 via a positive feedback loop of IL-6 secretion and maintenance. Taken together, our results suggest that therapeutic approaches targeting cytokine receptors and adhesion molecules on cancer cells may potentially reduce metastatic load and improve current cancer treatments.	[Geng, Yue; Chandrasekaran, Siddarth; Hsu, Jong-Wei; Gidwani, Mishka; Hughes, Andrew D.; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	King, MR (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	mike.king@cornell.edu		Gidwani, Mishka/0000-0002-8477-2539	National Institutes of Health [U54CA143876]; National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grant No. U54CA143876 to M. R. K. and a National Science Foundation graduate research fellowship to Y.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agastin S, 2011, BIOMICROFLUIDICS, V5; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Ben-Baruch A, HOST MICROENVIROMNEN; Berberoglu U, 2004, INT J BIOL MARKER, V19, P130, DOI 10.1177/172460080401900207; Chandrasekaran S, 2012, BIOMATERIALS, V33, P9037, DOI 10.1016/j.biomaterials.2012.08.052; Chandrasekaran S, 2011, BIOMATERIALS, V32, P7159, DOI 10.1016/j.biomaterials.2011.06.013; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davril M, 1999, GLYCOBIOLOGY, V9, P311, DOI 10.1093/glycob/9.3.311; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Geng Y, 2012, FRONT ONCOL, V2, P1, DOI 10.2389/fonc.2012.00076; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Geng Y, 2010, CELL MOL BIOENG, V3, P361, DOI 10.1007/s12195-010-0145-8; Glinsky GV, 1996, CANCER LETT, V101, P43, DOI 10.1016/0304-3835(96)04112-2; Goetz DJ, 1996, INT J CANCER, V65, P192, DOI 10.1002/(SICI)1097-0215(19960117)65:2<192::AID-IJC11>3.0.CO;2-G; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Groux-Degroote S, 2008, BIOCHEM J, V410, P213, DOI 10.1042/BJ20070958; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hou Jian-Mei, 2010, Cancers (Basel), V2, P1236, DOI 10.3390/cancers2021236; Hughes AD, 2012, JOVE-J VIS EXP, DOI 10.3791/4248; Hughes AD, 2012, CLIN CHEM, V58, P846, DOI 10.1373/clinchem.2011.176669; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Kozlowski L, 2003, Rocz Akad Med Bialymst, V48, P82; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lagow EL, 2002, J CELL BIOCHEM, V86, P759, DOI 10.1002/jcb.10261; Lee D, 2007, J BIOL CHEM, V282, P4812, DOI 10.1074/jbc.M609994200; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Luque-Ramirez M, 2010, HORM METAB RES, V42, P815, DOI 10.1055/s-0030-1262855; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muthukumaran N, 2006, MOL CANCER RES, V4, P511, DOI 10.1158/1541-7786.MCR-05-0232; Narita, 1996, Breast Cancer, V3, P19, DOI 10.1007/BF02966958; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Stockler M, 2000, CANCER TREAT REV, V26, P151, DOI 10.1053/ctrv.1999.0161; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thorlacius H, 1997, CLIN IMMUNOL IMMUNOP, V83, P68, DOI 10.1006/clin.1996.4325; Witz IP, 2008, CANCER METAST REV, V27, P19, DOI 10.1007/s10555-007-9101-z; Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494	47	57	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54959	10.1371/journal.pone.0054959	http://dx.doi.org/10.1371/journal.pone.0054959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372803	gold, Green Published, Green Submitted			2022-12-25	WOS:000314021500150
J	McCormack, T; Frings, O; Alexeyenko, A; Sonnhammer, ELL				McCormack, Theodore; Frings, Oliver; Alexeyenko, Andrey; Sonnhammer, Erik L. L.			Statistical Assessment of Crosstalk Enrichment between Gene Groups in Biological Networks	PLOS ONE			English	Article							PATHWAY; GENOME	Motivation: Analyzing groups of functionally coupled genes or proteins in the context of global interaction networks has become an important aspect of bioinformatic investigations. Assessing the statistical significance of crosstalk enrichment between or within groups of genes can be a valuable tool for functional annotation of experimental gene sets. Results: Here we present CrossTalkZ, a statistical method and software to assess the significance of crosstalk enrichment between pairs of gene or protein groups in large biological networks. We demonstrate that the standard z-score is generally an appropriate and unbiased statistic. We further evaluate the ability of four different methods to reliably recover crosstalk within known biological pathways. We conclude that the methods preserving the second-order topological network properties perform best. Finally, we show how CrossTalkZ can be used to annotate experimental gene sets using known pathway annotations and that its performance at this task is superior to gene enrichment analysis (GEA). Availability and Implementation: CrossTalkZ (available at http://sonnhammer.sbc.su.se/download/software/CrossTalkZ/) is implemented in C++, easy to use, fast, accepts various input file formats, and produces a number of statistics. These include z-score, p-value, false discovery rate, and a test of normality for the null distributions.	[McCormack, Theodore; Frings, Oliver; Alexeyenko, Andrey; Sonnhammer, Erik L. L.] Stockholm Bioinformat Ctr, Sci Life Lab, Solna, Sweden; [McCormack, Theodore; Frings, Oliver; Sonnhammer, Erik L. L.] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Alexeyenko, Andrey] Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Sonnhammer, Erik L. L.] Swedish eSci Res Ctr, Stockholm, Sweden	Stockholm University; Royal Institute of Technology; Swedish e-Science Research Centre (SeRC)	Sonnhammer, ELL (corresponding author), Stockholm Bioinformat Ctr, Sci Life Lab, Solna, Sweden.	Erik.Sonnhammer@sbc.su.se	Alexeyenko, Andrey/F-1924-2016	Alexeyenko, Andrey/0000-0001-8812-6481; Sonnhammer, Erik/0000-0002-9015-5588	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Alexeyenko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010465; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Annibale A, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/48/485001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Deng Minghua, 2003, Pac Symp Biocomput, P140; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Hong MG, 2010, J HUM GENET, V55, P707, DOI 10.1038/jhg.2010.92; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; LI L, 2005, THEORY SCALE FREE GR; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milenkovic T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005967; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Milo R, 2004, ARXIVCONDMAT0312028V; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Newman M, 2003, ARXIVCONDMAT0303516V; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ostlund G, 2010, MOL CELL PROTEOMICS, V9, P648, DOI 10.1074/mcp.M900227-MCP200; Penrose M., 2003, OXFORD STUDIES PROBA; Reynolds CA, 2010, HUM MOL GENET, V19, P2068, DOI 10.1093/hmg/ddq079; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taylor JR, 1997, INTRO ERROR ANAL STU, VSecond	36	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54945	10.1371/journal.pone.0054945	http://dx.doi.org/10.1371/journal.pone.0054945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372799	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500148
J	Zheng, H; Chen, L; Pledger, WJ; Fang, J; Chen, J				Zheng, H.; Chen, L.; Pledger, W. J.; Fang, J.; Chen, J.			p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression	ONCOGENE			English	Article						p53; JMJD2b; SUV39H1; heterochromatin; DNA damage; repair	DOUBLE-STRAND BREAKS; TELOMERIC REPEAT-LENGTH; RADIATION SENSITIVITY; H2AX PHOSPHORYLATION; MAMMALIAN-CELLS; ATM-DEFICIENT; CANCER; DAMAGE; P53-DEFICIENT; SENESCENCE	Constitutive heterochromatin (HC) is important for maintaining chromosome stability, but also delays the repair of DNA double-strand breaks (DSBs). DSB repair in complex mammalian genomes involves a fast phase (2-6 h) in which most of the breaks are rapidly repaired, and a slow phase (up to 24 h) in which the remaining damages in HC are repaired. We found that p53 deficiency delays the slow-phase DNA repair after ionizing irradiation. p53 deficiency prevents downregulation of histone H3K9 trimethylation at the pericentric HC after DNA damage. Moreover, p53 directly induces expression of the H3K9 demethylase Jumonji domain 2 family demethylase (JMJD2b) through promoter binding. The p53 activation also indirectly downregulates expression of the H3K9 methyltransferase SUV39H1. Depletion of JMJD2b or sustained expression of SUV39H1 delays the repair of HC DNA and reduces clonogenic survival after ionizing irradiation. The results suggest that by regulating JMJD2b and SUV39H1 expression, p53 not only controls transcription but also promotes HC relaxation to accelerate a rate-limiting step in the repair of complex genomes.	[Zheng, H.; Chen, L.; Pledger, W. J.; Fang, J.; Chen, J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Chen, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, MRC3057A,12902 Magnolia Dr, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org		Fang, Jia/0000-0001-8583-1652	Florida Department of Health James and Esther King Biomedical Research Program; National Institutes of Health [CA141244, CA109636]; NATIONAL CANCER INSTITUTE [R01CA109636, R01CA141244, P30CA076292] Funding Source: NIH RePORTER	Florida Department of Health James and Esther King Biomedical Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Moffitt Molecular Genomics Core for DNA sequence analyses, and Analytic Microscopy Core for image quantification. We also want to thank Dr. Savitha Sharma for providing the inducible p27 cell line. H Zheng is supported by a postdoctoral fellowship from the Florida Department of Health James and Esther King Biomedical Research Program. This work is supported by grants from the National Institutes of Health to J Chen (CA141244, CA109636).	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; BATZER MA, 1994, GENET ANAL-BIOMOL E, V11, P34, DOI 10.1016/1050-3862(94)90058-2; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bertheau P, 2002, LANCET, V360, P852, DOI 10.1016/S0140-6736(02)09969-5; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; Bishop AJR, 2003, CANCER RES, V63, P5335; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; BOUFFLER SD, 1995, CANCER RES, V55, P3883; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chen LH, 2010, EMBO J, V29, P2538, DOI 10.1038/emboj.2010.140; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Cuddihy AR, 2004, CANCER METAST REV, V23, P237, DOI 10.1023/B:CANC.0000031764.81141.e4; Dikomey E, 1998, INT J RADIAT BIOL, V73, P269, DOI 10.1080/095530098142365; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Finelli P, 1996, GENOMICS, V38, P325, DOI 10.1006/geno.1996.0635; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HARVEY M, 1993, ONCOGENE, V8, P2457; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; HIYAMA K, 1995, ONCOGENE, V10, P937; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Kroger N, 2006, CLIN CANCER RES, V12, P159, DOI 10.1158/1078-0432.CCR-05-1340; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mekeel KL, 1997, ONCOGENE, V14, P1847, DOI 10.1038/sj.onc.1201143; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ohki S, 2003, INT J MOL MED, V11, P485; Palomera-Sanchez Z, 2010, J BIOL CHEM, V285, P31370, DOI 10.1074/jbc.M110.128462; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Puerto S, 2001, MUTAGENESIS, V16, P291, DOI 10.1093/mutage/16.4.291; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Scott SL, 2003, CANCER RES, V63, P7190; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sharma SS, 2012, ONCOGENE, V31, P3989, DOI 10.1038/onc.2011.550; Slee RB, 2012, ONCOGENE, V31, P3244, DOI 10.1038/onc.2011.502; TAKAHASHI K, 1985, INT J RADIAT BIOL, V48, P389, DOI 10.1080/09553008514551391; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	65	45	45	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					734	744		10.1038/onc.2013.6	http://dx.doi.org/10.1038/onc.2013.6			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23376847	Green Accepted			2022-12-25	WOS:000331129200008
J	Lin, YH; Huang, YH; Wu, MH; Wu, SM; Chi, HC; Liao, CJ; Chen, CY; Tseng, YH; Tsai, CY; Tsai, MM; Lin, KH				Lin, Y-H; Huang, Y-H; Wu, M-H; Wu, S-M; Chi, H-C; Liao, C-J; Chen, C-Y; Tseng, Y-H; Tsai, C-Y; Tsai, M-M; Lin, K-H			Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability	ONCOGENE			English	Article						thyroid hormome; endoglin; hepatocellular carcinoma; cell proliferation	HEPATOCELLULAR-CARCINOMA; PITUITARY-TUMOR; CANCER-CELLS; CYCLE ARREST; EXPRESSION; RECEPTOR; INVASION; GENE; MIGRATION; BINDING	Hypothyroidism has been associated with significantly elevated risk for hepatocellular carcinoma (HCC), although the precise underlying mechanisms remain unknown at present. Thyroid hormone (T-3) and its receptor (TR) are involved in metabolism and growth. Endoglin is a T-3/TR candidate target gene identified from our previous studies. Here, we demonstrated that T-3 positively regulates endoglin mRNA and protein levels, both in vitro and in vivo. The thyroid hormone response elements of endoglin were identified at positions -2114/-2004 and -2032/-1973 of the promoter region using the electrophoretic mobility shift assay and chromatin immunoprecipitation assay. Endoglin was downregulated in the subgroups of HCC patients and significantly associated with histology grade (negative association, P = 0.001), and this expression level was significantly associated with TR alpha 1 in these HCC patients. Our results clearly indicate that p21 is involved in T-3-mediated suppression of cell proliferation. Knock down of endoglin expression in HCC cells facilitated p21 polyubiquitination and promoted cell proliferation in the presence of T-3. The data collectively suggest that T-3/TR signaling suppresses cell proliferation by upregulating endoglin, in turn, affecting p21 stability. The results indicate that endoglin has a suppressor role to inhibit cell proliferation in HCC cell lines.	[Lin, Y-H; Wu, M-H; Wu, S-M; Chi, H-C; Liao, C-J; Chen, C-Y; Tseng, Y-H; Tsai, C-Y; Lin, K-H] Chang Gung Univ, Dept Biochem, Coll Med, Tao Yuan, Taiwan; [Huang, Y-H] Chang Gung Mem Hosp, Liver Res Ctr, Linkou, Taiwan; [Tsai, M-M] Chang Gung Univ Sci & Technol, Dept Nursing, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology	Lin, KH (corresponding author), Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1 Rd, Tao Yuan, Taiwan.	khlin@mail.cgu.edu.tw			Chang-Gung University, Taoyuan, Taiwan [CMRPD 34013, NMRP 140511]; National Science Council of the Republic of China [NSC 94-2320-B-182-052]	Chang-Gung University, Taoyuan, Taiwan; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grants from Chang-Gung University, Taoyuan, Taiwan (CMRPD 34013, NMRP 140511) and from the National Science Council of the Republic of China (NSC 94-2320-B-182-052).	Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Ando S, 2001, MOL ENDOCRINOL, V15, P1529, DOI 10.1210/me.15.9.1529; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Benetti A, 2008, CANCER RES, V68, P8626, DOI 10.1158/0008-5472.CAN-08-1218; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chamba A, 1996, J CLIN ENDOCR METAB, V81, P360, DOI 10.1210/jc.81.1.360; Chen RN, 2008, ENDOCRINOLOGY, V149, P3817, DOI 10.1210/en.2007-0989; Chen RN, 2008, CANCER RES, V68, P1697, DOI 10.1158/0008-5472.CAN-07-5492; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; Craft CS, 2007, ONCOGENE, V26, P7240, DOI 10.1038/sj.onc.1210533; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; GOUGOS A, 1988, J IMMUNOL, V141, P1934; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henry LA, 2011, ONCOGENE, V30, P1046, DOI 10.1038/onc.2010.488; Huang Ya-Hui, 2008, Chang Gung Med J, V31, P325; Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549; Kress E, 2010, GASTROENTEROLOGY, V138, P1863, DOI 10.1053/j.gastro.2010.01.041; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lee H, 2006, J BIOL CHEM, V281, P26876, DOI 10.1074/jbc.M605366200; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Li Y, 2002, J BIOL CHEM; Liao CH, 2012, HEPATOLOGY, V55, P910, DOI 10.1002/hep.24740; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liao CJ, 2011, CANCER SCI, V102, P2255, DOI 10.1111/j.1349-7006.2011.02102.x; Lin KH, 2000, ENDOCRINOLOGY, V141, P2540, DOI 10.1210/en.141.7.2540; Lin KH, 2001, ENDOCRINOLOGY, V142, P653, DOI 10.1210/en.142.2.653; Liu YQ, 2002, ONCOGENE, V21, P8272, DOI 10.1038/sj.onc.1206117; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Oxmann D, 2008, ONCOGENE, V27, P3567, DOI 10.1038/sj.onc.1211025; Perez-Gomez E, 2007, CANCER RES, V67, P10268, DOI 10.1158/0008-5472.CAN-07-1348; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Wu SM, 2011, ONCOGENE, V30, P2057, DOI 10.1038/onc.2010.585; Yen CC, 2006, J MOL ENDOCRINOL, V36, P9, DOI 10.1677/jme.1.01911; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yoo YD, 1999, INT J CANCER, V83, P512, DOI 10.1002/(SICI)1097-0215(19991112)83:4<512::AID-IJC13>3.0.CO;2-Z; Yu DC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-122	44	24	24	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3904	3914		10.1038/onc.2013.5	http://dx.doi.org/10.1038/onc.2013.5			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	23376845				2022-12-25	WOS:000323210200013
J	Herman, T; Rosenberg-Katz, K; Jacob, Y; Auriel, E; Gurevich, T; Giladi, N; Hausdorff, JM				Herman, Talia; Rosenberg-Katz, Keren; Jacob, Yael; Auriel, Eitan; Gurevich, Tanya; Giladi, Nir; Hausdorff, Jeffrey M.			White Matter Hyperintensities in Parkinson's Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes?	PLOS ONE			English	Article							IMPAIRED EXECUTIVE FUNCTION; MILD COGNITIVE IMPAIRMENT; SMALL-VESSEL DISEASE; OLDER-PEOPLE; ELDERLY-PEOPLE; CAUTIOUS GAIT; RATING-SCALE; LESIONS; DISORDERS; PHENOTYPE	Background: Brain white matter hyperintensities (WMHs) commonly observed on brain imaging of older adults are associated with balance and gait impairment and have also been linked to cognitive deficits. Parkinson's disease (PD) is traditionally sub-classified into the postural instability gait difficulty (PIGD) sub-type, and the tremor dominant (TD) sub-type. Considering the known association between WMHs and axial symptoms like gait disturbances and postural instability, one can hypothesize that WMHs might contribute to the disparate clinical sub-types of patients with PD. Methods: 110 patients with PD underwent a clinical evaluation and a 3T MRI exam. Based on the Unified Parkinson Disease Rating Scale, the patients were classified into motor sub-types, i.e., TD or PIGD, and scores reflecting PIGD and TD symptoms were computed. We compared white matter burden using three previously validated methods: one using a semi-quantitative visual rating scale in specific brain regions and two automated methods. Results: Overall, MRI data were obtained in 104 patients. The mean WMHs scores and the percent of subjects with lesions in specific brain regions were similar in the two subtypes, p = 0.678. The PIGD and the TD scores did not differ even when comparing patients with a relatively high burden of WMHs to patients with a relatively low burden. Across most of the brain regions, mild to moderate correlations between WMHs and age were found (r = 0.23 to 0.41; p < 0.021). Conversely, no significant correlations were found between WMHs and the PIGD score or disease duration. In addition, depressive symptoms and cerebro-vascular risk factors were similar among the two subtypes. Conclusions: In contrast to what has been reported previously among older adults, the present study could not demonstrate any association between WMHs and the PIGD or TD motor sub-types in patients with PD.	[Herman, Talia; Rosenberg-Katz, Keren; Jacob, Yael; Auriel, Eitan; Gurevich, Tanya; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Movement Disorders Unit, Dept Neurol, IL-69978 Tel Aviv, Israel; [Rosenberg-Katz, Keren; Jacob, Yael] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Funct Brain Imaging Unit, Wohl Inst Adv Imaging, IL-69978 Tel Aviv, Israel; [Herman, Talia; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School	Hausdorff, JM (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Movement Disorders Unit, Dept Neurol, IL-69978 Tel Aviv, Israel.	jhausdor@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522	Michael J Fox Foundation	Michael J Fox Foundation	This work was supported by the Michael J Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya HJ, 2007, CAN J NEUROL SCI, V34, P56, DOI 10.1017/S0317167100005795; Alcalay RN, 2009, ARCH NEUROL-CHICAGO, V66, P1517, DOI 10.1001/archneurol.2009.267; Annweiler C, 2012, PANMINERVA MED, V54, P189; [Anonymous], 2012, NEURODEGENER DIS; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; BALOH RW, 1995, ARCH NEUROL-CHICAGO, V52, P975, DOI 10.1001/archneur.1995.00540340067014; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Benson RR, 2002, NEUROLOGY, V58, P48, DOI 10.1212/WNL.58.1.48; Beyer MK, 2006, MOVEMENT DISORD, V21, P223, DOI 10.1002/mds.20704; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Bohnen NI, 2011, NAT REV NEUROL, V7, P229, DOI 10.1038/nrneurol.2011.21; Bokde ALW, 2005, BRAIN RES PROTOC, V14, P135, DOI 10.1016/j.brainresprot.2004.10.001; Cameron IGM, 2010, NEUROPSYCHOLOGIA, V48, P1948, DOI 10.1016/j.neuropsychologia.2010.03.015; Choi SA, 2010, ACTA NEUROPATHOL, V119, P147, DOI 10.1007/s00401-009-0620-2; Dalaker TO, 2009, MOVEMENT DISORD, V24, P2233, DOI 10.1002/mds.22754; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franch O, 2009, J NEUROL SCI, V280, P84, DOI 10.1016/j.jns.2009.02.001; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Giladi N, 2007, J NEURAL TRANSM, V114, P1349, DOI 10.1007/s00702-007-0772-y; Giladi N, 2005, J NEUROL, V252, P300, DOI 10.1007/s00415-005-0641-2; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Green J, 2002, NEUROLOGY, V59, P1320, DOI 10.1212/01.WNL.0000031426.21683.E2; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Gurevich T, 2003, PARKINSONISM RELAT D, V9, P169, DOI 10.1016/S1353-8020(02)00049-4; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hedden T., 2011, CEREB CORTEX; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Huber-Mahlin V, 2010, J NEUROL, V257, P1279, DOI 10.1007/s00415-010-5507-6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Lee SJ, 2009, ARCH GERONTOL GERIAT, V49, P255, DOI 10.1016/j.archger.2008.09.005; Marras C, 2011, NEUROLOGY, V77, P325, DOI 10.1212/WNL.0b013e318227042d; Murray ME, 2010, ARCH NEUROL-CHICAGO, V67, P1379, DOI 10.1001/archneurol.2010.280; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nieuwboer A, 2009, GAIT POSTURE; Novak V, 2009, MAGN RESON IMAGING, V27, P752, DOI 10.1016/j.mri.2009.01.010; Pantoni L, 2006, J AM GERIATR SOC, V54, P1095, DOI 10.1111/j.1532-5415.2006.00798.x; Petrovic IN, 2012, WHITE MATTER LESIONS; PICCINI P, 1995, ARCH NEUROL-CHICAGO, V52, P191, DOI 10.1001/archneur.1995.00540260097023; Poggesi A, 2008, J AM GERIATR SOC, V56, P1638, DOI 10.1111/j.1532-5415.2008.01832.x; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rodriguez-Ferreiro J, 2010, MOVEMENT DISORD, V25, P2136, DOI 10.1002/mds.23239; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Silbert LC, 2008, NEUROLOGY, V71, P108, DOI 10.1212/01.wnl.0000316799.86917.37; Slawek J, 2008, NEUROL NEUROCHIR POL, V42, P505; Smart Sean D, 2011, J Aging Res, V2011, P391783, DOI 10.4061/2011/391783; Sneed JR, 2011, AM J GERIAT PSYCHIAT, V19, P99, DOI 10.1097/JGP.0b013e318202fc8a; Soumare A, 2009, ANN NEUROL, V65, P706, DOI 10.1002/ana.21674; STERN MB, 1989, NEUROLOGY, V39, P1524, DOI 10.1212/WNL.39.11.1524; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; Verbaan D, 2007, J NEUROL NEUROSUR PS, V78, P1182, DOI 10.1136/jnnp.2006.112367; Verbaan D, 2007, NEUROLOGY, V69, P333, DOI 10.1212/01.wnl.0000266593.50534.e8; Wolfson L, 2005, J NEUROL SCI, V232, P23, DOI 10.1016/j.jns.2004.12.017; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67; Zheng JJJ, 2011, STROKE, V42, P2086, DOI 10.1161/STROKEAHA.110.610360; Zheng JJ, 2011, NEUROBIOL AGING	74	56	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55193	10.1371/journal.pone.0055193	http://dx.doi.org/10.1371/journal.pone.0055193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383104	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600074
J	Singh, DP; Khattar, JIS; Kaur, M; Kaur, G; Gupta, M; Singh, Y				Singh, D. P.; Khattar, J. I. S.; Kaur, Mandeep; Kaur, Gurdeep; Gupta, Meenu; Singh, Yadvinder			Anilofos Tolerance and Its Mineralization by the Cyanobacterium Synechocystis sp Strain PUPCCC 64	PLOS ONE			English	Article							RICE FIELDS; PHOTOSYNTHETIC PIGMENTS; SUPEROXIDE-DISMUTASE; GREEN-ALGAE; GROWTH; PESTICIDES; HERBICIDES; RESISTANT; MOLINATE; STRESS	This study deals with anilofos tolerance and its mineralization by the common rice field cyanobacterium Synechocystis sp. strain PUPCCC 64. The organism tolerated anilofos up to 25 mg L-1. The herbicide caused inhibitory effects on photosynthetic pigments of the test organism in a dose-dependent manner. The organism exhibited 60, 89, 96, 85 and 79% decrease in chlorophyll a, carotenoids, phycocyanin, allophycocyanin and phycoerythrin, respectively, in 20 mg L-1 anilofos on day six. Activities of superoxide dismutase, catalase and peroxidase increased by 1.04 to 1.80 times over control cultures in presence of 20 mg L-1 anilofos. Glutathione content decreased by 26% while proline content was unaffected by 20 mg L-1 anilofos. The test organism showed intracellular uptake and metabolized the herbicide. Uptake of herbicide by test organism was fast during initial six hours followed by slow uptake until 120 hours. The organism exhibited maximum anilofos removal at 100 mg protein L-1, pH 8.0 and 30 degrees C. Its growth in phosphate deficient basal medium in the presence of anilofos (2.5 mg L-1) indicated that herbicide was used by the strain PUPCCC 64 as a source of phosphate.	[Singh, D. P.; Khattar, J. I. S.; Kaur, Mandeep; Kaur, Gurdeep; Gupta, Meenu; Singh, Yadvinder] Punjabi Univ, Dept Bot, Patiala, Punjab, India	Punjabi University	Singh, DP (corresponding author), Punjabi Univ, Dept Bot, Patiala, Punjab, India.	dp.khokhar@rediffmail.com	KHATTAR, JIS/D-9797-2011; Singh, Yadvinder/AAM-7656-2021	Singh, Yadvinder/0000-0002-5835-718X	Council of Scientific and Industrial Research (CSIR), New Delhi, India [(38)1152/07/EMR-II]	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research (CSIR), New Delhi, India (scheme no. (38)1152/07/EMR-II). The funders had no role in designing the experiment, collection of data, decision to publish and preparation of this manuscript.	ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; Bagchi SN, 2003, PHOTOSYNTH RES, V75, P171, DOI 10.1023/A:1022836218176; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Broser M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215970; Caceres TP, 2008, CURR MICROBIOL, V57, P643, DOI 10.1007/s00284-008-9293-7; Chen WC, 2009, ECOTOX ENVIRON SAFE, V72, P120, DOI 10.1016/j.ecoenv.2008.03.013; Chen Z, 2007, AQUAT TOXICOL, V81, P256, DOI 10.1016/j.aquatox.2006.12.008; Clay J., 2004, WORLD AGR ENV COMMOD; Dowidar SMA, 2010, J GENET ENG BIOTECHN, p[8, 89]; EGASHIRA T, 1989, PLANT CELL PHYSIOL, V30, P1171, DOI 10.1093/oxfordjournals.pcp.a077860; Eladel HM, 1998, J APPL PHYCOL, V10, P547, DOI 10.1023/A:1008092826338; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Faria MS, 2007, ECOTOX ENVIRON SAFE, V67, P218, DOI 10.1016/j.ecoenv.2006.11.018; Fatma T, 2007, J APPL PHYCOL, V19, P625, DOI 10.1007/s10811-007-9195-2; Forlani G, 2008, PLANT CELL PHYSIOL, V49, P443, DOI 10.1093/pcp/pcn021; Funari Enzo, 1995, P3; GAHAGAN HE, 1968, PHYSIOL PLANTARUM, V21, P1270, DOI 10.1111/j.1399-3054.1968.tb07358.x; Galhano V, 2009, WATER AIR SOIL POLL, V197, P211, DOI 10.1007/s11270-008-9804-y; Galhano V, 2011, AQUAT TOXICOL, V101, P367, DOI 10.1016/j.aquatox.2010.11.011; Galhano V, 2010, ENVIRON TOXICOL, V25, P147, DOI 10.1002/tox.20486; Gonzalez-Barreiro O, 2006, ENVIRON POLLUT, V144, P266, DOI 10.1016/j.envpol.2005.12.014; Holm G., 1954, Acta Agriculturae Scandinavica, V4, P457; Janardhan G., 1999, Current Research - University of Agricultural Sciences (Bangalore), V28, P12; Kang HS, 2009, B ENVIRON CONTAM TOX, V82, P305, DOI 10.1007/s00128-008-9602-7; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kulshrestha G, 2000, PEST MANAG SCI, V56, P202, DOI 10.1002/(SICI)1526-4998(200002)56:2<202::AID-PS97>3.0.CO;2-C; Kumar D, 2010, APPL BIOCHEM BIOTECH, V160, P2475, DOI 10.1007/s12010-009-8710-0; Kumar S, 2008, SCI TOTAL ENVIRON, V403, P130, DOI 10.1016/j.scitotenv.2008.05.026; Leitao S, 2007, AQUAT ECOL, V41, P373, DOI 10.1007/s10452-007-9082-6; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lipok J, 2007, ENZYME MICROB TECH, V41, P286, DOI 10.1016/j.enzmictec.2007.02.004; [刘新 Liu Xin], 2003, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V9, P78; Lopez-Rodas V, 2007, EVOL ECOL, V21, P535, DOI 10.1007/s10682-006-9134-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ZM, 2009, ECOTOX ENVIRON SAFE, V72, P136, DOI 10.1016/j.ecoenv.2008.01.009; Mallory-Smith CA, 2003, WEED TECHNOL, V17, P605, DOI 10.1614/0890-037X(2003)017[0605:RCOHBS]2.0.CO;2; Marchesan E, 2007, SCI AGR, V64, P131, DOI 10.1590/S0103-90162007000200005; Min H, 2001, J ENVIRON SCI HEAL B, V36, P581, DOI 10.1081/PFC-100106187; Moraes BS, 2009, PESTIC BIOCHEM PHYS, V95, P57, DOI 10.1016/j.pestbp.2009.06.006; Mostaffa FI, 2002, J ENV SCI HLTH, V36, P709; MYERS J, 1955, J GEN PHYSIOL, V39, P11, DOI 10.1085/jgp.39.1.11; Narusaka Y, 1998, PLANT CELL PHYSIOL, V39, P620, DOI 10.1093/oxfordjournals.pcp.a029413; Oettmeier W, 1999, CELL MOL LIFE SCI, V55, P1255, DOI 10.1007/s000180050370; ORUS MI, 1991, B ENVIRON CONTAM TOX, V47, P392, DOI 10.1007/BF01702200; PADHY RN, 1985, RESIDUE REV, V95, P1; Pereira T, 2000, ENVIRON TOXICOL, V15, P401, DOI 10.1002/1522-7278(2000)15:5<401::AID-TOX7>3.3.CO;2-8; Phong TK, 2009, B ENVIRON CONTAM TOX, V83, P794, DOI 10.1007/s00128-009-9810-9; Pingali P, 1995, IMPACT PESTICIDES FA; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2009, ECOTOXICOLOGY, V18, P537, DOI 10.1007/s10646-009-0311-8; Rai A. K., 2000, Journal of the Indian Society of Soil Science, V48, P57; Rao V., 2000, PRINCIPLES WEED SCI, VSecond; Roberts T., 1998, METABOLIC PATHWAYS A; ROGER PA, 1992, PLANT SOIL, V141, P41, DOI 10.1007/BF00011309; SAFFERMAN RS, 1964, J BACTERIOL, V88, P771, DOI 10.1128/JB.88.3.771-775.1964; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Singh DP, 2010, RES J BIOTECHNOL, V5, P27; Singh DP, 2012, TOXICOL ENVIRON CHEM, V94, P1304, DOI 10.1080/02772248.2012.703203; Singh S, 2007, PLANT SOIL, V296, P95, DOI 10.1007/s11104-007-9293-6; Singh S, 2006, J BASIC MICROB, V46, P219, DOI 10.1002/jobm.200510074; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; SUBRAMANIAN G, 1994, INT BIODETER BIODEGR, V33, P129, DOI 10.1016/0964-8305(94)90032-9; Thengodkar RRM, 2010, BIODEGRADATION, V21, P637, DOI 10.1007/s10532-010-9331-6; TIWARI DN, 1991, APPL BIOCHEM BIOTECH, V28-9, P387, DOI 10.1007/BF02922618; Valiente EF, 2000, PLANT SOIL, V221, P107, DOI 10.1023/A:1004737422842; [王晓 Wang Xiao], 2006, [土壤学报, Acta Pedologica Sinica], V43, P648; Whitton B.A., 2000, ECOLOGY CYANOBACTERI, P1, DOI [10.1007/0-306-46855-7, DOI 10.1007/0-306-46855-7, DOI 10.1007/0-306-46855-7_1]; Xu GM, 2007, BIOTECHNOL LETT, V29, P1469, DOI 10.1007/s10529-007-9444-0; Yaduraju N. T., 2006, AGR ENVIRON, P192; Zimmermann K, 2006, BBA-BIOENERGETICS, V1757, P106, DOI 10.1016/j.bbabio.2005.12.002	73	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53445	10.1371/journal.pone.0053445	http://dx.doi.org/10.1371/journal.pone.0053445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382844	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600015
J	Abdel-Moneim, AS; Kamel, MM; Al-Ghamdi, AS; Al-Malky, MIR				Abdel-Moneim, Ahmed S.; Kamel, Mahmoud M.; Al-Ghamdi, Abdullhamid S.; Al-Malky, Mater I. R.			Detection of Bocavirus in Children Suffering from Acute Respiratory Tract Infections in Saudi Arabia	PLOS ONE			English	Article							EPIDEMIOLOGIC PROFILE; HUMAN PARVOVIRUSES; FREQUENT DETECTION; VIRUS; INFANTS	Human bocavirus (HBoV) was recently discovered in children with respiratory distress and/or diarrhea. To our knowledge, no previous study has reported the existence of bocavirus in Saudi Arabia. Swabs samples from 80 children with respiratory tract infections were examined for the presence of HBoV. Real-time polymerase chain reaction was used as a sensitive method to detect the HBoV. Direct gene sequencing was used to determine the genotype of the detected virus isolates. HBoV was detected in 22.5% of the examined patients. The NP1 partial gene sequence from all patients showed that the circulated strains were related to HBoV-1 genotype. Most of HBoV infected patients showed evidence of mixed coinfection with other viral pathogens. The current study clearly demonstrated that genetically conserved HBoV1 circulates in Saudi Arabia. Interestingly, most of the HBoV1 infected cases were associated with high rates of co-infections with other viruses.	[Abdel-Moneim, Ahmed S.; Kamel, Mahmoud M.; Al-Ghamdi, Abdullhamid S.] Taif Univ, Coll Med, Al Taif, Saudi Arabia; [Abdel-Moneim, Ahmed S.] Beni Suef Univ, Dept Virol, Fac Vet Med, Bani Suwayf, Egypt; [Kamel, Mahmoud M.] Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt; [Al-Malky, Mater I. R.] Pediat Hosp, Al Taif, Saudi Arabia	Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt	Abdel-Moneim, AS (corresponding author), Taif Univ, Coll Med, Al Taif, Saudi Arabia.	asa@bsu.edu.eg	Al-Ghamdi, Abdulhamed/ABE-2906-2020; Abdel-Moneim, Ahmed S./G-7445-2012; Kamel, Mahmoud/CAE-9055-2022	Abdel-Moneim, Ahmed S./0000-0002-3148-6782; Kamel, Mahmoud/0000-0003-0264-3096; 0000-0002-3160-7687, 0000-0002-3160-7687/0000-0001-6264-6921	Taif University, Saudi Arabia [1652-433-1]	Taif University, Saudi Arabia	This study was supported by a research grant (Project No. 1652-433-1) through the Research Support of Taif University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Christensen A, 2008, J CLIN VIROL, V41, P34, DOI 10.1016/j.jcv.2007.10.025; Claude M, 2004, 8 INT COMM TAX VIR; Foulongne V, 2006, EMERG INFECT DIS, V12, P1251, DOI 10.3201/eid1708.060213.; Kaplan NM, 2006, EMERG INFECT DIS, V12, P1418, DOI 10.3201/eid1209.060417; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kupfer B, 2006, EMERG INFECT DIS, V12, P1614, DOI 10.3201/eid1210.060520; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Lin Feng, 2007, Infect Agent Cancer, V2, P3; Lindner J, 2008, VIRAL IMMUNOL, V21, P443, DOI 10.1089/vim.2008.0045; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Ghietto LM, 2012, BRAZ J INFECT DIS, V16, P38, DOI 10.1590/S1413-86702012000100007; Regamey N, 2007, PEDIATR INFECT DIS J, V26, P177, DOI 10.1097/01.inf.0000250623.43107.bc; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Smuts H, 2006, EMERG INFECT DIS, V12, P1457, DOI 10.3201/eid1209.051616; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044876	31	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55500	10.1371/journal.pone.0055500	http://dx.doi.org/10.1371/journal.pone.0055500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383205	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800160
J	Bagshaw, ATM; Horwood, LJ; Liu, YF; Fergusson, DM; Sullivan, PF; Kennedy, MA				Bagshaw, Andrew T. M.; Horwood, L. John; Liu, Youfang; Fergusson, David M.; Sullivan, Patrick F.; Kennedy, Martin A.			No Effect of Genome-Wide Copy Number Variation on Measures of Intelligence in a New Zealand Birth Cohort	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CHROMOSOMAL REGIONS; GENETIC-ANALYSIS; LINKAGE; POLYMORPHISMS; DUPLICATIONS; HERITABILITY; ASSOCIATION; SCAN; IQ	Variation in human intelligence is approximately 50% heritable, but understanding of the genes involved is limited. Several forms of genetic variation remain under-studied in relation to intelligence, one of which is copy number variation (CNV). Using single-nucleotide polymorphism (SNP) - based microarrays, we genotyped CNVs genome-wide in a birth cohort of 723 New Zealanders, and correlated them with four intelligence-related phenotypes. We found no significant association for any common CNV after false discovery correction, which is consistent with previous work. In contrast to a previous study, however, we found no effect on any cognitive measure of rare CNV burden, defined as total number of bases inserted or deleted in CNVs rarer than 5%. We discuss possible reasons for this failure to replicate, including interaction between CNV and aging in determining the effects of rare CNVs. While our results suggest that no CNV assayable by SNP chips contributes more than a very small amount to variation in human intelligence, it remains possible that common CNVs in segmental duplication arrays, which are not well covered by SNP chips, are important contributors.	[Bagshaw, Andrew T. M.; Kennedy, Martin A.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Horwood, L. John; Fergusson, David M.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Liu, Youfang; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of Otago; University of Otago; University of North Carolina; University of North Carolina Chapel Hill	Bagshaw, ATM (corresponding author), Univ Otago, Dept Pathol, Christchurch, New Zealand.	andrew.bagshaw@gmail.com	Kennedy, Martin A/A-4942-2008; Kennedy, Martin/O-4540-2019	Kennedy, Martin A/0000-0002-6445-8526; Kennedy, Martin/0000-0002-6445-8526; Fergusson, David/0000-0002-8117-017X; Horwood, L./0000-0003-4881-1956; Bagshaw, Andrew/0000-0002-2930-7298	Royal Society of New Zealand Marsden Grant [UOC 202]; Health Research Council of New Zealand; National Child Health Research Foundation; Canterbury Medical Research Foundation; New Zealand Lottery Grants Board; University of Otago; Carney Centre for Pharmacogenomics; James Hume Bequest Fund; US National Institutes of Health [MH077874]; NIDA [R01DA024413]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024413] Funding Source: NIH RePORTER	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); National Child Health Research Foundation; Canterbury Medical Research Foundation; New Zealand Lottery Grants Board; University of Otago; Carney Centre for Pharmacogenomics; James Hume Bequest Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	ATB and MAK were supported by a Royal Society of New Zealand Marsden Grant (UOC 202). This research was also funded by grants from the Health Research Council of New Zealand, the National Child Health Research Foundation, the Canterbury Medical Research Foundation, the New Zealand Lottery Grants Board, the University of Otago, the Carney Centre for Pharmacogenomics, the James Hume Bequest Fund, and US National Institutes of Health grant MH077874. Gene chip data were generated with NIDA support under "A developmental model of gene-environment interplay in SUDs (R01DA024413) 2007-2012''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Baker K, 2012, CURR OPIN NEUROL, V25, P150, DOI 10.1097/WCO.0b013e328351820e; Banks GC, 2010, INTELLIGENCE, V38, P393, DOI 10.1016/j.intell.2010.04.003; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Buyske S, 2006, BEHAV GENET, V36, P65, DOI 10.1007/s10519-005-9008-9; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Dick DM, 2006, BEHAV GENET, V36, P77, DOI 10.1007/s10519-005-9009-8; Dumas L, 2009, COLD SH Q B, V74, P375, DOI 10.1101/sqb.2009.74.025; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Fergusson D.M., 2008, RES SOCIAL STRATIFIC, V26, P277, DOI [DOI 10.1016/J.RSSM.2008.05.001, 10.1016/j.rssm.2008.05.001]; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; Fergusson DM, 1989, PAEDIATRIC PERINATAL, V3, P302, DOI DOI 10.1111/J.1365-3016.1989.TB00382.X; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Haworth CMA, 2009, BEHAV GENET, V39, P359, DOI 10.1007/s10519-009-9262-3; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Langley K, 2011, BRIT J PSYCHIAT, V199, P398, DOI 10.1192/bjp.bp.111.092130; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Luciano M, 2006, BEHAV GENET, V36, P45, DOI 10.1007/s10519-005-9003-1; Lundvall M, 2012, ACTA PAEDIATR, V101, P85, DOI 10.1111/j.1651-2227.2011.02417.x; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Morley KI, 2001, BEHAV GENET, V31, P511, DOI 10.1023/A:1013337209957; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; NEED AC, 2009, HUM MOL GENET; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Posthuma D, 2005, AM J HUM GENET, V77, P318, DOI 10.1086/432647; Reid, 1981, BURT WORD READING TE; REID NA, 1981, TEST SCHOLASTIC ABIL; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shoukier M, 2012, CLIN GENET; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vinkhuyzen AAE, 2012, BEHAV GENET, V42, P187, DOI 10.1007/s10519-011-9507-9; Wahlsten D, 2012, DEV PSYCHOBIOL; Wainwright MA, 2006, BEHAV GENET, V36, P56, DOI 10.1007/s10519-005-9013-z; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler D., 2003, MANUAL WECHSLER INTE, V4th; Wechsler D., 2002, WECHSLER MEMORY SCAL; *WHO, 1997, COMP INT DIAGN INT C; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339	59	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55208	10.1371/journal.pone.0055208	http://dx.doi.org/10.1371/journal.pone.0055208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383111	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800131
J	Chen, H; Kobayashi, K; Miyao, A; Hirochika, H; Yamaoka, N; Nishiguchi, M				Chen, Hui; Kobayashi, Kappei; Miyao, Akio; Hirochika, Hirohiko; Yamaoka, Naoto; Nishiguchi, Masamichi			Both OsRecQ1 and OsRDR1 Are Required for the Production of Small RNA in Response to DNA-Damage in Rice	PLOS ONE			English	Article							SMALL SILENCING RNAS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CELLULAR-RESPONSE; GENE; REPAIR; PROTEIN; ARABIDOPSIS; POLYMERASE; ATM	Small RNA-mediated gene silencing pathways play important roles in the regulation of development, genome stability and various stress responses in many eukaryotes. Recently, a new type of small interfering RNAs (qiRNAs) approximately 20-21 nucleotides long in Neurospora crassa have been shown to mediate gene silencing in the DNA damage response (DDR) pathway. However, the mechanism for RNA silencing in the DDR pathway is largely unknown in plants. Here, we report that a class of small RNAs (qiRNAs) derived from rDNA was markedly induced after treatment by DNA-damaging agents [ ethyl methanesulphonate (EMS and UV-C)], and that aberrant RNAs (aRNAs) as precursors were also highly induced after the DNA damage treatment in rice. However, these RNAs were completely abolished in OsRecQ1 (RecQ DNA helicase homologue) and OsRDR1 (RNA-dependent RNA polymerase homologue) mutant lines where either gene was disrupted by the insertion of rice retrotransposon Tos17 after the same treatment. DNA damage resulted in a more significant increase in cell death and a more severe inhibition of root growth in both mutant lines than in the WT. Together, these results strongly suggest that both OsRecQ1 and OsRDR1 play a pivotal role in the aRNA and qiRNA biogenesis required for the DDR and repair pathway in rice, and it may be a novel mechanism of regulation to the DDR through the production of qiRNA in plants.	[Chen, Hui; Kobayashi, Kappei; Yamaoka, Naoto; Nishiguchi, Masamichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Miyao, Akio; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Ehime University; National Institute of Agrobiological Sciences - Japan	Chen, H (corresponding author), Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada.	huichen98@hotmail.com; mnishigu@agr.ehime-u.ac.jp	Miyao, Akio/V-7306-2019; Chen, Hui/Y-4376-2019	Miyao, Akio/0000-0002-2822-2866; Chen, Hui/0000-0001-6050-0873	Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan [22119010]; Grants-in-Aid for Scientific Research [24580065] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN) and the Ministry of Education, Culture, Sports and Technology of Japan [Grant-in-Aid for Scientific Research for Scientific Research (C), No. 22119010] to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; BATSCHAUER A, 1993, PLANT J, V4, P705, DOI 10.1046/j.1365-313X.1993.04040705.x; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Chen H, 2008, PLANT J, V56, P274, DOI 10.1111/j.1365-313X.2008.03587.x; Chen H, 2010, J GEN PLANT PATHOL, V76, P152, DOI 10.1007/s10327-010-0226-5; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Culligan KM, 2008, PLANT J, V55, P629, DOI 10.1111/j.1365-313X.2008.03530.x; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hartung F, 2007, P NATL ACAD SCI USA, V104, P18836, DOI 10.1073/pnas.0705998104; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Ishibashi T, 2006, DNA REPAIR, V5, P80, DOI 10.1016/j.dnarep.2005.07.010; Le Trionnaire G, 2011, J EXP BOT, V62, P1601, DOI 10.1093/jxb/erq399; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nielsen BL, 2010, J EXP BOT, V61, P2535, DOI 10.1093/jxb/erq163; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Wang S, 2011, DNA REPAIR, V10, P620, DOI 10.1016/j.dnarep.2011.04.009; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wu YL, 2010, DNA REPAIR, V9, P315, DOI 10.1016/j.dnarep.2009.12.010; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106	50	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55252	10.1371/journal.pone.0055252	http://dx.doi.org/10.1371/journal.pone.0055252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383126	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800135
J	Paine, SML; Anderson, G; Bedford, K; Lawler, K; Mayer, RJ; Lowe, J; Bedford, L				Paine, Simon M. L.; Anderson, Glenn; Bedford, Karen; Lawler, Karen; Mayer, R. John; Lowe, James; Bedford, Lynn			Pale Body-Like Inclusion Formation and Neurodegeneration following Depletion of 26S Proteasomes in Mouse Brain Neurones are Independent of alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; PROTEIN-DEGRADATION; LEWY BODIES; COMPLEX-I; UBIQUITIN; INHIBITION; AUTOPHAGY; SYSTEM; MODEL; DEGENERATION	Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. alpha-synuclein is the main component of LB, but the pathological mechanisms that lead to neurodegeneration associated with LB formation remain unclear. Three pivotal elements have emerged in the development of PD: alpha-synuclein, mitochondria and protein degradation systems. We previously reported a unique model, created by conditional genetic depletion of 26S proteasomes in the SNpc of mice, which mechanistically links these three elements with the neuropathology of PD: progressive neurodegeneration and intraneuronal inclusion formation. Using this model, we tested the hypothesis that alpha-synuclein was essential for the formation of inclusions and neurodegeneration caused by 26S proteasomal depletion. We found that both of these processes were independent of alpha-synuclein. This provides an important insight into the relationship between the proteasome, alpha-synuclein, inclusion formation and neurodegeneration. We also show that the autophagy-lysosomal pathway is not activated in 26S proteasome-depleted neurones. This leads us to suggest that the paranuclear accumulation of mitochondria in inclusions in our model may reflect a role for the ubiquitin proteasome system in mitochondrial homeostasis and that neurodegeneration may be mediated through mitochondrial factors linked to inclusion biogenesis.	[Paine, Simon M. L.] UCL, Inst Child Hlth, Neural Dev Unit, London, England; [Paine, Simon M. L.; Anderson, Glenn] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England; [Bedford, Karen] Hull Royal Infirm, Hull Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bedford, Karen] Hull Royal Infirm, East Yorkshire Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Paine, Simon M. L.; Lawler, Karen; Mayer, R. John; Bedford, Lynn] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Lowe, James] Univ Nottingham, Div Histopathol, Sch Mol Med Sci, Nottingham NG7 2RD, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Hull; University of Hull; University of Nottingham; University of Nottingham	Bedford, L (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	lynn.bedford@nottingham.ac.uk		Paine, Simon/0000-0002-1434-3931; Lowe, James/0000-0002-9856-1599	Parkinson's UK; Pathological Society of Great Britain; Pathological Society of Ireland; Alzheimers Research UK [ART-RF2004B-1] Funding Source: researchfish; National Institute for Health Research [ACF-2006-12-002] Funding Source: researchfish; Parkinson&quot;s UK [F-0702] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Pathological Society of Great Britain; Pathological Society of Ireland; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by Parkinson's UK and a Centenary Clinical Research Training Fellowship from the Pathological Society of Great Britain and Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; BAYER SA, 1995, EXP BRAIN RES, V105, P191; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; Chan NC, 2011, AUTOPHAGY, V7, P771, DOI 10.4161/auto.7.7.15453; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cook C, 2009, BBA-MOL BASIS DIS, V1792, P664, DOI 10.1016/j.bbadis.2009.01.012; DALE GE, 1992, ACTA NEUROPATHOL, V83, P525, DOI 10.1007/BF00310030; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Dickson DW, 2008, ACTA NEUROPATHOL, V115, P437, DOI 10.1007/s00401-008-0345-7; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; GIBB WRG, 1989, ANN NEUROL, V26, P691, DOI 10.1002/ana.410260520; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Hawlitschka A, 2007, BRAIN RES, V1173, P137, DOI 10.1016/j.brainres.2007.07.072; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jantas D, 2011, NEUROTOXICOLOGY, V32, P845, DOI 10.1016/j.neuro.2011.05.013; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Keane PC, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/716871; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Sai Y, 2012, NEUROSCI BIOBEHAV R, V36, P2034, DOI 10.1016/j.neubiorev.2012.06.007; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Schapira AHV, 2006, ANN NEUROL, V60, P253, DOI 10.1002/ana.20934; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200; Zigoneanu IG, 2011, BIOCHIM BIOPHYS ACTA, V1818, P512	76	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54711	10.1371/journal.pone.0054711	http://dx.doi.org/10.1371/journal.pone.0054711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382946	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800068
J	Laska, MJ; Nissen, KK; Nexo, BA				Laska, Magdalena Janina; Nissen, Kari Konstantin; Nexo, Bjorn Andersen			(Some) Cellular Mechanisms Influencing the Transcription of Human Endogenous Retrovirus, HERV-Fc1	PLOS ONE			English	Article							DNA METHYLATION; CPG METHYLATION; GENE-EXPRESSION; HUMAN GENOME; CELLS; INDUCTION; SEQUENCES; 5-AZA-2'-DEOXYCYTIDINE; 5-AZA-2-DEOXYCYTIDINE; METHYLTRANSFERASES	DNA methylation and histone acetylation are epigenetic modifications that act as regulators of gene expression. DNA methylation is considered an important mechanism for silencing of retroelements in the mammalian genome. However, the methylation of human endogenous retroviruses (HERVs) is not well investigated. The aim of this study was to investigate the transcriptional potential of HERV-Fc1 proviral 5'LTR in more detail, and examined the specific influence of CpG methylation on this LTR in number of cell lines. Specifically, the role of demethylating chemicals e.g. 5-aza-2' deoxycytidine and Trichostatin-A, in inducing or reactivating expression of HERV-Fc1 specific sequences and the mechanisms were investigated. In our present study, 5-aza-dC is shown to be a powerful inducer of HERV-Fc1, and at the same time it strongly inhibits methylation of DNA. Treatment with this demethylating agent 5-aza-dC, results in significantly increased levels of HERV-Fc1 expression in cells previously not expressing HERV-Fc1, or with a very low expression level. The extent of expression of HERV-Fc1 RNAs precisely correlates with the apparent extent of demethylation of the related DNA sequences. In conclusion, the results suggest that inhibition of DNA methylation/histone deacetylase can interfere with gene silencing mechanisms affecting HERV-Fc1 expression in human cells.	[Laska, Magdalena Janina; Nissen, Kari Konstantin; Nexo, Bjorn Andersen] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University	Laska, MJ (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	laska@hum-gen.au.dk		Laska, Magdalena Janina/0000-0001-5188-3446	Warwara Larsen Fonden [J.2008-7306]; LundbeckFonden [R44-A4331]	Warwara Larsen Fonden; LundbeckFonden(Lundbeckfonden)	This work was supported by grant J.2008-7306 from Warwara Larsen Fonden and grant R44-A4331 from LundbeckFonden (http://www.lundbeckfonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1974, P NATL ACAD SCI USA, V71, P3941, DOI 10.1073/pnas.71.10.3941; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Bartoli A, 2003, PHARMACOL RES, V48, P111, DOI 10.1016/S1043-6618(03)00079-3; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kjellman C, 1999, J GEN VIROL, V80, P2383, DOI 10.1099/0022-1317-80-9-2383; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; LIU WM, 1993, NUCLEIC ACIDS RES, V21, P1351, DOI 10.1093/nar/21.6.1351; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; McInerney JM, 2000, GENE THER, V7, P653, DOI 10.1038/sj.gt.3301155; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; MICHALOWSKY LA, 1987, MOL CELL BIOL, V7, P3076, DOI 10.1128/MCB.7.9.3076; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; NIWA O, 1981, P NATL ACAD SCI-BIOL, V78, P6290, DOI 10.1073/pnas.78.10.6290; Ogasawara H, 2003, CLIN EXP RHEUMATOL, V21, P733; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okada M, 2002, J RHEUMATOL, V29, P1678; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; Patzke S, 2002, VIROLOGY, V303, P164, DOI 10.1006/viro.2002.1615; RASCATI RJ, 1988, MUTAT RES, V208, P21, DOI 10.1016/0165-7992(88)90015-2; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Sekigawa I, 1997, Nihon Rinsho, V55, P1492; Stengel S, 2010, GENE CHROMOSOME CANC, V49, P401, DOI 10.1002/gcc.20751; Strissel PL, 2012, ONCOTARGET; SUTTER D, 1980, P NATL ACAD SCI-BIOL, V77, P253, DOI 10.1073/pnas.77.1.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VERTINO PM, 1994, CELL GROWTH DIFFER, V5, P1395; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Wentzensen N, 2007, INT J CANCER, V121, P1417, DOI 10.1002/ijc.22826; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; YUNG RL, 1995, J IMMUNOL, V154, P3025	49	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e53895	10.1371/journal.pone.0053895	http://dx.doi.org/10.1371/journal.pone.0053895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382858	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500007
J	Kuo, CY; Yen, MF; Chen, LS; Fann, CY; Chiu, YH; Chen, HH; Pan, SL				Kuo, Cheng-Ya; Yen, Ming-Fang; Chen, Li-Sheng; Fann, Ching-Yuan; Chiu, Yueh-Hsia; Chen, Hsiu-Hsi; Pan, Shin-Liang			Increased Risk of Hemorrhagic Stroke in Patients with Migraine: A Population-Based Cohort Study	PLOS ONE			English	Article							CEREBRAL VASOCONSTRICTION SYNDROME; INTRACEREBRAL HEMORRHAGE; HEALTH-INSURANCE; ISCHEMIC-STROKE; WOMEN; EPIDEMIOLOGY; FREQUENCY; SEX	Objective: Previous studies on the association between migraine and the risk of developing hemorrhagic stroke (HS) have generated inconsistent results. The aim of the present population-based, age- and sex- matched follow-up study was to investigate whether migraine is associated with an increased risk of HS. Method: A total of 20925 persons with at least two ambulatory visits in 2001 with the principal diagnosis of migraine were enrolled in the migraine group. The non-migraine group consisted of 104625, age- and sex- matched, randomly sampled subjects without migraine. The two-year HS-free survival rates for these 2 groups were estimated using the Kaplan-Meier method. Cox proportional hazards regression was used to estimate the effect of migraine on the occurrence of HS. Results: During the 2 year follow-up, 113 subjects in the migraine group (0.54%) and 255 in the non-migraine group (0.24%) developed HS. The crude hazard ratio (HR) for developing HS in the migraine group was 2.22 compared to the non-migraine group (95% confidence interval [CI]: 1.78-2.77, p<0.0001) and the adjusted HR was 2.13 (95% CI: 1.71-2.67, p<0.0001) after controlling for demographic characteristics and comorbid medical disorders. Conclusions: This population-based age- and sex- matched cohort study shows that migraine was linked to an increased risk of HS.	[Kuo, Cheng-Ya; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kuo, Cheng-Ya; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yen, Ming-Fang; Chen, Li-Sheng] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan; [Fann, Ching-Yuan] Kainan Univ, Dept Nutr & Hlth Sci, Tao Yuan, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Tao Yuan, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Ctr Biostat Consultat, Taipei 10764, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Div Biostat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Nan Kai University Technology; Chang Gung University; National Taiwan University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		PAN, SHIN-LIANG/0000-0001-6451-4666; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; Chen, Hsiu-Hsi/0000-0002-5799-6705	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health, Executive Yuan, Republic of China	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Carter KN, 2005, J CLIN NEUROSCI, V12, P534, DOI 10.1016/j.jocn.2004.09.009; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Daneshtalab N, 2010, CARDIOVASC RES, V86, P160, DOI 10.1093/cvr/cvp395; Donaghy M, 2002, J NEUROL NEUROSUR PS, V73, P747, DOI 10.1136/jnnp.73.6.747; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros A, 2010, STROKE, V41, P2505, DOI 10.1161/STROKEAHA.109.572313; Gerretsen P, 2009, CURR NEUROL NEUROSCI, V9, P108, DOI 10.1007/s11910-009-0018-5; Heckmann JG, 1998, CEPHALALGIA, V18, P133, DOI 10.1046/j.1468-2982.1998.1803133.x; KRALL JM, 1975, BIOMETRICS, V31, P49, DOI 10.2307/2529709; Kurth T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3659; Lipton RB, 2005, HEADACHE, V45, pS3, DOI 10.1111/j.1526-4610.2005.4501001.x; Mathew NT, 1999, CEPHALALGIA, V19, P17, DOI 10.1177/0333102499019S2504; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; SMEDA JS, 1992, CAN J PHYSIOL PHARM, V70, P552, DOI 10.1139/y92-070; Smeda JS, 2003, STROKE, V34, P1491, DOI 10.1161/01.STR.0000073797.91891.9E; Sochurkova D, 1999, NEUROEPIDEMIOLOGY, V18, P85, DOI 10.1159/000069411; Soo Y, 2010, CEPHALALGIA, V30, P42, DOI 10.1111/j.1468-2982.2009.01868.x; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004	25	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55253	10.1371/journal.pone.0055253	http://dx.doi.org/10.1371/journal.pone.0055253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372843	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400083
J	Ueda, K; Kawabata, R; Irie, T; Nakai, Y; Tohya, Y; Sakaguchi, T				Ueda, Kyoko; Kawabata, Ryoko; Irie, Takashi; Nakai, Yoshiaki; Tohya, Yukinobu; Sakaguchi, Takemasa			Inactivation of Pathogenic Viruses by Plant-Derived Tannins: Strong Effects of Extracts from Persimmon (Diospyros kaki) on a Broad Range of Viruses	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; GREEN TEA; INHIBITION; FRUITS; REPLICATION; POLYPHENOL; MEMBRANE; PROTEIN; BINDS; CD4	Tannins, plant-derived polyphenols and other related compounds, have been utilized for a long time in many fields such as the food industry and manufacturing. In this study, we investigated the anti-viral effects of tannins on 12 different viruses including both enveloped viruses (influenza virus H3N2, H5N3, herpes simplex virus-1, vesicular stomatitis virus, Sendai virus and Newcastle disease virus) and non-enveloped viruses (poliovirus, coxsachievirus, adenovirus, rotavirus, feline calicivirus and mouse norovirus). We found that extracts from persimmon (Diospyros kaki), which contains ca. 22% of persimmon tannin, reduced viral infectivity in more than 4-log scale against all of the viruses tested, showing strong anti-viral effects against a broad range of viruses. Other tannins derived from green tea, acacia and gallnuts were effective for some of the viruses, while the coffee extracts were not effective for any of the virus. We then investigated the mechanism of the antiviral effects of persimmon extracts by using mainly influenza virus. Persimmon extracts were effective within 30 seconds at a concentration of 0.25% and inhibited attachment of the virus to cells. Pretreatment of cells with the persimmon extracts before virus infection or post-treatment after virus infection did not inhibit virus replication. Protein aggregation seems to be a fundamental mechanism underlying the anti-viral effect of persimmon tannin, since viral proteins formed aggregates when purified virions were treated with the persimmon extracts and since the anti-viral effect was competitively inhibited by a non-specific protein, bovine serum albumin. Considering that persimmon tannin is a food supplement, it has a potential to be utilized as a safe and highly effective anti-viral reagent against pathogenic viruses.	[Ueda, Kyoko; Kawabata, Ryoko; Irie, Takashi; Sakaguchi, Takemasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan; [Nakai, Yoshiaki] Altan Corp, Tokyo, Japan; [Tohya, Yukinobu] Nihon Univ, Coll Biosource Sci, Dept Vet Med, Kanagawa, Japan	Hiroshima University; Nihon University	Sakaguchi, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan.	tsaka@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	Hiroshima University; Altan Corporation	Hiroshima University; Altan Corporation	This work was supported by the basic research fund from Hiroshima University. It was also supported by the Altan Corporation as joint research to evaluate anti-viral activity of various reagents. However, the Altan Corporation was involved in the initial study design alone and not involved in any of the study design thereafter; collection, analysis, or interpretations presented in the paper.	Flint SJ, 2009, PRINCIPLES VIROLOGY, P82; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; FUKUCHI K, 1989, ANTIVIR RES, V11, P285, DOI 10.1016/0166-3542(89)90038-7; Green KY, 2006, FIELDS VIROLOGY, P949; Harrison SC, 2007, FIELDS VIROLOGY, P59; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2003, INT C HARMONIZATION; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07; ITO S, 1964, NATURE, V204, P475, DOI 10.1038/204475a0; Kawai K, 2003, J ALLERGY CLIN IMMUN, V112, P951, DOI 10.1016/S0091-6749(03)02007-4; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; KUZUYA M, 1993, J CLIN MICROBIOL, V31, P1308, DOI 10.1128/JCM.31.5.1308-1311.1993; Matsumoto K, 2011, PHYTOTHER RES, V25, P624, DOI 10.1002/ptr.3306; MATSUO T, 1978, AGR BIOL CHEM TOKYO, V42, P1637, DOI 10.1080/00021369.1978.10863225; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; NAKASHIMA H, 1992, ANTIVIR RES, V18, P91, DOI 10.1016/0166-3542(92)90008-S; Nakatsubo F, 2002, J WOOD SCI, V48, P414, DOI 10.1007/BF00770702; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Noma K, 1998, ARCH VIROL, V143, P1893, DOI 10.1007/s007050050428; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Sakaguchi T, 1999, VIROLOGY, V263, P230, DOI 10.1006/viro.1999.9960; Sakaguchi T, 2002, J VIROL, V76, P1682, DOI 10.1128/JVI.76.4.1682-1690.2002; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; WHITE T., 1957, Journal of the Science of Food and Agriculture, V8, P377, DOI 10.1002/jsfa.2740080702; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; WRIGHT PF, 2006, FIELDS VIROLOGY, P1692; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9	28	84	93	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55343	10.1371/journal.pone.0055343	http://dx.doi.org/10.1371/journal.pone.0055343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372851	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400091
J	Yu, D; Jin, C; Ramachandran, M; Xu, J; Nilsson, B; Korsgren, O; Le Blanc, K; Uhrbom, L; Forsberg-Nilsson, K; Westermark, B; Adamson, R; Maitland, N; Fan, XL; Essand, M				Yu, Di; Jin, Chuan; Ramachandran, Mohanraj; Xu, Jing; Nilsson, Berith; Korsgren, Olle; Le Blanc, Katarina; Uhrbom, Lene; Forsberg-Nilsson, Karin; Westermark, Bengt; Adamson, Rachel; Maitland, Norman; Fan, Xiaolong; Essand, Magnus			Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures	PLOS ONE			English	Article							VIVO GENE-TRANSFER; CANCER STEM-CELLS; ONCOLYTIC ADENOVIRUS; IN-VIVO; BINDING ABLATION; RECOMBINANT ADENOVIRUSES; RAPID GENERATION; PROSTATE-CANCER; TUMOR-CELLS; CAR-BINDING	Recombinant adenovirus serotype 5 (Ad5) vectors represent one of the most efficient gene delivery vectors in life sciences. However, Ad5 is dependent on expression of the coxsackievirus-adenovirus- receptor (CAR) on the surface of target cell for efficient transduction, which limits it's utility for certain cell types. Herein we present a new vector, Ad5PTDf35, which is an Ad5 vector having serotype 35 fiber-specificity and Tat-PTD hexon-modification. This vector shows dramatically increased transduction capacity of primary human cell cultures including T cells, monocytes, macrophages, dendritic cells, pancreatic islets and exocrine cells, mesenchymal stem cells and tumor initiating cells. Biodistribution in mice following systemic administration (tail-vein injection) show significantly reduced uptake in the liver and spleen of Ad5PTDf35 compared to unmodified Ad5. Therefore, replication-competent viruses with these modifications may be further developed as oncolytic agents for cancer therapy. User-friendly backbone plasmids containing these modifications were developed for compatibility to the AdEasy-system to facilitate the development of surface-modified adenoviruses for gene delivery to difficult-to-transduce cells in basic, pre-clinical and clinical research.	[Yu, Di; Jin, Chuan; Ramachandran, Mohanraj; Xu, Jing; Nilsson, Berith; Korsgren, Olle; Uhrbom, Lene; Forsberg-Nilsson, Karin; Westermark, Bengt; Essand, Magnus] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Le Blanc, Katarina] Karolinska Univ Hosp, Div Clin Immunol, Huddinge, Sweden; [Adamson, Rachel; Maitland, Norman] Univ York, YCR Canc Res Unit, Dept Biol, Heslington, England; [Fan, Xiaolong] Lund Univ, Rausing Lab, Lund, Sweden; [Fan, Xiaolong] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing, Peoples R China	Uppsala University; Karolinska Institutet; Karolinska University Hospital; University of York - UK; Lund University; Beijing Normal University	Essand, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	magnus.essand@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Le Blanc, Katarina/L-4631-2019	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Essand, Magnus/0000-0002-9725-0422; Westermark, Bengt/0000-0001-7153-5545; Maitland, Norman/0000-0003-1607-9035; Yu, Di/0000-0002-8636-0351; Korsgren, Olle/0000-0002-8524-9547; Xu, Jing/0000-0002-9506-5514	The Swedish Cancer Society [10-0105, 10-0552]; Swedish Children Cancer Foundation [PROJ10/027]; Swedish Research Council [K2013-55X-22191-01-3]; Gunnar Nilsson's Cancer Foundation; Marcus and Marianne Wallenberg Foundation; Medical Research Council [G0900871] Funding Source: researchfish; MRC [G0900871] Funding Source: UKRI	The Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson's Cancer Foundation; Marcus and Marianne Wallenberg Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Swedish Cancer Society (10-0105 and 10-0552), the Swedish Children Cancer Foundation (PROJ10/027), the Swedish Research Council (K2013-55X-22191-01-3), Gunnar Nilsson's Cancer Foundation and the Marcus and Marianne Wallenberg Foundation supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WC, 2011, P NATL ACAD SCI USA, V108, P7499, DOI 10.1073/pnas.1017146108; Adamson RE, 2012, HUM GENE THER, V23, P218, DOI 10.1089/hum.2011.021; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bayo-Puxan N, 2009, HUM GENE THER, V20, P1214, DOI 10.1089/hum.2009.038; Bilbao G, 2002, AM J TRANSPLANT, V2, P237, DOI 10.1034/j.1600-6143.2002.20308.x; Brouwer E, 2007, CANCER GENE THER, V14, P211, DOI 10.1038/sj.cgt.7701010; Carlsson B, 2003, BRIT J HAEMATOL, V121, P428, DOI 10.1046/j.1365-2141.2003.04300.x; Coughlan L, 2012, MOL THER; Danielsson A, 2008, CANCER GENE THER, V15, P203, DOI 10.1038/sj.cgt.7701117; de Vrij J, 2008, GENE THER, V15, P978, DOI 10.1038/gt.2008.26; Di BY, 2012, J BIOTECHNOL, V157, P373, DOI 10.1016/j.jbiotec.2011.12.022; Einfeld DA, 2001, J VIROL, V75, P11284, DOI 10.1128/JVI.75.23.11284-11291.2001; Escutenaire S, 2011, ANN MED, V43, P151, DOI 10.3109/07853890.2010.538079; Flotte T, 2001, DIABETES, V50, P515, DOI 10.2337/diabetes.50.3.515; Forsberg O, 2008, BRIT J HAEMATOL, V141, P188, DOI 10.1111/j.1365-2141.2008.07026.x; Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Koizumi N, 2003, J VIROL, V77, P13062, DOI 10.1128/JVI.77.24.13062-13072.2003; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Leissner P, 2001, GENE THER, V8, P49, DOI 10.1038/sj.gt.3301343; Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532; Leja J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008916; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Magnusson MK, 2012, HUM GENE THER, V23, P70, DOI 10.1089/hum.2011.016; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mathis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016792; Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj.gt.3301701; Molnar C, 2012, CELL TRANSPLANT; Mui TS, 2010, CURR OPIN ORGAN TRAN; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Ni Choileain S, 2012, IMMUNOBIOLOGY, V217, P169, DOI 10.1016/j.imbio.2011.06.003; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Pietras A, 2011, ADV CANCER RES, V112, P255, DOI 10.1016/B978-0-12-387688-1.00009-0; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Sakurai F, 2003, MOL THER, V8, P813, DOI 10.1016/S1525-0016(03)00243-0; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Yoshioka Y, 2008, LIFE SCI, V83, P747, DOI 10.1016/j.lfs.2008.09.022; Yu D, 2011, J VIROL, V85, P13114, DOI 10.1128/JVI.05759-11; Yun CO, 2005, HUM GENE THER, V16, P248, DOI 10.1089/hum.2005.16.248	49	18	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54952	10.1371/journal.pone.0054952	http://dx.doi.org/10.1371/journal.pone.0054952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372800	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400045
J	Baugh, L; Gallagher, LA; Patrapuvich, R; Clifton, MC; Gardberg, AS; Edwards, TE; Armour, B; Begley, DW; Dieterich, SH; Dranow, DM; Abendroth, J; Fairman, JW; Fox, D; Staker, BL; Phan, I; Gillespie, A; Choi, R; Nakazawa-Hewitt, S; Nguyen, MT; Napuli, A; Barrett, L; Buchko, GW; Stacy, R; Myler, PJ; Stewart, LJ; Manoil, C; Van Voorhis, WC				Baugh, Loren; Gallagher, Larry A.; Patrapuvich, Rapatbhorn; Clifton, Matthew C.; Gardberg, Anna S.; Edwards, Thomas E.; Armour, Brianna; Begley, Darren W.; Dieterich, Shellie H.; Dranow, David M.; Abendroth, Jan; Fairman, James W.; Fox, David, III; Staker, Bart L.; Phan, Isabelle; Gillespie, Angela; Choi, Ryan; Nakazawa-Hewitt, Steve; Mary Trang Nguyen; Napuli, Alberto; Barrett, Lynn; Buchko, Garry W.; Stacy, Robin; Myler, Peter J.; Stewart, Lance J.; Manoil, Colin; Van Voorhis, Wesley C.			Combining Functional and Structural Genomics to Sample the Essential Burkholderia Structome	PLOS ONE			English	Article							TRANSFER-RNA HYDROLASE; PEPTIDYL-TRANSFER-RNA; SYNTHASE-III FABH; ESSENTIAL GENES; THYMIDYLATE SYNTHASE; PLASMODIUM-FALCIPARUM; BACILLUS-SUBTILIS; IDENTIFICATION; PROTEINS; THAILANDENSIS	Background: The genus Burkholderia includes pathogenic gram-negative bacteria that cause melioidosis, glanders, and pulmonary infections of patients with cancer and cystic fibrosis. Drug resistance has made development of new antimicrobials critical. Many approaches to discovering new antimicrobials, such as structure-based drug design and whole cell phenotypic screens followed by lead refinement, require high-resolution structures of proteins essential to the parasite. Methodology/Principal Findings: We experimentally identified 406 putative essential genes in B. thailandensis, a low-virulence species phylogenetically similar to B. pseudomallei, the causative agent of melioidosis, using saturation-level transposon mutagenesis and next-generation sequencing (Tn-seq). We selected 315 protein products of these genes based on structure-determination criteria, such as excluding very large and/or integral membrane proteins, and entered them into the Seattle Structural Genomics Center for Infection Disease (SSGCID) structure determination pipeline. To maximize structural coverage of these targets, we applied an "ortholog rescue'' strategy for those producing insoluble or difficult to crystallize proteins, resulting in the addition of 387 orthologs (or paralogs) from seven other Burkholderia species into the SSGCID pipeline. This structural genomics approach yielded structures from 31 putative essential targets from B. thailandensis, and 25 orthologs from other Burkholderia species, yielding an overall structural coverage for 49 of the 406 essential gene families, with a total of 88 depositions into the Protein Data Bank. Of these, 25 proteins have properties of a potential antimicrobial drug target i.e., no close human homolog, part of an essential metabolic pathway, and a deep binding pocket. We describe the structures of several potential drug targets in detail. Conclusions/Significance: This collection of structures, solubility and experimental essentiality data provides a resource for development of drugs against infections and diseases caused by Burkholderia. All expression clones and proteins created in this study are freely available by request.	[Gillespie, Angela; Choi, Ryan; Nakazawa-Hewitt, Steve; Mary Trang Nguyen; Napuli, Alberto; Barrett, Lynn; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Gallagher, Larry A.; Patrapuvich, Rapatbhorn; Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Clifton, Matthew C.; Gardberg, Anna S.; Edwards, Thomas E.; Armour, Brianna; Begley, Darren W.; Dieterich, Shellie H.; Dranow, David M.; Abendroth, Jan; Fairman, James W.; Fox, David, III; Staker, Bart L.; Stewart, Lance J.] Emerald BioStruct, Bainbridge Isl, WA USA; [Baugh, Loren; Phan, Isabelle; Stacy, Robin; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Buchko, Garry W.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Myler, Peter J.; Van Voorhis, Wesley C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Van Voorhis, Wesley C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle		wesley@uw.edu	Myler, Peter John/AAR-9535-2021; Buchko, Garry/G-6173-2015	Buchko, Garry/0000-0002-3639-1061; Myler, Peter/0000-0002-0056-0513; Edwards, Thomas/0000-0002-0474-8003; Staker, Bart/0000-0001-9570-5086	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200700057C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200700057C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley DW, 2011, ACTA CRYSTALLOGR F, V67, P1070, DOI 10.1107/S1744309111029009; Begley Darren W., 2011, Journal of Structural and Functional Genomics, V12, P63, DOI 10.1007/s10969-011-9102-6; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bryan CM, 2011, ACTA CRYSTALLOGR F, V67, P1010, DOI 10.1107/S1744309111018367; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Castillo YP, 2008, MINI-REV MED CHEM, V8, P36; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen M S, 1978, Methods Enzymol, V51, P354; Choi R, 2011, ACTA CRYSTALLOGR F, V67, P998, DOI 10.1107/S1744309111017374; Chong Chan-Eng, 2006, In Silico Biology, V6, P341; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Costi PM, 1999, J MED CHEM, V42, P2112, DOI 10.1021/jm9900016; DANNEBERG PB, 1958, CANCER RES, V18, P329; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; de Bono JS, 2001, INVEST NEW DRUG, V19, P41, DOI 10.1023/A:1006404701008; Edwards TE, 2012, PROTEIN SCI, V21, P1093, DOI 10.1002/pro.2084; Freiberg C, 2001, J MOL MICROB BIOTECH, V3, P483; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackman AL, 1995, ANN ONCOL, V6, P871, DOI 10.1093/oxfordjournals.annonc.a059353; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2002, J MED MICROBIOL, V51, P533, DOI 10.1099/0022-1317-51-7-533; Mann T, 2010, INFECTION, V38, P187, DOI 10.1007/s15010-010-0017-0; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Menez J, 2002, MOL MICROBIOL, V45, P123, DOI 10.1046/j.1365-2958.2002.02992.x; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Tondi D, 2005, J MED CHEM, V48, P913, DOI 10.1021/jm0491445; Unger F. M., 1981, ADV CARBOHYD CHEM BI, V38, P323; Van Lanen SG, 2008, P NATL ACAD SCI USA, V105, P494, DOI 10.1073/pnas.0708750105; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; West TE, 2009, INFECT IMMUN, V77, P5612, DOI 10.1128/IAI.00618-09; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	53	91	5724	2	476	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53851	10.1371/journal.pone.0053851	http://dx.doi.org/10.1371/journal.pone.0053851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382856	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600020
J	Giri, S; Karakoti, A; Graham, RP; Maguire, JL; Reilly, CM; Seal, S; Rattan, R; Shridhar, V				Giri, Shailendra; Karakoti, Ajay; Graham, Rondell P.; Maguire, Jacie L.; Reilly, Christopher M.; Seal, Sudipta; Rattan, Ramandeep; Shridhar, Viji			Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CERIUM OXIDE NANOPARTICLES; PHASE-II; TUMOR ANGIOGENESIS; BEVACIZUMAB; METASTASIS; ACTIVATION; EXPRESSION; PROTECTION; DAMAGE	Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among women in United Sates and the leading cause of death from gynecological malignancies. While most OvCa patients initially respond to surgical debulking and chemotherapy, 75% of patients later succumb to the disease. Thus, there is an urgent need to test novel therapeutic agents to counteract the high mortality rate associated with OvCa. In this context, we have developed and engineered Nanoceria (NCe), nanoparticles of cerium oxide, possessing anti-oxidant properties, to be used as a therapeutic agent in OvCa. We show for the first time that NCe significantly inhibited production of reactive oxygen species (ROS) in A2780 cells, attenuated growth factor (SDF1, HB-EGF, VEGF(165) and HGF) mediated cell migration and invasion of SKOV3 cells, without affecting the cell proliferation. NCe treatment also inhibited VEGF165 induced proliferation, capillary tube formation, activation of VEGFR2 and MMP2 in human umbilical vascular endothelial cells (HUVEC). NCe (0.1 mg/kg body weigh) treatment of A2780 ovarian cancer cells injected intra-peritoneally in nude mice showed significant reduction (p<0.002) in tumor growth accompanied by decreased tumor cell proliferation as evident from reduced tumor size and Ki67 staining. Accumulation of NCe was found in tumors isolated from treated group using transmission electron microscopy (TEM) and inductively coupled plasma mass spectroscopy (ICP-MS). Reduction of the tumor mass was accompanied by attenuation of angiogenesis, as observed by reduced CD31 staining and specific apoptosis of vascular endothelial cells. Collectively, these results indicate that cerium oxide based NCe is a novel nanoparticle that can potentially be used as an anti-angiogenic therapeutic agent in ovarian cancer.	[Giri, Shailendra; Maguire, Jacie L.; Shridhar, Viji] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN USA; [Karakoti, Ajay; Seal, Sudipta] Univ Cent Florida, Nanosci Technol Ctr, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA; [Graham, Rondell P.] Mayo Clin, Coll Med, Rochester, MN USA; [Reilly, Christopher M.] Virginia Tech, Via Virginia Coll Osteopath Med, Blacksburg, VA USA; [Reilly, Christopher M.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Rattan, Ramandeep] Henry Ford Hlth Syst, Womens Hlth Serv, Detroit, MI USA	Mayo Clinic; State University System of Florida; University of Central Florida; Mayo Clinic; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Henry Ford Health System; Henry Ford Hospital	Seal, S (corresponding author), Univ Cent Florida, Nanosci Technol Ctr, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA.	shridhar.vijayalakshmi@mayo.edu; rrattan1@hfhs.org; Sudipta.Seal@ucf.edu	Karakoti, Ajay/AGI-8160-2022; Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AAY-5886-2020	KARAKOTI, AJAY/0000-0001-9081-2325; Graham, Rondell/0000-0002-8686-4867; Reilly, Chris/0000-0003-4787-7750	Mayo Clinic College of Medicine; Marsh Rivkin grants; NSF CBET [0708172, 0930170];  [CA123249]; NATIONAL CANCER INSTITUTE [R01CA123249] Funding Source: NIH RePORTER	Mayo Clinic College of Medicine; Marsh Rivkin grants; NSF CBET(National Science Foundation (NSF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is mainly supported by CA123249 and support from Mayo Clinic College of Medicine to VS and partly supported by Marsh Rivkin grants to SG and RR. This work was partly supported by NSF CBET, 0708172 and 0930170 to SS (for the nanoparticle development in biomedical applications). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili L, 2011, BIOMATERIALS; Amin KA, 2011, INT J NANOMED, V6, P143, DOI 10.2147/IJN.S15308; Bansal N, 2011, GYNECOL ONCOL, V120, P313, DOI 10.1016/j.ygyno.2010.10.002; Bast Robert C Jr, 2002, Cancer Treat Res, V107, P61; Bharali DJ, 2010, PHARMACOL THERAPEUT, V128, P324, DOI 10.1016/j.pharmthera.2010.07.007; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Colon J, 2010, NANOMED-NANOTECHNOL, V6, P698, DOI 10.1016/j.nano.2010.01.010; Colon J, 2009, NANOMED-NANOTECHNOL, V5, P225, DOI 10.1016/j.nano.2008.10.003; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Deshpande S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061873; Ferrara N, 1996, EUR J CANCER, V32A, P2413, DOI 10.1016/S0959-8049(96)00387-5; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2008, J NEUROCHEM, V105, P1820, DOI 10.1111/j.1471-4159.2008.05279.x; Gomez-Raposo C, 2009, CLIN TRANSL ONCOL, V11, P564, DOI 10.1007/s12094-009-0406-y; Hardas SS, 2010, TOXICOL SCI, V116, P562, DOI 10.1093/toxsci/kfq137; Hirst SM, 2011, ENVIRON TOXICOL; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Karakoti AS, 2007, J PHYS CHEM C, V111, P17232, DOI 10.1021/jp076164k; Karakoti AS, 2009, J AM CHEM SOC, V131, P14144, DOI 10.1021/ja9051087; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Koskas M, 2010, ANTICANCER RES, V30, P4743; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lecarpentier E, 2010, INVEST NEW DRUGS; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Markman M, 2009, EXPERT OPIN PHARMACO, V10, P2269, DOI 10.1517/14656560903120907; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Penson RT, 2010, J CLIN ONCOL, V28, P154, DOI 10.1200/JCO.2009.22.7900; Penson RT, 2003, GYNECOL ONCOL, V28, P154; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Seigneuric R, 2010, CURR MOL MED, V10, P640, DOI 10.2174/156652410792630634; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f; Tempfer C, 1998, OBSTET GYNECOL, V92, P360, DOI 10.1016/S0029-7844(98)00190-2; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567	55	164	176	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54578	10.1371/journal.pone.0054578	http://dx.doi.org/10.1371/journal.pone.0054578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382918	Green Published, gold			2022-12-25	WOS:000314610600031
J	Guo, L; Du, H; Yan, SQ; Wu, XP; McKhann, GM; Chen, JX; Yan, SS				Guo, Lan; Du, Heng; Yan, Shiqiang; Wu, Xiaoping; McKhann, Guy M.; Chen, John Xi; Yan, Shirley ShiDu			Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer's Neurons	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; LONG-TERM DEPRESSION; PERMEABILITY TRANSITION; A-BETA; HIPPOCAMPAL-NEURONS; MOUSE MODEL; CELL-DEATH; SYNAPTIC DEGENERATION; CORTICAL-NEURONS; FREE-RADICALS	Normal axonal mitochondrial transport and function is essential for the maintenance of synaptic function. Abnormal mitochondrial motility and mitochondrial dysfunction within axons are critical for amyloid beta (A beta)-induced synaptic stress and the loss of synapses relevant to the pathogenesis of Alzheimer's disease (AD). However, the mechanisms controlling axonal mitochondrial function and transport alterations in AD remain elusive. Here, we report an unexplored role of cyclophilin D (CypD)-dependent mitochondrial permeability transition pore (mPTP) in A beta-impaired axonal mitochondrial trafficking. Depletion of CypD significantly protects axonal mitochondrial motility and dynamics from A beta toxicity as shown by increased axonal mitochondrial density and distribution and improved bidirectional transport of axonal mitochondria. Notably, blockade of mPTP by genetic deletion of CypD suppresses A beta-mediated activation of the p38 mitogen-activated protein kinase signaling pathway, reverses axonal mitochondrial abnormalities, improves synaptic function, and attenuates loss of synapse, suggesting a role of CypD-dependent signaling in A beta-induced alterations in axonal mitochondrial trafficking. The potential mechanisms of the protective effects of lacking CypD on A beta-induced abnormal mitochondrial transport in axon are increased axonal calcium buffer capability, diminished reactive oxygen species (ROS), and suppressing downstream signal transduction P38 activation. These findings provide new insights into CypD-dependent mitochondrial mPTP and signaling on mitochondrial trafficking in axons and synaptic degeneration in an environment enriched for A beta.	[Guo, Lan; Du, Heng; Yan, Shiqiang; Yan, Shirley ShiDu] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Guo, Lan; Du, Heng; Yan, Shiqiang; Yan, Shirley ShiDu] Univ Kansas, Sch Pharm, Higuchi Biosci Ctr, Lawrence, KS 66045 USA; [Yan, Shiqiang] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Gansu, Peoples R China; [Wu, Xiaoping; McKhann, Guy M.] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA; [Chen, John Xi] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA	University of Kansas; University of Kansas; Lanzhou University; Columbia University; Memorial Sloan Kettering Cancer Center	Yan, SS (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA.	shidu@ku.edu		Wu, Xiaoping/0000-0001-8578-4016	National Institute of Aging [R37AG037319, K99AG037716]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R37AG037319, K99AG037716] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from National Institute of Aging (R37AG037319 and K99AG037716) and the Alzheimer's Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Baines CP, 2007, AM J PHYSIOL-HEART C, V293, pH903, DOI 10.1152/ajpheart.00575.2007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Billups B, 2002, J NEUROSCI, V22, P5840; Bus AI, 1999, NEUROBIOL AGING, V20, P339; Bush AI, 1999, NEUROBIOL AGING, V20, P335; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen KC, 2008, TOXICOL LETT, V180, P53, DOI 10.1016/j.toxlet.2008.05.014; David G, 2000, J NEUROSCI, V20, P7290; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Ferreira IL, 2011, CELL CALCIUM; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; HARTMANN H, 1993, BIOCHEM BIOPH RES CO, V194, P1216, DOI 10.1006/bbrc.1993.1952; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; Kimura A, 2000, J NEUROPHYSIOL, V84, P1894, DOI 10.1152/jn.2000.84.4.1894; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lee MW, 2002, FEBS LETT, V512, P313, DOI 10.1016/S0014-5793(02)02225-1; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin FH, 1999, MOL BRAIN RES, V71, P131, DOI 10.1016/S0169-328X(99)00161-8; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Malaiyandi LM, 2005, J NEUROSCI, V25, P9507, DOI 10.1523/JNEUROSCI.0868-05.2005; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mao P, 2012, HUM MOL GENET; Matsuyama D, 2011, BASIC RES CARDIOL, V106, P815, DOI 10.1007/s00395-011-0178-8; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1995, NEUROBIOL AGING, V16, P679, DOI 10.1016/0197-4580(95)00063-K; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; MORRIS RL, 1993, J CELL SCI, V104, P917; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Origlia N, 2010, J NEUROSCI, V30, P11414, DOI 10.1523/JNEUROSCI.2127-10.2010; Parameshwaran K, 2007, SYNAPSE, V61, P367, DOI 10.1002/syn.20386; Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rohrbough J, 1999, J NEUROSCI, V19, P8528; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Sberna G, 1997, J NEUROCHEM, V69, P1177; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Trinchese F, 2004, J MOL NEUROSCI, V24, P15, DOI 10.1385/JMN:24:1:015; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; Zhu XW, 2005, NEUROCHEM RES, V30, P791, DOI 10.1007/s11064-005-6872-x	77	88	91	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54914	10.1371/journal.pone.0054914	http://dx.doi.org/10.1371/journal.pone.0054914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382999	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600051
J	Li, G; Campbell, DA				Li, Gang; Campbell, Douglas A.			Rising CO2 Interacts with Growth Light and Growth Rate to Alter Photosystem II Photoinactivation of the Coastal Diatom Thalassiosira pseudonana	PLOS ONE			English	Article							CO2-CONCENTRATING MECHANISM; PHYSIOLOGICAL-RESPONSES; SEAWATER ACIDIFICATION; OCEAN ACIDIFICATION; RIVER ESTUARY; CELL-SIZE; PHYTOPLANKTON; PHOTOINHIBITION; PHOTOPROTECTION; ACCLIMATION	We studied the interactive effects of pCO(2) and growth light on the coastal marine diatom Thalassiosira pseudonana CCMP 1335 growing under ambient and expected end-of-the-century pCO(2) (750 ppmv), and a range of growth light from 30 to 380 mu mol photons.m(-2).s(-1). Elevated pCO(2) significantly stimulated the growth of T. pseudonana under sub-saturating growth light, but not under saturating to super-saturating growth light. Under ambient pCO(2) susceptibility to photoinactivation of photosystem II (sigma i) increased with increasing growth rate, but cells growing under elevated pCO(2) showed no dependence between growth rate and sigma i, so under high growth light cells under elevated pCO(2) were less susceptible to photoinactivation of photosystem II, and thus incurred a lower running cost to maintain photosystem II function. Growth light altered the contents of RbcL (RUBISCO) and PsaC (PSI) protein subunits, and the ratios among the subunits, but there were only limited effects on these and other protein pools between cells grown under ambient and elevated pCO(2).	[Li, Gang; Campbell, Douglas A.] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Li, Gang] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China	Mount Allison University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Campbell, DA (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	dcampbell@mta.ca	Campbell, Douglas A./B-3768-2010	Campbell, Douglas A./0000-0001-8996-5463	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; National Natural Science Foundation of China [41206132]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) (DAC) and the National Natural Science Foundation of China (No. 41206132)(http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Barnett A. B, 2007, FIREWORX; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Burey SC, 2007, PLANT CELL ENVIRON, V30, P1422, DOI 10.1111/j.1365-3040.2007.01715.x; Campbell DA, 2012, BBA-BIOENERGETICS, V1817, P258, DOI 10.1016/j.bbabio.2011.04.010; Chen BZ, 2009, MAR ECOL PROG SER, V379, P77, DOI 10.3354/meps07888; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; CULLEN JJ, 1988, J PLANKTON RES, V10, P1039, DOI 10.1093/plankt/10.5.1039; EHRMAN J. M., 2012, CURRENT ADV ALGAL TA, P253; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Finkel Z., 2007, LIGHT ABSORPTION SIZ, P1; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fuhrmann T, 2004, APPL PHYS B-LASERS O, V78, P257, DOI 10.1007/s00340-004-1419-4; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Grouneva I, 2013, PLANTA, V237, P399, DOI 10.1007/s00425-012-1744-5; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hong Y, 2008, PESTIC BIOCHEM PHYS, V90, P203, DOI 10.1016/j.pestbp.2007.11.009; Hoogstraten A, 2012, J PHYCOL, V48, P559, DOI 10.1111/j.1529-8817.2012.01148.x; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; Ingalls AE, 2010, GEOCHIM COSMOCHIM AC, V74, P104, DOI 10.1016/j.gca.2009.09.012; Intergovernmental Panel on Climate Change Climate, 2007, CLIM CHANG 2007 MIT; Janknegt PJ, 2008, J PHYCOL, V44, P957, DOI 10.1111/j.1529-8817.2008.00553.x; Janknegt PJ, 2009, EUR J PHYCOL, V44, P525, DOI 10.1080/09670260902943273; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Leonardos N, 2004, EUR J PHYCOL, V39, P173, DOI 10.1080/0967026042000201867; Lewis E., 1998, ORNLCDIAC105; Li G, 2011, MAR POLLUT BULL, V62, P1852, DOI 10.1016/j.marpolbul.2011.02.050; Litchman E, 2002, LIMNOL OCEANOGR, V47, P86, DOI 10.4319/lo.2002.47.1.0086; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Low-Decarie E, 2011, GLOBAL CHANGE BIOL, V17, P2525, DOI 10.1111/j.1365-2486.2011.02402.x; Macgillivary ML, 2011, DIATOM RES, V26, P321, DOI 10.1080/0269249X.2011.639145; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; McGinn PJ, 2005, CAN J BOT, V83, P711, DOI 10.1139/B05-055; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; MOREL A, 1981, DEEP-SEA RES, V28, P1375, DOI 10.1016/0198-0149(81)90039-X; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nielsen LT, 2012, AQUAT MICROB ECOL, V65, P271, DOI 10.3354/ame01554; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Oguchi R, 2011, PHYSIOL PLANTARUM, V142, P47, DOI 10.1111/j.1399-3054.2011.01452.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PENG T-H, 1987, Tellus Series B Chemical and Physical Meteorology, V39, P439, DOI 10.1111/j.1600-0889.1987.tb00205.x; PLATT T, 1980, J MAR RES, V38, P687; Quigg A, 2003, PLANT CELL ENVIRON, V26, P693, DOI 10.1046/j.1365-3040.2003.01004.x; Ragni M, 2008, J PHYCOL, V44, P670, DOI 10.1111/j.1529-8817.2008.00524.x; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P779, DOI 10.1111/j.1365-3040.1991.tb01442.x; Raven JA, 2012, PHILOS T R SOC B, V367, P493, DOI 10.1098/rstb.2011.0212; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Six C, 2009, PLANT PHYSIOL, V151, P379, DOI 10.1104/pp.109.140566; Takahashi S, 2010, PLANT PHYSIOL, V153, P988, DOI 10.1104/pp.110.155747; Thomas S, 2013, J PLANKTON IN PRESS; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; Wu HY, 2012, PLANT PHYSIOL, V160, P464, DOI 10.1104/pp.112.203067; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Yoshimura T., 2009, BIOGEOSCI DISCUSS, V6, P4143, DOI DOI 10.5194/BGD-6-4143-2009; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhai WD, 2005, MAR CHEM, V93, P21, DOI 10.1016/j.marchem.2004.07.003	82	73	77	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55562	10.1371/journal.pone.0055562	http://dx.doi.org/10.1371/journal.pone.0055562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383226	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600127
J	Sun, SC; Wang, XG; Ma, XS; Huang, XJ; Li, J; Liu, HL				Sun, Shao-Chen; Wang, Xu-Guang; Ma, Xue-Shan; Huang, Xian-Ju; Li, Juan; Liu, Hong-Lin			TBP Dynamics during Mouse Oocyte Meiotic Maturation and Early Embryo Development	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; ASSOCIATION; CELLS	To maintain cell lineage, cells develop a mechanism which can transmit the gene activity information to the daughter cells. In mitosis, TBP (TATA-binding protein), a transcription factor which belongs to TFIID was associated with M phase chromosomes and was proved to be a bookmark for cellular memory. Although previous work showed that TBP was dispensable for mouse oocyte maturation and early embryo development, exogenous TBP protein was detected in the nuclear of oocytes and early embryos. It is still unknown whether exogenous TBP can associate with condensed chromosomes during meiosis and mouse early embryo development. In present study by the injection of GFP-tagged TBP mRNA we for the first time investigated TBP dynamics in mouse early embryos and confirmed its localization pattern in oocytes. The exogenous TBP enriched at germinal vesicle at GV stage but disappeared from the chromosomes after GVBD. Moreover, exogenous TBP was still dispersed from the chromosomes of somatic donor nuclear in oocytes by nuclear transfer (NT), further proving that oocyte has some mechanism to remove TBP. During mouse embryo development, the exogenous TBP was removed from the chromosomes of M phase zygotes, but was found to express weakly at the M phase of 2-cell. Moreover, in the blastocyst TBP was also detected at the M phase chromosomes. Overexpression of TBP caused the failure of oocyte maturation and embryo development. Our results supported the idea that TBP might be a marker for transmitting cellular memory to daughter cells.	[Sun, Shao-Chen; Wang, Xu-Guang; Ma, Xue-Shan; Huang, Xian-Ju; Li, Juan; Liu, Hong-Lin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [31072028]; Fundamental Research Funds for the Central Universities [KYRC201202, KYZ200914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (31072028) and the Fundamental Research Funds for the Central Universities (KYRC201202 and KYZ200914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-45; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Gazdag E, 2007, REPRODUCTION, V134, P51, DOI 10.1530/REP-06-0337; Gazdag E, 2009, GENE DEV, V23, P2210, DOI 10.1101/gad.535209; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grealish S, 2011, CELL CYCLE, V10, P3421, DOI 10.4161/cc.10.20.17691; Jones KA, 2007, GENE DEV, V21, P2113, DOI 10.1101/gad.1598007; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Miyamoto K, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.16946; Mueller Ferenc, 2009, Journal of Biology (London), V8, P97, DOI 10.1186/jbiol196; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Simonsson S, 2005, CELL CYCLE, V4, P513, DOI 10.4161/cc.4.4.1581; Sun SC, 2011, CELL CYCLE, V10, P1853, DOI 10.4161/cc.10.11.15796; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Zhu SY, 2011, CELL CYCLE, V10, P871, DOI 10.4161/cc.10.6.15035	23	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55425	10.1371/journal.pone.0055425	http://dx.doi.org/10.1371/journal.pone.0055425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383188	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600103
J	Yu, DC				Yu, Dongchuan			Additional Brain Functional Network in Adults with Attention-Deficit/Hyperactivity Disorder: A Phase Synchrony Analysis	PLOS ONE			English	Article							RESTING-STATE; SMALL-WORLD; DISCRIMINATIVE ANALYSIS; CHILDREN	We develop a method to construct a new type of functional networks by the usage of phase synchrony degree that is different from the widely used Pearson's correlation approach. By a series of very strict statistical tests, we found that there is an additional network in attention-deficit/hyperactivity disorder (ADHD) subjects, superimposing the original (normal) brain functional network corresponding to healthy controls. The additional network leads to the increase in clustering coefficient, cost, local efficiency, and global efficiency. Our findings are inconsistent with many previous researches (using the Pearson's correlation approach) revealing both increased and decreased functional connections between brain regions and many reports revealing that the brain functional networks of ADHD patients have slow information flow and low global efficiency. We also confirm that the additional network in ADHD subjects contains 6 communities, and three of them are associated with emotional control, sensory information integration, and motor control, respectively. Furthermore, we find that there is a pathway connecting the left insula and left anterior cingular gyrus via the frontal gyrus and putamen in the additional network in ADHD subjects. This implies that due to the pathway connecting brain regions in the salience network, the ADHD patients are more sensitive to external stimuli or internal thoughts and are easier to switch to the executive network and hence harder to inhibit. For clinical diagnostic purposes, we apply the k-means clustering method to distinguish ADHD patients with healthy controls at the individual subject level, and obtain a meaningful diagnostic result. More interestingly, we find that the suggested technique using phase synchrony degree to construct functional networks may obtain higher classification accuracy than the method using the Pearson's correlation coefficient.	[Yu, Dongchuan] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Yu, Dongchuan] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yu, DC (corresponding author), Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	dcyu@seu.edu.cn			Natural Science Foundation of China [61074126, 61273224, 10602026]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Natural Science Foundation of China under Grant Nos. 61074126, 61273224, and 10602026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; [Anonymous], [No title captured]; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Seidman LJ, 2004, PSYCHIAT CLIN N AM, V27, P323, DOI 10.1016/j.psc.2004.01.002; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Yu DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024333; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zanin M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00630; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58	31	32	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54516	10.1371/journal.pone.0054516	http://dx.doi.org/10.1371/journal.pone.0054516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382908	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600029
J	Zhao, HY; Huang, Y; Xue, C; Chen, Y; Hou, X; Guo, Y; Zhao, LP; Hu, ZH; Huang, YJ; Luo, YZ; Zhang, L				Zhao, Hongyun; Huang, Yan; Xue, Cong; Chen, Yang; Hou, Xue; Guo, Ying; Zhao, Liping; Hu, Zhi Huang; Huang, Yujie; Luo, Yongzhang; Zhang, Li			Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; STAGE-I; TUMOR ANGIOGENESIS; BREAST-CANCER; SURFACE; SURVIVAL; NEOVASCULARIZATION; NEOANGIOGENESIS; SURGERY; MARKER	Nucleolin is implicated to play a role in angiogenesis, a vital process in tumor growth and metastasis. However, the presence and clinical relevance of nucleolin in human non small cell lung cancer (NSCLC) remains largely unknown. In this study, we explored the expression and prognostic implication of nucleolin in surgically resected NSCLC patients. A cohort of 146 NSCLC patients who underwent surgical resection was selected for tissue microarray. In this tissue microarray, nucleolin expression was measured by immunofluorescence. Staining for CD31, a marker of endothelial cells, was performed to mark blood vessels. A Cox proportional hazards model was used to assess the prognostic significance of nucleolin. Nucleolin expression was observed in 34.2% of all patients, and 64.1% in high CD31 expression patients. The disease-free survival (DFS) was significantly shorter in patients with high nucleolin (CD31(hi) NCLhi) compared to patients with low tumor blood vessels (CD31(lo) NCLlo) (5 ys of DFS 24% vs 64%, p = 0.002). Such a difference was demonstrated in the following stratified analyses: stage I (p<0.001), squamous cell carcinoma and adenosquamous cell carcinoma (p = 0.028), small tumor (<5 cm, p = 0.008), and surgery alone (p = 0.015). Multivariate analysis further revealed that nucleolin expression independently predicted for worse survival (p = 0.003). This study demonstrates that nucleolin is associated with the clinical outcomes in postoperative NSCLC patients. Thus, the expression levels of nucleolin may provide a new prognostic marker to identify patients at higher risk for treatment failure, especially in some subgroups.	[Zhao, Hongyun; Huang, Yan; Xue, Cong; Hou, Xue; Guo, Ying; Zhao, Liping; Hu, Zhi Huang; Zhang, Li] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yang; Huang, Yujie; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Natl Engn Lab Anti Tumor Prot Therapeut, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China; [Chen, Yang; Huang, Yujie; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Canc Biol Lab, Beijing 100084, Peoples R China	Sun Yat Sen University; Tsinghua University; Tsinghua University	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn	Chen, Yang/C-9919-2016	Chen, Yang/0000-0003-4441-5614				Bremnes RM, 2006, LUNG CANCER, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Deng JS, 1996, MOL BIOL REP, V23, P191, DOI 10.1007/BF00351168; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fontanini G, 1997, CLIN CANCER RES, V3, P861; Fontanini G, 1997, BRIT J CANCER, V75, P1295, DOI 10.1038/bjc.1997.220; Giatromanolaki A, 1997, CLIN CANCER RES, V3, P2485; Ginisty H, 1999, J CELL SCI, V112, P761; Han H, 2001, ANN SURG ONCOL, V8, P72, DOI 10.1245/aso.2001.8.1.72; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He LR, 2010, ANN ONCOL, V21, P1675, DOI 10.1093/annonc/mdp592; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; HOSKINS WJ, 1989, BAILLIERE CLIN OB GY, V3, P59, DOI 10.1016/S0950-3552(89)80042-2; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Koukourakis MI, 1997, INT J CANCER, V74, P565, DOI 10.1002/(SICI)1097-0215(19971219)74:6<565::AID-IJC1>3.0.CO;2-S; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Maniwa Y, 2000, AM J SURG, V179, P122, DOI 10.1016/S0002-9610(00)00244-0; Matsuyama K, 1998, ANN THORAC SURG, V65, P1405, DOI 10.1016/S0003-4975(97)01416-1; Mitsudomi T, 1996, J SURG ONCOL, V63, P159, DOI 10.1002/(SICI)1096-9098(199611)63:3<159::AID-JSO5>3.0.CO;2-C; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Offersen BV, 2001, CANCER, V91, P1500, DOI 10.1002/1097-0142(20010415)91:8<1500::AID-CNCR1158>3.3.CO;2-D; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; ORRICK LR, 1973, P NATL ACAD SCI USA, V70, P1316, DOI 10.1073/pnas.70.5.1316; PFEIFLE J, 1983, BIOCHIM BIOPHYS ACTA, V762, P86, DOI 10.1016/0167-4889(83)90120-9; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Sinclair JF, 2002, J BIOL CHEM, V277, P2876, DOI 10.1074/jbc.M110230200; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; van Rens MTM, 2000, CHEST, V117, P374, DOI 10.1378/chest.117.2.374; VARANI J, 1981, J SURG ONCOL, V17, P9, DOI 10.1002/jso.2930170103; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yano T, 2000, EUR J CANCER, V36, P601, DOI 10.1016/S0959-8049(99)00327-5	43	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54674	10.1371/journal.pone.0054674	http://dx.doi.org/10.1371/journal.pone.0054674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382938	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600034
J	Aure, MR; Steinfeld, I; Baumbusch, LO; Liestol, K; Lipson, D; Nyberg, S; Naume, B; Sahlberg, KK; Kristensen, VN; Borresen-Dale, AL; Lingjaerde, OC; Yakhini, Z				Aure, Miriam Ragle; Steinfeld, Israel; Baumbusch, Lars Oliver; Liestol, Knut; Lipson, Doron; Nyberg, Sandra; Naume, Bjorn; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingjaerde, Ole Christian; Yakhini, Zohar			Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ISOLATED TUMOR-CELLS; BONE-MARROW; MOLECULAR SUBTYPES; ANALYSIS REVEALS; CARCINOMA; AMPLIFICATION; PATTERNS; PROTEIN; RAD21	Genomic copy number alterations are common in cancer. Finding the genes causally implicated in oncogenesis is challenging because the gain or loss of a chromosomal region may affect a few key driver genes and many passengers. Integrative analyses have opened new vistas for addressing this issue. One approach is to identify genes with frequent copy number alterations and corresponding changes in expression. Several methods also analyse effects of transcriptional changes on known pathways. Here, we propose a method that analyses in-cis correlated genes for evidence of in-trans association to biological processes, with no bias towards processes of a particular type or function. The method aims to identify cis-regulated genes for which the expression correlation to other genes provides further evidence of a network-perturbing role in cancer. The proposed unsupervised approach involves a sequence of statistical tests to systematically narrow down the list of relevant genes, based on integrative analysis of copy number and gene expression data. A novel adjustment method handles confounding effects of co-occurring copy number aberrations, potentially a large source of false positives in such studies. Applying the method to whole-genome copy number and expression data from 100 primary breast carcinomas, 6373 genes were identified as commonly aberrant, 578 were highly in-cis correlated, and 56 were in addition associated in-trans to biological processes. Among these in-trans process associated and cis-correlated (iPAC) genes, 28% have previously been reported as breast cancer associated, and 64% as cancer associated. By combining statistical evidence from three separate subanalyses that focus respectively on copy number, gene expression and the combination of the two, the proposed method identifies several known and novel cancer driver candidates. Validation in an independent data set supports the conclusion that the method identifies genes implicated in cancer.	[Aure, Miriam Ragle; Baumbusch, Lars Oliver; Nyberg, Sandra; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Aure, Miriam Ragle; Nyberg, Sandra; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingjaerde, Ole Christian] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Steinfeld, Israel; Lipson, Doron; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, Lab Computat Biol, IL-32000 Haifa, Israel; [Liestol, Knut; Lingjaerde, Ole Christian] Univ Oslo, Dept Comp Sci, Biomed Informat Lab, Oslo, Norway; [Liestol, Knut; Lingjaerde, Ole Christian] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Naume, Bjorn] Oslo Univ Hosp, Radiumhosp, Dept Oncol, Div Canc Med & Radiotherapy, Oslo, Norway; [Kristensen, Vessela N.] Akershus Univ Hosp, Inst Clin Epidemiol & Mol Biol EpiGen, Akershus, Norway; [Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel	University of Oslo; University of Oslo; Technion Israel Institute of Technology; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Agilent Technologies	Lingjaerde, OC (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway.	ole@ifi.uio.no; zohar_yakhini@agilent.com		Liestol, Knut/0000-0002-7929-582X; Lingjaerde, Ole Christian/0000-0003-3565-4912; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Baumbusch, Lars O./0000-0003-1290-312X; Yakhini, Zohar/0000-0002-0420-5412	Norwegian Research Council [193387/V50]; Norwegian Cancer Society [138296-PR2008- 0108]; South-Eastern Norway Regional Health Authority [2011042]; K.G. Jebsen Center for Breast Cancer Research	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; K.G. Jebsen Center for Breast Cancer Research	(1) Norwegian Research Council (Grant no 193387/V50, Understanding breast cancer genomics); (2) Norwegian Cancer Society (Grant no 138296-R2008-0108, Exploring The Systems Biology of Breast Cancer); (3) South-Eastern Norway Regional Health Authority (Project no 2011042, OSBREAC: Towards personalized therapy for breast cancer); (4) K.G. Jebsen Center for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atienza JM, 2005, MOL CANCER THER, V4, P361; Balleine RL, 2000, GENE CHROMOSOME CANC, V29, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Byrne JA, 2005, INT J CANCER, V117, P1049, DOI 10.1002/ijc.21250; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Goh XY, 2011, GUT; Gomulkiewicz A, FOLIA HISTOCHEMICA C, V48, P242; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hyman E, 2002, CANCER RES, V62, P6240; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Jung Y, 2011, CLIN CANCER RES, V17, P700, DOI 10.1158/1078-0432.CCR-10-1300; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kim HG, 2011, FEBS LETT, V585, P421, DOI 10.1016/j.febslet.2010.12.030; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kristensen VN, 2011, P NATL ACAD SCI; Lambros MB, MOD PATHOL, V23, P1334; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lipson D, 2004, P WORKSH ALG BIOINF; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Matsuura T, 2002, J INORG BIOCHEM, V88, P183, DOI 10.1016/S0162-0134(01)00377-4; Namba R, 2004, MOL CANCER RES, V2, P453; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Naume B, 2001, CLIN CANCER RES, V7, P4122; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Olesen C, 2004, MOL REPROD DEV, V67, P116, DOI 10.1002/mrd.20007; Ostrakhovitch EA, 2006, FEBS LETT, V580, P1235, DOI 10.1016/j.febslet.2006.01.036; Ostrakhovitch EA, 2007, J CELL BIOCHEM, V102, P1571, DOI 10.1002/jcb.21381; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shehata M, 2008, CLIN CANCER RES, V14, P5050, DOI 10.1158/1078-0432.CCR-07-4994; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigman V, 2011, BREAST CANC RES TREA, P1; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Woo HG, 2009, CANCER RES, V69, P4059, DOI 10.1158/0008-5472.CAN-09-0164; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814	65	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53014	10.1371/journal.pone.0053014	http://dx.doi.org/10.1371/journal.pone.0053014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382830	Green Published, gold			2022-12-25	WOS:000315563800016
J	Boggs, ASP; Lowers, RH; Cloy-McCoy, JA; Guillette, LJ				Boggs, Ashley S. P.; Lowers, Russell H.; Cloy-McCoy, Jessica A.; Guillette, Louis J., Jr.			Organizational Changes to Thyroid Regulation in Alligator mississippiensis: Evidence for Predictive Adaptive Responses	PLOS ONE			English	Article							CENTRAL CONGENITAL HYPOTHYROIDISM; JUVENILE AMERICAN ALLIGATORS; HORMONE CONCENTRATIONS; NEONATAL HYPERTHYROIDISM; SEASONAL-VARIATION; GROWTH-RATES; HPT AXIS; FLORIDA; CONTAMINANTS; NUTRITION	During embryonic development, organisms are sensitive to changes in thyroid hormone signaling which can reset the hypothalamic-pituitary-thyroid axis. It has been hypothesized that this developmental programming is a 'predictive adaptive response', a physiological adjustment in accordance with the embryonic environment that will best aid an individual's survival in a similar postnatal environment. When the embryonic environment is a poor predictor of the external environment, the developmental changes are no longer adaptive and can result in disease states. We predicted that endocrine disrupting chemicals (EDCs) and environmentally-based iodide imbalance could lead to developmental changes to the thyroid axis. To explore whether iodide or EDCs could alter developmental programming, we collected American alligator eggs from an estuarine environment with high iodide availability and elevated thyroid-specific EDCs, a freshwater environment contaminated with elevated agriculturally derived EDCs, and a reference freshwater environment. We then incubated them under identical conditions. We examined plasma thyroxine and triiodothyronine concentrations, thyroid gland histology, plasma inorganic iodide, and somatic growth at one week (before external nutrition) and ten months after hatching (on identical diets). Neonates from the estuarine environment were thyrotoxic, expressing follicular cell hyperplasia (p = 0.01) and elevated plasma triiodothyronine concentrations (p = 0.0006) closely tied to plasma iodide concentrations (p = 0.003). Neonates from the freshwater contaminated site were hypothyroid, expressing thyroid follicular cell hyperplasia (p = 0.01) and depressed plasma thyroxine concentrations (p = 0.008). Following a ten month growth period under identical conditions, thyroid histology (hyperplasia p = 0.04; colloid depletion p = 0.01) and somatic growth (body mass p<0.0001; length p = 0.02) remained altered among the contaminated sites. This work supports the hypothesis that embryonic EDC exposure or iodide imbalance could induce adult metabolic disease states, thereby stressing the need to consider the multiple environmental variables present during development.	[Boggs, Ashley S. P.; Guillette, Louis J., Jr.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Boggs, Ashley S. P.; Guillette, Louis J., Jr.] Univ Florida, Dept Biol, Gainesville, FL USA; [Boggs, Ashley S. P.; Cloy-McCoy, Jessica A.; Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Boggs, Ashley S. P.; Cloy-McCoy, Jessica A.; Guillette, Louis J., Jr.] Hollings Marine Lab, Charleston, SC USA; [Lowers, Russell H.] NASA, Kennedy Space Ctr, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical University of South Carolina; National Aeronautics & Space Administration (NASA)	Boggs, ASP (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	aspboggs@gmail.com			National Aeronautics and Space Administration Graduate Student Research Program [NNX09AK51H- SF 425]; NASA's Kennedy Space Center	National Aeronautics and Space Administration Graduate Student Research Program; NASA's Kennedy Space Center	Funding for this research was provided, in part, by the National Aeronautics and Space Administration Graduate Student Research Program (grant number NNX09AK51H- SF 425) and NASA's Kennedy Space Center (https://fellowships.nasaprs.com/gsrp/nav/). Employees of the NASA Ecological Program (Innovative Health Applications) assisted in the collection of eggs from Merritt Island National Wildlife Refuge at Kennedy Space Center, but had no other influence on experimental design, experimental conduct, or the writing of this manuscript.	Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bermudez DS, 2005, COMP BIOCHEM PHYS A, V141, P8, DOI 10.1016/j.cbpb.2005.02.015; Boggs ASP, 2011, GEN COMP ENDOCR, V174, P362, DOI 10.1016/j.ygcen.2011.09.014; CHABRECK RH, 1979, HERPETOLOGICA, V35, P51; Crain DA, 1998, ENVIRON TOXICOL CHEM, V17, P446, DOI 10.1002/etc.5620170315; DANFORTH E, 1989, ANNU REV NUTR, V9, P201, DOI 10.1146/annurev.nu.09.070189.001221; DELANY MF, 1988, J WILDLIFE DIS, V24, P62, DOI 10.7589/0090-3558-24.1.62; DUSSAULT JH, 1982, ENDOCRINOLOGY, V110, P1037, DOI 10.1210/endo-110-3-1037; Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; GERWIEN RW, 1992, GEN COMP ENDOCR, V87, P312, DOI 10.1016/0016-6480(92)90036-J; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Grim KC, 2009, TOXICOL PATHOL, V37, P415, DOI 10.1177/0192623309335063; Grim KC, 2007, GUIDANCE DOCUMENT 2; Guillette Jr L.J., 1995, HUM ECOL RISK ASSESS, V1, P25; Guillette LJ, 1999, ARCH ENVIRON CON TOX, V36, P447, DOI 10.1007/PL00006617; Guillette LJ, 2003, PURE APPL CHEM, V75, P2275, DOI 10.1351/pac200375112275; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HEINZ GH, 1991, ENVIRON MONIT ASSESS, V16, P277, DOI 10.1007/BF00397615; Hooth MJ, 2001, TOXICOL PATHOL, V29, P250, DOI 10.1080/019262301317052530; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; Kempers MJE, 2005, J CLIN ENDOCR METAB, V90, P4094, DOI 10.1210/jc.2005-0197; Kempers MJE, 2003, J CLIN ENDOCR METAB, V88, P5851, DOI 10.1210/jc.2003-030665; Langer P, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-3; Legradi G, 1997, ENDOCRINOLOGY, V138, P2569, DOI 10.1210/en.138.6.2569; McNabb FMA, 2007, CRIT REV TOXICOL, V37, P163, DOI 10.1080/10408440601123552; McNabb FMA, 2004, TOXICOL SCI, V82, P106, DOI 10.1093/toxsci/kfh247; Moore BC, 2012, MOL CELL ENDOCRINOL, V354, P111, DOI 10.1016/j.mce.2011.10.020; Muller EB, 1996, ASTM STP; Ogilvy-Stuart AL, 2002, ARCH DIS CHILD-FETAL, V87, P165, DOI 10.1136/fn.87.3.F165; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; RAPOPORT B, 1974, AM J MED, V56, P586, DOI 10.1016/0002-9343(74)90628-7; Roti E, 2001, THYROID, V11, P493, DOI 10.1089/105072501300176453; TAPLIN LE, 1982, J COMP PHYSIOL, V149, P43, DOI 10.1007/BF00735713; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; WALKER P, 1985, ENDOCRINOLOGY, V116, P2246, DOI 10.1210/endo-116-6-2246; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; Wilson CM, 1997, GEN COMP ENDOCR, V107, P153, DOI 10.1006/gcen.1997.6906; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	42	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55515	10.1371/journal.pone.0055515	http://dx.doi.org/10.1371/journal.pone.0055515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383213	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800162
J	Goode, EL; DeRycke, M; Kalli, KR; Oberg, AL; Cunningham, JM; Maurer, MJ; Fridley, BL; Armasu, SM; Serie, DJ; Ramar, P; Goergen, K; Vierkant, RA; Rider, DN; Sicotte, H; Wang, C; Winterhoff, B; Phelan, CM; Schildkraut, JM; Weber, RP; Iversen, E; Berchuck, A; Sutphen, R; Birrer, MJ; Hampras, S; Preus, L; Gayther, SA; Ramus, SJ; Wentzensen, N; Yang, HP; Garcia-Closas, M; Song, HL; Tyrer, J; Pharoah, PPD; Konecny, G; Sellers, TA; Ness, RB; Sucheston, LE; Odunsi, K; Hartmann, LC; Moysich, KB; Knutson, KL				Goode, Ellen L.; DeRycke, Melissa; Kalli, Kimberly R.; Oberg, Ann L.; Cunningham, Julie M.; Maurer, Matthew J.; Fridley, Brooke L.; Armasu, Sebastian M.; Serie, Daniel J.; Ramar, Priya; Goergen, Krista; Vierkant, Robert A.; Rider, David N.; Sicotte, Hugues; Wang, Chen; Winterhoff, Boris; Phelan, Catherine M.; Schildkraut, Joellen M.; Weber, Rachel P.; Iversen, Ed; Berchuck, Andrew; Sutphen, Rebecca; Birrer, Michael J.; Hampras, Shalaka; Preus, Leah; Gayther, Simon A.; Ramus, Susan J.; Wentzensen, Nicolas; Yang, Hannah P.; Garcia-Closas, Montserrat; Song, Honglin; Tyrer, Jonathan; Pharoah, Paul P. D.; Konecny, Gottfried; Sellers, Thomas A.; Ness, Roberta B.; Sucheston, Lara E.; Odunsi, Kunle; Hartmann, Lynn C.; Moysich, Kirsten B.; Knutson, Keith L.			Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer	PLOS ONE			English	Article							TGF-BETA; MEDIATED SUPPRESSION; OX40 COSTIMULATION; IMMUNE SUPPRESSION; EXPRESSION; SURVIVAL; RECEPTOR; WOMEN; FOXP3; GITR	Although ovarian cancer is the most lethal of gynecologic malignancies, wide variation in outcome following conventional therapy continues to exist. The presence of tumor-infiltrating regulatory T cells (Tregs) has a role in outcome of this disease, and a growing body of data supports the existence of inherited prognostic factors. However, the role of inherited variants in genes encoding Treg-related immune molecules has not been fully explored. We analyzed expression quantitative trait loci (eQTL) and sequence-based tagging single nucleotide polymorphisms (tagSNPs) for 54 genes associated with Tregs in 3,662 invasive ovarian cancer cases. With adjustment for known prognostic factors, suggestive results were observed among rarer histological subtypes; poorer survival was associated with minor alleles at SNPs in RGS1 (clear cell, rs10921202, p = 2.7x10(-5)), LRRC32 and TNFRSF18/TNFRSF4 (mucinous, rs3781699, p = 4.5x10(-4), and rs3753348, p = 9.0x10(-4), respectively), and CD80 (endometrioid, rs13071247, p = 8.0x10(-4)). Fo0r the latter, correlative data support a CD80 rs13071247 genotype association with CD80 tumor RNA expression (p = 0.006). An additional eQTL SNP in CD80 was associated with shorter survival (rs7804190, p = 8.1x10(-4)) among all cases combined. As the products of these genes are known to affect induction, trafficking, or immunosuppressive function of Tregs, these results suggest the need for follow-up phenotypic studies.	[Goode, Ellen L.; DeRycke, Melissa; Oberg, Ann L.; Maurer, Matthew J.; Fridley, Brooke L.; Armasu, Sebastian M.; Serie, Daniel J.; Ramar, Priya; Goergen, Krista; Vierkant, Robert A.; Rider, David N.; Sicotte, Hugues; Wang, Chen] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Kalli, Kimberly R.; Hartmann, Lynn C.] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Cunningham, Julie M.] Mayo Clin, Dept Expt Pathol, Rochester, MN USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Hampras, Shalaka; Preus, Leah; Sucheston, Lara E.; Moysich, Kirsten B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Winterhoff, Boris] Mayo Clin, Dept Gynecol Oncol, Rochester, MN USA; [Schildkraut, Joellen M.; Berchuck, Andrew] Duke Univ, Duke Comprehens Canc Ctr, Durham, NC USA; [Weber, Rachel P.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Iversen, Ed] Duke Univ, Dept Stat Sci, Durham, NC USA; [Sutphen, Rebecca] Univ S Florida, Coll Med, Tampa, FL USA; [Birrer, Michael J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gayther, Simon A.; Ramus, Susan J.] Univ So Calif, Los Angeles, CA USA; [Wentzensen, Nicolas; Yang, Hannah P.] NCI, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat] Inst Canc Res, Sutton, Surrey, England; [Song, Honglin; Tyrer, Jonathan; Pharoah, Paul P. D.] Univ Cambridge, Cambridge, England; [Konecny, Gottfried] Univ Calif Los Angeles, Dept Gynecol Oncol, Los Angeles, CA USA; [Phelan, Catherine M.; Sellers, Thomas A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Knutson, Keith L.] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Mayo Clinic; Duke University; Duke University; Duke University; State University System of Florida; University of South Florida; Harvard University; Brigham & Women's Hospital; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK; University of Cambridge; University of California System; University of California Los Angeles; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Mayo Clinic	Goode, EL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	egoode@mayo.edu	Ramus, Susan/AAG-8352-2019; Fridley, Brooke L/D-8315-2015; wang, chen/GWM-9481-2022; Wang, Chen/B-3244-2011; Wentzensen, Nicolas/AAG-8522-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Garcia-Closas, Montserrat/F-3871-2015; Pharoah, Paul/V-6658-2019; Vierkant, Robert/AAP-4927-2020	Ramus, Susan/0000-0003-0005-7798; Fridley, Brooke L/0000-0001-7739-7956; Wang, Chen/0000-0003-2638-3081; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Pharoah, Paul/0000-0001-8494-732X; Vierkant, Robert/0000-0001-6242-5221; Weber, Rachel/0000-0001-7119-7734; Maurer, Matthew/0000-0002-1867-0526	Mayo Clinic Ovarian Cancer SPORE [P50-CA136393]; National Cancer Institute GAME-ON Post-GWAS Initiative [U19-CA148112]; National Cancer Institute [R01-CA086888, R01-CA122443, R01-CA106414, R01-CA76016, R01-CA114343]; Cancer Research United Kingdom [A10119, A10124, A8339, A6187, A11306, A7058]; Medical Research Council [G0801875-89310]; Ovarian Cancer Research Fund; Mayo Foundation; Minnesota Ovarian Cancer Alliance; Roswell Park Cancer Institute Alliance Foundation; Fred C. and Katherine B. Andersen Foundation; The Francis Crick Institute [10124, 10119] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA114343, ZIACP010126, U19CA148112, R01CA106414, R25CA092049, R01CA122443, P50CA136393, R01CA076016, R01CA086888, R01CA149429] Funding Source: NIH RePORTER	Mayo Clinic Ovarian Cancer SPORE; National Cancer Institute GAME-ON Post-GWAS Initiative; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research United Kingdom(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ovarian Cancer Research Fund; Mayo Foundation; Minnesota Ovarian Cancer Alliance; Roswell Park Cancer Institute Alliance Foundation; Fred C. and Katherine B. Andersen Foundation; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The scientific development and funding for this project were supported in part by the Mayo Clinic Ovarian Cancer SPORE (P50-CA136393) to ELG, LCH, and KLK, the National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112), National Cancer Institute Research project grants (R01-CA086888, R01-CA122443, R01-CA106414, R01-CA76016, R01-CA114343), Cancer Research United Kingdom (A10119, A10124, A8339, A6187, A11306, A7058), the Medical Research Council (G0801875-89310), the Ovarian Cancer Research Fund, the Mayo Foundation, the Minnesota Ovarian Cancer Alliance, the Mayo Foundation, the Roswell Park Cancer Institute Alliance Foundation, and the Fred C. and Katherine B. Andersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Bolton KL, 2012, JAMA-J AM MED ASSOC, V307, P382, DOI 10.1001/jama.2012.20; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fridley BL, 2012, CANCER EPIDEM BIOMAR, V21, P529, DOI 10.1158/1055-9965.EPI-11-0741; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HOSKINS WJ, 1992, GYNECOL ONCOL, V47, P159, DOI 10.1016/0090-8258(92)90100-W; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kitamura N, 2009, INT J CANCER, V125, P630, DOI 10.1002/ijc.24435; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Knutson Keith L, 2006, Future Oncol, V2, P379, DOI 10.2217/14796694.2.3.379; Knutson KL, 2006, J CLIN ONCOL, V24, P4254, DOI 10.1200/JCO.2006.05.9311; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; McGuire V, 2002, GYNECOL ONCOL, V84, P399, DOI 10.1006/gyno.2001.6536; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Probst-Kepper M, 2010, CURR MOL MED, V10, P533; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sicotte H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-129; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wahl SM, 2004, J LEUKOCYTE BIOL, V76, P15, DOI 10.1189/jlb.1103539; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; White KL, 2012, CANCER RES, V72, P1064, DOI 10.1158/0008-5472.CAN-11-3512; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53903	10.1371/journal.pone.0053903	http://dx.doi.org/10.1371/journal.pone.0053903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382860	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800026
J	Huang, Y; Chen, WJ; Wang, XY; Liu, HL; Chen, YY; Guo, L; Luo, F; Sun, JF; Mao, Q; Liang, P; Xie, ZZ; Zhou, CH; Tian, YL; Lv, XL; Huang, LS; Zhou, JJ; Hu, Y; Li, R; Zhang, F; Lei, HL; Li, WF; Hu, XC; Liang, C; Xu, J; Li, XR; Yu, XB				Huang, Yan; Chen, Wenjun; Wang, Xiaoyun; Liu, Hailiang; Chen, Yangyi; Guo, Lei; Luo, Fang; Sun, Jiufeng; Mao, Qiang; Liang, Pei; Xie, Zhizhi; Zhou, Chenhui; Tian, Yanli; Lv, Xiaoli; Huang, Lisi; Zhou, Juanjuan; Hu, Yue; Li, Ran; Zhang, Fan; Lei, Huali; Li, Wenfang; Hu, Xuchu; Liang, Chi; Xu, Jin; Li, Xuerong; Yu, Xinbing			The Carcinogenic Liver Fluke, Clonorchis sinensis: New Assembly, Reannotation and Analysis of the Genome and Characterization of Tissue Transcriptomes	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; PROTEIN-DEFICIENT; IDENTIFICATION; CLONING; BINDING; CHOLANGIOCARCINOMA; CHOLESTEROL; COMPONENTS; FEATURES; ANTIGEN	Clonorchis sinensis (C. sinensis), an important food-borne parasite that inhabits the intrahepatic bile duct and causes clonorchiasis, is of interest to both the public health field and the scientific research community. To learn more about the migration, parasitism and pathogenesis of C. sinensis at the molecular level, the present study developed an upgraded genomic assembly and annotation by sequencing paired-end and mate-paired libraries. We also performed transcriptome sequence analyses on multiple C. sinensis tissues (sucker, muscle, ovary and testis). Genes encoding molecules involved in responses to stimuli and muscle-related development were abundantly expressed in the oral sucker. Compared with other species, genes encoding molecules that facilitate the recognition and transport of cholesterol were observed in high copy numbers in the genome and were highly expressed in the oral sucker. Genes encoding transporters for fatty acids, glucose, amino acids and oxygen were also highly expressed, along with other molecules involved in metabolizing these substrates. All genes involved in energy metabolism pathways, including the beta-oxidation of fatty acids, the citrate cycle, oxidative phosphorylation, and fumarate reduction, were expressed in the adults. Finally, we also provide valuable insights into the mechanism underlying the process of pathogenesis by characterizing the secretome of C. sinensis. The characterization and elaborate analysis of the upgraded genome and the tissue transcriptomes not only form a detailed and fundamental C. sinensis resource but also provide novel insights into the physiology and pathogenesis of C. sinensis. We anticipate that this work will aid the development of innovative strategies for the prevention and control of clonorchiasis.	[Huang, Yan; Chen, Wenjun; Wang, Xiaoyun; Sun, Jiufeng; Mao, Qiang; Liang, Pei; Xie, Zhizhi; Zhou, Chenhui; Tian, Yanli; Lv, Xiaoli; Huang, Lisi; Zhou, Juanjuan; Hu, Yue; Li, Ran; Zhang, Fan; Lei, Huali; Li, Wenfang; Hu, Xuchu; Liang, Chi; Xu, Jin; Li, Xuerong; Yu, Xinbing] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Yan; Chen, Wenjun; Wang, Xiaoyun; Sun, Jiufeng; Mao, Qiang; Liang, Pei; Xie, Zhizhi; Zhou, Chenhui; Tian, Yanli; Lv, Xiaoli; Huang, Lisi; Zhou, Juanjuan; Hu, Yue; Li, Ran; Zhang, Fan; Lei, Huali; Li, Wenfang; Hu, Xuchu; Liang, Chi; Xu, Jin; Li, Xuerong; Yu, Xinbing] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Hailiang; Chen, Yangyi; Guo, Lei; Luo, Fang] Guangzhou iGen Co Ltd, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, J (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China.	xujin@mail.sysu.edu.cn; xuerong2@mail.sysu.edu.cn; yuxb@mail.sysu.edu.cn	Wang, Xiaoyun/F-1212-2015; sun, Jiufeng/CAG-6546-2022	sun, jiufeng/0000-0003-1047-929X; Liu, Hailiang/0000-0002-4364-2826	National Basic Research Program of China (973 program) [2010CB530000]; National Natural Science Foundation of China [81171602, 81101270]; National S & T Major Program [2012ZX10004-220]; Sun Yat-sen University [50000-3181310]; Sun Yat-sen University innovative talents cultivation program for excellent tutors	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Sun Yat-sen University; Sun Yat-sen University innovative talents cultivation program for excellent tutors	This work was supported by the National Basic Research Program of China (973 program; No. 2010CB530000), the National Natural Science Foundation of China (No. 81171602, 81101270), the National S & T Major Program (No. 2012ZX10004-220), the Sun Yat-sen University grant (No. 50000-3181310), and the Sun Yat-sen University innovative talents cultivation program for excellent tutors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Choi D, 2006, J HEPATOL, V44, P1066, DOI 10.1016/j.jhep.2005.11.040; Choi YA, 2010, BIOL CELL, V102, P107, DOI 10.1042/BC20090073; CONNELLY MC, 1984, BIOCHEM BIOPH RES CO, V121, P931, DOI 10.1016/0006-291X(84)90766-6; COUSIN C, 1995, J MORPHOL, V223, P215, DOI 10.1002/jmor.1052230209; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Donlin Maureen J, 2007, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s17; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fried B, 2011, CANCER LETT, V305, P239, DOI 10.1016/j.canlet.2010.07.008; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Garg G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S14; Grosse Y, 2009, LANCET ONCOL, V10, P13, DOI 10.1016/S1470-2045(08)70286-9; Hernandez M, 2010, NEURO-ONCOLOGY, V12, P1014, DOI 10.1093/neuonc/noq078; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Hu FY, 2009, MOL BIOCHEM PARASIT, V167, P127, DOI 10.1016/j.molbiopara.2009.05.003; Huang LS, 2012, MOL CELL BIOCHEM, V363, P367, DOI 10.1007/s11010-011-1189-3; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang Y, 2012, PARASITOL RES, V111, P1143, DOI 10.1007/s00436-012-2946-2; Iguchi N, 2002, MOL HUM REPROD, V8, P525, DOI 10.1093/molehr/8.6.525; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Janvilisri T, 2007, MOL CELL BIOCHEM, V305, P95, DOI 10.1007/s11010-007-9532-4; Ju JW, 2009, PROTEOMICS, V9, P3066, DOI 10.1002/pmic.200700613; Kiger L, 1998, BIOPHYS J, V75, P990, DOI 10.1016/S0006-3495(98)77587-3; Kim HG, 2009, WORLD J GASTROENTERO, V15, P86, DOI 10.3748/wjg.15.86; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leksomboon R, 2012, PARASITOL INT, V61, P107, DOI 10.1016/j.parint.2011.07.014; Li SY, 2008, PARASITOL RES, V103, P1019, DOI 10.1007/s00436-008-1084-3; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Na BK, 2006, CELL MICROBIOL, V8, P1034, DOI 10.1111/j.1462-5822.2006.00685.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rashid AK, 1997, J BIOL CHEM, V272, P2992, DOI 10.1074/jbc.272.5.3000; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Santamaria I, 1999, J BIOL CHEM, V274, P13800, DOI 10.1074/jbc.274.20.13800; Schroder Bernd, 2010, Biochem J, V427, pe1, DOI 10.1042/BJ20100391; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sim S, 2003, PARASITOL RES, V91, P338, DOI 10.1007/s00436-003-0869-7; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; TODD JR, 1966, EXP PARASITOL, V19, P151, DOI 10.1016/0014-4894(66)90063-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Grinsven KWA, 2009, MOL BIOCHEM PARASIT, V164, P74, DOI 10.1016/j.molbiopara.2008.11.008; VANVUGT F, 1980, VET SCI COMMUN, V3, P299; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045830; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yoo WG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001208; Young ND, 2010, BIOTECHNOL ADV, V28, P859, DOI 10.1016/j.biotechadv.2010.07.006; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng MH, 2011, PARASITOL RES, V109, P737, DOI 10.1007/s00436-011-2316-5; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	60	58	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54732	10.1371/journal.pone.0054732	http://dx.doi.org/10.1371/journal.pone.0054732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382950	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800071
J	Mishra, S; Triptahi, V; Singh, S; Phukan, UJ; Gupta, MM; Shanker, K; Shukla, RK				Mishra, Sonal; Triptahi, Vineeta; Singh, Seema; Phukan, Ujjal J.; Gupta, M. M.; Shanker, Karuna; Shukla, Rakesh Kumar			Wound Induced Tanscriptional Regulation of Benzylisoquinoline Pathway and Characterization of Wound Inducible PsWRKY Transcription Factor from Papaver somniferum	PLOS ONE			English	Article							BERBERINE BRIDGE ENZYME; INDOLE ALKALOID BIOSYNTHESIS; TYROSINE DOPA DECARBOXYLASE; OPIUM POPPY; MOLECULAR-CLONING; MORPHINE BIOSYNTHESIS; DIHYDROBENZOPHENANTHRIDINE OXIDASE; GENE TRANSCRIPT; EXPRESSION; ACCUMULATION	Wounding is required to be made in the walls of the green seed pod of Opium poppy prior exudation of latex. To withstand this kind of trauma plants regulate expression of some metabolites through an induced transcript level. 167 unique wound-inducible ESTs were identified by a repetitive round of cDNA subtraction after 5 hours of wounding in Papaver somniferum seedlings. Further repetitive reverse northern analysis of these ESTs revealed 80 transcripts showing more than two fold induction, validated through semi-quantitative RT-PCR & real time expression analysis. One of the major classified categories among identified ESTs belonged to benzylisoquinoline transcripts. Tissue specific metabolite analysis of benzylisoquinoline alkaloids (BIAs) in response to wounding revealed increased accumulation of narcotine and papaverine. Promoter analysis of seven transcripts of BIAs pathway showed the presence of W-box cis-element with the consensus sequence of TGAC, which is the proposed binding site for WRKY type transcription factors. One of the Wound inducible 'WRKY' EST isolated from our subtracted library was made full-length and named as 'PsWRKY'. Bacterially expressed PsWRKY interacted with the W-box element having consensus sequence TTGACT/C present in the promoter region of BIAs biosynthetic pathway genes. PsWRKY further activated the TYDC promoter in yeast and transiently in tobacco BY2 cells. Preferential expression of PsWRKY in straw and capsule and its interaction with consensus W-box element present in BIAs pathway gene transcripts suggest its possible involvement in the wound induced regulation of BIAs pathway.	[Mishra, Sonal; Singh, Seema; Phukan, Ujjal J.; Shukla, Rakesh Kumar] Cent Inst Med & Aromat Plants CSIR CIMAP, Div Biotechnol, Lucknow, Uttar Pradesh, India; [Gupta, M. M.; Shanker, Karuna] Cent Inst Med & Aromat Plants CSIR CIMAP, Div Analyt Chem, Lucknow, Uttar Pradesh, India; [Triptahi, Vineeta] CSIR Cent Drug Res Inst CSIR CDRI, Dept Bot, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Shukla, RK (corresponding author), Cent Inst Med & Aromat Plants CSIR CIMAP, Div Biotechnol, Lucknow, Uttar Pradesh, India.	rk.shukla@cimap.res.in	Phukan, Ujjal Jyoti/Y-9156-2019; Shanker, Karuna/D-3596-2009; Shanker, Karuna/E-6692-2010	Phukan, Ujjal Jyoti/0000-0001-9788-4938; Shanker, Karuna/0000-0003-0144-3623; Shanker, Karuna/0000-0003-0144-3623; Mishra, Dr. Sonal/0000-0003-0727-6520	Council of Scientific and Industrial Research (CSIR) [NWP08]; Department of Science and Technology Fast Track Project [SR/FT/LS-189/2009]; Department of Science and Technology, India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology Fast Track Project(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India)); Department of Science and Technology, India(Department of Science & Technology (India))	The authors acknowledge Council of Scientific and Industrial Research (CSIR) Network Project (NWP08), and Department of Science and Technology Fast Track Project (Number: SR/FT/LS-189/2009) from Department of Science and Technology, India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai S, 1999, J PHYTOPATHOL, V147, P535, DOI 10.1111/j.1439-0434.1999.tb03861.x; BALANDRIN MF, 1985, SCIENCE, V228, P1154, DOI 10.1126/science.3890182; Berger B, 2007, PLANT J, V50, P911, DOI 10.1111/j.1365-313X.2007.03088.x; Boominathan P, 2004, PLANT PHYSIOL, V135, P1608, DOI 10.1104/pp.104.043141; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Facchini PJ, 1998, PLANT PHYSIOL, V118, P69, DOI 10.1104/pp.118.1.69; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Facchini PJ, 2003, PHYTOCHEMISTRY, V64, P177, DOI 10.1016/S0031-9422(03)00292-9; FACCHINI PJ, 1995, PLANT CELL, V7, P1811, DOI 10.1105/tpc.7.11.1811; FACCHINI PJ, 1994, J BIOL CHEM, V269, P26684; FUJIWARA H, 1993, PHYTOCHEMISTRY, V34, P949, DOI 10.1016/S0031-9422(00)90692-7; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Gupta MM, 1996, INDIAN J PHARM SCI, P161; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Han X, 2010, PHYTOCHEMISTRY, V71, P1305, DOI 10.1016/j.phytochem.2010.04.022; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong SB, 2006, J BIOTECHNOL, V122, P28, DOI 10.1016/j.jbiotec.2005.08.008; Huang FC, 2000, PHYTOCHEMISTRY, V53, P555, DOI 10.1016/S0031-9422(99)00600-7; Ignatov A, 1996, PHYTOCHEMISTRY, V43, P1141, DOI 10.1016/S0031-9422(96)00540-7; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Lee EJ, 2011, PLANT PHYSIOL, V157, P1067, DOI 10.1104/pp.111.185512; Lee EJ, 2010, PLANT CELL, V22, P3489, DOI 10.1105/tpc.110.077958; Lee LY, 2008, PLANT METHODS, P4; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu DH, 2007, J INTEGR PLANT BIOL, V49, P961, DOI 10.1111/j.1672-9072.2007.00457.x; Memelink J., 2007, Phytochemistry Reviews, V6, P353, DOI 10.1007/s11101-006-9051-z; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Morimoto S, 2001, J BIOL CHEM, V276, P38179; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; NESSLER CL, 1977, AM J BOT, V64, P541, DOI 10.2307/2442002; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; Park SU, 1999, PLANT MOL BIOL, V40, P121, DOI 10.1023/A:1026433112119; Pauw B, 2004, J BIOL CHEM, V279, P52940, DOI 10.1074/jbc.M404391200; PenaCortes H, 1996, PLANTA, V198, P447, DOI 10.1007/BF00620062; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; RUEFFER M, 1986, PLANT CELL REP, V5, P182, DOI 10.1007/BF00269113; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samanani N, 2005, PLANT CELL, V17, P915, DOI 10.1105/tpc.104.028654; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; Schmeller T, 1997, PHYTOCHEMISTRY, V44, P257, DOI 10.1016/S0031-9422(96)00545-6; SCHUMACHER HM, 1988, PLANT CELL REP, V7, P43, DOI 10.1007/BF00272975; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shukla RK, 2006, PLANT PHYSIOL, V142, P113, DOI 10.1104/pp.106.081752; Shukla RK, 2009, FEBS J, V276, P5252, DOI 10.1111/j.1742-4658.2009.07219.x; Suttipanta N, 2011, PLANT PHYSIOL, V157, P2081, DOI 10.1104/pp.111.181834; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200; Zuyu Z, 2006, PLANT J, P592	63	56	59	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52784	10.1371/journal.pone.0052784	http://dx.doi.org/10.1371/journal.pone.0052784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382823	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800011
J	Qiu, LP; Wei, XR; Zhang, XC; Cheng, JM				Qiu, Liping; Wei, Xiaorong; Zhang, Xingchang; Cheng, Jimin			Ecosystem Carbon and Nitrogen Accumulation after Grazing Exclusion in Semiarid Grassland	PLOS ONE			English	Article							RESOURCE AVAILABILITY; OXIDE EMISSIONS; SOIL RESOURCES; DIOXIDE FLUXES; IMPACTS; SEQUESTRATION; DISTURBANCE; STORAGE; HETEROGENEITY; STEPPE	The grazing exclusion in degraded grassland has been extensively used to prevent the loss of grassland resources and to improve grassland services. The effects of grazing exclusion on C and N balance, however, have not been well addressed but are essential for assessing grassland C sinks, the sustainable use of grassland resources and the support of grassland services. To understand the response of ecosystem C and N to grazing exclusion in semiarid grassland, we determined the C and N in litter, aboveground biomass, roots and soils from ungrazed grassland fenced at different times in northwest China. Our results showed that the aboveground biomass, root biomass and plant litter were 70-92%, 56-151% and 59-141% higher, respectively, in grazer excluded grassland than in grazed grassland. Grazing exclusion significantly increased C and N stored in plant biomass and litter and increased the concentrations and stocks of C and N in soils. Grazing exclusion thus significantly increased the C and N stored in grassland ecosystems. The increase in C and N stored in soil contributed to more than 95% and 97% of the increases in ecosystem C and N storage. The highest C and N stocks in ecosystems were observed in 17-year grazer excluded grassland. The results from this study indicate that grazing exclusion has the potential to increase C and N storage in degraded semiarid grassland and that the recovery of ecosystem C and N was mainly due to the accumulation of C and N in soils.	[Qiu, Liping; Wei, Xiaorong; Zhang, Xingchang; Cheng, Jimin] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China	Northwest A&F University - China	Wei, XR (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	xrwei78@163.com			National Natural Science Foundation of China [40901145]; Chinese Academy of Sciences [KZCX2-XB3-13-02]; Science and Technology Development Research Program in Shaanxi Province [2011KJXX25]; Program for Youthful Talents in Northwest A F University; Program from Northwest A F University [QN2011147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Development Research Program in Shaanxi Province; Program for Youthful Talents in Northwest A F University; Program from Northwest A F University	This study was supported by the National Natural Science Foundation of China (40901145), Chinese Academy of Sciences (KZCX2-XB3-13-02), Science and Technology Development Research Program in Shaanxi Province (2011KJXX25), the Program for Youthful Talents in Northwest A & F University, and the Program from Northwest A & F University (QN2011147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bakker C, 2003, OECOLOGIA, V137, P385, DOI 10.1007/s00442-003-1360-y; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Follett RF, 2005, GRASSLAND: A GLOBAL RESOURCE, P265; Follett RF, 2010, RANGELAND ECOL MANAG, V63, P4, DOI 10.2111/08-225.1; Frank AB, 2002, ENVIRON POLLUT, V116, P397, DOI 10.1016/S0269-7491(01)00216-0; Gendron F, 2007, PLANT ECOL, V191, P199, DOI 10.1007/s11258-006-9237-x; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hiernaux P, 1999, J ARID ENVIRON, V41, P231, DOI 10.1006/jare.1998.0475; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huxman TE, 2004, OECOLOGIA, V141, P295, DOI 10.1007/s00442-003-1389-y; Ingram LJ, 2008, SOIL SCI SOC AM J, V72, P939, DOI 10.2136/sssaj2007.0038; Jia HongTao, 2009, Agricultural Research in the Arid Areas, V27, P33; Johnson LC, 2001, ECOLOGY, V82, P3377, DOI 10.1890/0012-9658(2001)082[3377:FAGRBP]2.0.CO;2; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Klumpp K, 2009, J ECOL, V97, P876, DOI 10.1111/j.1365-2745.2009.01549.x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li LH, 2002, ACTA BOT SIN, V44, P740; Liu TZ, 2011, NUTR CYCL AGROECOSYS, V91, P67, DOI 10.1007/s10705-011-9445-1; Liu YR, 2003, CHIN J APPL ECOL, V15, P1604; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Owensby CE, 2006, RANGELAND ECOL MANAG, V59, P111, DOI 10.2111/05-116R2.1; Polley HW, 2008, GLOBAL CHANGE BIOL, V14, P1620, DOI 10.1111/j.1365-2486.2008.01599.x; Qiu LP, 2012, PLANT SOIL, V355, P299, DOI 10.1007/s11104-011-1099-x; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Shan YM, 2011, SOIL BIOL BIOCHEM, V43, P1943, DOI 10.1016/j.soilbio.2011.06.002; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Suttie J. M., 2006, P1; Tanentzap AJ, 2012, BIOL REV, V87, P72, DOI 10.1111/j.1469-185X.2011.00185.x; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Wang JY, 2012, ENVIRON POLLUT, V162, P223, DOI 10.1016/j.envpol.2011.11.027; Wang XD, 2012, PLANT SOIL, V354, P173, DOI 10.1007/s11104-011-1053-y; Wardle DA, 2002, COMMUNITIES ECOSYSTE; Wei X, 2013, J ARID ENVIRON, V88, P175, DOI 10.1016/j.jaridenv.2012.09.003; Werth M, 2005, J PLANT NUTR SOIL SC, V168, P472, DOI 10.1002/jpln.200421704; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; Wu HH, 2012, BIOL FERT SOILS, V48, P305, DOI 10.1007/s00374-011-0627-4; Yunwushan Natural Grassland Protection Zone Bureau (YNGPZB), 2000, COLL WORKS SCI INV M	47	59	68	12	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55433	10.1371/journal.pone.0055433	http://dx.doi.org/10.1371/journal.pone.0055433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383191	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800155
J	Downs, CA; Trac, DQ; Kreiner, LH; Eaton, AF; Johnson, NM; Brown, A; Helms, MN				Downs, Charles A.; Trac, David Q.; Kreiner, Lisa H.; Eaton, Amity F.; Johnson, Nicholle M.; Brown, Ann; Helms, My N.			Ethanol Alters Alveolar Fluid Balance via Nadph Oxidase (NOX) Signaling to Epithelial Sodium Channels (ENaC) in the Lung	PLOS ONE			English	Article							CHRONIC ALCOHOL-ABUSE; MULTIPLE ORGAN DYSFUNCTION; NA+ TRANSPORT; IN-VIVO; CELLS; CLEARANCE; INFLAMMATION; MACROPHAGES; CONSUMPTION; INHIBITION	Chronic alcohol consumption is associated with increased incidence of ICU-related morbidity and mortality, primarily from acute respiratory distress syndrome (ARDS). However, the mechanisms involved are unknown. One explanation is that alcohol regulates epithelial sodium channels (ENaC) via oxidant signaling to promote a pro-injury environment. We used small rodent models to mimic acute and chronic alcohol consumption and tested the hypothesis that ethanol (EtOH) would affect lung fluid clearance by up-regulating ENaC activity in the lung. Fluorescence labeling of rat lung slices and in vivo mouse lung revealed an increase in ROS production in response to acute EtOH exposure. Using western blots and fluorescein-5-maleimide labeling, we conclude that EtOH exposure modifies cysteines of a-ENaC while data from single channel patch clamp analysis confirm that 0.16% EtOH increased ENaC activity in rat alveolar cells. In vivo lung fluid clearance demonstrated a latent increase in fluid clearance in mice receiving EtOH diet. Ethanol mice given a tracheal instillation of LPS demonstrated early lung fluid clearance compared to caloric control mice and C57Bl/6 mice. Standard biochemical techniques reveal that chronic EtOH consumption resulted in greater protein expression of the catalytic gp91(phox) subunit and the obligate Rac1 protein. Collectively these data suggest that chronic EtOH consumption may lead to altered regulation of ENaC, contributing to a 'pro-injury' environment in the alcohol lung.	[Downs, Charles A.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Downs, Charles A.; Trac, David Q.; Kreiner, Lisa H.; Eaton, Amity F.; Johnson, Nicholle M.; Brown, Ann; Helms, My N.] Emory Univ, Dept Pediat, Emory Children Ctr Dev Lung Biol, Atlanta, GA 30322 USA; [Downs, Charles A.; Brown, Ann; Helms, My N.] Emory Univ, Emory Alcohol & Lung Biol Ctr, Atlanta, GA 30322 USA; [Kreiner, Lisa H.; Eaton, Amity F.; Johnson, Nicholle M.; Helms, My N.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Downs, CA (corresponding author), Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA.	mhelms@emory.edu		Trac, David/0000-0002-0563-4964; Eaton, Amity/0000-0003-0791-3411	Children's Center for Developmental Lung Biology; National Institute of Alcohol Abuse and Alcoholism [012197-08];  [HL092226-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL092226, K99HL092226] Funding Source: NIH RePORTER	Children's Center for Developmental Lung Biology; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by HL092226-05 and Children's Center for Developmental Lung Biology grants awarded to MNH and National Institute of Alcohol Abuse and Alcoholism 012197-08 awarded to LAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Bao HF, 2012, AM J PHYSIOL-CELL PH, V303, pC1129, DOI 10.1152/ajpcell.00139.2012; Brown LAS, 2006, ALCOHOL CLIN EXP RES, V30, P1624, DOI 10.1111/j.1530-0277.2006.00195.x; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; Brown SD, 2009, ALCOHOL CLIN EXP RES, V33, P1782, DOI 10.1111/j.1530-0277.2009.01017.x; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Downs CA, 2012, J BIOMEDICINE BIOTEC; Downs CA, 2012, AM J PHYSIOL-LUNG C, V302, pL1167, DOI 10.1152/ajplung.00038.2012; Dubowski K M, 1985, J Stud Alcohol Suppl, V10, P98; Dubowski KM, 1999, J ANAL TOXICOL, V23, P386, DOI 10.1093/jat/23.6.386; DUBOWSKI KM, 1974, CLIN CHEM, V20, P966; DUBOWSKI KM, 1980, AM J CLIN PATHOL, V74, P747; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Fukuda N, 2000, J APPL PHYSIOL, V89, P672, DOI 10.1152/jappl.2000.89.2.672; Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011; Guidot D, 1999, CHEST, V116, p82S, DOI 10.1378/chest.116.suppl_1.82S; Guidot DM, 2000, AM J PHYSIOL-LUNG C, V279, pL127, DOI 10.1152/ajplung.2000.279.1.L127; Helms MN, 2008, J BIOL CHEM, V283, P22875, DOI 10.1074/jbc.M801363200; Helms My N, 2010, J Vis Exp, DOI 10.3791/1941; Hummler E, 1997, P NATL ACAD SCI USA, V94, P11710, DOI 10.1073/pnas.94.21.11710; Jerrells TR, 2007, ALCOHOL, V41, P357, DOI 10.1016/j.alcohol.2007.07.001; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Moss M, 1999, CHEST, V116, p97S, DOI 10.1378/chest.116.suppl_1.97S-a; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Oldenburg PJ, 2012, AM J PHYSIOL-LUNG C, V302, pL308, DOI 10.1152/ajplung.00077.2011; Pierrakos Charalampos, 2012, J Clin Med Res, V4, P7, DOI 10.4021/jocmr761w; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Song KJ, 2002, J LEUKOCYTE BIOL, V72, P1109; Song WF, 2010, J BIOL CHEM, V285, P9716, DOI 10.1074/jbc.M109.073981; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Thibodeau PH, 2013, CELL TISSUE RES, V351, P309, DOI 10.1007/s00441-012-1439-z; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yeligar SM, 2012, J IMMUNOL, V188, P3648, DOI 10.4049/jimmunol.1101278; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006	47	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54750	10.1371/journal.pone.0054750	http://dx.doi.org/10.1371/journal.pone.0054750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382956	Green Submitted, Green Published, gold			2022-12-25	WOS:000315483200026
J	Dean, P; Young, L; Quitard, S; Kenny, B				Dean, Paul; Young, Lorna; Quitard, Sabine; Kenny, Brendan			Insights into the Pathogenesis of Enteropathogenic E. coli Using an Improved Intestinal Enterocyte Model	PLOS ONE			English	Article							CELL-LINE CACO-2; ESCHERICHIA-COLI; SUCRASE-ISOMALTASE; SIGNALING PATHWAYS; EFFECTOR MOLECULES; HOST MITOCHONDRIA; ESPF EFFECTOR; PROTEIN; EPEC; BARRIER	Enteropathogenic E. coli (EPEC) is a human pathogen that targets the small intestine, causing severe and often fatal diarrhoea in infants. A defining feature of EPEC disease is the loss (effacement) of absorptive microvilli (MV) from the surface of small intestinal enterocytes. Much of our understanding of EPEC pathogenesis is derived from studies using cell lines such as Caco-2-the most extensively used small intestinal model. However, previous work has revealed fundamental differences between Caco-2 cells and in vivo differentiated enterocytes in relation to MV effacement. This, and the high heterogeneity and low transfection efficiency of the Caco-2 cell line prompted the isolation of several sub-clones (NCL-1-12) to identify a more tractable and improved in vivo-like cell model. Along with established Caco-2 clones (TC-7, BBE1), sub-clones were assessed for growth rate, apical surface morphology, epithelial barrier function and transfection efficiency. TC-7 cells provided the best all-round clone and exhibited highest levels of ectopic gene expression following cell polarisation. Novel alterations in EGFP-labelled mitochondria, that were not previously documented in non-polarised cell types, highlighted the potential of the TC-7 model for defining dynamic enterocyte-specific changes during infection. Crucially, the TC-7 cell line also mimicked ex vivo derived enterocytes with regard to MV effacement, enabling a better dissection of the process. Effacement activity caused by the EPEC protein Map in the Caco-2 but not ex vivo model, was linked to a defect in suppressing its Cdc42-dependent functionality. MV effacement activity of the EPEC protein EspF in the TC-7 model was dependent on its N-WASP binding motif, which is also shown to play an essential role in epithelial barrier dysfunction. Together, this study highlights the many advantages of using TC-7 cells as a small intestinal model to study host-pathogen interactions.	[Dean, Paul; Young, Lorna; Quitard, Sabine; Kenny, Brendan] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Dean, P (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.	p.dean@ncl.ac.uk; brendan.kenny@ncl.ac.uk		Dean, Paul/0000-0002-2822-4677; , Brendan/0000-0001-7455-360X	Faculty Research Fellowship; BBSRC; Wellcome Trust [WT064409MA]	Faculty Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Faculty Research Fellowship awarded to PD, a BBSRC-funded Studentship for LY and a Wellcome Trust grant (WT064409MA) awarded to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Artursson P., 2012, ADV DRUG DELIV REV; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Campellone KG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000191; CHANTRET I, 1994, J CELL SCI, V107, P213; Cheng HC, 2008, NATURE, V454, P1009, DOI 10.1038/nature07160; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Dean P, 2011, MICROBIOL-SGM, V157, P1761, DOI 10.1099/mic.0.047506-0; Dean P, 2010, CELL MICROBIOL, V12, P1308, DOI 10.1111/j.1462-5822.2010.01469.x; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kenny B, 1996, MOL MICROBIOL, V20, P313, DOI 10.1111/j.1365-2958.1996.tb02619.x; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Orchard RC, 2012, CELL, V148, P803, DOI 10.1016/j.cell.2011.11.063; PETERSON MD, 1992, J CELL SCI, V102, P581; PINTO M, 1983, BIOL CELL, V47, P323; Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2005.00680.x; ROUSSET M, 1985, J CELL PHYSIOL, V123, P377, DOI 10.1002/jcp.1041230313; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sarmento B, 2012, EXPERT OPIN DRUG MET, V8, P607, DOI 10.1517/17425255.2012.673586; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Shah P, 2006, BIOTECHNOL PROGR, V22, P186, DOI 10.1021/bp050208u; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Volpe DA, 2008, J PHARM SCI-US, V97, P712, DOI 10.1002/jps.21010; WALTER E, 1995, EUR J PHARM SCI, V3, P215, DOI 10.1016/0928-0987(95)00010-B; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x	41	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55284	10.1371/journal.pone.0055284	http://dx.doi.org/10.1371/journal.pone.0055284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383137	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500072
J	Liu, YM; Wang, HW; Wang, XY; Mu, LL; Kong, QF; Wang, DD; Wang, JH; Zhang, Y; Yang, JF; Zhou, MY; Wang, GY; Sun, B; Li, HL				Liu, Yumei; Wang, Hongwei; Wang, Xinyue; Mu, Lili; Kong, Qingfei; Wang, Dandan; Wang, Jinghua; Zhang, Yao; Yang, Jinfeng; Zhou, Mingyan; Wang, Guangyou; Sun, Bo; Li, Hulun			The Mechanism of Effective Electroacupuncture on T Cell Response in Rats with Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							BETA-ENDORPHIN CONCENTRATIONS; ENDOGENOUS OPIOIDS; IMMUNE-SYSTEM; PROLIFERATION; RECEPTORS; APOPTOSIS; PEPTIDES; PRETREATMENT; ACUPUNCTURE; STIMULATION	Previously, we demonstrated that electroacupuncture (EA) decreased lymphocyte infiltration into the spinal cords of rats presenting with experimental autoimmune encephalomyelitis (EAE), a disease model used in the study of multiple sclerosis (MS). The aim of this study was to characterize the effects of EA on the EAE. Female Lewis rats were divided into either CFA, EAE, EA, or injection with naloxone after electroacupuncture (NAL) groups. Electroacupuncture was administered every day for 21 days. To evaluate proliferation and apoptosis, lymphocytes from rats presenting with EAE were collected and cultured with beta-endorphin. Immunohistochemisty, flow cytometry and radio-immunity methods were applied to detect the expression of beta-endorphin. Results presented in this report demonstrate that the beneficial anti-inflammatory effects of EA on EAE were related to beta-endorphin production that balances the Thl/Th2 and Th17/Treg responses. These results suggest that b-endorphin could be an important component in the development of EA-based therapies used for the treatment of EAE.	[Liu, Yumei; Wang, Xinyue; Mu, Lili; Kong, Qingfei; Wang, Dandan; Wang, Jinghua; Zhang, Yao; Yang, Jinfeng; Zhou, Mingyan; Wang, Guangyou; Sun, Bo; Li, Hulun] Harbin Med Univ, Dept Neurobiol, Heilongjiang Prov Key Lab Neurobiol, Harbin, Peoples R China; [Wang, Hongwei] Harbin Med Univ, Dept Orthopaed, Affiliated Hosp 2, Harbin, Peoples R China; [Li, Hulun] Harbin Med Univ, Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Sun, B (corresponding author), Harbin Med Univ, Dept Neurobiol, Heilongjiang Prov Key Lab Neurobiol, Harbin, Peoples R China.	sunbo720@yahoo.com.cn; lihulun@yahoo.com.cn	Yang, Jinfeng/GSN-6506-2022; Kong, qingfei/HCI-0643-2022		National Nature Science Foundation of China [81100883]; Science and Technology Study project of the Education Department of Heilongjiang Province [11541114]; Harbin Medical University [HCXB2010001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Study project of the Education Department of Heilongjiang Province; Harbin Medical University	The study is financially supported by National Nature Science Foundation of China (81100883), the Science and Technology Study project of the Education Department of Heilongjiang Province (11541114) and the Harbin Medical University Innovation Fund for Postgraduates (HCXB2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Boranic Milivoj, 2009, Acta Medica Croatica, V63, P27; Cheng CH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep132; CRINE P, 1978, P NATL ACAD SCI USA, V75, P4719, DOI 10.1073/pnas.75.10.4719; Feng SF, 2010, NEUROSCI LETT, V478, P150, DOI 10.1016/j.neulet.2010.05.006; GARCIA I, 1992, LYMPHOKINE CYTOK RES, V11, P339; Gein SV, 2006, B EXP BIOL MED+, V142, P226, DOI 10.1007/s10517-006-0334-6; GILMAN SC, 1982, P NATL ACAD SCI-BIOL, V79, P4226, DOI 10.1073/pnas.79.13.4226; GILMORE W, 1989, IMMUNOPHARMACOLOGY, V17, P19, DOI 10.1016/0162-3109(89)90004-0; Gironi M, 2000, ARCH NEUROL-CHICAGO, V57, P1178, DOI 10.1001/archneur.57.8.1178; Gironi M, 2003, J NEUROL NEUROSUR PS, V74, P495, DOI 10.1136/jnnp.74.4.495; Gutstein HB, 2001, GOODMAN GILMANS PHAR, P569; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Kravetz RE, 2007, AM J GASTROENTEROL, V102, P2371, DOI 10.1111/j.1572-0241.2007.01473.x; Liu JL, 2010, CHIN J INTEGR MED, V16, P315, DOI 10.1007/s11655-010-0503-3; Liu YM, 2010, J NEUROIMMUNOL, V220, P25, DOI 10.1016/j.jneuroim.2009.12.005; Machelska H, 2011, CNS NEUROL DISORD-DR, V10, P559, DOI 10.2174/187152711796234952; MANFREDI B, 1993, J NEUROIMMUNOL, V44, P43, DOI 10.1016/0165-5728(93)90266-2; Morch H, 1995, AUTOIMMUNITY, V21, P161, DOI 10.3109/08916939509008013; Navolotskaya EV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P357, DOI 10.1023/A:1014844718799; Pan BH, 1996, BRAIN RES BULL, V40, P175, DOI 10.1016/0361-9230(96)00011-1; PANERAI AE, 1994, J NEUROIMMUNOL, V51, P169, DOI 10.1016/0165-5728(94)90078-7; PANERAI AE, 1995, J NEUROIMMUNOL, V58, P71, DOI 10.1016/0165-5728(94)00189-U; Panerai AE, 1997, IMMUNOL TODAY, V18, P317, DOI 10.1016/S0167-5699(97)01045-1; Peplow PV, 2012, J ACUPUNCT MERIDIAN, V5, P1, DOI 10.1016/j.jams.2011.11.018; SACERDOTE P, 1991, PEPTIDES, V12, P1353, DOI 10.1016/0196-9781(91)90219-F; Sacerdote P, 1998, CLIN EXP IMMUNOL, V113, P465; Sacerdote P, 2000, BLOOD, V95, P2031, DOI 10.1182/blood.V95.6.2031; Shahabi NA, 1996, ENDOCRINOLOGY, V137, P3386, DOI 10.1210/en.137.8.3386; SHARP B, 1993, ENDOCRINOLOGY, V133, pA1921, DOI 10.1210/endo.133.5.8404637; Sharp BM, 2001, J IMMUNOL, V167, P1097, DOI 10.4049/jimmunol.167.2.1097; Singhal P, 2001, ADV EXP MED BIOL, V493, P127; Su TF, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-98; Tjen-A-Looi SC, 2004, AM J PHYSIOL-REG I, V287, pR852, DOI 10.1152/ajpregu.00262.2004; VANDENBERGH P, 1993, IMMUNOLOGY, V79, P18; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wollemann M, 2004, LIFE SCI, V75, P257, DOI 10.1016/j.lfs.2003.12.005; Wu HG, 2007, DIGEST DIS SCI, V52, P379, DOI 10.1007/s10620-006-9561-y; YOSHINO S, 1992, J RHEUMATOL, V19, P660; ZAGON IS, 1987, BRAIN RES, V412, P68, DOI 10.1016/0006-8993(87)91440-5; ZAGON IS, 1989, BRAIN RES, V480, P16, DOI 10.1016/0006-8993(89)91562-X; ZAGON IS, 1988, LIFE SCI, V43, P1313, DOI 10.1016/0024-3205(88)90586-3; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357	46	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e51573	10.1371/journal.pone.0051573	http://dx.doi.org/10.1371/journal.pone.0051573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382807	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500003
J	Ruhs, A; Cemic, F; Braun, T; Kruger, M				Ruhs, Aaron; Cemic, Franz; Braun, Thomas; Krueger, Marcus			ResA(3) : A Web Tool for Resampling Analysis of Arbitrary Annotations	PLOS ONE			English	Article							MOUSE	Resampling algorithms provide an empirical, non-parametric approach to determine the statistical significance of annotations in different experimental settings. ResA(3) (Resampling Analysis of Arbitrary Annotations, short: ResA) is a novel tool to facilitate the analysis of enrichment and regulation of annotations deposited in various online resources such as KEGG, Gene Ontology and Pfam or any kind of classification. Results are presented in readily accessible navigable table views together with relevant information for statistical inference. The tool is able to analyze multiple types of annotations in a single run and includes a Gene Ontology annotation feature. We successfully tested ResA using a dataset obtained by measuring incorporation rates of stable isotopes into proteins in intact animals. ResA complements existing tools and will help to evaluate the increasing number of large-scale transcriptomics and proteomics datasets (resa.mpi-bn.mpg.de).	[Ruhs, Aaron; Braun, Thomas; Krueger, Marcus] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Cemic, Franz] Univ Appl Sci, Inst Biochem Engn & Analyt, Giessen, Germany	Max Planck Society	Ruhs, A (corresponding author), Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany.	Aaron.Ruhs@mpi-bn.mpg.de; marcus.krueger@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Cemic, Franz/0000-0002-8194-1210	Max-Planck-Society; Excellence Initiative 'Cardiopulmonary System'; University of Giessen-Marburg Lung Centre (UGMLC); Cell and Gene Therapy Centre (CGT); Hessisches Ministerium fur Wissenschaft und Kunst (HMWK)	Max-Planck-Society(Max Planck Society); Excellence Initiative 'Cardiopulmonary System'; University of Giessen-Marburg Lung Centre (UGMLC); Cell and Gene Therapy Centre (CGT); Hessisches Ministerium fur Wissenschaft und Kunst (HMWK)	This work was funded by the Max-Planck-Society and the Excellence Initiative 'Cardiopulmonary System', the University of Giessen-Marburg Lung Centre (UGMLC), and the Cell and Gene Therapy Centre (CGT) supported by the Hessisches Ministerium fur Wissenschaft und Kunst (HMWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowley, 1920, ELEMENTARY MANUAL ST; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	10	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e53743	10.1371/journal.pone.0053743	http://dx.doi.org/10.1371/journal.pone.0053743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382850	Green Published, Green Submitted, gold			2022-12-25	WOS:000315211500006
J	Yi, JP; Zhang, L; Tang, BS; Han, WW; Zhou, YF; Chen, Z; Jia, DD; Jiang, H				Yi, Jiping; Zhang, Li; Tang, Beisha; Han, Weiwei; Zhou, Yafang; Chen, Zhao; Jia, Dandan; Jiang, Hong			Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MACHADO-JOSEPH-DISEASE; CREB-BINDING PROTEIN; ATAXIA TYPE-I; DROSOPHILA-MELANOGASTER; EXPANDED POLYGLUTAMINE; DEACETYLASE INHIBITION; ALTERED TRANSCRIPTION; GENE-EXPRESSION; MOUSE MODEL	Spinocerebellar ataxia type 3 (SCA3) also known as Machado-Joseph Disease (MJD), is one of nine polyglutamine (polyQ) diseases caused by a CAG-trinucelotide repeat expansion within the coding sequence of the ATXN3 gene. There are no disease-modifying treatments for polyQ diseases. Recent studies suggest that an imbalance in histone acetylation may be a key process leading to transcriptional dysregulation in polyQ diseases. Because of this possible imbalance, the application of histone deacetylase (HDAC) inhibitors may be feasible for the treatment of polyQ diseases. To further explore the therapeutic potential of HDAC inhibitors, we constructed two independent preclinical trials with valproic acid (VPA), a promising therapeutic HDAC inhibitor, in both Drosophila and cell SCA3 models. We demonstrated that prolonged use of VPA at specific dose partly prevented eye depigmentation, alleviated climbing disability, and extended the average lifespan of SCA3/MJD transgenic Drosophila. We found that VPA could both increase the acetylation levels of histone H3 and histone H4 and reduce the early apoptotic rate of cells without inhibiting the aggregation of mutant ataxin-3 proteins in MJDtr-Q68-expressing cells. These results collectively support the premise that VPA is a promising therapeutic agent for the treatment of SCA3 and other polyQ diseases.	[Yi, Jiping; Zhang, Li; Tang, Beisha; Han, Weiwei; Zhou, Yafang; Chen, Zhao; Jia, Dandan; Jiang, Hong] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Beisha; Jiang, Hong] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent S Univ, Natl Lab Med Genet China, Changsha, Hunan, Peoples R China; [Yi, Jiping] Univ S China, Peoples Hosp Chenzhou 1, Dept Neurol, Chenzhou, Peoples R China; [Yi, Jiping] Univ S China, Peoples Hosp Chenzhou 1, Inst Translat Med, Chenzhou, Peoples R China	Central South University; Central South University; Central South University; University of South China; University of South China	Jiang, H (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	jianghong73868@yahoo.com.cn			National Basic Research Program (973 Program) [2012CB944600, 2012CB517902, 2011CB510002]; New Century Excellent Talents in University [NCET-10-0836]; National Natural Science Foundation of China [81271260, 30971585, 30871354, 30710303061, 30400262]; Undergraduate Innovation Project of Central South University [CY12400]	National Basic Research Program (973 Program)(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Undergraduate Innovation Project of Central South University	This study was supported by the National Basic Research Program (973 Program) (No. 2012CB944600, 2012CB517902 and 2011CB510002 to Hong Jiang), New Century Excellent Talents in University (No. NCET-10-0836 to Hong Jiang), the National Natural Science Foundation of China (No. 81271260, 30971585, 30871354, 30710303061, and 30400262 to Hong Jiang), and Undergraduate Innovation Project of Central South University (No. CY12400 to Hong Jiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele M, 1997, BRAIN, V120, P2141, DOI 10.1093/brain/120.12.2141; Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Bettencourt C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-35; Bijur GN, 2000, J NEUROCHEM, V75, P2401, DOI 10.1046/j.1471-4159.2000.0752401.x; Burk K, 1999, J NEUROL, V246, P789, DOI 10.1007/s004150050456; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen T, 2002, ARCH BIOCHEM BIOPHYS, V408, P171, DOI 10.1016/S0003-9861(02)00564-7; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Evidente VGH, 2000, MAYO CLIN PROC, V75, P475; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; Li WZ, 2012, GENET MOL RES, V11, P1997, DOI 10.4238/2012.August.6.4; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; Palladino MJ, 2002, GENETICS, V161, P1197; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; U M, 2001, CELL DEATH DIFFER, V8, P377, DOI 10.1038/sj.cdd.4400819; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Zhang ZZ, 2012, EXP EYE RES, V94, P98, DOI 10.1016/j.exer.2011.11.013	40	52	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54792	10.1371/journal.pone.0054792	http://dx.doi.org/10.1371/journal.pone.0054792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382971	gold, Green Submitted, Green Published			2022-12-25	WOS:000315211500027
J	Shi, XL; Gupta, S; Lindquist, IE; Cameron, CT; Mudge, J; Rashotte, AM				Shi, Xiuling; Gupta, Sarika; Lindquist, Ingrid E.; Cameron, Connor T.; Mudge, Joann; Rashotte, Aaron M.			Transcriptome Analysis of Cytokinin Response in Tomato Leaves	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSFER-RNA; ETHYLENE BIOSYNTHESIS; MICROARRAY ANALYSIS; GENE-EXPRESSION; FAMILY; PROTEINS; BOUNDARIES; DOMAIN; FRUIT	Tomato is one of the most economically and agriculturally important Solanaceous species and vegetable crops, serving as a model for examination of fruit biology and compound leaf development. Cytokinin is a plant hormone linked to the control of leaf development and is known to regulate a wide range of genes including many transcription factors. Currently there is little known of the leaf transcriptome in tomato and how it might be regulated by cytokinin. We employ high throughput mRNA sequencing technology and bioinformatic methodologies to robustly analyze cytokinin regulated tomato leaf transcriptomes. Leaf samples of two ages, 13d and 35d were treated with cytokinin or the solvent vehicle control dimethyl sulfoxide (DMSO) for 2 h or 24 h, after which RNA was extracted for sequencing. To confirm the accuracy of RNA sequencing results, we performed qPCR analysis of select transcripts identified as cytokinin regulated by the RNA sequencing approach. The resulting data provide the first hormone transcriptome analysis of leaves in tomato. Specifically we identified several previously untested tomato orthologs of cytokinin-related genes as well as numerous novel cytokinin-regulated transcripts in tomato leaves. Principal component analysis of the data indicates that length of cytokinin treatment and plant age are the major factors responsible for changes in transcripts observed in this study. Two hour cytokinin treatment showed a more robust transcript response indicated by both greater fold change of induced transcripts and the induction of twice as many cytokinin-related genes involved in signaling, metabolism, and transport in young vs. older leaves. This difference in transcriptome response in younger vs. older leaves was also found to a lesser extent with an extended (24 h) cytokinin treatment. Overall data presented here provides a solid foundation for future study of cytokinin and cytokinin regulated genes involved in compound leaf development or other developmental processes in tomato.	[Shi, Xiuling; Gupta, Sarika; Rashotte, Aaron M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Lindquist, Ingrid E.; Cameron, Connor T.; Mudge, Joann] Natl Ctr Genome Resources, Santa Fe, NM USA	Auburn University System; Auburn University; National Center for Genome Resources (NCGR)	Rashotte, AM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	rashotte@auburn.edu		Rashotte, Aaron/0000-0001-5034-4395; Mudge, Joann/0000-0002-2972-1640	USDA-NRI [2008-35304-04457]; AAES-HATCH [370220-310007-2055, 103600-310010-2055]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER; EPSCoR [1158862] Funding Source: National Science Foundation	USDA-NRI(United States Department of Agriculture (USDA)); AAES-HATCH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by USDA-NRI grant 2008-35304-04457 and AAES-HATCH grants 370220-310007-2055 and 103600-310010-2055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Allen M, 2002, PHYSIOL PLANTARUM, V115, P56, DOI 10.1034/j.1399-3054.2002.1150106.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Brand A, 2007, PLANTA, V226, P941, DOI 10.1007/s00425-007-0540-0; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Cantu D, 2009, PLANT PHYSIOL, V150, P1434, DOI 10.1104/pp.109.138701; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CHORY J, 1994, PLANT PHYSIOL, V104, P339, DOI 10.1104/pp.104.2.339; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Gillissen B, 2000, PLANT CELL, V12, P291, DOI 10.1105/tpc.12.2.291; Golovko A, 2002, PLANT MOL BIOL, V49, P161, DOI 10.1023/A:1014958816241; Gordon A, FASTX TOOLKIT UNPUB; Gray J, 1996, PLANT PHYSIOL, V110, P431, DOI 10.1104/pp.110.2.431; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Harris JM, 2010, PLANT SIGNAL BEHAV, V5, P1365, DOI 10.4161/psb.5.11.13165; Heyl A, 2008, PLANT PHYSIOL, V147, P1380, DOI 10.1104/pp.107.115436; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Jung KH, 2010, PLANT PHYSIOL, V152, P1674, DOI 10.1104/pp.109.152157; Kiba T, 2005, PLANT CELL PHYSIOL, V46, P339, DOI 10.1093/pcp/pci033; Koenig RL, 2002, J BACTERIOL, V184, P1832, DOI 10.1128/JB.184.7.1832-1842.2002; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kusnetsov V, 1998, MOL GEN GENET, V259, P21, DOI 10.1007/PL00008626; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lin WC, 2003, PLANT CELL, V15, P2241, DOI 10.1105/tpc.014969; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; MOFFATT B, 1991, PLANT PHYSIOL, V95, P900, DOI 10.1104/pp.95.3.900; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1269, DOI 10.1271/bbb.60681; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pischke MS, 2006, PLANT PHYSIOL, V140, P1255, DOI 10.1104/pp.105.076059; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rashotte AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-74; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Schaff JE, 2007, PLANT PHYSIOL, V144, P1079, DOI 10.1104/pp.106.090241; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Shani E, 2010, PLANT CELL, V22, P3206, DOI 10.1105/tpc.110.078253; Shi XL, 2012, J EXP BOT, V63, P973, DOI 10.1093/jxb/err325; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Woo HH, 2003, PLANT PHYSIOL, V133, P538, DOI 10.1104/pp.103.026278; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Yendrek CR, 2010, PLANT J, V62, P100, DOI 10.1111/j.1365-313X.2010.04134.x; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044	90	31	31	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55090	10.1371/journal.pone.0055090	http://dx.doi.org/10.1371/journal.pone.0055090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372818	gold, Green Published, Green Submitted			2022-12-25	WOS:000315210400061
J	Malovichko, MV; Sabo, TM; Maurer, MC				Malovichko, Marina V.; Sabo, T. Michael; Maurer, Muriel C.			Ligand Binding to Anion-binding Exosites Regulates Conformational Properties of Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; ALLOSTERIC LINKAGE; SOLVENT ACCESSIBILITY; HYDROGEN-EXCHANGE; ALPHA-THROMBIN; PROTEIN-C; THROMBOMODULIN; ACTIVATION; SELECTION; COMPLEX	Thrombin participates in coagulation, anticoagulation, and initiation of platelet activation. To fulfill its diverse roles and maintain hemostasis, this serine protease is regulated via the extended active site region and anion-binding exosites (ABEs) I and II. For the current project, amide proton hydrogen-deuterium exchange coupled with MALDI-TOF mass spectrometry was used to characterize ligand binding to individual exosites and to investigate the presence of exosite-active site and exosite-exosite interactions. PAR3(44-56) and PAR1(49-62) were observed to bind to thrombin ABE I and then to exhibit long range effects over to ABE II. By contrast, Hirudin(54-65) focused more on ABE I and did not transmit influences over to ABE II. Although these three ligands were each directed to ABE I, they did not promote the same conformational consequences. D-Phe-Pro-Arg-chloromethyl ketone inhibition at the thrombin active site led to further local and long range consequences to thrombin-ABE I ligand complexes with the autolysis loop often most affected. When Hirudin(54-65) was bound to ABE I, it was still possible to bind GpIb alpha(269-286) or fibrinogen gamma'(410-427) to ABE II. Each ligand exerted its predominant influences on thrombin and also allowed interexosite communication. The results obtained support the proposal that thrombin is a highly dynamic protein. The transmission of ligand-specific local and long range conformational events is proposed to help regulate this multifunctional enzyme.	[Malovichko, Marina V.; Sabo, T. Michael; Maurer, Muriel C.] Univ Louisville, Dept Chem, Louisville, KY 40292 USA	University of Louisville	Maurer, MC (corresponding author), Univ Louisville, Dept Chem, 2320 South Brook St, Louisville, KY 40292 USA.	muriel.maurer@louisville.edu	Sabo, T./H-9681-2019	Sabo, T./0000-0002-9573-145X; Malovichko, Marina/0000-0003-2127-5858	National Institutes of Health [R01 HL68440]; Telemedicine and Advanced Technology Research Center of the United States Army [W81XWH]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telemedicine and Advanced Technology Research Center of the United States Army; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL68440. This work was also supported by Grant W81XWH from the Telemedicine and Advanced Technology Research Center of the United States Army.	Adams TE, 2009, J THROMB HAEMOST, V7, P1688, DOI 10.1111/j.1538-7836.2009.03563.x; Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Baerga-Ortiz A, 2002, PROTEIN SCI, V11, P1300, DOI 10.1110/ps.4670102; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Ban D, 2011, ANGEW CHEM INT EDIT, V50, P11437, DOI 10.1002/anie.201105086; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BODE W, 1992, PROTEIN SCI, V1, P426; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P2144, DOI 10.1021/bi00406a049; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Koeppe JR, 2005, BIOCHEMISTRY-US, V44, P14784, DOI 10.1021/bi0510577; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lancellotti S, 2008, J BIOL CHEM, V283, P30193, DOI 10.1074/jbc.M803659200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Li W, 2010, J BIOL CHEM, V285, P38621, DOI 10.1074/jbc.M110.144964; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Mengwasser KE, 2005, J BIOL CHEM, V280, P26997, DOI 10.1074/jbc.M502678200; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Ng NMY, 2009, ARCH BIOCHEM BIOPHYS, V489, P48, DOI 10.1016/j.abb.2009.07.012; NI F, 1989, BIOCHEMISTRY-US, V28, P3094, DOI 10.1021/bi00433a053; NI F, 1992, BIOCHEMISTRY-US, V31, P11551, DOI 10.1021/bi00161a037; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pineda AO, 2002, J BIOL CHEM, V277, P32015, DOI 10.1074/jbc.M205009200; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; Sabo TM, 2009, BIOCHEMISTRY-US, V48, P7110, DOI 10.1021/bi900745b; Sidhu PS, 2011, J MED CHEM, V54, P5522, DOI 10.1021/jm2005767; Trumbo TA, 2000, J BIOL CHEM, V275, P20627, DOI 10.1074/jbc.M000209200; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200; YE J, 1992, J BIOL CHEM, V267, P11023	53	32	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8667	8678		10.1074/jbc.M112.410829	http://dx.doi.org/10.1074/jbc.M112.410829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23378535	Green Published, hybrid			2022-12-25	WOS:000316564500067
J	Maier, JA; Lo, YT; Harfe, BD				Maier, Jennifer A.; Lo, YinTing; Harfe, Brian D.			Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs	PLOS ONE			English	Article							SONIC-HEDGEHOG; TRANSCRIPTION FACTORS; NOTOCHORD DEVELOPMENT; MESODERM FORMATION; PRIMITIVE STREAK; MOUSE EMBRYO; T-GENE; EXPRESSION; CELLS; MICE	The intervertebral disc (IVD) is composed of 3 main structures, the collagenous annulus fibrosus (AF), which surrounds the gel-like nucleus pulposus (NP), and hyaline cartilage endplates, which are attached to the vertebral bodies. An IVD is located between each vertebral body. Degeneration of the IVD is thought to be a major cause of back pain, a potentially chronic condition for which there exist few effective treatments. The NP forms from the embryonic notochord. Foxa1 and Foxa2, transcription factors in the forkhead box family, are expressed early during notochord development. However, embryonic lethality and the absence of the notochord in Foxa2 null mice have precluded the study of potential roles these genes may play during IVD formation. Using a conditional Foxa2 allele in conjunction with a tamoxifen-inducible Cre allele (ShhcreER(T2)), we removed Foxa2 from the notochord of E7.5 mice null for Foxa1. Foxa1(-/-); Foxa2(c/c); ShhcreER(T2) double mutant animals had a severely deformed nucleus pulposus, an increase in cell death in the tail, decreased hedgehog signaling, defects in the notochord sheath, and aberrant dorsal-ventral patterning of the neural tube. Embryos lacking only Foxa1 or Foxa2 from the notochord were indistinguishable from control animals, demonstrating a functional redundancy for these genes in IVD formation. In addition, we provide in vivo genetic evidence that Foxa genes are required for activation of Shh in the notochord.	[Harfe, Brian D.] Univ Florida, Coll Med, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Harfe, BD (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32611 USA.	bharfe@mgm.ufl.edu			University of Florida Alumni Fellowship; National Institutes of Health/National Institute on Aging [AG029353]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR055568]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029353] Funding Source: NIH RePORTER	University of Florida Alumni Fellowship(University of Florida); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.A.M. was supported by a University of Florida Alumni Fellowship. B.D.H. was supported by grants from the National Institutes of Health/National Institute on Aging (AG029353) and National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek Hanaa Ben, 2004, Genes Dev, V18, P1725; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bruggeman BJ, 2012, DEV DYNAM, V241, P675, DOI 10.1002/dvdy.23750; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Choi KS, 2012, MECH DEV; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Devereaux MW, 2007, NEUROL CLIN, V25, P331, DOI 10.1016/j.ncl.2007.02.003; Dufort D, 1998, DEVELOPMENT, V125, P3015; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1999, DEVELOPMENT, V126, P281; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Gofflot F, 1997, DEV DYNAM, V210, P431, DOI 10.1002/(SICI)1097-0177(199712)210:4<431::AID-AJA7>3.0.CO;2-H; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; JUNQUEIRA LCU, 1982, HISTOCHEMISTRY, V74, P153, DOI 10.1007/BF00495061; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1; Mavromatakis YE, 2011, MECH DEVELOP, V128, P90, DOI 10.1016/j.mod.2010.11.002; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Moore RJ, 2006, EUR SPINE J, V15, pS333, DOI 10.1007/s00586-006-0170-4; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; PAAVOLA LG, 1980, J EMBRYOL EXP MORPH, V55, P227; PEACOCK A, 1952, J ANAT, V86, P162; Peters H, 1999, DEVELOPMENT, V126, P5399; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; SASAKI H, 1993, DEVELOPMENT, V118, P47; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; STOTT D, 1993, GENE DEV, V7, P197, DOI 10.1101/gad.7.2.197; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Ukita K, 2009, MECH DEVELOP, V126, P791, DOI 10.1016/j.mod.2009.08.003; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wang Y, 2012, SPINE; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wilson V, 1996, MECH DEVELOP, V55, P79, DOI 10.1016/0925-4773(95)00493-9; YAMADA K, 1963, NATURE, V198, P799, DOI 10.1038/198799a0; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016	71	50	50	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55528	10.1371/journal.pone.0055528	http://dx.doi.org/10.1371/journal.pone.0055528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383217	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600121
J	Sauter, KA; Bouhlel, MA; O'Neal, J; Sester, DP; Tagoh, H; Ingram, RM; Pridans, C; Bonifer, C; Hume, DA				Sauter, Kristin A.; Bouhlel, M. Amine; O'Neal, Julie; Sester, David P.; Tagoh, Hiromi; Ingram, Richard M.; Pridans, Clare; Bonifer, Constanze; Hume, David A.			The Function of the Conserved Regulatory Element within the Second Intron of the Mammalian Csf1r Locus	PLOS ONE			English	Article							ACTIVATOR GENE-TRANSCRIPTION; STIMULATING FACTOR-I; RECEPTOR C-FMS; EXPRESSION; MACROPHAGES; ENHANCERS; CSF-1; PROMOTER; ETS; LIPOPOLYSACCHARIDE	The gene encoding the receptor for macrophage colony-stimulating factor (CSF-1R) is expressed exclusively in cells of the myeloid lineages as well as trophoblasts. A conserved element in the second intron, Fms-Intronic Regulatory Element (FIRE), is essential for macrophage-specific transcription of the gene. However, the molecular details of how FIRE activity is regulated and how it impacts the Csf1r promoter have not been characterised. Here we show that agents that down-modulate Csf1r mRNA transcription regulated promoter activity altered the occupancy of key FIRE cis-acting elements including RUNX1, AP1, and Sp1 binding sites. We demonstrate that FIRE acts as an anti-sense promoter in macrophages and reversal of FIRE orientation within its native context greatly reduced enhancer activity in macrophages. Mutation of transcription initiation sites within FIRE also reduced transcription. These results demonstrate that FIRE is an orientation-specific transcribed enhancer element.	[Sauter, Kristin A.; O'Neal, Julie; Sester, David P.; Pridans, Clare; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin, Midlothian, Scotland; [Bouhlel, M. Amine; Tagoh, Hiromi; Ingram, Richard M.; Bonifer, Constanze] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Expt Haematol, Leeds, W Yorkshire, England; [Bonifer, Constanze] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Saint James's University Hospital; University of Leeds; University of Birmingham	Hume, DA (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin, Midlothian, Scotland.	david.hume@roslin.ed.ac.uk	Sester, David/GLR-2942-2022; Pridans, Clare/AAF-9953-2020; Tagoh, Hiromi/B-2954-2009	Pridans, Clare/0000-0001-9423-557X; Hume, David/0000-0002-2615-1478; Sauter, Kristin/0000-0002-8721-3222; Tagoh, Hiromi/0000-0001-9905-6992; Bonifer, Constanze/0000-0002-4267-0825	Medical Research Council [G0901193]; Roslin Foundation Grant; BBSRC [BBS/E/D/20251969, BB/I001220/1] Funding Source: UKRI; MRC [G0901193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I001220/1, BBS/E/D/20251969] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roslin Foundation Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) Grant G0901193 and a Roslin Foundation Grant (http://www.roslin.ed.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chang S, 1999, J LEUKOCYTE BIOL, V66, P528, DOI 10.1002/jlb.66.3.528; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; Costelloe EO, 1999, J LEUKOCYTE BIOL, V66, P172, DOI 10.1002/jlb.66.1.172; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; FAVOT P, 1995, ONCOGENE, V11, P1371; Follows GA, 2005, ONCOGENE, V24, P3643, DOI 10.1038/sj.onc.1208655; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Fowles LF, 2000, BIOCHEM J, V347, P313, DOI 10.1042/0264-6021:3470313; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; GUSELLA GL, 1990, J IMMUNOL, V144, P3574; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Ingram RM, 2011, EXP HEMATOL, V39, P730, DOI 10.1016/j.exphem.2011.04.004; Kanoksilaptham W, 2007, SILPAKORN U SCI TECH, V1, P7; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; STACEY KJ, 1995, MOL CELL BIOL, V15, P3430; Sweet MJ, 1998, J INFLAMM, V48, P67; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Tagoh H, 2006, METH MOL B, V325, P285; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; YUE X, 1993, MOL CELL BIOL, V13, P3191, DOI 10.1128/MCB.13.6.3191	40	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54935	10.1371/journal.pone.0054935	http://dx.doi.org/10.1371/journal.pone.0054935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383005	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600053
J	Spengler, JR; Haddock, E; Gardner, D; Hjelle, B; Feldmann, H; Prescott, J				Spengler, Jessica R.; Haddock, Elaine; Gardner, Don; Hjelle, Brian; Feldmann, Heinz; Prescott, Joseph			Experimental Andes Virus Infection in Deer Mice: Characteristics of Infection and Clearance in a Heterologous Rodent Host	PLOS ONE			English	Article							SIN-NOMBRE-VIRUS; MOUSE PEROMYSCUS-MANICULATUS; CHEMOKINE RECEPTOR CCR5; HANTAVIRUS PULMONARY SYNDROME; MONOCLONAL-ANTIBODIES; INTERFERON RESPONSES; FUNCTIONAL EXPRESSION; HEMORRHAGIC-FEVER; MOLECULAR-CLONING; LETHAL CHALLENGE	New World hantaviruses can cause hantavirus cardiopulmonary syndrome with high mortality in humans. Distinct virus species are hosted by specific rodent reservoirs, which also serve as the vectors. Although regional spillover has been documented, it is unknown whether rodent reservoirs are competent for infection by hantaviruses that are geographically separated, and known to have related, but distinct rodent reservoir hosts. We show that Andes virus (ANDV) of South America, carried by the long tailed pygmy rice rat (Oligoryzomys longicaudatus), infects and replicates in vitro and in vivo in the deer mouse (Peromyscus maniculatus), the reservoir host of Sin Nombre virus (SNV), found in North America. In experimentally infected deer mice, viral RNA was detected in the blood, lung, heart and spleen, but virus was cleared by 56 days post inoculation (dpi). All of the inoculated deer mice mounted a humoral immune response by 14 dpi, and produced measurable amounts of neutralizing antibodies by 21 dpi. An up-regulation of Ccl3, Ccl4, Ccl5, and Tgfb, a strong CD4(+) T-cell response, and down-regulation of Il17, Il21 and Il23 occurred during infection. Infection was transient with an absence of clinical signs or histopathological changes. This is the first evidence that ANDV asymptomatically infects, and is immunogenic in deer mice, a non-natural host species of ANDV. Comparing the immune response in this model to that of the immune response in the natural hosts upon infection with their co-adapted hantaviruses may help clarify the mechanisms governing persistent infection in the natural hosts of hantaviruses.	[Spengler, Jessica R.; Haddock, Elaine; Feldmann, Heinz; Prescott, Joseph] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA; [Spengler, Jessica R.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Gardner, Don] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Hjelle, Brian] Univ New Mexico HSC, Dept Pathol, Albuquerque, NM USA; [Hjelle, Brian] Univ New Mexico HSC, Dept Biol, Albuquerque, NM USA; [Hjelle, Brian] Univ New Mexico HSC, Dept Mol Genet & Microbiol, Albuquerque, NM USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; University of New Mexico	Prescott, J (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.	prescottjb@niaid.nih.gov	Spengler, Jessica R./AAN-9099-2020	Spengler, Jessica R./0000-0002-5383-0513; Prescott, Joseph/0000-0001-5718-5155	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; ARIKAWA J, 1989, J GEN VIROL, V70, P615, DOI 10.1099/0022-1317-70-3-615; ARIKAWA J, 1992, ARCH VIROL, V126, P271, DOI 10.1007/BF01309700; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; Blanpain C, 1999, BLOOD, V94, P1899; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2001, COMPARATIVE MED, V51, P314; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Brown KS, 2011, J VIROL, V85, P12781, DOI 10.1128/JVI.00794-11; Calisher CH, 1999, EMERG INFECT DIS, V5, P126, DOI 10.3201/eid0501.990115; CHILDS JE, 1991, AM J TROP MED HYG, V44, P117, DOI 10.4269/ajtmh.1991.44.117; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; DANTAS JR, 1986, VIROLOGY, V151, P379, DOI 10.1016/0042-6822(86)90058-9; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Easterbrook JD, 2008, J GEN VIROL, V89, P2723, DOI 10.1099/vir.0.2008/03715-0; Enria DA, 2000, INFECT DIS CLIN N AM, V14, P167, DOI 10.1016/S0891-5520(05)70223-3; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Geimonen E, 2002, P NATL ACAD SCI USA, V99, P13837, DOI 10.1073/pnas.192298899; Hjelle Brian, 2002, Expert Rev Vaccines, V1, P373, DOI 10.1586/14760584.1.3.373; Hooper JW, 2001, CURR TOP MICROBIOL, V256, P171; Klingstrom J, 2002, J MED VIROL, V68, P581, DOI 10.1002/jmv.10232; Levine JR, 2010, J VIROL, V84, P11790, DOI 10.1128/JVI.00916-10; LUNDKVIST A, 1992, ARCH VIROL, V126, P93, DOI 10.1007/BF01309687; Meissner JD, 2002, VIRUS RES, V89, P131, DOI 10.1016/S0168-1702(02)00129-6; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; RAND MS, 1994, LAB ANIM SCI, V44, P301; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Ray N, 2010, J VIROL METHODS, V163, P416, DOI 10.1016/j.jviromet.2009.11.004; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Safronetz D, 2009, J VIROL, V83, P7285, DOI 10.1128/JVI.00373-09; Saksida A, 2008, J INFECT DIS, V197, P681, DOI 10.1086/527485; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; SCHMALJOHN CS, 1990, J VIROL, V64, P3162, DOI 10.1128/JVI.64.7.3162-3170.1990; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; Staudinger R, 2003, J BIOL CHEM, V278, P10389, DOI 10.1074/jbc.M212013200; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Viral Special Pathogens Branch CDC, 2012, HANT TECHN CLIN INF; Wang XH, 2003, BIOCHEM BIOPH RES CO, V307, P1066, DOI 10.1016/S0006-291X(03)01315-9; Warner GS, 1996, SOUTHERN MED J, V89, P264, DOI 10.1097/00007611-199603000-00002; Xiao RB, 2006, J INFECT DIS, V194, P1403, DOI 10.1086/508494; Yaeger MJ, 2002, J VET DIAGN INVEST, V14, P15, DOI 10.1177/104063870201400104; ZAKI SR, 1995, AM J PATHOL, V146, P552; ZHANG XK, 1989, ARCH VIROL, V105, P235, DOI 10.1007/BF01311360	52	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55310	10.1371/journal.pone.0055310	http://dx.doi.org/10.1371/journal.pone.0055310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383148	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600086
J	Bugault, F; Benati, D; Mouthon, L; Landires, I; Rohrlich, P; Pestre, V; Theze, J; Lortholary, O; Chakrabarti, LA				Bugault, Florence; Benati, Daniela; Mouthon, Luc; Landires, Ivan; Rohrlich, Pierre; Pestre, Vincent; Theze, Jacques; Lortholary, Olivier; Chakrabarti, Lisa A.			Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T-CELL HOMEOSTASIS; HIV-INFECTION; CRYPTOCOCCAL MENINGITIS; INTERLEUKIN-7 RECEPTOR; CLONOGENIC CAPABILITY; SIGNAL-TRANSDUCTION; CXCR4 EXPRESSION; EPITHELIAL-CELL; CUTTING EDGE	Idiopathic CD4 lymphocytopenia (ICL) is a rare immune deficiency characterized by a protracted CD4(+) T cell loss of unknown etiology and by the occurrence of opportunistic infections similar to those seen in AIDS. We investigated whether a defect in responses to cytokines that control CD4(+) T cell homeostasis could play a role in ICL. Immunophenotype and signaling responses to interleukin-7 (IL-7), IL-2, and thymic stromal lymphopoietin (TSLP) were analyzed by flow cytometry in CD4(+) T cells from 15 ICL patients and 15 healthy blood donors. The induction of phospho-STAT5 after IL-7 stimulation was decreased in memory CD4(+) T cells of some ICL patients, which correlated with a decreased expression of the IL-7R alpha receptor chain (R = 0.74, p<0.005) and with lower CD4(+) T cell counts (R = 0.69, p<0.005). IL-2 responses were also impaired, both in the Treg and conventional memory subsets. Decreased IL-2 responses correlated with decreased IL-7 responses (R = 0.75, p<0.005), pointing to combined defects that may significantly perturb CD4(+) T cell homeostasis in a subset of ICL patients. Unexpectedly, responses to the IL-7-related cytokine TSLP were increased in ICL patients, while they remained barely detectable in healthy controls. TSLP responses correlated inversely with IL-7 responses (R = 20.41; p<0.05), suggesting a cross-regulation between the two cytokine systems. In conclusion, IL-7 and IL-2 signaling are impaired in ICL, which may account for the loss of CD4(+) T cell homeostasis. Increased TSLP responses point to a compensatory homeostatic mechanism that may mitigate defects in gamma c cytokine responses.	[Bugault, Florence; Benati, Daniela; Landires, Ivan; Theze, Jacques; Chakrabarti, Lisa A.] Inst Pasteur, Unite Immunogenet Cellulaire, Paris, France; [Mouthon, Luc; Pestre, Vincent] Univ Paris 05, Hop Cochin, AP HP, Paris, France; [Rohrlich, Pierre] INSERM, U645, Besancon, France; [Rohrlich, Pierre] Univ Besancon, F-25030 Besancon, France; [Rohrlich, Pierre] CHU Besancon, Serv Pediat, F-25030 Besancon, France; [Lortholary, Olivier] Inst Pasteur, Unite Mycol Mol, Paris, France; [Lortholary, Olivier] CNRS, URA 3012, Paris, France; [Lortholary, Olivier] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Malad Infect & Trop,Ctr Infectiol Necker Pas, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Chakrabarti, LA (corresponding author), Inst Pasteur, Unite Immunogenet Cellulaire, Paris, France.	chakra@pasteur.fr		Chakrabarti, Lisa/0000-0002-1895-3630; Landires, Ivan/0000-0001-6323-1170; Benati, Daniela/0000-0002-6599-7193; Rohrlich, Pierre S/0000-0001-8801-4164	SENACYT Research Agency from Panama; Assistance Publique des Hopitaux de Paris (AP-HP); Ligue contre le Cancer du Grand Est; Pasteur Institute, Paris	SENACYT Research Agency from Panama; Assistance Publique des Hopitaux de Paris (AP-HP); Ligue contre le Cancer du Grand Est; Pasteur Institute, Paris	I. L. is the recipient of a fellowship from the SENACYT Research Agency from Panama. This work was supported by Assistance Publique des Hopitaux de Paris (AP-HP), Ligue contre le Cancer du Grand Est, and by the Pasteur Institute, Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Alves NL, 2010, J IMMUNOL, V184, P5949, DOI 10.4049/jimmunol.1000601; Chahroudi A, 2010, EUR CYTOKINE NETW, V21, P202, DOI 10.1684/ecn.2010.0205; Cunningham-Rundles C, 1999, CLIN EXP IMMUNOL, V116, P322; Fruhwirth M, 2001, INT ARCH ALLERGY IMM, V125, P80, DOI 10.1159/000053800; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gorska MM, 2012, BLOOD, V119, P1399, DOI 10.1182/blood-2011-04-350686; HO DD, 1993, NEW ENGL J MED, V328, P380, DOI 10.1056/NEJM199302113280602; Hubert P, 2000, INT IMMUNOL, V12, P449, DOI 10.1093/intimm/12.4.449; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Isgro A, 2005, INT ARCH ALLERGY IMM, V136, P379, DOI 10.1159/000084258; Isgro A, 2008, CLIN INFECT DIS, V46, P1902, DOI 10.1086/588480; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Laurence J, 1996, J CLIN INVEST, V97, P672, DOI 10.1172/JCI118464; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Malaspina A, 2007, BLOOD, V109, P2086, DOI 10.1182/blood-2006-06-031385; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Netea MG, 2004, CLIN INFECT DIS, V39, pE83, DOI 10.1086/425121; Niehues T, 2010, CLIN IMMUNOL, V135, P183, DOI 10.1016/j.clim.2010.01.013; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pedroza-Martins L, 2002, J VIROL, V76, P6929, DOI 10.1128/JVI.76.14.6929-6943.2002; Puronen CE, 2012, J INFECT DIS, V205, P1382, DOI 10.1093/infdis/jis219; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2010, P NATL ACAD SCI US; Roger PM, 1999, CLIN INFECT DIS, V28, P1012, DOI 10.1086/514739; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Schmitt N, 2003, J VIROL, V77, P5784, DOI 10.1128/JVI.77.10.5784-5793.2003; Scott-Algara D, 2010, BLOOD, V115, P3708, DOI 10.1182/blood-2009-02-202796; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Trojan T, 2009, CLIN EXP IMMUNOL, V156, P440, DOI 10.1111/j.1365-2249.2009.03910.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walker UA, 2006, CURR OPIN RHEUMATOL, V18, P389, DOI 10.1097/01.bor.0000231908.57913.2f; Warnatz K, 2000, IMMUNOBIOLOGY, V202, P204, DOI 10.1016/S0171-2985(00)80068-6; Wohlmann A, 2010, BIOL CHEM, V391, P181, DOI [10.1515/BC.2010.029, 10.1515/bc.2010.029]; Yamada Y, 2009, INTERNAL MED, V48, P1967, DOI 10.2169/internalmedicine.48.2623; Yilmaz-Demirdag Y, 2008, ALLERGY ASTHMA PROC, V29, P421, DOI 10.2500/aap.2008.29.3143; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Zonios DI, 2008, BLOOD, V112, P287, DOI 10.1182/blood-2007-12-127878; Zonios DI, 2007, MEDICINE, V86, P78, DOI 10.1097/md.0b013e31803b52f5	58	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55570	10.1371/journal.pone.0055570	http://dx.doi.org/10.1371/journal.pone.0055570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383227	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800166
J	Chen, FL; Su, LF; Liu, YD; Hu, DW				Chen, Fanglin; Su, Longfei; Liu, Yadong; Hu, Dewen			Confirming the Diversity of the Brain after Normalization: An Approach Based on Identity Authentication	PLOS ONE			English	Article							OPEN ACCESS SERIES; MRI DATA; NETWORKS; CLASSIFICATION; SCHIZOPHRENIA; REGISTRATION; GENDER; IMAGES; MODES; YOUNG	During the development of neuroimaging, numerous analyses were performed to identify population differences, such as studies on age, gender, and diseases. Researchers first normalized the brain image and then identified features that represent key differences between groups. In these studies, the question of whether normalization (a pre-processing step widely used in neuroimaging studies) reduces the diversity of brains was largely ignored. There are a few studies that identify the differences between individuals after normalization. In the current study, we analyzed brain diversity on an individual level, both qualitatively and quantitatively. The main idea was to utilize brain images for identity authentication. First, the brain images were normalized and registered. Then, a pixel-level matching method was developed to compute the identity difference between different images for matching. Finally, by analyzing the performance of the proposed brain recognition strategy, the individual differences in brain images were evaluated. Experimental results on a 150-subject database showed that the proposed approach could achieve a 100% identification ratio, which indicated distinct differences between individuals after normalization. Thus, the results proved that after the normalization stage, brain images retain their main distinguishing information and features. Based on this result, we suggest that diversity (individual differences) should be considered when conducting group analysis, and that this approach may facilitate group pattern classification.	[Chen, Fanglin; Su, Longfei; Liu, Yadong; Hu, Dewen] Natl Univ Def Technol, Dept Automat Control, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Hu, DW (corresponding author), Natl Univ Def Technol, Dept Automat Control, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015; Chen, Fanglin/I-1527-2013	Chen, Fanglin/0000-0002-9193-5412; Su, Longfei/0000-0003-0573-2756	National 973 program of China [2011CB707802]; National Natural Science Foundation of China [61003202, 61005084]	National 973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National 973 program of China (2011CB707802) and National Natural Science Foundation of China (61003202, 61005084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Ashburner J., 1997, CLIN MRI DEV MR, V7, P26; Ashburner J., 2008, SPM8 MANUAL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bergfield KL, 2010, NEUROIMAGE, V49, P1750, DOI 10.1016/j.neuroimage.2009.09.051; Buckner R., 2012, OPEN ACCESS SERIES I; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Cappelli R, 2011, 2011 INT JOINT C BIO, P1; Chen FL, 2009, IEEE T IMAGE PROCESS, V18, P1665, DOI 10.1109/TIP.2009.2017995; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Devanand DP, 2012, NEUROIMAGE, V60, P1622, DOI 10.1016/j.neuroimage.2012.01.075; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fornito A, 2012, NEUROIMAGE IN PRESS; Friston K, 2009, STAT PARAMETRIC MAPP; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Giot Romain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1128, DOI 10.1109/ICPR.2010.282; Holden M, 2008, IEEE T MED IMAGING, V27, P111, DOI 10.1109/TMI.2007.904691; Hollingsworth K. P., 2009, IEEE 3 INT C BIOM TH, P1; Hollingsworth KP, 2011, IEEE T PATTERN ANAL, V33, P2465, DOI 10.1109/TPAMI.2011.89; Jain A.K., 2005, BIOMETRICS PERSONAL; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Li S. Z., 2011, HDB FACE RECOGNITION; Linchuan Zhang, 2010, 2010 9th IEEE International Conference on Cognitive Informatics (ICCI), P524, DOI 10.1109/COGINF.2010.5599683; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Marcus DS, 2010, J COGNITIVE NEUROSCI, V22, P2677, DOI 10.1162/jocn.2009.21407; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Miller M, 1997, Stat Methods Med Res, V6, P267, DOI 10.1191/096228097673360480; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Sabuncu M, 2011, CEREBRAL CORTEX; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shinkareva SV, 2006, NEUROIMAGE, V33, P63, DOI 10.1016/j.neuroimage.2006.06.032; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tonks J, 2011, BRAIN INJURY, V25, P1; Westbrook C, 2011, MRI PRACTICE; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yang YL, 2010, PSYCHIAT RES-NEUROIM, V182, P9, DOI 10.1016/j.pscychresns.2009.10.013; Zhang D, 2010, IEEE T INSTRUM MEAS, V59, P480, DOI 10.1109/TIM.2009.2028772; Zhou J, 2009, PATTERN RECOGN, V42, P896, DOI 10.1016/j.patcog.2008.09.011; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54328	10.1371/journal.pone.0054328	http://dx.doi.org/10.1371/journal.pone.0054328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382891	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800045
J	Istok, E; Friberg, A; Huotilainen, M; Tervaniemi, M				Istok, Eva; Friberg, Anders; Huotilainen, Minna; Tervaniemi, Mari			Expressive Timing Facilitates the Neural Processing of Phrase Boundaries in Music: Evidence from Event-Related Potentials	PLOS ONE			English	Article							CROSS-CULTURAL ERP; BRAIN POTENTIALS; PERCEPTION; COMPONENT; ATTENTION; MISMATCH; PITCH; N1; P2	The organization of sound into meaningful units is fundamental to the processing of auditory information such as speech and music. In expressive music performance, structural units or phrases may become particularly distinguishable through subtle timing variations highlighting musical phrase boundaries. As such, expressive timing may support the successful parsing of otherwise continuous musical material. By means of the event-related potential technique (ERP), we investigated whether expressive timing modulates the neural processing of musical phrases. Musicians and laymen listened to short atonal scale-like melodies that were presented either isochronously (deadpan) or with expressive timing cues emphasizing the melodies' two-phrase structure. Melodies were presented in an active and a passive condition. Expressive timing facilitated the processing of phrase boundaries as indicated by decreased N2b amplitude and enhanced P3a amplitude for target phrase boundaries and larger P2 amplitude for non-target boundaries. When timing cues were lacking, task demands increased especially for laymen as reflected by reduced P3a amplitude. In line, the N2b occurred earlier for musicians in both conditions indicating general faster target detection compared to laymen. Importantly, the elicitation of a P3a-like response to phrase boundaries marked by a pitch leap during passive exposure suggests that expressive timing information is automatically encoded and may lead to an involuntary allocation of attention towards significant events within a melody. We conclude that subtle timing variations in music performance prepare the listener for musical key events by directing and guiding attention towards their occurrences. That is, expressive timing facilitates the structuring and parsing of continuous musical material even when the auditory input is unattended.	[Istok, Eva; Huotilainen, Minna; Tervaniemi, Mari] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Istok, Eva; Huotilainen, Minna] Univ Jyvaskyla, Dept Mus, Finnish Ctr Excellence Interdisciplinary Mus Res, Jyvaskyla, Finland; [Friberg, Anders] KTH Royal Inst Technol, Dept Speech Mus & Hearing, Stockholm, Sweden; [Huotilainen, Minna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Tervaniemi, Mari] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla; Royal Institute of Technology; Finnish Institute of Occupational Health; University of Jyvaskyla	Istok, E (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	eva.istok@helsinki.fi	Friberg, Anders K/A-2490-2012	Tervaniemi, Mari/0000-0002-9651-2929; Huotilainen, Minna/0000-0002-7251-6984	European Commission [FP6-2004-NEST-PATH-028570-BrainTuning]; Finnish Centre of Excellence in Interdisciplinary Music Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Centre of Excellence in Interdisciplinary Music Research	This work was supported by the European Commission FP6-2004-NEST-PATH-028570-BrainTuning (http://ec.europa.eu/research/fp6/index_en.cfm) and the Finnish Centre of Excellence in Interdisciplinary Music Research https://www.jyu.fi/hum/laitokset/musiikki/en/research/coe/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregman A. S., 1999, AUDITORY SCENE ANAL; Carlson R., 1989, CONTEMP MUSIC REV, V4, P391, DOI [10.1080/07494468900640441, DOI 10.1080/07494468900640441]; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOWLING WJ, 1973, PERCEPT PSYCHOPHYS, V14, P37, DOI 10.3758/BF03198614; Eimer M, 1996, J EXP PSYCHOL LEARN, V22, P970, DOI 10.1037/0278-7393.22.4.970; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friberg A, 2000, COMPUT MUSIC J, V24, P23, DOI 10.1162/014892600559407; Friberg A., 1995, SPEECH MUSIC HEARING, V36, P63; Friberg A, 2006, ADV COGN PSYCHOL, V2, P145, DOI DOI 10.2478/V10053-008-0052-X; James CE, 2012, HUM BRAIN MAPP, V33, P2751, DOI 10.1002/hbm.21397; Juslin P.N., 2002, MUSICAE SCI S, V5, P63, DOI DOI 10.1177/10298649020050S104; Knosche TR, 2005, HUM BRAIN MAPP, V24, P259, DOI 10.1002/hbm.20088; Koffka K, 1935, PRINCIPLES GESTALT P; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Lerdahl F., 1983, GENERATIVE THEORY TO; Munte TF, 2003, ANN NY ACAD SCI, V999, P131, DOI 10.1196/annals.1284.014; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nan Y, 2006, BRAIN RES, V1094, P179, DOI 10.1016/j.brainres.2006.03.115; Nan Y, 2009, BIOL PSYCHOL, V82, P70, DOI 10.1016/j.biopsycho.2009.06.002; Neuhaus C, 2006, J COGNITIVE NEUROSCI, V18, P472, DOI 10.1162/089892906775990642; Nittono H, 2000, BIOL PSYCHOL, V52, P1, DOI 10.1016/S0301-0511(99)00042-3; Palmer C, 2009, ANN NY ACAD SCI, V1169, P470, DOI 10.1111/j.1749-6632.2009.04584.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; REPP BH, 1992, COGNITION, V44, P241, DOI 10.1016/0010-0277(92)90003-Z; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Russeler J, 2003, COGNITIVE BRAIN RES, V15, P116, DOI 10.1016/S0926-6410(02)00145-3; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Seppanen M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00043; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Steinhauer K, 2003, BRAIN LANG, V86, P142, DOI 10.1016/S0093-934X(02)00542-4; TAN N, 1981, MEM COGNITION, V9, P533, DOI 10.3758/BF03202347; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283	40	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55150	10.1371/journal.pone.0055150	http://dx.doi.org/10.1371/journal.pone.0055150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383088	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800122
J	Paris, D; Beaulieu-Abdelahad, D; Mullan, M; Ait-Ghezala, G; Mathura, V; Bachmeier, C; Crawford, F; Mullan, MJ				Paris, Daniel; Beaulieu-Abdelahad, David; Mullan, Myles; Ait-Ghezala, Ghania; Mathura, Venkat; Bachmeier, Corbin; Crawford, Fiona; Mullan, Michael J.			Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; T-CELLS; IN-VIVO; DISEASE; NEURODEGENERATION; PHOSPHORYLATION; PATHOGENESIS; INHIBITION; TRANSDUCER; ACTIVATOR	Anatabine, a naturally occurring alkaloid, is becoming a commonly used human food supplement, taken for its claimed anti-inflammatory properties although this has not yet been reported in human clinical trials. We have previously shown that anatabine does display certain anti-inflammatory properties and readily crosses the blood-brain barrier suggesting it could represent an important compound for mitigating neuro-inflammatory conditions. The present study was designed to determine whether anatabine had beneficial effects on the development of experimental autoimmune encephalomyelitis (EAE) in mice and to precisely determine its underlying mechanism of action in this mouse model of multiple sclerosis (MS). We found that orally administered anatabine markedly suppressed neurological deficits associated with EAE. Analyses of cytokine production in the periphery of the animals revealed that anatabine significantly reduced Th1 and Th17 cytokines known to contribute to the development of EAE. Anatabine appears to significantly suppress STAT3 and p65 NF kappa B phosphorylation in the spleen and the brain of EAE mice. These two transcription factors regulate a large array of inflammatory genes including cytokines suggesting a mechanism by which anatabine antagonizes pro-inflammatory cytokine production. Additionally, we found that anatabine alleviated the infiltration of macrophages/microglia and astrogliosis and significantly prevented demyelination in the spinal cord of EAE mice. Altogether our data suggest that anatabine may be effective in the treatment of MS and should be piloted in clinical trials.	[Paris, Daniel; Beaulieu-Abdelahad, David; Mullan, Myles; Ait-Ghezala, Ghania; Mathura, Venkat; Bachmeier, Corbin; Crawford, Fiona; Mullan, Michael J.] Roskamp Inst, Sarasota, FL USA		Paris, D (corresponding author), Roskamp Inst, Sarasota, FL USA.	dparis@rfdn.org		Mullan, Michael/0000-0002-1473-7527; Ait-Ghezala, Ghania/0000-0002-9836-8617; Paris, Daniel/0000-0002-9622-0846	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals partially funded this study. The Roskamp Institute is a not-for-profit public charity and none of its staff (who comprise all the authors on this paper) receive remuneration from Rock Creek Pharmaceuticals. Rock Creek Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Caturegli P, 2012, ENDOCRINOLOGY, V153, P4580, DOI 10.1210/en.2012-1452; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Joe Y, 2011, J BIOL CHEM, V286, P24735, DOI 10.1074/jbc.M110.204859; Kim do Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0035476); Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Luessi F, 2012, EXPERT REV NEUROTHER, V12, P1061, DOI [10.1586/ERN.12.59, 10.1586/ern.12.59]; Martinelli V, 2009, NEUROL SCI, V30, P167, DOI 10.1007/s10072-009-0142-7; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Park SY, 2008, CYTOKINE, V44, P126, DOI 10.1016/j.cyto.2008.07.006; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rinaldi F, 2009, MULT SCLER J, V15, P1359, DOI 10.1177/1352458509107011; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Skundric DS, 2005, CURR NEUROVASC RES, V2, P349, DOI 10.2174/156720205774322601; Stangel M, 2012, CURR PHARM DESIGN, V18, P4471, DOI 10.2174/138161212802502189; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888; Yamamoto I, 1998, ARCH INSECT BIOCHEM, V37, P24, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;24::AID-ARCH4&gt;3.0.CO;2-V	30	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55392	10.1371/journal.pone.0055392	http://dx.doi.org/10.1371/journal.pone.0055392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383175	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800147
J	Simon, S; Demeure, C; Lamourette, P; Filali, S; Plaisance, M; Creminon, C; Volland, H; Carniel, E				Simon, Stephanie; Demeure, Christian; Lamourette, Patricia; Filali, Sofia; Plaisance, Marc; Creminon, Christophe; Volland, Herve; Carniel, Elisabeth			Fast and Simple Detection of Yersinia pestis Applicable to Field Investigation of Plague Foci	PLOS ONE			English	Article							BETA-BARREL PROTEINS; MONOCLONAL-ANTIBODIES; PLASMINOGEN-ACTIVATOR; SURFACE PROTEASE; GENOME SEQUENCE; ASSAY; ACETYLCHOLINESTERASE; HYBRIDIZATION; PERSISTENCE; EXPRESSION	Yersinia pestis, the plague bacillus, has a rodent-flea-rodent life cycle but can also persist in the environment for various periods of time. There is now a convenient and effective test (F1-dipstick) for the rapid identification of Y. pestis from human patient or rodent samples, but this test cannot be applied to environmental or flea materials because the F1 capsule is mostly produced at 37 degrees C. The plasminogen activator (PLA), a key virulence factor encoded by a Y. pestis-specific plasmid, is synthesized both at 20 degrees C and 37 degrees C, making it a good candidate antigen for environmental detection of Y. pestis by immunological methods. A recombinant PLA protein from Y. pestis synthesized by an Escherichia coli strain was used to produce monoclonal antibodies (mAbs). PLA-specific mAbs devoid of cross-reactions with other homologous proteins were further cloned. A pair of mAbs was selected based on its specificity, sensitivity, comprehensiveness, and ability to react with Y. pestis strains grown at different temperatures. These antibodies were used to develop a highly sensitive one-step PLA-enzyme immunoassay (PLA-EIA) and an immunostrip (PLA-dipstick), usable as a rapid test under field conditions. These two PLA-immunometric tests could be valuable, in addition to the F1-disptick, to confirm human plague diagnosis in nonendemic areas (WHO standard case definition). They have the supplementary advantage of allowing a rapid and easy detection of Y. pestis in environmental and flea samples, and would therefore be of great value for surveillance and epidemiological investigations of plague foci. Finally, they will be able to detect natural or genetically engineered F1-negative Y. pestis strains in human patients and environmental samples.	[Simon, Stephanie; Lamourette, Patricia; Plaisance, Marc; Creminon, Christophe; Volland, Herve] CEA Saclay, iBiTec S, Lab Etud & Rech Immunoanal, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France; [Demeure, Christian; Filali, Sofia; Carniel, Elisabeth] Inst Pasteur, Yersinia Res Unit, Paris, France; [Demeure, Christian; Filali, Sofia; Carniel, Elisabeth] WHO Collaborating Ctr Yersinia, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Simon, S (corresponding author), CEA Saclay, iBiTec S, Lab Etud & Rech Immunoanal, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France.	stephanie.simon@cea.fr	Demeure, Christian/AAD-4922-2020; Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255; Demeure, Christian E./0000-0001-7195-1645				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P278; BALTAZARD M., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1230; BEESLEY ED, 1967, J BACTERIOL, V94, P19, DOI 10.1128/JB.94.1.19-26.1967; Begon M, 2006, EMERG INFECT DIS, V12, P268; BERCOVIER H, 1980, CURR MICROBIOL, V4, P225, DOI 10.1007/BF02605861; Bertherat E, 2005, Med Trop (Mars), V65, P511; Bertherat E, 2007, EMERG INFECT DIS, V13, P1459, DOI 10.3201/eid1310.070284; Bertherat E, 2011, EMERG INFECT DIS, V17, P778, DOI 10.3201/eid1705.100029; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chanteau S, 2003, Med Trop (Mars), V63, P574; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Engelthaler DM, 2000, J MED ENTOMOL, V37, P422, DOI 10.1603/0022-2585(2000)037[0422:QOYPIF]2.0.CO;2; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Feodorova VA, 2000, J MED MICROBIOL, V49, P261, DOI 10.1099/0022-1317-49-3-261; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Freeman BA, 1985, TXB MICROBIOLOGY, P513; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Frobert Y, 1998, METH MOL B, V80, P57; Gabitzsch ES, 2008, AM J TROP MED HYG, V79, P99, DOI 10.4269/ajtmh.2008.79.99; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; GRASSI J, 1989, J IMMUNOL METHODS, V123, P193, DOI 10.1016/0022-1759(89)90223-8; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kenny JH, 2008, J MICROBIOL METH, V75, P293, DOI 10.1016/j.mimet.2008.06.021; Khreich N, 2008, ANAL BIOCHEM, V377, P182, DOI 10.1016/j.ab.2008.02.032; Kutyrev V, 1999, INFECT IMMUN, V67, P1359, DOI 10.1128/IAI.67.3.1359-1367.1999; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lowell JL, 2007, MICROBIOL-SGM, V153, P169, DOI 10.1099/mic.0.29059-0; Mahesh S, 2005, COMP IMMUNOL MICROB, V28, P131, DOI 10.1016/j.cimid.2004.08.002; MCCLEAN KL, 1995, CLIN INFECT DIS, V21, P650, DOI 10.1093/clinids/21.3.650; Meka-Mechenko TV, 2004, GENUS YERSINIA ENTER, P379; Meyer MHF, 2007, J MICROBIOL METH, V68, P218, DOI 10.1016/j.mimet.2006.08.004; Mollaret H, 1971, Bull Soc Pathol Exot Filiales, V64, P713; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1186; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; RAMALINGASWAMI V, 1995, NAT MED, V1, P1237, DOI 10.1038/nm1295-1237; Rasoamanana B, 1997, CLIN DIAGN LAB IMMUN, V4, P587, DOI 10.1128/CDLI.4.5.587-591.1997; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sha J, 2011, J CLIN MICROBIOL, V49, P1708, DOI 10.1128/JCM.00064-11; Shen E L, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P40; Shen E L, 1990, Zhonghua Liu Xing Bing Xue Za Zhi, V11, P156; Simond, 1898, ANN I PASTEUR, P625; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stepanov V. M., 1997, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V0, P44; Suomalainen M, 2007, ADV EXP MED BIOL, V603, P268; Tarantola A, 2009, EUROSURVEILLANCE, V14; Torosian SD, 2009, CAN J MICROBIOL, V55, P1125, DOI [10.1139/W09-061, 10.1139/w09-061]; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Wimsatt J, 2009, J VECTOR DIS, V46, P85; WINTER C C, 1960, Bull World Health Organ, V23, P408; Yersin A, 1994, Rev Med Suisse Romande, V114, P393	66	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54947	10.1371/journal.pone.0054947	http://dx.doi.org/10.1371/journal.pone.0054947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383008	Green Published, gold			2022-12-25	WOS:000315483200028
J	Zhong, XM; Hou, L; Luo, XN; Shi, HS; Hu, GY; He, HB; Chen, XR; Zheng, D; Zhang, YF; Tan, Y; Liu, XJ; Mu, N; Chen, JP; Ning, YP				Zhong, Xiao-Mei; Hou, Le; Luo, Xin-Ni; Shi, Hai-Shan; Hu, Guo-Yan; He, Hong-Bo; Chen, Xin-Ru; Zheng, Dong; Zhang, Yue-Feng; Tan, Yan; Liu, Xue-Jun; Mu, Nan; Chen, Jian-Ping; Ning, Yu-Ping			Alterations of CSF Cystatin C Levels and Their Correlations with CSF A beta 40 and A beta 42 Levels in Patients with Alzheimer's Disease, Dementia with Lewy Bodies and the Atrophic Form of General Paresis	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; CEREBROSPINAL-FLUID LEVELS; BETA-PROTEIN; COGNITIVE IMPAIRMENT; NEURODEGENERATION; HEMORRHAGE; RISK; POLYMORPHISM; DEPOSITION; DIAGNOSIS	Immunohistochemical studies have revealed that cystatin C (CysC) co-localizes with amyloid-beta (A beta) in amyloid-laden vascular walls and in the senile plaque cores of amyloid. In vitro and in vivo animal studies suggest that CysC protects against neurodegeneration by inhibition of cysteine proteases, inhibition of A beta aggregation, induction of autophagy and induction of cell division. CysC levels may be altered and may have a potential link with cerebrospinal fluid (CSF) A beta levels in various types of dementia with characteristic amyloid deposits, such as Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and the atrophic form of general paresis (AF-GP). We assessed the serum and CSF levels of CysC and the CSF levels of A beta 40 and A beta 42 in patients with AD (n = 51), DLB (n = 26) and AF-GP (n = 43) and normal controls (n = 30). Using these samples, we explored the correlation between CSF CysC and CSF A beta levels. We found that in comparison to the normal control group, both CSF CysC and CSF A beta 42 levels were significantly lower in all three dementia groups (all p<0.001); serum CysC levels were the same in the AD and DLB groups, and were lower in the AF-GP group (p = 0.008). The CSF CysC levels were positively correlated with both the CSF A beta 40 and A beta 42 levels in the AD, AF-GP and normal control groups (r = 0.306 similar to 0.657, all p<0.05). Lower CSF CysC levels might be a common feature in dementia with characteristic amyloid deposits. Our results provide evidence for the potential role of CysC involvement in A beta metabolism and suggest that modulation of the CysC level in the brain might produce a disease-modifying effect in dementia with characteristic amyloid deposits.	[Zhong, Xiao-Mei; Hou, Le; Luo, Xin-Ni; Shi, Hai-Shan; Chen, Xin-Ru; Zheng, Dong; Zhang, Yue-Feng; Tan, Yan; Ning, Yu-Ping] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Hu, Guo-Yan; Liu, Xue-Jun; Chen, Jian-Ping] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [He, Hong-Bo] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Mol Biol Lab, Guangzhou, Peoples R China; [Mu, Nan] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Geriatr Psychiat, Guangzhou, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Ning, YP (corresponding author), Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	ningjeny@126.com			National Natural Science Foundation of China [30970902]; Guangzhou Municipal Science and Technology Program [2010Y1-C631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Municipal Science and Technology Program	This study was supported by the following grants: National Natural Science Foundation of China (number 30970902) and Guangzhou Municipal Science and Technology Program (number 2010Y1-C631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Blennow K., 2012, COLD SPRING HARB PER, V2; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Esiri MM, 2007, J NEUROIMMUNOL, V184, P4, DOI 10.1016/j.jneuroim.2006.11.013; Fujishiro H, 2010, NEUROSCI LETT, V486, P19, DOI 10.1016/j.neulet.2010.09.036; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Ghanem KG, 2010, CNS NEUROSCI THER, V16, pe157, DOI 10.1111/j.1755-5949.2010.00183.x; Ghidoni R, 2010, J ALZHEIMERS DIS, V22, P985, DOI 10.3233/JAD-2010-101095; HAAN J, 1994, ACTA NEUROL SCAND, V89, P367; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Maetzler W, 2010, J ALZHEIMERS DIS, V19, P937, DOI 10.3233/JAD-2010-1289; Mares J, 2009, NEUROL SCI, V30, P1, DOI 10.1007/s10072-008-0005-7; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; MIKLOSSY J, 2006, ALZHEIMERS DIS NEW A, P429; Miklossy Judith, 2008, Handb Clin Neurol, V89, P825, DOI 10.1016/S0072-9752(07)01272-9; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Nagai A, 1998, MOL CHEM NEUROPATHOL, V33, P63, DOI 10.1007/BF02815860; NITSCH RM, 1995, ANN NEUROL, V37, P512, DOI 10.1002/ana.410370414; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Pirttila TJ, 2005, NEUROBIOL DIS, V20, P241, DOI 10.1016/j.nbd.2005.03.006; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Sundelof J, 2008, NEUROLOGY, V71, P1072, DOI 10.1212/01.wnl.0000326894.40353.93; Sundelof J, 2010, J ALZHEIMERS DIS, V21, P471, DOI 10.3233/JAD-2010-091594; Tizon B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009819; Wang JH, 2011, DEMENT GERIATR COGN, V31, P284, DOI 10.1159/000326908; Yamamoto-Watanabe Y, 2010, BRAIN RES, V1361, P140, DOI 10.1016/j.brainres.2010.09.033	43	23	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55328	10.1371/journal.pone.0055328	http://dx.doi.org/10.1371/journal.pone.0055328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383156	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200006
J	Pacak, CA; Eddy, MT; Woodhull, L; Wang, KR; Alpatov, I; Fullen, S; Dowd, RP; Choi, YH; Cowan, DB				Pacak, Christina A.; Eddy, Mau-Thek; Woodhull, Lindsey; Wang, Kai-Roy; Alpatov, Ivan; Fullen, Shelby; Dowd, Rory P.; Choi, Yeong-Hoon; Cowan, Douglas B.			Microcarrier-Based Expansion of Adult Murine Side Population Stem Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; PROGENITOR CELLS; IN-VITRO; REGENERATION; DIFFERENTIATION; EXPRESSION; PHENOTYPE; CULTURE; TISSUES; EFFLUX	The lack of reliable methods to efficiently isolate and propagate stem cell populations is a significant obstacle to the advancement of cell-based therapies for human diseases. One isolation technique is based on efflux of the fluorophore Hoechst 33342. Using fluorescence-activated cell sorting (FACS), a sub-population containing adult stem cells has been identified in a multitude of tissues in every mammalian species examined. These rare cells are referred to as the 'side population' or SP due to a distinctive FACS profile that results from weak staining by Hoechst dye. Although the SP contains multi-potent cells capable of differentiating toward hematopoietic and mesenchymal lineages; there is currently no method to efficiently expand them. Here, we describe a spinner-flask culture system containing C2C12 myoblasts attached to spherical microcarriers that act to support the growth of non-adherent, post-natal murine skeletal muscle and bone marrow SP cells. Using FACS and hemocytometry, we show expansion of unfractionated EGFP(+) SP cells over 6 wks. A significant number of these cells retain characteristics of freshly-isolated, unfractionated SP cells with respect to protein expression and dye efflux capacity. Expansion of the SP will permit further study of these heterogeneous cells and determine their therapeutic potential for regenerative and reparative therapies.	[Pacak, Christina A.; Eddy, Mau-Thek; Woodhull, Lindsey; Wang, Kai-Roy; Alpatov, Ivan; Fullen, Shelby; Dowd, Rory P.; Choi, Yeong-Hoon; Cowan, Douglas B.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Pacak, Christina A.; Alpatov, Ivan; Choi, Yeong-Hoon; Cowan, Douglas B.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Cowan, DB (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA.	douglas.cowan@childrens.harvard.edu		Cowan, Douglas/0000-0002-6309-2737; Pacak, Christina/0000-0002-7430-124X	National Institutes of Health [HL088206]; American Heart Foundation [12GRNT11910008]; Children's Hospital Medical Corporation Anesthesia Foundation; Cardiac Conduction Fund; Ryan Family Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Foundation(American Heart Association); Children's Hospital Medical Corporation Anesthesia Foundation; Cardiac Conduction Fund; Ryan Family Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by a Research Grant from the National Institutes of Health (HL088206), a Grant-in-Aid from the American Heart Foundation (12GRNT11910008), the Children's Hospital Medical Corporation Anesthesia Foundation, and philanthropic donations to the Cardiac Conduction Fund, the Ryan Family Fund, and by David Pullman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Chan YM, 1998, BIOCHEM BIOPH RES CO, V248, P134, DOI 10.1006/bbrc.1998.8920; Doyle MJ, 2011, J CELL BIOL, V195, P147, DOI 10.1083/jcb.201103159; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Lapidos KA, 2004, J CLIN INVEST, V114, P1577, DOI 10.1172/JCI200423071; Liadaki K, 2005, EXP CELL RES, V303, P360, DOI 10.1016/j.yexcr.2004.10.011; Liadaki K, 2012, J HISTOCHEM CYTOCHEM, V60, P31, DOI 10.1369/0022155411428991; Luth ES, 2008, J CELL SCI, V121, P1426, DOI 10.1242/jcs.021675; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014; VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	20	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55187	10.1371/journal.pone.0055187	http://dx.doi.org/10.1371/journal.pone.0055187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383102	gold, Green Published, Green Submitted			2022-12-25	WOS:000315211500062
J	Udine, C; Brackman, G; Bazzini, S; Buroni, S; Van Acker, H; Pasca, MR; Riccardi, G; Coenye, T				Udine, Claudia; Brackman, Gilles; Bazzini, Silvia; Buroni, Silvia; Van Acker, Heleen; Pasca, Maria Rosalia; Riccardi, Giovanna; Coenye, Tom			Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; XANTHOMONAS-CAMPESTRIS; BIOFILM FORMATION; IN-VITRO; VIRULENCE; ACID; SUSCEPTIBILITY	Many putative virulence factors of Burkholderia cenocepacia are controlled by various quorum sensing (QS) circuits. These QS systems either use N-acyl homoserine lactones (AHL) or cis-2-dodecenoic acid ("Burkholderia diffusible signal factor'', BDSF) as signalling molecules. Previous work suggested that there is little cross-talk between both types of systems. We constructed mutants in B. cenocepacia strain J2315, in which genes encoding CepI (BCAM1870), CciI (BCAM0239a) and the BDSF synthase (BCAM0581) were inactivated, and also constructed double (Delta cepI Delta BCAM0581, Delta cciI Delta BCAM0581 and Delta cepI Delta cciI) mutants and a triple (Delta cepI Delta cciI Delta BCAM0581) mutant. Subsequently we investigated phenotypic properties (antibiotic susceptibility, biofilm formation, production of AHL and BDSF, protease activity and virulence in Caenorhabditis elegans) and measured gene expression in these mutants, and this in the presence and absence of added BDSF, AHL or both. The triple mutant was significantly more affected in biofilm formation, antimicrobial susceptibility, virulence in C. elegans, and protease production than either the single or double mutants. The Delta BCAM0581 mutant and the Delta cepI Delta BCAM0581 and Delta cciI Delta BCAM0581 double mutants produced significantly less AHL compared to the WT strain and the Delta cepI and Delta cciI single mutant, respectively. The expression of cepI and cciI in Delta BCAM0581, was approximately 3-fold and 7-fold (p < 0.05) lower than in the WT, respectively. The observed differences in AHL production, expression of cepI and cciI and QS-controlled phenotypes in the Delta BCAM0581 mutant could (at least partially) be restored by addition of BDSF. Our data suggest that, in B. cenocepacia J2315, AHL and BDSF-based QS systems co-regulate the same set of genes, regulate different sets of genes that are involved in the same phenotypes and/or that the BDSF system controls the AHL-based QS system. As the expression of the gene encoding the C6-HSL synthase CciI (and to a lesser extent the C8-HSL synthase CepI) is partially controlled by BDSF, it seems likely that the BDSF QS systems controls AHL production through this system.	[Udine, Claudia; Bazzini, Silvia; Buroni, Silvia; Pasca, Maria Rosalia; Riccardi, Giovanna] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Brackman, Gilles; Van Acker, Heleen; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium	University of Pavia; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	tom.coenye@ugent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Pasca, Maria Rosalia/J-8752-2016; Buroni, Silvia/AAX-5454-2020	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Pasca, Maria Rosalia/0000-0002-8906-4937; RICCARDI, Giovanna/0000-0003-3295-0070; Buroni, Silvia/0000-0002-6979-2275	Italian Cystic Fibrosis Research Foundation [FFC-2012]; FWO-Vlaanderen; Ghent University	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); FWO-Vlaanderen(FWO); Ghent University(Ghent University)	This research was supported by a grant from Italian Cystic Fibrosis Research Foundation (FFC-2012). GB, HVA and TC acknowledge the support received from FWO-Vlaanderen. TC also acknowledges the support of the Special Research Fund of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Bi HK, 2012, MOL MICROBIOL, V83, P840, DOI 10.1111/j.1365-2958.2012.07968.x; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Brackman G, 2009, RES MICROBIOL, V160, P144, DOI 10.1016/j.resmic.2008.12.003; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brackman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016084; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Deng YY, 2009, J BACTERIOL, V191, P7270, DOI 10.1128/JB.00681-09; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2005, CHRON RESP DIS, V2; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x; McKeon SA, 2011, J INFECT DIS, V203, P383, DOI 10.1093/infdis/jiq054; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2009, J BACTERIOL, V191, P5013, DOI 10.1128/JB.00473-09; Schmid N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049966; Sokol PA, 2007, FUTURE MICROBIOL, V2, P555, DOI 10.2217/17460913.2.5.555; Stiernagle Theresa, 2006, WormBook, P1; Tomlin KL, 2005, APPL ENVIRON MICROB, V71, P5208, DOI 10.1128/AEM.71.9.5208-5218.2005; Venturi V, 2004, RES MICROBIOL, V155, P238, DOI 10.1016/j.resmic.2004.01.006; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x	35	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55112	10.1371/journal.pone.0055112	http://dx.doi.org/10.1371/journal.pone.0055112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383071	gold, Green Published			2022-12-25	WOS:000315211500059
J	Touraine, S; Ea, HK; Bousson, V; Cohen-Solal, M; Laouisset, L; Chappard, C; Liote, F; Laredo, JD				Touraine, Sebastien; Ea, Hang Korng; Bousson, Valerie; Cohen-Solal, Martine; Laouisset, Liess; Chappard, Christine; Liote, Frederic; Laredo, Jean-Denis			Chondrocalcinosis of Femoro-Tibial and Proximal Tibio-Fibular Joints in Cadaveric Specimens: A High-Resolution CT Imaging Study of the Calcification Distribution	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; TIBIOFIBULAR JOINT; INORGANIC PYROPHOSPHATE; OSTEOARTHRITIS; KNEE; RADIOGRAPHY; PREVALENCE; DEPOSITION; CRYSTALS	Objectives: To analyze calcium deposits by computed tomography (CT) in femoro-tibial compartments and proximal tibio-fibular joints; to assess the relationship with CT-assessed osteoarthritis (OA). Methods: 68 (34 pairs) cadaveric knees (mean age of 84) were scanned at high resolution CT. Menisci and hyaline cartilage calcifications in the femoro-tibial and proximal tibio-fibular joints were analyzed. OA was CT-assessed by the Kellgren and Lawrence score. Gross appearance of OA was evaluated on 29 left knees after dissection and India ink staining of tibial plateaus. Results: In femoro-tibial joints, meniscal calcifications (MC) and hyaline cartilage calcifications (HCC) were detected in 23(34%) and 14(21%) knees respectively. Calcifications mainly involved the three meniscal segments and were mainly observed in all thirds of the femoro-tibial compartments. In proximal tibio-fibular joints, HCC were detected in 19(28%) knees. The association HCC-MC in femoro-tibial joints and between calcifications in femoro-tibial and proximal tibio-fibular joints was strong (p<0.0001). Femoro-tibial and proximal tibio-fibular CT-assessed OA were respectively found in 23(34%) and 19(28%) knees. HCC were significantly associated with femoro-tibial OA (p = 0.04) while MC were not (p = 0.34). OA macroscopic evaluation showed a mean surface of cartilage lesions of 35% (range 0.13-0.55). No significant difference was demonstrated regarding the CT-detection of MC, HCC or CT-assessed OA. Conclusions: This is the first study to report a strong association of chondrocalcinosis between femoro-tibial and tibio-fibular joints in addition to a strong association between MC and HCC in femoro-tibial compartments. No significant relationship between chondrocalcinosis and OA was demonstrated.	[Touraine, Sebastien; Bousson, Valerie; Laouisset, Liess; Chappard, Christine; Laredo, Jean-Denis] Univ Paris Diderot, CNRS UMR 7052, Lab B2OA, Hop Lariboisiere, Paris, France; [Ea, Hang Korng; Cohen-Solal, Martine; Liote, Frederic] Univ Paris Diderot, Inserm UMR 606, Hop Lariboisiere, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Touraine, S (corresponding author), Univ Paris Diderot, CNRS UMR 7052, Lab B2OA, Hop Lariboisiere, Paris, France.	sebastien.touraine@lrb.aphp.fr	Chappard, Christine/AAB-2613-2022; Liote, Frederic/AAD-6926-2020; Cohen-Solal, Martine/P-7808-2017; Ea, HK/P-5527-2016	Liote, Frederic/0000-0003-4419-0726; Cohen-Solal, Martine/0000-0002-8582-8258; Ea, HK/0000-0002-2393-7475				Abreu M, 2004, SKELETAL RADIOL, V33, P392, DOI 10.1007/s00256-004-0767-9; Bozkurt M, 2003, CLIN ORTHOP RELAT R, P136, DOI 10.1097/01.blo.0000030167.56585.2f; CHAN WP, 1991, AM J ROENTGENOL, V157, P799, DOI 10.2214/ajr.157.4.1892040; Cheung HS, 2006, ARTHRITIS RHEUM-US, V54, P2452, DOI 10.1002/art.22017; Dirim B, 2008, AM J ROENTGENOL, V191, pW44, DOI 10.2214/AJR.07.3406; Ea HK, 2011, P NATL ACAD SCI USA, V108, pE1361, DOI 10.1073/pnas.1114968108; Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761; Espregueira-Mendes JD, 2006, KNEE SURG SPORT TR A, V14, P241, DOI 10.1007/s00167-005-0684-z; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Fuerst M, 2010, RHEUMATOL INT, V30, P623, DOI 10.1007/s00296-009-1032-2; Fuerst M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-166; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Liu YZ, 2009, OSTEOARTHR CARTILAGE, V17, P1333, DOI 10.1016/j.joca.2009.04.022; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; McCarthy Geraldine M, 2009, Curr Rheumatol Rep, V11, P141; MITROVIC DR, 1983, ANN RHEUM DIS, V42, P19, DOI 10.1136/ard.42.Suppl_1.19; MITROVIC DR, 1988, J RHEUMATOL, V15, P633; Mitsuyama H, 2007, OSTEOARTHR CARTILAGE, V15, P559, DOI 10.1016/j.joca.2006.10.017; Neame RL, 2003, ANN RHEUM DIS, V62, P513, DOI 10.1136/ard.62.6.513; Nguyen C, 2009, REV RHUM, V76, P986; Nguyen C, 2011, J SYNCHROTRON RADIAT, V18, P475, DOI 10.1107/S0909049511006984; Nguyen C, 2010, ARTHRITIS RHEUM-US, V62, P2829, DOI 10.1002/art.27576; Ozcan O, 2009, KNEE, V16, P248, DOI 10.1016/j.knee.2008.12.013; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; RESNICK D, 1978, AM J ROENTGENOL, V131, P133, DOI 10.2214/ajr.131.1.133; Rosen F, 1997, ARTHRITIS RHEUM-US, V40, P1275, DOI 10.1002/art.12; ROSENTHAL AK, 1993, ARTHRITIS RHEUM, V36, P539, DOI 10.1002/art.1780360415; Rothschild B, 1996, J Clin Rheumatol, V2, P170, DOI 10.1097/00124743-199606000-00013; Rothschild Bruce, 1997, Comprehensive Therapy, V23, P327; Ru LB, 2005, JOINT BONE SPINE, V72, P295, DOI 10.1016/j.jbspin.2004.12.010; Suan JC, 2005, SKELETAL RADIOL, V34, P714, DOI 10.1007/s00256-005-0930-y; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Thouverey C, 2009, OSTEOARTHR CARTILAGE, V17, P64, DOI 10.1016/j.joca.2008.05.020; Zhang W, 2011, ANN RHEUM DIS, V70, P571, DOI 10.1136/ard.2010.139360; ZITNAN D, 1963, ANN RHEUM DIS, V22, P142, DOI 10.1136/ard.22.3.142	37	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54955	10.1371/journal.pone.0054955	http://dx.doi.org/10.1371/journal.pone.0054955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372802	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400046
J	Nishiura, H; Yen, HL; Cowling, BJ				Nishiura, Hiroshi; Yen, Hui-Ling; Cowling, Benjamin J.			Sample Size Considerations for One-to-One Animal Transmission Studies of the Influenza A Viruses	PLOS ONE			English	Article							PANDEMIC INFLUENZA; FERRETS; PATHOGENESIS; MODEL; TRIALS; COHORT; HA	Background: Animal transmission studies can provide important insights into host, viral and environmental factors affecting transmission of viruses including influenza A. The basic unit of analysis in typical animal transmission experiments is the presence or absence of transmission from an infectious animal to a susceptible animal. In studies comparing two groups (e.g. two host genetic variants, two virus strains, or two arrangements of animal cages), differences between groups are evaluated by comparing the proportion of pairs with successful transmission in each group. The present study aimed to discuss the significance and power to estimate transmissibility and identify differences in the transmissibility based on one-to- one trials. The analyses are illustrated on transmission studies of influenza A viruses in the ferret model. Methodology/Principal Findings: Employing the stochastic general epidemic model, the basic reproduction number, R-0, is derived from the final state of an epidemic and is related to the probability of successful transmission during each one-to-one trial. In studies to estimate transmissibility, we show that 3 pairs of infectious/susceptible animals cannot demonstrate a significantly higher transmissibility than R-0 = 1, even if infection occurs in all three pairs. In comparisons between two groups, at least 4 pairs of infectious/susceptible animals are required in each group to ensure high power to identify significant differences in transmissibility between the groups. Conclusions: These results inform the appropriate sample sizes for animal transmission experiments, while relating the observed proportion of infected pairs to R-0, an interpretable epidemiological measure of transmissibility. In addition to the hypothesis testing results, the wide confidence intervals of R-0 with small sample sizes also imply that the objective demonstration of difference or similarity should rest on firmly calculated sample size.	[Nishiura, Hiroshi; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yen, Hui-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Japan Science & Technology Agency (JST); University of Hong Kong	Nishiura, H (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	nishiura@hku.hk	Yen, Hui-Ling/C-4501-2009; Cowling, Benjamin John/C-4263-2009; Yen, Hui-Ling/GNH-5083-2022	Yen, Hui-Ling/0000-0003-2493-3609; Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537	Japan Science and Technology Agency (JST) PRESTO program; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Japan Science and Technology Agency (JST) PRESTO program(Japan Science & Technology Agency (JST)); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HN received funding support from the Japan Science and Technology Agency (JST) PRESTO program. This work also received financial support from the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (Grant no. U54 GM088558) and the Area of Excellence Scheme of the Hong Kong University Grants Committee (Grant no. AoE/M-12/06). The funding bodies were not involved in the collection, analysis, and interpretation of data, the writing of the paper or the decision to submit for publication.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; BARTLETT MS, 1949, J R STAT SOC B, V11, P211; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; BILLARD L, 1993, IMA J MATH APPL MED, V10, P67; De Jong MC, 1994, VACCINE, V128, P761; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Kiso M, 2010, PLOS PATHOG, V26, P6, DOI DOI 10.1371/JOURNAL.PPAT.1001079; Klick B, 2011, EPIDEMIOLOGY, V22, P793, DOI 10.1097/EDE.0b013e3182302e8e; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Krishnamoorthy K, 2007, COMMUN STAT-SIMUL C, V36, P1171, DOI 10.1080/03610910701569218; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nishiura Hiroshi, 2012, Osong Public Health Res Perspect, V3, P121, DOI 10.1016/j.phrp.2012.07.010; Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039; Nishiura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017908; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Roberts KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043303; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; THOMAS RG, 1992, CONTROL CLIN TRIALS, V13, P134, DOI 10.1016/0197-2456(92)90019-V; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Velthuis AGJ, 2007, EPIDEMIOL INFECT, V135, P202, DOI 10.1017/S095026880600673X; Velthuis AGJ, 2002, EPIDEMIOL INFECT, V128, P193, DOI 10.1017/S0950268801006707	33	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55358	10.1371/journal.pone.0055358	http://dx.doi.org/10.1371/journal.pone.0055358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383167	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600092
J	Stander, BA; Joubert, F; Tu, CK; Sippel, KH; McKenna, R; Joubert, AM				Stander, Barend Andre; Joubert, Fourie; Tu, Chingkuang; Sippel, Katherine H.; McKenna, Robert; Joubert, Annie Margaretha			Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; ENDOPLASMIC-RETICULUM STRESS; CARBONIC-ANHYDRASE; OXIDATIVE STRESS; IN-VITRO; HYDROGEN-PEROXIDE; HEME OXYGENASE; PROTEIN; 2-METHOXYESTRADIOL; GROWTH	The aim of this study was to characterize the in vitro action of 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10) 16-tetraene (ESE-16) on non-tumorigenic MCF-12A, tumorigenic MCF-7 and metastatic MDA-MB-231 breast cancer cells. ESE-16 is able to inhibit the activity of a carbonic anhydrase II and a mimic of carbonic anhydrase IX in the nanomolar range. Gene and protein expression studies using various techniques including gene and antibody microarrays and various flow cytometry assays yielded valuable information about the mechanism of action of ESE-16. The JNK pathway was identified as an important pathway mediating the effects of ESE-16 while the p38 stress-induced pathway is more important in MDA-MB-231 cells exposed to ESE-16. Lysosomal rupture and iron metabolism was identified as important mediators of mitochondrial membrane depolarization. Abrogation of Bcl-2 phosphorylation status as a result of ESE-16 also plays a role in inducing mitochondrial membrane depolarization. The study provides a basis for future research projects to develop the newly synthesized compound into a clinically usable anticancer agent either alone or in combination with other agents. Keywords: Antimitotic, anticarbonic anhydrase IX, apoptosis, autophagy, cell cycle arrest, Bcl-2, JNK, p38, mitochondrial membrane depolarization, flow cytometry, gene expression and protein microarray, anticancer.	[Stander, Barend Andre] Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa; [Joubert, Fourie; Joubert, Annie Margaretha] Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, Gauteng, South Africa; [Tu, Chingkuang] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Sippel, Katherine H.] Baylor Coll Med, Houston, TX 77030 USA; [McKenna, Robert] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Pretoria; University of Pretoria; State University System of Florida; University of Florida; Baylor College of Medicine; State University System of Florida; University of Florida	Stander, BA (corresponding author), Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa.	standerandre@gmail.com	Joubert, Annie/AAU-4562-2021	Joubert, Annie/0000-0002-6931-7554; Joubert, Fourie/0000-0003-4998-7531	Medical Research Council of South Africa [AG374, AK076]; Cancer Association of South Africa [AK246]; National Research Foundation (NRF) [AL239]; Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa [AJ038, AN074]	Medical Research Council of South Africa(South African Medical Research Council); Cancer Association of South Africa; National Research Foundation (NRF); Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa	This research was supported by grants from the Medical Research Council of South Africa (AG374, AK076), the Cancer Association of South Africa (AK246), National Research Foundation (NRF) (AL239), the Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria and the Struwig-Germeshuysen Cancer Research Trust of South Africa (AJ038, AN074). Flow cytometric analyses were performed at the Department of Pharmacology at the Faculty of Health Sciences (University of Pretoria, Pretoria, South Africa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston GE, 2009, BIOORG MED CHEM LETT, V19, P6241, DOI 10.1016/j.bmcl.2009.08.020; Attalla H, 1996, BIOCHEM BIOPH RES CO, V228, P467, DOI 10.1006/bbrc.1996.1683; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Bresgen N, 2010, FREE RADICAL BIO MED, V48, P1347, DOI 10.1016/j.freeradbiomed.2010.02.019; Bughani Usha, 2009, Recent Pat Antiinfect Drug Discov, V4, P164; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Genis C, 2009, BIOCHEMISTRY-US, V48, P1322, DOI 10.1021/bi802035f; Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034; Guthrie H. David, 2008, V477, P89, DOI 10.1007/978-1-60327-517-0_8; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Hasan MR, 2006, EXP CELL RES, V312, P1950, DOI 10.1016/j.yexcr.2006.02.023; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kurokawa H, 1999, ONCOL REP, V6, P33; Kutuk O, 2008, CURR MOL MED, V8, P102; LaVallee TM, 2008, MOL CANCER THER, V7, P1472, DOI 10.1158/1535-7163.MCT-08-0107; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Moser C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-206; Newman SP, 2006, CANCER RES, V66, P324, DOI 10.1158/0008-5472.CAN-05-2391; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pasquier E, 2010, MOL CANCER THER, V9, P1408, DOI 10.1158/1535-7163.MCT-09-0894; Pastorekova S, 2008, BJU INT, V101, P8, DOI 10.1111/j.1464-410X.2008.07642.x; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Ryter SW, 2000, AM J PHYSIOL-HEART C, V279, pH2889, DOI 10.1152/ajpheart.2000.279.6.H2889; Sadowski-Debbing K, 2002, ARCH IMMUNOL THER EX, V50, P19; Segel IH, 1975, ENZYME KINETICS BEHA; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sippel KH, 2011, LETT DRUG DES DISCOV, V8, P678; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Snoeks TJA, 2011, MOL CANCER THER, V10, P874, DOI 10.1158/1535-7163.MCT-10-0997; Stander A, 2011, CHEM BIOL DRUG DES, V77, P173, DOI 10.1111/j.1747-0285.2010.01064.x; Stander BA, 2010, J STEROID BIOCHEM, V119, P149, DOI 10.1016/j.jsbmb.2010.02.019; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Van Zijl C, 2008, CELL BIOCHEM FUNCT, V26, P632, DOI 10.1002/cbf.1489; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yan S, 2012, J CANCER RES CLIN, P1; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zhou Q, 2011, INVEST NEW DRUG, V29, P340, DOI 10.1007/s10637-009-9383-9; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0; Zoubine MN, 1999, INT J ONCOL, V15, P639	66	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53853	10.1371/journal.pone.0053853	http://dx.doi.org/10.1371/journal.pone.0053853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382857	Green Published, gold			2022-12-25	WOS:000314610600021
J	Yu, CC; Tsai, CH; Hsu, HI; Chang, YC				Yu, Cheng-Chia; Tsai, Chung-Hung; Hsu, Hsin-I; Chang, Yu-Chao			Elevation of S100A4 Expression in Buccal Mucosal Fibroblasts by Arecoline: Involvement in the Pathogenesis of Oral Submucous Fibrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-I; NF-KAPPA-B; UP-REGULATION; CANCER; INHIBITOR; PROTEIN; VITRO; GENE	Background: S100A4, a member of the calcium-binding proteins, is dramatically elevated in a variety of fibrotic diseases. Areca quid chewing is the most important etiological factor in the pathogenesis of oral submucous fibrosis (OSF). OSF has been considered as a pre-cancerous condition of oral mucosa. The aim of this study was to determine the critical role of S100A4 expression in the pathogenesis of OSF both in vitro and in vivo. Methodology/Principal Finding: Thirty OSF tissues from areca quid chewers and ten normal buccal mucosa samples without areca quid chewing were analyzed by using immunohistochemistry for S100A4 expression in vivo. Collagen gel contraction capability and expression of tissue inhibitor of metalloproteinases 1 (TIMP1)/MMP9 in arecoline-stimulated BMFs with S100A4 knockdown was presented in vitro. Initially, S100A4 expression was higher in areca quid chewing-associated OSF specimens than normal buccal mucosa specimens (p = 0.001). Arecoline, a major areca nut alkaloid, led to dose- and time-dependent elevation of S100A4 expression in normal buccal mucosa fibroblasts BMFs (p<0.05). The additions of pharmacological agents rapamycin (mTOR inhibitor), PD98059 (ERK inhibitor), and Bay117082 (NF-kappa B inhibitor) were found to inhibit arecoline-induced S100A4 expression (p<0.05) in BMFs. Down-regulation of S100A4 by lentiviral infection significantly reversed arecoline-induced collagen gel contraction and TIMP1/MMP9 expression. Conclusion/Significance: These results suggest that S100A4 expression is significantly up-regulated in OSF specimens. Arecoline-induced S100A4 expression was down-regulated by rapamycin, PD98059, and Bay117082. Targeting S100A4 might be a potential therapeutic target for OSF through TIMP1/MMP9 down-regulation.	[Yu, Cheng-Chia; Hsu, Hsin-I] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Tsai, Chung-Hung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Tsai, Chung-Hung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Chang, YC (corresponding author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.	cyc@csmu.edu.tw			Taiwan National Science Council Research Grant [NSC100-2314-B-040-008, NSC100-2632-B-040-001-MY3]	Taiwan National Science Council Research Grant	This work was supported by research grants from a Taiwan National Science Council Research Grant (NSC100-2314-B-040-008, NSC100-2632-B-040-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YC, 2002, ORAL ONCOL, V38, P195, DOI 10.1016/S1368-8375(01)00045-8; Chang YC, 2002, ORAL ONCOL, V38, P425, DOI 10.1016/S1368-8375(01)00083-5; Chiu CJ, 2001, J DENT RES, V80, P2055, DOI 10.1177/00220345010800120601; Chole RH, 2012, ORAL ONCOL, V48, P393, DOI 10.1016/j.oraloncology.2011.11.021; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; Greenway S, 2004, AM J PATHOL, V164, P253, DOI 10.1016/S0002-9440(10)63115-X; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Kuo MYP, 1995, J DENT RES, V74, P1783, DOI 10.1177/00220345950740111101; Lin SC, 2005, INT J CANCER, V116, P526, DOI 10.1002/ijc.21104; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; More CB, 2012, ORAL ONCOL, V48, P200, DOI 10.1016/j.oraloncology.2011.10.011; Moutasim KA, 2011, J PATHOL, V223, P366, DOI 10.1002/path.2786; Ni WF, 2007, ORAL ONCOL, V43, P557, DOI 10.1016/j.oraloncology.2006.06.007; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai CH, 2005, ORAL ONCOL, V41, P940, DOI 10.1016/j.oraloncology.2005.05.006; Tsai CH, 2005, J ORAL PATHOL MED, V34, P100, DOI 10.1111/j.1600-0714.2004.00288.x; Tsai CH, 2004, ORAL DIS, V10, P360, DOI 10.1111/j.1601-0825.2004.01041.x; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Tsai CH, 2007, ORAL ONCOL, V43, P680, DOI 10.1016/j.oraloncology.2006.08.009; Tulchinsky E, 1997, J BIOL CHEM, V272, P4828, DOI 10.1074/jbc.272.8.4828; Yang SF, 2003, ORAL ONCOL, V39, P367, DOI 10.1016/S1368-8375(02)00123-9; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	28	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55122	10.1371/journal.pone.0055122	http://dx.doi.org/10.1371/journal.pone.0055122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383075	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600066
J	Ali, SS; Nugent, B; Mullins, E; Doohan, FM				Ali, Shahin S.; Nugent, Brian; Mullins, Ewen; Doohan, Fiona M.			Insights from the Fungus Fusarium oxysporum Point to High Affinity Glucose Transporters as Targets for Enhancing Ethanol Production from Lignocellulose	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HXT GENES; HEXOSE TRANSPORTERS; BIOETHANOL PRODUCTION; CHEMOSTAT CULTURES; DIRECT CONVERSION; RICE STRAW; FERMENTATION; WHEAT; EXPRESSION	Ethanol is the most-widely used biofuel in the world today. Lignocellulosic plant biomass derived from agricultural residue can be converted to ethanol via microbial bioprocessing. Fungi such as Fusarium oxysporum can simultaneously saccharify straw to sugars and ferment sugars to ethanol. But there are many bottlenecks that need to be overcome to increase the efficacy of microbial production of ethanol from straw, not least enhancement of the rate of fermentation of both hexose and pentose sugars. This research tested the hypothesis that the rate of sugar uptake by F. oxysporum would enhance the ethanol yields from lignocellulosic straw and that high affinity glucose transporters can enhance ethanol yields from this substrate. We characterized a novel hexose transporter (Hxt) from this fungus. The F. oxysporum Hxt represents a novel transporter with homology to yeast glucose signaling/transporter proteins Rgt2 and Snf3, but it lacks their C-terminal domain which is necessary for glucose signalling. Its expression level decreased with increasing glucose concentration in the medium and in a glucose uptake study the Km(glucose) was 0.9 mM, which indicated that the protein is a high affinity glucose transporter. Post-translational gene silencing or over expression of the Hxt in F. oxysporum directly affected the glucose and xylose transport capacity and ethanol yielded by F. oxysporum from straw, glucose and xylose. Thus we conclude that this Hxt has the capacity to transport both C5 and C6 sugars and to enhance ethanol yields from lignocellulosic material. This study has confirmed that high affinity glucose transporters are ideal candidates for improving ethanol yields from lignocellulose because their activity and level of expression is high in low glucose concentrations, which is very common during the process of consolidated processing.	[Ali, Shahin S.; Nugent, Brian; Doohan, Fiona M.] Univ Coll Dublin, Sch Biol & Environm Sci, Mol Plant Microbe Interact Lab, Dublin 2, Ireland; [Mullins, Ewen] Teagasc Crop Res Ctr, Dept Crop Sci, Carlow, Ireland	University College Dublin; Teagasc	Ali, SS (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Mol Plant Microbe Interact Lab, Dublin 2, Ireland.	shahin.ali@ucd.ie	Ali, Shahin S./H-8474-2019; Mullins, Ewen/AAN-2907-2021	Mullins, Ewen/0000-0003-3005-4264; Doohan, Fiona/0000-0002-1953-6070	Irish Department of Agriculture, Fisheries & Food Research Stimulus Fund [RSF 07 513]	Irish Department of Agriculture, Fisheries & Food Research Stimulus Fund	This work was supported by the Irish Department of Agriculture, Fisheries & Food Research Stimulus Fund (RSF 07 513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-16; Ali SS, 2012, IDENTIFICATION UNPUB; Ansari KI, 2007, THEOR APPL GENET, V114, P927, DOI 10.1007/s00122-006-0490-0; BRANDAO RL, 1990, APPL ENVIRON MICROB, V56, P2417; Brennan JM, 2005, PLANT PATHOL, V54, P156, DOI 10.1111/j.1365-3059.2005.01157.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHRISTAKOPOULOS P, 1991, BIORESOURCE TECHNOL, V35, P297, DOI 10.1016/0960-8524(91)90128-7; CHRISTAKOPOULOS P, 1991, ENZYME MICROB TECH, V13, P272, DOI 10.1016/0141-0229(91)90141-V; Delgado-Jarana J, 2003, EUKARYOT CELL, V2, P708, DOI 10.1128/EC.2.4.708-717.2003; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESHPANDE V, 1986, ENZYME MICROB TECH, V8, P149, DOI 10.1016/0141-0229(86)90103-1; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; DOMBEK KM, 1987, APPL ENVIRON MICROB, V53, P1286, DOI 10.1128/AEM.53.6.1286-1291.1987; Doohan FM, 1998, PHYSIOL MOL PLANT P, V53, P253, DOI 10.1006/pmpp.1998.0178; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; Goshadrou A, 2011, IND CROP PROD, V34, P1219, DOI 10.1016/j.indcrop.2011.04.018; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hector RE, 2008, APPL MICROBIOL BIOT, V80, P675, DOI 10.1007/s00253-008-1583-2; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1; Jorgensen TR, 2007, MICROBIOL-SGM, V153, P1963, DOI 10.1099/mic.0.2006/005090-0; Karimi K, 2006, ENZYME MICROB TECH, V40, P138, DOI 10.1016/j.enzmictec.2005.10.046; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; KO CH, 1993, MOL CELL BIOL, V13, P638, DOI 10.1128/MCB.13.1.638; Kourtoglou E, 2009, NEW BIOTECHNOL, V25, pS263, DOI 10.1016/j.nbt.2009.06.588; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEAO C, 1982, BIOTECHNOL BIOENG, V24, P2601, DOI 10.1002/bit.260241124; LEAO C, 1985, APPL MICROBIOL BIOT, V22, P359, DOI 10.1007/BF00582420; Leung H, 1995, FUNGAL GENET NEWSL, V42, P41, DOI DOI 10.4148/1941-4765.1341; Luyten K, 2002, YEAST, V19, P713, DOI 10.1002/yea.869; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Madi L, 1997, GENETICS, V146, P499; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; MISHRA C, 1984, APPL ENVIRON MICROB, V48, P224, DOI 10.1128/AEM.48.1.224-228.1984; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P1671, DOI 10.1271/bbb.90099; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Okamoto K, 2011, ENZYME MICROB TECH, V48, P273, DOI 10.1016/j.enzmictec.2010.12.001; Ozcan S, 1996, MOL CELL BIOL, V16, P5536; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Pall ML, 1993, FUNGAL GENET NEWSL, V40, P59, DOI DOI 10.4148/1941-4765.1413; RAO M, 1983, ENZYME MICROB TECH, V5, P133, DOI 10.1016/0141-0229(83)90048-0; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; RIDE JP, 1972, PHYSIOL PLANT PATHOL, V2, P7, DOI 10.1016/0048-4059(72)90043-4; SALMON JM, 1993, AM J ENOL VITICULT, V44, P56; Saloheimo A, 2007, APPL MICROBIOL BIOT, V74, P1041, DOI 10.1007/s00253-006-0747-1; Schertler G. F. X., 1992, CURR OPIN STRUC BIOL, V2, P534, DOI DOI 10.1016/0959-440X(92)90083-J; Scotti CT, 2001, BIOCHEM ENG J, V7, P1, DOI 10.1016/S1369-703X(00)00090-5; SINGH A, 1991, CRIT REV BIOTECHNOL, V11, P129, DOI 10.3109/07388559109040619; SNEATH P H, 1973, P573; Snedecor GW, 1980, STAT METHODS, V7th; THEODORIS G, 1994, GENETICS, V137, P957; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Walter S, 2008, FUNCT INTEGR GENOMIC, V8, P421, DOI 10.1007/s10142-008-0089-4; WENDELL DL, 1993, J BACTERIOL, V175, P7689, DOI 10.1128/JB.175.23.7689-7696.1993; WENDELL DL, 1994, J BACTERIOL, V176, P3730, DOI 10.1128/JB.176.12.3730-3737.1994; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006	64	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54701	10.1371/journal.pone.0054701	http://dx.doi.org/10.1371/journal.pone.0054701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382943	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800065
J	Brown, A; Lee, M				Brown, Amy; Lee, Michelle			Breastfeeding Is Associated with a Maternal Feeding Style Low in Control from Birth	PLOS ONE			English	Article							CHILDHOOD OBESITY; FED INFANTS; 1ST YEAR; CHILDREN; BOTTLE; OVERWEIGHT; DECISIONS	Background: The influence of maternal child-feeding style upon child weight and eating style for children over the age of twelve months is well established. However there is little empirical evidence examining maternal child-feeding style during milk feeding despite evidence that mothers who breastfeed exert lower levels of control over later diet. The aim of this paper was to examine variation in maternal child-feeding style during the first six months postpartum and to explore associations with mode of milk feeding and infant weight. Methods: The Child Feeding Questionnaire (CFQ) is frequently used to measure maternal child-feeding style in preschool children. 390 mothers with an infant aged 0-6 months completed an adapted version of the CFQ to measure maternal child-feeding style during milk feeding. Participants reported breastfeeding duration, infant weight and perceived size. Results: Principle components analysis of questionnaire items produced six factors; encouraging feeding, feeding to a routine, limiting intake, concern for weight, monitoring and perceived responsibility. Breastfeeding was associated with lower levels of control compared to formula feeding. Infant birth weight was significantly inversely associated with concern for weight, monitoring and encouraging feeding. Discussion: Formula feeding is associated with greater maternal control of child-feeding from birth whilst a lower birth weight is linked to concerns for infant weight and pressure to eat. As early maternal child-feeding relationships may impact negatively upon longer term child weight and eating style, identifying variations in maternal feeding style and understanding the factors that influence this is pertinent.	[Brown, Amy] Swansea Univ, Coll Human & Hlth Sci, Dept Publ Hlth & Policy Studies, Swansea, W Glam, Wales; [Lee, Michelle] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Swansea, W Glam, Wales	Swansea University; Swansea University	Brown, A (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Publ Hlth & Policy Studies, Swansea, W Glam, Wales.	a.e.brown@swansea.ac.uk	Brown, Amy/AAT-2339-2020	Brown, Amy/0000-0002-0438-0157	Economic and Social Research Council, UK	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Amy Brown was supported by a Postdoctoral fellowship from the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR LS, 1984, J AM DIET ASSOC, V84, P543; Anzman SL, 2009, J PEDIATR-US, V155, P651, DOI 10.1016/j.jpeds.2009.04.052; Arden MA, 2010, MATERN CHILD NUTR, V6, P159, DOI 10.1111/j.1740-8709.2009.00194.x; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Bartok CJ, 2009, INT J PEDIATR OBES, V4, P196, DOI 10.3109/17477160902763309; Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Blissett J, 2007, INT J OBESITY, V31, P1520, DOI 10.1038/sj.ijo.0803661; Bonuck KA, 2002, CLIN PEDIATR, V41, P603, DOI 10.1177/000992280204100808; Brown A, 2012, PEDIATR OBES, V7, P382, DOI 10.1111/j.2047-6310.2012.00071.x; Brown A, 2011, J HUM NUTR DIET, V24, P177, DOI 10.1111/j.1365-277X.2010.01145.x; Brown A, 2011, J ADV NURS, V67, P1993, DOI 10.1111/j.1365-2648.2011.05647.x; Daly S E, 1995, J Hum Lact, V11, P21, DOI 10.1177/089033449501100119; Dollberg S, 2001, J AM COLL NUTR, V20, P209, DOI 10.1080/07315724.2001.10719033; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Faith MS, 2005, MATERN CHILD NUTR, V1, P164, DOI 10.1111/j.1740-8709.2005.00024.x; Farrow C, 2006, APPETITE, V46, P49, DOI 10.1016/j.appet.2005.10.005; Farrow C, 2006, PEDIATRICS, V118, pE293, DOI 10.1542/peds.2005-2919; Farrow CV, 2008, PEDIATRICS, V121, pE164, DOI 10.1542/peds.2006-3437; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Grovslien AH, 2009, J HUM LACT, V25, P206, DOI 10.1177/0890334409333425; Hardyment C, 2007, DREAM BABIES; Health and Social Care Information Centre, 2012, INF FEED SURV 2010; HEINIG MJ, 1993, AM J CLIN NUTR, V58, P152, DOI 10.1093/ajcn/58.2.152; Kroller K, 2008, APPETITE, V51, P166, DOI 10.1016/j.appet.2008.01.012; Li RW, 2010, PEDIATRICS, V125, pE1386, DOI 10.1542/peds.2009-2549; Snethen JA, 2007, JOGNN-J OBST GYN NEO, V36, P501, DOI [10.1111/J.1552-6909.2007.00181.x, 10.1111/j.1552-6909.2007.00181.x]; Tabachnick B. G., 2006, USING MULTIVARIATE S; Taveras EM, 2004, PEDIATRICS, V114, pE577, DOI 10.1542/peds.2004-0801; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; TYSON J, 1992, PEDIATRICS, V89, P215; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Welsh Assembly Government, 2008, WELSH IND MULT DEPR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; WRIGHT P, 1980, BEHAV PROCESS, V5, P1, DOI 10.1016/0376-6357(80)90045-5	37	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54229	10.1371/journal.pone.0054229	http://dx.doi.org/10.1371/journal.pone.0054229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382881	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800038
J	Pradel, N; Ji, BY; Gimenez, G; Talla, E; Lenoble, P; Garel, M; Tamburini, C; Fourquet, P; Lebrun, R; Bertin, P; Denis, Y; Pophillat, M; Barbe, V; Ollivier, B; Dolla, A				Pradel, Nathalie; Ji, Boyang; Gimenez, Gregory; Talla, Emmanuel; Lenoble, Patricia; Garel, Marc; Tamburini, Christian; Fourquet, Patrick; Lebrun, Regine; Bertin, Philippe; Denis, Yann; Pophillat, Matthieu; Barbe, Valerie; Ollivier, Bernard; Dolla, Alain			The First Genomic and Proteomic Characterization of a Deep-Sea Sulfate Reducer: Insights into the Piezophilic Lifestyle of Desulfovibrio piezophilus	PLOS ONE			English	Article							SP-NOV.; HYDROTHERMAL VENT; ESCHERICHIA-COLI; LOW-TEMPERATURE; HIGH-PRESSURE; BACTERIUM; SEQUENCE; ADAPTATION; PROTEIN; GROWTH	Desulfovibrio piezophilus strain C1TLV30(T) is a piezophilic anaerobe that was isolated from wood falls in the Mediterranean deep-sea. D. piezophilus represents a unique model for studying the adaptation of sulfate-reducing bacteria to hydrostatic pressure. Here, we report the 3.6 Mbp genome sequence of this piezophilic bacterium. An analysis of the genome revealed the presence of seven genomic islands as well as gene clusters that are most likely linked to life at a high hydrostatic pressure. Comparative genomics and differential proteomics identified the transport of solutes and amino acids as well as amino acid metabolism as major cellular processes for the adaptation of this bacterium to hydrostatic pressure. In addition, the proteome profiles showed that the abundance of key enzymes that are involved in sulfate reduction was dependent on hydrostatic pressure. A comparative analysis of orthologs from the non-piezophilic marine bacterium D. salexigens and D. piezophilus identified aspartic acid, glutamic acid, lysine, asparagine, serine and tyrosine as the amino acids preferentially replaced by arginine, histidine, alanine and threonine in the piezophilic strain. This work reveals the adaptation strategies developed by a sulfate reducer to a deep-sea lifestyle.	[Pradel, Nathalie; Garel, Marc; Tamburini, Christian; Ollivier, Bernard] Aix Marseille Univ, Univ Sud Toulon Var, CNRS INSU, IRD,MIO,UM110, Marseille, France; [Ji, Boyang; Talla, Emmanuel; Dolla, Alain] Aix Marseille Univ, CNRS, LCB, UMR 7283, Marseille, France; [Gimenez, Gregory] Fac Med Marseille, UMR 6236, F-13385 Marseille, France; [Lenoble, Patricia; Barbe, Valerie] Inst Genom Genoscope, CEA, Lab Finit, Evry, France; [Fourquet, Patrick; Pophillat, Matthieu] CIML, Marseille, France; [Lebrun, Regine; Denis, Yann] IBiSA Marseille Prote IMM CNRS, Plate Formes Prote & Transcriptom FR3479, Marseille, France; [Bertin, Philippe] Univ Louis Pasteur, CNRS, UMR 7156, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pradel, N (corresponding author), Aix Marseille Univ, Univ Sud Toulon Var, CNRS INSU, IRD,MIO,UM110, Marseille, France.	nathalie.pradel@ird.fr; dolla@imm.cnrs.fr	Tamburini, Christian/I-7821-2012; Ollivier, Bernard/I-6150-2016; Tamburini, Christian/AAO-8577-2020	Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Philippe, Bertin/0000-0003-1158-6396; Garel, Marc/0000-0002-4374-5905; Ji, Boyang/0000-0002-7269-4342; TALLA, Emmanuel/0000-0002-7775-8296	Institut de Recherche pour le Developpement; National Centre for Scientific Research	Institut de Recherche pour le Developpement; National Centre for Scientific Research	The work was supported by Institut de Recherche pour le Developpement and National Centre for Scientific Research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2007, BIOSCI BIOTECH BIOCH, V71, P2347, DOI 10.1271/bbb.70015; Alain K, 2010, INT J SYST EVOL MICR, V60, P33, DOI 10.1099/ijs.0.009449-0; Alazard D, 2003, INT J SYST EVOL MICR, V53, P173, DOI 10.1099/ijs.0.02323-0; Audiffrin C, 2003, INT J SYST EVOL MICR, V53, P1585, DOI 10.1099/ijs.0.02551-0; Bakermans C, 2009, EXTREMOPHILES, V13, P21, DOI 10.1007/s00792-008-0193-3; Bale SJ, 1997, INT J SYST BACTERIOL, V47, P515, DOI 10.1099/00207713-47-2-515; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Basak S, 2004, J BIOMOL STRUCT DYN, V22, P205, DOI 10.1080/07391102.2004.10506996; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Chikuma S, 2007, FEMS MICROBIOL LETT, V267, P108, DOI 10.1111/j.1574-6968.2006.00555.x; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Di Giulio M, 2005, GENE, V346, P7, DOI 10.1016/j.gene.2004.07.045; Di Giulio M, 2005, GENE, V346, P1, DOI 10.1016/j.gene.2004.10.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Hajj ZW, 2010, ANN NY ACAD SCI, V1189, P143, DOI 10.1111/j.1749-6632.2009.05178.x; El-Hajj ZW, 2009, J BACTERIOL, V191, P6383, DOI 10.1128/JB.00576-09; ELSGAARD L, 1995, OCEANOL ACTA, V18, P95; Fagervold SK, 2012, FEMS MICROB IN PRESS; Fauque G., 2004, MICROBIAL DIVERSITY, P169, DOI [10.1128/9781555817770.ch17, DOI 10.1128/9781555817770.CH17]; Fernandes PMB, 2004, FEBS LETT, V556, P153, DOI 10.1016/S0014-5793(03)01396-6; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hu YF, 2010, MAR BIOTECHNOL, V12, P719, DOI 10.1007/s10126-010-9259-1; Jeanthon C, 2002, INT J SYST EVOL MICR, V52, P765, DOI 10.1099/00207713-52-3-765; Jomaa A, 2009, J BACTERIOL, V191, P1924, DOI 10.1128/JB.01187-08; JORGENSEN BB, 1982, PHILOS T R SOC B, V298, P543, DOI 10.1098/rstb.1982.0096; Jun X, 2011, J BACTERIOL, V193, P4297, DOI 10.1128/JB.05345-11; Kallmeyer J, 2004, APPL ENVIRON MICROB, V70, P1231, DOI 10.1128/AEM.70.2.1231-1233.2004; Kaneko R, 2007, MAR BIOTECHNOL, V9, P429, DOI 10.1007/s10126-007-9003-7; Keller KL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00135; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Martin DD, 2002, EXTREMOPHILES, V6, P507, DOI 10.1007/s00792-002-0288-1; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004192; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Oger PM, 2010, RES MICROBIOL, V161, P799, DOI 10.1016/j.resmic.2010.09.017; Rhodes ME, 2010, ENVIRON MICROBIOL, V12, P2613, DOI 10.1111/j.1462-2920.2010.02232.x; Simonato F, 2006, J BIOTECHNOL, V126, P11, DOI 10.1016/j.jbiotec.2006.03.038; Skorko-Glonek J, 2008, MICROBIOL-SGM, V154, P3649, DOI 10.1099/mic.0.2008/020487-0; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Vossmeyer A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00253; Wilquet V, 1999, RES MICROBIOL, V150, P21, DOI 10.1016/S0923-2508(99)80043-6; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021	47	20	20	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55130	10.1371/journal.pone.0055130	http://dx.doi.org/10.1371/journal.pone.0055130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383081	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800116
J	Choudhry, Z; Sengupta, SM; Grizenko, N; Harvey, WJ; Fortier, ME; Schmitz, N; Joober, R				Choudhry, Zia; Sengupta, Sarojini M.; Grizenko, Natalie; Harvey, William J.; Fortier, Marie-Eve; Schmitz, Norbert; Joober, Ridha			Body Weight and ADHD: Examining the Role of Self-Regulation	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SOCIOECONOMIC-STATUS; MASS INDEX; CHILDHOOD OBESITY; BULIMIA-NERVOSA; ANTHROPOMETRIC CHANGES; EATING-DISORDERS; BRAIN DOPAMINE; CHILDREN	Objective: Attention-Deficit/Hyperactivity Disorder (ADHD) is a complex and heterogeneous childhood disorder that often coexists with other psychiatric and somatic disorders. Recently, a link between ADHD and body weight dysregulation has been reported and often interpreted as impaired self-regulation that is shared between the two conditions. The objective of this study is to investigate the relation between body weight/BMI and cognitive, emotional and motor characteristics in children with ADHD. Methods: 284 ADHD children were stratified by weight status/BMI according to WHO classification and compared with regard to their neurocognitive characteristics, motivational style, and motor profile as assessed by a comprehensive battery of tests. All comparisons were adjusted for demographic characteristics of relevance including, socioeconomic status (SES). Results: Both Obese and overweight ADHD children exhibited significantly lower SES compared to normal weight ADHD children. No significant differences were observed between the three groups with regards to their neurocognitive, emotional and motor profile. Conclusions: Our findings provide evidence that differences in weight/BMI are not accounted for by cognitive, motivational and motor profiles. Socio-economic characteristics are strongly associated with overweight and obesity in ADHD children and may inform strategies aimed at promoting healthier weight.	[Choudhry, Zia; Fortier, Marie-Eve; Joober, Ridha] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sengupta, Sarojini M.; Grizenko, Natalie; Schmitz, Norbert; Joober, Ridha] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Harvey, William J.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Choudhry, Zia; Sengupta, Sarojini M.; Grizenko, Natalie; Harvey, William J.; Fortier, Marie-Eve; Schmitz, Norbert; Joober, Ridha] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Joober, R (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	ridha.joober@douglas.mcgill.ca	Schmitz, Norbert/AAH-3624-2020; Schmitz, Norbert/A-5177-2010	Schmitz, Norbert/0000-0001-7777-6323	Fonds de la recherche en sante du Quebec; Canadian Institutes of Health Research; AstraZeneca	Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca)	This work was supported in part by a grant from the Fonds de la recherche en sante du Quebec and the Canadian Institutes of Health Research to RJ and NG. And, no additional external funding was received for this study. Further, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Ridha Joober sits on the advisory boards and speakers' bureaus of Pfizer Canada and Janssen Ortho Canada; he has received grant funding from them and from AstraZeneca. He has received honoraria from Janssen Ortho Canada for CME presentations and royalties for Henry Stewart talks. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agranat-Meged AN, 2005, INT J EAT DISORDER, V37, P357, DOI 10.1002/eat.20096; Barkley R. A, 2014, ATTENTION DEFICIT HY; Barkley Russell A, 2010, J Clin Psychiatry, V71, pe17, DOI 10.4088/JCP.9066tx1c; Bhattacharya A, 2012, LEARN MEMORY, V19, P434, DOI 10.1101/lm.025007.111; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Calkins S.D., 2007, SOCIOEMOTIONAL DEV T, P261, DOI DOI 10.1002/(SICI)1098-2302(199709)31:2%3C125:AID-DEV5%3E3.0.CO;2-M; Calkins SD, 2002, DEV PSYCHOPATHOL, V14, P477, DOI 10.1017/S095457940200305X; Chen AY, 2010, OBESITY, V18, P210, DOI 10.1038/oby.2009.185; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P281; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Cortese S, 2008, MED HYPOTHESES, V70, P12, DOI 10.1016/j.mehy.2007.04.036; Cortese S, 2007, J PSYCHOSOM RES, V63, P587, DOI 10.1016/j.jpsychores.2007.08.005; Cortese Samuele, 2012, Curr Top Behav Neurosci, V9, P199, DOI 10.1007/7854_2011_154; Cserjesi R, 2007, APPETITE, V49, P675, DOI 10.1016/j.appet.2007.04.001; Curtin Carol, 2005, BMC Pediatr, V5, P48, DOI 10.1186/1471-2431-5-48; Curtin C, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-11; Davis Caroline, 2006, Eat Behav, V7, P266, DOI 10.1016/j.eatbeh.2005.09.006; Dunton GF, 2009, MED SCI SPORT EXER, V41, P1698, DOI 10.1249/MSS.0b013e3181a06c9b; Ebenegger V, 2012, J CHILD NEUROL, V27, P852, DOI 10.1177/0883073811428009; Escaron AL, 2009, AM J PUBLIC HEALTH, V99, P1159, DOI 10.2105/AJPH.2009.159954; Fischer M, 1998, J LEARN DISABIL, V31, P608, DOI 10.1177/002221949803100611; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; Geary DC, 1999, J EXP CHILD PSYCHOL, V74, P213, DOI 10.1006/jecp.1999.2515; Graziano PA, 2011, INT J OBESITY; Grizenko N, 2006, J PSYCHIATR NEUROSCI, V31, P46; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Gupta R, 2009, PROG BRAIN RES, V176, P259, DOI 10.1016/S0079-6123(09)17614-8; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hjern A, 2010, ACTA PAEDIATR, V99, P920, DOI 10.1111/j.1651-2227.2009.01638.x; Holtkamp K, 2004, INT J OBESITY, V28, P685, DOI 10.1038/sj.ijo.0802623; Huang DY, 2012, J ADOLESCENCE; Huang XF, 2005, MOL BRAIN RES, V135, P150, DOI 10.1016/j.molbrainres.2004.12.013; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Karama S, 2009, J ATTEN DISORD, V12, P442, DOI 10.1177/1087054708314605; Katz DL, 2010, PREV CHRONIC DIS, V7; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Khalifa N, 2010, NORD J PSYCHIAT, V64, P11, DOI 10.3109/08039480903248096; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Lasky-Su J, 2007, BEHAV GENET, V37, P487, DOI 10.1007/s10519-006-9136-x; Li SX, 2012, AM J EPIDEMIOL, V176, pS142, DOI 10.1093/aje/kws236; Lieb DC, 2009, CLIN SPORT MED, V28, P349, DOI 10.1016/j.csm.2009.02.004; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Mana S, 2010, EUR PSYCHIAT, V25, P345, DOI 10.1016/j.eurpsy.2010.04.010; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Oliver LN, 2005, CAN J PUBLIC HEALTH, V96, P415, DOI 10.1007/BF03405180; Olsson GM, 2010, EAT WEIGHT DISORD-ST, V15, pE68; Oreskovic NM, 2009, ACAD PEDIATR, V9, P315, DOI 10.1016/j.acap.2009.02.009; Orsi CM, 2011, CURR OPIN ENDOCRINOL, V18, P14, DOI 10.1097/MED.0b013e3283423de1; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Poulton A, 2003, J PAEDIATR CHILD H, V39, P180, DOI 10.1046/j.1440-1754.2003.00107.x; Ptacek R, 2009, MED SCI MONITOR, V15, pCR595; Ptacek R, 2009, NEUROENDOCRINOL LETT, V30, P377; Rader R, 2009, AM FAM PHYSICIAN, V79, P657; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reichenberg Abraham, 2005, Dialogues Clin Neurosci, V7, P31; Rosval L, 2006, INT J EAT DISORDER, V39, P590, DOI 10.1002/eat.20296; Sanchez-Vaznaugh EV, 2008, SOC SCI MED, V67, P1300, DOI 10.1016/j.socscimed.2008.06.015; Sanchez-Vaznaugh EV, 2009, AM J EPIDEMIOL, V169, P1102, DOI 10.1093/aje/kwp027; Schertz M, 1996, PEDIATRICS, V98, P763; Schweickert LA, 1997, INT J EAT DISORDER, V21, P299, DOI 10.1002/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Singh GK, 2010, HEALTH AFFAIR, V29, P503, DOI 10.1377/hlthaff.2009.0730; Snyder EE, 2004, OBES RES, V12, P369, DOI 10.1038/oby.2004.47; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sokol MS, 1999, INT J EAT DISORDER, V25, P233, DOI 10.1002/(SICI)1098-108X(199903)25:2<233::AID-EAT14>3.0.CO;2-2; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P399, DOI 10.1111/j.1469-7610.1992.tb00875.x; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Surman CBH, 2006, J CLIN PSYCHIAT, V67, P351, DOI 10.4088/JCP.v67n0303; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Thakur GA, 2013, NICOTINE TOB RES, V15, P149, DOI 10.1093/ntr/nts102; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van den Heuvel E, 2007, ACTA PAEDIATR, V96, P454, DOI 10.1111/j.1651-2227.2006.00145.x; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2008, AM J PSYCHIAT, V165, P553, DOI 10.1176/appi.ajp.2008.08020237; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Waring ME, 2008, PEDIATRICS, V122, pE1, DOI 10.1542/peds.2007-1955; Welsh MC, 1988, ASSESSING FRONTAL LO, P199; Weschler D., 1992, WESCHLER INTELLIGENC; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	94	24	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55351	10.1371/journal.pone.0055351	http://dx.doi.org/10.1371/journal.pone.0055351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	097OK	23383165	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200012
J	Liu, HY; Pfleger, CM				Liu, Hsiu-Yu; Pfleger, Cathie M.			Mutation in E1, the Ubiquitin Activating Enzyme, Reduces Drosophila Lifespan and Results in Motor Impairment	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; GROWTH-FACTOR RECEPTOR; RNA-BINDING PROTEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; PROTEASOME SYSTEM; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; DEFECTIVE UBIQUITINATION	Neurodegenerative diseases cause tremendous suffering for those afflicted and their families. Many of these diseases involve accumulation of mis-folded or aggregated proteins thought to play a causal role in disease pathology. Ubiquitinated proteins are often found in these protein aggregates, and the aggregates themselves have been shown to inhibit the activity of the proteasome. These and other alterations in the Ubiquitin Pathway observed in neurodegenerative diseases have led to the question of whether impairment of the Ubiquitin Pathway on its own can increase mortality or if ongoing neurodegeneration alters Ubiquitin Pathway function as a side-effect. To address the role of the Ubiquitin Pathway in vivo, we studied loss-of-function mutations in the Drosophila Ubiquitin Activating Enzyme, Uba1 or E1, the most upstream enzyme in the Ubiquitin Pathway. Loss of only one functional copy of E1 caused a significant reduction in adult lifespan. Rare homozygous hypomorphic E1 mutants reached adulthood. These mutants exhibited further reduced lifespan and showed inappropriate Ras activation in the brain. Removing just one functional copy of Ras restored the lifespan of heterozygous E1 mutants to that of wild-type flies and increased the survival of homozygous E1 mutants. E1 homozygous mutants also showed severe motor impairment. Our findings suggest that processes that impair the Ubiquitin Pathway are sufficient to cause early mortality. Reduced lifespan and motor impairment are seen in the human disease X-linked Infantile Spinal Muscular Atrophy, which is associated with mutation in human E1 warranting further analysis of these mutants as a potential animal model for study of this disease.	[Liu, Hsiu-Yu; Pfleger, Cathie M.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Pfleger, CM (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	cathie.pfleger@mssm.edu			Alzheimer's Disease Research Center (ADRC) at The Mount Sinai School of Medicine [P50 AG005138-24]; National Institutes of Health (NIH), National Cancer Institute (NCI) [CA140451-01]; Sidney Kimmel Foundation for Cancer Research; NIH-NCI [5R24 CA095823-04]; National Science Foundation [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R24CA095823, R01CA140451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	Alzheimer's Disease Research Center (ADRC) at The Mount Sinai School of Medicine; National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Foundation for Cancer Research; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project received pilot funding from the Alzheimer's Disease Research Center (ADRC) at The Mount Sinai School of Medicine (P50 AG005138-24). This work was also supported by the National Institutes of Health (NIH), National Cancer Institute (NCI) (CA140451-01). CMP is a Kimmel Scholar and received funding from the Sidney Kimmel Foundation for Cancer Research. Confocal laser scanning microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources grant (5R24 CA095823-04), National Science Foundation Major Research Instrumentation grant (DBI-9724504) and NIH shared instrumentation grant (1 S10 RR0 9145-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arendt T, 2000, ANN NY ACAD SCI, V920, P249; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cookson MR, 2003, NEUROMOL MED, V3, P1, DOI 10.1385/NMM:3:1:1; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; Dawson TM, 2006, J NEURAL TRANSM-SUPP, P209; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Dressman D, 2007, GENET MED, V9, P52, DOI 10.1097/GIM.0b013e31802d8353; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X; GARTNER U, 1995, NEUROREPORT, V6, P1441; Gartner U, 1999, NEUROSCIENCE, V91, P1, DOI 10.1016/S0306-4522(99)00059-7; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; KOBAYASHI H, 1995, HUM MOL GENET, V4, P1213, DOI 10.1093/hmg/4.7.1213; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McShea A, 1999, BRAIN RES, V815, P237, DOI 10.1016/S0006-8993(98)01135-4; Mei M, 2006, J NEUROCHEM, V99, P1377, DOI 10.1111/j.1471-4159.2006.04174.x; Metzger S, 2006, HUM GENET, V120, P285, DOI 10.1007/s00439-006-0221-2; Mitchell MJ, 1998, HUM MOL GENET, V7, P429, DOI 10.1093/hmg/7.3.429; Naarding P, 2001, EUR PSYCHIAT, V16, P439, DOI 10.1016/S0924-9338(01)00604-6; Nerelius C, 2009, FRONT BIOSCI-LANDMRK, V14, P1716, DOI 10.2741/3335; Neumann CJ, 1996, GENETICS, V142, P1147; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Pfleger CM, 2007, FLY, V1, P95, DOI 10.4161/fly.4285; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Rao SS, 2006, AM FAM PHYSICIAN, V74, P2046; Rezak M, 2007, DM-DIS MON, V53, P195, DOI 10.1016/j.disamonth.2007.05.001; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; SAWAMOTO K, 1994, DEV BIOL, V164, P267, DOI 10.1006/dbio.1994.1197; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Smith MA, 2002, NEUROCHEM INT, V40, P527, DOI 10.1016/S0197-0186(01)00123-1; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; van Leeuwen FW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P319; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yan H, 2009, J CELL SCI, V122, P1461, DOI 10.1242/jcs.042267; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zaffran S, 1997, DEVELOPMENT, V124, P2087; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	78	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e32835	10.1371/journal.pone.0032835	http://dx.doi.org/10.1371/journal.pone.0032835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382794	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200044
J	Zhuo, C; Li, XQ; Zong, ZY; Zhong, NS				Zhuo, Chao; Li, Xiao-qiang; Zong, Zhi-yong; Zhong, Nan-shan			Epidemic Plasmid Carrying bla(CTX-M-15) in Klebsiella penumoniae in China	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; GENOTYPE DISTRIBUTION; INCF PLASMIDS; ENTEROBACTERIACEAE; DISSEMINATION; RESISTANCE; SEQUENCE; STRAINS; INFECTION	Objective: To investigate the local epidemiology of Klebsiella penumoniae carrying blaCTX-M-15 in southern China and to characterize the genetic environment of bla(CTX-M-15). Methods: PCR and DNA sequencing were used to detect and characterize the genetic contexts of bla(CTX-M-15). The clonal relatedness of isolates carrying bla(CTX-M-15) was determined by pulse-field gel electrophoresis. Conjugative plasmids carrying bla(CTX-M-15) were obtained by mating and were further subject to restriction analysis and replicon typing. Results: A total of 47 CTX-M-15 ESBL-producing isolates of K. pneumoniae were collected from nine hospitals in China from October 2007 to October 2008. Isolates were clustered into various clonal groups. The local spread of bla(CTX-M-15) was mainly mediated by one major conjugative plasmid as determined by S1-PFGE and restriction analysis. A 90-kb plasmid belonging to incompatible group FII was the major carrier of bla(CTX-M-15) in K. pneumoniae. Except bla(TEM-1), the resistance genes such as bla(SHV), bla(DHA-1), bla(OXA-1), qnrB, qnrS, aac(3)-II, and aac(69)-Ib were not found in the plasmid. In the comparing of conjugative gene sequence, it is 100% identical with the plasmid pKF3-94, which was found in K. pneumonia from Zhejiang province of china previously. Conclusions: bla(CTX-M-15) was prevalent in K. pneumonia of southern China. The dissemination of bla(CTX-M-15) appeared to be due to the horizontal transfer of a 90-kb epidemic plasmid.	[Zhuo, Chao; Li, Xiao-qiang; Zhong, Nan-shan] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zong, Zhi-yong] Sichuan Univ, Dept Infect Dis, West China Hosp, Chengdu 610064, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sichuan University	Zhuo, C (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chao_sheep@263.net		ZONG, ZHIYONG/0000-0002-7675-260X	Key Foundation of Guangdong province Bureau of Science and Technology [201002021, 2009A030301011]; Natural Science Foundation of China [81271881]	Key Foundation of Guangdong province Bureau of Science and Technology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by a grant (no. 201002021) from Special Fund for Health-Scientific Research in the Public Interest: Research & application for the prevention & control of nosocomial infections coursed by multi-drug resistant bacteria, and a grant (no. 2009A030301011) from the Key Foundation of Guangdong province Bureau of Science and Technology. Grant from the Natural Science Foundation of China (No. 81271881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SC, 2012, FEMS MICROBIOL LETT, V332, P137, DOI 10.1111/j.1574-6968.2012.02586.x; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CLSI, 2009, M100S19 CLSI S; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Huang XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040360; Jeong SH, 2005, J APPL MICROBIOL, V98, P921, DOI 10.1111/j.1365-2672.2004.02526.x; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Machado E, 2006, ANTIMICROB AGENTS CH, V50, P3220, DOI 10.1128/AAC.00473-06; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; SEIFERT H, 1995, J CLIN MICROBIOL, V33, P1402, DOI 10.1128/JCM.33.5.1402-1407.1995; Shi ZY, 1996, J CLIN MICROBIOL, V34, P2784, DOI 10.1128/JCM.34.11.2784-2790.1996; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; TAKAHASHI S, 1984, J CLIN MICROBIOL, V20, P608, DOI 10.1128/JCM.20.4.608-613.1984; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Yu YS, 2007, J INFECTION, V54, P53, DOI 10.1016/j.jinf.2006.01.014; Zhao FQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010141; [卓超 ZHUO Chao], 2009, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V32, P1114	27	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e52222	10.1371/journal.pone.0052222	http://dx.doi.org/10.1371/journal.pone.0052222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382815	Green Submitted, Green Published, gold			2022-12-25	WOS:000315483200024
J	Robinson, CP; Schwarz, EM; Sternberg, PW				Robinson, Carmie Puckett; Schwarz, Erich M.; Sternberg, Paul W.			Identification of DVA Interneuron Regulatory Sequences in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; GENE-EXPRESSION; DNA-SEQUENCE; NEURON; DIFFERENTIATION; CELL; SPECIFICATION; CONSERVATION	Background: The identity of each neuron is determined by the expression of a distinct group of genes comprising its terminal gene battery. The regulatory sequences that control the expression of such terminal gene batteries in individual neurons is largely unknown. The existence of a complete genome sequence for C. elegans and draft genomes of other nematodes let us use comparative genomics to identify regulatory sequences directing expression in the DVA interneuron. Methodology/Principal Findings: Using phylogenetic comparisons of multiple Caenorhabditis species, we identified conserved non-coding sequences in 3 of 10 genes (fax-1, nmr-1, and twk-16) that direct expression of reporter transgenes in DVA and other neurons. The conserved region and flanking sequences in an 85-bp intronic region of the twk-16 gene directs highly restricted expression in DVA. Mutagenesis of this 85 bp region shows that it has at least four regions. The central 53 bp region contains a 29 bp region that represses expression and a 24 bp region that drives broad neuronal expression. Two short flanking regions restrict expression of the twk-16 gene to DVA. A shared GA-rich motif was identified in three of these genes but had opposite effects on expression when mutated in the nmr-1 and twk-16 DVA regulatory elements. Conclusions/Significance: We identified by multi-species conservation regulatory regions within three genes that direct expression in the DVA neuron. We identified four contiguous regions of sequence of the twk-16 gene enhancer with positive and negative effects on expression, which combined to restrict expression to the DVA neuron. For this neuron a single binding site may thus not achieve sufficient specificity for cell specific expression. One of the positive elements, an 8-bp sequence required for expression was identified in silico by sequence comparisons of seven nematode species, demonstrating the potential resolution of expanded multi-species phylogenetic comparisons.	[Robinson, Carmie Puckett; Schwarz, Erich M.; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Robinson, Carmie Puckett; Schwarz, Erich M.; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Robinson, Carmie Puckett] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Robinson, Carmie Puckett] Univ So Calif, Keck Sch Med, VA Greater Angeles Healthcare Syst, Los Angeles, CA 90033 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Southern California; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Sternberg, PW (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	pws@caltech.edu		Schwarz, Erich/0000-0003-3151-4381	Howard Hughes Medical Insitute; National Institutes of Health [GM084389]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084389] Funding Source: NIH RePORTER	Howard Hughes Medical Insitute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Howard Hughes Medical Insitute, with which PWS is an investigator; National Institutes of Health GM084389 (to PWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bai XD, 2007, J PARASITOL, V93, P1343, DOI 10.1645/GE-1246.1; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; BRENNER S, 1974, GENETICS, V77, P71; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Cameron RA, 2005, P NATL ACAD SCI USA, V102, P11769, DOI 10.1073/pnas.0505291102; Ciche T., 2007, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.135.1, DOI 10.1895/WORMBOOK.1.135.1]; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fire A, 2006, GENETICS, V173, P1259, DOI 10.1534/genetics.106.057364; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Haerty W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-399; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hobert O, 2005, SPECIFICATION NERVOU, DOI [10.1895/wormbook.1.12.2, DOI 10.1895/WORMBOOK.1.12.2]; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; Kiontke Karin, 2005, P1; Kirchhamer CV, 1996, P NATL ACAD SCI USA, V93, P9322, DOI 10.1073/pnas.93.18.9322; Korf I., 2003, BLAST; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kuntz SG, 2008, GENOME RES, V18, P1955, DOI 10.1101/gr.085472.108; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; MADURO M, 1995, GENETICS, V141, P977; Morgan T. H., 1934, EMBRYOLOGY GENETICS; Mortazavi A, 2010, GENOME RES, V20, P1740, DOI 10.1101/gr.111021.110; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nokes EB, 2009, DEV DYNAM, V238, P3080, DOI 10.1002/dvdy.22147; Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Ruvinsky I, 2007, DEV BIOL, V302, P617, DOI 10.1016/j.ydbio.2006.09.014; Salkoff L, 2001, NEUROSCIENCE, V103, P853, DOI 10.1016/S0306-4522(01)00079-3; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Buskirk C, 2010, DEVELOPMENT, V137, P2065, DOI 10.1242/dev.040881; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 1996, J NEUROSCI, V16, P4017; Wightman B, 2005, DEV BIOL, V287, P74, DOI 10.1016/j.ydbio.2005.08.032	48	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54971	10.1371/journal.pone.0054971	http://dx.doi.org/10.1371/journal.pone.0054971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383017	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000315211500042
J	Dai, M; Li, B; Hu, SJ; Xu, CH; Yang, B; Li, JB; Fu, F; Fei, Z; Dong, XZ				Dai, Meng; Li, Bing; Hu, Shijie; Xu, Canhua; Yang, Bin; Li, Jianbo; Fu, Feng; Fei, Zhou; Dong, Xiuzhen			In Vivo Imaging of Twist Drill Drainage for Subdural Hematoma: A Clinical Feasibility Study on Electrical Impedance Tomography for Measuring Intracranial Bleeding in Humans	PLOS ONE			English	Article							RECONSTRUCTION ALGORITHMS; SPONTANEOUS RESOLUTION; BRAIN-FUNCTION; HUMAN HEAD; EIT; HEMORRHAGE; QUANTIFICATION; VENTILATION; CRANIOSTOMY; ELECTRODES	Intracranial bleeding is one of the most severe medical emergencies in neurosurgery. Early detection or diagnosis would largely reduce the rate of disability and mortality, and improve the prognosis of the patients. Electrical Impedance Tomography (EIT) can non-invasively image the internal resistivity distribution within a human body using a ring of external electrodes, and is thus a promising technique to promptly detect the occurrence of intracranial bleedings because blood differs from other brain tissues in resistivity. However, so far there is no experimental study that has determined whether the intracranial resistivity changes in humans could be repeatedly detected and imaged by EIT. Hence, we for the first time attempt to clinically validate this by in vivo imaging the influx and efflux of irrigating fluid (5% dextrose in water, D5W) during the twist-drill drainage operation for the patients with subdural hematoma (SDH). In this study, six patients (four male, two female) with subacute or chronic SDH received the surgical operation in order to evacuate the hematoma around subdural region, and EIT measurements were performed simultaneously on each patient's head. The results showed that the resistivity significantly increased on the corresponding position of EIT images during the influx of D5W and gradually decreased back to baseline during the efflux. In the quantitative analysis, the average resistivity values demonstrated the similar results and had highly linear correlation (R-2 = 0.93 +/- 0.06) with the injected D5W volumes, as well as the area of the resistivity gain(R-2 = 0.94 +/- 0.05). In conclusion, it was clinically validated that intracranial resistivity changes in humans were detectable and quantifiable by the EIT method. After further technical improvements, EIT has the great potential of being a routine neuroimaging tool for early detection of intracranial bleedings.	[Dai, Meng; Xu, Canhua; Yang, Bin; Li, Jianbo; Fu, Feng; Dong, Xiuzhen] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Li, Bing; Hu, Shijie; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Neurosurg Unit, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Neurosurg Unit, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn; dongxiuzhen@fmmu.edu.cn		Yang, Bin/0000-0001-9687-5968	National Key Technology R&D Program of China [2011BAI08B13, 2012BAI20B02]; National Natural Science Foundation of China [51207161]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Key Technology R&D Program of China under grant NO. 2011BAI08B13, 2012BAI20B02, and by National Natural Science Foundation of China under grant NO. 51207161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2008, NEUROIMAGE, V43, P258, DOI 10.1016/j.neuroimage.2008.07.023; Bagshaw AP, 2003, NEUROIMAGE, V20, P752, DOI 10.1016/S1053-8119(03)00301-X; BENDER MB, 1974, ARCH NEUROL-CHICAGO, V31, P73, DOI 10.1001/archneur.1974.00490380021001; BOONE K, 1994, PHYSIOL MEAS, V15, pA189, DOI 10.1088/0967-3334/15/2A/024; Bozkurt G, 2006, TURK NEUROSURG, V16, P19; CAMEL M, 1986, J NEUROSURG, V65, P183, DOI 10.3171/jns.1986.65.2.0183; Clay MT, 2002, IEEE T MED IMAGING, V21, P629, DOI 10.1109/TMI.2002.800572; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; Dawodu S, 2009, TRAUMATIC BRAIN INJU; Drapkin J, 1991, BRIT J NEUROSURG, V5, P67; Fabrizi L, 2006, PHYSIOL MEAS, V27, pS163, DOI 10.1088/0967-3334/27/5/S14; Holder D. S, 2005, ELECT IMPEDANCE TOMO; Holder DS, 1996, PHYSIOL MEAS, V17, pA179, DOI 10.1088/0967-3334/17/4A/022; Horesh L, 2006, THESIS U COLL LONDON; Ji ZY, 2009, MED BIOL ENG COMPUT, V47, P1045, DOI 10.1007/s11517-009-0516-2; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lindgren S, 2007, INTENS CARE MED, V33, P172, DOI 10.1007/s00134-006-0425-x; Lionheart WRB, 2004, PHYSIOL MEAS, V25, P125, DOI 10.1088/0967-3334/25/1/021; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; MARKWALDER TM, 1985, NEUROSURGERY, V16, P185, DOI 10.1227/00006123-198502000-00010; Murphy D, 1987, Clin Phys Physiol Meas, V8 Suppl A, P131, DOI 10.1088/0143-0815/8/4A/017; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; Parlato C, 2000, SURG NEUROL, V53, P312, DOI 10.1016/S0090-3019(00)00200-7; Pulletz S, 2006, PHYSIOL MEAS, V27, pS115, DOI 10.1088/0967-3334/27/5/S10; Sadleir RJ, 2009, PHYSIOL MEAS, V30, P63, DOI 10.1088/0967-3334/30/1/005; Sadleir RJ, 2001, IEEE T BIO-MED ENG, V48, P484, DOI 10.1109/10.915715; Shi X, 2006, THESIS 4 MILITARY ME; Shi XT, 2005, P ANN INT IEEE EMBS, P1492, DOI 10.1109/IEMBS.2005.1616714; Shuai WJ, 2009, ANN BIOMED ENG, V37, P2373, DOI 10.1007/s10439-009-9778-y; Tang C, 2009, PHYSIOL MEAS, V30, P1293, DOI 10.1088/0967-3334/30/12/001; Tidswell T, 2001, NEUROIMAGE, V13, P283, DOI 10.1006/nimg.2000.0698; Tizzard A, 2005, PHYSIOL MEAS, V26, pS251, DOI 10.1088/0967-3334/26/2/024; Tucker AS, 2011, PHYSIOL MEAS, V32, P151, DOI 10.1088/0967-3334/32/2/001; WINN HR, 2003, YOUMANS NEUROLOGICAL; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu SW, 2011, ANN BIOMED ENG, V39, P2059, DOI 10.1007/s10439-011-0302-9	36	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55020	10.1371/journal.pone.0055020	http://dx.doi.org/10.1371/journal.pone.0055020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372808	Green Submitted, Green Published, gold			2022-12-25	WOS:000315210400051
J	Tripathi, V; Popescu, NC; Zimonjic, DB				Tripathi, V.; Popescu, N. C.; Zimonjic, D. B.			DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion	ONCOGENE			English	Article						E-cadherin; DLC1; Rho; invasion; prostate cancer	GTPASE-ACTIVATING PROTEIN; EPITHELIAL TUMOR-CELLS; HEPATOCELLULAR-CARCINOMA; ADHERENS JUNCTIONS; BREAST-CANCER; RHO/ROCK PATHWAY; GENE-EXPRESSION; FAMILY GTPASES; IN-VIVO; ADHESION	E-cadherin is a cell-cell adhesion molecule that acts as a suppressor of cancer cell invasion and its expression is downregulated in many advanced, poorly differentiated, human cancers. In this study, we found that the expression of DLC1 (deleted in liver cancer 1) tumor-suppressor gene in metastatic prostate carcinoma (PCA) cells increased the expression of E-cadherin and resulted in an elevated rate of cell-cell aggregation as measured by aggregation assay. DLC1-mediated increase in E-cadherin expression was not dependent on alpha-catenin, a DLC1-binding protein associated with E-cadherin, and/or cellular density. The increase of E-cadherin expression occurred at mRNA level and relied on DLC1 RhoGAP function, leading to suppression of high level of RhoA-GTP and RhoC-GTP activity in metastatic PCA cells. Application of Rho/ROCK inhibitors produced the same effect as introduction of DLC1. Knocking down of RhoA produced a moderate increase in E-cadherin whereas knocking down of RhoC resulted in a significant increase of E-cadherin. Downregulation of E-cadherin caused by constitutively active RhoA(V14) and RhoC(V14) could not be reversed by expression of DLC1 in DLC1-negative cell line. DLC1-mediated suppression of metastatic PCA cells invasion was comparable with the one associated with ectopic E-cadherin expression, or caused by suppression of Rho pathway either by Rho/ROCK inhibitors, or by shRNA repression. This study demonstrates that DLC1 expression positively regulates E-cadherin and suppresses highly metastatic PCA cell invasion by modulating Rho pathway, which appears as a feasible therapeutic target in cancers with high activity of RhoGTPases.	[Tripathi, V.; Popescu, N. C.; Zimonjic, D. B.] NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Popescu, NC (corresponding author), NCI, Expt Carcinogenesis Lab, NIH, Bldg 37,Room 4128B,37 Convent Dr,MSC 4262, Bethesda, MD 20892 USA.	popescun@mail.nih.gov	Zimonjic, Drazen/AAX-7513-2020		National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA	National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.	Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Brouxhon S, 2007, CANCER RES, V67, P7654, DOI 10.1158/0008-5472.CAN-06-4415; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Chang YWE, 2006, CANCER RES, V66, P11700, DOI 10.1158/0008-5472.CAN-06-1818; Cheng L, 1996, AM J PATHOL, V148, P1375; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2008, CANCER GENE THER, V15, P371, DOI 10.1038/cgt.2008.13; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Hajra KM, 2002, CANCER RES, V62, P1613; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Hodge JC, 2003, CANCER RES, V63, P1359; Jeong KJ, 2012, ONCOGENE, V31, P4279, DOI 10.1038/onc.2011.595; JIANG WG, 1995, CANCER RES, V55, P5043; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Koksal IT, 2002, PATHOLOGY, V34, P233, DOI 10.1080/00313020220131282; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Li LC, 2001, J UROLOGY, V166, P705, DOI 10.1016/S0022-5347(05)66047-8; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Noe V, 2001, J CELL SCI, V114, P111; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Rashid MG, 2001, CANCER RES, V61, P489; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sawada K, 2008, METHOD ENZYMOL, V439, P395, DOI 10.1016/S0076-6879(07)00428-4; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Thiolloy S, 2011, SEMIN CANCER BIOL, V21, P89, DOI 10.1016/j.semcancer.2010.12.008; Tripathi V, 2012, MOL CELL BIOL, V32, P2145, DOI 10.1128/MCB.06580-11; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Zhou Q, 2009, MOL CANCER THER, V8, P1684, DOI 10.1158/1535-7163.MCT-09-0191; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246; Zimonjic DB, 2012, INT J ONCOL, V41, P393, DOI 10.3892/ijo.2012.1474	57	28	30	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					724	733		10.1038/onc.2013.7	http://dx.doi.org/10.1038/onc.2013.7			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23376848				2022-12-25	WOS:000331129200007
J	Fang, ZY; Luna, EJ				Fang, Zhiyou; Luna, Elizabeth J.			Supervillin-mediated Suppression of p53 Protein Enhances Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SMOOTH-MUSCLE; NUCLEAR-LOCALIZATION; ACTIN; PROLIFERATION; ARCHVILLIN; INHIBITOR; REVEALS; PATHWAY; CANCER	Integrin-based adhesions promote cell survival as well as cell motility and invasion. We show here that the adhesion regulatory protein supervillin increases cell survival by decreasing levels of the tumor suppressor protein p53 and downstream target genes. RNAi-mediated knockdown of a new splice form of supervillin (isoform 4) or both isoforms 1 and 4 increases the amount of p53 and cell death, whereas p53 levels decrease after overexpression of either supervillin isoform. Cellular responses to DNA damage induced by etoposide or doxorubicin include down-regulation of endogenous supervillin coincident with increases in p53. In DNA-damaged supervillin knockdown cells, p53 knockdown or inhibition partially rescues the loss of cell metabolic activity, a measure of cell proliferation. Knockdown of the p53 deubiquitinating enzyme USP7/HAUSP also reverses the supervillin phenotype, blocking the increase in p53 levels seen after supervillin knockdown and accentuating the decrease in p53 levels triggered by supervillin overexpression. Conversely, supervillin overexpression decreases the association of USP7 and p53 and attenuates USP7-mediated p53 deubiquitination. USP7 binds directly to the supervillin N terminus and can deubiquitinate and stabilize supervillin. Supervillin also is stabilized by derivatization with the ubiquitin-like protein SUMO1. These results show that supervillin regulates cell survival through control of p53 levels and suggest that supervillin and its interaction partners at sites of cell-substrate adhesion constitute a locus for cross-talk between survival signaling and cell motility pathways.	[Fang, Zhiyou; Luna, Elizabeth J.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fang, ZY (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, 377 Plantat St, Worcester, MA 01605 USA.	zhiyou.fang@umassmed.edu; elizabeth.luna@umassmed.edu	Fang, Zhiyou/GQY-6875-2022		National Institutes of Health [GM033048-26S1]; Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM033048-26S1. This work was also supported by the Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA.	Andoh T, 2000, CELL BIOCHEM BIOPHYS, V33, P181, DOI 10.1385/CBB:33:2:181; Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Edelstein LC, 2012, CIRCULATION, V125, P2762, DOI 10.1161/CIRCULATIONAHA.112.091462; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fang ZY, 2010, TRAFFIC, V11, P782, DOI 10.1111/j.1600-0854.2010.01062.x; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gangopadhyay SS, 2009, J BIOL CHEM, V284, P17607, DOI 10.1074/jbc.M109.002386; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Golubovskaya VM, 2011, ANTI-CANCER AGENT ME, V11, P617; Hall CL, 2002, CELL COMMUN ADHES, V9, P273, DOI 10.1080/15419060216306; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Ilic D, 1998, J CELL BIOL, V143, P547; Iqbal MS, 2010, BIOCHEM BIOPH RES CO, V392, P415, DOI 10.1016/j.bbrc.2010.01.038; Janouskova H, 2012, CANCER RES, V72, P3463, DOI 10.1158/0008-5472.CAN-11-4199; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Mak AS, 2011, CELL ADHES MIGR, V5, P144, DOI 10.4161/cam.5.2.14375; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Nagano M, 2012, INT J CELL BIOL; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Oh SW, 2003, J CELL SCI, V116, P2261, DOI 10.1242/jcs.00422; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; Pope RK, 1998, GENOMICS, V52, P342, DOI 10.1006/geno.1998.5466; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ren XP, 2002, CANCER BIOL THER, V1, P703, DOI 10.4161/cbt.323; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125	64	26	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7918	7929		10.1074/jbc.M112.416842	http://dx.doi.org/10.1074/jbc.M112.416842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23382381	hybrid, Green Published			2022-12-25	WOS:000316455300045
J	Aleksic, E; Merker, M; Cox, H; Reiher, B; Sekawi, Z; Hearps, AC; Ryan, CE; Lee, AV; Goursaud, R; Malau, C; O'Connor, J; Cherry, CL; Niemann, S; Crowe, SM				Aleksic, Eman; Merker, Matthias; Cox, Helen; Reiher, Bereka; Sekawi, Zamberi; Hearps, Anna C.; Ryan, Claire E.; Lee, Adele V.; Goursaud, Regis; Malau, Clement; O'Connor, Janet; Cherry, Catherine L.; Niemann, Stefan; Crowe, Suzanne M.			First Molecular Epidemiology Study of Mycobacterium tuberculosis in Kiribati	PLOS ONE			English	Article							STRAINS; IDENTIFICATION; LINEAGE; SPREAD	Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, however the genetic diversity of circulating Mycobacterium tuberculosis complex strains (MTBC) and transmission dynamics are unknown. Here, we analysed MTBC strains isolated from culture positive pulmonary tuberculosis (TB) cases from the main TB referral centre between November 2007 and October 2009. Strain genotyping (IS6110 typing, spoligotyping, 24-loci MIRU-VNTR and SNP typing) was performed and demographic information collected. Among 73 MTBC strains analysed, we identified seven phylogenetic lineages, dominated by Beijing strains (49%). Beijing strains were further differentiated in two main branches, Beijing-A (n = 8) and -B (n = 28), that show distinct genotyping patterns and are characterized by specific deletion profiles (Beijing A: only RD105, RD207 deleted; Beijing B: RD150 and RD181 additionally deleted). Many Kiribati strains (59% based on IS6110 typing of all strains) occurred in clusters, suggesting ongoing local transmission. Beijing-B strains and over-crowded living conditions were associated with strain clustering (likely recent transmission), however little evidence of antituberculous drug resistance was observed. We suggest enhanced case finding amongst close contacts and continued supervised treatment of all identified cases using standard first-line drugs to reduce TB burden in Kiribati. Beijing strains can be subdivided in different principle branches that might be associated with differential spreading patterns in the population.	[Aleksic, Eman; Cox, Helen; Hearps, Anna C.; Ryan, Claire E.; Lee, Adele V.; Malau, Clement; Cherry, Catherine L.; Crowe, Suzanne M.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Merker, Matthias; Niemann, Stefan] Forschungszentrum, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Cox, Helen; Crowe, Suzanne M.] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Reiher, Bereka] Tungaru Cent Hosp, TB Clin, Tarawa, Kiribati; [Sekawi, Zamberi] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Goursaud, Regis] Inst Pasteur, Dept Microbiol, Noumea, New Caledonia; [Malau, Clement] Univ Melbourne, Nossal Inst Hlth, Melbourne, Vic 3010, Australia; [O'Connor, Janet] Secretariat Pacific Community, Noumea, New Caledonia; [Cherry, Catherine L.; Crowe, Suzanne M.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	Burnet Institute; Monash University; Universiti Putra Malaysia; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Aleksic, E (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	eman@burnet.edu.au	Sekawi, Zamberi/I-1755-2013; Nightingale, Claire Elizabeth/K-1667-2019; Merker, Matthias/P-7399-2015; Niemann, Stefan/C-9327-2011	Sekawi, Zamberi/0000-0002-5387-9640; Nightingale, Claire Elizabeth/0000-0002-4103-6240; Merker, Matthias/0000-0003-1386-2331; Cherry, Catherine Louise/0000-0001-9816-5193; Niemann, Stefan/0000-0002-6604-0684; Cox, Helen/0000-0002-6538-7192	Secretariat of the Pacific Community, Noumea, New Caledonia; National Health and Medical Research Council's Principal Research Fellowship Award	Secretariat of the Pacific Community, Noumea, New Caledonia; National Health and Medical Research Council's Principal Research Fellowship Award	This work was supported by the Secretariat of the Pacific Community, Noumea, New Caledonia; www.spc.int. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. Professor Suzanne Crowe AM is a recipient of a National Health and Medical Research Council's Principal Research Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Government K, 2010, KIRIBATI POPULATION; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Homolka S, 2009, J CLIN MICROBIOL, V47, P223, DOI 10.1128/JCM.01237-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Massey P. D., 2011, Journal of Rural and Tropical Public Health, V10, P44; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; O'Connor J, 2005, ADDRESSING TB EPIDEM; Region WP, 2011, TUBERCULOSIS CONTROL; Region WP, 2011, REGIONAL STRATEGY TO; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TACQUET A, 1961, ANN I PASTEUR PARIS, V100, P676; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Viney K, 2011, ASIA-PAC J PUBLIC HE, V23, P86, DOI 10.1177/1010539510390671; Viney Kerri, 2010, Pac Health Dialog, V16, P157; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	27	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55423	10.1371/journal.pone.0055423	http://dx.doi.org/10.1371/journal.pone.0055423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383187	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600102
J	Pierro, VSD; Ferreira, DD; de Jesus, HE; Rosado, AS; Luiz, RR; dos Santos, KRN; Maia, LC				da Silva Pierro, Viviane Santos; Ferreira, Dennis de Carvalho; de Jesus, Hugo Emiliano; Rosado, Alexandre Soares; Luiz, Ronir Raggio; Netto dos Santos, Katia Regina; Maia, Lucianne Cople			Topical Effect of a Medically Prescribed Pediatric Antibiotic on Dental Biofilm: A Cross-Over, In Situ Study	PLOS ONE			English	Article							ENAMEL DEMINERALIZATION; CYSTIC-FIBROSIS; ANTIMICROBIAL SUSCEPTIBILITY; ADMINISTERED ANTIBIOTICS; MUTANS STREPTOCOCCI; SUCROSE EXPOSURE; CHILDREN; CARIES; HEALTH; PLAQUE	Objective: This study aimed to investigate the possible topical effect of a broad-spectrum antibiotic on dental biofilm formed in situ in the absence or presence of sucrose. Methods: A crossover study was conducted in three phases of 14 days each, during which 11 volunteers wore palatal devices containing 6 enamel blocks covered with meshes to allow biofilm formation. Dental blocks were extraorally submitted to a 20% sucrose solution at three different frequencies of exposure (0, 3 and 8 times/day), and to a suspension of amoxicillin/clavulanate potassium (A/CP) or a placebo (P) suspension at an 8-hour time interval application regimen. On the 14th day of each phase, biofilms were collected for microbiological (conventional culture) and molecular (Denaturing Gradient Gel Electrophoresis - DGGE) analyses. Results: In the absence of sucrose exposure (SE) and at the 3-time daily frequency, dental biofilms treated with A/CP showed lower total biofilm weight and lower counts of total microbiota than the ones treated with P (p > 0.05). A/CP presented higher counts of Candida spp. when compared with P in the presence of SE, especially at the 8-time daily frequency (p < 0.05). Considering the DGGE analysis, the mean number of bands was higher for P (p > 0.05), regardless of SE. However, DGGE profiles demonstrated large interindividual variability. Conclusion: Both conventional culture and DGGE have demonstrated some differences on total microbiota of dental biofilms when exposed to the A/CP or P suspensions, mainly in the absence of sucrose, which suggests a possible topical effect of the sugar-free A/CP suspension on dental biofilm.	[da Silva Pierro, Viviane Santos; Maia, Lucianne Cople] Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, Ilha Fundao, Rio De Janeiro, Brazil; [Ferreira, Dennis de Carvalho; de Jesus, Hugo Emiliano; Rosado, Alexandre Soares; Netto dos Santos, Katia Regina] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Ilha Fundao, Rio De Janeiro, Brazil; [Luiz, Ronir Raggio] Univ Fed Rio de Janeiro, Inst Studies Publ Hlth IESC, Ilha Fundao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Pierro, VSD (corresponding author), Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, Ilha Fundao, Rio De Janeiro, Brazil.	vivipierro@gmail.com	Luiz, Ronir R/C-3372-2013; Maia, Lucianne Cople/E-9938-2011; Ferreira, Dennis/AAC-7407-2020; Rosado, Alexandre Soares/G-1955-2012; Luiz, Ronir Raggio/ABE-2684-2021	Luiz, Ronir R/0000-0002-7784-9905; Maia, Lucianne Cople/0000-0003-1026-9401; Rosado, Alexandre Soares/0000-0001-5135-1394; Luiz, Ronir Raggio/0000-0002-7784-9905; Ferreira, Dennis/0000-0003-4166-3284	CNPq [470693/2010-0, 302382/2009-7]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Processes No. 470693/2010-0 and 302382/2009-7). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Aires CP, 2006, CARIES RES, V40, P28, DOI 10.1159/000088902; Baglie S, 2007, INT J CLIN PHARM TH, V45, P556; Ccahuana-Vasquez RA, 2007, CARIES RES, V41, P9, DOI 10.1159/000096100; Papa AMCD, 2010, PEDIATR DENT, V32, P35; Ciofi Degli Atti ML, 2008, EUROSURVEILLANCE, V13, P1, DOI DOI 10.2807/ESE.13.41.19003-EN; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Cury JA, 2001, CARIES RES, V35, P106, DOI 10.1159/000047440; de Jong J, 2009, ACTA PAEDIATR, V98, P1142, DOI 10.1111/j.1651-2227.2009.01309.x; DIBDIN GH, 1988, J DENT RES, V67, P890, DOI 10.1177/00220345880670060101; FEIGAL RJ, 1981, PEDIATRICS, V68, P416; Fukuda JT, 2005, PEDIATR DENT, V27, P186; Gammelsrud KW, 2011, CLIN MICROBIOL INFEC, V17, P1875, DOI 10.1111/j.1469-0691.2011.03528.x; Hara AT, 2003, CARIES RES, V37, P339, DOI 10.1159/000072165; JAGELS AE, 1976, J DENT RES, V55, P991, DOI 10.1177/00220345760550065101; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; KARJALAINEN S, 1992, CARIES RES, V26, P310, DOI 10.1159/000261458; Leme AFP, 2004, J DENT RES, V83, P71, DOI 10.1177/154405910408300114; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LITTLETON NW, 1964, J AM DENT ASSOC, V68, P520, DOI 10.14219/jada.archive.1964.0111; LOESCHE WJ, 1989, ORAL MICROBIOL IMMUN, V4, P77, DOI 10.1111/j.1399-302X.1989.tb00103.x; Maguire A, 1997, Community Dent Health, V14, P31; Maguire A, 1996, CARIES RES, V30, P16, DOI 10.1159/000262131; Maguire A, 1999, COMMUNITY DENT HLTH, V16, P138; Mariri BP, 2003, COMMUNITY DENT ORAL, V31, P40, DOI 10.1034/j.1600-0528.2003.00019.x; Marsh Philip D, 2010, Dent Clin North Am, V54, P441, DOI 10.1016/j.cden.2010.03.002; McBain AJ, 2003, ANTIMICROB AGENTS CH, V47, P3531, DOI 10.1128/AAC.47.11.3531-3538.2003; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P4770, DOI 10.1128/AEM.69.8.4770-4776.2003; MCMAHON J, 1993, EUR J CLIN NUTR, V47, P794; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Moynihan P, 2006, QUINTESSENCE INT, V37, P444; Nubel U, 1999, APPL ENVIRON MICROB, V65, P422; Pecharki GD, 2005, CARIES RES, V39, P123, DOI 10.1159/000083157; Ribeiro CCC, 2005, BRIT J NUTR, V94, P44, DOI 10.1079/BJN20051452; ROBERTS IF, 1979, BRIT MED J, V2, P14, DOI 10.1136/bmj.2.6181.14; STAVES E, 1991, Pediatric Dentistry, V13, P176; SWALLOW JN, 1967, ARCH DIS CHILD, V42, P311, DOI 10.1136/adc.42.223.311; Wefel J S, 1995, Adv Dent Res, V9, P335; Zero D T, 1995, Adv Dent Res, V9, P214	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55558	10.1371/journal.pone.0055558	http://dx.doi.org/10.1371/journal.pone.0055558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383224	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600125
J	Goto, K; Kato, G; Kawahara, I; Luo, Y; Obata, K; Misawa, H; Ishikawa, T; Kuniyasu, H; Nabekura, J; Takaki, M				Goto, Kei; Kato, Go; Kawahara, Isao; Luo, Yi; Obata, Koji; Misawa, Hiromi; Ishikawa, Tatsuya; Kuniyasu, Hiroki; Nabekura, Junich; Takaki, Miyako			In Vivo Imaging of Enteric Neurogenesis in the Deep Tissue of Mouse Small Intestine	PLOS ONE			English	Article							REFLEX	One of the challenges of using imaging techniques as a tool to study cellular physiology has been the inability to resolve structures that are not located near the surface of the preparation. Nonlinear optical microscopy, in particular two photon-excited fluorescence microscopy (2PM), has overcome this limitation, providing deeper optical penetration (several hundred mm) in ex vivo and in vivo preparations. We have used this approach in the gut to achieve the first in vivo imaging of enteric neurons and nerve fibers in the mucosa, submucosa, submucosal and myenteric plexuses, and circular and longitudinal muscles of the small intestine in H-line: Thy1 promoter GFP mice. Moreover, we obtained clear three-dimensional imaging of enteric neurons that were newly generated after gut transection and reanastomosis. Neurogenesis was promoted by oral application of the 5-HT4-receptor agonist, mosapride citrate (MOS). The number of newly generated neurons observed in mice treated with MOS for one week was 421 +/- 89 per 864,900 mu m(2) (n = 5), which was significantly greater than that observed in preparations treated with MOS plus an antagonist (113 +/- 76 per 864,900 mu m(2)) or in 4 week vehicle controls (100 +/- 34 per 864,900 mu m(2)) (n = 4 both). Most neurons were located within 100 mu m of the surface. These results confirm that activation of enteric neural 5-HT4-receptor by MOS promotes formation of new enteric neurons. We conclude that in vivo 2PM imaging made it possible to perform high-resolution deep imaging of the living mouse whole gut and reveal formation of new enteric neurons promoted by 5-HT4-receptor activation.	[Goto, Kei; Kawahara, Isao; Obata, Koji; Misawa, Hiromi; Takaki, Miyako] Nara Med Univ, Sch Med, Dept Physiol 2, Kashihara, Nara 634, Japan; [Goto, Kei; Kawahara, Isao; Luo, Yi; Kuniyasu, Hiroki; Takaki, Miyako] Nara Med Univ, Sch Med, Dept Mol Pathol, Kashihara, Nara 634, Japan; [Kato, Go; Ishikawa, Tatsuya; Nabekura, Junich] Natl Inst Physiol Sci, Div Homeostat Dev, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Nara Medical University; Nara Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Takaki, M (corresponding author), Nara Med Univ, Sch Med, Dept Physiol 2, Kashihara, Nara 634, Japan.	mtakaki@naramed-u.ac.jp		Kato, Go/0000-0002-3098-9759	Cooperative Study Program of National Institute for Physiological Sciences; Ministry of Education, Science, Sports and Culture of Japan [20659210, 23390330, 24650325, 23591969]; Grants-in-Aid for Scientific Research [24650325] Funding Source: KAKEN	Cooperative Study Program of National Institute for Physiological Sciences; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Cooperative Study Program of National Institute for Physiological Sciences. This work was supported by Grants-in-aid for Scientific Research (20659210, 23390330, 24650325 for M.T. and 23591969 for H.M.) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha AE, 2000, GUT, V47, P667, DOI 10.1136/gut.47.5.667; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gershon MD, 2011, J CLIN INVEST, V121, P3386, DOI 10.1172/JCI59573; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Katsui R, 2008, AM J PHYSIOL-GASTR L, V294, pG1084, DOI 10.1152/ajpgi.00345.2007; Kawahara I, 2012, AM J PHYSIOL-GASTR L, V302, pG588, DOI 10.1152/ajpgi.00284.2011; Kurosaki R, 2004, PHARMACOL BIOCHEM BE, V78, P143, DOI 10.1016/j.pbb.2004.03.006; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Liu M, 2006, NEUROGASTROENT MOTIL, V18, P780; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Matsuyoshi H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01474.x; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohya TR, 2012, GASTROINTEST ENDOSC, V75, P405, DOI 10.1016/j.gie.2011.09.045; Surendran S, 2005, BIOCHEM BIOPH RES CO, V338, P919, DOI 10.1016/j.bbrc.2005.10.039; Takaki M, 2011, BIOCHEM BIOPH RES CO, V406, P529, DOI 10.1016/j.bbrc.2011.02.072; Thacker M, 2011, NEUROGASTROENT MOTIL, V23, pE500, DOI 10.1111/j.1365-2982.2011.01696.x; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Yamanouchi M, 2002, AM J PHYSIOL-GASTR L, V283, pG148, DOI 10.1152/ajpgi.00497.2001; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	21	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54814	10.1371/journal.pone.0054814	http://dx.doi.org/10.1371/journal.pone.0054814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382976	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600044
J	Smith, ME; Henkel, TW; Uehling, JK; Fremier, AK; Clarke, HD; Vilgalys, R				Smith, Matthew E.; Henkel, Terry W.; Uehling, Jessie K.; Fremier, Alexander K.; Clarke, H. David; Vilgalys, Rytas			The Ectomycorrhizal Fungal Community in a Neotropical Forest Dominated by the Endemic Dipterocarp Pakaraimaea dipterocarpacea	PLOS ONE			English	Article							SPATIAL STRUCTURE; CANOPY TREES; RAIN-FOREST; HOST; DIVERSITY; CAESALPINIACEAE; PHYLOGENY; PATTERNS; CLADES	Ectomycorrhizal (ECM) plants and fungi can be diverse and abundant in certain tropical ecosystems. For example, the primarily paleotropical ECM plant family Dipterocarpaceae is one of the most speciose and ecologically important tree families in Southeast Asia. Pakaraimaea dipterocarpacea is one of two species of dipterocarp known from the Neotropics, and is also the only known member of the monotypic Dipterocarpaceae subfamily Pakaraimoideae. This Guiana Shield endemic is only known from the sandstone highlands of Guyana and Venezuela. Despite its unique phylogenetic position and unusual geographical distribution, the ECM fungal associations of P. dipterocarpacea are understudied throughout the tree's range. In December 2010 we sampled ECM fungi on roots of P. dipterocarpacea and the co-occurring ECM tree Dicymbe jenmanii (Fabaceae subfamily Caesalpinioideae) in the Upper Mazaruni River Basin of Guyana. Based on ITS rDNA sequencing we documented 52 ECM species from 11 independent fungal lineages. Due to the phylogenetic distance between the two host tree species, we hypothesized that P. dipterocarpacea would harbor unique ECM fungi not found on the roots of D. jenmanii. Although statistical tests suggested that several ECM fungal species did exhibit host preferences for either P. dipterocarpacea or D. jenmanii, most of the ECM fungi were multi-host generalists. We also detected several ECM fungi that have never been found in long-term studies of nearby rainforests dominated by other Dicymbe species. One particular mushroom-forming fungus appears to be unique and may represent a new ECM lineage of Agaricales that is endemic to the Neotropics.	[Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Henkel, Terry W.; Uehling, Jessie K.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Fremier, Alexander K.] Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID USA; [Clarke, H. David] Univ N Carolina, Dept Biol, Asheville, NC 28804 USA; [Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC USA	State University System of Florida; University of Florida; California State University System; California State Polytechnic University, Humboldt; Idaho; University of Idaho; University of North Carolina; University of North Carolina - Asheville; Duke University	Smith, ME (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	trufflesmith@ufl.edu	Smith, Matthew E./ABC-3015-2020; Fremier, Alexander/AAC-7706-2019; Uehling, Jessie/HGV-1602-2022; Smith, Matthew E/A-8115-2012	Smith, Matthew E./0000-0002-0878-0932; Uehling, Jessie/0000-0002-8705-5893; Smith, Matthew E/0000-0002-0878-0932; Vilgalys, Rytas/0000-0001-8299-3605; Fremier, Alexander/0000-0002-4104-6633	National Science Foundation [DEB-0918591, DEB-3331108]; University of Florida's Institute for Food and Agricultural Sciences (IFAS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; Direct For Biological Sciences [0918591] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Florida's Institute for Food and Agricultural Sciences (IFAS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation grants DEB-0918591 to TWH and DEB-3331108 to RV. Participation by MES was also possible in part due to support from University of Florida's Institute for Food and Agricultural Sciences (IFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Alexander IJ, 2006, NEW PHYTOL, V172, P589, DOI 10.1111/j.1469-8137.2006.01930.x; ASHTON PS, 1988, ANNU REV ECOL SYST, V19, P347, DOI 10.1146/annurev.es.19.110188.002023; Ashton PS, 1977, TAXON, V26, P343; Bandou E, 2006, MYCORRHIZA, V16, P559, DOI 10.1007/s00572-006-0073-6; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Brearley FQ, 2006, SOIL BIOL BIOCHEM, V38, P3407, DOI 10.1016/j.soilbio.2006.05.012; Brearley FQ, 2012, BIOTROPICA, V44, P637, DOI 10.1111/j.1744-7429.2012.00862.x; Bruns TD, 1998, MOL ECOL, V7, P257, DOI 10.1046/j.1365-294X.1998.00337.x; Co-David D, 2009, PERSOONIA, V23, P147, DOI 10.3767/003158509X480944; Curtet L., 1998, REV DIPTEROCARPS TAX, P5; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Diedhiou AG, 2010, ENVIRON MICROBIOL, V12, P2219, DOI 10.1111/j.1462-2920.2010.02183.x; Fanshawe D.B., 1952, 29 IMP FOR I; FASSI BRUNO, 1962, ALLIONIA [TURIN], V8, P121; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibbs AK, 1993, GEOLGOY GUIANA SHIEL; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Hammond DS, 1998, CONSERV BIOL, V12, P944, DOI 10.1046/j.1523-1739.1998.012005944.x; Henkel TW, 2012, BIODIVERS CONSERV, V21, P2195, DOI 10.1007/s10531-011-0166-1; Henkel TW, 2003, J TROP ECOL, V19, P417, DOI 10.1017/S0266467403003468; Henkel TW, 2002, MYCOL RES, V106, P515, DOI 10.1017/S0953756202005919; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Kennedy PG, 2003, J ECOL, V91, P1071, DOI 10.1046/j.1365-2745.2003.00829.x; Lilleskov EA, 2004, FEMS MICROBIOL ECOL, V49, P319, DOI 10.1016/j.femsec.2004.04.004; LONDONO AC, 1995, BRITTONIA, V47, P225, DOI 10.2307/2807116; Lopez-Quintero CA, 2012, BIODIVERS CONSERV, V21, P2221, DOI 10.1007/s10531-012-0280-8; MAGUIRE B, 1980, TAXON, V29, P225, DOI 10.2307/1220284; Maguire B, 1981, MEM NY BOT GARD, V32, P306; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; McCune B., 2011, PC ORD MULTIVARIATE; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Morris MH, 2009, FEMS MICROBIOL ECOL, V69, P274, DOI 10.1111/j.1574-6941.2009.00704.x; Morton CM, 1999, PLANT SYST EVOL, V216, P197, DOI 10.1007/BF01084398; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Moyersoen B, 2012, TROPICAL FORESTS, P93; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; SINGER R, 1979, Acta Amazonica, V9, P25; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith ME, 2009, NEW PHYTOL, V182, P295, DOI 10.1111/j.1469-8137.2009.02801.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2007, NEW PHYTOL, V175, P321, DOI 10.1111/j.1469-8137.2007.02104.x; Tedersoo L, 2011, MOL ECOL, V20, P3071, DOI 10.1111/j.1365-294X.2011.05145.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; White T., 1990, PCR PROTOCOLS GUIDE, P315; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	52	64	66	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55160	10.1371/journal.pone.0055160	http://dx.doi.org/10.1371/journal.pone.0055160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383090	Green Published, gold			2022-12-25	WOS:000314610600068
J	Alvarez, YD; Belingheri, AV; Bay, AEP; Javis, SE; Tedford, HW; Zamponi, G; Marengo, FD				Alvarez, Yanina D.; Veronica Belingheri, Ana; Perez Bay, Andres E.; Javis, Scott E.; Tedford, H. William; Zamponi, Gerald; Marengo, Fernando D.			The Immediately Releasable Pool of Mouse Chromaffin Cell Vesicles Is Coupled to P/Q-Type Calcium Channels via the Synaptic Protein Interaction Site	PLOS ONE			English	Article							BUFFERED CA2+ DIFFUSION; N-TYPE; NEUROTRANSMITTER RELEASE; SYNTAXIN 1A; EXOCYTOSIS; SECRETION; RIM; CA(V)2.2; MICRODOMAINS; CAPACITANCE	It is generally accepted that the immediately releasable pool is a group of readily releasable vesicles that are closely associated with voltage dependent Ca2+ channels. We have previously shown that exocytosis of this pool is specifically coupled to P/Q Ca2+ current. Accordingly, in the present work we found that the Ca2+ current flowing through P/Q-type Ca2+ channels is 8 times more effective at inducing exocytosis in response to short stimuli than the current carried by L-type channels. To investigate the mechanism that underlies the coupling between the immediately releasable pool and P/Q-type channels we transiently expressed in mouse chromaffin cells peptides corresponding to the synaptic protein interaction site of Cav2.2 to competitively uncouple P/Q-type channels from the secretory vesicle release complex. This treatment reduced the efficiency of Ca2+ current to induce exocytosis to similar values as direct inhibition of P/Q-type channels via v omega-agatoxin-IVA. In addition, the same treatment markedly reduced immediately releasable pool exocytosis, but did not affect the exocytosis provoked by sustained electric or high K+ stimulation. Together, our results indicate that the synaptic protein interaction site is a crucial factor for the establishment of the functional coupling between immediately releasable pool vesicles and P/Q-type Ca2+ channels.	[Alvarez, Yanina D.; Veronica Belingheri, Ana; Perez Bay, Andres E.; Marengo, Fernando D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias CONICET, Lab Fisiol & Biol Mol,Dept Fisiol & Biol Mol & Ce, Buenos Aires, DF, Argentina; [Javis, Scott E.; Tedford, H. William; Zamponi, Gerald] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Calgary	Marengo, FD (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias CONICET, Lab Fisiol & Biol Mol,Dept Fisiol & Biol Mol & Ce, Buenos Aires, DF, Argentina.	fernando@fbmc.fcen.uba.ar	Marengo, Fernando Diego/HHN-6611-2022	Marengo, Fernando D./0000-0002-4372-2092; Zamponi, Gerald W./0000-0002-0644-9066	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT 05-11661-2002, PICT 01002-2007, PICT 0029-2010]; Universidad de Buenos Aires (Argentina) [UBACyT X082 2004-2006, UBACyT X461 2008-2010, UBACyT 2011-2014]; CONICET (Argentina) [PIP 5847]; Canadian Institutes of Health Research; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina; Alberta Heritage Foundation for Medical Research (AHFMR)	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Universidad de Buenos Aires (Argentina)(University of Buenos Aires); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by grants PICT 05-11661-2002, PICT 01002-2007 and PICT 0029-2010 from Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina), UBACyT X082 2004-2006, UBACyT X461 2008-2010, and UBACyT 2011-2014 from Universidad de Buenos Aires (Argentina), PIP 5847 from CONICET (Argentina); and an operating grant to GZ from the Canadian Institutes of Health Research. YDA, AVB and AEPB held a Fellowship from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina. FDM is a CONICET researcher. HWT held a Fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR) and SEJ held an AHFMR Studentship. GZ is an AHFMR Scientist and a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Albillos A, 2000, J NEUROSCI, V20, P8323, DOI 10.1523/JNEUROSCI.20-22-08323.2000; Aldea M, 2002, J NEUROCHEM, V81, P911, DOI 10.1046/j.1471-4159.2002.00845.x; Alvarez YD, 2008, CELL CALCIUM, V43, P155, DOI 10.1016/j.ceca.2007.04.014; Alvarez YD, 2011, J NEUROCHEM, V116, P155, DOI 10.1111/j.1471-4159.2010.07108.x; Andres-Mateos E, 2005, EUR J NEUROSCI, V22, P2187, DOI 10.1111/j.1460-9568.2005.04385.x; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Bay AEP, 2007, AM J PHYSIOL-CELL PH, V293, pC1509, DOI 10.1152/ajpcell.00632.2006; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; Davies JN, 2011, BIOCHEM BIOPH RES CO, V411, P562, DOI 10.1016/j.bbrc.2011.06.185; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Elhamdani A, 1998, J NEUROSCI, V18, P6230; Engisch KL, 1996, J NEUROSCI, V16, P1359; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Giancippoli A, 2006, BIOPHYS J, V90, P1830, DOI 10.1529/biophysj.105.071647; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Graham ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017999; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Harkins AB, 2004, P NATL ACAD SCI USA, V101, P15219, DOI 10.1073/pnas.0401001101; Hernandez-Guijo JM, 1998, PFLUG ARCH EUR J PHY, V436, P75, DOI 10.1007/s004240050606; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jarvis SE, 2005, CELL CALCIUM, V37, P483, DOI 10.1016/j.ceca.2005.01.017; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Lara B, 1998, PFLUG ARCH EUR J PHY, V435, P472, DOI 10.1007/s004240050541; Lomax RB, 1997, AM J PHYSIOL-CELL PH, V272, pC476, DOI 10.1152/ajpcell.1997.272.2.C476; Marengo FD, 2000, BIOPHYS J, V79, P1800, DOI 10.1016/S0006-3495(00)76431-9; Marengo FD, 2005, CELL CALCIUM, V38, P87, DOI 10.1016/j.ceca.2005.06.006; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Moser T, 1997, J NEUROSCI, V17, P2314; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Prakriya M, 1999, J NEUROPHYSIOL, V81, P2267, DOI 10.1152/jn.1999.81.5.2267; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Santana F, 1999, N-S ARCH PHARMACOL, V360, P33, DOI 10.1007/s002109900041; Segura J, 2000, BIOPHYS J, V79, P1771, DOI 10.1016/S0006-3495(00)76429-0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SMITH PD, 1984, ANAL BIOCHEM, V143, P188, DOI 10.1016/0003-2697(84)90575-X; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200; Sun L, 2002, ANN NY ACAD SCI, V971, P244, DOI 10.1111/j.1749-6632.2002.tb04468.x; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Wykes RCE, 2007, J NEUROSCI, V27, P5236, DOI 10.1523/JNEUROSCI.3545-06.2007; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	61	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54846	10.1371/journal.pone.0054846	http://dx.doi.org/10.1371/journal.pone.0054846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382986	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800081
J	Crowder, DW; Dykstra, EA; Brauner, JM; Duffy, A; Reed, C; Martin, E; Peterson, W; Carriere, Y; Dutilleul, P; Owen, JP				Crowder, David W.; Dykstra, Elizabeth A.; Brauner, Jo Marie; Duffy, Anne; Reed, Caitlin; Martin, Emily; Peterson, Wade; Carriere, Yves; Dutilleul, Pierre; Owen, Jeb P.			West Nile Virus Prevalence across Landscapes Is Mediated by Local Effects of Agriculture on Vector and Host Communities	PLOS ONE			English	Article							CULEX-TARSALIS DIPTERA; COREGIONALIZATION ANALYSIS; MULTISCALE ASSESSMENT; SPATIAL RELATIONSHIPS; LARGE-SCALE; CULICIDAE; RISK; EPIDEMIOLOGY; DIVERSITY; OUTBREAKS	Arthropod-borne viruses (arboviruses) threaten the health of humans, livestock, and wildlife. West Nile virus (WNV), the world's most widespread arbovirus, invaded the United States in 1999 and rapidly spread across the county. Although the ecology of vectors and hosts are key determinants of WNV prevalence across landscapes, the factors shaping local vector and host populations remain unclear. Here, we used spatially-explicit models to evaluate how three land-use types (orchards, vegetable/forage crops, natural) and two climatic variables (temperature, precipitation) influence the prevalence of WNV infections and vector/host distributions at landscape and local spatial scales. Across landscapes, we show that orchard habitats were associated with greater prevalence of WNV infections in reservoirs (birds) and incidental hosts (horses), while increased precipitation was associated with fewer infections. At local scales, orchard habitats increased the prevalence of WNV infections in vectors (mosquitoes) and the abundance of mosquitoes and two key reservoir species, the American robin and the house sparrow. Thus, orchard habitats benefitted WNV vectors and reservoir hosts locally, creating focal points for the transmission of WNV at landscape scales in the presence of suitable climatic conditions.	[Crowder, David W.; Martin, Emily; Peterson, Wade; Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Dykstra, Elizabeth A.; Brauner, Jo Marie; Duffy, Anne; Reed, Caitlin] Washington State Dept Hlth, Olympia, WA USA; [Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Dutilleul, Pierre] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada	Washington State University; University of Arizona; McGill University	Crowder, DW (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	dcrowder@wsu.edu		Crowder, David/0000-0002-3720-1581; Scott, Emily/0000-0001-9295-9320; Owen, Jeb/0000-0002-2042-0526	United States Department of Agriculture (USDA) Agriculture and Food Research Initiative [2011-67012-30718]; USDA Risk Avoidance and Mitigation Program [2006-0207436]	United States Department of Agriculture (USDA) Agriculture and Food Research Initiative; USDA Risk Avoidance and Mitigation Program	This study was supported by United States Department of Agriculture (USDA) Agriculture and Food Research Initiative Project 2011-67012-30718 and USDA Risk Avoidance and Mitigation Program Project 2006-0207436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Benton, Yakima, Franklin, Columbia and Grant #1 Mosquito Control Districts, and the Kittitas County Local Health Department, for sharing their mosquito surveillance data. * Disclaimer. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views or policies of the Washington State Department of Health.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Carriere Y, 2004, ECOL APPL, V14, P1615, DOI 10.1890/03-5268; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Center for Disease Control, ARBONET; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Clements AN, 2010, BIOL MOSQUITOES; Darsie RF, 2004, IDENTIFICATION GEOGR; Dutilleul P, 2011, SPAT TEMP HET CONC A; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; ESRI, 2010, ARCGIS DESKT REL 10; FLUETSCH KM, 1994, ENVIRON TOXICOL CHEM, V13, P1651, DOI [10.1897/1552-8618(1994)13[1651:ANSADI]2.0.CO;2, 10.1002/etc.5620131015]; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Jones CE, 2012, J MED ENTOMOL, V49, P467, DOI 10.1603/ME11191; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kesavaraju B, 2012, AM J TROP MED HYG, V87, P359, DOI 10.4269/ajtmh.2012.11-0662; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lothrop HD, 2001, J MED ENTOMOL, V38, P325, DOI 10.1603/0022-2585-38.2.325; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Pelletier B, 2009, ENVIRON ECOL STAT, V16, P467, DOI 10.1007/s10651-008-0096-6; Pelletier B, 2009, ENVIRON ECOL STAT, V16, P439, DOI 10.1007/s10651-008-0090-z; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Rochlin I, 2009, AM J TROP MED HYG, V80, P661, DOI 10.4269/ajtmh.2009.80.661; SAS Institute, 2010, JMP 10 0; Service MW, 1997, J MED ENTOMOL, V34, P578; Shaman J, 2002, EMERG INFECT DIS, V8, P575, DOI 10.3201/eid0806.010417; The Mathworks Inc, 2008, MATLAB VERS R2008A; US Department of Agriculture National Agriculture Statistics Service Spatial Analysis Research Section, CROPL DAT LAYER; US Geological Survey Patuxent Wildlife Research Center, N AM BREED BIRD SURV; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Ward MP, 2009, VET RES COMMUN, V33, P461, DOI 10.1007/s11259-008-9192-1; Washington State Department of Health, W NIL VIR SURV MAPS; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Western Regional Climate Center, COOP CLIM DAT SUMM; Wimberly MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003744	44	36	37	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55006	10.1371/journal.pone.0055006	http://dx.doi.org/10.1371/journal.pone.0055006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383032	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800102
J	Hirai, H; Kamio, N; Huang, G; Matsusue, A; Ogino, S; Kimura, N; Satake, S; Ashihara, E; Imanishi, J; Tenen, DG; Maekawa, T				Hirai, Hideyo; Kamio, Naoka; Huang, Gang; Matsusue, Akiko; Ogino, Shinpei; Kimura, Nobuhiko; Satake, Sakiko; Ashihara, Eishi; Imanishi, Jiro; Tenen, Daniel G.; Maekawa, Taira			Cyclic AMP Responsive Element Binding Proteins Are Involved in 'Emergency' Granulopoiesis through the Upregulation of CCAAT/Enhancer Binding Protein beta	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; FACTOR-C/EBP-ALPHA; G-CSF; HEMATOPOIETIC-CELLS; GENE-TRANSCRIPTION; DEFICIENT MICE; NF-IL6 GENE; CREB; DIFFERENTIATION; EXPRESSION	In contrast to the definitive role of the transcription factor, CCAAT/Enhancer binding protein alpha (C/EBP alpha), in steady-state granulopoiesis, previous findings have suggested that granulopoiesis during emergency situations, such as infection, is dependent on C/EBP beta. In this study, a novel lentivirus-based reporter system was developed to elucidate the molecular switch required for C/EBP beta-dependency. The results demonstrated that two cyclic AMP responsive elements (CREs) in the proximal promoter region of C/EBP beta were involved in the positive regulation of C/EBP beta transcription during granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced differentiation of bone marrow cells. In addition, the transcripts of CRE binding (CREB) family proteins were readily detected in hematopoietic stem/progenitor cells. CREB was upregulated, phosphorylated and bound to the CREs in response to GM-CSF stimulation. Retroviral transduction of a dominant negative CREB mutant reduced C/EBP beta mRNA levels and significantly impaired the proliferation/differentiation of granulocyte precursors, while a constitutively active form of CREB facilitated C/EBP beta transcription. These data suggest that CREB proteins are involved in the regulation of granulopoiesis via C/EBP beta upregulation.	[Hirai, Hideyo; Kamio, Naoka; Matsusue, Akiko; Ogino, Shinpei; Kimura, Nobuhiko; Satake, Sakiko; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Huang, Gang] Div Expt Hematol, Cincinnati, OH USA; [Huang, Gang] Div Pathol, Cincinnati, OH USA; [Ashihara, Eishi] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Kyoto 607, Japan; [Imanishi, Jiro] Meiji Univ Integrat Med, Kyoto, Japan; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	Kyoto University; University System of Ohio; University of Cincinnati; Kyoto Pharmaceutical University; Harvard University; Harvard Medical School; National University of Singapore	Hirai, H (corresponding author), Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan.	hhirai@kuhp.kyoto-u.ac.jp		Tenen, Daniel/0000-0002-6423-3888	Mitsubishi Foundation; Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Yasuda Medical Foundation; Fujiwara Foundation; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Senshin Medical Research Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Cancer Center Research and Development Fund [23-A-23]; Grants-in-Aid for Scientific Research [23592678] Funding Source: KAKEN	Mitsubishi Foundation; Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Yasuda Medical Foundation; Fujiwara Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Mitsubishi Foundation, Mitsubishi Pharma Research Foundation, the Kanae Foundation for the Promotion of Medical Science, the Yasuda Medical Foundation, the Fujiwara Foundation, Takeda Science Foundation (to HH), the Kobayashi Foundation for Cancer Research, and Senshin Medical Research Foundation (to TM), and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to HH, EA and TM), the Global COE Program 'Center for Frontier Medicine' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to TM) and the National Cancer Center Research and Development Fund (23-A-23) (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Akasaka K, 1999, CELL MOL BIOL, V45, P555; Basu S, 2000, BLOOD, V95, P3725; Berrier A, 1998, J IMMUNOL, V161, P2267; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Foka P, 2001, BIOCHEM BIOPH RES CO, V285, P430, DOI 10.1006/bbrc.2001.5203; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hirai H, 2005, BLOOD, V106, P1948, DOI 10.1182/blood-2004-12-4872; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Kamio N, 2010, BIOCHEM BIOPH RES CO, V393, P498, DOI 10.1016/j.bbrc.2010.02.033; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Lin WC, 2002, DNA CELL BIOL, V21, P551, DOI 10.1089/104454902320308924; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Nerlov C, 2010, BIOESSAYS, V32, P680, DOI 10.1002/bies.201000004; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Parker D, 1996, MOL CELL BIOL, V16, P694; Pigazzi M, 2008, LEUKEMIA, V22, P2217, DOI 10.1038/leu.2008.244; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang YM, 2002, BBA-GENE STRUCT EXPR, V1577, P102, DOI 10.1016/S0167-4781(02)00401-3; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54862	10.1371/journal.pone.0054862	http://dx.doi.org/10.1371/journal.pone.0054862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382991	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800084
J	Juraschek, SP; Shantha, GPS; Chu, AY; Miller, ER; Guallar, E; Hoogeveen, RC; Ballantyne, CM; Brancati, FL; Schmidt, MI; Pankow, JS; Young, JH				Juraschek, Stephen P.; Shantha, Ghanshyam Palamaner Subash; Chu, Audrey Y.; Miller, Edgar R., III; Guallar, Eliseo; Hoogeveen, Ron C.; Ballantyne, Christie M.; Brancati, Frederick L.; Schmidt, Maria Ines; Pankow, James S.; Young, J. Hunter			Lactate and Risk of Incident Diabetes in a Case-Cohort of the Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; 1ST-DEGREE RELATIVES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; GLUCOSE; MELLITUS; RELEASE; OBESITY; INFLAMMATION	Background: Oxidative capacity is decreased in type 2 diabetes. Whether decreased oxidative capacity is a cause or consequence of diabetes is unknown. Our purpose is to evaluate whether lactate, a marker of oxidative capacity, is associated with incident diabetes. Methods and Findings: We conducted a case-cohort study in the Atherosclerosis Risk in Communities (ARIC) study at year 9 of follow-up. We evaluated lactate's association with diabetes risk factors at baseline and estimated the hazard ratio for incident diabetes by quartiles of plasma lactate in 544 incident diabetic cases and 533 non-cases. Plasma lactate showed a graded positive relationship with fasting glucose and insulin (P < 0.001). The relative hazard for incident diabetes increased across lactate quartiles (P-trend <= 0.001). Following adjustment for demographic factors, medical history, physical activity, adiposity, and serum lipids, the hazard ratio in the highest quartile was 2.05 times the hazard in the lowest quartile (95% CI: 1.28, 3.28). After including fasting glucose and insulin the association became non-significant. Conclusions: Lactate, an indicator of oxidative capacity, predicts incident diabetes independent of many other risk factors and is strongly related to markers of insulin resistance. Future studies should evaluate the temporal relationship between elevated lactate and impaired fasting glucose and insulin resistance.	[Juraschek, Stephen P.; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Juraschek, Stephen P.; Shantha, Ghanshyam Palamaner Subash; Miller, Edgar R., III; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Med Inst, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Juraschek, Stephen P.; Shantha, Ghanshyam Palamaner Subash; Miller, Edgar R., III; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Chu, Audrey Y.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Miller, Edgar R., III; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA; [Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Grad Studies Program Epidemiol, Sch Med, Porto Alegre, RS, Brazil; [Schmidt, Maria Ines] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Young, JH (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	jhyoung@jhmi.edu	Guallar, Eliseo/D-3807-2014; Schmidt, Maria Inês/AGT-5691-2022; Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGP-6441-2022; Ballantyne, Christie/A-6599-2008	Guallar, Eliseo/0000-0002-4471-9565; Schmidt, Maria Inês/0000-0002-3837-0731; Ballantyne, Christie/0000-0002-6432-1730; Juraschek, Stephen/0000-0003-4168-2696; Pankow, James/0000-0001-7076-483X; Hoogeveen, Ron/0000-0003-2399-4653	National Institutes of Health/National Heart, Lung, and Blood Institute [T32HL007024]; P60 Diabetes P & C Core of the Diabetes Research Training Center [5P60DK079637-04]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055022, N01HC055021, N01HC055020, N01HC055018, N01HC055015, N01HC055019, N01HC055016] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024, T32HL007575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); P60 Diabetes P & C Core of the Diabetes Research Training Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SPJ is supported in part by a National Institutes of Health/National Heart, Lung, and Blood Institute T32HL007024 Cardiovascular Epidemiology Training Grant. This work was supported by P60 Diabetes P & C Core of the Diabetes Research Training Center (5P60DK079637-04). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieff A. I., 1987, AM J PHYSIOL-ENDOC M, V253, P271; Avogaro A, 1996, J CLIN INVEST, V98, P108, DOI 10.1172/JCI118754; BARHAM D, 1972, ANALYST, V97, P142, DOI 10.1039/an9729700142; Bernal-Mizrachi C, 2006, NAT MED, V12, P46, DOI 10.1038/nm0106-46; Bjorntorp P, 1967, Diabetologia, V3, P346, DOI 10.1007/BF00429867; Brecher AS, 1996, ALCOHOL, V13, P553, DOI 10.1016/S0741-8329(96)00067-5; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; CHEN YDI, 1993, DIABETES METAB, V19, P348; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; CRANDALL DL, 1983, HORM METAB RES, V15, P326, DOI 10.1055/s-2007-1018710; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; Dela F, 2010, AM J PHYSIOL-ENDOC M, V299, pE80, DOI 10.1152/ajpendo.00765.2009; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Gladden LB, 2008, MED SCI SPORT EXER, V40, P477, DOI [10.1249/mss.0b013e31815fa580, 10.1249/MSS.0b013e31815fa580]; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOWELL R. RODNEY, 1965, ARTHRITIS RHEUM, V8, P780, DOI 10.1002/art.1780080441; Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE1137, DOI 10.1210/jc.2010-2863; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; OHLSON LO, 1988, DIABETOLOGIA, V31, P798; Ostergard T, 2006, AM J PHYSIOL-ENDOC M, V290, pE998, DOI 10.1152/ajpendo.00012.2005; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Sandqvist MM, 2001, DIABETES, V50, P2344, DOI 10.2337/diabetes.50.10.2344; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Skov V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002466; Stefanovski D, 2012, DIABETES CARE, V35, P1015, DOI 10.2337/dc11-1540; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Woerle HJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE67, DOI 10.1152/ajpendo.00529.2004; Ye JP, 2011, CURR DIABETES REP, V11, P203, DOI 10.1007/s11892-011-0183-1; YKIJARVINEN H, 1990, METABOLISM, V39, P859, DOI 10.1016/0026-0495(90)90133-W; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716	54	41	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55113	10.1371/journal.pone.0055113	http://dx.doi.org/10.1371/journal.pone.0055113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383072	Green Published, gold			2022-12-25	WOS:000315563800111
J	Kramer, S; Bannerman-Chukualim, B; Ellis, L; Boulden, EA; Kelly, S; Field, MC; Carrington, M				Kramer, Susanne; Bannerman-Chukualim, Bridget; Ellis, Louise; Boulden, Elizabeth A.; Kelly, Steve; Field, Mark C.; Carrington, Mark			Differential Localization of the Two T-brucei Poly(A) Binding Proteins to the Nucleus and RNP Granules Suggests Binding to Distinct mRNA Pools	PLOS ONE			English	Article							EUKARYOTIC TRANSLATION INITIATION; CYTOPLASMIC PROCESSING BODIES; P-BODY FORMATION; POLY(A)-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; STRESS GRANULES; GENE-EXPRESSION; MAXIMUM-LIKELIHOOD; MIXED MODELS	The number of paralogs of proteins involved in translation initiation is larger in trypanosomes than in yeasts or many metazoan and includes two poly(A) binding proteins, PABP1 and PABP2, and four eIF4E variants. In many cases, the paralogs are individually essential and are thus unlikely to have redundant functions although, as yet, distinct functions of different isoforms have not been determined. Here, trypanosome PABP1 and PABP2 have been further characterised. PABP1 and PABP2 diverged subsequent to the differentiation of the Kinetoplastae lineage, supporting the existence of specific aspects of translation initiation regulation. PABP1 and PABP2 exhibit major differences in intracellular localization and distribution on polysome fractionation under various conditions that interfere with mRNA metabolism. Most striking are differences in localization to the four known types of inducible RNP granules. Moreover, only PABP2 but not PABP1 can accumulate in the nucleus. Taken together, these observations indicate that PABP1 and PABP2 likely associate with distinct populations of mRNAs. The differences in localization to inducible RNP granules also apply to paralogs of components of the eIF4F complex: eIF4E1 showed similar localization pattern to PABP2, whereas the localisation of eIF4E4 and eIF4G3 resembled that of PABP1. The grouping of translation initiation as either colocalizing with PABP1 or with PABP2 can be used to complement interaction studies to further define the translation initiation complexes in kinetoplastids.	[Kramer, Susanne; Bannerman-Chukualim, Bridget; Ellis, Louise; Boulden, Elizabeth A.; Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QW, England; [Kelly, Steve] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, Steve] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Cambridge; University of Cambridge; University of Oxford; University of Oxford	Carrington, M (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mc115@cam.ac.uk	Kelly, Steven/F-7237-2011; Carrington, Mark/N-3653-2019; Field, Mark/AAD-6455-2021; Carrington, Mark/N-4892-2018	Kelly, Steven/0000-0001-8583-5362; Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Field, Mark/0000-0002-4866-2885	Wellcome Trust [085956/Z/08/Z]; Deutsche Forschungsgemeinschaft [Kr4017/1-1]; BBSRC [BB/D020190/1]; Schumberger Foundation; Faculty for the Future (BBC); EAB a Nuffield Foundation Vacation Bursary.; Biotechnology and Biological Sciences Research Council [BB/D020190/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Schumberger Foundation; Faculty for the Future (BBC); EAB a Nuffield Foundation Vacation Bursary.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust (085956/Z/08/Z) (MC), the Deutsche Forschungsgemeinschaft (Kr4017/1-1) (SKr), the BBSRC (BB/D020190/1) (SKe) and the Schumberger Foundation, Faculty for the Future (BBC). LE received a BBSRC Ph.D. studentship and EAB a Nuffield Foundation Vacation Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Bag J, 2010, RNA BIOL, V7, P5, DOI 10.4161/rna.7.1.10256; Bates EJ, 2000, NUCLEIC ACIDS RES, V28, P1211, DOI 10.1093/nar/28.5.1211; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Belostotsky DA, 2003, GENETICS, V163, P311; BELOSTOTSKY DA, 1993, P NATL ACAD SCI USA, V90, P6686, DOI 10.1073/pnas.90.14.6686; Belostotsky DA, 1996, PLANT CELL, V8, P1261, DOI 10.1105/tpc.8.8.1261; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bravo J, 2005, MOL GENET GENOMICS, V272, P651, DOI 10.1007/s00438-004-1090-9; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brook M, 2012, BIOCHEM J, V441, P803, DOI 10.1042/BJ20111474; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Burgess HM, 2010, BIOCHEM SOC T, V38, P1517, DOI 10.1042/BST0381517; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; Dhalia R, 2005, MOL BIOCHEM PARASIT, V140, P23, DOI 10.1016/j.molbiopara.2004.12.001; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Freire ER, 2011, MOL BIOCHEM PARASIT, V176, P25, DOI 10.1016/j.molbiopara.2010.11.011; Friend K, 2012, BIOCHEM J, V445, P93, DOI 10.1042/BJ20120304; GONZALEZ CI, 2007, TRANSLATIONAL CONTRO, P719; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guerra N, 2011, FEBS LETT, V585, P193, DOI 10.1016/j.febslet.2010.11.042; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall BS, 2005, EUKARYOT CELL, V4, P971, DOI 10.1128/EC.4.5.971-980.2005; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; HILSON P, 1993, PLANT PHYSIOL, V103, P525, DOI 10.1104/pp.103.2.525; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Hotchkiss TL, 1999, MOL BIOCHEM PARASIT, V98, P117, DOI 10.1016/S0166-6851(98)00156-X; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kramer S, 2012, J CELL SCI; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Liu Y, 1996, EMBO J, V15, P6750, DOI 10.1002/j.1460-2075.1996.tb01064.x; Marchetti MA, 2000, J CELL SCI, V113, P899; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Mittra B, 2004, EUKARYOT CELL, V3, P1185, DOI 10.1128/EC.3.5.1185-1197.2004; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Palanivelu R, 2000, PLANT J, V22, P199, DOI 10.1046/j.1365-313x.2000.00720.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pitula J, 1998, EXP PARASITOL, V88, P157, DOI 10.1006/expr.1998.4211; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Sunter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035167; Tani T, 1996, MOL BIOL CELL, V7, P173, DOI 10.1091/mbc.7.1.173; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; Vazquez-Pianzola P, 2011, DEV BIOL, V357, P404, DOI 10.1016/j.ydbio.2011.07.009; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; WOODWARD R, 1990, J CELL SCI, V95, P49; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Yoffe Y, 2009, NUCLEIC ACIDS RES, V37, P3243, DOI 10.1093/nar/gkp190; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	86	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54004	10.1371/journal.pone.0054004	http://dx.doi.org/10.1371/journal.pone.0054004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382864	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800029
J	Lovy, M; Skliba, J; Sumbera, R				Loevy, Matej; Skliba, Jan; Sumbera, Radim			Spatial and Temporal Activity Patterns of the Free-Living Giant Mole-Rat (Fukomys mechowii), the Largest Social Bathyergid	PLOS ONE			English	Article							CRYPTOMYS-HOTTENTOTUS-HOTTENTOTUS; CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; COLONY; DAMARENSIS; RODENTIA; SOLITARY; EUSOCIALITY; ORGANIZATION; DISPERSAL	Despite the considerable attention devoted to the biology of social species of African mole-rats (Bathyergidae, Rodentia), knowledge is lacking about their behaviour under natural conditions. We studied activity of the largest social bathyergid, the giant mole-rat Fukomys mechowii, in its natural habitat in Zambia using radio-telemetry. We radio-tracked six individuals during three continuous 72-h sessions. Five of these individuals, including a breeding male, belonged to a single family group; the remaining female was probably a solitary disperser. The non-breeders of the family were active (i.e. outside the nest) 5.8 hours per 24h-day with the activity split into 6.5 short bouts. The activity was more concentrated in the night hours, when the animals also travelled longer distances from the nest. The breeding male spent only 3.2 hours per day outside the nest, utilizing less than 20% of the whole family home range. The dispersing female displayed a much different activity pattern than the family members. Her 8.0 hours of outside-nest activity per day were split into 4.6 bouts which were twice as long as in the family non-breeders. Her activity peak in the late afternoon coincided with the temperature maximum in the depth of 10 cm (roughly the depth of the foraging tunnels). Our results suggest that the breeding individuals (at least males) contribute very little to the work of the family group. Nevertheless, the amount of an individual's activity and its daily pattern are probably flexible in this species and can be modified in response to actual environmental and social conditions.	[Loevy, Matej; Skliba, Jan; Sumbera, Radim] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Lovy, M (corresponding author), Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic.	mates.lovy@gmail.com	Lövy, Matěj/AGN-3116-2022; Šumbera, Radim/D-9072-2016	Lövy, Matěj/0000-0002-6451-2393; Šumbera, Radim/0000-0001-8658-9378; Skliba, Jan/0000-0002-0567-9302	Grant Agency of the University of South Bohemia [04-136/2010/P]; Czech Science Foundation [P506/11/1512]; Grant Agency of the Academy of Sciences of the Czech Republic [KJB601410826]	Grant Agency of the University of South Bohemia; Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work was supported by the Grant Agency of the University of South Bohemia (04-136/2010/P, to ML), the Czech Science Foundation (P506/11/1512, to RS, gacr.cz) and the Grant Agency of the Academy of Sciences of the Czech Republic (KJB601410826, to JS, gaav.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEDIX JH, 1994, ANIM BEHAV, V48, P501, DOI 10.1006/anbe.1994.1271; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; BENNETT NC, 1992, J ZOOL, V228, P435, DOI 10.1111/j.1469-7998.1992.tb04446.x; BENNETT NC, 1990, J ZOOL, V220, P225, DOI 10.1111/j.1469-7998.1990.tb04305.x; BENNETT NC, 1994, OECOLOGIA, V97, P222, DOI 10.1007/BF00323153; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Brett R.A., 1991, P137; BURDA H, 1993, NATURWISSENSCHAFTEN, V80, P235, DOI 10.1007/BF01175742; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Dammann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018757; de Vries JL, 2008, J ZOOL, V276, P343, DOI 10.1111/j.1469-7998.2008.00496.x; Favreau A, 2009, ANIM BEHAV, V77, P983, DOI 10.1016/j.anbehav.2009.01.004; Gaylard A, 1998, J ZOOL, V244, P313, DOI 10.1017/S095283699800301X; Hazell RWA, 2000, J ZOOL, V252, P19; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Jarvis JUM, 1998, OECOLOGIA, V113, P290, DOI 10.1007/s004420050380; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Kawalika M, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P205, DOI 10.1007/978-3-540-69276-8_15; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; Lacey E.A., 1991, P275; LAVER P. N., 2005, ABODE KERNEL HOME RA; Lovegrove B.G., 1987, Koedoe, V30, P149; LOVEGROVE BG, 1995, PHYSIOL BEHAV, V58, P679, DOI 10.1016/0031-9384(95)00106-S; LOVEGROVE BG, 1988, J ZOOL, V216, P391, DOI 10.1111/j.1469-7998.1988.tb02437.x; Lovy M, 2012, J ZOOL, V286, P145, DOI 10.1111/j.1469-7998.2011.00860.x; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Nemec P, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P129, DOI 10.1007/978-3-540-69276-8_11; Nevo, 1999, MOSAIC EVOLUTION SUB; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; ORiain MJ, 1996, NATURE, V380, P619, DOI 10.1038/380619a0; RADO R, 1993, CAN J ZOOL, V71, P1733, DOI 10.1139/z93-245; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Rezende EL, 2003, J ARID ENVIRON, V55, P63, DOI 10.1016/S0140-1963(02)00259-8; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Scantlebury M, 2006, NATURE, V440, P795, DOI 10.1038/nature04578; Scharff A, 2001, J MAMMAL, V82, P1003, DOI 10.1644/1545-1542(2001)082<1003:NHOTGM>2.0.CO;2; Schielke CKM, 2012, MAMM BIOL, V77, P1, DOI 10.1016/j.mambio.2011.09.004; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Skliba J, 2007, J MAMMAL, V88, P1009, DOI 10.1644/06-MAMM-A-235R1.1; Skliba J, 2009, ETHOLOGY, V115, P217, DOI 10.1111/j.1439-0310.2008.01604.x; Spinks AC, 1999, OIKOS, V85, P435, DOI 10.2307/3546693; StatSoft Inc, 2010, STATISTICA DAT AN SO; Sumbera R, 2007, PHYSIOL BEHAV, V92, P526, DOI 10.1016/j.physbeh.2007.04.029; Sumbera R, 2012, ACTA THERIOL, V57, P121, DOI 10.1007/s13364-011-0059-4; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Wallace ED, 1998, J ZOOL, V244, P51, DOI 10.1111/j.1469-7998.1998.tb00006.x	48	38	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55357	10.1371/journal.pone.0055357	http://dx.doi.org/10.1371/journal.pone.0055357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383166	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800145
J	Yokochi, N; Tanaka, S; Matsumoto, K; Oishi, H; Tashiro, Y; Yoshikane, Y; Nakashima, M; Kanda, K; Kobayashi, G				Yokochi, Nana; Tanaka, Shigemitsu; Matsumoto, Kouichi; Oishi, Hirotaka; Tashiro, Yukihiro; Yoshikane, Yu; Nakashima, Mikio; Kanda, Kohzo; Kobayashi, Genta			Distribution of Virulence Markers among Vibrio vulnificus Isolates of Clinical and Environmental Origin and Regional Characteristics in Japan	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CAPSULAR POLYSACCHARIDE OPERON; OLIGONUCLEOTIDE PROBES; PHENOTYPIC METHODS; PCR; EPIDEMIOLOGY; IDENTIFICATION; SEPTICEMIA; INFECTION; STRAINS	Background: Vibrio vulnificus is an opportunistic human pathogen that is widely distributed in estuarine environments and is capable of causing necrotizing fasciitis and sepsis. In Japan, based on epidemiological research, the incidences of V. vulnificus were concentrated in Kyusyu, mainly in coastal areas of the Ariake Sea. To examine the virulence potential, various genotyping methods have recently been developed. This study aimed to investigate the distribution of virulence markers among V. vulnificus isolates of clinical and environmental origin in three coastal areas with different infection incidences and to determine whether these isolates have the siderophore encoding gene viuB. Methodology/Principal Findings: We examined the distribution of genotypes of the 16S ribosomal ribonucleic acid (rRNA) gene, vvhA, vcg, and capsular polysaccharide (CPS), and the presence of viuB in 156 isolates collected from patients and environmental samples in Japan. The environmental samples were collected from three coastal areas: the Ariake Sea, Ise & Mikawa Bay, and Karatsu Bay. The results showed disparity in the ratios of genotypes depending on the sample origins. V. vulnificus isolates obtained from patients were classified into the clinical type for all genotypes. In the environmental isolates, the ratios of the clinical type for genotypes of the 16S rRNA gene, vvhA, and vcg were in the order of the Ariake Sea>Ise & Mikawa Bay>Karatsu Bay. Meanwhile, CPS analysis showed no significant difference. Most isolates possessed viuB. Conclusions: Many V. vulnificus belonging to the clinical type existed in the Ariake Sea. Three coastal areas with different infection incidences showed distinct ratios of genotypes. This may indicate that the distribution of clinical isolates correlates with the incidence of V. vulnificus infection.	[Yokochi, Nana; Kanda, Kohzo; Kobayashi, Genta] Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga 840, Japan; [Tanaka, Shigemitsu] Osaka Municipal Tech Res Inst, Biomat & Commod Chem Res Div, Osaka 536, Japan; [Matsumoto, Kouichi; Oishi, Hirotaka; Nakashima, Mikio] Saga Univ, Fac Med, Dept Anesthesiol & Crit Care Med, Saga 840, Japan; [Tashiro, Yukihiro] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka, Japan; [Yoshikane, Yu] Kochi Univ, Tosa Food Business Creator Project Team, Nankoku, Kochi, Japan	Saga University; Saga University; Kyushu University; Kochi University	Kobayashi, G (corresponding author), Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga 840, Japan.	gentak@cc.saga-u.ac.jp		Matsumoto, Kouichi/0000-0002-5743-3822; Tashiro, Yukihiro/0000-0003-3245-7227	Ariake Sea Research Project, Saga University, Japan	Ariake Sea Research Project, Saga University, Japan	This study was supported by the Ariake Sea Research Project, Saga University, Japan (http://www.ariake.civil.saga-u.ac.jp/index_e.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acinas SG, 1999, APPL ENVIRON MICROB, V65, P514; AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Bertilsson S, 2002, APPL ENVIRON MICROB, V68, P6077, DOI 10.1128/AEM.68.12.6077-6086.2002; Biosca EG, 1997, APPL ENVIRON MICROB, V63, P1460, DOI 10.1128/AEM.63.4.1460-1466.1997; Bisharat N, 1999, LANCET, V354, P1421, DOI 10.1016/S0140-6736(99)02471-X; Bisharat N, 1996, LANCET, V348, P1585, DOI 10.1016/S0140-6736(05)66199-5; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Colodner R, 2004, J CLIN MICROBIOL, V42, P4137, DOI 10.1128/JCM.42.9.4137-4140.2004; Dalsgaard A, 1996, EUR J CLIN MICROBIOL, V15, P227, DOI 10.1007/BF01591359; DePaola A, 2003, APPL ENVIRON MICROB, V69, P4006, DOI 10.1128/AEM.69.7.4006-4011.2003; Han FF, 2009, FOODBORNE PATHOG DIS, V6, P1251, DOI 10.1089/fpd.2009.0343; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Hsueh PR, 2004, EMERG INFECT DIS, V10, P1363, DOI 10.3201/eid1008.040047; Inoue Y, 2008, J DERMATOL, V35, P129, DOI 10.1111/j.1346-8138.2008.00432.x; Inoue Y, 2007, BIOSCI TRENDS, V1, P134; Jones MK, 2008, APPL ENVIRON MICROB, V74, P182, DOI 10.1128/AEM.02436-07; Kim MS, 2001, AQUACULTURE, V193, P199, DOI 10.1016/S0044-8486(00)00495-6; Mahmud ZH, 2008, FEMS MICROBIOL ECOL, V64, P209, DOI 10.1111/j.1574-6941.2008.00460.x; Matsumoto K, 2010, J INFECT CHEMOTHER, V16, P272, DOI 10.1007/s10156-010-0050-z; MAXWELL EL, 1991, MED J AUSTRALIA, V154, P214, DOI 10.5694/j.1326-5377.1991.tb121039.x; MELHUS A, 1995, SCAND J INFECT DIS, V27, P81, DOI 10.3109/00365549509018980; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oishi Hirotaka, 2006, Kansenshogaku Zasshi, V80, P680; Panicker G, 2004, CAN J MICROBIOL, V50, P911, DOI 10.1139/W04-085; PARK SD, 1991, J AM ACAD DERMATOL, V24, P397, DOI 10.1016/0190-9622(91)70059-B; Powell JL, 1997, INFECT IMMUN, V65, P3713, DOI 10.1128/IAI.65.9.3713-3718.1997; Randa MA, 2004, APPL ENVIRON MICROB, V70, P5469, DOI 10.1128/AEM.70.9.5469-5476.2004; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Sanjuan E, 2009, APPL ENVIRON MICROB, V75, P1604, DOI 10.1128/AEM.01594-08; Senoh M, 2005, MICROBIOL IMMUNOL, V49, P513, DOI 10.1111/j.1348-0421.2005.tb03756.x; SIMPSON LM, 1987, INFECT IMMUN, V55, P269, DOI 10.1128/IAI.55.1.269-272.1987; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Wright AC, 2001, INFECT IMMUN, V69, P6893, DOI 10.1128/IAI.69.11.6893-6901.2001; Yahiro S, 2008, KUMAMOTO PREFECTURAL, V38, P27	38	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55219	10.1371/journal.pone.0055219	http://dx.doi.org/10.1371/journal.pone.0055219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383115	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800133
J	Reen, FJ; Haynes, JM; Mooij, MJ; O'Gara, F				Reen, F. Jerry; Haynes, Jill M.; Mooij, Marlies J.; O'Gara, Fergal			A Non-Classical LysR-Type Transcriptional Regulator PA2206 Is Required for an Effective Oxidative Stress Response in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SALMONELLA-TYPHIMURIUM; SINORHIZOBIUM-MELILOTI; OPPORTUNISTIC PATHOGEN; HUMAN NEUTROPHILS; GENE-EXPRESSION; FULL VIRULENCE; OXYR	LysR-type transcriptional regulators (LTTRs) are emerging as key circuit components in regulating microbial stress responses and are implicated in modulating oxidative stress in the human opportunistic pathogen Pseudomonas aeruginosa. The oxidative stress response encapsulates several strategies to overcome the deleterious effects of reactive oxygen species. However, many of the regulatory components and associated molecular mechanisms underpinning this key adaptive response remain to be characterised. Comparative analysis of publically available transcriptomic datasets led to the identification of a novel LTTR, PA2206, whose expression was altered in response to a range of host signals in addition to oxidative stress. PA2206 was found to be required for tolerance to H2O2 in vitro and lethality in vivo in the Zebrafish embryo model of infection. Transcriptomic analysis in the presence of H2O2 showed that PA2206 altered the expression of 58 genes, including a large repertoire of oxidative stress and iron responsive genes, independent of the master regulator of oxidative stress, OxyR. Contrary to the classic mechanism of LysR regulation, PA2206 did not autoregulate its own expression and did not influence expression of adjacent or divergently transcribed genes. The PA2214-15 operon was identified as a direct target of PA2206 with truncated promoter fragments revealing binding to the 5'-ATTGCCTGGGGTTAT-3' LysR box adjacent to the predicted -35 region. PA2206 also interacted with the pvdS promoter suggesting a global dimension to the PA2206 regulon, and suggests PA2206 is an important regulatory component of P. aeruginosa adaptation during oxidative stress.	[Reen, F. Jerry; Haynes, Jill M.; Mooij, Marlies J.; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	University College Cork	O'Gara, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	f.ogara@ucc.ie	Reen, Jerry/AAG-7155-2019	O'Gara, Fergal/0000-0002-2659-0673; Reen, F. Jerry/0000-0002-7717-9892	European Commission [MTKD-CT-2006-042062, O36314, FP7-PEOPLE-2009-RG, EU 256596]; Science Foundation Ireland [SFI 04/BR/B0597, 07/IN.1/B948, 08/RFP/GEN1295, 08/RFP/GEN1319, 09/RFP/BMT2350]; Department of Agriculture and Food [DAF RSF 06 321, DAF RSF 06 377, FIRM 08/RDC/629]; Irish Research Council for Science, Engineering and Technology [05/EDIV/FP107, PD/2011/2414]; Health Research Board [RP/2006/271, RP/2007/290, HRA/2009/146]; Environmental Protection Agency [EPA2006-PhD-S-21, EPA2008-PhD-S-2]; Marine Institute [C2CRA 2007/082]; Higher Education Authority of Ireland [PRTLI3]; Health Service Executive (HSE) surveillance fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture and Food(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; Environmental Protection Agency(United States Environmental Protection Agency); Marine Institute; Higher Education Authority of Ireland; Health Service Executive (HSE) surveillance fund	This research was supported in part by grants awarded by the European Commission (MTKD-CT-2006-042062; O36314; FP7-PEOPLE-2009-RG, EU 256596, 2010-2013), Science Foundation Ireland (SFI 04/BR/B0597; 07/IN.1/B948; 08/RFP/GEN1295; 08/RFP/GEN1319; 09/RFP/BMT2350), the Department of Agriculture and Food (DAF RSF 06 321; DAF RSF 06 377; FIRM 08/RDC/629), the Irish Research Council for Science, Engineering and Technology (05/EDIV/FP107; PD/2011/2414), the Health Research Board (RP/2006/271; RP/2007/290; HRA/2009/146), the Environmental Protection Agency (EPA2006-PhD-S-21; EPA2008-PhD-S-2), the Marine Institute (Beaufort award C2CRA 2007/082), the Higher Education Authority of Ireland (PRTLI3) and the Health Service Executive (HSE) surveillance fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braz VS, 2010, J BACTERIOL, V192, P5480, DOI 10.1128/JB.00496-10; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Cheung DOY, 2000, INFECT IMMUN, V68, P4585, DOI 10.1128/IAI.68.8.4585-4592.2000; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; CORNELIS P, 1992, J GEN MICROBIOL, V138, P1337, DOI 10.1099/00221287-138-7-1337; Fargier E, 2012, J BACTERIOL, V194, P3502, DOI 10.1128/JB.06632-11; Flores-Cruz Z, 2011, APPL ENVIRON MICROB, V77, P6426, DOI 10.1128/AEM.05813-11; Fradrich C, 2012, J BACTERIOL, V194, P1100, DOI 10.1128/JB.06425-11; Frisk A, 2004, INFECT IMMUN, V72, P5433, DOI 10.1128/IAI.72.9.5433-5438.2004; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gonzalez-Flecha B, 1999, J BACTERIOL, V181, P3833; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Harris AG, 2002, MICROBIOL-SGM, V148, P3813, DOI 10.1099/00221287-148-12-3813; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; HOIBY N, 1990, THORAX, V45, P881, DOI 10.1136/thx.45.11.881; HRYNIEWICZ MM, 1994, J BACTERIOL, V176, P3673, DOI 10.1128/JB.176.12.3673-3682.1994; Imperi F, 2010, ENVIRON MICROBIOL, V12, P1630, DOI 10.1111/j.1462-2920.2010.02210.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Johnson JR, 2006, INFECT IMMUN, V74, P461, DOI 10.1128/IAI.74.1.461-468.2006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lau GW, 2005, INFECT IMMUN, V73, P2550, DOI 10.1128/IAI.73.4.2550-2553.2005; Lee JS, 2005, INFECT IMMUN, V73, P4399, DOI 10.1128/IAI.73.7.4399-4403.2005; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; MacLean AM, 2008, J BACTERIOL, V190, P1237, DOI 10.1128/JB.01456-07; MacLean AM, 2011, MICROBIOL-SGM, V157, P2522, DOI 10.1099/mic.0.050542-0; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mailloux RJ, 2011, ANTON LEEUW INT J G, V99, P433, DOI 10.1007/s10482-010-9538-x; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Melstrom KA, 2007, J SURG RES, V143, P50, DOI 10.1016/j.jss.2007.02.046; NEU HC, 1983, J ANTIMICROB CHEMOTH, V11, P1; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; PAPPSZABO E, 1994, INFECT IMMUN, V62, P2662; PARSEK MR, 1994, P NATL ACAD SCI USA, V91, P12393, DOI 10.1073/pnas.91.26.12393; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Salva PS, 1996, PEDIATR PULM, V21, P11, DOI 10.1002/(SICI)1099-0496(199601)21:1<11::AID-PPUL2>3.0.CO;2-T; Sambrook J., 2002, MOL CLONING LAB MANU; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Turlin E, 2005, RES MICROBIOL, V156, P312, DOI 10.1016/j.resmic.2004.10.012; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Vinckx T, 2010, MICROBIOL-SGM, V156, P678, DOI 10.1099/mic.0.031971-0; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Wilson R, 1996, EUR RESPIR J, V9, P1523, DOI 10.1183/09031936.96.09071523; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861	62	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54479	10.1371/journal.pone.0054479	http://dx.doi.org/10.1371/journal.pone.0054479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382903	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500013
J	Codolo, G; Plotegher, N; Pozzobon, T; Brucale, M; Tessari, I; Bubacco, L; de Bernard, M				Codolo, Gaia; Plotegher, Nicoletta; Pozzobon, Tommaso; Brucale, Marco; Tessari, Isabella; Bubacco, Luigi; de Bernard, Marina			Triggering of Inflammasome by Aggregated alpha-Synuclein, an Inflammatory Response in Synucleinopathies	PLOS ONE			English	Article							STATISTICAL-MECHANICAL THEORY; PARKINSONS-DISEASE; NALP3 INFLAMMASOME; ESCHERICHIA-COLI; MICROGLIAL ACTIVATION; CEREBROSPINAL-FLUID; NLRP3 INFLAMMASOME; FUTURE-DIRECTIONS; SUBSTANTIA-NIGRA; IMMUNE-RESPONSE	Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. Another feature is represented by the formation in these cells of inclusions called Lewy bodies (LB), principally constituted by fibrillar a-synuclein (alpha Syn). This protein is considered a key element in the aetiology of a group of neurodegenerative disorders termed synucleinopathies, which include PD, but the cellular and molecular mechanisms involved are not completely clear. It is established that the inflammatory process plays a crucial role in the pathogenesis and/or progression of PD; moreover, it is known that aggregated alpha Syn, released by neurons, activates microglia cells to produce pro-inflammatory mediators, such as IL-1 beta. IL-1b is one of the strongest pro-inflammatory cytokines; it is produced as an inactive mediator, and its maturation and activation requires inflammasome activation. In particular, the NLRP3 inflammasome is activated by a wide variety of stimuli, among which are crystallized and particulate material. In this work, we investigated the possibility that IL-1 beta production, induced by fibrillar alpha Syn, is involved the inflammasome activation. We demonstrated the competence of monomeric and fibrillar alpha Syn to induce synthesis of IL-1 beta, through TLR2 interaction; we found that the secretion of the mature cytokine was a peculiarity of the fibrillated protein. Moreover, we observed that the secretion of IL-1 beta involves NLRP3 inflammasome activation. The latter relies on the phagocytosis of fibrillar alpha Syn, followed by increased ROS production and cathepsin B release into the cytosol. Taken together, our data support the notion that fibrillar alpha Syn, likely released by neuronal degeneration, acts as an endogenous trigger inducing a strong inflammatory response in PD.	[Codolo, Gaia; Plotegher, Nicoletta; Tessari, Isabella; Bubacco, Luigi; de Bernard, Marina] Univ Padua, Dept Biol, Padua, Italy; [Codolo, Gaia; Pozzobon, Tommaso; de Bernard, Marina] Venetian Inst Mol Med, Padua, Italy; [Brucale, Marco] Natl Res Council CNR, Inst Nanostruct Mat ISMN, Rome, Italy	University of Padua; Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR)	de Bernard, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	luigi.bubacco@unipd.it; marina.debernard@unipd.it	Bubacco, Luigi/B-5602-2012; Brucale, Marco/G-2455-2018; Tessari, Isabella/K-7847-2016	Bubacco, Luigi/0000-0001-7927-9208; Tessari, Isabella/0000-0002-5823-645X; CODOLO, GAIA/0000-0002-7793-2549; BRUCALE, MARCO/0000-0001-7244-4389; de Bernard, Marina/0000-0002-0091-4502; Plotegher, Nicoletta/0000-0001-7421-8705	Italian Ministry of University and Research; Fondazione Cariplo [2011-0485]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Italian Ministry of University and Research, Prin projects (to MdB and LB) and Fondazione Cariplo, grant No 2011-0485 (to MdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Beraud D, J NEUROIMMUNE PHARM; Beraud Dawn, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS17, DOI 10.1016/S1353-8020(11)70008-6; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Litteljohn D, 2010, PARKINSONS DIS, V2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire-Zeiss KA, 2010, J NEURAL TRANSM, V117, P1019, DOI 10.1007/s00702-010-0431-6; Mankan AK, 2012, CLIN EXP IMMUNOL, V167, P369, DOI 10.1111/j.1365-2249.2011.04534.x; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ren GP, 2007, J BACTERIOL, V189, P2777, DOI 10.1128/JB.01406-06; Reynolds AD, 2008, J NEUROIMMUNE PHARM, V3, P59, DOI 10.1007/s11481-008-9100-z; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Su E, DEV NEUROSCI, V32, P385; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; van Gestel J, 2006, BIOPHYS J, V90, P3134, DOI 10.1529/biophysj.105.076000; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	66	349	369	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55375	10.1371/journal.pone.0055375	http://dx.doi.org/10.1371/journal.pone.0055375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383169	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600093
J	He, F; Kiener, TK; Lim, XF; Tan, YR; Raj, KVA; Tang, ML; Chow, VTK; Chen, QF; Kwang, J				He, Fang; Kiener, Tanja K.; Lim, Xiao Fang; Tan, Yunrui; Raj, Kattur Venkatachalam Ashok; Tang, Manli; Chow, Vincent T. K.; Chen, Qingfeng; Kwang, Jimmy			Development of A Sensitive and Specific Epitope-Blocking ELISA for Universal Detection of Antibodies to Human Enterovirus 71 Strains	PLOS ONE			English	Article							MOUTH-DISEASE; CAPSID PROTEIN; FOOT; OUTBREAK; HAND; INFECTION; EPIDEMIC; INFLUENZA; EVOLUTION; POLIOVIRUS	Background: Human Enterovirus 71 (EV71) is a common cause of hand, foot and mouth disease (HFMD) in young children. It is often associated with severe neurological diseases and mortalities in recent outbreaks across the Asia Pacific region. Currently, there is no efficient universal antibody test available to detect EV71 infections. Methodology/Principal Finding: In the present study, an epitope-blocking ELISA was developed to detect specific antibodies to human EV71 viruses in human or animal sera. The assay relies on a novel monoclonal antibody (Mab 1C6) that specifically binds to capsid proteins in whole EV71 viruses without any cross reaction to any EV71 capsid protein expressed alone. The sensitivity and specificity of the epitope-blocking ELISA for EV71 was evaluated and compared to microneutralization using immunized animal sera to multiple virus genotypes of EV71 and coxsackieviruses. Further, 200 serum sample from human individuals who were potentially infected with EV71 viruses were tested in both the blocking ELISA and microneutralization. Results indicated that antibodies to EV71 were readily detected in immunized animals or human sera by the epitope blocking ELISA whereas specimens with antibodies to other enteroviruses yielded negative results. This assay is not only simpler to perform but also shows higher sensitivity and specificity as compared to microneutralization. Conclusion: The epitope-blocking ELISA based on a unique Mab 1C6 provided highly sensitive and 100% specific detection of antibodies to human EV71 viruses in human sera.	[He, Fang; Kiener, Tanja K.; Lim, Xiao Fang; Tan, Yunrui; Raj, Kattur Venkatachalam Ashok; Tang, Manli; Kwang, Jimmy] Temasek Life Sci Lab, Singapore, Singapore; [Chow, Vincent T. K.; Kwang, Jimmy] Natl Univ Singapore, Dept Microbiol, Fac Med, Singapore 117548, Singapore; [Chen, Qingfeng] Natl Univ Singapore, Inst Mol & Cell Biol, Humanized Mouse Unit, Singapore 117548, Singapore; [Chen, Qingfeng] Singapore Massachusetts Inst Technol Alliance Res, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Kwang, J (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	kwang@tll.org.sg		Chow, Vincent/0000-0003-2634-6213; Kattur Venkatachalam, Ashok Raj/0000-0002-2628-3032	Temasek Life Science Laboratory	Temasek Life Science Laboratory	The authors are grateful for the financial support from Temasek Life Science Laboratory. (www.tll.org.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2007, J CLIN MICROBIOL, V45, P2037, DOI 10.1128/JCM.02432-06; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Alho A, 2003, J CLIN MICROBIOL, V41, P2294, DOI 10.1128/JCM.41.6.2294-2299.2003; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; BLOMBERG J, 1974, LANCET, V2, P112; Buttinelli G, 2003, VIROLOGY, V312, P74, DOI 10.1016/S0042-6822(03)00182-X; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Fiore L, 1997, J VIROL, V71, P6905, DOI 10.1128/JVI.71.9.6905-6912.1997; Frimann TH, 2007, VACCINE, V25, P6191, DOI 10.1016/j.vaccine.2007.06.002; Gallagher S, 2004, CURR PROTOC NEUROSCI; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Joki-Korpela P, 2000, J GEN VIROL, V81, P1709, DOI 10.1099/0022-1317-81-7-1709; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; Kuck D, 2007, J VIROL METHODS, V140, P17, DOI 10.1016/j.jviromet.2006.10.005; Lim XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029751; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Olcese VA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-29; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Ranganathan Shoba, 2002, Appl Bioinformatics, V1, P43; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Singh BK, 2004, VET RES COMMUN, V28, P437, DOI 10.1023/B:VERC.0000034996.18533.90; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Stelzer-Braid S, 2008, J CLIN VIROL, V43, P241, DOI 10.1016/j.jcv.2008.06.012; TAKEDA N, 1994, J VIROL, V68, P854, DOI 10.1128/JVI.68.2.854-862.1994; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yamaguchi T, 1996, ARCH VIROL, V141, P1493, DOI 10.1007/BF01718250; Yokoyama Wayne M, 2006, Curr Protoc Immunol, VChapter 2, DOI 10.1002/0471142735.im0205s74	45	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55517	10.1371/journal.pone.0055517	http://dx.doi.org/10.1371/journal.pone.0055517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383215	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600119
J	Mack, B; Eggert, C; Eder, K; Imrich, S; Baumeister, P; Harreus, U; Gires, O				Mack, Brigitte; Eggert, Carola; Eder, Katharina; Imrich, Sannia; Baumeister, Philipp; Harreus, Ulrich; Gires, Olivier			Rapid and Non-Enzymatic In Vitro Retrieval of Tumour Cells from Surgical Specimens	PLOS ONE			English	Article							MOUSE MODELS; CANCER; LYMPHOCYTES; LINES; NECK; HEAD	The study of tumourigenesis commonly involves the use of established cell lines or single cell suspensions of primary tumours. Standard methods for the generation of short-term tumour cell cultures include the disintegration of tissue based on enzymatic and mechanical stress. Here, we describe a simple and rapid method for the preparation of single cells from primary carcinomas, which is independent of enzymatic treatment and feeder cells. Tumour biopsies are processed to 1 mm 3 cubes termed explants, which are cultured 1-3 days on agarose-coated well plates in specified medium. Through incisions generated in the explants, single cells are retrieved and collected from the culture supernatant and can be used for further analysis including in vitro and in vivo studies. Collected cells retain tumour-forming capacity in xenotransplantation assays, mimic the phenotype of the primary tumour, and facilitate the generation of cell lines.	[Mack, Brigitte; Eggert, Carola; Eder, Katharina; Imrich, Sannia; Baumeister, Philipp; Harreus, Ulrich; Gires, Olivier] Univ Munich, Grosshadern Clin, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany	University of Munich	Harreus, U (corresponding author), Univ Munich, Grosshadern Clin, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	Uli.harreus@med.uni-muenchen.de; Olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064				Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Comer DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032924; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Dairkee SH, 1997, CANCER RES, V57, P1590; Denzel S, 2012, INT J EXP PATHOL, V93, P341, DOI 10.1111/j.1365-2613.2012.00826.x; Dieudonne A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041952; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; KEDAR E, 1982, EUR J CANCER CLIN ON, V18, P991, DOI 10.1016/0277-5379(82)90248-6; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Paget C, 2012, J BIOL CHEM, V287, P8816, DOI 10.1074/jbc.M111.304758; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; Silasi Dan-Arin, 2008, V414, P35; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G; Zender L, 2007, CELL, V129, P838, DOI 10.1016/j.cell.2007.05.013	17	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55540	10.1371/journal.pone.0055540	http://dx.doi.org/10.1371/journal.pone.0055540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383219	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600123
J	Nasu, A; Ikeya, M; Yamamoto, T; Watanabe, A; Jin, YH; Matsumoto, Y; Hayakawa, K; Amano, N; Sato, S; Osafune, K; Aoyama, T; Nakamura, T; Kato, T; Toguchida, J				Nasu, Akira; Ikeya, Makoto; Yamamoto, Takuya; Watanabe, Akira; Jin, Yonghui; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Amano, Naoki; Sato, Shingo; Osafune, Kenji; Aoyama, Tomoki; Nakamura, Takashi; Kato, Tomohisa; Toguchida, Junya			Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; EPIGENETIC MEMORY; DNA METHYLATION; SOMATIC-CELLS; GENERATION; EXPRESSION; GENE; EFFICIENT	Background: For regenerative therapy using induced pluripotent stem cell (iPSC) technology, cell type of origin to be reprogrammed should be chosen based on accessibility and reprogramming efficiency. Some studies report that iPSCs exhibited a preference for differentiation into their original cell lineages, while others did not. Therefore, the type of cell which is most appropriate as a source for iPSCs needs to be clarified. Methodology/Principal Findings: Genetically matched human iPSCs from different origins were generated using bone marrow stromal cells (BMSCs) and dermal fibroblasts (DFs) of the same donor, and global gene expression profile, DNA methylation status, and differentiation properties into the chondrogenic and osteogenic lineage of each clone were analyzed. Although genome-wide profiling of DNA methylation suggested tissue memory in iPSCs, genes expressed differentially in BMSCs and DFs were equally silenced in our bona fide iPSCs. After cell-autonomous and induced differentiation, each iPSC clone exhibited various differentiation properties, which did not correlate with cell-of-origin. Conclusions/Significance: The reprogramming process may remove the difference between DFs and BMSCs at least for chondrogenic and osteogenic differentiation. Qualified and genetically matched human iPSC clone sets established in this study are valuable resources for further basic study of clonal differences.	[Nasu, Akira; Jin, Yonghui; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Sato, Shingo; Aoyama, Tomoki; Kato, Tomohisa; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Nasu, Akira; Nakamura, Takashi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Nasu, Akira; Ikeya, Makoto; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Osafune, Kenji; Kato, Tomohisa; Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Yamamoto, Takuya; Watanabe, Akira; Amano, Naoki] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto, Japan; [Matsumoto, Yoshihisa; Hayakawa, Kazuo] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Nagoya City University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Ikeya, Makoto/0000-0002-3930-8032; Sato, Shingo/0000-0002-6227-5910; Kato, Tomohisa/0000-0002-3047-9847	Ministry of Education, Culture, Sports, Science and Technology; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [24659133] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, and the Leading Project for Realization of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kaneko S, 2010, CURR OPIN HEMATOL, V17, P271, DOI 10.1097/MOH.0b013e32833a25ee; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Quattrocelli M, 2011, J PATHOL, V223, P593, DOI 10.1002/path.2845; Rizzi R., 2012, CELL DEATH DIFFER; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	47	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53771	10.1371/journal.pone.0053771	http://dx.doi.org/10.1371/journal.pone.0053771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382851	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600018
J	Shen, Y; Wu, LJ; Xi, B; Liu, X; Zhao, XY; Cheng, H; Hou, DQ; Wang, XY; Mi, J				Shen, Yue; Wu, Lijun; Xi, Bo; Liu, Xin; Zhao, Xiaoyuan; Cheng, Hong; Hou, Dongqing; Wang, Xingyu; Mi, Jie			GCKR Variants Increase Triglycerides While Protecting from Insulin Resistance in Chinese Children	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TYPE-2 DIABETES RISK; FASTING GLUCOSE; POPULATION; OBESITY; GENES; ADOLESCENTS; LOCI; POLYMORPHISMS; ASSOCIATIONS	Background: Variants in gene encoding glucokinase regulator protein (GCKR) were found to have converse effects on triglycerides and glucose metabolic traits. We aimed to investigate the influence of GCKR variants for triglycerides and glucose metabolic traits in Chinese children and adults. Methods and Results: We genotyped two GCKR variants rs1260326 and rs1260333 in children and adults, and analyzed the association between two variants and triglycerides, glucose, insulin and HOMA-IR using linear regression model, and estimated the effect on insulin resistance using logistic regression model. Rs1260326 and rs1260333 associated with increased triglycerides in children and adults (p<0.05). In children, both variants significantly reduced insulin (p<0.05. for rs1260326, beta = -0.07; for rs1260333, beta = -0.07) and HOMA-IR (p<0.05. for rs1260326, beta = -0.03; for rs1260333, beta = -0.03). There were significant associations between two variants and insulin resistance for children. Under co-dominant model, for CT vs. CC, OR is 0.83 (95% CI 0.69-1.00) for rs1260326, and 0.83 (95% CI 0.68-1.00) for rs1260333; for TT vs. CC, OR is 0.72 (95% CI 0.58-0.88) for rs1260326, and 0.72 (95% CI 0.58-0.89) for rs1260333. Under allele model, for allele T vs. C, the ORs are 0.85 (95% CI 0.76-0.94) and 0.85 (95% CI 0.76-0.94) for rs1260326 and rs1260333, respectively). Conclusions: Our study confirmed the associations between GCKR variants and triglycerides in Chinese children and adults. Triglycerides-increasing alleles of GCKR variants reduce insulin and HOMA-IR index, and protect from insulin resistance in children. Our results suggested GCKR has an effect on development of insulin resistance in Chinese children.	[Shen, Yue] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Shen, Yue; Wu, Lijun; Zhao, Xiaoyuan; Cheng, Hong; Hou, Dongqing; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Xi, Bo] Shandong Univ, Sch Publ Hlth, Inst Maternal & Child Hlth Care, Jinan, Shandong, Peoples R China; [Liu, Xin; Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Institute of Pediatrics (CIP); Shandong University; Chinese Hypertension League	Wang, XY (corresponding author), Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China.	xingyuw@yahoo.com; jiemi2010@foxmail.com			National Nature Science Foundation of China [81172746]; Beijing Key Science and Technology Program [D111100000611002]; Beijing Health System Leading Talent [2009-1-08]; Beijing Training Project for the Leading Talents in S T [2011LJ07]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Key Science and Technology Program; Beijing Health System Leading Talent; Beijing Training Project for the Leading Talents in S T	This work was supported by National Nature Science Foundation of China (81172746), Beijing Key Science and Technology Program (D111100000611002), Beijing Health System Leading Talent Grant (2009-1-08), and the Beijing Training Project for the Leading Talents in S & T (2011LJ07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Hishida A, 2012, ENDOCR J; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Ling Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-66; Marshall WA, 1986, HUMAN GROWTH; Mi Jie, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P469; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perez-Martinez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020555; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Roemmich JN, 2002, INT J OBESITY, V26, P701, DOI 10.1038/sj.ijo.0801975; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55350	10.1371/journal.pone.0055350	http://dx.doi.org/10.1371/journal.pone.0055350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383164	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600091
J	Sohn, JC; Regier, JC; Mitter, C; Davis, D; Landry, JF; Zwick, A; Cummings, MP				Sohn, Jae-Cheon; Regier, Jerome C.; Mitter, Charles; Davis, Donald; Landry, Jean-Francois; Zwick, Andreas; Cummings, Michael P.			A Molecular Phylogeny for Yponomeutoidea (Insecta, Lepidoptera, Ditrysia) and Its Implications for Classification, Biogeography and the Evolution of Host Plant Use	PLOS ONE			English	Article							CONSENSUS TREES; ADVANCED MOTHS; ERMINE MOTH; GENE; BUTTERFLIES; SUPPORT; DISTRIBUTIONS; HISTORY; BIOLOGY	Background: Yponomeutoidea, one of the early-diverging lineages of ditrysian Lepidoptera, comprise about 1,800 species worldwide, including notable pests and insect-plant interaction models. Yponomeutoids were one of the earliest lepidopteran clades to evolve external feeding and to extensively colonize herbaceous angiosperms. Despite the group's economic importance, and its value for tracing early lepidopteran evolution, the biodiversity and phylogeny of Yponomeutoidea have been relatively little studied. Methodology/Principal Findings: Eight nuclear genes (8 kb) were initially sequenced for 86 putative yponomeutoid species, spanning all previously recognized suprageneric groups, and 53 outgroups representing 22 families and 12 superfamilies. Eleven to 19 additional genes, yielding a total of 14.8 to 18.9 kb, were then sampled for a subset of taxa, including 28 yponomeutoids and 43 outgroups. Maximum likelihood analyses were conducted on data sets differing in numbers of genes, matrix completeness, inclusion/weighting of synonymous substitutions, and inclusion/exclusion of "rogue" taxa. Monophyly for Yponomeutoidea was supported very strongly when the 18 "rogue" taxa were excluded, and moderately otherwise. Results from different analyses are highly congruent and relationships within Yponomeutoidea are well supported overall. There is strong support overall for monophyly of families previously recognized on morphological grounds, including Yponomeutidae, Ypsolophidae, Plutellidae, Glyphipterigidae, Argyresthiidae, Attevidae, Praydidae, Heliodinidae, and Bedelliidae. We also assign family rank to Scythropiinae (Scythropiidae stat. rev.), which in our trees are strongly grouped with Bedelliidae, in contrast to all previous proposals. We present a working hypothesis of among-family relationships, and an informal higher classification. Host plant family associations of yponomeutoid subfamilies and families are non-random, but show no trends suggesting parallel phylogenesis. Our analyses suggest that previous characterizations of yponomeutoids as predominantly Holarctic were based on insufficient sampling. Conclusions/Significance: We provide the first robust molecular phylogeny for Yponomeutoidea, together with a revised classification and new insights into their life history evolution and biogeography.	[Sohn, Jae-Cheon; Regier, Jerome C.; Mitter, Charles] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Davis, Donald] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Landry, Jean-Francois] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, CEF, Ottawa, ON, Canada; [Zwick, Andreas] State Museum Nat Hist, Dept Entomol, Stuttgart, Germany; [Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History; Agriculture & Agri Food Canada; University System of Maryland; University of Maryland College Park	Sohn, JC (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jsohn@umd.edu	Yakovlev, Roman/J-7243-2013; Zwick, Andreas/A-5735-2015	Zwick, Andreas/0000-0002-7532-1752	U.S. National Science Foundation's Assembling the Tree of Life program [0531769]; Maryland Agricultural Experiment Station; Direct For Biological Sciences [1042845] Funding Source: National Science Foundation	U.S. National Science Foundation's Assembling the Tree of Life program; Maryland Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U.S. National Science Foundation's Assembling the Tree of Life program, award number 0531769, and the Maryland Agricultural Experiment Station. This is contribution 244 of the Evolution of Terrestrial Ecosystems consortium of the National Museum of Natural History, in Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer A.J., 2011, ROGUENAROK EFFICIENT; Aberer AJ, 2011, ROGUENAROK; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Alonso C, 2000, ANN ZOOL FENN, V37, P179; Bazinet A. L., 2011, 2011 IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, P1896, DOI 10.1109/IPDPS.2011.344; Bazinet AL, 2009, SCI MADE TRANSPARENT, P2; Borner C., 1939, Verhandlungen 7 Internat Kong Ent Berlin, V2, P1372; BROCK JP, 1971, J NAT HIST, V5, P29, DOI 10.1080/00222937100770031; Brown WM, 1985, MOL EVOLUTIONARY GEN, DOI DOI 10.1007/978-1-4684-4988-4_2; Bruand CT, 1851, TINEIDES MEM SOC EMU, V3, P23; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Common I.F.B., 1970, INSECTS AUSTR, P765; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Davis D. R., 1998, HDB ZOOLOGY 5, P91, DOI [10.1515/9783110804744, DOI 10.1515/9783110804744]; Dugdale John S., 1999, Handbuch der Zoologie (Berlin), V4, P119; DUGDALE JS, 1998, HDB ZOOLOGY, V4, P217, DOI DOI 10.1515/9783110804744.217; Edwards E.D., 1996, Monographs on Australian Lepidoptera, V4, P50; Fracker S. B., 1915, Illinois Biological Monographs, V2; FRIESE GERRIT, 1960, BEITR ENT, V10, P1; Fu DeZhi, 2004, Kew Bulletin, V59, P111, DOI 10.2307/4111081; Gaedike R, 1997, LEPIDOPTERORUM CATAT; Gerasimov AM, 1952, INSECTS LEPIDOPTERA, V1, P1; Gershenson ZS, 1998, K NED AKAD WET VERH, V99, P1; Griffiths CS, 1999, P 22 INT ORN C DURB, P754; Grimaldi David, 2005, pi; Handlirsch A, 1925, HDB ENTOMOLOGIE, V3, P377; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heppner J.B., 2011, Lepidoptera Novae, V4, P61; Heppner J. B., 1998, Holarctic Lepidoptera, V5, P1; Heppner J.B., 1995, Tropical Lepidoptera, V6, P146; HEPPNER J. B, 1984, ATLAS NEOTROPICAL LE; Heppner JB, 2005, LEPID NEWS, V2003, P31; Heppner JB, 1977, J LEPID SOC, V31, P124; HEPPNER JB, 1983, CHECK LIST LEPIDOPTE, P26; HOEBEKE ER, 1987, ANN ENTOMOL SOC AM, V80, P462, DOI 10.1093/aesa/80.4.462; Holder MT, 2008, PHILOS T R SOC B, V363, P4013, DOI 10.1098/rstb.2008.0162; HSU Y.-F., 2005, UNIVERSITY OF CAL IF, V124, P1, DOI DOI 10.1525/CALIF0RNIA/9780520098473.003.0001; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Karoko H., 1964, Esakia Hikosan, Vno. 4, P1; Karsholt O., 1996, The Lepidoptera of Europe : a distributional checklist.; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; Kloet GS, 1945, CHEKC LIST BRIT INSE; KUZNETSOV V I, 1977, Entomologicheskoe Obozrenie, V56, P19; Kuznetzov V.I., 1988, T ZOOLOGICHESKOGO I, V176, P52; Kyrki J., 1988, Nota Lepidopterologica, V11, P45; Kyrki J., 1990, Nota Lepidopterologica, V13, P28; KYRKI J, 1984, ENTOMOL SCAND, V15, P71, DOI 10.1163/187631284X00064; KYRKI J, 1986, SYST ENTOMOL, V11, P93, DOI 10.1111/j.1365-3113.1986.tb00168.x; LEATHER S R, 1986, Entomologist's Gazette, V37, P209; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Mason PG, 2010, CAN ENTOMOL, V142, P393, DOI 10.4039/n10-026; MENKEN SBJ, 1992, ANNU REV ENTOMOL, V37, P41, DOI 10.1146/annurev.en.37.010192.000353; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Mey W, 2006, DEUT ENTOMOL Z, V53, P114, DOI 10.1002/mmnd.200600012; Mey Wolfram, 2011, Esperiana Memoir, V6, P7; Mey Wolfram, 2007, Esperiana Memoir, V4, P9; Meyrick E, 1914, LEPIDOPTERORUM CATAL, V19; Meyrick E, 1928, REV HDB BRIT LEPIDOP; MINET J, 1986, Alexanor, V14, P291; MINET J, 1983, ANN SOC ENTOMOL FR, V19, P175; Moriuti S, 1977, FAUNA JAPONICA YPONO; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nielsen ES, 1996, MONOGRAPHS AUST LEPI, V4, P56; Pierce F. N., 1935, GENITALIA TINEID FAM; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Rambaut A, 2009, FIGTREE V1 3 1; Regier JC, 2008, PROTOCOLS CONCEPTS R; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; Robinson GS, 2010, HOSTS DATABASE WORLD; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Seksyaeva S. V., 1994, Entomologicheskoe Obozrenie, V73, P716; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simmons MP, 2012, MOL PHYLOGENET EVOL, V62, P472, DOI 10.1016/j.ympev.2011.10.017; Stainton HT, 1854, INSECTA BRITANNICA L, V3; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Staudinger O, 1901, CATALOG LEPIDOPTEREN, V3; Stephens JF, 1829, SYSTEMETIC CATALOGUE; Swofford DL, 2001, PAUP PHYLOGENETIC AN; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Turner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009933; Ulenberg Sandrine A., 2009, Tijdschrift voor Entomologie, V152, P187; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; WILKINSON M, 1995, SYST BIOL, V44, P435, DOI 10.2307/2413604; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zeller P. C., 1839, ISIS OKEN, V3, P168; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A., 2010, DEGENERACY CODING WE; Zwick A, 2011, SYST ENTOMOL, V36, P31, DOI 10.1111/j.1365-3113.2010.00543.x; Zwickl DJ, 2011, GARLI 2 0	101	55	63	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55066	10.1371/journal.pone.0055066	http://dx.doi.org/10.1371/journal.pone.0055066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383061	gold, Green Published			2022-12-25	WOS:000314610600063
J	Wong, MH; Johnson, MD				Wong, Mandi H.; Johnson, Meshell D.			Differential Response of Primary Alveolar Type I and Type II Cells to LPS Stimulation	PLOS ONE			English	Article							SURFACTANT-PROTEIN-D; NF-KAPPA-B; ACUTE LUNG INJURY; EPITHELIAL-CELLS; PULMONARY SURFACTANT; PNEUMOCOCCAL PNEUMONIA; GENE-EXPRESSION; PRIMARY CULTURE; HOST-DEFENSE; TNF-ALPHA	The alveolar epithelium serves as a barrier between organism and environment and functions as the first line of protection against potential respiratory pathogens. Alveolar type II (TII) cells have traditionally been considered the immune cells of the alveolar epithelium, as they possess immunomodulatory functions; however, the precise role of alveolar type I (TI) cells, which comprise similar to 95% of the alveolar epithelial surface area, in lung immunity is not clear. We sought to determine if there was a difference in the response of TI and TII cells to lung injury and if TI cells could actively participate in the alveolar immune response. TI cells isolated via fluorescence activated cell sorting (FACS) from LPS-injured rats demonstrated greater fold-induction of multiple inflammatory mediators than TII cells isolated in the same manner from the same animals. Levels of the cytokines TNF-alpha, IL-6 and IL-1 beta from cultured primary rat TI cells after LPS stimulation were significantly increased compared to similarly studied primary rat TII cells. We found that contrary to published reports, cultured TII cells produce relatively small amounts of TNF-alpha, IL-6 and IL-1 beta after LPS treatment; the higher levels of cytokine expression from cultured TII cells reported in the literature were likely from macrophage contamination due to traditional non-FACS TII cell isolation methods. Co-culture of TII cells with macrophages prior to LPS stimulation increased TNF-alpha and IL-6 production to levels reported by other investigators for TII cells, however, co-culture of TI cells and macrophages prior to LPS treatment resulted in marked increases in TNF-alpha and IL-6 production. Finally, exogenous surfactant blunted the IL-6 response to LPS in cultured TI cells. Taken together, these findings advocate a role for TI cells in the innate immune response and suggest that both TI and TII cells are active players in host defense mechanisms in the lung.	[Wong, Mandi H.; Johnson, Meshell D.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Wong, Mandi H.; Johnson, Meshell D.] No Calif Inst Res & Educ, San Francisco, CA USA; [Johnson, Meshell D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Northern California Institute for Research & Education; University of California System; University of California San Francisco	Johnson, MD (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	meshell.johnson@ucsf.edu			Department of Veterans Affairs [CDA2]; Northern California Institute for Research and Education	Department of Veterans Affairs(US Department of Veterans Affairs); Northern California Institute for Research and Education	This work was supported by grants from the Department of Veterans Affairs (CDA2) and the Northern California Institute for Research and Education (www.ncire.org). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Baloglu E, 2011, AM J RESP CELL MOL, V45, P1059, DOI 10.1165/rcmb.2010-0273OC; Barbarin V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-112; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Carter JM, 2006, J OCCUP ENVIRON MED, V48, P1265, DOI 10.1097/01.jom.0000230489.06025.14; Chen JT, 2006, AM J RESP CELL MOL, V34, P264, DOI 10.1165/rcmb.2005-0117OC; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; CRESTANI B, 1994, J CLIN INVEST, V94, P731, DOI 10.1172/JCI117392; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Driscoll KE, 1998, ENVIRON HEALTH PERSP, V106, P1171, DOI 10.2307/3433981; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Gonzalez RF, 1998, BBA-PROTEIN STRUCT M, V1429, P208, DOI 10.1016/S0167-4838(98)00231-3; Gonzalez RF, 2009, AM J PHYSIOL-LUNG C, V297, pL1045, DOI 10.1152/ajplung.90389.2008; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gutierrez JA, 1998, AM J PHYSIOL-LUNG C, V274, pL196, DOI 10.1152/ajplung.1998.274.2.L196; Haddad JJ, 2009, MOL IMMUNOL, V47, P205, DOI 10.1016/j.molimm.2009.09.034; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hortobagyi L, 2008, J ALLERGY CLIN IMMUN, V122, P521, DOI 10.1016/j.jaci.2008.05.002; Ikegami M, 2007, CHEST, V132, P1447, DOI 10.1378/chest.07-0864; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Kanj RS, 2005, J TOXICOL ENV HEAL A, V68, P185, DOI 10.1080/15287390590890509; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Ledeboer A, 2002, AM J PHYSIOL-REG I, V282, pR1762, DOI 10.1152/ajpregu.00766.2001; Manzer R, 2006, AM J RESP CELL MOL, V34, P158, DOI 10.1165/rcmb.2005-0205OC; MASON RJ, 1977, AM REV RESPIR DIS, V115, P81; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; McRitchie DI, 2000, CYTOKINE, V12, P644, DOI 10.1006/cyto.1999.0656; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miura TA, 2006, ADV EXP MED BIOL, V581, P351; Moxley MA, 2000, AM J PHYSIOL-LUNG C, V279, pL985, DOI 10.1152/ajplung.2000.279.5.L985; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; PAINE R, 1993, J IMMUNOL, V150, P4561; Rosenberg GA, 2007, BRAIN RES, V1133, P186, DOI 10.1016/j.brainres.2006.11.041; Rubins JB, 2003, AM J RESP CRIT CARE, V167, P103, DOI 10.1164/rccm.2210007; Schroeter M, 2003, MOL BRAIN RES, V117, P1, DOI 10.1016/S0169-328X(03)00255-9; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; Takahashi F, 2004, LUNG, V182, P173; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; THOMASSEN MJ, 1992, AM J RESP CELL MOL, V7, P257, DOI 10.1165/ajrcmb/7.3.257; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; van der Windt GJW, 2011, J INFECT DIS, V203, P1850, DOI 10.1093/infdis/jir185; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Walker MG, 2009, EXP LUNG RES, V35, P591, DOI 10.1080/01902140902780460; Wang SH, 2011, AM J RESP CELL MOL, V44, P692, DOI 10.1165/rcmb.2009-0359OC; Wong MH, 2012, AM J RESP CELL MOL, V46, P641, DOI 10.1165/rcmb.2011-0289OC; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Yamamoto K, 2012, J IMMUNOL, V189, P2450, DOI 10.4049/jimmunol.1200634; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zhang F, 2008, INFLAMMATION, V31, P344, DOI 10.1007/s10753-008-9084-0	58	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55545	10.1371/journal.pone.0055545	http://dx.doi.org/10.1371/journal.pone.0055545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383221	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600124
J	Barh, D; Barve, N; Gupta, K; Chandra, S; Jain, N; Tiwari, S; Leon-Sicairos, N; Canizalez-Roman, A; dos Santos, AR; Hassan, SS; Almeida, S; Ramos, RTJ; de Abreu, VAC; Carneiro, AR; Soares, SD; Castro, TLD; Miyoshi, A; Silva, A; Kumar, A; Misra, AN; Blum, K; Braverman, ER; Azevedo, V				Barh, Debmalya; Barve, Neha; Gupta, Krishnakant; Chandra, Sudha; Jain, Neha; Tiwari, Sandeep; Leon-Sicairos, Nidia; Canizalez-Roman, Adrian; dos Santos, Anderson Rodrigues; Hassan, Syed Shah; Almeida, Sintia; Juca Ramos, Rommel Thiago; Carvalho de Abreu, Vinicius Augusto; Carneiro, Adriana Ribeiro; Soares, Siomar de Castro; de Paula Castro, Thiago Luiz; Miyoshi, Anderson; Silva, Artur; Kumar, Anil; Misra, Amarendra Narayan; Blum, Kenneth; Braverman, Eric R.; Azevedo, Vasco			Exoproteome and Secretome Derived Broad Spectrum Novel Drug and Vaccine Candidates in Vibrio cholerae Targeted by Piper betel Derived Compounds	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; PROTEIN-STRUCTURE; ESSENTIAL GENES; TDR TARGETS; PREDICTION; IDENTIFICATION; BETLE; DATABASE; EXTRACT; PATHOGEN	Vibrio cholerae is the causal organism of the cholera epidemic, which is mostly prevalent in developing and underdeveloped countries. However, incidences of cholera in developed countries are also alarming. Because of the emergence of new drug-resistant strains, even though several generic drugs and vaccines have been developed over time, Vibrio infections remain a global health problem that appeals for the development of novel drugs and vaccines against the pathogen. Here, applying comparative proteomic and reverse vaccinology approaches to the exoproteome and secretome of the pathogen, we have identified three candidate targets (ompU, uppP and yajC) for most of the pathogenic Vibrio strains. Two targets (uppP and yajC) are novel to Vibrio, and two targets (uppP and ompU) can be used to develop both drugs and vaccines (dual targets) against broad spectrum Vibrio serotypes. Using our novel computational approach, we have identified three peptide vaccine candidates that have high potential to induce both B-and T-cell-mediated immune responses from our identified two dual targets. These two targets were modeled and subjected to virtual screening against natural compounds derived from Piper betel. Seven compounds were identified first time from Piper betel to be highly effective to render the function of these targets to identify them as emerging potential drugs against Vibrio. Our preliminary validation suggests that these identified peptide vaccines and betel compounds are highly effective against Vibrio cholerae. Currently we are exhaustively validating these targets, candidate peptide vaccines, and betel derived lead compounds against a number of Vibrio species.	[Barh, Debmalya; Barve, Neha; Gupta, Krishnakant; Chandra, Sudha; Jain, Neha; Tiwari, Sandeep; Blum, Kenneth] IIOAB, Ctr Genom & Appl Gene Technol, Purba Medinipur, W Bengal, India; [Barh, Debmalya; Misra, Amarendra Narayan] Fakir Mohan Univ, Sch Biotechnol, Dept Biosci & Biotechnol, Balasore, Orissa, India; [Barve, Neha; Gupta, Krishnakant; Chandra, Sudha; Kumar, Anil] Devi Ahilya Univ, Sch Biotechnol, Indore, Madhya Pradesh, India; [Leon-Sicairos, Nidia; Canizalez-Roman, Adrian] Autonomous Univ Sinaloa, Sch Med, Unit Res, Fracc Fresnos, Culiacan, Mexico; [dos Santos, Anderson Rodrigues; Hassan, Syed Shah; Almeida, Sintia; Carvalho de Abreu, Vinicius Augusto; Soares, Siomar de Castro; de Paula Castro, Thiago Luiz; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil; [Juca Ramos, Rommel Thiago; Carneiro, Adriana Ribeiro; Silva, Artur] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Misra, Amarendra Narayan] Cent Univ Jharkhand, Sch Nat Sci, Ctr Life Sci, Ranchi, Jharkhand State, India; [Blum, Kenneth] Univ Florida, Coll Med, Gainesville, FL USA; [Blum, Kenneth] Univ Vermont, Coll Med, Ctr Clin & Translat Sci, Burlington, VT USA; [Braverman, Eric R.] Cornell Univ, Weill Cornell Coll Med, New York, NY 10021 USA	Fakir Mohan University; Devi Ahilya University; Universidad Autonoma de Sinaloa; Universidade Federal de Minas Gerais; Universidade Federal do Para; Central University of Jharkhand; State University System of Florida; University of Florida; University of Vermont; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Barh, D (corresponding author), IIOAB, Ctr Genom & Appl Gene Technol, Purba Medinipur, W Bengal, India.	dr.barh@gmail.com	tiwari, Sandeep/K-9616-2015; Silva, Artur/E-1474-2014; MISRA, AMARENDRA N./B-8378-2012; Leon-Sicairos, Nidia/AAA-4630-2022; Boothapati, Anil Kumar/HHS-1813-2022; Folador, Adriana R.C./H-6410-2016; de Castro Soares, Siomar/I-2705-2012; Azevedo, Vasco A.C/F-4315-2011; Braverman, Eric new/ABC-1152-2021; Folador, Adriana Ribeiro Carneiro/R-2658-2019; Hassan, Syed Shah/AAQ-5460-2021; Azevedo, Vasco/B-1556-2019; Kumar, Anil/K-2136-2019; de Paula Castro, Thiago Luiz/H-5135-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; Canizalez-Roman, Adrian/B-7621-2019; Misra, Amarendra Narayan Narayan/AAH-3996-2021; Abreu, Vinicius AC/G-3694-2014; dos Santos, Anderson Rodrigues/G-3020-2011; Ramos, Rommel Thiago Juca/L-9329-2013; Almeida, Sintia/K-1217-2012; Barh, Debmalya/O-4246-2015	tiwari, Sandeep/0000-0002-8554-1660; Silva, Artur/0000-0002-4082-1132; MISRA, AMARENDRA N./0000-0002-5565-8411; Leon-Sicairos, Nidia/0000-0003-1470-3383; Folador, Adriana R.C./0000-0003-1522-9871; de Castro Soares, Siomar/0000-0001-7299-3724; Azevedo, Vasco A.C/0000-0002-4775-2280; Hassan, Syed Shah/0000-0003-1251-5215; Azevedo, Vasco/0000-0002-4775-2280; de Paula Castro, Thiago Luiz/0000-0002-2869-5065; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Canizalez-Roman, Adrian/0000-0001-8605-0639; Misra, Amarendra Narayan Narayan/0000-0002-5565-8411; dos Santos, Anderson Rodrigues/0000-0003-3418-0823; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Almeida, Sintia/0000-0003-0270-9059; Barh, Debmalya/0000-0002-2557-7768; Jain, Neha/0000-0003-4627-3349				Abadio AKR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-75; Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Al-Adhroey AH, 2011, MOLECULES, V16, P107, DOI 10.3390/molecules16010107; Ali I, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-7; Barh D, 2011, CHEM BIOL DRUG DES, V78, P73, DOI 10.1111/j.1747-0285.2011.01118.x; Barh D, 2010, BIOINFORMATION, V5, P77, DOI 10.6026/97320630005077; Barh D, 2011, DRUG DEVELOP RES, V72, P162, DOI 10.1002/ddr.20413; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Butt AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043080; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; DALLO SF, 1988, J EXP MED, V167, P718, DOI 10.1084/jem.167.2.718; Dasgupta N, 2004, FOOD CHEM, V88, P219, DOI 10.1016/j.foodchem.2004.01.036; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Duffield M, 2010, MOL BIOSYST, V6, P2482, DOI 10.1039/c0mb00001a; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fazil MHUT, 2011, FUTURE MICROBIOL, V6, P1199, DOI [10.2217/FMB.11.93, 10.2217/fmb.11.93]; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Ganguly S, 2007, J PHARM PHARMACOL, V59, P711, DOI 10.1211/jpp.59.5.0012; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Georrge JJ, 2011, INDIAN J BIOTECHNOL, V10, P432; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Tran HD, 2012, J MED MICROBIOL, V61, P431, DOI 10.1099/jmm.0.034744-0; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kangueane P, 2005, BIOINFORMATION, V1, P21, DOI 10.6026/97320630001021; Kanjwani DG, 2008, SCAND J IMMUNOL, V67, P589, DOI 10.1111/j.1365-3083.2008.02110.x; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin May Young, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P15, DOI 10.2174/187153008783928398; Lin Y, 2010, BIOCHEM BIOPH RES CO, V396, P472, DOI 10.1016/j.bbrc.2010.04.119; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magarinos MP, 2012, NUCLEIC ACIDS RES, V40, pD1118, DOI 10.1093/nar/gkr1053; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Majumdar Biswajit, 2003, Indian Journal of Experimental Biology, V41, P311; Mandal S, 2011, ASIAN PAC J TROP MED, V4, P573, DOI 10.1016/S1995-7645(11)60149-1; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Reddy G. K., 2011, INT J PHARM STUDIES, V2, P48; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sarkar A, 2008, PARASITOL RES, V102, P1249, DOI 10.1007/s00436-008-0902-y; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shanmugam A, 2010, BIOINFORMATION, V4, P392, DOI 10.6026/97320630004392; SHIMADA T, 1977, JPN J MED SCI BIOL, V30, P275, DOI 10.7883/yoken1952.30.275; Siddique AK, 1996, TROP MED INT HEALTH, V1, P393, DOI 10.1046/j.1365-3156.1996.d01-54.x; SIDDIQUE AK, 1992, J DIARRHOEAL DIS RES, V10, P79; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh M, 2009, INT IMMUNOPHARMACOL, V9, P716, DOI 10.1016/j.intimp.2009.02.012; Singh T, 2011, J CHEM INF MODEL, V51, P2515, DOI 10.1021/ci200193z; Sperandio V, 1996, INFECT IMMUN, V64, P5406, DOI 10.1128/IAI.64.12.5406-5409.1996; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Trakranrungsie N, 2008, RES VET SCI, V84, P80, DOI 10.1016/j.rvsc.2007.03.006; Umashankar V, 2007, BIOINFORMATION, V2, P62; Valentao P, 2010, J SEP SCI, V33, P3168, DOI 10.1002/jssc.201000429; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wirotesangthong M, 2008, INT IMMUNOPHARMACOL, V8, P453, DOI 10.1016/j.intimp.2007.11.005; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	82	61	61	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52773	10.1371/journal.pone.0052773	http://dx.doi.org/10.1371/journal.pone.0052773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382822	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800010
J	Kurosawa, N; Fujimoto, R; Ozawa, T; Itoyama, T; Sadamori, N; Isobe, M				Kurosawa, Nobuyuki; Fujimoto, Rika; Ozawa, Tatsuhiko; Itoyama, Takahiro; Sadamori, Naoki; Isobe, Masaharu			Reduced Level of the BCL11B Protein Is Associated with Adult T-Cell Leukemia/Lymphoma	PLOS ONE			English	Article							VIRUS TYPE-1 HTLV-1; NF-KAPPA-B; TUMOR-SUPPRESSOR; THYMIC LYMPHOMAS; LEUKEMIA-VIRUS; GENE; PROMOTER; EXPRESSION; IDENTIFICATION; TRANSCRIPTION	Background: Adult T-cell leukemia/lymphoma (ATLL) develops in a small proportion of human T-cell leukemia virus type I (HTLV-I)-infected individuals. However, the mechanism by which HTLV-I causes ATLL has not been fully elucidated. To provide fundamental insights into the multistep process of leukemogenesis, we have mapped the chromosomal abnormalities in 50 ATLL cases to identify potential key regulators of ATLL. Results: The analysis of breakpoints in one ATLL case with the translocations t(14;17)(q32;q22-23) resulted in the identification of a Kruppel zinc finger gene, BCL11B, which plays a crucial role in T-cell development. Among the 7 ATLL cases that we examined by immunofluorescence analysis, 4 displayed low and one displayed moderate BCL11B signal intensities. A dramatically reduced level of the BCL11B protein was also found in HTLV-I-positive T-cell lines. The ectopic expression of BCL11B resulted in significant growth suppression in ATLL-derived cell lines but not in Jurkat cells. Conclusions: Our genetic and functional data provide the first evidence that a reduction in the level of the BCL11B protein is a key event in the multistep progression of ATLL leukemogenesis.	[Kurosawa, Nobuyuki; Isobe, Masaharu] Toyama Univ, Grad Sch, Fac Sci & Engn, Toyama 930, Japan; [Fujimoto, Rika] Kochi Med Sch, Dept Immunol, Kochi, Japan; [Ozawa, Tatsuhiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Immunol, Toyama 930, Japan; [Itoyama, Takahiro] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan; [Sadamori, Naoki] Nagasaki Univ, Dept Nursing, Fac Nursing & Nutr, Nagasaki 852, Japan	University of Toyama; Kochi University; University of Toyama; Nagasaki University	Isobe, M (corresponding author), Toyama Univ, Grad Sch, Fac Sci & Engn, Toyama 930, Japan.	isobe@eng.u-toyama.ac.jp		Kurosawa, Nobuyuki/0000-0002-1548-4541; Ozawa, Tatsuhiko/0000-0002-3112-452X	Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan; Hokuriku Innovation Cluster for Health Science; Grants-in-Aid for Scientific Research [23650607] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokuriku Innovation Cluster for Health Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by funds from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan and the Hokuriku Innovation Cluster for Health Science to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya N, 2011, VIRUSES-BASEL, V3, P1532, DOI 10.3390/v3091532; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Fujimoto R, 2012, CANCER GENET-NY, V205, P356, DOI 10.1016/j.cancergen.2012.04.006; Ganguli-Indra G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005367; Gesk S, 2003, LEUKEMIA, V17, P738, DOI 10.1038/sj.leu.2402884; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Grabarczyk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012532; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Hidaka T, 2008, BLOOD, V112, P383, DOI 10.1182/blood-2008-01-131185; Itoyama A, 2001, BLOOD, V97, P3612, DOI 10.1182/blood.V97.11.3612; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Karlsson A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-195; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagamachi A, 2009, CANCER SCI, V100, P1219, DOI 10.1111/j.1349-7006.2009.01172.x; NARDUCCI MG, 1995, BLOOD, V86, P2358, DOI 10.1182/blood.V86.6.2358.bloodjournal8662358; Nicot C, 2005, AM J HEMATOL, V78, P232, DOI 10.1002/ajh.20307; Ohi H, 2007, ONCOGENE, V26, P5280, DOI 10.1038/sj.onc.1210325; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Saitou M, 2000, ONCOGENE, V19, P2796, DOI 10.1038/sj.onc.1203604; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Sugimoto J, 1999, CANCER RES, V59, P2313; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534	40	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55147	10.1371/journal.pone.0055147	http://dx.doi.org/10.1371/journal.pone.0055147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383087	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800121
J	Patton, JL; Wei, YJ; Bajaj, P; Scheidt, RA				Patton, James L.; Wei, Yejun John; Bajaj, Preeti; Scheidt, Robert A.			Visuomotor Learning Enhanced by Augmenting Instantaneous Trajectory Error Feedback during Reaching	PLOS ONE			English	Article							INTERNAL-MODEL; ARM MOVEMENTS; ADAPTATION; REHABILITATION; COORDINATION; STROKE; FORCE	We studied reach adaptation to a 30 degrees visuomotor rotation to determine whether augmented error feedback can promote faster and more complete motor learning. Four groups of healthy adults reached with their unseen arm to visual targets surrounding a central starting point. A manipulandum tracked hand motion and projected a cursor onto a display immediately above the horizontal plane of movement. For one group, deviations from the ideal movement were amplified with a gain of 2 whereas another group experienced a gain of 3.1. The third group experienced an offset equal to the average error seen in the initial perturbations, while a fourth group served as controls. Learning in the gain 2 and offset groups was nearly twice as fast as controls. Moreover, the offset group averaged more reduction in error. Such error augmentation techniques may be useful for training novel visuomotor transformations as required of robotic teleoperators or in movement rehabilitation of the neurologically impaired.	[Patton, James L.] Univ Illinois, Chicago, IL 60607 USA; [Patton, James L.; Wei, Yejun John; Bajaj, Preeti; Scheidt, Robert A.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Patton, James L.; Scheidt, Robert A.] Northwestern Univ, Dept Phys Med, Chicago, IL 60611 USA; [Patton, James L.; Scheidt, Robert A.] Northwestern Univ, Dept Rehabil, Chicago, IL 60611 USA; [Scheidt, Robert A.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Marquette University	Patton, JL (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	pattonj@uic.edu	Scheidt, Robert A/F-5047-2010	Scheidt, Robert A/0000-0002-2024-5051	American Heart Association [0330411Z]; National Institutes of Health (NIH) [R24 HD39627, 5 RO1 NS 35673, F32HD08658, R01HD053727]; Whitaker [RG010157]; NSF [BES0238442]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053727] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008658, R24HD039627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035673] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitaker; NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association 0330411Z, National Institutes of Health (NIH) R24 HD39627, NIH 5 RO1 NS 35673, NIH F32HD08658, Whitaker RG010157, NSF BES0238442, NIH R01HD053727, the summer internship in neural engineering (SINE) program at the Sensory Motor Performance Program at the Rehabilitation Institute of Chicago, and the Falk Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C.M., 2006, PATTERN RECOGNITION; Brewer BR, 2005, IEEE T NEUR SYS REH, V13, P1, DOI 10.1109/TNSRE.2005.843443; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Emken JL, 2005, IEEE T NEUR SYS REH, V13, P33, DOI 10.1109/TNSRE.2004.843173; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KAWATO M, 1990, ADVANCED NEURAL COMPUTERS, P365; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; MILES FA, 1980, J NEUROPHYSIOL, V43, P1406, DOI 10.1152/jn.1980.43.5.1406; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nudo RJ, 1999, REV NEUROL, V155, P713; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Patton JL, 2006, J REHABILIT IN PRESS, P43; Ravaioli E, 2005, EXP BRAIN RES, V160, P450, DOI 10.1007/s00221-004-2030-y; Robles-De-La-Torre G, 2001, NATURE, V412, P445, DOI 10.1038/35086588; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Wei Y, 2005, REAL TIME HAPTIC GRA; Winstein CJ, 1999, NEUROPSYCHOLOGIA, V37, P975, DOI 10.1016/S0028-3932(98)00145-6; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	30	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e46466	10.1371/journal.pone.0046466	http://dx.doi.org/10.1371/journal.pone.0046466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382796	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800001
J	Shine, JM; Matar, E; Ward, PB; Bolitho, SJ; Pearson, M; Naismith, SL; Lewis, SJG				Shine, James M.; Matar, Elie; Ward, Philip B.; Bolitho, Samuel J.; Pearson, Mark; Naismith, Sharon L.; Lewis, Simon J. G.			Differential Neural Activation Patterns in Patients with Parkinson's Disease and Freezing of Gait in Response to Concurrent Cognitive and Motor Load	PLOS ONE			English	Article							BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; NUCLEUS-ACCUMBENS; CONTROL NETWORK; MRI; QUESTIONNAIRE; SUPPLEMENTARY	Freezing of gait is a devastating symptom of Parkinson's disease (PD) that is exacerbated by the processing of cognitive information whilst walking. To date, no studies have explored the neural correlates associated with increases in cognitive load whilst performing a motor task in patients with freezing. In this experiment, 14 PD patients with and 15 PD patients without freezing of gait underwent 3T fMRI while performing a virtual reality gait task. Directions to walk and stop were presented on the viewing screen as either direct cues or as more cognitively indirect pre-learned cues. Both groups showed a consistent pattern of BOLD response within the Cognitive Control Network during performance of the paradigm. However, a between group comparison revealed that those PD patients with freezing of gait were less able to recruit the bilateral anterior insula, ventral striatum and the pre-supplementary motor area, as well as the left subthalamic nucleus when responding to indirect cognitive cues whilst maintaining a motor output. These results suggest that PD patients with freezing of gait are unable to properly recruit specific cortical and subcortical regions within the Cognitive Control Network during the performance of simultaneous motor and cognitive functions.	[Shine, James M.; Matar, Elie; Bolitho, Samuel J.; Pearson, Mark; Naismith, Sharon L.; Lewis, Simon J. G.] Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Clin, Sydney, NSW 2006, Australia; [Ward, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Ward, Philip B.] South Western Sydney Local Hlth Dist, Schizophrenia Res Unit, Liverpool, NSW, Australia	University of Sydney; University of New South Wales Sydney	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Clin, Sydney, NSW 2006, Australia.	simon.lewis@sydney.edu.au	Ward, Philip/E-3959-2010; Lewis, Simon/R-9469-2016	Ward, Philip/0000-0002-5779-7722; Lewis, Simon/0000-0002-4093-7071; Naismith, Sharon/0000-0001-9076-2778; Matar, Elie/0000-0002-4994-0488; Shine, James/0000-0003-1762-5499	Michael J. Fox Foundation	Michael J. Fox Foundation	The study was funded in it's entirety by the Michael J. Fox Foundation (https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Amboni M, 2008, MOVEMENT DISORD, V23, P395, DOI 10.1002/mds.21850; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Bartels AL, 2008, MOVEMENT DISORD, V23, pS461, DOI 10.1002/mds.21912; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Brett M, 2002, P INT C FUNCT MAPP H; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Lieberman A, 2006, J NEUROL SCI, V248, P219, DOI 10.1016/j.jns.2006.05.023; Maidan I, 2010, MOVEMENT DISORD, V25, P2346, DOI 10.1002/mds.23280; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; Mazaika P, 2007, P HUM BRAIN MAPP C; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Naismith SL, 2010, MOVEMENT DISORD, V25, P1000, DOI 10.1002/mds.23005; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Prodoehl J, 2008, NEUROIMAGE, V39, P956, DOI 10.1016/j.neuroimage.2007.09.027; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Seeley WW, J NEUROSCI, V27, P2349; Shine JM, 2011, J CLIN NEUROSCI, V18, P1154, DOI 10.1016/j.jocn.2011.02.007; Shine JM, 2011, J CLIN NEUROSCI, V18, P807, DOI 10.1016/j.jocn.2011.02.003; Shine JM, 2012, PARKINSONISM RELAT D; Shine JM, 2013, GAIT POSTUR IN PRESS; Shine JM, 2013, PARKINSONISM RELAT D; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tessitore A, 2012, AM J NEURORADIOL, V33, P1804, DOI 10.3174/ajnr.A3066; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zumer JM, 2010, NEUROIMAGE, V49, P1479, DOI 10.1016/j.neuroimage.2009.09.020	55	84	89	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52602	10.1371/journal.pone.0052602	http://dx.doi.org/10.1371/journal.pone.0052602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382821	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800009
J	Stoneman, P; Sturgis, P; Allum, N; Sibley, E				Stoneman, Paul; Sturgis, Patrick; Allum, Nick; Sibley, Elissa			Incommensurable Worldviews? Is Public Use of Complementary and Alternative Medicines Incompatible with Support for Science and Conventional Medicine?	PLOS ONE			English	Article							CONTROLLED-TRIALS; HOMEOPATHY; ATTITUDES; POPULATION; THERAPIES; CARE	Proponents of controversial Complementary and Alternative Medicines, such as homeopathy, argue that these treatments can be used with great effect in addition to, and sometimes instead of, 'conventional' medicine. In doing so, they accept the idea that the scientific approach to the evaluation of treatment does not undermine use of and support for some of the more controversial CAM treatments. For those adhering to the scientific canon, however, such efficacy claims lack the requisite evidential basis from randomised controlled trials. It is not clear, however, whether such opposition characterises the views of the general public. In this paper we use data from the 2009 Wellcome Monitor survey to investigate public use of and beliefs about the efficacy of a prominent and controversial CAM within the United Kingdom, homeopathy. We proceed by using Latent Class Analysis to assess whether it is possible to identify a sub-group of the population who are at ease in combining support for science and conventional medicine with use of CAM treatments, and belief in the efficacy of homeopathy. Our results suggest that over 40% of the British public maintain positive evaluations of both homeopathy and conventional medicine simultaneously. Explanatory analyses reveal that simultaneous support for a controversial CAM treatment and conventional medicine is, in part, explained by a lack of scientific knowledge as well as concerns about the regulation of medical research.	[Stoneman, Paul] Univ Surrey, Dept Sociol, Guildford GU2 5XH, Surrey, England; [Sturgis, Patrick] Univ Southampton, Natl Ctr Res Methods, Southampton, Hants, England; [Allum, Nick; Sibley, Elissa] Univ Essex, Dept Sociol, Colchester CO4 3SQ, Essex, England	University of Surrey; University of Southampton; University of Essex	Stoneman, P (corresponding author), Univ Surrey, Dept Sociol, Guildford GU2 5XH, Surrey, England.	p.stoneman@surrey.ac.uk			Wellcome Trust [EDU/28/4/20/SotonUni/DO18-1299]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust, as part of the 'Developing a novel segmentation of adults and young people in relation to biomedical science' project, grant reference number: EDU/28/4/20/SotonUni/DO18-1299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; [Anonymous], 1987, SAGE U PAPER SERIES; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bains SS, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-138; Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Berman BM, 2000, ALTERN THER HEALTH M, V6, P98; Beyerstein BL, 2001, ACAD MED, V76, P230, DOI 10.1097/00001888-200103000-00009; Blais R, 1997, CAN J PUBLIC HEALTH, V88, P159, DOI 10.1007/BF03403880; Boissel JP, 1996, CRITICAL LIT REV EFF, V1996, P195; Braun LA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-38; Butt S., 2009, WELLCOME TRUST MONIT; Callahan D., 2002, HAST CENT S; Caulfield Timothy, 2005, BMC Complement Altern Med, V5, P12, DOI 10.1186/1472-6882-5-12; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Conboy Lisa, 2007, Complement Ther Clin Pract, V13, P146, DOI 10.1016/j.ctcp.2006.12.003; Cucherat M, 2000, EUR J CLIN PHARMACOL, V56, P27, DOI 10.1007/s002280050716; Easthope G, 2000, SOC SCI MED, V51, P1555, DOI 10.1016/S0277-9536(00)00048-4; Ernst E, 2008, BRIT J CLIN PHARMACO, V65, P163, DOI 10.1111/j.1365-2125.2007.03007.x; Ernst E, 2002, BRIT J CLIN PHARMACO, V54, P577, DOI 10.1046/j.1365-2125.2002.01699.x; Ernst E, 1999, J MANIP PHYSIOL THER, V22, P87, DOI 10.1016/S0161-4754(99)70112-0; Ernst E, 2012, GUARDIAN NEWSPA 0403; Ernst E, 2007, J HEALTH PSYCHOL, V12, P868, DOI 10.1177/1359105307082448; Goldacre B, 2007, LANCET, V370, P1672, DOI 10.1016/S0140-6736(07)61706-1; Grossinger R, 1998, HOMEOPATHY GREAT RID; Hameen-Anttila KP, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-107; Hori S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-14; House of Commons (HoC) Report, 2010, 4 HOC; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; KISH L, 1962, J AM STAT ASSOC, V57, P92, DOI 10.2307/2282442; KLEIJNEN J, 1991, BRIT MED J, V302, P316, DOI 10.1136/bmj.302.6772.316; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Linde K, 1998, J ALTERN COMPLEM MED, V4, P371, DOI 10.1089/acm.1998.4.371; MacLennan AH, 2002, PREV MED, V35, P166, DOI 10.1006/pmed.2002.1057; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; Miller JD, 1998, PUBLIC UNDERST SCI, V7, P203, DOI 10.1088/0963-6625/7/3/001; Muth?n B., 2001, NEW DEV TECHNIQUES S, V2, P1, DOI DOI 10.4324/9781410601858-6; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nguyen LT, 2011, J GEN INTERN MED, V26, P399, DOI 10.1007/s11606-010-1542-3; O'Mathuna DP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002766.pub2; Pawluch D, 2000, SOC SCI MED, V51, P251, DOI 10.1016/S0277-9536(99)00450-5; Sehon S, 2010, J EVAL CLIN PRACT, V16, P276, DOI 10.1111/j.1365-2753.2010.01384.x; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Testerman J, 2004, COMPLEMENT HLTH PRAC, V9, P81, DOI [10.1177/1076167503261254, DOI 10.1177/1076167503261254]; Vermunt J. K., 1997, ADV QUANTITATIVE TEC, V8; Vincent C, 1997, COMPLEMENTARY MED RE; Walach H, 2009, J ALTERN COMPLEM MED, V15, P1139, DOI 10.1089/acm.2009.0423; YATES PM, 1993, SOCIOL HEALTH ILL, V15, P199, DOI 10.1111/1467-9566.ep11346886	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53174	10.1371/journal.pone.0053174	http://dx.doi.org/10.1371/journal.pone.0053174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382836	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800019
J	Xu, ZX; Sun, X; Sun, JB				Xu, Zixiang; Sun, Xiao; Sun, Jibin			Construction and Analysis of the Model of Energy Metabolism in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; THERMODYNAMIC ANALYSIS; RECONSTRUCTION; NETWORKS; CONSTRAINTS; PREDICTION; GSM/GPR	Genome-scale models of metabolism have only been analyzed with the constraint-based modelling philosophy and there have been several genome-scale gene-protein-reaction models. But research on the modelling for energy metabolism of organisms just began in recent years and research on metabolic weighted complex network are rare in literature. We have made three research based on the complete model of E. coli's energy metabolism. We first constructed a metabolic weighted network using the rates of free energy consumption within metabolic reactions as the weights. We then analyzed some structural characters of the metabolic weighted network that we constructed. We found that the distribution of the weight values was uneven, that most of the weight values were zero while reactions with abstract large weight values were rare and that the relationship between w (weight values) and v (flux values) was not of linear correlation. At last, we have done some research on the equilibrium of free energy for the energy metabolism system of E. coli. We found that E-out (free energy rate input from the environment) can meet the demand of E-in(ch) (free energy rate dissipated by chemical process) and that chemical process plays a great role in the dissipation of free energy in cells. By these research and to a certain extend, we can understand more about the energy metabolism of E. coli.	[Xu, Zixiang; Sun, Jibin] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Xu, Zixiang; Sun, Xiao] Southeast Univ, State Key Lab Bioelect, Nanjing, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Southeast University - China	Sun, X (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China.	xzx21c@163.com		Sun, Jibin/0000-0002-0208-504X	National Basic Research Program of China [2011CBA00804]; State Key Laboratory of Bioelectronics [2011E12]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioelectronics	Support for this work was provided by "National Basic Research Program of China (2011CBA00804)" and the Open Research Fund of State Key Laboratory of Bioelectronics (2011E12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard DA, 2004, J THEOR BIOL, V228, P327, DOI 10.1016/j.jtbi.2004.01.008; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bork P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100016; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Scott AB, 2005, BMC MICROBIOL, V5; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Yang F, 2005, METAB ENG, V7, P251, DOI 10.1016/j.ymben.2005.03.002; Zhu Y, 2013, BIOTECHNOL BIOENG, V110, P914, DOI 10.1002/bit.24739	24	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55137	10.1371/journal.pone.0055137	http://dx.doi.org/10.1371/journal.pone.0055137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383083	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800118
J	Kumar, V; Chichili, VPR; Tang, XH; Sivaraman, J				Kumar, Veerendra; Chichili, Vishnu Priyanka Reddy; Tang, Xuhua; Sivaraman, J.			A Novel Trans Conformation of Ligand-Free Calmodulin	PLOS ONE			English	Article							AMPHIPHILIC ALPHA-HELIX; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CALCIUM-BINDING; ION-BINDING; PROTEIN; COMPLEX; ACTIVATION; REVEALS	Calmodulin (CaM) is a highly conserved eukaryotic protein that binds specifically to more than 100 target proteins in response to calcium (Ca2+) signal. CaM adopts a considerable degree of structural plasticity to accomplish this physiological role; however, the nature and extent of this plasticity remain to be fully understood. Here, we report the crystal structure of a novel trans conformation of ligand-free CaM where the relative disposition of two lobes of CaM is different, a conformation to-date not reported. While no major structural changes were observed in the independent N- and C-lobes as compared with previously reported structures of Ca2+/CaM, the central helix was tilted by similar to 90 degrees at Arg75. This is the first crystal structure of CaM to show a drastic conformational change in the central helix, and reveals one of several possible conformations of CaM to engage with its binding partner.	[Kumar, Veerendra; Chichili, Vishnu Priyanka Reddy; Tang, Xuhua; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg		Kumar, Veerendra/0000-0002-9241-1303; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of Singapore (BMRC), A*STAR [R154000461305]; National University of Singapore (NUS)	Biomedical Research Council of Singapore (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore (NUS)(National University of Singapore)	The authors are grateful to the Biomedical Research Council of Singapore (BMRC), A*STAR, for the partial support of this study (R154000461305). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; X-ray diffraction data for this study were measured at beamline X8C at BNL, New York, USA. Veerendra Kumar is a graduate scholar in receipt of a research scholarship from the National University of Singapore (NUS).	ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAUDIER J, 1983, BIOCHEM BIOPH RES CO, V114, P1138, DOI 10.1016/0006-291X(83)90681-2; Black DJ, 2005, AM J PHYSIOL-CELL PH, V288, pC669, DOI 10.1152/ajpcell.00191.2004; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dash S, 1997, BIOCHEMISTRY-US, V36, P2025, DOI 10.1021/bi9621674; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fok AK, 2008, J EUKARYOT MICROBIOL, V55, P481, DOI 10.1111/j.1550-7408.2008.00347.x; Fujiwara T, 2005, J BACTERIOL, V187, P480, DOI 10.1128/JB.187.2.480-487.2005; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; HABERMANN E, 1983, ARCH TOXICOL, V54, P61, DOI 10.1007/BF00277816; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hui OY, 1998, BIOMETALS, V11, P213, DOI 10.1023/A:1009226215543; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kursula P, 2007, ACTA CRYSTALLOGR F, V63, P653, DOI 10.1107/S1744309107034525; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINSE S, 1991, J BIOL CHEM, V266, P8050; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Medvedeva MV, 1999, FEBS LETT, V450, P139, DOI 10.1016/S0014-5793(99)00483-4; MURTAUGH TJ, 1983, METHOD ENZYMOL, V102, P158; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagnozzi D, 2010, BIOCHEMISTRY-US, V49, P7542, DOI 10.1021/bi100447t; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2004, BIOCHEM BIOPH RES CO, V317, P309, DOI 10.1016/j.bbrc.2004.03.046; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VanderSpoel D, 1996, PROTEIN SCI, V5, P2044; Warren JT, 2007, J MOL BIOL, V374, P517, DOI 10.1016/j.jmb.2007.09.048; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wilson MA, 2003, ACTA CRYSTALLOGR D, V59, P1782, DOI 10.1107/S0907444903016846; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y	45	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54834	10.1371/journal.pone.0054834	http://dx.doi.org/10.1371/journal.pone.0054834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382982	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200002
J	McCormack, JE; Harvey, MG; Faircloth, BC; Crawford, NG; Glenn, TC; Brumfield, RT				McCormack, John E.; Harvey, Michael G.; Faircloth, Brant C.; Crawford, Nicholas G.; Glenn, Travis C.; Brumfield, Robb T.			A Phylogeny of Birds Based on Over 1,500 Loci Collected by Target Enrichment and High-Throughput Sequencing	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; MITOCHONDRIAL-DNA; SPECIES TREES; SISTER GROUP; AVIAN TREE; EVOLUTION; ALGORITHMS; UTILITY; INCONSISTENCY; PROBABILITIES	Evolutionary relationships among birds in Neoaves, the clade comprising the vast majority of avian diversity, have vexed systematists due to the ancient, rapid radiation of numerous lineages. We applied a new phylogenomic approach to resolve relationships in Neoaves using target enrichment (sequence capture) and high-throughput sequencing of ultraconserved elements (UCEs) in avian genomes. We collected sequence data from UCE loci for 32 members of Neoaves and one outgroup (chicken) and analyzed data sets that differed in their amount of missing data. An alignment of 1,541 loci that allowed missing data was 87% complete and resulted in a highly resolved phylogeny with broad agreement between the Bayesian and maximum-likelihood (ML) trees. Although results from the 100% complete matrix of 416 UCE loci were similar, the Bayesian and ML trees differed to a greater extent in this analysis, suggesting that increasing from 416 to 1,541 loci led to increased stability and resolution of the tree. Novel results of our study include surprisingly close relationships between phenotypically divergent bird families, such as tropicbirds (Phaethontidae) and the sunbittern (Eurypygidae) as well as between bustards (Otididae) and turacos (Musophagidae). This phylogeny bolsters support for monophyletic waterbird and landbird clades and also strongly supports controversial results from previous studies, including the sister relationship between passerines and parrots and the non-monophyly of raptorial birds in the hawk and falcon families. Although significant challenges remain to fully resolving some of the deep relationships in Neoaves, especially among lineages outside the waterbirds and landbirds, this study suggests that increased data will yield an increasingly resolved avian phylogeny.	[McCormack, John E.; Harvey, Michael G.; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Harvey, Michael G.; Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Crawford, Nicholas G.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; University of California System; University of California Los Angeles; Boston University; University System of Georgia; University of Georgia	McCormack, JE (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	mccormack@oxy.edu	Brumfield, Robb T/K-6108-2015; Glenn, Travis C/A-2390-2008; Faircloth, Brant C/Y-3978-2019	Brumfield, Robb T/0000-0003-2307-0688; Glenn, Travis C/0000-0001-7725-3637; Faircloth, Brant/0000-0002-1943-0217	NSF [DEB-0841729, DEB-1242260]; Amazon; Direct For Biological Sciences [0841729] Funding Source: National Science Foundation; Division Of Environmental Biology [1242260] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Amazon; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by NSF grant DEB-0841729 to RTB. DEB-1242260 to BCF and TCG and an Amazon Web Services grant to BCF, NGC, JEM, and TCG provided partial support for computational analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2008, SYST BIOL, V57, P503, DOI 10.1080/10635150802164587; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Braun EL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-141; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Chubb AL, 2004, MOL PHYLOGENET EVOL, V30, P140, DOI 10.1016/S1055-7903(03)00159-3; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Degnan JH, 2005, EVOLUTION, V59, P24; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Fain MG, 2004, EVOLUTION, V58, P2558; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Gibb GC, 2010, MOL PHYLOGENET EVOL, V56, P698, DOI 10.1016/j.ympev.2010.04.016; Glenn TC, 2008, INTEGR COMP BIOL, V48, P463, DOI 10.1093/icb/icn061; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrath O, 2012, PROC ROY SOC B IN PR; Han KL, 2011, SYST BIOL, V60, P375, DOI 10.1093/sysbio/syq100; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Janes DE, 2011, GENOME BIOL EVOL, V3, P102, DOI 10.1093/gbe/evq087; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kolaczkowski B, 2006, MOL BIOL EVOL, V23, P1819, DOI 10.1093/molbev/msl059; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Matzke A, 2012, MOL BIOL EVOL, V29, P1497, DOI 10.1093/molbev/msr319; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Nabholz B, 2011, MOL BIOL EVOL, V28, P2197, DOI 10.1093/molbev/msr047; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Pasko L, 2011, MOL PHYLOGENET EVOL, V61, P760, DOI 10.1016/j.ympev.2011.07.021; Poe S, 2004, EVOLUTION, V58, P404, DOI 10.1111/j.0014-3820.2004.tb01655.x; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Rambaut A., 2007, TRACE V1 4; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J, 2001, MOL CLONING LAB MANU; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Sibley CG, 1990, DISTRIBUTION TAXONOM; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Thomas B. T., 1996, HDB BIRDS WORLD, V3, P24; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	73	241	247	8	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54848	10.1371/journal.pone.0054848	http://dx.doi.org/10.1371/journal.pone.0054848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382987	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200003
J	Zehetleitner, M; Koch, AI; Goschy, H; Muller, HJ				Zehetleitner, Michael; Koch, Anja Isabel; Goschy, Harriet; Mueller, Hermann Joseph			Salience-Based Selection: Attentional Capture by Distractors Less Salient Than the Target	PLOS ONE			English	Article							VISUAL-SEARCH; CONNECTIONIST MODEL; DIFFUSION-MODEL; PARIETAL CORTEX; GUIDED SEARCH; STIMULUS; DRIVEN; MECHANISMS; MEMORY; TIME	Current accounts of attentional capture predict the most salient stimulus to be invariably selected first. However, existing salience and visual search models assume noise in the map computation or selection process. Consequently, they predict the first selection to be stochastically dependent on salience, implying that attention could even be captured first by the second most salient (instead of the most salient) stimulus in the field. Yet, capture by less salient distractors has not been reported and salience-based selection accounts claim that the distractor has to be more salient in order to capture attention. We tested this prediction using an empirical and modeling approach of the visual search distractor paradigm. For the empirical part, we manipulated salience of target and distractor parametrically and measured reaction time interference when a distractor was present compared to absent. Reaction time interference was strongly correlated with distractor salience relative to the target. Moreover, even distractors less salient than the target captured attention, as measured by reaction time interference and oculomotor capture. In the modeling part, we simulated first selection in the distractor paradigm using behavioral measures of salience and considering the time course of selection including noise. We were able to replicate the result pattern we obtained in the empirical part. We conclude that each salience value follows a specific selection time distribution and attentional capture occurs when the selection time distributions of target and distractor overlap. Hence, selection is stochastic in nature and attentional capture occurs with a certain probability depending on relative salience.	[Zehetleitner, Michael; Koch, Anja Isabel; Goschy, Harriet; Mueller, Hermann Joseph] Univ Munich, Dept Psychol, Munich, Germany; [Koch, Anja Isabel; Goschy, Harriet] Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany; [Mueller, Hermann Joseph] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; University of Munich; University of London; Birkbeck University London	Zehetleitner, M (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	mzehetleitner@psy.lmu.de; Isabel.Koch@psy.lmu.de	Zehetleitner, Michael/AHE-2494-2022		German Research Foundation (DFG) [EC 142, MZ-887/3-1]; German-Israeli Foundation for Scientific Research and Development [1130-158.4]; LMU Graduate School of Systemic Neurosciences [GSC 82/1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); LMU Graduate School of Systemic Neurosciences	This research was supported by German Research Foundation (DFG, www.dfg.de/en/) grant EC 142 (Excellence Cluster "Cognition for Technical Systems"), DFG grant MZ-887/3-1, German-Israeli Foundation for Scientific Research and Development (www.gif.org.il) grant 1130-158.4, and a fellowship of the LMU Graduate School of Systemic Neurosciences (www.gsn.lmu.de), GSC 82/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Cave KR, 1999, PSYCHOL RES-PSYCH FO, V62, P182, DOI 10.1007/s004260050050; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Gao DS, 2009, NEURAL COMPUT, V21, P239, DOI 10.1162/neco.2009.11-06-391; Geyer T, 2010, J VISION, V10, DOI 10.1167/10.2.3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Green DM, 1966, SIGNAL DETECTION THE; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2010, EXP BRAIN RES, V201, P789, DOI 10.1007/s00221-009-2094-9; Hodsoll J, 2009, CEREB CORTEX, V19, P106, DOI 10.1093/cercor/bhn070; HUMPHREYS GW, 1993, COGNITIVE PSYCHOL, V25, P43, DOI 10.1006/cogp.1993.1002; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P510, DOI 10.1037/0096-1523.9.4.510; Kiss M, 2012, J COGNITIVE NEUROSCI, V24, P749, DOI 10.1162/jocn_a_00127; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Lavie N, 2006, VIS COGN, V14, P863, DOI 10.1080/13506280500195953; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Mueller HJ, 2009, J EXP PSYCHOL HUMAN, V35, P1, DOI 10.1037/0096-1523.35.1.1; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NOTHDURFT HC, 1993, SPATIAL VISION, V7, P341, DOI 10.1163/156856893X00487; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; PHAF RH, 1990, COGNITIVE PSYCHOL, V22, P273, DOI 10.1016/0010-0285(90)90006-P; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Soltani A, 2010, J NEUROSCI, V30, P12831, DOI 10.1523/JNEUROSCI.1517-10.2010; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Tollner T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016276; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Usher M, 1996, J COGNITIVE NEUROSCI, V8, P311, DOI 10.1162/jocn.1996.8.4.311; van Zoest W, 2005, VIS COGN, V12, P353, DOI 10.1080/13506280444000229; van Zoest W, 2008, Q J EXP PSYCHOL, V61, P1553, DOI 10.1080/17470210701595555; Vandekerckhove J, 2007, PSYCHON B REV, V14, P1011, DOI 10.3758/BF03193087; VANZANDT T, 1993, PERCEPT PSYCHOPHYS, V53, P563, DOI 10.3758/BF03205204; VERGHESE P, 1994, VISION RES, V34, P2453, DOI 10.1016/0042-6989(94)90289-5; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Zehetleitner M, 2008, FRONT BIOSCI-LANDMRK, V13, P5279, DOI 10.2741/3080; Zehetleitner M, 2012, J EXP PSYCHOL HUMAN, V38, P941, DOI 10.1037/a0027629; Zehetleitner M, 2012, ATTEN PERCEPT PSYCHO, V74, P879, DOI 10.3758/s13414-012-0287-y; Zehetleitner M, 2011, ATTEN PERCEPT PSYCHO, V73, P349, DOI 10.3758/s13414-010-0035-0; Zehetleitner M, 2010, J VISION, V10, DOI 10.1167/10.14.35; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1739, DOI 10.3758/APP.71.8.1739; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1760, DOI 10.3758/APP.71.8.1760	73	35	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e52595	10.1371/journal.pone.0052595	http://dx.doi.org/10.1371/journal.pone.0052595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093SF	23382820	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000315211500005
J	Lauterbach, R; Wells, K; O'Hara, RB; Kalko, EKV; Renner, SC				Lauterbach, Ralf; Wells, Konstans; O'Hara, Robert B.; Kalko, Elisabeth K. V.; Renner, Swen C.			Variable Strength of Forest Stand Attributes and Weather Conditions on the Questing Activity of Ixodes ricinus Ticks over Years in Managed Forests	PLOS ONE			English	Article							LYME-DISEASE VECTOR; CLIMATE-CHANGE; POPULATION-DYNAMICS; SATURATION DEFICIT; RANGE EXPANSION; LOCAL CLIMATE; ABUNDANCE; ACARI; SCAPULARIS; IXODIDAE	Given the ever-increasing human impact through land use and climate change on the environment, we crucially need to achieve a better understanding of those factors that influence the questing activity of ixodid ticks, a major disease-transmitting vector in temperate forests. We investigated variation in the relative questing nymph densities of Ixodes ricinus in differently managed forest types for three years (2008-2010) in SW Germany by drag sampling. We used a hierarchical Bayesian modeling approach to examine the relative effects of habitat and weather and to consider possible nested structures of habitat and climate forces. The questing activity of nymphs was considerably larger in young forest successional stages of thicket compared with pole wood and timber stages. Questing nymph density increased markedly with milder winter temperatures. Generally, the relative strength of the various environmental forces on questing nymph density differed across years. In particular, winter temperature had a negative effect on tick activity across sites in 2008 in contrast to the overall effect of temperature across years. Our results suggest that forest management practices have important impacts on questing nymph density. Variable weather conditions, however, might override the effects of forest management practices on the fluctuations and dynamics of tick populations and activity over years, in particular, the preceding winter temperatures. Therefore, robust predictions and the detection of possible interactions and nested structures of habitat and climate forces can only be quantified through the collection of long-term data. Such data are particularly important with regard to future scenarios of forest management and climate warming.	[Lauterbach, Ralf; Wells, Konstans; Kalko, Elisabeth K. V.; Renner, Swen C.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Wells, Konstans; O'Hara, Robert B.] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Renner, Swen C.] Smithsonian Conservat Biol Inst, Front Royal, VA USA	Ulm University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Renner, SC (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	swen.renner@uni-ulm.de	Wells, Konstans/A-7232-2010; O'Hara, Bob/A-7499-2008	Wells, Konstans/0000-0003-0377-2463; O'Hara, Bob/0000-0001-9737-3724; /0000-0002-6893-4219	DFG [KA 1241/15-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (KA 1241/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauhus J, 2009, FOREST ECOL MANAG, V258, P525, DOI 10.1016/j.foreco.2009.01.053; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Daniel M, 1998, EXP APPL ACAROL, V22, P417, DOI 10.1023/A:1006030827216; Daniel Milan, 1994, P91; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Dobson ADM, 2011, TICKS TICK-BORNE DIS, V2, P67, DOI 10.1016/j.ttbdis.2011.03.002; Ecke F, 2002, J APPL ECOL, V39, P781, DOI 10.1046/j.1365-2664.2002.00759.x; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Estrada-Pena A, 2001, J MED ENTOMOL, V38, P361, DOI 10.1603/0022-2585-38.3.361; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Gelman A., 2007, DATA ANAL USING REGR; Gilbert L, 2012, ECOL APPL, V22, P658, DOI 10.1890/11-0458.1; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grimmond CSB, 2000, CLIM RES, V15, P137, DOI 10.3354/cr015137; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hubalek Z, 2006, MED VET ENTOMOL, V20, P166, DOI 10.1111/j.1365-2915.2006.00615.x; Hubalek Z, 2003, J VECTOR ECOL, V28, P159; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Lasch P, 2002, FOREST ECOL MANAG, V162, P73, DOI 10.1016/S0378-1127(02)00051-8; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Lohmus A, 2003, ECOGRAPHY, V26, P545, DOI 10.1034/j.1600-0587.1999.03575.x; Lubelczyk CB, 2004, ENVIRON ENTOMOL, V33, P900, DOI 10.1603/0046-225X-33.4.900; Malo AF, 2013, BEHAV ECOL, V24, P759, DOI 10.1093/beheco/ars202; Muller-Westermeier G., 1995, NUMERISCHES VERFAHRE; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Perret JL, 2003, J EXP BIOL, V206, P1809, DOI 10.1242/jeb.00345; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Renaud V, 2009, AGR FOREST METEOROL, V149, P873, DOI 10.1016/j.agrformet.2008.11.006; Rosa R, 2007, VECTOR-BORNE ZOONOT, V7, P285, DOI 10.1089/vbz.2006.0607; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Schulze TL, 2005, J MED ENTOMOL, V42, P285, DOI 10.1603/0022-2585(2005)042[0285:IOMAMH]2.0.CO;2; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Taylor AR, 2005, SOIL BIOL BIOCHEM, V37, P2117, DOI 10.1016/j.soilbio.2005.03.015; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wells K, 2011, BASIC APPL ECOL, V12, P97, DOI 10.1016/j.baae.2011.01.002; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Wikle CK, 2003, ECOLOGY, V84, P1382, DOI 10.1890/0012-9658(2003)084[1382:HBMFPT]2.0.CO;2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	54	12	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55365	10.1371/journal.pone.0055365	http://dx.doi.org/10.1371/journal.pone.0055365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372852	Green Published, gold, Green Submitted			2022-12-25	WOS:000315210400092
J	Boch, S; Muller, J; Pratil, D; Blaserl, S; Fischer, M				Boch, Steffen; Mueller, Joerg; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus			Up in the Tree - The Overlooked Richness of Bryophytes and Lichens in Tree Crowns	PLOS ONE			English	Article							EPIPHYTIC BRYOPHYTES; VERTICAL-DISTRIBUTION; STAND STRUCTURE; SPECIES COMPOSITION; BEECH FORESTS; DIVERSITY; BIODIVERSITY; ECOLOGY	Assessing diversity is among the major tasks in ecology and conservation science. In ecological and conservation studies, epiphytic cryptogams are usually sampled up to accessible heights in forests. Thus, their diversity, especially of canopy specialists, likely is underestimated. If the proportion of those species differs among forest types, plot-based diversity assessments are biased and may result in misleading conservation recommendations. We sampled bryophytes and lichens in 30 forest plots of 20 m x 20 m in three German regions, considering all substrates, and including epiphytic litter fall. First, the sampling of epiphytic species was restricted to the lower 2 m of trees and shrubs. Then, on one representative tree per plot, we additionally recorded epiphytic species in the crown, using tree climbing techniques. Per tree, on average 54% of lichen and 20% of bryophyte species were overlooked if the crown was not been included. After sampling all substrates per plot, including the bark of all shrubs and trees, still 38% of the lichen and 4% of the bryophyte species were overlooked if the tree crown of the sampled tree was not included. The number of overlooked lichen species varied strongly among regions. Furthermore, the number of overlooked bryophyte and lichen species per plot was higher in European beech than in coniferous stands and increased with increasing diameter at breast height of the sampled tree. Thus, our results indicate a bias of comparative studies which might have led to misleading conservation recommendations of plot-based diversity assessments.	[Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	University of Bern; University of Bern; University of Potsdam	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Fischer, Markus/C-6411-2008; Schulze, Ernst-Detlef/K-9627-2014	Fischer, Markus/0000-0002-5589-5900; 	DFG (German Research Foundation); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" [FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation)(German Research Foundation (DFG)); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"(FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptroot A., 1997, V68, P203; Barkman J.J., 1958, BRYOLOGIST; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bohn U., 2000, KARTE NATURLICHEN VE; CORNELISSEN JHC, 1989, J TROP ECOL, V5, P131, DOI 10.1017/S0266467400003400; Diaz IA, 2010, FOREST ECOL MANAG, V259, P1490, DOI 10.1016/j.foreco.2010.01.025; EVERSMAN S, 1987, BRYOLOGIST, V90, P212, DOI 10.2307/3242928; Fengel D., 1984, Wood: chemistry, ultrastructure, reactions.; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2009, BIODIVERS CONSERV, V18, P289, DOI 10.1007/s10531-008-9483-4; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; HARRIS GP, 1971, J ECOL, V59, P431, DOI 10.2307/2258323; Holz I, 2002, BRYOLOGIST, V105, P334, DOI 10.1639/0007-2745(2002)105[0334:BDMDAD]2.0.CO;2; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; JARMAN SJ, 1995, NEW ZEAL J BOT, V33, P65, DOI 10.1080/0028825X.1995.10412944; Jonsson MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045701; Kiraly I, 2010, BIOL CONSERV, V143, P2063, DOI 10.1016/j.biocon.2010.05.014; Lutzoni F, 2009, CURR BIOL, V19, pR502, DOI 10.1016/j.cub.2009.04.034; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; MAZIMPAKA V, 1995, NOVA HEDWIGIA, V61, P431; McCune B, 1997, NORTHWEST SCI, V71, P145; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Milne J, 1999, OERST HIKOBIA, V13, P23; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Nascimbene J, 2013, FOREST ECOL MANAG, V298, P27, DOI 10.1016/j.foreco.2013.03.008; Nascimbene J, 2009, BIODIVERS CONSERV, V18, P1509, DOI 10.1007/s10531-008-9537-7; Nebel, 2000, MOOSE BADEN WURTTEMB; Nebel M, 2005, MOOSE BADEN WURTTEMB, V3; Nebel M, 2001, MOOSE BADEN WURTTEMB, V2; Nimis PL, 2002, EARTH ENV SCI, V7; Normann F, 2010, ECOL INDIC, V10, P1111, DOI 10.1016/j.ecolind.2010.03.008; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Porley R., 2005, MOSSES LIVERWORTS; R Core Team, 2016, R FDN STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Redei K, 2001, LESNICKY CASOPIS, V47, P135; Romanski J, 2011, BRYOLOGIST, V114, P720, DOI 10.1639/0007-2745-114.4.720; Sillett SC, 2000, NORTHWEST SCI, V74, P44; SILLETT SC, 1995, BRYOLOGIST, V98, P251, DOI 10.2307/3243312; Sillett SC, 2004, FOREST CANOPIES, P151, DOI [DOI 10.1016/B978-012457553-0/50013-7, 10.1016/B978-012457553-0/50013-7]; Sporn SG, 2010, BIODIVERS CONSERV, V19, P745, DOI 10.1007/s10531-009-9731-2; Svensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062825; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; Will-Wolf S, 2002, NATO SCI S SS IV EAR, V7, P203; WIRTH V., 2013, FLECHTEN DTSCH; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; [No title captured]	53	62	69	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84913	10.1371/journal.pone.0084913	http://dx.doi.org/10.1371/journal.pone.0084913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358373	gold, Green Submitted, Green Published			2022-12-25	WOS:000328737700107
J	Yang, WK; Kang, CK; Chang, CH; Hsu, AD; Lee, TH; Hwang, PP				Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han; Hwang, Pung-Pung			Expression Profiles of Branchial FXYD Proteins in the Brackish Medaka Oryzias dancena: A Potential Saltwater Fish Model for Studies of Osmoregulation	PLOS ONE			English	Article							PHOSPHOLEMMAN-LIKE PROTEIN; NA+/K+-ATPASE EXPRESSION; SHARK RECTAL GLANDS; FUNCTIONAL INTERACTION; ION REGULATION; GENUS ORYZIAS; SODIUM-PUMP; FRESH-WATER; K+-ATPASE; NA,K-ATPASE	FXYD proteins are novel regulators of Na+-K+-ATPase (NKA). In fish subjected to salinity challenges, NKA activity in osmoregulatory organs (e. g., gills) is a primary driving force for the many ion transport systems that act in concert to maintain a stable internal environment. Although teleostean FXYD proteins have been identified and investigated, previous studies focused on only a limited group of species. The purposes of the present study were to establish the brackish medaka (Oryzias dancena) as a potential saltwater fish model for osmoregulatory studies and to investigate the diversity of teleostean FXYD expression profiles by comparing two closely related euryhaline model teleosts, brackish medaka and Japanese medaka (O. latipes), upon exposure to salinity changes. Seven members of the FXYD protein family were identified in each medaka species, and the expression of most branchial fxyd genes was salinity-dependent. Among the cloned genes, fxyd11 was expressed specifically in the gills and at a significantly higher level than the other fxyd genes. In the brackish medaka, branchial fxyd11 expression was localized to the NKA-immunoreactive cells in gill epithelia. Furthermore, the FXYD11 protein interacted with the NKA a-subunit and was expressed at a higher level in freshwater-acclimated individuals relative to fish in other salinity groups. The protein sequences and tissue distributions of the FXYD proteins were very similar between the two medaka species, but different expression profiles were observed upon salinity challenge for most branchial fxyd genes. Salinity changes produced different effects on the FXYD11 and NKA a-subunit expression patterns in the gills of the brackish medaka. To our knowledge, this report is the first to focus on FXYD expression in the gills of closely related euryhaline teleosts. Given the advantages conferred by the well-developed Japanese medaka system, we propose the brackish medaka as a saltwater fish model for osmoregulatory studies.	[Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yang, Wen-Kai] MingDao Univ, Dept Biotechnol, Changhua, Taiwan; [Lee, Tsung-Han] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Chung Hsing University; Mingdao University; China Medical University Taiwan; Academia Sinica - Taiwan	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@email.nchu.edu.tw	He, Xinhua/B-8047-2015; Hwang, Pung-Pung/AEQ-4633-2022; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AAH-1538-2022; Chang, Chia-Hao/AAW-2598-2020; GUO, Liang-dong/C-1407-2015; hwang, pp/A-3641-2011; Zheng, Yong/E-3947-2012; Zheng, Yong/AAN-8928-2021	He, Xinhua/0000-0002-5570-3454; Gao 高程, Cheng/0000-0003-2522-7909; Chang, Chia-Hao/0000-0002-7583-4291; Zheng, Yong/0000-0001-5239-9824; Zheng, Yong/0000-0001-5239-9824; Yang, Wen-Kai/0000-0001-8095-2420; Lee, Tsung-Han/0000-0002-3542-4335	Academia Sinica of Taiwan [AS-98-TP-B08]; ATU plan of the Ministry of Education, Taiwan [CC-97118]; NICHD, USA [N01-HD-6-2915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	Academia Sinica of Taiwan(Academia Sinica - Taiwan); ATU plan of the Ministry of Education, Taiwan; NICHD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Academia Sinica of Taiwan to PPH and THL (AS-98-TP-B08). The work was also supported in part by a grant from the ATU plan of the Ministry of Education, Taiwan, to THL (CC-97118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody against the Na<SUP>+</SUP>-K<SUP>+</SUP>-ATPase alpha-subunit (alpha 5) was purchased from the Developmental Studies Hybridoma Bank maintained by the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, and the Department of Biological Sciences, University of Iowa, Iowa City, IA 52242, under Contract N01-HD-6-2915, NICHD, USA.	Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bystriansky JS, 2011, J EXP BIOL, V214, P2435, DOI 10.1242/jeb.050633; Chen XP, 2009, COMP BIOCHEM PHYS C, V149, P647, DOI 10.1016/j.cbpc.2009.01.009; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Cutler CP, 2000, AM J PHYSIOL-REG I, V279, pR222, DOI 10.1152/ajpregu.2000.279.1.R222; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Freire CA, 2008, COMP BIOCHEM PHYS A, V149, P435, DOI 10.1016/j.cbpa.2008.02.003; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Inoue K, 2012, ENVIRON BIOL FISH, V94, P559, DOI 10.1007/s10641-011-9852-9; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kang CK, 2013, COMP BIOCHEM PHYS A, V164, P181, DOI 10.1016/j.cbpa.2012.08.010; Kang CK, 2010, COMP BIOCHEM PHYS A, V157, P7, DOI 10.1016/j.cbpa.2010.05.013; Kang CK, 2008, COMP BIOCHEM PHYS A, V151, P566, DOI 10.1016/j.cbpa.2008.07.020; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mahmmoud YA, 2005, J BIOL CHEM, V280, P27776, DOI 10.1074/jbc.M503150200; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts TR, 1998, ICHTHYOL RES, V45, P213, DOI 10.1007/BF02673919; Saito K, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00129; Sakamoto T, 2001, AQUACULTURE, V193, P347, DOI 10.1016/S0044-8486(00)00471-3; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CH, 2012, COMP BIOCHEM PHYS A, V163, P302, DOI 10.1016/j.cbpa.2012.07.017; Tipsmark CK, 2011, J ENDOCRINOL, V209, P237, DOI 10.1530/JOE-10-0495; Tipsmark CK, 2010, AM J PHYSIOL-REG I, V299, pR1212, DOI 10.1152/ajpregu.00015.2010; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1367, DOI 10.1152/ajpregu.00454.2007; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang PJ, 2008, J EXP BIOL, V211, P3750, DOI 10.1242/jeb.018440; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yang WK, 2011, J COMP PHYSIOL B, V181, P953, DOI 10.1007/s00360-011-0568-0; Yang WK, 2009, J EXP MAR BIOL ECOL, V375, P41, DOI 10.1016/j.jembe.2009.05.004; Yusof S, 2012, ENVIRON BIOL FISH, V93, P43, DOI 10.1007/s10641-011-9888-x	55	118	135	11	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55470	10.1371/journal.pone.0055470	http://dx.doi.org/10.1371/journal.pone.0055470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	24086741	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600108
J	Petersen, JL; Mickelson, JR; Cothran, EG; Andersson, LS; Axelsson, J; Bailey, E; Bannasch, D; Binns, MM; Borges, AS; Brama, P; Machado, AD; Distl, O; Felicetti, M; Fox-Clipsham, L; Graves, KT; Guerin, G; Haase, B; Hasegawa, T; Hemmann, K; Hill, EW; Leeb, T; Lindgren, G; Lohi, H; Lopes, MS; McGivney, BA; Mikko, S; Orr, N; Penedo, MCT; Piercy, RJ; Raekallio, M; Rieder, S; Roed, KH; Silvestrelli, M; Swinburne, J; Tozaki, T; Vaudin, M; Wade, CM; McCue, ME				Petersen, Jessica L.; Mickelson, James R.; Cothran, E. Gus; Andersson, Lisa S.; Axelsson, Jeanette; Bailey, Ernie; Bannasch, Danika; Binns, Matthew M.; Borges, Alexandre S.; Brama, Pieter; Machado, Artur da Camara; Distl, Ottmar; Felicetti, Michela; Fox-Clipsham, Laura; Graves, Kathryn T.; Guerin, Gerard; Haase, Bianca; Hasegawa, Telhisa; Hemmann, Karin; Hill, Emmeline W.; Leeb, Tosso; Lindgren, Gabriella; Lohi, Hannes; Lopes, Maria Susana; McGivney, Beatrice A.; Mikko, Sofia; Orr, Nicholas; Penedo, M. Cecilia T.; Piercy, Richard J.; Raekallio, Marja; Rieder, Stefan; Roed, Knut H.; Silvestrelli, Maurizio; Swinburne, June; Tozaki, Teruaki; Vaudin, Mark; Wade, Claire M.; McCue, Molly E.			Genetic Diversity in the Modern Horse Illustrated from Genome-Wide SNP Data	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GENETICS; MICROSATELLITE DIVERSITY; LINKAGE DISEQUILIBRIUM; DOMESTICATION; PROGRAM; ORIGINS; INFERENCE; LINEAGES; NUMBER	Horses were domesticated from the Eurasian steppes 5,000-6,000 years ago. Since then, the use of horses for transportation, warfare, and agriculture, as well as selection for desired traits and fitness, has resulted in diverse populations distributed across the world, many of which have become or are in the process of becoming formally organized into closed, breeding populations (breeds). This report describes the use of a genome-wide set of autosomal SNPs and 814 horses from 36 breeds to provide the first detailed description of equine breed diversity. FST calculations, parsimony, and distance analysis demonstrated relationships among the breeds that largely reflect geographic origins and known breed histories. Low levels of population divergence were observed between breeds that are relatively early on in the process of breed development, and between those with high levels of within-breed diversity, whether due to large population size, ongoing outcrossing, or large within-breed phenotypic diversity. Populations with low within-breed diversity included those which have experienced population bottlenecks, have been under intense selective pressure, or are closed populations with long breed histories. These results provide new insights into the relationships among and the diversity within breeds of horses. In addition these results will facilitate future genome-wide association studies and investigations into genomic targets of selection.	[Petersen, Jessica L.; Mickelson, James R.; McCue, Molly E.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Cothran, E. Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Andersson, Lisa S.; Axelsson, Jeanette; Lindgren, Gabriella; Mikko, Sofia] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Bailey, Ernie; Graves, Kathryn T.] Univ Kentucky, Dept Vet Sci, Lexington, KY USA; [Bannasch, Danika; Penedo, M. Cecilia T.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Binns, Matthew M.] Equine Anal, Midway, KY USA; [Borges, Alexandre S.] Univ Estadual Paulista, Dept Vet Clin Sci, Botucatu, SP, Brazil; [Brama, Pieter] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Machado, Artur da Camara; Lopes, Maria Susana] Univ Azores, Inst Biotechnol & Bioengn, Biotechnol Ctr Azores, Angra Do Heroismo, Portugal; [Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Felicetti, Michela; Silvestrelli, Maurizio] Univ Perugia, Fac Vet Med, I-06100 Perugia, Italy; [Fox-Clipsham, Laura; Swinburne, June; Vaudin, Mark] Anim Hlth Trust, Newmarket, Suffolk, England; [Guerin, Gerard] French Natl Inst Agr Res, Anim Genet & Integrat Biol Unit, Jouy En Josas, France; [Haase, Bianca; Wade, Claire M.] Univ Sydney, Sydney, NSW 2006, Australia; [Hasegawa, Telhisa] Nihon Bioresource Coll, Koga, Ibaraki, Japan; [Hemmann, Karin; Lohi, Hannes; Raekallio, Marja] Univ Helsinki, Fac Vet Med, Helsinki, Finland; [Hill, Emmeline W.; McGivney, Beatrice A.] Univ Coll Dublin, Coll Agr Food Sci & Vet Med, Dublin 2, Ireland; [Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Orr, Nicholas] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Piercy, Richard J.] Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Rieder, Stefan] Swiss Natl Stud Farm, Agroscope Liebefeld Posieux Res Stn, Avenches, Switzerland; [Roed, Knut H.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Swinburne, June] Anim DNA Diagnost Ltd, Cambridge, England; [Tozaki, Teruaki] Lab Racing Chem, Dept Mol Genet, Utsunomiya, Tochigi, Japan	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Swedish University of Agricultural Sciences; University of Kentucky; University of California System; University of California Davis; Universidade Estadual Paulista; University College Dublin; Universidade dos Acores; University of Veterinary Medicine Hannover, Foundation; University of Perugia; Animal Health Trust; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; University of Helsinki; University College Dublin; University of Bern; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University of London Royal Veterinary College; Swiss Federal Research Station Agroscope; Norwegian University of Life Sciences	Petersen, JL (corresponding author), Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA.	jlpeters@umn.edu	da Câmara Machado, Artur/J-8668-2013; Raekallio, Marja/I-1606-2019; Lopes, Maria Susana/AAH-6614-2021; Bailey, Ernest/M-1859-2018; Borges, Alexandre S/B-5506-2013; Bannasch, Danika/GZL-8044-2022; Lopes, Maria/J-5379-2013; Mikko, Sofia/F-1347-2017; Leeb, Tosso/G-3187-2014; Tozaki, Teruaki/ABD-9286-2021; Petersen, Jessica/ABF-2462-2020; Lohi, Hannes/F-4596-2011	da Câmara Machado, Artur/0000-0002-6098-502X; Raekallio, Marja/0000-0002-2653-003X; Bailey, Ernest/0000-0001-8246-9117; Lopes, Maria/0000-0003-1170-9771; Mikko, Sofia/0000-0002-6375-1376; Leeb, Tosso/0000-0003-0553-4880; Tozaki, Teruaki/0000-0001-8797-6644; Petersen, Jessica/0000-0001-5438-8555; Lohi, Hannes/0000-0003-1087-5532; Waud, Bianca/0000-0001-6493-9808; Bannasch, Danika/0000-0002-7614-7207; Hill, Emmeline/0000-0002-1805-2250; McCue, Molly/0000-0002-6807-0318; Hemmann, Karin/0000-0003-3981-4231; Lindgren, Gabriella/0000-0001-6046-9669; Mickelson, James/0000-0001-6951-0234; Secorun Borges, Alexandre/0000-0001-6256-8089; Wade, Claire/0000-0003-3413-4771	National Research Initiative from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2008-35205-18766, 2009-55205-05254, 2012-67015-19432]; Foundation for the Advancement of the Tennessee Walking Show Horse; Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS) [1K08AR055713-01A2, 2T32AR007612]; American Quarter Horse Foundation; Morris Animal Foundation [D07EQ-500]; Swedish Research Council FORMAS [221-2009-1631, 2008-617]; Swedish-Norwegian Foundation for Equine Research [H0847211, H0947256]; Carl Tryggers Stiftelse [CTS 08: 29]; FCT; DRCT; Science Foundation Ireland [04/Y11/B539]; Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany [VWZN2012];  [FRCT/2011/317/005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055713, T32AR007612] Funding Source: NIH RePORTER	National Research Initiative from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Foundation for the Advancement of the Tennessee Walking Show Horse; Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS); American Quarter Horse Foundation; Morris Animal Foundation; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish-Norwegian Foundation for Equine Research; Carl Tryggers Stiftelse; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); DRCT; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Research Initiative Competitive Grants 2008-35205-18766, 2009-55205-05254, and 2012-67015-19432 from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Foundation for the Advancement of the Tennessee Walking Show Horse and Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS) grant 1K08AR055713-01A2 (MEM salary support), and 2T32AR007612 (JLP salary support), American Quarter Horse Foundation grant "Selective Breeding Practices in the American Quarter Horse: Impact on Health and Disease 2011-2012''; Morris Animal Foundation Grant D07EQ-500; The Swedish Research Council FORMAS (Contract 221-2009-1631 and 2008-617); The Swedish-Norwegian Foundation for Equine Research (Contract H0847211 and H0947256); The Carl Tryggers Stiftelse (Contract CTS 08: 29); IBB-CBA-UAc, was supported by FCT and DRCT and MSL by FRCT/2011/317/005; Science Foundation Ireland Award (04/Y11/B539) to EWH; Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany (VWZN2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle KS, 2004, ANIM GENET, V35, P270, DOI 10.1111/j.1365-2052.2004.01166.x; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Achmann R, 2004, ANIM GENET, V35, P285, DOI 10.1111/j.1365-2052.2004.01157.x; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Belkhir KP, 2001, GENTETIX LOGICIEL WI; Binns MM, 2012, ANIM GENET, V43, P340, DOI 10.1111/j.1365-2052.2011.02259.x; Bjornstad G, 2000, J ANIM BREED GENET, V117, P307, DOI 10.1046/j.1439-0388.2000.00264.x; Bjornstad G, 2003, ANIM GENET, V34, P55, DOI 10.1046/j.1365-2052.2003.00922.x; Bomcke E, 2011, GENET MOL BIOL, V34, P68, DOI 10.1590/S1415-47572010005000113; Bower MA, 2012, ARCHAEOMETRY, V54, P916, DOI 10.1111/j.1475-4754.2012.00666.x; Bower MA, 2011, BIOL LETTERS, V7, P316, DOI 10.1098/rsbl.2010.0800; Bowling AT, 2000, GENETICS HORSE, Vviii; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Conant EK, 2012, ANIM GENET, V43, P53, DOI 10.1111/j.1365-2052.2011.02210.x; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corbin LJ, 2010, ANIM GENET, V41, P8, DOI 10.1111/j.1365-2052.2010.02092.x; Cothran EG, 2011, GENET MOL RES, V10, P2394, DOI 10.4238/2011.October.7.1; COTHRAN EG, 1987, ANIM GENET, V18, P285, DOI 10.1111/j.1365-2052.1987.tb00772.x; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Felicetti M, 2010, ANIM GENET, V41, P53, DOI 10.1111/j.1365-2052.2010.02102.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Firouz L, 1969, BIOL CONSERV, V1, P1; FLETCHER JL, 1946, J HERED, V37, P369, DOI 10.1093/oxfordjournals.jhered.a105563; GATES S, 1979, MAMMAL REV, V9, P3, DOI 10.1111/j.1365-2907.1979.tb00228.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Goloboff P., 2003, SYST BIOL, V54, P176; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hendricks B., 2007, INT ENCY HORSE BREED; Hund A., 2008, PARASITE IMMUNOL, V20, P73; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Keyser-Tracqui C, 2005, ANIM GENET, V36, P203, DOI 10.1111/j.1365-2052.2005.01316.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lei CZ, 2009, ANIM GENET, V40, P933, DOI 10.1111/j.1365-2052.2009.01950.x; Leroy G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-5; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lopes MS, 2011, MOL TOOLS CHARACTERI; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Luis C, 2007, ANIM GENET, V38, P20, DOI 10.1111/j.1365-2052.2006.01545.x; Lynghaug F, 2009, OFFICIAL HORSE BREED; MACCLUER JW, 1983, J HERED, V74, P394, DOI 10.1093/oxfordjournals.jhered.a109824; Mackay-Smith A, 2000, SPEED THOROUGHBRED C, Vxxvii; Marletta D, 2006, J ANIM BREED GENET, V123, P315, DOI 10.1111/j.1439-0388.2006.00603.x; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peilieu C, 1984, FAO ANIMAL PRODUCTIO, V46, P1; Petersen JL, 2012, PLOS GENET IN PRESS; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Shasavarani H, 2010, AFR J BIOTECHNOL, V9, P293; Silvestrelli M, 1991, ANIMAL GENETIC RESOU, V8, P74; Solis A, 2005, J HERED, V96, P670, DOI 10.1093/jhered/esi123; Ticklen M, 2006, GET KNOW FINNHORSE; Tozaki T, 2003, J HERED, V94, P374, DOI 10.1093/jhered/esg079; Tryon RC, 2009, JAVMA-J AM VET MED A, V234, P120, DOI 10.2460/javma.234.1.120; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Warmuth V, 2013, ANIM GENET, V44, P53, DOI 10.1111/j.1365-2052.2012.02371.x; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weatherby and Sons, 1791, INTR GEN STUD BOOK; Weatherley L, 1978, GREAT HORSES BRITAIN, Vviii; WEIR BS, 1980, GENETICS, V95, P477; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	81	165	176	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54997	10.1371/journal.pone.0054997	http://dx.doi.org/10.1371/journal.pone.0054997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383025	Green Published, gold, Green Accepted			2022-12-25	WOS:000315563800095
J	Xu, JY; Yu, Y; Wu, X; Wu, YF; Jiang, C; Wang, SZ; Huang, QH; Liu, JM				Xu, Jinyu; Yu, Ying; Wu, Xi; Wu, Yongfa; Jiang, Che; Wang, Shengzhang; Huang, Qinghai; Liu, Jianmin			Morphological and Hemodynamic Analysis of Mirror Posterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; WALL SHEAR-STRESS; COMPUTATIONAL FLUID-DYNAMICS; INTERNAL CAROTID-ARTERY; ASPECT RATIO; CEREBRAL ANEURYSMS; SACCULAR ANEURYSM; FLOW DYNAMICS; RUPTURE RISK; SIZE	Background and Purpose: Hemodynamic factors are commonly believed to play an important role in the pathogenesis, progression, and rupture of cerebral aneurysms. In this study, we aimed to identify significant hemodynamic and morphological parameters that discriminate intracranial aneurysm rupture status using 3-dimensional-angiography and computational fluid dynamics technology. Materials and Methods: 3D-DSA was performed in 8 patients with mirror posterior communicating artery aneurysms (Pcom-MANs). Each pair was divided into ruptured and unruptured groups. Five morphological and three hemodynamic parameters were evaluated for significance with respect to rupture. Results: The normalized mean wall shear stress (WSS) of the aneurysm sac in the ruptured group was significantly lower than that in the unruptured group (0.52 +/- 0.20 versus 0.81 +/- 0.21, P = .012). The percentage of the low WSS area in the ruptured group was higher than that in the unruptured group (4.11 +/- 4.66% versus 0.02 +/- 0.06%, P = .018). The AR was 1.04 +/- 0.21 in the ruptured group, which was significantly higher than 0.70 +/- 0.17 in the unruptured group (P = .012). By contrast, parameters that had no significant differences between the two groups were OSI (P = .674), aneurysm size (P = .327), size ratio (P = .779), vessel angle (P = 1.000) and aneurysm inclination angle (P = 1.000). Conclusions: Pcom-MANs may be a useful disease model to investigate possible causes of aneurysm rupture. The ruptured aneurysms manifested lower WSS, higher percentage of low WSS area, and higher AR, compared with the unruptured one. And hemodynamics is as important as morphology in discriminating aneurysm rupture status.	[Xu, Jinyu; Yu, Ying; Wu, Xi; Wu, Yongfa; Jiang, Che; Huang, Qinghai; Liu, Jianmin] Second Mil Med Univ, Dept Neurosurg, Changhai Hosp, Shanghai, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Naval Medical University; Fudan University	Huang, QH (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changhai Hosp, Shanghai, Peoples R China.	ocinhqh@163.com; chstroke@163.com		Smith, M. Kumi/0000-0001-5861-8100; xu, junjie/0000-0003-4303-7295	National Natural Science Foundation of China [81171092, 81171093]; Shanghai Science and Technology Committee [11QA1408400, 11JC1415800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported by the National Natural Science Foundation of China (Grant No. 81171092 and 81171093), Rising-star Plan and Key Project of Shanghai Science and Technology Committee (Grant No. 11QA1408400 and 11JC1415800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2009, ACTA NEUROCHIR, V151, P1569, DOI 10.1007/s00701-009-0316-3; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Beck J, 2006, SURG NEUROL, V65, P18, DOI 10.1016/j.surneu.2005.05.019; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Castro MA, 2009, AM J NEURORADIOL, V30, P297, DOI 10.3174/ajnr.A1323; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Goubergrits L, 2012, J R SOC INTERFACE, V9, P677, DOI 10.1098/rsif.2011.0490; Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; NISHIOKA H, 1984, ARCH NEUROL-CHICAGO, V41, P1142, DOI 10.1001/archneur.1984.04050220036011; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Tremmel M, 2009, NEUROSURGERY, V64, P622, DOI 10.1227/01.NEU.0000341529.11231.69; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Valencia A, 2006, INT J NUMER METH FL, V50, P751, DOI 10.1002/fld.1078; Weir B, 2003, J NEUROSURG, V99, P447, DOI 10.3171/jns.2003.99.3.0447; White PM, 2003, J NEURORADIOLOGY, V30, P336; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Zeng Z, 2011, AM J NEURORADIOL, V32, P595, DOI 10.3174/ajnr.A2324; Zeng ZJ, 2011, J BIOMECH, V44, P2809, DOI 10.1016/j.jbiomech.2011.08.002	30	82	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55413	10.1371/journal.pone.0055413	http://dx.doi.org/10.1371/journal.pone.0055413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383184	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600100
J	Gao, XM; Zhao, YJ; Yang, XJ; Sun, SC				Gao, Xianming; Zhao, Yujie; Yang, Xuejun; Sun, Shucun			Linking Trait Differences to Community Dynamics: Evidence from Eupatorium adenophorum and Co-Occurring Native Species during a Three-Year Succession	PLOS ONE			English	Article							ALIEN INVASIVE PLANTS; RESOURCE-USE; IMPACTS; LEAF; ECOLOGY; HERBIVORY; PHENOLOGY; DOMINANCE; FRAMEWORK; RESPONSES	Trait differences between invasive and native species are believed to be closely related to whether the former are successful. However, few studies have measured trait differences between invasive and native species directly under field conditions or during long term experiments. We examined the phenological pattern, plant height and biomass accumulation and allocation of Crofton weed (Eupatorium adenophorum Spreng.) and co-occurring native species in a community during a three-year succession. The phenological pattern of Crofton weed differed from that of co-occurring native species. Crofton weed had longer vegetative stage (when resources were more available), a higher biomass accumulation and a higher above/below-ground ratio compared to native species. Crofton weed was shorter than grasses and two forbs (Artemisia tangutica and Cynoglossum amabile) during its first year of growth, but was significantly taller than all other species during subsequent years. The dominance (calculated as the importance value) of Crofton weed was the highest among all other species and continually increased over time while the dominance of co-occurring native species decreased. This study provides direct field evidence that trait differences are important to plant invasion.	[Gao, Xianming; Zhao, Yujie; Yang, Xuejun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhao, Yujie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Shucun] Chinese Acad Sci, Chengdu Inst Biol, ECORES Lab, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Gao, XM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	xmgao@ibcas.ac.cn	Yang, Xuejun/B-4718-2014	Yang, Xuejun/0000-0002-8595-545X	National Basic Research and Development Program of China [2009CB112000]; key project of the Chinese Academy of Science [KSCX1-SW-13-03-06]; National Nature Science Foundation of China [30670333]	National Basic Research and Development Program of China(National Basic Research Program of China); key project of the Chinese Academy of Science(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Basic Research and Development Program of China (2009CB112000), the key project of the Chinese Academy of Science (KSCX1-SW-13-03-06) and National Nature Science Foundation of China (30670333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AC, 1979, P 7 AS PAC WEED SCI, P351; Augspurger CK, 2008, OECOLOGIA, V156, P281, DOI 10.1007/s00442-008-1000-7; Barney JN, 2009, PLANT ECOL, V202, P275, DOI 10.1007/s11258-008-9481-3; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Cadotte MW, 2002, ECOSCIENCE, V9, P397, DOI 10.1080/11956860.2002.11682727; Cleland EE, 2011, NEW PHYTOL, V189, P649, DOI 10.1111/j.1469-8137.2010.03607.x; Coleman HM, 2007, BIOL INVASIONS, V9, P65, DOI 10.1007/s10530-006-9008-6; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Cronk QCB, 1995, PLANT INVADERS THREA; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dassonville N, 2008, OECOLOGIA, V157, P131, DOI 10.1007/s00442-008-1054-6; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Field CB, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P617; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harper J. L., 1977, Population biology of plants.; Hina Fatimah, 2009, Advances in Environmental Biology, V3, P150; Ishii H, 2010, ECOL RES, V25, P715, DOI 10.1007/s11284-009-0668-4; KLUGE RL, 1991, AGR ECOSYST ENVIRON, V37, P187, DOI 10.1016/0167-8809(91)90146-O; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kudo G, 1996, ECOL RES, V11, P283, DOI 10.1007/BF02347785; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Manea A, 2011, OECOLOGIA, V165, P735, DOI 10.1007/s00442-010-1765-3; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Page AL., 1982, CHEM MICROBIOLOGICAL, V15, P99, DOI DOI 10.2134/AGRONMONOGR9.2.2ED; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rejmanek M., 2005, INVASIVE ALIEN SPECI; Scharfy D, 2011, NEW PHYTOL, V189, P818, DOI 10.1111/j.1469-8137.2010.03531.x; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; SHARMA K C, 1977, Nepalese Journal of Agriculture, V12, P135; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tao ZG, 2002, SICHUAN ANIM VET SCI, V29, P25; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; van der Wal R, 2008, GLOBAL CHANGE BIOL, V14, P1428, DOI 10.1111/j.1365-2486.2008.01576.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Waser NM., 2006, PLANT POLLINATOR INT; Weigelt A, 2002, BASIC APPL ECOL, V3, P85, DOI 10.1078/1439-1791-00080; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilsey BJ, 2006, OECOLOGIA, V150, P300, DOI 10.1007/s00442-006-0515-z; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y; Zheng YL, 2009, PLANT ECOL, V203, P263, DOI 10.1007/s11258-008-9544-5; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	60	51	56	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e50247	10.1371/journal.pone.0050247	http://dx.doi.org/10.1371/journal.pone.0050247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23613942	Green Published, gold			2022-12-25	WOS:000314610600002
J	Kumar, S; Kaur, G				Kumar, Sushil; Kaur, Gurcharan			Intermittent Fasting Dietary Restriction Regimen Negatively Influences Reproduction in Young Rats: A Study of Hypothalamo-Hypophysial-Gonadal Axis	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; CHRONIC FOOD RESTRICTION; NEURON-GLIAL PLASTICITY; NEUROPEPTIDE-Y; METABOLIC HORMONES; BODY-WEIGHT; SEXUAL DEVELOPMENT; ANOREXIA-NERVOSA; FEED RESTRICTION; ENERGY-BALANCE	Nutritional infertility is very common in societies where women fail to eat enough to match their energy expenditure and such females often present as clinical cases of anorexia nervosa. The cellular and molecular mechanisms that link energy balance and central regulation of reproduction are still not well understood. Peripheral hormones such as estradiol, testosterone and leptin, as well as neuropeptides like kisspeptin and neuropeptides Y (NPY) play a potential role in regulation of reproduction and energy balance with their primary target converging on the hypothalamic median eminence-arcuate region. The present study was aimed to explore the effects of negative energy state resulting from intermittent fasting dietary restriction (IF-DR) regimen on complete hypothalamo-hypophysial-gonadal axis in Wistar strain young female and male rats. Significant changes in body weight, blood glucose, estrous cyclicity and serum estradiol, testosterone and LH level indicated the negative role of IF-DR regimen on reproduction in these young animals. Further, it was elucidated whether serum level of metabolic hormone, leptin plays a mechanistic role in suppressing hypothalamo-hypophysial-gonadal (HPG) axis via energy regulators, kisspeptin and NPY in rats on IF-DR regimen. We also studied the effect of IF-DR regimen on structural remodeling of GnRH axon terminals in median eminence region of hypothalamus along with the glial cell marker, GFAP and neuronal plasticity marker, PSA-NCAM using immunostaining, Western blotting and RT-PCR. Together these data suggest that IF-DR regimen negatively influences reproduction in young animals due to its adverse effects on complete hypothalamus-hypophysial-gonadal axis and may explain underlying mechanism(s) to understand the clinical basis of nutritional infertility.	[Kumar, Sushil; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Kaur, Gurcharan/V-6033-2019	Kaushik, Nutan/0000-0002-3870-8093	Indo-French Centre for Promotion of Advanced Research (IFCPAR); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	Indo-French Centre for Promotion of Advanced Research (IFCPAR)(French National Research Agency (ANR)); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	The study was supported by a Grant from the Indo-French Centre for Promotion of Advanced Research (IFCPAR) and Indian Council of Medical Research (ICMR) under the National Task Force Program. Mr. Sushil Kumar is thankful to the IFCPAR, New Delhi for the research fellowship provided during this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; ALMOND GW, 1990, J ANIM SCI, V68, P1077, DOI 10.2527/1990.6841077x; Archer ZA, 2004, J ENDOCRINOL, V182, P409, DOI 10.1677/joe.0.1820409; Backholer K, 2010, ENDOCRINOLOGY, V151, P2233, DOI 10.1210/en.2009-1190; Bojkowska K, 2008, HORM BEHAV, V53, P342, DOI 10.1016/j.yhbeh.2007.10.013; Bonfanti L, 2009, CELL ADHES MIGR, V3, P43, DOI 10.4161/cam.3.1.7258; Booth PJ, 1996, J ANIM SCI, V74, P840; Brito LFC, 2007, REPRODUCTION, V134, P171, DOI 10.1530/REP-06-0353; Brito LFC, 2007, DOMEST ANIM ENDOCRIN, V33, P1, DOI 10.1016/j.domaniend.2006.04.001; CAMERON JL, 1991, J CLIN ENDOCR METAB, V73, P35, DOI 10.1210/jcem-73-1-35; Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254-255, P127; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Glidewell-Kenney C, 2007, P NATL ACAD SCI USA, V104, P8173, DOI 10.1073/pnas.0611514104; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; GUY J, 1988, REGUL PEPTIDES, V23, P209, DOI 10.1016/0167-0115(88)90028-6; Haas VK, 2009, AM J CLIN NUTR, V89, P1005, DOI 10.3945/ajcn.2008.26958; Henry BA, 2004, J NEUROENDOCRINOL, V16, P244, DOI 10.1111/j.0953-8194.2004.01157.x; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Ichimaru T, 2001, ENDOCRINOLOGY, V142, P2489, DOI 10.1210/en.142.6.2489; Kaiser UB, 2005, ENDOCRINE, V26, P277, DOI 10.1385/ENDO:26:3:277; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kaur G, 2002, BRAIN RES, V954, P21, DOI 10.1016/S0006-8993(02)03301-2; Kinzig KP, 2009, AM J PHYSIOL-ENDOC M, V296, pE282, DOI 10.1152/ajpendo.90523.2008; Kumar S, 2011, MOL CELL ENDO, DOI 10.1016; Langle SL, 2002, J PHYSIOL-PARIS, V96, P169, DOI 10.1016/S0928-4257(02)00003-7; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Martin B, 2008, AGEING RES REV, V7, P209, DOI 10.1016/j.arr.2008.01.002; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Miller KK, 2007, J CLIN ENDOCR METAB, V92, P1334, DOI 10.1210/jc.2006-2501; Nagatani S, 2001, J NEUROENDOCRINOL, V13, P371, DOI 10.1046/j.1365-2826.2001.00638.x; Narita K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028136; Parkash J, 2005, J ENDOCRINOL, V186, P397, DOI 10.1677/joe.1.06156; Parkash J, 2007, NEURON GLIA BIOL, V3, P299, DOI 10.1017/S1740925X07000701; Parkash J, 2007, BRAIN RES BULL, V74, P317, DOI 10.1016/j.brainresbull.2007.07.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Prevot V, 1998, NEUROSCIENCE, V84, P177, DOI 10.1016/S0306-4522(97)00537-X; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Quesnel H, 1998, J ANIM SCI, V76, P856; Santos ZA, 2011, J NUTR SCI VITAMINOL, V55, P1; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Singh R, 2012, AGE, V34, P917, DOI 10.1007/s11357-011-9289-2; Smith JT, 2008, ENDOCRINOLOGY, V149, P1951, DOI 10.1210/en.2007-1425; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022333; Sucajtys-Szulc E, 2008, NEUROSCI LETT, V433, P174, DOI 10.1016/j.neulet.2008.01.004; Tropp J, 2001, PHYSIOL BEHAV, V73, P553, DOI 10.1016/S0031-9384(01)00487-5; True C, 2011, J NEUROENDOCRINOL, V23, P1099, DOI 10.1111/j.1365-2826.2011.02144.x; VELDHUIS JD, 1993, J CLIN ENDOCR METAB, V76, P587, DOI 10.1210/jcem.76.3.8445014; VERMEULEN A, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431381; Wade GN, 2004, AM J PHYSIOL-REG I, V287, pR1277, DOI 10.1152/ajpregu.00475.2004; Wagenmaker ER, 2010, BIOL REPROD, V82, P1206, DOI 10.1095/biolreprod.109.078774; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	60	59	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e52416	10.1371/journal.pone.0052416	http://dx.doi.org/10.1371/journal.pone.0052416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23409154	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200038
J	Chen, YY; Chen, F; Gunnell, D; Yip, PSF				Chen, Ying-Yeh; Chen, Feng; Gunnell, David; Yip, Paul S. F.			The Impact of Media Reporting on the Emergence of Charcoal Burning Suicide in Taiwan	PLOS ONE			English	Article							PROCESS INTENSITY FUNCTION; ESTIMATORS	We investigated the association of the intensity of newspaper reporting of charcoal burning suicide with the incidence of such deaths in Taiwan during 1998-2002. A counting process approach was used to estimate the incidence of suicides and intensity of news reporting. Conditional Poisson generalized linear autoregressive models were performed to assess the association of the intensity of newspaper reporting of charcoal burning and non-charcoal burning suicides with the actual number of charcoal burning and non-charcoal burning suicides the following day. We found that increases in the reporting of charcoal burning suicide were associated with increases in the incidence of charcoal burning suicide on the following day, with each reported charcoal burning news item being associated with a 16% increase in next day charcoal burning suicide (p<.0001). However, the reporting of other methods of suicide was not related to their incidence. We conclude that extensive media reporting of charcoal burning suicides appears to have contributed to the rapid rise in the incidence of the novel method in Taiwan during the initial stage of the suicide epidemic. Regulating media reporting of novel suicide methods may prevent an epidemic spread of such new methods.	[Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Chen, Feng] Univ New S Wales, Dept Stat, Sydney, NSW, Australia; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Yip, Paul S. F.] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of New South Wales Sydney; University of Bristol; University of Hong Kong; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chen, Ying-Yeh/AAY-1478-2021; Gunnell, David/ABE-6653-2020; Chen, Feng/B-5366-2009	Gunnell, David/0000-0002-0829-6470; Chen, Feng/0000-0002-9646-3338; Chen, Ying-Yeh/0000-0001-5543-5704	National Science Council, Taiwan [101-2314-B-532-005-MY2]; Department of Health, Taipei City Government [96001-61-001-043]; National Health Research Institute, Taiwan [NHRI-EX100-10024PC]; University of Hong Kong [HKU7030-PPR-12, HKU784210]; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taipei City Government; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); University of Hong Kong(University of Hong Kong); National Institute for Health Research(National Institute for Health Research (NIHR))	Y-YC was supported by the National Science Council, Taiwan (grant number 101-2314-B-532-005-MY2), Department of Health, Taipei City Government (grant number 96001-61-001-043) and the National Health Research Institute, Taiwan (grant number NHRI-EX100-10024PC). DG is a National Institute for Health Research senior investigator. PSFY was supported by General Research Fund grants of the University of Hong Kong (grant number HKU7030-PPR-12 and HKU784210). The funding agency has no role in the design, analysis, interpretation and the presentation of the data.	Chang SS, 2010, SOC PSYCH PSYCH EPID, V45, P143, DOI 10.1007/s00127-009-0049-x; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; Chen F, 2008, COMMUN STAT-THEOR M, V37, P294, DOI 10.1080/03610920701649035; Chen F, 2011, SCAND J STAT, V38, P631, DOI 10.1111/j.1467-9469.2011.00733.x; Chen F, 2011, STAT SINICA, V21, P107; Chen YY, 2011, J EPIDEMIOL COMMUN H, V65, P934, DOI 10.1136/jech.2010.117903; Chen YY, 2010, SOC SCI MED, V71, P2083, DOI 10.1016/j.socscimed.2010.09.043; Guan RJ, 2010, PC HOME PERSONAL NEW; Lin JJ, 2008, J EPIDEMIOL COMMUN H, V62, P566, DOI 10.1136/jech.2007.065771; Lin LY, 2008, MASS COMMUNICATION R, V95, P183; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Niederkrotenthaler T., 2009, SOC SCI MED, V69, P1085, DOI DOI 10.1016/j.socscimed.2009.07.041; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Pirkis JE, 2006, SOC SCI MED, V62, P2874, DOI 10.1016/j.socscimed.2005.11.033; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Taiwan Suicide Prevention Center, 2009, SURV RES; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135; Yip PSF, 2007, CRISIS, V28, P21, DOI 10.1027/0227-5910.28.S1.21	19	112	117	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55000	10.1371/journal.pone.0055000	http://dx.doi.org/10.1371/journal.pone.0055000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23555643	Green Published, gold			2022-12-25	WOS:000315563800097
J	Boch, S; Prati, D; Hessenmoller, D; Schulze, ED; Fischer, M				Boch, Steffen; Prati, Daniel; Hessenmoeller, Dominik; Schulze, Ernst-Detlef; Fischer, Markus			Richness of Lichen Species, Especially of Threatened Ones, Is Promoted by Management Methods Furthering Stand Continuity	PLOS ONE			English	Article							EPIPHYTIC LICHENS; OLD-GROWTH; BRYOPHYTE COMMUNITIES; BEECH FORESTS; DIVERSITY; CONSERVATION; BIODIVERSITY; DISPERSAL; INDICATOR; QUALITY	Lichens are a key component of forest biodiversity. However, a comprehensive study analyzing lichen species richness in relation to several management types, extending over different regions and forest stages and including information on site conditions is missing for temperate European forests. In three German regions (Schwabische Alb, Hainich-Dun, Schorfheide-Chorin), the so-called Biodiversity Exploratories, we studied lichen species richness in 631 forest plots of 400 m(2) comprising different management types (unmanaged, selection cutting, deciduous and coniferous age-class forests resulting from clear cutting or shelterwood logging), various stand ages, and site conditions, typical for large parts of temperate Europe. We analyzed how lichen species richness responds to management and habitat variables (standing biomass, cover of deadwood, cover of rocks). We found strong regional differences with highest lichen species richness in the Schwabische Alb, probably driven by regional differences in former air pollution, and in precipitation and habitat variables. Overall, unmanaged forests harbored 22% more threatened lichen species than managed age-class forests. In general, total, corticolous, and threatened lichen species richness did not differ among management types of deciduous forests. However, in the Schwabische-Alb region, deciduous forests had 61% more lichen species than coniferous forests and they had 279% more threatened and 76% more corticolous lichen species. Old deciduous age classes were richer in corticolous lichen species than young ones, while old coniferous age-classes were poorer than young ones. Overall, our findings highlight the importance of stand continuity for conservation. To increase total and threatened lichen species richness we suggest (1) conserving unmanaged forests, (2) promoting silvicultural methods assuring stand continuity, (3) conserving old trees in managed forests, (4) promoting stands of native deciduous tree species instead of coniferous plantations, and (5) increasing the amount of deadwood in forests.	[Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Bot Gardens, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Hessenmoeller, Dominik; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Bern; University of Bern; University of Bern; Max Planck Society	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Fischer, Markus/C-6411-2008; Schulze, Ernst-Detlef/K-9627-2014	Fischer, Markus/0000-0002-5589-5900; 	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories" [SSP 1374, FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories"(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" (FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini A, 2005, CONSERV BIOL, V19, P1051, DOI 10.1111/j.1523-1739.2005.00086.x; Berge E, 1998, TELLUS B, V50, P205, DOI 10.1034/j.1600-0889.1998.t01-2-00001.x; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Edman M, 2008, J APPL ECOL, V45, P26, DOI 10.1111/j.1365-2664.2007.01354.x; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; Gilbert Oliver L., 1992, P159; Graae BJ, 1997, FOREST ECOL MANAG, V96, P111, DOI 10.1016/S0378-1127(97)00046-7; Gustafsson L, 2004, BASIC APPL ECOL, V5, P123, DOI 10.1078/1439-1791-00223; Hessenmoller D., 2011, Forstarchiv, V82, P171; Horstkotte T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028779; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Jairus K, 2009, J APPL ECOL, V46, P930, DOI 10.1111/j.1365-2664.2009.01672.x; Juriado I, 2009, BIODIVERS CONSERV, V18, P105, DOI 10.1007/s10531-008-9460-y; Kirschbaum U, 2006, GEFAHRST REINHALT L, V66, P272; LESICA P, 1991, CAN J BOT, V69, P1745, DOI 10.1139/b91-222; Lohmus A, 2007, BIOL CONSERV, V135, P405, DOI 10.1016/j.biocon.2006.10.015; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Moning C, 2009, ECOL INDIC, V9, P922, DOI 10.1016/j.ecolind.2008.11.002; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Nascimbene J, 2007, FOREST ECOL MANAG, V247, P43, DOI 10.1016/j.foreco.2007.04.011; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Neitlich PN, 1997, CONSERV BIOL, V11, P172, DOI 10.1046/j.1523-1739.1997.95492.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Parviainen J, 2003, J ENVIRON MANAGE, V67, P27, DOI 10.1016/S0301-4797(02)00185-8; Parviainen J, 2000, FORESTRY, V73, P107, DOI 10.1093/forestry/73.2.107; Perhans K, 2009, BIOL CONSERV, V142, P1125, DOI 10.1016/j.biocon.2008.12.033; Peterson EB, 2001, J VEG SCI, V12, P511, DOI 10.2307/3237003; Purvis OW, 2010, SYST BIODIVERS, V8, P193, DOI 10.1080/14772001003782088; PYKALA J, 2006, BASIC APPL ECOL, V223, P84, DOI DOI 10.1016/J.FORECO.2005.10.059; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rolstad J, 2001, ECOL APPL, V11, P421, DOI 10.1890/1051-0761(2001)011[0421:ELINCS]2.0.CO;2; Rose Francis, 1992, P211; Rudolphi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018639; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Svoboda D, 2010, ENVIRON POLLUT, V158, P812, DOI 10.1016/j.envpol.2009.10.001; Thor Goran, 1995, Mitteilungen der Eidgenoessischen Forschungsanstalt fuer Wald Schnee und Landschaft, V70, P29; Uliczka H, 2000, BIOL CONSERV, V95, P343, DOI 10.1016/S0006-3207(00)00022-7; Umweltbundesamt, 2005, DAT UMW ZUST UMW DEU; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Wirth V., 1996, SCHRIFTENREIHE VEGET, V28, P307; Wolseley PA, 2006, LICHENOLOGIST, V38, P307, DOI 10.1017/S0024282906006190	53	62	69	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55461	10.1371/journal.pone.0055461	http://dx.doi.org/10.1371/journal.pone.0055461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	24358373	Green Published, gold, Green Submitted			2022-12-25	WOS:000315483200052
J	Lee, BH; Gauna, AE; Perez, G; Park, YJ; Pauley, KM; Kawai, T; Cha, S				Lee, Byung Ha; Gauna, Adrienne E.; Perez, Geidys; Park, Yun-Jong; Pauley, Kaleb M.; Kawai, Toshihisa; Cha, Seunghee			Autoantibodies against Muscarinic Type 3 Receptor in Sjogren's Syndrome Inhibit Aquaporin 5 Trafficking	PLOS ONE			English	Article							APICAL PLASMA-MEMBRANE; 2ND EXTRACELLULAR LOOP; SALIVARY ACINAR-CELLS; ACETYLCHOLINE-RECEPTOR; WATER CHANNEL; ABNORMAL DISTRIBUTION; SUBMANDIBULAR-GLANDS; MOUSE MODEL; HSG CELLS; NOD MICE	Sjogren's syndrome (SjS) is a chronic autoimmune disease that mainly targets the salivary and lacrimal glands. It has been controversial whether anti-muscarinic type 3 receptor (alpha-M3R) autoantibodies in patients with SjS inhibit intracellular trafficking of aquaporin-5 (AQP5), water transport protein, leading to secretory dysfunction. To address this issue, GFP-tagged human AQP5 was overexpressed in human salivary gland cells (HSG-hAQP5) and monitored AQP5 trafficking to the plasma membrane following carbachol (CCh, M3R agonist) stimulation. AQP5 trafficking was indeed mediated by M3R stimulation, shown in partial blockage of trafficking by M3R-antagonist 4-DAMP. HSG-hAQP5 pre-incubated with SjS plasma for 24 hours significantly reduced AQP5 trafficking with CCh, compared with HSG-hAQP5 pre-incubated with healthy control (HC) plasma. This inhibition was confirmed by monoclonal a-M3R antibody and pre-absorbed plasma. Interestingly, HSG-hAQP5 pre-incubated with SjS plasma showed no change in cell volume, compared to the cells incubated with HC plasma showing shrinkage by twenty percent after CCh-stimulation. Our findings clearly indicate that binding of anti-M3R autoantibodies to the receptor, which was verified by immunoprecipitation, suppresses AQP5 trafficking to the membrane and contribute to impaired fluid secretion in SjS. Our current study urges further investigations of clinical associations between SjS symptoms, such as degree of secretory dysfunction, cognitive impairment, and/or bladder irritation, and different profiles (titers, isotypes, and/or specificity) of anti-M3R autoantibodies in individuals with SjS.	[Lee, Byung Ha; Gauna, Adrienne E.; Perez, Geidys; Park, Yun-Jong; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA; [Pauley, Kaleb M.] Cedarville Univ, Coll Arts & Sci, Dept Sci & Math, Cedarville, OH USA; [Kawai, Toshihisa] Forsyth Inst, Dept Immunol, Cambridge, MA USA	State University System of Florida; University of Florida; Cedarville University; Harvard University; Forsyth Institute	Cha, S (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA.	scha@dental.ufl.edu		Williams, Adrienne/0000-0003-0247-1175	NIH/NIDCR [DE019644, DE 016705];  [UL1 RR029890];  [TL1 RR029889];  [T90 DE021990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890, TL1RR029889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE019644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016705] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	S.CHA was supported by NIH/NIDCR grants DE019644 and DE 016705. The funders had no role in study design, data c S.CHA was supported by NIH/NIDCR grants DE019644 and DE 016705. AE.GAUNA was supported by UL1 RR029890, TL1 RR029889, and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukas T, 2001, LANCET, V358, P1875, DOI 10.1016/S0140-6736(01)06900-8; Cavill D, 2004, SCAND J IMMUNOL, V59, P261, DOI 10.1111/j.0300-9475.2004.01395.x; Cha SH, 2006, J RHEUMATOL, V33, P296; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Dawson L, 2005, ARTHRITIS RHEUM-US, V52, P2984, DOI 10.1002/art.21347; FATHERAZI S, 1994, J MEMBRANE BIOL, V142, P181; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; Ishii M, 2006, CURR PHARM DESIGN, V12, P3573, DOI 10.2174/138161206778522056; ISHIKAWA T, 1994, PFLUG ARCH EUR J PHY, V427, P203, DOI 10.1007/BF00374525; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Ishikawa Y, 2000, FEBS LETT, V477, P253, DOI 10.1016/S0014-5793(00)01763-4; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Katz J, 2008, CANCER LETT, V270, P87, DOI 10.1016/j.canlet.2008.04.051; Konttinen YT, 2005, J RHEUMATOL, V32, P1071; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Li JC, 2004, LAB INVEST, V84, P1430, DOI 10.1038/labinvest.3700173; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Marczinovits I, 2005, J AUTOIMMUN, V24, P47, DOI 10.1016/j.jaut.2004.11.005; Nagy K, 2007, ACTA PHYSIOL HUNG, V94, P301, DOI 10.1556/APhysiol.94.2007.4.2; Nguyen CQ, 2007, FRONT BIOSCI-LANDMRK, V12, P1767, DOI 10.2741/2187; Nguyen KHT, 2000, ARTHRITIS RHEUM-US, V43, P2297, DOI 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Ohashi Y, 2008, CURR EYE RES, V33, P621, DOI 10.1080/02713680802262819; Roescher N, 2011, ANN RHEUM DIS, V70, P235, DOI 10.1136/ard.2010.129049; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Smith AJ, 2005, HUM IMMUNOL, V66, P411, DOI 10.1016/j.humimm.2005.01.020; Soyfoo MS, 2007, ARTHRITIS RHEUM-US, V56, P2566, DOI 10.1002/art.22826; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Tada J, 1999, BIOCHEM BIOPH RES CO, V266, P443, DOI 10.1006/bbrc.1999.1828; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; Wellner RB, 2005, TISSUE ENG, V11, P1449, DOI 10.1089/ten.2005.11.1449; Yuan ZF, 2003, EUR J PHARMACOL, V464, P197, DOI 10.1016/S0014-2999(03)01375-X	43	59	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53113	10.1371/journal.pone.0053113	http://dx.doi.org/10.1371/journal.pone.0053113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382834	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800018
J	Yang, W; Zheng, Y; Gao, C; He, XH; Ding, Q; Kim, Y; Rui, YC; Wang, SP; Guo, LD				Yang, Wei; Zheng, Yong; Gao, Cheng; He, Xinhua; Ding, Qiong; Kim, Yongchan; Rui, Yichao; Wang, Shiping; Guo, Liang-Dong			The Arbuscular Mycorrhizal Fungal Community Response to Warming and Grazing Differs between Soil and Roots on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SPECIES COMPOSITION; ATMOSPHERIC CO2; CARBON ALLOCATION; ELEVATED CO2; PLANT; DIVERSITY; GRASSLAND; TEMPERATURE; SPORE; COLONIZATION	Arbuscular mycorrhizal (AM) fungi form symbiotic associations with most plant species in terrestrial ecosystems, and are affected by environmental variations. To reveal the impact of disturbance on an AM fungal community under future global warming, we examined the abundance and community composition of AM fungi in both soil and mixed roots in an alpine meadow on the Qinghai-Tibetan Plateau, China. Warming and grazing had no significant effect on AM root colonization, spore density and extraradical hyphal density. A total of 65 operational taxonomic units (OTUs) of AM fungi were identified from soil and roots using molecular techniques. AM fungal OTU richness was higher in soil (54 OTUs) than in roots (34 OTUs), and some AM fungi that differed between soil and roots, showed significantly biased occurrence to warming or grazing. Warming and grazing did not significantly affect AM fungal OTU richness in soil, but warming with grazing significantly increased AM fungal OTU richness in roots compared to the grazing-only treatment. Non-metric multidimensional scaling analysis showed that the AM fungal community composition was significantly different between soil and roots, and was significantly affected by grazing in roots, whereas in soil it was significantly affected by warming and plant species richness. The results suggest that the AM fungal community responds differently to warming and grazing in soil compared with roots. This study provides insights into the role of AM fungi under global environmental change scenarios in alpine meadows of the Qinghai-Tibetan Plateau.	[Yang, Wei; Zheng, Yong; Gao, Cheng; Ding, Qiong; Kim, Yongchan; Guo, Liang-Dong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Yang, Wei; Kim, Yongchan; Rui, Yichao] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Lab Alpine Ecol & Biodivers, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Western Australia; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Guo, LD (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	guold@sun.im.ac.cn	He, Xinhua/B-8047-2015; Hwang, Pung-Pung/AEQ-4633-2022; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AAH-1538-2022; Chang, Chia-Hao/AAW-2598-2020; GUO, Liang-dong/C-1407-2015; hwang, pp/A-3641-2011; Zheng, Yong/E-3947-2012; Zheng, Yong/AAN-8928-2021	He, Xinhua/0000-0002-5570-3454; Gao 高程, Cheng/0000-0003-2522-7909; Chang, Chia-Hao/0000-0002-7583-4291; Zheng, Yong/0000-0001-5239-9824; Zheng, Yong/0000-0001-5239-9824; Yang, Wen-Kai/0000-0001-8095-2420; Lee, Tsung-Han/0000-0002-3542-4335	National Natural Science Foundation of China [31070434]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Natural Science Foundation of China (No. 31070434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ba L, 2012, PLANT SOIL, V352, P143, DOI 10.1007/s11104-011-0985-6; Bai G, 2013, MYCORRHIZA, V23, P289, DOI 10.1007/s00572-012-0468-5; Barto EK, 2010, J ECOL, V98, P745, DOI 10.1111/j.1365-2745.2010.01658.x; Beauregard MS, 2013, MYCORRHIZA, V23, P143, DOI 10.1007/s00572-012-0459-6; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Bunn R, 2009, ECOLOGY, V90, P1378, DOI 10.1890/07-2080.1; Clark NM, 2009, J ARID ENVIRON, V73, P834, DOI 10.1016/j.jaridenv.2009.03.004; Colwell RK, 2013, ESTIMATES STAT ESTIM; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Eom AH, 2001, MYCOLOGIA, V93, P233, DOI 10.2307/3761643; Frank DA, 2003, OECOLOGIA, V137, P603, DOI 10.1007/s00442-003-1385-2; Gange AC, 2002, OECOLOGIA, V131, P103, DOI 10.1007/s00442-001-0863-7; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; Heinemeyer A, 2004, GLOBAL CHANGE BIOL, V10, P52, DOI 10.1111/j.1365-2486.2003.00713.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson NC, 2005, GLOBAL CHANGE BIOL, V11, P1156, DOI 10.1111/j.1365-2486.2005.00967.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Klironomos JN, 2005, NATURE, V433, P621, DOI 10.1038/nature03268; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kula AAR, 2005, ECOL LETT, V8, P61, DOI 10.1111/j.1461-0248.2004.00690.x; Lekberg Y, 2008, BOTANY, V86, P1117, DOI 10.1139/B08-077; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu YJ, 2012, MYCORRHIZA, V22, P31, DOI 10.1007/s00572-011-0378-y; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lugo MA, 2002, MYCOLOGIA, V94, P579, DOI 10.2307/3761709; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Miller SP, 1999, OECOLOGIA, V119, P586, DOI 10.1007/s004420050823; MONZ CA, 1994, PLANT SOIL, V165, P75, DOI 10.1007/BF00009964; Murray TR, 2010, ECOLOGY, V91, P815, DOI 10.1890/09-0209.1; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; R Development Core Team, 2010, R LANG ENV STAT COMP; Renker C, 2005, ENVIRON POLLUT, V135, P255, DOI 10.1016/j.envpol.2004.11.002; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Staddon PL, 2004, GLOBAL CHANGE BIOL, V10, P1909, DOI 10.1111/j.1365-2486.2004.00861.x; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Su YY, 2007, MYCORRHIZA, V17, P689, DOI 10.1007/s00572-007-0151-4; Swofford DL, 2001, PAUP PHYLOGENETIC AN; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2004, NEW PHYTOL, V164, P201, DOI 10.1111/j.1469-8137.2004.01205.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Diepen LTA, 2011, MOL ECOL, V20, P799, DOI 10.1111/j.1365-294X.2010.04969.x; Wagner H, 2009, VEGAN COMMUNITY ECOL; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wolf J, 2003, NEW PHYTOL, V157, P579, DOI 10.1046/j.1469-8137.2003.00696.x; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017; Zavalloni C, 2012, PLANT SOIL, V359, P121, DOI 10.1007/s11104-012-1190-y; Zheng Y, 2012, APPL MICROBIOL BIOT, V93, P2193, DOI 10.1007/s00253-011-3535-5	74	118	135	11	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76447	10.1371/journal.pone.0076447	http://dx.doi.org/10.1371/journal.pone.0076447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086741	Green Submitted, gold, Green Published			2022-12-25	WOS:000325220000067
J	Wang, XL; Falkner, B; Zhu, HD; Shi, HD; Su, SY; Xu, XJ; Sharma, AK; Dong, YB; Treiber, F; Gutin, B; Harshfield, G; Snieder, H				Wang, Xiaoling; Falkner, Bonita; Zhu, Haidong; Shi, Huidong; Su, Shaoyong; Xu, Xiaojing; Sharma, Ashok Kumar; Dong, Yanbin; Treiber, Frank; Gutin, Bernard; Harshfield, Gregory; Snieder, Harold			A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; DNA METHYLATION; MALE TWINS; HSULF-1; CANCER; GENE; VARIANTS; HEMODYNAMICS; INFLAMMATION	Objective: There is emerging evidence from animal studies suggesting a key role for methylation in the pathogenesis of essential hypertension. However, to date, very few studies have investigated the role of methylation in the development of human hypertension, and none has taken a genome-wide approach. Based on the recent studies that highlight the involvement of inflammation in the development of hypertension, we hypothesize that changes in DNA methylation of leukocytes are involved in the pathogenesis of hypertension. Method & Results: We conducted a genome-wide methylation analysis on 8 hypertensive cases and 8 normotensive age-matched controls aged 14-23 years and performed validation of the most significant CpG sites in 2 genes in an independent sample of 36 hypertensive cases and 60 normotensive controls aged 14-30 years. Validation of the CpG sites in the SULF1 gene was further conducted in a second replication sample of 36 hypertensive cases and 34 controls aged 15.8-40 years. A CpG site in the SULF1 gene showed higher methylation levels in cases than in healthy controls in the genome-wide step (p = 6.2 x 10(-5)), which was confirmed in the validation step (p = 0.011) for subjects <= 30 years old but was not significant for subjects of all ages combined (p = 0.095). Conclusion: The identification of a difference in a blood leukocyte DNA methylation site between hypertensive cases and normotensive controls suggests that changes in DNA methylation may play an important role in the pathogenesis of hypertension. The age dependency of the effect further suggests complexity of epigenetic regulation in this age-related disease.	[Wang, Xiaoling; Zhu, Haidong; Su, Shaoyong; Xu, Xiaojing; Dong, Yanbin; Gutin, Bernard; Harshfield, Gregory] Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA; [Falkner, Bonita] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Shi, Huidong] Georgia Hlth Sci Univ, Sch Med, Canc Res Ctr, Augusta, GA USA; [Sharma, Ashok Kumar] Georgia Hlth Sci Univ, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Treiber, Frank] Med Univ S Carolina, Coll Nursing, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Treiber, Frank] Med Univ S Carolina, Coll Med, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands	University System of Georgia; Augusta University; Jefferson University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Medical University of South Carolina; Medical University of South Carolina; University of Groningen	Wang, XL (corresponding author), Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA.	xwang@georgiahealth.edu	xu, xiaojing/C-2759-2014; Falkner, Bonita/Y-8451-2019	Shi, Huidong/0000-0003-1137-3390; Sanfacon, Helene/0000-0003-3807-3590; Sharma, Ashok/0000-0001-9597-4374	National Institutes of Health [HL69999, HL56622, HL077230, HL64157, DK046107, HL092030]; NLHBI [HL105689]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104125, R01HL092030, P01HL069999, R01HL056622, R01HL105689, R01HL064157, R01HL077230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLHBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The participants in this study were recruited by several National Institutes of Health funded projects including HL69999, HL56622, HL077230, HL64157, DK046107 & HL092030. The current study is funded by the NLHBI HL105689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Cantarin MPM, 2010, CTS-CLIN TRANSL SCI, V3, P279, DOI 10.1111/j.1752-8062.2010.00242.x; CARMELLI D, 1994, J HYPERTENS, V12, P323; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; COLLETTO GMDD, 1993, GENET EPIDEMIOL, V10, P533, DOI 10.1002/gepi.1370100634; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Falkner B, 2012, J PEADIAT IN PRESS; Frey FJ, 2005, NEPHROL DIAL TRANSPL, V20, P868, DOI 10.1093/ndt/gfh746; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Ge DL, 2006, TWIN RES HUM GENET, V9, P965, DOI 10.1375/twin.9.6.965; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Groom A, 2011, ARCH DIS CHILD, V96, P863, DOI 10.1136/adc.2009.165712; Gutin B, 2007, OBESITY, V15, P1029, DOI 10.1038/oby.2007.602; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Kapur G, 2010, CLIN HYPERTENSION VA, P241; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Kupper N, 2006, HYPERTENSION, V47, P948, DOI 10.1161/01.HYP.0000217521.79447.9a; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Snieder H, 2002, AM J HYPERTENS, V15, P973, DOI 10.1016/S0895-7061(02)02991-6; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Wang X, 2010, CLIN HYPERTENSION VA, P241; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940; Zhang DY, 2009, KIDNEY INT, V75, P260, DOI 10.1038/ki.2008.475; Zhu HD, 2009, PEDIATR RES, V65, P443, DOI 10.1203/PDR.0b013e3181994b85	41	163	175	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53938	10.1371/journal.pone.0053938	http://dx.doi.org/10.1371/journal.pone.0053938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23325143	gold, Green Published, Green Submitted			2022-12-25	WOS:000313552400062
J	Sugihara, M; Odagiri, F; Suzuki, T; Murayama, T; Nakazato, Y; Unuma, K; Yoshida, K; Daida, H; Sakurai, T; Morimoto, S; Kurebayashi, N				Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Murayama, Takashi; Nakazato, Yuji; Unuma, Kana; Yoshida, Ken-ichi; Daida, Hiroyuki; Sakurai, Takashi; Morimoto, Sachio; Kurebayashi, Nagomi			Usefulness of Running Wheel for Detection of Congestive Heart Failure in Dilated Cardiomyopathy Mouse Model	PLOS ONE			English	Article							CHAIN ISOFORM EXPRESSION; KNOCKOUT MICE; TROPONIN MUTATION; NATURAL-HISTORY; EXERCISE; HYPERACTIVITY; DYSFUNCTION; PHENOTYPE	Background: Inherited dilated cardiomyopathy (DCM) is a progressive disease that often results in death from congestive heart failure (CHF) or sudden cardiac death (SCD). Mouse models with human DCM mutation are useful to investigate the developmental mechanisms of CHF and SCD, but knowledge of the severity of CHF in live mice is necessary. We aimed to diagnose CHF in live DCM model mice by measuring voluntary exercise using a running wheel and to determine causes of death in these mice. Methodology/Principal Findings: A knock-in mouse with a mutation in cardiac troponin T (Delta K210) (DCM mouse), which results in frequent death with a t(1/2) of 70 to 90 days, was used as a DCM model. Until 2 months of age, average wheel-running activity was similar between wild-type and DCM mice (approximately 7 km/day). At approximately 3 months, some DCM mice demonstrated low running activity (LO: <1 km/day) while others maintained high running activity (HI: >5 km/day). In the LO group, the lung weight/body weight ratio was much higher than that in the other groups, and the lungs were infiltrated with hemosiderin-loaded alveolar macrophages. Furthermore, echocardiography showed more severe ventricular dilation and a lower ejection fraction, whereas Electrocardiography (ECG) revealed QRS widening. There were two patterns in the time courses of running activity before death in DCM mice: deaths with maintained activity and deaths with decreased activity. Conclusions/Significance: Our results indicate that DCM mice with low running activity developed severe CHF and that running wheels are useful for detection of CHF in mouse models. We found that approximately half of Delta K210 DCM mice die suddenly before onset of CHF, whereas others develop CHF, deteriorate within 10 to 20 days, and die.	[Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Murayama, Takashi; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Tokyo, Japan; [Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Nakazato, Yuji; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Unuma, Kana] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan; [Unuma, Kana; Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Grad Sch Med, Tokyo, Japan; [Morimoto, Sachio] Kyushu Univ, Dept Clin Pharmacol, Fac Med Sci, Fukuoka 812, Japan	Juntendo University; Juntendo University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Kyushu University	Kurebayashi, N (corresponding author), Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Tokyo, Japan.	nagomik@juntendo.ac.jp		Morimoto, Sachio/0000-0001-9171-3636	Ministry of Education, Culture, Sports, Science and Technology of Japan [23136514]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences	This work was supported by a Grant-in Aid (# 23136514), a "High Technology Research Center'' Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015. The authors also thank the Vehicle Racing Commemorative Foundation and the Institute of Seizon and Life Sciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Hayek S, 2011, CARDIOVASC THER, V29, P362, DOI 10.1111/j.1755-5922.2010.00152.x; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Jing XF, 1998, ARCH PATHOL LAB MED, V122, P94; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Libby P., 2011, BRAUNWALDS HEART DIS, V8th; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Lygate CA, 2009, J MOL CELL CARDIOL, V46, P93, DOI 10.1016/j.yjmcc.2008.09.710; Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007; Millane T, 2000, BRIT MED J, V320, P559, DOI 10.1136/bmj.320.7234.559; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Ojaimi C, 2005, AM J PHYSIOL-HEART C, V289, pH1399, DOI 10.1152/ajpheart.00170.2005; Okutucu S, 2010, CARDIOL J, V17, P219; Rundell VLM, 2004, AM J PHYSIOL-HEART C, V287, pH408, DOI 10.1152/ajpheart.00049.2004; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; Unuma K, 2010, CIRC J, V74, P2693, DOI 10.1253/circj.CJ-10-0529; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Watanabe T, 2008, J AM COLL CARDIOL, V52, P779, DOI 10.1016/j.jacc.2008.06.003; Watson PA, 2007, AM J PHYSIOL-HEART C, V293, pH246, DOI 10.1152/ajpheart.00734.2006; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168	32	70	73	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55514	10.1371/journal.pone.0055514	http://dx.doi.org/10.1371/journal.pone.0055514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23585901	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600117
J	Yuan, J; Tang, ZL; Yang, SL; Li, K				Yuan, Jing; Tang, Zhonglin; Yang, Shulin; Li, Kui			CRABP2 Promotes Myoblast Differentiation and Is Modulated by the Transcription Factors MyoD and Sp1 in C2C12 Cells	PLOS ONE			English	Article							LIPID-BINDING PROTEINS; GENE-EXPRESSION; MOUSE EMBRYOGENESIS; MUSCLE; ACID; PHOSPHORYLATION; ACTIVATION; MYOGENESIS; HOMOLOGY; PATTERN	Cellular retinoic acid binding protein 2 (CRABP2), a member of a family of specific carrier proteins for Vitamin A, belongs to a family of small cytosolic lipid binding proteins. Our previous study suggested that CRABP2 was involved in skeletal muscle development; however, the molecular function and regulatory mechanism of CRABP2 in myogenesis remained unclear. In this study, we found that the expression of the CRABP2 gene was upregulated during C2C12 differentiation. An overexpression assay revealed that CRABP2 promotes myogenic transformation by regulating the cell cycle during C2C12 differentiation. The region from -459 to -4 bp was identified as the core promoter and contains a TATA box, a GC box and binding sites for the transcription factors MyoD and Sp1. Over-expression, site-directed mutagenesis and EMSA assays indicated that the transcription factors MyoD and Sp1 regulate CRABP2 expression and promote myoblast differentiation in C2C12 cells.	[Yuan, Jing; Tang, Zhonglin; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing 100193, Peoples R China; [Yuan, Jing] Yangtze Univ, Coll Anim Sci, Jinzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Yangtze University	Tang, ZL (corresponding author), Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing 100193, Peoples R China.	zhonglinqy_99@sina.com; kuili@iascaas.net.cn	Lin, Rongcheng/I-8105-2014	Lin, Rongcheng/0000-0001-8346-3390	National Key Project [2012CB124706-6, 2011ZX08006-002, 2009CB941604]; National Natural Science Foundation of China [31171192, 31172182]	National Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Project (2012CB124706-6, 2011ZX08006-002, 2009CB941604) and the National Natural Science Foundation of China (31171192, 31172182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McGrane MM, 2007, J NUTR BIOCHEM, V18, P497, DOI 10.1016/j.jnutbio.2006.10.006; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Qin RF, 2000, J 4 MIL MED U, V21, P921; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBERTE E, 1992, DEVELOPMENT, V115, P973; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Xu JW, 2007, GENE, V392, P221, DOI 10.1016/j.gene.2006.12.032; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284	26	18	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55479	10.1371/journal.pone.0055479	http://dx.doi.org/10.1371/journal.pone.0055479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383201	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600110
J	Sun, ZZ; Dragon, S; Becker, A; Gounni, AS				Sun, Zhizhi; Dragon, Stephane; Becker, Allan; Gounni, Abdelilah S.			Leptin Inhibits Neutrophil Apoptosis in Children via ERK/NF-kappa B-Dependent Pathways	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; PROTEIN-KINASE; ADIPOSE-TISSUE; DEFICIENT MICE; SURVIVAL; ACTIVATION; RECEPTOR; OBESITY	Introduction and Rationale: Previous studies have shown that delayed neutrophil apoptosis is associated with chronic airway diseases. Leptin is an adipocyte-derived hormone that acts as a regulator of energy homeostasis and food intake. Emerging evidence suggests that leptin can regulate immune responses including the release of proinflammatory cytokines and protection of inflammatory cells from apoptosis. Serum leptin is increased during allergic reactions in the airways. However, the expression and function of leptin receptor in neutrophils isolated from children is not known. Methods: Flow cytometry was used to detect leptin receptor expression in neutrophils isolated from allergic asthmatic (n = 14), allergic non asthmatic (n = 21), non allergic asthmatic (n = 7) and healthy children (n = 23); confocal laser scanning microscopy combined with immunofluorescence was performed to detect intracellular pool of leptin receptor; Annexin-V/PI staining and caspase 3 activity was used to determine neutrophil survival. Pharmacological inhibitors were utilized to understand the role of MAPK and NF-kB pathway in leptin-induced neutrophil survival. Results and Conclusion: A heterogeneous leptin receptor expression was observed on neutrophils isolated from children. Neutrophils isolated from healthy children expressed more leptin receptor than those from allergic asthmatic (P<0.05) but not allergic non-asthmatic (P>0.05) or non-allergic asthmatic children (n = 7, P>0.05). Neutrophils isolated from children express an intracellular pool of leptin receptor that was mobilized to the cell surface upon GM-CSF stimulation. Finally, leptin exhibited anti-apoptotic properties on neutrophils via NF-kappa B and MEK1/2 MAPK pathway. Collectively, our data suggest that leptin may enhance airway inflammation by promoting neutrophil survival.	[Sun, Zhizhi; Dragon, Stephane; Becker, Allan; Gounni, Abdelilah S.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Becker, Allan; Gounni, Abdelilah S.] Univ Manitoba, GREAT ICE, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Gounni, AS (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Kim, Do-Gyoon/0000-0001-7673-1254; Gounni, Abdelilah/0000-0003-1265-6560; DRAGON, Stephane/0000-0002-4999-5307; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR) [ROP:88714]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR grant number ROP:88714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Beuther DA, 2006, AM J RESP CRIT CARE, V174, P112, DOI 10.1164/rccm.200602-231PP; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; BRACH MA, 1992, BLOOD, V80, P2920; Bruno A, 2005, EUR RESPIR J, V26, P398, DOI 10.1183/09031936.05.00092404; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Bruno A, 2009, J ALLERGY CLIN IMMUN, V124, P230, DOI 10.1016/j.jaci.2009.04.032; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Caldefie-Chezet F, 2003, FREE RADICAL RES, V37, P809, DOI 10.1080/1071576031000097526; Caldefie-Chezet F, 2001, J LEUKOCYTE BIOL, V69, P414; COLOTTA F, 1992, BLOOD, V80, P2012; Conus S, 2005, J ALLERGY CLIN IMMUN, V116, P1228, DOI 10.1016/j.jaci.2005.09.003; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Girard D, 1997, BIOCHEM J, V325, P147, DOI 10.1042/bj3250147; Gorska E, 2010, EUR J MED RES, V15, P50; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; KLEBANOFF SJ, 1992, BLOOD, V80, P225; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Lam QLK, 2007, J BIOL CHEM, V282, P27587, DOI 10.1074/jbc.M704579200; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lo CKC, 2009, CELL MOL IMMUNOL, V6, P353, DOI 10.1038/cmi.2009.46; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; Mattioli B, 2005, J IMMUNOL, V174, P6820, DOI 10.4049/jimmunol.174.11.6820; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Moore SI, 2003, INFECT IMMUN, V71, P4182, DOI 10.1128/IAI.71.7.4182-4185.2003; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; O'Donnell CP, 2000, RESP PHYSIOL, V119, P163, DOI 10.1016/S0034-5687(99)00111-5; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Procaccini C, 2009, CURR SIGNAL TRANSD T, V4, P22, DOI 10.2174/157436209787048711; Raso GM, 2006, NEUROSCI LETT, V396, P121, DOI 10.1016/j.neulet.2005.11.022; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Saffar AS, 2008, J ALLERGY CLIN IMMUN, V121, P492, DOI 10.1016/j.jaci.2007.10.003; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Suzukawa M, 2011, J IMMUNOL, V186, P5254, DOI 10.4049/jimmunol.1004054; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; THOMAS EL, 1988, REV INFECT DIS, V10, pS450; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866	58	171	183	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55249	10.1371/journal.pone.0055249	http://dx.doi.org/10.1371/journal.pone.0055249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383125	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600080
J	Li, FZ; Li, LB; Zhong, Y; Xie, QD; Huang, JH; Kang, XJ; Wang, D; Xu, L; Huang, TH				Li, FangZheng; Li, LianBing; Zhong, Ying; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua			Relationship between LTR Methylation and gag Expression of HIV-1 in Human Spermatozoa and SpermDerived Embryos	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GERM-CELL DEVELOPMENT; PATERNAL GENOME; ACTIVE DEMETHYLATION; DNA METHYLATION; HUMAN-SPERM; VERTICAL TRANSMISSION; PARENTAL ALLELES; MOUSE EMBRYO; GENE	Objective: Studying the methylation status of long terminal repeats (LTR) and its relationship to gag expression of HIV-1 in order to explore regulation mechanism of HIV-1 gene expression in vertical transmission from sperm to embryo. Methods/Principal Findings: Sperm samples were collected from a healthy donor and seven patients with HIV/AIDS. Zona-free hamster ova were fertilized by donor's spermatozoa transfected with pIRES2-EGFP-LTR-gag and patient's spermatozoa to obtain zygotes and 2-cell embryos, respectively. Interspecific in vitro fertilization, bisulfite sequencing PCR (BSP), RT-PCR, nested RT-PCR, nested real-time qRT-PCR and 2(-Delta Delta Ct) method, indirect immunofluoresence (IF) assay were performed. For donor's samples, the methylation rates of HIV-1 LTR were 0.56%, 1.67%, 0.56%, 0.56% in plasmid, spermatozoa, zygotes and 2-cell embryos, respectively while spermatozoa were transfected with unmethylated plasmid, and were 95.0%, 84.44%, 3.3%, 1.67% while transfected with methylated plasmid. The positive bands for HIV-1 gag cDNA were detected in spermatozoa and 2-cell embryos. The positive signals for HIV-1 p24 Gag protein were detected in 2-cell embryos but not in spermatozoa. For patient's samples, methylation rates of HIV-1 LTR were different in spermatozoa among patients. After fertilization, CpG sites in HIV-1 LTR were highly demethylated in zygotes and 2-cell embryos. The gag transcription levels increased with decreasing of methylation rates of HIV-1 LTR, which showed a strong negative correlations between gag transcription levels and methylation rates of HIV-LTR ether in the spermatozoa (r = -0.9877, P < 0.0001) or in the sperm-derived 2-cell embryos (r = 20.9092, P = 0.0045). Conclusion: LTR methylation regulates expression of HIV-1 gag in vertical transmission from sperm to embryo.	[Li, FangZheng; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Li, LianBing] Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Zhong, Ying] Chengdu Jinjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn	; Scott, Maxwell/J-1935-2015	li, feng/0000-0003-2227-9893; Scott, Maxwell/0000-0001-6536-4735	National Natural Science Foundation of China; Li Ka Shing Shantou University Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Shantou University Foundation	This work was financially supported by the National Natural Science Foundation of China and the Li Ka Shing Shantou University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; BACHILLER D, 1991, MOL REPROD DEV, V30, P194, DOI 10.1002/mrd.1080300305; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gao YS, 2009, CURR HIV RES, V7, P562, DOI 10.2174/157016209789346237; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KOHLER M, 1995, INFUSIONSTHERAPIE, V22, P46; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; McGowan JP, 2000, J ANTIMICROB CHEMOTH, V46, P657, DOI 10.1093/jac/46.5.657; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RAHE B, 1983, NUCLEIC ACIDS RES, V11, P7947, DOI 10.1093/nar/11.22.7947; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Wang DA, 2011, J MED VIROL, V83, P16, DOI 10.1002/jmv.21767; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	37	122	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54801	10.1371/journal.pone.0054801	http://dx.doi.org/10.1371/journal.pone.0054801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23409170	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500028
J	Sun, ZK; Fu, Q; Cao, LX; Jin, W; Cheng, LL; Li, ZL				Sun, Zikai; Fu, Qiang; Cao, Longxing; Jin, Wen; Cheng, LingLing; Li, Zhiliang			Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RENAL-FUNCTION; SODIUM-BICARBONATE; SYSTEMATIC REVIEWS; REPERFUSION INJURY; CREATININE; CYSTEINE; PLASMA; CARE; PHARMACOKINETICS	Background: Contrast-induced nephropathy (CIN) is one of the common causes of acute renal insufficiency after contrast procedures. Whether intravenous N-acetylcysteine (NAC) is beneficial for the prevention of contrast-induced nephropathy is uncertain. In this meta-analysis of randomized controlled trials, we aimed to assess the efficacy of intravenous NAC for preventing CIN after administration of intravenous contrast media. Study Design: Relevant studies published up to September 2012 that investigated the efficacy of intravenous N-acetylcysteine for preventing CIN were collected from MEDLINE, OVID, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials, and the conference proceedings from major cardiology and nephrology meetings. The primary outcome was CIN. Secondary outcomes included renal failure requiring dialysis, mortality, and length of hospitalization. Data were combined using random-effects models with the performance of standard tests to assess for heterogeneity and publication bias. Meta-regression analyses were also performed. Results: Ten trials involving 1916 patients met our inclusion criteria. Trials varied in patient demographic characteristics, inclusion criteria, dosing regimens, and trial quality. The summary risk ratio for contrast-induced nephropathy was 0.68 (95% CI, 0.46 to 1.02), a nonsignificant trend towards benefit in patients treated with intravenous NAC. There was evidence of significant heterogeneity in NAC effect across studies (Q = 17.42, P = 0.04; I-2 = 48%). Meta-regression revealed no significant relation between the relative risk of CIN and identified differences in participant or study characteristics. Conclusion: This meta-analysis showed that research on intravenous N-acetylcysteine and the incidence of CIN is too inconsistent at present to warrant a conclusion on efficacy. A large, well designed trial that incorporates the evaluation of clinically relevant outcomes in participants with different underlying risks of CIN is required to more adequately assess the role for intravenous NAC in CIN prevention.	[Sun, Zikai; Fu, Qiang; Cao, Longxing; Cheng, LingLing; Li, Zhiliang] Southern Med Univ, Zhujiang Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China; [Jin, Wen] Guangdong 2 Prov Peoples Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Li, ZL (corresponding author), Southern Med Univ, Zhujiang Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China.	lizhiliang010@163.com	Gounni, Abdelilah Soussi/AAH-3456-2020	Kim, Do-Gyoon/0000-0001-7673-1254; Gounni, Abdelilah/0000-0003-1265-6560; DRAGON, Stephane/0000-0002-4999-5307; Soussi Gounni, Abdelilah/0000-0002-7282-0388				Ariarajah N, 2011, Rev Med Suisse, V7, P490; Aslanger E, 2012, CORONARY ARTERY DIS, V23, P265, DOI 10.1097/MCA.0b013e328351aacc; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; Baranska-Kosakowska A, 2007, TRANSPL P, V39, P2853, DOI 10.1016/j.transproceed.2007.08.057; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; Brautigam M, 2006, RADIOLOGY, V240, P615, DOI 10.1148/radiol.2402051532; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Carbonell N, 2007, INT J CARDIOL, V115, P57, DOI 10.1016/j.ijcard.2006.04.023; Carbonell N, 2010, REV ESP CARDIOL, V63, P12, DOI 10.1016/S0300-8932(10)70004-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292, DOI 10.1152/ajprenal.1997.272.3.F292; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Haase M, 2008, NEPHROL DIAL TRANSPL, V23, P1581, DOI 10.1093/ndt/gfm818; Hashimoto S, 2001, BRIT J PHARMACOL, V132, P270, DOI 10.1038/sj.bjp.0703787; Heyman SN, 2003, KIDNEY INT, V63, P634, DOI 10.1046/j.1523-1755.2003.00783.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann U, 2004, J AM SOC NEPHROL, V15, P407, DOI 10.1097/01.ASN.0000106780.14856.55; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaffery Z, 2012, CATHETER CARDIO INTE, V79, P921, DOI 10.1002/ccd.23157; Kefer JM, 2003, ACTA CARDIOL, V58, P555, DOI 10.2143/AC.58.6.2005321; Kiefer P, 2000, CRIT CARE MED, V28, P3935, DOI 10.1097/00003246-200012000-00037; Koc F, 2012, INT J CARDIOL, V155, P418, DOI 10.1016/j.ijcard.2010.10.041; Kotlyar Eugene, 2005, Heart Lung Circ, V14, P245, DOI 10.1016/j.hlc.2005.06.007; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moist L, 2010, AM J KIDNEY DIS, V56, P643, DOI 10.1053/j.ajkd.2010.03.028; Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551; Murphy SW, 2000, J AM SOC NEPHROL, V11, P177, DOI 10.1681/ASN.V111177; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Parfrey P, 2005, CARDIOVASC INTER RAD, V28, pS3, DOI 10.1007/s00270-005-0196-8; Poletti PA, 2007, AM J ROENTGENOL, V189, P687, DOI 10.2214/AJR.07.2356; Quintavalle C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.38; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Ratcliffe JA, 2009, INT J ANGIOL, V18, P193, DOI 10.1055/s-0031-1278353; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schultz MJ, 2006, CURR MED CHEM, V13, P2565, DOI 10.2174/092986706778201684; Shalansky SJ, 2005, PHARMACOTHERAPY, V25, P1095, DOI 10.1592/phco.2005.25.8.1095; Shalansky SJ, 2005, HEART, V91, P997, DOI 10.1136/hrt.2004.053579; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Trivedi H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.035; Tsikas D, 1998, J CHROMATOGR B, V708, P55, DOI 10.1016/S0378-4347(97)00670-1; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Walser M, 1998, AM J KIDNEY DIS, V32, P23, DOI 10.1053/ajkd.1998.v32.pm9669420; Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041; Weinbroum AA, 2000, TRANSPLANTATION, V69, P853; Weisbord Steven D, 2005, J Intensive Care Med, V20, P63, DOI 10.1177/0885066604273503	57	171	183	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55124	10.1371/journal.pone.0055124	http://dx.doi.org/10.1371/journal.pone.0055124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383125	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800113
J	Yang, YL; Ji, C; Bi, ZG; Lu, CC; Wang, R; Gu, B; Cheng, L				Yang, Yan-li; Ji, Chao; Bi, Zhi-gang; Lu, Chun-cheng; Wang, Rong; Gu, Bing; Cheng, Lei			Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER CHEMOPREVENTIVE ACTIVITY; AMPK ACTIVATION; DOWN-REGULATION; AKT INHIBITOR; IN-VITRO; CERAMIDE; GROWTH; HSP90; CONTRIBUTES	Head and neck squamous cell carcinoma (HNSCC) represents more than 5% of all cancers diagnosed annually in United States and around the world. Despite advances in the management of patients with this disease, the survival has not been significantly improved, and the search for potential alternative therapies is encouraging. Here we demonstrate that deguelin administration causes a significant HNSCC cell death. Deguelin induces both cell apoptosis and autophagy by modulating multiple signaling pathways in cultured HNSCC cells. Deguelin inhibits Akt signaling, and down-regulates survivin and cyclin-dependent kinase 4 (Cdk4) expressions, by disrupting their association with heat shock protein-90 (Hsp-90). Deguelin induces ceramide production through de novo synthase pathway to promote HNSCC cell death. Importantly, increased ceramide level activates AMP-activated protein kinase (AMPK), which then directly phosphorylates Ulk1 and eventually leads to cell autophagy. We found that a low dose of deguelin sensitized HNSCC cells to 5-FU. Finally, using a nude mice Hep-2 xenograft model, we also showed a significant anti-tumor ability of deguelin in vivo. Together, we suggest that deguelin may represent a novel and effective chemo-agent against HNSCC.	[Yang, Yan-li; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Bi, Zhi-gang] Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Lu, Chun-cheng] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Rong] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Gu, Bing] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Bi, ZG (corresponding author), Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	eltonbibenqhospital@yahoo.com.cn; jspent@126.com	Cheng, Lei/AAT-2690-2021; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022	Cheng, Lei/0000-0001-6541-7702; Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation [810701297, 81101188, 30671894, 30972822, 30801016]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province [XK200719, XK200731, RC2007065, RC2011071]; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China [2010NJMUZ19]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China	This research was supported by grants from the National Natural Science Foundation (810701297, 81101188, 30671894, 30972822 and 30801016), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Health Promotion Project of Jiangsu Province (XK200719, XK200731, RC2007065 and RC2011071), and the Science & Technology Development Foundation of Nanjing Medical University (2010NJMUZ19), the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bozec A, 2009, EXPERT OPIN EMERG DR, V14, P299, DOI 10.1517/14728210902997947; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Bruzzese F, 2006, CLIN CANCER RES, V12, P617, DOI 10.1158/1078-0432.CCR-05-1671; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; GERHAUSER C, 1995, NAT MED, V1, P260, DOI 10.1038/nm0395-260; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jang K.Y., 2012, CANC LETT; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Ji C, 2012, BIOCH BIOPHYS RES CO; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Ji C, 2012, BIOCHEM BIOPH RES CO, V421, P462, DOI 10.1016/j.bbrc.2012.04.012; Ji C, 2010, INT J MOL MED, V26, P257, DOI 10.3892/ijmm_00000460; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Lee YK, 2010, CANCER LETT, V292, P228, DOI 10.1016/j.canlet.2009.12.005; Lippert BM, 2007, INT J CANCER, V121, P1169, DOI 10.1002/ijc.22941; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sano D, 2011, HEAD NECK-J SCI SPEC, V33, P349, DOI 10.1002/hed.21455; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simmonds MA, 2003, CA-CANCER J CLIN, V53, P4, DOI 10.3322/canjclin.53.1.4; Sommer K, 2001, INT J ONCOL, V18, P1145; STELL PM, 1989, EUR J SURG ONCOL, V15, P407; STELL PM, 1991, HEAD NECK-J SCI SPEC, V13, P277, DOI 10.1002/hed.2880130403; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tripathi A, 2003, J CANCER RES CLIN, V129, P642, DOI 10.1007/s00432-003-0485-z; Udeani GO, 1997, CANCER RES, V57, P3424; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Yao C, 2012, CELL BIOCH BIOPHYS; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093; Zhu QY, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.96	66	286	295	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54736	10.1371/journal.pone.0054736	http://dx.doi.org/10.1371/journal.pone.0054736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23383172	Green Published, Green Submitted, gold			2022-12-25	WOS:000314021500119
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200037
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400011
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
